Name,Term,ES,NES,NOM p-val,FDR q-val,FWER p-val,Tag %,Gene %,Lead_genes
prerank,CellMarker_Augmented_2021__PP cell:Pancreas,0.885043299705577,2.0966381985907785,0.0,0.19450041831197284,0.1,2/33,0.16%,CPA1;GCK
prerank,KEGG_2021_Human__Nicotine addiction,0.7419036652470314,1.9317782104012806,0.0,1.0,0.69,6/38,3.42%,GRIN3A;GABRE;SLC17A6;GABRA5;GABRR2;GABRG3
prerank,Reactome_2022__Amine Ligand-Binding Receptors R-HSA-375280,0.8018284657645609,1.916968586195979,0.0,1.0,0.74,7/31,4.25%,ADRA1A;ADRA1B;CHRM2;HTR1F;HTR2C;HRH3;DRD5
prerank,CellMarker_Augmented_2021__Osteogenic Precursor-Like cell:Dermis,0.6731730566712544,1.9003496559471091,0.0,1.0,0.78,36/99,16.89%,MLF1;MYO10;NOVA1;NEUROD2;NLGN1;KIAA1549;OSBPL6;LRRC4C;PDE10A;UNC5C;IL17RD;PCDH7;ZFHX4;PCLO;RASSF8;CADM1;ZNF462;EFNA5;SCD5;RPGRIP1L;CAP2;STOX2;FGF12;NPAS3;MPDZ;DDAH1;RNF150;NFIB;LRP1B;RPS6KA6;PRICKLE2;PPP1R9A;TMEFF2;MARK1;LRRIQ1;PBX1
prerank,CellMarker_Augmented_2021__Cardiomyocyte:Undefined,0.6589441461823706,1.900098769320073,0.0,1.0,0.8,44/93,23.52%,PCM1;ZNF518A;ANKRD26;BOD1L1;BDP1;MGA;ALMS1;GCC2;CEP290;MTR;AKAP9;PHF3;BPTF;MACF1;REV3L;SREK1;SMC5;CHD9;KIAA0586;ZNF638;CSPP1;ANKRD36;UBN2;SHPRH;ZMYM4;TTC21B;NEK1;SMG1;ASH1L;ZNF292;GOLGB1;ERCC6L2;NIPBL;RANBP2;CEP350;TRIP11;MYO9A;BRWD1;TPR;CEP192;NEMF;UBR5;HERC1;SENP6
prerank,GO_Biological_Process_2021__positive regulation of synaptic transmission (GO:0050806),0.6775198655648668,1.8835841869582814,0.0,0.9874636621992468,0.84,17/67,13.93%,ADRA1A;ARC;CRHR2;NLGN1;CACNG4;TSHZ3;SLC8A3;RGS14;NMU;GRIK2;SYT1;CACNG2;RIMS2;ZDHHC12;NLGN3;CLSTN2;MPP2
prerank,GO_Biological_Process_2021__positive regulation of heart rate (GO:0010460),0.8725382910197627,1.8823652694903843,0.0,0.8592216281473964,0.84,2/14,0.48%,ADRA1A;ADRA1B
prerank,GO_Biological_Process_2021__nucleoside phosphate biosynthetic process (GO:1901293),0.8792665452850157,1.8601615016711524,0.0,0.9481895392708676,0.9,2/13,3.83%,PNP;AK3
prerank,GO_Biological_Process_2021__modulation of chemical synaptic transmission (GO:0050804),0.6566362485281122,1.852450353916199,0.0,0.8993566351006609,0.93,29/101,13.60%,ARC;NGF;GRID2;CEL;NLGN1;GRM3;SNCAIP;LRRC4C;DLGAP4;CX3CR1;GRIK1;SLC8A3;GRM8;NRG3;NMU;GRIK2;SYT1;GRM4;GRM2;GRM7;AKAP9;NPAS4;NLGN4X;RIMS2;NLGN3;PXK;CDH2;CLSTN2;LRP8
prerank,GO_Biological_Process_2021__endoplasmic reticulum to cytosol transport (GO:1903513),0.815285692283058,1.8489283536556773,0.0,0.8348556416775449,0.93,1/15,0.97%,AUP1
prerank,CellMarker_Augmented_2021__Acinar cell:Pancreatic Islet,0.7128022109873872,1.8305534842621083,0.0,0.8854529532943658,0.94,13/53,7.31%,CPA1;SLC38A5;PRSS3;CEL;GALNT7;SDC4;PSAT1;SLC25A37;AKR1C3;CBS;AKR1C1;BCAT1;SGK1
prerank,GO_Biological_Process_2021__natural killer cell mediated immunity (GO:0002228),0.9051956712333995,1.8297898340997345,0.0,0.821639587612757,0.94,2/13,1.42%,CLEC2A;KLRD1
prerank,CellMarker_Augmented_2021__Cancer Stem cell:Serum,-0.7823742750689229,-1.8277224140384516,0.0,0.21192412115602363,0.19,7/58,4.59%,CD44;DENND1C;MACC1;MISP;CAPN8;SMIM22;TMC4
prerank,GO_Biological_Process_2021__regulation of neuron differentiation (GO:0045664),0.6408799408153758,1.8245432601470029,0.0,0.7941141339364572,0.94,13/60,10.01%,VWC2;NGF;NEUROD2;FGFR1;NLGN1;BRINP3;BIN1;DTX1;ZC4H2;HES1;ZEB1;BEND6;BRINP1
prerank,KEGG_2021_Human__Glycosaminoglycan biosynthesis,0.7024898284216536,1.8122004959831517,0.0,0.8239550687831376,0.94,23/49,12.56%,EXTL1;CSGALNACT1;HS6ST2;CHST6;CHSY3;HS3ST3B1;EXT1;NDST3;HS3ST1;CHSY1;CHST12;HS3ST5;ST3GAL3;B4GALT2;HS2ST1;UST;HS3ST2;B4GALT3;CHPF2;CHST11;B3GAT3;CHST3;EXT2
prerank,Reactome_2022__Deadenylation Of mRNA R-HSA-429947,-0.8306299523161937,-1.81044579339684,0.0,0.1571161587880865,0.27,1/24,0.07%,NLRP4
prerank,GO_Biological_Process_2021__adrenergic receptor signaling pathway (GO:0071875),0.8732047137951019,1.7898292307413297,0.0,0.9555456448352306,0.96,3/17,4.25%,ADRA1A;ADRA1B;DRD5
prerank,GO_Biological_Process_2021__leukotriene metabolic process (GO:0006691),0.7949773152630786,1.7896905151289928,0.0,0.8976942383629516,0.96,2/20,1.84%,CPA1;MAPKAPK2
prerank,GO_Biological_Process_2021__protein destabilization (GO:0031648),0.7436891787876967,1.7875419770433068,0.02702702702702703,0.8642507275219788,0.96,5/31,7.21%,IRGM;SIRT1;PYHIN1;SNCA;KDM8
prerank,CellMarker_Augmented_2021__Enteroendocrine cell:Small Intestine,0.7398307372360695,1.7871550119261812,0.02702702702702703,0.8220551867971844,0.96,3/35,3.26%,CPA1;TRPC3;METTL1
prerank,GO_Biological_Process_2021__regulation of cAMP-mediated signaling (GO:0043949),-0.8721114981324082,-1.7826137229603536,0.0,0.2192318494717486,0.49,2/22,3.68%,GPR62;SCTR
prerank,GO_Biological_Process_2021__natural killer cell mediated cytotoxicity (GO:0042267),0.8736362028972904,1.782152007698123,0.0,0.8142244232169227,0.96,1/14,0.06%,CLEC2A
prerank,GO_Biological_Process_2021__glutamine family amino acid metabolic process (GO:0009064),0.7449263287014202,1.779329767259983,0.030303030303030304,0.7907190082913665,0.97,10/30,13.11%,GLYATL1;SLC39A8;DDAH2;KYAT1;RIMKLB;GLUD1;ALDH18A1;AADAT;DDAH1;GLUD2
prerank,GO_Biological_Process_2021__regulation of trans-synaptic signaling (GO:0099177),0.7778281643886014,1.7677313262716996,0.0,0.8243112966555038,0.98,15/33,15.02%,ARC;NGF;GRID2;CEL;NLGN1;LRRC4C;CX3CR1;GRIK1;NRG3;GRIK2;NLGN4X;NLGN3;PXK;LRP8;BCR
prerank,GO_Biological_Process_2021__hyaluronan metabolic process (GO:0030212),-0.9021969027726788,-1.7603805023884798,0.0,0.2356742381821297,0.59,3/20,1.85%,CD44;TGFB1;LYVE1
prerank,GO_Biological_Process_2021__plasma membrane bounded cell projection morphogenesis (GO:0120039),0.6830827588768302,1.7539538205131375,0.0,0.892253667221358,0.98,7/48,9.21%,NGF;NYAP2;CNTNAP2;SRGAP2;SGK1;PLXNB1;TNIK
prerank,GO_Biological_Process_2021__positive chemotaxis (GO:0050918),0.8430687084680077,1.7536033989279503,0.0,0.8554115387299139,0.98,4/16,4.26%,FGF10;SCRIB;ANGPT1;SEMA5A
prerank,"GO_Biological_Process_2021__regulation of synaptic transmission, glutamatergic (GO:0051966)",0.6493255108498285,1.752425658100522,0.0,0.8253799802726027,0.98,18/42,19.46%,NLGN1;GRM3;CACNG4;TSHZ3;GRIK1;GRM8;SYT1;GRM4;CACNG2;GRM2;GRM7;NLGN3;CDH2;NRXN1;GRIK3;GRM5;CDK5;DGKZ
prerank,GO_Biological_Process_2021__regulation of postsynaptic membrane potential (GO:0060078),0.7236558436583644,1.7517600014872432,0.0,0.7959555580151504,0.98,12/34,15.52%,GABRE;GRID2;GABRA5;GABRG3;ARRB2;DRD4;GRIN1;GABRG1;NPAS4;NLGN3;MPP2;INSYN2A
prerank,CellMarker_Augmented_2021__Lake Et al.Science.Ex3:Brain,0.6632156093493909,1.7508314615224039,0.0,0.7762753381741164,0.98,48/101,19.93%,CDH20;ZNF385D;VWC2;SPHKAP;GRID2;NOVA1;GRM3;TRPC3;LRRC4C;TMEM132C;UNC5D;CADM2;RORB;NEGR1;MAGI2;SLC35F1;PCDH9;ADCY2;SORCS1;CELF4;DOK6;FGF12;NLGN4X;NPAS3;RAB3C;XKR4;RNF150;OLFM3;SNAP91;RBFOX1;FRRS1L;ASXL3;DPP6;SRRM4;NCAM1;NRXN1;JAKMIP2;GABRB2;GRIK3;SLITRK2;PPFIA2;LSAMP;FAT3;SLC24A2;ADGRB3;CTNNA2;ATP8A2;PAK3
prerank,GO_Biological_Process_2021__positive regulation of heart contraction (GO:0045823),0.8791785885305864,1.748632866243341,0.0,0.7724603507888608,0.99,1/15,0.05%,ADRA1A
prerank,GO_Biological_Process_2021__cytosolic calcium ion transport (GO:0060401),0.721451047097494,1.7484575895269396,0.0,0.7470098483520274,0.99,5/28,10.27%,ADRA1A;SLC8A1;JPH1;MICU1;MCU
prerank,GO_Biological_Process_2021__adenylate cyclase-activating adrenergic receptor signaling pathway (GO:0071880),0.8878243874296583,1.7467032899028552,0.0,0.7295055477271342,0.99,3/14,4.25%,ADRA1A;ADRA1B;DRD5
prerank,GO_Biological_Process_2021__negative regulation of response to DNA damage stimulus (GO:2001021),-0.8418056452210922,-1.745809587450842,0.0,0.2601551280398083,0.65,1/29,0.01%,CD44
prerank,Reactome_2022__Hyaluronan Metabolism R-HSA-2142845,-0.9249729886527247,-1.7429435820034624,0.0,0.24115503441892341,0.66,2/15,1.85%,CD44;LYVE1
prerank,GO_Biological_Process_2021__nucleotide metabolic process (GO:0009117),0.7786096819754639,1.7378557559557102,0.024390243902439025,0.7655336977150725,0.99,3/22,6.60%,PNP;FHIT;REXO2
prerank,GO_Biological_Process_2021__calcium ion transport into cytosol (GO:0060402),0.8061068193087652,1.7326759850793056,0.0,0.7717274662055696,0.99,4/20,5.60%,ADRA1A;TRPM2;SLC8A1;JPH1
prerank,PanglaoDB_Augmented_2021__Immature Neurons,0.5992019281271708,1.732531119729963,0.0,0.7490136301340877,0.99,53/128,19.93%,SLC17A6;ROBO2;NOVA1;BCL2;GRM3;EPHA7;POU3F2;LRRTM3;LRRC4C;ELAVL3;CADM2;PCLO;PAK5;PROX1;SLC35F1;HIVEP2;EPHA3;ERC2;ADGRA1;FEZF2;CELF5;CELF4;NXPH1;ELAVL4;NPAS3;RAB3C;OLFM3;ASCL1;SNAP91;FUT9;RBFOX1;NF1;SOX5;SCRT1;ANK2;SRRM4;NRXN1;NOTCH1;GRIK3;STIM2;SYN1;PAX6;PPFIA2;EFR3B;LSAMP;FAT3;MMD2;ST8SIA3;ADGRB3;CREB1;CTNNA2;UNC79;PAK3
prerank,GO_Biological_Process_2021__positive regulation of signaling receptor activity (GO:2000273),0.7120669262848177,1.7301040345315928,0.0,0.7399176752567358,0.99,6/26,13.17%,ARC;NCOA3;GREM1;TGFA;NLGN3;HDAC1
prerank,Reactome_2022__Hyaluronan Uptake And Degradation R-HSA-2160916,-0.9347726174429469,-1.7289239486348253,0.0,0.2682980253059018,0.8,2/11,1.85%,CD44;LYVE1
prerank,Reactome_2022__Degradation Of Cysteine And Homocysteine R-HSA-1614558,-0.9248778525095048,-1.7240699018560526,0.015384615384615385,0.2603378212477014,0.83,2/12,1.05%,SQOR;VSIG2
prerank,Reactome_2022__GRB2 Events In ERBB2 Signaling R-HSA-1963640,0.8097447839652643,1.7234679338992571,0.0,0.7586396406557493,0.99,4/13,7.38%,NRG2;ERBB2;NRG1;NRG3
prerank,Reactome_2022__Regulation Of Innate Immune Responses To Cytosolic DNA R-HSA-3134975,-0.9228397196832646,-1.7209215298051193,0.0,0.25171064198608173,0.87,1/12,0.07%,NLRP4
prerank,CellMarker_Augmented_2021__Pancreatic Ductal Stem cell:Pancreas,0.7245777487901813,1.7184187138490077,0.03125,0.7711620980984594,1.0,2/42,2.14%,CPA1;GOLT1A
prerank,GO_Biological_Process_2021__regulation of dendritic spine development (GO:0060998),0.8050482117021138,1.7175141066995732,0.0,0.7543125197355357,1.0,3/21,2.68%,GRIN3A;APOE;NLGN1
prerank,PanglaoDB_Augmented_2021__Acinar Cells,0.7264546347154425,1.7124343935435733,0.0,0.7695099709931067,1.0,4/46,2.06%,CPA1;PPP1R14D;PRSS3;CEL
prerank,CellMarker_Augmented_2021__Oxyntic Progenitor cell:Stomach,-0.7007624940342254,-1.7120212883608819,0.0,0.22532162306818604,0.89,16/85,9.82%,NEK2;BUB1;TICRR;ERCC6L;POLQ;KIF14;FOXM1;DTL;CEP55;CENPU;CDC25A;DEPDC1;TTK;SHCBP1;BRCA1;NUF2
prerank,CellMarker_Augmented_2021__Oxyntic Stem cell:Stomach,-0.7007624940342254,-1.7120212883608819,0.0,0.22532162306818604,0.89,16/85,9.82%,NEK2;BUB1;TICRR;ERCC6L;POLQ;KIF14;FOXM1;DTL;CEP55;CENPU;CDC25A;DEPDC1;TTK;SHCBP1;BRCA1;NUF2
prerank,CellMarker_Augmented_2021__Progenitor cell:Stomach,-0.7007624940342254,-1.7120212883608819,0.0,0.22532162306818604,0.89,16/85,9.82%,NEK2;BUB1;TICRR;ERCC6L;POLQ;KIF14;FOXM1;DTL;CEP55;CENPU;CDC25A;DEPDC1;TTK;SHCBP1;BRCA1;NUF2
prerank,PanglaoDB_Augmented_2021__His Bundle Cells,0.6171655548182033,1.710365139030538,0.0,0.7587091216339508,1.0,33/93,16.24%,PDLIM3;LAMA4;GPR161;AMOTL1;ADGRL2;PARVA;ALDH7A1;PDE10A;IL17RD;RASSF8;SLIT2;EDNRA;ZNF462;TENM3;PPFIBP1;GUCY1A2;DENND2A;CHST3;FLRT2;RBMS3;MPDZ;FARP1;RNF150;TYRO3;NAV1;MAGI1;WWTR1;ANK2;CDH11;ANTXR1;CSRP2;CALD1;DIXDC1
prerank,GO_Biological_Process_2021__regulation of heterotypic cell-cell adhesion (GO:0034114),-0.9085785780458149,-1.7095834324513735,0.0,0.21810758357702167,0.89,1/15,0.01%,CD44
prerank,GO_Biological_Process_2021__regulation of gluconeogenesis (GO:0006111),0.7723287858335661,1.7091920338475868,0.0,0.7480785319691262,1.0,5/24,5.48%,GCK;ZNF692;SIRT1;CRY1;SIRT7
prerank,GO_Biological_Process_2021__calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules (GO:0016339),0.7094614981729939,1.7060514516031908,0.0,0.7506968068310182,1.0,8/31,6.01%,CDH20;CDH19;CDH12;CDH7;NLGN1;CDH5;CDH13;CDH6
prerank,CellMarker_Augmented_2021__Oligodendrocyte Progenitor cell:Embryonic Prefrontal Cortex,0.5979972269299214,1.7048595167073761,0.0,0.740415288470906,1.0,33/109,10.83%,ARC;PCDH15;BCHE;FIBIN;LHFPL3;GRID2;SEZ6L;NOVA1;NEUROD2;ALCAM;RAB31;BRINP3;LRRC4C;PSAT1;SEMA5A;MMP2;CADM2;BCL11A;SLC35F1;C2ORF80;PTPRZ1;ETV1;OCIAD2;LUZP2;TRIB2;SYT1;SCD5;KANK1;RND3;PDE4B;NXPH1;CSPG5;ELAVL4
prerank,GO_Biological_Process_2021__fatty acid catabolic process (GO:0009062),0.6442665089957762,1.7028000797631606,0.0,0.732048277712645,1.0,26/66,20.34%,ACADS;GLYATL2;CEL;ACAD10;PEX13;SLC27A2;ABHD3;ECHS1;ABCD3;AIG1;NUDT19;ABCD2;ACADM;MECR;BDH2;ECI1;PLA2G15;ECHDC1;PCCA;LPIN2;SLC27A4;ACOX1;DECR1;HADHB;ECHDC2;ACADVL
prerank,GO_Biological_Process_2021__long-term memory (GO:0007616),0.8112982321197927,1.7020943699411393,0.0,0.7188512776968442,1.0,6/17,10.59%,ARC;APOE;SGK1;RGS14;LDLR;NPAS4
prerank,GO_Biological_Process_2021__adherens junction organization (GO:0034332),0.6777582028651361,1.6982032613764324,0.0,0.7276763901881502,1.0,11/44,7.01%,CDH20;CDH19;CDH12;CDH7;CDH5;CDH13;CSK;CADM2;CADM1;CDH6;ZNF703
prerank,CellMarker_Augmented_2021__Epithelial Progenitor cell:Lung,-0.717797465494595,-1.6925148204769274,0.0,0.2782156565915286,0.94,22/59,15.90%,PLEKHS1;ST6GALNAC1;CLCA4;MISP;TCN1;CAPN8;SMIM22;TMC4;LIPH;FUT2;MUC5B;CEACAM1;MS4A8;OLFM4;SPINT1;ITGB6;CYP4F12;GPX2;TMEM45B;PROM2;TJP3;PRRG4
prerank,GO_Biological_Process_2021__energy derivation by oxidation of organic compounds (GO:0015980),0.7365587659494938,1.6905922740534771,0.03225806451612903,0.7570554743527558,1.0,8/22,16.04%,MRAP2;PID1;MYC;LEPR;SDHAF4;COX10;ACSM1;NR4A3
prerank,GO_Biological_Process_2021__axon development (GO:0061564),0.591669557260352,1.6897622241162682,0.0,0.7454765196840162,1.0,24/74,20.10%,SLITRK6;LLGL1;PARD3;DSCAML1;SPTBN4;SEMA5A;DCC;DHFR;GRM7;MTR;NTNG2;ARHGAP35;RAB10;RYK;NREP;PARD6B;EPHB2;SLITRK2;S100B;CDK5;CTNNA2;NRCAM;PAK3;MARK2
prerank,GO_Biological_Process_2021__positive regulation of leukocyte cell-cell adhesion (GO:1903039),-0.8323178923394597,-1.683519066374209,0.0,0.31325795380074295,0.96,3/23,2.28%,CD44;SIRPG;ITGB2
prerank,CellMarker_Augmented_2021__Stem cell:Periodontal Ligament,-0.8700256229263081,-1.681681512509366,0.0,0.3082947883196464,0.97,1/16,0.01%,CD44
prerank,CellMarker_Augmented_2021__Cancer Stem cell:Liver,-0.9063473651675457,-1.6798631493375298,0.0,0.30133632643077596,0.97,1/16,0.01%,CD44
prerank,GO_Biological_Process_2021__hyaluronan catabolic process (GO:0030214),-0.9086892970634015,-1.6797783185662096,0.0,0.28459541940684396,0.97,3/16,1.85%,CD44;TGFB1;LYVE1
prerank,CellMarker_Augmented_2021__Cancer Stem cell:Brain,-0.8434395179669839,-1.678691758218834,0.0,0.2769244414379982,0.97,1/22,0.01%,CD44
prerank,GO_Biological_Process_2021__regulation of tumor necrosis factor superfamily cytokine production (GO:1903555),0.8832204473410532,1.676297647369243,0.08108108108108109,0.8126997838796509,1.0,2/8,4.29%,MAPKAPK2;CX3CR1
prerank,CellMarker_Augmented_2021__Lake Et al.Science.Ex6:Brain,0.728375374851785,1.676050419594536,0.0,0.7982621334887219,1.0,14/34,15.01%,ZNF385D;BCL11B;ITGA8;SEMA5A;ANKRD18A;RBM20;LUZP2;TSPAN18;GRM4;FEZF2;PDE9A;HS3ST4;SYT6;VAV2
prerank,GO_Biological_Process_2021__cartilage development (GO:0051216),-0.797379614761073,-1.675601126067732,0.0,0.27513597108704446,0.98,2/42,1.49%,CD44;TGFB1
prerank,CellMarker_Augmented_2021__Fibroblast:Undefined,-0.8893697684742107,-1.6751674157200467,0.0,0.26516614174201975,0.98,1/19,0.01%,CD44
prerank,Reactome_2022__Transport Of Nucleosides And Free Purine And Pyrimidine Bases Across Plasma Membrane R-HSA-83936,-0.9520273183742141,-1.674341953410933,0.0,0.2557704910503733,0.98,3/11,2.79%,SLC28A2;SLC28A1;SLC28A3
prerank,GO_Biological_Process_2021__regulation of lamellipodium morphogenesis (GO:2000392),-0.9581562803153854,-1.6739082386636883,0.0,0.2465563988261984,0.98,2/10,0.09%,CD44;ENPP2
prerank,CellMarker_Augmented_2021__Multipotent Progenitor cell:Heart,0.5898578108233623,1.673130450534777,0.03571428571428571,0.8057874472924589,1.0,29/85,16.74%,SLITRK6;ADGRL2;KCNB2;KIAA1549;HS6ST2;MID1;PCDH7;PCLO;JPH1;RAI14;CKMT1A;SLIT2;TENM3;AADAT;EFNA5;KITLG;RND3;TSPAN6;RBFOX2;LRIG3;TSPAN12;RFX6;PTPRF;DLG5;FRAS1;WWC1;CKMT1B;MARK1;LRRIQ1
prerank,GO_Biological_Process_2021__cytoskeleton organization (GO:0007010),0.5977740606399011,1.672989864943505,0.0,0.7908686239977604,1.0,31/103,17.72%,ARC;KLHL20;APOE;PACSIN2;FGD4;BIN1;SYNE3;PCLO;RHOBTB3;PAK5;RHOBTB1;FGD5;MAST1;MAST2;FGD1;SIPA1;TNIK;WASF3;RND3;SH3KBP1;CSPG5;LRCH3;PDZD8;CFAP410;DST;SIPA1L3;ZMYM4;MARK1;MICAL1;ARHGAP10;MAST4
prerank,GO_Biological_Process_2021__positive regulation of cell-cell adhesion (GO:0022409),-0.7828823979712038,-1.6714434164044563,0.0,0.2545525363310858,1.0,5/34,5.43%,CD44;SIRPG;NODAL;CXCL13;RNASE10
prerank,GO_Biological_Process_2021__connective tissue development (GO:0061448),-0.8068357369343406,-1.6708441254980646,0.0,0.24758583533676137,1.0,2/33,4.14%,CD44;RORC
prerank,CellMarker_Augmented_2021__Malignant Mesothelioma cell:Pleura,-0.7170623559572101,-1.670309137173531,0.0,0.23168205326890962,1.0,21/53,17.94%,PLEKHS1;MACC1;MISP;TMC4;DUOXA1;MUC5B;SERPINB5;BPIFB1;MYO5B;RP1;GPR87;ZNF750;LAMC2;ITGB6;TRIM29;DNAH3;MUC4;PROM2;ADH7;SCNN1A;CYP4B1
prerank,CellMarker_Augmented_2021__Malignant Mesothelioma cell:Lung,-0.7170623559572101,-1.670309137173531,0.0,0.23168205326890962,1.0,21/53,17.94%,PLEKHS1;MACC1;MISP;TMC4;DUOXA1;MUC5B;SERPINB5;BPIFB1;MYO5B;RP1;GPR87;ZNF750;LAMC2;ITGB6;TRIM29;DNAH3;MUC4;PROM2;ADH7;SCNN1A;CYP4B1
prerank,GO_Biological_Process_2021__positive regulation of heart rate by epinephrine-norepinephrine (GO:0001996),0.9541654890380492,1.6672679928087435,0.0,0.8149655536510717,1.0,2/6,0.48%,ADRA1A;ADRA1B
prerank,GO_Biological_Process_2021__positive regulation of endothelial cell chemotaxis (GO:2001028),0.8051947530776731,1.6671571760979251,0.0,0.7995808616700777,1.0,4/13,8.49%,FGFR1;HSPB1;SEMA5A;FGF18
prerank,CellMarker_Augmented_2021__Follicular Dendritic cell:Spleen,-0.7424156115770071,-1.6659863935981771,0.0,0.24324295679484484,1.0,31/53,20.41%,RASGRP4;GMFG;HCK;CYTIP;ARHGAP9;TAGAP;SCIMP;PARVG;WAS;LY86;CD37;NFAM1;TRAF3IP3;MYO1F;IGSF6;PTPRC;SPI1;CLEC12A;ITGAM;HVCN1;CD300LF;ADGRE3;PSTPIP1;IKZF1;HK3;NAPSB;LAT2;SASH3;P2RX1;ITGAX;CD86
prerank,CellMarker_Augmented_2021__Natural Killer cell:Undefined,0.6013446571474159,1.6633843543406852,0.0,0.8152644529535233,1.0,4/48,1.53%,IL7R;CD38;KLRD1;KIT
prerank,Reactome_2022__ERBB2 Regulates Cell Motility R-HSA-6785631,0.8031518822040975,1.6563253736569683,0.0,0.8458828733710158,1.0,4/13,7.38%,NRG2;ERBB2;NRG1;NRG3
prerank,KEGG_2021_Human__Protein digestion and absorption,0.6000883279979089,1.6544044589790878,0.0,0.8454647554036525,1.0,8/80,4.22%,CPA1;COL22A1;COL8A1;PRSS3;COL9A2;SLC3A2;SLC8A1;COL12A1
prerank,Reactome_2022__MAPK Targets/ Nuclear Events Mediated By MAP Kinases R-HSA-450282,0.7178265909347836,1.6536512263687058,0.02857142857142857,0.8365121012840481,1.0,11/29,21.90%,DUSP4;MAPKAPK2;KCNH8;MAPK8;RPS6KA3;PPP2R1B;RPS6KA2;PPP2R5D;CREB1;FOS;DUSP6
prerank,GO_Biological_Process_2021__positive regulation of telomere capping (GO:1904355),-0.8264759093695498,-1.6525138390904086,0.016129032258064516,0.2897892263132309,1.0,1/16,0.37%,NEK2
prerank,Reactome_2022__Sulfur Amino Acid Metabolism R-HSA-1614635,-0.8166596835911096,-1.6522846534867484,0.015384615384615385,0.28061676732383817,1.0,3/22,1.05%,SQOR;BHMT;VSIG2
prerank,GO_Biological_Process_2021__regulation of long-term synaptic depression (GO:1900452),0.9243206213583872,1.6498402096646927,0.0,0.842835146018549,1.0,2/9,1.38%,ARC;GRID2
prerank,GO_Biological_Process_2021__RNA modification (GO:0009451),0.6298736585845027,1.649775231483672,0.038461538461538464,0.8285614636844253,1.0,18/53,24.33%,TRDMT1;TFB1M;METTL1;PUS7L;CTU1;TRMT9B;PUS7;CDKAL1;TRMT61A;ANKRD16;NSUN4;DTWD1;THUMPD1;ADAR;THG1L;NSUN2;ADAT2;TRMT1
prerank,GO_Biological_Process_2021__fatty acid transport (GO:0015908),0.7970659082135768,1.647295533373534,0.04878048780487805,0.8332834088306946,1.0,5/17,4.33%,SLC5A8;APOE;MFSD2A;LCN12;PPARG
prerank,Reactome_2022__FGFR2 Alternative Splicing R-HSA-6803529,0.6931455393688322,1.6458402660537912,0.027777777777777776,0.8306165299963867,1.0,7/23,15.98%,HNRNPF;HNRNPH1;ESRP1;RBFOX2;TIAL1;GTF2F2;PTBP1
prerank,PanglaoDB_Augmented_2021__Neutrophils,-0.6725702090417333,-1.6458021223831478,0.014925373134328358,0.2982024619158731,1.0,32/70,17.79%,LILRB3;RASGRP4;ITGB2;HCK;MMP9;DOCK8;TAGAP;NR1I3;PTAFR;FCGR3A;CEACAM1;LY86;NFAM1;MYO1F;IGSF6;FPR1;SLC11A1;CEACAM8;SPI1;CLEC12A;ARG2;ITGAM;TLR2;NLRP3;CD300LF;ADGRE3;PSTPIP1;ELANE;HK3;CD24;TBXAS1;ALOX5AP
prerank,GO_Biological_Process_2021__inositol phosphate-mediated signaling (GO:0048016),-0.8670299952949155,-1.645311784774718,0.0,0.29116730007966607,1.0,2/16,0.81%,GPR62;NMUR2
prerank,CellMarker_Augmented_2021__Stem cell:Muscle,-0.8801024650890243,-1.6451814611896824,0.0,0.28278694118729586,1.0,1/15,0.01%,CD44
prerank,GO_Biological_Process_2021__negative regulation of BMP signaling pathway (GO:0030514),0.642765022452911,1.643964186206706,0.0,0.830980349610295,1.0,9/44,9.07%,VWC2L;BAMBI;VWC2;GREM2;PPARG;DLX1;GREM1;FSTL3;CRIM1
prerank,GO_Biological_Process_2021__cellular response to leptin stimulus (GO:0044320),0.8519511452745968,1.6434971604947815,0.021739130434782608,0.8190253346784564,1.0,3/9,8.97%,GCK;SIRT1;LEPR
prerank,GO_Biological_Process_2021__glutamate receptor signaling pathway (GO:0007215),0.7390514028942309,1.6434706913363362,0.0,0.8062624177889471,1.0,11/36,9.93%,GRIN3A;GRID2;GRM3;GRIK1;GRM8;PLCB1;GRIK2;GRM4;GRM2;GRM7;GRIN1
prerank,GO_Biological_Process_2021__regulation of type B pancreatic cell development (GO:2000074),0.9060404322151802,1.6420100881023003,0.0,0.803015549160609,1.0,1/8,0.86%,FOXO1
prerank,Reactome_2022__ERBB2 Activates PTK6 Signaling R-HSA-8847993,0.8333621389931057,1.6400044028146157,0.02631578947368421,0.8035514323397599,1.0,4/11,7.38%,NRG2;ERBB2;NRG1;NRG3
prerank,GO_Biological_Process_2021__neuron projection morphogenesis (GO:0048812),0.5563230491555909,1.6391232432497944,0.0,0.7977237436361683,1.0,32/131,19.93%,ARC;NGF;SLITRK6;NYAP2;LLGL1;ALCAM;NLGN1;PARD3;DSCAML1;SPTBN4;CNTNAP2;SRGAP2;DCC;SGK1;PLXNB1;TNIK;NTNG2;FARP1;MAP6;RAB10;RYK;PARD6B;EPHB2;DCDC2;SLITRK2;S100B;IMPACT;CPNE1;CDK5;CTNNA2;NRCAM;PAK3
prerank,"GO_Biological_Process_2021__regulation of synaptic transmission, GABAergic (GO:0032228)",0.853139231101257,1.633892315326424,0.023809523809523808,0.8242262273128494,1.0,2/13,2.68%,ADRA1A;NLGN1
prerank,CellMarker_Augmented_2021__Pigment Epithelial cell:Retina,0.5612880127772261,1.633398624544474,0.0,0.8162856922368996,1.0,20/94,15.02%,GPR161;LYPD1;GPRIN1;TBC1D16;B4GALT2;NAT14;TENM3;FGD1;P3H4;B4GALNT4;CHST3;GPSM1;RBFOX2;KIAA1549L;FRMD5;CDH24;FJX1;MPP2;SRRM3;FSCN1
prerank,Reactome_2022__Interleukin-7 Signaling R-HSA-1266695,0.7700081621820201,1.6329566741171853,0.0,0.8074911458124714,1.0,2/18,2.61%,IL7R;IRS1
prerank,CellMarker_Augmented_2021__Regulatory B cell:Peripheral Blood,-0.7514793353982356,-1.6323516106706852,0.0,0.3370152352663743,1.0,21/42,18.96%,HCK;ARHGAP9;TAGAP;ALOX5;PARVG;C19ORF38;WAS;LY86;CD37;NFAM1;MYO1F;SPI1;CLEC12A;HVCN1;CD300LF;ADGRE3;IKZF1;HK3;NAPSB;SASH3;P2RX1
prerank,GO_Biological_Process_2021__long-term synaptic potentiation (GO:0060291),0.7270071248196778,1.6321193943777732,0.0,0.8010852393772244,1.0,5/20,7.32%,ARC;CRHR2;TSHZ3;SLC8A3;RGS14
prerank,CellMarker_Augmented_2021__Cancer cell:Blood,-0.9098814953452192,-1.6313462635394105,0.0,0.33239724224668926,1.0,1/11,0.01%,CD44
prerank,CellMarker_Augmented_2021__Circulating Fetal cell:Blood,0.6928477442929073,1.6297264766008448,0.027777777777777776,0.8068711827914886,1.0,2/30,0.39%,IL7R;SELPLG
prerank,GO_Biological_Process_2021__icosanoid metabolic process (GO:0006690),0.639852831193707,1.6297232746426262,0.0,0.7956646385860513,1.0,3/50,1.84%,CPA1;PTGS1;MAPKAPK2
prerank,GO_Biological_Process_2021__positive regulation of cellular response to insulin stimulus (GO:1900078),0.8165812232423134,1.6296898025823983,0.0,0.7851750290338967,1.0,5/12,10.80%,IRS1;ZBTB7B;SIRT1;SNX5;GKAP1
prerank,Reactome_2022__Adrenoceptors R-HSA-390696,0.9625911629307051,1.6296181656386044,0.0,0.7747667390555925,1.0,2/6,0.48%,ADRA1A;ADRA1B
prerank,GO_Biological_Process_2021__regulation of fatty acid beta-oxidation (GO:0031998),0.7896633945701039,1.6283657915267162,0.0,0.7742114086859144,1.0,7/14,10.67%,IRS1;MFSD2A;PLIN5;TWIST1;AKT2;ABCD2;IRS2
prerank,CellMarker_Augmented_2021__Neutrophil:Undefined,-0.8376716608406461,-1.6275167356300366,0.0,0.34508717046478943,1.0,7/17,12.50%,CD44;ITGB2;FCGR3A;CEACAM1;CEACAM8;ITGAM;TLR2
prerank,GO_Biological_Process_2021__regulation of chromosome segregation (GO:0051983),-0.8388965980242475,-1.6272557360994513,0.0,0.33714303337682416,1.0,2/16,0.57%,BUB1;IHO1
prerank,GO_Biological_Process_2021__smooth muscle contraction (GO:0006939),0.8432155768435462,1.6228798316469402,0.0,0.8010346175216776,1.0,3/12,7.93%,ADRA1A;SLC8A1;EDNRA
prerank,"GO_Biological_Process_2021__positive regulation of synaptic transmission, glutamatergic (GO:0051968)",0.7629813365557442,1.6228766717932457,0.0,0.7906315705408766,1.0,6/15,15.58%,NLGN1;CACNG4;TSHZ3;CACNG2;NLGN3;NRXN1
prerank,GO_Biological_Process_2021__protein acylation (GO:0043543),0.6717642147645777,1.6210603246126214,0.02702702702702703,0.791236908813499,1.0,13/35,20.96%,FOXO1;ZDHHC16;ZDHHC18;ZDHHC12;KAT6A;ZDHHC14;ZDHHC3;ZDHHC13;EP300;ZDHHC9;KAT2B;ZDHHC5;ZDHHC23
prerank,GO_Biological_Process_2021__positive regulation of fatty acid beta-oxidation (GO:0032000),0.8671426833444823,1.6192990210636744,0.02040816326530612,0.7925844699470362,1.0,6/9,10.67%,IRS1;PLIN5;TWIST1;AKT2;ABCD2;IRS2
prerank,PanglaoDB_Augmented_2021__Clara Cells,-0.6759210887492054,-1.6188990627533069,0.0,0.3725018354620851,1.0,28/70,18.44%,PLEKHS1;DUOX1;ST6GALNAC1;SFTPA1;VSIG2;AHR;FOXM1;CAPN8;SMIM22;TMC4;DUOXA1;SFTPD;CYP2B7P;SYT2;MUC5B;BPIFB1;MS4A8;ITGB6;STEAP4;TRIM29;CYP4F12;MUC4;CYP2E1;PROM2;ADH7;SCNN1A;CYP4B1;CAPN13
prerank,GO_Biological_Process_2021__regulation of peptidyl-tyrosine phosphorylation (GO:0050730),-0.6693643955224715,-1.6186942707169611,0.0,0.3648242828388842,1.0,6/74,5.82%,CD44;ENPP2;TGFB1;ITGB2;TEC;VTN
prerank,Reactome_2022__Assembly And Cell Surface Presentation Of NMDA Receptors R-HSA-9609736,0.6956280442877152,1.6171063416210925,0.0,0.7968906561801118,1.0,3/25,2.58%,GRIN3A;LLGL1;GPRIN1
prerank,CellMarker_Augmented_2021__Pericyte:Undefined,-0.883293539045529,-1.6167544692119329,0.016129032258064516,0.3666652682414995,1.0,1/15,0.01%,CD44
prerank,GO_Biological_Process_2021__cellular response to interleukin-7 (GO:0098761),0.8209797137995379,1.6165519005557738,0.0,0.7829280440681758,1.0,2/13,2.61%,IL7R;IRS1
prerank,GO_Biological_Process_2021__interleukin-7-mediated signaling pathway (GO:0038111),0.8209797137995379,1.6165519005557738,0.0,0.7829280440681758,1.0,2/13,2.61%,IL7R;IRS1
prerank,CellMarker_Augmented_2021__Stem cell:Eye,-0.9751928147958695,-1.6158085748914879,0.0,0.3643169921302879,1.0,1/7,0.01%,CD44
prerank,KEGG_2021_Human__Morphine addiction,0.5725620704919653,1.6153270964760262,0.0,0.7803450517817706,1.0,28/82,20.72%,GABRE;GRK5;GABRA5;GABRR2;GABRG3;PDE10A;ARRB2;KCNJ3;KCNJ6;PDE1A;PDE7A;ADCY2;PDE4B;GABRG1;ADCY3;ARRB1;GNAO1;ADORA1;GABRB2;GABRP;GABRA2;GNG7;ADCY6;PDE3B;GABRR1;GNAI2;PDE7B;GNAS
prerank,KEGG_2021_Human__N-Glycan biosynthesis,0.6590849031473003,1.6150182596818152,0.03125,0.7739050527156794,1.0,12/48,16.52%,MGAT4C;DPM3;ST6GAL2;B4GALT2;MAN1A2;MAN2A1;B4GALT3;ALG12;MAN1A1;ALG3;MGAT2;MOGS
prerank,CellMarker_Augmented_2021__Mesenchymal Stem cell:Ligament,-0.8028972595698113,-1.6130731763864825,0.014285714285714285,0.3709542087887048,1.0,1/20,0.01%,CD44
prerank,GO_Biological_Process_2021__regulation of insulin receptor signaling pathway (GO:0046626),0.6626600524033607,1.6126880582309264,0.0,0.7797618580289952,1.0,13/38,18.32%,IRS1;ZBTB7B;PID1;SIRT1;SNX5;KANK1;VWA2;GKAP1;PTPRE;PIP4K2A;NCK1;SLC27A4;SIK2
prerank,GO_Biological_Process_2021__negative regulation of cysteine-type endopeptidase activity (GO:2000117),-0.7064402194123036,-1.6126302173583682,0.0,0.36436673276544873,1.0,1/41,0.01%,CD44
prerank,GO_Biological_Process_2021__cellular response to interferon-gamma (GO:0071346),-0.7057370206694772,-1.6125641386151104,0.016129032258064516,0.356583924860488,1.0,21/74,13.10%,CD44;TRIM62;HCK;IRF4;WNT5A;SP100;IRF1;TRIM5;PTAFR;CIITA;TRIM25;STAT1;OAS2;HLA-A;HLA-DPB1;GBP1;HLA-DRB1;AQP4;OAS1;TLR2;HLA-DPA1
prerank,CellMarker_Augmented_2021__Cancer Stem cell:Lung,-0.7797655528216036,-1.6120807048503334,0.014705882352941176,0.351095747079941,1.0,1/21,0.01%,CD44
prerank,GO_Biological_Process_2021__interferon-gamma-mediated signaling pathway (GO:0060333),-0.742457170816259,-1.6116509151894751,0.015625,0.34632277670174777,1.0,16/51,10.21%,CD44;TRIM62;HCK;IRF4;SP100;IRF1;TRIM5;PTAFR;CIITA;TRIM25;STAT1;OAS2;HLA-A;HLA-DPB1;GBP1;HLA-DRB1
prerank,GO_Biological_Process_2021__regulation of DNA recombination (GO:0000018),0.6710982085855796,1.6116059521550865,0.030303030303030304,0.7792194755092364,1.0,1/36,0.03%,IL7R
prerank,CellMarker_Augmented_2021__Mesenchymal Stem cell:Bone Marrow,-0.851151340841471,-1.6109754661762716,0.015384615384615385,0.3433077472578871,1.0,1/16,0.01%,CD44
prerank,CellMarker_Augmented_2021__Type II pneumocyte:Lung,-0.7220851563267434,-1.6068850171451288,0.0,0.3588399091700773,1.0,15/65,9.10%,CD44;PLEKHS1;DUOX1;SFTPA1;CAPN8;SCTR;PGC;TMC4;DUOXA1;SFTPD;SLC5A1;SLCO2A1;MUC5B;BPIFB1;MS4A8
prerank,GO_Biological_Process_2021__epiboly involved in wound healing (GO:0090505),-0.8193824494141332,-1.6065717751850894,0.0,0.3530080188432849,1.0,1/16,0.01%,CD44
prerank,GO_Biological_Process_2021__positive regulation of heterotypic cell-cell adhesion (GO:0034116),-0.9201579577251628,-1.6046406242291857,0.01639344262295082,0.3551555961442327,1.0,1/8,0.01%,CD44
prerank,GO_Biological_Process_2021__regulation of presynapse assembly (GO:1905606),0.7637756017133319,1.6042387740617419,0.02564102564102564,0.8075847788303068,1.0,9/18,18.08%,GPC4;IL1RAPL2;GPC6;SNCA;LRFN5;WNT3A;PTPRD;MDGA1;SLITRK2
prerank,GO_Biological_Process_2021__regulation of presynapse organization (GO:0099174),0.7637756017133319,1.6042387740617419,0.02564102564102564,0.8075847788303068,1.0,9/18,18.08%,GPC4;IL1RAPL2;GPC6;SNCA;LRFN5;WNT3A;PTPRD;MDGA1;SLITRK2
prerank,GO_Biological_Process_2021__leukocyte aggregation (GO:0070486),-0.9686396641198071,-1.6040706642677678,0.0,0.35148740310731974,1.0,1/5,0.01%,CD44
prerank,GO_Biological_Process_2021__nucleotide biosynthetic process (GO:0009165),0.7877760715863852,1.6035469874234758,0.03225806451612903,0.8030496960037117,1.0,1/16,0.17%,PNP
prerank,GO_Biological_Process_2021__zinc ion import across plasma membrane (GO:0071578),0.8674726559504077,1.603303981756411,0.05128205128205128,0.7952905993200666,1.0,1/7,3.19%,SLC39A8
prerank,GO_Biological_Process_2021__monocyte activation (GO:0042117),0.8173837305549443,1.6032725161160273,0.023255813953488372,0.7865511421846814,1.0,1/10,0.75%,MT1G
prerank,CellMarker_Augmented_2021__Neuron:Spinal Cord,0.6038831425577443,1.6030410747270636,0.05,0.779140053622627,1.0,36/97,22.73%,ADGRL2;NLGN1;LRRTM3;CADM2;PCLO;PTPRZ1;ZNF462;SYT1;GUCY1A2;WASF3;BRINP1;CAP2;STOX2;NPAS3;MPDZ;DDAH1;RBFOX2;MMP16;SNAP91;MAP6;LRP1B;MAGI1;ANK2;PRICKLE2;TMEFF2;MARK1;DLG2;PPFIA2;CNTN1;NRCAM;DCLK2;NBEA;PLPPR5;SHC3;RAPGEF4;PLPPR4
prerank,Reactome_2022__ERK/MAPK Targets R-HSA-198753,0.7212175167030602,1.6008818960560043,0.02631578947368421,0.7866890368449522,1.0,6/21,17.44%,DUSP4;KCNH8;RPS6KA3;PPP2R1B;RPS6KA2;PPP2R5D
prerank,GO_Biological_Process_2021__cholesterol transport (GO:0030301),0.6275126323796749,1.5998386681366144,0.027777777777777776,0.786119121147982,1.0,10/42,9.94%,TSKU;LIPC;CEL;APOB;APOE;SOAT1;AKR1C1;SOAT2;ABCA1;LDLR
prerank,GO_Biological_Process_2021__negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage (GO:1902230),-0.821401204192929,-1.5995979075476503,0.0,0.3659485487336111,1.0,1/23,0.01%,CD44
prerank,GO_Biological_Process_2021__regulation of triglyceride biosynthetic process (GO:0010866),0.7716211353194317,1.5991400663218105,0.05263157894736842,0.7811514775930245,1.0,6/14,16.95%,CTDNEP1;MFSD2A;PLIN5;LDLR;NR1H3;GPLD1
prerank,GO_Biological_Process_2021__heparan sulfate proteoglycan biosynthetic process (GO:0015012),0.7900586493008788,1.5966316193626455,0.05555555555555555,0.7923398451106329,1.0,10/18,12.56%,CSGALNACT1;HS6ST2;HS3ST3B1;EXT1;NDST3;HS3ST5;HS2ST1;B3GAT3;UGDH;EXT2
prerank,KEGG_2021_Human__Nicotinate and nicotinamide metabolism,0.7033712994140405,1.5966038865375123,0.03333333333333333,0.7844798790917478,1.0,6/33,5.48%,PNP;CD38;ASPDH;NT5C1A;SIRT1;SIRT7
prerank,"GO_Biological_Process_2021__chemical synaptic transmission, postsynaptic (GO:0099565)",0.6663262404442609,1.5949614990583585,0.0,0.7863984730965243,1.0,8/24,15.52%,GRID2;ARRB2;DRD4;GRIN1;NPAS4;NLGN3;MPP2;INSYN2A
prerank,GO_Biological_Process_2021__induction of positive chemotaxis (GO:0050930),0.9150915895408529,1.5941042094844236,0.0,0.784651260198728,1.0,2/8,4.19%,VEGFC;IL16
prerank,GO_Biological_Process_2021__regulation of protein kinase C signaling (GO:0090036),0.7880565849280948,1.5939081414042195,0.025,0.7774032104223161,1.0,2/12,0.67%,ADRA1A;DGKD
prerank,CellMarker_Augmented_2021__Monocyte:Undefined,-0.7077086531448867,-1.5935562298542425,0.0,0.3975128440421705,1.0,22/43,13.64%,LILRB3;CLEC5A;HCK;PTAFR;C3AR1;MS4A4A;FCGR3A;OSCAR;LY86;VSIG4;NFAM1;MYO1F;IGSF6;FPR1;NLRC4;SLC11A1;SPI1;CLEC12A;ITGAM;TLR2;CD300LF;ADGRE3
prerank,GO_Biological_Process_2021__mammary gland epithelium development (GO:0061180),0.8009218259541974,1.5931867204100527,0.05405405405405406,0.7748908516298019,1.0,5/12,9.44%,SCRIB;WNT4;ZNF703;LATS1;AKT2
prerank,KEGG_2021_Human__Primary immunodeficiency,0.6814251735749152,1.591687254388446,0.03333333333333333,0.7763881705318796,1.0,1/26,0.03%,IL7R
prerank,GO_Biological_Process_2021__interleukin-27-mediated signaling pathway (GO:0070106),-0.8064405407904524,-1.5913930049155103,0.015625,0.40368432529273207,1.0,5/15,12.20%,CRLF1;STAT1;OAS2;IL27;OAS1
prerank,CellMarker_Augmented_2021__Cancer Stem cell:Peripheral Blood,-0.6550726723411707,-1.5913293838806493,0.028169014084507043,0.3968760814376443,1.0,6/67,4.51%,CD44;AHR;TCN1;SLC28A3;SP100;TGFBI
prerank,CellMarker_Augmented_2021__Cancer Stem cell:Blood,-0.9347466541040763,-1.5909371090465811,0.0,0.3930513872672064,1.0,1/8,0.01%,CD44
prerank,GO_Biological_Process_2021__nuclear envelope organization (GO:0006998),0.7620118687728896,1.5906838879439753,0.05128205128205128,0.775677545769929,1.0,2/19,2.60%,CTDNEP1;TOR1B
prerank,Reactome_2022__Regulation Of KIT Signaling R-HSA-1433559,0.7564245166500883,1.5906173506026748,0.025,0.7689384141105731,1.0,3/15,9.81%,SH2B2;KIT;KITLG
prerank,GO_Biological_Process_2021__negative regulation of signal transduction by p53 class mediator (GO:1901797),-0.8805334584150204,-1.5904363696196584,0.0,0.39038653897162245,1.0,1/17,0.01%,CD44
prerank,CellMarker_Augmented_2021__Vascular Progenitor cell:Blood,-0.6691069836754102,-1.5901465030762656,0.0,0.3792587136059289,1.0,13/84,7.32%,NEK2;BUB1;TICRR;POLQ;KIF14;FOXM1;DTL;CEP55;MCM3;CENPU;CDC25A;DEPDC1;TTK
prerank,CellMarker_Augmented_2021__Vascular Stem cell:Blood,-0.6691069836754102,-1.5901465030762656,0.0,0.3792587136059289,1.0,13/84,7.32%,NEK2;BUB1;TICRR;POLQ;KIF14;FOXM1;DTL;CEP55;MCM3;CENPU;CDC25A;DEPDC1;TTK
prerank,CellMarker_Augmented_2021__Osteoblast:Bone,-0.7940900958184778,-1.5900366587717851,0.014492753623188406,0.3737903033493313,1.0,1/19,0.01%,CD44
prerank,GO_Biological_Process_2021__protein deacetylation (GO:0006476),0.6661783412458632,1.589492810625809,0.09090909090909091,0.7678848016726898,1.0,17/43,21.52%,HDAC3;HDAC10;PRDM5;SIRT1;SIRT7;MIER2;FLNA;HDAC1;HDAC4;HDAC11;BAZ2A;SIRT6;BRMS1L;HDAC5;TBL1X;RCOR2;HDAC7
prerank,GO_Biological_Process_2021__heparan sulfate proteoglycan metabolic process (GO:0030201),0.7719858249250638,1.588560883021116,0.0967741935483871,0.76501615910805,1.0,11/21,12.57%,HS6ST2;HS3ST3B1;EXT1;NDST3;HPSE;HS3ST5;HS2ST1;B3GAT3;UGDH;EXT2;HS3ST4
prerank,GO_Biological_Process_2021__regulation of lamellipodium organization (GO:1902743),-0.8969194991897919,-1.5884557706316669,0.0,0.37652770649710693,1.0,1/13,0.01%,CD44
prerank,Reactome_2022__Glutamate And Glutamine Metabolism R-HSA-8964539,0.8114247622340282,1.5872403658558878,0.024390243902439025,0.7662561411571611,1.0,5/11,13.11%,KYAT1;RIMKLB;GLUD1;ALDH18A1;GLUD2
prerank,GO_Biological_Process_2021__regulation of synapse assembly (GO:0051963),0.6750947719518018,1.585929251431536,0.047619047619047616,0.7667804952683545,1.0,18/45,16.57%,GPC4;GRID2;ROBO2;LHFPL4;NLGN1;IL1RAPL2;GPC6;SNCA;LRFN5;SYNDIG1;WNT3A;NLGN3;CLSTN2;NRXN1;PTPRD;DLG5;MDGA1;EPHB2
prerank,Reactome_2022__STING Mediated Induction Of Host Immune Responses R-HSA-1834941,-0.8589488171947678,-1.5849933924501753,0.0,0.3901383987911225,1.0,1/14,0.07%,NLRP4
prerank,GO_Biological_Process_2021__negative regulation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0043154),-0.6953314587763632,-1.5845529417471822,0.0,0.38672962229566654,1.0,2/46,2.53%,CD44;MMP9
prerank,Reactome_2022__Retrograde Neurotrophin Signaling R-HSA-177504,0.8158356823820829,1.5840333467949868,0.0,0.7699032084063907,1.0,1/13,0.65%,NGF
prerank,CellMarker_Augmented_2021__Stem cell:Salivary Gland,-0.6391794212840602,-1.5836377299974618,0.0,0.38662450120382325,1.0,7/93,4.46%,CD44;MICB;AHR;RBM43;ELK3;SP100;NEMP2
prerank,CellMarker_Augmented_2021__Progenitor cell:Breast,-0.9748104876396102,-1.5829974258829136,0.0,0.38427408281765985,1.0,1/6,0.01%,CD44
prerank,GO_Biological_Process_2021__positive regulation of alcohol biosynthetic process (GO:1902932),0.7978253487715881,1.581726352892771,0.02,0.7788177589191304,1.0,2/9,5.38%,WNT4;SNCA
prerank,CellMarker_Augmented_2021__Monocyte:Blood,0.9445935969089875,1.5814620357915252,0.0,0.7740927944321968,1.0,2/5,3.69%,SELPLG;CD14
prerank,GO_Biological_Process_2021__poly(A)+ mRNA export from nucleus (GO:0016973),0.6996538290813497,1.5812797424841225,0.058823529411764705,0.7685171061461399,1.0,3/15,8.70%,NXF5;IWS1;NXF1
prerank,CellMarker_Augmented_2021__Trophoblast Stem cell:Undefined,0.6113816273979127,1.5811141989853212,0.0,0.7626428927685251,1.0,6/48,8.91%,ADGRF4;PERP;ANXA3;DSP;ESRP1;WNT3A
prerank,GO_Biological_Process_2021__cellular response to fibroblast growth factor stimulus (GO:0044344),-0.6505193123043015,-1.5801826482130847,0.0136986301369863,0.3931779280172622,1.0,3/78,0.93%,CD44;TBX1;FGF20
prerank,"GO_Biological_Process_2021__heparan sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process (GO:0015014)",0.8653236219457259,1.5794605485525726,0.046511627906976744,0.768421018364778,1.0,5/7,12.56%,CSGALNACT1;EXT1;NDST3;HS2ST1;EXT2
prerank,GO_Biological_Process_2021__cellular response to nerve growth factor stimulus (GO:1990090),0.6782130509717835,1.5788526180998745,0.046511627906976744,0.7666829198076628,1.0,5/20,12.41%,NGF;MAGI2;RAPGEF1;RAB35;RAP1A
prerank,Reactome_2022__Azathioprine ADME R-HSA-9748787,-0.8322292805535461,-1.5786885935671007,0.01639344262295082,0.3977803756335657,1.0,3/17,4.02%,SLC28A2;SLC28A3;VAV3
prerank,"GO_Biological_Process_2021__negative regulation of DNA damage response, signal transduction by p53 class mediator (GO:0043518)",-0.9085160306832278,-1.5780002816914085,0.0,0.3956919949779305,1.0,1/13,0.01%,CD44
prerank,Reactome_2022__Notch-HLH Transcription Pathway R-HSA-350054,0.7061883502819808,1.577914305243437,0.06666666666666667,0.7662645790394103,1.0,13/27,21.52%,HDAC3;HDAC10;MAML1;MAMLD1;HDAC1;HDAC4;HDAC11;NOTCH1;RBPJ;KAT2B;HDAC5;TBL1X;HDAC7
prerank,CellMarker_Augmented_2021__Ectoderm cell:Germ,0.553360129108092,1.5776963319889632,0.0,0.7609940758544053,1.0,35/96,23.86%,RASSF2;SEZ6L;TSHZ3;TBKBP1;TMEM132C;DTX1;ITPKB;VASH1;KCNIP1;MYO9B;ADAMTS10;LRRN2;NTNG2;TNRC6C;NLGN3;GNAO1;CELF2;HDAC4;NCAM1;JPH4;NOTCH1;KIF21B;PLXNA4;GALNT8;S100B;TTYH1;PDZD4;HDAC5;MLC1;MVB12B;SDK2;CRTC1;RTN1;ABCA2;TNK2
prerank,Reactome_2022__Transcriptional Activation Of Mitochondrial Biogenesis R-HSA-2151201,0.6310350539230739,1.5775732500987756,0.0,0.7550521454027368,1.0,19/50,25.59%,HDAC3;TFB1M;SMARCD3;ACSS2;NCOA2;GLUD1;IDH2;GLUD2;CHD9;CARM1;PPARGC1B;GABPA;CREB1;TBL1X;CRTC1;NR1D1;NRF1;TFB2M;RXRA
prerank,CellMarker_Augmented_2021__Stromal cell:Bone Marrow,-0.8768337884185637,-1.5773534188314695,0.01639344262295082,0.39419369262504744,1.0,1/12,0.01%,CD44
prerank,Reactome_2022__Plasma Lipoprotein Assembly R-HSA-8963898,0.8308471489848812,1.5772471980922704,0.021739130434782608,0.7505930816564175,1.0,3/11,7.63%,APOB;APOE;ABCA1
prerank,GO_Biological_Process_2021__cell differentiation in hindbrain (GO:0021533),0.913597898959778,1.5763569150457946,0.0,0.7523176436502846,1.0,2/8,6.26%,GRID2;PROX1
prerank,Reactome_2022__SHC1 Events In ERBB4 Signaling R-HSA-1250347,0.79631701083739,1.5763474695534292,0.027777777777777776,0.7461001424630922,1.0,3/11,7.38%,NRG2;NRG1;NRG3
prerank,GO_Biological_Process_2021__regulation of skeletal muscle satellite cell proliferation (GO:0014842),0.9098572784682761,1.5753022573965505,0.0,0.7461163587705189,1.0,2/6,2.81%,CFLAR;ANGPT1
prerank,GO_Biological_Process_2021__retina homeostasis (GO:0001895),-0.7550142396888612,-1.5739541197197566,0.0,0.4099635585121698,1.0,3/21,1.75%,SLC28A2;JCHAIN;TULP1
prerank,GO_Biological_Process_2021__mitotic nuclear membrane disassembly (GO:0007077),0.8694901641107131,1.5728400950589374,0.0,0.7542821100391142,1.0,1/12,0.68%,CTDNEP1
prerank,CellMarker_Augmented_2021__T cell:Peripheral Blood,0.8145190545799746,1.5724859648329381,0.0,0.7497677415574436,1.0,1/11,0.03%,IL7R
prerank,CellMarker_Augmented_2021__Stem cell:Pancreas,0.5235344747414156,1.5721780483802958,0.0,0.7450862178412498,1.0,27/85,20.05%,LGR5;MGAT4C;GRID2;IGDCC3;PCDH11X;CHST6;CNTNAP2;MAGI2;TRIM71;ADCY2;HIF3A;DENND2A;ZNF519;TERF1;SLC35E3;TYRO3;COL9A1;MIPOL1;SHPRH;WNK3;TMEM45A;TBC1D8B;ASTN2;ZNF445;FAT3;NANOGP1;POU2F1
prerank,Reactome_2022__Synthesis Of PC R-HSA-1483191,0.698828051917929,1.5688169592115386,0.05405405405405406,0.7595965665089683,1.0,9/24,16.93%,BCHE;SLC44A5;MFSD2A;ABHD3;CHPT1;CEPT1;CHKA;ACHE;LPIN2
prerank,CellMarker_Augmented_2021__Specialist Antigen Presenting cell:Undefined,0.6787658450342186,1.5679608526573459,0.02564102564102564,0.7585634121809771,1.0,3/29,1.53%,IL7R;CD38;KIT
prerank,KEGG_2021_Human__Pyrimidine metabolism,0.5899703092770121,1.5667194816883148,0.02702702702702703,0.762455666255408,1.0,8/51,12.76%,PNP;NME1-NME2;NT5C1A;DUT;UPP2;UCK2;AK9;NT5C3A
prerank,GO_Biological_Process_2021__SRP-dependent cotranslational protein targeting to membrane (GO:0006614),-0.6523256528084392,-1.565212246469673,0.0,0.45709325986104943,1.0,57/85,27.80%,RPL37A;RPL38;RPL15;RPS4X;RPL3;RPL35A;RPS9;RPS27;RPS21;SRP14;RPL13A;RPL27A;RPS16;RPL36;RPS20;RPL7A;RPL9;RPL13;RPS8;RPS27A;RPL21;RPL34;RPL4;RPL32;RPL5;RPL23;RPL41;RPS7;RPS11;SRP19;RPL27;RPL35;RPS14;RPL11;RPS15;RPLP1;RPS12;RPL24;RPL18A;RPS13;RPL29;RPLP2;RPL28;RPL12;RPL18;RPS3;RPL22;RPSA;RPS28;RPS19;RPS24;RPS3A;RPL19;RPL8;RPS6;RPL10;SRP68
prerank,"GO_Biological_Process_2021__retrograde protein transport, ER to cytosol (GO:0030970)",0.7081269417675109,1.5651823661896023,0.037037037037037035,0.7645478577892217,1.0,2/17,9.36%,AUP1;RHBDD1
prerank,GO_Biological_Process_2021__cytoplasmic translation (GO:0002181),-0.6551558753896849,-1.565124766444914,0.0,0.45145521594923044,1.0,58/87,27.27%,RPL37A;RPL38;RPL15;RPS4X;RPL3;RPL35A;RPS9;RPS27;RPS21;RPL13A;RPL27A;RPS16;RPL36;RPS20;RPL7A;RPL9;RPL13;RPS8;RPS27A;RPL21;EIF4A2;RPL34;RPL4;RPL32;RPL5;RPL23;RPL41;RPS7;RPS11;RPL27;RPL35;TMA7;RPS14;RPL11;DRG1;RPS15;RPLP1;RPS12;RPL24;RPL18A;RPS13;RPL29;ZC3H15;RPL28;RPL12;RPL18;RPS3;RPL22;RPSA;RPS28;RPS19;RPS24;RPL26L1;RPS3A;RPL19;RPL8;RPS6;RPL10
prerank,GO_Biological_Process_2021__filopodium assembly (GO:0046847),0.8028709382873794,1.564435430903941,0.05714285714285714,0.7643060816626104,1.0,6/13,11.85%,FGD4;VSTM5;SRGAP2;FGD5;FGD1;PPP1R9B
prerank,PanglaoDB_Augmented_2021__Pyramidal Cells,0.5758059145331229,1.5627792942789098,0.0,0.7693216780677916,1.0,39/127,19.40%,CDH20;SLC17A6;POU3F1;SPHKAP;SEZ6L;GRM3;KCNB2;LRRTM3;KCNC2;ELAVL3;NGB;CADM2;PAK5;KCND2;ADGRA1;NR4A2;FEZF2;CELF4;BRINP1;GABRG1;NXPH1;ELAVL4;RAB3C;OLFM3;SNAP91;RBFOX1;SCRT1;VSTM2B;SRRM4;NRXN1;KCND3;RIT2;SYN1;SATB2;MMD2;ST8SIA3;ADGRB3;GRM5;CTNNA2
prerank,CellMarker_Augmented_2021__Activated B cell:Undefined,-0.6878242316022738,-1.5626135620182084,0.014705882352941176,0.4645913303188974,1.0,23/49,18.85%,ITGB2;HCK;DOCK8;CYTIP;ARHGAP9;TAGAP;TMC8;ALOX5;PARVG;WAS;LY86;CD37;TRAF3IP3;MYO1F;PTPRC;SPI1;ITGAM;HVCN1;IKZF1;NAPSB;ALOX5AP;LAT2;SASH3
prerank,CellMarker_Augmented_2021__Urothelium cell:Undefined,-0.691106868387874,-1.5625677604250994,0.028985507246376812,0.45841182218371934,1.0,21/38,16.71%,DENND1C;TMEM150B;HCK;ASGR2;OSCAR;ICAM3;C19ORF38;KCNQ1;NFAM1;FRAT1;UPK3A;CFD;FPR1;SPI1;CLEC12A;HSH2D;CD300LF;ADGRE3;TSPAN16;HK3;NAPSB
prerank,GO_Biological_Process_2021__monocyte differentiation (GO:0030224),0.8264279252366485,1.5622011409600152,0.0,0.7681406380537529,1.0,3/11,4.79%,MT1G;PPARG;IFI16
prerank,GO_Biological_Process_2021__megakaryocyte development (GO:0035855),0.9754025967051632,1.5617387566171037,0.0,0.7655149488796849,1.0,1/5,1.53%,KIT
prerank,GO_Biological_Process_2021__positive regulation of fatty acid oxidation (GO:0046321),0.7877946181857369,1.5613707364565115,0.0196078431372549,0.7624818350473379,1.0,7/12,16.04%,IRS1;PLIN5;TWIST1;AKT2;ABCD2;IRS2;NR4A3
prerank,CellMarker_Augmented_2021__Mesenchymal Stromal cell:Undefined,-0.7335501522453535,-1.5613610034032195,0.0,0.459120210982613,1.0,2/39,2.28%,CD44;ITGB2
prerank,GO_Biological_Process_2021__cotranslational protein targeting to membrane (GO:0006613),-0.6460646484428182,-1.5606592184065073,0.0,0.456925328372697,1.0,57/88,27.27%,RPL37A;RPL38;RPL15;RPS4X;RPL3;SEC62;RPL35A;RPS9;RPS27;RPS21;SRP14;RPL13A;RPL27A;RPS16;RPL36;RPS20;RPL7A;RPL9;RPL13;RPS8;RPS27A;RPL21;RPL34;RPL4;RPL32;RPL5;RPL23;RPL41;RPS7;RPS11;SRP19;RPL27;RPL35;RPS14;RPL11;RPS15;RPLP1;RPS12;RPL24;RPL18A;RPS13;RPL29;RPLP2;RPL28;RPL12;RPL18;RPS3;RPL22;RPSA;RPS28;RPS19;RPS24;RPS3A;RPL19;RPL8;RPS6;RPL10
prerank,CellMarker_Augmented_2021__M2 macrophage:Peripheral Blood,0.9359091528927761,1.5606085078796268,0.0,0.7627076232609669,1.0,1/5,3.69%,CD14
prerank,GO_Biological_Process_2021__positive regulation of glycogen metabolic process (GO:0070875),0.8218577196398971,1.560531385896399,0.023255813953488372,0.7574295136187404,1.0,5/12,10.67%,GCK;IRS1;PPP1R3E;AKT2;IRS2
prerank,GO_Biological_Process_2021__retinal ganglion cell axon guidance (GO:0031290),0.8852154265530561,1.5590150501484061,0.023809523809523808,0.7602006804433705,1.0,4/6,9.08%,ROBO2;ALCAM;SLIT2;PTPRM
prerank,GO_Biological_Process_2021__regulation of telomere capping (GO:1904353),-0.7408470609340071,-1.5586106700956404,0.03076923076923077,0.46494235089268243,1.0,1/22,0.37%,NEK2
prerank,GO_Biological_Process_2021__positive regulation of glycogen biosynthetic process (GO:0045725),0.8242295368344791,1.5583616910109928,0.023255813953488372,0.7600044216092138,1.0,5/11,10.67%,GCK;IRS1;PPP1R3E;AKT2;IRS2
prerank,Reactome_2022__Interleukin-27 Signaling R-HSA-9020956,-0.8541305491736022,-1.5581735981246678,0.016666666666666666,0.46113639448715665,1.0,3/11,9.32%,CRLF1;STAT1;IL27
prerank,Reactome_2022__Diseases Associated With Glycosylation Precursor Biosynthesis R-HSA-5609975,0.7315563413567688,1.557942438739924,0.0,0.7569047822743735,1.0,4/13,11.98%,DPM3;GALE;NUS1;GALT
prerank,GO_Biological_Process_2021__central nervous system neuron differentiation (GO:0021953),0.6508890572886549,1.5571881877927336,0.03225806451612903,0.7558799223739472,1.0,7/28,8.53%,GRID2;ZC4H2;MDGA2;TOX;PROX1;NR4A2;LRP6
prerank,CellMarker_Augmented_2021__Adipose-derived Stromal cell:Adipose Tissue,-0.8272278047757831,-1.5568041257368297,0.015873015873015872,0.4629769648127011,1.0,1/15,0.01%,CD44
prerank,PanglaoDB_Augmented_2021__Alveolar Macrophages,-0.6846306919359372,-1.556743692314644,0.0,0.4575551391683286,1.0,24/62,13.42%,LILRB3;CLEC5A;ITGB2;HCK;KLHDC4;TNFRSF1B;PTAFR;TRIM25;C3AR1;MS4A4A;FCGR3A;LY86;VSIG4;NFAM1;MYO1F;IGSF6;FPR1;SLC11A1;SPI1;CLEC12A;ITGAM;TLR2;NLRP3;CD300LF
prerank,GO_Biological_Process_2021__positive regulation of synapse assembly (GO:0051965),0.6925758588344904,1.5562867280232036,0.0,0.7554001516437178,1.0,12/26,18.08%,GRID2;NLGN1;VSTM5;SYNDIG1;SEMA4A;NLGN3;CLSTN2;NRXN1;PTPRD;DLG5;EPHB2;SLITRK2
prerank,CellMarker_Augmented_2021__Stem cell:Dental Pulp,-0.8843536947409026,-1.5561179280752053,0.0,0.4559661593539989,1.0,1/11,0.01%,CD44
prerank,CellMarker_Augmented_2021__Adipose-derived Stem cell:Subcutaneous Adipose Tissue,-0.9552813673359405,-1.5558940206208598,0.0,0.45200973191898736,1.0,1/9,0.01%,CD44
prerank,GO_Biological_Process_2021__positive regulation of triglyceride biosynthetic process (GO:0010867),0.7847159848446988,1.5558710919784091,0.02631578947368421,0.7526091484303479,1.0,6/11,16.95%,CTDNEP1;MFSD2A;PLIN5;LDLR;NR1H3;GPLD1
prerank,GO_Biological_Process_2021__lipid phosphorylation (GO:0046834),0.8296693601677115,1.5556014388999018,0.02564102564102564,0.749124795650202,1.0,1/10,0.67%,DGKD
prerank,Reactome_2022__Depolymerisation Of Nuclear Lamina R-HSA-4419969,0.81211175765917,1.5552976429400873,0.0,0.7470395340080581,1.0,2/15,4.93%,CTDNEP1;LMNB1
prerank,GO_Biological_Process_2021__left/right pattern formation (GO:0060972),0.9685001823536165,1.5550877543720039,0.0,0.742919369679684,1.0,1/6,0.13%,PKD1L1
prerank,GO_Biological_Process_2021__regulation of glycogen biosynthetic process (GO:0005979),0.7314402805080239,1.5543955787125052,0.02702702702702703,0.740905176183121,1.0,5/23,10.67%,GCK;IRS1;PPP1R3E;AKT2;IRS2
prerank,GO_Biological_Process_2021__positive regulation of triglyceride metabolic process (GO:0090208),0.7626630663335374,1.5540274694909118,0.046511627906976744,0.7374934751902434,1.0,6/15,16.95%,CTDNEP1;MFSD2A;PLIN5;LDLR;NR1H3;GPLD1
prerank,CellMarker_Augmented_2021__Mesenchymal Progenitor cell:Cartilage,0.5624973274869057,1.5539266564672303,0.043478260869565216,0.7330158696362344,1.0,29/91,16.27%,EDIL3;ALCAM;ARSJ;ADGRL2;PARVA;DCBLD2;MID1;COL12A1;RASSF8;NTN4;RAI14;PPFIBP1;SNAI2;CRIM1;KITLG;RND3;CAP2;COL16A1;CHST3;MPDZ;DDAH1;RBFOX2;LRIG3;EFEMP1;DST;WWTR1;ANTXR1;CALD1;SGCB
prerank,CellMarker_Augmented_2021__Adventitial cell:Undefined,-0.95941927718479,-1.5538100168838676,0.01694915254237288,0.46073906356853833,1.0,1/6,0.01%,CD44
prerank,CellMarker_Augmented_2021__Mesenchymal Stem cell:Placenta,-0.9157583492742839,-1.5535156858818777,0.0,0.45690701326413635,1.0,1/9,0.01%,CD44
prerank,Reactome_2022__p75NTR Recruits Signaling Complexes R-HSA-209543,0.7832647567116294,1.553008502567835,0.0196078431372549,0.7327153084266732,1.0,2/11,3.92%,NGF;RIPK2
prerank,CellMarker_Augmented_2021__Lake Et al.Science.Ex4:Brain,0.7473100406894206,1.552843408797835,0.075,0.7285287463336664,1.0,6/11,10.35%,TSHZ2;PAPSS2;PLCXD3;HS3ST3B1;CXXC4;GABRG1
prerank,GO_Biological_Process_2021__synaptic membrane adhesion (GO:0099560),0.7501332783081975,1.5525099909607016,0.0,0.7257848008839536,1.0,7/14,18.08%,GPC4;LRRC4C;GPC6;LRFN5;PTPRF;PTPRD;SLITRK2
prerank,GO_Biological_Process_2021__positive regulation of insulin receptor signaling pathway (GO:0046628),0.820011112992713,1.5520583304102802,0.0,0.7241597052232713,1.0,5/11,10.80%,IRS1;ZBTB7B;SIRT1;SNX5;GKAP1
prerank,GO_Biological_Process_2021__positive regulation of T cell migration (GO:2000406),-0.8278314723891015,-1.5518143929933983,0.01639344262295082,0.4626221890225408,1.0,3/13,3.57%,WNT5A;DOCK8;CXCL13
prerank,CellMarker_Augmented_2021__Cancer Stem cell:Bladder,-0.9452039580019483,-1.5514440499283921,0.0,0.4588573593594737,1.0,1/6,0.01%,CD44
prerank,CellMarker_Augmented_2021__Mesenchymal Stem cell:Skeletal Muscle,-0.8883202265700009,-1.5513031092006655,0.0,0.45425511185563844,1.0,1/11,0.01%,CD44
prerank,Reactome_2022__GRB7 Events In ERBB2 Signaling R-HSA-1306955,0.8981565873351514,1.5506759086074005,0.024390243902439025,0.7276408308996429,1.0,3/5,5.50%,NRG2;ERBB2;NRG1
prerank,KEGG_2021_Human__Salivary secretion,0.5863622095559844,1.5495564996386666,0.0,0.7292308390857484,1.0,4/63,1.88%,ADRA1A;ADRA1B;CD38;ITPR2
prerank,GO_Biological_Process_2021__negative regulation of immune system process (GO:0002683),-0.8165523509978787,-1.5487144607164158,0.017543859649122806,0.46545246829134496,1.0,2/11,5.18%,AMBP;GPER1
prerank,Reactome_2022__Scavenging Of Heme From Plasma R-HSA-2168880,-0.889953107714855,-1.5484945930658367,0.025,0.46129008626677276,1.0,3/10,1.12%,AMBP;APOL1;JCHAIN
prerank,GO_Biological_Process_2021__regulation of attachment of spindle microtubules to kinetochore (GO:0051988),-0.8839761605665015,-1.5483484628815662,0.015625,0.4573013986018103,1.0,1/9,0.37%,NEK2
prerank,Reactome_2022__Interferon Gamma Signaling R-HSA-877300,-0.6893013444029942,-1.5481714086124605,0.014705882352941176,0.4531594602817133,1.0,17/66,13.10%,CD44;TRIM62;IRF4;SP100;IRF1;TRIM5;PTAFR;CIITA;TRIM25;STAT1;OAS2;HLA-A;GBP1;HLA-DRB1;OAS1;TRIM29;HLA-DPA1
prerank,KEGG_2021_Human__AMPK signaling pathway,0.56145686612132,1.5476504968186535,0.03333333333333333,0.7373641168660847,1.0,26/107,14.95%,ADRA1A;FOXO1;FBP2;IRS1;PPARG;CREB3L2;SIRT1;CREB3L4;PFKP;G6PC3;ACACB;GYS1;SCD5;CPT1C;LEPR;AKT2;ADIPOR1;IRS2;PPP2R1B;ADIPOR2;CPT1A;IRS4;RAB10;EEF2K;INSR;PIK3CA
prerank,CellMarker_Augmented_2021__Fibroblast:Heart,0.5331812639937589,1.5476298759173115,0.0,0.7328292388174479,1.0,20/81,14.00%,TEAD2;VEGFC;CD151;PAPSS2;ARSJ;LOXL1;TWIST2;PARVA;PERP;EXT1;CUEDC1;NTN4;CRIM1;P3H4;RND3;MPZL1;COL13A1;QSOX1;LTBP2;WLS
prerank,Reactome_2022__Thyroxine Biosynthesis R-HSA-209968,-0.9807223543996446,-1.5474106369552678,0.0,0.45196710996168454,1.0,2/7,0.88%,DUOX1;IYD
prerank,"GO_Biological_Process_2021__wound healing, spreading of cells (GO:0044319)",-0.7639295283486681,-1.5471801725772054,0.01694915254237288,0.4481287589739721,1.0,1/22,0.01%,CD44
prerank,CellMarker_Augmented_2021__Lymphoid cell:Undefined,0.6353375924172082,1.5466961473158103,0.0,0.7336887410994016,1.0,4/34,1.53%,IL7R;CD38;KLRD1;KIT
prerank,GO_Biological_Process_2021__bone cell development (GO:0098751),0.9428743985113787,1.5466658042628378,0.023255813953488372,0.7290451414721902,1.0,1/8,1.53%,KIT
prerank,Reactome_2022__Interleukin-6 Family Signaling R-HSA-6783589,-0.7819097876772938,-1.5464629463767203,0.03076923076923077,0.4498917421606415,1.0,4/19,9.19%,CRLF1;CLCF1;STAT1;OSMR
prerank,CellMarker_Augmented_2021__Mesenchymal Stem cell:Periodontal Ligament,-0.9418744246431567,-1.5455888960472683,0.0,0.451694533367757,1.0,1/8,0.01%,CD44
prerank,CellMarker_Augmented_2021__Mesenchymal Stromal cell:Bone Marrow,-0.8406642485493735,-1.5447914391304787,0.0,0.4526985447251697,1.0,1/13,0.01%,CD44
prerank,GO_Biological_Process_2021__excitatory postsynaptic potential (GO:0060079),0.6709449329540527,1.5447276344898784,0.022222222222222223,0.7375395639715738,1.0,5/18,13.93%,GRID2;ARRB2;GRIN1;NPAS4;MPP2
prerank,CellMarker_Augmented_2021__Adipose-derived Stem cell:Adipose Tissue,-0.787126332930147,-1.5430357317826333,0.05172413793103448,0.45970884724282124,1.0,1/25,0.01%,CD44
prerank,Reactome_2022__Defective B3GALTL Causes PpS R-HSA-5083635,0.6342717005248129,1.542687333407198,0.02857142857142857,0.7448056883917614,1.0,7/33,8.68%,ADAMTS1;ADAMTS16;SEMA5A;SPON1;ADAMTS12;ADAMTS6;ADAMTS10
prerank,GO_Biological_Process_2021__glycosaminoglycan biosynthetic process (GO:0006024),0.5437760669270694,1.5425460098789543,0.037037037037037035,0.7412017852156213,1.0,32/85,12.56%,VCAN;GPC4;CSGALNACT1;ANGPT1;SDC4;HS6ST2;CHST6;CHSY3;HS3ST3B1;EXT1;HS3ST1;GPC6;PRELP;CHSY1;CHST12;HS3ST5;ST3GAL3;B4GALT2;HS2ST1;UST;HS3ST2;B4GALT3;GPC5;CHPF2;CHST11;CSPG5;B3GAT3;CHST3;UGDH;SDC3;DSEL;EXT2
prerank,GO_Biological_Process_2021__hepaticobiliary system development (GO:0061008),0.6992657814559365,1.5414808243952356,0.0,0.743737829376219,1.0,8/17,17.89%,WNT4;PKD2;PRKCSH;PROX1;COBL;NF1;ARID5B;NIPBL
prerank,PanglaoDB_Augmented_2021__Erythroid-like And Erythroid Precursor Cells,-0.6300941800568688,-1.5401961598235394,0.031746031746031744,0.471646750989391,1.0,17/84,11.60%,CD44;RASGRP4;GMFG;NR1I3;PKLR;SLFN14;LOX;GYPB;ICAM3;C19ORF38;CA1;CEACAM1;MYO1F;THBS1;FPR1;ALAS2;CLEC12A
prerank,CellMarker_Augmented_2021__Monocyte:Synovium,-0.6924808818636303,-1.5400542475958394,0.0136986301369863,0.463017666084333,1.0,22/44,13.64%,LILRB3;CLEC5A;C1QB;ITGB2;HCK;PTAFR;C3AR1;MS4A4A;FCGR3A;LY86;VSIG4;NFAM1;IGSF6;FPR1;SLC11A1;SPI1;CLEC12A;ITGAM;TLR2;FPR3;CD300LF;ADGRE3
prerank,CellMarker_Augmented_2021__Monocyte:Plasma,-0.6924808818636303,-1.5400542475958394,0.0136986301369863,0.463017666084333,1.0,22/44,13.64%,LILRB3;CLEC5A;C1QB;ITGB2;HCK;PTAFR;C3AR1;MS4A4A;FCGR3A;LY86;VSIG4;NFAM1;IGSF6;FPR1;SLC11A1;SPI1;CLEC12A;ITGAM;TLR2;FPR3;CD300LF;ADGRE3
prerank,GO_Biological_Process_2021__intestinal lipid absorption (GO:0098856),0.8412524700453703,1.5400432134376227,0.047619047619047616,0.7487210534076273,1.0,4/10,9.94%,CEL;AKR1C1;SOAT2;LDLR
prerank,GO_Biological_Process_2021__protein targeting to ER (GO:0045047),-0.6343963778083835,-1.5397909633006885,0.0,0.46016982265357126,1.0,63/97,27.80%,RPL37A;RPL38;RPL15;RPS4X;RPL3;SEC62;RPL35A;RPS9;RPS27;RPS21;SRP14;RPL13A;RPL27A;RPS16;RPL36;RPS20;RPL7A;RPL9;RPL13;RPS8;RPS27A;RPL21;RPL34;RPL4;RPL32;RPL5;RPL23;RPL41;RPS7;RPS11;SRP19;RPL27;RPL35;RPS14;RPL11;SGTB;RPS15;RPLP1;RPS12;RPL24;RPL18A;RPS13;RPL29;RPLP2;RPL28;RPL12;RPL18;RPS3;RPL22;RPSA;RPS28;SPCS2;RPS19;RPS24;CHMP4B;RPS3A;RPL19;SPCS1;RPL8;RPS6;RPL10;ZFAND2A;SRP68
prerank,GO_Biological_Process_2021__regulation of mitochondrial fusion (GO:0010635),0.8356161606557457,1.5396671463139204,0.1,0.7465276374516293,1.0,2/10,3.92%,PLD6;PID1
prerank,CellMarker_Augmented_2021__Endothelial Progenitor cell:Bone Marrow,0.8430848243010691,1.5391165933012,0.05,0.7452675702126362,1.0,2/7,2.83%,KIT;CDH5
prerank,KEGG_2021_Human__Malaria,-0.7204259655171523,-1.539064632174544,0.014705882352941176,0.46002866191441094,1.0,11/31,15.16%,TGFB1;ITGB2;KLRB1;SDC2;GYPB;SELP;THBS1;TLR2;IL12A;TGFB3;IL18
prerank,CellMarker_Augmented_2021__Cancer cell:Brain,-0.6546118857479082,-1.538118344214614,0.01282051282051282,0.46074162798366836,1.0,9/93,10.03%,CD44;DTL;CEP55;MCM3;ACTL6A;ZWILCH;DARS2;NUF2;C5ORF34
prerank,GO_Biological_Process_2021__protein C-linked glycosylation via 2'-alpha-mannosyl-L-tryptophan (GO:0018406),0.9200739193824792,1.5372297676986748,0.041666666666666664,0.7475409905090286,1.0,3/5,4.38%,DPY19L3;DPM3;DPY19L1
prerank,GO_Biological_Process_2021__protein C-linked glycosylation via tryptophan (GO:0018317),0.9200739193824792,1.5372297676986748,0.041666666666666664,0.7475409905090286,1.0,3/5,4.38%,DPY19L3;DPM3;DPY19L1
prerank,GO_Biological_Process_2021__T cell activation (GO:0042110),-0.6732012830062705,-1.537034534981183,0.0,0.46284621553538713,1.0,4/59,4.00%,CD44;MICB;IRF4;IFNK
prerank,GO_Biological_Process_2021__peptidyl-lysine deacetylation (GO:0034983),0.772345936716875,1.536791793964841,0.1282051282051282,0.7457630507987456,1.0,3/8,14.76%,HDAC10;SIRT1;HDAC4
prerank,CellMarker_Augmented_2021__Mesenchymal Stem cell:Dental Pulp,-0.9278737630465713,-1.5365222472183053,0.0,0.46101326060344844,1.0,1/9,0.01%,CD44
prerank,CellMarker_Augmented_2021__Endocrine cell:Pancreas,0.5319221617510398,1.5365219132241623,0.038461538461538464,0.74232408172321,1.0,38/99,25.60%,KIAA1549;MID1;PCLO;TENM3;SYT1;CASKIN1;CAP2;CSPG5;DDAH1;CLDN12;RBFOX2;TYRO3;RASAL2;SPIRE2;VWA5B2;SNAP91;MAGI1;MAGI3;SCRT1;SRRM3;PTPRF;ZNRF3;SRCIN1;CKMT1B;CDR2L;EPB41L4B;PRKAA2;HPCA;CBARP;SYT7;PTPN21;CDC42BPA;PLEKHH1;AGAP1;MAP2;NCS1;B4GALNT1;FAT1
prerank,GO_Biological_Process_2021__positive regulation of cilium assembly (GO:0045724),0.6942958724241458,1.5360340605273535,0.1,0.7407737651275454,1.0,7/19,14.59%,CEP135;CEP120;CROCC;CCDC88A;ARHGAP35;SEPTIN9;MARK4
prerank,GO_Biological_Process_2021__membrane depolarization during AV node cell action potential (GO:0086045),-0.9536085265269829,-1.5354364456312837,0.0,0.46211040471985243,1.0,1/5,1.19%,SCN5A
prerank,Reactome_2022__Highly Calcium Permeable Postsynaptic Nicotinic Acetylcholine Receptors R-HSA-629594,-0.8198642402630006,-1.5340224962100213,0.029850746268656716,0.46585060599588696,1.0,1/10,0.28%,CHRNA9
prerank,Reactome_2022__Signaling By NTRK1 (TRKA) R-HSA-187037,0.5487829779453268,1.5339909776825076,0.0,0.7486034993599818,1.0,30/108,19.39%,ARC;NGF;DUSP4;MAPKAPK2;IRS1;BCL11B;KCNH8;TPH1;RALB;CRK;RAPGEF1;SGK1;RALA;RPS6KA3;IRS2;PPP2R1B;RAP1A;ASCL1;CHD4;RPS6KA2;PIK3CA;MAPK12;CRKL;RIT2;BRAF;PPP2R5D;EP300;CREB1;SOS1;CDK5
prerank,GO_Biological_Process_2021__ionotropic glutamate receptor signaling pathway (GO:0035235),0.794548708820659,1.5339013698393933,0.06976744186046512,0.745121012191574,1.0,2/9,9.93%,GRIN3A;GRIN1
prerank,GO_Biological_Process_2021__actin cytoskeleton reorganization (GO:0031532),0.6154560651502832,1.5337392222615778,0.043478260869565216,0.7417652680577105,1.0,16/57,10.27%,FGF10;KIT;PARVA;CAPN10;AUTS2;FER;PHACTR1;PDLIM4;FLNA;EFS;RALA;RAP2A;CASS4;TNIK;FARP2;MCU
prerank,GO_Biological_Process_2021__uridine transport (GO:0015862),-0.966968121265136,-1.533416478642345,0.0,0.456201548582575,1.0,3/5,2.79%,SLC28A2;SLC28A1;SLC28A3
prerank,GO_Biological_Process_2021__pyrimidine nucleoside transport (GO:0015864),-0.966968121265136,-1.533416478642345,0.0,0.456201548582575,1.0,3/5,2.79%,SLC28A2;SLC28A1;SLC28A3
prerank,GO_Biological_Process_2021__nucleoside transport (GO:0015858),-0.966968121265136,-1.533416478642345,0.0,0.456201548582575,1.0,3/5,2.79%,SLC28A2;SLC28A1;SLC28A3
prerank,Reactome_2022__Nicotinate Metabolism R-HSA-196807,0.6569069664880403,1.5330487450386499,0.07407407407407407,0.7406837326875924,1.0,3/31,1.73%,SLC5A8;CD38;RNLS
prerank,GO_Biological_Process_2021__regulation of transcription by RNA polymerase I (GO:0006356),0.7957753796849785,1.5328195656909602,0.04878048780487805,0.7376481798662424,1.0,4/17,8.20%,ERBB2;SIRT7;EIF2AK3;FLNA
prerank,CellMarker_Augmented_2021__Neutrophil:Sputum,-0.6675265976297576,-1.5323593725323628,0.0,0.45340539344618475,1.0,20/50,17.22%,ST6GALNAC1;VSIG2;TCN1;CAPN8;SMIM22;TMC4;LIPH;SERPINB5;CEACAM1;OLFM4;SPINT1;CXCL16;TRIM29;CYP4F12;GPX2;IL18;TMEM45B;TJP3;PRRG4;SCNN1A
prerank,CellMarker_Augmented_2021__Neutrophil:Bronchoalveolar System,-0.6675265976297576,-1.5323593725323628,0.0,0.45340539344618475,1.0,20/50,17.22%,ST6GALNAC1;VSIG2;TCN1;CAPN8;SMIM22;TMC4;LIPH;SERPINB5;CEACAM1;OLFM4;SPINT1;CXCL16;TRIM29;CYP4F12;GPX2;IL18;TMEM45B;TJP3;PRRG4;SCNN1A
prerank,GO_Biological_Process_2021__regulation of membrane depolarization (GO:0003254),-0.8456775733781563,-1.5321785666692793,0.017543859649122806,0.4503630087673325,1.0,2/16,2.76%,SCN5A;CAV3
prerank,GO_Biological_Process_2021__regulation of defense response to virus by host (GO:0050691),-0.6990279959956873,-1.5317155987650368,0.0625,0.4495534971770096,1.0,5/28,11.29%,MICB;AIM2;STAT1;TRAF3IP2;USP17L2
prerank,GO_Biological_Process_2021__cell-matrix adhesion (GO:0007160),-0.6282958649579686,-1.531703418274115,0.014285714285714285,0.44577142725922214,1.0,9/86,10.40%,CD44;LYVE1;ECM2;ITGB2;VTN;PARVG;ACTN3;ITGBL1;CD63
prerank,GO_Biological_Process_2021__regulation of BMP signaling pathway (GO:0030510),0.5661758210943666,1.5315562811257528,0.0,0.7402577109530855,1.0,26/61,22.14%,VWC2L;BAMBI;VWC2;CDH5;CCN1;PPARG;DLX1;GREM1;UBE2O;FSTL3;CRIM1;ITGA3;TWSG1;SMAD2;BMPER;SMURF1;ELAPOR2;NOTCH1;SKI;RBPJ;ACVR2A;FSTL1;BMPR2;BMP4;SMAD5;SMAD7
prerank,Reactome_2022__Metabolism Of Amine-Derived Hormones R-HSA-209776,-0.8484611610779337,-1.531315872769194,0.014084507042253521,0.4439444951802909,1.0,3/13,0.88%,DBH;DUOX1;IYD
prerank,Reactome_2022__Cell Surface Interactions At Vascular Wall R-HSA-202733,-0.6428279465798095,-1.5312903117079422,0.0,0.4403374754347087,1.0,30/110,13.78%,CD44;CD99L2;SIRPG;JCHAIN;TGFB1;PSG4;ITGB2;PSG8;SLC16A8;ANGPT2;SLC7A7;GYPE;PSG3;PROCR;SDC2;GYPB;INPP5D;CEACAM1;PSG5;PSG2;PSG6;CEACAM8;ITGAM;SLC16A3;TNFRSF10A;PSG9;PIK3CB;TEK;ITGA5;PSG11
prerank,PanglaoDB_Augmented_2021__Myeloid-derived Suppressor Cells,-0.6977632704166643,-1.531253002047816,0.014925373134328358,0.43679159161701775,1.0,24/51,14.67%,LILRB3;ITGB2;HCK;CYTIP;TAGAP;TNFRSF1B;PTAFR;PARVG;FCGR3A;LY86;NFAM1;ADGRE1;MYO1F;IGSF6;PTPRC;FPR1;CEACAM8;SPI1;CLEC12A;ITGAM;CD300LF;ADGRE3;PSTPIP1;CD80
prerank,GO_Biological_Process_2021__positive regulation by symbiont of host autophagy (GO:0075044),0.8587441212456034,1.5310792850785688,0.022727272727272728,0.7393720812580733,1.0,1/7,0.82%,IRGM
prerank,Reactome_2022__ZBP1(DAI) Mediated Induction Of Type I IFNs R-HSA-1606322,-0.8295929015846046,-1.5307605962092385,0.01639344262295082,0.43656000501250997,1.0,1/17,0.07%,NLRP4
prerank,GO_Biological_Process_2021__purine ribonucleotide catabolic process (GO:0009154),0.6419208437362977,1.530433016085192,0.04878048780487805,0.7404296391141612,1.0,6/24,11.50%,PNP;NT5C1A;NUDT4B;PRTFDC1;PDE9A;NUDT18
prerank,Reactome_2022__IL-6-type Cytokine Receptor Ligand Interactions R-HSA-6788467,-0.8309370922518751,-1.5302552972526218,0.06060606060606061,0.43560150535317155,1.0,3/14,9.19%,CRLF1;CLCF1;OSMR
prerank,CellMarker_Augmented_2021__Mesenchymal Stromal cell:Adipose Tissue,-0.9535077956596143,-1.5300126798317635,0.01818181818181818,0.4333301707878226,1.0,1/6,0.01%,CD44
prerank,GO_Biological_Process_2021__regulation of receptor signaling pathway via STAT (GO:1904892),0.8823384388887701,1.5290462775461813,0.0,0.7449023326155143,1.0,1/11,0.03%,IL7R
prerank,KEGG_2021_Human__Calcium signaling pathway,0.5023517841149456,1.527241640449947,0.0,0.7529826023453683,1.0,29/199,11.15%,ADRA1A;TACR3;ADRA1B;CD38;MCOLN3;NGF;CHRM2;FGF10;ITPR2;VEGFC;FGFR1;HTR2C;SLC8A1;DRD5;FGF17;ERBB2;ITPKB;SLC8A3;PDGFD;PLCB1;PDE1A;EDNRA;ADCY2;FGF18;FGFR3;GRIN1;MCU;F2R;ADCY3
prerank,CellMarker_Augmented_2021__Dendritic cell:Synovium,-0.7025929064814026,-1.5271807436067497,0.015384615384615385,0.4445135395983186,1.0,23/55,13.64%,LILRB3;RASGRP4;HCK;DOCK8;CYTIP;ARHGAP9;TAGAP;SCIMP;ARHGAP15;PARVG;FCGR3A;NFAM1;TRAF3IP3;MYO1F;IGSF6;PTPRC;FPR1;SLC11A1;SPI1;CLEC12A;ITGAM;CD300LF;ADGRE3
prerank,GO_Biological_Process_2021__meiotic DNA double-strand break formation (GO:0042138),-0.9747615978392337,-1.5271067702627008,0.0,0.44119667050872763,1.0,1/5,0.57%,IHO1
prerank,GO_Biological_Process_2021__glycine transport (GO:0015816),0.8244620847351612,1.5250324116391556,0.05,0.7622961571071031,1.0,4/9,11.22%,SLC38A5;SLC6A17;SLC6A20;SLC7A8
prerank,GO_Biological_Process_2021__cellular response to chemokine (GO:1990869),-0.7606174842757059,-1.524983983358054,0.017857142857142856,0.44924849153847835,1.0,2/18,3.57%,DOCK8;CXCL13
prerank,Reactome_2022__RAF-independent MAPK1/3 Activation R-HSA-112409,0.6820329426541567,1.5245602187640848,0.025,0.7609027353743113,1.0,2/22,1.22%,DUSP4;DUSP2
prerank,GO_Biological_Process_2021__leptin-mediated signaling pathway (GO:0033210),0.7806204581690842,1.5240969022661708,0.0,0.7596880567275544,1.0,2/10,8.97%,SIRT1;LEPR
prerank,PanglaoDB_Augmented_2021__Kidney Progenitor Cells,0.5463344186967413,1.5231721556811633,0.0,0.7609259676268568,1.0,25/94,15.10%,EYA4;GPR161;ADGRL2;KIAA1549;MID1;IL17RD;GPC6;ZFHX4;KCNIP3;OSR1;RAI14;SLIT2;TENM3;AADAT;PRTG;CAP2;CHST3;MPDZ;DDAH1;RBFOX2;CDH2;FJX1;NR2F2;MAGI1;ANTXR1
prerank,PanglaoDB_Augmented_2021__Langerhans Cells,-0.6526847891780927,-1.5230941253253318,0.015384615384615385,0.4558268614216596,1.0,29/63,16.71%,AHR;ITGB2;HCK;CYTIP;TAGAP;ALOX5;CLDN1;PTAFR;HLA-DMA;CIITA;MS4A4A;PARVG;FCGR3A;LY86;NFAM1;HLA-DPB1;MYO1F;IGSF6;HLA-DRB1;PTPRC;SPI1;ITGAM;TLR2;HLA-DPA1;CD300LF;CD80;HLA-F;HK3;NAPSB
prerank,CellMarker_Augmented_2021__Mesothelial cell:Lung,0.5372814208750003,1.5229070912236957,0.0,0.750718809140782,1.0,33/95,21.33%,EDIL3;LYPD1;ADGRL2;NLGN1;GPC6;P3H3;ZFHX4;ETV1;SLIT2;TENM3;AADAT;WASF3;CAP2;MPDZ;DDAH1;RBFOX2;KIAA1549L;MMP16;CDH2;NECTIN3;ANK2;ANTXR1;PTPRD;CALD1;SGCB;DZIP1;SLC16A2;NAV2;AKAP12;DCLK2;TRPC4;KHDRBS3;FSTL1
prerank,CellMarker_Augmented_2021__Interstitial cell:Bladder,0.5372814208750003,1.5229070912236957,0.0,0.750718809140782,1.0,33/95,21.33%,EDIL3;LYPD1;ADGRL2;NLGN1;GPC6;P3H3;ZFHX4;ETV1;SLIT2;TENM3;AADAT;WASF3;CAP2;MPDZ;DDAH1;RBFOX2;KIAA1549L;MMP16;CDH2;NECTIN3;ANK2;ANTXR1;PTPRD;CALD1;SGCB;DZIP1;SLC16A2;NAV2;AKAP12;DCLK2;TRPC4;KHDRBS3;FSTL1
prerank,CellMarker_Augmented_2021__Primitive Endoderm cell:Germ,0.5372814208750003,1.5229070912236957,0.0,0.750718809140782,1.0,33/95,21.33%,EDIL3;LYPD1;ADGRL2;NLGN1;GPC6;P3H3;ZFHX4;ETV1;SLIT2;TENM3;AADAT;WASF3;CAP2;MPDZ;DDAH1;RBFOX2;KIAA1549L;MMP16;CDH2;NECTIN3;ANK2;ANTXR1;PTPRD;CALD1;SGCB;DZIP1;SLC16A2;NAV2;AKAP12;DCLK2;TRPC4;KHDRBS3;FSTL1
prerank,CellMarker_Augmented_2021__Urine-derived Stem cell:Urine,-0.8374175902875927,-1.521928440154428,0.0,0.4592269270151601,1.0,1/14,0.01%,CD44
prerank,CellMarker_Augmented_2021__Cancer Stem cell:Ovary,-0.8351850375077539,-1.5215000777541257,0.03508771929824561,0.4575673666664946,1.0,1/12,0.01%,CD44
prerank,Reactome_2022__Integrin Cell Surface Interactions R-HSA-216083,-0.6641132273929785,-1.5208492454043723,0.0273972602739726,0.4571897527525423,1.0,13/53,12.27%,CD44;ITGB2;COL18A1;VTN;ICAM3;COL4A4;ITGA9;COL4A3;THBS1;ITGA2B;ITGAM;ITGB6;COL23A1
prerank,GO_Biological_Process_2021__nucleobase-containing compound biosynthetic process (GO:0034654),0.6318046842074584,1.5207163340850194,0.09375,0.7627217713183092,1.0,3/19,6.48%,PNP;AMPD1;POLD3
prerank,CellMarker_Augmented_2021__Endothelial cell:Plasma,-0.6871672345934109,-1.5201610690660023,0.013888888888888888,0.45744113294169764,1.0,27/56,19.97%,RASGRP4;GMFG;HCK;ARHGAP9;TNFRSF1B;PARVG;GP1BA;WAS;CD37;NFAM1;SELP;TRAF3IP3;MYO1F;IGSF6;PTPRC;SPI1;CLEC12A;ITGAM;CD300LF;HK3;PIK3CG;CLEC1B;CARD8;SASH3;P2RX1;ITGAX;GAB3
prerank,GO_Biological_Process_2021__negative regulation of dendritic spine development (GO:0061000),0.9295913979131984,1.5199269989243624,0.03571428571428571,0.7645441758473887,1.0,2/7,2.68%,GRIN3A;NLGN1
prerank,GO_Biological_Process_2021__negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator (GO:1902166),-0.891869982572983,-1.5196857352628852,0.014925373134328358,0.4531349397605633,1.0,1/10,0.01%,CD44
prerank,GO_Biological_Process_2021__regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator (GO:1902165),-0.891869982572983,-1.5196857352628852,0.014925373134328358,0.4531349397605633,1.0,1/10,0.01%,CD44
prerank,Reactome_2022__O-glycosylation Of TSR Domain-Containing Proteins R-HSA-5173214,0.6263079380549414,1.5189790495860152,0.02857142857142857,0.7663473971708986,1.0,7/34,8.68%,ADAMTS1;ADAMTS16;SEMA5A;SPON1;ADAMTS12;ADAMTS6;ADAMTS10
prerank,GO_Biological_Process_2021__protein heterooligomerization (GO:0051291),0.7089311103792214,1.5186214422894535,0.02857142857142857,0.7647634248811077,1.0,5/15,12.78%,KCNC2;PKD2;GRIN1;MAT2A;CPSF7
prerank,CellMarker_Augmented_2021__Mesoderm cell:Germ,-0.8544216423925075,-1.5185710140667974,0.015384615384615385,0.4572312739361544,1.0,1/15,0.01%,CD44
prerank,CellMarker_Augmented_2021__T Helper cell:Undefined,0.664260231557384,1.518231962042137,0.05714285714285714,0.763118027455589,1.0,3/28,2.66%,IL7R;CD38;APOE
prerank,CellMarker_Augmented_2021__Macrophage:Synovium,-0.675857118011729,-1.517601400122122,0.0,0.4592879773770292,1.0,23/53,13.42%,LILRB3;CLEC5A;C1QB;ITGB2;HCK;SLC7A7;TNFRSF1B;C3AR1;MS4A4A;FCGR3A;LY86;VSIG4;NFAM1;MYO1F;IGSF6;FPR1;SLC11A1;SPI1;CLEC12A;ITGAM;TLR2;FPR3;CD300LF
prerank,CellMarker_Augmented_2021__Neutrophil:Lung,-0.6938179105526986,-1.5173682742462715,0.030303030303030304,0.4572238373062537,1.0,22/55,13.88%,RASGRP4;GMFG;ITGB2;HCK;ARHGAP9;TAGAP;NLRP12;PTAFR;PARVG;NFAM1;TRAF3IP3;MYO1F;IGSF6;PTPRC;FPR1;SLC11A1;CEACAM8;CLEC12A;ITGAM;CD300LF;ADGRE3;PSTPIP1
prerank,CellMarker_Augmented_2021__Monocyte:Spleen,-0.6826818314249957,-1.5164107148058417,0.02857142857142857,0.45919599483181317,1.0,21/49,13.42%,LILRB3;CLEC5A;ITGB2;HCK;ALOX5;PTAFR;C3AR1;MS4A4A;FCGR3A;LY86;VSIG4;NFAM1;MYO1F;IGSF6;FPR1;SLC11A1;SPI1;CLEC12A;ITGAM;TLR2;CD300LF
prerank,CellMarker_Augmented_2021__Osteocyte:Bone,-0.9491484246892916,-1.5157451463555502,0.0,0.4592584846654498,1.0,1/9,0.01%,CD44
prerank,GO_Biological_Process_2021__cellular response to nitric oxide (GO:0071732),0.8619964761689936,1.515131865021812,0.0,0.7739913553445518,1.0,3/7,10.21%,FOXO1;KCNC2;MTR
prerank,GO_Biological_Process_2021__cellular response to reactive nitrogen species (GO:1902170),0.8619964761689936,1.515131865021812,0.0,0.7739913553445518,1.0,3/7,10.21%,FOXO1;KCNC2;MTR
prerank,"Reactome_2022__Transport Of Vitamins, Nucleosides, And Related Molecules R-HSA-425397",-0.7049842065663872,-1.51501856073897,0.0,0.4599601552298997,1.0,5/36,6.94%,SLC28A2;SLC28A1;SLC28A3;SLCO2B1;SLCO2A1
prerank,CellMarker_Augmented_2021__Mesenchymal cell:Ovary,-0.8249491405558832,-1.5149293743703207,0.04918032786885246,0.457209610709922,1.0,2/13,2.54%,CD44;WNT5A
prerank,GO_Biological_Process_2021__neuron projection development (GO:0031175),0.4940235850228582,1.5143416841877526,0.0,0.7750860851232938,1.0,22/157,12.22%,ARC;GPRIN3;NGF;NYAP2;TSKU;IFT88;GPRIN1;APOE;NLGN1;CNTNAP2;WHRN;SRGAP2;SAMD14;HMGB1;SGK1;PLXNB1;PTPRM;TNIK;GRM7;RAB35;PPP1R9B;ADGRV1
prerank,GO_Biological_Process_2021__membrane lipid catabolic process (GO:0046466),-0.8906404134617104,-1.5133693946578026,0.0,0.46254240087588583,1.0,4/10,9.22%,ENPP2;CYP1B1;PDXDC1;PPT1
prerank,CellMarker_Augmented_2021__Stem cell:Adipose Tissue,-0.9027040041422985,-1.5133094218956529,0.0,0.4598127052372936,1.0,1/10,0.01%,CD44
prerank,CellMarker_Augmented_2021__Glutamatergic neuron:Dorsolateral Prefrontal Cortex,0.5670755280160173,1.5132204099563011,0.04,0.7779253387038129,1.0,27/98,19.02%,SPHKAP;GRM3;LRRTM3;KCNC2;ELAVL3;MAGI2;GRIK2;ADGRA1;SYT1;BEND6;CELF5;CELF4;SLC6A17;NAV3;GABRG1;FRMPD4;KIAA1549L;SNAP91;RBFOX1;SCRT1;ANK2;SRRM4;FGF14;EFR3B;NALCN;MMD2;GRM5
prerank,GO_Biological_Process_2021__adenylate cyclase-activating G protein-coupled receptor signaling pathway (GO:0007189),0.577945462757316,1.5131897121111373,0.043478260869565216,0.774052426175567,1.0,15/83,7.95%,ADRA1A;GPR3;LGR5;ADRA1B;ADGRG6;GPR161;ADGRL2;ADGRG3;DRD5;GPR26;GPR78;RXFP1;S1PR5;ABCA1;ADCY2
prerank,GO_Biological_Process_2021__regulation of AMPA receptor activity (GO:2000311),0.6715475682132448,1.5130415920760298,0.0,0.7711253958328216,1.0,5/24,8.83%,ARC;NLGN1;CACNG4;CNIH3;CACNG2
prerank,GO_Biological_Process_2021__negative regulation of gluconeogenesis (GO:0045721),0.8365261865426811,1.5118334788176127,0.0,0.7761972627185185,1.0,2/8,5.35%,GCK;CRY1
prerank,Reactome_2022__HS-GAG Biosynthesis R-HSA-2022928,0.6893873612406859,1.5117905027423333,0.037037037037037035,0.7726155078177137,1.0,14/27,12.57%,GPC4;SDC4;HS6ST2;HS3ST3B1;EXT1;NDST3;HS3ST1;GPC6;HS3ST5;HS2ST1;HS3ST2;GPC5;SDC3;HS3ST4
prerank,CellMarker_Augmented_2021__CD4+ T cell:Undefined,0.7955201945576736,1.5114651720440555,0.02564102564102564,0.7707814127900798,1.0,1/12,0.03%,IL7R
prerank,GO_Biological_Process_2021__magnesium ion transport (GO:0015693),0.8069512008410088,1.5114194765384354,0.0,0.7673359991287275,1.0,1/12,0.33%,NIPAL1
prerank,PanglaoDB_Augmented_2021__Monocytes,-0.605152119566694,-1.5111064221341808,0.0,0.46836837439153467,1.0,28/99,13.64%,CD44;ITGB2;HCK;TAGAP;TNFRSF1B;PTAFR;C3AR1;PARVG;FCGR3A;PLAU;IFIT3;LY86;NFAM1;PSAP;ADGRE1;MYO1F;IGSF6;GBP1;PTPRC;FPR1;SPI1;CLEC12A;ITGAM;IFIT1;OAS1;TLR2;CD300LF;ADGRE3
prerank,GO_Biological_Process_2021__positive regulation of cell growth (GO:0030307),0.5191136393308944,1.5108086307152735,0.037037037037037035,0.7671674324400626,1.0,23/87,18.66%,NGF;TGFBR1;BCL2;MFSD2A;ERBB2;SYT3;SLC25A33;SYT17;GOLGA4;SYT1;RPS6KA3;ADNP2;RIMS2;MACF1;MAP3K13;CPNE6;KLHL22;SMURF1;DNPH1;CPNE9;BRAT1;LIMK1;ADAM10
prerank,CellMarker_Augmented_2021__Keratinocyte:Skin,-0.9923022497875542,-1.510520516547197,0.0,0.4683121667119512,1.0,1/5,0.01%,CD44
prerank,GO_Biological_Process_2021__diol biosynthetic process (GO:0034312),0.7067120937943874,1.509823580147843,0.03225806451612903,0.7692007493423723,1.0,3/15,10.38%,DHFR;ACER2;ACER3
prerank,GO_Biological_Process_2021__glutamine family amino acid biosynthetic process (GO:0009084),0.862947637988512,1.509755667392272,0.06382978723404255,0.7658134669221505,1.0,3/7,13.11%,GLUD1;ALDH18A1;GLUD2
prerank,GO_Biological_Process_2021__positive regulation of receptor recycling (GO:0001921),0.8563912281458159,1.5096151331009229,0.04878048780487805,0.7627495866737636,1.0,2/9,5.38%,SCRIB;SNCA
prerank,CellMarker_Augmented_2021__Dental Pulp Stem cell:Dental Pulp,-0.8995545175443576,-1.5086678714514723,0.03278688524590164,0.4756155764647002,1.0,1/8,0.01%,CD44
prerank,CellMarker_Augmented_2021__Epithelial cell:Embryoid Body,0.5221804443860671,1.5086612521204519,0.0,0.7644133868700945,1.0,34/98,15.54%,FIBIN;MYO10;MXRA5;ADGRL2;PARVA;ALDH7A1;MID1;COL12A1;PCDH7;ASAP3;RASSF8;PTPRZ1;SLIT2;EDNRA;ZNF462;TENM3;EFS;PDZRN3;RND3;CAP2;STOX2;COL16A1;CHST3;MPDZ;PAMR1;RASAL2;LRIG3;EFEMP1;DST;MAGI1;ANK2;PRICKLE2;ANTXR1;CSRP2
prerank,CellMarker_Augmented_2021__Myeloid Dendritic cell:Thymus,-0.6820089915960985,-1.5085736203594302,0.03076923076923077,0.4693577503748033,1.0,21/54,13.88%,LILRB3;RASGRP4;ITGB2;HCK;ARHGAP9;TAGAP;TNFRSF1B;PARVG;FCGR3A;LY86;NFAM1;MYO1F;IGSF6;PTPRC;FPR1;SLC11A1;SPI1;CLEC12A;ITGAM;CD300LF;PSTPIP1
prerank,CellMarker_Augmented_2021__Dendritic cell:Spleen,-0.6820089915960985,-1.5085736203594302,0.03076923076923077,0.4693577503748033,1.0,21/54,13.88%,LILRB3;RASGRP4;ITGB2;HCK;ARHGAP9;TAGAP;TNFRSF1B;PARVG;FCGR3A;LY86;NFAM1;MYO1F;IGSF6;PTPRC;FPR1;SLC11A1;SPI1;CLEC12A;ITGAM;CD300LF;PSTPIP1
prerank,Reactome_2022__Nuclear Envelope Breakdown R-HSA-2980766,0.6147065269769262,1.5083609171596963,0.03125,0.7623927269558433,1.0,6/51,10.02%,CTDNEP1;NUP210;NUP42;LMNB1;VRK2;AAAS
prerank,GO_Biological_Process_2021__sterol catabolic process (GO:0016127),0.8748676991144587,1.508217936135081,0.027777777777777776,0.7560580363101304,1.0,2/8,2.66%,CEL;APOE
prerank,GO_Biological_Process_2021__cholesterol catabolic process (GO:0006707),0.8748676991144587,1.508217936135081,0.027777777777777776,0.7560580363101304,1.0,2/8,2.66%,CEL;APOE
prerank,GO_Biological_Process_2021__NAD biosynthesis via nicotinamide riboside salvage pathway (GO:0034356),0.7325768172934899,1.5080731281819129,0.12121212121212122,0.7534675337160129,1.0,2/14,1.73%,SLC5A8;RNLS
prerank,CellMarker_Augmented_2021__Neural Crest cell:Germ,0.530967490836117,1.5079088701446215,0.0,0.7511837636112624,1.0,34/95,20.24%,RASSF2;SEZ6L;KSR1;TSHZ3;BCL11B;DTX1;ITGA4;ZEB2;BACH2;ITPKB;VASH1;TRIB2;SIK3;MYO9B;ADAMTS10;CROCC;NTNG2;EVL;TNRC6C;NLGN3;CELF2;NCAM1;JPH4;S1PR1;NOTCH1;MICAL1;KIF21B;GALNT8;S100B;ELMO1;AEBP1;PDZD4;HDAC5;MLC1
prerank,CellMarker_Augmented_2021__Glutamatergic neuron:Brain,0.5844781980637475,1.5068217866385363,0.06666666666666667,0.7532764485292872,1.0,36/98,22.39%,VWC2L;SLC17A6;GRM3;KCNC2;ELAVL3;NGB;CADM2;PAK5;HCN1;RALYL;ADGRA1;CELF5;CELF4;GABRG1;NXPH1;ELAVL4;RAB3C;OLFM3;SNAP91;RBFOX1;SCRT1;VSTM2B;SRRM4;NRXN1;RIT2;MMD2;ST8SIA3;GRM5;CTNNA2;UNC79;TNR;HPCA;GRM1;TMEM196;SNCB;GRIA4
prerank,CellMarker_Augmented_2021__M1 macrophage:Peripheral Blood,0.8103993963028644,1.5065265859687078,0.0,0.7515742260437484,1.0,1/12,0.03%,IL7R
prerank,GO_Biological_Process_2021__glycerolipid metabolic process (GO:0046486),0.7428436946789312,1.5057329495297986,0.08108108108108109,0.7531585071164515,1.0,4/10,19.46%,PNPLA3;GAL3ST1;PLA2G15;DGKZ
prerank,Reactome_2022__Nicotinamide Salvaging R-HSA-197264,0.6678195618938696,1.5056929831446497,0.034482758620689655,0.7498794617683113,1.0,2/19,1.73%,SLC5A8;RNLS
prerank,CellMarker_Augmented_2021__Mesenchymal Stem cell:Umbilical Cord,-0.8992777499482868,-1.5054463122902921,0.0,0.4809586396287744,1.0,1/10,0.01%,CD44
prerank,CellMarker_Augmented_2021__Cancer Stem cell:Prostate,-0.7360743333804047,-1.5054360935403621,0.015873015873015872,0.4777862370233505,1.0,1/25,0.01%,CD44
prerank,GO_Biological_Process_2021__regulation of DNA-dependent DNA replication (GO:0090329),-0.8559096241976967,-1.5045733587345402,0.02127659574468085,0.47895246393602725,1.0,1/10,0.45%,TICRR
prerank,GO_Biological_Process_2021__intracellular pH elevation (GO:0051454),0.8765753563881921,1.5042961777752466,0.09302325581395349,0.7539390550306356,1.0,2/6,2.31%,SLC26A3;BCL2
prerank,PanglaoDB_Augmented_2021__Red Pulp Macrophages,-0.6809726686104566,-1.5037745969703633,0.0,0.4810839399258125,1.0,21/49,13.64%,LILRB3;CLEC5A;HCK;SLC7A7;C3AR1;MS4A4A;FCGR3A;LY86;VSIG4;NFAM1;ADGRE1;MYO1F;IGSF6;FPR1;SLC11A1;SPI1;CLEC12A;ITGAM;TLR2;CD300LF;ADGRE3
prerank,CellMarker_Augmented_2021__Chromaffin cell:Adrenal Gland,0.5808661368396395,1.503590164897124,0.07407407407407407,0.7481465391083962,1.0,39/98,19.93%,CDH20;MEGF10;SPHKAP;SEZ6L;LRRTM3;LRRC4C;TMEM132C;ELAVL3;CADM2;PAK5;SLC35F1;KCNIP1;SORCS1;ADGRA1;SYNDIG1;CELF4;ELAVL4;NPAS3;RAB3C;SNAP91;RBFOX1;GNAO1;ASXL3;VSTM2B;NCAM1;UBE2QL1;NRXN1;JPH4;JAKMIP2;GRIK3;PLXNA4;LSAMP;FAT3;MMD2;ST8SIA3;ADGRB3;CTNNA2;PDZD4;PAK3
prerank,CellMarker_Augmented_2021__Natural Killer cell:Breast,0.5808661368396395,1.503590164897124,0.07407407407407407,0.7481465391083962,1.0,39/98,19.93%,CDH20;MEGF10;SPHKAP;SEZ6L;LRRTM3;LRRC4C;TMEM132C;ELAVL3;CADM2;PAK5;SLC35F1;KCNIP1;SORCS1;ADGRA1;SYNDIG1;CELF4;ELAVL4;NPAS3;RAB3C;SNAP91;RBFOX1;GNAO1;ASXL3;VSTM2B;NCAM1;UBE2QL1;NRXN1;JPH4;JAKMIP2;GRIK3;PLXNA4;LSAMP;FAT3;MMD2;ST8SIA3;ADGRB3;CTNNA2;PDZD4;PAK3
prerank,CellMarker_Augmented_2021__Definitive Zone cell:Adrenal Gland,0.5808661368396395,1.503590164897124,0.07407407407407407,0.7481465391083962,1.0,39/98,19.93%,CDH20;MEGF10;SPHKAP;SEZ6L;LRRTM3;LRRC4C;TMEM132C;ELAVL3;CADM2;PAK5;SLC35F1;KCNIP1;SORCS1;ADGRA1;SYNDIG1;CELF4;ELAVL4;NPAS3;RAB3C;SNAP91;RBFOX1;GNAO1;ASXL3;VSTM2B;NCAM1;UBE2QL1;NRXN1;JPH4;JAKMIP2;GRIK3;PLXNA4;LSAMP;FAT3;MMD2;ST8SIA3;ADGRB3;CTNNA2;PDZD4;PAK3
prerank,GO_Biological_Process_2021__negative regulation of intrinsic apoptotic signaling pathway by p53 class mediator (GO:1902254),-0.868119612326298,-1.5035144248582821,0.0,0.4796792866441859,1.0,1/14,0.01%,CD44
prerank,CellMarker_Augmented_2021__PROM1High Progenitor cell:Large Intestine,0.5079838685857127,1.5034129371252414,0.034482758620689655,0.7456413530414442,1.0,32/94,15.10%,NGF;COL8A1;MYO10;CLMP;GPR161;ARSJ;PARVA;ALDH7A1;DCBLD2;COL12A1;ADAMTS12;ZFHX4;RASSF8;RAI14;SLIT2;TENM3;PPFIBP1;ABL2;RPGRIP1L;NAV3;RND3;CHST3;FLRT2;RBMS3;DSEL;FARP1;RASAL2;KIAA1549L;NAV1;BMPER;WWTR1;ANTXR1
prerank,Reactome_2022__PI3K Events In ERBB2 Signaling R-HSA-1963642,0.7473810162352168,1.5031103960741425,0.06896551724137931,0.7441696531534318,1.0,4/14,7.38%,NRG2;ERBB2;NRG1;NRG3
prerank,Reactome_2022__Eukaryotic Translation Termination R-HSA-72764,-0.606987256449923,-1.5011790985646267,0.0,0.4895210060500522,1.0,53/83,27.12%,RPL37A;RPL38;RPL15;RPS4X;RPL3;RPL35A;RPS9;FAU;RPS27;RPS21;RPL13A;RPL27A;RPS16;RPL36;RPS20;RPL7A;RPL9;RPS8;RPS27A;RPL21;RPL34;RPL4;RPL32;RPL5;RPL23;RPL41;RPS7;RPS11;RPL27;RPL35;RPS14;RPL11;RPS15;RPLP1;RPS12;RPL18A;RPS13;RPL29;RPLP2;RPL28;RPL12;RPL18;RPS3;RPL22;RPSA;RPS28;RPS19;RPS24;RPL26L1;RPS3A;RPL19;RPL8;RPS6
prerank,GO_Biological_Process_2021__purine nucleotide metabolic process (GO:0006163),0.715286422470601,1.5010888467126093,0.05714285714285714,0.7512989597300697,1.0,3/21,4.57%,PNP;FHIT;NT5C1A
prerank,GO_Biological_Process_2021__determination of bilateral symmetry (GO:0009855),-0.7325401040321526,-1.5009983004012466,0.045454545454545456,0.48726201631495,1.0,3/21,2.91%,TBX1;DNAH11;MMP21
prerank,Reactome_2022__Signaling To ERKs R-HSA-187687,0.6149788970172696,1.5004024873926802,0.0625,0.7520860955332465,1.0,12/33,17.32%,NGF;MAPKAPK2;BCL11B;RALB;CRK;RAPGEF1;RALA;RAP1A;MAPK12;CRKL;RIT2;BRAF
prerank,GO_Biological_Process_2021__positive regulation of peptidyl-tyrosine phosphorylation (GO:0050731),-0.5971788112971353,-1.4997221808331458,0.012987012987012988,0.49224475831281933,1.0,7/99,5.82%,CD44;ENPP2;CRLF1;TGFB1;TEC;CLCF1;VTN
prerank,GO_Biological_Process_2021__heparin metabolic process (GO:0030202),0.8982110350550395,1.4990174176209163,0.0196078431372549,0.7571219702222641,1.0,2/5,2.81%,CSGALNACT1;ANGPT1
prerank,GO_Biological_Process_2021__regulation of platelet aggregation (GO:0090330),-0.8346007271219867,-1.4986439113275263,0.043478260869565216,0.4947426975308335,1.0,4/18,7.40%,C1QTNF1;ALOX12;BLK;CEACAM1
prerank,Reactome_2022__IRF3-mediated Induction Of Type I IFN R-HSA-3270619,-0.8665853593877901,-1.4985448175025924,0.01694915254237288,0.4920694221369118,1.0,1/12,0.07%,NLRP4
prerank,CellMarker_Augmented_2021__Stem cell:Cartilage,-0.9147466143587591,-1.4981235170084302,0.0,0.49135104040794253,1.0,1/8,0.01%,CD44
prerank,CellMarker_Augmented_2021__Mesenchymal Stem cell:Foreskin,-0.9594792192153301,-1.497950796076465,0.01818181818181818,0.48596393299570934,1.0,1/5,0.01%,CD44
prerank,CellMarker_Augmented_2021__Mesenchymal Stem cell:Embryonic Stem Cell,-0.9594792192153301,-1.497950796076465,0.01818181818181818,0.48596393299570934,1.0,1/5,0.01%,CD44
prerank,Reactome_2022__Chylomicron Assembly R-HSA-8963888,0.952430939948123,1.4970992047966052,0.0,0.7651585550884213,1.0,2/6,2.66%,APOB;APOE
prerank,GO_Biological_Process_2021__regulation of nervous system process (GO:0031644),0.7298520173113406,1.4959530182060132,0.0425531914893617,0.7704879329267917,1.0,4/18,10.32%,HTR2C;DLGAP4;SLC8A3;AKAP9
prerank,CellMarker_Augmented_2021__Immune cell:Undefined,-0.7978049316651826,-1.4957837544456896,0.015625,0.49600631436040055,1.0,7/15,11.77%,LILRB3;SIRPG;ITGB2;CD5;ICAM3;PTPRC;ITGAM
prerank,GO_Biological_Process_2021__positive regulation of chemokine (C-X-C motif) ligand 2 production (GO:2000343),0.881038445147016,1.4954108493850038,0.023809523809523808,0.7711770971667695,1.0,2/5,9.91%,HMGB1;LPL
prerank,GO_Biological_Process_2021__positive regulation of receptor binding (GO:1900122),-0.9142835793731807,-1.4951552378622044,0.03636363636363636,0.496149079335751,1.0,1/6,2.53%,MMP9
prerank,Reactome_2022__SHC1 Events In ERBB2 Signaling R-HSA-1250196,0.7051836236555937,1.494526401986776,0.0,0.7738202735932168,1.0,10/19,26.09%,NRG2;ERBB2;NRG1;NRG3;SOS1;PRKCE;ERBB3;PTPN12;PRKCD;BTC
prerank,GO_Biological_Process_2021__regulation of gastrulation (GO:0010470),0.8148181056475925,1.494406232079895,0.06666666666666667,0.7711063406923497,1.0,2/11,6.85%,PHLDB2;OSR1
prerank,CellMarker_Augmented_2021__Myotube:Muscle,-0.6597506766431658,-1.4942940022506197,0.039473684210526314,0.49896805822835033,1.0,13/61,7.99%,MYH1;SMTNL1;MYBPH;MYH7;CASQ2;ART1;MYH8;CAV3;KCNA7;LRRC39;TECRL;CSRP3;NEB
prerank,GO_Biological_Process_2021__regulation of extent of cell growth (GO:0061387),0.7442863662135815,1.494003844403536,0.13157894736842105,0.7697112791273677,1.0,2/8,7.57%,APOE;ABL1
prerank,GO_Biological_Process_2021__positive regulation of leukocyte degranulation (GO:0043302),-0.8101429861549108,-1.4937918276541473,0.05454545454545454,0.4987299028312042,1.0,4/11,16.13%,ITGB2;ITGAM;HLA-F;F2RL1
prerank,GO_Biological_Process_2021__positive regulation of peptidyl-serine phosphorylation (GO:0033138),-0.6278064791429193,-1.4931300229925046,0.014285714285714285,0.49934649067818726,1.0,5/64,5.61%,CD44;TGFB1;TERF2IP;IFNK;PINK1
prerank,GO_Biological_Process_2021__negative regulation of endothelial cell apoptotic process (GO:2000352),0.7207376564223116,1.4925341443855837,0.02631578947368421,0.7741967910594277,1.0,4/15,5.25%,ANGPT1;CDH5;SEMA5A;SERPINE1
prerank,GO_Biological_Process_2021__positive regulation of vascular endothelial cell proliferation (GO:1905564),0.803480931591342,1.492376953790358,0.045454545454545456,0.7718372492934678,1.0,4/11,7.74%,FGFR1;ITGA4;HMGB1;SP1
prerank,CellMarker_Augmented_2021__Cancer Stem cell:Stomach,-0.973313102566436,-1.4922506211654956,0.0,0.5007576269031525,1.0,1/6,0.01%,CD44
prerank,GO_Biological_Process_2021__protein mannosylation (GO:0035268),0.685476976217623,1.4920328825755762,0.06451612903225806,0.7710323946167261,1.0,6/21,7.63%,DPY19L3;DPM3;TMTC2;DPY19L1;FKTN;FKRP
prerank,GO_Biological_Process_2021__protein hydroxylation (GO:0018126),0.7625283834895478,1.4919860457574345,0.0,0.7678150719615031,1.0,6/13,10.07%,EGLN3;JMJD4;P3H3;P3H2;PLOD3;P3H4
prerank,GO_Biological_Process_2021__DNA topological change (GO:0006265),0.7707445986940304,1.4918339330369073,0.09090909090909091,0.7657027550104328,1.0,3/9,7.17%,TOP2A;HMGB1;TOP1MT
prerank,GO_Biological_Process_2021__response to insulin (GO:0032868),0.5607549799704901,1.491602221990752,0.04,0.7644289403893798,1.0,24/72,20.13%,GCK;FOXO1;CPEB1;IRS1;RAB31;ZBTB7B;CAPN10;PPARG;SIRT1;SLC25A33;FER;AKT2;IRS2;TBC1D4;RAB10;INSR;LPIN2;GPLD1;SYAP1;MYO5A;PDE3B;KAT2B;HDAC5;MARS1
prerank,CellMarker_Augmented_2021__Mesoderm cell:Undefined,0.5514609805851304,1.4903199775558489,0.07142857142857142,0.7686978394049139,1.0,21/92,15.18%,LLGL1;SCRIB;P3H3;SOX12;PRKCSH;PTOV1;B4GALT2;PLOD3;ABL1;NAT14;FGD1;KHSRP;TTYH3;P3H4;GPSM1;CDH2;CDH24;FJX1;FSCN1;CDK16;THOP1
prerank,GO_Biological_Process_2021__protein O-linked glycosylation via serine (GO:0018242),0.8368403684382345,1.4896753646615826,0.058823529411764705,0.7699261811454631,1.0,4/9,9.48%,POGLUT3;GALNT1;POGLUT2;GALNT13
prerank,GO_Biological_Process_2021__protein localization to presynapse (GO:1905383),0.7925020237112679,1.4895817967062488,0.023809523809523808,0.760752589742157,1.0,3/8,17.56%,HSPB1;RAB27B;DLG2
prerank,GO_Biological_Process_2021__anterograde axonal protein transport (GO:0099641),0.7925020237112679,1.4895817967062488,0.023809523809523808,0.760752589742157,1.0,3/8,17.56%,HSPB1;RAB27B;DLG2
prerank,GO_Biological_Process_2021__axo-dendritic protein transport (GO:0099640),0.7925020237112679,1.4895817967062488,0.023809523809523808,0.760752589742157,1.0,3/8,17.56%,HSPB1;RAB27B;DLG2
prerank,Reactome_2022__Diseases Associated With Surfactant Metabolism R-HSA-5687613,-0.8402695610226035,-1.4895520645049385,0.1016949152542373,0.5149512553147516,1.0,2/8,6.00%,SFTPA1;SFTPD
prerank,GO_Biological_Process_2021__regulation of type I interferon production (GO:0032479),-0.6252886549311245,-1.4894403176305426,0.014084507042253521,0.512509476214879,1.0,6/78,7.22%,NLRP4;IRF1;UBE2L6;TRIM25;NFKB2;POLR1C
prerank,GO_Biological_Process_2021__neutral amino acid transport (GO:0015804),0.6382861833339865,1.488814146028274,0.08,0.7640867968507701,1.0,6/26,11.22%,SLC38A5;SLC3A2;SLC7A9;SLC6A17;SLC6A20;SLC7A8
prerank,KEGG_2021_Human__Neurotrophin signaling pathway,0.5313560687340887,1.4886581891643627,0.04,0.7619363801842921,1.0,35/106,20.89%,NGF;SH2B2;MAPKAPK2;BCL2;IRS1;RIPK2;SHC4;CRK;RAPGEF1;ZNF274;ABL1;MAPK8;MAP3K1;AKT2;RPS6KA3;RAP1A;GAB1;NFKB1;RPS6KA2;RPS6KA6;PIK3CA;IRAK4;MAGED1;TP53;MAPK12;MATK;CRKL;BRAF;MAP2K7;SOS1;PRDM4;TRAF6;RAF1;NTRK2;PLCG2
prerank,GO_Biological_Process_2021__axon choice point recognition (GO:0016198),0.9633707297492811,1.4884922704659715,0.0,0.7599256532101067,1.0,1/5,2.08%,ROBO2
prerank,GO_Biological_Process_2021__regulation of collateral sprouting (GO:0048670),0.8630334028153306,1.4884185141427064,0.0,0.7572622602884221,1.0,2/8,6.21%,NGF;DCC
prerank,CellMarker_Augmented_2021__Lake Et al.Science.In4:Brain,0.9177066911244047,1.487414894684515,0.019230769230769232,0.7594662861399922,1.0,3/6,3.05%,FREM1;KIT;TRPC3
prerank,GO_Biological_Process_2021__nerve growth factor signaling pathway (GO:0038180),0.8042057368282703,1.4866118774607566,0.041666666666666664,0.7621351689004817,1.0,4/8,12.41%,NGF;MAGI2;RAPGEF1;RAP1A
prerank,CellMarker_Augmented_2021__Mesenchymal Stem cell:Cartilage,-0.7485176316988521,-1.486524638349896,0.046875,0.5274254454457057,1.0,1/23,0.01%,CD44
prerank,CellMarker_Augmented_2021__Cancer Stem cell:Embryo,-0.5968645789341043,-1.4865169156213407,0.01639344262295082,0.5243295066532654,1.0,2/71,2.29%,CD44;MISP
prerank,GO_Biological_Process_2021__COPI coating of Golgi vesicle (GO:0048205),0.8610856054573909,1.486436494820748,0.05263157894736842,0.7536220621263477,1.0,1/6,5.79%,GBF1
prerank,GO_Biological_Process_2021__Golgi transport vesicle coating (GO:0048200),0.8610856054573909,1.486436494820748,0.05263157894736842,0.7536220621263477,1.0,1/6,5.79%,GBF1
prerank,GO_Biological_Process_2021__COPI-coated vesicle budding (GO:0035964),0.8610856054573909,1.486436494820748,0.05263157894736842,0.7536220621263477,1.0,1/6,5.79%,GBF1
prerank,Reactome_2022__Protein-protein Interactions At Synapses R-HSA-6794362,0.5262569092164695,1.4861756673548239,0.0,0.7522345238133992,1.0,37/87,23.90%,SLITRK6;LLGL1;GPRIN1;NLGN1;LRRTM3;IL1RAPL2;PPFIBP2;DLGAP4;APBA3;PPFIA3;SYT1;PPFIBP1;EPB41;EPB41L5;SHARPIN;SYT12;NLGN4X;APBA1;NLGN3;MPP2;PTPRF;NRXN1;PTPRD;SLITRK2;PPFIA2;GRM5;LIN7A;CASK;DLG1;GRM1;LRRTM4;NRXN3;GRIA4;SYT7;DLGAP1;IL1RAP;SLITRK3
prerank,CellMarker_Augmented_2021__Fibroblast:Vocal Fold,-0.8993048933523801,-1.4860264354755324,0.0,0.5237781839548896,1.0,1/9,0.01%,CD44
prerank,GO_Biological_Process_2021__ventricular cardiac muscle tissue development (GO:0003229),-0.8128598551759372,-1.485823198141183,0.03125,0.5215998551941563,1.0,4/14,4.08%,PKP2;TGFB1;MYH7;MYBPC3
prerank,CellMarker_Augmented_2021__Germinal Center B cell:Lymphoid Tissue,-0.6597753971088127,-1.4853598456737547,0.0273972602739726,0.5210282083351966,1.0,23/55,20.68%,GMFG;HCK;DOCK8;CYTIP;TAGAP;ALOX5;PTAFR;INPP5D;WAS;LY86;CD37;TRAF3IP3;PTPRC;SPI1;CLEC12A;CD300LF;IKZF1;NAPSB;PIK3CG;SASH3;P2RX1;CD86;LMO2
prerank,GO_Biological_Process_2021__long-chain fatty acid catabolic process (GO:0042758),0.8719823881061024,1.4852062884549524,0.02127659574468085,0.7552340657531788,1.0,2/5,10.07%,GLYATL2;AIG1
prerank,GO_Biological_Process_2021__regulation of receptor recycling (GO:0001919),0.7700342252885666,1.4851445714292693,0.1,0.7526730300394878,1.0,3/14,5.38%,SCRIB;TBC1D16;SNCA
prerank,"GO_Biological_Process_2021__synaptic transmission, GABAergic (GO:0051932)",0.8016349548611128,1.484713846763253,0.1,0.7520096113135915,1.0,3/11,3.42%,GABRE;GABRA5;GABRG3
prerank,CellMarker_Augmented_2021__Mesenchymal Stem cell:Fat Pad,-0.9494231367948178,-1.4844937970171581,0.0,0.5230973896698,1.0,1/7,0.01%,CD44
prerank,CellMarker_Augmented_2021__GABAergic neuron:Undefined,-0.9413922958981553,-1.483921997185825,0.03636363636363636,0.523537484075694,1.0,1/5,2.41%,GAD1
prerank,GO_Biological_Process_2021__regulation of excitatory synapse assembly (GO:1904889),0.8434191751320544,1.483385096985167,0.08333333333333333,0.7567866336303295,1.0,3/6,10.79%,VSTM5;SEMA4A;ABI3
prerank,GO_Biological_Process_2021__purine-containing compound salvage (GO:0043101),0.6995752501568598,1.4833234666337554,0.05714285714285714,0.7543658846113571,1.0,2/12,4.74%,PNP;AMPD1
prerank,CellMarker_Augmented_2021__Granulocyte:Peripheral Blood,-0.8161571353722066,-1.4832860723991885,0.04477611940298507,0.5244345027497556,1.0,7/12,11.77%,CD44;FCGR3A;IL3RA;PTPRC;CD63;CEACAM8;ITGAM
prerank,KEGG_2021_Human__Pancreatic secretion,0.5789955885021405,1.482851481686796,0.0,0.7540515621081045,1.0,6/73,2.06%,CPA1;CD38;SLC26A3;PRSS3;ITPR2;CEL
prerank,GO_Biological_Process_2021__development of primary female sexual characteristics (GO:0046545),0.8630466266228299,1.4821699615944408,0.05263157894736842,0.7553571339017988,1.0,1/6,0.55%,LHFPL2
prerank,GO_Biological_Process_2021__histone H3 deacetylation (GO:0070932),0.7632133018988323,1.482008016235596,0.0,0.7538329822150426,1.0,4/14,5.48%,PER2;HDAC3;SIRT1;SIRT7
prerank,PanglaoDB_Augmented_2021__Granulosa Cells,0.5386457152951089,1.4819269683584002,0.0,0.7514606494699829,1.0,24/96,15.15%,TEAD2;ADAMTS1;AMOTL1;PARVA;MID1;COL12A1;B4GALT2;RAI14;TENM3;SNAI2;P3H4;RND3;CAP2;CHST3;AMH;MPDZ;DDAH1;RBFOX2;TEAD4;FJX1;NR2F2;MAGI1;ANTXR1;PTPRF
prerank,CellMarker_Augmented_2021__Adipose-derived Stem cell:Abdominal Adipose Tissue,-0.8731789151822916,-1.4815030944799708,0.015873015873015872,0.5324202058599609,1.0,1/10,0.01%,CD44
prerank,GO_Biological_Process_2021__dendritic spine morphogenesis (GO:0060997),0.7656806602409204,1.4813034234730507,0.05714285714285714,0.7507624778471835,1.0,1/15,0.23%,ARC
prerank,CellMarker_Augmented_2021__Stem cell:Hair Follicle,0.9335979439305717,1.481097831019967,0.022222222222222223,0.748818077285902,1.0,1/5,0.35%,LGR5
prerank,CellMarker_Augmented_2021__Megakaryocyte:Blood,-0.7061554322546713,-1.4809309064778229,0.015384615384615385,0.5324676586412317,1.0,24/47,13.42%,LILRB3;RASGRP4;CLEC5A;TMEM150B;ITGB2;HCK;TNFRSF1B;C3AR1;MS4A4A;PARVG;FCGR3A;OSCAR;LY86;NFAM1;MYO1F;IGSF6;FPR1;SLC11A1;SPI1;CLEC12A;ITGAM;TLR2;NLRP3;CD300LF
prerank,CellMarker_Augmented_2021__Cancer Stem cell:Thyroid,-0.9416192332344502,-1.4808784280108844,0.0,0.5298722327910398,1.0,1/5,0.01%,CD44
prerank,Reactome_2022__Peptide Chain Elongation R-HSA-156902,-0.627701490851972,-1.4806493105458778,0.0,0.52882499120704,1.0,55/80,27.12%,RPL37A;RPL38;RPL15;RPS4X;RPL3;RPL35A;RPS9;FAU;RPS27;EEF2;RPS21;RPL13A;RPL27A;RPS16;RPL36;RPS20;RPL7A;RPL9;RPS8;RPS27A;RPL21;RPL34;RPL4;RPL32;RPL5;RPL23;RPL41;RPS7;RPS11;RPL27;RPL35;RPS14;RPL11;RPS15;RPLP1;RPS12;RPL18A;RPS13;RPL29;RPLP2;RPL28;RPL12;RPL18;RPS3;RPL22;EEF1A1;RPSA;RPS28;RPS19;RPS24;RPL26L1;RPS3A;RPL19;RPL8;RPS6
prerank,CellMarker_Augmented_2021__Natural Killer T (NKT) cell:Kidney,0.8979240860616833,1.4805354354833244,0.021739130434782608,0.7484185676654759,1.0,2/5,1.42%,IL7R;KLRD1
prerank,GO_Biological_Process_2021__serine transport (GO:0032329),0.8112529042650948,1.480168873001003,0.058823529411764705,0.7480220732119965,1.0,2/7,9.19%,SLC38A5;SFXN2
prerank,GO_Biological_Process_2021__positive regulation of response to wounding (GO:1903036),-0.7374210594572125,-1.4800925958766784,0.0,0.5288100830926554,1.0,5/21,8.67%,DUOX1;CLDN1;VTN;ACTG1;ANXA1
prerank,GO_Biological_Process_2021__fat cell differentiation (GO:0045444),0.570954776128263,1.4799160931886661,0.08108108108108109,0.7465598763027229,1.0,23/49,21.10%,FOXO1;PER2;MAFB;METRNL;PID1;PPARG;SDF4;SIRT1;BBS9;NR4A2;AKT2;CTBP2;OSBPL11;GDF6;NR4A3;CLIP3;IL11;FAM120B;NR4A1;EP300;OSBPL8;PRDM16;ZBTB7A
prerank,GO_Biological_Process_2021__regulation of peptide hormone secretion (GO:0090276),0.5694898169942609,1.4798773358436181,0.0625,0.7440439511225513,1.0,6/54,3.51%,GCK;GRP;PER2;ITPR2;HTR2C;KCNC2
prerank,CellMarker_Augmented_2021__Mesenchymal Stem cell:Tendon,-0.754672138806634,-1.4794011529337152,0.06349206349206349,0.5241889734164245,1.0,1/21,0.01%,CD44
prerank,CellMarker_Augmented_2021__Mesenchymal Stem cell:Muscle,-0.754672138806634,-1.4794011529337152,0.06349206349206349,0.5241889734164245,1.0,1/21,0.01%,CD44
prerank,CellMarker_Augmented_2021__Mesenchymal Stem cell:Bone,-0.754672138806634,-1.4794011529337152,0.06349206349206349,0.5241889734164245,1.0,1/21,0.01%,CD44
prerank,GO_Biological_Process_2021__cerebellar granule cell differentiation (GO:0021707),0.9174787930927397,1.4789917357978415,0.022222222222222223,0.7456221546999741,1.0,2/5,6.26%,GRID2;PROX1
prerank,GO_Biological_Process_2021__purine nucleobase transport (GO:0006863),-0.9596147204951915,-1.4789124168095915,0.01818181818181818,0.5237604622352375,1.0,3/6,2.79%,SLC28A2;SLC28A1;SLC28A3
prerank,PanglaoDB_Augmented_2021__Follicular Cells,-0.5998232019848432,-1.4788242992080527,0.014925373134328358,0.5213905289610716,1.0,36/78,17.77%,SLC28A1;BHMT;IYD;LECT2;ABCC6;ITIH2;SMLR1;FMO5;CYP3A5;RORC;ALDOB;TSHR;OIT3;SLC5A9;PON3;SLC3A1;SERPINA10;PDZK1;PLG;CYP3A4;HNF1A;SLC22A7;CYP4F12;SLC6A4;C4BPB;HAO2;PIK3C2G;NR1H4;TMEM45B;DIO1;TG;SLC10A1;ACKR2;ANGPTL3;ASGR1;PRODH2
prerank,GO_Biological_Process_2021__regulation of vasoconstriction (GO:0019229),0.7189108392682798,1.4787913705219837,0.045454545454545456,0.7441295672278766,1.0,3/20,0.87%,ADRA1A;ADRA1B;PER2
prerank,CellMarker_Augmented_2021__Stem cell:Deciduous Tooth,-0.9611415320046165,-1.4787801534906375,0.01694915254237288,0.5161377789445091,1.0,1/5,0.01%,CD44
prerank,CellMarker_Augmented_2021__Mesenchymal Stromal cell:Skeletal Muscle,-0.9611415320046165,-1.4787801534906375,0.01694915254237288,0.5161377789445091,1.0,1/5,0.01%,CD44
prerank,Reactome_2022__Prolonged ERK Activation Events R-HSA-169893,0.7079743460444603,1.4775706549388992,0.06818181818181818,0.7478014658461747,1.0,6/14,17.32%,NGF;CRK;RAPGEF1;RAP1A;CRKL;BRAF
prerank,GO_Biological_Process_2021__DNA methylation (GO:0006306),0.6764844933253156,1.476922811676223,0.05714285714285714,0.7486306194465943,1.0,10/20,27.55%,GATAD2A;DNMT1;TEX15;BAZ2A;ATF7IP;FOS;METTL4;DMAP1;DNMT3A;PPM1D
prerank,Reactome_2022__EML4 And NUDC In Mitotic Spindle Formation R-HSA-9648025,-0.5603554634912814,-1.4766482092145496,0.0,0.5253357847502168,1.0,23/91,23.42%,BUB1;ERCC6L;SPC25;CENPU;ITGB3BP;ZWILCH;NUF2;CENPH;CENPS-CORT;DYNLL1;RPS27;INCENP;NDEL1;CDCA8;CENPN;KIF18A;BUB1B;SKA2;SEC13;CENPL;DYNLL2;PPP2R5A;CENPM
prerank,CellMarker_Augmented_2021__Basal cell:Undefined,-0.6253419096263096,-1.476431724072747,0.02857142857142857,0.5237853141191156,1.0,19/80,16.14%,CD44;AHR;TGFBI;LRP10;DRAM1;IFIT3;HLA-A;ST6GALNAC2;ANXA1;GBP1;CD63;FTH1;OAS1;CXCL16;FOSL2;VDR;IL18;GRN;ADIRF
prerank,KEGG_2021_Human__Complement and coagulation cascades,-0.6674056792093626,-1.4763335566650575,0.027777777777777776,0.5214006155425978,1.0,26/55,14.68%,F8;C1QB;F7;ITGB2;PROCR;SERPIND1;VTN;C3AR1;MASP1;PLAU;VSIG4;CPB2;CLU;PLG;CFD;C4BPA;VWF;ITGAM;MASP2;F13A1;PLAT;A2M;F5;C4BPB;C1S;TFPI
prerank,GO_Biological_Process_2021__positive regulation of lipid catabolic process (GO:0050996),0.7364699902779837,1.4758548598446262,0.023255813953488372,0.7514338842081054,1.0,6/15,10.67%,IRS1;PLIN5;TWIST1;AKT2;ABCD2;IRS2
prerank,Reactome_2022__Muscarinic Acetylcholine Receptors R-HSA-390648,0.9059458011451084,1.475760804585072,0.023255813953488372,0.7491198134421969,1.0,1/5,0.95%,CHRM2
prerank,Reactome_2022__Unattached Kinetochores Signal Amplification Via A MAD2 Inhibitory Signal R-HSA-141444,-0.5613155204477144,-1.4754351937191859,0.0,0.5238871967815241,1.0,23/87,23.42%,BUB1;ERCC6L;SPC25;CENPU;ITGB3BP;ZWILCH;NUF2;CENPH;CENPS-CORT;DYNLL1;RPS27;INCENP;NDEL1;CDCA8;CENPN;KIF18A;BUB1B;SKA2;SEC13;CENPL;DYNLL2;PPP2R5A;CENPM
prerank,CellMarker_Augmented_2021__Mesenchymal Stem cell:Chorionic Villus,-0.6415575972862112,-1.4754202198645816,0.0375,0.5212208525922567,1.0,14/68,6.58%,CD44;CMAHP;GMFG;ITGB2;CYTIP;TAGAP;SP100;TNFRSF1B;DOCK2;CIITA;C3AR1;GPR183;PARVG;FCGR3A
prerank,GO_Biological_Process_2021__regulation of cardiac muscle hypertrophy in response to stress (GO:1903242),0.9103784819544443,1.4748045542710764,0.0,0.7512455797687037,1.0,2/5,3.05%,FOXO1;TRPC3
prerank,GO_Biological_Process_2021__zinc ion transmembrane transport (GO:0071577),0.7189421487612991,1.4747919174487183,0.0967741935483871,0.7485681833718697,1.0,4/19,4.30%,SLC30A10;SLC39A8;TRPM2;SLC39A11
prerank,CellMarker_Augmented_2021__Bone Marrow Stem cell:Bone Marrow,-0.859488512768165,-1.4747605744989156,0.01639344262295082,0.521931658299668,1.0,1/9,0.01%,CD44
prerank,KEGG_2021_Human__Ascorbate and aldarate metabolism,0.8021918221932478,1.4744162728629338,0.05357142857142857,0.7482953663262187,1.0,4/12,11.08%,UGT2B15;RGN;ALDH7A1;UGDH
prerank,GO_Biological_Process_2021__AV node cell action potential (GO:0086016),-0.8889204623139048,-1.4736633543079718,0.01639344262295082,0.5257399360820775,1.0,1/7,1.19%,SCN5A
prerank,PanglaoDB_Augmented_2021__Trichocytes,0.5291307954372507,1.4731873542574716,0.030303030303030304,0.752399563200717,1.0,5/53,3.43%,ADGRF4;ADGRG6;LAMA3;FAM83H;PERP
prerank,GO_Biological_Process_2021__neurotransmitter-gated ion channel clustering (GO:0072578),0.8928304492177934,1.4731735313682959,0.024390243902439025,0.7496930899517935,1.0,4/6,8.93%,LHFPL4;APOE;NLGN1;GPHN
prerank,GO_Biological_Process_2021__cellular response to peptide hormone stimulus (GO:0071375),0.5230562882456793,1.4731362768807443,0.043478260869565216,0.7474350235545293,1.0,32/87,20.13%,GCK;FOXO1;CPEB1;IRS1;SLC30A10;RAB31;CAPN10;PPARG;SLC25A33;FER;MGARP;ADCY2;NR4A2;AKT2;PRKAR2A;IRS2;ADCY3;TBC1D4;RAB10;NFKB1;INSR;NR4A3;LPIN2;GPLD1;SYAP1;ADCY6;MYO5A;NR4A1;PDE3B;KAT2B;HDAC5;MARS1
prerank,GO_Biological_Process_2021__N-terminal protein amino acid modification (GO:0031365),0.7645571700059905,1.4730383464051262,0.05,0.7454068229263795,1.0,3/11,9.39%,NAA40;METAP1D;AANAT
prerank,GO_Biological_Process_2021__heart contraction (GO:0060047),-0.7073726950821452,-1.4729733142685428,0.04477611940298507,0.5265331257587803,1.0,8/31,8.12%,SCN5A;MYH7;CASQ2;ACTC1;MYBPC3;TRDN;CSRP3;KCNQ1
prerank,GO_Biological_Process_2021__regulation of mesenchymal cell proliferation (GO:0010464),-0.8165790327733384,-1.472760232274851,0.0,0.525556830255009,1.0,3/11,6.09%,TBX1;WNT5A;STAT1
prerank,GO_Biological_Process_2021__lymphocyte apoptotic process (GO:0070227),0.9550434798513802,1.472654569755671,0.044444444444444446,0.7449371345750921,1.0,1/5,1.59%,CLC
prerank,GO_Biological_Process_2021__negative regulation of cellular response to insulin stimulus (GO:1900077),0.6748919919922504,1.472598601076615,0.0,0.7424016239605662,1.0,11/26,25.85%,IRS1;PID1;KANK1;PTPRE;PIP4K2A;NCK1;SLC27A4;APPL2;ENPP1;PRKCD;RPS6KB1
prerank,CellMarker_Augmented_2021__Mesenchymal Stem cell:Adipose Tissue,-0.7286860528321539,-1.4720193453728887,0.0625,0.5264919976854696,1.0,1/25,0.01%,CD44
prerank,CellMarker_Augmented_2021__Mesenchymal Stem cell:Liver,-0.9123159888296477,-1.4718908012237024,0.01818181818181818,0.5247468261636812,1.0,1/7,0.01%,CD44
prerank,GO_Biological_Process_2021__regulation of cholesterol storage (GO:0010885),0.6998212678622414,1.4717342206662938,0.044444444444444446,0.7449593352633893,1.0,7/14,22.82%,APOB;PPARG;ABCA1;LPL;NR1H3;SREBF2;SCARB1
prerank,CellMarker_Augmented_2021__Endothelial cell:Cornea,-0.7960357213144603,-1.4716425647928657,0.045454545454545456,0.5233514521059587,1.0,1/12,0.01%,CD44
prerank,Reactome_2022__Nonsense Mediated Decay (NMD) Independent Of Exon Junction Complex (EJC) R-HSA-975956,-0.6002448438230553,-1.4715322373427826,0.013157894736842105,0.521492712621156,1.0,53/86,27.12%,RPL37A;RPL38;RPL15;RPS4X;RPL3;RPL35A;RPS9;FAU;RPS27;RPS21;RPL13A;RPL27A;RPS16;RPL36;RPS20;RPL7A;RPL9;RPS8;RPS27A;RPL21;RPL34;RPL4;RPL32;RPL5;RPL23;RPL41;RPS7;RPS11;RPL27;RPL35;RPS14;RPL11;RPS15;RPLP1;RPS12;RPL18A;RPS13;RPL29;RPLP2;RPL28;RPL12;RPL18;RPS3;RPL22;RPSA;RPS28;RPS19;RPS24;RPL26L1;RPS3A;RPL19;RPL8;RPS6
prerank,PanglaoDB_Augmented_2021__Megakaryocytes,-0.6416993972146983,-1.4713369080126932,0.025974025974025976,0.5203467947211953,1.0,31/76,13.88%,LILRB3;RASGRP4;MPL;TGFB1;GMFG;IL21R;ALOX12;ITGB2;HCK;ARHGAP9;TAGAP;PDE6B;TNFRSF1B;PARVG;FCGR3A;GP1BA;WAS;NFAM1;SELP;MYO1F;FPR1;VWF;ITGA2B;SLC11A1;SPI1;CLEC12A;ITGAM;F13A1;CD300LF;ADGRE3;PSTPIP1
prerank,GO_Biological_Process_2021__iron ion transmembrane transport (GO:0034755),0.8237366826333329,1.4710395797540585,0.045454545454545456,0.746550765953133,1.0,2/8,4.17%,SLC39A8;SLC25A37
prerank,PanglaoDB_Augmented_2021__Photoreceptor Cells,0.5203605177250248,1.4710041608129105,0.041666666666666664,0.7440887797986243,1.0,41/139,20.61%,CDH20;PCDH15;VWC2L;SLC17A6;SPHKAP;SEZ6L;ELAVL3;CNTNAP2;CADM2;MAGI2;PAK5;HCN1;PROX1;RNF152;PCBP3;CELF4;RAB3C;OLFM3;SGIP1;SAG;SNAP91;RBFOX1;FRRS1L;SCRT1;VSTM2B;SRRM4;NCAM1;NRXN1;AP3B2;PPFIA2;LSAMP;SLC24A2;MMD2;ST8SIA3;ADGRB3;GRM5;CTNNA2;UNC79;PAK3;TNR;LIN7A
prerank,Reactome_2022__Multifunctional Anion Exchangers R-HSA-427601,0.8710235472988258,1.4708832085823749,0.044444444444444446,0.7421671421710485,1.0,3/7,7.40%,SLC26A3;SLC26A7;SLC5A12
prerank,GO_Biological_Process_2021__dendritic spine organization (GO:0097061),0.654645710493076,1.4708499737325997,0.029411764705882353,0.7396854557567898,1.0,1/25,0.23%,ARC
prerank,GO_Biological_Process_2021__regulation of neuronal synaptic plasticity (GO:0048168),0.5960172916817796,1.4707923488486008,0.06060606060606061,0.7374807527662305,1.0,4/29,7.88%,ARC;APOE;PPFIA3;GRIK2
prerank,GO_Biological_Process_2021__actin filament reorganization (GO:0090527),0.7736708600852062,1.47078628553365,0.09090909090909091,0.7349289162514684,1.0,3/8,10.27%,EFS;CASS4;MCU
prerank,GO_Biological_Process_2021__peptidyl-tyrosine dephosphorylation (GO:0035335),0.6221529648904645,1.470567994435686,0.023255813953488372,0.7340456105418434,1.0,10/34,15.15%,DUSP4;DUSP2;PTPRO;PTPRZ1;PTPN9;DUSP18;PTPRB;UBASH3B;PTPRT;PTPRF
prerank,GO_Biological_Process_2021__cell junction assembly (GO:0034329),0.5251549477805646,1.4703320929405188,0.05,0.7328084753371793,1.0,26/92,16.07%,CDH20;SLITRK6;CDH19;CDH12;CDH7;NLGN1;CDH5;FZD5;SDK1;CDH6;DSCAM;FLNA;FARP1;LIMS1;NLGN3;CDH2;CDH24;CDH10;RYK;PKP4;FSCN1;CDH11;ACHE;NRXN1;PARD6B;CDHR3
prerank,CellMarker_Augmented_2021__Cancer Stem cell:Endometrium,-0.6407816738215732,-1.4700359756323818,0.013888888888888888,0.5253929447290612,1.0,17/76,12.14%,CD44;AHR;CLCA4;TCN1;RARRES1;SLC28A3;B3GNT5;TGFBI;PLAU;HLA-A;ANXA1;GBP1;OLFM4;CP;LAMC2;NSUN7;ITGB6
prerank,CellMarker_Augmented_2021__Oligodendrocyte Precursor cell:Brain,0.5431221855204239,1.4692072778533798,0.08571428571428572,0.7366524009671321,1.0,38/102,20.77%,PCDH15;LHFPL3;GRID2;PCDH17;ROBO2;NOVA1;LRRTM3;LRRC4C;ELAVL3;CADM2;MAGI2;PTPRZ1;KCNIP1;ADCY2;SORCS1;SCD5;NXPH1;NPAS3;RAB3C;ANK2;NRXN1;PTPRD;GABRB2;DLG2;SLITRK2;PPFIA2;LSAMP;FAT3;MMD2;ST8SIA3;ADGRB3;GRM5;CTNNA2;CSMD2;TNR;KCNJ10;PMP2;NTRK2
prerank,GO_Biological_Process_2021__regulation of sister chromatid cohesion (GO:0007063),-0.8295763587999659,-1.469169835342831,0.01639344262295082,0.5279291055018527,1.0,1/10,0.44%,BUB1
prerank,GO_Biological_Process_2021__postsynaptic membrane organization (GO:0001941),0.6509361042444448,1.469040467649749,0.030303030303030304,0.7351084331895934,1.0,8/19,15.58%,CEL;LHFPL4;APOE;NLGN1;GPHN;NLGN4X;NLGN3;NRXN1
prerank,CellMarker_Augmented_2021__Basophil:Undefined,-0.7539185866082209,-1.4687658583405871,0.05128205128205128,0.5282803597697718,1.0,1/20,0.01%,CD44
prerank,GO_Biological_Process_2021__C21-steroid hormone biosynthetic process (GO:0006700),0.7691231292807515,1.4687288520966157,0.044444444444444446,0.7341856449468426,1.0,1/9,10.75%,STARD3NL
prerank,CellMarker_Augmented_2021__Mesenchymal Stromal cell:Lymph,-0.9011209338316295,-1.468022184233024,0.0,0.5276179843953416,1.0,1/8,0.01%,CD44
prerank,CellMarker_Augmented_2021__Mesenchymal Stromal cell:Tonsil,-0.9011209338316295,-1.468022184233024,0.0,0.5276179843953416,1.0,1/8,0.01%,CD44
prerank,GO_Biological_Process_2021__mesonephric tubule development (GO:0072164),0.8222338085081429,1.4677830521125963,0.08695652173913043,0.7373772051728221,1.0,4/10,7.88%,ROBO2;PKD2;OSR1;SLIT2
prerank,GO_Biological_Process_2021__positive regulation of hormone secretion (GO:0046887),0.8111497242108822,1.4676912455652795,0.08571428571428572,0.735391524433704,1.0,1/10,0.49%,GRP
prerank,CellMarker_Augmented_2021__Red Blood Cell (erythrocyte):Blood,-0.6547892506927416,-1.4675851090130982,0.030303030303030304,0.527965633606478,1.0,27/52,18.85%,HCK;DOCK8;CYTIP;TAGAP;KLRB1;ALOX5;SLFN14;ARHGAP15;GYPB;FCGR3A;CA1;TRAF3IP3;MYO1F;IGSF6;PTPRC;ALAS2;SPI1;CLEC12A;ITGAM;ADGRE3;KCNE3;IKZF1;ADAM28;CD24;PIK3CG;SLC4A1;SASH3
prerank,GO_Biological_Process_2021__regulation of fat cell proliferation (GO:0070344),0.8897314028956205,1.467551174452557,0.06521739130434782,0.7336710935756469,1.0,2/5,3.92%,PER2;PID1
prerank,GO_Biological_Process_2021__negative regulation of insulin receptor signaling pathway (GO:0046627),0.6720204104317754,1.467321267430422,0.0,0.7331169613297439,1.0,10/25,25.85%,IRS1;PID1;KANK1;PTPRE;PIP4K2A;NCK1;SLC27A4;ENPP1;PRKCD;RPS6KB1
prerank,CellMarker_Augmented_2021__Oviduct-derived Stem cell:Oviduct,-0.7934911206028328,-1.4672368016985216,0.03076923076923077,0.5269684085450549,1.0,1/17,0.01%,CD44
prerank,GO_Biological_Process_2021__cytoplasmic sequestering of protein (GO:0051220),0.7763415870401518,1.4671085873057697,0.06382978723404255,0.7321662260717228,1.0,3/11,8.20%,PKD2;LATS1;FLNA
prerank,Reactome_2022__MyD88 Cascade Initiated On Plasma Membrane R-HSA-975871,0.4916817490220352,1.4662857802431375,0.0,0.7338151679595815,1.0,31/88,21.90%,DUSP4;MAPKAPK2;RIPK2;KCNH8;HMGB1;MAPK8;MAP3K1;ALPK1;RPS6KA3;N4BP1;PPP2R1B;TANK;NKIRAS2;TAB3;PELI1;NFKB1;RPS6KA2;PELI2;IRAK4;TP53;MAP2K7;PPP2R5D;S100B;TAB1;CREB1;TAB2;MAP2K6;TRAF6;FOS;CUL1;DUSP6
prerank,Reactome_2022__N-Glycan Antennae Elongation R-HSA-975577,0.7132067017859377,1.4662261219667472,0.18604651162790697,0.7317748935315267,1.0,3/15,8.40%,MGAT4C;B4GALT2;B4GALT3
prerank,Reactome_2022__Vitamin B5 (Pantothenate) Metabolism R-HSA-199220,-0.7732691448291178,-1.465996855491093,0.05970149253731343,0.5313913018045188,1.0,1/15,0.09%,ENPP2
prerank,"GO_Biological_Process_2021__heparan sulfate proteoglycan biosynthetic process, enzymatic modification (GO:0015015)",0.9155825215995859,1.4656856448352253,0.022727272727272728,0.7325720034587728,1.0,4/6,7.25%,HS6ST2;HS3ST3B1;HS3ST5;HS2ST1
prerank,GO_Biological_Process_2021__histone deacetylation (GO:0016575),0.621413597271243,1.4655310486780135,0.09090909090909091,0.7308949458882514,1.0,17/44,22.08%,PER2;HDAC3;HDAC10;PRDM5;SIRT1;SIRT7;MIER2;HDAC1;HDAC4;HDAC11;BAZ2A;SIRT6;BRMS1L;HDAC5;TBL1X;RCOR2;SMARCAD1
prerank,GO_Biological_Process_2021__positive regulation of superoxide anion generation (GO:0032930),-0.811703108730981,-1.465331859664154,0.04477611940298507,0.5328697585246329,1.0,4/10,16.13%,TGFB1;ITGB2;ITGAM;F2RL1
prerank,CellMarker_Augmented_2021__Cancer Stem-Like cell:Undefined,-0.93439998862436,-1.4650799796048748,0.015384615384615385,0.5315850369095922,1.0,1/5,0.01%,CD44
prerank,CellMarker_Augmented_2021__Monocyte:Lung,-0.66735590957035,-1.4648499603884728,0.014285714285714285,0.5306588305854868,1.0,20/47,13.42%,LILRB3;CLEC5A;ITGB2;HCK;PTAFR;C3AR1;MS4A4A;FCGR3A;LY86;VSIG4;NFAM1;IGSF6;FPR1;SPI1;CLEC12A;ITGAM;TLR2;FPR3;F13A1;CD300LF
prerank,GO_Biological_Process_2021__response to organic cyclic compound (GO:0014070),-0.6318463920399406,-1.4648045838718666,0.041666666666666664,0.5284314862267148,1.0,12/42,15.16%,AQP3;TGFB1;WNT8B;CYP1B1;CYP24A1;ESR1;ANXA1;CDKN2D;GLDC;GGT5;FGFR4;IL18
prerank,GO_Biological_Process_2021__nuclear DNA replication (GO:0033260),-0.8677285319529594,-1.4645528193538335,0.030303030303030304,0.5275630906615144,1.0,4/10,8.41%,MCM2;DONSON;MCM3;MCMDC2
prerank,GO_Biological_Process_2021__negative regulation of cellular carbohydrate metabolic process (GO:0010677),0.6553377805857316,1.4640106236234025,0.06666666666666667,0.7376448050758727,1.0,2/19,5.35%,GCK;CRY1
prerank,GO_Biological_Process_2021__insulin-like growth factor receptor signaling pathway (GO:0048009),0.8160855692762635,1.4639864901176358,0.06666666666666667,0.7353244061781774,1.0,3/11,7.70%,IRS1;EIF2AK3;PLCB1
prerank,Reactome_2022__Toll Like Receptor 3 (TLR3) Cascade R-HSA-168164,0.49505847336694453,1.4637654236060296,0.0,0.733899265676901,1.0,31/94,21.90%,DUSP4;MAPKAPK2;RIPK2;KCNH8;SARM1;HMGB1;MAPK8;ALPK1;RPS6KA3;N4BP1;PPP2R1B;TICAM1;TANK;FADD;NKIRAS2;TAB3;NFKB1;RPS6KA2;TP53;MAP2K7;PPP2R5D;S100B;TAB1;CREB1;TAB2;MAP2K6;TRAF6;FOS;UBE2D2;CUL1;DUSP6
prerank,Reactome_2022__Hormone Ligand-Binding Receptors R-HSA-375281,-0.9148705737091276,-1.4632478389711627,0.0,0.5327129052584545,1.0,3/7,5.89%,GNRHR;TSHR;GPHB5
prerank,GO_Biological_Process_2021__intestinal cholesterol absorption (GO:0030299),0.8435389774572624,1.4632249188339141,0.07894736842105263,0.7349201473677149,1.0,4/9,9.94%,CEL;AKR1C1;SOAT2;LDLR
prerank,GO_Biological_Process_2021__positive regulation of lamellipodium morphogenesis (GO:2000394),-0.8981840901868933,-1.463200458668131,0.01818181818181818,0.5306430440237114,1.0,1/7,0.09%,ENPP2
prerank,Reactome_2022__Cytosolic Sensors Of Pathogen-Associated DNA R-HSA-1834949,-0.6398660461084559,-1.4624965362622246,0.02702702702702703,0.5319078915732764,1.0,2/56,2.27%,NLRP4;AIM2
prerank,CellMarker_Augmented_2021__Eosinophil:Blood,-0.9044510991781257,-1.4623910538184206,0.016666666666666666,0.5301639026472715,1.0,1/11,0.01%,CD44
prerank,GO_Biological_Process_2021__positive regulation of cAMP-mediated signaling (GO:0043950),-0.9522948483070887,-1.4623011838901783,0.0,0.5284023919301487,1.0,2/6,3.68%,GPR62;SCTR
prerank,CellMarker_Augmented_2021__Transitional B cell:Blood,-0.6661519062580036,-1.4620396442622627,0.04225352112676056,0.527224234650476,1.0,11/35,12.65%,DENND1C;JCHAIN;MACC1;HCK;VAV3;ALOX5;PTAFR;CEACAM1;NSUN7;BLNK;HSH2D
prerank,GO_Biological_Process_2021__very-low-density lipoprotein particle remodeling (GO:0034372),0.881368646812814,1.4616834591704462,0.02,0.7407920527616348,1.0,3/5,9.91%,LIPC;APOE;LPL
prerank,PanglaoDB_Augmented_2021__Airway Epithelial Cells,-0.6218909187641565,-1.4612931742792994,0.057971014492753624,0.528647709748921,1.0,25/57,19.98%,PLEKHS1;DUOX1;ST6GALNAC1;CLCA4;TMC4;DUOXA1;FUT2;SLC5A1;CYP2B7P;MAP3K19;BPIFB1;MS4A8;CP;ZNF750;TRIM29;CYP4F12;MUC4;PROM2;ADH7;CYP4B1;MUC15;CAPN13;FAM3D;CBLC;FAM83F
prerank,GO_Biological_Process_2021__regulation of DNA-dependent DNA replication initiation (GO:0030174),-0.959617862794804,-1.4606221058916828,0.0,0.5303889691594038,1.0,1/5,0.45%,TICRR
prerank,GO_Biological_Process_2021__regulation of cilium beat frequency (GO:0003356),-0.8926626027729143,-1.460511730227267,0.016129032258064516,0.5283290066098445,1.0,2/6,2.89%,DNAH11;CCDC39
prerank,GO_Biological_Process_2021__leukocyte adhesion to vascular endothelial cell (GO:0061756),0.7495253053525752,1.4601728386209467,0.075,0.7484174672263291,1.0,5/15,4.73%,SELPLG;PODXL2;SLC39A8;CX3CR1;ITGA4
prerank,GO_Biological_Process_2021__negative regulation of protein transport (GO:0051224),0.6434311891891894,1.460158818552549,0.075,0.7461480067253351,1.0,4/21,7.94%,APOE;CSK;DRD4;WWP2
prerank,Reactome_2022__Signaling By NTRKs R-HSA-166520,0.5222449356618397,1.4599169631110869,0.0,0.7449515155975512,1.0,31/124,19.39%,ARC;NGF;DUSP4;MAPKAPK2;IRS1;BCL11B;KCNH8;TPH1;RALB;CRK;RAPGEF1;SGK1;RALA;RPS6KA3;IRS2;PPP2R1B;RAP1A;ASCL1;CHD4;RPS6KA2;PIK3CA;FURIN;MAPK12;CRKL;RIT2;BRAF;PPP2R5D;EP300;CREB1;SOS1;CDK5
prerank,CellMarker_Augmented_2021__Decidual cell:Blood,-0.6230248321007199,-1.4596598349760004,0.02857142857142857,0.5305803998201915,1.0,8/83,10.00%,CD44;APOL1;AHR;SP100;LRP10;NFKB2;ANXA1;GBP1
prerank,GO_Biological_Process_2021__N-glycan processing (GO:0006491),0.6934622499873964,1.4593629524712017,0.07894736842105263,0.7458726593748582,1.0,6/19,12.41%,GANC;PRKCSH;ST8SIA4;MAN1A2;MAN2A1;MAN1A1
prerank,CellMarker_Augmented_2021__Colonic Stem cell:Colon,0.538779497092544,1.4593277029740277,0.029411764705882353,0.7437764829034892,1.0,24/89,16.18%,TEAD2;GPR161;LOXL1;PARD3;TBC1D16;DCBLD2;MID1;IL17RD;P3H3;ERBB2;ASAP3;RAI14;AADAT;P3H4;CHST3;TSPAN6;RBFOX2;LRIG3;MAGI1;ANTXR1;PTPRF;MAGED1;DLG5;FRAS1
prerank,GO_Biological_Process_2021__positive regulation of macrophage activation (GO:0043032),-0.7531199133168189,-1.4590336279254126,0.046153846153846156,0.531245749523505,1.0,3/12,9.78%,WNT5A;TAFA3;THBS1
prerank,GO_Biological_Process_2021__response to vitamin (GO:0033273),-0.8401692309988863,-1.4585717667989972,0.08771929824561403,0.5314829607045471,1.0,3/7,11.88%,AQP3;CYP24A1;CDKN2D
prerank,GO_Biological_Process_2021__protein localization to cell surface (GO:0034394),0.6191105073740569,1.4584225613406527,0.075,0.7461725994035998,1.0,6/25,14.65%,FGF10;ANGPT1;FLNA;GGA1;SMURF1;ANK2
prerank,CellMarker_Augmented_2021__Lymphocyte:Peripheral Blood,-0.6598718186744653,-1.4582688935672399,0.04225352112676056,0.530845025483436,1.0,26/49,19.68%,RASGRP4;TMEM150B;GMFG;ITGB2;HCK;ARHGAP9;RAB44;C3AR1;MS4A4A;PARVG;WAS;LY86;NFAM1;MYO1F;SPI1;CLEC12A;ITGAM;CD300LF;KCNE3;IKZF1;CD4;HK3;TBXAS1;SASH3;P2RX1;ITGAX
prerank,GO_Biological_Process_2021__bundle of His cell action potential (GO:0086043),-0.9675699353905799,-1.457949015048219,0.0,0.5306634077374894,1.0,2/5,2.14%,SCN5A;KCNA5
prerank,CellMarker_Augmented_2021__Monocyte:Liver,-0.6627591955561439,-1.4577913456161224,0.030303030303030304,0.5292013255304153,1.0,20/41,13.64%,LILRB3;ITGB2;HCK;PTAFR;C3AR1;MS4A4A;FCGR3A;LY86;VSIG4;NFAM1;MYO1F;IGSF6;FPR1;SLC11A1;SPI1;CLEC12A;ITGAM;TLR2;CD300LF;ADGRE3
prerank,GO_Biological_Process_2021__regulation of sprouting angiogenesis (GO:1903670),-0.6671757913742716,-1.4572495762196827,0.05263157894736842,0.5306240455627708,1.0,6/29,13.78%,EPN1;ALOX5;CEACAM1;THBS1;PIK3CB;ITGA5
prerank,GO_Biological_Process_2021__positive regulation of cell projection organization (GO:0031346),0.5174501292450289,1.4561561085703223,0.0,0.7563905156576722,1.0,37/109,22.41%,NGF;ZNF804A;ROBO2;APOE;GRIP1;MAGI2;TOX;EPHA3;RAPGEF1;FZD1;SLIT2;TENM3;ARSB;STYXL1;PLXNB1;ABL2;RETREG3;AVIL;MAP3K13;RET;RAP1A;ARHGAP35;MAP6;FUT9;CUX1;PTPRD;RIT2;ROR1;PLXNA4;EP300;CHODL;MARK2;NTRK2;PTK7;PLPPR5;CARMIL2;LRRC7
prerank,GO_Biological_Process_2021__regulation of hepatocyte proliferation (GO:2000345),-0.8942404518292268,-1.4561172152201003,0.029411764705882353,0.534576212661184,1.0,1/6,7.40%,CEACAM1
prerank,CellMarker_Augmented_2021__Mesenchymal Progenitor cell:Osteoarthritic Cartilage,-0.9495050546284904,-1.4560331181140178,0.031746031746031744,0.5326100169850446,1.0,1/5,0.01%,CD44
prerank,GO_Biological_Process_2021__peptidyl-threonine dephosphorylation (GO:0035970),0.6823859642935726,1.4552861456493367,0.07317073170731707,0.759015629493485,1.0,5/20,11.51%,DUSP4;DUSP2;PPP5C;DUSP18;PPM1A
prerank,GO_Biological_Process_2021__positive regulation of receptor signaling pathway via STAT (GO:1904894),0.7253985597964255,1.4549688407499528,0.14285714285714285,0.758556351155066,1.0,5/20,7.70%,IL7R;KIT;HES1;F2;OCIAD2
prerank,GO_Biological_Process_2021__gamma-delta T cell activation (GO:0046629),-0.9577422434170805,-1.4548479988887604,0.041666666666666664,0.5366455487715777,1.0,2/6,0.67%,MICB;TCF7
prerank,CellMarker_Augmented_2021__Myoepithelial cell:Breast,-0.9908495098794654,-1.4536453820791677,0.0,0.5421518955606074,1.0,1/6,0.01%,CD44
prerank,CellMarker_Augmented_2021__Mesenchymal Stem cell:Brown Adipose Tissue,0.5639440675864783,1.4535863956365929,0.0,0.7643104246439281,1.0,39/100,19.89%,FREM1;ESRRG;ADGRL2;EPHA7;ALDH7A1;MID1;GPC6;PCLO;USH2A;DTNA;PROX1;CGNL1;HFM1;ZNF385B;GUCY1A2;CAP2;STOX2;FGF12;COBL;MPDZ;DDAH1;FARP1;RNF150;DST;CDH2;LRP1B;MAGI1;ASXL3;ANK2;PPP1R9A;PTPRD;FRAS1;MARK1;PBX1;DZIP1;EPB41L4B;NAV2;PRKAA2;SLC25A27
prerank,GO_Biological_Process_2021__cilium-dependent cell motility (GO:0060285),-0.7714614365762735,-1.453218768512946,0.08333333333333333,0.5425207534221106,1.0,8/20,17.71%,TEKT5;CCDC39;TEKT3;DRC1;DNAH17;DNAH3;DNAH2;RSPH9
prerank,GO_Biological_Process_2021__urate metabolic process (GO:0046415),0.8004527962598569,1.4530363183458146,0.08163265306122448,0.7649161616228514,1.0,2/7,0.95%,PNP;SLC16A9
prerank,CellMarker_Augmented_2021__Intestinal Stem cell:Small Intestine,0.7661721211618088,1.4521575631095338,0.05263157894736842,0.7675285738003237,1.0,2/9,2.39%,LGR5;ALCAM
prerank,Reactome_2022__Ephrin Signaling R-HSA-3928664,0.7006113266373589,1.4520291495842879,0.08333333333333333,0.7656968301052216,1.0,1/18,0.26%,EFNB1
prerank,CellMarker_Augmented_2021__Luminal progenitor:Breast,-0.9202296458301475,-1.451976702910117,0.0,0.5468357550298864,1.0,1/5,0.01%,CD44
prerank,GO_Biological_Process_2021__cardiac muscle cell contraction (GO:0086003),-0.7439799868119042,-1.4517642983044285,0.03225806451612903,0.545726287442104,1.0,2/19,1.19%,PKP2;SCN5A
prerank,GO_Biological_Process_2021__protein processing involved in protein targeting to mitochondrion (GO:0006627),0.8696241641610165,1.4514142797821037,0.0,0.7664320114801702,1.0,2/5,6.40%,IMMP2L;IMMP1L
prerank,GO_Biological_Process_2021__long-chain fatty acid transport (GO:0015909),0.6640795578615215,1.4513950703747691,0.0,0.764105477607598,1.0,10/29,12.79%,APOE;MFSD2A;LCN12;PPARG;SLC27A2;ACACB;ABCD3;ABCD2;ACSL1;CPT1A
prerank,GO_Biological_Process_2021__exit from mitosis (GO:0010458),0.716432434277978,1.4509121707980857,0.07894736842105263,0.765025743156328,1.0,3/11,13.00%,SIRT7;SPAST;EPS8
prerank,CellMarker_Augmented_2021__Lake Et al.Science.Ex8:Brain,0.5688894177962732,1.450604880592877,0.041666666666666664,0.764467206269496,1.0,19/58,16.18%,PLD5;ZNF804B;MYO10;ITGA11;RASGEF1C;RIN2;SMYD1;FAM151B;OLFML2B;LTBP1;NR4A2;GAS2L3;RNF152;NTNG2;LIMS1;TESC;HPSE2;SNTB1;FRAS1
prerank,Reactome_2022__Eukaryotic Translation Elongation R-HSA-156842,-0.616910064076983,-1.450414718300324,0.013513513513513514,0.551964745062415,1.0,55/83,27.12%,RPL37A;RPL38;RPL15;RPS4X;RPL3;RPL35A;RPS9;FAU;RPS27;EEF2;RPS21;RPL13A;RPL27A;RPS16;RPL36;RPS20;RPL7A;RPL9;RPS8;RPS27A;RPL21;RPL34;RPL4;RPL32;RPL5;RPL23;RPL41;RPS7;RPS11;RPL27;RPL35;RPS14;RPL11;RPS15;RPLP1;RPS12;RPL18A;RPS13;RPL29;RPLP2;RPL28;RPL12;RPL18;RPS3;RPL22;EEF1A1;RPSA;RPS28;RPS19;RPS24;RPL26L1;RPS3A;RPL19;RPL8;RPS6
prerank,Reactome_2022__Nuclear Events (Kinase And Transcription Factor Activation) R-HSA-198725,0.5501980869783097,1.4503463170826436,0.029411764705882353,0.7635449408816167,1.0,11/58,14.29%,ARC;DUSP4;MAPKAPK2;KCNH8;TPH1;SGK1;RPS6KA3;PPP2R1B;ASCL1;CHD4;RPS6KA2
prerank,GO_Biological_Process_2021__negative regulation of small molecule metabolic process (GO:0062014),0.6718945020112218,1.4500653905083778,0.03333333333333333,0.7629485945312038,1.0,4/16,5.35%,GCK;WNT4;BCKDK;CRY1
prerank,GO_Biological_Process_2021__positive regulation of keratinocyte proliferation (GO:0010838),0.878189898422091,1.4491532666230393,0.0,0.7652296007508576,1.0,1/7,1.19%,FGF10
prerank,CellMarker_Augmented_2021__Unrestricted Somatic Stem cell:Undefined,-0.9141850128057701,-1.4491425039015402,0.01818181818181818,0.5566462463688137,1.0,1/6,0.01%,CD44
prerank,KEGG_2021_Human__Glucagon signaling pathway,0.5365235277750932,1.4489973655164656,0.0625,0.7635858133917081,1.0,15/83,9.44%,GCK;FOXO1;FBP2;ITPR2;CREB3L2;SIRT1;CREB3L4;PFKP;G6PC3;ACACB;PLCB1;ADCY2;GYS1;CPT1C;AKT2
prerank,CellMarker_Augmented_2021__Stem cell:Liver,-0.7839332684774895,-1.4484969651081177,0.016129032258064516,0.557527690832338,1.0,1/18,0.01%,CD44
prerank,GO_Biological_Process_2021__hematopoietic stem cell proliferation (GO:0071425),-0.8090165433971205,-1.4478481158746779,0.05555555555555555,0.5587062786051548,1.0,2/11,2.54%,ARIH2;WNT5A
prerank,CellMarker_Augmented_2021__Myeloid-derived Suppressor cell:Liver,-0.6613169301735605,-1.4477543682829481,0.028985507246376812,0.5545720269350775,1.0,19/52,13.42%,RASGRP4;GMFG;ITGB2;HCK;ARHGAP9;C3AR1;PARVG;FCGR3A;WAS;LY86;NFAM1;MYO1F;IGSF6;PTPRC;SLC11A1;SPI1;CLEC12A;ITGAM;CD300LF
prerank,CellMarker_Augmented_2021__Myeloid-derived Suppressor cell:Blood,-0.6613169301735605,-1.4477543682829481,0.028985507246376812,0.5545720269350775,1.0,19/52,13.42%,RASGRP4;GMFG;ITGB2;HCK;ARHGAP9;C3AR1;PARVG;FCGR3A;WAS;LY86;NFAM1;MYO1F;IGSF6;PTPRC;SLC11A1;SPI1;CLEC12A;ITGAM;CD300LF
prerank,GO_Biological_Process_2021__positive regulation of regulated secretory pathway (GO:1903307),0.6448057604875213,1.4474003365312884,0.05555555555555555,0.7702941974639671,1.0,3/16,4.44%,RAB27A;NLGN1;DOC2B
prerank,PanglaoDB_Augmented_2021__Retinal Progenitor Cells,0.5344874021687473,1.4473975910430612,0.10526315789473684,0.7680574269014739,1.0,29/102,14.87%,LGR5;MEGF10;LHFPL4;LRRC4C;UNC5D;ELAVL3;CADM2;PCLO;HES1;PAK5;SLC35F1;PTPRZ1;ERC2;CASKIN1;CELF5;GALNT13;WNK2;STOX2;CSPG5;RIMS4;RHBDL3;CRABP1;SAG;SNAP91;MAP6;MSI1;SCRT1;ANK2;SRRM3
prerank,Reactome_2022__MAP Kinase Activation R-HSA-450294,0.5394822167123259,1.4472787771646112,0.029411764705882353,0.7665101054375223,1.0,20/59,21.90%,DUSP4;MAPKAPK2;RIPK2;KCNH8;MAPK8;RPS6KA3;PPP2R1B;TAB3;NFKB1;RPS6KA2;MAP2K7;PPP2R5D;TAB1;CREB1;TAB2;MAP2K6;TRAF6;FOS;CUL1;DUSP6
prerank,GO_Biological_Process_2021__cellular component disassembly (GO:0022411),-0.6566526636158706,-1.4470175469037065,0.057971014492753624,0.5559286652036686,1.0,4/46,4.05%,CD44;MMP9;MMP19;SCUBE3
prerank,CellMarker_Augmented_2021__Delta cell:Pancreas,0.6843302423396727,1.4470015495424935,0.075,0.7656460218189719,1.0,4/16,9.33%,POU3F1;ETV1;PDLIM4;LCORL
prerank,CellMarker_Augmented_2021__T cell:Undefined,0.5450754485312844,1.4468786790707064,0.0,0.7638912099203299,1.0,5/57,4.73%,IL7R;CD38;KLRD1;APOE;ITGA4
prerank,GO_Biological_Process_2021__endosomal vesicle fusion (GO:0034058),0.8431557628187228,1.4468709235100226,0.03636363636363636,0.7616109376519111,1.0,2/8,6.49%,SAMD9;VPS8
prerank,PanglaoDB_Augmented_2021__Anterior Pituitary Gland Cells,0.5268176569901616,1.4468678230654604,0.043478260869565216,0.7594332954008005,1.0,31/117,15.95%,ZNF385D;SLC17A6;RAB27A;FGF10;ROBO2;CNGA3;NOVA1;ANGPT1;UNC5D;CADM2;MAGI2;HFM1;RSPO2;CELF4;PDZRN3;RAB3C;RNF150;OLFM3;SGIP1;PDZRN4;SNAP91;MAP6;RBFOX1;ASXL3;NKTR;CDH11;CFC1;NRXN1;FGF14;NREP;PTPRD
prerank,GO_Biological_Process_2021__homologous chromosome pairing at meiosis (GO:0007129),-0.6955821301688377,-1.4468143128075122,0.030303030303030304,0.5549381064019165,1.0,4/26,3.06%,IHO1;MEIOB;SYCP1;STAG3
prerank,GO_Biological_Process_2021__extracellular matrix disassembly (GO:0022617),-0.6640431535120654,-1.4466764872904183,0.030303030303030304,0.5532696021566619,1.0,4/46,4.05%,CD44;MMP9;MMP19;SCUBE3
prerank,GO_Biological_Process_2021__negative regulation of striated muscle tissue development (GO:0045843),-0.9025538924037746,-1.4465900465373864,0.0,0.5512284822219197,1.0,1/5,1.49%,TGFB1
prerank,CellMarker_Augmented_2021__Stem cell:Endometrium,0.8078376164264576,1.4465557900655095,0.02857142857142857,0.7588224491641725,1.0,4/12,2.83%,LGR5;KIT;ALCAM;CDH5
prerank,CellMarker_Augmented_2021__Stem cell:Amniotic Membrane,-0.6096023211496612,-1.446384767725806,0.05714285714285714,0.549825194410658,1.0,19/92,11.19%,CD44;CLCA2;RAB34;TIMP3;PDCD1LG2;ELK3;LPAR1;TGFBI;DAB2;PLAU;TGM2;ABCG2;ANXA1;HEG1;OSMR;ITGBL1;GBP1;CAV2;AFAP1L1
prerank,CellMarker_Augmented_2021__CD4+ Memory T cell:Peripheral Blood,0.6061532832343878,1.4461313265788587,0.02857142857142857,0.7586136024193424,1.0,7/30,5.09%,IL7R;SELPLG;CD247;TRAC;GPR174;IL16;PYHIN1
prerank,Reactome_2022__Signaling By Leptin R-HSA-2586552,0.7745875763120863,1.446126187306972,0.02127659574468085,0.7563758041821173,1.0,3/8,10.67%,IRS1;STAT5B;IRS2
prerank,GO_Biological_Process_2021__regulation of nitrogen compound metabolic process (GO:0051171),0.8667514612866867,1.4460521933307613,0.06818181818181818,0.7545032064201552,1.0,3/6,9.94%,APOE;MFSD2A;LDLR
prerank,GO_Biological_Process_2021__regulation of response to DNA damage stimulus (GO:2001020),0.6274738769164432,1.445800870308005,0.05714285714285714,0.7532119740946621,1.0,7/38,8.03%,SMYD2;RFWD3;CRY1;SIRT7;RADX;ABL1;MYC
prerank,Reactome_2022__SRP-dependent Cotranslational Protein Targeting To Membrane R-HSA-1799339,-0.5865840569521825,-1.4445368293329188,0.013333333333333334,0.5584518832242714,1.0,58/102,27.12%,RPL37A;RPL38;RPL15;RPS4X;RPL3;RPL35A;RPS9;FAU;RPS27;RPS21;SRP14;RPL13A;RPL27A;RPS16;RPL36;RPS20;RPL7A;RPL9;RPS8;RPS27A;RPL21;RPL34;RPL4;RPL32;RPL5;RPL23;RPL41;RPS7;RPS11;SRP19;RPL27;RPL35;SSR4;RPS14;RPL11;RPS15;RPLP1;RPS12;RPL18A;RPS13;RPL29;RPLP2;RPL28;RPL12;RPL18;RPS3;RPL22;RPSA;RPS28;SPCS2;RPS19;RPS24;RPL26L1;RPS3A;RPL19;SPCS1;RPL8;RPS6
prerank,GO_Biological_Process_2021__positive regulation of alpha-beta T cell differentiation (GO:0046638),0.801258467205135,1.444254413836433,0.125,0.7586216270688081,1.0,4/10,8.09%,PNP;ZBTB7B;CBFB;NKAP
prerank,PanglaoDB_Augmented_2021__Kupffer Cells,-0.6050978504633616,-1.4440671411272072,0.05555555555555555,0.5585276207894039,1.0,30/75,16.09%,LILRB3;CLEC5A;C1QB;ITGB2;HCK;CHIT1;TNFRSF1B;PTAFR;C3AR1;MS4A4A;PARVG;FCGR3A;LY86;VSIG4;NFAM1;ADGRE1;MYO1F;IGSF6;FPR1;SLC11A1;SPI1;GPIHBP1;CLEC12A;ITGAM;TLR2;CD300LF;VDR;STARD5;CD4;HK3
prerank,GO_Biological_Process_2021__AV node cell to bundle of His cell communication (GO:0086067),-0.9453912328398948,-1.4438951043860164,0.017857142857142856,0.5575796704898138,1.0,2/5,2.05%,SCN5A;GJC3
prerank,"GO_Biological_Process_2021__regulation of DNA damage response, signal transduction by p53 class mediator (GO:0043516)",-0.7332871486184456,-1.443313700090407,0.015873015873015872,0.5591140022915617,1.0,1/24,0.01%,CD44
prerank,CellMarker_Augmented_2021__Megakaryocyte Erythroid cell:Undefined,0.5456292525361646,1.443204861399974,0.0,0.7616442709453595,1.0,5/55,4.73%,IL7R;CD38;KLRD1;APOE;ITGA4
prerank,GO_Biological_Process_2021__cellular response to hormone stimulus (GO:0032870),0.5570369009714382,1.4425047671838955,0.0,0.7631270884843193,1.0,10/64,7.88%,GCK;ROBO2;URI1;AKR1C3;STAT5B;NCOA3;NCOA2;AKR1C1;MGARP;SLIT2
prerank,PanglaoDB_Augmented_2021__Retinal Ganglion Cells,0.5141806694687627,1.4424745255355604,0.03571428571428571,0.7612620608803503,1.0,35/154,14.87%,SLC17A6;NGF;THEM4;POU6F2;NKAIN3;YDJC;GRIP1;CDK14;CPNE4;HRH3;ELAVL3;DTX1;PAK5;SLC35F1;KCTD8;ERC2;ADGRA1;CSDC2;GPHN;CELF5;DPP10;BTBD10;BRINP1;NXPH1;FGF12;AKAP7;OLFM3;FBLL1;SNAP91;MAP6;RBFOX1;RTN2;SCRT1;VSTM2B;SRRM3
prerank,GO_Biological_Process_2021__carbohydrate transport (GO:0008643),-0.7925258269320512,-1.4423711818942881,0.06779661016949153,0.5626950803108213,1.0,2/12,6.12%,AQP3;SLC5A1
prerank,PanglaoDB_Augmented_2021__GABAergic Neurons,0.5163325393936178,1.441837204592357,0.06896551724137931,0.7628671364739494,1.0,29/112,15.51%,NTSR2;SLC17A6;SPHKAP;SPTBN4;LRRTM3;KCNC2;ELAVL3;NKAIN2;CADM2;PAK5;DLX1;KCNIP1;LRFN5;ADGRA1;PARM1;ABCC8;BRINP1;RGS7BP;NXPH1;OLFM3;SNAP91;MAP6;RBFOX1;SYN2;PTPRT;SCRT1;ANK2;VSTM2B;UBE2QL1
prerank,PanglaoDB_Augmented_2021__Glutaminergic Neurons,0.5653700226703081,1.4414217638927846,0.08,0.7632556871998544,1.0,38/107,22.61%,SLC17A6;SPHKAP;GRM3;LRRTM3;KCNC2;ELAVL3;MAGI2;PAK5;ADGRA1;CELF5;CELF4;GRIN1;GABRG1;NXPH1;OLFM3;SNAP91;FUT9;RBFOX1;FRRS1L;SCRT1;SRRM4;NRXN1;RIT2;DLG2;GABRA2;PPFIA2;LSAMP;MMD2;ST8SIA3;GRM5;CTNNA2;UNC79;TNR;HPCA;GRM1;TMEM196;GRIA4;NOL4
prerank,GO_Biological_Process_2021__negative regulation of ion transmembrane transporter activity (GO:0032413),-0.7345270180838372,-1.4407317790714318,0.07692307692307693,0.5704938417544804,1.0,3/18,2.76%,CASQ2;MMP9;CAV3
prerank,GO_Biological_Process_2021__SA node cell action potential (GO:0086015),-0.8950259433693579,-1.4406327277587947,0.045454545454545456,0.5687944441018988,1.0,2/7,2.14%,SCN5A;KCNA5
prerank,Reactome_2022__Interleukin-17 Signaling R-HSA-448424,0.5246415167057934,1.4405075164810623,0.02702702702702703,0.7657486628104659,1.0,20/62,21.90%,DUSP4;MAPKAPK2;RIPK2;KCNH8;MAPK8;RPS6KA3;PPP2R1B;TAB3;NFKB1;RPS6KA2;MAP2K7;PPP2R5D;TAB1;CREB1;TAB2;MAP2K6;TRAF6;FOS;CUL1;DUSP6
prerank,GO_Biological_Process_2021__cell cycle checkpoint signaling (GO:0000075),-0.8118255898916265,-1.4404591153972817,0.07272727272727272,0.5674809259136687,1.0,2/11,6.24%,BUB1;ZWILCH
prerank,Reactome_2022__Signaling By ERBB2 TMD/JMD Mutants R-HSA-9665686,0.7024050799222902,1.4402422174619807,0.03225806451612903,0.7656980320630697,1.0,4/19,7.38%,NRG2;ERBB2;NRG1;NRG3
prerank,GO_Biological_Process_2021__protein localization to kinetochore (GO:0034501),-0.7648620133786065,-1.4402070704704488,0.07547169811320754,0.566463127723617,1.0,2/13,7.32%,ZWILCH;TTK
prerank,GO_Biological_Process_2021__ceramide catabolic process (GO:0046514),0.7001675039752455,1.4399388703408444,0.05128205128205128,0.765476701255494,1.0,5/14,15.83%,GLA;ACER2;ACER3;NEU4;NEU3
prerank,CellMarker_Augmented_2021__Stem cell:Amniotic Fluid,-0.8534255061851448,-1.4398976671435897,0.03225806451612903,0.5662778576173636,1.0,1/10,0.01%,CD44
prerank,GO_Biological_Process_2021__epithelial tube morphogenesis (GO:0060562),0.6384851485035952,1.439728966485619,0.06060606060606061,0.7645319971167093,1.0,5/27,7.88%,FGF10;SCRIB;PKD2;HES1;SLIT2
prerank,CellMarker_Augmented_2021__Epithelial cell:Breast,0.9466371693529323,1.4397071037514595,0.0,0.7627000669121593,1.0,2/5,2.39%,KIT;ALCAM
prerank,GO_Biological_Process_2021__negative regulation of amino acid transport (GO:0051956),0.8721306474056545,1.4395325988228893,0.06976744186046512,0.7615566607604114,1.0,2/5,9.91%,HRH3;GRM7
prerank,Reactome_2022__Erythropoietin Activates STAT5 R-HSA-9027283,0.8409191977781779,1.4393359504888645,0.0,0.7604619788542649,1.0,3/7,10.67%,STAT5B;EPOR;IRS2
prerank,GO_Biological_Process_2021__protein localization to endosome (GO:0036010),0.7412009389653498,1.4392980496055936,0.04878048780487805,0.7587412851290243,1.0,4/10,12.14%,PACSIN2;WASHC2C;RAB35;WASHC2A
prerank,Reactome_2022__Frs2-mediated Activation R-HSA-170968,0.6945025378515784,1.4391735234097045,0.06818181818181818,0.7570722851062832,1.0,5/12,17.32%,NGF;RAPGEF1;RAP1A;CRKL;BRAF
prerank,Reactome_2022__p75NTR Signals Via NF-kB R-HSA-193639,0.7078385761536384,1.4385604536166925,0.04081632653061224,0.758723458978659,1.0,2/14,3.92%,NGF;RIPK2
prerank,GO_Biological_Process_2021__regulation of protein metabolic process (GO:0051246),0.5877315201737418,1.437991733738532,0.0,0.759947487448413,1.0,14/38,21.17%,APOE;SPOPL;MAPK8;CHMP6;LDLR;ODC1;SSH1;FURIN;SNF8;SPOP;FAF1;ABCA7;GSAP;ACE
prerank,CellMarker_Augmented_2021__M2 macrophage:Lung,-0.6428250616682203,-1.437947448935334,0.0273972602739726,0.5753561444857401,1.0,23/51,16.09%,CLEC5A;C1QB;ITGB2;HCK;SLC7A7;HLA-DMA;C3AR1;MS4A4A;FCGR3A;LY86;VSIG4;HLA-DPB1;IGSF6;SPI1;CLEC12A;ITGAM;TLR2;FPR3;HLA-DPA1;CD300LF;ADAMDEC1;CD4;HK3
prerank,GO_Biological_Process_2021__purine-containing compound catabolic process (GO:0072523),0.7456950684431616,1.4376545406326748,0.08333333333333333,0.7596226965014633,1.0,2/12,4.57%,PNP;NT5C1A
prerank,PanglaoDB_Augmented_2021__Serotonergic Neurons,-0.5794832906654143,-1.437610688438054,0.027777777777777776,0.5750533235628967,1.0,22/60,14.69%,SLC28A2;CLCA1;IYD;ABCC6;SCTR;FMO5;CYP3A5;ALDOB;PBLD;SLC5A1;SLC5A9;SLC3A1;CYP3A4;HNF1A;ACSM3;SLC18A2;VIL1;SLC22A3;SLC6A4;MUC17;TFPI;NR1H4
prerank,GO_Biological_Process_2021__carbohydrate derivative catabolic process (GO:1901136),0.6849911734492546,1.4364798417850635,0.09090909090909091,0.763621941466707,1.0,5/17,17.02%,AOAH;NEU4;NGLY1;FBXO27;SAMHD1
prerank,GO_Biological_Process_2021__regulation of cellular component movement (GO:0051270),0.5668303863881049,1.4364629231506993,0.10714285714285714,0.7615480900239721,1.0,9/48,10.13%,TGFBR1;ZSWIM5;NRG2;ERBB2;NRG1;CDK6;ABL1;ABL2;PKN2
prerank,CellMarker_Augmented_2021__Cancer Stem cell:Colorectum,-0.7590580289089186,-1.4364500081144485,0.06153846153846154,0.579699601968566,1.0,1/16,0.01%,CD44
prerank,CellMarker_Augmented_2021__Mesenchymal Stem cell:Gingiva,-0.8994629086548818,-1.4361566480540948,0.017241379310344827,0.5792704640767569,1.0,1/7,0.01%,CD44
prerank,GO_Biological_Process_2021__positive regulation of sodium ion transport (GO:0010765),-0.8430819474292524,-1.43608156591359,0.046153846153846156,0.5774221053135037,1.0,2/10,1.19%,PKP2;SCN5A
prerank,GO_Biological_Process_2021__cellular response to type I interferon (GO:0071357),-0.6588182435769616,-1.4354404685578166,0.06349206349206349,0.5767569211607769,1.0,17/42,22.43%,IRF4;SP100;IRF1;STAT1;OAS2;IFIT3;HLA-A;IFIT1;OAS1;HLA-F;IFIT2;IFI35;IFI27;MX1;IFI6;ISG15;HLA-C
prerank,GO_Biological_Process_2021__type I interferon signaling pathway (GO:0060337),-0.6588182435769616,-1.4354404685578166,0.06349206349206349,0.5767569211607769,1.0,17/42,22.43%,IRF4;SP100;IRF1;STAT1;OAS2;IFIT3;HLA-A;IFIT1;OAS1;HLA-F;IFIT2;IFI35;IFI27;MX1;IFI6;ISG15;HLA-C
prerank,GO_Biological_Process_2021__pyrimidine ribonucleotide metabolic process (GO:0009218),0.9093699632403088,1.4348018146805142,0.0,0.7672971240887752,1.0,1/5,3.83%,AK3
prerank,GO_Biological_Process_2021__modulation of excitatory postsynaptic potential (GO:0098815),0.6432628331701612,1.4347081650394888,0.0,0.7657191717312632,1.0,7/27,15.58%,NLGN1;SLC8A3;GRIN1;NLGN4X;RIMS2;NLGN3;NRXN1
prerank,"GO_Biological_Process_2021__DNA damage response, signal transduction resulting in transcription (GO:0042772)",-0.7765783837554094,-1.434598274456413,0.08064516129032258,0.5791305749378858,1.0,2/10,4.03%,FOXM1;SP100
prerank,GO_Biological_Process_2021__cardiac myofibril assembly (GO:0055003),-0.7970896837232077,-1.4344624349857615,0.03571428571428571,0.577612736233523,1.0,4/14,7.99%,NRAP;ACTC1;CSRP3;NEB
prerank,GO_Biological_Process_2021__negative regulation of macromolecule biosynthetic process (GO:0010558),-0.8134031727390791,-1.4335599870332285,0.045454545454545456,0.5808686069087291,1.0,2/10,3.87%,TGFB1;TAF7
prerank,Reactome_2022__Initiation Of Nuclear Envelope (NE) Reformation R-HSA-2995383,0.7043380135713366,1.4335144958820507,0.05128205128205128,0.7703153718479888,1.0,2/18,6.34%,LMNB1;VRK2
prerank,Reactome_2022__Adherens Junctions Interactions R-HSA-418990,0.6167023122956135,1.4334556722752274,0.09090909090909091,0.7684918530058729,1.0,17/26,21.71%,CDH19;CDH12;CDH5;CDH13;CADM2;CADM1;CDH6;CDH2;CDH24;NECTIN3;CDH10;CDH11;CDH4;JUP;FZR1;CDH8;CDH9
prerank,GO_Biological_Process_2021__phospholipid catabolic process (GO:0009395),-0.7141446560114042,-1.4329091142120585,0.03508771929824561,0.5823823185345282,1.0,1/20,0.09%,ENPP2
prerank,GO_Biological_Process_2021__negative regulation of steroid biosynthetic process (GO:0010894),0.8147838977431805,1.4327799081465746,0.024390243902439025,0.771134067052765,1.0,4/8,14.09%,WNT4;PROX1;SNAI2;NFKB1
prerank,GO_Biological_Process_2021__zinc ion transport (GO:0006829),0.7233506506087933,1.4316200746511685,0.08333333333333333,0.776044846570261,1.0,4/18,4.30%,SLC30A10;SLC39A8;TRPM2;SLC39A11
prerank,GO_Biological_Process_2021__positive regulation of neuron differentiation (GO:0045666),0.5804066097031647,1.4314777850990728,0.06896551724137931,0.7748304707754134,1.0,11/33,10.01%,VWC2;NGF;NEUROD2;FGFR1;BRINP3;ZC4H2;PROX1;DLX1;ZEB1;BEND6;BRINP1
prerank,Reactome_2022__Heparan Sulfate/Heparin (HS-GAG) Metabolism R-HSA-1638091,0.6378078957423554,1.4314192301568707,0.05263157894736842,0.7731361218204499,1.0,20/48,12.57%,VCAN;GPC4;SDC4;HS6ST2;HS3ST3B1;EXT1;NDST3;HS3ST1;GPC6;GLB1L;HPSE;HS3ST5;HS2ST1;HS3ST2;GPC5;CSPG5;B3GAT3;SDC3;GLB1;HS3ST4
prerank,GO_Biological_Process_2021__regulation of cAMP-dependent protein kinase activity (GO:2000479),0.725229792867587,1.4311544158977363,0.08823529411764706,0.7725022851209832,1.0,3/12,10.12%,PKIA;SIRT1;PRKAR2A
prerank,CellMarker_Augmented_2021__Naive CD4+ T cell:Peripheral Blood,0.6341724621000812,1.4310551915389575,0.07692307692307693,0.7706620348210245,1.0,3/27,1.52%,IL7R;FHIT;TSHZ2
prerank,GO_Biological_Process_2021__intracellular lipid transport (GO:0032365),0.6486939044481181,1.4309756224220636,0.046511627906976744,0.7691132132712689,1.0,12/20,28.94%,ACACB;ABCD3;ABCD2;CPT1A;PRKAA2;PRKAG2;NPC2;THRSP;ACACA;CERT1;ARV1;MID1IP1
prerank,GO_Biological_Process_2021__synapse assembly (GO:0007416),0.5573703683502319,1.4305611757955459,0.08333333333333333,0.7692974887204223,1.0,24/65,19.70%,SLITRK6;GRID2;NLGN1;LRRTM3;FZD5;SDK1;DSCAM;FZD1;PLXNB1;WNT3A;NPAS4;NLGN4X;FARP1;NLGN3;CDH2;RYK;ACHE;NRXN1;GABRB2;GABRA2;KIRREL3;CDK5;PCDHB6;NRCAM
prerank,GO_Biological_Process_2021__regulation of T cell tolerance induction (GO:0002664),0.9125412817438553,1.4304323287254506,0.046511627906976744,0.7674805687608389,1.0,1/5,1.59%,CLC
prerank,GO_Biological_Process_2021__short-chain fatty acid catabolic process (GO:0019626),0.8406630080249853,1.4301313934007915,0.029411764705882353,0.7667505721270756,1.0,1/7,1.23%,ACADS
prerank,GO_Biological_Process_2021__cholesterol efflux (GO:0033344),0.6694987388309795,1.4297983424275968,0.09090909090909091,0.7669396609134543,1.0,5/18,7.63%,TSKU;APOE;SOAT1;SOAT2;ABCA1
prerank,GO_Biological_Process_2021__regulation of release of cytochrome c from mitochondria (GO:0090199),-0.6458216220221549,-1.4294784316233071,0.015151515151515152,0.5998042136910454,1.0,7/34,13.03%,MMP9;CIDEB;GPER1;PINK1;CLU;BIK;MOAP1
prerank,Reactome_2022__Digestion And Absorption R-HSA-8963743,-0.7588719608001716,-1.4293320094271096,0.07272727272727272,0.5985300147183023,1.0,6/14,10.35%,TREH;PNLIPRP3;CHIT1;GUCY2C;SLC5A1;LCT
prerank,Reactome_2022__Viral mRNA Translation R-HSA-192823,-0.5962765152932382,-1.4288710398840374,0.02666666666666667,0.5990988929537316,1.0,54/82,27.12%,RPL37A;RPL38;RPL15;RPS4X;RPL3;RPL35A;GNL3;RPS9;FAU;RPS27;RPS21;RPL13A;RPL27A;RPS16;RPL36;RPS20;RPL7A;RPL9;RPS8;RPS27A;RPL21;RPL34;RPL4;RPL32;RPL5;RPL23;RPL41;RPS7;RPS11;RPL27;RPL35;RPS14;RPL11;RPS15;RPLP1;RPS12;RPL18A;RPS13;RPL29;RPLP2;RPL28;RPL12;RPL18;RPS3;RPL22;RPSA;RPS28;RPS19;RPS24;RPL26L1;RPS3A;RPL19;RPL8;RPS6
prerank,Reactome_2022__P2Y Receptors R-HSA-417957,-0.8584076133906717,-1.4282211533678342,0.03076923076923077,0.6007382541897424,1.0,4/7,9.43%,P2RY12;P2RY14;LPAR6;P2RY6
prerank,GO_Biological_Process_2021__regulation of animal organ morphogenesis (GO:2000027),-0.8695740665567819,-1.42803760157345,0.01639344262295082,0.5993943313029785,1.0,1/7,0.55%,TBX1
prerank,GO_Biological_Process_2021__dermatan sulfate proteoglycan biosynthetic process (GO:0050651),0.6985517329103572,1.4279729647923072,0.1111111111111111,0.774231516190222,1.0,7/14,11.69%,VCAN;CSGALNACT1;CHST12;UST;CSPG5;B3GAT3;DSEL
prerank,Reactome_2022__Beta-oxidation Of pristanoyl-CoA R-HSA-389887,-0.8252357180796788,-1.427928178085859,0.017241379310344827,0.5975268072463571,1.0,2/9,4.13%,AMACR;ACOX2
prerank,GO_Biological_Process_2021__positive regulation of cardiac muscle contraction (GO:0060452),0.9203768537710175,1.4279247758048148,0.05,0.7724207699141534,1.0,1/5,0.05%,ADRA1A
prerank,GO_Biological_Process_2021__regulation of chondrocyte differentiation (GO:0032330),0.6453184190550799,1.4277882381511746,0.075,0.7712512020623125,1.0,8/22,14.26%,TGFBR1;ADAMTS12;WNT9A;GREM1;SNAI2;GDF6;EFEMP1;SOX5
prerank,GO_Biological_Process_2021__JNK cascade (GO:0007254),0.5743230188909708,1.4277178172902505,0.1,0.7696153191789743,1.0,12/38,20.40%,RIPK2;TNFRSF19;MAPK8;MAP3K10;MAP3K13;TAB3;MAP4K2;CRKL;MAP2K7;TAB1;TAB2;TRAF6
prerank,CellMarker_Augmented_2021__Oocyte:Ovary,-0.6956112212481849,-1.4276401023172995,0.046153846153846156,0.5974267199786487,1.0,13/39,12.29%,NLRP4;TOPAZ1;CCDC73;SLFN14;GP1BA;NLRP5;TGM4;NLRP9;PP2D1;CCDC38;DCAF4L1;TULP2;WDR87
prerank,GO_Biological_Process_2021__fat-soluble vitamin catabolic process (GO:0042363),-0.8633835527436875,-1.427551324490672,0.08771929824561403,0.5957916759436336,1.0,4/7,13.26%,CYP26B1;CYP24A1;CYP3A4;CYP4F12
prerank,GO_Biological_Process_2021__protein localization to condensed chromosome (GO:1903083),-0.7749599995262377,-1.4270859419463435,0.07547169811320754,0.5965691711317268,1.0,2/11,7.32%,ZWILCH;TTK
prerank,PanglaoDB_Augmented_2021__Beta Cells,0.5027953855902192,1.4262752013616988,0.05263157894736842,0.7753706358913595,1.0,45/127,19.93%,SLC17A6;SEZ6L;PCDH17;ROBO2;NOVA1;MAFB;PLPPR1;KCNB2;EDARADD;LRRC4C;UNC5D;ELAVL3;RGS16;CADM2;CXXC4;PAK5;PROX1;WSCD2;KCNIP1;ADGRA1;EFNA5;ABCC8;CELF4;FGF12;ELAVL4;RAB3C;SNAP91;MAP6;RBFOX1;ASXL3;PTPRT;DPP6;CFC1;UBE2QL1;NRXN1;IAPP;PAX6;SCGN;LSAMP;SERTM1;ST8SIA3;ADGRB3;CNTN1;UNC79;PAK3
prerank,Reactome_2022__Pregnenolone Biosynthesis R-HSA-196108,0.7427960059169256,1.426234770746281,0.1,0.7735367019052484,1.0,2/10,13.68%,STARD3NL;STARD4
prerank,KEGG_2021_Human__Galactose metabolism,0.5971534253410098,1.4258791878225532,0.02857142857142857,0.7738999371718204,1.0,7/26,6.72%,GCK;GANC;GLA;GALE;PFKP;G6PC3;B4GALT2
prerank,"GO_Biological_Process_2021__positive regulation of synaptic transmission, GABAergic (GO:0032230)",0.9166561634197692,1.4258767428675876,0.04878048780487805,0.7718845727521021,1.0,2/6,2.68%,ADRA1A;NLGN1
prerank,KEGG_2021_Human__Folate biosynthesis,0.6652149176587636,1.4249156023803673,0.05555555555555555,0.7740378285590159,1.0,4/21,8.93%,TPH1;AKR1C3;DHFR;GPHN
prerank,KEGG_2021_Human__Other glycan degradation,0.6663061647301254,1.4248291231925845,0.08333333333333333,0.7724589152130942,1.0,5/15,18.71%,NEU4;GLB1;HEXD;NEU3;GBA2
prerank,GO_Biological_Process_2021__mesonephros development (GO:0001823),0.792813787888309,1.4248269739785646,0.058823529411764705,0.7704628973443265,1.0,2/8,6.85%,FGF10;OSR1
prerank,CellMarker_Augmented_2021__B cell:Spleen,-0.6249365904236541,-1.4247695392513047,0.014492753623188406,0.60935413700295,1.0,17/60,10.89%,GMFG;DOCK8;CYTIP;TBC1D10C;ARHGAP9;TAGAP;TMC8;ARHGAP15;DOCK2;PARVG;WAS;LY86;CD37;TRAF3IP3;MYO1F;PTPRC;SPI1
prerank,GO_Biological_Process_2021__positive regulation of cellular biosynthetic process (GO:0031328),0.47507143958713793,1.4247272360688874,0.041666666666666664,0.7689398972163066,1.0,41/150,20.68%,GCK;CTDNEP1;PRR16;IRS1;MFSD2A;SAMD4A;SLC25A37;DDAH2;PLIN5;SIRT1;ERBB2;ZEB2;PKD2;SNCA;PCIF1;PPP1R3E;SP1;MYC;AKT2;LDLR;CTC1;IRS2;DDAH1;MLXIPL;EIF3E;STARD4;YTHDF1;ABCB10;INSR;NR1H3;GPLD1;OPN3;ZCCHC4;FAF1;AGXT2;EIF4A3;ELOVL5;DNA2;HIF1A;PIWIL2;FXR2
prerank,GO_Biological_Process_2021__cardiac muscle cell action potential involved in contraction (GO:0086002),-0.7052409381802875,-1.4246198265556276,0.031746031746031744,0.6079034640848044,1.0,5/29,8.12%,PKP2;SCN5A;KCNA5;CAV3;KCNQ1
prerank,GO_Biological_Process_2021__positive regulation of leukocyte adhesion to vascular endothelial cell (GO:1904996),-0.7448021977662069,-1.4243694770913204,0.078125,0.6072722230367436,1.0,3/12,8.55%,ITGB2;ALOX5;SELP
prerank,GO_Biological_Process_2021__regulation of carbohydrate biosynthetic process (GO:0043255),0.7490545663018429,1.4237722128882302,0.15,0.7728093543884654,1.0,2/10,5.48%,ZNF692;SIRT7
prerank,GO_Biological_Process_2021__negative regulation of heart rate (GO:0010459),0.8428121544184488,1.4236695066126799,0.06976744186046512,0.7717868669823018,1.0,2/6,3.11%,RNLS;SPTBN4
prerank,GO_Biological_Process_2021__positive regulation of striated muscle contraction (GO:0045989),0.9202461281840103,1.4235522597797374,0.027777777777777776,0.7705782852580187,1.0,1/6,0.05%,ADRA1A
prerank,CellMarker_Augmented_2021__Mesenchymal Stem cell:Fetal Liver,-0.9359727083014446,-1.423533278685318,0.0,0.6097662128783023,1.0,1/5,0.01%,CD44
prerank,PanglaoDB_Augmented_2021__Airway Goblet Cells,-0.6004781458974694,-1.4225883649228936,0.04477611940298507,0.6137973506605007,1.0,26/69,19.93%,PLEKHS1;TMEM184A;MISP;CAPN8;SMIM22;TMC4;LIPH;FUT2;EPN3;MUC5B;SERPINB5;CEACAM1;BPIFB1;MS4A8;ITGB6;TRIM29;MUC4;GPX2;PROM2;TJP3;GALNT6;SCNN1A;CAPN13;GALNT5;FAM3D;CBLC
prerank,GO_Biological_Process_2021__positive regulation of peptide hormone secretion (GO:0090277),0.6160738174971664,1.4223092974373068,0.02857142857142857,0.7753681314771836,1.0,8/31,10.84%,GCK;GRP;CAPN10;DOC2B;GLUD1;MCU;IRS2;UCN
prerank,Reactome_2022__Defective CSF2RA Causes SMDP4 R-HSA-5688890,-0.8568762408864586,-1.4222269918035222,0.09615384615384616,0.6141848692209116,1.0,2/6,6.00%,SFTPA1;SFTPD
prerank,GO_Biological_Process_2021__regulation of hemopoiesis (GO:1903706),0.778841034554983,1.4220390482419356,0.1282051282051282,0.7748799205953993,1.0,5/11,17.42%,MAFB;CBFB;GFI1B;RUNX1;LGALS3
prerank,GO_Biological_Process_2021__ganglioside metabolic process (GO:0001573),0.6397312581299409,1.4216116216499102,0.06451612903225806,0.7751156850027313,1.0,8/17,25.43%,ST6GALNAC3;ST8SIA4;NEU4;NEU3;ST8SIA3;ST6GALNAC5;ABCA2;B4GALNT1
prerank,GO_Biological_Process_2021__regulation of superoxide anion generation (GO:0032928),-0.7834249724867823,-1.421537780297896,0.045454545454545456,0.6161907393544558,1.0,4/11,16.13%,TGFB1;ITGB2;ITGAM;F2RL1
prerank,Reactome_2022__JNK (c-Jun Kinases) Phosphorylation And Activation Mediated By Activated Human TAK1 R-HSA-450321,0.7192888009692933,1.4212363025686061,0.08108108108108109,0.77516086869611,1.0,7/16,20.40%,RIPK2;MAPK8;TAB3;MAP2K7;TAB1;TAB2;TRAF6
prerank,CellMarker_Augmented_2021__Megakaryocyte Progenitor cell:Peripheral Blood,-0.6433642434417999,-1.4211415661982505,0.07575757575757576,0.6167722698471859,1.0,22/36,20.33%,TRIM58;P2RY12;SLFN14;FCGR3A;CA1;DYTN;SELP;FPR1;ALAS2;ITGA2B;PTP4A2P2;PTGDR;CLEC12A;MAX;F13A1;SH2D1B;ADGRE3;CMTM2;SLC4A1;CLEC1B;BEND2;IFIT1B
prerank,Reactome_2022__Insulin-like Growth Factor-2 mRNA Binding Proteins (IGF2BPs/IMPs/VICKZs) Bind RNA R-HSA-428359,-0.9414313854311674,-1.419783025378778,0.0392156862745098,0.623303232635645,1.0,1/5,0.01%,CD44
prerank,CellMarker_Augmented_2021__Liver Progenitor cell:Fetal Liver,0.49346454018519387,1.4196210281890447,0.0,0.7821198833481253,1.0,24/95,16.01%,TEAD2;GPC4;MXRA5;ADGRL2;TBC1D16;COL12A1;ERBB2;ASAP3;EDNRA;PTGFRN;PLXNB1;EFS;PDZRN3;RND3;COL16A1;CHST3;MPDZ;RBFOX2;LRIG3;MAGI1;BCAM;ANTXR1;PTPRF;DLG5
prerank,Reactome_2022__Deadenylation-dependent mRNA Decay R-HSA-429914,-0.6084774637666852,-1.4192631280610633,0.046153846153846156,0.6241360155925089,1.0,1/53,0.07%,NLRP4
prerank,CellMarker_Augmented_2021__Platelet:Liver,-0.6132531292839444,-1.4192499333604427,0.08333333333333333,0.6199178802363768,1.0,18/61,12.60%,LILRB3;RASGRP4;MPL;TGFB1;ALOX12;TBC1D10C;RGL4;SLFN14;GP1BA;C19ORF38;WAS;CD37;DYTN;MYO1F;NLRC4;ITGA2B;MMP25;MAX
prerank,CellMarker_Augmented_2021__T Helper cell:Lung,-0.6132531292839444,-1.4192499333604427,0.08333333333333333,0.6199178802363768,1.0,18/61,12.60%,LILRB3;RASGRP4;MPL;TGFB1;ALOX12;TBC1D10C;RGL4;SLFN14;GP1BA;C19ORF38;WAS;CD37;DYTN;MYO1F;NLRC4;ITGA2B;MMP25;MAX
prerank,CellMarker_Augmented_2021__Stromal cell:Adipose Tissue,-0.9416538103939289,-1.4191922677261675,0.018867924528301886,0.6182086164471733,1.0,1/5,0.01%,CD44
prerank,PanglaoDB_Augmented_2021__Embryonic Stem Cells,0.48459896022834337,1.419028098531559,0.0,0.7826371220857856,1.0,43/149,17.40%,TEAD2;MYO10;KIT;ADGRL2;PARD3;ALDH7A1;DCBLD2;PRDM5;MID1;IL17RD;FZD5;ITGA4;ERBB2;HES1;KCNIP3;FBXO15;DSP;RAI14;PML;FZD1;MYC;TENM3;LRP6;PIWIL1;KITLG;PRTG;RND3;ARHGAP42;TSPAN6;RBFOX2;LRIG3;TEAD4;CDK8;SMAD2;MAGI1;ANTXR1;PTPRF;SPRY4;NR6A1;FRAS1;ZFX;PAWR;ROR1
prerank,GO_Biological_Process_2021__modulation by symbiont of host autophagy (GO:0075071),0.902438691662305,1.4187570616530099,0.05,0.7818736375088371,1.0,1/5,0.82%,IRGM
prerank,CellMarker_Augmented_2021__Lymphoid cell:Blood,0.5292606503538909,1.4184939465396644,0.0,0.7810389845806982,1.0,19/74,11.56%,GPRIN3;RASSF2;CD247;TRAC;AOAH;RCBTB2;RORA;CX3CR1;C1ORF162;ZEB2;BACH2;KLRC4-KLRK1;SAMD3;CD8A;LRRN3;PNISR;ABCD2;ZMAT1;EVL
prerank,KEGG_2021_Human__Amphetamine addiction,0.5394016686370068,1.4184529211986017,0.125,0.7794230224586328,1.0,5/57,4.89%,ARC;GRIN3A;CREB3L2;SIRT1;CREB3L4
prerank,GO_Biological_Process_2021__lipoprotein metabolic process (GO:0042157),0.9018517138060651,1.418342742656996,0.08,0.7780762945478383,1.0,1/5,2.66%,APOE
prerank,GO_Biological_Process_2021__regulation of response to oxidative stress (GO:1902882),-0.8095191280788016,-1.4179654778463702,0.015873015873015872,0.6234421414645624,1.0,3/12,5.61%,ALOX5;ACOX2;PINK1
prerank,PanglaoDB_Augmented_2021__Enterocytes,-0.5445756054607787,-1.417433273199859,0.0,0.6244103475251287,1.0,35/130,15.61%,SLC28A2;SLC28A1;TREH;CLCA1;SLC51A;CDHR5;DEGS2;NR1I3;SOX10;ACSL5;TMC4;ALDOB;COL18A1;SLC5A1;CA1;ASPN;CEACAM1;CLDN2;RBP2;ABCG2;PDZK1;ART3;CYP3A4;HNF1A;LCT;VIL1;CYP4F12;GPX2;MUC17;VDR;NR1H4;GATA4;SDSL;TMEM45B;AQP11
prerank,PanglaoDB_Augmented_2021__Urothelial Cells,-0.5999164090821911,-1.4166484486285478,0.013513513513513514,0.6273173467478294,1.0,23/75,15.90%,DENND1C;AQP3;UMODL1;TMEM184A;ELMO3;UPK1B;CARD14;TMC4;LRP10;TRIM25;DTX2;ALOX15;UPK1A;SLC14A1;UPK3A;SPINT1;TMCO4;SYTL1;TMEM79;PROM2;EPHA1;TJP3;PRRG4
prerank,GO_Biological_Process_2021__response to interleukin-6 (GO:0070741),0.8152238729329206,1.4166339486483008,0.07317073170731707,0.7859662904539307,1.0,6/9,15.86%,SELPLG;PID1;NFKB1;PTPRT;ST3GAL6;PTGIS
prerank,Reactome_2022__tRNA Modification In Mitochondrion R-HSA-6787450,0.812926953966477,1.4166114184239236,0.02631578947368421,0.7840902528629254,1.0,2/8,13.78%,MTO1;TRMT61B
prerank,GO_Biological_Process_2021__tachykinin receptor signaling pathway (GO:0007217),0.8295559925964094,1.4165109125011859,0.1276595744680851,0.7826679056750255,1.0,2/7,1.09%,TACR3;GRK5
prerank,GO_Biological_Process_2021__cell morphogenesis involved in neuron differentiation (GO:0048667),0.5220584465926793,1.4161547488329396,0.0,0.7825455576642965,1.0,21/72,19.93%,SLITRK6;LLGL1;MFSD2A;PARD3;DSCAML1;SPTBN4;DCC;NTNG2;CDHR1;FARP1;MAP6;RAB10;RYK;PARD6B;DCDC2;SLITRK2;S100B;CDK5;CTNNA2;NRCAM;PAK3
prerank,CellMarker_Augmented_2021__Lake Et al.Science.Ex5:Brain,0.8329266938939514,1.416129931867973,0.06666666666666667,0.7808023613478743,1.0,5/9,11.42%,RNF182;ARSJ;IL1RAPL2;IFITM10;TLL1
prerank,PanglaoDB_Augmented_2021__Hematopoietic Stem Cells,-0.5723428945894627,-1.416008544051498,0.0,0.6292351779339359,1.0,30/118,13.55%,CD44;C1QB;MPL;MGST1;LYVE1;HCK;HMGB3;TAF7;PROCR;C3AR1;DAB2;MS4A4A;FCGR3A;VSIG4;IL3RA;SELP;ABCG2;PTPRC;VWF;ITGA2B;SPI1;CLEC12A;ENG;TLR2;FPR3;ABCB1;F13A1;GNL3;CD300LF;TEK
prerank,Reactome_2022__NOTCH2 Intracellular Domain Regulates Transcription R-HSA-2197563,0.7466582501486364,1.4159214099665038,0.10526315789473684,0.7803543526604725,1.0,5/11,19.24%,MAML1;MAMLD1;RBPJ;EP300;CREB1
prerank,GO_Biological_Process_2021__Golgi to endosome transport (GO:0006895),0.6825386015807928,1.4159073163132392,0.15,0.7785517309919863,1.0,5/15,20.60%,KLHL20;GBF1;MON2;DOP1B;KIF16B
prerank,GO_Biological_Process_2021__nucleoside triphosphate biosynthetic process (GO:0009142),0.7654221147559532,1.4158928843635408,0.06451612903225806,0.7766847623847671,1.0,1/8,3.83%,AK3
prerank,GO_Biological_Process_2021__regulation of lipopolysaccharide-mediated signaling pathway (GO:0031664),-0.7379968583006046,-1.4156631968985824,0.03076923076923077,0.6294555135680374,1.0,5/16,18.68%,SCIMP;TRIM5;LY86;CACTIN;CARD8
prerank,GO_Biological_Process_2021__regulation of cell morphogenesis (GO:0022604),-0.692438507246024,-1.4153522129339895,0.043478260869565216,0.6291559067497794,1.0,1/31,0.01%,CD44
prerank,CellMarker_Augmented_2021__T Helper2 (Th2) cell:Brain,-0.6367724887676909,-1.4150772402648846,0.039473684210526314,0.628735291756632,1.0,15/52,10.28%,SIRPG;GMFG;IRF4;CYTIP;TBC1D10C;ARHGAP9;TAGAP;TMC8;PARVG;CD5;ICAM3;WAS;CD37;TRAF3IP3;PTPRC
prerank,GO_Biological_Process_2021__negative regulation of cartilage development (GO:0061037),0.7612306112106374,1.414956236226133,0.04,0.7793153721333006,1.0,6/11,12.82%,TGFBR1;ADAMTS12;WNT9A;GREM1;SNAI2;EFEMP1
prerank,GO_Biological_Process_2021__mitotic DNA replication checkpoint signaling (GO:0033314),-0.7763343169284925,-1.4149347958191347,0.1,0.6274592094444776,1.0,1/9,0.45%,TICRR
prerank,Reactome_2022__Presynaptic Depolarization And Calcium Channel Opening R-HSA-112308,0.7516338198550224,1.4145548283663918,0.05128205128205128,0.7792757729373765,1.0,3/12,8.83%,CACNG4;CACNB4;CACNG2
prerank,GO_Biological_Process_2021__glucose import (GO:0046323),-0.7746234981473509,-1.4143837257434941,0.05454545454545454,0.6294422576694998,1.0,3/10,10.05%,SLC5A2;SLC5A1;HNF1A
prerank,GO_Biological_Process_2021__negative regulation of cellular response to growth factor stimulus (GO:0090288),0.5080389563318584,1.4142517877481924,0.0,0.7785827051173819,1.0,27/66,23.53%,VWC2L;BAMBI;VWC2;PPARG;ADAMTS12;DLX1;GREM1;SLIT2;FSTL3;CRIM1;BMPER;SMURF1;SPRY4;NOTCH1;NEDD4;SKI;ACVR2A;EMILIN1;CASK;SULF2;BMPR2;SPRY1;SMAD5;SMAD7;CREB3L1;BMPR1A;SPRY3
prerank,GO_Biological_Process_2021__very long-chain fatty acid catabolic process (GO:0042760),0.8047484240216144,1.4140087448639047,0.1111111111111111,0.7779292201213083,1.0,5/7,18.13%,SLC27A2;ABCD3;ABCD2;SLC27A4;ACOX1
prerank,GO_Biological_Process_2021__endoderm development (GO:0007492),0.8060567144129529,1.4138816032169381,0.0625,0.7764838327482438,1.0,2/9,1.22%,DUSP4;DUSP2
prerank,Reactome_2022__Signaling By ERBB2 KD Mutants R-HSA-9664565,0.6365262696455183,1.4134110402431743,0.030303030303030304,0.7767759060147853,1.0,4/22,7.38%,NRG2;ERBB2;NRG1;NRG3
prerank,GO_Biological_Process_2021__regulation of sequestering of triglyceride (GO:0010889),0.7563435328782578,1.4127963868437072,0.023255813953488372,0.7776779854215585,1.0,4/12,11.41%,PPARG;PLIN5;LPL;OSBPL11
prerank,GO_Biological_Process_2021__regulation of myoblast proliferation (GO:2000291),0.8592360659375273,1.4125562280183939,0.06976744186046512,0.777104696590854,1.0,2/5,5.36%,MEGF10;KLHL41
prerank,GO_Biological_Process_2021__regulation of vascular endothelial cell proliferation (GO:1905562),0.6856523540520831,1.4122147659515634,0.0975609756097561,0.7767847033872718,1.0,5/15,7.74%,FGFR1;PPARG;ITGA4;HMGB1;SP1
prerank,"GO_Biological_Process_2021__synaptic transmission, glutamatergic (GO:0035249)",0.7007791363479363,1.4121038954536824,0.058823529411764705,0.7754664190345354,1.0,7/18,17.09%,SLC17A6;GRID2;GRIK1;GRIK2;UNC13B;GRIK3;UNC13C
prerank,GO_Biological_Process_2021__desensitization of G protein-coupled receptor signaling pathway (GO:0002029),0.8141396821721818,1.4120545324099993,0.045454545454545456,0.7738338071412062,1.0,3/7,13.66%,ARRB2;SAG;ARRB1
prerank,GO_Biological_Process_2021__somatic hypermutation of immunoglobulin genes (GO:0016446),-0.827480062143652,-1.4120100407533562,0.05357142857142857,0.6423249598578376,1.0,1/7,0.77%,POLQ
prerank,CellMarker_Augmented_2021__Non-classical monocyte:Blood,-0.6555890881235498,-1.411961693203838,0.03125,0.6340415857090834,1.0,19/40,13.64%,LILRB3;HCK;PTAFR;C3AR1;MS4A4A;FCGR3A;LY86;VSIG4;NFAM1;MYO1F;IGSF6;FPR1;SLC11A1;SPI1;CLEC12A;ITGAM;TLR2;CD300LF;ADGRE3
prerank,CellMarker_Augmented_2021__CD14++CD16- monocyte:Blood,-0.6555890881235498,-1.411961693203838,0.03125,0.6340415857090834,1.0,19/40,13.64%,LILRB3;HCK;PTAFR;C3AR1;MS4A4A;FCGR3A;LY86;VSIG4;NFAM1;MYO1F;IGSF6;FPR1;SLC11A1;SPI1;CLEC12A;ITGAM;TLR2;CD300LF;ADGRE3
prerank,CellMarker_Augmented_2021__Classical monocyte:Blood,-0.6555890881235498,-1.411961693203838,0.03125,0.6340415857090834,1.0,19/40,13.64%,LILRB3;HCK;PTAFR;C3AR1;MS4A4A;FCGR3A;LY86;VSIG4;NFAM1;MYO1F;IGSF6;FPR1;SLC11A1;SPI1;CLEC12A;ITGAM;TLR2;CD300LF;ADGRE3
prerank,CellMarker_Augmented_2021__Intermediate monocyte:Blood,-0.6555890881235498,-1.411961693203838,0.03125,0.6340415857090834,1.0,19/40,13.64%,LILRB3;HCK;PTAFR;C3AR1;MS4A4A;FCGR3A;LY86;VSIG4;NFAM1;MYO1F;IGSF6;FPR1;SLC11A1;SPI1;CLEC12A;ITGAM;TLR2;CD300LF;ADGRE3
prerank,GO_Biological_Process_2021__iron import into cell (GO:0033212),0.8223706735050311,1.4118616965101067,0.175,0.773310634472598,1.0,1/6,3.19%,SLC39A8
prerank,GO_Biological_Process_2021__protein exit from endoplasmic reticulum (GO:0032527),0.5758742677927642,1.4117841788309107,0.17647058823529413,0.771974500241505,1.0,1/23,0.97%,AUP1
prerank,GO_Biological_Process_2021__regulation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0043281),-0.5917081532099765,-1.4115663741211024,0.07894736842105263,0.6341910189800779,1.0,8/68,9.78%,CD44;NODAL;NLRP12;GPER1;UACA;BEX3;REST;THBS1
prerank,GO_Biological_Process_2021__glycosaminoglycan catabolic process (GO:0006027),-0.6283363921717678,-1.4113670623844523,0.02631578947368421,0.6335752686803365,1.0,7/48,8.55%,CD44;TGFB1;LYVE1;OGN;SDC2;DCN;GPC3
prerank,CellMarker_Augmented_2021__Lake Et al.Science.In1:Brain,0.538336530315513,1.4113259171904133,0.03571428571428571,0.772200969737587,1.0,35/95,19.78%,SLC17A6;XKR7;SEZ6L;KCNH8;TMEM132C;UNC5D;ELAVL3;CNTNAP2;PAK5;SLC35F1;PTPRZ1;WSCD2;KCNIP1;SORCS1;KHDRBS2;ADGRA1;ELAVL4;RAB3C;NLGN3;SNAP91;RBFOX1;ASXL3;NCAM1;UBE2QL1;NRXN1;JPH4;MAGEL2;GRIK3;GALNT8;LSAMP;FAT3;ST8SIA3;ADGRB3;CTNNA2;PDZD4
prerank,CellMarker_Augmented_2021__Stem cell:Blood Vessel,0.813683015093694,1.4108927261466484,0.02127659574468085,0.7726028045973595,1.0,1/8,1.53%,KIT
prerank,CellMarker_Augmented_2021__Epithelial cell:Bone Marrow,-0.6421659161486784,-1.4107317250931237,0.046875,0.6354391120139337,1.0,24/53,16.09%,C1QB;ITGB2;HCK;ALOX5;PTAFR;C3AR1;MS4A4A;FCGR3A;LY86;VSIG4;NFAM1;MYO1F;IGSF6;HLA-DRB1;PTPRC;FPR1;SPI1;CLEC12A;ITGAM;TLR2;FPR3;CD300LF;KCNE3;HK3
prerank,KEGG_2021_Human__Proteoglycans in cancer,-0.5375277581632497,-1.4101950822892435,0.01282051282051282,0.6367688718747607,1.0,26/177,12.50%,CD44;TGFB1;TIMP3;MMP9;WNT5A;CAV3;WNT8B;CCND1;VAV3;FZD8;ESR1;COL1A1;SDC2;VTN;DCN;PLAU;ACTG1;PIK3R3;GPC3;THBS1;CD63;CAV2;WNT8A;CDKN1A;WNT6;TLR2
prerank,CellMarker_Augmented_2021__Megakaryocyte:Undefined,-0.8594381324173406,-1.410181396369888,0.016666666666666666,0.6348027296138808,1.0,5/11,10.72%,MPL;GP1BA;IL3RA;SELP;ITGA2B
prerank,Reactome_2022__Toll Like Receptor 7/8 (TLR7/8) Cascade R-HSA-168181,0.48136852589993057,1.4096481433079322,0.0,0.7743576373076202,1.0,32/91,21.90%,DUSP4;MAPKAPK2;RIPK2;KCNH8;HMGB1;MAPK8;MAP3K1;ALPK1;RPS6KA3;N4BP1;PPP2R1B;TICAM1;TANK;NKIRAS2;TAB3;PELI1;NFKB1;RPS6KA2;PELI2;IRAK4;TP53;MAP2K7;PPP2R5D;S100B;TAB1;CREB1;TAB2;MAP2K6;TRAF6;FOS;CUL1;DUSP6
prerank,Reactome_2022__MyD88 Dependent Cascade Initiated On Endosome R-HSA-975155,0.48136852589993057,1.4096481433079322,0.0,0.7743576373076202,1.0,32/91,21.90%,DUSP4;MAPKAPK2;RIPK2;KCNH8;HMGB1;MAPK8;MAP3K1;ALPK1;RPS6KA3;N4BP1;PPP2R1B;TICAM1;TANK;NKIRAS2;TAB3;PELI1;NFKB1;RPS6KA2;PELI2;IRAK4;TP53;MAP2K7;PPP2R5D;S100B;TAB1;CREB1;TAB2;MAP2K6;TRAF6;FOS;CUL1;DUSP6
prerank,Reactome_2022__TRAF6 Mediated Induction Of NFkB And MAP Kinases Upon TLR7/8 Or 9 Activation R-HSA-975138,0.48136852589993057,1.4096481433079322,0.0,0.7743576373076202,1.0,32/91,21.90%,DUSP4;MAPKAPK2;RIPK2;KCNH8;HMGB1;MAPK8;MAP3K1;ALPK1;RPS6KA3;N4BP1;PPP2R1B;TICAM1;TANK;NKIRAS2;TAB3;PELI1;NFKB1;RPS6KA2;PELI2;IRAK4;TP53;MAP2K7;PPP2R5D;S100B;TAB1;CREB1;TAB2;MAP2K6;TRAF6;FOS;CUL1;DUSP6
prerank,GO_Biological_Process_2021__odontogenesis of dentin-containing tooth (GO:0042475),-0.7366262749778931,-1.4090350688763278,0.109375,0.6396855341145559,1.0,2/12,1.19%,TBX1;SCN5A
prerank,GO_Biological_Process_2021__fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540),-0.7553286143111907,-1.4083981614548882,0.04918032786885246,0.6418817183300917,1.0,2/15,4.13%,AMACR;ACOX2
prerank,Reactome_2022__Receptor-type Tyrosine-Protein Phosphatases R-HSA-388844,0.7053813826985267,1.4083251417988392,0.0967741935483871,0.7801340466334108,1.0,9/20,18.10%,SLITRK6;IL1RAPL2;PPFIBP2;PPFIA3;PPFIBP1;PTPRF;PTPRD;SLITRK2;PPFIA2
prerank,GO_Biological_Process_2021__amino sugar catabolic process (GO:0046348),0.7341699553880251,1.4081145086279856,0.11904761904761904,0.7796756951376125,1.0,3/7,10.69%,ALDH1A1;NPL;NAGK
prerank,CellMarker_Augmented_2021__Cytotoxic T cell:Undefined,0.8114192106009853,1.4079927632174773,0.02702702702702703,0.778140850649188,1.0,3/13,2.66%,IL7R;CD38;APOE
prerank,KEGG_2021_Human__Ether lipid metabolism,-0.6469018465019202,-1.4077230682723791,0.06578947368421052,0.6439935578232614,1.0,3/38,6.32%,ENPP2;PLD4;PLA2G10
prerank,Reactome_2022__Selenocysteine Synthesis R-HSA-2408557,-0.58509115894382,-1.407563990738572,0.05333333333333334,0.6429633549097428,1.0,54/84,27.12%,RPL37A;RPL38;RPL15;RPS4X;RPL3;RPL35A;RPS9;FAU;RPS27;RPS21;RPL13A;RPL27A;RPS16;RPL36;RPS20;RPL7A;RPL9;RPS8;RPS27A;RPL21;RPL34;RPL4;RPL32;RPL5;RPL23;RPL41;RPS7;RPS11;RPL27;RPL35;RPS14;RPL11;RPS15;RPLP1;RPS12;RPL18A;RPS13;RPL29;RPLP2;RPL28;RPL12;SEPSECS;RPL18;RPS3;RPL22;RPSA;RPS28;RPS19;RPS24;RPL26L1;RPS3A;RPL19;RPL8;RPS6
prerank,GO_Biological_Process_2021__metanephric nephron tubule development (GO:0072234),0.8026969129246798,1.407500675241056,0.06666666666666667,0.7787306592883252,1.0,2/5,6.85%,PKD2;OSR1
prerank,"GO_Biological_Process_2021__regulation of wound healing, spreading of epidermal cells (GO:1903689)",0.8402369040610015,1.4071367937485049,0.06666666666666667,0.7789021381474839,1.0,1/8,0.53%,PHLDB2
prerank,GO_Biological_Process_2021__negative regulation of platelet aggregation (GO:0090331),-0.8537460442341109,-1.4067940733669788,0.08064516129032258,0.6456168509761971,1.0,3/9,7.40%,C1QTNF1;ALOX12;CEACAM1
prerank,GO_Biological_Process_2021__negative regulation of retinoic acid receptor signaling pathway (GO:0048387),-0.9464000781836094,-1.4066065574924604,0.019230769230769232,0.6448432262345738,1.0,2/5,2.44%,PRAME;CYP26B1
prerank,GO_Biological_Process_2021__white fat cell differentiation (GO:0050872),0.8910131988879764,1.406573832799608,0.0,0.7802130832269225,1.0,4/6,10.16%,PER2;PPARG;SIRT1;CTBP2
prerank,Reactome_2022__RAS Signaling Downstream Of NF1 Loss-Of-Function Variants R-HSA-6802953,0.8458155374317324,1.406572195418563,0.05128205128205128,0.7784153572287038,1.0,4/6,13.81%,SPRED3;SPRED2;SPRED1;NF1
prerank,GO_Biological_Process_2021__activation of adenylate cyclase activity (GO:0007190),0.5967288455144222,1.4063851707745405,0.10344827586206896,0.7773481793578954,1.0,7/27,11.15%,LGR5;DRD5;RXFP1;EDNRA;ADCY2;CAP2;ADCY3
prerank,Reactome_2022__HuR (ELAVL1) Binds And Stabilizes mRNA R-HSA-450520,-0.8551039499260646,-1.4063058157487398,0.05357142857142857,0.6443751322448104,1.0,1/9,0.09%,ENPP2
prerank,CellMarker_Augmented_2021__Hematopoietic cell:Liver,-0.587920058413217,-1.406190625555234,0.05,0.6429187223888114,1.0,5/90,5.08%,CD44;AHR;SP100;DRAM1;TEC
prerank,GO_Biological_Process_2021__response to growth factor (GO:0070848),0.6059024244427731,1.4061668624318042,0.1,0.776972207378209,1.0,6/33,8.03%,TGFBR1;URI1;HTRA2;ERBB2;STAT5B;MYC
prerank,GO_Biological_Process_2021__very-low-density lipoprotein particle assembly (GO:0034379),0.7955368778149943,1.405450972428263,0.08108108108108109,0.7782413322741515,1.0,4/9,7.58%,APOB;MFSD2A;SOAT1;SOAT2
prerank,GO_Biological_Process_2021__negative regulation of mononuclear cell migration (GO:0071676),0.7337867808019309,1.4054285741378862,0.023809523809523808,0.7766011609277665,1.0,3/12,7.88%,GREM1;PLCB1;SLIT2
prerank,GO_Biological_Process_2021__inositol lipid-mediated signaling (GO:0048017),0.551853481702642,1.4050593326787661,0.10344827586206896,0.7771837286115697,1.0,10/48,11.09%,NGF;PLCH1;FGFR1;IRS1;PI4KB;PLCL2;PIK3C2B;PLCB1;IRS2;PLCH2
prerank,GO_Biological_Process_2021__thyroid hormone generation (GO:0006590),-0.8136573365873847,-1.404997225556509,0.030303030303030304,0.6476301867728321,1.0,6/10,18.04%,DUOX1;IYD;CGA;DIO1;TG;CPQ
prerank,CellMarker_Augmented_2021__Mesenchymal Stem cell:Undefined,-0.6073591572657145,-1.4045691111193026,0.05405405405405406,0.6483031703292043,1.0,12/66,14.70%,CD44;ITGB2;GYPB;DAZL;PTPRC;CD63;STRA8;ITGAM;ENG;GNL3;ITGA5;ACTA2
prerank,GO_Biological_Process_2021__regulation of histone H3-K9 trimethylation (GO:1900112),0.8987543582492874,1.4044368218720396,0.07692307692307693,0.7778996625389865,1.0,3/5,9.20%,SMARCB1;ZNF274;PIH1D1
prerank,GO_Biological_Process_2021__inhibitory postsynaptic potential (GO:0060080),0.8056109038533181,1.4041512077718523,0.046511627906976744,0.7771874381110542,1.0,5/7,19.11%,DRD4;NPAS4;NLGN3;INSYN2A;INSYN1
prerank,GO_Biological_Process_2021__establishment or maintenance of epithelial cell apical/basal polarity (GO:0045197),0.6149330716996493,1.4041194430984467,0.1,0.7754967949055512,1.0,12/29,22.83%,SCRIB;PARD3;PDZD11;RAP2A;DLG2;MARK2;LIN7A;MYO9A;CAMSAP3;DLG1;LRRC7;ANK1
prerank,GO_Biological_Process_2021__regulation of centriole elongation (GO:1903722),0.8296660185757188,1.4040030933951089,0.10256410256410256,0.7747932100182269,1.0,1/5,6.54%,CEP120
prerank,Reactome_2022__Acetylcholine Neurotransmitter Release Cycle R-HSA-264642,0.7092617002274402,1.4038593785697564,0.15151515151515152,0.7735536387334804,1.0,4/14,18.10%,PPFIA3;SYT1;UNC13B;PPFIA2
prerank,GO_Biological_Process_2021__L-methionine salvage (GO:0071267),-0.8909529183016018,-1.4036711766057035,0.0,0.6524202820373318,1.0,1/6,0.65%,BHMT
prerank,GO_Biological_Process_2021__positive regulation of protein localization to centrosome (GO:1904781),0.7923791184106262,1.4034999941987039,0.12195121951219512,0.7733955267813848,1.0,3/6,14.59%,BICD1;CEP250;MARK4
prerank,PanglaoDB_Augmented_2021__Gamma (PP) Cells,0.4796173947130751,1.402991685641767,0.08695652173913043,0.774210961404281,1.0,53/115,23.00%,ESRRG;SLITRK6;PCDH17;NOVA1;ADGRL2;PLCXD3;PLPPR1;ARX;UNC5C;CXXC4;PCLO;PAK5;PROX1;CNTN3;ETV1;ADGRA1;ABCC8;GUCY1A2;RGS7BP;STOX2;FGF12;PXK;NFIB;RNF180;PDZRN4;SNAP91;MAP6;MAGI1;ASXL3;PTPRT;ANK2;CFC1;NRXN1;FGF14;PPP1R9A;PTPRD;PBX1;PAX6;PPFIA2;SCGN;SERTM1;ST8SIA3;CNTN1;ENTPD2;NTRK2;ABCC9;TMEM196;FAM149A;RAPGEF4;SYT7;NOL4;PLPPR4;NME5
prerank,GO_Biological_Process_2021__regulation of calcium ion transmembrane transport (GO:1903169),-0.7150711297760459,-1.4026968991542363,0.078125,0.6567166315380614,1.0,3/19,6.40%,CASQ2;CAV3;TRDN
prerank,GO_Biological_Process_2021__axonogenesis (GO:0007409),0.44628479841447205,1.4020582660583412,0.0,0.7780016732478913,1.0,45/223,16.67%,EFNB1;SLITRK6;LLGL1;ROBO2;LAMA3;PTPRO;EPHA7;PARD3;DSCAML1;SPTBN4;SEMA6C;AUTS2;UNC5C;BSG;SEMA5A;UNC5D;NTN4;DCC;EPHA3;DSCAM;SLIT2;DOK5;EFNA5;DOK6;SEMA4A;NTNG2;SH3KBP1;IRS2;EVL;RET;GAB1;NLGN3;ARHGAP35;ANOS1;RAB10;RYK;EMB;PIK3CA;NCAM1;NRXN1;CNTN6;EFNA2;PARD6B;EPHB2;NOTCH1
prerank,GO_Biological_Process_2021__kidney development (GO:0001822),0.5499205577075917,1.4020061492169944,0.03571428571428571,0.7764988369113462,1.0,11/51,13.81%,FGF10;TGFBR1;ROBO2;IFT88;ITGA8;WNT4;PROX1;OSR1;CEP290;GDF6;NF1
prerank,CellMarker_Augmented_2021__Bone Marrow Stromal cell:Bone Marrow,0.501534707750428,1.4016707295377369,0.02857142857142857,0.7762022861331326,1.0,11/68,10.23%,ADGRF4;LAMA3;ARSJ;SDC4;PARVA;PERP;DSP;ESRP1;ITGA3;RND3;CDCP1
prerank,GO_Biological_Process_2021__hexose import across plasma membrane (GO:0140271),-0.8693964243835557,-1.4006258517971841,0.06666666666666667,0.6667507769803831,1.0,2/5,6.12%,SLC5A2;SLC5A1
prerank,GO_Biological_Process_2021__pre-replicative complex assembly involved in nuclear cell cycle DNA replication (GO:0006267),-0.8602289767221385,-1.4005210673990502,0.11940298507462686,0.6653200203731383,1.0,3/8,8.41%,MCM2;MCM3;MCMDC2
prerank,GO_Biological_Process_2021__regulation of myotube differentiation (GO:0010830),0.6949955023388675,1.4001690843901102,0.06451612903225806,0.7829556155262647,1.0,8/18,20.80%,HDAC3;SMYD1;MAML1;HDAC1;HDAC4;NOTCH1;HDAC5;RBM24
prerank,GO_Biological_Process_2021__regulation of oxidative stress-induced neuron death (GO:1903203),-0.8983458443216399,-1.4001027828841797,0.0,0.6657926918268052,1.0,2/5,9.69%,PINK1;REST
prerank,Reactome_2022__Diseases Of Glycosylation R-HSA-3781865,0.5038209036418443,1.400006671868106,0.05555555555555555,0.7819825789612526,1.0,31/125,12.59%,VCAN;ADAMTS1;GPC4;ADAMTS16;PAPSS2;GALNT12;SDC4;DPM3;CHST6;EXT1;SEMA5A;GALE;SPON1;GPC6;ADAMTS12;ADAMTS6;PRELP;CHSY1;ST3GAL3;MUC13;ADAMTS10;NUS1;ALG12;GPC5;CSPG5;B3GAT3;CHST3;SDC3;GLB1;GALT;ADAMTS19
prerank,PanglaoDB_Augmented_2021__Natural Killer T Cells,-0.6274045759058872,-1.399971917179503,0.05714285714285714,0.6644861144193963,1.0,13/66,8.84%,CD44;TCF7;SIRPG;GMFG;ITGB2;CYTIP;ARHGAP9;TAGAP;KLRB1;PARVG;CD5;TRAF3IP3;MYO1F
prerank,GO_Biological_Process_2021__DNA unwinding involved in DNA replication (GO:0006268),-0.7273587711672644,-1.3995995869347795,0.03571428571428571,0.6649808603864439,1.0,2/16,8.41%,MCM2;MCMDC2
prerank,Reactome_2022__Signal Regulatory Protein Family Interactions R-HSA-391160,-0.8099679674376632,-1.3994115478099631,0.05263157894736842,0.664176408389436,1.0,1/11,0.90%,SIRPG
prerank,Reactome_2022__p75NTR Negatively Regulates Cell Cycle Via SC1 R-HSA-193670,0.8635406363603875,1.3993760984280135,0.0625,0.7835626110076618,1.0,2/5,1.65%,NGF;HDAC3
prerank,CellMarker_Augmented_2021__B cell:Undefined,0.5241278269940495,1.3992623499356651,0.03571428571428571,0.7822292252166351,1.0,4/53,4.73%,IL7R;CD38;CD14;ITGA4
prerank,GO_Biological_Process_2021__positive regulation of lipopolysaccharide-mediated signaling pathway (GO:0031666),-0.8641459252293375,-1.3989363556655987,0.06451612903225806,0.664914158092974,1.0,2/6,7.52%,SCIMP;LY86
prerank,Reactome_2022__NF-kB Is Activated And Signals Survival R-HSA-209560,0.6799459509557555,1.398685011329386,0.125,0.7842301685140661,1.0,1/12,0.65%,NGF
prerank,Reactome_2022__Tachykinin Receptors Bind Tachykinins R-HSA-380095,0.9128844574635844,1.3983405792488603,0.045454545454545456,0.7847097181059881,1.0,1/5,0.14%,TACR3
prerank,"GO_Biological_Process_2021__DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator (GO:0006978)",-0.7826330639803366,-1.398101175900579,0.06896551724137931,0.6682017961153609,1.0,2/9,4.03%,FOXM1;SP100
prerank,GO_Biological_Process_2021__water transport (GO:0006833),-0.8136048670135472,-1.3975446906976214,0.034482758620689655,0.6693214798266264,1.0,5/11,15.61%,AQP3;SLC5A1;UPK3A;AQP4;AQP11
prerank,GO_Biological_Process_2021__negative regulation of monocyte chemotaxis (GO:0090027),0.8556361874398762,1.397452455360212,0.06,0.78725422351172,1.0,2/6,7.88%,GREM1;SLIT2
prerank,GO_Biological_Process_2021__aromatic amino acid transport (GO:0015801),0.8362380389780968,1.3973685272562082,0.075,0.7861536012330254,1.0,5/6,11.22%,SLC38A5;SLC3A2;SLC16A10;SLC25A29;SLC7A8
prerank,GO_Biological_Process_2021__nuclear membrane disassembly (GO:0051081),0.7100441754429944,1.3972049796474562,0.10810810810810811,0.7852537882739676,1.0,1/14,0.68%,CTDNEP1
prerank,GO_Biological_Process_2021__negative regulation of response to cytokine stimulus (GO:0060761),-0.765792980528676,-1.3966710054677878,0.08928571428571429,0.6729071037310599,1.0,2/9,13.26%,PTPRC;PALM3
prerank,GO_Biological_Process_2021__positive regulation of protein autophosphorylation (GO:0031954),0.5903495026419974,1.3963772175972282,0.06666666666666667,0.7879760536741464,1.0,4/21,8.46%,RASSF2;PDGFD;GREM1;RAP2A
prerank,GO_Biological_Process_2021__chylomicron assembly (GO:0034378),0.8960154394725597,1.3962430202249725,0.0,0.7870111407850847,1.0,2/6,2.66%,APOB;APOE
prerank,Reactome_2022__PI3K Events In ERBB4 Signaling R-HSA-1250342,0.7975708224066733,1.395808370285809,0.05405405405405406,0.7879327808740324,1.0,4/8,14.95%,NRG2;NRG1;NRG3;PIK3CA
prerank,Reactome_2022__DSCAM Interactions R-HSA-376172,0.6759222616009006,1.395527791383484,0.13333333333333333,0.7876522101538134,1.0,4/11,7.84%,DSCAML1;DCC;DSCAM;MAPK8
prerank,Reactome_2022__Downregulation Of ERBB2:ERBB3 Signaling R-HSA-1358803,0.6935652709116451,1.3952920114877951,0.0625,0.7871789649575774,1.0,4/13,9.44%,NRG2;ERBB2;NRG1;AKT2
prerank,GO_Biological_Process_2021__vitamin D metabolic process (GO:0042359),-0.7821994372627578,-1.395269844303557,0.07142857142857142,0.6793545986040209,1.0,4/10,14.65%,CYP24A1;CYP3A4;LRP2;VDR
prerank,GO_Biological_Process_2021__glutamine metabolic process (GO:0006541),0.8528529378462568,1.395234795012448,0.08108108108108109,0.7857726614463637,1.0,2/8,8.06%,GLYATL1;GLUD1
prerank,GO_Biological_Process_2021__cellular response to inorganic substance (GO:0071241),0.7113141023032519,1.3951091444896229,0.08823529411764706,0.78491938870481,1.0,5/16,14.75%,FOXO1;KCNC2;MTR;TIMELESS;SPIDR
prerank,GO_Biological_Process_2021__glutamine transport (GO:0006868),0.8355219360619709,1.3950715733111603,0.07317073170731707,0.7833955442080122,1.0,1/6,1.04%,SLC38A5
prerank,Reactome_2022__Heme Signaling R-HSA-9707616,0.6193148853736726,1.3947413505406345,0.0967741935483871,0.7835121446611114,1.0,17/40,23.83%,HDAC3;RORA;APOB;SMARCD3;SIRT1;NCOA2;NRIP1;CHD9;CARM1;EP300;CREB1;TBL1X;XPO1;CRTC1;NFE2L2;BRIP1;NR1D1
prerank,Reactome_2022__Resolution Of Sister Chromatid Cohesion R-HSA-2500257,-0.5351529942208711,-1.3946847527053208,0.014285714285714285,0.6805404288256652,1.0,23/99,23.42%,BUB1;ERCC6L;SPC25;CENPU;ITGB3BP;ZWILCH;NUF2;CENPH;CENPS-CORT;DYNLL1;RPS27;INCENP;NDEL1;CDCA8;CENPN;KIF18A;BUB1B;SKA2;SEC13;CENPL;DYNLL2;PPP2R5A;CENPM
prerank,GO_Biological_Process_2021__negative regulation of sprouting angiogenesis (GO:1903671),-0.8252372913329793,-1.3941813299002876,0.03571428571428571,0.6816972788414442,1.0,4/9,13.53%,EPN1;ALOX5;THBS1;PIK3CB
prerank,CellMarker_Augmented_2021__Clara cell:Lung,-0.6599718756385529,-1.3941040919874625,0.029850746268656716,0.6800550156499265,1.0,24/44,18.53%,CFAP126;VWA3B;DUOXA1;MROH9;CYP2B7P;CCDC60;MAP3K19;BPIFB1;DRC1;MS4A8;C11ORF16;AKAP14;SNTN;CFAP77;OR7E122P;FAM81B;APOBEC4;DNAH3;DNAI1;C7ORF57;ADH7;PLEKHG7;CYP4B1;CCDC190
prerank,GO_Biological_Process_2021__neurotrophin signaling pathway (GO:0038179),0.6787178374721261,1.3940668774576161,0.13157894736842105,0.7850988285511883,1.0,5/18,12.41%,NGF;MAGI2;RAPGEF1;CASP3;RAP1A
prerank,GO_Biological_Process_2021__positive regulation of organelle organization (GO:0010638),0.5636389015109867,1.3938639359617526,0.07142857142857142,0.7843818739469883,1.0,7/31,9.44%,IRGM;HTRA2;DOC2B;SORBS3;MGARP;STX18;AKT2
prerank,GO_Biological_Process_2021__response to nitric oxide (GO:0071731),0.8063408806173353,1.393316746202351,0.02702702702702703,0.7848139628581633,1.0,3/8,10.21%,FOXO1;KCNC2;MTR
prerank,GO_Biological_Process_2021__kynurenine metabolic process (GO:0070189),0.7947722162345345,1.3931825747629332,0.10256410256410256,0.7838465331155057,1.0,3/9,8.21%,TDO2;KYAT1;AADAT
prerank,CellMarker_Augmented_2021__Cancer Stem cell:Breast,-0.7339354818412753,-1.3930001712257452,0.13333333333333333,0.6849037868764717,1.0,1/18,0.01%,CD44
prerank,"Reactome_2022__Glutamate Binding, Activation Of AMPA Receptors And Synaptic Plasticity R-HSA-399721",0.5636100581329408,1.3927517648576326,0.07692307692307693,0.7849435884386218,1.0,4/30,13.84%,LLGL1;CACNG4;CACNG2;GRIP2
prerank,Reactome_2022__Netrin-1 Signaling R-HSA-373752,0.5752270445541035,1.3927372871589254,0.058823529411764705,0.7834106131619176,1.0,10/49,7.88%,MYO10;TRPC3;DSCAML1;UNC5C;UNC5D;NTN4;DCC;DSCAM;MAPK8;SLIT2
prerank,GO_Biological_Process_2021__polyol transport (GO:0015791),-0.8213054218472465,-1.392503949865021,0.07142857142857142,0.6857554903753291,1.0,2/9,6.12%,AQP3;SLC5A1
prerank,Reactome_2022__Atorvastatin ADME R-HSA-9754706,-0.8363826961165682,-1.3924692826663447,0.09803921568627451,0.6840076944514506,1.0,5/6,12.73%,SLCO2B1;PON3;CYP3A4;PON1;ABCB1
prerank,GO_Biological_Process_2021__negative regulation of vitamin metabolic process (GO:0046137),0.859049599828007,1.3922116197771444,0.045454545454545456,0.7842830077568304,1.0,3/5,14.09%,AKR1C3;SNAI2;NFKB1
prerank,CellMarker_Augmented_2021__Mesenchymal Stem cell:Amniotic Membrane,-0.9348349064943465,-1.3921499809441964,0.0,0.6839516342221866,1.0,1/5,0.01%,CD44
prerank,GO_Biological_Process_2021__positive regulation of axon extension involved in axon guidance (GO:0048842),0.8925339871957323,1.3920772268163293,0.0625,0.7834193367215204,1.0,2/5,7.35%,SEMA5A;DSCAM
prerank,PanglaoDB_Augmented_2021__Podocytes,0.494825043970477,1.3920157310175651,0.18181818181818182,0.7821192483608306,1.0,51/168,16.88%,EFNB1;LAMA3;MAFB;ADGRL2;PTPRO;CCN2;CDH13;PARVA;GOLIM4;MID1;COL12A1;RASSF8;MAGI2;NTN4;RAI14;EDNRA;TRIB2;ITGA3;KANK1;KITLG;RND3;EHD4;EPB41L5;CAP2;COL16A1;CHST3;MPDZ;DDAH1;DACH1;RBFOX2;UNC13B;SYNPO;RASAL2;LRIG3;EFEMP1;NFIB;DST;EMC2;NR2F2;MAGI1;WWTR1;ETF1;BCAM;PRICKLE2;ANTXR1;PTPRF;PLSCR4;CALD1;GPRC5A;CORO2B;ADAMTS13
prerank,Reactome_2022__MyD88-independent TLR4 Cascade R-HSA-166166,0.46959401882499546,1.391755945113892,0.0,0.7822360800326222,1.0,31/98,21.90%,DUSP4;MAPKAPK2;RIPK2;KCNH8;SARM1;HMGB1;MAPK8;ALPK1;RPS6KA3;N4BP1;PPP2R1B;TICAM1;TANK;FADD;NKIRAS2;TAB3;NFKB1;RPS6KA2;TP53;MAP2K7;PPP2R5D;S100B;TAB1;CREB1;TAB2;MAP2K6;TRAF6;FOS;UBE2D2;CUL1;DUSP6
prerank,Reactome_2022__Transport Of Inorganic Cations/Anions And Amino Acids/Oligopeptides R-HSA-425393,0.4998617811286674,1.3911440433165887,0.13636363636363635,0.7840113417892334,1.0,18/90,11.22%,SLC5A8;SLC17A6;SLC26A3;SLC38A5;SLC26A7;SLC12A1;SLC3A2;SLC8A1;SLC8A3;SLC7A9;SLC5A12;SLC4A7;SLC16A10;SLC6A20;SLC7A11;SLC7A6;SLC25A29;SLC7A8
prerank,PanglaoDB_Augmented_2021__Alpha Cells,0.5077764180165595,1.3903557683553491,0.043478260869565216,0.7869348866150383,1.0,31/113,16.63%,SLC38A5;EDIL3;PCDH17;CNGA3;MAFB;PLPPR1;KCNB2;ARX;RESP18;ALDH1A1;GPC6;KLHL41;PROX1;CNTN3;KCNIP1;ABCC8;PDZRN3;RGS7BP;DDAH1;RAB3C;MAP6;MAGI1;ASXL3;PTPRT;RFX6;CFC1;RAI2;FGF14;PTPRD;DEPP1;MAGEL2
prerank,GO_Biological_Process_2021__odontogenesis (GO:0042476),-0.6809238471491897,-1.390073302222542,0.03125,0.6946640563653838,1.0,3/28,1.19%,AQP3;TBX1;SCN5A
prerank,GO_Biological_Process_2021__positive regulation of lipid biosynthetic process (GO:0046889),0.6031309986638571,1.3900643338018759,0.06896551724137931,0.7865422364878722,1.0,11/30,19.66%,CTDNEP1;APOE;MFSD2A;PLIN5;ZBTB20;LDLR;MLXIPL;NR1H3;GPLD1;CREB1;ELOVL5
prerank,PanglaoDB_Augmented_2021__Mast Cells,0.46111144611943083,1.390017479572133,0.05555555555555555,0.7851558546347064,1.0,24/183,7.93%,CPA1;MLPH;MXRA5;KIT;ST6GALNAC3;ESYT3;PAPSS2;MITF;CDH5;HNMT;ALDH1A1;RIN2;HS6ST2;PID1;EXT1;HS3ST1;TPH1;PCDH7;OLFML2B;HS2ST1;CFH;ABCA1;GRIK2;EDNRA
prerank,GO_Biological_Process_2021__commissural neuron axon guidance (GO:0071679),0.7677186757996074,1.3893895576577466,0.0967741935483871,0.7865378390691158,1.0,4/8,16.57%,NFIB;RYK;NCAM1;EPHB2
prerank,CellMarker_Augmented_2021__Hematopoietic Stem cell:Blood,-0.6584240708491577,-1.3892728849529754,0.0410958904109589,0.6977273269893637,1.0,1/29,0.01%,CD44
prerank,GO_Biological_Process_2021__regulation of long-term synaptic potentiation (GO:1900271),0.6289033281495849,1.3891966455207028,0.14814814814814814,0.7858077101032214,1.0,3/27,7.57%,ARC;APOE;ABL1
prerank,Reactome_2022__Signaling By ERBB2 In Cancer R-HSA-1227990,0.6174892999051821,1.3890746949941284,0.11764705882352941,0.7846478254947246,1.0,4/23,7.38%,NRG2;ERBB2;NRG1;NRG3
prerank,GO_Biological_Process_2021__response to lead ion (GO:0010288),0.8454248505160089,1.3889141337711701,0.11363636363636363,0.7839863015036443,1.0,2/5,12.97%,PPP5C;PLSCR1
prerank,Reactome_2022__Circadian Clock R-HSA-400253,0.5303402115158556,1.3889076952038664,0.06060606060606061,0.7824039460903434,1.0,16/65,14.01%,PER2;HDAC3;RORA;SMARCD3;BMAL2;SIRT1;SERPINE1;CRY1;NCOA2;NRIP1;CREM;NAMPT;CPT1A;CHD9;CARM1;NR3C1
prerank,Reactome_2022__Neutrophil Degranulation R-HSA-6798695,-0.5068848775055798,-1.3887567759461525,0.0,0.6989778031110955,1.0,60/375,16.23%,CD44;CLEC5A;MGST1;GMFG;ITGB2;TCN1;MMP9;TBC1D10C;FLG2;ARHGAP9;CHIT1;PRDX4;ALOX5;RAB44;TNFRSF1B;DOCK2;CLEC4C;PTAFR;C3AR1;HRNR;OSCAR;PLAU;HLA-A;CEACAM1;NFAM1;ATP6V1D;PTX3;SNAP23;CYBA;OLFM4;PTPRC;FPR1;ENPP4;CD63;PDAP1;SLC11A1;CEACAM8;CTSZ;FTH1;PYGL;CLEC12A;ITGAM;SVIP;ACP3;HSPA8;TLR2;HVCN1;ORMDL3;DYNLL1;ADGRE3;ATP6AP2;NDUFA2;EEF2;DDX3X;ITM2C;SRP14;GRN;ELANE;TUBB;CYSTM1
prerank,GO_Biological_Process_2021__regulation of calcium ion transmembrane transport via high voltage-gated calcium channel (GO:1902514),0.7659555338683451,1.3885576945175557,0.07692307692307693,0.7822720188718628,1.0,1/10,3.49%,BIN1
prerank,GO_Biological_Process_2021__positive regulation of lipase activity (GO:0060193),0.7984059243361104,1.3884506055647239,0.0975609756097561,0.7812515226080851,1.0,3/8,9.62%,FGFR1;PLIN5;FGFR3
prerank,PanglaoDB_Augmented_2021__Pulmonary Alveolar Type II Cells,-0.6054274095961696,-1.3881547231287739,0.05555555555555555,0.7002422931572362,1.0,25/72,20.84%,CRLF1;SFTPA1;C1QB;INMT;CAPN8;PGC;DUOXA1;SLCO2B1;SFTPD;MS4A4A;VSIG4;SPINT1;STEAP4;CXCL16;FPR3;CLDN18;ADGRF5;ALOX15B;SCNN1A;CYP4B1;CSF1R;FAM3D;NRN1;IFI27;AGER
prerank,CellMarker_Augmented_2021__Esophageal Mucosal cell:Esophagus,0.48557928749641505,1.3879254122941258,0.0,0.7758166162782453,1.0,33/99,19.58%,MEGF10;NOVA1;ADGRL2;NLGN1;IL17RD;PTPRZ1;LRFN5;ERC2;SLIT2;ZNF462;TENM3;SYNDIG1;GUCY1A2;PDZRN3;WASF3;BRINP1;STOX2;NPAS3;MPDZ;MMP16;MAP6;ANK2;PRICKLE2;CDH11;PTPRD;MARK1;PBX1;PPFIA2;LSAMP;FAT3;DZIP1;ADGRB3;CNTN1
prerank,CellMarker_Augmented_2021__Intestinal Stem cell:Esophagus,0.48557928749641505,1.3879254122941258,0.0,0.7758166162782453,1.0,33/99,19.58%,MEGF10;NOVA1;ADGRL2;NLGN1;IL17RD;PTPRZ1;LRFN5;ERC2;SLIT2;ZNF462;TENM3;SYNDIG1;GUCY1A2;PDZRN3;WASF3;BRINP1;STOX2;NPAS3;MPDZ;MMP16;MAP6;ANK2;PRICKLE2;CDH11;PTPRD;MARK1;PBX1;PPFIA2;LSAMP;FAT3;DZIP1;ADGRB3;CNTN1
prerank,CellMarker_Augmented_2021__Small Intestinal Stem cell:Small Intestinal Crypt,0.48557928749641505,1.3879254122941258,0.0,0.7758166162782453,1.0,33/99,19.58%,MEGF10;NOVA1;ADGRL2;NLGN1;IL17RD;PTPRZ1;LRFN5;ERC2;SLIT2;ZNF462;TENM3;SYNDIG1;GUCY1A2;PDZRN3;WASF3;BRINP1;STOX2;NPAS3;MPDZ;MMP16;MAP6;ANK2;PRICKLE2;CDH11;PTPRD;MARK1;PBX1;PPFIA2;LSAMP;FAT3;DZIP1;ADGRB3;CNTN1
prerank,CellMarker_Augmented_2021__Intestinal Stem cell:Intestine,0.48557928749641505,1.3879254122941258,0.0,0.7758166162782453,1.0,33/99,19.58%,MEGF10;NOVA1;ADGRL2;NLGN1;IL17RD;PTPRZ1;LRFN5;ERC2;SLIT2;ZNF462;TENM3;SYNDIG1;GUCY1A2;PDZRN3;WASF3;BRINP1;STOX2;NPAS3;MPDZ;MMP16;MAP6;ANK2;PRICKLE2;CDH11;PTPRD;MARK1;PBX1;PPFIA2;LSAMP;FAT3;DZIP1;ADGRB3;CNTN1
prerank,CellMarker_Augmented_2021__Intestinal Stem cell:Colon,0.48557928749641505,1.3879254122941258,0.0,0.7758166162782453,1.0,33/99,19.58%,MEGF10;NOVA1;ADGRL2;NLGN1;IL17RD;PTPRZ1;LRFN5;ERC2;SLIT2;ZNF462;TENM3;SYNDIG1;GUCY1A2;PDZRN3;WASF3;BRINP1;STOX2;NPAS3;MPDZ;MMP16;MAP6;ANK2;PRICKLE2;CDH11;PTPRD;MARK1;PBX1;PPFIA2;LSAMP;FAT3;DZIP1;ADGRB3;CNTN1
prerank,Reactome_2022__Plasma Lipoprotein Clearance R-HSA-8964043,0.617404221343796,1.3877509340106302,0.03333333333333333,0.7750638749644498,1.0,6/31,9.94%,LIPC;APOB;APOE;SOAT1;SOAT2;LDLR
prerank,CellMarker_Augmented_2021__Mesenchymal Stem cell:Meniscus,-0.9029704293324816,-1.3877212568971404,0.061224489795918366,0.700734669251463,1.0,1/6,0.01%,CD44
prerank,CellMarker_Augmented_2021__Neuronal Progenitor cell:Undefined,0.5136654816587617,1.386688448991266,0.07407407407407407,0.77908978747621,1.0,39/97,23.81%,SLC17A6;MEGF10;POU3F2;LRRTM3;ELAVL3;CADM2;PCLO;PAK5;SLC35F1;PTPRZ1;KCNIP1;ERC2;ADGRA1;SYT1;GALNT13;STOX2;NXPH1;FGF12;CSPG5;NPAS3;SNAP91;MAP6;LRP1B;SCRT1;MARK1;GRIK3;PAX6;ST8SIA3;ADGRB3;GRM5;CNTN1;PLPPR5;SNCB;GRIA4;ADGRL3;NOL4;TUBB2B;PPM1E;CACNA1B
prerank,Reactome_2022__Erythropoietin Activates RAS R-HSA-9027284,0.7278127695152459,1.386678864045661,0.027777777777777776,0.7776095353077462,1.0,5/13,19.27%,RAPGEF1;EPOR;IRS2;CRKL;SOS1
prerank,GO_Biological_Process_2021__secretion (GO:0046903),-0.7617605532716596,-1.386635044282866,0.08333333333333333,0.7056723734445705,1.0,3/11,18.26%,SLC22A6;SLC22A4;ABCB11
prerank,GO_Biological_Process_2021__regulation of response to wounding (GO:1903034),-0.8823367573144155,-1.3863971704729736,0.05263157894736842,0.7058082799274464,1.0,3/5,11.76%,ALOX5;PLAU;VIL1
prerank,GO_Biological_Process_2021__DNA alkylation (GO:0006305),0.676921884023138,1.3863325757373666,0.058823529411764705,0.7764694642065089,1.0,9/18,27.55%,GATAD2A;DNMT1;TEX15;BAZ2A;ATF7IP;FOS;DMAP1;DNMT3A;PPM1D
prerank,GO_Biological_Process_2021__DNA methylation or demethylation (GO:0044728),0.676921884023138,1.3863325757373666,0.058823529411764705,0.7764694642065089,1.0,9/18,27.55%,GATAD2A;DNMT1;TEX15;BAZ2A;ATF7IP;FOS;DMAP1;DNMT3A;PPM1D
prerank,GO_Biological_Process_2021__alcohol catabolic process (GO:0046164),0.7898781867494619,1.385993453069378,0.11428571428571428,0.77647253476571,1.0,3/9,12.24%,CEL;APOE;ADH4
prerank,GO_Biological_Process_2021__regulation of ketone biosynthetic process (GO:0010566),0.8255178981878784,1.385824371653322,0.14634146341463414,0.7756377450868689,1.0,2/7,6.20%,AKR1C3;H6PD
prerank,Reactome_2022__Interferon Signaling R-HSA-913531,-0.5519879087512694,-1.3856998649447447,0.02666666666666667,0.7082810337592553,1.0,21/151,13.35%,CD44;TRIM62;IRF4;SP100;IRF1;TRIM5;PTAFR;UBE2L6;CIITA;TRIM25;STAT1;OAS2;IFIT3;HLA-A;GBP1;HLA-DRB1;IFIT1;OAS1;TRIM29;HLA-DPA1;GNL3
prerank,CellMarker_Augmented_2021__Regulatory T (Treg) cell:Blood,0.8976900700563072,1.3856017915330925,0.044444444444444446,0.774985468388455,1.0,2/5,4.73%,IL7R;ITGA4
prerank,CellMarker_Augmented_2021__B cell:Thyroid,-0.6701114332499689,-1.3855970603623773,0.057971014492753624,0.7070227145463891,1.0,11/35,8.72%,JCHAIN;BLK;CYTIP;TBC1D10C;ARHGAP9;TAGAP;TMC8;ICAM3;WAS;CD37;TRAF3IP3
prerank,Reactome_2022__Aberrant Regulation Of Mitotic Exit In Cancer Due To RB1 Defects R-HSA-9687136,0.6643761058898467,1.38543342414061,0.09090909090909091,0.7742165746996811,1.0,8/18,25.87%,UBE2E1;ANAPC16;CDC26;ANAPC7;FZR1;ANAPC4;ANAPC2;RB1
prerank,Reactome_2022__Toll Like Receptor 9 (TLR9) Cascade R-HSA-168138,0.4772907485968101,1.3854152896273322,0.0,0.7727666107577694,1.0,33/95,21.90%,DUSP4;MAPKAPK2;RIPK2;KCNH8;HMGB1;MAPK8;MAP3K1;ALPK1;RPS6KA3;N4BP1;PPP2R1B;TICAM1;TANK;NKIRAS2;TAB3;PELI1;NFKB1;RPS6KA2;PELI2;IRAK4;TP53;MAP2K7;PPP2R5D;S100B;TAB1;CREB1;TAB2;MAP2K6;TRAF6;FOS;PIK3R4;CUL1;DUSP6
prerank,CellMarker_Augmented_2021__Lake Et al.Science.In2:Brain,0.5710049923098377,1.3845653005963503,0.09090909090909091,0.7754190211732359,1.0,28/102,15.20%,TACR3;PCDH15;SLC17A6;MGAT4C;SPHKAP;GRID2;GRM3;LRRTM3;PCDH11X;SYT14;MAGI2;HCN1;FER;ERC2;CELF4;NAV3;FGF12;SLC7A11;RIMS2;ADGRV1;FRMD5;GPR149;RBFOX1;FRRS1L;PGAP1;ANK2;RPS6KA6;SRRM4
prerank,GO_Biological_Process_2021__positive regulation of vascular associated smooth muscle cell migration (GO:1904754),0.7513368033669818,1.384162535315304,0.05357142857142857,0.7758981652966118,1.0,1/8,1.13%,ADAMTS1
prerank,GO_Biological_Process_2021__negative regulation of cellular biosynthetic process (GO:0031327),0.5424414439999387,1.3840944939013822,0.10714285714285714,0.7747491578915038,1.0,9/40,9.90%,GCK;GLA;WNT4;AKR1C3;CRY1;PROX1;KHSRP;SNAI2;WDTC1
prerank,Reactome_2022__Cargo Recognition For Clathrin-Mediated Endocytosis R-HSA-8856825,0.48149264303013684,1.3837814740276513,0.037037037037037035,0.7746670431053859,1.0,11/88,10.73%,IL7R;CHRM2;TOR1B;APOB;KIAA0319;ARRB2;SYT1;TGFA;LDLR;SH3KBP1;SYT12
prerank,CellMarker_Augmented_2021__IL-17Ralpha T cell:Peripheral Blood,0.6039872318372262,1.383781270668668,0.16666666666666666,0.7731421079811627,1.0,5/28,5.09%,IL7R;CD247;TRAC;GPR174;PYHIN1
prerank,Reactome_2022__Response Of EIF2AK4 (GCN2) To Amino Acid Deficiency R-HSA-9633012,-0.5707337765244413,-1.3832960455625443,0.039473684210526314,0.71896320758949,1.0,55/91,27.12%,RPL37A;RPL38;RPL15;RPS4X;RPL3;RPL35A;RPS9;FAU;RPS27;RPS21;RPL13A;RPL27A;EIF2S3;RPS16;RPL36;RPS20;RPL7A;RPL9;EIF2S2;RPS8;RPS27A;RPL21;RPL34;RPL4;RPL32;RPL5;RPL23;RPL41;RPS7;RPS11;RPL27;RPL35;RPS14;RPL11;RPS15;RPLP1;RPS12;RPL18A;RPS13;RPL29;RPLP2;RPL28;RPL12;RPL18;RPS3;RPL22;RPSA;RPS28;RPS19;RPS24;RPL26L1;RPS3A;RPL19;RPL8;RPS6
prerank,GO_Biological_Process_2021__negative regulation of osteoblast differentiation (GO:0045668),0.641683161091798,1.3830510353910164,0.07692307692307693,0.774974086261926,1.0,8/29,9.07%,BAMBI;TWIST2;PPARG;RORB;GREM1;CDK6;TWIST1;CRIM1
prerank,CellMarker_Augmented_2021__Macrophage:Intervertebral Disc,-0.614043326564194,-1.382852104475954,0.04285714285714286,0.7197277222038709,1.0,21/55,13.42%,CLEC5A;C1QB;ITGB2;HCK;TNFRSF1B;C3AR1;MS4A4A;PARVG;FCGR3A;LY86;VSIG4;HLA-DPB1;MYO1F;IGSF6;PTPRC;SPI1;CLEC12A;ITGAM;FPR3;HLA-DPA1;CD300LF
prerank,PanglaoDB_Augmented_2021__Ciliated Cells,-0.5937110820323267,-1.3822101895595031,0.02666666666666667,0.7219452623250098,1.0,25/71,14.98%,ECT2L;CFAP126;CCDC39;ANKUB1;CCDC187;DYDC2;VWA3B;VWA3A;CCDC60;MAP3K19;RSPH10B;BPIFB1;DRC1;DCDC2B;C11ORF16;AKAP14;SNTN;CFAP77;FAM81B;ATP5MK;APOBEC4;DRC3;DNAH3;EFHB;DNAI1
prerank,GO_Biological_Process_2021__water homeostasis (GO:0030104),-0.7831529947835789,-1.3821865130418454,0.12698412698412698,0.7199773238333561,1.0,3/7,15.61%,SCTR;AQP4;AQP11
prerank,GO_Biological_Process_2021__histone H2A monoubiquitination (GO:0035518),0.6752071339956458,1.3821322678876642,0.16216216216216217,0.7776202998786522,1.0,7/17,20.52%,PCGF1;RNF168;PCGF5;RYBP;BCOR;RNF2;PCGF6
prerank,GO_Biological_Process_2021__response to chemokine (GO:1990868),-0.7606166576958171,-1.3820517201334208,0.1111111111111111,0.7189107116718992,1.0,1/11,2.86%,DOCK8
prerank,Reactome_2022__ARMS-mediated Activation R-HSA-170984,0.7592210583536623,1.3814530149349518,0.1320754716981132,0.7796705764307579,1.0,4/7,17.32%,NGF;CRK;RAP1A;BRAF
prerank,GO_Biological_Process_2021__mRNA transcription (GO:0009299),0.7503100760587701,1.3812020332818309,0.15555555555555556,0.7794627641306436,1.0,5/10,18.84%,ZBTB1;TFCP2;HSF1;TP53;C5AR1
prerank,GO_Biological_Process_2021__mRNA 5'-splice site recognition (GO:0000395),0.8334339479333914,1.3809147655154743,0.10204081632653061,0.7792849268699826,1.0,2/5,12.12%,PRPF39;SFSWAP
prerank,GO_Biological_Process_2021__interleukin-21-mediated signaling pathway (GO:0038114),-0.8972456014183361,-1.3808497427484805,0.034482758620689655,0.722106483344551,1.0,2/6,6.09%,IL21R;STAT1
prerank,GO_Biological_Process_2021__cellular response to interleukin-21 (GO:0098757),-0.8972456014183361,-1.3808497427484805,0.034482758620689655,0.722106483344551,1.0,2/6,6.09%,IL21R;STAT1
prerank,Reactome_2022__Role Of ABL In ROBO-SLIT Signaling R-HSA-428890,0.7982275227705053,1.380708220893789,0.13333333333333333,0.7787002679859171,1.0,3/8,8.76%,ABL1;SLIT2;ABL2
prerank,GO_Biological_Process_2021__regulation of cilium movement (GO:0003352),-0.8478902961310334,-1.3806851370936861,0.05,0.7211455153363295,1.0,3/7,8.44%,DNAH11;CCDC39;DRC1
prerank,CellMarker_Augmented_2021__Cancer Stem cell:Ovarian Cortex,-0.574216701387044,-1.3805895178372443,0.04,0.7174229591744948,1.0,18/90,10.00%,CD44;C1QTNF1;AHR;FLG;PDCD1LG2;ELK3;LPAR1;FILIP1L;TGFBI;GLIS3;DAB2;DCN;PLAU;ANXA1;HEG1;OSMR;ITGBL1;GBP1
prerank,CellMarker_Augmented_2021__Stem cell:Stomach,-0.574216701387044,-1.3805895178372443,0.04,0.7174229591744948,1.0,18/90,10.00%,CD44;C1QTNF1;AHR;FLG;PDCD1LG2;ELK3;LPAR1;FILIP1L;TGFBI;GLIS3;DAB2;DCN;PLAU;ANXA1;HEG1;OSMR;ITGBL1;GBP1
prerank,GO_Biological_Process_2021__mitotic DNA replication (GO:1902969),-0.8541133667079386,-1.3801801296413327,0.01639344262295082,0.718009751756452,1.0,3/9,8.41%,MCM2;MCM3;MCMDC2
prerank,GO_Biological_Process_2021__positive regulation of mitotic cell cycle (GO:0045931),0.6413519913762226,1.3796257258865463,0.0967741935483871,0.7827951861711887,1.0,7/22,21.78%,HES1;PKN2;KLHL18;HSF1;EIF4EBP1;PPP1R10;EIF4E
prerank,GO_Biological_Process_2021__negative regulation of cAMP-dependent protein kinase activity (GO:2000480),0.8128575104645622,1.3795420799242146,0.0625,0.7815101035722426,1.0,3/8,10.12%,PKIA;SIRT1;PRKAR2A
prerank,GO_Biological_Process_2021__cardiac muscle cell-cardiac muscle cell adhesion (GO:0086042),-0.7912578032805777,-1.3793913954741688,0.1111111111111111,0.7213945802339815,1.0,2/7,3.78%,PKP2;CTNNA3
prerank,GO_Biological_Process_2021__negative regulation of potassium ion transmembrane transporter activity (GO:1901017),-0.8357689204248929,-1.3793262536454467,0.03278688524590164,0.7199023326651703,1.0,2/8,2.76%,CASQ2;CAV3
prerank,GO_Biological_Process_2021__inflammatory response (GO:0006954),-0.5320047437506572,-1.378972401573287,0.013888888888888888,0.7207600325542645,1.0,40/134,17.59%,CD44;TGFB1;XCR1;ITGB2;CXCL13;TAC4;CIITA;C3AR1;LTB4R;ALOX15;NFAM1;ANXA1;PTX3;THBS1;CYBA;TRAF3IP2;FPR1;NLRC4;SLC11A1;MMP25;PTGDR;HPR;TLR2;BLNK;FPR3;NLRP3;PTGER3;NOS2;GPR68;GGT5;AFAP1L2;HYAL1;IL18;HRH4;NAIP;PARP4;RAC1;IL10RB;PIK3CG;ABCF1
prerank,GO_Biological_Process_2021__establishment or maintenance of apical/basal cell polarity (GO:0035088),0.65609811516838,1.378675907718399,0.02857142857142857,0.7844551166764838,1.0,8/17,25.20%,SCRIB;PARD3;FSCN1;DLG2;MARK2;DLG1;LRRC7;DLG3
prerank,Reactome_2022__RORA Activates Gene Expression R-HSA-1368082,0.7047313330738362,1.3785325386045109,0.0,0.7836628080844145,1.0,8/17,20.68%,RORA;SMARCD3;NCOA2;CPT1A;CHD9;CARM1;EP300;TBL1X
prerank,GO_Biological_Process_2021__cellular response to fluid shear stress (GO:0071498),0.778897194105114,1.3784310363343932,0.058823529411764705,0.7826717588809935,1.0,2/11,5.34%,HDAC3;PKD2
prerank,GO_Biological_Process_2021__cellular zinc ion homeostasis (GO:0006882),0.6663546655975449,1.3783142864796765,0.15151515151515152,0.781943471666344,1.0,3/22,3.19%,MT1G;SLC30A10;SLC39A8
prerank,GO_Biological_Process_2021__acetylcholine receptor signaling pathway (GO:0095500),0.6188143603946235,1.3780210478944088,0.10526315789473684,0.7817061696250128,1.0,3/19,7.70%,CHRM2;LYPD1;PLCB1
prerank,CellMarker_Augmented_2021__M1 macrophage:Lung,-0.596700530226426,-1.3779942629919313,0.041666666666666664,0.72481391261532,1.0,26/57,20.41%,PSMB9;APOL1;HCK;SLC7A7;IRF1;PTAFR;HLA-DMA;C3AR1;MS4A4A;FCGR3A;OAS2;IFIT3;LY86;TAPBPL;GBP1;OAS1;TLR2;FPR3;ADAMDEC1;HK3;IL10RB;IFI35;CSF1R;TFEC;DHX58;CD86
prerank,CellMarker_Augmented_2021__FGFR1LowNME5- Epithelial cell:Esophagus,-0.6431542850317761,-1.3777439349277592,0.029850746268656716,0.7242681503244323,1.0,6/45,11.08%,CLCA2;TCF7;CYTIP;MBNL3;SPATC1L;GAS7
prerank,CellMarker_Augmented_2021__Cancer Stem cell:Oral Cavity,-0.6084986120778517,-1.3775543512390709,0.04477611940298507,0.7234450820833026,1.0,12/65,13.26%,CD44;CLDN1;TGFBI;DUOXA1;BACE2;CP;LAMC2;NSUN7;ITGB6;GPX3;TRIM29;CYP4F12
prerank,GO_Biological_Process_2021__epithelial cell morphogenesis (GO:0003382),0.6693539959798268,1.377383418495134,0.09302325581395349,0.7825875952829512,1.0,1/12,0.09%,COL22A1
prerank,GO_Biological_Process_2021__positive regulation of behavior (GO:0048520),0.7477730066502132,1.3772914492929043,0.061224489795918366,0.7813487167752484,1.0,4/8,16.04%,NLGN1;INSL5;SGIP1;NR4A3
prerank,GO_Biological_Process_2021__centromeric sister chromatid cohesion (GO:0070601),-0.8636055406538915,-1.377199198026324,0.09803921568627451,0.7240041979685862,1.0,1/5,0.44%,BUB1
prerank,GO_Biological_Process_2021__protein localization to synapse (GO:0035418),0.6946317452891085,1.3771398422893684,0.10526315789473684,0.7806285138945005,1.0,4/12,15.58%,NLGN1;PCLO;ZDHHC12;NRXN1
prerank,CellMarker_Augmented_2021__Monocyte:Bone Marrow,-0.6498808374758401,-1.3769121326990634,0.05970149253731343,0.7238832566481334,1.0,19/43,13.64%,LILRB3;ITGB2;HCK;C3AR1;MS4A4A;FCGR3A;LY86;VSIG4;NFAM1;MYO1F;IGSF6;FPR1;SLC11A1;SPI1;CLEC12A;ITGAM;TLR2;CD300LF;ADGRE3
prerank,GO_Biological_Process_2021__cholesterol metabolic process (GO:0008203),0.5289349553594939,1.3768881651735128,0.07692307692307693,0.7807375033076642,1.0,7/62,7.63%,TSKU;CEL;APOB;APOE;SOAT1;SOAT2;ABCA1
prerank,GO_Biological_Process_2021__regulation of osteoblast proliferation (GO:0033688),0.6511127941984425,1.3767243899461201,0.10256410256410256,0.7799643127424112,1.0,4/15,8.27%,CCN1;HPSE;GREM1;PLXNB1
prerank,Reactome_2022__Organic Anion Transporters R-HSA-428643,0.793733098950641,1.3767146962707904,0.11363636363636363,0.7785126946359537,1.0,2/9,0.54%,SLC5A8;SLC17A6
prerank,CellMarker_Augmented_2021__Mesenchymal Stem cell:Germ,-0.8948363771666294,-1.3762123900141066,0.057692307692307696,0.7261260695456484,1.0,1/6,0.01%,CD44
prerank,GO_Biological_Process_2021__negative regulation of G protein-coupled receptor signaling pathway (GO:0045744),0.6557963675350332,1.3760852500611465,0.05128205128205128,0.7800985600420471,1.0,7/20,9.51%,MRAP2;KLK14;CRY1;SNCA;BICD1;RGS14;RPGRIP1L
prerank,CellMarker_Augmented_2021__Mesenchymal Stem cell:Synovium,-0.8638465426402553,-1.3755473276346573,0.018518518518518517,0.7282379014250352,1.0,1/8,0.01%,CD44
prerank,GO_Biological_Process_2021__neurotransmitter receptor diffusion trapping (GO:0099628),0.769719199924388,1.3746927424544562,0.16129032258064516,0.7839016133679497,1.0,3/8,8.93%,CACNG4;CACNG2;GPHN
prerank,GO_Biological_Process_2021__postsynaptic neurotransmitter receptor diffusion trapping (GO:0098970),0.769719199924388,1.3746927424544562,0.16129032258064516,0.7839016133679497,1.0,3/8,8.93%,CACNG4;CACNG2;GPHN
prerank,GO_Biological_Process_2021__triglyceride-rich lipoprotein particle remodeling (GO:0034370),0.7715637296871509,1.3740791977859725,0.18181818181818182,0.7857783088344631,1.0,4/7,9.91%,LIPC;APOB;APOE;LPL
prerank,"GO_Biological_Process_2021__nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay (GO:0000288)",0.5471777640771889,1.3739184880039415,0.08108108108108109,0.7853699655552565,1.0,16/51,21.06%,DCP1B;SAMD4A;DCPS;EXOSC1;CNOT9;LSM2;CNOT4;PATL1;LSM7;DIS3;RC3H1;SAMD4B;CNOT6;EXOSC5;TUT7;LSM6
prerank,CellMarker_Augmented_2021__Type II pneumocyte:Undefined,-0.5722487942949077,-1.3738921940805444,0.0958904109589041,0.7352638344188168,1.0,13/59,17.22%,PLEKHS1;SERINC2;MISP;ELMO3;SMIM22;TMC4;MUC5B;LAMC2;ITGB6;TRIM29;MUC4;TJP3;SCNN1A
prerank,CellMarker_Augmented_2021__Epithelial cell:Bladder,-0.5722487942949077,-1.3738921940805444,0.0958904109589041,0.7352638344188168,1.0,13/59,17.22%,PLEKHS1;SERINC2;MISP;ELMO3;SMIM22;TMC4;MUC5B;LAMC2;ITGB6;TRIM29;MUC4;TJP3;SCNN1A
prerank,GO_Biological_Process_2021__positive regulation of autophagy of mitochondrion in response to mitochondrial depolarization (GO:1904925),-0.8613492217161722,-1.3737982889808493,0.02,0.7337784295088015,1.0,4/6,13.34%,HK2;PINK1;TOMM7;ATP5IF1
prerank,GO_Biological_Process_2021__homocysteine metabolic process (GO:0050667),0.7215924712945987,1.3734962004985323,0.15384615384615385,0.7860579035921742,1.0,3/11,13.71%,NOX4;CBS;MTHFR
prerank,GO_Biological_Process_2021__lymphocyte activation involved in immune response (GO:0002285),-0.8086882847643834,-1.3733045652816767,0.03773584905660377,0.7350046527955425,1.0,4/8,16.13%,IFNK;GPR183;LCP1;F2RL1
prerank,Reactome_2022__FGFR1b Ligand Binding And Activation R-HSA-190370,0.836847826183206,1.3732704389876735,0.1509433962264151,0.7858186736381305,1.0,2/5,2.37%,FGF10;FGFR1
prerank,CellMarker_Augmented_2021__Primitive Endoderm cell:Embryo,0.510938251695836,1.3728866112024845,0.05714285714285714,0.7861396490536116,1.0,11/78,8.06%,PHLDB2;RSPO3;DUSP4;KIT;GPR161;AMOTL1;CPN1;ALDH1A1;CADM1;CMBL;CNIH3
prerank,GO_Biological_Process_2021__glucosamine-containing compound catabolic process (GO:1901072),-0.8545856868581327,-1.37239500491474,0.05454545454545454,0.7389207532507234,1.0,1/7,3.02%,CHIT1
prerank,GO_Biological_Process_2021__regulation of alpha-beta T cell differentiation (GO:0046637),0.8144746714173328,1.37232551852618,0.07894736842105263,0.7875201351658567,1.0,3/6,8.09%,PNP;SH3RF1;NKAP
prerank,Reactome_2022__Digestion Of Dietary Carbohydrate R-HSA-189085,-0.8599203778218563,-1.3722337351128653,0.06666666666666667,0.7377103016535568,1.0,3/6,10.35%,TREH;CHIT1;LCT
prerank,PanglaoDB_Augmented_2021__Erythroblasts,-0.5609226807867645,-1.3719289871614646,0.0136986301369863,0.7379250763070345,1.0,15/90,10.72%,CD44;RASGRP4;TRIM58;GMFG;TMC8;RAB44;SLFN14;DOCK2;GYPB;ICAM3;SNAP23;CGA;MFSD2B;ALAS2;ITGA2B
prerank,GO_Biological_Process_2021__DNA duplex unwinding (GO:0032508),-0.6008210817249656,-1.371817840017163,0.014084507042253521,0.7366655355724432,1.0,12/49,23.78%,MCM2;MCMDC2;ANXA1;PIF1;RBX1;RPS27A;DDX1;RECQL4;HMGA1;DDX11;BLM;DDB1
prerank,CellMarker_Augmented_2021__Amacrine cell:Eye,0.509793204401694,1.371799621169517,0.029411764705882353,0.7891740937812105,1.0,19/77,14.25%,TACR3;XKR7;GRID2;CACNG4;EPHA7;IGDCC3;HRH3;UNC5D;VAT1L;BRINP1;NLGN4X;RIMS4;RHBDL3;PRR36;ADAMTS19;CRABP1;CHST8;MSI1;SYT6
prerank,GO_Biological_Process_2021__regulation of microtubule-based process (GO:0032886),0.5887067080473048,1.3717978103957633,0.06451612903225806,0.7877072274358923,1.0,14/35,21.29%,PHLDB2;ERBB2;BICD1;EPHA3;MAP10;EFNA5;MACF1;KLHL42;MAP6;MARK4;PRKAA2;MARK2;IGBP1;CAMSAP3
prerank,Reactome_2022__Acetylcholine Binding And Downstream Events R-HSA-181431,-0.7266878905622925,-1.3717195236508322,0.14516129032258066,0.7351806676994405,1.0,2/12,7.92%,CHRNA9;CHRNE
prerank,PanglaoDB_Augmented_2021__Osteoblasts,-0.5325867690336878,-1.3717134797989021,0.038461538461538464,0.7332987218346587,1.0,16/131,9.19%,CD44;OLFML1;C1QTNF1;LMOD1;TIMP3;ANGPTL2;WNT5A;ESR1;COL1A1;GPER1;COL5A1;LOX;DCN;PHEX;SFRP4;OSMR
prerank,GO_Biological_Process_2021__glycerolipid biosynthetic process (GO:0045017),0.7741496421657761,1.3715737150823704,0.1,0.7873561246495091,1.0,5/9,18.48%,CPNE7;CRLS1;CPNE6;HDHD5;CPNE1
prerank,Reactome_2022__Interferon Alpha/Beta Signaling R-HSA-909733,-0.6204568101703949,-1.3712294997925198,0.029411764705882353,0.734484388322324,1.0,16/47,22.43%,IRF4;IRF1;STAT1;OAS2;IFIT3;HLA-A;IFIT1;OAS1;HLA-F;IFIT2;IFI35;IFI27;MX1;IFI6;ISG15;HLA-C
prerank,GO_Biological_Process_2021__inner ear receptor cell development (GO:0060119),0.7146143166244939,1.3707517322930856,0.13157894736842105,0.7901094628208731,1.0,6/9,14.36%,TSKU;IFT88;WHRN;SLC4A7;ADGRV1;PDZD7
prerank,GO_Biological_Process_2021__fatty acid homeostasis (GO:0055089),0.7813571192259241,1.3707257666316768,0.0,0.7887319679023839,1.0,3/9,12.09%,APOE;SIRT1;MLXIPL
prerank,GO_Biological_Process_2021__regulation of water loss via skin (GO:0033561),-0.7732662729313217,-1.3706939583746371,0.10344827586206896,0.7340249619747813,1.0,8/17,14.91%,FLG;ALOX12;FLG2;CLDN1;ALOX12B;HRNR;TMEM79;ABCA12
prerank,GO_Biological_Process_2021__establishment of skin barrier (GO:0061436),-0.7732662729313217,-1.3706939583746371,0.10344827586206896,0.7340249619747813,1.0,8/17,14.91%,FLG;ALOX12;FLG2;CLDN1;ALOX12B;HRNR;TMEM79;ABCA12
prerank,GO_Biological_Process_2021__positive regulation of dendritic spine development (GO:0060999),0.6649014398733692,1.3705802806033973,0.11627906976744186,0.7883257090765428,1.0,5/21,19.06%,APOE;NLGN1;LRP8;DLG5;FOXO6
prerank,Reactome_2022__Defective Factor VIII Causes Hemophilia A R-HSA-9662001,-0.8721515785818142,-1.3705617240780168,0.058823529411764705,0.7330052185514504,1.0,3/6,10.59%,F8;FAM110A;VWF
prerank,Reactome_2022__FGFRL1 Modulation Of FGFR1 Signaling R-HSA-5658623,0.7672346590606385,1.370561699628073,0.075,0.787066786950206,1.0,5/10,11.02%,FGF10;FGF17;FGF18;SPRED2;SPRED1
prerank,GO_Biological_Process_2021__regulation of dendritic spine maintenance (GO:1902950),0.8126123932085186,1.3701054698829866,0.17142857142857143,0.7880402270776241,1.0,1/6,2.66%,APOE
prerank,GO_Biological_Process_2021__cardiac muscle tissue morphogenesis (GO:0055008),-0.7231451846646393,-1.369999229646141,0.11764705882352941,0.7350927647174681,1.0,8/18,14.24%,PKP2;TGFB1;MYH7;ACTC1;MYBPC3;ZFPM1;ENG;TTN
prerank,KEGG_2021_Human__Various types of N-glycan biosynthesis,0.595162941667746,1.3697054659940544,0.03225806451612903,0.7886806658693954,1.0,13/37,15.24%,MGAT4C;ST3GAL3;B4GALT2;MAN1A2;MAN2A1;B4GALT3;ALG12;B4GALNT4;MAN1A1;HEXD;CHST8;ALG3;MGAT2
prerank,GO_Biological_Process_2021__positive regulation of sequestering of triglyceride (GO:0010890),0.8089733813037616,1.369632755720371,0.13043478260869565,0.7875376193696957,1.0,3/7,11.41%,PLIN5;LPL;OSBPL11
prerank,PanglaoDB_Augmented_2021__Basophils,-0.5750251211679562,-1.3693801178349545,0.05263157894736842,0.7367518820126338,1.0,27/99,13.64%,CD44;LILRB3;CLEC5A;HCK;TEC;PTAFR;C3AR1;RNF39;GPR183;MS4A4A;FCGR3A;VSIG4;HTR1B;NFAM1;IL3RA;MYO1F;PLG;FPR1;ID1;SPI1;CLEC12A;ITGAM;TLR2;H1-3;F13A1;CD300LF;ADGRE3
prerank,GO_Biological_Process_2021__endothelial cell differentiation (GO:0045446),0.7562799630731303,1.3693106148666512,0.08888888888888889,0.7876295943906018,1.0,3/10,6.26%,SCUBE1;JAG1;PROX1
prerank,CellMarker_Augmented_2021__Lake Et al.Science.In8:Brain,-0.588455975136423,-1.3689553848330753,0.07246376811594203,0.7378723085631607,1.0,22/79,18.78%,NEK2;BUB1;TICRR;HMGB3;CEP55;CENPU;CDC25A;DEPDC1;TTK;NUF2;CDKN3;CKS1B;EI24;PDCL2;ECT2;PAICS;CDCA8;IQGAP3;PKMYT1;CDC6;RAD54L;BUB1B
prerank,PanglaoDB_Augmented_2021__Epithelial Cells,-0.541588255088204,-1.3684813234003312,0.0273972602739726,0.7388925297010785,1.0,41/135,21.21%,PLEKHS1;AQP3;VSIG2;TMEM184A;PLEKHG6;MISP;FMO5;CLDN1;TMC4;LIPH;EPN3;SERPINB5;CEACAM1;ALOX15;BRCA1;MYO5B;SPINT1;LAMC2;ITGB6;STAP2;BAIAP2L1;TRIM29;ITGA5;F5;PRG4;INCENP;GPX2;ECT2;CD24;SCNN1A;LGALS4;SCNN1G;PLA2G4A;ANPEP;FAM3D;CBLC;MECOM;COL17A1;AGER;EMILIN2;CRYBA1
prerank,GO_Biological_Process_2021__purine-containing compound biosynthetic process (GO:0072522),0.581918891272062,1.3684195556783336,0.07142857142857142,0.7908882815358267,1.0,2/23,4.74%,PNP;AMPD1
prerank,GO_Biological_Process_2021__chromatin-mediated maintenance of transcription (GO:0048096),0.7262879347986426,1.3681979824125117,0.075,0.7907830514443766,1.0,5/11,17.84%,ELOF1;CDCA4;ARID1A;SERTAD2;ARID1B
prerank,Reactome_2022__Miscellaneous Transport And Binding Events R-HSA-5223345,0.6687460112964927,1.3679179180194165,0.08333333333333333,0.7911678554105479,1.0,1/21,0.33%,NIPAL1
prerank,GO_Biological_Process_2021__cellular response to insulin stimulus (GO:0032869),0.4710555160238325,1.367638469372471,0.05555555555555555,0.7911711138288361,1.0,11/111,5.65%,GCK;ATP6V0D2;FOXO1;SH2B2;CPEB1;TCIRG1;IRS1;RAB31;CAPN10;PPARG;SLC25A33
prerank,CellMarker_Augmented_2021__Syncytiotrophoblast:Placenta,-0.6485127874544336,-1.3676145233238832,0.058823529411764705,0.7421111110726664,1.0,18/29,19.48%,ISM2;PSG4;PSG8;PSG3;PLAC1;PSG5;LVRN;PSG2;CGA;GNGT1;PSG6;PSG9;PSG11;HSD3B1;GLDN;INHA;PSG1;TRIM60
prerank,GO_Biological_Process_2021__protein localization to centrosome (GO:0071539),0.6660234701755051,1.3675578449150085,0.1111111111111111,0.7900901886557983,1.0,9/17,25.97%,PCM1;C2CD3;PIBF1;GOLGB1;CCDC14;CEP192;HOOK3;KIAA0753;CEP83
prerank,GO_Biological_Process_2021__regulation of basement membrane assembly involved in embryonic body morphogenesis (GO:1904259),0.9491711255690762,1.3673859629402856,0.0625,0.7883991546489062,1.0,1/5,0.53%,PHLDB2
prerank,GO_Biological_Process_2021__positive regulation of basement membrane assembly involved in embryonic body morphogenesis (GO:1904261),0.9491711255690762,1.3673859629402856,0.0625,0.7883991546489062,1.0,1/5,0.53%,PHLDB2
prerank,Reactome_2022__G Alpha (12/13) Signaling Events R-HSA-416482,0.5214874331528985,1.3673264783436572,0.03333333333333333,0.7871942779110074,1.0,7/69,8.44%,ADRA1A;ADRA1B;PLEKHG2;FGD4;PRPF38B;PLXNB1;FGD1
prerank,CellMarker_Augmented_2021__Endothelial cell:Undefined,-0.6847458966748906,-1.367279051690511,0.0547945205479452,0.7420819638245939,1.0,10/23,16.84%,F8;PROCR;FLT4;A4GALT;IL3RA;PTPRC;ENG;TEK;TSPAN7;NT5E
prerank,GO_Biological_Process_2021__regulation of cytoplasmic translation (GO:2000765),0.73668016490673,1.3669462527772667,0.1282051282051282,0.78758138394505,1.0,1/14,1.51%,CPEB1
prerank,KEGG_2021_Human__Glutamatergic synapse,0.5056114266083862,1.366904207984745,0.07407407407407407,0.7863554406964514,1.0,15/100,11.15%,GRIN3A;SLC17A6;ITPR2;GRM3;GRIK1;GRM8;KCNJ3;PLCB1;GRIK2;ADCY2;GRM4;GRM2;GRM7;GRIN1;ADCY3
prerank,GO_Biological_Process_2021__positive regulation of protein localization to synapse (GO:1902474),-0.9002452158932801,-1.366775886885268,0.09836065573770492,0.7439454803057123,1.0,1/5,2.54%,WNT5A
prerank,Reactome_2022__Chylomicron Clearance R-HSA-8964026,0.8389757472405187,1.3665264465640936,0.0784313725490196,0.7867158496955604,1.0,4/5,9.94%,LIPC;APOB;APOE;LDLR
prerank,GO_Biological_Process_2021__protein import into peroxisome membrane (GO:0045046),0.6271114048277154,1.3663708022554013,0.13513513513513514,0.7862452577862273,1.0,4/20,10.37%,PEX13;GDAP1;ABCD3;ABCD2
prerank,Reactome_2022__LDL Clearance R-HSA-8964038,0.6611321337929197,1.366292432567089,0.1282051282051282,0.7853755902058728,1.0,4/16,9.94%,APOB;SOAT1;SOAT2;LDLR
prerank,GO_Biological_Process_2021__regulation of atrial cardiac muscle cell membrane depolarization (GO:0060371),-0.9165099965124839,-1.3661451929390325,0.016666666666666666,0.745967673313376,1.0,1/5,1.19%,SCN5A
prerank,Reactome_2022__CREB3 Factors Activate Genes R-HSA-8874211,0.7562617993605614,1.3660410502745546,0.10526315789473684,0.7849890734395459,1.0,2/8,4.89%,CREB3L2;CREB3L4
prerank,GO_Biological_Process_2021__tRNA thio-modification (GO:0034227),0.8346017742226104,1.3655192368753233,0.15217391304347827,0.7858285447211626,1.0,1/5,7.06%,CTU1
prerank,GO_Biological_Process_2021__neuron cell-cell adhesion (GO:0007158),0.659178274450522,1.3647511197044748,0.08571428571428572,0.7879937701580296,1.0,8/16,18.67%,CEL;NLGN1;NLGN4X;RET;NLGN3;NCAM2;NRXN1;ASTN2
prerank,GO_Biological_Process_2021__phosphatidylcholine biosynthetic process (GO:0006656),0.6038983324995263,1.3644588826894386,0.10810810810810811,0.7880556364966963,1.0,8/28,16.93%,SLC44A5;MFSD2A;ABHD3;CHPT1;CEPT1;CHKA;ACHE;LPIN2
prerank,GO_Biological_Process_2021__proton-transporting V-type ATPase complex assembly (GO:0070070),-0.9085174911109437,-1.3644043184388275,0.017857142857142856,0.7544483799423185,1.0,1/5,4.68%,ALDOB
prerank,PanglaoDB_Augmented_2021__Plasmacytoid Dendritic Cells,-0.5649798109316344,-1.3640484495481153,0.0684931506849315,0.7550947365011675,1.0,38/90,20.41%,JCHAIN;GMFG;ITGB2;HCK;DOCK8;CYTIP;ARHGAP9;TAGAP;CLEC4C;GPR183;PARVG;WAS;LY86;CD37;NFAM1;IL3RA;TRAF3IP3;MYO1F;PTPRC;SPI1;ITGAM;BLNK;CD300LF;PSTPIP1;NIBAN3;CD80;ITM2C;IKZF1;IGLL1;CD4;NAPSB;ALOX5AP;SERPINF1;CARD6;SASH3;ITGAX;IL17RB;CD86
prerank,GO_Biological_Process_2021__gas transport (GO:0015669),0.7479629920034204,1.3639478066579815,0.17073170731707318,0.7894413166394193,1.0,3/6,15.23%,NGB;MYC;CA2
prerank,GO_Biological_Process_2021__digestive system development (GO:0055123),0.7874658890565444,1.3638164272804376,0.06666666666666667,0.7885223536621568,1.0,3/8,10.68%,KIT;CLMP;COBL
prerank,GO_Biological_Process_2021__positive regulation of DNA methylation-dependent heterochromatin assembly (GO:0090309),0.716858860725948,1.3637052295731023,0.09375,0.7875802449270728,1.0,4/11,17.05%,DNMT1;RESF1;MPHOSPH8;ATF7IP
prerank,CellMarker_Augmented_2021__Preadipocyte:Adipose Tissue,-0.6173100329688896,-1.3636475200218108,0.11267605633802817,0.7557192645284599,1.0,19/52,13.42%,GMFG;HCK;TNFRSF1B;C3AR1;MS4A4A;PARVG;FCGR3A;LY86;VSIG4;NFAM1;SELP;MYO1F;IGSF6;PTPRC;SPI1;CLEC12A;ITGAM;F13A1;CD300LF
prerank,Reactome_2022__Glucagon-type Ligand Receptors R-HSA-420092,-0.7041753459413383,-1.363417111138136,0.031746031746031744,0.7552490962856703,1.0,3/24,9.69%,C1QTNF1;SCTR;GNGT1
prerank,GO_Biological_Process_2021__ERBB2 signaling pathway (GO:0038128),0.5786427517948689,1.3631861296842545,0.12903225806451613,0.7889857840870156,1.0,7/29,15.71%,NRG2;ERBB2;NRG1;PTPRR;GAB1;PIK3CA;MATK
prerank,GO_Biological_Process_2021__regulation of barbed-end actin filament capping (GO:2000812),0.8019512601294139,1.3631769850139348,0.1590909090909091,0.7877306383385266,1.0,2/5,8.07%,WASHC2C;CRACD
prerank,GO_Biological_Process_2021__regulation of endopeptidase activity (GO:0052548),-0.6104978250591031,-1.3629467556872847,0.05263157894736842,0.7563683345369158,1.0,15/49,17.92%,PSMB9;TIMP3;SERPIND1;VTN;SERPINB5;SERPINA10;TIMP4;SERPINE3;A2ML1;SPOCK3;AGT;PSMA3;VSIR;SERPINB7;SERPINF1
prerank,GO_Biological_Process_2021__sequestering of BMP from receptor via BMP binding (GO:0038098),0.8211126196767832,1.3628509481525692,0.09803921568627451,0.7877660667178041,1.0,2/6,7.18%,GREM2;GREM1
prerank,GO_Biological_Process_2021__negative regulation of ruffle assembly (GO:1900028),0.7689845301879294,1.3627553988750476,0.10638297872340426,0.7867794773883346,1.0,3/6,11.56%,KANK1;ABI3;EVL
prerank,CellMarker_Augmented_2021__Neutrophil:Spleen,-0.5971409824859535,-1.362547946543036,0.03225806451612903,0.7550829629544548,1.0,21/44,18.96%,RASGRP4;CLEC5A;HCK;ARHGAP9;RAB44;PARVG;OSCAR;C19ORF38;LY86;NFAM1;MYO1F;SPI1;CLEC12A;ITGAM;NLRP3;CD300LF;ELANE;HK3;LAT2;CLEC1B;P2RX1
prerank,CellMarker_Augmented_2021__Neutrophil:Brain,-0.5971409824859535,-1.362547946543036,0.03225806451612903,0.7550829629544548,1.0,21/44,18.96%,RASGRP4;CLEC5A;HCK;ARHGAP9;RAB44;PARVG;OSCAR;C19ORF38;LY86;NFAM1;MYO1F;SPI1;CLEC12A;ITGAM;NLRP3;CD300LF;ELANE;HK3;LAT2;CLEC1B;P2RX1
prerank,KEGG_2021_Human__DNA replication,-0.6394493995799626,-1.3619837659136216,0.10606060606060606,0.7568169159458309,1.0,3/31,4.42%,MCM2;RPA3;MCM3
prerank,CellMarker_Augmented_2021__Foxp3+IL-17+ T cell:Undefined,-0.8853711587763253,-1.3618642789411424,0.06779661016949153,0.7556373771667494,1.0,2/5,7.00%,SIRPG;CD5
prerank,KEGG_2021_Human__Phospholipase D signaling pathway,0.44575352706998894,1.3616379183596306,0.0,0.7909230297091763,1.0,43/127,22.48%,DGKD;KIT;GRM3;SHC4;RALB;PDGFD;RRAS2;GRM8;F2;PLCB1;ADCY2;RALA;GRM4;GRM2;AKT2;KITLG;GRM7;PLPP2;F2R;ADCY3;GAB1;PLA2G4C;AGPAT5;INSR;PIK3CA;DGKH;AGPAT2;PIK3R5;ADCY6;RAPGEF3;GRM5;SOS1;DGKZ;CYTH1;PLPP3;PLD2;RAF1;GNAS;PLCG2;GNA12;GRM1;SHC3;RAPGEF4
prerank,GO_Biological_Process_2021__ventricular cardiac muscle cell action potential (GO:0086005),-0.7516227848753602,-1.361515145390073,0.08196721311475409,0.756049188614666,1.0,4/16,8.12%,PKP2;SCN5A;CAV3;KCNQ1
prerank,GO_Biological_Process_2021__positive regulation of release of cytochrome c from mitochondria (GO:0090200),-0.6841984545451077,-1.3614237371417521,0.03636363636363636,0.7546774652420931,1.0,6/21,13.03%,MMP9;CIDEB;GPER1;PINK1;BIK;MOAP1
prerank,GO_Biological_Process_2021__tongue development (GO:0043586),-0.8578730175424992,-1.3608943794254322,0.06060606060606061,0.7560869475247336,1.0,1/5,0.55%,TBX1
prerank,GO_Biological_Process_2021__negative regulation of lens fiber cell differentiation (GO:1902747),0.7931774756962798,1.3607091643663387,0.14285714285714285,0.7946343442728244,1.0,3/5,11.02%,SPRED3;SPRED2;SPRED1
prerank,GO_Biological_Process_2021__positive regulation of protein kinase C signaling (GO:0090037),0.7684313886691853,1.3606468006835202,0.08108108108108109,0.7936670111473144,1.0,1/7,0.05%,ADRA1A
prerank,CellMarker_Augmented_2021__Macrophage:Alveolus,-0.5667485017565297,-1.3603505552467594,0.08108108108108109,0.7577246018458372,1.0,23/56,16.09%,GMFG;ITGB2;HCK;DOCK8;CYTIP;ARHGAP9;TAGAP;TMC8;PARVG;FCGR3A;WAS;LY86;NFAM1;TRAF3IP3;MYO1F;PTPRC;SPI1;CLEC12A;ITGAM;CD300LF;PSTPIP1;IKZF1;HK3
prerank,KEGG_2021_Human__Ribosome,-0.5542957319018279,-1.359605879137275,0.012987012987012988,0.7606172331384435,1.0,61/122,27.27%,RPL37A;RPL38;RPL15;RPS4X;RPL3;RPL35A;RPS9;FAU;RPS27;RPS21;MRPL19;RPL13A;RPL27A;RPS16;RPL36;RPS20;RPL7A;RPL9;RPL13;RPS8;RPS27A;RPL21;RPL34;MRPL20;MRPL34;RPL4;RPL32;RPL5;RPL23;RPL41;RPS7;RPS11;RPL27;RPL35;RPS14;RPL11;RPS15;RPLP1;RPS12;RPL24;RPL18A;RPS13;RPL29;RPLP2;RPL28;RPL12;RPL18;RPS3;RPL22;RPSA;RPL36A-HNRNPH2;RPS28;RPS19;RPS24;MRPS2;RPL26L1;RPS3A;RPL19;RPL8;RPS6;RPL10
prerank,Reactome_2022__Inactivation Of CDC42 And RAC1 R-HSA-428543,0.7917774896339851,1.3594535151236824,0.18181818181818182,0.7980631879660895,1.0,2/7,7.88%,SRGAP2;SLIT2
prerank,KEGG_2021_Human__ErbB signaling pathway,0.5261441213150135,1.3594353591067778,0.05263157894736842,0.7966776615980928,1.0,35/80,26.11%,NRG2;SHC4;ERBB2;NRG1;PAK5;STAT5B;CRK;NRG3;ABL1;MAPK8;CBLB;MYC;TGFA;ABL2;AKT2;GAB1;PIK3CA;CRKL;NCK1;EIF4EBP1;BRAF;MAP2K7;SOS1;PAK3;PAK2;RAF1;PLCG2;NCK2;SHC3;CBL;ERBB3;PIK3CD;RPS6KB1;BTC;AKT3
prerank,GO_Biological_Process_2021__bleb assembly (GO:0032060),0.8554265770214515,1.359281861625651,0.05128205128205128,0.7963341350191971,1.0,1/7,1.32%,EMP1
prerank,GO_Biological_Process_2021__positive regulation of lymphocyte chemotaxis (GO:0140131),-0.7923926858513155,-1.3590222859693226,0.16326530612244897,0.7625596498128162,1.0,2/9,3.57%,WNT5A;CXCL13
prerank,GO_Biological_Process_2021__radial glial cell differentiation (GO:0060019),0.7627242715389166,1.3588208541242979,0.10204081632653061,0.7972083954181713,1.0,2/6,5.56%,FGF10;HES1
prerank,Reactome_2022__Synthesis Of Active Ubiquitin: Roles Of E1 And E2 Enzymes R-HSA-8866652,0.5350165591183224,1.358724135144846,0.03333333333333333,0.7963224911810904,1.0,7/27,21.64%,UBE2E3;UBE2E1;UBE2A;UBE2Z;UBE2L3;CDC34;UBE2D2
prerank,GO_Biological_Process_2021__pigment granule transport (GO:0051904),0.6559553481921667,1.35860510157132,0.1111111111111111,0.7942250630978243,1.0,2/14,0.97%,MLPH;RAB27A
prerank,GO_Biological_Process_2021__melanosome transport (GO:0032402),0.6559553481921667,1.35860510157132,0.1111111111111111,0.7942250630978243,1.0,2/14,0.97%,MLPH;RAB27A
prerank,CellMarker_Augmented_2021__Colorectal Stem cell:Colorectum,0.8828572294766086,1.3582864256078713,0.044444444444444446,0.7942486021896265,1.0,2/5,3.31%,LGR5;ALDH1A1
prerank,GO_Biological_Process_2021__negative regulation of DNA replication (GO:0008156),0.6448687679695676,1.3580433594922663,0.15555555555555556,0.7940924190298687,1.0,5/12,18.39%,GMNC;SLFN11;TERF1;RAD17;ATR
prerank,GO_Biological_Process_2021__establishment of epithelial cell polarity (GO:0090162),0.6200961235265215,1.3580126407185287,0.0967741935483871,0.7929120056316594,1.0,10/18,24.23%,PARD3;RAP2A;SIPA1L3;FERMT1;CYTH1;MYO9A;FBF1;CAMSAP3;MYO18A;CYTH3
prerank,GO_Biological_Process_2021__purine ribonucleoside monophosphate catabolic process (GO:0009169),0.8236595390190787,1.3575148905507273,0.08695652173913043,0.7943443119462938,1.0,3/8,6.55%,PNP;NT5C1A;PRTFDC1
prerank,Reactome_2022__Transcriptional Regulation Of White Adipocyte Differentiation R-HSA-381340,0.47384970558775324,1.3574471316691543,0.0,0.7933206875544264,1.0,24/74,21.31%,HDAC3;MED17;SMARCD3;PPARG;NCOA3;NCOA2;MED25;CDK4;CCND3;LPL;CHD9;CARM1;MED16;CDK8;NR2F2;NFKB1;ZNF638;MED13L;MED9;FAM120B;EP300;SREBF2;TBL1X;MED27
prerank,Reactome_2022__Regulation Of PTEN mRNA Translation R-HSA-8943723,0.6729839319823568,1.357381439323763,0.17073170731707318,0.7921985980283616,1.0,6/11,22.04%,MOV10;TNRC6C;TNRC6A;AGO3;AGO2;PTEN
prerank,KEGG_2021_Human__Coronavirus disease,-0.5338388835905682,-1.3571419856807245,0.012345679012345678,0.7726800499727461,1.0,78/169,27.27%,C1QB;RPL37A;STAT1;C3AR1;MASP1;OAS2;PIK3R3;SELP;RPL38;CFD;RPL15;VWF;RPS4X;RPL3;MASP2;OAS1;TLR2;RPL35A;F13A1;NLRP3;PIK3CB;RPS9;FAU;RPS27;C1S;IL12A;RPS21;RPL13A;RPL27A;RPS16;RPL36;RPS20;RPL7A;RPL9;RPL13;RPS8;RPS27A;RPL21;RPL34;RPL4;RPL32;RPL5;RPL23;RPL41;RPS7;RPS11;ACE2;RPL27;RPL35;RPS14;RPL11;MX1;ISG15;RPS15;RPLP1;RPS12;RPL24;RPL18A;RPS13;RPL29;RPLP2;RPL28;RPL12;RPL18;RPS3;RPL22;IL6R;RPSA;RPL36A-HNRNPH2;RPS28;RPS19;RPS24;RPL26L1;RPS3A;RPL19;RPL8;RPS6;RPL10
prerank,GO_Biological_Process_2021__positive regulation of BMP signaling pathway (GO:0030513),0.568531719051577,1.356543680279196,0.13333333333333333,0.7950242765773929,1.0,11/22,23.49%,CDH5;CCN1;UBE2O;SMAD2;ELAPOR2;NOTCH1;RBPJ;ACVR2A;BMPR2;BMP4;BMPR1A
prerank,GO_Biological_Process_2021__negative regulation of smooth muscle cell apoptotic process (GO:0034392),0.9079102191461121,1.3565069709103277,0.022222222222222223,0.7938268999173911,1.0,4/5,8.53%,APOH;DNMT1;DIPK2A;LRP6
prerank,GO_Biological_Process_2021__negative regulation of extracellular matrix organization (GO:1903054),-0.7940994342784389,-1.3564138184916812,0.0967741935483871,0.7755147564074975,1.0,2/10,4.89%,TGFB1;TNFRSF1B
prerank,Reactome_2022__Surfactant Metabolism R-HSA-5683826,-0.7123373923783931,-1.356003142166225,0.12903225806451613,0.775869912914524,1.0,2/20,6.00%,SFTPA1;SFTPD
prerank,Reactome_2022__Formyl Peptide Receptors Bind Formyl Peptides And Many Other Ligands R-HSA-444473,-0.8196933997730785,-1.3558313752753932,0.11864406779661017,0.7751182658396262,1.0,3/6,12.70%,ANXA1;FPR1;FPR3
prerank,GO_Biological_Process_2021__G protein-coupled receptor internalization (GO:0002031),0.8236250693657002,1.3553109998319637,0.08,0.7980096041537774,1.0,3/5,13.66%,ARRB2;SAG;ARRB1
prerank,Reactome_2022__Formation Of A Pool Of Free 40S Subunits R-HSA-72689,-0.5624449994629585,-1.35472197735385,0.0410958904109589,0.7799710900873638,1.0,54/91,27.12%,RPL37A;RPL38;RPL15;RPS4X;RPL3;RPL35A;RPS9;FAU;RPS27;RPS21;RPL13A;RPL27A;RPS16;RPL36;RPS20;RPL7A;RPL9;RPS8;RPS27A;RPL21;RPL34;RPL4;RPL32;RPL5;RPL23;RPL41;RPS7;RPS11;RPL27;RPL35;RPS14;RPL11;RPS15;RPLP1;RPS12;RPL18A;RPS13;RPL29;RPLP2;RPL28;RPL12;EIF1AX;RPL18;RPS3;RPL22;RPSA;RPS28;RPS19;RPS24;RPL26L1;RPS3A;RPL19;RPL8;RPS6
prerank,GO_Biological_Process_2021__mitotic DNA replication initiation (GO:1902975),-0.8706520624730257,-1.3546756667364304,0.07575757575757576,0.7764240157239974,1.0,3/6,8.41%,MCM2;MCM3;MCMDC2
prerank,GO_Biological_Process_2021__nuclear cell cycle DNA replication initiation (GO:1902315),-0.8706520624730257,-1.3546756667364304,0.07575757575757576,0.7764240157239974,1.0,3/6,8.41%,MCM2;MCM3;MCMDC2
prerank,GO_Biological_Process_2021__positive regulation of neuron projection development (GO:0010976),0.48467161605842646,1.3545215460419466,0.07142857142857142,0.8008111066592003,1.0,19/81,13.60%,ZNF804A;APOE;MAGI2;TOX;EPHA3;RAPGEF1;FZD1;TENM3;ARSB;STYXL1;ABL2;RETREG3;COBL;AVIL;RET;RAP1A;ARHGAP35;FUT9;LRP8
prerank,Reactome_2022__L13a-mediated Translational Silencing Of Ceruloplasmin Expression R-HSA-156827,-0.554797136483325,-1.3544141646614782,0.04225352112676056,0.7762607926102324,1.0,57/100,27.12%,RPL37A;RPL38;RPL15;RPS4X;RPL3;RPL35A;RPS9;FAU;RPS27;RPS21;RPL13A;RPL27A;EIF2S3;RPS16;RPL36;RPS20;RPL7A;RPL9;EIF2S2;RPS8;RPS27A;RPL21;EIF4A2;RPL34;RPL4;RPL32;RPL5;RPL23;RPL41;RPS7;RPS11;RPL27;RPL35;RPS14;RPL11;RPS15;RPLP1;RPS12;RPL18A;RPS13;RPL29;RPLP2;RPL28;RPL12;EIF1AX;RPL18;RPS3;RPL22;RPSA;RPS28;RPS19;RPS24;RPL26L1;RPS3A;RPL19;RPL8;RPS6
prerank,GO_Biological_Process_2021__exonucleolytic catabolism of deadenylated mRNA (GO:0043928),0.5728204137416438,1.3542105747928013,0.030303030303030304,0.8012022169082852,1.0,11/28,23.05%,DCP1B;DCPS;EXOSC1;LSM2;PATL1;LSM7;DIS3;CNOT6;EXOSC5;LSM6;DCP1A
prerank,CellMarker_Augmented_2021__Fibroblast:Pancreas,0.4732225698019751,1.3541361231533307,0.038461538461538464,0.8003052625315579,1.0,29/98,17.08%,FIBIN;MEGF10;EDIL3;ADGRL2;NLGN1;GPC6;ADAMTS12;MMP2;ZFHX4;LRFN5;SLIT2;TENM3;EFS;DOK5;PDZRN3;BRINP1;COL16A1;MPDZ;KIAA1549L;MMP16;CDH2;NAV1;ANK2;PRICKLE2;CDH11;ANTXR1;CALD1;MAGEL2;CLIP3
prerank,GO_Biological_Process_2021__regulation of DNA-templated transcription in response to stress (GO:0043620),0.7597962941719,1.3539728214758215,0.14634146341463414,0.7996883943261881,1.0,3/8,13.77%,RGS14;RPS6KA3;TCIM
prerank,GO_Biological_Process_2021__inner dynein arm assembly (GO:0036159),-0.7728232125168549,-1.353884224047405,0.0847457627118644,0.7776127287287081,1.0,1/10,2.89%,CCDC39
prerank,GO_Biological_Process_2021__diacylglycerol metabolic process (GO:0046339),0.663319619478985,1.3536719675441105,0.11904761904761904,0.800330874471037,1.0,5/21,19.46%,DGKD;PGS1;PLA2G15;DGKH;DGKZ
prerank,GO_Biological_Process_2021__adherens junction assembly (GO:0034333),0.7301099743045939,1.3536717616714944,0.14814814814814814,0.798988037433334,1.0,4/9,22.14%,ZNF703;PAK2;VCL;SMAD7
prerank,Reactome_2022__RUNX3 Regulates NOTCH Signaling R-HSA-8941856,0.7537688275706185,1.3534979473103657,0.027777777777777776,0.7983514142180397,1.0,7/13,19.29%,MAML1;JAG1;MAMLD1;NOTCH1;RBPJ;EP300;KAT2B
prerank,Reactome_2022__RUNX3 Regulates YAP1-mediated Transcription R-HSA-8951671,0.7946767950521056,1.3532393779927907,0.125,0.7981922878063892,1.0,2/7,3.16%,TEAD2;CCN2
prerank,GO_Biological_Process_2021__aminoglycan biosynthetic process (GO:0006023),0.5540998465638537,1.3530054240457978,0.06451612903225806,0.7979337823801572,1.0,15/42,12.56%,GPC4;SDC4;HS6ST2;HS3ST3B1;EXT1;HS3ST1;GPC6;HS3ST5;HS2ST1;HS3ST2;GPC5;B3GAT3;UGDH;SDC3;EXT2
prerank,CellMarker_Augmented_2021__Mesodermal Embryonic Stem cell:Germ,-0.5813207575546137,-1.35243609100638,0.06172839506172839,0.7857037605226681,1.0,18/70,14.86%,ENPP2;C1QB;CYYR1;GALNT15;LYVE1;ANGPT2;DCN;CLDN5;ZNF366;SELP;ITGA9;VWF;GPIHBP1;EDNRB;TEK;A2M;GGT5;ADGRF5
prerank,GO_Biological_Process_2021__negative regulation of glial cell proliferation (GO:0060253),0.8056917981121567,1.3524033266907833,0.08108108108108109,0.7992221676047488,1.0,4/5,17.21%,HES1;RNF10;NOTCH1;SKI
prerank,Reactome_2022__Common Pathway Of Fibrin Clot Formation R-HSA-140875,-0.7658766835659858,-1.3523314468367207,0.10344827586206896,0.7845030354478254,1.0,6/12,13.89%,F8;PROCR;SERPIND1;FAM110A;F13A1;F5
prerank,Reactome_2022__Interleukin-18 Signaling R-HSA-9012546,-0.8441710806965981,-1.3519292200247761,0.09836065573770492,0.7854758983186755,1.0,3/5,15.16%,ALOX5;IL18BP;IL18
prerank,Reactome_2022__GTP Hydrolysis And Joining Of 60S Ribosomal Subunit R-HSA-72706,-0.5589889821972971,-1.3518369360272797,0.028169014084507043,0.7841768031781035,1.0,57/101,27.12%,RPL37A;RPL38;RPL15;RPS4X;RPL3;RPL35A;RPS9;FAU;RPS27;RPS21;RPL13A;RPL27A;EIF2S3;RPS16;RPL36;RPS20;RPL7A;RPL9;EIF2S2;RPS8;RPS27A;RPL21;EIF4A2;RPL34;RPL4;RPL32;RPL5;RPL23;RPL41;RPS7;RPS11;RPL27;RPL35;RPS14;RPL11;RPS15;RPLP1;RPS12;RPL18A;RPS13;RPL29;RPLP2;RPL28;RPL12;EIF1AX;RPL18;RPS3;RPL22;RPSA;RPS28;RPS19;RPS24;RPL26L1;RPS3A;RPL19;RPL8;RPS6
prerank,GO_Biological_Process_2021__regulation of phagocytosis (GO:0050764),-0.6221524613799589,-1.3516068966254104,0.06451612903225806,0.7836146670364398,1.0,11/43,12.50%,SIRPG;TULP1;HCK;DOCK2;SFTPD;TGM2;CYBA;OLFM4;PTPRC;SLC11A1;TLR2
prerank,Reactome_2022__Nucleotide-like (Purinergic) Receptors R-HSA-418038,-0.8007721817636719,-1.350935286633475,0.09523809523809523,0.7859019173937362,1.0,4/9,9.43%,P2RY12;P2RY14;LPAR6;P2RY6
prerank,GO_Biological_Process_2021__negative regulation of cell cycle G1/S phase transition (GO:1902807),0.5663067728429771,1.3508072881207653,0.1,0.8062070967660617,1.0,6/27,7.77%,SLFN11;PKD2;GFI1B;CDK6;CDK4;RBL1
prerank,GO_Biological_Process_2021__positive regulation of locomotion (GO:0040017),-0.6991642996233258,-1.3507820572663505,0.14285714285714285,0.7849400689459257,1.0,7/20,16.13%,DUOX1;TGFB1;P2RY12;CAVIN1;THBS1;NTN1;F2RL1
prerank,Reactome_2022__Caspase Activation Via Dependence Receptors In Absence Of Ligand R-HSA-418889,0.7539421759873385,1.3504539946598377,0.10869565217391304,0.8066324529431882,1.0,4/10,15.28%,DAPK2;DCC;CASP3;MAGED1
prerank,GO_Biological_Process_2021__protein side chain deglutamylation (GO:0035610),0.8284126378658265,1.350275413467178,0.06666666666666667,0.8061879821141245,1.0,1/5,11.19%,AGBL4
prerank,"GO_Biological_Process_2021__nuclear-transcribed mRNA catabolic process, exonucleolytic (GO:0000291)",0.5700768710881035,1.350264945864956,0.0,0.8049523170486333,1.0,11/30,23.05%,DCP1B;DCPS;EXOSC1;LSM2;PATL1;LSM7;DIS3;CNOT6;EXOSC5;LSM6;DCP1A
prerank,Reactome_2022__RHOD GTPase Cycle R-HSA-9013405,0.5435985223021115,1.3501579865932085,0.0625,0.80406695498989,1.0,14/47,21.95%,VANGL1;LMNB1;RAB7A;VRK2;SLC4A7;PLXNB1;PGRMC2;ARHGAP21;ARHGAP35;MOSPD2;ARHGAP5;AKAP12;ADD3;ESYT1
prerank,GO_Biological_Process_2021__positive regulation of T cell differentiation (GO:0045582),0.5608749490228436,1.3500626763886294,0.15625,0.8031351367972172,1.0,6/33,8.09%,PNP;BCL6;SOX12;HLA-DRA;ZBTB1;NKAP
prerank,CellMarker_Augmented_2021__Activated CD4+ T cell:Blood,0.7373055081017723,1.3497915355488603,0.14634146341463414,0.8034141597869413,1.0,2/7,3.69%,CD38;CD14
prerank,GO_Biological_Process_2021__regulation of dendrite development (GO:0050773),0.5536401572309453,1.3497232459884447,0.10810810810810811,0.8022896176904415,1.0,12/38,16.75%,MFSD2A;KIAA0319;BCL11A;SARM1;DCC;RAP2A;TNIK;COBL;CSMD3;LRP8;MARK1;NEDD4
prerank,Reactome_2022__Conversion From APC/C:Cdc20 To APC/C:Cdh1 In Late Anaphase R-HSA-176407,0.6494825967567717,1.349125910742195,0.09090909090909091,0.8037483498161556,1.0,7/17,25.48%,UBE2E1;ANAPC16;CDC26;ANAPC7;FZR1;ANAPC4;ANAPC2
prerank,CellMarker_Augmented_2021__Neural Stem cell:Hippocampus,-0.5467536274508525,-1.3489029179350742,0.08860759493670886,0.7945729277190018,1.0,10/89,10.45%,NEK2;BUB1;MCM2;DTL;MCM3;CENPU;TTK;OIP5;NUF2;CENPH
prerank,Reactome_2022__Chondroitin Sulfate/Dermatan Sulfate Metabolism R-HSA-1793185,0.5600131825537417,1.348686092971245,0.12903225806451613,0.8044910114290933,1.0,19/45,11.69%,VCAN;GPC4;CSGALNACT1;SDC4;CHSY3;GPC6;CHSY1;SPAM1;CHST12;UST;ARSB;GPC5;CHPF2;CHST11;CSPG5;B3GAT3;CHST3;SDC3;DSEL
prerank,GO_Biological_Process_2021__post-Golgi vesicle-mediated transport (GO:0006892),0.49134517155072266,1.3483459434972525,0.14285714285714285,0.8045211184237526,1.0,25/82,21.50%,LLGL1;KLHL20;COMMD1;ACBD3;GBF1;SORCS1;CCDC22;ARRB1;RAB10;RP2;ARL3;EXOC6B;CLINT1;GOLGB1;MON2;AP4S1;CLVS1;MYO5A;AP4B1;DOP1B;VAMP8;AP1B1;EXOC6;KIF16B;EXOC4
prerank,GO_Biological_Process_2021__cell-cell adhesion via plasma-membrane adhesion molecules (GO:0098742),0.4474649815674552,1.3483013164732867,0.0,0.8034021175196535,1.0,25/141,9.08%,CDH20;GPC4;GRID2;CDH19;CDH12;ROBO2;ALCAM;CDH7;NLGN1;CDH5;DSCAML1;CDH13;LRRC4C;BSG;UNC5D;GPC6;SDK1;CDH26;CADM1;CDH6;DSCAM;LRFN5;TENM3;TENM1;PTPRM
prerank,GO_Biological_Process_2021__kinetochore organization (GO:0051383),-0.7194825949637296,-1.3476661518379676,0.1746031746031746,0.8002134857801741,1.0,2/12,10.45%,NUF2;CENPH
prerank,GO_Biological_Process_2021__regulation of norepinephrine secretion (GO:0014061),0.8802326911010959,1.3474968551092446,0.06521739130434782,0.8062895368221888,1.0,1/5,3.50%,HRH3
prerank,Reactome_2022__Diseases Associated With Glycosaminoglycan Metabolism R-HSA-3560782,0.5826147708515478,1.3474472815655822,0.1,0.8052687702274826,1.0,15/34,11.20%,VCAN;GPC4;PAPSS2;SDC4;CHST6;EXT1;GPC6;PRELP;CHSY1;ST3GAL3;GPC5;CSPG5;B3GAT3;CHST3;SDC3
prerank,GO_Biological_Process_2021__neuropeptide signaling pathway (GO:0007218),0.5195349618034446,1.3472344815475739,0.05263157894736842,0.8056136775986217,1.0,8/47,7.95%,NXPH2;NXPH4;GRP;GALR3;UTS2R;OPRD1;NMU;SORCS1
prerank,GO_Biological_Process_2021__G protein-coupled glutamate receptor signaling pathway (GO:0007216),0.7012014305793443,1.3469840367222292,0.11428571428571428,0.8053745468040344,1.0,8/14,21.59%,GRM3;GRM8;GRM4;GRM2;GRM7;GRIK3;GRM5;GRM1
prerank,GO_Biological_Process_2021__regulation of production of miRNAs involved in gene silencing by miRNA (GO:1903798),-0.7302851406662039,-1.3465264038475364,0.07142857142857142,0.8056383588352397,1.0,3/14,10.71%,TGFB1;ESR1;TERT
prerank,GO_Biological_Process_2021__positive regulation of transcription by RNA polymerase I (GO:0045943),0.640832357098514,1.3464438955225166,0.05263157894736842,0.8069791074684134,1.0,7/22,20.42%,ERBB2;SMARCB1;EIF2AK3;PIH1D1;SMARCA4;MARS1;IPPK
prerank,GO_Biological_Process_2021__regulation of MHC class I biosynthetic process (GO:0045343),-0.8648930107580087,-1.346429479518583,0.07142857142857142,0.8043647434843733,1.0,3/5,5.93%,NLRP12;TAF7;CIITA
prerank,GO_Biological_Process_2021__positive regulation of myotube differentiation (GO:0010831),0.7941491792850324,1.3463845602627935,0.17391304347826086,0.8061817189181846,1.0,2/6,4.83%,SMYD1;MAML1
prerank,Reactome_2022__Synthesis Of PI R-HSA-1483226,0.8392915786131283,1.346339191582621,0.16666666666666666,0.8050726895905544,1.0,1/5,3.68%,PITPNM1
prerank,GO_Biological_Process_2021__granulocyte migration (GO:0097530),-0.8036608844361386,-1.3460888024541617,0.07017543859649122,0.8044491088539846,1.0,3/7,8.67%,UMODL1;ITGB2;ANXA1
prerank,GO_Biological_Process_2021__hydrogen peroxide biosynthetic process (GO:0050665),-0.8489725403164399,-1.3457926132178781,0.09523809523809523,0.804413561071845,1.0,2/5,10.17%,DUOX1;CYBA
prerank,Reactome_2022__CREB Phosphorylation R-HSA-199920,0.8024217503770132,1.3456346352046806,0.1,0.8063321312005287,1.0,4/7,19.24%,MAPKAPK2;RPS6KA3;RPS6KA2;CREB1
prerank,CellMarker_Augmented_2021__T Helper cell:Liver,-0.7611742142071858,-1.3456115729708265,0.14035087719298245,0.8038841833932213,1.0,2/8,15.75%,ABCB1;CD4
prerank,GO_Biological_Process_2021__mitochondrial tRNA modification (GO:0070900),0.7383632234422829,1.3454838425706628,0.09090909090909091,0.8057323782493877,1.0,2/8,13.78%,MTO1;TRMT61B
prerank,GO_Biological_Process_2021__regulation of glucocorticoid receptor signaling pathway (GO:2000322),0.8258929998666599,1.3451155189466086,0.18604651162790697,0.8061207666199784,1.0,1/5,5.35%,CRY1
prerank,GO_Biological_Process_2021__regulation of platelet-derived growth factor receptor-beta signaling pathway (GO:2000586),0.8312502707610496,1.3449885076704486,0.19047619047619047,0.805523278308457,1.0,1/5,2.90%,HIP1
prerank,GO_Biological_Process_2021__membrane depolarization during SA node cell action potential (GO:0086046),-0.8716536762479834,-1.3448644815299176,0.15789473684210525,0.807164084547341,1.0,1/5,1.19%,SCN5A
prerank,Reactome_2022__NOTCH1 Intracellular Domain Regulates Transcription R-HSA-2122947,0.5632575083339603,1.3445440716510495,0.12903225806451613,0.8061265488248074,1.0,20/46,21.68%,HDAC3;HDAC10;TLE2;MAML1;MYC;MAMLD1;HDAC1;CDK8;HDAC4;HDAC11;NOTCH1;RBPJ;EP300;KAT2B;HDAC5;HIF1A;TBL1X;NBEA;HDAC7;CUL1
prerank,CellMarker_Augmented_2021__Responder T cell:Peripheral Blood,-0.6099901383557942,-1.3444481075835033,0.09230769230769231,0.8081228468308184,1.0,24/55,15.75%,SIRPG;GMFG;ITGB2;HCK;DOCK8;CYTIP;TBC1D10C;ARHGAP9;TAGAP;TNFRSF1B;GPR183;PARVG;CD5;WAS;LY86;CD37;TRAF3IP3;MYO1F;PTPRC;ITGAM;CD300LF;PSTPIP1;IKZF1;CD4
prerank,KEGG_2021_Human__Sulfur metabolism,-0.7921216475240112,-1.3439419249153655,0.15517241379310345,0.809821476061807,1.0,1/10,0.11%,SQOR
prerank,GO_Biological_Process_2021__cell communication by electrical coupling involved in cardiac conduction (GO:0086064),-0.7500794374948447,-1.3438507615398583,0.15625,0.8086094204688543,1.0,2/13,2.05%,PKP2;GJC3
prerank,GO_Biological_Process_2021__cerebral cortex neuron differentiation (GO:0021895),0.8006059462184202,1.3437914402748847,0.06818181818181818,0.8086669084303697,1.0,2/5,13.36%,TOX;ASCL1
prerank,KEGG_2021_Human__Other types of O-glycan biosynthesis,0.5604376129016656,1.3437447554770015,0.09375,0.8076619115282008,1.0,14/42,9.48%,GALNT7;GALNT12;ST6GAL2;RFNG;COLGALT1;GALNT1;GALNT17;ST3GAL3;B4GALT2;PLOD3;POFUT1;B4GALT3;COLGALT2;GALNT13
prerank,GO_Biological_Process_2021__negative regulation of nitrogen compound metabolic process (GO:0051172),-0.8205305785155941,-1.343535223452951,0.13846153846153847,0.808935216000134,1.0,2/7,2.55%,TGFB1;ACMSD
prerank,Reactome_2022__MyD88:MAL(TIRAP) Cascade Initiated On Plasma Membrane R-HSA-166058,0.450741690385361,1.3433260079846154,0.0,0.8083543333009928,1.0,31/97,21.90%,DUSP4;MAPKAPK2;RIPK2;KCNH8;HMGB1;MAPK8;MAP3K1;ALPK1;RPS6KA3;N4BP1;PPP2R1B;TANK;NKIRAS2;TAB3;PELI1;NFKB1;RPS6KA2;PELI2;IRAK4;TP53;MAP2K7;PPP2R5D;S100B;TAB1;CREB1;TAB2;MAP2K6;TRAF6;FOS;CUL1;DUSP6
prerank,Reactome_2022__ERKs Are Inactivated R-HSA-202670,0.7351670194144896,1.3432298836054901,0.14,0.8072815622857912,1.0,4/12,21.90%,DUSP4;PPP2R1B;PPP2R5D;DUSP6
prerank,CellMarker_Augmented_2021__Colony-forming cell:Prostate,0.47413041137419454,1.3430755810531363,0.05263157894736842,0.8067117142045444,1.0,27/88,16.51%,PHLDB2;ADGRG6;EMP1;LAMA3;ARSJ;PARVA;PERP;COL12A1;JAG1;CAPN2;NTN4;DSP;KIAA1671;TGFA;CRIM1;PTPRM;ITGA3;TSPAN6;ITGB4;LPP;NECTIN3;DOCK9;RYK;FLNB;CALD1;LRRC1;EXOC6B
prerank,GO_Biological_Process_2021__regulation of hyaluronan biosynthetic process (GO:1900125),-0.8435765096537281,-1.342936427124526,0.109375,0.8111242442945928,1.0,1/6,1.49%,TGFB1
prerank,CellMarker_Augmented_2021__Cytotrophoblast:Endometrium,-0.5974936187904355,-1.3421089832580824,0.08571428571428572,0.8125959772220197,1.0,18/44,15.90%,APOL1;TCN1;CIDEB;ACSL5;IRF1;CEACAM1;C4BPA;TAPBPL;OLFM4;OAS1;HSH2D;CYP4F12;F5;APOL6;GPX2;TMEM45B;HLA-F;PRRG4
prerank,CellMarker_Augmented_2021__Trophoblast cell:Endometrium,-0.5974936187904355,-1.3421089832580824,0.08571428571428572,0.8125959772220197,1.0,18/44,15.90%,APOL1;TCN1;CIDEB;ACSL5;IRF1;CEACAM1;C4BPA;TAPBPL;OLFM4;OAS1;HSH2D;CYP4F12;F5;APOL6;GPX2;TMEM45B;HLA-F;PRRG4
prerank,CellMarker_Augmented_2021__Hematopoietic Stem cell:Umbilical Cord Blood,-0.5697566933322966,-1.341489877673843,0.057971014492753624,0.8144613366676468,1.0,18/64,12.14%,PLEKHS1;AHR;CMAHP;ERN2;CLCA4;RARRES1;CAPN8;DUOXA1;FUT2;MROH9;SLC5A1;SLCO2A1;MAP3K19;BPIFB1;MS4A8;CP;LAMC2;ITGB6
prerank,GO_Biological_Process_2021__positive regulation of lamellipodium organization (GO:1902745),-0.6429632989732572,-1.3413876068986128,0.05084745762711865,0.8133884480438914,1.0,1/31,0.09%,ENPP2
prerank,CellMarker_Augmented_2021__Purkinje cell:Brain,0.4773401260987522,1.3413321044591993,0.10714285714285714,0.8135294663852187,1.0,38/92,26.82%,LLGL1;SCRIB;ABL1;MAST2;MAP3K10;KLHL29;ANO8;EVI5L;PLEC;GPSM1;RAB11FIP3;MACF1;TOM1L2;GOLGA3;ARHGAP35;HERC2;DLG5;ATN1;SKI;ZHX3;GOLGA2P7;FAM168A;PRRC2A;SMG6;PCBP4;ADD1;ANKRD52;LARP1;MICAL3;CYTH3;EPN2;MAPKBP1;AGAP1;ZC3H7B;NLGN2;EP400;TAOK2;MAP4
prerank,GO_Biological_Process_2021__cardiac muscle contraction (GO:0060048),-0.6995225125954689,-1.3411942076074956,0.04477611940298507,0.8127356480227286,1.0,6/25,8.12%,SCN5A;MYH7;CASQ2;MYBPC3;CSRP3;KCNQ1
prerank,Reactome_2022__Dopamine Receptors R-HSA-390651,0.862358288426273,1.3410683186086918,0.08333333333333333,0.8136154277650903,1.0,2/5,7.29%,DRD5;DRD4
prerank,GO_Biological_Process_2021__positive regulation of telomere maintenance via telomere lengthening (GO:1904358),-0.6258828446670935,-1.3410414269065938,0.12307692307692308,0.811969812858328,1.0,1/34,0.37%,NEK2
prerank,Reactome_2022__Synthesis Of Lipoxins (LX) R-HSA-2142700,-0.8317405816579271,-1.340988319312725,0.05263157894736842,0.8086174589357144,1.0,3/6,4.48%,ALOX12;ALOX5;PTGR1
prerank,GO_Biological_Process_2021__lipoxin metabolic process (GO:2001300),-0.8317405816579271,-1.340988319312725,0.05263157894736842,0.8086174589357144,1.0,3/6,4.48%,ALOX12;ALOX5;PTGR1
prerank,CellMarker_Augmented_2021__Langerhans cell:Skin,-0.5814092526557724,-1.3403206929196585,0.16923076923076924,0.8110590899601221,1.0,19/38,16.71%,CLEC5A;C1QB;XCR1;HCK;PTAFR;MS4A4A;LY86;NFAM1;HLA-DPB1;IGSF6;HLA-DRB1;SPI1;FPR3;F13A1;HLA-DPA1;CD300LF;CD4;HK3;NAPSB
prerank,GO_Biological_Process_2021__regulation of osteoblast differentiation (GO:0045667),0.5071696128353586,1.3401564496228247,0.07407407407407407,0.8164945749245306,1.0,27/75,23.49%,BAMBI;CCN4;TWIST2;CCN1;PPARG;WNT4;RORB;GREM1;CDK6;TWIST1;SNAI2;CRIM1;SUCO;WWTR1;MEN1;NOTCH1;SKI;ZHX3;ACVR1;PTCH1;ACVR2A;BMPR2;HDAC7;BMP4;TNN;LRP3;BMPR1A
prerank,GO_Biological_Process_2021__macromolecule biosynthetic process (GO:0009059),-0.8543126106612795,-1.3401456508924388,0.14035087719298245,0.8103203281149034,1.0,2/5,10.72%,COL5A1;SLC11A1
prerank,PanglaoDB_Augmented_2021__Bergmann Glia,0.5007020538135426,1.3399497511750416,0.1,0.8160555890921344,1.0,40/128,20.33%,CDH20;NTSR2;GRIN3A;SPHKAP;GJB6;GRM3;LRRTM3;LRRC4C;BAALC;ELAVL3;CADM2;ZEB2;MAGI2;PTPRZ1;KCNIP1;ADCY2;ADGRA1;GABRG1;RGS7BP;NPAS3;RBFOX1;DPP6;NRXN1;TTC21B;KCND3;DLG2;SLITRK2;PPFIA2;S100B;LSAMP;MMD2;ST8SIA3;ADGRB3;GRM5;PTCH1;CTNNA2;SLC1A3;TNR;KCNJ10;PMP2
prerank,GO_Biological_Process_2021__positive regulation of intracellular transport (GO:0032388),0.5648030299874913,1.339765849865494,0.11538461538461539,0.8157359815323907,1.0,10/34,17.20%,PCM1;CAPN10;STX18;TENM1;CEP290;B3GAT3;PLK3;PGAP1;NEDD4;ICE1
prerank,GO_Biological_Process_2021__growth hormone receptor signaling pathway (GO:0060396),0.5967047221307661,1.3396074532964501,0.03125,0.8153231344963667,1.0,2/14,12.34%,STAT5B;PXN
prerank,GO_Biological_Process_2021__microtubule depolymerization (GO:0007019),-0.68712617737628,-1.3394201726846262,0.09375,0.8129929676449342,1.0,5/17,21.21%,KIF14;STMN4;KIF18A;STMN1;STMND1
prerank,CellMarker_Augmented_2021__Cancer Stem cell:Colon,-0.7699738220678424,-1.3393473904908955,0.0847457627118644,0.8115338559118268,1.0,1/12,0.01%,CD44
prerank,PanglaoDB_Augmented_2021__Cajal-Retzius Cells,0.4914910976813435,1.3389244784035381,0.15789473684210525,0.8174757542744383,1.0,35/163,15.53%,SLC17A6;MEGF10;EDIL3;GRID2;LINGO2;NOVA1;NLGN1;EPHA7;ELAVL3;CNTNAP2;CADM2;NRG1;PAK5;KCNH7;SLC35F1;RALGPS2;MAPK8;ERC2;SYT1;GALNT13;BRINP1;ISOC1;GNL3L;TRIM44;DACH1;RIMS4;OLFM3;CLSTN2;SNAP91;MAP6;FUT9;SCRT1;ANK2;INSYN2A;ACHE
prerank,GO_Biological_Process_2021__positive regulation of G2/M transition of mitotic cell cycle (GO:0010971),-0.7102187128879307,-1.338788093029644,0.12698412698412698,0.8139308649509903,1.0,4/19,5.16%,DTL;CCND1;CDC25A;RAB11A
prerank,Reactome_2022__Clathrin-mediated Endocytosis R-HSA-8856828,0.4637600913429246,1.3386427462445976,0.05555555555555555,0.8175781984085814,1.0,9/123,3.49%,IL7R;CHRM2;SNX18;TOR1B;APOB;PACSIN2;HIP1;KIAA0319;BIN1
prerank,GO_Biological_Process_2021__establishment of melanosome localization (GO:0032401),0.6545548473285292,1.338462863945395,0.11428571428571428,0.8156748612897794,1.0,2/15,0.97%,MLPH;RAB27A
prerank,GO_Biological_Process_2021__melanosome localization (GO:0032400),0.6545548473285292,1.338462863945395,0.11428571428571428,0.8156748612897794,1.0,2/15,0.97%,MLPH;RAB27A
prerank,Reactome_2022__Formation Of Fibrin Clot (Clotting Cascade) R-HSA-140877,-0.6882207850204854,-1.3384586192206507,0.08450704225352113,0.8141688224183186,1.0,10/24,14.68%,F8;F7;PROCR;SERPIND1;GP1BA;FAM110A;VWF;F13A1;F5;TFPI
prerank,GO_Biological_Process_2021__positive regulation of heterochromatin assembly (GO:0031453),0.6821588540767425,1.3383007408788168,0.1935483870967742,0.8146808987685026,1.0,6/13,22.33%,DNMT1;RESF1;MPHOSPH8;ATF7IP;SIRT6;TPR
prerank,GO_Biological_Process_2021__sulfur amino acid biosynthetic process (GO:0000097),0.7574998813265704,1.3382949211859594,0.08571428571428572,0.8134566276959756,1.0,3/7,13.71%,CBS;MTR;MTHFR
prerank,GO_Biological_Process_2021__negative regulation of chondrocyte differentiation (GO:0032331),0.7387219496554343,1.338230199517936,0.06976744186046512,0.8126323492138141,1.0,6/13,12.82%,TGFBR1;ADAMTS12;WNT9A;GREM1;SNAI2;EFEMP1
prerank,GO_Biological_Process_2021__regulation of peptidyl-serine phosphorylation (GO:0033135),-0.5378748213501807,-1.3381990726156694,0.05555555555555555,0.8139510192017024,1.0,3/82,2.96%,CD44;TGFB1;TERF2IP
prerank,GO_Biological_Process_2021__positive regulation of autophagosome maturation (GO:1901098),0.8888369206151718,1.3380241300234348,0.08695652173913043,0.8122992706389487,1.0,1/5,0.82%,IRGM
prerank,GO_Biological_Process_2021__medium-chain fatty acid catabolic process (GO:0051793),0.8541077572550406,1.3380069017828926,0.11904761904761904,0.8110611686203159,1.0,3/5,10.45%,GLYATL2;ABHD3;ACADM
prerank,GO_Biological_Process_2021__ATP synthesis coupled electron transport (GO:0042773),-0.8566547435678504,-1.3379995845689208,0.046153846153846156,0.8132966903573892,1.0,1/6,9.91%,NDUFS2
prerank,CellMarker_Augmented_2021__Cancer Stem cell:Pancreas,-0.8586800706628118,-1.337967716100034,0.05084745762711865,0.8117075394232013,1.0,1/7,0.01%,CD44
prerank,Reactome_2022__Mitotic Spindle Checkpoint R-HSA-69618,-0.5068458604951891,-1.337859577606226,0.05555555555555555,0.8105448327231793,1.0,23/102,23.42%,BUB1;ERCC6L;SPC25;CENPU;ITGB3BP;ZWILCH;NUF2;CENPH;CENPS-CORT;DYNLL1;RPS27;INCENP;NDEL1;CDCA8;CENPN;KIF18A;BUB1B;SKA2;SEC13;CENPL;DYNLL2;PPP2R5A;CENPM
prerank,PanglaoDB_Augmented_2021__Astrocytes,0.4685737977894717,1.3378235762862976,0.07407407407407407,0.810545988917742,1.0,22/146,10.40%,CDH20;NTSR2;SPHKAP;GJB6;NFATC3;APOE;LRRTM3;BAALC;TMEM132C;CADM2;SRR;PTPRZ1;KCNIP1;LUZP2;PLXNB1;ADGRA1;SYNDIG1;AANAT;FGFR3;BRINP1;GABRG1;RGS7BP
prerank,Reactome_2022__Regulation Of TP53 Degradation R-HSA-6804757,0.5616180946914339,1.3378068941302588,0.14705882352941177,0.8093607547428201,1.0,7/34,16.83%,CCNG1;SGK1;MLST8;AKT2;PPP2R1B;TP53;ATM
prerank,GO_Biological_Process_2021__cellular response to cold (GO:0070417),0.7680827717087019,1.3377643360133962,0.13043478260869565,0.8084335541774547,1.0,2/6,7.38%,FOXO1;EIF2AK3
prerank,GO_Biological_Process_2021__glycerol transport (GO:0015793),-0.8897357371300543,-1.3376277364494698,0.1320754716981132,0.810224256608659,1.0,1/5,0.34%,AQP3
prerank,GO_Biological_Process_2021__regulation of vascular associated smooth muscle cell differentiation (GO:1905063),0.7219644475969912,1.3374230042175532,0.21052631578947367,0.8087560128955109,1.0,2/7,2.55%,KIT;NFATC3
prerank,CellMarker_Augmented_2021__Amniotic Fluid Stem cell:Amniotic Fluid,-0.5575113730346573,-1.3371587822210362,0.04054054054054054,0.8077198526999974,1.0,15/87,9.78%,CD44;PDCD1LG2;LPAR1;MMP19;PLAC9;TGFBI;APCDD1L;DAB2;DCN;PLAU;ANXA1;HEG1;OSMR;ITGBL1;THBS1
prerank,CellMarker_Augmented_2021__Mesenchymal Stem cell:Synovial Fluid,-0.5575113730346573,-1.3371587822210362,0.04054054054054054,0.8077198526999974,1.0,15/87,9.78%,CD44;PDCD1LG2;LPAR1;MMP19;PLAC9;TGFBI;APCDD1L;DAB2;DCN;PLAU;ANXA1;HEG1;OSMR;ITGBL1;THBS1
prerank,CellMarker_Augmented_2021__Progenitor cell:Bone,-0.5575113730346573,-1.3371587822210362,0.04054054054054054,0.8077198526999974,1.0,15/87,9.78%,CD44;PDCD1LG2;LPAR1;MMP19;PLAC9;TGFBI;APCDD1L;DAB2;DCN;PLAU;ANXA1;HEG1;OSMR;ITGBL1;THBS1
prerank,Reactome_2022__Signaling To RAS R-HSA-167044,0.6184875162235125,1.3369339697357603,0.11428571428571428,0.8098151824656847,1.0,4/19,8.31%,NGF;MAPKAPK2;RALB;RALA
prerank,Reactome_2022__Regulation Of Commissural Axon Pathfinding By SLIT And ROBO R-HSA-428542,0.7297427732276229,1.3367408337581932,0.0975609756097561,0.8096281317994477,1.0,3/9,7.88%,ROBO2;DCC;SLIT2
prerank,CellMarker_Augmented_2021__Non-classical monocyte:Bone Marrow,-0.6177551404008976,-1.3365362535095877,0.11428571428571428,0.809833516734978,1.0,20/51,13.64%,HCK;TAGAP;C3AR1;PARVG;FCGR3A;LY86;P2RY14;NFAM1;MYO1F;IGSF6;PTPRC;FPR1;SLC11A1;SPI1;PTGDR;CLEC12A;ITGAM;F13A1;CD300LF;ADGRE3
prerank,Reactome_2022__rRNA Processing In Mitochondrion R-HSA-8868766,0.7880908752713954,1.3364062724214938,0.05405405405405406,0.809579550449906,1.0,1/8,2.74%,TFB1M
prerank,CellMarker_Augmented_2021__M1 macrophage:Undefined,-0.7916954224152635,-1.3359742059210937,0.16363636363636364,0.8114762625799239,1.0,4/7,14.67%,ROS1;STAT1;FCGR3A;CD80
prerank,GO_Biological_Process_2021__regulation of ribonuclease activity (GO:0060700),-0.8302929822377065,-1.3357507932621147,0.10416666666666667,0.8109989793864323,1.0,2/5,12.20%,OAS2;OAS1
prerank,GO_Biological_Process_2021__activin receptor signaling pathway (GO:0032924),0.6385008196041915,1.335608142306268,0.1111111111111111,0.811665207186502,1.0,7/13,20.31%,TGFBR1;GDF6;SMAD2;CFC1;HJV;ACVR1;ACVR2A
prerank,GO_Biological_Process_2021__regulation of pH (GO:0006885),-0.7397016988153121,-1.3355840742124672,0.12280701754385964,0.8105079149306221,1.0,3/10,10.86%,ATP1A4;ATP6AP1;LACC1
prerank,GO_Biological_Process_2021__fluid transport (GO:0042044),-0.7807953000597572,-1.3355814862108792,0.06896551724137931,0.8087535687944086,1.0,4/11,15.61%,AQP3;UPK3A;AQP4;AQP11
prerank,Reactome_2022__Signal Attenuation R-HSA-74749,0.7661469116495201,1.3355654964182395,0.14893617021276595,0.8106742608922397,1.0,4/9,19.27%,IRS1;IRS2;INSR;SOS1
prerank,GO_Biological_Process_2021__secondary alcohol metabolic process (GO:1902652),0.5881791299491711,1.3350253052484067,0.2,0.81140212146425,1.0,6/36,7.63%,TSKU;APOB;APOE;SOAT1;SOAT2;ABCA1
prerank,GO_Biological_Process_2021__positive regulation of production of molecular mediator of immune response (GO:0002702),-0.6563187086538114,-1.3347545743747915,0.11267605633802817,0.8118680974174084,1.0,8/25,20.41%,WNT5A;SCIMP;CLCF1;PTPRC;LACC1;F2RL1;SASH3;CD86
prerank,GO_Biological_Process_2021__vacuolar acidification (GO:0007035),0.6010085079900698,1.3344851949175012,0.09375,0.8129043907089241,1.0,2/18,1.86%,ATP6V0D2;TCIRG1
prerank,Reactome_2022__Synthesis Of PE R-HSA-1483213,0.6689997917946626,1.3344368470842298,0.12195121951219512,0.8119388944542956,1.0,5/12,24.32%,CEPT1;CHKA;LPIN2;ETNPPL;PCYT2
prerank,GO_Biological_Process_2021__cellular cation homeostasis (GO:0030003),0.7472688702887659,1.334343464052856,0.14,0.8110674275376684,1.0,4/7,22.40%,LETM2;TESMIN;SLC4A11;CLDN16
prerank,GO_Biological_Process_2021__zymogen activation (GO:0031638),0.5903565526885146,1.334198055381906,0.06666666666666667,0.810835272037053,1.0,9/32,6.11%,HGFAC;TBC1D10A;APOH;PRSS3;PERP;RIPK2;KLKB1;IFI16;F11
prerank,GO_Biological_Process_2021__negative regulation of amyloid-beta clearance (GO:1900222),-0.8717874952847591,-1.3341826448819294,0.08064516129032258,0.8140242364796549,1.0,1/5,2.65%,LRPAP1
prerank,GO_Biological_Process_2021__acetyl-CoA metabolic process (GO:0006084),0.68192496998079,1.33383749643335,0.18181818181818182,0.8113757382553152,1.0,3/14,11.15%,TDO2;ACACB;PPCS
prerank,Reactome_2022__Signaling By NOTCH1 R-HSA-1980143,0.5321747550806103,1.3336896411120422,0.11538461538461539,0.8107811143759931,1.0,29/69,21.76%,HDAC3;HDAC10;TLE2;DTX1;MAML1;JAG1;ARRB2;MYC;MAMLD1;NUMB;HDAC1;ARRB1;CDK8;HDAC4;HDAC11;NOTCH1;RBPJ;MIB2;ADAM10;EP300;KAT2B;CNTN1;HDAC5;HIF1A;TBL1X;NBEA;HDAC7;CUL1;JAG2
prerank,GO_Biological_Process_2021__postsynapse organization (GO:0099173),-0.8311754728607601,-1.3336881367720754,0.10526315789473684,0.8148824271547748,1.0,1/8,2.54%,WNT5A
prerank,GO_Biological_Process_2021__positive regulation of double-strand break repair via nonhomologous end joining (GO:2001034),0.729118461961767,1.3336449906607561,0.125,0.8097129598829519,1.0,8/14,17.85%,SHLD2;SHLD1;SETMAR;KMT5C;SMCHD1;WRAP53;KMT5B;PNKP
prerank,CellMarker_Augmented_2021__Glial cell:Sympathetic Ganglion,0.5571250416251866,1.3335573186343657,0.13333333333333333,0.8052474808332931,1.0,27/93,20.33%,CDH20;NTSR2;SPHKAP;GRM3;SNTG1;LRRTM3;KCNC2;ELAVL3;CADM2;ADGRA1;GABRG1;NXPH1;CPNE6;FRRS1L;SCRT1;VSTM2B;DPP6;RIT2;TTYH1;SLC24A2;MMD2;ST8SIA3;GRM5;CTNNA2;TNR;KCNJ10;PMP2
prerank,CellMarker_Augmented_2021__Glial cell:Brain,0.5571250416251866,1.3335573186343657,0.13333333333333333,0.8052474808332931,1.0,27/93,20.33%,CDH20;NTSR2;SPHKAP;GRM3;SNTG1;LRRTM3;KCNC2;ELAVL3;CADM2;ADGRA1;GABRG1;NXPH1;CPNE6;FRRS1L;SCRT1;VSTM2B;DPP6;RIT2;TTYH1;SLC24A2;MMD2;ST8SIA3;GRM5;CTNNA2;TNR;KCNJ10;PMP2
prerank,CellMarker_Augmented_2021__Schwann cell:Intervertebral Disc,0.5571250416251866,1.3335573186343657,0.13333333333333333,0.8052474808332931,1.0,27/93,20.33%,CDH20;NTSR2;SPHKAP;GRM3;SNTG1;LRRTM3;KCNC2;ELAVL3;CADM2;ADGRA1;GABRG1;NXPH1;CPNE6;FRRS1L;SCRT1;VSTM2B;DPP6;RIT2;TTYH1;SLC24A2;MMD2;ST8SIA3;GRM5;CTNNA2;TNR;KCNJ10;PMP2
prerank,CellMarker_Augmented_2021__Astrocyte:Spinal Cord,0.5571250416251866,1.3335573186343657,0.13333333333333333,0.8052474808332931,1.0,27/93,20.33%,CDH20;NTSR2;SPHKAP;GRM3;SNTG1;LRRTM3;KCNC2;ELAVL3;CADM2;ADGRA1;GABRG1;NXPH1;CPNE6;FRRS1L;SCRT1;VSTM2B;DPP6;RIT2;TTYH1;SLC24A2;MMD2;ST8SIA3;GRM5;CTNNA2;TNR;KCNJ10;PMP2
prerank,CellMarker_Augmented_2021__Natural Killer cell:Lung,-0.6055662149550216,-1.3335459845566893,0.12307692307692308,0.8105957100981063,1.0,13/45,13.88%,RASGRP4;ARHGAP9;NLRP12;KLRB1;SCML4;CD37;TRAF3IP3;MYO1F;SLC11A1;NLRC3;SH2D1B;ADGRE3;PSTPIP1
prerank,CellMarker_Augmented_2021__Natural Killer cell:Splenic Red Pulp,-0.6055662149550216,-1.3335459845566893,0.12307692307692308,0.8105957100981063,1.0,13/45,13.88%,RASGRP4;ARHGAP9;NLRP12;KLRB1;SCML4;CD37;TRAF3IP3;MYO1F;SLC11A1;NLRC3;SH2D1B;ADGRE3;PSTPIP1
prerank,CellMarker_Augmented_2021__Natural Killer cell:Gut,-0.6055662149550216,-1.3335459845566893,0.12307692307692308,0.8105957100981063,1.0,13/45,13.88%,RASGRP4;ARHGAP9;NLRP12;KLRB1;SCML4;CD37;TRAF3IP3;MYO1F;SLC11A1;NLRC3;SH2D1B;ADGRE3;PSTPIP1
prerank,CellMarker_Augmented_2021__Immature Transitional B cell:Blood,-0.6289034978084792,-1.333313549167575,0.1044776119402985,0.8086079123140253,1.0,14/31,20.41%,DENND1C;JCHAIN;HCK;ALOX5;LY86;SPI1;BLNK;HSH2D;IKZF1;NAPSB;CD24;SASH3;PAX5;CD86
prerank,CellMarker_Augmented_2021__Plasmablast:Peripheral Blood,-0.6289034978084792,-1.333313549167575,0.1044776119402985,0.8086079123140253,1.0,14/31,20.41%,DENND1C;JCHAIN;HCK;ALOX5;LY86;SPI1;BLNK;HSH2D;IKZF1;NAPSB;CD24;SASH3;PAX5;CD86
prerank,GO_Biological_Process_2021__glucan biosynthetic process (GO:0009250),0.6736002040715614,1.3331151149519795,0.16666666666666666,0.805031197416491,1.0,2/12,8.39%,PER2;GYS1
prerank,GO_Biological_Process_2021__glycogen biosynthetic process (GO:0005978),0.6736002040715614,1.3331151149519795,0.16666666666666666,0.805031197416491,1.0,2/12,8.39%,PER2;GYS1
prerank,GO_Biological_Process_2021__regulation of cell development (GO:0060284),0.5876782891481578,1.3331074320409202,0.06896551724137931,0.8038260608934124,1.0,4/32,5.56%,FOXO1;PER2;CX3CR1;HES1
prerank,GO_Biological_Process_2021__regulation of leukocyte cell-cell adhesion (GO:1903037),0.6916681217507723,1.3326597925240413,0.18181818181818182,0.8043018332955951,1.0,4/10,22.90%,SKAP1;FUT9;MIA3;WNK1
prerank,GO_Biological_Process_2021__cellular response to ATP (GO:0071318),-0.7747420663801752,-1.3322374410385207,0.10909090909090909,0.8138419980319249,1.0,1/10,2.75%,P2RY12
prerank,GO_Biological_Process_2021__double-strand break repair via break-induced replication (GO:0000727),-0.8153091914079287,-1.3322330158200415,0.06666666666666667,0.8121796864116517,1.0,3/11,8.41%,MCM2;MCM3;MCMDC2
prerank,GO_Biological_Process_2021__negative regulation of striated muscle cell differentiation (GO:0051154),0.6404786327770886,1.3319432199315786,0.06818181818181818,0.8060713662235688,1.0,7/14,25.69%,HDAC3;HDAC1;HDAC4;NOTCH1;HDAC5;FZD7;BMP2
prerank,GO_Biological_Process_2021__negative regulation of long-term synaptic potentiation (GO:1900272),0.7593282775538388,1.3318419074321532,0.0851063829787234,0.8055166928738199,1.0,2/7,7.57%,APOE;ABL1
prerank,GO_Biological_Process_2021__regulation of catabolic process (GO:0009894),0.6603716272034642,1.3317979565483333,0.1282051282051282,0.8044515927710855,1.0,7/17,23.91%,CHMP6;ODC1;FURIN;SNF8;FAF1;FAP;HPGD
prerank,GO_Biological_Process_2021__lipoxygenase pathway (GO:0019372),-0.7156944554705705,-1.3312549354332839,0.11290322580645161,0.8165807027469908,1.0,8/15,17.79%,ALOX12;ALOX5;ALOX12B;ALOX15;PON3;PON1;ALOX15B;ALOX5AP
prerank,GO_Biological_Process_2021__histone H4-K12 acetylation (GO:0043983),0.7975555951807971,1.3312311923894509,0.1568627450980392,0.8058573166522692,1.0,2/6,18.99%,JADE3;JADE2
prerank,CellMarker_Augmented_2021__Stem cell:Undefined,-0.7884317660882156,-1.3309327001709943,0.11538461538461539,0.8173247023836343,1.0,1/9,0.01%,CD44
prerank,GO_Biological_Process_2021__cytoskeleton-dependent intracellular transport (GO:0030705),0.6371810368471532,1.3309142711170705,0.11428571428571428,0.8061933567968763,1.0,5/21,13.47%,MYO10;CCDC88B;DYNC1I2;CCDC88A;MAP6
prerank,CellMarker_Augmented_2021__Microglial cell:Optic Nerve,-0.585095508182712,-1.3307897763602576,0.11267605633802817,0.8164040227416006,1.0,26/54,20.41%,GMFG;ITGB2;HCK;CYTIP;ARHGAP9;TAGAP;MS4A4A;PARVG;FCGR3A;WAS;LY86;MYO1F;PTPRC;SPI1;CLEC12A;ITGAM;CD300LF;PSTPIP1;IKZF1;CD4;HK3;ALOX5AP;SASH3;P2RX1;ITGAX;CD86
prerank,GO_Biological_Process_2021__regulation of atrial cardiac muscle cell membrane repolarization (GO:0060372),-0.8236086695443878,-1.3306241659761817,0.09259259259259259,0.8159784873545823,1.0,3/6,8.12%,SCN5A;KCNA5;KCNQ1
prerank,GO_Biological_Process_2021__phosphatidylinositol-mediated signaling (GO:0048015),0.49750336175658616,1.3305105152286913,0.07142857142857142,0.8074815087299339,1.0,13/66,12.05%,NGF;PLCH1;NYAP2;FGFR1;IRS1;ERBB2;PI4KB;PLCL2;PIK3C2B;PLCB1;IRS2;PLCH2;TYRO3
prerank,GO_Biological_Process_2021__neuronal action potential (GO:0019228),-0.6733674158020329,-1.3304063202148677,0.13114754098360656,0.8154628150721337,1.0,2/20,5.18%,SCN5A;GPER1
prerank,CellMarker_Augmented_2021__M2 macrophage:Serum,-0.5958412549656456,-1.3303865037471625,0.0684931506849315,0.8105031923838527,1.0,21/53,13.42%,CLEC5A;C1QB;HCK;C3AR1;MS4A4A;FCGR3A;LY86;VSIG4;NFAM1;MYO1F;IGSF6;PTPRC;FPR1;SLC11A1;SPI1;CLEC12A;ITGAM;TLR2;FPR3;F13A1;CD300LF
prerank,CellMarker_Augmented_2021__M2 macrophage:Brain,-0.5958412549656456,-1.3303865037471625,0.0684931506849315,0.8105031923838527,1.0,21/53,13.42%,CLEC5A;C1QB;HCK;C3AR1;MS4A4A;FCGR3A;LY86;VSIG4;NFAM1;MYO1F;IGSF6;PTPRC;FPR1;SLC11A1;SPI1;CLEC12A;ITGAM;TLR2;FPR3;F13A1;CD300LF
prerank,CellMarker_Augmented_2021__Kupffer cell:Fetal Liver,-0.5958412549656456,-1.3303865037471625,0.0684931506849315,0.8105031923838527,1.0,21/53,13.42%,CLEC5A;C1QB;HCK;C3AR1;MS4A4A;FCGR3A;LY86;VSIG4;NFAM1;MYO1F;IGSF6;PTPRC;FPR1;SLC11A1;SPI1;CLEC12A;ITGAM;TLR2;FPR3;F13A1;CD300LF
prerank,GO_Biological_Process_2021__negative regulation of transcription regulatory region DNA binding (GO:2000678),0.6577904643923843,1.3298471835916421,0.15,0.8096290170994854,1.0,1/11,0.87%,PER2
prerank,GO_Biological_Process_2021__pre-replicative complex assembly (GO:0036388),-0.5453803985325996,-1.3297388395145253,0.06578947368421052,0.8129505913640884,1.0,3/56,4.42%,MCM2;PSMB9;MCM3
prerank,GO_Biological_Process_2021__negative regulation of lymphocyte activation (GO:0051250),0.6240512455943494,1.329587146980344,0.10810810810810811,0.8096927992403206,1.0,8/16,22.16%,SAMSN1;PAG1;PIBF1;BANK1;LGALS3;LAPTM5;LST1;IL4I1
prerank,Reactome_2022__Vitamin D (Calciferol) Metabolism R-HSA-196791,-0.7425738760849399,-1.3293796254456658,0.07547169811320754,0.8133865485691452,1.0,5/11,22.95%,CYP24A1;LRP2;VDR;LDLRAP1;GC
prerank,GO_Biological_Process_2021__regulation of protein deacetylation (GO:0090311),0.7587908810178895,1.3293255776319726,0.061224489795918366,0.8096901915932503,1.0,3/8,11.02%,SPRED3;SPRED2;SPRED1
prerank,Reactome_2022__RSK Activation R-HSA-444257,0.7718357050942818,1.3284377997620518,0.0425531914893617,0.8127063474114075,1.0,3/7,14.79%,RPS6KA3;RPS6KA2;RPS6KA6
prerank,GO_Biological_Process_2021__proteolysis (GO:0006508),0.4304797950366544,1.3283761688942775,0.0,0.8118412256646125,1.0,15/221,5.55%,CPA1;HGFAC;PRSS3;CPN1;KLK14;NAALAD2;CAPN10;TMPRSS7;MMP17;HTRA2;KLKB1;ADAMTS12;MMP2;PRSS57;CAPN2
prerank,GO_Biological_Process_2021__protein localization to microtubule organizing center (GO:1905508),0.6633802271850766,1.3283706376930347,0.1111111111111111,0.8106930346449562,1.0,8/15,25.97%,PCM1;C2CD3;PIBF1;CCDC14;CEP192;HOOK3;KIAA0753;CEP83
prerank,GO_Biological_Process_2021__leukocyte tethering or rolling (GO:0050901),0.7247462298985256,1.328368595710542,0.14634146341463414,0.8095043351806673,1.0,4/14,4.73%,SELPLG;PODXL2;CX3CR1;ITGA4
prerank,GO_Biological_Process_2021__diadenosine polyphosphate catabolic process (GO:0015961),0.767514247685637,1.3280839560493107,0.21951219512195122,0.8095458338931488,1.0,2/6,5.02%,FHIT;NUDT4B
prerank,Reactome_2022__ROBO Receptors Bind AKAP5 R-HSA-9010642,0.7987242177986298,1.3280637147995342,0.1590909090909091,0.8084060346349407,1.0,2/7,10.12%,ROBO2;PRKAR2A
prerank,GO_Biological_Process_2021__mitochondrial RNA metabolic process (GO:0000959),0.7193934766125938,1.3279383882705158,0.15625,0.8078156059818433,1.0,5/13,14.06%,TFB1M;TEFM;SLC25A33;EARS2;PNPT1
prerank,PanglaoDB_Augmented_2021__Pluripotent Stem Cells,-0.5460547008513377,-1.327893183211775,0.07575757575757576,0.8209166106720589,1.0,16/91,15.49%,BUB1;TICRR;ERCC6L;HK2;SALL4;MCM3;SLC7A3;ZNF296;CLDN6;CENPH;TERT;PIF1;CHAF1A;ATAD5;CCNF;ZGRF1
prerank,GO_Biological_Process_2021__cellular response to glucose starvation (GO:0042149),0.5362642459784276,1.3274998303304566,0.05128205128205128,0.8088844487950716,1.0,13/33,21.62%,KPTN;IFI16;EIF2AK3;TP53;MTMR3;SIK2;IMPACT;SESN2;PRKAA2;NIM1K;PRKAG2;SZT2;PIK3R4
prerank,GO_Biological_Process_2021__ubiquinone metabolic process (GO:0006743),0.6498423437113947,1.3274702563495342,0.15151515151515152,0.8078812582802535,1.0,7/14,27.43%,PDSS2;UBIAD1;AIFM2;COQ2;COQ9;COQ6;COQ3
prerank,GO_Biological_Process_2021__regulation of feeding behavior (GO:0060259),0.731397959975204,1.327176615292564,0.2391304347826087,0.8084032368436135,1.0,5/9,16.04%,LEPR;INSL5;UCN;SGIP1;NR4A3
prerank,GO_Biological_Process_2021__phosphate ion transport (GO:0006817),-0.7807430724651421,-1.327121421790041,0.10344827586206896,0.8237500856390948,1.0,1/13,1.36%,SLC37A2
prerank,CellMarker_Augmented_2021__Regulatory B cell:Undefined,-0.6362269394445921,-1.3267729253456313,0.1076923076923077,0.8208514621254663,1.0,17/38,17.21%,JCHAIN;BLK;CYTIP;TBC1D10C;ARHGAP9;TAGAP;TMC8;WAS;LY86;CD37;TRAF3IP3;PTPRC;HSH2D;CD27;IKZF1;NAPSB;CD24
prerank,CellMarker_Augmented_2021__Transitional B cell:Peripheral Blood,-0.6362269394445921,-1.3267729253456313,0.1076923076923077,0.8208514621254663,1.0,17/38,17.21%,JCHAIN;BLK;CYTIP;TBC1D10C;ARHGAP9;TAGAP;TMC8;WAS;LY86;CD37;TRAF3IP3;PTPRC;HSH2D;CD27;IKZF1;NAPSB;CD24
prerank,CellMarker_Augmented_2021__Naive B cell:Blood,-0.6362269394445921,-1.3267729253456313,0.1076923076923077,0.8208514621254663,1.0,17/38,17.21%,JCHAIN;BLK;CYTIP;TBC1D10C;ARHGAP9;TAGAP;TMC8;WAS;LY86;CD37;TRAF3IP3;PTPRC;HSH2D;CD27;IKZF1;NAPSB;CD24
prerank,GO_Biological_Process_2021__microtubule cytoskeleton organization involved in mitosis (GO:1902850),-0.5114146928924872,-1.326652817214202,0.08450704225352113,0.820007981231112,1.0,26/120,23.66%,BUB1;ERCC6L;SPC25;CENPU;GPSM2;ITGB3BP;ZWILCH;TTK;NUF2;CENPH;DYNLL1;RPS27;INCENP;NDEL1;CDCA8;CENPN;KIF18A;BUB1B;STMN1;SKA2;SEC13;CENPL;DYNLL2;SBDS;CENPM;AURKA
prerank,GO_Biological_Process_2021__negative regulation of defense response to virus (GO:0050687),-0.7895489827222362,-1.3266414302476288,0.061224489795918366,0.8183908502127721,1.0,1/10,0.36%,MICB
prerank,GO_Biological_Process_2021__positive regulation of type I interferon-mediated signaling pathway (GO:0060340),-0.7983521930517774,-1.3264602131937333,0.2037037037037037,0.8177646259921354,1.0,1/5,2.54%,WNT5A
prerank,"GO_Biological_Process_2021__nuclear-transcribed mRNA catabolic process, nonsense-mediated decay (GO:0000184)",-0.552625986204578,-1.3262298329438376,0.04054054054054054,0.8174535030812166,1.0,54/104,27.27%,RPL37A;RPL38;RPL15;RPS4X;RPL3;RPL35A;RPS9;RPS27;RPS21;RPL13A;RPL27A;RPS16;RPL36;RPS20;RPL7A;RPL9;RPL13;RPS8;RPS27A;RPL21;RPL34;RPL4;RPL32;RPL5;RPL23;RPL41;RPS7;RPS11;RPL27;RPL35;RPS14;RPL11;RPS15;RPLP1;RPS12;RPL24;RPL18A;RPS13;RPL29;RPLP2;RPL28;RPL12;RPL18;RPS3;RPL22;RPSA;RPS28;RPS19;RPS24;RPS3A;RPL19;RPL8;RPS6;RPL10
prerank,GO_Biological_Process_2021__regulation of dendritic spine morphogenesis (GO:0061001),0.635125337269305,1.325947939066959,0.058823529411764705,0.8128323834156265,1.0,8/31,19.39%,ARC;NLGN1;LZTS3;ABI3;LRP8;SRCIN1;PPFIA2;CDK5
prerank,GO_Biological_Process_2021__bundle of His cell-Purkinje myocyte adhesion involved in cell communication (GO:0086073),-0.7942390442862048,-1.325880766224312,0.19607843137254902,0.8158270812188032,1.0,2/6,3.78%,PKP2;CTNNA3
prerank,GO_Biological_Process_2021__bundle of His cell to Purkinje myocyte communication (GO:0086069),-0.7942390442862048,-1.325880766224312,0.19607843137254902,0.8158270812188032,1.0,2/6,3.78%,PKP2;CTNNA3
prerank,KEGG_2021_Human__Epstein-Barr virus infection,-0.50469015177031,-1.325715187705515,0.05555555555555555,0.815107566649313,1.0,21/157,15.53%,CD44;CCND1;HLA-DMA;STAT1;OAS2;NFKB2;HLA-A;PIK3R3;HLA-DPB1;CCND2;HLA-DRB1;SAP30;CDKN1A;OAS1;TLR2;BLNK;HLA-DPA1;PIK3CB;SAP30L;CCNE2;HLA-F
prerank,GO_Biological_Process_2021__metanephros development (GO:0001656),0.6582302574662102,1.325694725295368,0.2,0.8128252709969469,1.0,8/18,19.18%,FGF10;ROBO2;PKD2;OSR1;GDF6;NF1;NIPBL;PTCH1
prerank,GO_Biological_Process_2021__negative regulation of RNA metabolic process (GO:0051253),-0.7245776139328521,-1.3256741170528898,0.07575757575757576,0.8137561464466163,1.0,3/15,10.71%,TGFB1;ESR1;TERT
prerank,GO_Biological_Process_2021__positive regulation of exosomal secretion (GO:1903543),0.6786381339682108,1.3256078730329233,0.1724137931034483,0.8119520969274164,1.0,4/13,16.49%,SDC4;RAB7A;SMPD3;SNF8
prerank,PanglaoDB_Augmented_2021__Pancreatic Progenitor Cells,0.48007831964825654,1.3255307726217018,0.07692307692307693,0.811146308782824,1.0,30/103,16.74%,DUSP15;CACNG4;ARX;HS6ST2;RGS16;CXXC4;PCLO;HES1;JPH1;CKMT1A;PLXNB1;ABCC8;FGFR3;WNK2;COBL;DDAH1;PRR36;LRIG3;TSPAN12;NR2F2;MSI1;MAGI1;NKD2;RFX6;PTPRF;CGN;EFNA2;WWC1;CKMT1B;MARK1
prerank,PanglaoDB_Augmented_2021__Macrophages,-0.5481683405293267,-1.3253314345653207,0.05555555555555555,0.8144286407996852,1.0,38/120,13.42%,CLEC5A;SLC37A2;AHR;LYVE1;ITGB2;HCK;MMP9;CYTIP;CHIT1;TAGAP;SLC7A7;SCIMP;CPM;TNFRSF1B;PTAFR;SLCO2B1;C3AR1;DAB2;MS4A4A;PARVG;FCGR3A;LY86;VSIG4;NFAM1;ADGRE1;MYO1F;IGSF6;P2RY6;PTPRC;FPR1;SLC11A1;SPI1;CLEC12A;ITGAM;CXCL16;TLR2;F13A1;CD300LF
prerank,GO_Biological_Process_2021__positive regulation of RNA splicing (GO:0033120),0.5625512004468026,1.324721170352552,0.11764705882352941,0.8138187665967161,1.0,10/28,26.74%,RBM20;TRA2A;CELF4;ERN1;HSPA1A;U2AF2;SF3B4;SETX;DYRK1A;NUP98
prerank,GO_Biological_Process_2021__metal ion transport (GO:0030001),0.5132445324189008,1.3247073986134368,0.07407407407407407,0.8127323509136627,1.0,9/75,5.34%,GRIN3A;NIPAL1;TRPC3;SLC39A8;SLC3A2;TRPM2;SLC8A1;SLC8A3;PKD2
prerank,GO_Biological_Process_2021__tRNA processing (GO:0008033),0.4986071252340125,1.3245602592341652,0.058823529411764705,0.8120365555225155,1.0,17/61,24.33%,CPSF1;TRDMT1;METTL1;CTU1;POP1;TRMT9B;CDKAL1;TRMT61A;ANKRD16;TSEN2;DTWD1;FARS2;THUMPD1;THG1L;NSUN2;ADAT2;TRMT1
prerank,GO_Biological_Process_2021__cellular response to indole-3-methanol (GO:0071681),-0.8492084235643929,-1.3245165885555306,0.06,0.8160883585355974,1.0,2/5,8.63%,CTNNA1;BRCA1
prerank,GO_Biological_Process_2021__response to indole-3-methanol (GO:0071680),-0.8492084235643929,-1.3245165885555306,0.06,0.8160883585355974,1.0,2/5,8.63%,CTNNA1;BRCA1
prerank,GO_Biological_Process_2021__negative regulation of Arp2/3 complex-mediated actin nucleation (GO:0034316),-0.802379296811605,-1.32432812856664,0.12121212121212122,0.8154048194213419,1.0,1/6,1.65%,GMFG
prerank,GO_Biological_Process_2021__negative regulation of sterol biosynthetic process (GO:0106119),0.8457315543097584,1.3241452086725465,0.13333333333333333,0.810539874151305,1.0,1/5,2.66%,APOE
prerank,GO_Biological_Process_2021__negative regulation of cholesterol metabolic process (GO:0090206),0.8457315543097584,1.3241452086725465,0.13333333333333333,0.810539874151305,1.0,1/5,2.66%,APOE
prerank,GO_Biological_Process_2021__negative regulation of cholesterol biosynthetic process (GO:0045541),0.8457315543097584,1.3241452086725465,0.13333333333333333,0.810539874151305,1.0,1/5,2.66%,APOE
prerank,CellMarker_Augmented_2021__Macrophage:Subcutaneous Adipose Tissue,-0.6043691384978686,-1.32398610934148,0.08823529411764706,0.8143668255394009,1.0,19/52,13.42%,ITGB2;HCK;CYTIP;ARHGAP9;TAGAP;TNFRSF1B;C3AR1;PARVG;FCGR3A;LY86;NFAM1;MYO1F;IGSF6;PTPRC;FPR1;SPI1;CLEC12A;ITGAM;CD300LF
prerank,CellMarker_Augmented_2021__Monocyte:Subcutaneous Adipose Tissue,-0.6043691384978686,-1.32398610934148,0.08823529411764706,0.8143668255394009,1.0,19/52,13.42%,ITGB2;HCK;CYTIP;ARHGAP9;TAGAP;TNFRSF1B;C3AR1;PARVG;FCGR3A;LY86;NFAM1;MYO1F;IGSF6;PTPRC;FPR1;SPI1;CLEC12A;ITGAM;CD300LF
prerank,GO_Biological_Process_2021__mitotic DNA integrity checkpoint signaling (GO:0044774),-0.7123192298919365,-1.3238712281672058,0.16666666666666666,0.813603457302525,1.0,1/12,0.45%,TICRR
prerank,GO_Biological_Process_2021__positive regulation of mesenchymal cell proliferation (GO:0002053),-0.7612867675117583,-1.3237922141953857,0.1,0.8125816151626487,1.0,2/10,6.09%,TBX1;STAT1
prerank,GO_Biological_Process_2021__dermatan sulfate metabolic process (GO:0030205),0.6658837383716635,1.3237633403357187,0.12121212121212122,0.8108786010048177,1.0,5/12,11.69%,VCAN;CHST12;UST;CSPG5;DSEL
prerank,GO_Biological_Process_2021__presynaptic active zone organization (GO:1990709),0.7789073450338312,1.323609755667985,0.12244897959183673,0.8102972921566156,1.0,3/6,18.70%,PCLO;ERC2;ERC1
prerank,CellMarker_Augmented_2021__Follicular T cell:Undefined,-0.6127015980911499,-1.3235608522598652,0.11267605633802817,0.8122308031553181,1.0,11/40,7.87%,SIRPG;IRF4;CYTIP;TBC1D10C;ARHGAP9;TAGAP;TMC8;PARVG;CD5;WAS;CD37
prerank,GO_Biological_Process_2021__neuron fate commitment (GO:0048663),0.7483637676853901,1.3234102316092677,0.08888888888888889,0.8099310736423511,1.0,5/10,17.45%,TGFBR1;POU3F2;MYT1L;ASCL1;PAX6
prerank,GO_Biological_Process_2021__dermatan sulfate biosynthetic process (GO:0030208),0.6701492247818467,1.323129193383621,0.0967741935483871,0.8103970968545314,1.0,5/11,11.69%,VCAN;CHST12;UST;CSPG5;DSEL
prerank,Reactome_2022__mRNA Decay By 5 To 3 Exoribonuclease R-HSA-430039,0.6464005025909465,1.3224842830777959,0.11428571428571428,0.8125218262736075,1.0,7/15,26.76%,DCP1B;LSM2;PATL1;LSM7;LSM6;DCP1A;XRN1
prerank,GO_Biological_Process_2021__leukocyte chemotaxis involved in inflammatory response (GO:0002232),-0.8414638304804992,-1.3218888636908463,0.17543859649122806,0.8212005429486641,1.0,1/5,4.10%,ALOX5
prerank,GO_Biological_Process_2021__neuromuscular process controlling balance (GO:0050885),0.7254591059243145,1.3215921988183195,0.11764705882352941,0.8155968699255444,1.0,1/10,0.43%,PCDH15
prerank,"GO_Biological_Process_2021__negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515)",0.7201595436668438,1.3213120453876415,0.16666666666666666,0.8154162108893543,1.0,5/8,15.67%,CBFB;HMGB1;TWSG1;LGALS9;RUNX1
prerank,GO_Biological_Process_2021__C-terminal protein lipidation (GO:0006501),0.8222795701149685,1.3210126773496627,0.2222222222222222,0.8154903679519532,1.0,1/5,0.82%,IRGM
prerank,CellMarker_Augmented_2021__Cancer Stem cell:Kidney,0.5139019170099609,1.320743015270607,0.08695652173913043,0.8156489634423207,1.0,34/95,19.00%,GPRIN3;RASSF2;KIT;SEZ6L;ST6GALNAC3;PTPRO;AUTS2;KCNH8;TMEM132C;DTX1;PAK5;NCALD;KCNIP1;KHDRBS2;DPP10;ELAVL4;ZMAT1;DACH1;RAB3C;LRRN1;PDZRN4;ASXL3;CELF2;PELI2;PPM1L;NCAM1;NRXN1;JPH4;JAKMIP2;GRIK3;KIF21B;GALNT8;ST8SIA3;ELMO1
prerank,GO_Biological_Process_2021__negative regulation of heart contraction (GO:0045822),0.7177867654044011,1.3206566111279396,0.20833333333333334,0.8148350314745069,1.0,2/10,3.11%,RNLS;SPTBN4
prerank,GO_Biological_Process_2021__response to interleukin-4 (GO:0070670),-0.84170804222723,-1.320515054318097,0.13846153846153847,0.8283006760706981,1.0,1/5,0.67%,TCF7
prerank,GO_Biological_Process_2021__peptidyl-diphthamide biosynthetic process from peptidyl-histidine (GO:0017183),0.7443111415647985,1.3204897445980799,0.225,0.8130876100289786,1.0,4/6,23.36%,DPH1;DPH5;DPH3;DPH2
prerank,GO_Biological_Process_2021__peptidyl-diphthamide metabolic process (GO:0017182),0.7443111415647985,1.3204897445980799,0.225,0.8130876100289786,1.0,4/6,23.36%,DPH1;DPH5;DPH3;DPH2
prerank,Reactome_2022__Reduction Of Cytosolic Ca++ Levels R-HSA-418359,0.7065415491740189,1.3198452140158008,0.16666666666666666,0.814911089424371,1.0,2/10,5.32%,SLC8A1;SLC8A3
prerank,GO_Biological_Process_2021__photoperiodism (GO:0009648),0.5472122061303515,1.3198247948527955,0.0625,0.8138295917031543,1.0,6/27,7.51%,PER2;ATOH7;OPN5;CRY1;PER3;PML
prerank,CellMarker_Augmented_2021__Cytotoxic T cell:Peripheral Blood,-0.603072051776924,-1.3197794939532406,0.09090909090909091,0.8297004843820237,1.0,24/48,18.85%,SIRPG;ITGB2;HCK;CYTIP;ARHGAP9;TAGAP;TMC8;KLRB1;PARVG;FCGR3A;CD5;WAS;TRAF3IP3;MYO1F;PTPRC;CLEC12A;ITGAM;CD300LF;PSTPIP1;HK3;TNFSF8;ALOX5AP;CD8B;SASH3
prerank,CellMarker_Augmented_2021__Cytotoxic T cell:Blood,-0.603072051776924,-1.3197794939532406,0.09090909090909091,0.8297004843820237,1.0,24/48,18.85%,SIRPG;ITGB2;HCK;CYTIP;ARHGAP9;TAGAP;TMC8;KLRB1;PARVG;FCGR3A;CD5;WAS;TRAF3IP3;MYO1F;PTPRC;CLEC12A;ITGAM;CD300LF;PSTPIP1;HK3;TNFSF8;ALOX5AP;CD8B;SASH3
prerank,GO_Biological_Process_2021__histone H3-K27 demethylation (GO:0071557),0.87030342047627,1.3197671117496705,0.13725490196078433,0.8128140795462582,1.0,1/5,6.99%,KDM7A
prerank,CellMarker_Augmented_2021__Eosinophil:Bronchoalveolar System,-0.5769946632351641,-1.3197222838755966,0.05714285714285714,0.8283432080629998,1.0,17/47,14.90%,NOTUM;AMBP;SLC28A1;F7;ITIH2;SMLR1;PKLR;VTN;FTCD;CPB2;SLC22A7;ITIH3;UROC1;FGL1;HAO2;NR1H4;FGFR4
prerank,PanglaoDB_Augmented_2021__Nuocytes,0.5663178235791323,1.3197164795178855,0.11764705882352941,0.8119271394455949,1.0,7/36,5.09%,IL7R;CD247;TRAC;RORA;GPR174;BCL11B;PYHIN1
prerank,Reactome_2022__Dermatan Sulfate Biosynthesis R-HSA-2022923,0.635203439543885,1.3196215495879178,0.13333333333333333,0.8111891572116126,1.0,4/10,11.69%,VCAN;UST;CSPG5;DSEL
prerank,Reactome_2022__Oncogenic MAPK Signaling R-HSA-6802957,0.5091422710853718,1.3191941092921748,0.1111111111111111,0.8119786479121874,1.0,17/73,13.81%,SPRED3;KSR1;AGTRAP;KIAA1549;CSK;TENT4A;ARRB2;KDM7A;ESRP1;SPRED2;AKAP9;SPRED1;CNKSR2;RAP1A;MARK3;ARRB1;NF1
prerank,GO_Biological_Process_2021__negative regulation of cytoplasmic translation (GO:2000766),0.7886359829958453,1.3190523253544415,0.10869565217391304,0.8113469868904761,1.0,1/7,1.51%,CPEB1
prerank,GO_Biological_Process_2021__citrulline metabolic process (GO:0000052),0.8123466740219831,1.3189423436283834,0.075,0.8109046259492633,1.0,3/6,11.24%,DDAH2;ALDH18A1;DDAH1
prerank,CellMarker_Augmented_2021__T Helper cell:Blood,-0.593181063164259,-1.318826308613919,0.12903225806451613,0.8325651883468287,1.0,27/59,16.70%,RASGRP4;GMFG;ITGB2;HCK;CYTIP;TBC1D10C;ARHGAP9;TAGAP;TMC8;PARVG;GP1BA;WAS;LY86;CD37;NFAM1;TRAF3IP3;MYO1F;PTPRC;SPI1;CLEC12A;ITGAM;CD300LF;PSTPIP1;IKZF1;CD4;HK3;TNFSF8
prerank,CellMarker_Augmented_2021__T Helper cell:Eye,-0.5739604824126648,-1.3188059511723982,0.11594202898550725,0.8294842554622487,1.0,29/58,18.85%,GMFG;ITGB2;HCK;CYTIP;ARHGAP9;TAGAP;TNFRSF1B;C3AR1;GPR183;MS4A4A;PARVG;FCGR3A;LY86;NFAM1;HLA-DPB1;MYO1F;PTPRC;SPI1;CLEC12A;ITGAM;CD300LF;PSTPIP1;IKZF1;CD4;HK3;TNFSF8;ALOX5AP;CSF1R;SASH3
prerank,CellMarker_Augmented_2021__T Helper cell:Salivary Gland,-0.5739604824126648,-1.3188059511723982,0.11594202898550725,0.8294842554622487,1.0,29/58,18.85%,GMFG;ITGB2;HCK;CYTIP;ARHGAP9;TAGAP;TNFRSF1B;C3AR1;GPR183;MS4A4A;PARVG;FCGR3A;LY86;NFAM1;HLA-DPB1;MYO1F;PTPRC;SPI1;CLEC12A;ITGAM;CD300LF;PSTPIP1;IKZF1;CD4;HK3;TNFSF8;ALOX5AP;CSF1R;SASH3
prerank,Reactome_2022__Regulation Of TP53 Expression And Degradation R-HSA-6806003,0.5370705597296391,1.3186389892050956,0.10526315789473684,0.8112126144724455,1.0,7/35,16.83%,CCNG1;SGK1;MLST8;AKT2;PPP2R1B;TP53;ATM
prerank,Reactome_2022__Cytosolic Iron-Sulfur Cluster Assembly R-HSA-2564830,0.6718125650221148,1.3185666283888937,0.125,0.8104184096332201,1.0,5/12,29.27%,CIAO3;NDOR1;BRIP1;NUBP2;ERCC2
prerank,GO_Biological_Process_2021__positive regulation of plasminogen activation (GO:0010756),0.7719434145820881,1.31793807025351,0.18421052631578946,0.8117845262311296,1.0,3/5,22.34%,F12;PLGRKT;ENO1
prerank,GO_Biological_Process_2021__regulation of vascular associated smooth muscle cell migration (GO:1904752),0.68671842706732,1.3177839075416133,0.10416666666666667,0.8113025652388716,1.0,1/11,1.13%,ADAMTS1
prerank,CellMarker_Augmented_2021__Endothelial cell:Adipose Tissue,-0.8342814555117117,-1.3176042902509935,0.17142857142857143,0.835573917768964,1.0,4/8,11.81%,ABCG2;PTPRC;VWF;ENG
prerank,GO_Biological_Process_2021__mitotic cell cycle checkpoint signaling (GO:0007093),-0.6782547764340421,-1.3174879552403205,0.08196721311475409,0.8345880692406346,1.0,2/18,6.24%,BUB1;ZWILCH
prerank,"Reactome_2022__FOXO-mediated Transcription Of Oxidative Stress, Metabolic And Neuronal Genes R-HSA-9615017",0.5905693851524285,1.317449085422587,0.1111111111111111,0.8118359305029265,1.0,8/21,19.06%,FOXO1;ABCA6;HDAC1;SMAD2;NR3C1;MAP4K2;PLXNA4;FOXO6
prerank,GO_Biological_Process_2021__ATP synthesis coupled proton transport (GO:0015986),-0.7288122736340773,-1.317307189829952,0.10714285714285714,0.8340033626344351,1.0,7/15,22.78%,ATP5F1E;STOML2;ATP5MC3;ATP5PF;ATP5ME;ATP5PB;ATP5F1A
prerank,GO_Biological_Process_2021__organophosphate catabolic process (GO:0046434),-0.7678452143191534,-1.3169662467123704,0.17307692307692307,0.8344264430895318,1.0,1/8,0.09%,ENPP2
prerank,Reactome_2022__Scavenging By Class B Receptors R-HSA-3000471,0.8731514663179485,1.3166177238048247,0.06976744186046512,0.814165690677338,1.0,2/5,4.31%,APOB;SSC5D
prerank,KEGG_2021_Human__Neuroactive ligand-receptor interaction,0.44359167276931016,1.316545840650221,0.058823529411764705,0.8132490700093609,1.0,43/233,10.84%,ADRA1A;TACR3;NTSR2;GRIN3A;GABRE;ADRA1B;GRP;CHRM2;PRSS3;GRID2;GABRA5;CRHR2;GABRR2;GRM3;HTR1F;GALR3;PARD3;HTR2C;GABRG3;HRH3;DRD5;GRIK1;UTS2R;GRM8;CHRNA10;OPRD1;DRD4;F2;RXFP1;S1PR5;NMU;GRIK2;NPW;EDNRA;GRM4;LEPR;INSL5;GRM2;GRM7;GRIN1;GABRG1;F2R;UCN
prerank,KEGG_2021_Human__Cholesterol metabolism,0.5286419194348936,1.3164637276138642,0.09090909090909091,0.8127059224995719,1.0,9/41,9.94%,APOH;LIPC;APOB;APOE;SOAT1;SOAT2;ABCA1;LPL;LDLR
prerank,GO_Biological_Process_2021__regulation of transmembrane transporter activity (GO:0022898),0.7736655550156138,1.3164138382924273,0.17647058823529413,0.8118349911724372,1.0,2/7,5.38%,BCL2;SNCA
prerank,GO_Biological_Process_2021__mitochondrial ATP synthesis coupled proton transport (GO:0042776),-0.7292220752235832,-1.3162456317297389,0.1724137931034483,0.8371236011034711,1.0,7/14,22.78%,ATP5F1E;STOML2;ATP5MC3;ATP5PF;ATP5ME;ATP5PB;ATP5F1A
prerank,GO_Biological_Process_2021__chemical homeostasis within a tissue (GO:0048875),-0.8172471916092721,-1.3161790598438503,0.13793103448275862,0.8342356209057264,1.0,2/7,12.20%,SFTPD;OAS1
prerank,GO_Biological_Process_2021__surfactant homeostasis (GO:0043129),-0.8172471916092721,-1.3161790598438503,0.13793103448275862,0.8342356209057264,1.0,2/7,12.20%,SFTPD;OAS1
prerank,GO_Biological_Process_2021__regulation of blood vessel remodeling (GO:0060312),-0.8877457063832042,-1.3161561827955333,0.058823529411764705,0.8328421214900151,1.0,3/5,7.40%,TGFB1;FLT4;CEACAM1
prerank,PanglaoDB_Augmented_2021__Eosinophils,-0.5746482170200052,-1.3161418907276499,0.09722222222222222,0.8312856552010652,1.0,30/66,19.68%,RASGRP4;GMFG;ITGB2;HCK;CYTIP;ARHGAP9;TAGAP;TNFRSF1B;C3AR1;PARVG;WAS;LY86;NFAM1;TRAF3IP3;MYO1F;PTPRC;FPR1;SPI1;CLEC12A;ITGAM;CD300LF;ADGRE3;PSTPIP1;IL5RA;HK3;PGLYRP1;ALOX5AP;SASH3;IL5;ITGAX
prerank,GO_Biological_Process_2021__response to interferon-gamma (GO:0034341),-0.5797501704062052,-1.315936261760493,0.11290322580645161,0.8311071013786269,1.0,12/43,17.49%,WNT5A;SP100;CIITA;STAT1;GBP1;AQP4;SLC11A1;CXCL16;TLR2;HLA-DPA1;RPL13A;GBP6
prerank,KEGG_2021_Human__Leukocyte transendothelial migration,-0.531775520980537,-1.315832965583081,0.06578947368421052,0.8301607312087315,1.0,24/94,18.23%,CD99L2;ITGB2;MMP9;CTNNA1;CTNNA3;VAV3;CLDN1;CLDN6;CLDN5;ACTG1;CLDN2;PIK3R3;CYBA;ITGAM;TXK;PIK3CB;CLDN18;JAM2;CLDN20;RAC2;VASP;RAC1;MSN;MYL9
prerank,Reactome_2022__Phase 1 - Inactivation Of Fast Na+ Channels R-HSA-5576894,0.8100531871777222,1.3157549237674868,0.0851063829787234,0.8136587131645516,1.0,5/7,16.86%,KCNIP3;KCNIP1;KCND2;KCNIP4;KCND3
prerank,GO_Biological_Process_2021__response to vitamin D (GO:0033280),-0.8249150815110646,-1.3153611421659606,0.10204081632653061,0.8315190707953904,1.0,3/7,11.88%,AQP3;CYP24A1;CDKN2D
prerank,Reactome_2022__Digestion R-HSA-8935690,-0.7545143155920904,-1.31514265188683,0.14814814814814814,0.8313828511268953,1.0,5/10,10.35%,TREH;PNLIPRP3;CHIT1;GUCY2C;LCT
prerank,Reactome_2022__Type I Hemidesmosome Assembly R-HSA-446107,0.6882898937436781,1.314993214561278,0.17073170731707318,0.8156621425527844,1.0,5/9,13.19%,LAMA4;CD151;PLEC;ITGB4;DST
prerank,GO_Biological_Process_2021__glomerular epithelial cell development (GO:0072310),0.8386707405519935,1.314514976329264,0.07142857142857142,0.8165533367721084,1.0,2/6,5.58%,JAG1;MAGI2
prerank,KEGG_2021_Human__Notch signaling pathway,0.528074867569389,1.3143131944230069,0.05263157894736842,0.8162754586044513,1.0,14/49,19.29%,RFNG;TLE2;ATXN1;DTX1;MAML1;JAG1;HES1;NUMB;CTBP2;HDAC1;NOTCH1;RBPJ;EP300;KAT2B
prerank,GO_Biological_Process_2021__positive regulation of cellular carbohydrate metabolic process (GO:0010676),0.736020466413049,1.3142308164473646,0.21951219512195122,0.8154055998463478,1.0,6/10,20.19%,IRS1;SNCA;AKT2;IRS2;GPLD1;PRKCE
prerank,GO_Biological_Process_2021__positive regulation of axonogenesis (GO:0050772),0.5667645414980804,1.3142177384347853,0.15,0.8143748231515471,1.0,11/40,19.01%,NGF;ROBO2;GOLGA4;SLIT2;PLXNB1;MACF1;MAP3K13;MAP6;PLXNA4;LIMK1;CHODL
prerank,CellMarker_Augmented_2021__Epithelial cell:Endometrium,-0.5684507983098356,-1.3140786155142241,0.12307692307692308,0.8365542828955557,1.0,25/61,21.56%,RASGRP4;TMEM150B;RIN3;SLC7A7;RAB44;TNFRSF1B;DOCK2;OSCAR;MYO1F;CYBA;TLDC2;CLEC12A;NLRP3;CD300LF;KCNE3;ADCY7;RAC2;PIK3CG;LAT2;P2RX1;TFEC;PIK3AP1;MLKL;EMILIN2;BST1
prerank,CellMarker_Augmented_2021__Epithelial cell:Prostate,-0.8478288325235797,-1.3140544456469747,0.08,0.835119426593046,1.0,1/6,1.59%,AMACR
prerank,Reactome_2022__Insulin Processing R-HSA-264876,0.6207465377776705,1.314009606308421,0.10810810810810811,0.8139583634493501,1.0,7/24,21.56%,RAB27A;EXOC7;MYO5A;MYRIP;EXOC6;EXOC4;SLC30A5
prerank,KEGG_2021_Human__Vascular smooth muscle contraction,0.4372111200576247,1.3136872203774212,0.04,0.8141740692018815,1.0,3/103,1.88%,ADRA1A;ADRA1B;ITPR2
prerank,GO_Biological_Process_2021__glycosaminoglycan metabolic process (GO:0030203),0.5379822122038873,1.3136551339137217,0.13333333333333333,0.8132304802017635,1.0,17/47,12.56%,GPC4;SDC4;HS6ST2;HS3ST3B1;EXT1;HS3ST1;GPC6;HPSE;HS3ST5;HS2ST1;HS3ST2;GPC5;B3GAT3;UGDH;SDC3;GLB1;EXT2
prerank,GO_Biological_Process_2021__regulation of neuron projection development (GO:0010975),0.44786781258307096,1.313487065246078,0.0625,0.8128984709807251,1.0,32/157,13.48%,ARC;TSKU;ZNF804A;APOE;PTPRO;MFSD2A;LRRC4C;MAGI2;LZTS3;TOX;DCC;EPHA3;RAPGEF1;FZD1;TENM3;ARSB;STYXL1;ABL2;PTPN9;WNT3A;KANK1;RETREG3;NTNG2;ABI3;AVIL;RET;RAP1A;CSMD3;CCDC88A;CDH2;ARHGAP35;FUT9
prerank,GO_Biological_Process_2021__negative regulation of homotypic cell-cell adhesion (GO:0034111),-0.7761751282612103,-1.3134808436064698,0.15873015873015872,0.8374545926664496,1.0,3/11,7.40%,C1QTNF1;ALOX12;CEACAM1
prerank,Reactome_2022__Signaling By ERBB4 R-HSA-1236394,0.5074537914008819,1.3133401359014891,0.07142857142857142,0.8124457227279874,1.0,7/51,7.59%,LLGL1;APOE;NRG2;GABRG3;NRG1;NRG3;WWOX
prerank,GO_Biological_Process_2021__positive regulation of fibroblast migration (GO:0010763),-0.7869169522528648,-1.3130854726153274,0.140625,0.8379712658447553,1.0,2/8,9.78%,TGFB1;THBS1
prerank,GO_Biological_Process_2021__regulation of DNA topoisomerase (ATP-hydrolyzing) activity (GO:2000371),0.7788197755620998,1.3126528784096247,0.08108108108108109,0.8131007092343346,1.0,2/5,12.97%,SETMAR;PLSCR1
prerank,GO_Biological_Process_2021__positive regulation of DNA topoisomerase (ATP-hydrolyzing) activity (GO:2000373),0.7788197755620998,1.3126528784096247,0.08108108108108109,0.8131007092343346,1.0,2/5,12.97%,SETMAR;PLSCR1
prerank,PanglaoDB_Augmented_2021__Trophoblast Cells,0.47167901647505023,1.3126038787898138,0.08695652173913043,0.8121447447069952,1.0,6/70,5.25%,ADGRF4;NIPAL1;PERP;ANXA3;SIRT1;SERPINE1
prerank,GO_Biological_Process_2021__tRNA wobble uridine modification (GO:0002098),0.7006970779842783,1.3124099441575634,0.06976744186046512,0.8120785659440591,1.0,8/13,27.44%,ELP4;CTU1;TRMT9B;MTO1;ELP3;DPH3;ELP1;ALKBH8
prerank,GO_Biological_Process_2021__protein acetylation (GO:0006473),0.5930389822098542,1.3122038798622357,0.17647058823529413,0.8119722919136226,1.0,10/25,21.08%,FOXO1;SIRT1;NAA40;AANAT;KAT6A;ESCO1;DSCC1;EP300;KAT2B;ESCO2
prerank,CellMarker_Augmented_2021__B cell:Brain,-0.6010370491613323,-1.312086702396859,0.15384615384615385,0.8393035861261473,1.0,11/40,10.28%,JCHAIN;IRF4;BLK;CYTIP;TBC1D10C;ARHGAP9;TAGAP;LY86;CD37;TRAF3IP3;PTPRC
prerank,CellMarker_Augmented_2021__B cell:Salivary Gland,-0.6010370491613323,-1.312086702396859,0.15384615384615385,0.8393035861261473,1.0,11/40,10.28%,JCHAIN;IRF4;BLK;CYTIP;TBC1D10C;ARHGAP9;TAGAP;LY86;CD37;TRAF3IP3;PTPRC
prerank,CellMarker_Augmented_2021__B cell:Synovium,-0.6010370491613323,-1.312086702396859,0.15384615384615385,0.8393035861261473,1.0,11/40,10.28%,JCHAIN;IRF4;BLK;CYTIP;TBC1D10C;ARHGAP9;TAGAP;LY86;CD37;TRAF3IP3;PTPRC
prerank,GO_Biological_Process_2021__regulation of cardiac muscle cell proliferation (GO:0060043),0.6523423015532707,1.3120690849263688,0.1,0.811665207186502,1.0,8/14,28.25%,TGFBR1;RUNX1;NOTCH1;RBPJ;BMPR1A;ZFPM2;TGFBR3;MEF2C
prerank,GO_Biological_Process_2021__deadenylation-dependent decapping of nuclear-transcribed mRNA (GO:0000290),0.7520621322002993,1.3118539210159668,0.13953488372093023,0.8114794427188318,1.0,3/7,16.06%,DCP1B;DCPS;PATL1
prerank,GO_Biological_Process_2021__positive regulation of cell migration by vascular endothelial growth factor signaling pathway (GO:0038089),0.7454769632758764,1.3116477010954974,0.08108108108108109,0.8112741205545075,1.0,3/7,14.86%,HSPB1;GAB1;MYO1C
prerank,GO_Biological_Process_2021__cellular response to vascular endothelial growth factor stimulus (GO:0035924),0.5753360137633996,1.31147009495432,0.043478260869565216,0.8111094058675691,1.0,9/29,16.67%,MT1G;MAPKAPK2;VEGFC;HSPB1;NUS1;ERN1;GAB1;PIK3CA;NOTCH1
prerank,CellMarker_Augmented_2021__Glomerular Epithelial cell:Renal Glomerulus,-0.519201863889408,-1.3112319327233406,0.056338028169014086,0.841278273799984,1.0,14/66,17.65%,CLIC1;MISP;ELMO3;EIF6;SERPINB5;CASP7;SPINT1;BIK;LAMC2;BAIAP2L1;ITPR3;TJP3;SCNN1A;CELSR1
prerank,CellMarker_Augmented_2021__Podocyte:Renal Glomerulus,-0.519201863889408,-1.3112319327233406,0.056338028169014086,0.841278273799984,1.0,14/66,17.65%,CLIC1;MISP;ELMO3;EIF6;SERPINB5;CASP7;SPINT1;BIK;LAMC2;BAIAP2L1;ITPR3;TJP3;SCNN1A;CELSR1
prerank,Reactome_2022__Signaling By Receptor Tyrosine Kinases R-HSA-9006934,0.3997967359090015,1.3110403225237666,0.0,0.8122052638807044,1.0,65/446,11.41%,ARC;ATP6V0D2;NGF;HGFAC;DUSP4;SH2B2;FGF10;THEM4;LAMA4;KIT;LLGL1;HDAC3;MAPKAPK2;TCIRG1;ITPR2;VEGFC;FGFR1;HSPB1;IRS1;APOE;CDH5;COL9A2;NRG2;GABRG3;BCL11B;CSK;KCNH8;TPH1;FGF17;ERBB2;RALB;PDGFD;HNRNPF;NRG1;STAT5B;CRK;PTPRZ1;RAPGEF1;SGK1;NRG3;FER;WWOX;NANOS3;MYC;RALA;HNRNPH1;ESRP1;FGF18;TGFA;SPRED2;MLST8;AKT2;PAG1;ITGA3;FGFR3;WASF3;KITLG;PKN2;RPS6KA3;SH3KBP1;IRS2;FLRT2;SPRED1;PPP2R1B;WASF2
prerank,GO_Biological_Process_2021__entrainment of circadian clock by photoperiod (GO:0043153),0.5484776004517457,1.3110275280209363,0.06060606060606061,0.8111808038647331,1.0,6/26,7.51%,PER2;ATOH7;OPN5;CRY1;PER3;PML
prerank,GO_Biological_Process_2021__positive regulation of T cell chemotaxis (GO:0010820),-0.8084991962612461,-1.3108266660476189,0.16,0.8402115166290702,1.0,2/8,3.57%,WNT5A;CXCL13
prerank,GO_Biological_Process_2021__regulation of T cell chemotaxis (GO:0010819),-0.8084991962612461,-1.3108266660476189,0.16,0.8402115166290702,1.0,2/8,3.57%,WNT5A;CXCL13
prerank,GO_Biological_Process_2021__tRNA wobble base modification (GO:0002097),0.7004440883556653,1.310664426355642,0.16216216216216217,0.8117150790886333,1.0,7/13,23.82%,ELP4;CTU1;TRMT9B;MTO1;ELP3;DPH3;ADAT2
prerank,Reactome_2022__RUNX1 Regulates Transcription Of Genes Involved In Differentiation Of Keratinocytes R-HSA-8939242,0.7800964281091763,1.3106344115375343,0.21739130434782608,0.8108334554232608,1.0,4/6,20.67%,CBFB;CTSV;RUNX1;SOCS4
prerank,GO_Biological_Process_2021__TORC1 signaling (GO:0038202),0.733296755375099,1.3105285096691937,0.18421052631578946,0.8103719863200661,1.0,4/8,20.92%,MLST8;CLEC16A;SMG1;LARP1
prerank,CellMarker_Augmented_2021__Glutamatergic neuron:Undefined,0.8765068732472172,1.3104908501178503,0.02631578947368421,0.8094746186566322,1.0,2/5,9.93%,SLC17A6;GRIN1
prerank,GO_Biological_Process_2021__regulation of hemoglobin biosynthetic process (GO:0046984),0.7756893382310348,1.310467723660794,0.17647058823529413,0.8085002595512479,1.0,2/6,14.74%,SLC25A37;ABCB10
prerank,GO_Biological_Process_2021__ganglioside biosynthetic process (GO:0001574),0.6284574221414225,1.310209105236271,0.1111111111111111,0.8084202307729935,1.0,6/14,25.43%,ST6GALNAC3;ST8SIA4;ST8SIA3;ST3GAL2;ST6GALNAC5;B4GALNT1
prerank,GO_Biological_Process_2021__amino sugar metabolic process (GO:0006040),0.6685405276184965,1.3098919682045442,0.21621621621621623,0.808815384207572,1.0,1/9,2.51%,CSGALNACT1
prerank,GO_Biological_Process_2021__positive regulation of myeloid leukocyte mediated immunity (GO:0002888),-0.7330623731786203,-1.3098426004687385,0.08771929824561403,0.8442535511718069,1.0,4/9,16.13%,ITGB2;SPI1;ITGAM;F2RL1
prerank,GO_Biological_Process_2021__regulation of glucose metabolic process (GO:0010906),0.5866212757928219,1.3098290615548438,0.13157894736842105,0.8080236359971938,1.0,9/31,10.67%,RORA;IRS1;ZNF692;BCKDK;SIRT1;SIRT7;AKT2;ADIPOR1;IRS2
prerank,GO_Biological_Process_2021__peptidyl-lysine hydroxylation (GO:0017185),0.8026876207337477,1.3095380323900885,0.12903225806451613,0.8082208878242695,1.0,3/7,10.07%,P3H3;PLOD3;P3H4
prerank,GO_Biological_Process_2021__folic acid metabolic process (GO:0046655),0.6066728707024428,1.30942961419803,0.16216216216216217,0.8075897068838772,1.0,7/17,25.77%,SLC19A1;DHFR;MTHFR;FPGS;SHMT2;MTHFD1L;MTHFD2L
prerank,GO_Biological_Process_2021__second-messenger-mediated signaling (GO:0019932),-0.5869375721153478,-1.3092231733388169,0.12121212121212122,0.8467049155403622,1.0,5/56,5.04%,GPR62;NMUR2;XCR1;P2RY12;ACKR4
prerank,GO_Biological_Process_2021__negative regulation of viral transcription (GO:0032897),-0.7534543333758662,-1.3088729535139056,0.08333333333333333,0.8473575361864448,1.0,1/12,1.82%,TRIM62
prerank,GO_Biological_Process_2021__mitochondrial transcription (GO:0006390),0.7875711585390668,1.308869340160779,0.2857142857142857,0.8093225402048092,1.0,3/10,5.65%,TFB1M;TEFM;SLC25A33
prerank,GO_Biological_Process_2021__regulation of wound healing (GO:0061041),-0.6026109195192121,-1.3088100478633158,0.07936507936507936,0.8462349389609496,1.0,9/33,11.76%,DUOX1;ALOX5;CLDN1;VTN;GP1BA;PLAU;ACTG1;ANXA1;VIL1
prerank,GO_Biological_Process_2021__neutrophil degranulation (GO:0043312),-0.4763632869237964,-1.3087986090880552,0.022222222222222223,0.844724765161138,1.0,63/386,16.23%,CD44;LILRB3;CLEC5A;MGST1;GMFG;ITGB2;TCN1;MMP9;TBC1D10C;FLG2;ARHGAP9;CHIT1;PRDX4;ALOX5;RAB44;TNFRSF1B;DOCK2;CLEC4C;PTAFR;C3AR1;HRNR;OSCAR;PLAU;CEACAM1;NFAM1;ATP6V1D;PSAP;PTX3;SNAP23;CFD;CYBA;OLFM4;PTPRC;FPR1;ENPP4;CD63;PDAP1;SLC11A1;CEACAM8;CTSZ;FTH1;MMP25;PYGL;CLEC12A;ITGAM;SVIP;ACP3;HSPA8;PGAM1;TLR2;HVCN1;ORMDL3;DYNLL1;ADGRE3;ATP6AP2;EEF2;DDX3X;SRP14;GRN;ELANE;HK3;TUBB;CYSTM1
prerank,GO_Biological_Process_2021__positive regulation of exocytosis (GO:0045921),0.592910995941465,1.3083636633452231,0.15151515151515152,0.8103233843269254,1.0,9/32,17.53%,RAB27A;SDC4;SNCA;RAB7A;SMPD3;RAB27B;SNF8;RAB5A;RAB3D
prerank,GO_Biological_Process_2021__sensory perception of smell (GO:0007608),-0.6620110500610683,-1.3081669530269642,0.15517241379310345,0.8473324464976654,1.0,7/17,18.70%,OR52A5;OR51M1;SYT10;OR51I2;OR9Q1;OR2M4;OR8A1
prerank,KEGG_2021_Human__Mannose type O-glycan biosynthesis,0.5684642947324351,1.3081465284706728,0.15625,0.8102613327761138,1.0,12/21,24.46%,FKTN;ST3GAL3;B4GALT2;FKRP;B4GALT3;FUT9;B3GALNT2;POMT2;RXYLT1;LARGE1;B3GAT2;CRPPA
prerank,GO_Biological_Process_2021__response to organophosphorus (GO:0046683),-0.6694194750673654,-1.3080894676633323,0.14285714285714285,0.8461891815460812,1.0,3/14,6.95%,DUOX1;STAT1;KCNJ11
prerank,GO_Biological_Process_2021__nucleotide catabolic process (GO:0009166),0.699638114325221,1.3080295602147465,0.14285714285714285,0.8097288309078141,1.0,2/15,4.57%,PNP;NT5C1A
prerank,GO_Biological_Process_2021__phosphatidylinositol dephosphorylation (GO:0046856),0.5722120926781671,1.3078893798895144,0.175,0.8091781398158194,1.0,13/24,34.68%,MTMR8;MTMR3;PIP4P2;MTMR1;MTM1;PTEN;MTMR11;MTMR9;SYNJ2;TPTE2;OCRL;INPP5J;MTMR12
prerank,CellMarker_Augmented_2021__Basophil:Umbilical Cord Blood,-0.5761367241041445,-1.3075945641741684,0.1111111111111111,0.8478442511893022,1.0,19/54,15.31%,GMFG;ITGB2;DOCK8;CYTIP;ARHGAP9;TAGAP;TMC8;KLRB1;ARHGAP15;GPR183;PARVG;FCGR3A;TRAF3IP3;MYO1F;PTPRC;SPI1;NLRC3;LCP1;IKZF1
prerank,GO_Biological_Process_2021__cellular response to interleukin-4 (GO:0071353),-0.8367194996892915,-1.3075874504976328,0.16666666666666666,0.8463153910158016,1.0,1/6,0.67%,TCF7
prerank,GO_Biological_Process_2021__microtubule anchoring at microtubule organizing center (GO:0072393),0.6883212422124846,1.3075192975769998,0.20512820512820512,0.8098805753945495,1.0,3/12,6.54%,PCM1;CCDC120;BICD1
prerank,GO_Biological_Process_2021__miRNA metabolic process (GO:0010586),0.6316870744366178,1.3071204088736084,0.1,0.8105811769378263,1.0,8/20,20.81%,TRIM71;KHSRP;LIN28B;DGCR8;XPO5;TARBP2;AGO2;TUT7
prerank,GO_Biological_Process_2021__mitochondrion distribution (GO:0048311),0.6849512280792227,1.307119557718682,0.15625,0.8095243566289111,1.0,5/12,28.81%,MSTO1;TRAK2;MTM1;TRAK1;MEF2A
prerank,GO_Biological_Process_2021__pericardium morphogenesis (GO:0003344),0.7214710715272896,1.30690603395781,0.2,0.8093079805623284,1.0,2/6,16.67%,LRP6;NOTCH1
prerank,Reactome_2022__RHO GTPases Activate Formins R-HSA-5663220,-0.5015430342963042,-1.306884704476696,0.07142857142857142,0.8490750487569143,1.0,19/112,18.78%,BUB1;ERCC6L;SPC25;CENPU;ITGB3BP;ZWILCH;ACTG1;NUF2;CENPH;CENPS-CORT;DYNLL1;RPS27;INCENP;FMNL1;NDEL1;CDCA8;CENPN;KIF18A;BUB1B
prerank,GO_Biological_Process_2021__stabilization of membrane potential (GO:0030322),0.6702357285775035,1.306773205574866,0.19047619047619047,0.8089365202135849,1.0,4/12,16.86%,KCNK6;KCNK2;KCNK12;KCNK10
prerank,GO_Biological_Process_2021__negative regulation of cholesterol storage (GO:0010887),0.7391742408953516,1.306742712213403,0.15555555555555556,0.8080608288051963,1.0,3/8,15.39%,PPARG;ABCA1;NR1H3
prerank,GO_Biological_Process_2021__establishment of protein localization to extracellular region (GO:0035592),0.5291561744824127,1.3065702727424156,0.1,0.8076337333858122,1.0,9/35,18.05%,OLFM2;ABCA1;RAB3C;TVP23B;PREB;RAB10;LTBP2;RAB3D;MIA3
prerank,Reactome_2022__Plasma Lipoprotein Remodeling R-HSA-8963899,0.5541912798548764,1.3065068049480255,0.08823529411764706,0.8068201389742667,1.0,3/24,2.66%,LIPC;APOB;APOE
prerank,GO_Biological_Process_2021__negative regulation of peptidyl-threonine phosphorylation (GO:0010801),0.6459449396636637,1.3063605866960875,0.2222222222222222,0.8063957536204324,1.0,4/16,11.02%,SPRED3;PARD3;SPRED2;SPRED1
prerank,GO_Biological_Process_2021__dephosphorylation (GO:0016311),0.4653231408024177,1.3061759917479314,0.06060606060606061,0.8062237573996981,1.0,53/142,24.48%,CTDNEP1;DUSP4;DUSP2;DUSP15;EPHX2;PLPPR1;PTPRO;DUSP23;PTPRZ1;PPP5C;PTPRR;CTDSP2;CTDSP1;PTPN9;PTPRM;PLPP2;PSPH;PPP2R1B;DUSP18;PPM1A;PTPRB;THNSL2;PTPRT;PTPRF;SSH1;PPM1L;CDC14B;PLPPR3;PTPRD;PTPRE;MTMR3;PPP2R5D;PNKP;TAB1;PPP1CB;PPP4R1;PPEF1;MTM1;PLPP3;ALPL;PTPN14;PTPRJ;PLPPR5;DUSP6;PTEN;PTPRA;PLPPR4;PTPN21;PPM1H;PPM1E;CTTNBP2NL;PTPN12;PPP3CC
prerank,GO_Biological_Process_2021__regulation of Notch signaling pathway (GO:0008593),0.5322964572542145,1.306023907260649,0.19047619047619047,0.8057047104962964,1.0,19/67,21.76%,LLGL1;RFNG;DTX1;MAML1;JAG1;CHAC1;POFUT1;WWP2;BEND6;DLK2;ARRB1;TCIM;NOTCH1;RBPJ;EP300;KAT2B;SREBF2;ZBTB7A;JAG2
prerank,GO_Biological_Process_2021__humoral immune response mediated by circulating immunoglobulin (GO:0002455),-0.8006102563769814,-1.3059782139784633,0.13559322033898305,0.8530537041023498,1.0,5/6,18.80%,C1QB;C1S;IGLL1;ZP3;CD81
prerank,GO_Biological_Process_2021__lipoprotein localization (GO:0044872),0.7454174366259503,1.3059418052438587,0.17073170731707318,0.8050713190954341,1.0,5/10,18.93%,APOB;PPARG;ZDHHC3;MIA3;UNC119B
prerank,GO_Biological_Process_2021__acid secretion (GO:0046717),-0.854504329573585,-1.3058180043549124,0.11363636363636363,0.8524438409751858,1.0,1/5,0.98%,SLC51A
prerank,GO_Biological_Process_2021__regulation of cardiac muscle cell contraction (GO:0086004),-0.7026926520504775,-1.30566113053947,0.14035087719298245,0.8517164007467702,1.0,4/24,3.78%,PKP2;SCN5A;CAV3;CTNNA3
prerank,Reactome_2022__N-glycan Antennae Elongation In medial/trans-Golgi R-HSA-975576,0.6260054599338257,1.3056203901102121,0.13157894736842105,0.8053638249577529,1.0,5/23,13.70%,MGAT4C;B4GALT2;MAN2A1;B4GALT3;CHST8
prerank,CellMarker_Augmented_2021__Eosinophil:Lung,-0.5954974515508386,-1.3056065731655029,0.14285714285714285,0.8505398552778494,1.0,18/36,16.09%,RASGRP4;HCK;NLRP12;RAB44;VSTM1;OSCAR;C19ORF38;NFAM1;MYO1F;FPR1;SPI1;CLEC12A;NLRP3;CD300LF;ADGRE3;TSPAN16;ELANE;HK3
prerank,GO_Biological_Process_2021__negative regulation of glucose transmembrane transport (GO:0010829),0.7175983876686431,1.3055730019127152,0.14634146341463414,0.8045786534839152,1.0,3/10,24.06%,PID1;APPL2;ENPP1
prerank,Reactome_2022__Synaptic Adhesion-Like Molecules R-HSA-8849932,0.5847217231820319,1.3053510804824044,0.21212121212121213,0.8044677121966323,1.0,2/21,2.58%,LLGL1;GPRIN1
prerank,GO_Biological_Process_2021__sensory organ morphogenesis (GO:0090596),-0.7939216909582067,-1.3053226063080898,0.13333333333333333,0.8506407962140962,1.0,2/8,5.27%,TBX1;COL5A1
prerank,GO_Biological_Process_2021__meiotic sister chromatid cohesion (GO:0051177),-0.8292990984905637,-1.3049827436571235,0.09090909090909091,0.8515886442705133,1.0,1/7,0.44%,BUB1
prerank,GO_Biological_Process_2021__regulation of ventricular cardiac muscle cell membrane depolarization (GO:0060373),-0.8962551798621534,-1.3048484583904685,0.058823529411764705,0.8509076563794673,1.0,2/5,2.76%,SCN5A;CAV3
prerank,Reactome_2022__Defective Factor IX Causes Hemophilia B R-HSA-9668250,-0.8578992260961518,-1.3048300085449227,0.15789473684210525,0.8495168212803581,1.0,3/5,9.58%,F8;GP1BA;FAM110A
prerank,GO_Biological_Process_2021__regulation of DNA repair (GO:0006282),0.5329239240922192,1.3047603329218918,0.10344827586206896,0.8059491199422252,1.0,9/42,7.51%,EYA4;FGF10;BRCC3;SIRT1;ERCC8;RNF168;SIRT7;RADX;PML
prerank,GO_Biological_Process_2021__regulation of nitric oxide mediated signal transduction (GO:0010749),-0.8476856784170446,-1.3046905831608073,0.09375,0.8487366837897562,1.0,1/5,9.78%,THBS1
prerank,CellMarker_Augmented_2021__Cancer Stem cell:Gall Bladder,0.5099624418780605,1.3045752022882364,0.06896551724137931,0.8058367079969602,1.0,23/69,16.18%,TACR3;GRID2;AASS;IGDCC3;PCDH11X;PLEKHG4B;CHST6;IL17RD;UNC5D;TRIM71;PTPRZ1;CGNL1;ADCY2;TERF1;LIN28B;NLGN4X;CRABP1;SYT6;COL9A1;ZNF663P;NR6A1;WNK3;FRAS1
prerank,GO_Biological_Process_2021__intraciliary retrograde transport (GO:0035721),0.6741884768230855,1.304336728061252,0.15,0.8058585106531868,1.0,7/12,25.17%,CILK1;IFT140;TTC21B;TTC21A;WDR19;WDR35;DYNC2I2
prerank,GO_Biological_Process_2021__osteoblast development (GO:0002076),-0.7733520197301864,-1.3042532219001164,0.11864406779661017,0.8498388582130569,1.0,1/8,0.82%,CLEC5A
prerank,GO_Biological_Process_2021__UV-damage excision repair (GO:0070914),0.7356023046649254,1.3041794188108657,0.25,0.8056891775345647,1.0,2/11,6.48%,SIRT1;POLD3
prerank,GO_Biological_Process_2021__negative regulation of natural killer cell mediated immunity (GO:0002716),0.7503889586988972,1.304141686727373,0.17307692307692307,0.804871432763517,1.0,3/7,11.29%,KLRD1;ARRB2;LGALS9
prerank,GO_Biological_Process_2021__neutrophil activation involved in immune response (GO:0002283),-0.4761500156991923,-1.304119927524614,0.02247191011235955,0.8491265427684644,1.0,63/388,16.23%,CD44;LILRB3;CLEC5A;MGST1;GMFG;ITGB2;TCN1;MMP9;TBC1D10C;FLG2;ARHGAP9;CHIT1;PRDX4;ALOX5;RAB44;TNFRSF1B;DOCK2;CLEC4C;PTAFR;C3AR1;HRNR;OSCAR;PLAU;CEACAM1;NFAM1;ATP6V1D;PSAP;PTX3;SNAP23;CFD;CYBA;OLFM4;PTPRC;FPR1;ENPP4;CD63;PDAP1;SLC11A1;CEACAM8;CTSZ;FTH1;MMP25;PYGL;CLEC12A;ITGAM;SVIP;ACP3;HSPA8;PGAM1;TLR2;HVCN1;ORMDL3;DYNLL1;ADGRE3;ATP6AP2;EEF2;DDX3X;SRP14;GRN;ELANE;HK3;TUBB;CYSTM1
prerank,Reactome_2022__Activation Of Gene Expression By SREBF (SREBP) R-HSA-2426168,0.5462937153738051,1.3040728327674032,0.09090909090909091,0.804151068046914,1.0,9/39,15.61%,ELOVL6;SMARCD3;NCOA2;ACACB;SC5D;CHD9;CARM1;NFYC;TM7SF2
prerank,KEGG_2021_Human__Axon guidance,0.4293628050904374,1.3038857692850143,0.047619047619047616,0.8040987640196388,1.0,23/172,10.36%,EFNB1;ROBO2;NFATC3;EPHA7;PARD3;TRPC3;LRRC4C;SEMA6C;UNC5C;SEMA5A;WNT4;UNC5D;SRGAP2;NTN4;PAK5;DCC;EPHA3;ABL1;SLIT2;PLXNB1;EFNA5;SEMA4A;NTNG2
prerank,GO_Biological_Process_2021__hydrogen peroxide metabolic process (GO:0042743),-0.6884539322501892,-1.3037467377717957,0.10344827586206896,0.849543061133982,1.0,5/17,12.76%,DUOX1;PRDX4;CYBA;PXDN;GPX3
prerank,Reactome_2022__TNF Receptor Superfamily (TNFSF) Members Mediating Non-Canonical NF-kB Pathway R-HSA-5676594,0.707253220139156,1.3037349245768441,0.16129032258064516,0.8035903315459967,1.0,4/11,12.57%,MAP3K14;TNFSF14;TNFSF13B;TANK
prerank,GO_Biological_Process_2021__NAD biosynthetic process (GO:0009435),0.6234766411880086,1.3036961781826661,0.12903225806451613,0.8026654806851475,1.0,2/21,1.73%,SLC5A8;RNLS
prerank,GO_Biological_Process_2021__platelet aggregation (GO:0070527),-0.6243591124810534,-1.3033068397555136,0.07462686567164178,0.8511738651822034,1.0,4/30,7.39%,CLIC1;P2RY12;GP1BA;ACTG1
prerank,GO_Biological_Process_2021__positive regulation of phospholipid transport (GO:2001140),0.7025187118571995,1.3028932262152917,0.14285714285714285,0.8048149316561131,1.0,1/9,2.66%,APOE
prerank,Reactome_2022__Synthesis Of PIPs At ER Membrane R-HSA-1483248,0.8059308299842085,1.3026898355631538,0.175,0.80493250039878,1.0,1/5,10.87%,PI4K2B
prerank,GO_Biological_Process_2021__regulation of stem cell division (GO:2000035),0.7500278570146595,1.3025731333139299,0.19444444444444445,0.8044823292467985,1.0,3/7,14.23%,SMYD5;NCOA3;MLLT3
prerank,GO_Biological_Process_2021__glycosylceramide metabolic process (GO:0006677),0.7916487713369385,1.3025266278949157,0.16666666666666666,0.8036365865782475,1.0,2/5,2.16%,ST6GALNAC3;GLA
prerank,CellMarker_Augmented_2021__M2 macrophage:Undefined,-0.8121920059354144,-1.3024786034260665,0.0967741935483871,0.8548867673061739,1.0,2/7,7.80%,IRF4;VSIG4
prerank,GO_Biological_Process_2021__regulation of brown fat cell differentiation (GO:0090335),0.6531020491147714,1.3021205150068338,0.15789473684210525,0.8042457397792673,1.0,4/15,9.43%,ZBTB7B;METRNL;SIRT1;TFE3
prerank,GO_Biological_Process_2021__regulation of glucokinase activity (GO:0033131),0.855330587541504,1.3020765155525653,0.14583333333333334,0.8033647388405978,1.0,1/5,2.85%,MIDN
prerank,GO_Biological_Process_2021__negative regulation of macrophage derived foam cell differentiation (GO:0010745),0.7075649256853691,1.3018117246080334,0.16666666666666666,0.8036151293990859,1.0,3/9,15.39%,PPARG;ABCA1;NR1H3
prerank,GO_Biological_Process_2021__cation transmembrane transport (GO:0098655),0.5261363997035053,1.301543121472519,0.11428571428571428,0.8036581354624104,1.0,10/39,11.22%,SLC38A5;SLC3A2;TRPM2;PKD2;SLC22A5;ABCC8;SFXN2;SLC6A20;SLC25A29;SLC7A8
prerank,GO_Biological_Process_2021__cell-cell junction assembly (GO:0007043),0.5100100878205855,1.3015231001668401,0.08333333333333333,0.8028187327024257,1.0,18/56,16.07%,CDH20;CDH19;CDH12;GJB6;CDH7;CDH5;CDH6;ZNF703;PKN2;CLDN12;CDH2;CDH24;CDH10;PKP4;FSCN1;CDH11;PARD6B;CDHR3
prerank,GO_Biological_Process_2021__negative regulation of sodium ion transport (GO:0010766),0.7610570476269317,1.301200374272657,0.1891891891891892,0.8032376056797321,1.0,5/8,22.90%,COMMD1;WNK2;WNK3;NEDD4;WNK1
prerank,GO_Biological_Process_2021__regulation of oxidative stress-induced intrinsic apoptotic signaling pathway (GO:1902175),0.6239494248569387,1.3011011334524234,0.18181818181818182,0.8028689646234858,1.0,3/15,4.59%,HSPB1;HTRA2;SIRT1
prerank,CellMarker_Augmented_2021__Myoepithelial cell:Undefined,-0.5744734262830771,-1.3010253492654191,0.13432835820895522,0.8621556262113578,1.0,4/47,0.91%,CD44;CLCA2;DUOX1;APOL1
prerank,GO_Biological_Process_2021__negative regulation of nitric oxide metabolic process (GO:1904406),0.7668403008231165,1.3008989801857338,0.10638297872340426,0.8020223721770373,1.0,3/8,15.86%,GLA;KHSRP;PTGIS
prerank,GO_Biological_Process_2021__negative regulation of nitric oxide biosynthetic process (GO:0045019),0.7668403008231165,1.3008989801857338,0.10638297872340426,0.8020223721770373,1.0,3/8,15.86%,GLA;KHSRP;PTGIS
prerank,GO_Biological_Process_2021__glial cell migration (GO:0008347),-0.8862987590926641,-1.300786534633234,0.07547169811320754,0.8621429012767108,1.0,1/5,2.75%,P2RY12
prerank,GO_Biological_Process_2021__positive regulation of transcription from RNA polymerase II promoter in response to stress (GO:0036003),0.6025871207608258,1.3007726057683378,0.11764705882352941,0.8016566253311047,1.0,11/23,24.27%,ATF3;HSF1;TP53;NOTCH1;RBPJ;ATF6;SESN2;HIF1A;NFE2L2;CREB3L1;GCN1
prerank,GO_Biological_Process_2021__mesoderm development (GO:0007498),-0.7650875256972798,-1.3007054562537828,0.11475409836065574,0.8611567231026145,1.0,7/15,17.81%,TBX1;HCK;TBX6;GDF11;IKZF1;BMX;MESP1
prerank,GO_Biological_Process_2021__regulation of cellular senescence (GO:2000772),0.5308487326085425,1.3005496578568196,0.14285714285714285,0.801534006644579,1.0,8/27,14.06%,SLC30A10;SIRT1;VASH1;CDK6;RBL1;TWIST1;ABI3;PNPT1
prerank,Reactome_2022__TP53 Regulates Transcription Of Genes Involved In Cytochrome C Release R-HSA-6803204,0.5974130767442908,1.3004394807838486,0.19047619047619047,0.8011511681177816,1.0,10/18,27.11%,TP53AIP1;PPP1R13B;BID;AIFM2;TP53;ATM;BNIP3L;TP53INP1;PRELID3A;CREBBP
prerank,CellMarker_Augmented_2021__Oligodendrocyte:Undefined,-0.8964878332165438,-1.3003171500489832,0.10204081632653061,0.8622471564300502,1.0,1/5,4.12%,SOX10
prerank,GO_Biological_Process_2021__SA node cell to atrial cardiac muscle cell signaling (GO:0086018),-0.8501502653994406,-1.3002545483241044,0.1774193548387097,0.8612125485000813,1.0,1/5,1.19%,SCN5A
prerank,GO_Biological_Process_2021__DNA replication initiation (GO:0006270),-0.6158274561990721,-1.3001674404215737,0.0967741935483871,0.8601945076092921,1.0,3/32,4.42%,MCM2;RPA3;MCM3
prerank,GO_Biological_Process_2021__DNA replication-independent nucleosome assembly (GO:0006336),-0.5809372375620128,-1.2997664461675553,0.11940298507462686,0.8613581989356791,1.0,10/35,23.42%,CENPU;ITGB3BP;HAT1;OIP5;CENPH;RBBP7;CENPN;SMARCA5;CENPL;CENPM
prerank,GO_Biological_Process_2021__neutrophil mediated immunity (GO:0002446),-0.47139515056949904,-1.2995561161585287,0.02197802197802198,0.8610639665255702,1.0,63/391,16.23%,CD44;LILRB3;CLEC5A;MGST1;GMFG;ITGB2;TCN1;MMP9;TBC1D10C;FLG2;ARHGAP9;CHIT1;PRDX4;ALOX5;RAB44;TNFRSF1B;DOCK2;CLEC4C;PTAFR;C3AR1;HRNR;OSCAR;PLAU;CEACAM1;NFAM1;ATP6V1D;PSAP;PTX3;SNAP23;CFD;CYBA;OLFM4;PTPRC;FPR1;ENPP4;CD63;PDAP1;SLC11A1;CEACAM8;CTSZ;FTH1;MMP25;PYGL;CLEC12A;ITGAM;SVIP;ACP3;HSPA8;PGAM1;TLR2;HVCN1;ORMDL3;DYNLL1;ADGRE3;ATP6AP2;EEF2;DDX3X;SRP14;GRN;ELANE;HK3;TUBB;CYSTM1
prerank,GO_Biological_Process_2021__response to copper ion (GO:0046688),0.7091025938214479,1.2995185265572,0.10810810810810811,0.8042076541193564,1.0,4/14,15.27%,MT1G;SNCA;MT4;HSF1
prerank,GO_Biological_Process_2021__regulation of protein ubiquitination (GO:0031396),0.4610765931403178,1.2994557305029604,0.09090909090909091,0.8033769425581095,1.0,22/98,16.80%,PER2;TGFBR1;HDAC3;PRICKLE1;ANGPT1;RIPK2;COMMD1;SPOPL;CRY1;ARRB2;SIRT7;DCUN1D1;GNL3L;N4BP1;HSPA1A;FOXF2;ARRB1;HSPBP1;MALT1;FBXO4;MINAR1;UBE2L3
prerank,GO_Biological_Process_2021__homologous chromosome segregation (GO:0045143),-0.713934769377963,-1.299246874778123,0.1111111111111111,0.8612973357424648,1.0,3/18,2.61%,IHO1;MEIOB;SYCP1
prerank,GO_Biological_Process_2021__chromatin remodeling at centromere (GO:0031055),-0.6102740445064975,-1.2990703750662618,0.15384615384615385,0.8606196252245344,1.0,9/29,23.42%,CENPU;ITGB3BP;OIP5;CENPH;RBBP7;CENPN;SMARCA5;CENPL;CENPM
prerank,GO_Biological_Process_2021__regulation of Cdc42 protein signal transduction (GO:0032489),0.8021691217895914,1.298896707078304,0.125,0.8046618201864689,1.0,3/7,7.63%,APOE;ABL1;ABCA1
prerank,GO_Biological_Process_2021__cell-cell adhesion mediated by cadherin (GO:0044331),0.745148397374445,1.2988189519002924,0.15,0.8040548042993904,1.0,4/8,16.84%,CDH5;FER;CDH2;MMP24
prerank,Reactome_2022__Cap-dependent Translation Initiation R-HSA-72737,-0.5413752283304385,-1.2986511954333313,0.058823529411764705,0.861620842605721,1.0,58/108,27.12%,RPL37A;RPL38;RPL15;RPS4X;RPL3;RPL35A;RPS9;FAU;RPS27;RPS21;EIF2B2;RPL13A;RPL27A;EIF2S3;RPS16;RPL36;RPS20;RPL7A;RPL9;EIF2S2;RPS8;RPS27A;RPL21;EIF4A2;RPL34;RPL4;RPL32;RPL5;RPL23;RPL41;RPS7;RPS11;RPL27;RPL35;RPS14;RPL11;RPS15;RPLP1;RPS12;RPL18A;RPS13;RPL29;RPLP2;RPL28;RPL12;EIF1AX;RPL18;RPS3;RPL22;RPSA;RPS28;RPS19;RPS24;RPL26L1;RPS3A;RPL19;RPL8;RPS6
prerank,GO_Biological_Process_2021__regulation of cholesterol transport (GO:0032374),0.6067247547351352,1.298168975784023,0.20512820512820512,0.8059829543077006,1.0,9/19,28.92%,OSBPL6;NUS1;NFKB1;NR1H3;ABCA13;ABCA2;YJEFN3;ABCA8;ARV1
prerank,GO_Biological_Process_2021__spindle assembly checkpoint signaling (GO:0071173),-0.6488508586025589,-1.2981676261502517,0.11940298507462686,0.8596765758176437,1.0,2/19,7.32%,BUB1;TTK
prerank,GO_Biological_Process_2021__mitotic spindle checkpoint signaling (GO:0071174),-0.6488508586025589,-1.2981676261502517,0.11940298507462686,0.8596765758176437,1.0,2/19,7.32%,BUB1;TTK
prerank,GO_Biological_Process_2021__mitotic spindle assembly checkpoint signaling (GO:0007094),-0.6488508586025589,-1.2981676261502517,0.11940298507462686,0.8596765758176437,1.0,2/19,7.32%,BUB1;TTK
prerank,GO_Biological_Process_2021__embryonic forelimb morphogenesis (GO:0035115),0.7363813811118226,1.2978983300264648,0.20454545454545456,0.8051206730504713,1.0,2/5,17.89%,OSR1;NIPBL
prerank,GO_Biological_Process_2021__forelimb morphogenesis (GO:0035136),0.7363813811118226,1.2978983300264648,0.20454545454545456,0.8051206730504713,1.0,2/5,17.89%,OSR1;NIPBL
prerank,GO_Biological_Process_2021__cellular response to cholesterol (GO:0071397),0.7206043945599858,1.297858281542616,0.16666666666666666,0.8043502520832571,1.0,7/9,25.35%,LRP6;OSBPL7;GPLD1;PTCH1;MLC1;GRAMD1B;GRAMD1A
prerank,CellMarker_Augmented_2021__Oral Keratinocyte Stem cell:Oral Mucosa,0.4696052541744082,1.2978224816190451,0.09090909090909091,0.803526517622828,1.0,5/78,3.43%,ADGRF4;ADGRG6;LAMA3;SDC4;PERP
prerank,GO_Biological_Process_2021__glycoprotein metabolic process (GO:0009100),0.5009556786383259,1.2977116354262987,0.10526315789473684,0.8028886101591002,1.0,18/50,23.19%,GANC;ST6GALNAC3;PRKCSH;ST8SIA4;HPSE;MAN1A2;MAN2A1;NEU4;MAN1A1;NGLY1;FBXO27;ADAMTS13;ST8SIA3;ST3GAL2;HIF1A;FBXO17;ST8SIA1;LARGE1
prerank,GO_Biological_Process_2021__regulation of myoblast fusion (GO:1901739),0.7460607063662887,1.2976365025073868,0.24242424242424243,0.8021604793355323,1.0,1/9,2.32%,CFLAR
prerank,GO_Biological_Process_2021__neuron fate specification (GO:0048665),0.8225223755644564,1.2974936465242342,0.15789473684210525,0.8016724915021105,1.0,3/5,13.36%,POU3F2;MYT1L;ASCL1
prerank,Reactome_2022__tRNA Modification In Nucleus And Cytosol R-HSA-6782315,0.5185676962647274,1.2973974299620075,0.11538461538461539,0.8011673854373882,1.0,8/40,15.76%,TRDMT1;METTL1;CTU1;TRMT9B;TRMT11;PUS7;CDKAL1;TRMT61A
prerank,CellMarker_Augmented_2021__Dendritic cell:Peripheral Blood,-0.7774277080985322,-1.2971290924208119,0.1836734693877551,0.8650443961909894,1.0,5/7,20.41%,CLEC4C;IL3RA;CD80;ITGAX;CD86
prerank,GO_Biological_Process_2021__regulation of lens fiber cell differentiation (GO:1902746),0.7613525388939506,1.2969707594377382,0.21951219512195122,0.8019987156425978,1.0,3/6,11.02%,SPRED3;SPRED2;SPRED1
prerank,GO_Biological_Process_2021__response to catecholamine (GO:0071869),0.7915919659403967,1.2969019210857569,0.15217391304347827,0.801256959479801,1.0,3/6,18.06%,DRD5;NR4A3;ADCY6
prerank,GO_Biological_Process_2021__polarized epithelial cell differentiation (GO:0030859),0.6313969786200845,1.2967482019891219,0.15625,0.8010096495604052,1.0,5/12,21.29%,SCRIB;RAP2A;RAB10;MYO9A;CAMSAP3
prerank,CellMarker_Augmented_2021__Cortical Thymus Epithelial cell:Thymus,-0.5433689114542939,-1.2966573565997723,0.11764705882352941,0.8647816241352088,1.0,15/62,15.88%,DENND1C;SIRPG;JCHAIN;TMC8;KLRB1;ACSL5;CD5;RAB19;PTPRC;SPINT1;DEF6;HSH2D;LCP1;EPHA1;TJP3
prerank,CellMarker_Augmented_2021__Medullary Thymus Epithelial cell:Thymus,-0.5433689114542939,-1.2966573565997723,0.11764705882352941,0.8647816241352088,1.0,15/62,15.88%,DENND1C;SIRPG;JCHAIN;TMC8;KLRB1;ACSL5;CD5;RAB19;PTPRC;SPINT1;DEF6;HSH2D;LCP1;EPHA1;TJP3
prerank,Reactome_2022__Conjugation Of Salicylate With Glycine R-HSA-177128,0.70755463369788,1.2966154387987336,0.20408163265306123,0.8006536005374802,1.0,2/6,1.76%,GLYATL1;GLYATL2
prerank,CellMarker_Augmented_2021__Intestinal Epithelial Stem cell:Jejunum,-0.5470965300149268,-1.296502883384102,0.13333333333333333,0.8628925207072254,1.0,14/59,12.98%,CD44;AHR;MISP;TCN1;SLC28A3;TGFBI;SERPINB5;ANXA1;SPINT1;GPR39;LAMC2;NSUN7;ITGB6;TRIM29
prerank,CellMarker_Augmented_2021__Epithelial Progenitor cell:Breast,-0.5470965300149268,-1.296502883384102,0.13333333333333333,0.8628925207072254,1.0,14/59,12.98%,CD44;AHR;MISP;TCN1;SLC28A3;TGFBI;SERPINB5;ANXA1;SPINT1;GPR39;LAMC2;NSUN7;ITGB6;TRIM29
prerank,GO_Biological_Process_2021__negative regulation of mitotic metaphase/anaphase transition (GO:0045841),-0.648451365770777,-1.296312173158049,0.11764705882352941,0.8626143300134363,1.0,2/20,7.32%,BUB1;TTK
prerank,GO_Biological_Process_2021__methylguanosine-cap decapping (GO:0110156),0.7073442089580941,1.2962551869356342,0.16666666666666666,0.8009718705068946,1.0,3/10,16.06%,DCP1B;DCPS;PATL1
prerank,GO_Biological_Process_2021__heme catabolic process (GO:0042167),-0.7718497654952351,-1.2961590858952639,0.09836065573770492,0.860629405870137,1.0,3/9,8.58%,AMBP;SLCO2B1;ABCG2
prerank,GO_Biological_Process_2021__porphyrin-containing compound catabolic process (GO:0006787),-0.7718497654952351,-1.2961590858952639,0.09836065573770492,0.860629405870137,1.0,3/9,8.58%,AMBP;SLCO2B1;ABCG2
prerank,GO_Biological_Process_2021__regulation of cardiac muscle cell action potential (GO:0098901),-0.6651791129646256,-1.295902577458022,0.12698412698412698,0.8608579164105631,1.0,3/24,3.78%,PKP2;CAV3;CTNNA3
prerank,CellMarker_Augmented_2021__Vaginal cell:Vagina,0.4915681197302781,1.2958699241290166,0.07692307692307693,0.8017620290506531,1.0,3/53,3.43%,ADGRF4;FAM83H;PERP
prerank,Reactome_2022__Negative Regulation Of Activity Of TFAP2 (AP-2) Family Transcription Factors R-HSA-8866904,-0.7447011194419977,-1.295832465932608,0.14285714285714285,0.8599469401396677,1.0,1/7,1.02%,TFAP2E
prerank,GO_Biological_Process_2021__dendrite extension (GO:0097484),0.8412740245593813,1.2956662106436183,0.17647058823529413,0.8016787219296327,1.0,1/5,3.86%,AUTS2
prerank,GO_Biological_Process_2021__protein localization to axon (GO:0099612),0.8013858112123052,1.2948476220954308,0.1568627450980392,0.8038625214075997,1.0,1/5,4.67%,CNTNAP2
prerank,"Reactome_2022__Plasma Lipoprotein Assembly, Remodeling, And Clearance R-HSA-174824",0.4792696837253591,1.2945065763974712,0.0967741935483871,0.8044289511690282,1.0,8/57,9.94%,LIPC;APOB;APOE;SOAT1;SOAT2;ABCA1;LPL;LDLR
prerank,Reactome_2022__TNF Signaling R-HSA-75893,0.5370493478540892,1.2944252966512495,0.10714285714285714,0.8038542541955064,1.0,11/41,19.91%,CFLAR;NSMAF;SMPD3;SHARPIN;TANK;FADD;TAB3;OTUD7B;CLIP3;TAB1;TAB2
prerank,CellMarker_Augmented_2021__Myeloid cell:Blood,-0.5993024617941001,-1.2944209490091716,0.12121212121212122,0.8664842169093088,1.0,22/46,19.20%,RASGRP4;MPL;TRIM58;ALOX12;NLRP12;RAB44;SLFN14;GP1BA;C19ORF38;CD37;DYTN;MFSD2B;ALAS2;ITGA2B;MMP25;ADGRE3;CMTM2;PGLYRP1;SLC4A1;CLEC1B;P2RX1;BEND2
prerank,Reactome_2022__EGFR Downregulation R-HSA-182971,-0.6096694227088553,-1.2943633424526257,0.1111111111111111,0.8654669843679649,1.0,1/27,0.29%,EPN1
prerank,GO_Biological_Process_2021__negative regulation of fatty acid oxidation (GO:0046322),0.6923334953957874,1.2942317904158889,0.16129032258064516,0.8037146140931104,1.0,2/8,4.35%,MFSD2A;PLIN5
prerank,GO_Biological_Process_2021__mitotic recombination (GO:0006312),0.6036868755230596,1.2940716652350093,0.1702127659574468,0.8033226426170754,1.0,8/14,35.22%,SMC5;RAD52;NSMCE2;SMC6;TPRKB;RAD54B;RAD50;MSH3
prerank,Reactome_2022__Activation Of TRKA Receptors R-HSA-187015,0.8343971041796114,1.2938750248145505,0.17647058823529413,0.8030397715829545,1.0,1/5,0.65%,NGF
prerank,GO_Biological_Process_2021__maintenance of epithelial cell apical/basal polarity (GO:0045199),0.7063911649778584,1.2937267732565227,0.22727272727272727,0.8016668498842223,1.0,3/8,22.83%,PDZD11;LIN7A;ANK1
prerank,GO_Biological_Process_2021__maintenance of apical/basal cell polarity (GO:0035090),0.7063911649778584,1.2937267732565227,0.22727272727272727,0.8016668498842223,1.0,3/8,22.83%,PDZD11;LIN7A;ANK1
prerank,GO_Biological_Process_2021__regulation of dopamine uptake involved in synaptic transmission (GO:0051584),0.7112299937274731,1.2934372211910663,0.16279069767441862,0.8016384403084285,1.0,2/8,7.29%,SNCA;DRD4
prerank,KEGG_2021_Human__Phototransduction,-0.6711812105825967,-1.292856830322181,0.12307692307692308,0.8729311784843576,1.0,10/19,23.57%,PDE6B;GRK7;SLC24A1;GNGT1;PDE6A;CALM1;GUCY2F;PDE6G;GNAT2;CNGB1
prerank,GO_Biological_Process_2021__peroxisomal membrane transport (GO:0015919),0.5967650451901724,1.2928432444903046,0.1935483870967742,0.8032784754432031,1.0,4/25,10.37%,PEX13;GDAP1;ABCD3;ABCD2
prerank,GO_Biological_Process_2021__negative regulation of establishment of protein localization to mitochondrion (GO:1903748),-0.8129442775761109,-1.2926495634697925,0.12121212121212122,0.8724408504006392,1.0,1/6,10.70%,DNAJA1
prerank,GO_Biological_Process_2021__intestinal epithelial cell differentiation (GO:0060575),-0.7845638267782865,-1.2924429223549234,0.11864406779661017,0.8723864325838442,1.0,2/6,16.08%,GATA4;YAP1
prerank,GO_Biological_Process_2021__negative regulation of viral life cycle (GO:1903901),-0.7545797975419398,-1.2924298981250097,0.19148936170212766,0.8710192853334338,1.0,3/11,9.15%,TRIM5;CIITA;PTX3
prerank,Reactome_2022__Aryl Hydrocarbon Receptor Signaling R-HSA-8937144,-0.77799841811891,-1.2921517475397228,0.20754716981132076,0.8714125978382408,1.0,1/6,1.39%,AHR
prerank,GO_Biological_Process_2021__regulation of neuroinflammatory response (GO:0150077),-0.7256169733967031,-1.2921157492862811,0.15,0.8701010908623391,1.0,3/12,15.16%,MMP9;TNFRSF1B;IL18
prerank,GO_Biological_Process_2021__cellular protein catabolic process (GO:0044257),0.5177158385186149,1.2919620136323533,0.07407407407407407,0.8061150916109945,1.0,7/51,10.45%,TCIRG1;HTRA2;ADAMTS12;CAPN2;RAB7A;CTSV;RSPRY1
prerank,GO_Biological_Process_2021__cilium movement involved in cell motility (GO:0060294),-0.8249550040750319,-1.2918824436956813,0.1346153846153846,0.8699770458295425,1.0,2/7,6.83%,TEKT5;TEKT3
prerank,Reactome_2022__Conjugation Of Benzoate With Glycine R-HSA-177135,0.7219182847392684,1.2918682854648593,0.16981132075471697,0.8054550815742225,1.0,2/5,1.76%,GLYATL1;GLYATL2
prerank,GO_Biological_Process_2021__axon guidance (GO:0007411),0.4277855276828442,1.2918536923857558,0.08333333333333333,0.804528520116283,1.0,41/186,16.67%,EFNB1;ROBO2;LAMA3;ALCAM;PTPRO;EPHA7;DSCAML1;SPTBN4;SEMA6C;UNC5C;BSG;SEMA5A;UNC5D;NTN4;DCC;EPHA3;DSCAM;SLIT2;PLXNB1;DOK5;EFNA5;PTPRM;DOK6;SEMA4A;SH3KBP1;IRS2;EVL;RET;GAB1;NFIB;ARHGAP35;ANOS1;RYK;EMB;PIK3CA;NCAM1;NRXN1;CNTN6;EFNA2;EPHB2;NOTCH1
prerank,Reactome_2022__Negative Regulation Of MAPK Pathway R-HSA-5675221,0.5441202561529103,1.2918115000928028,0.11764705882352941,0.8036577317309375,1.0,9/39,17.44%,DUSP4;DUSP2;KSR1;PPP5C;PPP2R1B;MARK3;MAPK12;BRAF;PPP2R5D
prerank,GO_Biological_Process_2021__cleavage furrow formation (GO:0036089),0.8063569540010402,1.291645122109275,0.13157894736842105,0.8033774956791683,1.0,3/6,13.40%,SNX18;SPIRE2;SNX9
prerank,Reactome_2022__Class I Peroxisomal Membrane Protein Import R-HSA-9603798,0.6380746980482642,1.2914198697129156,0.2222222222222222,0.8033116635795136,1.0,4/18,10.37%,PEX13;GDAP1;ABCD3;ABCD2
prerank,GO_Biological_Process_2021__positive regulation of hemostasis (GO:1900048),0.6528580039719425,1.291215402981007,0.20588235294117646,0.8022742450927802,1.0,6/10,10.85%,APOH;SERPINE1;HPSE;F2;F2R;F12
prerank,GO_Biological_Process_2021__positive regulation of coagulation (GO:0050820),0.6528580039719425,1.291215402981007,0.20588235294117646,0.8022742450927802,1.0,6/10,10.85%,APOH;SERPINE1;HPSE;F2;F2R;F12
prerank,GO_Biological_Process_2021__Cdc42 protein signal transduction (GO:0032488),-0.7782061976804763,-1.2910447483738958,0.13114754098360656,0.8739132675210808,1.0,2/7,13.70%,WAS;NTN1
prerank,GO_Biological_Process_2021__positive regulation of excitatory postsynaptic potential (GO:2000463),0.6021578826693588,1.2910404964318871,0.075,0.8022632000142448,1.0,5/18,15.58%,NLGN1;GRIN1;RIMS2;NLGN3;NRXN1
prerank,GO_Biological_Process_2021__protein hexamerization (GO:0034214),0.7081308036000041,1.2909097459037016,0.16666666666666666,0.8017912796436868,1.0,3/8,11.33%,SPAST;UGDH;MAT2A
prerank,GO_Biological_Process_2021__negative regulation of protein depolymerization (GO:1901880),0.5800264079575882,1.2905916831619946,0.17647058823529413,0.8022766002852799,1.0,9/24,29.79%,NAV3;PIK3CA;CAMSAP3;ATXN7;CIB1;MID1IP1;APC2;FGF13;CLASP2
prerank,GO_Biological_Process_2021__positive regulation of hemoglobin biosynthetic process (GO:0046985),0.7914721301363649,1.2902186869232648,0.19148936170212766,0.8028668840268179,1.0,2/5,14.74%,SLC25A37;ABCB10
prerank,Reactome_2022__Regulation Of Complement Cascade R-HSA-977606,-0.5953918471028079,-1.2900939915624625,0.16923076923076924,0.877946795282297,1.0,11/29,18.96%,C1QB;VTN;C3AR1;CPB2;CLU;C4BPA;C4BPB;C1S;ELANE;CD81;PSMA7
prerank,GO_Biological_Process_2021__ganglioside catabolic process (GO:0006689),0.7705835479108061,1.2898531746878834,0.13043478260869565,0.8029965049535895,1.0,2/5,15.83%,NEU4;NEU3
prerank,GO_Biological_Process_2021__regulation of oxidative stress-induced cell death (GO:1903201),-0.7310946480690153,-1.289801454237424,0.14814814814814814,0.8783497074249542,1.0,3/10,14.82%,PINK1;REST;GATA4
prerank,GO_Biological_Process_2021__regulation of epidermal growth factor-activated receptor activity (GO:0007176),0.5709600183919027,1.2896958169039856,0.24,0.8028258830233763,1.0,10/21,26.09%,CBLB;TGFA;CHMP6;GPRC5A;ZFYVE28;SOCS4;NCK2;TSG101;CBL;BTC
prerank,GO_Biological_Process_2021__T cell activation involved in immune response (GO:0002286),-0.740537388460994,-1.2896391103390965,0.140625,0.8778209727061701,1.0,5/10,21.70%,IFNK;SLC11A1;LCP1;F2RL1;TNFSF18
prerank,GO_Biological_Process_2021__positive regulation of mRNA metabolic process (GO:1903313),0.7211588450648669,1.2895789130975257,0.12,0.8025323049675857,1.0,4/12,17.93%,KHSRP;MOV10;PNPT1;RC3H1
prerank,GO_Biological_Process_2021__taurine metabolic process (GO:0019530),0.7518252339006827,1.289345794172773,0.13953488372093023,0.8022922232271242,1.0,2/6,16.82%,STAT5B;CSAD
prerank,GO_Biological_Process_2021__regulation of axonogenesis (GO:0050770),0.4957562697662523,1.2891643464868665,0.13793103448275862,0.802105449213336,1.0,15/49,22.04%,NGF;ROBO2;LRRC4C;SLIT2;PLXNB1;CDH2;ARHGAP35;MAP6;PLXNA4;CHODL;PAK3;PAK2;MARK2;NTRK2;PTEN
prerank,Reactome_2022__Formation Of ATP By Chemiosmotic Coupling R-HSA-163210,-0.718435227538514,-1.2891538314044442,0.1694915254237288,0.879200370239377,1.0,6/13,22.78%,ATP5F1E;ATP5MC3;ATP5PF;ATP5ME;ATP5PB;ATP5F1A
prerank,GO_Biological_Process_2021__carnitine shuttle (GO:0006853),0.6740885967946613,1.2888901806060653,0.14583333333333334,0.8025688532062201,1.0,7/10,28.94%,ACACB;CPT1A;PRKAA2;PRKAG2;THRSP;ACACA;MID1IP1
prerank,KEGG_2021_Human__Fat digestion and absorption,0.5450004161761813,1.2888376219973172,0.08571428571428572,0.8018384546065325,1.0,10/28,22.82%,CEL;APOB;ABCA1;PLPP2;AGPAT2;SLC27A4;PLA2G5;PLPP3;ABCG8;SCARB1
prerank,GO_Biological_Process_2021__CENP-A containing nucleosome assembly (GO:0034080),-0.6134810095032556,-1.2886159225652827,0.19672131147540983,0.8789735618153972,1.0,9/27,23.42%,CENPU;ITGB3BP;OIP5;CENPH;RBBP7;CENPN;SMARCA5;CENPL;CENPM
prerank,GO_Biological_Process_2021__CENP-A containing chromatin organization (GO:0061641),-0.6134810095032556,-1.2886159225652827,0.19672131147540983,0.8789735618153972,1.0,9/27,23.42%,CENPU;ITGB3BP;OIP5;CENPH;RBBP7;CENPN;SMARCA5;CENPL;CENPM
prerank,GO_Biological_Process_2021__organelle fusion (GO:0048284),0.593621151608918,1.2884625802029843,0.15384615384615385,0.8026514740553987,1.0,2/21,4.88%,PLD6;GDAP1
prerank,GO_Biological_Process_2021__positive regulation of telomere maintenance via telomerase (GO:0032212),-0.6274652412494517,-1.2884599890427053,0.15,0.8783986709755179,1.0,1/31,0.37%,NEK2
prerank,Reactome_2022__Carnitine Metabolism R-HSA-200425,0.655333034508303,1.2884407481228028,0.1702127659574468,0.8018351927927322,1.0,7/11,28.94%,SLC22A5;CPT1A;PRKAA2;PRKAG2;THRSP;RXRA;MID1IP1
prerank,CellMarker_Augmented_2021__Pancreatic Stem cell:Pancreas,0.47170885984675825,1.2881379099981347,0.07692307692307693,0.8019821345997988,1.0,23/92,11.72%,LGR5;FREM1;ESRRG;MEGF10;GRID2;KIT;ROBO2;SNCAIP;IGDCC3;ST6GAL2;UNC5D;CNTNAP2;MAGI2;SLC35F1;TRIM71;PTPRZ1;ADCY2;SORCS1;HIF3A;DENND2A;NLGN4X;RAB3C;LRRN1
prerank,GO_Biological_Process_2021__intestinal absorption (GO:0050892),-0.6856668958530489,-1.2880688538898446,0.11764705882352941,0.8791002938479823,1.0,2/13,8.12%,SLC5A1;KCNQ1
prerank,GO_Biological_Process_2021__positive regulation of protein-containing complex disassembly (GO:0043243),0.7473918479719311,1.287889083026106,0.2391304347826087,0.8021636496363457,1.0,2/10,4.16%,IRGM;JMJD4
prerank,Reactome_2022__STAT3 Nuclear Events Downstream Of ALK Signaling R-HSA-9701898,0.647815769916954,1.287833647130937,0.24324324324324326,0.8014379797039871,1.0,4/9,20.51%,HDAC3;HDAC1;EP300;HIF1A
prerank,GO_Biological_Process_2021__regulation of nuclear division (GO:0051783),-0.6883582354741941,-1.287659838018565,0.14285714285714285,0.8800783255189818,1.0,4/16,18.33%,NEK2;CAV2;BORA;PKMYT1
prerank,GO_Biological_Process_2021__DNA replication checkpoint signaling (GO:0000076),-0.6508290370234893,-1.287459187331467,0.2,0.8796375487855413,1.0,1/14,0.45%,TICRR
prerank,KEGG_2021_Human__FoxO signaling pathway,0.4474774156611454,1.2874386894552936,0.038461538461538464,0.8023338201433714,1.0,9/113,7.84%,IL7R;FOXO1;TGFBR1;BCL6;IRS1;SIRT1;G6PC3;SGK1;MAPK8
prerank,GO_Biological_Process_2021__mRNA metabolic process (GO:0016071),0.4886605480438961,1.2874238801307463,0.13636363636363635,0.8015052568918516,1.0,24/85,21.06%,LSM10;PCF11;RIDA;DXO;SNRPB;PCBP3;U2AF1;ERN1;LSM2;HSPA1A;SRSF4;PNPT1;SRRM4;HSF1;TP53;PTBP1;TBRG4;AGO3;AURKAIP1;METTL16;U2AF2;SF3B4;CPSF6;LSM6
prerank,GO_Biological_Process_2021__negative regulation of epithelial cell apoptotic process (GO:1904036),0.5734386396520997,1.2873534673746514,0.14285714285714285,0.8009392728344013,1.0,4/23,5.25%,ANGPT1;CDH5;SEMA5A;SERPINE1
prerank,KEGG_2021_Human__Insulin resistance,0.48659816384987054,1.2871582901549683,0.1,0.8008432358481551,1.0,31/93,20.19%,FOXO1;IRS1;CREB3L2;CREB3L4;G6PC3;PPP1R3E;SLC27A2;ACACB;MAPK8;GYS1;AKT2;RPS6KA3;IRS2;MLXIPL;TBC1D4;CPT1A;NFKB1;PPARGC1B;RPS6KA2;RPS6KA6;INSR;PIK3CA;PTPRF;NR1H3;SLC27A4;PPP1CB;CREB1;PRKAA2;PPP1R3D;PRKAG2;PRKCE
prerank,GO_Biological_Process_2021__regulation of extracellular exosome assembly (GO:1903551),0.7469621654199344,1.2870397392433677,0.23684210526315788,0.8002966672713513,1.0,1/5,3.30%,SDC4
prerank,GO_Biological_Process_2021__centromere complex assembly (GO:0034508),-0.5784745806963081,-1.2864415362778663,0.15942028985507245,0.8841988895333849,1.0,9/34,23.42%,CENPU;ITGB3BP;OIP5;CENPH;RBBP7;CENPN;SMARCA5;CENPL;CENPM
prerank,Reactome_2022__Beta Oxidation Of hexanoyl-CoA To butanoyl-CoA R-HSA-77350,0.8242838680279299,1.2863570655560397,0.08695652173913043,0.801985209515883,1.0,2/5,7.98%,ACADS;ECHS1
prerank,GO_Biological_Process_2021__delamination (GO:0060232),-0.817463149225632,-1.2862219422319678,0.16417910447761194,0.8844280695245867,1.0,2/6,14.91%,SPI1;ABCA12
prerank,GO_Biological_Process_2021__positive regulation of DNA metabolic process (GO:0051054),0.48154045495597975,1.2862113165129352,0.12,0.801559660774873,1.0,15/59,15.10%,EYA4;FGF10;BRCC3;SIRT1;ERCC8;RNF168;TOX;HMGB1;PML;MYC;H2AX;SMCHD1;WRAP53;MECP2;EYA3
prerank,Reactome_2022__Signaling To P38 Via RIT And RIN R-HSA-187706,0.8017219238561235,1.2859732870060874,0.1276595744680851,0.8016879473201701,1.0,2/5,3.45%,NGF;BCL11B
prerank,Reactome_2022__TNFR1-induced NFkappaB Signaling Pathway R-HSA-5357956,0.5605525761599816,1.2858640540074329,0.19047619047619047,0.801108412678264,1.0,8/23,24.70%,SHARPIN;TANK;TAB3;OTUD7B;TAB1;TAB2;IKBKB;TRAF1
prerank,GO_Biological_Process_2021__cellular response to nutrient levels (GO:0031669),0.5082179653247673,1.2858265724893743,0.12121212121212122,0.8002888977141605,1.0,9/56,11.88%,FOXO1;MFSD2A;KLF10;SIRT1;AKR1C3;RALB;FADS1;LPL;CLEC16A
prerank,CellMarker_Augmented_2021__Neutrophil:Pluripotent Stem Cell,-0.5662903116981803,-1.2856769806889479,0.14285714285714285,0.8861373026012112,1.0,18/48,13.64%,LILRB3;ITGB2;HCK;ARHGAP9;TAGAP;TNFRSF1B;C3AR1;FCGR3A;NFAM1;MYO1F;IGSF6;PTPRC;FPR1;SPI1;CLEC12A;ITGAM;CD300LF;ADGRE3
prerank,GO_Biological_Process_2021__regulation of acrosome reaction (GO:0060046),-0.7106015920926279,-1.2854907548993375,0.22580645161290322,0.8857615760318264,1.0,6/9,16.03%,PLA2G10;POMZP3;SERPINA10;ZP3;SPINK13;IQCF1
prerank,GO_Biological_Process_2021__interleukin-35-mediated signaling pathway (GO:0070757),-0.7136682963037999,-1.2853638025782166,0.19642857142857142,0.8850150972052188,1.0,2/11,14.26%,STAT1;IL12A
prerank,GO_Biological_Process_2021__striated muscle hypertrophy (GO:0014897),-0.8096902104084203,-1.2853036400535636,0.23636363636363636,0.8838996894931449,1.0,3/5,14.24%,CSRP3;HTR2B;TTN
prerank,GO_Biological_Process_2021__regulation of cytoplasmic translational elongation (GO:1900247),0.7221609328020591,1.2852437205340737,0.25,0.8021399034393921,1.0,4/8,23.36%,DPH1;DPH5;DPH3;DPH2
prerank,CellMarker_Augmented_2021__Dendritic cell:Thymus,-0.5590200634952247,-1.2851145092800085,0.13043478260869565,0.8834337877458395,1.0,26/58,20.41%,GMFG;ITGB2;HCK;CYTIP;ARHGAP9;TAGAP;TNFRSF1B;GPR183;PARVG;WAS;LY86;CD37;MYO1F;IGSF6;PTPRC;SPI1;ITGAM;CD80;IKZF1;PIK3CG;ALOX5AP;LAT2;SASH3;ITGAX;PIK3AP1;CD86
prerank,GO_Biological_Process_2021__outer dynein arm assembly (GO:0036158),-0.666640082846207,-1.284826476050928,0.14705882352941177,0.8836380895756175,1.0,7/15,29.01%,ODAD1;DNAH17;DNAI1;ZMYND10;ODAD2;DNAAF1;ODAD4
prerank,GO_Biological_Process_2021__monoamine transport (GO:0015844),-0.8386831571047411,-1.2846607037904763,0.09523809523809523,0.8834125597201988,1.0,3/5,14.15%,SLC18A2;SLC22A3;SLC6A4
prerank,CellMarker_Augmented_2021__Granulosa cell:Ovary,0.5102381796437202,1.2846342097646561,0.14705882352941177,0.8035911182035249,1.0,16/67,17.52%,FIBCD1;TWIST2;CBS;DLX1;RAI14;TWIST1;FADS1;P3H4;CHST3;TEAD4;FJX1;TRIP13;FSCN1;ANTXR1;CDR2L;IL11
prerank,Reactome_2022__Meiotic Synapsis R-HSA-1221632,-0.5599496040047931,-1.2843646678018794,0.09859154929577464,0.8837471508591611,1.0,10/41,15.67%,SYCP1;TERF2IP;STAG3;SYNE2;H2BC4;BRCA1;H2AZ1;SYCE2;SMC1B;SYCP3
prerank,Reactome_2022__Glutamate Neurotransmitter Release Cycle R-HSA-210500,0.6117029045922595,1.2843107862258392,0.13333333333333333,0.8040255303301698,1.0,5/20,19.41%,PPFIA3;SYT1;UNC13B;PPFIA2;SLC1A3
prerank,Reactome_2022__YAP1- And WWTR1 (TAZ)-stimulated Gene Expression R-HSA-2032785,0.6695725593219743,1.2843008370225049,0.20454545454545456,0.8031549559971285,1.0,2/13,3.16%,TEAD2;CCN2
prerank,GO_Biological_Process_2021__glycoprotein catabolic process (GO:0006516),0.6739508553880895,1.284236703750921,0.17391304347826086,0.8025777239888702,1.0,6/15,22.28%,ADAMTS12;NEU4;NGLY1;FBXO27;EDEM1;FBXO17
prerank,GO_Biological_Process_2021__peptide biosynthetic process (GO:0043043),-0.5104541298501051,-1.2841555954989181,0.075,0.8837004143747395,1.0,64/145,27.27%,RPL37A;RPL38;RPL15;COPS5;WARS1;RPS4X;RPL3;RPL35A;RPS9;RPS27;RPS21;GGT5;RPL13A;YARS2;RPL27A;RPS16;RPL36;RPS20;RPL7A;RPL9;ABCF1;RPL13;RPS8;RPS27A;RPL21;RPL34;MRPL34;RPL4;RPL32;RPL5;RPL23;RPL41;RPS7;RPS11;RPL27;RPL35;RPS14;RPL11;ASMT;RPS15;RPLP1;RPS12;RPL24;RPL18A;RPS13;RPL29;RPLP2;RPL28;RPL12;IGF2BP3;RPL18;RPS3;RPL22;EEF1A1;RPSA;RPS28;RPS19;RPS24;RPS3A;RPL19;RHCE;RPL8;RPS6;RPL10
prerank,GO_Biological_Process_2021__columnar/cuboidal epithelial cell differentiation (GO:0002065),-0.8330614236728808,-1.2841403271346568,0.13793103448275862,0.8823488781471994,1.0,2/5,14.82%,ROS1;GATA4
prerank,GO_Biological_Process_2021__regulation of glycoprotein biosynthetic process (GO:0010559),0.7418799086214249,1.2836719658894482,0.21739130434782608,0.80386772958211,1.0,1/7,5.59%,FKTN
prerank,GO_Biological_Process_2021__positive regulation of smooth muscle cell migration (GO:0014911),0.658884051387965,1.283643333990068,0.20754716981132076,0.8030345182948125,1.0,2/15,1.13%,CCN4;ADAMTS1
prerank,GO_Biological_Process_2021__spermidine metabolic process (GO:0008216),0.7404451789820377,1.2832806427439407,0.14634146341463414,0.803586642217977,1.0,1/6,2.76%,HDAC10
prerank,Reactome_2022__HCMV Infection R-HSA-9609646,0.49319928613728703,1.2832581724119208,0.14285714285714285,0.8027385916368361,1.0,14/97,10.02%,HDAC3;NUP210;IRS1;KCNH8;NUP42;USH2A;H2BC21;DUT;PML;MVB12A;DYNC1I2;CHMP6;UBAP1;AAAS
prerank,CellMarker_Augmented_2021__Endothelial cell:Intervertebral Disc,-0.5531398830482185,-1.2831188949962045,0.08641975308641975,0.8871961182269189,1.0,20/62,14.86%,C1QB;CYYR1;LYVE1;SLCO2B1;MS4A4A;FCGR3A;DCN;CLDN5;ZNF366;VSIG4;SELP;ITGA9;VWF;GPIHBP1;FPR3;F13A1;TEK;A2M;GGT5;ADGRF5
prerank,GO_Biological_Process_2021__microtubule anchoring (GO:0034453),0.7069289515783272,1.2830962921105684,0.29411764705882354,0.8021992020724054,1.0,3/12,9.27%,PCM1;BICD1;GCC2
prerank,PanglaoDB_Augmented_2021__Germ Cells,-0.5264795215037497,-1.282585946613446,0.07692307692307693,0.8889650474426707,1.0,29/115,17.30%,NEK2;C2ORF78;TOPAZ1;BANF2;SYCP1;SLC25A31;BCL2L14;DAZL;TNP1;BRCA1;GAPDHS;TAF7L;GSG1;GGNBP1;MEIOC;STRA8;TULP2;WDR87;DEPDC4;TSSK3;GALNTL5;DNAH3;SMC1B;AQP11;IQCF1;PGAM2;PDCL2;MOV10L1;MAEL
prerank,Reactome_2022__Miscellaneous Substrates R-HSA-211958,0.7216806969026055,1.28241318180634,0.15555555555555556,0.8038227229179064,1.0,2/8,6.53%,CYP2U1;CYP2S1
prerank,GO_Biological_Process_2021__linoleic acid metabolic process (GO:0043651),-0.6996420555551004,-1.2823393914416978,0.13432835820895522,0.8888629606126776,1.0,6/18,9.30%,ELOVL2;ALOX12;ALOX5;ALOX12B;ALOX15;CYP2J2
prerank,GO_Biological_Process_2021__renal water homeostasis (GO:0003091),-0.6322655022802063,-1.2821736976497577,0.17142857142857143,0.888584403216433,1.0,7/23,14.93%,AQP3;RAB11A;MYO5B;AQP4;WFS1;CYP4F12;ADCY7
prerank,GO_Biological_Process_2021__regulation of vesicle size (GO:0097494),-0.8041046331854,-1.282085073219096,0.15,0.8877654297368858,1.0,1/7,2.49%,RIN3
prerank,Reactome_2022__Mitochondrial Biogenesis R-HSA-1592230,0.4336717623768546,1.2820190905435391,0.0,0.8046944754113352,1.0,26/82,26.06%,HDAC3;TFB1M;SMARCD3;ACSS2;NCOA2;GLUD1;IDH2;GLUD2;CHD9;CARM1;PPARGC1B;GABPA;MAPK12;APOOL;CREB1;PRKAA2;PRKAG2;TBL1X;CRTC1;CHCHD3;NR1D1;MICOS10;NRF1;TFB2M;RXRA;APOO
prerank,GO_Biological_Process_2021__regulation of respiratory system process (GO:0044065),0.7808103836208303,1.2820124484073234,0.16666666666666666,0.8037810878115493,1.0,2/6,12.52%,TSHZ3;NLGN3
prerank,Reactome_2022__RND3 GTPase Cycle R-HSA-9696264,0.5314648254273049,1.2816184450071422,0.08823529411764706,0.804209866714837,1.0,13/37,16.01%,SCRIB;VANGL1;ANKRD26;MUC13;KTN1;RND3;RASAL2;ARHGAP21;CCDC88A;DST;ARHGAP35;PKP4;DLG5
prerank,KEGG_2021_Human__Retrograde endocannabinoid signaling,0.45882159972377484,1.2815980800718245,0.043478260869565216,0.8034007608905124,1.0,12/123,7.95%,GABRE;SLC17A6;ITPR2;GABRA5;GABRR2;NDUFC2-KCTD14;GABRG3;KCNJ3;KCNJ6;PLCB1;MAPK8;ADCY2
prerank,GO_Biological_Process_2021__regulation of nuclease activity (GO:0032069),-0.8443016292695947,-1.2815202245373531,0.20454545454545456,0.8895808117069876,1.0,2/6,12.20%,OAS2;OAS1
prerank,CellMarker_Augmented_2021__B cell:Blood,0.8109504627325455,1.2811216643522148,0.25,0.8042859709887975,1.0,1/5,0.51%,CD38
prerank,GO_Biological_Process_2021__sister chromatid segregation (GO:0000819),0.5398985943767922,1.2809315139255413,0.18421052631578946,0.8041041196515147,1.0,6/32,15.82%,KIFC1;TOP2A;LATS1;SGO2;KLHL22;ESPL1
prerank,Reactome_2022__Initial Triggering Of Complement R-HSA-166663,-0.7287859871298565,-1.280756606198975,0.1774193548387097,0.8924695166965217,1.0,4/11,14.21%,C1QB;MASP1;MASP2;C1S
prerank,Reactome_2022__NOD1/2 Signaling Pathway R-HSA-168638,0.5908827920426521,1.2806939997273197,0.14634146341463414,0.8041422052453677,1.0,10/27,24.24%,RIPK2;CARD9;TAB3;MAPK12;TAB1;TAB2;MAP2K6;TRAF6;CASP2;IKBKB
prerank,"Reactome_2022__GABA Synthesis, Release, Reuptake And Degradation R-HSA-888590",-0.6865264924895254,-1.2805029657777858,0.13333333333333333,0.8921986762903682,1.0,3/18,11.92%,GAD1;SLC6A12;HSPA8
prerank,GO_Biological_Process_2021__atrial cardiac muscle cell action potential (GO:0086014),-0.7246737536757442,-1.2805023844026238,0.16666666666666666,0.8907711584083036,1.0,3/12,8.12%,SCN5A;KCNA5;KCNQ1
prerank,Reactome_2022__Signaling By BRAF And RAF1 Fusions R-HSA-6802952,0.5210994470854723,1.280298477166246,0.24,0.8051922616026654,1.0,13/57,13.66%,KSR1;AGTRAP;KIAA1549;CSK;TENT4A;ARRB2;KDM7A;ESRP1;AKAP9;CNKSR2;RAP1A;MARK3;ARRB1
prerank,GO_Biological_Process_2021__xenobiotic catabolic process (GO:0042178),0.7340255169573007,1.2802848874901056,0.21153846153846154,0.8043360594070748,1.0,2/6,20.31%,GSTM2;CRYZ
prerank,GO_Biological_Process_2021__exocrine system development (GO:0035272),0.8497748114643077,1.2802095177423096,0.1956521739130435,0.803549102078693,1.0,1/5,1.19%,FGF10
prerank,"Reactome_2022__Incretin Synthesis, Secretion, And Inactivation R-HSA-400508",-0.6810056545119256,-1.280140441843936,0.13114754098360656,0.8917646545791451,1.0,3/18,14.82%,C1QTNF1;GNAT3;GATA4
prerank,GO_Biological_Process_2021__regulation of membrane repolarization (GO:0060306),-0.6787247969454969,-1.2799096349008086,0.24528301886792453,0.8917293356237896,1.0,2/12,8.12%,CASQ2;KCNQ1
prerank,CellMarker_Augmented_2021__Immature neuron:Undefined,0.4712522454000883,1.2796375117360481,0.11538461538461539,0.8051006079340538,1.0,23/96,14.87%,SLC17A6;LHFPL4;GRM3;POU3F2;ELAVL3;SYT14;PAK5;MAST1;ERC2;FSTL5;SYT1;CASKIN1;CELF5;CELF4;NXPH1;CSPG5;RIMS2;DPF1;OLFM3;FRMD5;SNAP91;SCRT1;SRRM3
prerank,GO_Biological_Process_2021__skeletal system development (GO:0001501),-0.5157504261846573,-1.279396509995365,0.075,0.8934279691476598,1.0,7/118,5.54%,CD44;NOTUM;LECT2;WNT5A;HHIP;COL1A1;CNMD
prerank,Reactome_2022__Regulation Of FZD By Ubiquitination R-HSA-4641263,0.6341428019950055,1.2793843354400352,0.1875,0.8050869857521831,1.0,5/19,8.91%,LGR5;RSPO3;RSPO2;LRP6;WNT3A
prerank,GO_Biological_Process_2021__sphingosine metabolic process (GO:0006670),0.6428416974387278,1.2793307884087965,0.15625,0.8044024716631246,1.0,5/17,23.46%,ACER2;PLPP2;ACER3;PLPP3;ABCA2
prerank,GO_Biological_Process_2021__positive regulation of vasoconstriction (GO:0045907),0.7437283504346538,1.2788757418206727,0.18604651162790697,0.8052273756991754,1.0,2/9,0.48%,ADRA1A;ADRA1B
prerank,CellMarker_Augmented_2021__Neutrophil:Vagina,-0.5734101651978162,-1.2788266447631225,0.171875,0.8952954717616542,1.0,18/36,17.21%,LILRB3;HCK;ALOX5;PTAFR;FCGR3A;NFAM1;MYO1F;IGSF6;FPR1;SPI1;CLEC12A;ITGAM;TLR2;CD300LF;ADGRE3;KCNE3;HK3;CD24
prerank,Reactome_2022__Constitutive Signaling By NOTCH1 HD+PEST Domain Mutants R-HSA-2894862,0.536410469801665,1.2780736666028765,0.14705882352941177,0.8076737814622372,1.0,22/54,22.85%,HDAC3;HDAC10;MAML1;JAG1;MYC;MAMLD1;HDAC1;CDK8;HDAC4;HDAC11;NOTCH1;RBPJ;MIB2;ADAM10;EP300;KAT2B;HDAC5;TBL1X;HDAC7;CUL1;JAG2;MIB1
prerank,GO_Biological_Process_2021__glucocorticoid biosynthetic process (GO:0006704),-0.7747399131086983,-1.2779861084120312,0.22807017543859648,0.8985837927528014,1.0,5/7,22.45%,CYP21A2;HSD11B1;HSD3B1;CYP17A1;HSD11B2
prerank,GO_Biological_Process_2021__dermatan sulfate proteoglycan metabolic process (GO:0050655),0.778222610638836,1.277588126295227,0.2916666666666667,0.8088776743327399,1.0,4/5,19.29%,CSGALNACT1;B3GAT3;DSEL;CSGALNACT2
prerank,"GO_Biological_Process_2021__protein localization to chromosome, centromeric region (GO:0071459)",-0.6510955265922266,-1.2775086025437938,0.21818181818181817,0.8999971202402814,1.0,2/15,7.32%,ZWILCH;TTK
prerank,GO_Biological_Process_2021__positive regulation of transcription from RNA polymerase II promoter in response to hypoxia (GO:0061419),0.7670479235152781,1.2774420935916373,0.24242424242424243,0.8084925526982402,1.0,4/5,22.74%,NOTCH1;RBPJ;HIF1A;NFE2L2
prerank,GO_Biological_Process_2021__histone methylation (GO:0016571),0.5344603942712305,1.2773707695639231,0.1388888888888889,0.807891455394796,1.0,8/25,17.91%,SMYD2;SMYD1;SIRT7;NSD1;FBLL1;CARM1;FBL;PRMT5
prerank,GO_Biological_Process_2021__phospholipase C-activating G protein-coupled receptor signaling pathway (GO:0007200),0.4871217344269678,1.27736569539853,0.1,0.8070251209692771,1.0,8/64,4.29%,ADRA1A;GPR33;ADRA1B;CHRM2;GPR174;HTR2C;DRD5;CX3CR1
prerank,GO_Biological_Process_2021__positive regulation of pseudopodium assembly (GO:0031274),-0.7575456750124743,-1.2773397313657573,0.18181818181818182,0.8981809963534234,1.0,2/9,16.13%,C15ORF62;F2RL1
prerank,GO_Biological_Process_2021__regulation of pseudopodium assembly (GO:0031272),-0.7575456750124743,-1.2773397313657573,0.18181818181818182,0.8981809963534234,1.0,2/9,16.13%,C15ORF62;F2RL1
prerank,CellMarker_Augmented_2021__Endometrial Stem cell:Endometrium,-0.7024523906478711,-1.2772165606792951,0.15873015873015872,0.897767102610702,1.0,1/21,0.01%,CD44
prerank,KEGG_2021_Human__Leishmaniasis,-0.565556230332369,-1.2769982557981014,0.11267605633802817,0.8978608747473151,1.0,15/54,14.87%,TGFB1;ITGB2;HLA-DMA;STAT1;FCGR3A;HLA-DPB1;CYBA;HLA-DRB1;ITGAM;TLR2;HLA-DPA1;NOS2;IL12A;TGFB3;IFNGR2
prerank,Reactome_2022__Transport Of Gamma-Carboxylated Protein Precursors From Endoplasmic Reticulum To Golgi Apparatus R-HSA-159763,-0.7863338624076854,-1.2768169672802216,0.16393442622950818,0.8974602760319637,1.0,2/7,9.58%,F7;FAM110A
prerank,Reactome_2022__Methionine Salvage Pathway R-HSA-1237112,0.7797063560506287,1.2767162122575952,0.2682926829268293,0.8087569374765665,1.0,1/5,2.14%,GOLT1A
prerank,GO_Biological_Process_2021__regulation of cyclase activity (GO:0031279),0.8032394270301504,1.2766294083261072,0.23529411764705882,0.8081907980046898,1.0,2/5,10.33%,MAPK8;CAP2
prerank,PanglaoDB_Augmented_2021__Osteocytes,0.4671539689754123,1.2765698383122828,0.12,0.8075428876401906,1.0,30/85,17.40%,MYO10;GPR161;VEGFC;ADGRL2;LOXL1;PARVA;MID1;IL17RD;ADAMTS12;MMP2;P3H2;RAI14;SLIT2;EDNRA;PDLIM4;ZNF462;TENM3;EFNA5;SNAI2;CXCL14;RND3;CHST3;FJX1;WWTR1;CDH11;ANTXR1;CSRP2;CALD1;CDR2L;ROR1
prerank,GO_Biological_Process_2021__maintenance of DNA methylation (GO:0010216),0.7332725000938486,1.2765649982412923,0.23076923076923078,0.806664194384092,1.0,2/6,18.69%,DNMT1;ZNF445
prerank,GO_Biological_Process_2021__regulation of smooth muscle cell apoptotic process (GO:0034391),0.8007627612340779,1.2764696438358818,0.1794871794871795,0.8062845094399467,1.0,4/7,8.53%,APOH;SIRT1;DIPK2A;LRP6
prerank,GO_Biological_Process_2021__synapse organization (GO:0050808),0.4873909637160826,1.2762462152143217,0.1111111111111111,0.806335975166722,1.0,42/118,19.93%,SLITRK6;GPC4;NLGN1;LRRC4C;PPFIBP2;CX3CR1;FZD5;GPC6;SDK1;ZC4H2;SLC8A3;SNCA;CACNB4;DSCAM;PPFIA3;LRFN5;PPFIBP1;GPHN;PDZRN3;F2R;NLGN4X;UNC13B;FARP1;NLGN3;CDH2;RYK;PTPRF;ACHE;NRXN1;CHRNA1;PTPRD;NEDD4;UNC13C;SLITRK2;PPFIA2;KIRREL3;C5AR1;GRM5;CDK5;PCDHB6;NRCAM;PAK3
prerank,GO_Biological_Process_2021__regulation of chemokine-mediated signaling pathway (GO:0070099),0.7162863655024027,1.276223902396644,0.24489795918367346,0.8055937852889183,1.0,5/8,25.83%,SLIT2;RNF113A;HIF1A;SLIT3;EDN1
prerank,Reactome_2022__HDL Remodeling R-HSA-8964058,0.7146165777539845,1.2760266173836006,0.2,0.805546816544238,1.0,1/7,2.66%,APOE
prerank,GO_Biological_Process_2021__protein K29-linked ubiquitination (GO:0035519),0.8145308097632086,1.2759210636724396,0.20833333333333334,0.8051040553432667,1.0,1/5,9.95%,UBE2D4
prerank,GO_Biological_Process_2021__vocal learning (GO:0042297),0.7645166720116333,1.2758549122867457,0.13043478260869565,0.8034972430173123,1.0,2/5,15.58%,CNTNAP2;NRXN1
prerank,GO_Biological_Process_2021__imitative learning (GO:0098596),0.7645166720116333,1.2758549122867457,0.13043478260869565,0.8034972430173123,1.0,2/5,15.58%,CNTNAP2;NRXN1
prerank,Reactome_2022__LGI-ADAM Interactions R-HSA-5682910,0.6204602683245908,1.2758220897575863,0.2,0.8027129267324978,1.0,3/14,8.83%,LLGL1;CACNG4;CACNG2
prerank,GO_Biological_Process_2021__protein targeting to peroxisome (GO:0006625),0.5593746695220009,1.2757503209344947,0.11428571428571428,0.8022095273888901,1.0,8/27,24.64%,PEX13;GDAP1;ABCD3;ABCD2;ZFAND6;SLC25A17;PEX3;PEX14
prerank,"GO_Biological_Process_2021__energy coupled proton transport, down electrochemical gradient (GO:0015985)",-0.7336499248520616,-1.2756291456801259,0.19298245614035087,0.9030493717879452,1.0,3/9,22.78%,ATP5MC3;ATP5PB;ATP5F1A
prerank,GO_Biological_Process_2021__negative regulation of myotube differentiation (GO:0010832),0.7127881984756921,1.2754765156785357,0.20512820512820512,0.8024618726155661,1.0,5/9,20.08%,HDAC3;HDAC1;HDAC4;NOTCH1;HDAC5
prerank,GO_Biological_Process_2021__peptidyl-serine dephosphorylation (GO:0070262),0.6711166774498499,1.2752875153959502,0.175,0.8025006306475374,1.0,4/13,22.18%,PPP5C;PPP1R15B;NCK1;PPP2R2B
prerank,Reactome_2022__Chemokine Receptors Bind Chemokines R-HSA-380108,-0.6778999020784493,-1.2744646958354187,0.22413793103448276,0.9087240339441297,1.0,6/15,15.84%,XCR1;CXCL13;ACKR4;CXCL16;CXCR5;ACKR2
prerank,GO_Biological_Process_2021__equilibrioception (GO:0050957),0.8285029721677754,1.2743683673927606,0.15555555555555556,0.8054203065312237,1.0,1/5,0.43%,PCDH15
prerank,GO_Biological_Process_2021__mitochondrial ATP synthesis coupled electron transport (GO:0042775),-0.5466201590536164,-1.2742678029730996,0.1125,0.9083311881138812,1.0,15/54,24.68%,COX6A1;NDUFS2;COX6C;NDUFA2;NDUFB4;NDUFC1;COX7C;NDUFA1;NDUFB9;COX4I1;NDUFB10;NDUFS5;NDUFB11;SDHC;NDUFB2
prerank,Reactome_2022__Selenoamino Acid Metabolism R-HSA-2408522,-0.5143943028778335,-1.273975805034609,0.0641025641025641,0.9084305579230649,1.0,57/104,27.12%,VSIG2;RPL37A;INMT;RPL38;RPL15;RPS4X;RPL3;RPL35A;RPS9;FAU;RPS27;RPS21;RPL13A;RPL27A;GNMT;RPS16;RPL36;RPS20;RPL7A;RPL9;RPS8;RPS27A;RPL21;RPL34;RPL4;RPL32;RPL5;RPL23;RPL41;RPS7;RPS11;RPL27;RPL35;RPS14;RPL11;RPS15;RPLP1;RPS12;RPL18A;RPS13;RPL29;RPLP2;RPL28;RPL12;SEPSECS;RPL18;RPS3;RPL22;RPSA;RPS28;RPS19;RPS24;RPL26L1;RPS3A;RPL19;RPL8;RPS6
prerank,GO_Biological_Process_2021__histone H3-K36 demethylation (GO:0070544),0.743519768182688,1.273813207270417,0.23076923076923078,0.8072380539071438,1.0,3/9,11.08%,KDM7A;KDM8;KDM2A
prerank,GO_Biological_Process_2021__regulation of carbohydrate catabolic process (GO:0043470),0.544318181226592,1.2737373944442674,0.05405405405405406,0.8066344607269718,1.0,3/41,4.13%,GCK;NUP210;NUP42
prerank,KEGG_2021_Human__Type I diabetes mellitus,-0.6104301204028276,-1.2732023430709039,0.22580645161290322,0.9114709498318408,1.0,9/23,15.53%,GAD1;HLA-DMA;HLA-A;HLA-DPB1;HLA-DRB1;HLA-DPA1;IL12A;CD80;HLA-F
prerank,GO_Biological_Process_2021__DNA damage induced protein phosphorylation (GO:0006975),0.7040221793100265,1.272929221891396,0.20454545454545456,0.8090179718143757,1.0,5/8,19.92%,CRY1;ABL1;MAPK12;ATM;MAP2K6
prerank,KEGG_2021_Human__MicroRNAs in cancer,-0.5070877560803072,-1.2729110819024954,0.06578947368421052,0.9119748986410708,1.0,15/152,9.78%,CD44;TIMP3;MMP9;CCND1;CYP1B1;CYP24A1;BCL2L2;CDC25A;PLAU;SERPINB5;PIK3R3;BRCA1;TNXB;CCND2;THBS1
prerank,GO_Biological_Process_2021__negative regulation of production of miRNAs involved in gene silencing by miRNA (GO:1903799),-0.7828435306452424,-1.272697467955408,0.15625,0.9118749322118064,1.0,3/8,10.71%,TGFB1;ESR1;TERT
prerank,GO_Biological_Process_2021__mRNA transcription by RNA polymerase II (GO:0042789),0.7550989472221142,1.272278210410689,0.2641509433962264,0.8111029259369827,1.0,3/6,18.84%,ZBTB1;TFCP2;C5AR1
prerank,GO_Biological_Process_2021__negative regulation of viral entry into host cell (GO:0046597),-0.7745172057540848,-1.2721731898365825,0.16666666666666666,0.9136702927415244,1.0,3/10,9.15%,TRIM5;CIITA;PTX3
prerank,GO_Biological_Process_2021__regulation of cardiac muscle cell membrane repolarization (GO:0099623),-0.6592593583346803,-1.27183806643772,0.1724137931034483,0.9141344983348094,1.0,4/19,8.12%,SCN5A;KCNA5;CAV3;KCNQ1
prerank,GO_Biological_Process_2021__negative regulation of hydrolase activity (GO:0051346),0.5132336523716317,1.271752304408045,0.10714285714285714,0.8121576854366015,1.0,7/42,11.34%,CSTA;URI1;PPP1R35;PLIN5;ECM1;RRP1B;GPSM1
prerank,Reactome_2022__ALK Mutants Bind TKIs R-HSA-9700645,0.6977840077068329,1.2717057986844034,0.16216216216216217,0.8114212685347729,1.0,3/11,7.38%,HIP1;BCL11A;EIF2AK3
prerank,Reactome_2022__Mucopolysaccharidoses R-HSA-2206281,0.6636924869264241,1.2716581859552747,0.24390243902439024,0.8106864508010266,1.0,6/9,26.02%,SPAM1;ARSB;GLB1;GNS;GUSB;GALNS
prerank,GO_Biological_Process_2021__positive regulation of protein deacetylation (GO:0090312),0.6446762960859554,1.2715787410449777,0.16,0.8101479546325083,1.0,3/12,17.89%,ZBTB7B;FNTA;NIPBL
prerank,GO_Biological_Process_2021__cellular response to oxygen levels (GO:0071453),-0.7562952012551261,-1.2713623614486738,0.21428571428571427,0.915468311775036,1.0,2/8,9.91%,ATP6AP1;NDUFS2
prerank,GO_Biological_Process_2021__negative regulation of MyD88-independent toll-like receptor signaling pathway (GO:0034128),0.8427558613267602,1.2712400217484914,0.13157894736842105,0.8096735695364543,1.0,4/5,12.39%,CD14;TICAM2;SARM1;TICAM1
prerank,GO_Biological_Process_2021__regulation of MyD88-independent toll-like receptor signaling pathway (GO:0034127),0.8427558613267602,1.2712400217484914,0.13157894736842105,0.8096735695364543,1.0,4/5,12.39%,CD14;TICAM2;SARM1;TICAM1
prerank,Reactome_2022__PI3K/AKT Signaling In Cancer R-HSA-2219528,0.4306920918652829,1.2712331245021349,0.0,0.8087982467585771,1.0,17/89,10.67%,FOXO1;FGF10;KIT;FGFR1;IRS1;NRG2;FGF17;ERBB2;NRG1;NRG3;FGF18;TGFA;MLST8;AKT2;FGFR3;KITLG;IRS2
prerank,GO_Biological_Process_2021__cellular response to copper ion (GO:0071280),0.7147851563094813,1.271148844356798,0.1891891891891892,0.808231801397227,1.0,4/11,15.27%,MT1G;SNCA;MT4;HSF1
prerank,GO_Biological_Process_2021__positive regulation of cell-matrix adhesion (GO:0001954),0.5374329620091012,1.270739499896076,0.06451612903225806,0.8089900396207225,1.0,8/37,11.91%,SKAP1;UTRN;CDH13;RIN2;CDK6;ABL1;COL16A1;LIMS1
prerank,GO_Biological_Process_2021__regulation of protein lipidation (GO:1903059),-0.8368705913729124,-1.2706672545318816,0.16666666666666666,0.9184470413006032,1.0,1/5,11.79%,SVIP
prerank,GO_Biological_Process_2021__rRNA catabolic process (GO:0016075),-0.649353008573579,-1.2705858229816853,0.2222222222222222,0.9175484432469345,1.0,2/15,5.36%,ERN2;SLFN14
prerank,GO_Biological_Process_2021__histone H4-K20 methylation (GO:0034770),0.8055638678332249,1.2705228459847677,0.20454545454545456,0.8081824949682389,1.0,3/5,16.13%,SMYD5;KMT5C;KMT5B
prerank,GO_Biological_Process_2021__histone H4-K20 trimethylation (GO:0034773),0.8055638678332249,1.2705228459847677,0.20454545454545456,0.8081824949682389,1.0,3/5,16.13%,SMYD5;KMT5C;KMT5B
prerank,Reactome_2022__APC-Cdc20 Mediated Degradation Of Nek2A R-HSA-179409,-0.6217328496644906,-1.2704665329772002,0.13636363636363635,0.9168327740825709,1.0,1/23,0.37%,NEK2
prerank,GO_Biological_Process_2021__negative regulation of macrophage cytokine production (GO:0010936),-0.8188363304517743,-1.270251557363796,0.16666666666666666,0.9166139839708544,1.0,2/5,14.43%,TGFB1;TGFB3
prerank,GO_Biological_Process_2021__histone H2A-K119 monoubiquitination (GO:0036353),0.7386425228033447,1.2701545662613456,0.19047619047619047,0.8088579017278222,1.0,4/8,20.52%,PCGF1;PCGF5;RNF2;PCGF6
prerank,GO_Biological_Process_2021__mRNA transport (GO:0051028),0.48401521595290714,1.2700503483847656,0.12121212121212122,0.8083265752849642,1.0,10/95,10.02%,ARC;CPSF1;NUP210;NXF5;NUP42;NXT1;NXF1;U2AF1;SRRM1;AAAS
prerank,GO_Biological_Process_2021__negative regulation of microtubule polymerization (GO:0031115),0.6122171877216911,1.2699641850828116,0.14285714285714285,0.807700069903318,1.0,3/12,9.27%,CDH5;SNCA;MAPRE1
prerank,KEGG_2021_Human__Bile secretion,-0.5454512772101792,-1.2699245118584954,0.13043478260869565,0.9170918401506868,1.0,17/58,19.66%,SLC22A8;SLC51A;SCTR;SLC5A1;ATP1A4;ABCG2;CYP3A4;SLC22A7;AQP4;ABCB1;NR1H4;ADCY7;SLC10A1;SLCO1A2;ABCB11;SLC27A5;ATP1A1
prerank,GO_Biological_Process_2021__energy reserve metabolic process (GO:0006112),0.6567919226918344,1.2697123550860312,0.1891891891891892,0.8083257140614738,1.0,4/17,8.97%,MRAP2;PID1;MYC;LEPR
prerank,CellMarker_Augmented_2021__Cancer cell:Peripheral Blood,-0.8263210040598992,-1.2694148753786645,0.20689655172413793,0.9186666313958283,1.0,1/5,3.71%,SALL4
prerank,GO_Biological_Process_2021__L-ascorbic acid metabolic process (GO:0019852),0.726616413158123,1.2694052448971878,0.16666666666666666,0.8086776987022998,1.0,2/9,8.03%,RGN;GSTO2
prerank,PanglaoDB_Augmented_2021__Interneurons,0.4302486979783609,1.2693756316028577,0.06666666666666667,0.8079568178863128,1.0,69/278,19.40%,NXPH4;SLC17A6;LYPD1;GABRA5;RORA;ADGRL2;GRM3;PTPRO;LRRTM3;CCN2;ARX;KCNC2;PCF11;ELAVL3;CALN1;CADM2;RORB;PAK5;DEPTOR;SLC35F1;DLX1;HIVEP2;NCALD;ETV1;NAT14;PDE1A;ERC2;ADGRA1;SYT1;CACNG2;PARM1;PCBP3;CELF5;CELF4;CXCL14;BRINP1;RGS7BP;NXPH1;FGF12;ELAVL4;CDHR1;TIMELESS;RAB3C;SLC22A15;OLFM3;OXR1;ARHGAP21;KCNQ5;SNAP91;RBFOX1;FRRS1L;SCRT1;VSTM2B;FAM81A;NRXN1;FCHSD2;RIT2;DZANK1;SYN1;CDH4;PAX6;PPFIA2;MMD2;ST8SIA3;ADGRB3;ELMO1;GRM5;FBXO11;CTNNA2
prerank,Reactome_2022__Downregulation Of ERBB2 Signaling R-HSA-8863795,0.5411495205783792,1.2692917911886412,0.18181818181818182,0.8076370920143606,1.0,5/27,9.44%,NRG2;ERBB2;NRG1;NRG3;AKT2
prerank,GO_Biological_Process_2021__phosphate ion transmembrane transport (GO:0035435),-0.780759751938352,-1.269152754365839,0.10714285714285714,0.9187258132916386,1.0,1/12,1.36%,SLC37A2
prerank,"GO_Biological_Process_2021__mitochondrial electron transport, NADH to ubiquinone (GO:0006120)",-0.6243812273657452,-1.2689211647360332,0.14084507042253522,0.9187512925135363,1.0,11/30,27.00%,NDUFS2;NDUFA2;NDUFB4;NDUFC1;NDUFA1;NDUFB9;NDUFB10;NDUFS5;NDUFB11;NDUFB2;NDUFS6
prerank,Reactome_2022__Biosynthesis Of EPA-derived SPMs R-HSA-9018679,-0.8085540705428942,-1.2688936552548193,0.21052631578947367,0.9174936576671102,1.0,2/6,7.49%,ALOX5;ALOX15
prerank,GO_Biological_Process_2021__lipid hydroxylation (GO:0002933),-0.7981319181290837,-1.2685205475383707,0.2222222222222222,0.9184678230231809,1.0,3/5,14.77%,CYP3A5;CYP3A4;CYP2E1
prerank,GO_Biological_Process_2021__mitochondrial DNA replication (GO:0006264),0.7582610905641949,1.2685018305998539,0.15384615384615385,0.8104317159037995,1.0,4/8,20.40%,TEFM;POLG;PRIMPOL;DNA2
prerank,GO_Biological_Process_2021__regulation of granulocyte chemotaxis (GO:0071622),-0.6340683455786313,-1.2683140081375255,0.1875,0.9182266296012817,1.0,7/17,30.71%,THBS1;CSF1R;BST1;CXCL17;CCL5;CSF1;MAPK3
prerank,GO_Biological_Process_2021__blood circulation (GO:0008015),-0.5488660817412654,-1.2682233903460849,0.11594202898550725,0.9173087051149211,1.0,12/37,22.36%,ACTC1;STAT1;C3AR1;TRDN;COL4A3;F5;PLN;SCPEP1;SGCG;ACE2;ELN;LPA
prerank,GO_Biological_Process_2021__negative regulation of protein ubiquitination (GO:0031397),0.5022292086312266,1.268075629369645,0.2,0.8111946673849437,1.0,14/46,20.02%,PER2;SPOPL;CRY1;ARRB2;SIRT7;ABL1;GNL3L;N4BP1;HSPA1A;ARRB1;MINAR1;LIMK1;MARCHF7;U2AF2
prerank,GO_Biological_Process_2021__heart trabecula morphogenesis (GO:0061384),0.6050579014262468,1.2678462242691029,0.23333333333333334,0.8111593180834133,1.0,3/16,5.50%,ADGRG6;TGFBR1;NRG1
prerank,GO_Biological_Process_2021__C21-steroid hormone metabolic process (GO:0008207),0.5624784264475887,1.2677913892797739,0.2,0.8105351311062934,1.0,3/17,10.75%,AKR1C3;AKR1C1;STARD3NL
prerank,GO_Biological_Process_2021__response to glucose (GO:0009749),0.52525153816186,1.2677252717487082,0.1282051282051282,0.8100235683251671,1.0,6/39,11.79%,GCK;ZBTB20;ERN1;LPL;IRS2;UNC13B
prerank,Reactome_2022__RUNX3 Regulates WNT Signaling R-HSA-8951430,-0.794694787548284,-1.2676434781157855,0.15789473684210525,0.9194652519372536,1.0,3/7,5.29%,TCF7;CCND1;TCF7L1
prerank,GO_Biological_Process_2021__organelle organization (GO:0006996),0.41673762696949623,1.2675818924491606,0.058823529411764705,0.8096719193783889,1.0,57/370,13.62%,ARC;AUP1;HPS3;TTC29;KLHL20;TOR1B;APOE;TFB1M;PACSIN2;RAB31;FGD4;BIN1;TICAM2;SYNE3;PLIN5;BLZF1;PCLO;PKD2;RAB7A;MSTO1;SLC25A33;GBF1;PAK5;UBXN2A;REEP6;SMPD4;FGD5;EIF2AK3;MAST1;TRAPPC12;PNPLA3;MAST2;MYC;FGD1;SIPA1;ABCD3;FAM161B;CHMP6;TTC17;TNIK;ZFYVE16;WASF3;IRAG2;DYRK3;TMED3;ABCD2;SH3KBP1;CSPG5;PI4K2B;PDZD8;MNS1;ARHGAP21;CFAP410;DST;MIEF2;COG7;FAM174B
prerank,GO_Biological_Process_2021__purine deoxyribonucleotide catabolic process (GO:0009155),0.7999349608277588,1.267282456697548,0.17391304347826086,0.8100349830261664,1.0,2/6,4.57%,PNP;NT5C1A
prerank,GO_Biological_Process_2021__regulation of DNA methylation-dependent heterochromatin assembly (GO:0090308),0.6600513340281733,1.2672598092674718,0.15151515151515152,0.8092402916061784,1.0,8/13,32.46%,DNMT1;RESF1;MPHOSPH8;ATF7IP;APOBEC1;PPHLN1;SETDB2;SETDB1
prerank,Reactome_2022__Signaling By ALK R-HSA-201556,0.5785245760152522,1.2670933296647457,0.1388888888888889,0.8090964084179944,1.0,8/24,20.51%,HDAC3;IRS1;PTPRZ1;MYC;HDAC1;PIK3CA;EP300;HIF1A
prerank,GO_Biological_Process_2021__regulation of oxidoreductase activity (GO:0051341),0.6964090407233091,1.2670830237019233,0.14705882352941177,0.8082727580298978,1.0,3/9,20.11%,ABL1;ABL2;SZT2
prerank,GO_Biological_Process_2021__interleukin-2-mediated signaling pathway (GO:0038110),0.6739090433303432,1.2668708047685677,0.19444444444444445,0.8073408713687902,1.0,2/9,15.73%,STAT5B;IL2RB
prerank,GO_Biological_Process_2021__cellular response to interleukin-2 (GO:0071352),0.6739090433303432,1.2668708047685677,0.19444444444444445,0.8073408713687902,1.0,2/9,15.73%,STAT5B;IL2RB
prerank,Reactome_2022__Fatty Acids R-HSA-211935,-0.7989123279484655,-1.2667101669728602,0.19696969696969696,0.9233757619543673,1.0,3/7,17.94%,CYP2J2;CYP4F12;CYP4B1
prerank,GO_Biological_Process_2021__negative regulation of G1/S transition of mitotic cell cycle (GO:2000134),0.5366245961486389,1.2665623372211143,0.17857142857142858,0.8077829239726475,1.0,6/30,7.77%,SLFN11;PKD2;GFI1B;CDK6;CDK4;RBL1
prerank,GO_Biological_Process_2021__neurotrophin TRK receptor signaling pathway (GO:0048011),0.657754182256048,1.2664727329654288,0.22857142857142856,0.8072161085490015,1.0,2/13,7.93%,NGF;CASP3
prerank,CellMarker_Augmented_2021__Platelet:Plasma,-0.5743692940058915,-1.2663625839681831,0.1323529411764706,0.9225399861053863,1.0,21/44,19.20%,RASGRP4;MPL;TRIM58;ALOX12;NLRP12;SLFN14;VSTM1;GYPB;GP1BA;DYTN;MFSD2B;ALAS2;ITGA2B;PTP4A2P2;TSPAN16;CMTM2;PGLYRP1;SLC4A1;CLEC1B;P2RX1;BEND2
prerank,CellMarker_Augmented_2021__Platelet:Peripheral Blood,-0.5743692940058915,-1.2663625839681831,0.1323529411764706,0.9225399861053863,1.0,21/44,19.20%,RASGRP4;MPL;TRIM58;ALOX12;NLRP12;SLFN14;VSTM1;GYPB;GP1BA;DYTN;MFSD2B;ALAS2;ITGA2B;PTP4A2P2;TSPAN16;CMTM2;PGLYRP1;SLC4A1;CLEC1B;P2RX1;BEND2
prerank,GO_Biological_Process_2021__stress-activated MAPK cascade (GO:0051403),0.4761036199314629,1.2663320131317783,0.09375,0.8071853888483693,1.0,15/59,21.68%,RIPK2;TNFRSF19;MAPK8;MAP3K10;LGALS9;MAP3K13;TAB3;NFKB1;MAP4K2;CRKL;MAP2K7;TAB1;TAB2;TRAF6;CUL1
prerank,GO_Biological_Process_2021__negative regulation of vascular endothelial growth factor signaling pathway (GO:1900747),-0.7825863954160397,-1.2662713775558476,0.15,0.9216335005243703,1.0,3/8,14.26%,DCN;PIK3CB;IL12A
prerank,GO_Biological_Process_2021__positive regulation of lipid metabolic process (GO:0045834),0.6066764314674695,1.2661155003922444,0.07894736842105263,0.8072333133626513,1.0,5/18,12.09%,APOE;PPARG;ZBTB20;F2;MLXIPL
prerank,GO_Biological_Process_2021__response to interferon-alpha (GO:0035455),0.6323025442164245,1.2658261990520405,0.20930232558139536,0.8076422245250731,1.0,2/13,5.09%,KLHL20;PYHIN1
prerank,GO_Biological_Process_2021__regulation of aspartic-type endopeptidase activity involved in amyloid precursor protein catabolic process (GO:1902959),0.6681311879643772,1.2656958236641598,0.2653061224489796,0.8072504460387178,1.0,1/9,3.49%,BIN1
prerank,Reactome_2022__SARS-CoV-2 Modulates Host Translation Machinery R-HSA-9754678,-0.5718484856623756,-1.2654738621127184,0.16176470588235295,0.9250439463754725,1.0,25/42,27.12%,SNRPD2;DDX20;RPS4X;RPS9;FAU;RPS27;RPS21;GEMIN4;RPS16;RPS20;RPS8;RPS27A;RPS7;RPS11;RPS14;RPS15;RPS12;RPS13;RPS3;RPSA;RPS28;RPS19;RPS24;RPS3A;RPS6
prerank,GO_Biological_Process_2021__type B pancreatic cell differentiation (GO:0003309),0.6935441393215517,1.2654405610332753,0.2727272727272727,0.8074704841093349,1.0,6/8,28.82%,CDK6;CDH2;RFX6;BMP4;INSM1;DLL1
prerank,GO_Biological_Process_2021__sprouting angiogenesis (GO:0002040),0.4944420827377221,1.2653501983293953,0.18518518518518517,0.8070640547095371,1.0,8/45,7.88%,RSPO3;VEGFC;ANGPT1;CDH13;PARVA;SEMA5A;GREM1;SLIT2
prerank,GO_Biological_Process_2021__caveolin-mediated endocytosis (GO:0072584),0.7719413195988833,1.2653033941295113,0.25,0.8063614320147041,1.0,1/5,2.80%,PACSIN2
prerank,GO_Biological_Process_2021__positive regulation of defense response to virus by host (GO:0002230),-0.6139845137363256,-1.2651823572584948,0.17857142857142858,0.9255320329854175,1.0,3/21,10.18%,AIM2;STAT1;TRAF3IP2
prerank,GO_Biological_Process_2021__skeletal muscle cell differentiation (GO:0035914),0.7879459781817917,1.2650982363162402,0.26666666666666666,0.8063162114203345,1.0,2/5,5.36%,MEGF10;KLHL41
prerank,GO_Biological_Process_2021__regulation of DNA metabolic process (GO:0051052),0.5524946644031951,1.2649175645356703,0.16129032258064516,0.8061462753682731,1.0,1/41,0.03%,IL7R
prerank,GO_Biological_Process_2021__response to manganese ion (GO:0010042),-0.7979406019370219,-1.2649022599153619,0.1509433962264151,0.9256016963983394,1.0,1/6,5.36%,SLFN14
prerank,Reactome_2022__Effects Of PIP2 Hydrolysis R-HSA-114508,0.5667369662129366,1.2647083592455397,0.10526315789473684,0.8061792979520618,1.0,3/27,3.05%,DGKD;ITPR2;TRPC3
prerank,GO_Biological_Process_2021__regulation of immune response (GO:0050776),-0.5064555229547234,-1.2646319822631669,0.14666666666666667,0.9258902732137931,1.0,24/105,15.53%,AMBP;MICB;AHR;ITGB2;IRF4;CXCL13;KLRB1;IRF1;COL1A1;SFTPD;CD160;FCGR3A;OSCAR;ICAM3;HLA-A;C17ORF99;GPR151;HLA-DRB1;CD300LF;SH2D1B;COLEC12;FGL1;ADCY7;HLA-F
prerank,GO_Biological_Process_2021__phasic smooth muscle contraction (GO:0014821),-0.7521569932313293,-1.2645966594709177,0.21428571428571427,0.9247667630436788,1.0,3/8,13.45%,HTR2B;EDNRB;PTGER3
prerank,GO_Biological_Process_2021__regulation of cytokine production involved in immune response (GO:0002718),-0.6558076245041814,-1.2645548124223616,0.18032786885245902,0.9236903050912074,1.0,5/14,10.86%,TRIL;WNT5A;SCIMP;TNFRSF1B;LACC1
prerank,Reactome_2022__Regulation Of Gene Expression In Late Stage (Branching Morphogenesis) Pancreatic Bud Precursor Cells R-HSA-210744,0.6367905527187946,1.2644084492544745,0.125,0.8066793143693717,1.0,6/14,19.29%,MAML1;MAMLD1;NOTCH1;RBPJ;EP300;KAT2B
prerank,GO_Biological_Process_2021__protein autoprocessing (GO:0016540),0.6893090575837859,1.2643595173262447,0.22857142857142856,0.8060274012023273,1.0,5/11,18.56%,HTRA2;F12;TMPRSS2;HJV;SPRTN
prerank,CellMarker_Augmented_2021__Nephron Epithelial cell:Kidney,0.6248113376488216,1.2640089261896317,0.075,0.8065886825692453,1.0,5/14,3.99%,ATP6V0D2;SLC16A9;SLC12A1;PTPRO;SLC8A1
prerank,CellMarker_Augmented_2021__Natural Killer cell:Liver,-0.6060556675310328,-1.2639845592333272,0.15151515151515152,0.9255728729439096,1.0,18/43,13.64%,LILRB3;HCK;C3AR1;MS4A4A;FCGR3A;VSIG4;NFAM1;MYO1F;IGSF6;FPR1;SLC11A1;SPI1;PTGDR;CLEC12A;ITGAM;F13A1;CD300LF;ADGRE3
prerank,GO_Biological_Process_2021__response to estradiol (GO:0032355),-0.6026938591409388,-1.2638846857257615,0.11475409836065574,0.9246617841877729,1.0,9/28,14.75%,TGFB1;WNT8B;ESR1;GPER1;ANXA1;FAM210B;H2AZ1;SSTR1;GGT5
prerank,GO_Biological_Process_2021__high-density lipoprotein particle remodeling (GO:0034375),0.6894541534366969,1.2638361401717368,0.11764705882352941,0.8062175813624115,1.0,2/11,2.66%,LIPC;APOE
prerank,"Reactome_2022__Synthesis, Secretion, And Deacylation Of Ghrelin R-HSA-422085",0.6862046698592144,1.2637596991328393,0.21621621621621623,0.8056301902213417,1.0,2/15,2.33%,BCHE;CRHR2
prerank,GO_Biological_Process_2021__serine family amino acid biosynthetic process (GO:0009070),0.652466665360176,1.263689769336609,0.19047619047619047,0.8050749915477264,1.0,8/11,25.49%,PSAT1;SRR;CBS;PSPH;SERINC5;SEPHS1;CTH;PHGDH
prerank,GO_Biological_Process_2021__sterol homeostasis (GO:0055092),0.5004082359223205,1.2635658794992146,0.14705882352941177,0.8047994398946448,1.0,14/63,9.94%,CYP7B1;TSKU;LIPC;EPHX2;RORA;APOB;APOE;SOAT1;SIRT1;AKR1C1;SOAT2;ABCA1;LPL;LDLR
prerank,GO_Biological_Process_2021__protein O-linked mannosylation (GO:0035269),0.6086067468396279,1.263545087871665,0.15625,0.8040298601866518,1.0,9/17,24.46%,DPM3;TMTC2;FKTN;FKRP;TMTC3;POMT2;RXYLT1;LARGE1;CRPPA
prerank,Reactome_2022__Erythropoietin Activates Phospholipase C Gamma (PLCG) R-HSA-9027277,0.7550253975276229,1.2634984455439273,0.2,0.8035552330086531,1.0,3/7,20.89%,EPOR;IRS2;PLCG2
prerank,GO_Biological_Process_2021__regulation of inositol phosphate biosynthetic process (GO:0010919),0.8049895712597389,1.263366717274309,0.22727272727272727,0.8033592218367006,1.0,1/5,5.38%,SNCA
prerank,GO_Biological_Process_2021__protein heterotetramerization (GO:0051290),0.6423457323049789,1.2633604390595827,0.21621621621621623,0.8025472778086908,1.0,4/11,20.63%,PKD2;GRIN1;CPSF7;CPSF6
prerank,"Reactome_2022__Respiratory Electron Transport, ATP Synthesis By Chemiosmotic Coupling, Heat Production By Uncoupling Proteins R-HSA-163200",-0.5136342113887554,-1.263263052816314,0.07792207792207792,0.9269614127391528,1.0,25/95,22.86%,COX6A1;TMEM186;ATP5F1E;NDUFS2;COX6C;ATP5MC3;UCP1;ATP5PF;NDUFA2;NDUFB4;NDUFC1;COX7C;ETFB;NDUFA1;NDUFB9;ATP5ME;COX20;COX4I1;NDUFB10;NDUFS5;ATP5PB;NDUFB11;NDUFAF5;ATP5F1A;CCNI
prerank,GO_Biological_Process_2021__regulation of RNA export from nucleus (GO:0046831),0.6971096554760696,1.2631648311826829,0.20454545454545456,0.8026605581905774,1.0,8/12,25.97%,IWS1;SETD2;KHDRBS1;CPSF6;NRDE2;TPR;NSUN2;NUP153
prerank,GO_Biological_Process_2021__synaptic vesicle fusion to presynaptic active zone membrane (GO:0031629),-0.7300817208725757,-1.2629979910220617,0.14285714285714285,0.927299688610097,1.0,2/11,17.04%,SNAP23;STX19
prerank,CellMarker_Augmented_2021__Basophil:Lung,-0.5609965052428248,-1.2628026800214538,0.12,0.9268888401404966,1.0,26/53,21.05%,CLEC5A;C1QB;HCK;C3AR1;MS4A4A;FCGR3A;ZNF366;LPAR6;VSIG4;HLA-DPB1;IGSF6;GBP1;HLA-DRB1;TLR2;FPR3;F13A1;HLA-DPA1;ADAMDEC1;CD4;HK3;CSF1R;TFEC;GPR34;MAF;CD86;CTSO
prerank,Reactome_2022__Prostanoid Ligand Receptors R-HSA-391908,-0.7791833212650474,-1.2625373148899595,0.16363636363636364,0.9270421747366103,1.0,2/5,13.45%,PTGDR;PTGER3
prerank,Reactome_2022__Signaling By FLT3 Fusion Proteins R-HSA-9703465,0.5600850338626544,1.2620991652168325,0.09090909090909091,0.8060949821463003,1.0,8/18,23.66%,NOX4;STAT5B;PIK3CA;GOLGB1;SOS1;TRIP11;MYO18A;LONP1
prerank,PanglaoDB_Augmented_2021__Foveolar Cells,-0.5175608902292504,-1.2620249146544678,0.15942028985507245,0.9286868700403834,1.0,22/57,19.93%,PTPRH;TMEM184A;MISP;CAPN8;SMIM22;PTGR1;PGC;LIPH;ANXA10;SLC5A1;CLDN2;MS4A8;GPR39;ITGB6;CLDN18;GPX2;SCNN1A;LGALS4;SLC44A3;FAM3D;ACE2;CBLC
prerank,GO_Biological_Process_2021__2-oxoglutarate metabolic process (GO:0006103),0.6281019620507163,1.261960449342741,0.24324324324324326,0.8058050026701524,1.0,3/11,12.54%,AADAT;OGDH;IDH2
prerank,GO_Biological_Process_2021__negative regulation of microtubule polymerization or depolymerization (GO:0031111),0.5405869032250997,1.2616245338812706,0.08695652173913043,0.8063289136584556,1.0,14/32,29.79%,CDH5;SNCA;MAPRE1;NAV3;CLIP3;CAMSAP3;ATXN7;DYRK1A;MAP2;CIB1;MID1IP1;APC2;FGF13;CLASP2
prerank,CellMarker_Augmented_2021__IgG Memory B cell:Undefined,-0.5955277624383646,-1.2615522087990763,0.13043478260869565,0.9217260193481076,1.0,13/45,8.72%,SIRPG;BLK;CYTIP;TBC1D10C;ARHGAP9;TAGAP;TMC8;CD5;ICAM3;WAS;LY86;CD37;TRAF3IP3
prerank,CellMarker_Augmented_2021__Memory B cell:Blood,-0.5955277624383646,-1.2615522087990763,0.13043478260869565,0.9217260193481076,1.0,13/45,8.72%,SIRPG;BLK;CYTIP;TBC1D10C;ARHGAP9;TAGAP;TMC8;CD5;ICAM3;WAS;LY86;CD37;TRAF3IP3
prerank,CellMarker_Augmented_2021__Switched Memory B cell:Peripheral Blood,-0.5955277624383646,-1.2615522087990763,0.13043478260869565,0.9217260193481076,1.0,13/45,8.72%,SIRPG;BLK;CYTIP;TBC1D10C;ARHGAP9;TAGAP;TMC8;CD5;ICAM3;WAS;LY86;CD37;TRAF3IP3
prerank,CellMarker_Augmented_2021__Non-switched Memory B cell:Peripheral Blood,-0.5955277624383646,-1.2615522087990763,0.13043478260869565,0.9217260193481076,1.0,13/45,8.72%,SIRPG;BLK;CYTIP;TBC1D10C;ARHGAP9;TAGAP;TMC8;CD5;ICAM3;WAS;LY86;CD37;TRAF3IP3
prerank,CellMarker_Augmented_2021__Double-negative B cell:Peripheral Blood,-0.5955277624383646,-1.2615522087990763,0.13043478260869565,0.9217260193481076,1.0,13/45,8.72%,SIRPG;BLK;CYTIP;TBC1D10C;ARHGAP9;TAGAP;TMC8;CD5;ICAM3;WAS;LY86;CD37;TRAF3IP3
prerank,CellMarker_Augmented_2021__Class-switched Memory B cell:Peripheral Blood,-0.5955277624383646,-1.2615522087990763,0.13043478260869565,0.9217260193481076,1.0,13/45,8.72%,SIRPG;BLK;CYTIP;TBC1D10C;ARHGAP9;TAGAP;TMC8;CD5;ICAM3;WAS;LY86;CD37;TRAF3IP3
prerank,CellMarker_Augmented_2021__Double-negative Memory B cell:Peripheral Blood,-0.5955277624383646,-1.2615522087990763,0.13043478260869565,0.9217260193481076,1.0,13/45,8.72%,SIRPG;BLK;CYTIP;TBC1D10C;ARHGAP9;TAGAP;TMC8;CD5;ICAM3;WAS;LY86;CD37;TRAF3IP3
prerank,GO_Biological_Process_2021__negative regulation of bone mineralization (GO:0030502),0.6571949521274136,1.261475854159918,0.1951219512195122,0.8060086297623913,1.0,3/11,14.25%,ECM1;GREM1;BCOR
prerank,Reactome_2022__Tandem Pore Domain Potassium Channels R-HSA-1296346,0.7094446017466989,1.2613997991549775,0.1794871794871795,0.8054439809098909,1.0,2/8,7.92%,KCNK6;KCNK2
prerank,CellMarker_Augmented_2021__Endothelial Precursor cell:Peripheral Blood,-0.5555455184072522,-1.2611987028262936,0.0875,0.9220878768205752,1.0,21/64,14.86%,C1QB;CYYR1;LYVE1;SLCO2B1;MS4A4A;FCGR3A;CLDN5;ZNF366;VSIG4;HLA-DPB1;SELP;ITGA9;VWF;GPIHBP1;FPR3;F13A1;EDNRB;TEK;A2M;GGT5;ADGRF5
prerank,GO_Biological_Process_2021__hepoxilin metabolic process (GO:0051121),-0.7820015434808699,-1.2609763388352484,0.1935483870967742,0.9207418097857941,1.0,4/8,7.49%,ALOX12;ALOX5;ALOX12B;ALOX15
prerank,GO_Biological_Process_2021__hepoxilin biosynthetic process (GO:0051122),-0.7820015434808699,-1.2609763388352484,0.1935483870967742,0.9207418097857941,1.0,4/8,7.49%,ALOX12;ALOX5;ALOX12B;ALOX15
prerank,GO_Biological_Process_2021__L-phenylalanine metabolic process (GO:0006558),0.6444206228003629,1.2609025381475265,0.23076923076923078,0.8065020884842611,1.0,5/9,25.08%,KYAT1;ASRGL1;GSTZ1;IL4I1;PAH
prerank,Reactome_2022__Biosynthesis Of E-series 18(S)-resolvins R-HSA-9018896,-0.825649633834657,-1.2608972502282356,0.23529411764705882,0.9197951491422658,1.0,2/5,7.49%,ALOX5;ALOX15
prerank,Reactome_2022__Competing Endogenous RNAs (ceRNAs) Regulate PTEN Translation R-HSA-8948700,0.6830432797120436,1.2606997454935773,0.22857142857142856,0.8066105192508782,1.0,5/10,20.09%,MOV10;TNRC6C;TNRC6A;AGO3;AGO2
prerank,GO_Biological_Process_2021__aerobic electron transport chain (GO:0019646),-0.5473799740397272,-1.260592758179687,0.1282051282051282,0.9202957913653445,1.0,15/53,24.68%,COX6A1;NDUFS2;COX6C;NDUFA2;NDUFB4;NDUFC1;COX7C;NDUFA1;NDUFB9;COX4I1;NDUFB10;NDUFS5;NDUFB11;SDHC;NDUFB2
prerank,GO_Biological_Process_2021__protein localization to ciliary membrane (GO:1903441),0.7220940665347159,1.2604543483800328,0.1794871794871795,0.8065507927332438,1.0,4/7,20.60%,ARL13B;ARL3;BBIP1;WDR19
prerank,GO_Biological_Process_2021__cochlea morphogenesis (GO:0090103),-0.75914383793268,-1.2603822277696561,0.23880597014925373,0.9201373908598006,1.0,2/7,12.02%,TBX1;MYO3B
prerank,CellMarker_Augmented_2021__Alpha cell:Pancreatic Islet,0.4404473125328987,1.2601782279037417,0.06451612903225806,0.806643701444385,1.0,22/80,20.19%,MCOLN3;EPHX2;HTR1F;ARX;FAM110B;KLHL41;FSTL5;KPNA6;C11ORF24;PNISR;CERCAM;FGF12;RAB3C;SREK1;ASXL3;BAZ2B;SETD2;TTC39A;ITPK1;FAP;PDE4DIP;PRKCE
prerank,GO_Biological_Process_2021__medium-chain fatty acid metabolic process (GO:0051791),0.5919705251352156,1.2598774846888228,0.1891891891891892,0.8070716088690134,1.0,5/13,15.24%,GLYATL2;CYP4Z1;ABHD3;ACADM;OXSM
prerank,GO_Biological_Process_2021__positive regulation of axon extension (GO:0045773),0.5774278986603538,1.2597246447494264,0.1935483870967742,0.8068746127218575,1.0,5/21,11.93%,SEMA5A;GOLGA4;DSCAM;MACF1;MAP3K13
prerank,Reactome_2022__Attenuation Phase R-HSA-3371568,-0.6482766536358525,-1.259685980891507,0.18055555555555555,0.9227119044216016,1.0,7/23,18.62%,GML;HSPA1L;CRYBA4;HSPA8;COL4A6;DNAJB1;HSPH1
prerank,PanglaoDB_Augmented_2021__Taste Receptor Cells,0.45766952422442203,1.2596202115499187,0.14285714285714285,0.8064043297055811,1.0,31/106,20.33%,MCOLN3;SEZ6L;KCNC2;CACNB4;HCN1;PROX1;KCNJ6;WSCD2;CATSPER2;ADCY2;GRM4;CACNG2;CELF4;MYT1L;XKR4;CPNE6;FRRS1L;NR3C1;DPP6;SRRM4;SEZ6;NRXN1;AP3B2;SLC7A14;UNC13C;GNG7;SLC24A2;ST8SIA3;CTNNA2;TNR;PMP2
prerank,KEGG_2021_Human__Taurine and hypotaurine metabolism,-0.7340470292280079,-1.2594572745487065,0.25,0.9226350705072017,1.0,2/9,14.75%,GAD1;GGT5
prerank,Reactome_2022__Passive Transport By Aquaporins R-HSA-432047,-0.8288703938570037,-1.2593639413319277,0.16666666666666666,0.921808677282704,1.0,3/6,15.61%,AQP3;AQP4;AQP11
prerank,GO_Biological_Process_2021__glycosphingolipid catabolic process (GO:0046479),0.6676941150264712,1.2593293252043951,0.175,0.806618525110426,1.0,3/8,15.83%,GLA;NEU4;NEU3
prerank,GO_Biological_Process_2021__positive regulation of reproductive process (GO:2000243),0.5445222271810353,1.2592815456053104,0.225,0.8059977156714824,1.0,2/27,0.55%,TACR3;LHFPL2
prerank,CellMarker_Augmented_2021__Neural Progenitor cell:Eye,0.4321359634756673,1.2592666017482679,0.09090909090909091,0.804426714508744,1.0,27/98,19.16%,TEAD2;GPR161;ADGRL2;TBC1D16;RASSF8;ETV1;RAI14;SLIT2;TENM3;RND3;CAP2;CHST3;MPDZ;SDC3;DDAH1;RBFOX2;UNC13B;MMP16;MAGI1;ANK2;ANTXR1;SPRY4;CDR2L;ADCY6;DOCK1;NAV2;AKAP12
prerank,CellMarker_Augmented_2021__Neural Stem cell:Spinal Cord,0.4321359634756673,1.2592666017482679,0.09090909090909091,0.804426714508744,1.0,27/98,19.16%,TEAD2;GPR161;ADGRL2;TBC1D16;RASSF8;ETV1;RAI14;SLIT2;TENM3;RND3;CAP2;CHST3;MPDZ;SDC3;DDAH1;RBFOX2;UNC13B;MMP16;MAGI1;ANK2;ANTXR1;SPRY4;CDR2L;ADCY6;DOCK1;NAV2;AKAP12
prerank,Reactome_2022__Recycling Pathway Of L1 R-HSA-437239,0.5496514293290637,1.2591791258592997,0.14285714285714285,0.8039461562069824,1.0,6/28,14.79%,NUMB;RPS6KA3;KIF4B;RPS6KA4;RPS6KA2;RPS6KA6
prerank,GO_Biological_Process_2021__triglyceride homeostasis (GO:0070328),0.5542251144234571,1.259046104274183,0.15555555555555556,0.8036479211014592,1.0,8/23,15.39%,LIPC;RORA;APOE;SIRT1;LPL;MLXIPL;ACSM2A;NR1H3
prerank,Reactome_2022__Nonsense Mediated Decay (NMD) Enhanced By Exon Junction Complex (EJC) R-HSA-975957,-0.5220198683224209,-1.2589184572821808,0.125,0.9230831364698632,1.0,53/104,27.12%,RPL37A;RPL38;RPL15;RPS4X;RPL3;RPL35A;RPS9;FAU;RPS27;RPS21;RPL13A;RPL27A;RPS16;RPL36;RPS20;RPL7A;RPL9;RPS8;RPS27A;RPL21;RPL34;RPL4;RPL32;RPL5;RPL23;RPL41;RPS7;RPS11;RPL27;RPL35;RPS14;RPL11;RPS15;RPLP1;RPS12;RPL18A;RPS13;RPL29;RPLP2;RPL28;RPL12;RPL18;RPS3;RPL22;RPSA;RPS28;RPS19;RPS24;RPL26L1;RPS3A;RPL19;RPL8;RPS6
prerank,GO_Biological_Process_2021__purinergic nucleotide receptor signaling pathway (GO:0035590),-0.6890898505898051,-1.2587003258118064,0.18333333333333332,0.9230587491134943,1.0,9/17,24.26%,C3AR1;NLRP3;PSTPIP1;IL18;TXNIP;NT5E;TXN;ENTPD5;HSP90AB1
prerank,CellMarker_Augmented_2021__Periodontal Ligament Stem cell:Periodontal Ligament,-0.5590230891043866,-1.2586036240669656,0.1267605633802817,0.9222773723124932,1.0,22/66,13.10%,GMFG;ITGB2;HCK;DOCK8;CYTIP;ARHGAP9;TAGAP;TNFRSF1B;ARHGAP15;C3AR1;MS4A4A;PARVG;FCGR3A;VSIG4;HLA-DPB1;SELP;MYO1F;PTPRC;SPI1;ITGAM;F13A1;HLA-DPA1
prerank,GO_Biological_Process_2021__regulation of Golgi organization (GO:1903358),0.5935269104231327,1.2583170902612275,0.25806451612903225,0.8059168539867594,1.0,7/17,21.29%,STX5;STX18;AKAP9;MYO5A;PDE4DIP;USP6NL;CAMSAP3
prerank,KEGG_2021_Human__PI3K-Akt signaling pathway,0.40982665642953775,1.2581428824490093,0.07692307692307693,0.8057529736273912,1.0,41/283,10.13%,IL7R;NGF;CHRM2;FGF10;THEM4;LAMA4;LAMB4;KIT;VEGFC;LAMA3;BCL2;FGFR1;IRS1;ANGPT1;ITGA11;COL9A2;ITGA8;CREB3L2;FGF17;ITGA4;ERBB2;CREB3L4;PDGFD;MAGI2;G6PC3;CDK6;SGK1;CDK4;CCND3;MYC;GYS1;EFNA5;FGF18;TGFA;EPOR;MLST8;AKT2;ITGA3;FGFR3;KITLG;PKN2
prerank,GO_Biological_Process_2021__regulation of lysosomal lumen pH (GO:0035751),-0.7578966468347745,-1.2578954280795343,0.14705882352941177,0.9251311057856915,1.0,3/9,15.82%,PPT1;ATP6AP2;GRN
prerank,GO_Biological_Process_2021__sensory perception of chemical stimulus (GO:0007606),-0.6170703114625823,-1.257848282998156,0.17543859649122806,0.92411833784263,1.0,9/22,20.51%,OR52A5;OR51M1;SYT10;OR51I2;OR9Q1;OR2M4;GNAL;OR8A1;OR3A2
prerank,PanglaoDB_Augmented_2021__Luteal Cells,0.4142734055157579,1.257845547742724,0.0,0.8061921049359928,1.0,27/118,14.12%,ADAMTS1;PC;EPHX2;RORA;ADGRL2;TBC1D16;PLIN5;GPC6;B4GALT2;BCAT1;ECHS1;AADAT;PLXNB1;RND3;CAP2;CHST3;MPDZ;DDAH1;CLDN12;CITED4;RBFOX2;UNC13B;CHKA;LRIG3;KCTD3;TSPAN12;MAGI1
prerank,Reactome_2022__SLBP Independent Processing Of Histone Pre-mRNAs R-HSA-111367,0.6970712884951533,1.2575895373020298,0.2,0.8064346782154905,1.0,2/9,8.90%,LSM10;SNRPB
prerank,GO_Biological_Process_2021__response to retinoic acid (GO:0032526),-0.5119760084758189,-1.2574412439808356,0.14925373134328357,0.9250034558036262,1.0,5/56,2.81%,AQP3;MICB;TBX1;WNT5A;WNT8B
prerank,GO_Biological_Process_2021__positive regulation of mRNA 3'-end processing (GO:0031442),0.710613928503765,1.2573906537173596,0.23684210526315788,0.8064963228575696,1.0,1/10,1.51%,CPEB1
prerank,PanglaoDB_Augmented_2021__Neural Stem/Precursor Cells,0.4709205703828655,1.2573703986292795,0.12,0.8057316525654618,1.0,29/122,16.94%,SLC17A6;MEGF10;APOE;CACNG4;POU3F2;ARX;ELAVL3;PAK5;SLC35F1;DLX1;PTPRZ1;KCNIP1;ADGRA1;RND3;STOX2;NXPH1;CSPG5;NPAS3;RIMS4;RHBDL3;ASCL1;SNAP91;MAP6;MSI1;SCRT1;SRRM3;MAGEL2;IFI44;GRIK3
prerank,GO_Biological_Process_2021__cellular water homeostasis (GO:0009992),-0.7907308100167834,-1.2572938001979768,0.16666666666666666,0.9243805864779465,1.0,3/5,15.61%,SCTR;AQP4;AQP11
prerank,CellMarker_Augmented_2021__Endothelial cell:Heart,-0.5381069080707322,-1.257291535342566,0.09090909090909091,0.9230704823948576,1.0,20/67,14.86%,C1QB;CYYR1;LYVE1;ANO2;SLCO2B1;CLDN5;ZNF366;VSIG4;SELP;ITGA9;TNXB;VWF;GPIHBP1;APOD;F13A1;COX7A1;TEK;A2M;GGT5;ADGRF5
prerank,GO_Biological_Process_2021__regulation of cytokine production (GO:0001817),-0.5176599229935493,-1.2571228003181039,0.1111111111111111,0.9230463566156207,1.0,18/112,11.15%,NLRP4;EOLA1;TRIL;S100A13;PLD4;NLRP12;ALOX5;TNFRSF1B;SFTPD;LRRC19;NFAM1;IGF2BP2;ANXA1;HTR2B;HLA-DRB1;PTPRC;SLC11A1;BTN3A3
prerank,CellMarker_Augmented_2021__Neural Progenitor cell:Brain,0.7027022727113986,1.2570548183854464,0.18604651162790697,0.8060940104965614,1.0,1/7,0.88%,SLITRK6
prerank,Reactome_2022__Class C/3 (Metabotropic Glutamate/Pheromone Receptors) R-HSA-420499,0.6292335318119121,1.2568819127245756,0.16216216216216217,0.8059759125395625,1.0,6/15,9.91%,GRM3;GRM8;TAS2R8;GRM4;GRM2;GRM7
prerank,Reactome_2022__Signaling By Erythropoietin R-HSA-9006335,0.5288119522361537,1.256672107877411,0.09375,0.8060826992227085,1.0,9/24,20.89%,STAT5B;RAPGEF1;EPOR;IRS2;PIK3CA;CRKL;PIK3R5;SOS1;PLCG2
prerank,Reactome_2022__SLBP Dependent Processing Of Replication-Dependent Histone Pre-mRNAs R-HSA-77588,0.6858433173792052,1.2565994223925423,0.20454545454545456,0.8055459247949945,1.0,2/10,8.90%,LSM10;SNRPB
prerank,GO_Biological_Process_2021__postsynaptic membrane assembly (GO:0097104),0.6526464089423323,1.2564544490718836,0.3023255813953488,0.8052643154519211,1.0,5/9,15.58%,CEL;NLGN1;NLGN4X;NLGN3;NRXN1
prerank,Reactome_2022__HCMV Early Events R-HSA-9609690,0.5041361684040911,1.256423652375391,0.16129032258064516,0.8045950438154964,1.0,11/73,10.02%,HDAC3;NUP210;IRS1;KCNH8;NUP42;USH2A;H2BC21;DUT;PML;DYNC1I2;AAAS
prerank,CellMarker_Augmented_2021__Goblet Progenitor cell:Large Intestine,-0.6778657542974019,-1.2564096454751401,0.23809523809523808,0.9259162432627801,1.0,6/14,21.91%,GPRIN2;SLC39A7;SPINK4;FOXA3;GALNT5;TSPAN15
prerank,Reactome_2022__Trafficking And Processing Of Endosomal TLR R-HSA-1679131,0.6716909988667543,1.2563143666361851,0.20588235294117646,0.8042254431223026,1.0,2/9,15.25%,CTSV;CNPY3
prerank,KEGG_2021_Human__Pantothenate and CoA biosynthesis,0.5708374992405228,1.2560720819468774,0.2222222222222222,0.8042887356063284,1.0,6/18,24.06%,PANK1;BCAT1;PPCS;ALDH1B1;PANK3;ENPP1
prerank,CellMarker_Augmented_2021__T cell:Skin,-0.5792541351204066,-1.2559900763102143,0.13043478260869565,0.9269276442577439,1.0,8/34,7.00%,CD44;PSMB9;SIRPG;CYTIP;TAGAP;IRF1;GPR183;CD5
prerank,GO_Biological_Process_2021__motile cilium assembly (GO:0044458),-0.6795210269177256,-1.255914738111658,0.18333333333333332,0.9262026625386226,1.0,6/10,29.66%,CCDC39;RSPH9;ZMYND10;BBOF1;DNAAF1;SPATA6
prerank,GO_Biological_Process_2021__engulfment of apoptotic cell (GO:0043652),0.6405633801800776,1.2558914980747173,0.1702127659574468,0.8042476921904101,1.0,5/13,11.80%,MEGF10;XKR7;RHOBTB1;XKR6;XKR4
prerank,GO_Biological_Process_2021__regulation of lymphocyte apoptotic process (GO:0070228),-0.8051829769296897,-1.2558323716784847,0.15254237288135594,0.9253657162123599,1.0,1/6,2.65%,BLK
prerank,CellMarker_Augmented_2021__Marginal Zone B cell:Undefined,-0.7822191264042724,-1.2554764599765393,0.203125,0.9258871074243584,1.0,3/7,20.09%,PTPRC;CD81;PAX5
prerank,GO_Biological_Process_2021__androgen biosynthetic process (GO:0006702),-0.7812883919472728,-1.255059744190353,0.24074074074074073,0.927047871158494,1.0,2/6,19.39%,HSD3B1;CYP17A1
prerank,GO_Biological_Process_2021__regulation of nuclear-transcribed mRNA poly(A) tail shortening (GO:0060211),0.6181870811016452,1.2550003094888305,0.18181818181818182,0.8072704317153913,1.0,7/15,29.71%,TENT4A;TNRC6C;TNRC6A;AGO2;PABPC1;TNRC6B;TOB1
prerank,Reactome_2022__Acetylcholine Inhibits Contraction Of Outer Hair Cells R-HSA-9667769,-0.8607051209946985,-1.2549514639249542,0.16981132075471697,0.9262545640181378,1.0,1/5,0.28%,CHRNA9
prerank,GO_Biological_Process_2021__regulation of mitophagy (GO:1901524),-0.7439863318100396,-1.2548506354185307,0.23076923076923078,0.925556258526755,1.0,1/5,13.77%,VDAC1
prerank,PanglaoDB_Augmented_2021__Myocytes,-0.5159894661282137,-1.2548271898792442,0.12,0.9244482170893916,1.0,18/115,8.67%,MYH1;NRAP;LMOD1;MYH4;MYH7;CASQ2;ACTC1;MYH8;ANGPTL2;MMP9;CAV3;TMOD4;NID1;KLHL38;TRDN;CSRP3;NEB;ACTN3
prerank,CellMarker_Augmented_2021__Natural Regulatory T (Treg) cell:Peripheral Blood,0.4637177606470101,1.2546581409443165,0.04,0.8075385177673476,1.0,9/62,5.09%,IL7R;SELPLG;CD247;SAMSN1;TRAC;AOAH;GPR174;IL16;PYHIN1
prerank,Reactome_2022__Activation Of Phototransduction Cascade R-HSA-2485179,-0.7638774047664386,-1.2546499209158422,0.16666666666666666,0.9241449842195405,1.0,6/8,23.57%,PDE6B;SLC24A1;GNGT1;PDE6A;PDE6G;CNGB1
prerank,GO_Biological_Process_2021__protein K11-linked ubiquitination (GO:0070979),0.6148154011210283,1.2545143036694435,0.13793103448275862,0.8074498440301681,1.0,12/26,25.48%,UBE2E3;UBE2D4;ANAPC13;UBE2E2;UBE2A;CDC26;UBE2L3;ANAPC7;FZR1;ANAPC4;UBE2D3;ANAPC2
prerank,GO_Biological_Process_2021__heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules (GO:0007157),0.5132691660612291,1.254242081135408,0.12121212121212122,0.8074206585288972,1.0,9/34,16.10%,GRID2;ALCAM;NLGN1;CADM1;TENM3;TENM1;NECTIN3;PTPRD;AMIGO2
prerank,GO_Biological_Process_2021__regulation of 3'-UTR-mediated mRNA stabilization (GO:1905868),0.7524797502351932,1.2538208674606546,0.175,0.8083395907424016,1.0,5/6,22.25%,TENT4A;ELAVL4;METTL16;RBM24;LARP4B
prerank,Reactome_2022__Binding And Uptake Of Ligands By Scavenger Receptors R-HSA-2173782,-0.571594294632599,-1.2534356834380826,0.1724137931034483,0.9300213284730128,1.0,8/35,13.95%,AMBP;APOL1;JCHAIN;COL1A1;MASP1;FTH1;HPR;COLEC12
prerank,GO_Biological_Process_2021__regulation of nitric oxide biosynthetic process (GO:0045428),0.5330255292640214,1.2534296327162262,0.16666666666666666,0.8089015342716607,1.0,8/29,15.86%,GLA;DDAH2;CX3CR1;PKD2;KHSRP;DDAH1;INSR;PTGIS
prerank,Reactome_2022__ABC Transporters In Lipid Homeostasis R-HSA-1369062,0.6130603423184091,1.2532809066762551,0.17073170731707318,0.8087970800085966,1.0,10/17,24.45%,ABCA9;ABCA6;ABCD3;ABCD2;ABCA10;ABCA7;ABCG8;ABCG4;ABCA2;PEX3
prerank,Reactome_2022__Regulation Of Cholesterol Biosynthesis By SREBP (SREBF) R-HSA-1655829,0.5078867690905438,1.2532732138368767,0.15151515151515152,0.8080282014906007,1.0,10/52,15.61%,ELOVL6;SMARCD3;NCOA2;SEC24C;ACACB;SC5D;CHD9;CARM1;NFYC;TM7SF2
prerank,Reactome_2022__MECP2 Regulates Neuronal Receptors And Channels R-HSA-9022699,0.5850897699191865,1.25311822887762,0.23076923076923078,0.807806774521612,1.0,7/18,19.24%,GPRIN1;TRPC3;HDAC1;MECP2;NOTCH1;OPRK1;CREB1
prerank,GO_Biological_Process_2021__tryptophan catabolic process to kynurenine (GO:0019441),0.8686140069287789,1.252908664376771,0.125,0.8079542954540246,1.0,1/5,2.79%,TDO2
prerank,GO_Biological_Process_2021__negative regulation of calcium ion transport (GO:0051926),-0.670899092041626,-1.2526774955547466,0.14545454545454545,0.932929400014794,1.0,1/11,2.76%,CAV3
prerank,Reactome_2022__Aquaporin-mediated Transport R-HSA-445717,-0.5913329481766105,-1.2526197808406345,0.15714285714285714,0.9319605283542955,1.0,8/37,15.61%,AQP3;RAB11A;MYO5B;GNGT1;AQP4;NLRP3;ADCY7;AQP11
prerank,GO_Biological_Process_2021__purine nucleotide catabolic process (GO:0006195),0.6666369372785207,1.2525375013342064,0.24,0.8083813191426218,1.0,2/12,4.57%,PNP;NT5C1A
prerank,Reactome_2022__Olfactory Signaling Pathway R-HSA-381753,-0.5439568886509593,-1.2525240074654662,0.11688311688311688,0.9311783376070896,1.0,24/60,19.44%,OR13A1;ANO2;OR2H2;OR2T6;OR52A5;OR51M1;OR2G6;OR10A2;OR52I2;OR51I2;OR5V1;OR2AJ1;OR52N2;OR7C1;OR2AG1;OR56A3;OR1L8;OR2T12;OR9Q1;OR1L6;OR2M4;GNAL;OR8A1;OR2T10
prerank,GO_Biological_Process_2021__negative regulation of actin nucleation (GO:0051126),-0.762389760805106,-1.2524197389435539,0.1935483870967742,0.9305106013193352,1.0,1/7,1.65%,GMFG
prerank,GO_Biological_Process_2021__lipid transport across blood-brain barrier (GO:1990379),0.7737471123839518,1.2522930369640541,0.2553191489361702,0.8085868309266292,1.0,2/5,17.52%,MFSD2A;SLC27A4
prerank,GO_Biological_Process_2021__synaptic vesicle localization (GO:0097479),0.7190815880381933,1.2522752805530193,0.14814814814814814,0.8079689055992676,1.0,3/13,8.64%,RAB27A;NLGN1;SYNDIG1
prerank,Reactome_2022__Regulation Of TP53 Activity Thru Association With Co-factors R-HSA-6804759,0.6552624234982922,1.2522692693513786,0.23404255319148937,0.8071760018646265,1.0,4/11,15.44%,PPP1R13B;AKT2;BANP;TP53
prerank,Reactome_2022__Formation Of Annular Gap Junctions R-HSA-196025,-0.7362989208907487,-1.2517220289366795,0.2714285714285714,0.933299846024058,1.0,1/9,6.21%,DAB2
prerank,Reactome_2022__Signaling By TGFB Family Members R-HSA-9006936,0.43298429218444096,1.2516456833022789,0.1111111111111111,0.808936920775791,1.0,37/104,22.14%,BAMBI;GREM2;TGFBR1;PARD3;ITGA8;TGIF1;SERPINE1;LTBP1;RBL1;MYC;FSTL3;ZFYVE16;AMH;PPM1A;HDAC1;CDK8;SMAD2;SMURF1;WWTR1;MEN1;FURIN;CGN;SRFBP1;PMEPA1;SKI;PPP1CB;EP300;USP15;ACVR2A;E2F5;ZFYVE9;XPO1;FSTL1;BMPR2;SMAD5;TFDP1;SMAD7
prerank,CellMarker_Augmented_2021__M1 macrophage:Brain,0.4731792512219887,1.2515088539317207,0.1,0.8086281988466275,1.0,19/84,16.69%,SLC10A3;TCIRG1;AGTRAP;DUSP23;SH3BGRL3;LGALS1;TSSC4;MVB12A;CTDSP1;CHMP6;SHARPIN;PGLS;ZDHHC12;TICAM1;JUNB;GPR108;ETHE1;ELOVL1;AGPAT2
prerank,GO_Biological_Process_2021__production of miRNAs involved in gene silencing by miRNA (GO:0035196),0.5571151486159057,1.251269807938383,0.14285714285714285,0.8085835920988406,1.0,12/28,25.92%,PUS10;TRIM71;LIN28B;DGCR8;SMAD2;AGO3;TARBP2;AGO2;TUT7;ADAR;ZC3H7B;LIN28A
prerank,CellMarker_Augmented_2021__CD4+ T cell:Colon,-0.5704809705120589,-1.25126796348595,0.12987012987012986,0.9347480170536148,1.0,11/45,10.28%,SIRPG;IRF4;CYTIP;TBC1D10C;ARHGAP9;TAGAP;KLRB1;SCML4;CD5;TRAF3IP3;PTPRC
prerank,GO_Biological_Process_2021__positive regulation of cell activation (GO:0050867),-0.773223714107117,-1.2511434541373534,0.1935483870967742,0.9343423592994146,1.0,2/6,17.74%,SELP;PLA2G4A
prerank,CellMarker_Augmented_2021__Pit cell:Stomach,0.6403265103286107,1.2510453398569883,0.1388888888888889,0.8085829481324943,1.0,5/10,7.77%,GREM2;GALNT7;ADAMTS6;RBL1;RSPO2
prerank,GO_Biological_Process_2021__protein localization to non-motile cilium (GO:0097499),0.7882872305378142,1.2510223497218769,0.23809523809523808,0.8078809818001739,1.0,4/5,18.14%,SPATA7;ARL13B;ZDHHC3;BBIP1
prerank,GO_Biological_Process_2021__glomerular visceral epithelial cell differentiation (GO:0072112),0.6604128235756552,1.2509332021858866,0.18181818181818182,0.8074869148981866,1.0,3/11,5.58%,PTPRO;JAG1;MAGI2
prerank,GO_Biological_Process_2021__negative regulation of neuroinflammatory response (GO:0150079),-0.6742148394900402,-1.2508982895169134,0.13636363636363635,0.9344047110147031,1.0,4/12,15.82%,TAFA3;TNFRSF1B;PTPRC;GRN
prerank,GO_Biological_Process_2021__glomerular filtration (GO:0003094),-0.7423134095510149,-1.2508383487432004,0.18032786885245902,0.9334634707650994,1.0,1/9,1.12%,JCHAIN
prerank,Reactome_2022__Activation Of Ca-permeable Kainate Receptor R-HSA-451308,0.6970712929393644,1.250742170040209,0.14634146341463414,0.8073706822807533,1.0,3/9,6.92%,LLGL1;GRIK1;NCALD
prerank,Reactome_2022__Abacavir ADME R-HSA-2161522,-0.776345607903496,-1.2506871907512598,0.18518518518518517,0.9330106701826065,1.0,3/7,13.81%,ABCG2;ABCB1;SLC22A3
prerank,Reactome_2022__Amino Acid Conjugation R-HSA-156587,0.6802472004192958,1.2506304284945267,0.25,0.8069633114475918,1.0,4/7,13.02%,GLYATL1;GLYATL2;ACSM2A;ACSM1
prerank,PanglaoDB_Augmented_2021__Dendritic Cells,-0.502080426396466,-1.2505444019795298,0.13157894736842105,0.932447939572025,1.0,31/118,13.42%,XCR1;ITGB2;HCK;CYTIP;PDCD1LG2;TAGAP;SCIMP;TNFRSF1B;PTAFR;HLA-DMA;DAB2;PARVG;FCGR3A;HLA-A;LY86;VSIG4;NFAM1;HLA-DPB1;ADGRE1;ANXA1;MYO1F;IGSF6;HLA-DRB1;PTPRC;SLC11A1;SPI1;CLEC12A;ITGAM;CXCL16;HLA-DPA1;CD300LF
prerank,GO_Biological_Process_2021__copper ion transport (GO:0006825),-0.7264517665899742,-1.249963549135885,0.125,0.9344000567678478,1.0,5/10,20.27%,STEAP4;COX17;STEAP2;ATOX1;CUTC
prerank,CellMarker_Augmented_2021__Cartilage Progenitor cell:Cartilage,0.44857155652710207,1.2498131458909874,0.13333333333333333,0.8092492337174968,1.0,25/96,16.74%,TEAD2;GPR161;ADGRL2;ALDH7A1;MID1;GPC6;P3H3;ASAP3;RAI14;SLIT2;TENM3;LRP6;PRTG;CAP2;CHST3;MPDZ;RBFOX2;LRIG3;CDH2;MAGI1;ANTXR1;CSRP2;CALD1;FRAS1;MARK1
prerank,GO_Biological_Process_2021__phospholipid dephosphorylation (GO:0046839),0.5119351308859121,1.2495456217890508,0.15384615384615385,0.8093497260161214,1.0,16/38,26.78%,EPHX2;PLPPR1;MTMR8;PLPP2;PLPPR3;MTMR3;PIP4P2;MTMR1;MTM1;PLPP3;PLPPR5;PTEN;PLPPR4;MTMR11;MTMR9;SYNJ2
prerank,Reactome_2022__Beta Oxidation Of decanoyl-CoA To octanoyl-CoA-CoA R-HSA-77346,0.7570179199072972,1.2495177561962811,0.2127659574468085,0.8086511043635197,1.0,4/6,19.84%,ECHS1;ACADM;MECR;HADHB
prerank,GO_Biological_Process_2021__positive regulation of innate immune response (GO:0045089),-0.5646664212814984,-1.2493977551794129,0.14516129032258066,0.9363568684380486,1.0,5/29,13.53%,TRIM62;WNT5A;IFNK;SPI1;SH2D1B
prerank,CellMarker_Augmented_2021__Goblet cell:Small Intestine,-0.5809926347975068,-1.249127331026848,0.0967741935483871,0.9366877050639352,1.0,7/31,10.89%,ST6GALNAC1;CLCA1;ERN2;PLEKHG6;ESR1;MYO1F;SPINK4
prerank,PanglaoDB_Augmented_2021__Salivary Mucous Cells,-0.5614291569357996,-1.2491024329059006,0.1267605633802817,0.9355802104348004,1.0,13/39,17.99%,CLCA2;DUOXA1;MUCL1;SERPINB5;THBS1;ZNF750;LAMC2;ITGB6;TRIM29;PROM2;ADIRF;SERPINB7;DSG3
prerank,CellMarker_Augmented_2021__Theca Interna cell:Ovarian Follicle,-0.5038103352498896,-1.248406708596495,0.15789473684210525,0.9379188226759293,1.0,22/79,15.25%,OLFML1;LMOD1;GALNT15;LYVE1;ECM2;ANGPTL2;OGN;ADAM33;MASP1;DAAM2;DCN;ASPN;SFRP4;OMD;ANGPTL1;COX7A1;TEK;A2M;C1S;ACTA2;ADGRF5;JAM2
prerank,GO_Biological_Process_2021__adenylate cyclase-modulating G protein-coupled receptor signaling pathway (GO:0007188),0.45086096030310024,1.2482995286654306,0.08823529411764706,0.8128007483140789,1.0,20/121,7.95%,GPR3;LGR5;ADRA1B;ADGRG6;CHRM2;GRK5;GPR161;CRHR2;ADGRL2;HTR1F;GALR3;ADGRG3;DRD5;GRM8;GPR26;GPR78;RXFP1;S1PR5;ABCA1;ADCY2
prerank,GO_Biological_Process_2021__positive regulation of mRNA catabolic process (GO:0061014),0.5081831480467103,1.2481130158749247,0.16666666666666666,0.8126075541744475,1.0,20/42,29.72%,RIDA;NANOS3;KHSRP;MOV10;TNRC6C;PNPT1;YTHDF1;TNRC6A;RC3H1;METTL16;AGO2;NANOS1;RBM24;MEX3D;PABPC1;ROCK1;TNRC6B;YTHDF3;TOB1;ZFP36L2
prerank,GO_Biological_Process_2021__monovalent inorganic anion homeostasis (GO:0055083),0.6582439893969716,1.2480871153174353,0.14285714285714285,0.8111225970327527,1.0,2/10,6.91%,SLC12A1;SLC12A9
prerank,GO_Biological_Process_2021__chloride ion homeostasis (GO:0055064),0.6582439893969716,1.2480871153174353,0.14285714285714285,0.8111225970327527,1.0,2/10,6.91%,SLC12A1;SLC12A9
prerank,GO_Biological_Process_2021__pyrimidine-containing compound catabolic process (GO:0072529),0.6149142160129105,1.2478974739370492,0.19047619047619047,0.8109749511497576,1.0,4/17,12.76%,TET2;NT5C1A;UPP2;NT5C3A
prerank,GO_Biological_Process_2021__regulation of fibrinolysis (GO:0051917),0.6504172527834674,1.2478484356465107,0.22580645161290322,0.8103798985118832,1.0,6/11,10.85%,APOH;KLKB1;SERPINE1;F11;F2;F12
prerank,CellMarker_Augmented_2021__Leydig cell:Fetal Gonad,0.3853892960788666,1.247820636116463,0.0,0.809713854795975,1.0,68/346,16.18%,ZNF385D;EFNB1;LAMA4;PRICKLE1;BTN3A2;PAPSS2;ALCAM;MAFB;CEP135;APOE;RPP25;RAB31;DNAJC30;NAALAD2;SLC39A8;TMEM69;VPS16;PSAT1;GATAD2A;NDUFAF6;HS3ST1;SLC39A11;GALE;EMID1;PI4KB;JAG1;CMSS1;DEPTOR;IKZF4;SLC16A7;TACO1;RIOK1;CDK6;CDK4;PPFIA3;NOL8;MGARP;SLIT2;SUSD4;SCD5;GPHN;TUBE1;PLAGL1;ANGEL1;ADNP2;UAP1;PI4K2B;MRPL41;PDZD8;ODC1;DSEL;BRD3;DPP9;GOLGA3;EARS2;NFKB1;MOB1A;SMG9;SPIDR;PIK3CA;CDH11;GADD45A;ME3;B3GALNT2;KLHL5;ATAD2B;CCDC124;PTCH2
prerank,Reactome_2022__Glucocorticoid Biosynthesis R-HSA-194002,-0.775464754609257,-1.2476901657403543,0.1896551724137931,0.9406419673996799,1.0,5/6,22.45%,CYP21A2;HSD11B1;HSD3B1;CYP17A1;HSD11B2
prerank,GO_Biological_Process_2021__negative regulation of transporter activity (GO:0032410),0.7538201704841181,1.2475857655734284,0.17073170731707318,0.809755372784076,1.0,2/6,7.94%,SNCA;WWP2
prerank,GO_Biological_Process_2021__meiosis I (GO:0007127),-0.5831692483776642,-1.2475002868151606,0.19402985074626866,0.9405847189276724,1.0,6/23,17.23%,MEIOB;SLC25A31;BTBD18;MEIOC;SYCP3;MOV10L1
prerank,GO_Biological_Process_2021__negative regulation of cellular senescence (GO:2000773),0.6571027544303866,1.2474977048673066,0.2857142857142857,0.8094080116160273,1.0,5/13,9.00%,SLC30A10;SIRT1;CDK6;RBL1;TWIST1
prerank,CellMarker_Augmented_2021__Mesenchymal cell:Liver,0.5008791357238395,1.2471491228982745,0.10714285714285714,0.8100971194944898,1.0,15/47,19.16%,ALCAM;SORBS3;ZBTB1;NXT1;EDNRA;FSTL3;LRRC17;MPZL1;COTL1;RAB35;FJX1;RHBDD2;CTSC;ROR1;AKAP12
prerank,GO_Biological_Process_2021__peptidyl-lysine acetylation (GO:0018394),0.67519734290046,1.2471007976329487,0.32558139534883723,0.8094626512782548,1.0,5/9,21.95%,SIRT1;ESCO1;EP300;KAT2B;BAG6
prerank,GO_Biological_Process_2021__positive regulation of voltage-gated calcium channel activity (GO:1901387),-0.7658064262945846,-1.2470608959893725,0.19607843137254902,0.9417472479542455,1.0,1/7,2.13%,STAC
prerank,GO_Biological_Process_2021__regulation of chromosome organization (GO:0033044),-0.6415947213101532,-1.2470117132383303,0.13043478260869565,0.9406304229998917,1.0,3/20,4.27%,BUB1;TERF2IP;SHCBP1L
prerank,CellMarker_Augmented_2021__Lake Et al.Science.Ex7:Brain,0.4333006848177002,1.2468961140641723,0.15384615384615385,0.8094611754272456,1.0,29/100,16.94%,MEGF10;GRID2;ROBO2;NOVA1;NLGN1;MAGI2;SLC35F1;LRFN5;SLIT2;EFS;DOK5;SYNDIG1;GUCY1A2;PDZRN3;WASF3;SNTG2;BRINP1;RNF150;MMP16;CHST8;ASXL3;ANK2;CDH11;UBE2QL1;NRXN1;PTPRD;MAGEL2;PBX1;GRIK3
prerank,Reactome_2022__Release Of Hh-Np From Secreting Cell R-HSA-5362798,-0.8349120681326258,-1.2468125616749997,0.17647058823529413,0.9403540930365744,1.0,1/6,0.22%,NOTUM
prerank,CellMarker_Augmented_2021__Endocrine Progenitor cell:Pancreas,0.4207006613223684,1.246642957791902,0.09523809523809523,0.8097609420835509,1.0,33/97,25.84%,TBC1D16;MID1;PCDH7;KCNIP3;LRRC73;PLXNB1;RND3;B4GALNT4;CAP2;CHST3;DDAH1;RBFOX2;MAP6;MAGI1;SRRM3;ANTXR1;PTPRF;DLG5;MARK1;CDR2L;EPB41L4B;NAV2;PCDH1;GNA11;SHC3;SYT7;PTPN21;EPN2;AGAP1;MAP2;NCS1;FAT1;NLGN2
prerank,GO_Biological_Process_2021__negative regulation of small GTPase mediated signal transduction (GO:0051058),0.5421867911052991,1.2465897078199122,0.10714285714285714,0.8092002740926574,1.0,9/19,23.53%,LZTR1;CGNL1;SLIT2;SPRY4;EPHB2;STAMBP;SPRY1;ARHGAP25;SPRY3
prerank,GO_Biological_Process_2021__sphingolipid catabolic process (GO:0030149),-0.6754020393891288,-1.2463662465691694,0.20634920634920634,0.9416714813163667,1.0,3/15,9.22%,ENPP2;PDXDC1;PPT1
prerank,Reactome_2022__Intrinsic Pathway Of Fibrin Clot Formation R-HSA-140837,-0.6988843163241973,-1.2459121033605651,0.18181818181818182,0.9429057449661109,1.0,5/16,10.59%,F8;SERPIND1;GP1BA;FAM110A;VWF
prerank,"Reactome_2022__Synthesis, Secretion, And Inactivation Of Glucose-dependent Insulinotropic Polypeptide (GIP) R-HSA-400511",-0.7546240858233768,-1.24582521058705,0.07017543859649122,0.9421508589005775,1.0,1/10,0.62%,C1QTNF1
prerank,GO_Biological_Process_2021__sulfur compound biosynthetic process (GO:0044272),0.4430769662520236,1.2458092501890061,0.08695652173913043,0.8112034745040905,1.0,25/92,11.69%,VCAN;PAPSS2;CSGALNACT1;ANGPT1;CHST6;CHSY3;PRELP;GSTM5;CHSY1;CHST12;CBS;ST3GAL3;B4GALT2;CHAC1;UST;GSTO2;B4GALT3;CHPF2;GSTM2;CHST11;CSPG5;CHST3;UGDH;MAT2A;DSEL
prerank,GO_Biological_Process_2021__interleukin-18-mediated signaling pathway (GO:0035655),-0.8068543329789506,-1.2455502437891444,0.16071428571428573,0.9411126213863563,1.0,3/6,15.16%,ALOX5;IL18BP;IL18
prerank,GO_Biological_Process_2021__cellular response to interleukin-18 (GO:0071351),-0.8068543329789506,-1.2455502437891444,0.16071428571428573,0.9411126213863563,1.0,3/6,15.16%,ALOX5;IL18BP;IL18
prerank,GO_Biological_Process_2021__regulation of vascular endothelial growth factor receptor signaling pathway (GO:0030947),-0.6338794707686435,-1.2455117756338947,0.15625,0.9401061207681402,1.0,4/19,13.78%,CNMD;VTN;TMEM204;ITGA5
prerank,GO_Biological_Process_2021__regulation of extrinsic apoptotic signaling pathway in absence of ligand (GO:2001239),0.5763975861379202,1.2454773763319913,0.1,0.8118726094563595,1.0,8/21,12.47%,EYA4;BCL2;FGFR1;HTRA2;SNAI2;PPP2R1B;RET;HSPA1A
prerank,GO_Biological_Process_2021__ubiquinone biosynthetic process (GO:0006744),0.6357309214738928,1.245454932158961,0.1875,0.8103946157867835,1.0,6/13,27.43%,PDSS2;UBIAD1;COQ2;COQ9;COQ6;COQ3
prerank,GO_Biological_Process_2021__quinone biosynthetic process (GO:1901663),0.6357309214738928,1.245454932158961,0.1875,0.8103946157867835,1.0,6/13,27.43%,PDSS2;UBIAD1;COQ2;COQ9;COQ6;COQ3
prerank,GO_Biological_Process_2021__positive regulation of miRNA metabolic process (GO:2000630),0.7329453919995872,1.2453740740762909,0.1951219512195122,0.8098074907176941,1.0,3/6,14.09%,LIN28B;PNPT1;NFKB1
prerank,Reactome_2022__Caspase Activation Via Extrinsic Apoptotic Signaling Pathway R-HSA-5357769,0.5839025293440382,1.244924578022389,0.16666666666666666,0.8108458830800596,1.0,8/23,15.28%,CFLAR;DAPK2;DCC;CASP3;TICAM1;TANK;FADD;MAGED1
prerank,GO_Biological_Process_2021__synaptic vesicle membrane organization (GO:0048499),-0.6572537735260764,-1.244919927811499,0.203125,0.941936553971342,1.0,3/16,20.81%,SNAP23;STX19;TOR1A
prerank,GO_Biological_Process_2021__positive regulation of endothelial cell proliferation (GO:0001938),0.49600848411768483,1.2448066921942875,0.13333333333333333,0.8104872148264556,1.0,11/59,7.74%,TGFBR1;VEGFC;FGFR1;CDH13;SEMA5A;SIRT1;ITGA4;PROX1;HMGB1;ECM1;SP1
prerank,GO_Biological_Process_2021__T-helper cell differentiation (GO:0042093),-0.7116495756211519,-1.2445407570245401,0.2545454545454545,0.9429139163222381,1.0,4/8,13.80%,RORC;GPR183;ZFPM1;LEF1
prerank,CellMarker_Augmented_2021__Endoderm Progenitor cell:Adipose Tissue,-0.5394894741931126,-1.2444779129679098,0.1,0.942056787849109,1.0,19/60,14.86%,C1QB;CYYR1;LYVE1;SLCO2B1;MS4A4A;FCGR3A;CLDN5;ZNF366;VSIG4;HLA-DPB1;SELP;ITGA9;VWF;F13A1;HLA-DPA1;TEK;A2M;GGT5;ADGRF5
prerank,GO_Biological_Process_2021__hippo signaling (GO:0035329),0.6039289411277329,1.2442128562240955,0.14634146341463414,0.8121487560474707,1.0,8/26,16.46%,TEAD2;AMOTL1;LATS1;CASP3;TEAD4;WWTR1;MOB1A;WWC1
prerank,Reactome_2022__Pre-NOTCH Processing In Golgi R-HSA-1912420,0.6300390738410673,1.243874320620192,0.26666666666666666,0.8126420428763953,1.0,5/15,16.67%,RFNG;ST3GAL3;FURIN;ST3GAL6;NOTCH1
prerank,KEGG_2021_Human__ECM-receptor interaction,-0.526249500754155,-1.2438659388415807,0.12987012987012986,0.9443296349632568,1.0,16/76,12.83%,CD44;COL1A1;VTN;GP1BA;COL4A4;ITGA9;TNXB;FREM2;COL4A3;THBS1;VWF;ITGA2B;LAMC2;COL6A6;ITGB6;CHAD
prerank,GO_Biological_Process_2021__regulation of glucose import (GO:0046324),0.521009284693827,1.2438121966314868,0.14705882352941177,0.8121549360167285,1.0,11/30,21.55%,IRS1;CAPN10;PID1;AKT2;IRS2;RTN2;INSR;PRKAG2;OSBPL8;APPL2;OCLN
prerank,GO_Biological_Process_2021__histone H2A ubiquitination (GO:0033522),0.6458934607185268,1.243811041023564,0.1875,0.8113851209114994,1.0,5/16,14.25%,PCGF1;RNF168;UBE2A;RYBP;BCOR
prerank,GO_Biological_Process_2021__regulation of cell cycle process (GO:0010564),-0.5249728917232359,-1.243547525544486,0.2,0.9447694401944031,1.0,8/92,11.55%,NEK2;BUB1;IHO1;RAB11A;GPER1;CAV2;ANKK1;ATF5
prerank,GO_Biological_Process_2021__sphingoid biosynthetic process (GO:0046520),0.6592939759086356,1.2435225436723387,0.25,0.8110954785032142,1.0,2/11,10.38%,ACER2;ACER3
prerank,GO_Biological_Process_2021__sphingosine biosynthetic process (GO:0046512),0.6592939759086356,1.2435225436723387,0.25,0.8110954785032142,1.0,2/11,10.38%,ACER2;ACER3
prerank,PanglaoDB_Augmented_2021__Proximal Tubule Cells,-0.4954101130066535,-1.2434747556643693,0.125,0.9438838455153681,1.0,28/102,14.77%,AMBP;SLC28A1;SLC22A8;BHMT;F7;SLC22A6;SMLR1;SLC5A2;TGFBI;ALDOB;C3P1;SLC5A1;OIT3;CLDN2;DAO;PDZK1;CYP3A4;HNF1A;SLC22A7;SCIN;LRP2;PON1;HSD11B1;HAAO;PPIC;HAO2;NR1H4;CYP2E1
prerank,GO_Biological_Process_2021__nucleic acid-templated transcription (GO:0097659),0.516515545992459,1.2434361483805427,0.16666666666666666,0.8105692509251106,1.0,5/38,8.45%,MLF1;DTX1;PPP5C;TAF1B;NR4A2
prerank,Reactome_2022__Mitochondrial Iron-Sulfur Cluster Biogenesis R-HSA-1362409,0.6393665906595728,1.2433731763245457,0.16666666666666666,0.8099592490611899,1.0,2/11,4.77%,SLC25A37;HSCB
prerank,GO_Biological_Process_2021__mesenchymal cell development (GO:0014031),0.6298317269769184,1.243214774959863,0.20930232558139536,0.809689150686961,1.0,5/12,16.67%,TCOF1;NRG1;SNAI2;CDH2;NOTCH1
prerank,CellMarker_Augmented_2021__Mesenchymal Stem cell:Anterior Cruciate Ligament,-0.5169745964767952,-1.2431671955394954,0.1232876712328767,0.9441957227450147,1.0,15/87,9.78%,CD44;PDCD1LG2;MMP19;TGFBI;COL1A1;APCDD1L;LOX;DAB2;DCN;PLAU;ANXA1;HEG1;OSMR;ITGBL1;THBS1
prerank,CellMarker_Augmented_2021__Granulocyte-monocyte progenitor:Germ,-0.5327032530162465,-1.24300598531111,0.13432835820895522,0.9425601770648555,1.0,20/64,10.89%,GMFG;ITGB2;HCK;DOCK8;CYTIP;ARHGAP9;TAGAP;TNFRSF1B;ARHGAP15;DOCK2;CIITA;GPR183;PARVG;LY86;HLA-DPB1;IL3RA;TRAF3IP3;MYO1F;PTPRC;SPI1
prerank,CellMarker_Augmented_2021__Megakaryocyte-erythroid progenitor:Germ,-0.5327032530162465,-1.24300598531111,0.13432835820895522,0.9425601770648555,1.0,20/64,10.89%,GMFG;ITGB2;HCK;DOCK8;CYTIP;ARHGAP9;TAGAP;TNFRSF1B;ARHGAP15;DOCK2;CIITA;GPR183;PARVG;LY86;HLA-DPB1;IL3RA;TRAF3IP3;MYO1F;PTPRC;SPI1
prerank,Reactome_2022__Metallothioneins Bind Metals R-HSA-5661231,0.7620204956609488,1.242800639680724,0.19148936170212766,0.8104489626364109,1.0,1/6,0.75%,MT1G
prerank,Reactome_2022__RUNX3 Regulates CDKN1A Transcription R-HSA-8941855,-0.7519359126065763,-1.242780400543481,0.203125,0.9424530365631075,1.0,3/6,16.15%,TGFB1;CDKN1A;SMAD3
prerank,GO_Biological_Process_2021__aspartate family amino acid biosynthetic process (GO:0009067),0.6990020691433902,1.242682858732231,0.23076923076923078,0.8100802950424997,1.0,3/6,23.37%,MTR;MTHFR;PLOD2
prerank,CellMarker_Augmented_2021__Neuron:Embryo,0.4893212758562178,1.242648015048914,0.18518518518518517,0.8095293479724603,1.0,25/96,19.78%,SEZ6L;GABRA5;LHFPL4;GRM3;HRH3;ELAVL3;PAK5;SLC35F1;ADGRA1;CELF5;CELF4;MYT1L;SNAP91;RBFOX1;FRRS1L;SCRT1;VSTM2B;NRXN1;JPH4;RIT2;TTYH1;MMD2;ST8SIA3;CTNNA2;PDZD4
prerank,GO_Biological_Process_2021__bone development (GO:0060348),-0.58641190317051,-1.2426173901005857,0.19718309859154928,0.9422779763050839,1.0,5/27,10.28%,NOTUM;CYP26B1;TGM2;SFRP4;PTPRC
prerank,GO_Biological_Process_2021__plasma membrane bounded cell projection assembly (GO:0120031),0.4062454580061078,1.242529881029788,0.125,0.8091481760357037,1.0,74/250,21.50%,PCM1;EMP1;KIT;IFT88;PTPRO;DZIP1L;CDH13;FGD4;PARVA;VSTM5;SCLT1;SRGAP2;FHDC1;GBF1;CILK1;BBS9;FGD5;SPAG16;FLNA;FGD1;RAP2A;CNGA4;TNIK;CEP290;EHD4;RPGR;CEP250;RAB11FIP3;AVIL;PPP1R9B;MKS1;RAP1A;CFAP410;CEP20;TTC36;CCDC88A;RILPL1;PIBF1;ARL13B;EXOC7;KIAA0586;RP2;PTPN23;CEP41;CEP162;FSCN1;CDC14B;IFT140;S1PR1;NEK1;ARL3;NOTCH1;CFAP70;DCDC2;KIF3B;BBIP1;CFAP221;PDE6D;DZIP1;UNC119B;CFAP43;ARFIP2;TMEM67;PTPDC1;VCL;EXOC6;TMEM138;WDR19;TTC39C;IQCB1;POC1B;FBF1;KIF27;EXOC4
prerank,GO_Biological_Process_2021__negative regulation of PERK-mediated unfolded protein response (GO:1903898),0.8079614134130422,1.2425261326305612,0.18,0.8084024609132658,1.0,3/5,18.26%,PPP1R15B;NCK1;ABCA7
prerank,GO_Biological_Process_2021__regulation of filopodium assembly (GO:0051489),0.5198571211740474,1.2423927258998115,0.07407407407407407,0.8080932374606832,1.0,17/39,24.95%,MYO10;NLGN1;TRPM2;RALA;TENM1;FSCN1;MIEN1;DOCK11;RAB5A;FXR2;PLPPR5;PALM;GPM6A;PRKCD;PPP1R16B;CAPZB;TENM2
prerank,KEGG_2021_Human__Adrenergic signaling in cardiomyocytes,0.4435630609094943,1.2423672761042033,0.16666666666666666,0.8074480634472384,1.0,18/127,11.36%,ADRA1A;ADRA1B;TPM2;BCL2;CACNG4;SLC8A1;CREB3L2;CREB3L4;SLC8A3;CACNB4;PLCB1;ADCY2;CACNG2;TPM4;AKT2;CREM;ADCY3;PPP2R1B
prerank,GO_Biological_Process_2021__regulation of monocyte chemotaxis (GO:0090025),0.6306383978736683,1.2423452511437665,0.23809523809523808,0.8067340528184659,1.0,4/18,7.88%,SERPINE1;HMGB1;GREM1;SLIT2
prerank,Reactome_2022__Mitotic Prophase R-HSA-68875,0.45179091769709395,1.2419931325839073,0.08571428571428572,0.8075049388305091,1.0,9/90,11.36%,CTDNEP1;NUP210;NUP42;LMNB1;BLZF1;VRK2;H2BC21;AAAS;PPP2R1B
prerank,CellMarker_Augmented_2021__Neuron:Adipose Tissue,0.4506477889025216,1.2419576739957028,0.1,0.8069040718568667,1.0,33/99,26.20%,GABRA5;LHFPL4;HRH3;ELAVL3;ERC2;ADGRA1;SYT1;CASKIN1;CPT1C;CELF5;BRINP1;NXPH1;RIMS4;TYRO3;KIAA1549L;FBLL1;SNAP91;SCRT1;SRRM3;EFR3B;ST8SIA3;HPCA;PLPPR5;JPH3;SNCB;SHC3;ABCG4;TUBB2B;CACNA1B;MAP2;TAGLN3;KCNQ2;KCTD16
prerank,GO_Biological_Process_2021__regulation of phospholipase C activity (GO:1900274),0.6201515051063353,1.2418618391565592,0.17073170731707318,0.8065138727576763,1.0,5/14,8.76%,KIT;FGFR1;BICD1;ABL1;ABL2
prerank,GO_Biological_Process_2021__regulation of microvillus organization (GO:0032530),-0.7461173492255143,-1.2416924221858066,0.30434782608695654,0.9458886103684093,1.0,1/8,1.01%,CDHR5
prerank,Reactome_2022__Gap Junction Degradation R-HSA-190873,-0.7271550275982225,-1.2416656740834504,0.2835820895522388,0.9447959810745249,1.0,1/10,6.21%,DAB2
prerank,GO_Biological_Process_2021__endothelium development (GO:0003158),0.7563301044902002,1.2413987876288173,0.21951219512195122,0.8076038106789831,1.0,2/8,5.28%,SCUBE1;JAG1
prerank,GO_Biological_Process_2021__regulation of complement-dependent cytotoxicity (GO:1903659),0.7114884084435289,1.2412117264719082,0.2,0.8075065040707556,1.0,3/7,21.96%,CFH;IL11;CD55
prerank,Reactome_2022__G Alpha (Q) Signaling Events R-HSA-416476,0.42654269268793965,1.2411659370658499,0.0625,0.8070193190968986,1.0,14/159,5.66%,ADRA1A;TACR3;NTSR2;ADRA1B;DGKD;GRK5;ITPR2;TRPC3;HTR2C;QRFPR;RIPK2;RGS16;PROKR2;UTS2R
prerank,GO_Biological_Process_2021__epithelial tube branching involved in lung morphogenesis (GO:0060441),0.7745390962862112,1.2410921822791734,0.19672131147540983,0.8064495340729128,1.0,1/5,1.19%,FGF10
prerank,GO_Biological_Process_2021__atrial cardiac muscle cell to AV node cell signaling (GO:0086026),-0.8376893124583056,-1.240928455660232,0.19672131147540983,0.9475008378763061,1.0,3/7,8.12%,SCN5A;KCNA5;KCNQ1
prerank,Reactome_2022__Prefoldin Mediated Transfer Of Substrate To CCT/TriC R-HSA-389957,-0.6311736274052977,-1.2408235800993646,0.18032786885245902,0.946864490096903,1.0,14/24,29.61%,TUBA4A;CCT6B;TUBA3D;TUBB;TUBB6;TUBB2A;TUBB4A;TUBB4B;PFDN6;CCT6A;CCT8;CCT7;CCT2;VBP1
prerank,PanglaoDB_Augmented_2021__T Cells,0.46656647391816247,1.2405276508257927,0.05263157894736842,0.8079248145266563,1.0,15/91,5.28%,IL7R;SELPLG;DUSP2;SKAP1;CD247;TRAC;EEF1B2P3;BCL2;RORA;GPR174;TGIF1;IL16;CCL4L2;PYHIN1;SYT3
prerank,GO_Biological_Process_2021__regulation of epithelial to mesenchymal transition (GO:0010717),0.47996063040796383,1.2402791093866086,0.10714285714285714,0.8081331929478177,1.0,15/62,14.49%,PHLDB2;BAMBI;TGFBR1;SPRED3;IL17RD;EPHA3;ZNF703;GREM1;SPRED2;TWIST1;ADIPOR1;SPRED1;BCL9L;SMAD2;WWTR1
prerank,Reactome_2022__Signaling By ERBB2 R-HSA-1227986,0.4726596543865745,1.2401738879769988,0.14814814814814814,0.808008088574742,1.0,16/47,27.85%,NRG2;ERBB2;NRG1;NRG3;AKT2;PIK3CA;MATK;SOS1;PRKCE;ERBB3;PTPN12;PRKCD;BTC;AKT3;AKT1;FYN
prerank,Reactome_2022__Phosphorylation Of APC/C R-HSA-176412,0.615583717812424,1.2401577770790095,0.22857142857142856,0.8073285702843085,1.0,8/18,28.54%,UBE2E1;ANAPC16;CDC26;ANAPC7;PLK1;ANAPC4;ANAPC2;CDK1
prerank,GO_Biological_Process_2021__transcription by RNA polymerase II (GO:0006366),0.39246315840943213,1.2400936692229978,0.0,0.8068026967287028,1.0,65/290,18.53%,TEAD2;ESRRG;CPSF1;INTS11;HDAC3;PKNOX1;LSM10;MED17;RORA;HDAC10;RARB;ZBTB7B;CCN2;CBFB;PPARG;PCF11;DTX1;ELOF1;MAML1;RORB;IWS1;GTF2I;ELP4;ARRB2;ZBTB1;SP1;TAF3;NR4A2;SNRPB;TAF12;ELOA;CCNH;INTS14;INTS9;CPSF7;TEAD4;NR3C2;HDAC1;MED16;TRIP13;NR3C1;NFKB1;MLLT3;GTF2F2;SOX5;WWTR1;TFCP2;THRB;SNAPC3;NFIC;NR1H3;NR6A1;NRBF2;NR4A3;SETD2;NOTCH1;ICE1;NR2C1;PAPOLA;TAF4;ERCC3;RBPJ;NFX1;RPRD2;NR4A1
prerank,Reactome_2022__Cation-coupled Chloride Cotransporters R-HSA-426117,0.6909319756760064,1.2400881144794262,0.21739130434782608,0.8060701887489716,1.0,1/7,2.63%,SLC12A1
prerank,Reactome_2022__SUMOylation Of Immune Response Proteins R-HSA-4755510,-0.69478093871618,-1.2398566520499115,0.20634920634920634,0.951243607169294,1.0,1/10,7.07%,NFKB2
prerank,Reactome_2022__Signaling By BMP R-HSA-201451,0.5651165172719341,1.2394605797347718,0.23529411764705882,0.8076206051421219,1.0,13/22,25.69%,GREM2;ZFYVE16;AMH;SMURF1;SKI;ACVR2A;FSTL1;BMPR2;SMAD5;SMAD7;BMPR1A;UBE2D3;BMP2
prerank,GO_Biological_Process_2021__nucleotide-binding oligomerization domain containing 2 signaling pathway (GO:0070431),0.7780988705879988,1.2391118733312216,0.2549019607843137,0.8080353339773627,1.0,2/5,3.92%,IRGM;RIPK2
prerank,CellMarker_Augmented_2021__Circulating Fetal cell:Peripheral Blood,-0.5135252942146724,-1.2388561921877517,0.1780821917808219,0.951583689534071,1.0,9/90,7.93%,TICRR;POLQ;DTL;CEP55;CDC25A;ZWILCH;TTK;SHCBP1;DARS2
prerank,CellMarker_Augmented_2021__Megakaryocyte Progenitor cell:Subcutaneous Adipose Tissue,-0.5135252942146724,-1.2388561921877517,0.1780821917808219,0.951583689534071,1.0,9/90,7.93%,TICRR;POLQ;DTL;CEP55;CDC25A;ZWILCH;TTK;SHCBP1;DARS2
prerank,CellMarker_Augmented_2021__Erythroblast:Blood,-0.5135252942146724,-1.2388561921877517,0.1780821917808219,0.951583689534071,1.0,9/90,7.93%,TICRR;POLQ;DTL;CEP55;CDC25A;ZWILCH;TTK;SHCBP1;DARS2
prerank,CellMarker_Augmented_2021__Mast Cell progenitor:Bone Marrow,-0.5135252942146724,-1.2388561921877517,0.1780821917808219,0.951583689534071,1.0,9/90,7.93%,TICRR;POLQ;DTL;CEP55;CDC25A;ZWILCH;TTK;SHCBP1;DARS2
prerank,Reactome_2022__Gastrin-CREB Signaling Pathway Via PKC And MAPK R-HSA-881907,0.6351110833042387,1.2388499482375772,0.21875,0.8082560670131372,1.0,5/14,24.09%,RPS6KA3;RPS6KA2;CREB1;SOS1;CCKBR
prerank,Reactome_2022__Complement Cascade R-HSA-166658,-0.5843766790641036,-1.2387098717572618,0.21212121212121213,0.9512546872035125,1.0,13/35,18.96%,C1QB;VTN;C3AR1;MASP1;CPB2;CLU;C4BPA;MASP2;C4BPB;C1S;ELANE;CD81;PSMA7
prerank,GO_Biological_Process_2021__regulation of calcium-mediated signaling (GO:0050848),0.5920302175535084,1.238498165096141,0.24324324324324326,0.8088073403523895,1.0,3/18,3.26%,NEUROD2;RGN;CDH13
prerank,GO_Biological_Process_2021__intracellular sterol transport (GO:0032366),0.6032040752487822,1.2384747252910737,0.2564102564102564,0.8081590195919138,1.0,6/12,28.92%,ABCA1;STARD4;NPC2;ABCG1;SERAC1;ARV1
prerank,GO_Biological_Process_2021__cilium movement (GO:0003341),-0.5235546515810153,-1.238434295506827,0.18840579710144928,0.9515891425056033,1.0,11/45,17.71%,DNAH11;TEKT5;CCDC39;TEKT3;DNHD1;ODAD1;DNAH17;CFAP61;DNAI1;ZBBX;RSPH9
prerank,GO_Biological_Process_2021__synaptic vesicle cycle (GO:0099504),0.5337687163041702,1.2382113888924875,0.15151515151515152,0.8081450400374477,1.0,6/27,8.91%,SLC17A6;NLGN1;PCLO;SNCA;SYNDIG1;WNT3A
prerank,GO_Biological_Process_2021__regulation of transcription from RNA polymerase II promoter in response to oxidative stress (GO:0043619),0.7445644912495188,1.237919588203204,0.2857142857142857,0.8084336179399442,1.0,2/7,20.51%,SESN2;HIF1A
prerank,GO_Biological_Process_2021__negative regulation of neuron projection development (GO:0010977),0.4867671554793385,1.2376952756512032,0.15625,0.8085568000633061,1.0,10/55,9.71%,TSKU;APOE;NLGN1;PTPRO;KIAA0319;BCL11A;DCC;PTPN9;WNT3A;KANK1
prerank,GO_Biological_Process_2021__polyol biosynthetic process (GO:0046173),0.6027010444020164,1.2376946210872715,0.2391304347826087,0.807828731045486,1.0,8/15,30.63%,ITPKB;ACER3;IP6K1;IPPK;IP6K2;CYP27A1;PPIP5K1;ISYNA1
prerank,GO_Biological_Process_2021__negative regulation of protein modification by small protein conjugation or removal (GO:1903321),0.4618957313394171,1.2376535582981065,0.125,0.8072391330124775,1.0,9/46,13.66%,PER2;SPOPL;CRY1;ARRB2;SIRT7;GNL3L;N4BP1;HSPA1A;ARRB1
prerank,GO_Biological_Process_2021__valine metabolic process (GO:0006573),0.7563016355665941,1.2375422597870238,0.20588235294117646,0.8069931416296986,1.0,3/5,18.76%,BCAT1;HIBADH;HIBCH
prerank,GO_Biological_Process_2021__negative regulation of cytokine production involved in immune response (GO:0002719),-0.7326824343180602,-1.2374006415116128,0.2033898305084746,0.9562574879495622,1.0,3/11,15.53%,TGFB1;TGFB3;HLA-F
prerank,CellMarker_Augmented_2021__Multipotent Progenitor cell:Undefined,-0.5339672137586771,-1.2371558428503453,0.14473684210526316,0.9564791559347158,1.0,18/74,8.55%,C1QB;JCHAIN;CMAHP;GMFG;ARHGAP9;TAGAP;TNFRSF1B;ARHGAP15;DOCK2;CIITA;C3AR1;MS4A4A;PARVG;FCGR3A;P2RY14;VSIG4;HLA-DPB1;SELP
prerank,GO_Biological_Process_2021__thiamine-containing compound metabolic process (GO:0042723),-0.7664644674147048,-1.2370167637689538,0.1724137931034483,0.9559254713942881,1.0,3/6,16.49%,ACP3;SLC25A19;SLC19A3
prerank,GO_Biological_Process_2021__positive regulation of deacetylase activity (GO:0090045),0.7489819998005017,1.236716227540532,0.1956521739130435,0.809321045272509,1.0,2/6,12.75%,MAPK8;FNTA
prerank,GO_Biological_Process_2021__cellular lipid catabolic process (GO:0044242),-0.5820897203526566,-1.2365373183729877,0.12903225806451613,0.9573983826342713,1.0,2/25,3.70%,ENPP2;CYP1B1
prerank,GO_Biological_Process_2021__protein depolymerization (GO:0051261),-0.5973761922515246,-1.2363628689556612,0.2112676056338028,0.9571597675152539,1.0,8/27,23.93%,KIF14;VIL1;CFL1;STMN4;KIF18A;STMN1;STMND1;DSTN
prerank,GO_Biological_Process_2021__negative regulation by host of viral process (GO:0044793),-0.8001377096358494,-1.2363491921876757,0.23076923076923078,0.955959479215467,1.0,1/6,9.15%,PTX3
prerank,Reactome_2022__Beta Defensins R-HSA-1461957,-0.7850413010007113,-1.2363450587420965,0.234375,0.9547147403102384,1.0,3/5,19.90%,DEFB109B;TLR2;DEFB119
prerank,PanglaoDB_Augmented_2021__Trophoblast Progenitor Cells,-0.49826909866379143,-1.23627716282101,0.12,0.9539198748882993,1.0,14/69,17.12%,DENND1C;IRF1;LRP10;DTX2;NFKB2;ST6GALNAC2;DEF6;MMP25;CXCL16;FOXO4;SYTL1;HLA-F;LITAF;VASP
prerank,Reactome_2022__Gastrulation R-HSA-9758941,-0.715566107811154,-1.2362543095299534,0.22388059701492538,0.9527664329142125,1.0,3/11,16.15%,TCF7;LEF1;SMAD3
prerank,CellMarker_Augmented_2021__Dendritic cell:Bone Marrow,-0.5440300713477624,-1.236000140382899,0.18309859154929578,0.952914502824954,1.0,24/53,20.41%,GMFG;ITGB2;HCK;CYTIP;TAGAP;PTAFR;HLA-DMA;GPR183;PARVG;LY86;HLA-DPB1;HLA-DRB1;PTPRC;SPI1;ITGAM;HLA-DPA1;CD80;IKZF1;NAPSB;ALOX5AP;SASH3;TFEC;ITGAX;CD86
prerank,Reactome_2022__Transport Of SLBP Dependant Mature mRNA R-HSA-159230,0.5267538594518535,1.2349406646133172,0.13513513513513514,0.8153372197245955,1.0,12/34,27.98%,NUP210;NUP42;NXF1;AAAS;RANBP2;EIF4E;NUP214;TPR;SEH1L;NUP153;NUP98;NUP37
prerank,Reactome_2022__rRNA Modification In Mitochondrion R-HSA-6793080,0.8037360739568938,1.2346350647751951,0.13157894736842105,0.8158360011935081,1.0,1/5,2.74%,TFB1M
prerank,GO_Biological_Process_2021__positive regulation of macrophage migration (GO:1905523),-0.6691857590149114,-1.2346048946487642,0.21818181818181817,0.9595842419969818,1.0,5/16,25.89%,P2RY12;THBS1;CSF1R;CXCL17;CCL5
prerank,Reactome_2022__Scavenging By Class F Receptors R-HSA-3000484,0.7414732234023159,1.2345867880621413,0.24,0.8152417870291282,1.0,1/6,2.65%,APOB
prerank,GO_Biological_Process_2021__negative regulation of cellular protein metabolic process (GO:0032269),0.4673995843023434,1.234535237411183,0.11538461538461539,0.8147441265774232,1.0,24/87,20.92%,CSTA;APOE;SAMD4A;PCIF1;DHFR;TRIM71;RIDA;F2;EIF2AK3;NANOS3;CNOT9;NFKB1;PUS7;MALSU1;SYNCRIP;LSM14A;SAMD4B;DNAJC1;CDK5;EIF4A3;NANOS1;RNF139;FXR2;LARP1
prerank,CellMarker_Augmented_2021__Primitive Vesicle cell:Fetal Kidney,-0.7280056683104976,-1.2344703355280424,0.2542372881355932,0.9590235333252292,1.0,4/8,23.27%,RSPO1;CAMK2A;RFPL1;KREMEN2
prerank,GO_Biological_Process_2021__L-alanine transport (GO:0015808),0.7447891018191954,1.2343154006673567,0.20512820512820512,0.8148196731273191,1.0,1/7,1.04%,SLC38A5
prerank,GO_Biological_Process_2021__negative regulation of microtubule depolymerization (GO:0007026),0.5900796961544095,1.234265933245293,0.21875,0.8142280057969331,1.0,8/21,29.79%,NAV3;CAMSAP3;ATXN7;CIB1;MID1IP1;APC2;FGF13;CLASP2
prerank,CellMarker_Augmented_2021__Neural cell:Embryoid Body,0.47319418290362936,1.2339327860146967,0.13333333333333333,0.8145759127472546,1.0,28/92,16.74%,MEGF10;GRID2;NLGN1;EPHA7;IGDCC3;IL17RD;UNC5D;PAK5;SLC35F1;PTPRZ1;VAT1L;ERC2;BRINP1;STOX2;NLGN4X;ADGRV1;CRABP1;SNAP91;MAP6;MSI1;SYT6;ANK2;ZNF663P;NRXN1;WNK3;PTPRD;MAGEL2;MARK1
prerank,GO_Biological_Process_2021__leukotriene biosynthetic process (GO:0019370),-0.6522975899416203,-1.2338495574798827,0.2,0.9611551037068681,1.0,4/12,17.79%,ALOX5;GGT5;PLA2G4A;ALOX5AP
prerank,GO_Biological_Process_2021__regulation of adenylate cyclase-activating G protein-coupled receptor signaling pathway (GO:0106070),0.7533558470054373,1.233738364942416,0.1956521739130435,0.8147329406759122,1.0,1/5,1.07%,MRAP2
prerank,CellMarker_Augmented_2021__CD4+ Memory T cell:Lymphoid Tissue,-0.5755992881711925,-1.2334817927285266,0.13432835820895522,0.9619516381745967,1.0,14/46,13.88%,SIRPG;GMFG;CYTIP;TBC1D10C;ARHGAP9;TAGAP;TMC8;CD5;WAS;CD37;TRAF3IP3;CXCR5;CD27;PSTPIP1
prerank,GO_Biological_Process_2021__antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885),-0.736952573857878,-1.2331792126603953,0.21568627450980393,0.9624165185701787,1.0,3/7,18.50%,HLA-A;ERAP2;ERAP1
prerank,GO_Biological_Process_2021__regulation of T cell migration (GO:2000404),-0.6938541586719175,-1.2331367269662397,0.22807017543859648,0.9614412288330746,1.0,2/12,12.51%,DOCK8;APOD
prerank,GO_Biological_Process_2021__acylglycerol metabolic process (GO:0006639),0.5349649726656786,1.2330603775451494,0.15151515151515152,0.8163016648755667,1.0,7/32,11.11%,DGKD;APOH;APOE;PNPLA3;LPL;PGS1;AWAT2
prerank,Reactome_2022__Degradation Of Extracellular Matrix R-HSA-1474228,-0.5112150308314333,-1.2329206353137119,0.08974358974358974,0.9615580304379991,1.0,9/87,6.82%,CD44;MMP9;CAPN8;MMP19;SCUBE3;COL18A1;NID1;CAPN12;DCN
prerank,Reactome_2022__Hedgehog Ligand Biogenesis R-HSA-5358346,-0.5324815249479846,-1.2327922960825928,0.1527777777777778,0.9610929157928793,1.0,2/56,0.62%,NOTUM;PSMB9
prerank,GO_Biological_Process_2021__regulation of proton transport (GO:0010155),0.7022896212583534,1.2326632657510386,0.1875,0.816755261023699,1.0,2/7,12.32%,DNAJC30;ATPSCKMT
prerank,GO_Biological_Process_2021__brain development (GO:0007420),0.42249811180043356,1.23263334837229,0.05555555555555555,0.8160832072122618,1.0,28/125,17.99%,KLHL17;ROBO2;ADGRL2;EPHA7;MFSD2A;DSCAML1;DNAJC30;PITPNM1;CX3CR1;ATXN1;CNTNAP2;SPEF2;JHY;PROX1;MAST1;SLC6A17;GRIN1;BPTF;NFIB;CDH2;UTP3;NF1;SMG9;AMIGO2;MDGA1;PBX1;NIPBL;MACROH2A2
prerank,Reactome_2022__NR1H2 And NR1H3-mediated Signaling R-HSA-9024446,0.5315407888098435,1.232408341533612,0.17857142857142858,0.8164684806564758,1.0,13/40,21.85%,HDAC3;APOE;NRIP1;ABCA1;MOV10;TNRC6C;NR1H3;TNRC6A;AGO3;EP300;AGO2;TBL1X;ABCG8
prerank,GO_Biological_Process_2021__regulation of apoptotic signaling pathway (GO:2001233),0.5610006354934319,1.2323036630377733,0.06451612903225806,0.8162443135711593,1.0,7/33,8.45%,TGFBR1;BCL2;DAPK2;CX3CR1;DEPTOR;STYXL1;NR4A2
prerank,"GO_Biological_Process_2021__tRNA splicing, via endonucleolytic cleavage and ligation (GO:0006388)",0.6333850702161025,1.2322107854959508,0.14285714285714285,0.8158043047549851,1.0,1/15,1.41%,CPSF1
prerank,Reactome_2022__Transport Of Mature mRNA Derived From An Intronless Transcript R-HSA-159231,0.5082062175690928,1.2321110387863359,0.15,0.8154326062915451,1.0,5/40,10.02%,CPSF1;NUP210;NUP42;NXF1;AAAS
prerank,GO_Biological_Process_2021__positive regulation of binding (GO:0051099),0.48225394984477993,1.2320797027239159,0.09090909090909091,0.8147917572276895,1.0,14/80,11.34%,BAMBI;NGF;APOE;RIPK2;PPARG;RALB;PYHIN1;HES1;HMGB1;MED25;WNT3A;EPB41;ZNF618;GPSM1
prerank,Reactome_2022__Expression And Translocation Of Olfactory Receptors R-HSA-9752946,-0.5468116121983431,-1.2318650914671043,0.17105263157894737,0.9650604751511285,1.0,20/53,17.43%,OR13A1;OR2H2;OR2T6;OR52A5;OR51M1;OR2G6;OR10A2;OR52I2;OR51I2;OR5V1;OR2AJ1;OR52N2;OR7C1;OR2AG1;OR56A3;OR1L8;OR2T12;OR9Q1;OR1L6;OR2M4
prerank,Reactome_2022__Signaling By NOTCH2 R-HSA-1980145,0.542465315978985,1.231753128645318,0.18181818181818182,0.8153112475990723,1.0,11/29,22.85%,MAML1;JAG1;MAMLD1;RBPJ;MIB2;ADAM10;EP300;CREB1;CNTN1;JAG2;MIB1
prerank,GO_Biological_Process_2021__vesicle fusion with endoplasmic reticulum-Golgi intermediate compartment (ERGIC) membrane (GO:1990668),0.7304409099972307,1.231515767110509,0.23214285714285715,0.8153988664662218,1.0,2/5,25.38%,SEC22B;TAPBP
prerank,GO_Biological_Process_2021__negative regulation of peptidyl-serine phosphorylation (GO:0033137),0.6262961165766091,1.2314973864335144,0.2,0.8147059580538586,1.0,10/19,22.14%,RASSF2;NLRP2B;MLXIPL;GADD45A;NCK1;DMD;PDE4D;NCK2;PTEN;SMAD7
prerank,GO_Biological_Process_2021__Golgi disassembly (GO:0090166),0.7548101060387425,1.2311826963960906,0.20930232558139536,0.8149687166066533,1.0,3/7,13.92%,STX5;GBF1;PLK3
prerank,GO_Biological_Process_2021__positive regulation of CREB transcription factor activity (GO:0032793),0.5836875748078212,1.2311496881822566,0.21428571428571427,0.8142774383259633,1.0,5/18,22.38%,OPRD1;LRP8;RPS6KA4;TSSK4;CRTC1
prerank,GO_Biological_Process_2021__T cell apoptotic process (GO:0070231),0.7343636536905399,1.2310601334149394,0.16666666666666666,0.8139362796804173,1.0,1/6,1.59%,CLC
prerank,GO_Biological_Process_2021__cholesterol homeostasis (GO:0042632),0.5004144192396096,1.230875173579535,0.15625,0.8140113316147206,1.0,14/62,9.94%,CYP7B1;TSKU;LIPC;EPHX2;RORA;APOB;APOE;SOAT1;SIRT1;AKR1C1;SOAT2;ABCA1;LPL;LDLR
prerank,GO_Biological_Process_2021__positive regulation of dendrite extension (GO:1903861),0.5367447567347414,1.2308354525009846,0.17142857142857143,0.8134433168573866,1.0,7/17,17.08%,SYT3;SYT17;SYT1;RIMS2;CPNE6;SMURF1;CPNE9
prerank,Reactome_2022__NR1H3 And NR1H2 Regulate Gene Expression Linked To Cholesterol Transport And Efflux R-HSA-9029569,0.5624729430914615,1.2308348205017403,0.18518518518518517,0.8127157289174426,1.0,12/32,21.85%,HDAC3;APOE;ABCA1;MOV10;TNRC6C;NR1H3;TNRC6A;AGO3;EP300;AGO2;TBL1X;ABCG8
prerank,GO_Biological_Process_2021__clathrin coat assembly (GO:0048268),0.5932804713483936,1.230613832900323,0.16129032258064516,0.8129922276386545,1.0,2/15,12.02%,HIP1;SGIP1
prerank,GO_Biological_Process_2021__glycerophospholipid catabolic process (GO:0046475),-0.6293592680626465,-1.2305948865037002,0.19642857142857142,0.9709453929144006,1.0,2/23,6.32%,ENPP2;PLA2G10
prerank,Reactome_2022__Neurexins And Neuroligins R-HSA-6794361,0.4813064883082185,1.2305557834382355,0.07894736842105263,0.8125335126253949,1.0,15/56,13.93%,LLGL1;GPRIN1;NLGN1;LRRTM3;DLGAP4;APBA3;SYT1;EPB41;EPB41L5;SHARPIN;SYT12;NLGN4X;APBA1;NLGN3;MPP2
prerank,GO_Biological_Process_2021__regulation of protein localization to cell cortex (GO:1904776),-0.7060059244321604,-1.230554017827485,0.2222222222222222,0.9699654325562496,1.0,2/8,5.55%,MISP;GPSM2
prerank,Reactome_2022__Interleukin-35 Signaling R-HSA-8984722,-0.6619825450237559,-1.2300727396038758,0.22413793103448276,0.9714518836873293,1.0,2/12,14.26%,STAT1;IL12A
prerank,CellMarker_Augmented_2021__Endothelial cell:Embryo,-0.5593744524764007,-1.2300439172931068,0.11842105263157894,0.9704178507016898,1.0,17/55,13.10%,C1QB;LYVE1;HCK;TNFRSF1B;C3AR1;MS4A4A;FCGR3A;CLDN5;ZNF366;VSIG4;SELP;VWF;SPI1;ITGAM;FPR3;F13A1;HLA-DPA1
prerank,"KEGG_2021_Human__Growth hormone synthesis, secretion and action",0.42618778840704274,1.2300006728409134,0.08695652173913043,0.8137572912165851,1.0,34/103,22.92%,ITPR2;IRS1;CREB3L2;SHC4;CREB3L4;STAT5B;CRK;PLCB1;MAPK8;ADCY2;MAP3K1;AKT2;IRS2;ADCY3;JUNB;IRS4;PIK3CA;MAPK12;CRKL;ADCY6;EP300;CREB1;SOS1;MAP2K6;GNAQ;RAF1;FOS;GNAI2;GNAS;PLCG2;GNA11;SHC3;SSTR3;CREB3L1
prerank,Reactome_2022__Recycling Of Bile Acids And Salts R-HSA-159418,-0.6393719728565621,-1.2299370763006923,0.16417910447761194,0.969777438932906,1.0,8/14,21.90%,SLC51A;NR1H4;STARD5;SLC10A1;SLCO1A2;ABCB11;SLC27A5;ALB
prerank,GO_Biological_Process_2021__positive regulation of leukocyte activation (GO:0002696),-0.6469207048445274,-1.2298706067598568,0.19047619047619047,0.9688690331467958,1.0,2/13,9.78%,WNT5A;THBS1
prerank,Reactome_2022__Vasopressin Regulates Renal Water Homeostasis Via Aquaporins R-HSA-432040,-0.5948185773252322,-1.2298681334493364,0.16666666666666666,0.9676472271686114,1.0,7/33,14.93%,AQP3;RAB11A;MYO5B;GNGT1;AQP4;NLRP3;ADCY7
prerank,GO_Biological_Process_2021__negative regulation of interleukin-2 production (GO:0032703),-0.6334250599756392,-1.229833249729954,0.1935483870967742,0.9665490811905044,1.0,4/17,10.28%,SFTPD;VSIG4;GBP1;PTPRC
prerank,Reactome_2022__Transport Of SLBP Independent Mature mRNA R-HSA-159227,0.5321486332557763,1.2298023739658022,0.1388888888888889,0.8136187455988635,1.0,12/33,27.98%,NUP210;NUP42;NXF1;AAAS;RANBP2;EIF4E;NUP214;TPR;SEH1L;NUP153;NUP98;NUP37
prerank,GO_Biological_Process_2021__cellular polysaccharide biosynthetic process (GO:0033692),0.5532615094719391,1.2296987350537774,0.1935483870967742,0.8132939266973342,1.0,6/21,13.48%,CSGALNACT1;EXT1;NDST3;HS2ST1;EXT2;FUT9
prerank,GO_Biological_Process_2021__metal ion export (GO:0070839),-0.6365490716822431,-1.2296567671784175,0.2112676056338028,0.9662780380160166,1.0,7/23,19.66%,KCNA5;ATP1A4;KCNQ1;SLC11A1;KCNE3;ATP4A;ATP1A1
prerank,GO_Biological_Process_2021__protein deglycosylation (GO:0006517),0.7229201610178266,1.229503582520031,0.25,0.813249216889426,1.0,2/8,12.48%,MAN2A1;NGLY1
prerank,GO_Biological_Process_2021__positive regulation of cellular catabolic process (GO:0031331),0.42963046638089936,1.2292923748892277,0.18518518518518517,0.813271082435129,1.0,40/125,21.18%,IRGM;FOXO1;IRS1;APOE;PLIN5;SNCA;ZBTB20;TRIM8;HMGB1;DHRSX;DXO;KHSRP;RNF152;TWIST1;MOV10;AKT2;ABCD2;LIN28B;IRS2;TRIM65;PIM2;MLXIPL;TICAM1;SNX9;PNPT1;INSR;FURIN;GPLD1;TFEB;RC3H1;FAF1;ATF6;PFKFB4;PRKAA2;MID2;TRIM14;HIF1A;LAPTM5;PFKFB3;MTDH
prerank,GO_Biological_Process_2021__positive regulation of telomere maintenance (GO:0032206),-0.5887069459806039,-1.229269929937383,0.2191780821917808,0.967108465418643,1.0,1/30,0.37%,NEK2
prerank,GO_Biological_Process_2021__transport across blood-brain barrier (GO:0150104),-0.5054067494487493,-1.2286530837703502,0.16176470588235295,0.9692117191838041,1.0,7/79,8.58%,SLC28A2;SLC22A8;SLC7A3;SLCO2B1;SLC5A1;ATP1A4;ABCG2
prerank,GO_Biological_Process_2021__activation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0006919),0.4582826339527642,1.2285019293106914,0.17857142857142858,0.8156049102900339,1.0,15/65,14.12%,NGF;EGLN3;CFLAR;HIP1;PPARG;SNCA;ACER2;EIF2AK3;SENP1;ANP32B;F2R;FADD;CRADD;CASP8AP2;BID
prerank,GO_Biological_Process_2021__negative regulation of muscle hypertrophy (GO:0014741),-0.7543409547424158,-1.2283922073050442,0.22580645161290322,0.9694458219043858,1.0,1/7,2.76%,CAV3
prerank,KEGG_2021_Human__Circadian rhythm,0.571033379506152,1.2281834336579087,0.2,0.8159432605481177,1.0,5/28,5.42%,PER2;RORA;RORB;CRY1;PER3
prerank,Reactome_2022__Cell Recruitment (Pro-Inflammatory Response) R-HSA-9664424,-0.64879908538073,-1.228171512188454,0.18032786885245902,0.9692277847852303,1.0,7/18,16.84%,C3AR1;NFKB2;NLRP3;PSTPIP1;IL18;TXNIP;NT5E
prerank,GO_Biological_Process_2021__glucocorticoid metabolic process (GO:0008211),-0.7460225380207534,-1.2281210595513454,0.23636363636363636,0.968264798145501,1.0,5/7,22.45%,CYP21A2;HSD11B1;HSD3B1;CYP17A1;HSD11B2
prerank,GO_Biological_Process_2021__positive regulation of muscle contraction (GO:0045933),0.7025765114616821,1.2279456409280316,0.2391304347826087,0.8160422624267469,1.0,5/6,29.33%,NMU;F2R;ENO1;SRF;MYOCD
prerank,PanglaoDB_Augmented_2021__Airway Smooth Muscle Cells,0.4464043503874658,1.2277872995440273,0.08695652173913043,0.8160748286481978,1.0,15/79,9.01%,RSPO3;FIBIN;TPM2;ADAMTS1;LAMA4;VEGFC;LOXL1;MRGPRF;TWIST2;ITGA8;COL12A1;MMP2;CNN1;EDNRA;SNAI2
prerank,GO_Biological_Process_2021__mitochondrion localization (GO:0051646),0.6021777492849326,1.2270521611533398,0.22857142857142856,0.8181463477422346,1.0,6/18,20.11%,MSTO1;TRAK2;MARK1;BRAT1;MARK2;MTM1
prerank,GO_Biological_Process_2021__midbody abscission (GO:0061952),-0.641460149698714,-1.227036085963071,0.17391304347826086,0.9730125350999161,1.0,3/13,12.70%,CEP55;CHMP3;MITD1
prerank,GO_Biological_Process_2021__positive regulation of synapse maturation (GO:0090129),0.6916665904867204,1.2270226976779228,0.2702702702702703,0.8175552508002819,1.0,4/8,25.48%,NEUROD2;NRXN1;ADGRL1;ANAPC2
prerank,GO_Biological_Process_2021__muscle cell migration (GO:0014812),0.7041726341369587,1.2268585936882312,0.15789473684210525,0.8173484893198364,1.0,1/8,1.01%,MEGF10
prerank,GO_Biological_Process_2021__intermediate filament bundle assembly (GO:0045110),-0.8069953994140877,-1.2267319322759542,0.21428571428571427,0.9736446313118214,1.0,1/5,1.00%,PKP2
prerank,Reactome_2022__HSF1 Activation R-HSA-3371511,-0.6619374594066623,-1.226664765761964,0.19672131147540983,0.9728447704225008,1.0,7/26,18.62%,GML;HSPA1L;RPA3;CRYBA4;COL4A6;DNAJB1;HSPH1
prerank,GO_Biological_Process_2021__cellular macromolecule catabolic process (GO:0044265),0.5331600852436307,1.2265638948775535,0.19444444444444445,0.8175778667220568,1.0,6/42,14.06%,RNASET2;HTRA2;NEU4;NGLY1;FBXO27;PNPT1
prerank,GO_Biological_Process_2021__positive regulation of response to DNA damage stimulus (GO:2001022),0.4844820938885227,1.2264235605518035,0.2647058823529412,0.8173978372066181,1.0,18/49,18.39%,EYA4;FGF10;BRCC3;SPRED3;SIRT1;ERCC8;RNF168;MYC;SPRED2;SPRED1;ANKLE1;H2AX;SMCHD1;WRAP53;EYA3;ATM;FBH1;ATR
prerank,Reactome_2022__Estrogen Biosynthesis R-HSA-193144,-0.7811094034848575,-1.2262441471709271,0.3269230769230769,0.974217254561508,1.0,1/5,9.19%,AKR1B15
prerank,GO_Biological_Process_2021__late endosome to Golgi transport (GO:0034499),0.8045693321880352,1.2261388627988268,0.22950819672131148,0.8176399489418326,1.0,1/5,9.27%,GCC2
prerank,GO_Biological_Process_2021__growth hormone receptor signaling pathway via JAK-STAT (GO:0060397),0.5917084730919111,1.2260933871649042,0.1875,0.8171177514159953,1.0,1/10,6.32%,STAT5B
prerank,GO_Biological_Process_2021__regulation of protein targeting (GO:1903533),-0.7738820907434025,-1.2259636245638341,0.30357142857142855,0.9746168173366292,1.0,2/5,13.34%,PINK1;ATP5IF1
prerank,GO_Biological_Process_2021__hydrogen sulfide metabolic process (GO:0070813),-0.8679345828176318,-1.2259625943428447,0.09803921568627451,0.9733985463149584,1.0,1/5,0.11%,SQOR
prerank,GO_Biological_Process_2021__endothelial cell morphogenesis (GO:0001886),0.740202275673862,1.225866591210406,0.2564102564102564,0.8173070483576853,1.0,1/5,0.09%,COL22A1
prerank,GO_Biological_Process_2021__establishment of apical/basal cell polarity (GO:0035089),0.6245431005171058,1.225814277636427,0.21875,0.8169306808605554,1.0,5/12,21.29%,SCRIB;RAP2A;FSCN1;MYO9A;CAMSAP3
prerank,Reactome_2022__SUMOylation Of Ubiquitinylation Proteins R-HSA-3232142,0.5083041805897007,1.2255717481493715,0.07894736842105263,0.8171198096518257,1.0,4/37,10.02%,NUP210;NUP42;PML;AAAS
prerank,KEGG_2021_Human__Pertussis,-0.549709059253883,-1.2254493951565906,0.19718309859154928,0.9751118824485823,1.0,14/54,14.26%,SFTPA1;C1QB;ITGB2;IRF1;CASP7;C4BPA;ITGAM;CFL1;NLRP3;ITGA5;NOS2;C4BPB;C1S;IL12A
prerank,CellMarker_Augmented_2021__Endothelial cell:Blood,0.45389674360405996,1.22536336578426,0.17391304347826086,0.8175973387031695,1.0,9/80,5.04%,IL7R;SELPLG;SAMSN1;TRAC;IL16;SYNE3;ITGA4;IFI16;ZEB2
prerank,GO_Biological_Process_2021__anterograde axonal transport (GO:0008089),0.5671807388772421,1.2246047824323734,0.09090909090909091,0.8197131160207886,1.0,8/33,18.08%,HSPB1;MGARP;SPAST;TRAK2;RAB27B;AP3B2;DLG2;KIF3B
prerank,GO_Biological_Process_2021__phospholipid biosynthetic process (GO:0008654),0.4955367056309445,1.2243998191612993,0.125,0.8197814007163597,1.0,9/35,18.48%,CPNE7;NUS1;FADS1;CRLS1;CPNE6;AGPAT5;SAMD8;HDHD5;CPNE1
prerank,GO_Biological_Process_2021__intrinsic apoptotic signaling pathway in response to oxidative stress (GO:0008631),-0.6976944713250148,-1.2243520768382807,0.15873015873015872,0.980374579393759,1.0,1/10,3.70%,CYP1B1
prerank,CellMarker_Augmented_2021__Muller Glia Precursor cell:Retina,-0.5067808633641858,-1.2243075378316055,0.15584415584415584,0.9722169232301123,1.0,10/80,7.32%,CD44;PSMB9;AHR;RIN3;PDCD1LG2;ELK3;SP100;IRF1;IFIT3;HLA-A
prerank,CellMarker_Augmented_2021__Myometrial Stem cell:Myometrium,-0.5067808633641858,-1.2243075378316055,0.15584415584415584,0.9722169232301123,1.0,10/80,7.32%,CD44;PSMB9;AHR;RIN3;PDCD1LG2;ELK3;SP100;IRF1;IFIT3;HLA-A
prerank,CellMarker_Augmented_2021__Prostate Stem cell:Prostate,-0.5067808633641858,-1.2243075378316055,0.15584415584415584,0.9722169232301123,1.0,10/80,7.32%,CD44;PSMB9;AHR;RIN3;PDCD1LG2;ELK3;SP100;IRF1;IFIT3;HLA-A
prerank,CellMarker_Augmented_2021__Serous Acinar cell:Salivary Gland,-0.5067808633641858,-1.2243075378316055,0.15584415584415584,0.9722169232301123,1.0,10/80,7.32%,CD44;PSMB9;AHR;RIN3;PDCD1LG2;ELK3;SP100;IRF1;IFIT3;HLA-A
prerank,CellMarker_Augmented_2021__Cancer Stem cell:Myometrium,-0.5067808633641858,-1.2243075378316055,0.15584415584415584,0.9722169232301123,1.0,10/80,7.32%,CD44;PSMB9;AHR;RIN3;PDCD1LG2;ELK3;SP100;IRF1;IFIT3;HLA-A
prerank,CellMarker_Augmented_2021__Mesenchymal Stem cell:Amniotic Fluid,-0.5067808633641858,-1.2243075378316055,0.15584415584415584,0.9722169232301123,1.0,10/80,7.32%,CD44;PSMB9;AHR;RIN3;PDCD1LG2;ELK3;SP100;IRF1;IFIT3;HLA-A
prerank,CellMarker_Augmented_2021__Cancer Stem-Like cell:Oral Cavity,-0.5067808633641858,-1.2243075378316055,0.15584415584415584,0.9722169232301123,1.0,10/80,7.32%,CD44;PSMB9;AHR;RIN3;PDCD1LG2;ELK3;SP100;IRF1;IFIT3;HLA-A
prerank,GO_Biological_Process_2021__negative regulation of myeloid cell differentiation (GO:0045638),0.5776259719551935,1.224265065695673,0.2619047619047619,0.8196401301191738,1.0,2/16,7.26%,MAFB;CDK6
prerank,GO_Biological_Process_2021__regulation of dendrite extension (GO:1903859),0.5329278576749483,1.224230667298169,0.20588235294117646,0.8190675227301125,1.0,7/18,17.08%,SYT3;SYT17;SYT1;RIMS2;CPNE6;SMURF1;CPNE9
prerank,GO_Biological_Process_2021__positive regulation of transcription of nucleolar large rRNA by RNA polymerase I (GO:1901838),0.6632878098875739,1.2240399000349473,0.2631578947368421,0.819201526720357,1.0,5/10,20.42%,SMARCB1;PIH1D1;SMARCA4;MARS1;IPPK
prerank,GO_Biological_Process_2021__endosome to pigment granule transport (GO:0043485),-0.7840244786161283,-1.2239222029350634,0.2459016393442623,0.9716755646438966,1.0,1/6,10.40%,CD63
prerank,GO_Biological_Process_2021__endosome to melanosome transport (GO:0035646),-0.7840244786161283,-1.2239222029350634,0.2459016393442623,0.9716755646438966,1.0,1/6,10.40%,CD63
prerank,GO_Biological_Process_2021__positive regulation of fatty acid metabolic process (GO:0045923),0.6347672792848593,1.2237934963966357,0.1794871794871795,0.8194136296773167,1.0,8/14,28.94%,PPARG;MLXIPL;NR1H3;NR4A3;ELOVL5;SLC45A3;MLYCD;MID1IP1
prerank,GO_Biological_Process_2021__regulation of lipase activity (GO:0060191),0.6140420361218738,1.2237848252269827,0.20512820512820512,0.8187253206202997,1.0,4/12,9.91%,LIPC;PLIN5;SNCA;LPL
prerank,GO_Biological_Process_2021__negative regulation of binding (GO:0051100),-0.5077493992156793,-1.2235445738075021,0.1323529411764706,0.972566842235774,1.0,16/76,18.41%,DISC1;LRPAP1;TMC8;SP100;DAB2;ZFPM1;CTSZ;CDKN1A;IFIT1;ARHGAP28;MITD1;LEF1;EFHB;PLN;IFIT2;HMGA2
prerank,GO_Biological_Process_2021__positive regulation of histone deacetylation (GO:0031065),0.6246685422621379,1.2232536861875314,0.25,0.819784596131045,1.0,1/12,3.16%,ZBTB7B
prerank,GO_Biological_Process_2021__positive regulation of signaling (GO:0023056),0.5615360698439574,1.2230936159478971,0.15384615384615385,0.81970916738013,1.0,9/31,14.40%,SCRIB;SNCA;NMU;GRIK2;SYT1;RIMS2;CLSTN2;WLS;PTPN23
prerank,Reactome_2022__CLEC7A (Dectin-1) Induces NFAT Activation R-HSA-5607763,0.649396178158542,1.2230767639616105,0.24242424242424243,0.8190484170455017,1.0,2/10,2.55%,ITPR2;NFATC3
prerank,GO_Biological_Process_2021__protein quality control for misfolded or incompletely synthesized proteins (GO:0006515),0.5619762046476859,1.2230437740924327,0.20588235294117646,0.8184668073924595,1.0,9/23,26.08%,AUP1;NGLY1;POMT2;RNF185;ZER1;BAG6;LONP1;FBXL17;ZYG11B
prerank,GO_Biological_Process_2021__cellular response to magnesium ion (GO:0071286),-0.7823864020583267,-1.2229528286700035,0.25925925925925924,0.974552535939994,1.0,1/5,5.36%,SLFN14
prerank,GO_Biological_Process_2021__axonemal dynein complex assembly (GO:0070286),-0.5836728838161961,-1.222838276949607,0.13043478260869565,0.973831107272664,1.0,5/28,14.98%,CCDC39;ODAD1;DRC1;DNAH17;DNAI1
prerank,PanglaoDB_Augmented_2021__Osteoclasts,-0.5007986257930807,-1.2227734374311314,0.0975609756097561,0.9730845493689998,1.0,33/105,18.10%,CLEC5A;C1QB;HCK;MMP9;SLC7A7;MMP19;TGFBI;ESR1;C3AR1;DAB2;MS4A4A;FCGR3A;LTB4R;OSCAR;VSIG4;PSAP;P2RY6;VWF;CTSZ;ENG;TLR2;FPR3;F13A1;VDR;ITPR3;HK3;ITGB5;THRA;CASR;TNFRSF11A;COL8A2;SERPINF1;ANPEP
prerank,Reactome_2022__Abacavir Transmembrane Transport R-HSA-2161517,-0.7850187298807585,-1.2226098650990658,0.22033898305084745,0.9727696876356321,1.0,3/5,13.81%,ABCG2;ABCB1;SLC22A3
prerank,GO_Biological_Process_2021__microtubule anchoring at centrosome (GO:0034454),0.6572596475967869,1.2223954923727955,0.3023255813953488,0.8198732910789411,1.0,2/10,6.06%,PCM1;CCDC120
prerank,CellMarker_Augmented_2021__Mesenchymal Stem cell:Periosteum,0.4305582891309752,1.2223906669772628,0.1111111111111111,0.819188165190129,1.0,31/95,16.27%,EDIL3;VEGFC;ALCAM;ARSJ;PARVA;EXT1;COL12A1;ADAMTS12;MMP2;SERPINE1;NTN4;EDNRA;SNAI2;CRIM1;ITGA3;KITLG;RND3;COL16A1;CHST3;DDAH1;EFEMP1;EPS8;NECTIN3;LTBP2;WWTR1;PRICKLE2;CDH11;ANTXR1;PLSCR4;CALD1;SGCB
prerank,GO_Biological_Process_2021__positive regulation of blood vessel endothelial cell migration (GO:0043536),0.46015578872391116,1.2223658852266859,0.16666666666666666,0.8185690515239987,1.0,8/41,8.69%,FGFR1;HSPB1;ANGPT1;SIRT1;HMGB1;SP1;FGF18;NUS1
prerank,GO_Biological_Process_2021__positive regulation of cell cycle G2/M phase transition (GO:1902751),-0.629215276280968,-1.2222606607195534,0.31343283582089554,0.9736541714564553,1.0,4/22,5.16%,DTL;CCND1;CDC25A;RAB11A
prerank,CellMarker_Augmented_2021__B cell:Fetal Liver,-0.6776307227081939,-1.2222356225776574,0.24074074074074073,0.9725710890216536,1.0,6/13,20.09%,JCHAIN;BLK;BLNK;NAPSB;CD24;PAX5
prerank,Reactome_2022__Mitochondrial Fatty Acid Beta-Oxidation Of Unsaturated Fatty Acids R-HSA-77288,0.7495621688718643,1.2220599043499516,0.34146341463414637,0.8191168465893633,1.0,4/6,19.84%,ACADM;ECI1;DECR1;HADHB
prerank,GO_Biological_Process_2021__hexose catabolic process (GO:0019320),0.7190566176317167,1.2218517475363504,0.1951219512195122,0.8190553947601071,1.0,2/7,11.98%,GALE;GALT
prerank,GO_Biological_Process_2021__protein localization to endoplasmic reticulum exit site (GO:0070973),0.6981346495942123,1.221567230772975,0.2857142857142857,0.8193044015298169,1.0,2/6,18.05%,GBF1;MIA3
prerank,Reactome_2022__NrCAM Interactions R-HSA-447038,0.7134985602176928,1.2214841814663986,0.22857142857142856,0.8189457296867543,1.0,5/7,24.59%,LLGL1;NRCAM;DLG1;ANK1;MPP3
prerank,GO_Biological_Process_2021__positive regulation of autophagosome assembly (GO:2000786),0.681520401007411,1.2213711669006881,0.24489795918367346,0.8186005858111857,1.0,4/9,22.88%,RALB;PIP4K2A;LRSAM1;ELAPOR1
prerank,CellMarker_Augmented_2021__Keratinocyte Progenitor cell:Skin,-0.5127707847081583,-1.221219974052837,0.12,0.9768710668301385,1.0,21/73,14.86%,CLCA2;C1QB;LYVE1;TIMP3;ECM2;RERGL;SLCO2B1;DCN;SLCO2A1;ASPN;ABCG2;OMD;VWF;GPIHBP1;ITGB6;APOD;TEK;SLC22A3;PALMD;C1S;ADGRF5
prerank,GO_Biological_Process_2021__negative regulation of protein activation cascade (GO:2000258),-0.7058012908424984,-1.2209589205689149,0.28125,0.9770521876762259,1.0,2/9,1.83%,F8;F7
prerank,KEGG_2021_Human__Endometrial cancer,-0.5399056072210378,-1.220864548175566,0.14925373134328357,0.9762982613665966,1.0,9/57,13.80%,TCF7;CTNNA1;CCND1;CTNNA3;TCF7L1;PIK3R3;CDKN1A;PIK3CB;LEF1
prerank,GO_Biological_Process_2021__regulation of early endosome to late endosome transport (GO:2000641),-0.6356845430708248,-1.220854254863101,0.22413793103448276,0.9751816720298071,1.0,5/18,21.57%,DAB2;CHMP3;MSN;DENND10;MAP2K1
prerank,GO_Biological_Process_2021__tyrosine phosphorylation of STAT protein (GO:0007260),0.7366859240451546,1.2207426403310493,0.2857142857142857,0.8202681103041469,1.0,1/6,7.46%,FER
prerank,GO_Biological_Process_2021__positive regulation of developmental growth (GO:0048639),0.5001739144529163,1.2207225764453746,0.03225806451612903,0.8196775728583676,1.0,15/47,18.22%,NGF;SYT3;SYT17;GOLGA4;PLCB1;SYT1;PPIB;RIMS2;MACF1;MAP3K13;CPNE6;SMURF1;INSR;CPNE9;LIMK1
prerank,GO_Biological_Process_2021__pyridine-containing compound metabolic process (GO:0072524),-0.7597098497286696,-1.220153533449972,0.24561403508771928,0.978161189536545,1.0,2/5,12.80%,AOX1;HAAO
prerank,Reactome_2022__Transport Of Mature mRNAs Derived From Intronless Transcripts R-HSA-159234,0.5055518947882351,1.2200210919342012,0.1794871794871795,0.8216374416617187,1.0,5/41,10.02%,CPSF1;NUP210;NUP42;NXF1;AAAS
prerank,"GO_Biological_Process_2021__RNA splicing, via endonucleolytic cleavage and ligation (GO:0000394)",0.6047057714879646,1.2199685200443044,0.13333333333333333,0.8211110655200933,1.0,2/16,9.53%,CPSF1;ERN1
prerank,GO_Biological_Process_2021__regulation of adherens junction organization (GO:1903391),0.7272515199634042,1.2199535458923667,0.2564102564102564,0.8204313508085458,1.0,2/5,19.27%,PTPN23;ADD1
prerank,Reactome_2022__Eicosanoid Ligand-Binding Receptors R-HSA-391903,-0.7005471830146789,-1.2199247575250163,0.18333333333333332,0.9782334422444289,1.0,3/9,13.45%,LTB4R;PTGDR;PTGER3
prerank,CellMarker_Augmented_2021__Progenitor cell:Corneal Epithelium,0.4577934957671929,1.219598668115813,0.12903225806451613,0.8213581217273381,1.0,11/71,5.86%,ADGRF4;PHLDB2;EMP1;VEGFC;LAMA3;ARSJ;PERP;COL12A1;SERPINE1;CAPN2;NTN4
prerank,Reactome_2022__MECP2 Regulates Transcription Of Neuronal Ligands R-HSA-9022702,0.6825628040877308,1.2194370672353088,0.2,0.8212182855235691,1.0,5/7,30.89%,HDAC1;MECP2;CREB1;DLL1;CRH
prerank,GO_Biological_Process_2021__vascular transport (GO:0010232),-0.505504877164042,-1.219334022988306,0.16176470588235295,0.9803605415751401,1.0,7/77,8.58%,SLC28A2;SLC22A8;SLC7A3;SLCO2B1;SLC5A1;ATP1A4;ABCG2
prerank,CellMarker_Augmented_2021__Proerythroblast:Germ,-0.5417624138817579,-1.2193279047736472,0.18309859154929578,0.9792179000497205,1.0,29/64,20.41%,ITGB2;HCK;TNFRSF1B;DOCK2;HLA-DMA;C3AR1;MS4A4A;PARVG;LY86;VSIG4;CTSZ;SPI1;ITGAM;ENG;FPR3;CD300LF;ADAMDEC1;ADCY7;EHBP1L1;HK3;RAC2;ANPEP;CSF1R;P2RX1;TFEC;ITGAX;GAB3;SH3TC1;CD86
prerank,"GO_Biological_Process_2021__wound healing, spreading of epidermal cells (GO:0035313)",-0.7856196809327765,-1.2192777152091672,0.21818181818181817,0.9783431147909547,1.0,3/6,15.84%,COL5A1;ITGA5;PLET1
prerank,Reactome_2022__Transport And Synthesis Of PAPS R-HSA-174362,0.781003314063828,1.2192194542913612,0.18867924528301888,0.8199171085293094,1.0,1/5,2.21%,PAPSS2
prerank,GO_Biological_Process_2021__3'-phosphoadenosine 5'-phosphosulfate biosynthetic process (GO:0050428),0.781003314063828,1.2192194542913612,0.18867924528301888,0.8199171085293094,1.0,1/5,2.21%,PAPSS2
prerank,GO_Biological_Process_2021__purine ribonucleoside bisphosphate biosynthetic process (GO:0034036),0.781003314063828,1.2192194542913612,0.18867924528301888,0.8199171085293094,1.0,1/5,2.21%,PAPSS2
prerank,GO_Biological_Process_2021__N-terminal protein amino acid acetylation (GO:0006474),0.662317784738616,1.219190652398038,0.1388888888888889,0.8193186260135709,1.0,4/13,19.29%,NAA40;AANAT;EP300;KAT2B
prerank,PanglaoDB_Augmented_2021__Adipocytes,-0.46339913473293504,-1.2188262741558806,0.0759493670886076,0.979456238278029,1.0,33/150,14.86%,OLFML1;TBX1;C1QTNF1;TRIP10;LMOD1;TIMP3;ECM2;ANGPTL2;CYP1B1;ACOX2;PLAC9;COL1A1;LOX;PTGES;DAB2;ADAM33;NQO1;DCN;CAVIN1;ASPN;CFD;METRN;AOX1;UCP1;STEAP4;TLR2;HSD11B1;GPX3;COX7A1;APOL6;C1S;ACTA2;ADGRF5
prerank,GO_Biological_Process_2021__regulation of axon guidance (GO:1902667),0.6424929449524462,1.2185903829278495,0.2631578947368421,0.8209954266223767,1.0,2/9,14.53%,ZSWIM5;YTHDF1
prerank,GO_Biological_Process_2021__negative regulation of receptor internalization (GO:0002091),-0.7126514602609115,-1.2185684352515962,0.2413793103448276,0.9796058290348403,1.0,2/11,2.65%,RIN3;LRPAP1
prerank,PanglaoDB_Augmented_2021__Fibroblasts,-0.46316694642762585,-1.2185285600387414,0.09302325581395349,0.9787689562339709,1.0,25/190,9.52%,CD44;C1QTNF1;LMOD1;TIMP3;ANGPTL2;HCK;INMT;HHIP;CYP1B1;PLAC9;TNFRSF1B;COL1A1;CTHRC1;COL5A1;LOX;VTN;DAB2;ADAM33;DCN;ASPN;COL4A4;TNXB;PTX3;COL4A3;ITGBL1
prerank,GO_Biological_Process_2021__negative regulation of circadian rhythm (GO:0042754),0.643236707960513,1.218086953203749,0.2564102564102564,0.8223374538200547,1.0,2/9,5.35%,PER2;CRY1
prerank,GO_Biological_Process_2021__macrophage migration (GO:1905517),-0.7379613663490281,-1.2178607473301026,0.2,0.9811262821385286,1.0,4/9,13.30%,P2RY12;SFTPD;TAFA4;EDNRB
prerank,GO_Biological_Process_2021__regulation of cardiac muscle contraction (GO:0055117),0.5453474105453402,1.2178007500093448,0.12121212121212122,0.8226950607333102,1.0,2/28,3.99%,ADRA1A;SLC8A1
prerank,GO_Biological_Process_2021__determination of heart left/right asymmetry (GO:0061371),-0.5847185150448732,-1.2175178075159838,0.21621621621621623,0.9820726090258686,1.0,7/28,19.47%,CCDC39;MMP21;TBX6;ENG;GATA4;MESP1;DAND5
prerank,CellMarker_Augmented_2021__Neural Progenitor cell:Embryonic Prefrontal Cortex,-0.47254106928444917,-1.2173779121173325,0.10752688172043011,0.9816656552236571,1.0,14/146,9.82%,CLIC1;CDCA3;BUB1;MCM2;HMGB3;PCLAF;SPC25;RPA3;MCM3;CENPU;ITGB3BP;HAT1;OIP5;NUF2
prerank,KEGG_2021_Human__MAPK signaling pathway,0.40564496896796043,1.2172514599885176,0.0625,0.824122562637947,1.0,59/261,15.84%,NGF;DUSP4;FGF10;DUSP2;TGFBR1;KIT;MAPKAPK2;VEGFC;FGFR1;HSPB1;NFATC3;ANGPT1;MAP3K14;CACNG4;CD14;FGF17;ERBB2;PDGFD;ARRB2;CACNB4;RRAS2;CRK;RASA2;PPP5C;MAPK8;CASP3;PTPRR;MYC;MAP3K1;FLNA;EFNA5;FGF18;TGFA;CACNG2;AKT2;FGFR3;KITLG;RPS6KA3;PPM1A;MAP3K13;RAP1A;HSPA1A;PLA2G4C;ARRB1;NF1;RPS6KA4;FLT3;NFKB1;RPS6KA2;RPS6KA6;INSR;IRAK4;GADD45A;TP53;FLNB;MAP4K2;MAPK12;EFNA2;CRKL
prerank,GO_Biological_Process_2021__regulation of developmental growth (GO:0048638),0.5649807705335677,1.217240811432995,0.16129032258064516,0.8234211817335743,1.0,7/28,9.62%,APOE;MFSD2A;STAT5B;ABL1;LATS1;PLCB1;FGFR3
prerank,GO_Biological_Process_2021__positive regulation of cytokine production involved in inflammatory response (GO:1900017),0.6926353314141058,1.2169869261074964,0.23076923076923078,0.8235733960627453,1.0,3/8,20.51%,CARD9;TICAM1;HIF1A
prerank,Reactome_2022__Deposition Of New CENPA-containing Nucleosomes At Centromere R-HSA-606279,-0.5437433515091968,-1.2168471358762882,0.17391304347826086,0.9831085150691945,1.0,12/36,23.42%,CENPU;ITGB3BP;H2BC4;OIP5;CENPH;CENPS-CORT;H2AZ1;RBBP7;CENPN;SMARCA5;CENPL;CENPM
prerank,GO_Biological_Process_2021__positive regulation of establishment of protein localization (GO:1904951),0.645399111196589,1.216842409325687,0.2558139534883721,0.8234075613735281,1.0,4/16,16.39%,CEP135;CEP120;WRAP53;CORO2B
prerank,GO_Biological_Process_2021__microvillus organization (GO:0032528),0.5983279695538786,1.2168049148088202,0.21212121212121213,0.8227974793982328,1.0,3/13,12.41%,RAP2A;TNIK;RAP1A
prerank,CellMarker_Augmented_2021__Hepatocyte:Embryoid Body,-0.552088786795171,-1.2166477835462854,0.2,0.9829375932024149,1.0,17/51,15.80%,AMBP;F7;ITIH2;SMLR1;SERPIND1;VTN;OIT3;FTCD;CPB2;SLC22A7;PON1;HPR;ITIH3;FGL1;HAO2;NR1H4;AGT
prerank,GO_Biological_Process_2021__regulation of establishment of protein localization to mitochondrion (GO:1903747),-0.7957289884050314,-1.2166443005187435,0.25,0.9817705718329334,1.0,3/7,13.34%,PINK1;DNAJA1;ATP5IF1
prerank,Reactome_2022__RUNX1 Interacts With Co-Factors Whose Precise Effect On RUNX1 Targets Is Not Known R-HSA-8939243,0.5058860170674678,1.2166074315520328,0.14285714285714285,0.8229879055775022,1.0,17/31,19.89%,CBFB;PHC2;SMARCD3;SMARCB1;PCGF5;PBRM1;ARID1A;SMARCA2;SMARCA4;SCMH1;ARID2;RYBP;RUNX1;ARID1B;YAF2;EP300;RNF2
prerank,Reactome_2022__SOS-mediated Signaling R-HSA-112412,0.7765988136804979,1.2165065765880656,0.1951219512195122,0.8227595921945187,1.0,3/6,19.27%,IRS1;IRS2;SOS1
prerank,GO_Biological_Process_2021__T cell homeostasis (GO:0043029),0.6641623178451963,1.2164735088434062,0.28888888888888886,0.8222149514286238,1.0,2/9,12.94%,TNFSF14;FADD
prerank,GO_Biological_Process_2021__positive regulation of catalytic activity (GO:0043085),0.5391936340280519,1.2164244068827874,0.09523809523809523,0.8216585743775278,1.0,5/31,10.90%,ABL1;MAPK8;ABL2;PHACTR4;B3GAT3
prerank,GO_Biological_Process_2021__mitochondrial respirasome assembly (GO:0097250),-0.752518377375134,-1.2163120329801598,0.2542372881355932,0.9825620512824019,1.0,3/6,16.73%,HIGD1C;COX7A1;COX7A2
prerank,Reactome_2022__TNFR1-mediated Ceramide Production R-HSA-5626978,0.7594033552105308,1.2160717207350533,0.2391304347826087,0.8221654979923747,1.0,2/5,9.06%,NSMAF;SMPD3
prerank,GO_Biological_Process_2021__nuclear transport (GO:0051169),0.6117743221696927,1.216055021567391,0.21621621621621623,0.8215469202270402,1.0,6/15,20.98%,RGS14;NXT1;ANP32A;AAAS;NUTF2;XPO1
prerank,GO_Biological_Process_2021__regulation of microtubule depolymerization (GO:0031114),0.5743153851657966,1.2159067078138954,0.23333333333333334,0.8213586636070809,1.0,8/25,29.79%,NAV3;CAMSAP3;ATXN7;CIB1;MID1IP1;APC2;FGF13;CLASP2
prerank,GO_Biological_Process_2021__regulation of DNA replication (GO:0006275),0.4948526301265143,1.2158010083964255,0.13793103448275862,0.8210571880811229,1.0,13/44,21.08%,GMNC;SLFN11;RBBP6;CTC1;TERF1;CCDC88A;ESCO1;DSCC1;RAD17;FAF1;ATR;DNA2;ESCO2
prerank,Reactome_2022__Constitutive Signaling By Aberrant PI3K In Cancer R-HSA-2219530,0.43012864167458975,1.2158007699766942,0.1388888888888889,0.8203654802562862,1.0,14/63,10.67%,FGF10;KIT;FGFR1;IRS1;NRG2;FGF17;ERBB2;NRG1;NRG3;FGF18;TGFA;FGFR3;KITLG;IRS2
prerank,Reactome_2022__Regulation Of Localization Of FOXO Transcription Factors R-HSA-9614399,0.6031276617610457,1.215741009960355,0.21052631578947367,0.8198638456429312,1.0,3/12,9.44%,FOXO1;REXO2;AKT2
prerank,GO_Biological_Process_2021__response to lipid (GO:0033993),-0.49240036774768964,-1.2157364308290042,0.18421052631578946,0.9844940193362394,1.0,20/90,14.90%,AQP3;MICB;TGFB1;WNT8B;CYP24A1;MAPKAPK3;ESR1;SELP;ANXA1;SMAD6;SLC11A1;WNT8A;CDKN2D;GPX3;PALM3;RXRG;NOS2;IL12A;GGT5;FGFR4
prerank,GO_Biological_Process_2021__positive regulation of autophagy of mitochondrion (GO:1903599),-0.6539437259321746,-1.2157062883741285,0.2777777777777778,0.9834860965932865,1.0,3/9,25.54%,VDAC1;CAMKK2;PARK7
prerank,CellMarker_Augmented_2021__Endometrial Progenitor cell:Endometrium,0.44396366360677836,1.2155696430318943,0.12903225806451613,0.8196273045978303,1.0,32/99,26.28%,SMYD5;PC;LZTR1;SCRIB;PTOV1;B4GALT2;MAST2;EVI5L;ACAP3;OGDH;HSPBP1;PTPN23;THAP4;SCYL1;PPP2R5D;SMG5;TPRN;TAB1;PCBP4;CENPB;ANKRD52;FXR2;GIT1;BAG6;ALDH4A1;LONP1;PCYT2;AGAP3;PEX14;CUL7;TAOK2;ZNF768
prerank,GO_Biological_Process_2021__regulation of mRNA polyadenylation (GO:1900363),0.5975154876361222,1.2155345533654192,0.21621621621621623,0.8190894151382293,1.0,6/18,20.63%,CPEB1;CPSF7;HSF1;ZC3H14;RNF40;CPSF6
prerank,GO_Biological_Process_2021__cellular response to growth factor stimulus (GO:0071363),-0.4932683071577643,-1.215453468100803,0.15789473684210525,0.9835419342074815,1.0,4/137,2.54%,CD44;TBX1;TGFB1;WNT5A
prerank,GO_Biological_Process_2021__cellular response to vitamin D (GO:0071305),-0.7611994295740292,-1.215294908740448,0.2608695652173913,0.9833369590693578,1.0,2/5,14.65%,CYP24A1;VDR
prerank,PanglaoDB_Augmented_2021__Myoepithelial Cells,0.43360078276367997,1.215255899223909,0.14814814814814814,0.8194317823735703,1.0,18/85,10.72%,ADGRF4;EMP1;MXRA5;LAMA3;SDC4;PARVA;PERP;CA3;COL12A1;ERBB2;NTN4;CNN1;DSP;SNAI2;ITGA3;FHL2;RND3;COL16A1
prerank,CellMarker_Augmented_2021__Epithelial cell:Corneal Epithelium,-0.4868333370463615,-1.2151041506359213,0.1780821917808219,0.9829675695752692,1.0,10/84,6.93%,CD44;PSMB9;RIN3;CYTIP;TAGAP;SP100;IRF1;TNFRSF1B;GPR183;OAS2
prerank,GO_Biological_Process_2021__positive regulation of antigen receptor-mediated signaling pathway (GO:0050857),-0.6171865041365997,-1.2150988804522993,0.23529411764705882,0.9818188719323939,1.0,5/20,18.80%,NFAM1;PTPRC;PRKCH;TESPA1;CD81
prerank,CellMarker_Augmented_2021__Secretory Progenitor cell:Small Intestine,0.484036979806933,1.214954139089843,0.11538461538461539,0.8198112301269042,1.0,10/35,18.26%,ADAMTS16;CACNB4;HCN1;FADS6;ZNF385B;GNAO1;BCAM;BANK1;GABRB2;ABCA7
prerank,GO_Biological_Process_2021__regulation of cytoplasmic transport (GO:1903649),-0.6773888545146878,-1.2149150275570992,0.2835820895522388,0.9816426422594795,1.0,3/11,21.57%,CHMP3;DENND10;MAP2K1
prerank,GO_Biological_Process_2021__regulation of heart rate by cardiac conduction (GO:0086091),-0.569328342177854,-1.214867382155044,0.25396825396825395,0.9807749737630005,1.0,5/36,8.12%,PKP2;SCN5A;KCNA5;CTNNA3;KCNQ1
prerank,GO_Biological_Process_2021__methionine metabolic process (GO:0006555),0.6879915525942658,1.2147353168517503,0.2727272727272727,0.8197134787353904,1.0,3/7,22.65%,MTR;MTHFR;SMS
prerank,GO_Biological_Process_2021__regulation of amyloid precursor protein catabolic process (GO:1902991),0.6681864938075366,1.2144858622580452,0.2571428571428571,0.8201045855999225,1.0,4/11,27.48%,APOE;ABCA7;ABCA2;ROCK1
prerank,CellMarker_Augmented_2021__Central Nervous System Stem cell:Fetal Brain,-0.5296186369127053,-1.2144609155421024,0.22972972972972974,0.9816283138620561,1.0,26/59,17.21%,C1QB;CYYR1;LYVE1;ITM2A;VAV3;SLC5A1;MS4A4A;FCGR3A;CEACAM1;P2RY14;VSIG4;HLA-DPB1;SELP;ITGA9;OLFM4;HLA-DRB1;PTPRC;CP;VWF;NSUN7;F13A1;HLA-DPA1;KCNE3;ADAM28;MYO15B;CD24
prerank,PanglaoDB_Augmented_2021__Mller Cells,-0.49480092971130557,-1.214452939358468,0.14666666666666667,0.9805125055122527,1.0,11/134,5.75%,CD44;SFTPA1;TRIL;LMOD1;TIMP3;ANGPTL2;TSPAN11;SPC25;COL1A1;COL5A1;FBXL7
prerank,CellMarker_Augmented_2021__Migrating Cancer Stem cell:Liver,-0.5450549610412256,-1.2144356839245056,0.15384615384615385,0.9782629520224829,1.0,21/62,20.84%,MPL;MACC1;TMEM184A;PLEKHG6;TMC4;DUOXA1;LIPH;SERPINB5;DYTN;SPINT1;LAMC2;TNFRSF10A;VDR;IL18;EPHA1;F2RL1;SCNN1A;CBLC;FAM83F;MALL;COL17A1
prerank,CellMarker_Augmented_2021__Migrating Cancer Stem cell:Lung,-0.5450549610412256,-1.2144356839245056,0.15384615384615385,0.9782629520224829,1.0,21/62,20.84%,MPL;MACC1;TMEM184A;PLEKHG6;TMC4;DUOXA1;LIPH;SERPINB5;DYTN;SPINT1;LAMC2;TNFRSF10A;VDR;IL18;EPHA1;F2RL1;SCNN1A;CBLC;FAM83F;MALL;COL17A1
prerank,GO_Biological_Process_2021__organic anion transport (GO:0015711),-0.4868208260269484,-1.2143325837782901,0.14864864864864866,0.9776450887325447,1.0,10/77,8.58%,SLC22A25;SLC22A24;MGST1;ABCC6;SLC22A6;SLCO2B1;CA14;SLCO2A1;CA1;ABCG2
prerank,PanglaoDB_Augmented_2021__Luminal Epithelial Cells,-0.4964908437853695,-1.2138995980643636,0.1791044776119403,0.979055262586074,1.0,24/81,19.93%,AQP3;TMEM184A;MISP;WNT5A;CLDN1;TMC4;ESR1;EPN3;SERPINB5;ANXA1;MYO5B;LAMC2;SOWAHB;ITGB6;TRIM29;FGFR4;SCNN1A;ANKRD30A;ANPEP;CAPN13;SLC44A3;FAM3D;HMGA1;CBLC
prerank,CellMarker_Augmented_2021__Mesenchymal Stromal cell:Placenta,-0.5177757334234746,-1.2138777924223543,0.1566265060240964,0.9780347938796771,1.0,21/71,15.75%,ENPP2;C1QB;LYVE1;ADAM33;MS4A4A;DCN;VSIG4;HLA-DPB1;TMEM204;PTPRC;VWF;ENG;F13A1;HLA-DPA1;TEK;A2M;C1S;ACTA2;GGT5;ADGRF5;CD4
prerank,CellMarker_Augmented_2021__Epithelial cell:Airway Epithelium,-0.7351004443151596,-1.2137706101681514,0.18181818181818182,0.9751415570402053,1.0,4/7,25.47%,NOS2;CD24;ANPEP;IL6R
prerank,CellMarker_Augmented_2021__Epithelial cell:Skin,-0.7351004443151596,-1.2137706101681514,0.18181818181818182,0.9751415570402053,1.0,4/7,25.47%,NOS2;CD24;ANPEP;IL6R
prerank,CellMarker_Augmented_2021__Epithelial cell:Lung,-0.7351004443151596,-1.2137706101681514,0.18181818181818182,0.9751415570402053,1.0,4/7,25.47%,NOS2;CD24;ANPEP;IL6R
prerank,GO_Biological_Process_2021__gland morphogenesis (GO:0022612),-0.7945404782059877,-1.2137288490006144,0.14754098360655737,0.9743097073466609,1.0,3/6,17.52%,TGFB1;TGFB3;MSN
prerank,"GO_Biological_Process_2021__nucleotide-excision repair, DNA damage recognition (GO:0000715)",-0.6072093630504389,-1.21371788509467,0.2465753424657534,0.9732580942495903,1.0,12/23,33.37%,COPS5;RBX1;COPS4;RPS27A;DDB1;COPS7A;UBB;COPS7B;CETN2;UBC;GPS1;RAD23B
prerank,PanglaoDB_Augmented_2021__Delta Cells,0.4042662636330736,1.2136553425256553,0.14285714285714285,0.8222478578835213,1.0,26/116,15.95%,SLC17A6;BCHE;POU3F1;PCDH17;PLPPR1;KCNB2;RESP18;UNC5D;PROX1;ETV1;KCNIP1;ADGRA1;LEPR;ABCC8;LCORL;RGS7BP;ELAVL4;RAB3C;SNAP91;MAP6;ASXL3;PTPRT;RFX6;CFC1;NRXN1;PTPRD
prerank,GO_Biological_Process_2021__deadenylation-independent decapping of nuclear-transcribed mRNA (GO:0031087),0.7652793400818264,1.2136456771696342,0.2571428571428571,0.8215603596745886,1.0,1/5,3.60%,DCP1B
prerank,Reactome_2022__SMAD2/SMAD3:SMAD4 Heterotrimer Regulates Transcription R-HSA-2173796,0.5305668808713458,1.2136032549742044,0.22580645161290322,0.8209990024036774,1.0,14/32,22.14%,TGIF1;SERPINE1;RBL1;MYC;HDAC1;CDK8;SMAD2;WWTR1;MEN1;FURIN;EP300;E2F5;TFDP1;SMAD7
prerank,GO_Biological_Process_2021__protein kinase C signaling (GO:0070528),-0.6790010563707947,-1.2135768379778975,0.18867924528301888,0.9731117520472296,1.0,5/9,30.12%,HTR2B;ADGRG1;FLOT1;AZU1;MAS1
prerank,GO_Biological_Process_2021__lipoprotein transport (GO:0042953),0.7395512749455516,1.2132388801235843,0.2702702702702703,0.8216874613084592,1.0,4/9,18.93%,APOB;PPARG;MIA3;UNC119B
prerank,Reactome_2022__Response To Metal Ions R-HSA-5660526,0.6691625055457887,1.213216726182971,0.20408163265306123,0.8210894992844118,1.0,3/9,12.39%,MT1G;CSRP1;MT4
prerank,GO_Biological_Process_2021__leucine transport (GO:0015820),0.7566473736815764,1.2131661142326255,0.2857142857142857,0.8204925338637377,1.0,3/6,11.22%,SLC3A2;SLC6A17;SLC7A8
prerank,GO_Biological_Process_2021__lipoxin biosynthetic process (GO:2001301),-0.7580651266757419,-1.2128251138894812,0.30357142857142855,0.9761985058220285,1.0,5/7,17.79%,ALOX12;ALOX5;ALOX15;ALOX15B;ALOX5AP
prerank,GO_Biological_Process_2021__cellular modified amino acid biosynthetic process (GO:0042398),0.5684314726447696,1.2125933731080327,0.21052631578947367,0.8217527440934462,1.0,6/18,23.37%,CHAC1;PLSCR1;FPGS;GAMT;PTDSS2;PLOD2
prerank,GO_Biological_Process_2021__sterol metabolic process (GO:0016125),0.4725857579974146,1.212344784013677,0.1111111111111111,0.8219528429048462,1.0,8/54,7.63%,CYP7B1;CYP4V2;TSKU;APOB;APOE;SOAT1;SOAT2;ABCA1
prerank,GO_Biological_Process_2021__histone H4-K8 acetylation (GO:0043982),0.6456657319296747,1.2119803373436375,0.25,0.8217555687805043,1.0,1/15,3.84%,JADE3
prerank,GO_Biological_Process_2021__histone H4-K5 acetylation (GO:0043981),0.6456657319296747,1.2119803373436375,0.25,0.8217555687805043,1.0,1/15,3.84%,JADE3
prerank,GO_Biological_Process_2021__regulation of potassium ion import (GO:1903286),0.6606336099715796,1.2119687012701772,0.20588235294117646,0.8210984464340297,1.0,4/8,22.90%,WNK2;WNK3;DLG1;WNK1
prerank,Reactome_2022__Chylomicron Remodeling R-HSA-8963901,0.7120391036300519,1.211877147576241,0.30612244897959184,0.8201097556521849,1.0,3/5,9.91%,APOB;APOE;LPL
prerank,GO_Biological_Process_2021__chylomicron remodeling (GO:0034371),0.7120391036300519,1.211877147576241,0.30612244897959184,0.8201097556521849,1.0,3/5,9.91%,APOB;APOE;LPL
prerank,Reactome_2022__Activation Of Pre-Replicative Complex R-HSA-68962,-0.6067173976060543,-1.211865464462617,0.23214285714285715,0.9801533090258625,1.0,10/25,27.84%,RPA3;MCM3;POLE2;CDC6;ORC6;POLE3;CDC7;MCM5;MCM10;MCM6
prerank,CellMarker_Augmented_2021__Pancreatic Progenitor cell:Embryo,-0.5613714695971745,-1.2118585405123496,0.20689655172413793,0.9779385149193177,1.0,19/45,18.39%,AMBP;SLC28A1;ITIH2;SMLR1;ALDOB;C3P1;OIT3;CPB2;CYP3A4;HNF1A;SLC22A7;PON1;FGL1;HAO2;NR1H4;GBA3;ANGPTL3;PRODH2;HABP2
prerank,CellMarker_Augmented_2021__Pancreatic Progenitor cell:Embryonic Stem Cell,-0.5613714695971745,-1.2118585405123496,0.20689655172413793,0.9779385149193177,1.0,19/45,18.39%,AMBP;SLC28A1;ITIH2;SMLR1;ALDOB;C3P1;OIT3;CPB2;CYP3A4;HNF1A;SLC22A7;PON1;FGL1;HAO2;NR1H4;GBA3;ANGPTL3;PRODH2;HABP2
prerank,GO_Biological_Process_2021__organic cyclic compound catabolic process (GO:1901361),0.6981225766907571,1.2117157658414084,0.20833333333333334,0.8202111374358182,1.0,4/8,9.73%,CYP1A2;EPHX2;STS;ALLC
prerank,GO_Biological_Process_2021__mitochondrial tRNA processing (GO:0090646),-0.7058881360513489,-1.21132087693996,0.21153846153846154,0.9797775347616122,1.0,3/7,26.31%,TRMT10A;TRNT1;TRMT10B
prerank,Reactome_2022__HSF1-dependent Transactivation R-HSA-3371571,-0.6057359137980478,-1.2112335250104567,0.25,0.9792271362882597,1.0,8/32,18.62%,GML;HSPA1L;CRYBA4;HSPA8;COL4A6;DNAJB1;CAMK2A;HSPH1
prerank,GO_Biological_Process_2021__positive regulation of natural killer cell cytokine production (GO:0002729),-0.7768886990698397,-1.2110763243844602,0.21666666666666667,0.9779107521067177,1.0,2/5,15.53%,CD160;HLA-F
prerank,GO_Biological_Process_2021__regulation of natural killer cell cytokine production (GO:0002727),-0.7768886990698397,-1.2110763243844602,0.21666666666666667,0.9779107521067177,1.0,2/5,15.53%,CD160;HLA-F
prerank,Reactome_2022__Beta-oxidation Of Very Long Chain Fatty Acids R-HSA-390247,-0.6855977742939848,-1.211051083616686,0.2786885245901639,0.97690082989716,1.0,2/11,9.32%,ACOT6;ACOT4
prerank,GO_Biological_Process_2021__negative regulation of lipid storage (GO:0010888),0.6113578614643191,1.2110315823810616,0.24390243902439024,0.8220943748096117,1.0,9/14,33.25%,PPARG;ABCA1;NR1H3;OSBPL8;ABCG1;ITGAV;PTPN2;NR1H2;ABHD5
prerank,GO_Biological_Process_2021__regulation of nitric oxide metabolic process (GO:0080164),0.741187542016476,1.2109867433652959,0.2972972972972973,0.8216869865280059,1.0,2/8,6.37%,CX3CR1;TMEM106A
prerank,Reactome_2022__Pre-NOTCH Processing In Endoplasmic Reticulum R-HSA-1912399,0.711706346184694,1.2109155914166314,0.3023255813953488,0.8212926257833136,1.0,2/6,16.67%,POFUT1;NOTCH1
prerank,CellMarker_Augmented_2021__Leukocyte:Peripheral Blood,-0.5228178502940215,-1.2108173610528474,0.2028985507246377,0.977038224387323,1.0,15/66,10.28%,GMFG;DOCK8;CYTIP;TBC1D10C;ARHGAP9;TAGAP;TMC8;ARHGAP15;GPR183;PARVG;WAS;CD37;TRAF3IP3;MYO1F;PTPRC
prerank,GO_Biological_Process_2021__tricarboxylic acid metabolic process (GO:0072350),0.661368198460475,1.2106509913774557,0.3333333333333333,0.8215284868406825,1.0,3/12,12.54%,ACO1;GLUD1;IDH2
prerank,GO_Biological_Process_2021__regulation of chloride transport (GO:2001225),0.7973509178154713,1.2100207184665999,0.3111111111111111,0.8228493821059251,1.0,1/5,0.42%,GABRE
prerank,GO_Biological_Process_2021__protein K27-linked ubiquitination (GO:0044314),-0.7864372702457421,-1.2099992281922411,0.2653061224489796,0.9802447167442978,1.0,1/6,1.82%,TRIM62
prerank,GO_Biological_Process_2021__thyroid hormone transport (GO:0070327),0.7534462538787359,1.209984932521178,0.36585365853658536,0.822319472275255,1.0,4/6,24.65%,SLC16A10;SLC7A8;SLC16A2;SLC7A5
prerank,GO_Biological_Process_2021__negative regulation of epithelial to mesenchymal transition (GO:0010719),0.5868385714679245,1.2098900306173819,0.23076923076923078,0.8219628314228672,1.0,5/22,11.02%,SPRED3;IL17RD;SPRED2;ADIPOR1;SPRED1
prerank,PanglaoDB_Augmented_2021__Tanycytes,0.42200778161386526,1.2097214567769368,0.08,0.8220866301565325,1.0,32/115,16.89%,FIBIN;VCAN;MEGF10;EDIL3;ADGRL2;CCN2;LHX2;VAT1L;LRFN5;SLIT2;EDNRA;EFS;DOK5;SYNDIG1;GUCY1A2;PDZRN3;WASF3;BRINP1;RGS7BP;STOX2;MPDZ;PAMR1;SCN7A;MAP6;ASXL3;ANK2;PRICKLE2;CDH11;PTPRD;MAGEL2;MARK1;PBX1
prerank,GO_Biological_Process_2021__hormone transport (GO:0009914),0.716688860001724,1.209654454019483,0.20512820512820512,0.8216692976612741,1.0,4/8,24.65%,SLC16A10;SLC7A8;SLC16A2;SLC7A5
prerank,CellMarker_Augmented_2021__Neuron:Embryonic Prefrontal Cortex,0.6801217796761623,1.2096305497512412,0.3157894736842105,0.8210192597660503,1.0,4/11,15.54%,NEUROD2;ARX;RBFOX1;CSRP2
prerank,GO_Biological_Process_2021__regulation of sequestering of calcium ion (GO:0051282),-0.6858440170487632,-1.2095791458835263,0.24615384615384617,0.9813019174860729,1.0,2/11,6.40%,CASQ2;TRDN
prerank,GO_Biological_Process_2021__chondroitin sulfate proteoglycan biosynthetic process (GO:0050650),0.5417558960895335,1.2093930055216038,0.09375,0.8211435278807294,1.0,11/26,11.08%,VCAN;CSGALNACT1;CHSY3;CHSY1;CHST12;CHPF2;CHST11;CSPG5;B3GAT3;CHST3;UGDH
prerank,GO_Biological_Process_2021__ethanol metabolic process (GO:0006067),0.6564535973806338,1.2093544104456555,0.2619047619047619,0.8206666767351142,1.0,4/10,15.36%,ALDH1A1;ACSS2;ADH4;SULT2A1
prerank,GO_Biological_Process_2021__negative regulation of B cell proliferation (GO:0030889),-0.7304183017962077,-1.209263081349669,0.2727272727272727,0.9817609975482839,1.0,1/6,2.65%,BLK
prerank,Reactome_2022__Long-term Potentiation R-HSA-9620244,0.5665670089185195,1.2088962440980882,0.13333333333333333,0.8218203273072131,1.0,3/23,5.50%,LLGL1;GPRIN1;NRG1
prerank,GO_Biological_Process_2021__regulation of blood vessel endothelial cell migration (GO:0043535),0.4852660890212057,1.2087995466405614,0.13043478260869565,0.8214538943601406,1.0,11/44,8.69%,FGFR1;HSPB1;APOE;ANGPT1;PPARG;SIRT1;HMGB1;VASH1;SP1;FGF18;NUS1
prerank,Reactome_2022__Ubiquinol Biosynthesis R-HSA-2142789,0.7200610748845987,1.2087352787744934,0.24324324324324326,0.8210024261484878,1.0,5/8,27.43%,PDSS2;COQ2;COQ9;COQ6;COQ3
prerank,CellMarker_Augmented_2021__Red Blood Cell (erythrocyte):Plasma,-0.5103060718095419,-1.2087270964050407,0.1875,0.982148640646058,1.0,19/49,20.33%,TRIM58;OR52A5;GYPE;SLFN14;ARHGAP15;GYPB;CA1;MFSD2B;ALAS2;ITGA2B;CEACAM8;ABCC13;CTCFL;PIK3CG;SLC4A1;CLEC1B;BEND2;GAB3;IFIT1B
prerank,CellMarker_Augmented_2021__Erythroblast:Fetal Liver,-0.5103060718095419,-1.2087270964050407,0.1875,0.982148640646058,1.0,19/49,20.33%,TRIM58;OR52A5;GYPE;SLFN14;ARHGAP15;GYPB;CA1;MFSD2B;ALAS2;ITGA2B;CEACAM8;ABCC13;CTCFL;PIK3CG;SLC4A1;CLEC1B;BEND2;GAB3;IFIT1B
prerank,CellMarker_Augmented_2021__Transitional B cell:Bone Marrow,-0.5604159595629108,-1.2086286944720517,0.2028985507246377,0.9793857531081517,1.0,14/52,10.28%,SIRPG;GMFG;CYTIP;TBC1D10C;ARHGAP9;TAGAP;KLRB1;ARHGAP15;PARVG;CD5;CD37;TRAF3IP3;MYO1F;PTPRC
prerank,CellMarker_Augmented_2021__T2 (Transitional) B cell:Bone Marrow,-0.5604159595629108,-1.2086286944720517,0.2028985507246377,0.9793857531081517,1.0,14/52,10.28%,SIRPG;GMFG;CYTIP;TBC1D10C;ARHGAP9;TAGAP;KLRB1;ARHGAP15;PARVG;CD5;CD37;TRAF3IP3;MYO1F;PTPRC
prerank,CellMarker_Augmented_2021__T1 (Transitional) B cell:Bone Marrow,-0.5604159595629108,-1.2086286944720517,0.2028985507246377,0.9793857531081517,1.0,14/52,10.28%,SIRPG;GMFG;CYTIP;TBC1D10C;ARHGAP9;TAGAP;KLRB1;ARHGAP15;PARVG;CD5;CD37;TRAF3IP3;MYO1F;PTPRC
prerank,Reactome_2022__Phenylalanine And Tyrosine Metabolism R-HSA-8963691,0.6186592032433389,1.2085997821100845,0.2571428571428571,0.8208206127493267,1.0,5/11,25.08%,KYAT1;ASRGL1;GSTZ1;IL4I1;PAH
prerank,GO_Biological_Process_2021__cellular response to leucine starvation (GO:1990253),0.6322455905384591,1.2084730657116782,0.3076923076923077,0.8207001638236312,1.0,6/10,29.74%,IMPACT;SESN2;RRAGD;GCN1;SESN3;EIF2AK4
prerank,GO_Biological_Process_2021__cellular response to growth hormone stimulus (GO:0071378),0.6202837750779794,1.2084667094284367,0.2222222222222222,0.8200673616605763,1.0,2/7,27.93%,PXN;STAT3
prerank,GO_Biological_Process_2021__inner ear receptor cell stereocilium organization (GO:0060122),0.6435083219497768,1.2080677829857582,0.2826086956521739,0.8209110188713529,1.0,5/10,14.36%,TSKU;IFT88;WHRN;ADGRV1;PDZD7
prerank,CellMarker_Augmented_2021__Stem cell:Gastrointestinal Tract,0.421462937423831,1.2079560925801904,0.08695652173913043,0.8207420558235867,1.0,31/97,24.12%,ALCAM;ADGRL2;SH3RF1;AADAT;ABCD3;KITLG;RND3;DDAH1;TSPAN3;CLDN12;TSPAN6;TMTC3;EPS8;KCTD3;TSPAN12;MAGI3;ZMYND11;LRRC1;ZBTB41;KIF3B;SPIN1;CFAP43;ARHGAP5;ZNF664;SMAD5;CDS1;MIB1;NME5;SH3D19;PANK3;GOLM1
prerank,GO_Biological_Process_2021__pteridine-containing compound biosynthetic process (GO:0042559),0.7026591342026071,1.207941817259788,0.1951219512195122,0.8201351118019213,1.0,2/6,18.58%,DHFR;FPGS
prerank,GO_Biological_Process_2021__regulation of response to reactive oxygen species (GO:1901031),0.686022632366804,1.2077178206463839,0.2727272727272727,0.8200157098238484,1.0,1/6,6.34%,DHFR
prerank,GO_Biological_Process_2021__negative regulation of sodium ion transmembrane transport (GO:1902306),0.6933684606016701,1.2076026222789844,0.3111111111111111,0.8196777298867562,1.0,4/9,20.19%,COMMD1;OSR1;NEDD4;PRKCE
prerank,GO_Biological_Process_2021__signal complex assembly (GO:0007172),0.7466817267041899,1.2075922374140409,0.26666666666666666,0.8190609835821059,1.0,3/5,21.97%,PXN;NCK1;NCK2
prerank,GO_Biological_Process_2021__prepulse inhibition (GO:0060134),0.7829728578925799,1.2075710173514151,0.2619047619047619,0.8184695062424906,1.0,1/6,1.38%,GRID2
prerank,GO_Biological_Process_2021__regulation of T-helper 17 cell differentiation (GO:2000319),0.6990449690088303,1.2075413214636226,0.3333333333333333,0.8179396097844602,1.0,7/8,30.00%,MALT1;RC3H1;SMAD7;NFKBID;RC3H2;NFKBIZ;FOXP3
prerank,GO_Biological_Process_2021__regulation of proteolysis (GO:0030162),0.5330010393855676,1.20745760007901,0.16666666666666666,0.8175680616756025,1.0,5/45,7.30%,CSTA;TBC1D10A;PERP;SPOPL;F2
prerank,GO_Biological_Process_2021__detection of muscle stretch (GO:0035995),-0.7390424601346406,-1.2073459923033532,0.30357142857142855,0.9855517380509514,1.0,3/7,14.24%,CAV3;CSRP3;TTN
prerank,CellMarker_Augmented_2021__Cancer cell:Kidney,0.7912581222376254,1.2073231092321253,0.13043478260869565,0.8173423727446496,1.0,1/5,2.84%,PTPRO
prerank,GO_Biological_Process_2021__peptidyl-lysine monomethylation (GO:0018026),0.622078846336168,1.2069347935261572,0.2,0.8180241770843641,1.0,1/11,0.80%,SMYD2
prerank,CellMarker_Augmented_2021__Beta cell:Undefined,-0.5291771087020376,-1.2068061316745544,0.2033898305084746,0.9874006073797248,1.0,15/42,17.98%,RASGRP4;TBC1D10C;ARHGAP9;RAB44;ICAM3;FRAT1;MYO1F;ALAS2;MMP25;SH2D1B;ADGRE3;TSPAN16;CMTM2;PGLYRP1;CD8B
prerank,GO_Biological_Process_2021__icosanoid secretion (GO:0032309),-0.6576390278445577,-1.2067757671532984,0.20634920634920634,0.9864019899933267,1.0,3/11,14.17%,NMUR2;ANXA1;NOS2
prerank,GO_Biological_Process_2021__positive regulation of B cell receptor signaling pathway (GO:0050861),-0.7660496401634173,-1.2067155680598258,0.25,0.9856215523466806,1.0,3/7,18.80%,NFAM1;PRKCH;CD81
prerank,GO_Biological_Process_2021__positive regulation of intracellular steroid hormone receptor signaling pathway (GO:0033145),-0.7485145584035942,-1.2065235209739686,0.2641509433962264,0.9857055467319625,1.0,2/5,16.69%,YAP1;WBP2
prerank,Reactome_2022__Phase II - Conjugation Of Compounds R-HSA-156580,0.4827626179940856,1.2065137244689474,0.2413793103448276,0.8186686241376508,1.0,18/70,15.36%,CYP1A2;GLYATL1;PODXL2;GLYATL2;PAPSS2;UGT2B15;GSTM5;CHAC1;GSTO2;GSTM2;MTR;UGDH;MAT2A;ACSM2A;ACSM1;GSTA4;GSTZ1;SULT2A1
prerank,GO_Biological_Process_2021__cation homeostasis (GO:0055080),0.701809686221625,1.206463614401934,0.2564102564102564,0.8182252340225348,1.0,4/7,21.12%,SLC7A8;SLC4A11;CNNM4;TRPM7
prerank,Reactome_2022__Binding Of TCF/LEF:CTNNB1 To Target Gene Promoters R-HSA-4411364,-0.7557640206836463,-1.2063529539313516,0.25,0.9856070717162054,1.0,3/7,13.80%,TCF7;TCF7L1;LEF1
prerank,GO_Biological_Process_2021__positive regulation of production of miRNAs involved in gene silencing by miRNA (GO:1903800),-0.7243150484646514,-1.2062480976871421,0.22580645161290322,0.9850288104124748,1.0,1/10,1.49%,TGFB1
prerank,GO_Biological_Process_2021__sequestering of extracellular ligand from receptor (GO:0035581),0.6278105189553069,1.2062381834228193,0.20930232558139536,0.8183737824086769,1.0,3/11,7.55%,GREM2;GREM1;LTBP1
prerank,GO_Biological_Process_2021__glucose 6-phosphate metabolic process (GO:0051156),0.5334384171894296,1.2062184495717758,0.18181818181818182,0.8178469520256183,1.0,3/20,6.20%,GCK;G6PC3;H6PD
prerank,GO_Biological_Process_2021__regulation of cholesterol biosynthetic process (GO:0045540),0.5868472790137639,1.206103176628607,0.21875,0.817610082476788,1.0,8/17,29.51%,APOE;SEC14L2;SREBF2;ABCA2;LPCAT3;ERLIN1;ABCG1;PRKAA1
prerank,GO_Biological_Process_2021__positive regulation of small molecule metabolic process (GO:0062013),0.6601932894348429,1.2059160440330412,0.17073170731707318,0.8176263639517105,1.0,6/12,20.19%,IRS1;PPARG;AKT2;IRS2;GPLD1;PRKCE
prerank,GO_Biological_Process_2021__regulation of macrophage chemotaxis (GO:0010758),-0.6406790224339316,-1.205711757999552,0.2033898305084746,0.986625989232775,1.0,10/19,31.52%,THBS1;MTUS1;CSF1R;MST1;CXCL17;CCL5;PTK2B;CSF1;MAPK3;C5
prerank,GO_Biological_Process_2021__regulation of isotype switching (GO:0045191),0.6254355276493943,1.2056066038998188,0.20930232558139536,0.8181958606086762,1.0,5/14,22.37%,SHLD2;SHLD1;KMT5C;KMT5B;SLC15A4
prerank,GO_Biological_Process_2021__skeletal muscle tissue regeneration (GO:0043403),0.6548322675738489,1.2054647220309191,0.28205128205128205,0.8182597147273545,1.0,2/7,3.72%,CFLAR;EYS
prerank,Reactome_2022__Activation Of NMDA Receptors And Postsynaptic Events R-HSA-442755,0.44721400951989165,1.205388039266875,0.1,0.8179872512809121,1.0,20/71,22.41%,GRIN3A;LLGL1;GPRIN1;NRG1;PRKAR2A;RPS6KA3;APBA1;MPP2;RPS6KA2;RPS6KA6;CREB1;PRKAA2;PRKAG2;LIN7A;NBEA;CASK;DLG1;GIT1;GRIA4;LRRC7
prerank,GO_Biological_Process_2021__progesterone metabolic process (GO:0042448),0.6879387845775691,1.2053271319630703,0.29545454545454547,0.8175592501508939,1.0,2/5,7.00%,AKR1C3;AKR1C1
prerank,GO_Biological_Process_2021__negative regulation of potassium ion transport (GO:0043267),-0.6972976775236339,-1.2052186918559333,0.24489795918367346,0.988194786649021,1.0,2/12,2.76%,CASQ2;CAV3
prerank,Reactome_2022__Nuclear Pore Complex (NPC) Disassembly R-HSA-3301854,0.49733748418541923,1.2050607280434458,0.18421052631578946,0.8178512412008621,1.0,11/34,28.54%,NUP210;NUP42;AAAS;RANBP2;NUP214;TPR;SEH1L;NUP153;NUP98;NUP37;CDK1
prerank,GO_Biological_Process_2021__regulation of retinoic acid receptor signaling pathway (GO:0048385),-0.6792195704522692,-1.2049361277033777,0.24615384615384617,0.9884898507069669,1.0,2/12,2.44%,PRAME;CYP26B1
prerank,GO_Biological_Process_2021__regulation of amyloid-beta formation (GO:1902003),0.5566419487277513,1.2048722763549307,0.2571428571428571,0.8177833995036073,1.0,12/32,24.56%,APOE;LRRTM3;BIN1;SP1;CASP3;RTN2;ABCA7;GSAP;NTRK2;RTN1;ABCA2;SLC2A13
prerank,GO_Biological_Process_2021__negative regulation of vascular associated smooth muscle cell differentiation (GO:1905064),0.646595424024887,1.2048431237309005,0.25,0.8172249268360966,1.0,2/8,4.97%,NFATC3;DNMT1
prerank,GO_Biological_Process_2021__positive regulation of protein phosphorylation (GO:0001934),-0.4277689658554099,-1.204693900994975,0.12195121951219512,0.9886524302314657,1.0,41/306,15.80%,CD44;ENPP2;TBX1;FGF20;TGFB1;NODAL;MMP9;SPDYA;TERF2IP;CCND1;CARD14;TEC;GPER1;PINK1;VTN;DAB2;TTK;FLT4;CDK2AP1;PIK3R3;MTCP1;CCND2;HLA-DRB1;PTPRC;GDF11;ENG;BMP3;CDKN1A;FAXDC2;ATG14;TEK;RSPO1;ITGA5;TGFB3;CD80;TOM1L1;DDX3X;FGF22;PROM2;CD4;AGT
prerank,GO_Biological_Process_2021__positive regulation of cholesterol storage (GO:0010886),0.7322869323194596,1.204602142201966,0.325,0.8173490492699286,1.0,4/6,22.82%,APOB;LPL;SREBF2;SCARB1
prerank,Reactome_2022__Negative Regulation Of PI3K/AKT Network R-HSA-199418,0.41908998636624156,1.2043397859577918,0.034482758620689655,0.8175088238339925,1.0,21/94,14.97%,FGF10;THEM4;KIT;FGFR1;IRS1;NRG2;FGF17;ERBB2;NRG1;NRG3;FGF18;TGFA;AKT2;FGFR3;KITLG;IRS2;PPP2R1B;FLT3;INSR;PIK3CA;IRAK4
prerank,GO_Biological_Process_2021__steroid hormone biosynthetic process (GO:0120178),-0.567384447911579,-1.2041912853137404,0.19117647058823528,0.9902465633234049,1.0,4/22,19.39%,AKR1B15;CYP21A2;HSD3B1;CYP17A1
prerank,GO_Biological_Process_2021__regulation of biomineral tissue development (GO:0070167),-0.6340629963552473,-1.2040864671194267,0.21212121212121213,0.9896505456862477,1.0,2/23,1.49%,NOTUM;TGFB1
prerank,GO_Biological_Process_2021__cardiac muscle cell action potential (GO:0086001),-0.5665899059267581,-1.203863599338661,0.2647058823529412,0.989589577909536,1.0,3/30,8.12%,PKP2;SCN5A;KCNQ1
prerank,GO_Biological_Process_2021__cardiac ventricle morphogenesis (GO:0003208),-0.5933947814779327,-1.2034690557982284,0.19696969696969696,0.9906851888399741,1.0,4/29,4.08%,PKP2;TGFB1;MYH7;MYBPC3
prerank,Reactome_2022__Netrin Mediated Repulsion Signals R-HSA-418886,0.7255666815246843,1.2033566407497112,0.3617021276595745,0.8204027405587033,1.0,3/8,6.21%,UNC5C;UNC5D;DCC
prerank,GO_Biological_Process_2021__homophilic cell adhesion via plasma membrane adhesion molecules (GO:0007156),0.46564238278035514,1.2032739168222752,0.14814814814814814,0.8200348577475283,1.0,17/51,18.20%,ROBO2;DSCAML1;CDH13;BSG;SDK1;CADM1;DSCAM;TENM3;PTPRM;CDH2;NECTIN3;PTPRT;EMB;CNTN6;AMIGO2;CDH4;KIRREL3
prerank,CellMarker_Augmented_2021__Common Lymphoid progenitor:Germ,-0.5202631512920731,-1.2031764248790053,0.17721518987341772,0.9912622144500631,1.0,15/55,13.10%,C1QB;JCHAIN;CMAHP;LYVE1;TNFRSF1B;CIITA;MS4A4A;FCGR3A;P2RY14;VSIG4;HLA-DPB1;SELP;PTPRC;F13A1;HLA-DPA1
prerank,GO_Biological_Process_2021__negative regulation of excitatory postsynaptic potential (GO:0090394),0.712589929926736,1.203032687894932,0.37254901960784315,0.8201563455832351,1.0,2/6,22.04%,NLGN4X;PTEN
prerank,GO_Biological_Process_2021__phagosome acidification (GO:0090383),0.5230859625747575,1.202952925648281,0.1875,0.8198488051397311,1.0,4/25,5.56%,ATP6V0D2;TCIRG1;RAB20;RAB7A
prerank,CellMarker_Augmented_2021__Multipotent Progenitor cell:Stomach,-0.5522190558808503,-1.2029438064734281,0.15942028985507245,0.9914860638352962,1.0,1/41,0.10%,ZFP41
prerank,KEGG_2021_Human__Citrate cycle (TCA cycle),0.5849080971225503,1.202816673150526,0.2702702702702703,0.8195417540207195,1.0,4/26,12.54%,PC;ACO1;OGDH;IDH2
prerank,GO_Biological_Process_2021__mismatch repair (GO:0006298),0.5693932017600397,1.2027032148090226,0.1891891891891892,0.8192589773401154,1.0,4/24,7.57%,MSH4;POLD3;PMS1;ABL1
prerank,GO_Biological_Process_2021__axon ensheathment in central nervous system (GO:0032291),-0.739757085955989,-1.2025626238305847,0.28846153846153844,0.9925431800990901,1.0,3/7,19.63%,SOX10;PLP1;MYRF
prerank,CellMarker_Augmented_2021__Neural Stem cell:Inferior Colliculus,0.4331373358460905,1.202463685520909,0.16666666666666666,0.8193806954610208,1.0,28/97,16.89%,MEGF10;GPC4;ADGRL2;EPHA7;MID1;IL17RD;UNC5D;PTPRZ1;ZNF462;EFS;FGFR3;WNK2;STOX2;NLGN4X;MPDZ;RBFOX2;FARP1;CRABP1;MAP6;MSI1;MAGI1;ANK2;PPP1R9A;PTPRD;FRAS1;MAGEL2;MARK1;PBX1
prerank,Reactome_2022__Activation Of HOX Genes During Differentiation R-HSA-5619507,0.48971234887693355,1.2023140052717491,0.25,0.8193478549672009,1.0,16/59,22.28%,HDAC3;PKNOX1;MAFB;RARB;H2BC21;NCOA3;CNOT9;H2AX;PBX1;PAX6;EP300;H2AJ;KMT2C;CNOT6;RBBP4;POLR2F
prerank,Reactome_2022__Cell Junction Organization R-HSA-446728,0.45057036513038906,1.2021578451832715,0.1,0.8191608235635282,1.0,27/74,17.39%,LAMA4;CDH19;CDH12;CD151;CDH5;PARD3;CDH13;PARVA;SDK1;CADM2;CADM1;CDH6;FLNA;PLEC;CLDN12;LIMS1;ITGB4;DST;CDH2;CDH24;NECTIN3;CDH10;CDH11;PARD6B;CLDN15;RSU1;CDH4
prerank,Reactome_2022__Metabolism Of Folate And Pterines R-HSA-196757,0.6216575207665996,1.20208377963759,0.2631578947368421,0.8187962569009144,1.0,7/14,25.77%,SLC19A1;DHFR;MTHFR;FPGS;SHMT2;MTHFD1L;MTHFD2L
prerank,Reactome_2022__Interleukin-21 Signaling R-HSA-9020958,-0.7212896734400163,-1.2020308486677256,0.2698412698412698,0.9941694882618487,1.0,2/8,6.09%,IL21R;STAT1
prerank,GO_Biological_Process_2021__regulation of T-helper 1 cell differentiation (GO:0045625),-0.7765727629192725,-1.2019641975504254,0.2631578947368421,0.9933943179188608,1.0,3/5,14.67%,ANXA1;IL27;CD80
prerank,GO_Biological_Process_2021__t-circle formation (GO:0090656),0.6207076911889189,1.201708597689787,0.2631578947368421,0.8179543891528985,1.0,4/10,20.40%,SMARCAL1;TERF1;EXO1;DNA2
prerank,GO_Biological_Process_2021__telomere maintenance via telomere trimming (GO:0090737),0.6207076911889189,1.201708597689787,0.2631578947368421,0.8179543891528985,1.0,4/10,20.40%,SMARCAL1;TERF1;EXO1;DNA2
prerank,GO_Biological_Process_2021__formation of extrachromosomal circular DNA (GO:0001325),0.6207076911889189,1.201708597689787,0.2631578947368421,0.8179543891528985,1.0,4/10,20.40%,SMARCAL1;TERF1;EXO1;DNA2
prerank,Reactome_2022__FGFR2b Ligand Binding And Activation R-HSA-190377,0.7424763496411086,1.2016613516668402,0.16,0.8174973834191525,1.0,1/7,1.19%,FGF10
prerank,Reactome_2022__Unfolded Protein Response (UPR) R-HSA-381119,0.4295580543263845,1.201399035788558,0.15384615384615385,0.8175252540924165,1.0,22/82,20.74%,EXTL1;CREB3L2;CREB3L4;PDIA6;EXOSC1;ATF3;EIF2AK3;CTDSP2;KHSRP;ERN1;ACD;PREB;NFYC;YIF1A;DNAJC3;DIS3;ATF6;CXXC1;EDEM1;ADD1;ACADVL;EXOSC5
prerank,CellMarker_Augmented_2021__Secretory cell:Lung,-0.5431749417891943,-1.201398235483649,0.20588235294117646,0.9953174847143244,1.0,16/47,18.49%,RARRES1;PLAAT4;HLA-DMA;MUC5B;HLA-A;PRSS23;HLA-DPB1;TGM2;HLA-DRB1;CP;STEAP4;HLA-DPA1;SERPINB7;ANPEP;CAPN13;ALDH1A3
prerank,Reactome_2022__Interleukin-2 Signaling R-HSA-9020558,0.623062458603969,1.2011971769752088,0.20588235294117646,0.8174822847300474,1.0,2/10,15.73%,STAT5B;IL2RB
prerank,GO_Biological_Process_2021__negative regulation of intracellular protein transport (GO:0090317),-0.5840511550313998,-1.201116156312619,0.15384615384615385,0.9957797052936346,1.0,3/22,12.51%,SP100;USP17L2;APOD
prerank,GO_Biological_Process_2021__positive regulation of immune system process (GO:0002684),-0.6403096770063514,-1.201115193564632,0.24193548387096775,0.9946801814037814,1.0,5/16,15.80%,AQP3;ANXA1;GPR151;PIK3CB;ZP3
prerank,KEGG_2021_Human__Autoimmune thyroid disease,-0.5900487546069811,-1.20092233245031,0.25,0.9944681479963658,1.0,12/22,20.41%,TSHR;HLA-DMA;HLA-A;HLA-DPB1;CGA;HLA-DRB1;HLA-DPA1;CD80;HLA-F;TG;IL5;CD86
prerank,GO_Biological_Process_2021__endothelial cell development (GO:0001885),0.5207410044176536,1.200891975644841,0.21212121212121213,0.81780487457063,1.0,1/23,0.09%,COL22A1
prerank,GO_Biological_Process_2021__regulation of plasma membrane bounded cell projection assembly (GO:0120032),0.44562394891120544,1.2008068108470542,0.06896551724137931,0.8174201105387369,1.0,17/64,21.10%,TBC1D10A;MYO10;IFT88;TBC1D16;TRPM2;FER;SDCCAG8;TBC1D22B;FSCN1;IFT140;RAB5A;TBC1D2;DCDC2;TBC1D8;USP6NL;FXR2;TBC1D5
prerank,GO_Biological_Process_2021__axonal fasciculation (GO:0007413),0.5667187558082372,1.2006636087838318,0.20588235294117646,0.8173420108378335,1.0,5/12,19.70%,SEMA5A;EPHA3;ARHGAP35;EPHB2;NRCAM
prerank,PanglaoDB_Augmented_2021__Purkinje Fiber Cells,0.43653280096292657,1.2006129231376963,0.17857142857142858,0.8168876422210035,1.0,30/100,19.93%,GRID2;PCDH17;ROBO2;NOVA1;UNC5D;ELAVL3;MAGI2;SLC35F1;KCNIP1;CPT1C;GUCY1A2;BRINP1;DENND2A;RAB3C;SNAP91;RBFOX1;ASXL3;ANK2;SRRM4;NRXN1;PTPRD;MAGEL2;EFR3B;LSAMP;FAT3;ST8SIA3;ADGRB3;CTNNA2;CNTN1;PAK3
prerank,CellMarker_Augmented_2021__Plasmacytoid Dendritic cell:Undefined,-0.8011874073330875,-1.2005928285525043,0.2727272727272727,0.994962214955524,1.0,2/5,8.44%,CLEC4C;IL3RA
prerank,GO_Biological_Process_2021__negative regulation of glucose import (GO:0046325),0.7266535604324741,1.2005479144967666,0.18421052631578946,0.8165750234744849,1.0,3/8,24.06%,PID1;APPL2;ENPP1
prerank,GO_Biological_Process_2021__microtubule-based transport (GO:0099111),0.6575641483087531,1.2005092420574082,0.3191489361702128,0.8160632513030239,1.0,2/11,8.28%,SPEF2;DYNC1I2
prerank,GO_Biological_Process_2021__response to estrogen (GO:0043627),-0.5963386871902381,-1.200391422723102,0.2542372881355932,0.9948151525678299,1.0,7/29,17.21%,ESR1;TRIM25;ZNF366;BRCA1;GHRL;WBP2;CD24
prerank,Reactome_2022__Separation Of Sister Chromatids R-HSA-2467813,-0.4381339159732086,-1.2003814289381303,0.14457831325301204,0.9937701237147206,1.0,31/155,23.67%,BUB1;ERCC6L;PSMB9;SPC25;CENPU;ITGB3BP;ZWILCH;NUF2;CENPH;CENPS-CORT;DYNLL1;RPS27;INCENP;NDEL1;PSMA3;CDCA8;CENPN;RPS27A;KIF18A;BUB1B;PSMA7;PSMB6;SKA2;SEC13;CENPL;PSMA5;DYNLL2;PTTG1;PPP2R5A;CENPM;PSMD6
prerank,Reactome_2022__Gamma-carboxylation Of Protein Precursors R-HSA-159740,-0.7218785314655224,-1.2003686976139765,0.2923076923076923,0.9927435744128698,1.0,2/8,9.58%,F7;FAM110A
prerank,CellMarker_Augmented_2021__Limbal Stem cell:Corneal Epithelium,-0.533044441461454,-1.200342428427326,0.14285714285714285,0.9917919672695219,1.0,21/67,15.90%,CLCA2;DUOX1;KCNJ15;RHBDL2;MACC1;TMPRSS11D;DUOXA1;FUT2;SERPINB5;SOD2;ATP10B;ZNF750;A2ML1;ITGB6;STEAP4;CXCL16;TRIM29;APOL6;IL18;PROM2;PRRG4
prerank,CellMarker_Augmented_2021__Pericyte:Adipose Tissue,-0.7835142902997162,-1.2002409532967084,0.2222222222222222,0.9912296252182727,1.0,2/6,11.81%,PTPRC;ENG
prerank,GO_Biological_Process_2021__regulation of ER to Golgi vesicle-mediated transport (GO:0060628),0.6447117492294527,1.1997952097128675,0.23076923076923078,0.8182747010395468,1.0,7/9,34.02%,STX18;PGAP1;RNF139;GAS1;SCFD1;SORL1;TBC1D20
prerank,GO_Biological_Process_2021__negative regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway (GO:1903377),-0.7262542074190075,-1.1996448938333593,0.2037037037037037,0.9934562563548333,1.0,1/5,5.61%,PINK1
prerank,GO_Biological_Process_2021__mRNA modification (GO:0016556),0.5462441132938811,1.1995324514803394,0.17142857142857143,0.8185128225888526,1.0,7/22,19.85%,METTL8;PCIF1;TRMT61B;PUS7;ZC3H13;TRMT61A;METTL16
prerank,GO_Biological_Process_2021__negative regulation of anion transport (GO:1903792),0.7586262672401601,1.1992157303682351,0.28205128205128205,0.8188677330679119,1.0,3/5,9.91%,GABRE;HRH3;GRM7
prerank,GO_Biological_Process_2021__regulation of protein polymerization (GO:0032271),0.5512312466409108,1.1990221948811013,0.21212121212121213,0.8188708775531217,1.0,11/31,23.02%,PLEKHG2;ABL1;LATS1;HCLS1;COTL1;TPPP3;FCHSD2;GBA2;PAK3;CAMSAP3;ARHGAP18
prerank,GO_Biological_Process_2021__erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221),0.7071812516681164,1.1990041371389513,0.3111111111111111,0.817649835442255,1.0,4/6,25.08%,KYAT1;ASRGL1;IL4I1;PAH
prerank,Reactome_2022__Phenylalanine Metabolism R-HSA-8964208,0.7071812516681164,1.1990041371389513,0.3111111111111111,0.817649835442255,1.0,4/6,25.08%,KYAT1;ASRGL1;IL4I1;PAH
prerank,GO_Biological_Process_2021__diterpenoid metabolic process (GO:0016101),0.4755850507336927,1.1988645652011507,0.125,0.8173502536413962,1.0,15/46,13.60%,GPC4;CYP4V2;APOB;APOE;SDC4;ALDH1A1;GPC6;AKR1C3;AKR1C1;GPC5;LPL;AWAT2;SDC3;ADH4;LRP8
prerank,GO_Biological_Process_2021__positive regulation of glial cell migration (GO:1903977),-0.8001943334324921,-1.198798980908425,0.26229508196721313,0.9969415439707944,1.0,1/5,2.75%,P2RY12
prerank,GO_Biological_Process_2021__regulation of transcription from RNA polymerase II promoter involved in myocardial precursor cell differentiation (GO:0003256),0.7068231286079303,1.1987817934016813,0.35,0.8169927867472493,1.0,5/5,29.33%,GREM1;NOTCH1;RBPJ;SRF;MYOCD
prerank,Reactome_2022__Signaling By NTRK3 (TRKC) R-HSA-9034015,0.5954610372199285,1.1986216918138204,0.2619047619047619,0.8168691050024213,1.0,3/15,19.27%,IRS1;PIK3CA;SOS1
prerank,GO_Biological_Process_2021__protein localization to lysosome (GO:0061462),0.5429037103901334,1.1985773326549145,0.21951219512195122,0.816407698814406,1.0,8/28,20.87%,KPTN;RAB7A;GCC2;ZFYVE16;RNF128;NEDD4;SZT2;LAPTM5
prerank,GO_Biological_Process_2021__positive regulation of Arp2/3 complex-mediated actin nucleation (GO:2000601),0.6894606009273448,1.1982204241040226,0.21052631578947367,0.8171811948054962,1.0,3/8,15.99%,WASF3;WASF2;FCHSD2
prerank,GO_Biological_Process_2021__nucleotide-sugar metabolic process (GO:0009225),0.6392623503690985,1.198135787012845,0.1935483870967742,0.8168366054362731,1.0,3/11,11.98%,CSGALNACT1;GMDS;GALT
prerank,GO_Biological_Process_2021__glandular epithelial cell development (GO:0002068),0.7058791662684729,1.1979521470317218,0.2765957446808511,0.8169110570318956,1.0,4/7,21.65%,CDK6;CDH2;PAX6;BMP4
prerank,GO_Biological_Process_2021__phosphatidylcholine catabolic process (GO:0034638),-0.7156197977638978,-1.1977479296406974,0.2711864406779661,1.0,1.0,2/9,6.32%,ENPP2;PLA2G10
prerank,GO_Biological_Process_2021__mRNA cleavage involved in gene silencing by miRNA (GO:0035279),0.7398825275018217,1.1977247428845628,0.34782608695652173,0.8171131704084512,1.0,3/5,20.09%,MOV10;AGO3;AGO2
prerank,GO_Biological_Process_2021__negative regulation of cold-induced thermogenesis (GO:0120163),0.48525178393283697,1.1976829061823318,0.17857142857142858,0.8166069362010226,1.0,10/41,19.92%,LAMA4;NOVA1;ALDH1A1;PLCL2;TFE3;NR1H3;NOTCH1;IP6K1;RBPJ;MAP2K6
prerank,GO_Biological_Process_2021__heart trabecula formation (GO:0060347),0.7283497439590987,1.1974194858583656,0.26666666666666666,0.8167973738593135,1.0,1/5,0.91%,ADGRG6
prerank,CellMarker_Augmented_2021__Side-population cell:Undefined,-0.49707869051085407,-1.1971979872976684,0.2328767123287671,1.0,1.0,15/62,12.98%,CD44;AHR;MISP;CLDN1;TGFBI;BACE2;PLAU;SERPINB5;PRSS23;ANXA1;THBS1;GPR39;LAMC2;ITGB6;TRIM29
prerank,CellMarker_Augmented_2021__T Helper2 (Th2) cell:Undefined,-0.6766538484526965,-1.1970734539440515,0.22535211267605634,1.0,1.0,6/13,24.13%,IRF4;CD4;IL5;IL17RB;MAF;IL1R1
prerank,GO_Biological_Process_2021__regulation of interleukin-4 production (GO:0032673),-0.6326033527734394,-1.1968005943540505,0.19402985074626866,1.0,1.0,6/19,15.80%,IRF4;ZFPM1;HLA-DRB1;NLRP3;LEF1;ZP3
prerank,GO_Biological_Process_2021__negative regulation of chemokine-mediated signaling pathway (GO:0070100),0.7171853413522291,1.196751567168387,0.2222222222222222,0.8184129798470601,1.0,3/6,24.96%,SLIT2;RNF113A;SLIT3
prerank,GO_Biological_Process_2021__regulation of cell projection organization (GO:0031344),0.6326081529384985,1.1966572566836138,0.2222222222222222,0.8181500984853056,1.0,4/11,11.85%,MFSD2A;MOV10;NTNG2;MACF1
prerank,GO_Biological_Process_2021__Roundabout signaling pathway (GO:0035385),0.7901070782803337,1.1966115657341247,0.2391304347826087,0.8177024844340641,1.0,2/5,8.66%,SLIT2;MYO9B
prerank,GO_Biological_Process_2021__regulation of response to external stimulus (GO:0032101),-0.4769757195326419,-1.1963859394105112,0.18055555555555555,1.0,1.0,38/100,25.59%,HCK;WNT5A;P2RY12;PDE6B;ALOX5;IRF1;GRK7;TRIM5;PTGES;LRRC19;GP1BA;ALOX15;ANXA1;LACC1;PDE6A;GRN;F2RL1;SPATA2;CALM1;GUCY2F;ERAP1;NMT1;CASP8;ACE2;DHX58;PIK3AP1;SPAAR;BST1;PDE6G;SEMA7A;TMSB4X;CNGB1;IL1R1;TKFC;TNFSF4;USP18;PARK7;UFL1
prerank,GO_Biological_Process_2021__T cell chemotaxis (GO:0010818),-0.7612276154798724,-1.1962171158979942,0.2708333333333333,1.0,1.0,3/5,17.46%,GPR183;CXCL16;PIK3CG
prerank,GO_Biological_Process_2021__astrocyte development (GO:0014002),0.7426081651108822,1.1961931067049543,0.2391304347826087,0.8185620981342545,1.0,2/5,13.81%,CDK6;NF1
prerank,GO_Biological_Process_2021__axonal transport of mitochondrion (GO:0019896),0.6416518824876558,1.1961892752224308,0.2702702702702703,0.8179415571863821,1.0,3/11,10.37%,MGARP;SPAST;TRAK2
prerank,Reactome_2022__Phototransduction Cascade R-HSA-2514856,-0.5657299243606551,-1.1960666682092493,0.19696969696969696,1.0,1.0,11/27,23.57%,PDE6B;GRK7;SLC24A1;GNGT1;PDE6A;CALM1;GUCY2F;NMT1;CHURC1-FNTB;PDE6G;CNGB1
prerank,GO_Biological_Process_2021__estrogen biosynthetic process (GO:0006703),-0.7218721696577899,-1.1959530140750383,0.30357142857142855,1.0,1.0,2/7,17.21%,AKR1B15;HSD3B1
prerank,KEGG_2021_Human__Renin secretion,-0.5330370537637024,-1.195436583225469,0.2112676056338028,1.0,1.0,3/55,2.14%,CLCA2;CLCA1;CLCA4
prerank,GO_Biological_Process_2021__ovarian follicle development (GO:0001541),0.6387480855464014,1.1953378530403163,0.2682926829268293,0.8200810906711546,1.0,1/10,1.53%,KIT
prerank,GO_Biological_Process_2021__gastro-intestinal system smooth muscle contraction (GO:0014831),-0.7509890634005979,-1.1949612142235908,0.2727272727272727,1.0,1.0,2/5,13.45%,HTR2B;PTGER3
prerank,CellMarker_Augmented_2021__Epithelial cell:Placenta,0.4365968179059916,1.1948771695888596,0.08,0.8210060952553069,1.0,5/62,3.43%,ADGRF4;LAMA3;ARSJ;SDC4;PERP
prerank,GO_Biological_Process_2021__platelet-derived growth factor receptor signaling pathway (GO:0048008),0.6017213524575398,1.1948550026407616,0.2571428571428571,0.8204196855382825,1.0,4/16,7.57%,PDGFD;RGS14;FER;ABL1
prerank,KEGG_2021_Human__Staphylococcus aureus infection,-0.5944582707776515,-1.1948442258032748,0.25,1.0,1.0,18/34,14.21%,C1QB;ITGB2;PTAFR;HLA-DMA;C3AR1;FCGR3A;MASP1;HLA-DPB1;SELP;PLG;CFD;HLA-DRB1;FPR1;ITGAM;MASP2;FPR3;HLA-DPA1;C1S
prerank,CellMarker_Augmented_2021__Circulating Precursor cell:Peripheral Blood,-0.5285109519240161,-1.1947326390862938,0.11538461538461539,1.0,1.0,20/62,15.75%,C1QB;LYVE1;ITM2A;MS4A4A;PARVG;FCGR3A;P2RY14;LPAR6;VSIG4;HLA-DPB1;SELP;HLA-DRB1;PTPRC;VWF;F13A1;HLA-DPA1;A2M;IKZF1;ADAM28;CD4
prerank,KEGG_2021_Human__Lysine degradation,0.5122192538530658,1.1946246021090714,0.22580645161290322,0.8206173863854705,1.0,15/62,12.12%,SMYD2;HYKK;AASS;ALDH7A1;SMYD1;COLGALT1;DHTKD1;PLOD3;ECHS1;AADAT;COLGALT2;CAMKMT;SETMAR;NSD1;KMT5C
prerank,Reactome_2022__Ethanol Oxidation R-HSA-71384,0.7197608845359378,1.19461154995617,0.3111111111111111,0.8200436867445563,1.0,2/7,4.47%,ALDH1A1;ACSS2
prerank,CellMarker_Augmented_2021__Endothelial cell:Antecubital Vein,-0.8148375308678721,-1.1945394015339825,0.3076923076923077,1.0,1.0,3/5,11.81%,PTPRC;ITGAM;ENG
prerank,GO_Biological_Process_2021__lysosomal lumen acidification (GO:0007042),-0.7693549193018204,-1.1945247751824324,0.2857142857142857,1.0,1.0,3/6,15.82%,PPT1;ATP6AP2;GRN
prerank,Reactome_2022__Release Of Apoptotic Factors From Mitochondria R-HSA-111457,-0.7888563920230549,-1.1944101822985367,0.2653061224489796,1.0,1.0,1/5,6.85%,GSDME
prerank,GO_Biological_Process_2021__lymphocyte mediated immunity (GO:0002449),0.6697703536683765,1.1942879239901258,0.21428571428571427,0.8203678732751668,1.0,4/11,8.00%,KLRD1;BTN3A2;JAG1;CD8A
prerank,GO_Biological_Process_2021__vasodilation (GO:0042311),-0.6927107681000247,-1.1942860894029963,0.17647058823529413,1.0,1.0,3/9,16.13%,GPER1;SOD2;F2RL1
prerank,GO_Biological_Process_2021__positive regulation of stem cell proliferation (GO:2000648),-0.6513349902910786,-1.1939740544425836,0.3064516129032258,1.0,1.0,5/14,26.11%,PTPRC;TERT;HMGA2;EPCAM;KDM1A
prerank,GO_Biological_Process_2021__membrane assembly (GO:0071709),0.5095395726138424,1.1938639170160792,0.12903225806451613,0.8212546316861676,1.0,8/36,15.95%,CEL;NLGN1;UBXN2A;SPAST;NLGN4X;NLGN3;NRXN1;PTPRD
prerank,GO_Biological_Process_2021__regulation of telomere maintenance via telomere lengthening (GO:1904356),0.5703050554540346,1.1938389896642567,0.2,0.8207162110671568,1.0,4/17,18.68%,TERF1;ATM;SMG5;SMG6
prerank,Reactome_2022__Creation Of C4 And C2 Activators R-HSA-166786,-0.7455768915231101,-1.1935903242005392,0.23728813559322035,1.0,1.0,4/7,14.21%,C1QB;MASP1;MASP2;C1S
prerank,GO_Biological_Process_2021__regulation of morphogenesis of an epithelium (GO:1905330),0.803666167970095,1.1933841031424433,0.29545454545454547,0.8213145023611345,1.0,2/5,12.85%,ADAMTS12;RNF207
prerank,GO_Biological_Process_2021__synaptic vesicle recycling (GO:0036465),0.5241497101532528,1.193342675493543,0.17647058823529413,0.8207768610299114,1.0,12/30,22.60%,CEL;NLGN1;SNCA;SYT1;WNT3A;NLGN4X;NLGN3;RAB5A;CDK5;PLD2;SNCB;SYT7
prerank,CellMarker_Augmented_2021__Macrophage:Lymph Node,-0.5550822073755172,-1.193258136128766,0.18181818181818182,1.0,1.0,33/58,20.89%,LILRB3;TMEM150B;ITGB2;HCK;SLC7A7;TNFRSF1B;PTAFR;C3AR1;MS4A4A;FCGR3A;OSCAR;LY86;IGSF6;TAPBPL;FPR1;SPI1;CLEC12A;ITGAM;TLR2;FPR3;CD300LF;HK3;IL10RB;TBXAS1;ANPEP;IFI35;CSF1R;CARD6;TFEC;ITGAX;MVP;CD86;MLKL
prerank,CellMarker_Augmented_2021__Macrophage:Artery,-0.5550822073755172,-1.193258136128766,0.18181818181818182,1.0,1.0,33/58,20.89%,LILRB3;TMEM150B;ITGB2;HCK;SLC7A7;TNFRSF1B;PTAFR;C3AR1;MS4A4A;FCGR3A;OSCAR;LY86;IGSF6;TAPBPL;FPR1;SPI1;CLEC12A;ITGAM;TLR2;FPR3;CD300LF;HK3;IL10RB;TBXAS1;ANPEP;IFI35;CSF1R;CARD6;TFEC;ITGAX;MVP;CD86;MLKL
prerank,CellMarker_Augmented_2021__Macrophage:Visceral Adipose Tissue,-0.5550822073755172,-1.193258136128766,0.18181818181818182,1.0,1.0,33/58,20.89%,LILRB3;TMEM150B;ITGB2;HCK;SLC7A7;TNFRSF1B;PTAFR;C3AR1;MS4A4A;FCGR3A;OSCAR;LY86;IGSF6;TAPBPL;FPR1;SPI1;CLEC12A;ITGAM;TLR2;FPR3;CD300LF;HK3;IL10RB;TBXAS1;ANPEP;IFI35;CSF1R;CARD6;TFEC;ITGAX;MVP;CD86;MLKL
prerank,CellMarker_Augmented_2021__Monocyte:Kidney,-0.5550822073755172,-1.193258136128766,0.18181818181818182,1.0,1.0,33/58,20.89%,LILRB3;TMEM150B;ITGB2;HCK;SLC7A7;TNFRSF1B;PTAFR;C3AR1;MS4A4A;FCGR3A;OSCAR;LY86;IGSF6;TAPBPL;FPR1;SPI1;CLEC12A;ITGAM;TLR2;FPR3;CD300LF;HK3;IL10RB;TBXAS1;ANPEP;IFI35;CSF1R;CARD6;TFEC;ITGAX;MVP;CD86;MLKL
prerank,CellMarker_Augmented_2021__Macrophage:Eye,-0.5550822073755172,-1.193258136128766,0.18181818181818182,1.0,1.0,33/58,20.89%,LILRB3;TMEM150B;ITGB2;HCK;SLC7A7;TNFRSF1B;PTAFR;C3AR1;MS4A4A;FCGR3A;OSCAR;LY86;IGSF6;TAPBPL;FPR1;SPI1;CLEC12A;ITGAM;TLR2;FPR3;CD300LF;HK3;IL10RB;TBXAS1;ANPEP;IFI35;CSF1R;CARD6;TFEC;ITGAX;MVP;CD86;MLKL
prerank,CellMarker_Augmented_2021__Macrophage:Retinal Pigment Epithelium,-0.5550822073755172,-1.193258136128766,0.18181818181818182,1.0,1.0,33/58,20.89%,LILRB3;TMEM150B;ITGB2;HCK;SLC7A7;TNFRSF1B;PTAFR;C3AR1;MS4A4A;FCGR3A;OSCAR;LY86;IGSF6;TAPBPL;FPR1;SPI1;CLEC12A;ITGAM;TLR2;FPR3;CD300LF;HK3;IL10RB;TBXAS1;ANPEP;IFI35;CSF1R;CARD6;TFEC;ITGAX;MVP;CD86;MLKL
prerank,GO_Biological_Process_2021__hemidesmosome assembly (GO:0031581),0.6506276007589199,1.1932563055641792,0.2222222222222222,0.820411883437014,1.0,5/10,13.19%,CD151;LAMA3;PLEC;ITGB4;DST
prerank,GO_Biological_Process_2021__peptidyl-arginine modification (GO:0018195),-0.6434180254969047,-1.1932331515281784,0.23333333333333334,0.9999290757756809,1.0,2/11,9.57%,ART1;ART3
prerank,GO_Biological_Process_2021__regulation by virus of viral protein levels in host cell (GO:0046719),-0.7175733336121697,-1.193136877460781,0.2807017543859649,0.9993983521975324,1.0,2/7,12.09%,STAT1;IFIT1
prerank,GO_Biological_Process_2021__sulfur amino acid catabolic process (GO:0000098),0.6313433216844644,1.1930643882658551,0.2702702702702703,0.8204824602737127,1.0,4/9,30.66%,CBS;CTH;TST;MPST
prerank,KEGG_2021_Human__Transcriptional misregulation in cancer,0.4144798889953531,1.192885304063128,0.08333333333333333,0.8204271055884647,1.0,35/144,16.89%,ERG;FOXO1;PER2;MLF1;BCL6;MITF;CDK14;BCL2A1;BCL11B;CD14;PPARG;PAX3;ETV1;PML;SP1;MYC;ZEB1;TFE3;H3C6;ATF1;HDAC1;FLT3;NFKB1;MLLT3;TMPRSS2;ETV5;MEN1;GADD45A;TP53;RUNX1;IL2RB;NR4A3;FUS;ATM;PBX1
prerank,"GO_Biological_Process_2021__substrate-dependent cell migration, cell extension (GO:0006930)",-0.7779051413464506,-1.1928442154455838,0.16393442622950818,1.0,1.0,2/7,13.70%,P2RY12;NTN1
prerank,GO_Biological_Process_2021__late endosome to lysosome transport (GO:1902774),0.7574294259629731,1.192781578290784,0.22916666666666666,0.8202003889091596,1.0,1/5,7.32%,PLEKHM1
prerank,GO_Biological_Process_2021__double-strand break repair via homologous recombination (GO:0000724),-0.4887703150595053,-1.1927020065738483,0.19736842105263158,0.9997144098756763,1.0,8/89,8.63%,MCM2;POLQ;MEIOB;RPA3;MCM3;RAD51AP2;MCMDC2;BRCA1
prerank,GO_Biological_Process_2021__regulation of synapse maturation (GO:0090128),0.6744382262320061,1.1926610150402495,0.3235294117647059,0.8199854394084792,1.0,5/9,27.45%,NEUROD2;NRXN1;ADGRL1;ANAPC2;YWHAZ
prerank,GO_Biological_Process_2021__negative regulation of neural precursor cell proliferation (GO:2000178),-0.6833490682682256,-1.1925715743407423,0.30612244897959184,0.9993961895004724,1.0,1/7,2.54%,WNT5A
prerank,Reactome_2022__Cytosolic Sulfonation Of Small Molecules R-HSA-156584,0.6270921404867809,1.1925198157594354,0.25,0.8202273112080098,1.0,2/16,2.21%,PODXL2;PAPSS2
prerank,GO_Biological_Process_2021__synaptic vesicle docking (GO:0016081),0.760802222502797,1.1923199939527822,0.2608695652173913,0.8202521452135256,1.0,3/6,17.09%,UNC13B;SNPH;UNC13C
prerank,GO_Biological_Process_2021__pre-miRNA processing (GO:0031054),0.6149104884186998,1.1923051478612452,0.23255813953488372,0.8196388241361654,1.0,11/14,35.19%,LIN28B;AGO3;TARBP2;AGO2;TUT7;ADAR;LIN28A;DROSHA;PRKRA;TUT4;DICER1
prerank,GO_Biological_Process_2021__negative regulation of translation (GO:0017148),0.45160549878192374,1.1922887211769873,0.0967741935483871,0.8191175268086298,1.0,25/86,20.92%,CPEB1;SAMD4A;PCIF1;DHFR;TRIM71;RIDA;EIF2AK3;NANOS3;CNOT9;EIF3E;YTHDF1;PUS7;MALSU1;SYNCRIP;EIF4EBP1;LSM14A;SAMD4B;EIF4A3;METTL16;AGO2;NANOS1;RNF139;FXR2;RBM24;LARP1
prerank,GO_Biological_Process_2021__positive regulation of vascular endothelial growth factor receptor signaling pathway (GO:0030949),-0.7166993450560559,-1.192196263955832,0.24561403508771928,1.0,1.0,2/8,13.78%,VTN;ITGA5
prerank,KEGG_2021_Human__cGMP-PKG signaling pathway,0.4143763500077504,1.192155787629342,0.11764705882352941,0.8189383509364833,1.0,16/140,9.44%,ADRA1A;ADRA1B;ITPR2;NFATC3;IRS1;SLC8A1;CREB3L2;CREB3L4;GTF2I;SLC8A3;OPRD1;PLCB1;EDNRA;ADCY2;GUCY1A2;AKT2
prerank,Reactome_2022__Synthesis Of 12-Eicosatetraenoic Acid Derivatives R-HSA-2142712,-0.7544913844606737,-1.1920978172640297,0.17857142857142858,1.0,1.0,4/7,14.23%,ALOX12;ALOX12B;ALOX15;GPX2
prerank,CellMarker_Augmented_2021__Endothelial cell:Muscle,0.7575463408552903,1.1920515466865975,0.2916666666666667,0.8188049232666936,1.0,2/5,15.38%,CDH5;NCAM1
prerank,GO_Biological_Process_2021__negative regulation of hormone secretion (GO:0046888),0.7532512786326147,1.1919192864153396,0.3137254901960784,0.8187057792470618,1.0,3/6,17.52%,RAB11FIP3;RAB11FIP1;IL11
prerank,GO_Biological_Process_2021__mature B cell differentiation involved in immune response (GO:0002313),-0.7128509767190133,-1.1918650310114671,0.2916666666666667,1.0,1.0,2/8,8.82%,GPR183;C17ORF99
prerank,GO_Biological_Process_2021__sympathetic ganglion development (GO:0061549),-0.6963803610442441,-1.1915303810831896,0.22807017543859648,1.0,1.0,2/8,7.50%,SEMA3F;SEMA3A
prerank,GO_Biological_Process_2021__regulation of extracellular matrix disassembly (GO:0010715),-0.6189229704981185,-1.191512696096305,0.20588235294117646,1.0,1.0,1/14,1.49%,TGFB1
prerank,GO_Biological_Process_2021__negative regulation of Notch signaling pathway (GO:0045746),0.5731960251353461,1.1911776466223578,0.19230769230769232,0.8204571164886277,1.0,6/24,13.77%,CHAC1;WWP2;BEND6;DLK2;ARRB1;TCIM
prerank,GO_Biological_Process_2021__removal of superoxide radicals (GO:0019430),-0.7938662800007822,-1.191053601292117,0.23728813559322035,1.0,1.0,2/5,20.44%,SOD2;PRDX1
prerank,GO_Biological_Process_2021__positive regulation of lymphocyte migration (GO:2000403),-0.720693114723864,-1.1906192644499245,0.2909090909090909,1.0,1.0,2/7,15.25%,DOCK8;JAM2
prerank,GO_Biological_Process_2021__inositol phosphate biosynthetic process (GO:0032958),0.6074445465223411,1.1902006788106079,0.30434782608695654,0.8234421978736429,1.0,4/11,22.10%,ITPKB;IP6K1;IPPK;IP6K2
prerank,KEGG_2021_Human__Histidine metabolism,0.5559511646167045,1.1901503305317853,0.2,0.8229770613517322,1.0,3/18,3.54%,HNMT;ALDH7A1;CARNMT1
prerank,GO_Biological_Process_2021__negative regulation of leukocyte migration (GO:0002686),0.6914000298469389,1.190139853138985,0.34782608695652173,0.8224106955620616,1.0,2/7,20.62%,SLIT2;EMILIN1
prerank,GO_Biological_Process_2021__amino-acid betaine metabolic process (GO:0006577),-0.7681243633025738,-1.1897463438962737,0.3148148148148148,1.0,1.0,1/6,0.65%,BHMT
prerank,GO_Biological_Process_2021__postreplication repair (GO:0006301),-0.5362670321915171,-1.189589736618974,0.22535211267605634,1.0,1.0,6/44,8.63%,DTL;PCLAF;RPA3;UBE2L6;TRIM25;BRCA1
prerank,GO_Biological_Process_2021__positive regulation of metaphase/anaphase transition of cell cycle (GO:1902101),0.6116400650627387,1.1895241091930369,0.2631578947368421,0.822897685445978,1.0,8/12,35.24%,ESPL1;NSMCE2;ANAPC7;ANAPC4;RB1;DLGAP5;CDC16;ANAPC11
prerank,GO_Biological_Process_2021__positive regulation of mitotic sister chromatid separation (GO:1901970),0.6116400650627387,1.1895241091930369,0.2631578947368421,0.822897685445978,1.0,8/12,35.24%,ESPL1;NSMCE2;ANAPC7;ANAPC4;RB1;DLGAP5;CDC16;ANAPC11
prerank,GO_Biological_Process_2021__positive regulation of mitotic metaphase/anaphase transition (GO:0045842),0.6116400650627387,1.1895241091930369,0.2631578947368421,0.822897685445978,1.0,8/12,35.24%,ESPL1;NSMCE2;ANAPC7;ANAPC4;RB1;DLGAP5;CDC16;ANAPC11
prerank,Reactome_2022__Organic Cation/Anion/Zwitterion Transport R-HSA-549132,-0.6903743567069512,-1.189509469440297,0.2631578947368421,1.0,1.0,5/10,14.51%,SLC22A8;SLC22A6;SLC22A7;SLC22A3;SLC22A4
prerank,CellMarker_Augmented_2021__Dendritic cell:Placenta,-0.5187233637972404,-1.1894484554528422,0.2112676056338028,1.0,1.0,21/56,16.70%,GMFG;ITGB2;HCK;CYTIP;ARHGAP9;TAGAP;TNFRSF1B;C3AR1;GPR183;PARVG;FCGR3A;WAS;LY86;MYO1F;PTPRC;SPI1;ITGAM;CD300LF;IKZF1;HK3;TNFSF8
prerank,Reactome_2022__Interleukin-15 Signaling R-HSA-8983432,0.5804837073632945,1.1892199094972964,0.23529411764705882,0.823530014997318,1.0,6/13,30.72%,STAT5B;IL2RB;SOS1;STAT3;GAB2;SOS2
prerank,GO_Biological_Process_2021__inner ear morphogenesis (GO:0042472),-0.6212840277858729,-1.1892111376676093,0.2571428571428571,1.0,1.0,3/16,16.36%,TBX1;MYO3B;USH1C
prerank,Reactome_2022__Microbial Modulation Of RIPK1-mediated Regulated Necrosis R-HSA-9686347,-0.7609137747229076,-1.1892110383266086,0.23333333333333334,1.0,1.0,3/5,20.89%,GNL3;CASP8;MLKL
prerank,GO_Biological_Process_2021__peptidyl-glutamine methylation (GO:0018364),0.731294588757307,1.189210796037943,0.23255813953488372,0.8229202348733679,1.0,3/5,16.33%,SIRT7;FBLL1;FBL
prerank,Reactome_2022__CS/DS Degradation R-HSA-2024101,0.6592538531743195,1.1890366733161626,0.3076923076923077,0.8228525609671556,1.0,4/12,10.78%,VCAN;SPAM1;ARSB;CSPG5
prerank,CellMarker_Augmented_2021__Naive CD4+ T cell:Blood,-0.5273835235492379,-1.1890343898390994,0.208955223880597,1.0,1.0,25/54,17.79%,GMFG;ITGB2;DOCK8;CYTIP;TBC1D10C;ARHGAP9;TAGAP;TNFRSF1B;ARHGAP15;GPR183;PARVG;FCGR3A;WAS;LY86;CD37;TRAF3IP3;MYO1F;PTPRC;ITGAM;PSTPIP1;IKZF1;CD4;TNFSF8;PIK3CG;ALOX5AP
prerank,Reactome_2022__LRR FLII-interacting Protein 1 (LRRFIP1) Activates Type I IFN Production R-HSA-3134973,0.7289338137376186,1.18889297174711,0.23404255319148937,0.822886385166039,1.0,3/5,27.11%,EP300;LRRFIP1;CREBBP
prerank,GO_Biological_Process_2021__establishment of protein localization to chromatin (GO:0071169),0.7563204540016895,1.188882556876513,0.25,0.8222897235829786,1.0,3/6,17.99%,PIH1D1;NIPBL;MACROH2A2
prerank,GO_Biological_Process_2021__double-strand break repair via synthesis-dependent strand annealing (GO:0045003),-0.7335334503615989,-1.188820412124455,0.3090909090909091,1.0,1.0,1/5,18.73%,RAD54L
prerank,"GO_Biological_Process_2021__antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (GO:0002480)",-0.7290323413070517,-1.1883982192258318,0.2982456140350877,1.0,1.0,3/7,22.43%,HLA-A;HLA-F;HLA-C
prerank,GO_Biological_Process_2021__regulation of phospholipase activity (GO:0010517),0.6707397613122923,1.188221262797321,0.18421052631578946,0.8240675617954638,1.0,3/10,9.62%,FGFR1;SNCA;FGFR3
prerank,CellMarker_Augmented_2021__Muller cell:Retina,-0.5087162714043485,-1.1882121410340076,0.13157894736842105,1.0,1.0,17/69,16.09%,CLEC5A;C1QB;HCK;MS4A4A;FCGR3A;VSIG4;VWF;SPI1;GAS7;TLR2;FPR3;F13A1;FAXDC2;CD300LF;KCNE3;CD4;HK3
prerank,GO_Biological_Process_2021__coenzyme A metabolic process (GO:0015936),0.5460318047290633,1.187938153872157,0.2702702702702703,0.8244713449407594,1.0,6/14,27.56%,PANK1;PPCS;SLC25A16;ACOT7;PANK3;CROT
prerank,PanglaoDB_Augmented_2021__Platelets,-0.4790153316787351,-1.1878152773738166,0.13095238095238096,1.0,1.0,41/136,19.76%,MPL;GMFG;F7;ALOX12;ITGB2;HCK;P2RY12;TNFRSF1B;C3AR1;DAB2;FCGR3A;GP1BA;HLA-A;LY86;NFAM1;SELP;MYO1F;THBS1;FPR1;MFSD2B;VWF;ITGA2B;SPI1;CLEC12A;ITGAM;CDKN2D;F13A1;CD300LF;ADGRE3;F5;RTL8B;HK3;SMOX;TBXAS1;ALOX5AP;MYL9;CLEC1B;SASH3;P2RX1;ITGAX;TMEM71
prerank,GO_Biological_Process_2021__L-arginine import across plasma membrane (GO:0097638),-0.7375829286504421,-1.1876427625189652,0.21153846153846154,1.0,1.0,1/5,5.15%,SLC7A3
prerank,GO_Biological_Process_2021__regulation of purine nucleotide metabolic process (GO:1900542),0.5155807014050493,1.1872198220624224,0.1111111111111111,0.8263571999765263,1.0,3/41,4.13%,GCK;NUP210;NUP42
prerank,GO_Biological_Process_2021__positive regulation of protein kinase A signaling (GO:0010739),0.729865475730167,1.1871725335892684,0.2564102564102564,0.8258382929516035,1.0,3/5,17.11%,ADGRV1;TCIM;IAPP
prerank,GO_Biological_Process_2021__mitochondrial gene expression (GO:0140053),0.5105766253324897,1.1871652119653247,0.15625,0.8252640860472602,1.0,11/35,28.79%,TEFM;SLC25A33;LARS2;NOA1;MRPL2;QRSL1;MRPS7;TFB2M;FOXO3;MRPS16;MRPS18A
prerank,GO_Biological_Process_2021__cell-cell junction organization (GO:0045216),0.4047761566210991,1.1869571656081972,0.125,0.8253183408430024,1.0,24/73,16.07%,CDH20;CDH19;CDH12;CDH7;CDH5;CDH13;CSK;SDK1;CADM2;CADM1;CDH6;DSP;F2R;NLGN4X;LIMS1;CDH2;CDH24;NECTIN3;CDH10;PKP4;FSCN1;CDH11;PARD6B;CDHR3
prerank,GO_Biological_Process_2021__negative regulation of calcium ion import (GO:0090281),-0.7568750049420356,-1.1868536560890737,0.25,1.0,1.0,3/5,20.55%,VDAC1;PLN;MRLN
prerank,GO_Biological_Process_2021__regulation of synapse structural plasticity (GO:0051823),0.7036415536351237,1.1868029464805359,0.3409090909090909,0.8251709363714536,1.0,2/5,19.40%,FRMPD4;CTNNA2
prerank,GO_Biological_Process_2021__muscle tissue morphogenesis (GO:0060415),-0.6939470321873116,-1.1867760200517508,0.2857142857142857,1.0,1.0,5/13,14.24%,TBX1;ACTC1;ZFPM1;HEY2;TTN
prerank,GO_Biological_Process_2021__detection of stimulus involved in sensory perception of pain (GO:0062149),-0.7161927647925508,-1.1866182135877192,0.3148148148148148,1.0,1.0,1/6,5.91%,PRDM12
prerank,GO_Biological_Process_2021__microvillus assembly (GO:0030033),0.5986911966888976,1.18649288955265,0.25,0.8258406519190657,1.0,4/14,15.74%,RAP2A;TNIK;RAP1A;ESPN
prerank,GO_Biological_Process_2021__proline transmembrane transport (GO:0035524),0.7228719082512091,1.1863179551149834,0.2727272727272727,0.8258719900694135,1.0,2/5,11.22%,SLC6A20;SLC7A8
prerank,GO_Biological_Process_2021__chondroitin sulfate metabolic process (GO:0030204),0.5534596222404667,1.1860074345751712,0.19230769230769232,0.8263390553135886,1.0,12/26,11.69%,VCAN;CSGALNACT1;CHSY3;CHSY1;CHST12;ARSB;CHPF2;CHST11;CSPG5;CHST3;UGDH;DSEL
prerank,GO_Biological_Process_2021__lymphatic endothelial cell differentiation (GO:0060836),0.7323019240761807,1.1859651399905864,0.275,0.8259010299963623,1.0,3/6,21.51%,PROX1;NR2F2;BMPR2
prerank,GO_Biological_Process_2021__regulation of mitotic centrosome separation (GO:0046602),-0.7230275151497159,-1.1859384903094434,0.25,1.0,1.0,1/9,0.37%,NEK2
prerank,GO_Biological_Process_2021__response to fatty acid (GO:0070542),0.6131242333148181,1.1859048139526303,0.19444444444444445,0.825485972010913,1.0,5/14,9.91%,FOXO1;IRS1;PID1;PPP5C;LPL
prerank,Reactome_2022__Interleukin-2 Family Signaling R-HSA-451927,-0.5360151401552263,-1.1857629678411532,0.20833333333333334,1.0,1.0,9/35,20.22%,IL21R;STAT1;INPP5D;PIK3R3;IL3RA;PIK3CB;IL5RA;IL5;CSF2RA
prerank,GO_Biological_Process_2021__glycosphingolipid metabolic process (GO:0006687),0.49478521879242743,1.185729510116064,0.22580645161290322,0.8254171426437885,1.0,18/42,23.46%,ST6GALNAC3;GLA;ESYT3;STS;SMPD4;SMPD3;ESYT2;NEU4;GLB1;NEU3;GBA2;ST8SIA3;ESYT1;ST6GALNAC5;ST8SIA1;LARGE1;SUMF2;ABCA2
prerank,GO_Biological_Process_2021__protein dephosphorylation (GO:0006470),0.4276585274384916,1.1856524718019672,0.15151515151515152,0.8250253438873802,1.0,46/131,24.48%,CTDNEP1;EYA4;DUSP4;DUSP2;PTPRO;PTPRZ1;PPP5C;PTPRR;CTDSP2;CTDSP1;PTPN9;PTPRM;PPP2R1B;DUSP18;PPM1A;PTPRB;UBASH3B;PPP1R15B;PTPRT;EYA3;PTPRF;SSH1;PPM1L;CDC14B;PTPRD;PTPRE;MTMR3;NCK1;PPP2R5D;TAB1;PPP1CB;PPP4R1;PPEF1;MTM1;PTPN14;PTPRJ;DUSP6;PTEN;PPP2R2B;PTPRA;PTPN21;PPM1H;PPM1E;CTTNBP2NL;PTPN12;PPP3CC
prerank,Reactome_2022__Nuclear Signaling By ERBB4 R-HSA-1251985,0.5129012175317161,1.1855559184768552,0.1794871794871795,0.8248790348270876,1.0,5/27,7.59%,APOE;NRG2;NRG1;NRG3;WWOX
prerank,GO_Biological_Process_2021__purine nucleoside bisphosphate biosynthetic process (GO:0034033),0.594768930918682,1.1853606249783983,0.2564102564102564,0.8236416834611228,1.0,5/11,23.80%,PANK1;PPCS;SLC25A16;ACOT7;PANK3
prerank,GO_Biological_Process_2021__coenzyme A biosynthetic process (GO:0015937),0.594768930918682,1.1853606249783983,0.2564102564102564,0.8236416834611228,1.0,5/11,23.80%,PANK1;PPCS;SLC25A16;ACOT7;PANK3
prerank,GO_Biological_Process_2021__ribonucleoside bisphosphate biosynthetic process (GO:0034030),0.594768930918682,1.1853606249783983,0.2564102564102564,0.8236416834611228,1.0,5/11,23.80%,PANK1;PPCS;SLC25A16;ACOT7;PANK3
prerank,Reactome_2022__Regulation Of MECP2 Expression And Activity R-HSA-9022692,0.48948985038635706,1.1852461197919175,0.21212121212121213,0.8235967267987693,1.0,10/29,20.68%,HDAC3;MOV10;TNRC6C;HDAC1;MECP2;TNRC6A;AGO3;CREB1;AGO2;TBL1X
prerank,GO_Biological_Process_2021__regulation of dendritic cell differentiation (GO:2001198),0.720194163259299,1.1850789726835949,0.2978723404255319,0.8235740185089906,1.0,4/6,17.42%,LGALS1;HMGB1;LGALS9;LGALS3
prerank,Reactome_2022__Loss Of MECP2 Binding Ability To NCoR/SMRT Complex R-HSA-9022537,0.6434365532110708,1.1848032523113232,0.30612244897959184,0.8240833108171894,1.0,1/7,1.65%,HDAC3
prerank,PanglaoDB_Augmented_2021__Osteoclast Precursor Cells,-0.5471485336038744,-1.1847279240198052,0.18181818181818182,1.0,1.0,20/60,13.92%,CLEC5A;ITGB2;HCK;SP100;IRF1;TNFRSF1B;PTAFR;CIITA;C3AR1;GPR183;MS4A4A;NFKB2;LY86;IGSF6;PTPRC;ITGAM;TLR2;FPR3;NLRP3;APOL6
prerank,GO_Biological_Process_2021__sensory perception (GO:0007600),0.5027004444306371,1.1845099345886827,0.2222222222222222,0.8244478814355821,1.0,4/39,5.33%,NTSR2;PCDH15;WHRN;USH2A
prerank,GO_Biological_Process_2021__positive regulation of lipid transport (GO:0032370),0.6518650786152214,1.1844947798408676,0.3023255813953488,0.8238712814581285,1.0,1/10,2.66%,APOE
prerank,CellMarker_Augmented_2021__Acinar cell:Salivary Gland,0.444786223256649,1.1836843172730922,0.21212121212121213,0.8258388902367818,1.0,11/62,7.55%,ERG;LHFPL2;GRK5;PTGS1;VEGFC;PAPSS2;RAB31;SNCA;RHOBTB1;SH3RF3;LTBP1
prerank,Reactome_2022__Interleukin Receptor SHC Signaling R-HSA-912526,-0.6001854257493561,-1.1836423043112303,0.2222222222222222,1.0,1.0,7/21,20.22%,INPP5D;PIK3R3;IL3RA;PIK3CB;IL5RA;IL5;CSF2RA
prerank,GO_Biological_Process_2021__positive regulation of G protein-coupled receptor signaling pathway (GO:0045745),0.5529007324514366,1.1834944192501577,0.13157894736842105,0.8257925100391244,1.0,4/18,7.30%,GRP;MRAP2;KLK14;F2
prerank,GO_Biological_Process_2021__snoRNA localization (GO:0048254),0.7039959628547975,1.1834178838166327,0.3181818181818182,0.8255695303065335,1.0,4/6,28.51%,PIH1D1;FBL;NOP58;ZNHIT6
prerank,PanglaoDB_Augmented_2021__Ionocytes,-0.4948106647455944,-1.1833625447122311,0.26229508196721313,1.0,1.0,19/78,16.78%,PLEKHS1;CHST9;VWA3B;FUT2;MROH9;CCDC60;MAP3K19;BPIFB1;MS4A8;MYO5B;AKAP14;SNTN;APOBEC4;EYA2;DNAH3;MUC4;DNAI1;ADH7;ZBBX
prerank,GO_Biological_Process_2021__regulation of substrate adhesion-dependent cell spreading (GO:1900024),0.47417761255167784,1.1833005209968623,0.09375,0.8254020474859352,1.0,11/46,15.84%,WASHC2C;CRK;ABL1;FLNA;EFNA5;CASS4;KANK1;CSPG5;LIMS1;SPRY4;CRKL
prerank,GO_Biological_Process_2021__regulation of postsynapse organization (GO:0099175),0.5250550004069978,1.183252412914524,0.21212121212121213,0.8249702000892838,1.0,6/27,12.91%,ARC;ABHD17A;LZTS3;ABHD17C;ABI3;ABHD17B
prerank,Reactome_2022__RHOT2 GTPase Cycle R-HSA-9013419,0.6371988208534617,1.1831803296500718,0.38461538461538464,0.8247042490507945,1.0,4/7,28.22%,TRAK2;RAP1GDS1;MYO19;TRAK1
prerank,Reactome_2022__AKT Phosphorylates Targets In Nucleus R-HSA-198693,0.5998676337594401,1.1829422492955561,0.2857142857142857,0.8248350224016318,1.0,5/10,19.24%,FOXO1;AKT2;NR4A1;FOXO6;CREB1
prerank,GO_Biological_Process_2021__positive regulation of response to biotic stimulus (GO:0002833),-0.5590970898696251,-1.182787664479711,0.20967741935483872,1.0,1.0,10/35,20.83%,SCIMP;IFNK;LY86;CYBA;USP17L2;SH2D1B;GRN;IFI35;DHX58;DDX60
prerank,GO_Biological_Process_2021__intraciliary transport involved in cilium assembly (GO:0035735),0.4677498955597709,1.1826477427947633,0.18421052631578946,0.825163624226592,1.0,11/36,25.17%,PCM1;IFT88;IFT140;TTC21B;KIF3B;TRIP11;WDR19;WDR35;IFT57;CLUAP1;DYNC2I2
prerank,GO_Biological_Process_2021__negative regulation of sequestering of triglyceride (GO:0010891),0.742067929785736,1.1826155209521652,0.28888888888888886,0.8246122974293624,1.0,2/5,20.00%,PPARG;OSBPL8
prerank,Reactome_2022__HS-GAG Degradation R-HSA-2024096,0.6045589312558742,1.182454456814068,0.35294117647058826,0.8245231502359861,1.0,8/18,11.28%,GPC4;SDC4;GPC6;GLB1L;HPSE;GPC5;SDC3;GLB1
prerank,Reactome_2022__Signaling By TGF-beta Receptor Complex R-HSA-170834,0.4151478105391038,1.1823720044591015,0.19047619047619047,0.8241377564447547,1.0,29/83,22.14%,BAMBI;TGFBR1;PARD3;ITGA8;TGIF1;SERPINE1;LTBP1;RBL1;MYC;PPM1A;HDAC1;CDK8;SMAD2;SMURF1;WWTR1;MEN1;FURIN;CGN;SRFBP1;PMEPA1;SKI;PPP1CB;EP300;USP15;E2F5;ZFYVE9;XPO1;TFDP1;SMAD7
prerank,GO_Biological_Process_2021__regulation of protein modification process (GO:0031399),0.47543052289509713,1.182309443526345,0.14893617021276595,0.8236651765996138,1.0,11/44,13.96%,SPRED3;HSPB1;CDH5;FKTN;FER;PML;SPRED2;PPIB;SPRED1;CCDC88A;PUM3
prerank,GO_Biological_Process_2021__cysteine metabolic process (GO:0006534),0.6377331170144294,1.1822167899121934,0.3409090909090909,0.8235111540498813,1.0,4/6,30.66%,CBS;CTH;TST;MPST
prerank,GO_Biological_Process_2021__positive regulation of RNA polymerase II transcription preinitiation complex assembly (GO:0045899),-0.7089598222173907,-1.1819897262766854,0.32727272727272727,1.0,1.0,1/7,4.81%,ESR1
prerank,KEGG_2021_Human__Synaptic vesicle cycle,0.42664212090611764,1.1819838902369544,0.16666666666666666,0.8235106966788096,1.0,3/66,1.86%,ATP6V0D2;SLC17A6;TCIRG1
prerank,GO_Biological_Process_2021__negative regulation of wound healing (GO:0061045),0.5797302624370132,1.1819126184163669,0.2857142857142857,0.8230724471271724,1.0,5/22,6.41%,PHLDB2;APOH;APOE;SERPINE1;CRK
prerank,GO_Biological_Process_2021__androgen metabolic process (GO:0008209),-0.6226976125556591,-1.1817423621245964,0.25396825396825395,1.0,1.0,3/16,19.39%,CYP3A4;HSD3B1;CYP17A1
prerank,GO_Biological_Process_2021__arachidonic acid secretion (GO:0050482),-0.70099846690578,-1.1816429565471713,0.2631578947368421,1.0,1.0,2/8,8.67%,NMUR2;ANXA1
prerank,GO_Biological_Process_2021__arachidonate transport (GO:1903963),-0.70099846690578,-1.1816429565471713,0.2631578947368421,1.0,1.0,2/8,8.67%,NMUR2;ANXA1
prerank,GO_Biological_Process_2021__positive regulation of tumor necrosis factor-mediated signaling pathway (GO:1903265),0.7623194322312417,1.18150418143234,0.28205128205128205,0.8239691304096785,1.0,3/6,20.87%,HSPA1A;CPNE1;LAPTM5
prerank,GO_Biological_Process_2021__positive regulation of ERK1 and ERK2 cascade (GO:0070374),-0.45138220670829104,-1.1810119072282474,0.15853658536585366,1.0,1.0,15/122,10.28%,CD44;TGFB1;NODAL;SCIMP;GPER1;GPR183;ALKAL2;FLT4;ALOX15;ATP6AP1;HTR2B;P2RY6;PRXL2C;HLA-DRB1;PTPRC
prerank,GO_Biological_Process_2021__striated muscle cell development (GO:0055002),-0.6966058045201773,-1.1803476437225782,0.30303030303030304,1.0,1.0,3/10,10.22%,LMOD1;TMOD4;LMOD3
prerank,GO_Biological_Process_2021__regulation of platelet activation (GO:0010543),-0.6253912757766986,-1.1802592881371572,0.234375,1.0,1.0,5/17,13.03%,C1QTNF1;BLK;TEC;SELP;TXK
prerank,Reactome_2022__Signaling By MET R-HSA-6806834,0.45697606933656787,1.1802349886694046,0.24,0.8274218503342958,1.0,12/62,19.47%,HGFAC;LAMA4;CRK;RAPGEF1;ITGA3;SH3KBP1;RAP1A;PIK3CA;CRKL;STAM2;SOS1;SH3GL1
prerank,CellMarker_Augmented_2021__Intestinal Stem cell:Gastrointestinal Tract,0.4259988091986872,1.1801512865298176,0.12,0.8240833108171896,1.0,29/97,16.22%,LGR5;FREM1;ADGRL2;ALDH7A1;GPC6;PROX1;SLIT2;AADAT;LRP6;GUCY1A2;PDZRN3;FGFR3;CAP2;WNK2;RNF128;DDAH1;TSPAN6;RBFOX2;FARP1;LRIG3;ZNF704;NEO1;GSTA4;MAGI1;ANK2;FAM171A1;PTPRD;FRAS1;ZNRF3
prerank,CellMarker_Augmented_2021__Gastric Stem cell:Gastric Gland,0.4259988091986872,1.1801512865298176,0.12,0.8240833108171896,1.0,29/97,16.22%,LGR5;FREM1;ADGRL2;ALDH7A1;GPC6;PROX1;SLIT2;AADAT;LRP6;GUCY1A2;PDZRN3;FGFR3;CAP2;WNK2;RNF128;DDAH1;TSPAN6;RBFOX2;FARP1;LRIG3;ZNF704;NEO1;GSTA4;MAGI1;ANK2;FAM171A1;PTPRD;FRAS1;ZNRF3
prerank,CellMarker_Augmented_2021__Somatic Stem cell:Endometrium,0.4259988091986872,1.1801512865298176,0.12,0.8240833108171896,1.0,29/97,16.22%,LGR5;FREM1;ADGRL2;ALDH7A1;GPC6;PROX1;SLIT2;AADAT;LRP6;GUCY1A2;PDZRN3;FGFR3;CAP2;WNK2;RNF128;DDAH1;TSPAN6;RBFOX2;FARP1;LRIG3;ZNF704;NEO1;GSTA4;MAGI1;ANK2;FAM171A1;PTPRD;FRAS1;ZNRF3
prerank,CellMarker_Augmented_2021__Stem cell:Gastric Gland,0.4259988091986872,1.1801512865298176,0.12,0.8240833108171896,1.0,29/97,16.22%,LGR5;FREM1;ADGRL2;ALDH7A1;GPC6;PROX1;SLIT2;AADAT;LRP6;GUCY1A2;PDZRN3;FGFR3;CAP2;WNK2;RNF128;DDAH1;TSPAN6;RBFOX2;FARP1;LRIG3;ZNF704;NEO1;GSTA4;MAGI1;ANK2;FAM171A1;PTPRD;FRAS1;ZNRF3
prerank,CellMarker_Augmented_2021__Corneal Limbal Stem cell:Limbal Epithelium,0.4259988091986872,1.1801512865298176,0.12,0.8240833108171896,1.0,29/97,16.22%,LGR5;FREM1;ADGRL2;ALDH7A1;GPC6;PROX1;SLIT2;AADAT;LRP6;GUCY1A2;PDZRN3;FGFR3;CAP2;WNK2;RNF128;DDAH1;TSPAN6;RBFOX2;FARP1;LRIG3;ZNF704;NEO1;GSTA4;MAGI1;ANK2;FAM171A1;PTPRD;FRAS1;ZNRF3
prerank,CellMarker_Augmented_2021__Ovarian Somatic cell:Ovary,0.4259988091986872,1.1801512865298176,0.12,0.8240833108171896,1.0,29/97,16.22%,LGR5;FREM1;ADGRL2;ALDH7A1;GPC6;PROX1;SLIT2;AADAT;LRP6;GUCY1A2;PDZRN3;FGFR3;CAP2;WNK2;RNF128;DDAH1;TSPAN6;RBFOX2;FARP1;LRIG3;ZNF704;NEO1;GSTA4;MAGI1;ANK2;FAM171A1;PTPRD;FRAS1;ZNRF3
prerank,GO_Biological_Process_2021__myeloid leukocyte mediated immunity (GO:0002444),0.7228557273802283,1.180127372447682,0.35,0.8235279060001405,1.0,3/6,21.17%,CARD9;IRAK4;ACE
prerank,GO_Biological_Process_2021__ER-associated misfolded protein catabolic process (GO:0071712),0.6741079939237195,1.1798714041802927,0.2903225806451613,0.8237338815421259,1.0,1/11,0.97%,AUP1
prerank,GO_Biological_Process_2021__Golgi organization (GO:0007030),0.45540469619249946,1.1798077167800312,0.13043478260869565,0.8233315407511003,1.0,41/115,27.79%,TICAM2;STX5;BLZF1;STX6;FHDC1;GBF1;UBXN2A;TRAPPC12;GCC2;TMED3;BET1;PI4K2B;ARHGAP21;VTI1A;COG7;FAM174B;PLK3;SEC22B;GOLGB1;PRMT5;COG4;UBXN2B;TRIP11;USP6NL;TRAPPC11;COG2;VPS51;MYO18A;COG3;VMP1;ZNF501;GOLGA8H;CUL7;SYNE1;TRAPPC8;DNAJC28;SEC23IP;YWHAZ;ATP8B1;GOLPH3L;GORASP1
prerank,CellMarker_Augmented_2021__Vascular Smooth Muscle cell:Embryonic Stem Cell,-0.488170126917398,-1.1797295891598671,0.17105263157894737,1.0,1.0,10/84,6.82%,ENPP2;LMOD1;ANGPTL2;NID1;COL1A1;COL5A1;FBXL7;ADAM33;DAAM2;DCN
prerank,CellMarker_Augmented_2021__Naive B cell:Undefined,-0.5250320894528201,-1.1796982064180608,0.2077922077922078,1.0,1.0,17/55,13.88%,GMFG;BLK;CYTIP;TBC1D10C;ARHGAP9;TAGAP;TMC8;PARVG;WAS;LY86;CD37;TRAF3IP3;PTPRC;HVCN1;NLRC3;CD27;PSTPIP1
prerank,CellMarker_Augmented_2021__Naive B cell:Peripheral Blood,-0.5250320894528201,-1.1796982064180608,0.2077922077922078,1.0,1.0,17/55,13.88%,GMFG;BLK;CYTIP;TBC1D10C;ARHGAP9;TAGAP;TMC8;PARVG;WAS;LY86;CD37;TRAF3IP3;PTPRC;HVCN1;NLRC3;CD27;PSTPIP1
prerank,GO_Biological_Process_2021__positive regulation of 3'-UTR-mediated mRNA stabilization (GO:1905870),0.7496228333599619,1.1795420521310809,0.2978723404255319,0.8235156607984422,1.0,4/5,22.25%,TENT4A;ELAVL4;RBM24;LARP4B
prerank,CellMarker_Augmented_2021__Stem cell:Submandibular Gland,-0.5048510427523503,-1.1793631101381454,0.23076923076923078,1.0,1.0,19/69,14.86%,C1QB;CYYR1;LYVE1;TIMP3;RERGL;SLCO2B1;DCN;SLCO2A1;CLDN5;ABCG2;ITGA9;VWF;GPIHBP1;EDNRB;TEK;A2M;C1S;GGT5;ADGRF5
prerank,GO_Biological_Process_2021__synaptonemal complex assembly (GO:0007130),-0.659171745006055,-1.1793256364620046,0.23214285714285715,1.0,1.0,2/14,3.06%,SYCP1;STAG3
prerank,GO_Biological_Process_2021__synaptonemal complex organization (GO:0070193),-0.659171745006055,-1.1793256364620046,0.23214285714285715,1.0,1.0,2/14,3.06%,SYCP1;STAG3
prerank,GO_Biological_Process_2021__negative regulation of chemokine production (GO:0032682),-0.6441176189030571,-1.1792132359947898,0.19642857142857142,1.0,1.0,4/12,16.13%,OAS1;APOD;ELANE;F2RL1
prerank,Reactome_2022__Removal Of Aminoterminal Propeptides From Gamma-Carboxylated Proteins R-HSA-159782,-0.7186090503996589,-1.1791969664821265,0.3064516129032258,1.0,1.0,2/8,9.58%,F7;FAM110A
prerank,CellMarker_Augmented_2021__Cardiomyocyte:Heart,-0.6507300436507267,-1.1791549930003713,0.25,1.0,1.0,1/13,1.51%,MYH7
prerank,GO_Biological_Process_2021__positive regulation of TOR signaling (GO:0032008),0.4954603588640708,1.1791183409951373,0.25,0.8242741250514309,1.0,8/38,14.95%,HDAC3;SIK3;MLST8;TELO2;PIH1D1;CLEC16A;KLHL22;PIK3CA
prerank,GO_Biological_Process_2021__DNA ligation (GO:0006266),0.6809336856475342,1.1789858337378691,0.3142857142857143,0.8241214460298257,1.0,3/7,16.35%,TOP2A;MGMT;LIG4
prerank,GO_Biological_Process_2021__regulation of keratinocyte differentiation (GO:0045616),-0.5572072964420798,-1.1789467095303698,0.3064516129032258,1.0,1.0,7/24,17.25%,AQP3;PLAAT4;ETV4;PRKCH;VDR;ABCA12;ZFP36L1
prerank,Reactome_2022__Suppression Of Apoptosis R-HSA-9635465,-0.8065723015821584,-1.1789445011919286,0.15217391304347827,1.0,1.0,1/5,7.96%,RNF213
prerank,GO_Biological_Process_2021__establishment of mitotic spindle orientation (GO:0000132),-0.6029491067447399,-1.1789128235107378,0.25,1.0,1.0,4/23,15.88%,MISP;GPSM2;DCTN1;NDEL1
prerank,GO_Biological_Process_2021__negative regulation of T-helper 17 type immune response (GO:2000317),0.69801024395645,1.1787434611973586,0.24390243902439024,0.8244236811362216,1.0,4/5,30.00%,RC3H1;SMAD7;RC3H2;FOXP3
prerank,Reactome_2022__eNOS Activation R-HSA-203615,0.5990015974567519,1.1787139104354096,0.3157894736842105,0.8239682051688866,1.0,3/11,11.24%,DDAH2;NANOS3;DDAH1
prerank,GO_Biological_Process_2021__regulation of cellular protein localization (GO:1903827),0.46846537818435463,1.1786964740175305,0.20833333333333334,0.8234052835697169,1.0,6/45,9.31%,GPC4;TRIM67;GPC6;RALB;GBF1;GPC5
prerank,GO_Biological_Process_2021__isoprenoid biosynthetic process (GO:0008299),0.6361405635260622,1.1786360869635444,0.3333333333333333,0.8231132393056975,1.0,2/8,24.00%,PDSS2;MVK
prerank,Reactome_2022__Activation Of PPARGC1A (PGC-1alpha) By Phosphorylation R-HSA-2151209,0.6476837072614088,1.1786215396571251,0.3125,0.8225517468616949,1.0,3/8,19.98%,MAPK12;PRKAA2;PRKAG2
prerank,Reactome_2022__Hemostasis R-HSA-109582,-0.43562028111028595,-1.178286371820435,0.10112359550561797,1.0,1.0,72/477,15.41%,CD44;F8;CD99L2;SIRPG;JCHAIN;MPL;TGFB1;F7;TIMP3;PSG4;ITGB2;PSG8;P2RY12;DOCK6;DOCK8;SLC16A8;ANGPT2;SLC7A7;IRAG1;GYPE;VAV3;PSG3;PROCR;IRF1;SERPIND1;PDE5A;SDC2;DOCK2;GYPB;GP1BA;TRPC7;PLAU;INPP5D;CEACAM1;PIK3R3;PSG5;ZFPM1;GNAT3;PSG2;CLU;FAM110A;PLG;GNGT1;THBS1;PSG6;CD63;VWF;ITGA2B;CEACAM8;ITGAM;SLC16A3;ITIH3;TNFRSF10A;TUBA4A;PSG9;PRKCH;F13A1;PLAT;PIK3CB;TEK;ITGA5;PSG11;ITIH4;F5;TGFB3;TFPI;GATA4;ORAI1;ITPR3;TSPAN7;JAM2;IGLL1
prerank,GO_Biological_Process_2021__cardiac muscle hypertrophy (GO:0003300),-0.69885169437706,-1.1781827087429608,0.23214285714285715,1.0,1.0,3/8,14.24%,CSRP3;HTR2B;TTN
prerank,GO_Biological_Process_2021__iron-sulfur cluster assembly (GO:0016226),0.5433141018974711,1.1781562980614422,0.18421052631578946,0.8234149482239551,1.0,3/22,4.77%,IBA57;CIAO3;HSCB
prerank,CellMarker_Augmented_2021__PROCR+ Progenitor cell:Small Intestine,-0.63331446324758,-1.178001955547999,0.22807017543859648,1.0,1.0,3/18,8.55%,ITM2A;PLAC9;GPC3
prerank,GO_Biological_Process_2021__Rap protein signal transduction (GO:0032486),0.6414195404098602,1.1777751018870553,0.2727272727272727,0.8240182042706031,1.0,4/10,18.20%,RAPGEF1;RAP2A;RAP1A;RAPGEF3
prerank,GO_Biological_Process_2021__glycosylceramide catabolic process (GO:0046477),0.6787464209233603,1.17775650236772,0.2653061224489796,0.8234680444997514,1.0,1/5,2.16%,GLA
prerank,GO_Biological_Process_2021__collagen fibril organization (GO:0030199),0.43775220298895656,1.1775121835706541,0.16,0.8236183181181814,1.0,23/82,13.81%,COL22A1;COL8A1;TGFBR1;CD151;LAMA3;LOXL1;COL9A2;COL12A1;P3H2;COLGALT1;GREM1;PLOD3;COLGALT2;P3H4;PPIB;COL16A1;PLEC;TLL1;COL13A1;COL5A3;ITGB4;DST;NF1
prerank,GO_Biological_Process_2021__epithelial cell-cell adhesion (GO:0090136),0.6476960648367902,1.1774515110333583,0.1891891891891892,0.823230576582617,1.0,7/11,22.57%,KIT;DSP;SERPINB8;VCL;JUP;CAMSAP3;THBS4
prerank,GO_Biological_Process_2021__fatty acid alpha-oxidation (GO:0001561),0.6884533399516076,1.1772267738580102,0.2857142857142857,0.8235420287069889,1.0,2/7,7.35%,PEX13;SLC27A2
prerank,GO_Biological_Process_2021__negative regulation of cellular response to hypoxia (GO:1900038),0.7218850923358161,1.1770717208283692,0.25,0.8236919255809375,1.0,3/6,26.50%,DDAH1;ENO1;CD34
prerank,Reactome_2022__Synthesis Of PIPs At Late Endosome Membrane R-HSA-1660517,0.6222999604215513,1.17706798821331,0.24390243902439024,0.8231010418466614,1.0,5/11,31.32%,MTM1;PIK3R4;VAC14;MTMR9;PIK3C3
prerank,GO_Biological_Process_2021__protein localization to cell-cell junction (GO:0150105),0.5487979915533994,1.1769629485908373,0.23529411764705882,0.8228971103062822,1.0,4/15,6.95%,SCRIB;CDH5;CGNL1;DSP
prerank,GO_Biological_Process_2021__angiogenesis involved in wound healing (GO:0060055),0.7000791140743103,1.1766888336416774,0.3333333333333333,0.8231221692305565,1.0,2/7,12.11%,HPSE;ADIPOR2
prerank,GO_Biological_Process_2021__I-kappaB phosphorylation (GO:0007252),-0.766141599472542,-1.1766867603286983,0.3384615384615385,1.0,1.0,2/6,12.50%,PRDX4;TLR2
prerank,GO_Biological_Process_2021__regulation of antifungal innate immune response (GO:1905034),-0.7655768129195323,-1.176639158639013,0.32075471698113206,1.0,1.0,2/5,10.89%,TRIM62;SPI1
prerank,GO_Biological_Process_2021__positive regulation of macromolecule biosynthetic process (GO:0010557),0.4103195609622069,1.176579575513142,0.11538461538461539,0.8230577417374279,1.0,20/108,14.95%,GCK;PRR16;IRS1;SAMD4A;SLC25A37;SIRT1;ERBB2;PCIF1;TMEM106A;PPP1R3E;MYC;AKT2;CTC1;IRS2;NAMPT;EIF3E;NFKB1;YTHDF1;ABCB10;INSR
prerank,GO_Biological_Process_2021__ventricular septum morphogenesis (GO:0060412),0.5499253722403252,1.1764132052836134,0.22857142857142856,0.8230255127900102,1.0,5/23,7.88%,TGFBR1;ROBO2;HES1;PROX1;SLIT2
prerank,Reactome_2022__tRNA Processing R-HSA-72306,0.4413781186815204,1.1763981739493368,0.13636363636363635,0.822479995112932,1.0,16/99,15.76%,CPSF1;TRDMT1;NUP210;RPP25;METTL1;NUP42;CTU1;AAAS;TRMT9B;NLRP2B;MTO1;TRMT61B;TRMT11;PUS7;CDKAL1;TRMT61A
prerank,GO_Biological_Process_2021__regulation of striated muscle contraction (GO:0006942),-0.6310782088657569,-1.1763893683271176,0.22857142857142856,1.0,1.0,3/22,4.08%,MYBPH;CAV3;MYBPC3
prerank,CellMarker_Augmented_2021__Endothelial cell:Skin,-0.5100537486935813,-1.1763122097375196,0.1728395061728395,1.0,1.0,18/58,14.86%,C1QB;CYYR1;LYVE1;SLCO2B1;MS4A4A;FCGR3A;CLDN5;ZNF366;VSIG4;SELP;VWF;GPIHBP1;FPR3;F13A1;TEK;A2M;GGT5;ADGRF5
prerank,GO_Biological_Process_2021__peptidyl-tyrosine dephosphorylation involved in inactivation of protein kinase activity (GO:1990264),0.6817675856925715,1.1761337197920294,0.35555555555555557,0.8226833352787902,1.0,3/8,14.47%,PTPRO;PTPRB;PTPRT
prerank,GO_Biological_Process_2021__regulation of synaptic vesicle exocytosis (GO:2000300),0.5617447637098169,1.1760706614010568,0.23684210526315788,0.8223310663414509,1.0,6/19,17.37%,NLGN1;RIMS2;RIMS4;RAP1A;RAB5A;SYN1
prerank,GO_Biological_Process_2021__negative regulation of T-helper 17 cell differentiation (GO:2000320),0.6929913983360844,1.1760373906525932,0.2631578947368421,0.8218512408350688,1.0,4/6,30.00%,RC3H1;SMAD7;RC3H2;FOXP3
prerank,GO_Biological_Process_2021__response to UV-C (GO:0010225),0.6436828950445767,1.175934880237567,0.3225806451612903,0.8216067069930342,1.0,5/7,34.01%,IMPACT;BCL3;MAP3K4;YY1;POLH
prerank,CellMarker_Augmented_2021__Pigment Epithelial cell:Eye,0.43264574647401977,1.1757087876298244,0.16,0.8216502440021013,1.0,27/92,16.74%,LHFPL3;MEGF10;NKAIN3;CNGA3;HS6ST2;DCBLD2;TMPRSS7;IL17RD;PCDH7;PCLO;PTPRZ1;ETV1;KCNIP1;ZNF462;SCD5;NXPH1;CSPG5;NPAS3;CHST3;KIAA1549L;FRMD5;WLS;WWTR1;C6ORF118;CORO2B;RPE65;MARK1
prerank,CellMarker_Augmented_2021__B cell:Lymph Node,-0.7324137478768196,-1.1756398085336264,0.3484848484848485,1.0,1.0,3/6,20.09%,CD27;CD80;PAX5
prerank,GO_Biological_Process_2021__N-acetylneuraminate catabolic process (GO:0019262),0.6067096009977562,1.1755372030614466,0.35555555555555557,0.8214807429422677,1.0,2/6,10.69%,NPL;NAGK
prerank,GO_Biological_Process_2021__response to purine-containing compound (GO:0014074),-0.6360761133688585,-1.1751276071498329,0.2857142857142857,1.0,1.0,4/14,9.43%,DUOX1;STAT1;KCNJ11;P2RY6
prerank,GO_Biological_Process_2021__positive regulation of macrophage chemotaxis (GO:0010759),-0.6505738402344361,-1.1749990024373864,0.32727272727272727,1.0,1.0,6/13,30.71%,THBS1;CSF1R;CXCL17;CCL5;CSF1;MAPK3
prerank,GO_Biological_Process_2021__positive regulation of epidermal cell differentiation (GO:0045606),-0.6176342765930156,-1.1749608507773255,0.27419354838709675,1.0,1.0,5/14,14.65%,PLAAT4;SFRP4;ETV4;PRKCH;VDR
prerank,Reactome_2022__Fibronectin Matrix Formation R-HSA-1566977,-0.7776584111659626,-1.1749005625635798,0.21153846153846154,1.0,1.0,4/5,19.91%,CEACAM1;CEACAM8;ITGA5;FN1
prerank,Reactome_2022__NGF-stimulated Transcription R-HSA-9031628,0.4860484141528548,1.1746836992872325,0.1794871794871795,0.8238440959466538,1.0,4/37,7.31%,ARC;KCNH8;TPH1;SGK1
prerank,CellMarker_Augmented_2021__Basal cell:Epithelium,0.436945535039948,1.1746680534044562,0.12903225806451613,0.8233329992149757,1.0,6/55,3.43%,ADGRF4;CD151;LAMA3;HSPB1;SDC4;PERP
prerank,GO_Biological_Process_2021__ethanol oxidation (GO:0006069),0.6711012817532896,1.174579344606554,0.28888888888888886,0.82301389855217,1.0,3/8,12.24%,ALDH1A1;ACSS2;ADH4
prerank,Reactome_2022__Defective TPR May Confer Susceptibility Towards Thyroid Papillary Carcinoma (TPC) R-HSA-5619107,0.5247980378693581,1.1744849899850742,0.21052631578947367,0.8228757665921289,1.0,11/30,27.98%,NUP210;NUP42;AAAS;MAP4K2;RANBP2;NUP214;TPR;SEH1L;NUP153;NUP98;NUP37
prerank,GO_Biological_Process_2021__metallo-sulfur cluster assembly (GO:0031163),0.5433494915131498,1.1744771067775241,0.1891891891891892,0.8223239998866864,1.0,3/21,4.77%,IBA57;CIAO3;HSCB
prerank,Reactome_2022__TP53 Regulates Transcription Of Additional Cell Cycle Genes With Uncertain Roles In P53 Pathway R-HSA-6804115,0.5582348462944942,1.174474277849986,0.3076923076923077,0.8217412047060436,1.0,6/20,20.66%,CNOT9;PLAGL1;PLK3;CNOT4;TP53;CNOT6
prerank,KEGG_2021_Human__Inflammatory bowel disease,-0.5554432591861863,-1.1744154506203244,0.2328767123287671,1.0,1.0,14/39,16.15%,TGFB1;IL21R;RORC;HLA-DMA;STAT1;HLA-DPB1;HLA-DRB1;TLR2;HLA-DPA1;IL12A;TGFB3;IFNGR2;IL18;SMAD3
prerank,GO_Biological_Process_2021__positive regulation of nuclear-transcribed mRNA poly(A) tail shortening (GO:0060213),0.5928827996464445,1.1741908879095768,0.22857142857142856,0.8219645320175782,1.0,6/13,29.71%,TNRC6C;TNRC6A;AGO2;PABPC1;TNRC6B;TOB1
prerank,GO_Biological_Process_2021__regulation of ventricular cardiac muscle cell membrane repolarization (GO:0060307),-0.6471805741946363,-1.173921864645138,0.288135593220339,1.0,1.0,3/15,8.12%,SCN5A;CAV3;KCNQ1
prerank,GO_Biological_Process_2021__branching morphogenesis of an epithelial tube (GO:0048754),0.5637870744297436,1.173869897788927,0.2608695652173913,0.8225263756814394,1.0,5/33,8.53%,FGF10;PKD2;SLIT2;MYC;LRP6
prerank,GO_Biological_Process_2021__release of sequestered calcium ion into cytosol (GO:0051209),0.5263822303583439,1.1738138574880619,0.34146341463414637,0.8220928082226489,1.0,5/21,10.74%,ITPR2;HTR2C;TRPM2;PKD2;F2R
prerank,GO_Biological_Process_2021__oogenesis (GO:0048477),-0.6339735100893358,-1.1738089015537738,0.29310344827586204,1.0,1.0,2/15,11.03%,IHO1;STRA8
prerank,GO_Biological_Process_2021__regulation of transcription of nucleolar large rRNA by RNA polymerase I (GO:1901836),0.6204105489536116,1.1737896459596715,0.34375,0.8216492800318992,1.0,7/14,20.42%,SIRT7;SMARCB1;PIH1D1;SMARCA4;MACROH2A2;MARS1;IPPK
prerank,GO_Biological_Process_2021__modulation by symbiont of host apoptotic process (GO:0052150),-0.7555633676544958,-1.1736967397983882,0.24561403508771928,1.0,1.0,1/6,7.96%,RNF213
prerank,GO_Biological_Process_2021__mRNA export from nucleus (GO:0006406),0.43388061644442577,1.1731289973076722,0.16666666666666666,0.8233829909711597,1.0,28/96,26.04%,CPSF1;NUP210;NXF5;NUP42;IWS1;NXT1;NXF1;U2AF1;SRRM1;AAAS;SRSF4;SMG1;SMG5;RANBP2;SMG6;EIF4A3;U2AF2;SYMPK;EIF4E;NUP214;TPR;MAGOHB;PCID2;SEH1L;THOC1;WDR33;NUP153;RBM8A
prerank,GO_Biological_Process_2021__regulation of endocytosis (GO:0030100),0.4797557319009195,1.1730947629544128,0.17857142857142858,0.82296029553617,1.0,17/54,18.27%,CD151;APOE;PACSIN2;HIP1;CDH13;SNCA;EPHA3;ABL1;ABL2;ZFYVE16;CD22;RAB5A;RIT2;CLIP3;LGALS3;ABCA7;LRSAM1
prerank,GO_Biological_Process_2021__regulation of MDA-5 signaling pathway (GO:0039533),-0.7156000781933872,-1.1730096425358294,0.3090909090909091,1.0,1.0,4/7,24.62%,USP17L2;DHX58;DDX60;TKFC
prerank,GO_Biological_Process_2021__central nervous system projection neuron axonogenesis (GO:0021952),0.6102383867221356,1.1729850497520924,0.27906976744186046,0.822738668671715,1.0,2/13,3.11%,TSKU;SPTBN4
prerank,GO_Biological_Process_2021__positive regulation of transcription regulatory region DNA binding (GO:2000679),-0.6071174161007973,-1.1729037976881826,0.21428571428571427,1.0,1.0,2/13,7.35%,TGFB1;H1-0
prerank,GO_Biological_Process_2021__positive regulation of mitotic cell cycle spindle assembly checkpoint (GO:0090267),0.6612975524042808,1.1726761047198415,0.3,0.8226440498669504,1.0,2/7,23.16%,TPR;PCID2
prerank,GO_Biological_Process_2021__positive regulation of spindle checkpoint (GO:0090232),0.6612975524042808,1.1726761047198415,0.3,0.8226440498669504,1.0,2/7,23.16%,TPR;PCID2
prerank,GO_Biological_Process_2021__regulation of alcohol biosynthetic process (GO:1902930),0.5963368859881205,1.1725173790915875,0.24390243902439024,0.8224547001581469,1.0,5/12,25.25%,H6PD;SEC14L2;SREBF2;ABCA2;LPCAT3
prerank,GO_Biological_Process_2021__negative regulation of sequestering of calcium ion (GO:0051283),0.5376172515264867,1.1723941089723622,0.23076923076923078,0.8222550952656431,1.0,5/20,10.74%,ITPR2;HTR2C;TRPM2;PKD2;F2R
prerank,GO_Biological_Process_2021__lung epithelium development (GO:0060428),0.7157915385198933,1.1723715621583572,0.30612244897959184,0.8217403477804502,1.0,2/7,13.36%,FGF10;ASCL1
prerank,GO_Biological_Process_2021__negative regulation of cell junction assembly (GO:1901889),0.549544740584992,1.1723390198987995,0.3055555555555556,0.8212263232552087,1.0,2/22,2.08%,PHLDB2;ROBO2
prerank,PanglaoDB_Augmented_2021__Purkinje Neurons,0.41047750286374496,1.1723340231022374,0.15151515151515152,0.8206605234288114,1.0,43/150,19.40%,SLC17A6;GRID2;SEZ6L;GRM3;LRRTM3;HRH3;ELAVL3;CNTNAP2;CADM2;PAK5;HCN1;HIVEP2;PDE1A;ADGRA1;CACNG2;PCBP3;CELF5;CELF4;PDE9A;GRIN1;BRINP1;NXPH1;ELAVL4;GPSM1;RAB3C;SLC22A15;OLFM3;SNAP91;RBFOX1;SCRT1;VSTM2B;PKP4;SRRM4;NRXN1;RIT2;GRIK3;SYN1;SLC24A2;MMD2;ST8SIA3;ADGRB3;GRM5;CTNNA2
prerank,GO_Biological_Process_2021__histone exchange (GO:0043486),-0.5330890509829349,-1.172316901910144,0.23529411764705882,1.0,1.0,11/35,25.05%,CENPU;ITGB3BP;OIP5;CENPH;RBBP7;ANP32E;CENPN;SMARCA5;CENPL;CENPM;RNF8
prerank,GO_Biological_Process_2021__regulation of establishment or maintenance of cell polarity (GO:0032878),0.6223435320478828,1.1722442941905007,0.23684210526315788,0.8203683087610937,1.0,3/17,9.71%,LLGL1;CDH5;KANK1
prerank,GO_Biological_Process_2021__regulation of chemotaxis (GO:0050920),-0.5913012835022227,-1.171942237469598,0.2903225806451613,1.0,1.0,6/25,16.13%,TGFB1;P2RY12;GPR183;THBS1;ELANE;F2RL1
prerank,GO_Biological_Process_2021__positive regulation of adaptive immune response (GO:0002821),0.6848904973709922,1.1719299157260312,0.3181818181818182,0.820936243512973,1.0,3/7,12.94%,SKAP1;SIRT1;FADD
prerank,Reactome_2022__Signaling By FGFR R-HSA-190236,0.439672248795766,1.1719297480745463,0.15,0.8203613581883841,1.0,18/75,17.32%,FGF10;FGFR1;FGF17;HNRNPF;HNRNPH1;ESRP1;FGF18;SPRED2;FGFR3;FLRT2;SPRED1;RBFOX2;TIAL1;ANOS1;GTF2F2;PIK3CA;PTBP1;BRAF
prerank,GO_Biological_Process_2021__positive regulation of brown fat cell differentiation (GO:0090336),0.6121771880001052,1.1718900028266772,0.28205128205128205,0.8198815070880103,1.0,3/12,9.43%,ZBTB7B;METRNL;TFE3
prerank,GO_Biological_Process_2021__ncRNA metabolic process (GO:0034660),0.49976753090415066,1.1717397198767865,0.14705882352941177,0.8198312952172979,1.0,10/36,20.81%,PLD6;TRIM71;KHSRP;PIWIL1;DGCR8;XPO5;TARBP2;AGO2;PIWIL2;TUT7
prerank,Reactome_2022__MECP2 Regulates Transcription Factors R-HSA-9022707,0.7595802101544574,1.171508563072526,0.2972972972972973,0.8200007153571853,1.0,4/5,19.24%,PPARG;RBFOX1;MECP2;CREB1
prerank,GO_Biological_Process_2021__endocytic recycling (GO:0032456),-0.5159753655221259,-1.1714955043990773,0.28378378378378377,1.0,1.0,1/50,0.13%,DENND1C
prerank,CellMarker_Augmented_2021__Pancreatic Stem cell:Pancreatic Acinar Tissue,-0.4957680735226908,-1.1712896049833927,0.23684210526315788,1.0,1.0,15/58,10.28%,GMFG;CYTIP;TBC1D10C;ARHGAP9;TAGAP;TMC8;GPR183;PARVG;CD5;WAS;LY86;CD37;TRAF3IP3;MYO1F;PTPRC
prerank,CellMarker_Augmented_2021__Definitive Endoderm cell:Germ,-0.4957680735226908,-1.1712896049833927,0.23684210526315788,1.0,1.0,15/58,10.28%,GMFG;CYTIP;TBC1D10C;ARHGAP9;TAGAP;TMC8;GPR183;PARVG;CD5;WAS;LY86;CD37;TRAF3IP3;MYO1F;PTPRC
prerank,CellMarker_Augmented_2021__Endocrine Progenitor cell:Pancreatic Acinar Tissue,-0.4957680735226908,-1.1712896049833927,0.23684210526315788,1.0,1.0,15/58,10.28%,GMFG;CYTIP;TBC1D10C;ARHGAP9;TAGAP;TMC8;GPR183;PARVG;CD5;WAS;LY86;CD37;TRAF3IP3;MYO1F;PTPRC
prerank,CellMarker_Augmented_2021__T Helper17 (Th17) cell:Brain,-0.5699920234673561,-1.1711147768377976,0.2465753424657534,1.0,1.0,12/40,13.88%,SIRPG;CYTIP;TBC1D10C;ARHGAP9;TAGAP;KLRB1;SCML4;CD5;TRAF3IP3;PTPRC;NLRC3;PSTPIP1
prerank,CellMarker_Augmented_2021__T Helper1 (Th1) cell:Brain,-0.5699920234673561,-1.1711147768377976,0.2465753424657534,1.0,1.0,12/40,13.88%,SIRPG;CYTIP;TBC1D10C;ARHGAP9;TAGAP;KLRB1;SCML4;CD5;TRAF3IP3;PTPRC;NLRC3;PSTPIP1
prerank,GO_Biological_Process_2021__positive regulation of sphingolipid biosynthetic process (GO:0090154),0.6122976486183962,1.1708992303054575,0.22448979591836735,0.8208922051296661,1.0,4/9,24.44%,NSMAF;SMPD3;PLA2G6;PRKCD
prerank,GO_Biological_Process_2021__positive regulation of ceramide biosynthetic process (GO:2000304),0.6122976486183962,1.1708992303054575,0.22448979591836735,0.8208922051296661,1.0,4/9,24.44%,NSMAF;SMPD3;PLA2G6;PRKCD
prerank,GO_Biological_Process_2021__negative regulation of lipid catabolic process (GO:0050995),0.6362755736831143,1.1707510632137474,0.3111111111111111,0.8209457630328972,1.0,2/10,4.35%,MFSD2A;PLIN5
prerank,GO_Biological_Process_2021__regulation of secretion by cell (GO:1903530),0.4476573339831988,1.1707170003625602,0.20689655172413793,0.8204466586645647,1.0,13/51,20.90%,LLGL1;SNCAIP;RALA;SYT1;RIMS2;RAB3C;RAB10;ARFIP1;SYN1;RAB3D;DNAJC1;VAMP8;RAB26
prerank,GO_Biological_Process_2021__regulation of lipoprotein lipase activity (GO:0051004),0.5871082358664571,1.1707055700392073,0.2391304347826087,0.819906573743432,1.0,5/15,15.39%,APOH;LIPC;LPL;FURIN;NR1H3
prerank,CellMarker_Augmented_2021__Hematopoietic Stem cell:Undefined,0.5950865009475098,1.1705181395470023,0.23529411764705882,0.8201168807888115,1.0,5/16,9.59%,CD38;KIT;ITGA4;CASP3;ITGA3
prerank,GO_Biological_Process_2021__regulation of cytoplasmic mRNA processing body assembly (GO:0010603),0.6857214992041402,1.170504686467315,0.358974358974359,0.8195985852202496,1.0,5/6,31.02%,NBDY;CNOT6;ATXN2;CNOT2;CNOT6L
prerank,GO_Biological_Process_2021__mammary gland development (GO:0030879),0.5694179224634953,1.170354264539778,0.26666666666666666,0.8195696784016449,1.0,3/17,5.50%,ZBTB7B;WNT4;NRG1
prerank,GO_Biological_Process_2021__DNA replication (GO:0006260),-0.4790637288926872,-1.1701199959949402,0.21621621621621623,1.0,1.0,24/97,22.47%,TICRR;MCM2;DONSON;PCLAF;RPA3;MCM3;CDK2AP1;BRCA1;GRWD1;PIF1;RAD1;POLE2;POLD4;CDC6;RECQL4;SET;RMI1;ORC6;TOPBP1;POLE3;RPA2;PTMS;BAZ1A;BLM
prerank,GO_Biological_Process_2021__regulation of cell differentiation (GO:0045595),0.42589509294508665,1.1700652796065711,0.16666666666666666,0.819873291078941,1.0,20/129,9.32%,PHLDB2;NGF;MEGF10;SMYD5;TGFBR1;BCL6;FGFR1;MAFB;NLGN1;CCN2;BIN1;CBFB;KLHL41;DLX1;EPHA3;GREM1;CDK6;SNAI2;ANP32B;FADS1
prerank,PanglaoDB_Augmented_2021__Endothelial Cells,-0.4669980023410329,-1.1699283900603614,0.16666666666666666,1.0,1.0,37/173,14.86%,F8;TBX1;C1QTNF1;CYYR1;LMOD1;LYVE1;TIMP3;S100A13;ANGPTL2;INMT;ELK3;CYP1B1;NOSTRIN;PROCR;LOX;OIT3;DCN;SLCO2A1;CLDN5;FLT4;USHBP1;ABCG2;ARAP3;ID1;VWF;GPIHBP1;ENG;APOLD1;PRKCH;COX7A1;EDNRB;TEK;A2M;PALMD;C1S;GGT5;ADGRF5
prerank,Reactome_2022__Aspartate And Asparagine Metabolism R-HSA-8963693,0.6334120124768722,1.169896252824886,0.2564102564102564,0.8198027026678455,1.0,3/10,11.59%,GOLT1A;NAALAD2;SLC25A12
prerank,GO_Biological_Process_2021__metal ion homeostasis (GO:0055065),0.4816251808636991,1.1697994417103168,0.2692307692307692,0.8195039496400759,1.0,10/37,11.22%,LETM2;SLC12A1;TMTC2;SLC8A1;SNCA;SLC12A9;CNNM2;TESMIN;GRIN1;SLC7A8
prerank,GO_Biological_Process_2021__ureteric bud development (GO:0001657),0.6498258023676313,1.1697840977125735,0.3333333333333333,0.8189878747291659,1.0,4/11,7.88%,ROBO2;PKD2;OSR1;SLIT2
prerank,GO_Biological_Process_2021__positive regulation of potassium ion import across plasma membrane (GO:1903288),0.6418588019876954,1.1697795628169196,0.32432432432432434,0.8184207086109324,1.0,3/7,22.90%,WNK2;WNK3;WNK1
prerank,GO_Biological_Process_2021__positive regulation of receptor catabolic process (GO:2000646),0.7718727073353092,1.169609440077085,0.3142857142857143,0.818392736960162,1.0,1/5,2.66%,APOE
prerank,CellMarker_Augmented_2021__Granulocyte:Blood,-0.5352192186871169,-1.1695246468298623,0.24615384615384617,1.0,1.0,21/54,19.20%,RASGRP4;KCNJ15;NLRP12;SCIMP;SCML4;CLEC4C;CA1;MYO1F;IGSF6;FPR1;SLC11A1;CEACAM8;CLEC12A;ADGRE3;TSPAN16;HRH4;PGLYRP1;SLC4A1;LAT2;CLEC1B;BEND2
prerank,GO_Biological_Process_2021__mitotic spindle organization (GO:0007052),-0.4415181927768079,-1.169364064437744,0.17105263157894737,1.0,1.0,16/148,14.09%,BUB1;ERCC6L;MISP;SPC25;CENPU;ABRAXAS1;RAB11A;GPSM2;ITGB3BP;ZWILCH;TTK;NUF2;CENPH;DYNLL1;RPS27;INCENP
prerank,Reactome_2022__VEGFR2 Mediated Cell Proliferation R-HSA-5218921,0.5542210847985612,1.1693481840622286,0.2,0.8188304130424995,1.0,1/16,1.88%,ITPR2
prerank,GO_Biological_Process_2021__cellular nitrogen compound catabolic process (GO:0044270),-0.7032279251890317,-1.1691063506113015,0.3125,1.0,1.0,3/7,19.10%,CYP3A5;CYP3A4;NIT1
prerank,GO_Biological_Process_2021__regulation of microvillus assembly (GO:0032534),0.6968400860144051,1.1689660142569593,0.358974358974359,0.819732771451449,1.0,2/5,27.63%,FSCN1;ATP8B1
prerank,GO_Biological_Process_2021__actin nucleation (GO:0045010),-0.612506793035384,-1.1689276069636938,0.26865671641791045,1.0,1.0,3/18,10.85%,LMOD1;LMOD3;SCIN
prerank,GO_Biological_Process_2021__negative regulation of cation transmembrane transport (GO:1904063),-0.6329953364519609,-1.168629660406941,0.27586206896551724,1.0,1.0,3/16,4.01%,MMP9;CAV3;HAMP
prerank,GO_Biological_Process_2021__dopamine transport (GO:0015872),-0.7244909266814011,-1.1686105457013123,0.3793103448275862,1.0,1.0,3/6,24.50%,SLC18A2;SLC22A3;SLC22A1
prerank,KEGG_2021_Human__Glycerolipid metabolism,0.4682543087532342,1.1685519380856468,0.1956521739130435,0.8202929084875271,1.0,8/54,10.08%,DGKD;LIPC;CEL;GLA;ALDH7A1;PNPLA3;LPL;PLPP2
prerank,GO_Biological_Process_2021__apoptotic chromosome condensation (GO:0030263),-0.7296418901314983,-1.1684802754249428,0.288135593220339,1.0,1.0,2/5,5.18%,ERN2;GPER1
prerank,GO_Biological_Process_2021__regulation of spindle organization (GO:0090224),-0.6137686523897478,-1.168401499969222,0.2777777777777778,1.0,1.0,4/17,15.60%,GPSM2;ANKRD53;DCTN1;BORA
prerank,GO_Biological_Process_2021__positive regulation of skeletal muscle tissue development (GO:0048643),-0.7270866367782867,-1.1683479400319425,0.2698412698412698,1.0,1.0,2/6,10.22%,ACTN3;LMOD3
prerank,GO_Biological_Process_2021__positive regulation of fat cell differentiation (GO:0045600),0.44668757660070385,1.168326989863261,0.15151515151515152,0.8203256746632324,1.0,9/43,19.24%,ZBTB7B;METRNL;PPARG;TFE3;LPL;CARM1;SYAP1;SOX13;CREB1
prerank,GO_Biological_Process_2021__negative regulation of translational initiation (GO:0045947),0.5960226233764111,1.1683069637143786,0.3333333333333333,0.8198321610906892,1.0,7/13,29.74%,EIF3E;EIF4EBP1;AGO2;LARP1;TPR;FMR1;EIF2AK4
prerank,GO_Biological_Process_2021__hexose biosynthetic process (GO:0019319),0.5082089494807348,1.1682021822708448,0.1875,0.8196280417325139,1.0,8/38,11.59%,PER2;FBP2;PC;ENO3;CRY1;G6PC3;SLC25A1;SLC25A12
prerank,GO_Biological_Process_2021__pharyngeal arch artery morphogenesis (GO:0061626),0.7301033912353943,1.1676450451996827,0.3,0.8207843463158776,1.0,4/5,23.49%,HES1;BMPR2;BMP4;BMPR1A
prerank,Reactome_2022__Advanced Glycosylation Endproduct Receptor Signaling R-HSA-879415,0.6310928477426597,1.1674761963778515,0.26,0.820909357249479,1.0,5/11,21.44%,PRKCSH;HMGB1;LGALS3;S100B;CAPZA1
prerank,GO_Biological_Process_2021__regulation of mRNA metabolic process (GO:1903311),0.6065855043806169,1.1674656572123867,0.32432432432432434,0.820396220038989,1.0,4/13,13.56%,IWS1;SAFB2;SLTM;CDK11A
prerank,GO_Biological_Process_2021__angiotensin maturation (GO:0002003),-0.6805802130966365,-1.167110830920937,0.375,1.0,1.0,4/8,19.87%,CTSZ;ATP6AP2;REN;ACE2
prerank,GO_Biological_Process_2021__regulation of angiotensin levels in blood (GO:0002002),-0.6805802130966365,-1.167110830920937,0.375,1.0,1.0,4/8,19.87%,CTSZ;ATP6AP2;REN;ACE2
prerank,CellMarker_Augmented_2021__Neuron:Undefined,0.502742721416903,1.1667983500847068,0.1875,0.8220534729861146,1.0,9/32,21.17%,BCL2;ALCAM;CX3CR1;EPOR;CDH2;NCAM1;IL11;FOS;ACE
prerank,GO_Biological_Process_2021__response to nutrient levels (GO:0031667),-0.6591698311464902,-1.1666588375128475,0.2786885245901639,1.0,1.0,2/13,11.75%,SCTR;UCP1
prerank,GO_Biological_Process_2021__regulation of autophagosome maturation (GO:1901096),0.6264031204231666,1.166394867120098,0.2,0.8229480399901022,1.0,1/12,0.82%,IRGM
prerank,GO_Biological_Process_2021__calcium ion transport (GO:0006816),0.4016932552288079,1.1663747737959582,0.14285714285714285,0.822414022606388,1.0,8/98,5.34%,GRIN3A;MCOLN3;TRPC3;SLC3A2;TRPM2;SLC8A1;SLC8A3;PKD2
prerank,CellMarker_Augmented_2021__Dendritic cell:Blood,-0.5347738947931353,-1.1663223556953586,0.2923076923076923,1.0,1.0,18/53,13.42%,GMFG;ITGB2;HCK;CYTIP;ARHGAP9;TAGAP;C3AR1;GPR183;PARVG;LY86;NFAM1;IGSF6;PTPRC;SPI1;CLEC12A;ITGAM;NLRP3;CD300LF
prerank,Reactome_2022__Cyclin A/B1/B2 Associated Events During G2/M Transition R-HSA-69273,-0.6150502507912732,-1.1663081759647795,0.2631578947368421,1.0,1.0,2/22,5.14%,FOXM1;CDC25A
prerank,GO_Biological_Process_2021__positive regulation of growth (GO:0045927),0.46277715122680657,1.166181986117718,0.16666666666666666,0.8225374870852853,1.0,11/57,14.99%,TGFBR1;BCL2;MFSD2A;ERBB2;SLC25A33;PLCB1;RPS6KA3;ADNP2;KLHL22;INSR;DNPH1
prerank,Reactome_2022__Activation Of RAC1 R-HSA-428540,0.6313456055877384,1.1660827209518,0.2926829268292683,0.822322378048036,1.0,5/11,21.97%,SLIT2;PKN2;NCK1;SOS1;NCK2
prerank,GO_Biological_Process_2021__protein-containing complex subunit organization (GO:0043933),0.4139436138439126,1.1659532919134141,0.1724137931034483,0.8221895448896841,1.0,34/101,25.60%,TEAD2;LLGL1;CD247;MATN1;MITF;PARD3;HES1;SLC7A9;PML;WASF3;GEMIN5;SNX9;MAGI1;TP53;IL2RB;PARD6B;NDUFAF1;SKAP2;WDR19;LIN7A;PPIH;CAPZA1;MDM4;OCLN;LAMC1;TPR;TFAP4;SEH1L;IL1RAP;PEX14;TRAF1;MDN1;TAPBP;KMT2A
prerank,GO_Biological_Process_2021__response to ethanol (GO:0045471),0.6054062663561512,1.1657995941673203,0.3055555555555556,0.8220466529330277,1.0,3/13,9.93%,GRIN3A;SDF4;GRIN1
prerank,GO_Biological_Process_2021__positive regulation of blood coagulation (GO:0030194),0.56156687246057,1.1657578005383322,0.2972972972972973,0.8215867138451075,1.0,6/15,10.85%,APOH;SERPINE1;HPSE;F2;F2R;F12
prerank,GO_Biological_Process_2021__regulation of mRNA processing (GO:0050684),0.4954413850682098,1.1657388093766219,0.21875,0.8210558170563674,1.0,14/34,26.51%,IWS1;SAFB2;KHDRBS2;SLTM;CDK11A;PAPOLA;KHDRBS1;METTL16;KHDRBS3;SRPK2;RBM39;PTCD2;SF1;SON
prerank,GO_Biological_Process_2021__regulation of DNA damage checkpoint (GO:2000001),0.6843586500658483,1.165675653965097,0.2926829268292683,0.8207095992738337,1.0,2/9,5.35%,RFWD3;CRY1
prerank,GO_Biological_Process_2021__hemostasis (GO:0007599),-0.7911152468221806,-1.1656056782821997,0.3,1.0,1.0,2/5,10.59%,P2RY12;VWF
prerank,GO_Biological_Process_2021__rRNA metabolic process (GO:0016072),-0.4431051213074125,-1.1655340693981753,0.19753086419753085,1.0,1.0,58/154,27.27%,ERN2;RPL37A;SLFN14;SENP3;RPL38;PWP2;EMG1;RPL15;NOB1;RPL3;RPL35A;RPS9;RPS27;RPL13A;RPL27A;RPS16;RPL36;LAS1L;RPL7A;RPL9;RPL13;RPL21;WDR12;NOP53;EXOSC8;RPL34;RPL4;RPL32;RPL5;RPL23;RPL41;RPS7;RPL27;RPL35;RPS14;RPL11;RPS15;EXOSC2;RPLP1;RPL24;SBDS;RPL18A;RPL29;RPLP2;PDCD11;RPL28;RPL12;RPL18;EBNA1BP2;RPL22;IMP3;RPS28;RPS19;RPS24;RPL19;RPL8;RPS6;RPL10
prerank,GO_Biological_Process_2021__clathrin-dependent endocytosis (GO:0072583),0.48668472119791034,1.1654666197391306,0.17142857142857143,0.8208438499251677,1.0,9/26,33.74%,SGIP1;SNAP91;FCHSD2;DNAJC6;FNBP1L;DLL1;ITSN1;LMBRD1;ITSN2
prerank,"GO_Biological_Process_2021__regulation of alternative mRNA splicing, via spliceosome (GO:0000381)",0.47187389318120476,1.1651322420184704,0.14705882352941177,0.8214473800772579,1.0,18/47,21.13%,NOVA1;PUF60;KHDRBS2;CELF5;CELF4;HNRNPL;NSRP1;RBFOX2;RBFOX1;CELF2;SRRM4;PTBP1;KHDRBS1;RBM25;FXR2;RBM24;ZBTB7A;KHDRBS3
prerank,GO_Biological_Process_2021__regulation of collagen fibril organization (GO:1904026),0.7114216374898567,1.1650811271091839,0.34146341463414637,0.8211831934163614,1.0,4/6,25.87%,COLGALT1;AEBP1;EMILIN1;RB1
prerank,GO_Biological_Process_2021__SMAD protein complex assembly (GO:0007183),-0.7374459679356715,-1.1648655166223447,0.40384615384615385,1.0,1.0,1/6,1.49%,TGFB1
prerank,Reactome_2022__Lysine Catabolism R-HSA-71064,0.596719353023592,1.1646885382936256,0.3181818181818182,0.8219691226608997,1.0,5/12,12.14%,HYKK;AASS;ALDH7A1;AADAT;OGDH
prerank,CellMarker_Augmented_2021__Adipose Progenitor cell:Adipose Tissue,0.43491596982428554,1.1646054752223267,0.21212121212121213,0.8216336464399369,1.0,19/84,11.12%,PHLDB2;VEGFC;CD151;PAPSS2;ARSJ;PARVA;DCBLD2;EXT1;COL12A1;SERPINE1;CAPN2;NTN4;REXO2;RAI14;SNAI2;CRIM1;ITGA3;RND3;TWSG1
prerank,Reactome_2022__Linoleic Acid (LA) Metabolism R-HSA-2046105,-0.7230951911417431,-1.1645217576610016,0.3103448275862069,1.0,1.0,1/7,1.18%,ELOVL2
prerank,GO_Biological_Process_2021__glutathione metabolic process (GO:0006749),0.5205740910716135,1.1645117814403287,0.2222222222222222,0.8213800501628903,1.0,9/32,20.69%,GSTM5;CHAC1;GSTM2;GSTA4;GPX1;GSTZ1;ETHE1;GSR;GSTT2
prerank,Reactome_2022__Metabolism Of Angiotensinogen To Angiotensins R-HSA-2022377,-0.6732598576116595,-1.1644908107371168,0.3888888888888889,1.0,1.0,5/10,19.87%,CPB2;CTSZ;ATP6AP2;ANPEP;ACE2
prerank,CellMarker_Augmented_2021__Stem cell:Bone,-0.7444311581143078,-1.1644439084889662,0.35714285714285715,1.0,1.0,3/7,16.84%,PTPRC;ENG;NT5E
prerank,Reactome_2022__Urea Cycle R-HSA-70635,-0.7474034773346494,-1.1644073383149147,0.296875,1.0,1.0,2/6,11.64%,CYP21A2;ARG2
prerank,GO_Biological_Process_2021__positive regulation of response to cytokine stimulus (GO:0060760),-0.6608165246354515,-1.1642733341540816,0.27586206896551724,1.0,1.0,2/11,6.30%,WNT5A;IL7
prerank,GO_Biological_Process_2021__positive regulation of phosphoprotein phosphatase activity (GO:0032516),0.5978490862882629,1.1641095075223986,0.275,0.8223473210981346,1.0,2/13,5.58%,PPP1R14D;MAGI2
prerank,GO_Biological_Process_2021__muscle cell differentiation (GO:0042692),-0.5789239614675912,-1.1640200484307808,0.3448275862068966,1.0,1.0,7/28,14.72%,NRAP;TBX1;NEB;TMEM204;POPDC2;HEY2;FBXO40
prerank,"GO_Biological_Process_2021__protein localization to chromosome, telomeric region (GO:0070198)",-0.59184385090063,-1.1640133836436886,0.2542372881355932,1.0,1.0,2/15,10.71%,TERF2IP;TERT
prerank,GO_Biological_Process_2021__negative regulation of alpha-beta T cell proliferation (GO:0046642),0.6681850281417163,1.1638632239409097,0.2727272727272727,0.8226221182933323,1.0,3/6,11.29%,ZBTB7B;TWSG1;LGALS9
prerank,Reactome_2022__Transport Of Organic Anions R-HSA-879518,-0.7022469922251338,-1.1637996071450885,0.3269230769230769,1.0,1.0,4/9,15.91%,SLCO2B1;SLCO2A1;NLRP3;SLCO1A2
prerank,GO_Biological_Process_2021__protein import into mitochondrial matrix (GO:0030150),-0.6274952139385678,-1.16364225296805,0.22950819672131148,1.0,1.0,6/17,25.59%,TOMM20;PAM16;TIMM17A;ROMO1;DNAJC19;TIMM21
prerank,GO_Biological_Process_2021__skeletal muscle contraction (GO:0003009),-0.6290407018436704,-1.1636349249574232,0.3103448275862069,1.0,1.0,3/15,2.13%,MYH7;MYH8;STAC
prerank,Reactome_2022__Signaling By Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R) R-HSA-2404192,0.4706245319177734,1.1635353797070604,0.17857142857142858,0.8225209736714543,1.0,12/43,14.95%,FGF10;THEM4;FGFR1;IRS1;FGF17;FGF18;AKT2;FGFR3;IRS2;IRS4;FLT3;PIK3CA
prerank,Reactome_2022__IGF1R Signaling Cascade R-HSA-2428924,0.4706245319177734,1.1635353797070604,0.17857142857142858,0.8225209736714543,1.0,12/43,14.95%,FGF10;THEM4;FGFR1;IRS1;FGF17;FGF18;AKT2;FGFR3;IRS2;IRS4;FLT3;PIK3CA
prerank,GO_Biological_Process_2021__nucleoside triphosphate metabolic process (GO:0009141),0.5580673457877673,1.163535336352307,0.23333333333333334,0.8219633323333719,1.0,1/13,3.83%,AK3
prerank,CellMarker_Augmented_2021__Macrophage:Serum,-0.7991401015427009,-1.1634786707001137,0.3541666666666667,1.0,1.0,4/5,19.68%,ADGRE1;ITGAM;CSF1R;ITGAX
prerank,GO_Biological_Process_2021__translation (GO:0006412),-0.4473188284227442,-1.1632633359384696,0.11627906976744186,1.0,1.0,72/195,27.27%,RPL37A;NARS1;DARS2;RPL38;RPL15;COPS5;WARS1;RPS4X;RPL3;RPL35A;RPS9;RPS27;EEF2;RPS21;RPL13A;YARS2;RPL27A;RPS16;RPL36;RPS20;RPL7A;RPL9;ABCF1;RPL13;MRPS34;RPS8;RPS27A;RPL21;RPL34;MRPL34;RPL4;RPL32;RPL5;RPL23;RPL41;RPS7;RPS11;RPL27;RPL35;TMA7;RPS14;RPL11;ASMT;DRG1;RPS15;RPLP1;RPS12;RPL24;PPA1;RPL18A;RPS13;RPL29;RPLP2;ZC3H15;RPL28;RPL12;IGF2BP3;RPL18;RPS3;RPL22;EEF1A1;RPSA;RPS28;RPS19;RPS24;MRPS2;RPL26L1;RPS3A;RPL19;RPL8;RPS6;RPL10
prerank,Reactome_2022__Regulation Of TP53 Activity Thru Acetylation R-HSA-6804758,0.5224048532292233,1.1632232857121356,0.23076923076923078,0.8224707859816117,1.0,12/28,21.31%,GATAD2A;PML;AKT2;KAT6A;HDAC1;GATAD2B;CHD4;TP53;PIP4K2A;EP300;MAP2K6;RBBP4
prerank,CellMarker_Augmented_2021__Spermatogonium:Testis,0.6790229280675788,1.1631909894478265,0.4166666666666667,0.8221063980710949,1.0,1/5,1.53%,KIT
prerank,GO_Biological_Process_2021__regulation of RNA splicing (GO:0043484),0.39806526775870127,1.1631550808155973,0.08333333333333333,0.8216716433008657,1.0,24/71,25.54%,RBM20;HNRNPF;KHDRBS2;HNRNPH1;ESRP1;ERN1;HNRNPL;RRP1B;FASTK;HSPA1A;SRRM4;PTBP1;FUS;CLK2;KHDRBS1;METTL16;U2AF2;KHDRBS3;METTL4;SRPK2;SETX;DYRK1A;RBM39;SF1
prerank,GO_Biological_Process_2021__positive regulation of chromatin organization (GO:1905269),-0.6134334975359468,-1.1630351611070382,0.2,1.0,1.0,1/12,2.96%,TERF2IP
prerank,GO_Biological_Process_2021__regulation of microtubule cytoskeleton organization (GO:0070507),0.508062601752383,1.1630207829564065,0.2903225806451613,0.8215915365914338,1.0,10/36,21.29%,PHLDB2;BICD1;EPHA3;EFNA5;MAPRE1;MAP6;SKA1;PRKAA2;MARK2;CAMSAP3
prerank,GO_Biological_Process_2021__regulation of mitotic spindle organization (GO:0060236),-0.5331314287775026,-1.1627417692036202,0.25,1.0,1.0,9/31,24.59%,GPSM2;ANKRD53;CHMP3;DCTN1;BORA;EML3;DRG1;PSRC1;RAE1
prerank,CellMarker_Augmented_2021__Effector CD4+ Memory T (Tem) cell:Blood,-0.5047292702341201,-1.1627243652625463,0.2112676056338028,1.0,1.0,17/61,10.28%,GMFG;ITGB2;DOCK8;CYTIP;TBC1D10C;ARHGAP9;TAGAP;ARHGAP15;DOCK2;GPR183;PARVG;CD5;WAS;CD37;TRAF3IP3;MYO1F;PTPRC
prerank,GO_Biological_Process_2021__positive regulation of glucose transmembrane transport (GO:0010828),0.4975356301328127,1.1625850565901423,0.25,0.8225022367307034,1.0,10/25,21.55%,IRS1;CAPN10;AKT2;IRS2;INSR;NR4A3;CLIP3;BRAF;OSBPL8;OCLN
prerank,GO_Biological_Process_2021__presynaptic endocytosis (GO:0140238),0.5519799090123452,1.1625747157814577,0.14705882352941177,0.8219771742561507,1.0,6/23,12.52%,CEL;NLGN1;SNCA;SYT1;NLGN4X;NLGN3
prerank,GO_Biological_Process_2021__membrane lipid metabolic process (GO:0006643),-0.6053636779596414,-1.1623609039948783,0.2698412698412698,1.0,1.0,3/21,5.72%,CYP1B1;ALOX12B;FUT2
prerank,GO_Biological_Process_2021__regulation of epithelial cell migration (GO:0010632),-0.4956255148203458,-1.162284712554335,0.21739130434782608,1.0,1.0,3/48,7.40%,ENPP2;RAB11A;CEACAM1
prerank,Reactome_2022__p75NTR Regulates Axonogenesis R-HSA-193697,0.7309373319717185,1.1622315086374446,0.21428571428571427,0.8224219909356667,1.0,1/8,0.65%,NGF
prerank,CellMarker_Augmented_2021__Platelet:Bone Marrow,-0.5199599532679982,-1.1619973497668148,0.21621621621621623,1.0,1.0,24/57,19.97%,GMFG;ITGB2;HCK;TNFRSF1B;C3AR1;MS4A4A;PARVG;FCGR3A;LY86;SELP;MYO1F;IGSF6;PTPRC;SPI1;CLEC12A;ITGAM;CD300LF;HK3;PIK3CG;CSF1R;SASH3;TFEC;ITGAX;GAB3
prerank,CellMarker_Augmented_2021__Endothelial Progenitor cell:Umbilical Cord Blood,-0.5199599532679982,-1.1619973497668148,0.21621621621621623,1.0,1.0,24/57,19.97%,GMFG;ITGB2;HCK;TNFRSF1B;C3AR1;MS4A4A;PARVG;FCGR3A;LY86;SELP;MYO1F;IGSF6;PTPRC;SPI1;CLEC12A;ITGAM;CD300LF;HK3;PIK3CG;CSF1R;SASH3;TFEC;ITGAX;GAB3
prerank,CellMarker_Augmented_2021__Endothelial cell:Embryonic Stem Cell,-0.5199599532679982,-1.1619973497668148,0.21621621621621623,1.0,1.0,24/57,19.97%,GMFG;ITGB2;HCK;TNFRSF1B;C3AR1;MS4A4A;PARVG;FCGR3A;LY86;SELP;MYO1F;IGSF6;PTPRC;SPI1;CLEC12A;ITGAM;CD300LF;HK3;PIK3CG;CSF1R;SASH3;TFEC;ITGAX;GAB3
prerank,CellMarker_Augmented_2021__Endothelial cell:Eye,-0.5199599532679982,-1.1619973497668148,0.21621621621621623,1.0,1.0,24/57,19.97%,GMFG;ITGB2;HCK;TNFRSF1B;C3AR1;MS4A4A;PARVG;FCGR3A;LY86;SELP;MYO1F;IGSF6;PTPRC;SPI1;CLEC12A;ITGAM;CD300LF;HK3;PIK3CG;CSF1R;SASH3;TFEC;ITGAX;GAB3
prerank,Reactome_2022__NLRP3 Inflammasome R-HSA-844456,-0.63571103243654,-1.161949123753401,0.38333333333333336,1.0,1.0,4/13,15.44%,NFKB2;NLRP3;PSTPIP1;TXNIP
prerank,GO_Biological_Process_2021__nuclear migration (GO:0007097),0.5782932172750846,1.161691622931205,0.2857142857142857,0.823481619601456,1.0,3/13,6.54%,PCM1;SYNE3;CEP120
prerank,GO_Biological_Process_2021__positive regulation of mitophagy in response to mitochondrial depolarization (GO:0098779),-0.7209418657508604,-1.1616708720504643,0.2909090909090909,1.0,1.0,2/7,12.38%,PINK1;TOMM7
prerank,Reactome_2022__Diseases Of Signal Transduction By Growth Factor Receptors And Second Messengers R-HSA-5663202,0.3775618898618691,1.1612646620451232,0.18181818181818182,0.824439000987107,1.0,69/381,14.95%,FOXO1;FGF10;NOX4;TGFBR1;KIT;HDAC3;SPRED3;FGFR1;KSR1;IRS1;CNTRL;HDAC10;HIP1;BCL2A1;NRG2;AGTRAP;KIAA1549;CSK;FGF17;TENT4A;PSME4;ERBB2;MAML1;SEM1;JAG1;ARRB2;NRG1;BCL11A;GOLGA4;STAT5B;KDM7A;PSMA1;EIF2AK3;NRG3;MYC;ESRP1;PPFIBP1;FGF18;TGFA;LRP6;SPRED2;MLST8;WNT3A;GCC2;TPM4;AKT2;FGFR3;KANK1;KITLG;MAMLD1;CTBP2;AKAP9;IRS2;SPRED1;PPP2R1B;CNKSR2;RAP1A;MARK3;HDAC1;ARRB1;CDK8;NF1;SMAD2;FLT3;GTF2F2;CUX1;MECP2;HDAC4;PIK3CA
prerank,GO_Biological_Process_2021__chemokine-mediated signaling pathway (GO:0070098),-0.6089176004583882,-1.1612152944199363,0.288135593220339,1.0,1.0,1/15,3.57%,CXCL13
prerank,GO_Biological_Process_2021__pseudouridine synthesis (GO:0001522),0.6485981877916902,1.1609430766119713,0.14285714285714285,0.8249417120417523,1.0,3/13,14.89%,PUS7L;PUS10;PUS7
prerank,CellMarker_Augmented_2021__Vascular Endothelial cell:Placenta,-0.5094596156211237,-1.1606411005304458,0.189873417721519,1.0,1.0,17/56,14.86%,C1QB;CYYR1;LYVE1;SLCO2B1;MS4A4A;CLDN5;ZNF366;VSIG4;SELP;VWF;GPIHBP1;ENG;FPR3;TEK;A2M;GGT5;ADGRF5
prerank,GO_Biological_Process_2021__fatty acid transmembrane transport (GO:1902001),0.5491962954016203,1.1603954736942312,0.225,0.8259773691406623,1.0,8/18,24.93%,ACACB;ABCD3;ABCD2;CPT1A;PRKAA2;PRKAG2;THRSP;ACACA
prerank,GO_Biological_Process_2021__response to iron ion (GO:0010039),0.5971177738033899,1.16039218786536,0.2564102564102564,0.8254319651067006,1.0,3/11,5.38%,BCL2;ACO1;SNCA
prerank,CellMarker_Augmented_2021__Hematopoietic Stem cell:Tooth,-0.5002995358712994,-1.160384970029925,0.14864864864864866,1.0,1.0,20/69,13.10%,GMFG;HCK;DOCK8;CYTIP;ARHGAP9;TAGAP;ITM2A;ARHGAP15;DOCK2;GPR183;PARVG;FCGR3A;P2RY14;HLA-DPB1;TRAF3IP3;MYO1F;PTPRC;SPI1;TESPA1;HLA-DPA1
prerank,GO_Biological_Process_2021__IMP metabolic process (GO:0046040),0.6371212941069615,1.1603491770294556,0.22857142857142856,0.8249878423324576,1.0,3/9,4.74%,PNP;NT5C1A;AMPD1
prerank,GO_Biological_Process_2021__multi-ciliated epithelial cell differentiation (GO:1903251),0.7217567622387118,1.1603436374154348,0.28888888888888886,0.8244337873678287,1.0,2/6,9.19%,CEP152;CCDC78
prerank,Reactome_2022__Synthesis Of Bile Acids And Bile Salts Via 27-Hydroxycholesterol R-HSA-193807,0.6029772827303967,1.1601991201160433,0.3333333333333333,0.8244628728105913,1.0,4/13,7.00%,CYP7B1;AKR1C3;NCOA2;AKR1C1
prerank,CellMarker_Augmented_2021__Hepatoblast:Liver,-0.4762449482790171,-1.1601840837466275,0.21518987341772153,1.0,1.0,20/83,14.24%,ENPP2;OLFML1;ANGPTL2;GYPE;FILIP1L;OGN;SLCO2B1;ADAM33;MASP1;DCN;ASPN;ITGA9;PTPRC;ANGPTL1;COL6A6;TEK;A2M;COLEC12;C1S;TTN
prerank,"GO_Biological_Process_2021__regulation of mRNA splicing, via spliceosome (GO:0048024)",0.44294307023022866,1.1601580534644311,0.1875,0.8240102590168845,1.0,33/79,26.74%,NOVA1;TRA2A;PUF60;KHDRBS2;CELF5;CELF4;HNRNPL;NSRP1;RBFOX2;SFSWAP;SRSF4;RBFOX1;CELF2;SRRM4;PTBP1;PCBP4;KHDRBS1;METTL16;U2AF2;RBM25;SF3B4;FXR2;RBM24;ZBTB7A;KHDRBS3;SRPK2;RBM39;SF1;RBM8A;RBM11;SMU1;SON;NUP98
prerank,GO_Biological_Process_2021__ear morphogenesis (GO:0042471),-0.6065193227667524,-1.1600673970498685,0.296875,1.0,1.0,1/13,0.55%,TBX1
prerank,CellMarker_Augmented_2021__Common Myeloid progenitor:Undefined,0.7164766367654579,1.1599654780869366,0.3170731707317073,0.8243003137586349,1.0,1/6,0.51%,CD38
prerank,Reactome_2022__Synthesis Of 5-Eicosatetraenoic Acids R-HSA-2142688,-0.6756127724254021,-1.1599547128240988,0.40384615384615385,1.0,1.0,5/9,17.79%,ALOX5;PON3;PON1;GPX2;ALOX5AP
prerank,GO_Biological_Process_2021__actin-myosin filament sliding (GO:0033275),-0.5599755830544528,-1.1597769023732984,0.22535211267605634,1.0,1.0,7/26,8.67%,MYH4;MYH7;ACTC1;MYH8;MYBPC3;NEB;ACTN3
prerank,GO_Biological_Process_2021__muscle filament sliding (GO:0030049),-0.5599755830544528,-1.1597769023732984,0.22535211267605634,1.0,1.0,7/26,8.67%,MYH4;MYH7;ACTC1;MYH8;MYBPC3;NEB;ACTN3
prerank,Reactome_2022__FLT3 Signaling In Disease R-HSA-9682385,0.47674101135369146,1.1597654948519796,0.14705882352941177,0.824419620469338,1.0,11/26,25.64%,NOX4;STAT5B;FLT3;PIK3CA;GOLGB1;SOS1;TRIP11;MYO18A;LONP1;CBL;BCL2L1
prerank,GO_Biological_Process_2021__DNA synthesis involved in DNA repair (GO:0000731),-0.5387995109225348,-1.1596230084879524,0.24285714285714285,1.0,1.0,6/43,6.02%,DTL;SYCP1;PCLAF;RPA3;UBE2L6;TRIM25
prerank,CellMarker_Augmented_2021__Hematopoietic Stem cell:Germ,0.6338771872573389,1.1594615484412645,0.3783783783783784,0.8249593738690858,1.0,2/10,1.53%,CD38;KIT
prerank,GO_Biological_Process_2021__positive regulation of DNA repair (GO:0045739),0.45393941844707675,1.159301650178596,0.14285714285714285,0.8249279640358944,1.0,16/45,16.03%,EYA4;FGF10;BRCC3;HDAC10;SIRT1;ERCC8;RNF168;HMGB1;TIMELESS;SPIRE2;H2AX;SMCHD1;WRAP53;SPIDR;EYA3;MGMT
prerank,Reactome_2022__RUNX1 Regulates Transcription Of Genes Involved In Differentiation Of Myeloid Cells R-HSA-8939246,0.7536683658519847,1.1592220756440537,0.2619047619047619,0.8245765625978944,1.0,3/6,17.42%,CBFB;RUNX1;LGALS3
prerank,GO_Biological_Process_2021__protein O-linked glycosylation via threonine (GO:0018243),0.6613664426766133,1.1590438583889695,0.28205128205128205,0.8245254617090308,1.0,2/8,9.48%,GALNT1;GALNT13
prerank,GO_Biological_Process_2021__homotypic cell-cell adhesion (GO:0034109),-0.5268248698237096,-1.1589549527106018,0.2463768115942029,1.0,1.0,4/37,7.39%,CLIC1;P2RY12;GP1BA;ACTG1
prerank,CellMarker_Augmented_2021__Cancer Stem cell:Undefined,-0.4896341251101717,-1.1589108352964268,0.2857142857142857,1.0,1.0,6/94,4.49%,CD44;MPL;FOXM1;AMACR;SALL4;PROCR
prerank,Reactome_2022__Interactions Of Vpr With Host Cellular Proteins R-HSA-176033,0.4854833421683498,1.158786756459906,0.18421052631578946,0.8247640722689789,1.0,12/36,27.98%,NUP210;NUP42;AAAS;SGIP1;RANBP2;NUP214;TPR;SEH1L;NUP153;NUP98;BANF1;NUP37
prerank,GO_Biological_Process_2021__negative regulation of receptor signaling pathway via STAT (GO:1904893),0.6648811233083317,1.1587218412410119,0.3333333333333333,0.8244434265401175,1.0,4/8,23.79%,ADIPOR1;PTPRT;BCL3;NF2
prerank,CellMarker_Augmented_2021__Epithelial cell:Epithelium,-0.4955794707248175,-1.1586808514339118,0.19444444444444445,1.0,1.0,18/57,14.86%,C1QB;CYYR1;LYVE1;SLCO2B1;MS4A4A;CLDN5;ZNF366;VSIG4;SELP;ITGA9;VWF;GPIHBP1;FPR3;F13A1;TEK;A2M;GGT5;ADGRF5
prerank,Reactome_2022__APC:Cdc20 Mediated Degradation Of Cell Cycle Proteins Before Cycle Checkpoint Satisfied R-HSA-179419,-0.4865287399428956,-1.1586685672441908,0.2465753424657534,1.0,1.0,2/64,0.62%,NEK2;PSMB9
prerank,GO_Biological_Process_2021__regulation of keratinocyte apoptotic process (GO:1902172),-0.7351627023843799,-1.1585981685101285,0.3275862068965517,1.0,1.0,2/5,17.25%,SFRP4;ZFP36L1
prerank,Reactome_2022__Alpha-Linolenic (Omega3) And Linoleic (Omega6) Acid Metabolism R-HSA-2046104,-0.6623302331456238,-1.1585805545056036,0.3064516129032258,1.0,1.0,1/12,1.18%,ELOVL2
prerank,GO_Biological_Process_2021__cellular response to starvation (GO:0009267),0.4011342556785654,1.1584098132224194,0.21428571428571427,0.8249311331534211,1.0,15/134,9.32%,ATP6V0D2;FOXO1;TCIRG1;KPTN;MFSD2A;KLF10;SIRT1;AKR1C3;IFI16;RALB;EIF2AK3;MAPK8;MLST8;RNF152;FADS1
prerank,Reactome_2022__Defects Of Contact Activation System (CAS) And Kallikrein/Kinin System (KKS) R-HSA-9651496,-0.6795167696724522,-1.1584011156718257,0.208955223880597,1.0,1.0,4/12,10.59%,F8;GP1BA;FAM110A;VWF
prerank,GO_Biological_Process_2021__neuromuscular junction development (GO:0007528),0.5504242071997761,1.1582391970611503,0.28125,0.8248500290141123,1.0,11/24,17.09%,PPFIBP2;ZC4H2;CACNB4;PPFIBP1;GPHN;PDZRN3;F2R;UNC13B;CHRNA1;NEDD4;UNC13C
prerank,GO_Biological_Process_2021__gamma-aminobutyric acid transport (GO:0015812),-0.7783396712593698,-1.15815121402537,0.3225806451612903,1.0,1.0,1/5,8.18%,SLC6A12
prerank,Reactome_2022__PI3K Cascade R-HSA-109704,0.4794451821621718,1.158083326581576,0.13333333333333333,0.8248786049582337,1.0,9/36,10.67%,FGF10;THEM4;FGFR1;IRS1;FGF17;FGF18;AKT2;FGFR3;IRS2
prerank,Reactome_2022__Elastic Fibre Formation R-HSA-1566948,-0.520995103502858,-1.1580685135628925,0.22580645161290322,1.0,1.0,12/34,16.22%,TGFB1;LOX;VTN;FBN3;LOXL4;FBN2;ITGB6;MFAP5;ITGA5;TGFB3;FBLN2;ITGB5
prerank,KEGG_2021_Human__Ubiquitin mediated proteolysis,0.39143795940694687,1.1580654212734725,0.21428571428571427,0.824369601417049,1.0,41/128,25.48%,UBE2E3;MID1;ERCC8;RHOBTB1;UBE2J1;FANCL;PML;CBLB;WWP2;UBE2O;MAP3K1;UBE2E1;UBE2D4;ANAPC13;UBE2E2;UBE2A;SMURF1;CDC26;HERC2;UBE2QL1;UBE2Z;FBXO4;NEDD4;UBE2L3;UBE4B;ANAPC7;CDC34;UBE2J2;TRAF6;FZR1;UBE2D2;CUL1;UBR5;HERC1;PPIL2;CBL;UBE4A;ANAPC4;UBE2D3;CUL7;ANAPC2
prerank,GO_Biological_Process_2021__heterotypic cell-cell adhesion (GO:0034113),-0.5647827164205785,-1.15766493871467,0.2459016393442623,1.0,1.0,6/24,13.78%,PKP2;ITGB2;CTNNA3;RNASE10;IZUMO1;ITGA5
prerank,Reactome_2022__PPARA Activates Gene Expression R-HSA-1989781,0.40734905022628487,1.1576524041304102,0.18181818181818182,0.8252340784312612,1.0,27/102,18.84%,HDAC3;MED17;RORA;SMARCD3;PPARG;NCOA3;NCOA2;MED25;ABCA1;FHL2;ACADM;ACSL1;CPT1A;CHD9;CARM1;MED16;CDK8;NFYC;PPARGC1B;SULT2A1;NR1H3;MED13L;MED9;FAM120B;MIA3;ACOX1;EP300
prerank,Reactome_2022__Transcription Of E2F Targets Under Negative Control By P107 (RBL1) And P130 (RBL2) In Complex With HDAC1 R-HSA-1362300,0.5900847424469815,1.1576288488917517,0.1935483870967742,0.8247553388405932,1.0,6/15,21.88%,RBL1;LIN52;HDAC1;E2F5;RBBP4;TFDP1
prerank,GO_Biological_Process_2021__Golgi localization (GO:0051645),0.6243886800374765,1.1575927076572337,0.2702702702702703,0.8242673003844149,1.0,2/11,12.46%,TBCCD1;ARHGAP21
prerank,GO_Biological_Process_2021__regulation of T-helper 2 cell differentiation (GO:0045628),-0.7010046781530489,-1.1575253933060878,0.32075471698113206,1.0,1.0,6/7,28.50%,ANXA1;NLRP3;IL18;CD86;TNFSF4;RARA
prerank,GO_Biological_Process_2021__adenylate cyclase-inhibiting G protein-coupled acetylcholine receptor signaling pathway (GO:0007197),0.7007708502427163,1.15721702361334,0.3076923076923077,0.8249017792203154,1.0,2/8,3.50%,CHRM2;HRH3
prerank,Reactome_2022__Folding Of Actin By CCT/TriC R-HSA-390450,-0.6916739788735426,-1.1568827283776484,0.3148148148148148,1.0,1.0,5/9,29.23%,CCT6B;CCT6A;CCT8;CCT7;CCT2
prerank,GO_Biological_Process_2021__blood vessel endothelial cell proliferation involved in sprouting angiogenesis (GO:0002043),0.7263443816377235,1.1567456993779934,0.38461538461538464,0.8257834532208795,1.0,3/5,21.65%,SEMA5A;BMPER;BMP4
prerank,GO_Biological_Process_2021__insulin receptor signaling pathway (GO:0008286),0.4328072315517894,1.1566293985001077,0.21052631578947367,0.8257517886880943,1.0,13/64,14.95%,ATP6V0D2;FOXO1;SH2B2;TCIRG1;IRS1;FER;AKT2;IRS2;NAMPT;GAB1;IRS4;INSR;PIK3CA
prerank,GO_Biological_Process_2021__negative regulation of mRNA catabolic process (GO:1902373),-0.5619078786924242,-1.1565926033600678,0.3114754098360656,1.0,1.0,3/28,10.72%,TENT5B;MEIOC;SLC11A1
prerank,GO_Biological_Process_2021__Schwann cell differentiation (GO:0014037),0.7292824010536677,1.1565607122210741,0.275,0.8254427329971388,1.0,1/5,0.91%,ADGRG6
prerank,GO_Biological_Process_2021__L-serine metabolic process (GO:0006563),0.6041945396907185,1.1564598080203257,0.3541666666666667,0.8252232022877427,1.0,6/10,18.77%,PSAT1;SRR;CBS;PSPH;SERINC5;SHMT2
prerank,GO_Biological_Process_2021__negative regulation of response to external stimulus (GO:0032102),0.39049720799912424,1.1563435615207838,0.14285714285714285,0.8250930189309743,1.0,11/91,7.73%,GRID2;AOAH;RORA;APOE;CDH5;METRNL;PPARG;IFI16;SERPINE1;CRK;LRFN5
prerank,GO_Biological_Process_2021__selective autophagy (GO:0061912),0.4561093317193681,1.1562510850167644,0.22857142857142856,0.8248245661609622,1.0,13/55,22.73%,AUP1;IFT88;RAB7A;DYNC1I2;KLHL3;ARL13B;ATG2A;ATM;CALCOCO2;LGALS8;ATG2B;RETREG1;STING1
prerank,GO_Biological_Process_2021__positive regulation of dendritic cell differentiation (GO:2001200),0.7211813281197268,1.1561919948885995,0.3269230769230769,0.8244477644005319,1.0,4/5,17.42%,LGALS1;HMGB1;LGALS9;LGALS3
prerank,GO_Biological_Process_2021__histone lysine demethylation (GO:0070076),0.5502011998848028,1.1560955464284761,0.1875,0.8242195944309344,1.0,8/24,26.39%,KDM7A;KDM8;KDM2A;KDM3B;JMJD1C;KDM5B;KDM4C;PHF2
prerank,GO_Biological_Process_2021__positive regulation of phospholipase C activity (GO:0010863),0.4915156248377944,1.1559512128550073,0.16666666666666666,0.8241891076755367,1.0,3/34,2.37%,ADRA1A;KIT;FGFR1
prerank,CellMarker_Augmented_2021__Anterior Foregut Endoderm cell:Lung,-0.5126882077127572,-1.155889353714328,0.2236842105263158,1.0,1.0,25/66,20.22%,CLEC5A;C1QB;SP100;CPM;SLCO2B1;MS4A4A;FCGR3A;ZNF366;VSIG4;SOD2;IGSF6;TLR2;HSD11B1;FPR3;A2M;APOL6;SDS;ADAMDEC1;CPQ;CD302;CSF1R;TFEC;ITGAX;GPR34;CSF2RA
prerank,CellMarker_Augmented_2021__Alveolar Epithelial Progenitor cell:Embryonic Stem Cell,-0.5126882077127572,-1.155889353714328,0.2236842105263158,1.0,1.0,25/66,20.22%,CLEC5A;C1QB;SP100;CPM;SLCO2B1;MS4A4A;FCGR3A;ZNF366;VSIG4;SOD2;IGSF6;TLR2;HSD11B1;FPR3;A2M;APOL6;SDS;ADAMDEC1;CPQ;CD302;CSF1R;TFEC;ITGAX;GPR34;CSF2RA
prerank,Reactome_2022__TFAP2 (AP-2) Family Regulates Transcription Of Growth Factors And Their Receptors R-HSA-8866910,0.6005312744281418,1.1556927827710244,0.2564102564102564,0.8246616539301055,1.0,3/9,8.52%,KIT;ERBB2;TGFA
prerank,Reactome_2022__Negative Regulation Of NMDA Receptor-Mediated Neuronal Transmission R-HSA-9617324,0.534828334755794,1.1555909254130448,0.25,0.8244732184156705,1.0,2/21,2.58%,LLGL1;GPRIN1
prerank,CellMarker_Augmented_2021__Monocyte:Fetal Kidney,-0.41331842496596033,-1.1554344343049827,0.06818181818181818,1.0,1.0,114/646,17.23%,CD44;CLIC1;EPN1;LILRB3;RASGRP4;CLEC5A;HK2;AHR;GMFG;ITGB2;HCK;RIN3;LRPAP1;CYTIP;ASGR2;SLC7A7;PLD4;NLRP12;CYP1B1;SCIMP;ALOX5;TGFBI;RGL4;MAPKAPK3;TNFRSF1B;CPVL;DOCK2;PTAFR;VSTM1;HLA-DMA;PTGES;TRIM25;C3AR1;EIF1B;PARVG;FCGR3A;LTB4R;OSCAR;ICAM3;C19ORF38;HLA-A;WAS;LY86;CD37;ATXN7L3;NFAM1;SOD2;PSAP;ADGRE1;UPK3A;ANXA1;MYO1F;IGSF6;PTX3;PPT1;CFD;THBS1;CYBA;HLA-DRB1;PTPRC;FPR1;CD63;NLRC4;DNAJA1;SLC11A1;SPI1;GAS7;PYGL;GLRX;CLEC12A;ITGAM;ACP3;WARS1;SLC16A3;CDKN1A;STEAP4;CXCL16;PGAM1;TOMM7;SEC62;TLR2;HVCN1;COX17;NLRP3;CD300LF;SYTL1;GRINA;ADGRE3;PNRC1;OGFRL1;PSTPIP1;ATP6AP2;NDUFA2;LCP1;VDR;IFNGR2;DDX3X;NDUFA1;ACSL3;FMNL1;CD4;GRN;NDEL1;HK3;CMTM2;TM2D3;NAIP;ATOX1;RAC2;GABARAPL2;LITAF;VASP;RAC1;SCPEP1
prerank,CellMarker_Augmented_2021__Mesenchymal cell:Bone Marrow,0.4440608519210959,1.155302539717265,0.19047619047619047,0.8247085646053318,1.0,29/91,16.27%,FIBIN;EDIL3;LAMA4;MXRA5;CLMP;VEGFC;ARSJ;MRGPRF;PARVA;COL12A1;ADAMTS12;MMP2;SERPINE1;NTN4;EDNRA;SNAI2;CRIM1;RND3;COL16A1;PAMR1;SYNPO;EFEMP1;LTBP2;PRICKLE2;CDH11;ANTXR1;PLSCR4;CALD1;SGCB
prerank,GO_Biological_Process_2021__chondroitin sulfate biosynthetic process (GO:0030206),0.5641954338434709,1.1552342220166416,0.26666666666666666,0.8243530128142416,1.0,10/20,11.08%,VCAN;CSGALNACT1;CHSY3;CHSY1;CHST12;CHPF2;CHST11;CSPG5;CHST3;UGDH
prerank,GO_Biological_Process_2021__positive regulation of leukocyte proliferation (GO:0070665),-0.6867138167035584,-1.1550867168118821,0.3225806451612903,1.0,1.0,3/9,18.74%,IL12A;IL5RA;CSF1R
prerank,Reactome_2022__Unwinding Of DNA R-HSA-176974,-0.6974746373459115,-1.1550709782666104,0.328125,1.0,1.0,1/9,4.42%,MCM3
prerank,GO_Biological_Process_2021__nucleic acid transport (GO:0050657),0.6237995643625424,1.1550521421682323,0.3611111111111111,0.8244799252341387,1.0,5/9,27.15%,NXF5;RBFOX1;SIDT1;YBX1;ATXN2
prerank,GO_Biological_Process_2021__negative regulation of lipopolysaccharide-mediated signaling pathway (GO:0031665),-0.7516551571906536,-1.1550026232520563,0.40298507462686567,1.0,1.0,2/6,18.68%,CACTIN;CARD8
prerank,Reactome_2022__Class B/2 (Secretin Family Receptors) R-HSA-373080,-0.4786352104419251,-1.1549642287535813,0.22535211267605634,1.0,1.0,11/66,13.64%,C1QTNF1;WNT5A;WNT8B;SCTR;FZD8;ADGRE1;PTRH2;GNGT1;WNT8A;WNT6;ADGRE3
prerank,Reactome_2022__Drug ADME R-HSA-9748784,-0.4647059788828739,-1.1549447837034728,0.22580645161290322,1.0,1.0,14/56,14.77%,SLC28A2;SLC28A3;VAV3;SLCO2B1;PON3;GLYATL3;ABCG2;CYP3A4;SLC22A7;PON1;ABCB1;SLC22A3;GGT5;CYP2E1
prerank,CellMarker_Augmented_2021__T cell:Ascites,-0.5381641620047638,-1.1549361171078452,0.2714285714285714,1.0,1.0,18/46,16.70%,SIRPG;ITGB2;HCK;CYTIP;ARHGAP9;TAGAP;KLRB1;PARVG;FCGR3A;CD5;TRAF3IP3;MYO1F;PTPRC;PSTPIP1;IKZF1;CD4;HK3;TNFSF8
prerank,GO_Biological_Process_2021__striated muscle contraction (GO:0006941),-0.5452603223864716,-1.1548463024790772,0.22727272727272727,1.0,1.0,9/43,10.22%,SCN5A;MYH7;CASQ2;MYH8;STAC;MYBPC3;CSRP3;KCNQ1;LMOD3
prerank,Reactome_2022__Defective CHST3 Causes SEDCJD R-HSA-3595172,0.6222515364931673,1.1547093126579697,0.2647058823529412,0.8250293696597218,1.0,3/8,10.94%,VCAN;CSPG5;CHST3
prerank,GO_Biological_Process_2021__mammary gland epithelial cell differentiation (GO:0060644),0.6383049928420581,1.1546927771277713,0.28205128205128205,0.8245269513490836,1.0,3/7,9.44%,ZNF703;LATS1;AKT2
prerank,KEGG_2021_Human__GABAergic synapse,0.4537622433486941,1.154562215267209,0.23809523809523808,0.8244277018263952,1.0,11/79,11.15%,GABRE;SLC38A5;GABRA5;GABRR2;GABRG3;KCNJ6;ADCY2;GPHN;GABRG1;TRAK2;ADCY3
prerank,PanglaoDB_Augmented_2021__Spermatocytes,-0.5611584962002275,-1.154228827944246,0.2916666666666667,1.0,1.0,8/26,15.67%,BANF2;SYCP1;SLC25A31;TTC6;TNP1;WDR87;LYZL2;SYCP3
prerank,"GO_Biological_Process_2021__positive regulation of mRNA splicing, via spliceosome (GO:0048026)",0.5351062953544914,1.1536044956723173,0.28888888888888886,0.826781298965275,1.0,2/15,9.29%,TRA2A;CELF4
prerank,GO_Biological_Process_2021__fibroblast growth factor receptor signaling pathway (GO:0008543),0.43637032323092134,1.1533955578736523,0.2222222222222222,0.8270140530816223,1.0,16/64,14.24%,FGF10;FGFR1;FGF17;HNRNPF;TRIM71;HNRNPH1;ESRP1;FGF18;SPRED2;FGFR3;FLRT2;SPRED1;RBFOX2;TIAL1;ANOS1;GTF2F2
prerank,GO_Biological_Process_2021__regulation of response to interferon-gamma (GO:0060330),-0.6541871418212589,-1.1533286427259273,0.3188405797101449,1.0,1.0,3/11,16.62%,STAT1;IFNGR2;CDC37
prerank,CellMarker_Augmented_2021__FOXP3+ Natural Regulatory T (Treg) cell:Blood,-0.5192497086685711,-1.1532930087638154,0.18571428571428572,1.0,1.0,16/57,10.28%,SIRPG;GMFG;ITGB2;CYTIP;TBC1D10C;ARHGAP9;TAGAP;TNFRSF1B;ARHGAP15;GPR183;PARVG;CD5;CD37;TRAF3IP3;MYO1F;PTPRC
prerank,GO_Biological_Process_2021__regulation of humoral immune response (GO:0002920),-0.5335740019657227,-1.1532470848309988,0.2878787878787879,1.0,1.0,10/33,15.80%,C1QB;CXCL13;VTN;C3AR1;CPB2;CLU;C4BPA;C4BPB;C1S;ZP3
prerank,Reactome_2022__Insulin Receptor Signaling Cascade R-HSA-74751,0.4689093208111014,1.1532309241122503,0.2,0.826864379717178,1.0,12/44,14.95%,FGF10;THEM4;FGFR1;IRS1;FGF17;FGF18;AKT2;FGFR3;IRS2;FLT3;INSR;PIK3CA
prerank,CellMarker_Augmented_2021__Basal Progenitor cell:Breast,-0.4719054701132554,-1.153221681227882,0.24242424242424243,1.0,1.0,3/60,4.19%,CD44;MISP;CLDN1
prerank,Reactome_2022__Regulation Of TP53 Activity Thru Methylation R-HSA-6804760,0.5442454014783241,1.1531616404155796,0.2916666666666667,0.8265778198067766,1.0,8/18,23.33%,SMYD2;TP53;ATM;PRMT5;EP300;MDM4;TTC5;JMY
prerank,PanglaoDB_Augmented_2021__Cardiomyocytes,-0.47325508804155175,-1.153107686027058,0.1780821917808219,1.0,1.0,28/126,14.82%,NRAP;C14ORF180;LMOD1;MYH7;CASQ2;ACTC1;CAV3;CTNNA3;OBSCN;HAMP;MYBPC3;LOX;SLC5A1;KLHL38;TRDN;CSRP3;ART3;CKB;GPIHBP1;CKMT2;COX7A1;NEXN;DHRS7C;ASB5;RXRG;HEY2;TTN;GATA4
prerank,GO_Biological_Process_2021__lysine catabolic process (GO:0006554),0.6119323212457131,1.1530383899686902,0.3076923076923077,0.825868920489576,1.0,5/12,12.14%,HYKK;AASS;ALDH7A1;AADAT;OGDH
prerank,GO_Biological_Process_2021__lysine metabolic process (GO:0006553),0.6119323212457131,1.1530383899686902,0.3076923076923077,0.825868920489576,1.0,5/12,12.14%,HYKK;AASS;ALDH7A1;AADAT;OGDH
prerank,CellMarker_Augmented_2021__Mesenchymal Stem cell:White Adipose Tissue,-0.5121976767611749,-1.1525899222224676,0.2535211267605634,1.0,1.0,13/49,13.24%,C14ORF180;PLIN4;GSDMA;INMT;KCNA7;CPM;ATP1A4;USHBP1;CFD;SLC11A1;STEAP4;C1ORF167;MFAP5
prerank,Reactome_2022__Innate Immune System R-HSA-168249,-0.4081694142579682,-1.1523489809810419,0.07291666666666667,1.0,1.0,108/775,16.23%,CD44;NLRP4;PSMB9;RASGRP4;CLEC5A;C1QB;MGST1;GMFG;AIM2;ITGB2;HCK;TCN1;MMP9;TBC1D10C;FLG2;ARHGAP9;CHIT1;ATP6V1G2;PLD4;PRDX4;VAV3;ALOX5;MAPKAPK3;RAB44;TNFRSF1B;TEC;DOCK2;CLEC4C;PTAFR;UBE2L6;MUCL1;VTN;TRIM25;C3AR1;MASP1;GSDME;HRNR;OSCAR;ICAM3;NFKB2;PLAU;MUC5B;HLA-A;ACTG1;CEACAM1;WAS;LY86;ATP6V1C2;NFAM1;ATP6V1D;BPIFB1;CPB2;CLU;PTX3;SNAP23;C4BPA;CYBA;OLFM4;PTPRC;FPR1;ENPP4;CD63;NLRC4;PDAP1;SLC11A1;ATP6V0E2;CEACAM8;CTSZ;FTH1;PYGL;CLEC12A;ITGAM;SVIP;ACP3;HSPA8;MASP2;DEFB109B;TLR2;HVCN1;TXK;NLRC3;ORMDL3;NLRP3;DYNLL1;PIK3CB;ADGRE3;PSTPIP1;ATP6AP2;NCKIPSD;NDUFA2;POLR3H;C4BPB;MUC4;C1S;EEF2;MUC17;DDX3X;ITPR3;ITM2C;ATP6V1E1;TXNIP;SRP14;CD4;GRN;ELANE;TUBB;PSMA3;CYSTM1
prerank,GO_Biological_Process_2021__renal filtration (GO:0097205),-0.656159650216517,-1.1523095423514924,0.35,1.0,1.0,1/10,1.12%,JCHAIN
prerank,GO_Biological_Process_2021__RNA processing (GO:0006396),0.4039575427117281,1.1523038689022582,0.2608695652173913,0.8275185108897929,1.0,54/165,26.51%,SNRPN;NOVA1;ATXN1;TENT4A;HNRNPF;BICD1;RBMS1;HNRNPH1;KHSRP;SNRPB;U2AF1;SRRM1;HNRNPL;LIN28B;ELAVL4;ZMAT5;PPP1R9B;SF3B1;SRSF4;CELF2;SRRM4;PTBP1;FUS;NUFIP1;SYNCRIP;AURKAIP1;XRN2;U2AF2;SF3B4;TSEN2;RBM6;CPSF6;PIWIL2;TUT7;LSM6;ADAR;YJU2;NRDE2;PDCD7;PRPF18;MAGOHB;TCERG1;SNRNP48;SRPK2;SETX;RBM39;THOC1;SNRPF;SCAF11;LIN28A;RBM8A;SMU1;APOBEC1;SON
prerank,GO_Biological_Process_2021__negative regulation of platelet activation (GO:0010544),-0.6495039004899348,-1.1522138407277407,0.3225806451612903,1.0,1.0,3/14,7.40%,C1QTNF1;ALOX12;CEACAM1
prerank,GO_Biological_Process_2021__cellular glucose homeostasis (GO:0001678),0.4684803075070583,1.1521642030375432,0.2,0.8273396986200587,1.0,4/39,5.39%,GCK;FOXO1;SIRT1;ZBTB20
prerank,Reactome_2022__EPH-ephrin Mediated Repulsion Of Cells R-HSA-3928665,0.4485344239032253,1.1521436685425692,0.12,0.8268195312636719,1.0,5/45,8.43%,EFNB1;EPHA7;MMP2;EPHA3;EFNA5
prerank,Reactome_2022__Collagen Formation R-HSA-1474290,0.4277444004052708,1.152139351076765,0.23076923076923078,0.8262805354805794,1.0,22/84,13.19%,COL22A1;COL8A1;LAMA4;CD151;LOXL1;PCOLCE2;COL9A2;COL12A1;P3H3;P3H2;COLGALT1;PLOD3;COLGALT2;CTSV;PPIB;COL16A1;PLEC;TLL1;COL13A1;COL5A3;ITGB4;DST
prerank,GO_Biological_Process_2021__mononuclear cell differentiation (GO:1903131),0.537960689303963,1.1521341857859457,0.21212121212121213,0.8257617358752362,1.0,4/23,4.79%,MT1G;TRPM2;PPARG;IFI16
prerank,KEGG_2021_Human__Propanoate metabolism,0.4857624342180962,1.1521197376013916,0.25,0.8252630930019824,1.0,11/32,22.55%,ACADS;ACSS2;ACACB;ECHS1;ECHDC1;PCCA;ACOX1;HIBCH;BCKDHB;ACOX3;DBT
prerank,PanglaoDB_Augmented_2021__Goblet Cells,-0.4915622841164332,-1.152115510532606,0.2328767123287671,1.0,1.0,22/60,19.93%,AQP3;CLCA1;MISP;CAPN8;SMIM22;TMC4;BACE2;PLA2G10;MUC5B;MS4A8;SPINK4;MUC4;GPX2;MUC17;TJP3;USH1C;SCNN1A;LGALS4;CAPN13;FAM3D;ACE2;CBLC
prerank,"Reactome_2022__Defective EXT1 Causes Exostoses 1, TRPS2 And CHDS R-HSA-3656253",0.6102046960463843,1.1520389389506998,0.3157894736842105,0.8249403158133451,1.0,6/12,11.20%,GPC4;SDC4;EXT1;GPC6;GPC5;SDC3
prerank,CellMarker_Augmented_2021__Myoepithelial cell:Parotid Gland,0.42131772523448935,1.1520122464290106,0.13043478260869565,0.8244623113322158,1.0,15/95,9.44%,COL22A1;FIBIN;MEGF10;GPC4;MXRA5;SNCAIP;MMP2;PTPRZ1;SLIT2;EDNRA;PDLIM4;EFS;DOK5;SYNDIG1;PDZRN3
prerank,Reactome_2022__Transcriptional Regulation By MECP2 R-HSA-8986944,0.4092308319896997,1.1518452560243668,0.125,0.8245098954303514,1.0,20/57,22.31%,HDAC3;GPRIN1;TRPC3;PPARG;SGK1;MOV10;TNRC6C;DGCR8;HDAC1;RBFOX1;MECP2;TNRC6A;NOTCH1;AGO3;OPRK1;CREB1;AGO2;TBL1X;PTEN;GAMT
prerank,GO_Biological_Process_2021__regulation of macrophage cytokine production (GO:0010935),-0.6535560203272094,-1.151529785846788,0.36666666666666664,1.0,1.0,2/12,2.54%,TGFB1;WNT5A
prerank,GO_Biological_Process_2021__membrane raft organization (GO:0031579),-0.6100248528159702,-1.1514044127525174,0.30158730158730157,1.0,1.0,2/15,9.22%,CAV3;PPT1
prerank,Reactome_2022__Kinesins R-HSA-983189,0.5011169100694876,1.1512944970628933,0.24324324324324326,0.8258106921546455,1.0,9/40,21.22%,KIFC1;KIFC2;KIF6;KIF4B;KIF21B;KIF3B;KIF21A;KIF16B;KIF27
prerank,GO_Biological_Process_2021__base conversion or substitution editing (GO:0016553),-0.6426547153934212,-1.1512466031477153,0.2711864406779661,1.0,1.0,1/12,3.14%,ADAD2
prerank,GO_Biological_Process_2021__regulation of triglyceride catabolic process (GO:0010896),0.6878013947830389,1.1512269624773146,0.2708333333333333,0.8255466514575319,1.0,2/7,16.95%,PLIN5;GPLD1
prerank,GO_Biological_Process_2021__rRNA-containing ribonucleoprotein complex export from nucleus (GO:0071428),-0.6989020365493295,-1.1511980741713626,0.3157894736842105,1.0,1.0,1/7,5.98%,EIF6
prerank,GO_Biological_Process_2021__cellular response to superoxide (GO:0071451),-0.7528976434761839,-1.1509608969529006,0.26666666666666666,1.0,1.0,2/6,20.44%,SOD2;PRDX1
prerank,GO_Biological_Process_2021__glutathione biosynthetic process (GO:0006750),0.6241060262737008,1.1509591283933969,0.36585365853658536,0.8259233317355116,1.0,1/9,6.86%,CHAC1
prerank,GO_Biological_Process_2021__regulation of postsynaptic neurotransmitter receptor activity (GO:0098962),0.6301039303127912,1.150878247082118,0.3125,0.8255722925329275,1.0,2/10,10.32%,DLGAP4;AKAP9
prerank,GO_Biological_Process_2021__transport along microtubule (GO:0010970),0.6371880124545064,1.1507522261865253,0.3142857142857143,0.8255802430920417,1.0,5/13,21.29%,DYNC1I2;APBA1;ARHGAP21;CLIP3;CAMSAP3
prerank,GO_Biological_Process_2021__regulation of cellular amino acid metabolic process (GO:0006521),-0.49774986989024195,-1.1506248740895444,0.24285714285714285,1.0,1.0,4/46,8.70%,PSMB9;BHMT;NQO1;AZIN1
prerank,GO_Biological_Process_2021__regulation of posttranscriptional gene silencing (GO:0060147),0.4778120187322396,1.1505888618936388,0.12903225806451613,0.8250541677166351,1.0,12/51,23.62%,NUP210;NUP42;TRIM71;AAAS;TNRC6A;RANBP2;AGO2;IPO8;NUP214;POLR2F;TPR;SEH1L
prerank,GO_Biological_Process_2021__regulation of gene silencing by RNA (GO:0060966),0.4778120187322396,1.1505888618936388,0.12903225806451613,0.8250541677166351,1.0,12/51,23.62%,NUP210;NUP42;TRIM71;AAAS;TNRC6A;RANBP2;AGO2;IPO8;NUP214;POLR2F;TPR;SEH1L
prerank,GO_Biological_Process_2021__positive regulation of meiotic nuclear division (GO:0045836),-0.7207809610140468,-1.1505686922014888,0.29508196721311475,1.0,1.0,2/7,16.66%,STRA8;PRDM7
prerank,Reactome_2022__Respiratory Electron Transport R-HSA-611105,-0.481969135373552,-1.1505271714234175,0.18666666666666668,1.0,1.0,18/77,22.86%,COX6A1;TMEM186;NDUFS2;COX6C;NDUFA2;NDUFB4;NDUFC1;COX7C;ETFB;NDUFA1;NDUFB9;COX20;COX4I1;NDUFB10;NDUFS5;NDUFB11;NDUFAF5;CCNI
prerank,Reactome_2022__Highly Sodium Permeable Postsynaptic Acetylcholine Nicotinic Receptors R-HSA-629587,-0.7182742729683698,-1.1503008337106724,0.4230769230769231,1.0,1.0,4/6,25.02%,CHRNE;CHRNG;CHRNA3;CHRNB2
prerank,GO_Biological_Process_2021__meiotic sister chromatid segregation (GO:0045144),0.7382180254294342,1.1501528266326804,0.28888888888888886,0.8260489149650551,1.0,1/5,10.60%,SGO2
prerank,Reactome_2022__Nectin/Necl Trans Heterodimerization R-HSA-420597,0.6626697985885605,1.1500539883643057,0.32558139534883723,0.8258439049435913,1.0,4/6,29.42%,CADM1;NECTIN3;PVR;CADM3
prerank,GO_Biological_Process_2021__miRNA loading onto RISC involved in gene silencing by miRNA (GO:0035280),0.6755434487225943,1.1500354442390128,0.36585365853658536,0.8253976881784594,1.0,4/7,21.64%,AGO3;TARBP2;AGO2;ADAR
prerank,CellMarker_Augmented_2021__Villous cytotrophoblast:Placenta,-0.4729256878184736,-1.1499524594625958,0.15789473684210525,1.0,1.0,18/94,19.75%,TICRR;MCM2;TRAIP;MCM3;CDC25A;NUF2;CHAF1A;INCENP;CCNF;TUBB;PAICS;CDCA8;CDC6;RAD54L;BUB1B;STMN1;RECQL4;SET
prerank,PanglaoDB_Augmented_2021__Neuroblasts,0.4336825968137833,1.149950452635737,0.17391304347826086,0.8250582260653041,1.0,29/124,16.89%,GRID2;POU6F2;EPHA7;POU3F2;IGDCC3;UNC5D;ELAVL3;SIRT1;PROKR2;PAK5;SLC35F1;ERC2;CASKIN1;B4GALNT4;CSPG5;RIMS4;RHBDL3;PRR36;FBLL1;ASCL1;SNAP91;LRP8;MPP2;MSI1;SCRT1;NCAM1;EFNA2;MAGEL2;PBX1
prerank,GO_Biological_Process_2021__proton transmembrane transport (GO:1902600),-0.558631970219678,-1.1498376550548912,0.25757575757575757,1.0,1.0,11/27,26.90%,ATP1A4;ATP6V0E2;UCP1;HVCN1;ATP4A;NNT;ATP1A1;ATP6V0D1;SLC46A1;SLC36A3;DMAC2L
prerank,CellMarker_Augmented_2021__Macrophage:Undefined,-0.5946638956633337,-1.1497827709933552,0.25,1.0,1.0,12/19,22.37%,FCGR3A;ADGRE1;CD63;ITGAM;ENG;TLR2;CD80;CSF1R;ITGAX;CD86;TNFSF18;LAMP2
prerank,GO_Biological_Process_2021__negative regulation by host of viral transcription (GO:0043922),-0.627975012173139,-1.149609759344036,0.328125,1.0,1.0,2/11,9.69%,POU2F3;REST
prerank,Reactome_2022__MET Promotes Cell Motility R-HSA-8875878,0.4919963917712097,1.149487684011541,0.1875,0.8259925268461686,1.0,6/27,15.84%,LAMA4;CRK;RAPGEF1;ITGA3;RAP1A;CRKL
prerank,GO_Biological_Process_2021__positive regulation of cardiac muscle tissue growth (GO:0055023),0.5947096306732583,1.149067682552827,0.32432432432432434,0.8268485021330404,1.0,8/13,28.25%,NOTCH1;RBPJ;BMPR1A;AKAP6;EDN1;ZFPM2;TGFBR3;MEF2C
prerank,GO_Biological_Process_2021__response to UV-B (GO:0010224),-0.6780138186192028,-1.1490203495463012,0.35,1.0,1.0,3/9,14.93%,CDKN1A;IL12A;HYAL1
prerank,CellMarker_Augmented_2021__Epithelial Hair Follicle Stem cell:Hair Follicle,0.4295683628275252,1.1489967336678364,0.1388888888888889,0.8266340033107394,1.0,5/64,8.43%,ADGRF4;PERP;ERBB2;DSP;ESRP1
prerank,"KEGG_2021_Human__Valine, leucine and isoleucine degradation",0.501786654550405,1.1489170266412652,0.2,0.8263042471846881,1.0,16/45,23.72%,ACADS;ALDH7A1;BCAT1;ECHS1;ACADM;HIBADH;PCCA;HIBCH;AGXT2;BCKDHB;HADHB;MCCC1;ALDH1B1;IL4I1;DBT;HMGCLL1
prerank,PanglaoDB_Augmented_2021__Microglia,-0.47285659591681606,-1.1487130558617462,0.2638888888888889,1.0,1.0,25/94,11.77%,C1QB;IL21R;ITGB2;HCK;P2RY12;TAGAP;TNFRSF1B;PTAFR;SLCO2B1;C3AR1;GPR183;MS4A4A;PARVG;FCGR3A;LY86;VSIG4;NFAM1;MYO1F;IGSF6;P2RY6;PTPRC;FPR1;SPI1;CLEC12A;ITGAM
prerank,GO_Biological_Process_2021__acylglycerol homeostasis (GO:0055090),0.5658655010144291,1.1486669281184199,0.29545454545454547,0.8263982650910386,1.0,7/18,15.39%,LIPC;RORA;APOE;LPL;MLXIPL;ACSM2A;NR1H3
prerank,Reactome_2022__Regulation Of IFNG Signaling R-HSA-877312,-0.6695814238958927,-1.1486501296573774,0.2857142857142857,1.0,1.0,2/11,14.87%,STAT1;IFNGR2
prerank,CellMarker_Augmented_2021__Basal cell:Lung,-0.5023262014546813,-1.1485500701366822,0.2463768115942029,1.0,1.0,8/65,9.75%,CLCA2;AQP3;CLCA4;CLDN1;SERPINB5;CCND2;FAT2;LOXL4
prerank,Reactome_2022__RHOT1 GTPase Cycle R-HSA-9013425,0.6879040300625454,1.1483858215367104,0.3409090909090909,0.8267229318788368,1.0,4/5,28.22%,TRAK2;RAP1GDS1;MYO19;TRAK1
prerank,GO_Biological_Process_2021__transcription elongation from RNA polymerase II promoter (GO:0006368),0.44769831342303357,1.1483498102891156,0.17647058823529413,0.8263841447760166,1.0,19/62,31.71%,ELOF1;IWS1;ELP4;ELOA;CCNH;MLLT3;GTF2F2;SETD2;ERCC3;POLR2F;PCID2;CDK13;SSRP1;LEO1;ERCC2;AFF4;CDC73;CCNT1;POLR2C
prerank,KEGG_2021_Human__Autophagy,0.3996387803523857,1.148101351308867,0.13636363636363635,0.8265163426125643,1.0,43/128,26.43%,BCL2;CFLAR;IRS1;DAPK2;RAB7A;RRAS2;DEPTOR;HMGB1;EIF2AK3;MAPK8;MLST8;AKT2;ERN1;IRS2;TANK;IRS4;PIK3CA;ATG2A;NRBF2;MTMR3;ATG16L2;MTMR14;VAMP8;PRKAA2;IGBP1;TRAF6;RAF1;HIF1A;RUBCN;PIK3R4;ATG2B;PTEN;RRAGD;ATG12;VMP1;PRKCD;ATG4C;PIK3CD;PRKACB;BCL2L1;RPS6KB1;AKT3;AMBRA1
prerank,GO_Biological_Process_2021__protein localization to basolateral plasma membrane (GO:1903361),0.7396941988178589,1.1476029255831397,0.3181818181818182,0.8274353168421564,1.0,3/7,20.61%,PDZD11;RAB10;LIN7A
prerank,GO_Biological_Process_2021__regulation of interleukin-1 production (GO:0032652),-0.6454028262913714,-1.1474712288845894,0.36666666666666664,1.0,1.0,3/10,8.67%,NLRP12;CEACAM1;ANXA1
prerank,Reactome_2022__Cobalamin (Cbl) Metabolism R-HSA-9759218,0.6733764007652493,1.147468113437668,0.34146341463414637,0.8273556748570341,1.0,3/6,30.60%,MTR;MMAB;MMADHC
prerank,GO_Biological_Process_2021__inhibition of cysteine-type endopeptidase activity (GO:0097340),-0.6783042034918676,-1.1474136577084626,0.390625,1.0,1.0,2/6,29.51%,CARD8;BCL2L12
prerank,GO_Biological_Process_2021__positive regulation of activin receptor signaling pathway (GO:0032927),-0.7566904111596406,-1.1471621824644964,0.3333333333333333,1.0,1.0,1/5,1.82%,NODAL
prerank,GO_Biological_Process_2021__oligosaccharide metabolic process (GO:0009311),0.4728693080597898,1.1471092420414675,0.23529411764705882,0.8281675033097287,1.0,11/39,19.09%,ST6GALNAC3;GLA;ST6GAL2;ST8SIA4;ST3GAL3;NEU4;FUT9;ST3GAL6;NEU3;ST8SIA3;ST3GAL2
prerank,GO_Biological_Process_2021__positive regulation of neuroinflammatory response (GO:0150078),-0.7513410992611447,-1.1470400568556052,0.33962264150943394,1.0,1.0,2/6,15.16%,TAFA3;IL18
prerank,GO_Biological_Process_2021__adiponectin-activated signaling pathway (GO:0033211),0.7130638417435148,1.1470392703883523,0.3333333333333333,0.8277714050290895,1.0,3/5,20.03%,ADIPOR1;ADIPOR2;APPL2
prerank,GO_Biological_Process_2021__cellular response to fatty acid (GO:0071398),0.6334554489629732,1.1470253508285702,0.3125,0.8272800901714622,1.0,5/11,9.91%,IRS1;PID1;AKR1C3;AKR1C1;LPL
prerank,GO_Biological_Process_2021__placenta development (GO:0001890),-0.687848488009973,-1.1468717078321191,0.3050847457627119,1.0,1.0,2/10,5.98%,NODAL;PLAC1
prerank,GO_Biological_Process_2021__positive regulation of epithelial cell migration (GO:0010634),-0.4675985091769075,-1.1467900331473344,0.21518987341772153,1.0,1.0,16/85,17.46%,ENPP2;MMP9;WNT5A;RAB11A;FLT4;THBS1;VIL1;PIK3CB;TEK;ZNF580;HYAL1;RRAS;AGT;GRN;RAC1;PIK3CG
prerank,GO_Biological_Process_2021__regulation of cellular pH (GO:0030641),-0.5476978059012533,-1.146780879754172,0.29508196721311475,1.0,1.0,6/28,11.58%,ATP1A4;ATP6AP1;SLC9A2;LACC1;SLC9C1;SLC9B1
prerank,PanglaoDB_Augmented_2021__Enteric Neurons,0.3768777454830118,1.1466673359042705,0.24,0.8278321217520752,1.0,34/154,16.14%,PCDH17;NOVA1;PARVA;LRRC4C;ELAVL3;CADM2;PCLO;PAK5;TOX;NMU;KCNIP1;FSTL5;ADGRA1;EFNA5;HIVEP3;TAFA1;GUCY1A2;BRINP1;RGS7BP;ELAVL4;OLFM3;RET;SCN7A;GOLGA7B;SNAP91;MAP6;RBFOX1;ASXL3;SCRT1;ANK2;PIK3CA;NRXN1;TAFA5;SLC7A14
prerank,GO_Biological_Process_2021__regulation of cellular response to oxidative stress (GO:1900407),-0.6519174782596262,-1.146659592713838,0.375,1.0,1.0,2/9,5.61%,ALOX5;PINK1
prerank,GO_Biological_Process_2021__anoikis (GO:0043276),0.6826257418922955,1.146620257049017,0.34146341463414637,0.8274369970665796,1.0,2/8,14.95%,DAPK2;PIK3CA
prerank,Reactome_2022__Beta Oxidation Of octanoyl-CoA To hexanoyl-CoA R-HSA-77348,0.7430876650594446,1.1466188094836363,0.2857142857142857,0.826908620950956,1.0,3/5,19.84%,ECHS1;ACADM;HADHB
prerank,GO_Biological_Process_2021__plasma membrane phospholipid scrambling (GO:0017121),0.7571980110038512,1.1466056988246518,0.3541666666666667,0.8264095629362573,1.0,3/6,15.31%,ANO7;PLSCR1;PLSCR4
prerank,GO_Biological_Process_2021__regulation of viral entry into host cell (GO:0046596),-0.5494762166009258,-1.1466042208828218,0.22950819672131148,1.0,1.0,6/27,10.21%,TRIM62;TRIM5;CIITA;TRIM25;PTX3;HLA-DRB1
prerank,GO_Biological_Process_2021__protein-DNA covalent cross-linking repair (GO:0106300),-0.7702761335465833,-1.1464430180440703,0.3728813559322034,1.0,1.0,1/5,2.90%,TRAIP
prerank,GO_Biological_Process_2021__kidney epithelium development (GO:0072073),0.6469637453577337,1.146147087883712,0.3269230769230769,0.8271229523623946,1.0,1/6,6.85%,OSR1
prerank,GO_Biological_Process_2021__regulation of hair cycle (GO:0042634),0.6552640474719518,1.1460220340043967,0.35135135135135137,0.8269867518804649,1.0,2/8,6.07%,TSKU;HPSE
prerank,KEGG_2021_Human__Basal cell carcinoma,-0.5198766196395967,-1.1455145156505666,0.26153846153846155,1.0,1.0,12/55,16.93%,TCF7;WNT5A;WNT8B;HHIP;FZD8;TCF7L1;WNT8A;CDKN1A;WNT6;LEF1;GLI3;WNT10A
prerank,GO_Biological_Process_2021__purine ribonucleoside catabolic process (GO:0046130),0.7309080715318372,1.1454612633570433,0.26666666666666666,0.8283850006175827,1.0,1/5,0.17%,PNP
prerank,CellMarker_Augmented_2021__Intestinal Stem cell:Intestinal Crypt,-0.4899293133087899,-1.145414326835535,0.1891891891891892,1.0,1.0,17/71,12.14%,CD44;CLCA2;AHR;MISP;CLDN1;TGFBI;BACE2;SH2D4A;PLAU;SERPINB5;ANXA1;OSMR;THBS1;GPR39;LAMC2;AHNAK2;ITGB6
prerank,"Reactome_2022__Tristetraprolin (TTP, ZFP36) Binds And Destabilizes mRNA R-HSA-450513",0.5608533055189844,1.1453258098704082,0.32,0.8283053117693544,1.0,7/16,26.76%,MAPKAPK2;EXOSC1;DIS3;EXOSC5;DCP1A;EXOSC9;XRN1
prerank,GO_Biological_Process_2021__regulation of protein localization to cilium (GO:1903564),0.7368469437416741,1.1452210599693962,0.3235294117647059,0.8281591015364066,1.0,2/5,13.07%,CROCC;CCDC88A
prerank,GO_Biological_Process_2021__regulation of respiratory burst (GO:0060263),-0.6944349312377331,-1.1451313471150126,0.37254901960784315,1.0,1.0,3/7,17.19%,JCHAIN;RAC2;RAC1
prerank,GO_Biological_Process_2021__sinoatrial node development (GO:0003163),0.7080120135629432,1.1449466579930696,0.3488372093023256,0.8284696286277794,1.0,1/6,1.92%,GJB6
prerank,GO_Biological_Process_2021__RNA transport (GO:0050658),0.4529075788017263,1.1449464809207461,0.17647058823529413,0.8279432819768087,1.0,23/65,27.93%,ARC;NXF5;NXF1;U2AF1;SRRM1;SRSF4;RBFOX1;PNPT1;XPO5;SIDT1;EIF4A3;U2AF2;EIF4E;NUP214;TPR;MAGOHB;YBX1;THOC1;NUP153;RBM8A;ATXN2;TST;DDX39A
prerank,GO_Biological_Process_2021__positive regulation of cholesterol efflux (GO:0010875),0.4944537481921072,1.1449095991845462,0.19444444444444445,0.8274556013422567,1.0,3/20,4.59%,APOE;PPARG;SIRT1
prerank,GO_Biological_Process_2021__positive regulation of cell differentiation (GO:0045597),0.4249271313185271,1.1448375693037764,0.18181818181818182,0.8271394204746959,1.0,40/203,14.49%,BAMBI;VWC2;NGF;CCN4;TGFBR1;NEUROD2;FGFR1;APOB;CCN2;BRINP3;RIN2;CCN1;SMYD1;PPARG;WNT4;ZC4H2;DLX1;ZNF703;ABL1;PLCB1;ZEB1;BEND6;TWIST1;KITLG;LPL;BNIP2;BRINP1;RPS6KA3;SP7;BCL9L;GDF6;RAP1A;CDH2;ASCL1;CARM1;SMAD2;NFKB1;SUCO;SOX5;WWTR1
prerank,KEGG_2021_Human__Inositol phosphate metabolism,0.43231303107468516,1.1445535551690982,0.22857142857142856,0.8274213444340319,1.0,18/72,20.89%,PLCH1;PI4KB;ITPKB;PIK3C2B;PLCB1;MTMR8;INPP1;PI4K2B;PLCH2;PIK3CA;MTMR3;PIP4K2A;MTMR14;ITPK1;MTMR1;MTM1;IPPK;PLCG2
prerank,GO_Biological_Process_2021__response to angiotensin (GO:1990776),0.7004050192176228,1.1442689161909831,0.34782608695652173,0.8276934297250801,1.0,5/6,29.31%,SLC30A10;NFKB1;PRKCD;ROCK1;RELA
prerank,GO_Biological_Process_2021__positive regulation of NLRP3 inflammasome complex assembly (GO:1900227),-0.7663783660196253,-1.1442549794864696,0.3125,1.0,1.0,2/5,14.99%,USP50;DDX3X
prerank,Reactome_2022__Nucleotide Biosynthesis R-HSA-8956320,-0.6626731193136927,-1.1442510324150887,0.30303030303030304,1.0,1.0,1/11,1.23%,ADSS1
prerank,GO_Biological_Process_2021__V(D)J recombination (GO:0033151),0.5854191683424247,1.1441959012557912,0.2894736842105263,0.827396649652642,1.0,5/11,31.05%,HMGB1;LIG4;DCAF1;LIG3;RAG2
prerank,Reactome_2022__Intra-Golgi Traffic R-HSA-6811438,0.4676488018073499,1.1440078013787445,0.20689655172413793,0.8274222031003834,1.0,17/39,24.23%,GOLIM4;STX5;STX6;MAN1A2;MAN2A1;MAN1A1;VTI1A;COG7;CUX1;COG5;COG4;CYTH1;TRIP11;COG2;VPS45;COG3;CYTH3
prerank,GO_Biological_Process_2021__negative regulation of signaling receptor activity (GO:2000272),0.5328348109382873,1.1436678424830498,0.2413793103448276,0.8280439158418538,1.0,9/22,23.99%,PPARG;CBLB;CHMP6;GPRC5A;EPHB2;ZFYVE28;SOCS4;TSG101;CBL
prerank,GO_Biological_Process_2021__regulation of endothelial cell apoptotic process (GO:2000351),0.5084203487470937,1.1436040314446714,0.22857142857142856,0.8276907327544121,1.0,6/26,5.25%,ANGPT1;CDH5;SEMA5A;ITGA4;AKR1C3;SERPINE1
prerank,Reactome_2022__Ligand-receptor Interactions R-HSA-5632681,-0.7191160643454777,-1.1435528035890132,0.27692307692307694,1.0,1.0,1/6,2.89%,HHIP
prerank,GO_Biological_Process_2021__negative regulation of Ras protein signal transduction (GO:0046580),0.47119747295917075,1.143231538291671,0.2,0.8283209417785753,1.0,16/32,27.24%,LZTR1;ABL2;ITGA3;KANK1;ARHGAP35;SPRY4;EPHB2;CCDC125;STAMBP;RASIP1;SPRY1;SCAI;SPRY3;ARHGAP44;DLC1;SPRY2
prerank,Reactome_2022__Retinoid Metabolism And Transport R-HSA-975634,0.46100023544386787,1.1432158688551273,0.2564102564102564,0.8278357936351276,1.0,11/34,11.20%,GPC4;APOB;APOE;SDC4;GPC6;AKR1C3;AKR1C1;GPC5;LPL;LDLR;SDC3
prerank,Reactome_2022__Regulation Of FOXO Transcriptional Activity By Acetylation R-HSA-9617629,0.6126416965026503,1.143185426573203,0.3076923076923077,0.827407894526458,1.0,2/10,4.59%,FOXO1;SIRT1
prerank,GO_Biological_Process_2021__negative regulation of nervous system development (GO:0051961),0.5393195950830106,1.1431769573446515,0.2619047619047619,0.8269050668131871,1.0,7/15,20.03%,PCM1;ROBO2;WNT3A;ELAPOR2;NOTCH1;PAX6;APPL2
prerank,GO_Biological_Process_2021__retrograde axonal transport (GO:0008090),0.5430061666005658,1.1431711322277145,0.2702702702702703,0.826412300363978,1.0,3/16,17.56%,MGARP;DST;DLG2
prerank,Reactome_2022__Toll Like Receptor 4 (TLR4) Cascade R-HSA-166016,0.37336227396069377,1.1430408209963976,0.10344827586206896,0.8263252852185418,1.0,37/121,21.90%,DUSP4;MAPKAPK2;RIPK2;KCNH8;SARM1;HMGB1;MAPK8;MAP3K1;ALPK1;RPS6KA3;N4BP1;PPP2R1B;TICAM1;TANK;FADD;NKIRAS2;TAB3;PELI1;NFKB1;RPS6KA2;PELI2;IRAK4;TP53;LBP;MAP2K7;PPP2R5D;S100B;TAB1;CREB1;TAB2;MAP2K6;TRAF6;FOS;PLCG2;UBE2D2;CUL1;DUSP6
prerank,Reactome_2022__Citric Acid (TCA) Cycle And Respiratory Electron Transport R-HSA-1428517,-0.4520741214234309,-1.1430230569336999,0.23170731707317074,1.0,1.0,39/141,24.93%,COX6A1;TMEM186;SLC16A8;ATP5F1E;PLPP6;LDHAL6A;NDUFS2;COX6C;PDHX;ATP5MC3;UCP1;SLC16A3;ATP5PF;VDAC1;NDUFA2;NDUFB4;NDUFC1;COX7C;ETFB;NDUFA1;NDUFB9;ATP5ME;COX20;IDH3G;COX4I1;NNT;LDHB;NDUFB10;NDUFS5;ATP5PB;NDUFB11;NDUFAF5;ATP5F1A;CCNI;LDHD;LDHC;PDK4;NDUFB2;PDK3
prerank,GO_Biological_Process_2021__synaptic vesicle transport (GO:0048489),0.684597796845905,1.1429044148475442,0.26666666666666666,0.8262195481656244,1.0,1/11,0.97%,RAB27A
prerank,GO_Biological_Process_2021__alpha-amino acid metabolic process (GO:1901605),0.4878404671176877,1.142868913095004,0.3,0.8258222405367857,1.0,14/42,15.11%,NOX4;NAALAD2;DDAH2;SRR;CBS;KYAT1;RIMKLB;GLUD1;ALDH18A1;AADAT;DDAH1;SLC25A12;MTHFR;THAP4
prerank,GO_Biological_Process_2021__ADP transport (GO:0015866),0.7403086982664674,1.1427694086190787,0.3333333333333333,0.8256981448273686,1.0,3/5,19.08%,SLC25A42;SLC17A9;SLC25A41
prerank,GO_Biological_Process_2021__positive regulation of glycoprotein biosynthetic process (GO:0010560),0.5963604281086419,1.1426780431075774,0.3695652173913043,0.8253298577578979,1.0,2/9,7.70%,SOAT1;PLCB1
prerank,CellMarker_Augmented_2021__Cancer Stem-Like cell:Endometrium,-0.4841822258392111,-1.1425680012940578,0.26666666666666666,1.0,1.0,15/68,10.28%,DENND1C;CYTIP;ARHGAP9;TAGAP;ITM2A;PDE6B;KLRB1;VAV3;ALOX5;PARVG;INPP5D;KCNQ1;HLA-DPB1;HLA-DRB1;PTPRC
prerank,GO_Biological_Process_2021__positive regulation of isotype switching (GO:0045830),-0.5943966058741571,-1.1425650833708931,0.28125,1.0,1.0,2/14,5.44%,TGFB1;CLCF1
prerank,GO_Biological_Process_2021__cytoplasmic pattern recognition receptor signaling pathway in response to virus (GO:0039528),-0.743831560700898,-1.142545856256504,0.3333333333333333,1.0,1.0,1/7,6.02%,TRIM25
prerank,GO_Biological_Process_2021__positive regulation of smooth muscle cell differentiation (GO:0051152),0.6786180102865983,1.1423911444403123,0.358974358974359,0.8256382622516253,1.0,2/5,6.59%,KIT;OLFM2
prerank,GO_Biological_Process_2021__positive regulation of multicellular organismal process (GO:0051240),0.36101339367616114,1.1420624430196582,0.17647058823529413,0.8262090928237187,1.0,37/258,12.18%,ADRA1A;GPR3;ADRA1B;BAMBI;ESRRG;PER2;ELOVL6;TSKU;TGFBR1;HDAC3;APOE;NLGN1;ZBTB7B;SIRT1;IFI16;CCDC88B;SERPINE1;CADM1;NCOA3;ZNF703;CARD9;ABCA1;PLCB1;ALMS1;SHLD2;LEPR;TWIST1;SHLD1;ADIPOR1;PPIB;F2R;ACSL1;UCN;MAP3K13;ADIPOR2;KMT5C;BCL9L
prerank,Reactome_2022__Purine Ribonucleoside Monophosphate Biosynthesis R-HSA-73817,-0.6669876527030966,-1.1420007590633032,0.31746031746031744,1.0,1.0,1/9,1.23%,ADSS1
prerank,KEGG_2021_Human__Spinocerebellar ataxia,0.386482121530799,1.1419385690405683,0.125,0.8260569249002779,1.0,15/132,10.27%,GRIN3A;ITPR2;RORA;TRPC3;ATXN1;SEM1;PSMA1;PLCB1;SP1;MAPK8;AKT2;ERN1;ATXN8OS;GRIN1;MCU
prerank,PanglaoDB_Augmented_2021__Basal Cells,0.41372188418077877,1.1416845970236547,0.18518518518518517,0.8262049290296614,1.0,10/89,4.24%,ADGRF4;EMP1;CD151;LAMA3;BCL2;HSPB1;SDC4;PERP;SLC25A37;DUSP23
prerank,CellMarker_Augmented_2021__Pancreatic Endoderm cell:Embryonic Stem Cell,0.3965011428903744,1.1414804088055326,0.19230769230769232,0.826287167972611,1.0,24/89,15.10%,MYO10;EMP1;LAMA3;ARSJ;SDC4;PARVA;COL12A1;JAG1;NTN4;SH3RF1;PDLIM4;SNAI2;CRIM1;ITGA3;KITLG;RND3;COL16A1;CHST3;RASAL2;EFEMP1;EPS8;HRH1;WWTR1;ANTXR1
prerank,GO_Biological_Process_2021__positive regulation of gene silencing by miRNA (GO:2000637),-0.5634353248391035,-1.141325958679405,0.3333333333333333,1.0,1.0,1/25,1.49%,TGFB1
prerank,GO_Biological_Process_2021__regulation of exit from mitosis (GO:0007096),-0.526407892348646,-1.1412136982234649,0.3382352941176471,1.0,1.0,1/35,0.37%,NEK2
prerank,GO_Biological_Process_2021__protein localization to cell junction (GO:1902414),0.5135385674680487,1.1411186057732947,0.225,0.8267438113884579,1.0,4/22,6.95%,NLGN1;PCLO;CGNL1;DSP
prerank,"Reactome_2022__Inactivation, Recovery And Regulation Of Phototransduction Cascade R-HSA-2514859",-0.5408434382112282,-1.1410842413063471,0.27692307692307694,1.0,1.0,10/26,23.57%,PDE6B;GRK7;GNGT1;PDE6A;CALM1;GUCY2F;NMT1;CHURC1-FNTB;PDE6G;CNGB1
prerank,GO_Biological_Process_2021__positive regulation of fatty acid biosynthetic process (GO:0045723),0.6428798494350512,1.1410491649914587,0.275,0.8265074782476155,1.0,6/10,28.94%,ABCD2;MLXIPL;NR1H3;ELOVL5;SLC45A3;MID1IP1
prerank,Reactome_2022__FGFR2c Ligand Binding And Activation R-HSA-190375,-0.6388477106997104,-1.1410261281772807,0.32142857142857145,1.0,1.0,1/10,0.93%,FGF20
prerank,KEGG_2021_Human__Viral myocarditis,-0.5150468563321897,-1.1410074370758667,0.27941176470588236,1.0,1.0,16/46,20.41%,MYH7;ITGB2;CCND1;HLA-DMA;HLA-A;ACTG1;HLA-DPB1;HLA-DRB1;HLA-DPA1;CD80;HLA-F;RAC2;RAC1;CASP8;SGCG;CD86
prerank,Reactome_2022__Maturation Of Protein 3A R-HSA-9683673,0.6325281947072443,1.1409652646731054,0.24390243902439024,0.8261872816883528,1.0,3/9,6.55%,ST6GALNAC3;GALNT1;ST3GAL3
prerank,GO_Biological_Process_2021__regulation of actin filament-based movement (GO:1903115),-0.7252299306751632,-1.1402898592983117,0.3181818181818182,1.0,1.0,2/8,4.08%,SCN5A;MYBPC3
prerank,GO_Biological_Process_2021__positive regulation of vascular endothelial growth factor production (GO:0010575),-0.5794801834364248,-1.1402594146051017,0.2459016393442623,1.0,1.0,5/21,8.63%,TGFB1;NODAL;CYP1B1;FLT4;BRCA1
prerank,GO_Biological_Process_2021__type B pancreatic cell development (GO:0003323),0.6911931249124054,1.1402485334611954,0.3673469387755102,0.8278673452852088,1.0,3/6,21.65%,CDK6;CDH2;BMP4
prerank,GO_Biological_Process_2021__positive regulation of secretion (GO:0051047),-0.6991997628027988,-1.1400723570169151,0.3472222222222222,1.0,1.0,4/8,18.26%,ALOX12B;SCIN;ACSL3;ABCB11
prerank,GO_Biological_Process_2021__regulation of ventricular cardiac muscle cell action potential (GO:0098911),-0.6298680668835621,-1.1397955494102272,0.3387096774193548,1.0,1.0,2/12,3.78%,PKP2;CTNNA3
prerank,GO_Biological_Process_2021__regulation of cell cycle checkpoint (GO:1901976),0.7151787691750815,1.1397033719043037,0.32608695652173914,0.8291063639711754,1.0,2/6,5.35%,RFWD3;CRY1
prerank,GO_Biological_Process_2021__protein complex oligomerization (GO:0051259),0.383243776792118,1.139585118332269,0.17391304347826086,0.8290278159088422,1.0,18/84,14.06%,ARC;VSTM5;KCNC2;PKD2;SNCA;ZBTB1;IKZF4;CARD9;MICU1;SPAST;EHD4;MCU;UGDH;MAT2A;CPSF7;TRMT61B;MPP2;PNPT1
prerank,GO_Biological_Process_2021__organic hydroxy compound catabolic process (GO:1901616),-0.6917207651028063,-1.13947541083451,0.375,1.0,1.0,3/9,13.26%,CYP24A1;CYP3A4;CYP4F12
prerank,GO_Biological_Process_2021__calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules (GO:0016338),-0.6487161900544615,-1.1393765747334954,0.35,1.0,1.0,6/13,15.91%,CLDN1;CLDN6;CLDN5;CLDN2;CLDN18;CLDN20
prerank,GO_Biological_Process_2021__regulation of mitochondrion organization (GO:0010821),0.48621805727570877,1.1393553707418516,0.20833333333333334,0.8292478509865245,1.0,12/42,19.73%,HTRA2;PID1;FZD5;MARCHF5;SIRT7;MGARP;USP36;MIEF2;IAPP;EP300;STOX1;SREBF2
prerank,GO_Biological_Process_2021__fat-soluble vitamin metabolic process (GO:0006775),-0.5703570069619825,-1.1390718664608996,0.26229508196721313,1.0,1.0,6/21,14.65%,CYP24A1;RBP2;CYP3A4;LRP2;CYP4F12;VDR
prerank,GO_Biological_Process_2021__response to muramyl dipeptide (GO:0032495),0.588571074177225,1.138947489888627,0.32432432432432434,0.8301108195869246,1.0,1/11,3.92%,RIPK2
prerank,CellMarker_Augmented_2021__Vascular Smooth Muscle cell:Placenta,-0.4714089054645834,-1.138943425562265,0.24050632911392406,1.0,1.0,21/76,16.97%,OLFML1;LMOD1;CASQ2;LYVE1;INMT;FILIP1L;OGN;ADAM33;MASP1;DAAM2;DCN;ASPN;TNXB;NEXN;TEK;C1S;ACTA2;GGT5;JAM2;C1QTNF7;PLN
prerank,CellMarker_Augmented_2021__Paneth cell:Intestine,-0.7288727314879809,-1.1388340572777433,0.32727272727272727,1.0,1.0,2/5,19.23%,OR5V1;IL5
prerank,GO_Biological_Process_2021__histone H3-K9 demethylation (GO:0033169),0.608583434276662,1.1387992067902706,0.2857142857142857,0.8300970051379456,1.0,4/10,24.71%,KDM7A;KDM3B;JMJD1C;KDM4C
prerank,GO_Biological_Process_2021__intracellular pH reduction (GO:0051452),0.46318005922195643,1.1386847144052832,0.2903225806451613,0.8298690721477048,1.0,4/32,5.56%,ATP6V0D2;TCIRG1;RAB20;RAB7A
prerank,Reactome_2022__Vpr-mediated Nuclear Import Of PICs R-HSA-180910,0.4933268501266936,1.1386583175411147,0.1794871794871795,0.8294460290097979,1.0,12/33,27.98%,NUP210;NUP42;AAAS;SGIP1;RANBP2;NUP214;TPR;SEH1L;NUP153;NUP98;BANF1;NUP37
prerank,Reactome_2022__SUMOylation Of SUMOylation Proteins R-HSA-4085377,0.4921410582263923,1.138503739438525,0.24324324324324326,0.8294512508412434,1.0,10/32,27.98%,NUP210;NUP42;AAAS;RANBP2;NUP214;TPR;SEH1L;NUP153;NUP98;NUP37
prerank,CellMarker_Augmented_2021__Epithelial cell:Undefined,-0.5832584744030828,-1.1384769953258227,0.3333333333333333,1.0,1.0,10/22,28.54%,SFTPD;CEACAM1;NOS2;CD24;ANPEP;IL1R1;EPCAM;IL6R;KRT8;SFTPB
prerank,GO_Biological_Process_2021__nervous system development (GO:0007399),0.3557406659366963,1.1384467015600674,0.08333333333333333,0.8291219217492847,1.0,96/381,19.73%,NGF;POU3F1;SLITRK6;ADGRG6;CHRM2;VCAN;TGFBR1;POU6F2;ROBO2;NEUROD2;NLGN1;POU3F2;DSCAML1;IL1RAPL2;SEMA5A;ATXN1;FGF17;FZD5;SDK1;ZEB2;GRIK1;ZC4H2;JAG1;PKD2;NRG1;HES1;FKTN;ST8SIA4;PROX1;TRIM71;PTPRZ1;CHAC1;DSCAM;EFNA5;SCD5;TENM1;CRIM1;NAV3;SNTG2;MTR;RPS6KA3;TRAK2;FGF12;ALDH1A2;CSPG5;EVL;AVIL;DPF1;RBFOX2;MYT1L;FARP1;TYRO3;ADGRV1;APBA1;NLGN3;CPNE6;DPF2;CDH2;ASCL1;RBFOX1;NAV1;CHST8;NF1;MSI1;BTBD2;WWTR1;MARK4;RYK;HDAC4;RPS6KA6;SRRM4;ACHE;NRXN1;CNTN6;NRSN1;ADORA1;LIG4;EPHB2;ATN1;PPP2R5D;PAX6;KIRREL3;LIMK1;S100B;LSAMP;GBA2;EP300;UNC119B;NAV2;DPF3;CDK5;SH3GL1;PCDHB6;PCDH1;NRCAM;SREBF2
prerank,CellMarker_Augmented_2021__Primordial Germ cell:Embryonic Stem Cell,-0.531262348481466,-1.1383867791489624,0.22580645161290322,1.0,1.0,21/47,16.09%,HCK;ARHGAP9;TAGAP;ALOX5;PARVG;FCGR3A;LY86;NFAM1;HLA-DPB1;MYO1F;PTPRC;FPR1;SPI1;CLEC12A;HVCN1;HLA-DPA1;CD300LF;ADGRE3;IKZF1;CD4;HK3
prerank,CellMarker_Augmented_2021__Primordial Germ cell:Pluripotent Stem Cell,-0.531262348481466,-1.1383867791489624,0.22580645161290322,1.0,1.0,21/47,16.09%,HCK;ARHGAP9;TAGAP;ALOX5;PARVG;FCGR3A;LY86;NFAM1;HLA-DPB1;MYO1F;PTPRC;FPR1;SPI1;CLEC12A;HVCN1;HLA-DPA1;CD300LF;ADGRE3;IKZF1;CD4;HK3
prerank,KEGG_2021_Human__Phosphatidylinositol signaling system,0.4211322364486317,1.138276825022523,0.23333333333333334,0.8291087640166821,1.0,25/91,22.75%,DGKD;ITPR2;PI4KB;ITPKB;PIK3C2B;PLCB1;MTMR8;INPP1;PI4K2B;PIK3CA;DGKH;MTMR3;PIP4K2A;IP6K1;MTMR14;ITPK1;PIP4P2;DGKZ;MTMR1;MTM1;IPPK;PLCG2;PTEN;IP6K2;CDS1
prerank,CellMarker_Augmented_2021__Lymphatic Endothelial cell:Ovary,-0.7434964240675486,-1.1382245365181904,0.3387096774193548,1.0,1.0,2/5,7.35%,LYVE1;FLT4
prerank,GO_Biological_Process_2021__negative regulation of oxidative stress-induced neuron death (GO:1903204),-0.6417738942281651,-1.1382208228440787,0.2857142857142857,1.0,1.0,2/10,9.69%,PINK1;REST
prerank,GO_Biological_Process_2021__transcription initiation from RNA polymerase II promoter (GO:0006367),0.3793880342981177,1.138088648670368,0.15,0.82909562260881,1.0,32/128,18.53%,TEAD2;ESRRG;HDAC3;MED17;RORA;HDAC10;RARB;CCN2;PPARG;MAML1;RORB;TAF3;NR4A2;TAF12;CCNH;TEAD4;NR3C2;HDAC1;NR3C1;GTF2F2;WWTR1;THRB;NR1H3;NR6A1;NRBF2;NR4A3;NOTCH1;NR2C1;TAF4;ERCC3;RBPJ;NR4A1
prerank,GO_Biological_Process_2021__negative regulation of cytokine production (GO:0001818),-0.4400080093370737,-1.1380599211383522,0.23376623376623376,1.0,1.0,30/133,20.07%,PDCD1LG2;NLRP12;UBE2L6;SFTPD;TRIM25;CEACAM1;VSIG4;ZFPM1;ANXA1;THBS1;GBP1;HLA-DRB1;PTPRC;SLC11A1;APOD;NLRC3;LEF1;IL12A;NR1H4;ADCY7;ELANE;F2RL1;GHRL;VSIR;RAC1;CACTIN;AXL;INHA;FN1;DHX58
prerank,GO_Biological_Process_2021__regulation of vascular endothelial growth factor production (GO:0010574),-0.5763680041796057,-1.1380406412100623,0.3,1.0,1.0,5/22,8.63%,TGFB1;NODAL;CYP1B1;FLT4;BRCA1
prerank,GO_Biological_Process_2021__regulation of neutrophil migration (GO:1902622),-0.6683938298533714,-1.1378710717649445,0.23636363636363636,1.0,1.0,4/10,21.56%,OLFM4;RAC2;RAC1;BST1
prerank,KEGG_2021_Human__Carbohydrate digestion and absorption,-0.5390053470391982,-1.137711830016631,0.2608695652173913,1.0,1.0,8/34,16.09%,HK2;SLC5A1;ATP1A4;PIK3R3;GNAT3;LCT;PIK3CB;HK3
prerank,Reactome_2022__Platelet Calcium Homeostasis R-HSA-418360,0.517948739642483,1.1376860128536523,0.22857142857142856,0.8296946882344249,1.0,4/23,5.32%,ITPR2;TRPC3;SLC8A1;SLC8A3
prerank,GO_Biological_Process_2021__negative regulation of response to interferon-gamma (GO:0060331),0.6555093924329379,1.137539418275304,0.37209302325581395,0.829074824291183,1.0,2/6,15.39%,PPARG;NR1H3
prerank,GO_Biological_Process_2021__negative regulation of interferon-gamma-mediated signaling pathway (GO:0060336),0.6555093924329379,1.137539418275304,0.37209302325581395,0.829074824291183,1.0,2/6,15.39%,PPARG;NR1H3
prerank,GO_Biological_Process_2021__cognition (GO:0050890),0.4383965758601051,1.137462073651589,0.16666666666666666,0.8289043436534144,1.0,20/38,33.48%,MFSD2A;HRH3;HLA-DRA;NF1;NIPBL;C5AR1;DOP1B;GRM5;SOBP;METTL23;PTCHD1;RP9;ST3GAL4;MAGT1;TUSC3;CHD7;BBS4;NSUN5;LINS1;FAM107A
prerank,GO_Biological_Process_2021__T cell migration (GO:0072678),-0.6586047385227578,-1.1371918669397916,0.3157894736842105,1.0,1.0,4/10,17.52%,GPR183;CXCL16;PIK3CG;MSN
prerank,Reactome_2022__Negative Regulation Of FLT3 R-HSA-9706369,0.5454758029814555,1.1370748878958512,0.2631578947368421,0.8296408357329834,1.0,6/14,23.99%,CSK;ABL2;FLT3;SLA2;PTPRJ;CBL
prerank,GO_Biological_Process_2021__potassium ion export across plasma membrane (GO:0097623),-0.6589814028802307,-1.1370666249629966,0.3181818181818182,1.0,1.0,3/10,14.89%,KCNA5;KCNQ1;KCNE3
prerank,GO_Biological_Process_2021__regulation of non-motile cilium assembly (GO:1902855),0.7055259921223043,1.1369929823900173,0.3902439024390244,0.8293500056091344,1.0,2/6,14.34%,CEP135;SEPTIN9
prerank,PanglaoDB_Augmented_2021__B Cells,-0.44524868348827695,-1.136959919145783,0.189873417721519,1.0,1.0,29/111,17.79%,JCHAIN;GMFG;IL21R;IRF4;CYTIP;TBC1D10C;ARHGAP9;TAGAP;TMC8;PARVG;CD5;IFIT3;WAS;LY86;CD37;TRAF3IP3;PTPRC;HVCN1;BLNK;CD27;PSTPIP1;NIBAN3;CD80;IKZF1;IGLL1;NAPSB;CD24;POLD4;ALOX5AP
prerank,GO_Biological_Process_2021__negative regulation of alpha-beta T cell differentiation (GO:0046639),0.7454310105468187,1.136947600542508,0.3793103448275862,0.8289486398537691,1.0,3/5,6.42%,ZBTB7B;CBFB;HMGB1
prerank,GO_Biological_Process_2021__negative regulation of lymphocyte proliferation (GO:0050672),-0.5599133875606835,-1.1368491950693977,0.2571428571428571,1.0,1.0,6/24,14.67%,BLK;PDCD1LG2;SFTPD;VSIG4;HLA-DRB1;CD80
prerank,GO_Biological_Process_2021__ether lipid biosynthetic process (GO:0008611),0.6177915927465675,1.1366990748827113,0.3055555555555556,0.8291203729324484,1.0,4/9,16.45%,CHPT1;LPCAT2;PLA2G4C;DHRS7B
prerank,GO_Biological_Process_2021__regulation of G1/S transition of mitotic cell cycle (GO:2000045),0.43379335492806703,1.1366789337089627,0.22727272727272727,0.8286458053258013,1.0,11/62,7.77%,ADAMTS1;FGF10;LSM10;SLFN11;PKD2;GFI1B;CDK6;CDK4;CCND3;PLCB1;RBL1
prerank,GO_Biological_Process_2021__spinal cord dorsal/ventral patterning (GO:0021513),-0.7601062097863032,-1.1366625599335647,0.3076923076923077,1.0,1.0,1/5,3.07%,RFX4
prerank,GO_Biological_Process_2021__mRNA methylation (GO:0080009),0.5640507627305321,1.1366094160132183,0.2926829268292683,0.8283839783232966,1.0,7/15,23.43%,METTL8;PCIF1;TRMT61B;ZC3H13;TRMT61A;METTL16;NSUN2
prerank,GO_Biological_Process_2021__positive regulation of cardiac muscle cell proliferation (GO:0060045),0.5923356036905445,1.136592768359053,0.2972972972972973,0.8278920123115625,1.0,6/10,28.25%,NOTCH1;RBPJ;BMPR1A;ZFPM2;TGFBR3;MEF2C
prerank,Reactome_2022__IRS-related Events Triggered By IGF1R R-HSA-2428928,0.47063718557537987,1.1364934200831323,0.17857142857142858,0.8277323126021935,1.0,12/42,14.95%,FGF10;THEM4;FGFR1;IRS1;FGF17;FGF18;AKT2;FGFR3;IRS2;IRS4;FLT3;PIK3CA
prerank,GO_Biological_Process_2021__protein secretion (GO:0009306),0.4404897046475418,1.1364376625137116,0.20833333333333334,0.8273426314364766,1.0,12/50,18.05%,OLFM2;ABCA1;CYB5R4;RIMS2;RAB3C;TVP23B;PREB;RAB10;LTBP2;WLS;RAB3D;MIA3
prerank,Reactome_2022__Metabolism Of Fat-Soluble Vitamins R-HSA-6806667,0.4550648215141969,1.1364292662092725,0.25,0.8268890193776818,1.0,13/37,13.60%,GPC4;APOB;APOE;SDC4;GPC6;AKR1C3;AKR1C1;GPC5;LPL;LDLR;SDC3;UBIAD1;LRP8
prerank,GO_Biological_Process_2021__blood vessel morphogenesis (GO:0048514),-0.518425903992944,-1.136366837821592,0.2702702702702703,1.0,1.0,8/42,14.16%,TBX1;TGFB1;CYP1B1;LOX;FLT4;ID1;ENG;HEY2
prerank,GO_Biological_Process_2021__regulation of viral release from host cell (GO:1902186),-0.582819174833423,-1.136363255624915,0.3090909090909091,1.0,1.0,4/19,7.97%,TRIM62;TRIM5;TRIM25;CHMP3
prerank,GO_Biological_Process_2021__cellular potassium ion homeostasis (GO:0030007),-0.6614500846569566,-1.1361256530383324,0.3283582089552239,1.0,1.0,3/11,19.66%,ATP1A4;ATP4A;ATP1A1
prerank,Reactome_2022__MAPK Family Signaling Cascades R-HSA-5683057,0.3934513186329923,1.1360895246942484,0.3,0.827291174555261,1.0,55/280,13.97%,FOXO1;DUSP4;FGF10;DUSP2;KIT;LLGL1;SPRED3;FGFR1;HSPB1;KSR1;GPRIN1;IRS1;ANGPT1;SPTBN4;NRG2;CSK;ABHD17A;IL17RD;FGF17;MMP2;PSME4;ERBB2;SEM1;ARRB2;NRG1;RASA2;NCOA3;PPP5C;PSMA1;NRG3;CCND3;MYC;FGF18;TGFA;SPRED2;ABHD17C;MOV10;FGFR3;KITLG;PKN2;IRS2;SPRED1;PPP2R1B;TNRC6C;CNKSR2;RASAL2;RET;RAP1A;FNTA;ABHD17B;MARK3;ARRB1;NF1;MPP2;FLT3
prerank,GO_Biological_Process_2021__regulation of endothelial cell chemotaxis (GO:2001026),0.5500832910360876,1.1360145478705497,0.25,0.8270127642920112,1.0,2/13,4.26%,HSPB1;SEMA5A
prerank,GO_Biological_Process_2021__organelle disassembly (GO:1903008),0.46798724610096915,1.135997744997362,0.22857142857142856,0.8265326365741634,1.0,9/33,22.73%,STX5;GBF1;DYRK3;MRRF;PLK3;ATG2A;ATG2B;RETREG1;STING1
prerank,GO_Biological_Process_2021__synaptic vesicle endocytosis (GO:0048488),0.4965219588621004,1.135867439244546,0.23529411764705882,0.8264569685885663,1.0,7/34,13.46%,CEL;NLGN1;SNCA;SYT1;NLGN4X;NLGN3;SNAP91
prerank,"GO_Biological_Process_2021__nucleotide-excision repair, DNA incision, 3'-to lesion (GO:0006295)",-0.5691570053061941,-1.1357397730028798,0.3384615384615385,1.0,1.0,4/18,23.78%,RPA3;RBX1;RPA2;DDB1
prerank,"GO_Biological_Process_2021__nucleotide-excision repair, preincision complex stabilization (GO:0006293)",-0.5691570053061941,-1.1357397730028798,0.3384615384615385,1.0,1.0,4/18,23.78%,RPA3;RBX1;RPA2;DDB1
prerank,GO_Biological_Process_2021__regulation of thymocyte apoptotic process (GO:0070243),0.6854635699415386,1.1357341125374771,0.3958333333333333,0.8263722201402666,1.0,3/5,22.36%,TP53;BMP4;ADAM8
prerank,CellMarker_Augmented_2021__Germ cell:Embryo,-0.7621889807335904,-1.1357310253046835,0.39655172413793105,1.0,1.0,2/6,6.98%,DAZL;NLRP5
prerank,GO_Biological_Process_2021__pyrimidine deoxyribonucleotide biosynthetic process (GO:0009221),0.675782599855312,1.1357123280387598,0.3409090909090909,0.8259483732748342,1.0,2/5,17.51%,DUT;DTYMK
prerank,GO_Biological_Process_2021__calcium ion export (GO:1901660),0.6964505927959972,1.1354675926023843,0.391304347826087,0.826239682688399,1.0,2/7,21.25%,SLC35G1;SLC8B1
prerank,GO_Biological_Process_2021__organonitrogen compound catabolic process (GO:1901565),-0.49044535172347975,-1.1351417757233206,0.2602739726027397,1.0,1.0,17/58,18.74%,ENPP2;CYP3A5;PDXDC1;PLA2G10;LVRN;ERAP2;PPT1;CYP3A4;SIAH1;ELANE;GGACT;PLA2G4A;RENBP;CPQ;ANPEP;ERAP1;CLN8
prerank,GO_Biological_Process_2021__base-excision repair (GO:0006284),-0.5013583904008807,-1.1351147271252546,0.22972972972972974,1.0,1.0,8/44,22.81%,POLQ;RPA3;POLD4;SMUG1;HMGA2;OGG1;RPA2;XRCC1
prerank,GO_Biological_Process_2021__negative regulation of receptor-mediated endocytosis (GO:0048261),-0.6018973301156697,-1.135091492062793,0.3076923076923077,1.0,1.0,2/18,2.65%,RIN3;LRPAP1
prerank,Reactome_2022__Regulation Of Lipid Metabolism By PPARalpha R-HSA-400206,0.4036902307335971,1.1350703084808236,0.19047619047619047,0.8272631481804972,1.0,27/104,18.84%,HDAC3;MED17;RORA;SMARCD3;PPARG;NCOA3;NCOA2;MED25;ABCA1;FHL2;ACADM;ACSL1;CPT1A;CHD9;CARM1;MED16;CDK8;NFYC;PPARGC1B;SULT2A1;NR1H3;MED13L;MED9;FAM120B;MIA3;ACOX1;EP300
prerank,GO_Biological_Process_2021__activation of NF-kappaB-inducing kinase activity (GO:0007250),-0.6416041708178527,-1.1349726305241081,0.31746031746031744,1.0,1.0,2/11,12.48%,CARD14;TNFRSF10A
prerank,GO_Biological_Process_2021__signal transduction by p53 class mediator (GO:0072331),0.5571903212353232,1.1349261338164653,0.2972972972972973,0.8272147172225699,1.0,6/27,7.66%,FHIT;IFI16;PPP1R13B;ACER2;GREM1;ZNF385B
prerank,CellMarker_Augmented_2021__Basophil:Blood,-0.6959066494958843,-1.1349139146092118,0.3442622950819672,1.0,1.0,2/6,10.40%,IL3RA;CD63
prerank,GO_Biological_Process_2021__tetrahydrofolate metabolic process (GO:0046653),0.6132287215901692,1.134735322138481,0.34285714285714286,0.827266942828792,1.0,5/11,25.77%,DHFR;MTHFR;SHMT2;MTHFD1L;MTHFD2L
prerank,CellMarker_Augmented_2021__Thymic Emigrant cell:Blood,-0.4943911335362775,-1.1345343133727943,0.2647058823529412,1.0,1.0,17/55,11.77%,GMFG;ITGB2;DOCK8;CYTIP;ARHGAP9;TAGAP;TNFRSF1B;ARHGAP15;GPR183;PARVG;FCGR3A;LY86;CD37;TRAF3IP3;MYO1F;PTPRC;ITGAM
prerank,GO_Biological_Process_2021__regulation of generation of precursor metabolites and energy (GO:0043467),0.47768458037640493,1.1345152492586157,0.25,0.8275110368114436,1.0,3/46,4.13%,GCK;NUP210;NUP42
prerank,KEGG_2021_Human__Apoptosis,0.4150856294192222,1.1344547682230608,0.14285714285714285,0.8271885217784621,1.0,25/121,16.83%,NGF;ITPR2;BCL2;CFLAR;MAP3K14;BCL2A1;HTRA2;LMNB1;CAPN2;TP53AIP1;EIF2AK3;MAPK8;CASP3;TUBA8;AKT2;ERN1;CTSV;FADD;NFKB1;BID;PIK3CA;GADD45A;TP53;CTSC;ATM
prerank,Reactome_2022__CD28 Co-Stimulation R-HSA-389356,0.489466305595936,1.134391518241664,0.2962962962962963,0.8269029141967456,1.0,5/31,10.13%,THEM4;MAP3K14;MLST8;AKT2;PKN2
prerank,"Reactome_2022__PI5P, PP2A And IER3 Regulate PI3K/AKT Signaling R-HSA-6811558",0.3934430461516787,1.1342699444487852,0.13333333333333333,0.8266815152794433,1.0,19/87,14.97%,FGF10;KIT;FGFR1;IRS1;NRG2;FGF17;ERBB2;NRG1;NRG3;FGF18;TGFA;FGFR3;KITLG;IRS2;PPP2R1B;FLT3;INSR;PIK3CA;IRAK4
prerank,Reactome_2022__Influenza Infection R-HSA-168255,-0.44549895809525175,-1.1342275592995161,0.22784810126582278,1.0,1.0,62/146,27.12%,TGFB1;RPL37A;RPL38;RPL15;RPS4X;RPL3;RPL35A;GNL3;RPS9;FAU;RPS27;RPS21;RPL13A;RPL27A;RPS16;RPL36;RPS20;RPL7A;RPL9;RPS8;RPS27A;RPL21;RPL34;RPL4;RPL32;RPL5;RPL23;RPL41;RPS7;RPS11;NUP93;RPL27;RPL35;RPS14;RPL11;SEC13;ISG15;RPS15;RPLP1;RPS12;POLR2B;RPL18A;RPS13;RPL29;RPLP2;RPL28;KPNA7;RPL12;RPL18;RPS3;RPL22;RPSA;KPNA5;RPS28;RPS19;NDC1;RPS24;RPL26L1;RPS3A;RPL19;RPL8;RPS6
prerank,CellMarker_Augmented_2021__White Blood cell:Blood,-0.4944462716885929,-1.1340381248298623,0.2318840579710145,1.0,1.0,17/65,10.28%,GMFG;ITGB2;DOCK8;CYTIP;ARHGAP9;TAGAP;TMC8;TNFRSF1B;ARHGAP15;DOCK2;GPR183;PARVG;WAS;CD37;TRAF3IP3;MYO1F;PTPRC
prerank,CellMarker_Augmented_2021__Hematopoietic cell:Undefined,-0.4944462716885929,-1.1340381248298623,0.2318840579710145,1.0,1.0,17/65,10.28%,GMFG;ITGB2;DOCK8;CYTIP;ARHGAP9;TAGAP;TMC8;TNFRSF1B;ARHGAP15;DOCK2;GPR183;PARVG;WAS;CD37;TRAF3IP3;MYO1F;PTPRC
prerank,GO_Biological_Process_2021__regulation of cilium assembly (GO:1902017),0.4327541598575618,1.1339078193055931,0.25,0.8274724119982202,1.0,19/59,22.74%,TBC1D10A;IFT88;TBC1D16;CEP120;SDCCAG8;CROCC;TBC1D22B;EVI5L;CCDC88A;ARHGAP35;MARK4;IFT140;TBC1D2;DCDC2;TBC1D8;USP6NL;TBC1D5;RABEP2;LIMK2
prerank,CellMarker_Augmented_2021__Common Lymphoid progenitor:Undefined,-0.49073294955500724,-1.1338225033002576,0.2602739726027397,1.0,1.0,19/66,10.89%,GMFG;HCK;CYTIP;ARHGAP9;TAGAP;TNFRSF1B;ARHGAP15;DOCK2;CIITA;PARVG;FCGR3A;P2RY14;HLA-DPB1;SELP;TRAF3IP3;MYO1F;IGSF6;PTPRC;SPI1
prerank,Reactome_2022__ADP Signaling Thru P2Y Purinoceptor 12 R-HSA-392170,-0.6286329494212547,-1.1337838383857177,0.2909090909090909,1.0,1.0,3/18,9.69%,P2RY12;GNAT3;GNGT1
prerank,GO_Biological_Process_2021__central nervous system myelination (GO:0022010),-0.627850931554526,-1.133759651465615,0.3709677419354839,1.0,1.0,4/11,19.63%,SOX10;CLU;PLP1;MYRF
prerank,Reactome_2022__Toll-like Receptor Cascades R-HSA-168898,0.3725268112944687,1.1333826048626487,0.125,0.8284081341352628,1.0,41/137,21.90%,DUSP4;MAPKAPK2;APOB;RIPK2;KCNH8;SARM1;HMGB1;MAPK8;MAP3K1;ALPK1;CTSV;RPS6KA3;N4BP1;PPP2R1B;TICAM1;TANK;FADD;NKIRAS2;TAB3;PELI1;NFKB1;RPS6KA2;PELI2;IRAK4;CNPY3;TP53;LBP;MAP2K7;PPP2R5D;S100B;TAB1;CREB1;TAB2;MAP2K6;TRAF6;FOS;PLCG2;PIK3R4;UBE2D2;CUL1;DUSP6
prerank,Reactome_2022__Defective B3GAT3 Causes JDSSDHD R-HSA-3560801,0.5898002257016257,1.1330861984899405,0.25806451612903225,0.8287508109066124,1.0,8/19,11.20%,VCAN;GPC4;SDC4;GPC6;GPC5;CSPG5;B3GAT3;SDC3
prerank,Reactome_2022__Intracellular Signaling By Second Messengers R-HSA-9006925,0.3433328742437445,1.132992006837353,0.0,0.8286289344807898,1.0,46/272,14.97%,FOXO1;FGF10;THEM4;KIT;HDAC3;ITPR2;FGFR1;IRS1;NRG2;PHC2;GATAD2A;FRK;PPARG;FGF17;PSME4;ERBB2;SEM1;NRG1;PSMA1;NRG3;PML;PDE1A;WWP2;ADCY2;FGF18;TGFA;MLST8;SNAI2;MOV10;AKT2;FGFR3;KITLG;PRKAR2A;IRS2;PPP2R1B;TNRC6C;SCMH1;HDAC1;GATAD2B;CHD4;RNF146;FLT3;OTUD3;INSR;PIK3CA;IRAK4
prerank,GO_Biological_Process_2021__regulation of bone remodeling (GO:0046850),0.6503214259224926,1.1329691244285214,0.38095238095238093,0.8281888749427927,1.0,3/7,14.22%,GREM1;LEPR;SUCO
prerank,Reactome_2022__SARS-CoV-2 Modulates Autophagy R-HSA-9754560,0.6580660179009137,1.1329531387331717,0.45652173913043476,0.8277584397606375,1.0,1/9,3.74%,VPS16
prerank,GO_Biological_Process_2021__dendritic spine maintenance (GO:0097062),0.7041092298506175,1.1328334121609758,0.325,0.8275647147830894,1.0,2/7,14.95%,ITGA3;INSR
prerank,CellMarker_Augmented_2021__Circulating Stem Like cell:Peripheral Blood,-0.4953814870897576,-1.1327563087947399,0.26666666666666666,1.0,1.0,7/62,4.73%,CD44;NPFFR1;KCNA7;NLRP12;SP100;YWHAQP5;IRF1
prerank,GO_Biological_Process_2021__negative regulation of T cell receptor signaling pathway (GO:0050860),-0.6124919756422398,-1.132734871597074,0.34285714285714286,1.0,1.0,3/15,10.00%,CD160;CEACAM1;GBP1
prerank,Reactome_2022__Ribosomal Scanning And Start Codon Recognition R-HSA-72702,-0.5056388313711038,-1.1325598592514592,0.2903225806451613,1.0,1.0,26/52,27.12%,RPS4X;RPS9;FAU;RPS27;RPS21;EIF2S3;RPS16;RPS20;EIF2S2;RPS8;RPS27A;EIF4A2;RPS7;RPS11;RPS14;RPS15;RPS12;RPS13;EIF1AX;RPS3;RPSA;RPS28;RPS19;RPS24;RPS3A;RPS6
prerank,GO_Biological_Process_2021__negative regulation of epidermal growth factor-activated receptor activity (GO:0007175),0.5823419507442276,1.1324638487143885,0.3225806451612903,0.8280248857618463,1.0,7/12,23.99%,CBLB;CHMP6;GPRC5A;ZFYVE28;SOCS4;TSG101;CBL
prerank,GO_Biological_Process_2021__stress fiber assembly (GO:0043149),0.5680352493735076,1.1324234472782577,0.2619047619047619,0.8271390982750513,1.0,4/15,15.19%,FHDC1;PHACTR1;ARRB1;FAM171A1
prerank,GO_Biological_Process_2021__contractile actin filament bundle assembly (GO:0030038),0.5680352493735076,1.1324234472782577,0.2619047619047619,0.8271390982750513,1.0,4/15,15.19%,FHDC1;PHACTR1;ARRB1;FAM171A1
prerank,GO_Biological_Process_2021__histone H4-K16 acetylation (GO:0043984),0.5468120835305612,1.1323805722130669,0.29411764705882354,0.8268012237585364,1.0,3/19,18.99%,JADE3;MSL2;JADE2
prerank,GO_Biological_Process_2021__primary miRNA processing (GO:0031053),0.5668850809863921,1.1322641668660867,0.28205128205128205,0.8267716840790506,1.0,3/10,13.82%,PUS10;DGCR8;SMAD2
prerank,GO_Biological_Process_2021__vascular endothelial growth factor signaling pathway (GO:0038084),0.5660961260532335,1.1321807681005935,0.3125,0.8264977987686485,1.0,5/11,14.95%,VEGFC;NUS1;GAB1;MYO1C;PIK3CA
prerank,GO_Biological_Process_2021__manganese ion transport (GO:0006828),0.5515253522858847,1.1321753077378407,0.325,0.8260342851554616,1.0,3/14,3.19%,SLC30A10;TRPC3;SLC39A8
prerank,GO_Biological_Process_2021__establishment of mitotic spindle localization (GO:0040001),-0.55027047937102,-1.1320573142372798,0.2835820895522388,1.0,1.0,4/27,15.88%,MISP;GPSM2;DCTN1;NDEL1
prerank,CellMarker_Augmented_2021__Pluripotent Stem cell:Embryo,-0.5178367095639518,-1.1319111104845725,0.3076923076923077,1.0,1.0,16/58,13.55%,CYYR1;NODAL;SALL4;COL18A1;SLC7A3;TCF7L1;ARHGEF40;SYT2;CLDN6;C1ORF94;FBN3;ARAP3;NSUN7;FOXA3;CHST4;TEK
prerank,Reactome_2022__Signaling By Insulin Receptor R-HSA-74752,0.423512136220817,1.1319041152046432,0.2916666666666667,0.8261679864603567,1.0,11/65,10.67%,ATP6V0D2;FGF10;THEM4;TCIRG1;FGFR1;IRS1;FGF17;FGF18;AKT2;FGFR3;IRS2
prerank,GO_Biological_Process_2021__SCF-dependent proteasomal ubiquitin-dependent protein catabolic process (GO:0031146),-0.46394090320728626,-1.1318511983713866,0.18840579710144928,1.0,1.0,12/82,19.11%,PSMB9;FBXO48;KIF14;FBXL7;FBXL13;FBXO39;CCNF;RBX1;PSMA3;FBXL18;PSMA7;PSMB6
prerank,GO_Biological_Process_2021__carboxylic acid transport (GO:0046942),0.437510801447942,1.131829629019514,0.18181818181818182,0.8258859271058185,1.0,10/50,11.22%,SLC16A9;SLC38A5;SLC3A2;SLC16A7;SLC16A5;SLC6A17;SLC6A20;SLC7A6;SLC25A29;SLC7A8
prerank,GO_Biological_Process_2021__regulation of phosphatidylinositol dephosphorylation (GO:0060304),0.737385261026126,1.131815066444934,0.34146341463414637,0.8254145926367855,1.0,3/5,25.95%,MTMR3;MTMR1;MTMR9
prerank,GO_Biological_Process_2021__neural crest cell migration (GO:0001755),-0.5374538372715096,-1.1316634324798902,0.3,1.0,1.0,5/33,8.81%,TBX1;SOX10;SEMA3F;SEMA3A;HTR2B
prerank,GO_Biological_Process_2021__small RNA loading onto RISC (GO:0070922),0.6133150035614736,1.1315496372271543,0.325,0.8257740224426386,1.0,4/9,21.64%,AGO3;TARBP2;AGO2;ADAR
prerank,PanglaoDB_Augmented_2021__Mammary Epithelial Cells,0.379674106607414,1.1314615900006701,0.18181818181818182,0.8255287843205532,1.0,6/80,4.81%,ADGRF4;LAMA3;FAM83H;SDC4;PERP;ERBB2
prerank,GO_Biological_Process_2021__positive regulation of T-helper 2 cell differentiation (GO:0045630),-0.6928446504744774,-1.1313505604903173,0.33962264150943394,1.0,1.0,5/6,28.50%,NLRP3;IL18;CD86;TNFSF4;RARA
prerank,GO_Biological_Process_2021__regulation of adenylate cyclase activity (GO:0045761),0.5489457562930983,1.1313432187174202,0.3611111111111111,0.8254911405363893,1.0,6/19,13.81%,GRM3;DRD5;GRM2;CAP2;ADGRV1;NF1
prerank,Reactome_2022__PI3K/AKT Activation R-HSA-198203,0.6946952140557145,1.131317455113586,0.3111111111111111,0.8250932393542681,1.0,4/8,14.95%,NGF;IRS1;IRS2;PIK3CA
prerank,GO_Biological_Process_2021__arginine metabolic process (GO:0006525),0.6245156640203698,1.1307209295753535,0.2926829268292683,0.8264062251901055,1.0,3/8,11.24%,SLC39A8;DDAH2;DDAH1
prerank,Reactome_2022__RHOA GTPase Cycle R-HSA-8980692,-0.43273837851509306,-1.1306082175005294,0.21428571428571427,1.0,1.0,16/136,12.11%,RASGRF2;ACTC1;PLEKHG6;ARHGAP9;TAGAP;PLEKHG3;OBSCN;VAV3;DOCK2;ARHGEF40;CAVIN1;ATP6AP1;SNAP23;ARAP3;DEF6;ARHGAP28
prerank,Reactome_2022__Inactivation Of CSF3 (G-CSF) Signaling R-HSA-9705462,-0.5512834856205961,-1.1305690069125685,0.25757575757575757,1.0,1.0,2/21,6.09%,HCK;STAT1
prerank,GO_Biological_Process_2021__mitotic G2/M transition checkpoint (GO:0044818),-0.5230932172257161,-1.1303221090256448,0.2878787878787879,1.0,1.0,6/40,12.07%,TICRR;DTL;DONSON;ABRAXAS1;BRCA1;CDKN1A
prerank,GO_Biological_Process_2021__sodium ion import across plasma membrane (GO:0098719),-0.5833670308877117,-1.1303006406630778,0.38333333333333336,1.0,1.0,4/16,11.21%,SLC5A2;SLC5A1;SLC9A2;SLC9C1
prerank,Reactome_2022__Inactivation Of APC/C Via Direct Inhibition Of APC/C Complex R-HSA-141430,0.5145438627581583,1.130278910180187,0.2571428571428571,0.8274297364425801,1.0,6/18,25.48%,UBE2E1;ANAPC16;CDC26;ANAPC7;ANAPC4;ANAPC2
prerank,GO_Biological_Process_2021__neuronal ion channel clustering (GO:0045161),0.6519966822326915,1.130273430345471,0.3023255813953488,0.826941474323708,1.0,2/8,4.67%,SPTBN4;CNTNAP2
prerank,GO_Biological_Process_2021__negative regulation of sodium ion transmembrane transporter activity (GO:2000650),0.6704316692364435,1.1301242900169153,0.43478260869565216,0.8268312076949812,1.0,6/9,31.28%,OSR1;NEDD4;PRKCE;STK39;HECW1;HECW2
prerank,GO_Biological_Process_2021__RIG-I signaling pathway (GO:0039529),-0.779212111120575,-1.1300749334216589,0.3392857142857143,1.0,1.0,1/5,6.02%,TRIM25
prerank,GO_Biological_Process_2021__positive regulation of telomerase activity (GO:0051973),-0.5282358817279252,-1.1299791689780434,0.288135593220339,1.0,1.0,1/32,0.37%,NEK2
prerank,GO_Biological_Process_2021__Golgi inheritance (GO:0048313),0.6219411735748485,1.1294638738860863,0.35,0.8283375696667022,1.0,3/11,13.92%,STX5;GBF1;PLK3
prerank,Reactome_2022__RHOBTB3 ATPase Cycle R-HSA-9706019,0.6287465210827486,1.1293188409301214,0.3673469387755102,0.8282355729891175,1.0,2/9,20.71%,RHOBTB3;HTR7
prerank,GO_Biological_Process_2021__regulation of intrinsic apoptotic signaling pathway by p53 class mediator (GO:1902253),0.6092747382916073,1.1292232281006045,0.375,0.8279184242120183,1.0,1/8,5.52%,ARMC10
prerank,GO_Biological_Process_2021__positive regulation of phagocytosis (GO:0050766),-0.5138352396507432,-1.1291556938852845,0.25806451612903225,1.0,1.0,8/38,13.42%,SIRPG;TULP1;DOCK2;SFTPD;CYBA;PTPRC;SLC11A1;CD300LF
prerank,GO_Biological_Process_2021__cellular response to histamine (GO:0071420),0.6596791747503904,1.1291475879634516,0.40816326530612246,0.8275837266969176,1.0,6/6,34.05%,HRH1;GABRB2;GABRB1;GABRB3;GABRG2;DIAPH1
prerank,GO_Biological_Process_2021__G protein-coupled acetylcholine receptor signaling pathway (GO:0007213),0.5392066672758061,1.1287784594235906,0.30952380952380953,0.8282617997670146,1.0,3/18,7.70%,CHRM2;HRH3;PLCB1
prerank,GO_Biological_Process_2021__negative regulation of interleukin-6 production (GO:0032715),-0.5922760096893617,-1.1287087876433628,0.3387096774193548,1.0,1.0,3/16,16.67%,NLRP12;NLRC3;GHRL
prerank,GO_Biological_Process_2021__positive regulation of neurotransmitter transport (GO:0051590),-0.7333559898544522,-1.1286650956862405,0.3673469387755102,1.0,1.0,1/5,5.18%,GPER1
prerank,CellMarker_Augmented_2021__Leukocyte:Undefined,0.7330216606330592,1.128641846149103,0.36585365853658536,0.8281511389278323,1.0,2/5,4.29%,CD14;CX3CR1
prerank,GO_Biological_Process_2021__negative regulation of transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0090101),0.421417259350909,1.128634699065276,0.21052631578947367,0.8276826781461281,1.0,21/91,14.19%,VWC2L;BAMBI;VWC2;TGFBR1;SPRED3;IL17RD;PPARG;SIRT1;MAGI2;DLX1;GREM1;FSTL3;SPRED2;CRIM1;SPRED1;PPM1A;BCL9L;HSPA1A;SMAD2;BMPER;SMURF1
prerank,GO_Biological_Process_2021__negative regulation of blood coagulation (GO:0030195),-0.5303181039462159,-1.128633274143348,0.29577464788732394,1.0,1.0,11/32,14.68%,F8;C1QTNF1;F7;VTN;GP1BA;PLAU;CPB2;PLG;PLAT;A2M;TFPI
prerank,GO_Biological_Process_2021__peptidyl-lysine modification (GO:0018205),0.39528502565609686,1.1285757060143902,0.21739130434782608,0.8274294084086009,1.0,29/96,23.62%,NUP210;LOXL1;HDAC10;NUP42;SIRT1;P3H3;SIRT7;BCL11A;PLOD3;SENP1;AAAS;P3H4;ATPSCKMT;LIPT2;RNF212;ESCO1;HDAC4;NSMCE2;RNF113A;RANBP2;EP300;KAT2B;SENP5;NUP214;TPR;PLOD2;CTH;SENP6;SEH1L
prerank,GO_Biological_Process_2021__negative regulation of activin receptor signaling pathway (GO:0032926),0.6573894136013076,1.1285179098821252,0.3958333333333333,0.8272121917308306,1.0,4/8,18.70%,MAGI2;FSTL3;SKI;ACVR1
prerank,GO_Biological_Process_2021__aromatic amino acid family metabolic process (GO:0009072),-0.6578774755735297,-1.128483799743515,0.3333333333333333,1.0,1.0,1/9,0.88%,IYD
prerank,GO_Biological_Process_2021__kidney mesenchyme development (GO:0072074),0.6283206473450709,1.1283284625147527,0.3055555555555556,0.8272185414407258,1.0,2/5,6.85%,PKD2;OSR1
prerank,GO_Biological_Process_2021__female gonad development (GO:0008585),0.5422104998996577,1.1282773795437702,0.35294117647058826,0.8268499516122715,1.0,1/15,1.53%,KIT
prerank,KEGG_2021_Human__Sulfur relay system,0.620696818767992,1.1282469916915217,0.3191489361702128,0.8264461148530475,1.0,1/8,7.06%,CTU1
prerank,GO_Biological_Process_2021__DNA packaging (GO:0006323),-0.5997523907578639,-1.1282022993822634,0.3333333333333333,1.0,1.0,5/17,13.13%,BANF2;H1-0;HAT1;H1-3;CHAF1A
prerank,CellMarker_Augmented_2021__Naive Regulatory T (Treg) cell:Peripheral Blood,0.4489674029584166,1.1281332907515729,0.21428571428571427,0.8263102487688535,1.0,8/61,5.09%,IL7R;SELPLG;SAMSN1;TRAC;AOAH;IL16;C1ORF162;PYHIN1
prerank,GO_Biological_Process_2021__positive regulation of cardiocyte differentiation (GO:1905209),-0.6146158085216658,-1.1277251437295037,0.3050847457627119,1.0,1.0,2/10,5.18%,TGFB1;GPER1
prerank,"GO_Biological_Process_2021__positive regulation of DNA-templated transcription, initiation (GO:2000144)",0.5152912118455846,1.1276515564412968,0.3225806451612903,0.8275290166747454,1.0,4/21,13.63%,MED17;MITF;TWIST1;MED16
prerank,Reactome_2022__IRS-mediated Signaling R-HSA-112399,0.47054886924991046,1.1276062062648604,0.21428571428571427,0.8271254968471973,1.0,9/39,10.67%,FGF10;THEM4;FGFR1;IRS1;FGF17;FGF18;AKT2;FGFR3;IRS2
prerank,GO_Biological_Process_2021__steroid hormone mediated signaling pathway (GO:0043401),-0.6126577090360859,-1.127587341837874,0.3392857142857143,1.0,1.0,2/13,5.18%,ESR1;GPER1
prerank,Reactome_2022__Post-transcriptional Silencing By Small RNAs R-HSA-426496,0.6841567929710284,1.1273749564416897,0.3611111111111111,0.8274344890308364,1.0,4/7,20.09%,TNRC6C;TNRC6A;AGO3;AGO2
prerank,KEGG_2021_Human__Glycosaminoglycan degradation,0.5687274492762759,1.1273662274641054,0.3125,0.8269514492458236,1.0,5/15,15.54%,SPAM1;HPSE;ARSB;GLB1;HPSE2
prerank,CellMarker_Augmented_2021__Flk1+ Mesodermal cell:Pluripotent Stem Cell,0.39152647890978615,1.127337646370566,0.13043478260869565,0.8265489918822752,1.0,31/96,16.74%,ALDH7A1;MID1;IL17RD;PCLO;DSP;CKMT1A;AADAT;ESRP1;KIAA1671;LRP6;FGFR3;WNK2;STOX2;COBL;DDAH1;CLDN12;TSPAN6;RBFOX2;LRIG3;ZNF704;TSPAN12;MAGI1;MAGI3;PTPRF;PPP1R9A;CGN;FRAS1;ZNRF3;WWC1;CKMT1B;MARK1
prerank,Reactome_2022__Branched-chain Amino Acid Catabolism R-HSA-70895,0.5708985367311785,1.1272811482101603,0.3125,0.8261647815828632,1.0,9/20,22.55%,SOAT1;BCKDK;BCAT1;ECHS1;HIBADH;HIBCH;BCKDHB;MCCC1;DBT
prerank,Reactome_2022__Neurotransmitter Clearance R-HSA-112311,0.6945153450787984,1.1272604147963032,0.375,0.8257366309673694,1.0,1/9,0.56%,BCHE
prerank,PanglaoDB_Augmented_2021__Motor Neurons,0.43901924584293817,1.1271543625104186,0.22580645161290322,0.8255752083592376,1.0,23/70,25.43%,POU3F2;MID1;DLX1;TENM3;AADAT;CSPG5;RIMS4;RBFOX2;FJX1;NR2F2;MPP2;MSI1;SRRM3;EFNA2;CDR2L;FOXO6;RCOR2;CBARP;ABCG4;TUBB2B;FZD7;IGDCC4;B4GALNT1
prerank,"Reactome_2022__Formation Of Ternary Complex, And Subsequently, 43S Complex R-HSA-72695",-0.5156854358787499,-1.1271440618535145,0.30303030303030304,1.0,1.0,25/46,27.12%,RPS4X;RPS9;FAU;RPS27;RPS21;EIF2S3;RPS16;RPS20;EIF2S2;RPS8;RPS27A;RPS7;RPS11;RPS14;RPS15;RPS12;RPS13;EIF1AX;RPS3;RPSA;RPS28;RPS19;RPS24;RPS3A;RPS6
prerank,GO_Biological_Process_2021__ribosome localization (GO:0033750),-0.7343948899074794,-1.1271307003691104,0.3392857142857143,1.0,1.0,1/5,5.98%,EIF6
prerank,GO_Biological_Process_2021__transferrin transport (GO:0033572),0.45751846867267154,1.127060040781605,0.32,0.825431714610913,1.0,3/33,4.24%,ATP6V0D2;TCIRG1;REP15
prerank,PanglaoDB_Augmented_2021__Cholangiocytes,-0.4549390843510148,-1.1270069800233598,0.34545454545454546,1.0,1.0,23/73,21.90%,MISP;CAPN8;SCTR;SMIM22;TMC4;MUC5B;MYO5B;AQP4;SOWAHB;ITGB6;GPX2;TJP3;CD24;SCNN1A;LGALS4;CAPN13;SLC44A3;FAM3D;ACE2;CBLC;HNF1B;SOX9;ALB
prerank,CellMarker_Augmented_2021__B cell:Bone Marrow,0.7135431113151046,1.1270015001330307,0.28205128205128205,0.8251554385331491,1.0,2/7,2.31%,BCL6;BCL2
prerank,GO_Biological_Process_2021__regulation of pattern recognition receptor signaling pathway (GO:0062207),0.6252099342909909,1.1269745557612094,0.3,0.8247466159737775,1.0,4/7,34.60%,ZDHHC5;SLC15A4;XIAP;SLC15A2
prerank,Reactome_2022__Platelet Adhesion To Exposed Collagen R-HSA-75892,-0.6653308426045847,-1.1269532519947958,0.3050847457627119,1.0,1.0,2/9,10.59%,GP1BA;VWF
prerank,Reactome_2022__Chondroitin Sulfate Biosynthesis R-HSA-2022870,0.554128076127987,1.126570473366616,0.36666666666666664,0.8253917842731071,1.0,9/19,10.94%,VCAN;CSGALNACT1;CHSY3;CHSY1;CHST12;CHPF2;CHST11;CSPG5;CHST3
prerank,GO_Biological_Process_2021__negative regulation of erythrocyte differentiation (GO:0045647),0.7463330828201747,1.1264327986379874,0.3333333333333333,0.8251602607747446,1.0,1/5,2.49%,MAFB
prerank,GO_Biological_Process_2021__sensory perception of taste (GO:0050909),-0.6827653155100818,-1.12615125176162,0.3103448275862069,1.0,1.0,3/9,22.20%,GNAT3;PKD1L3;TAS1R1
prerank,GO_Biological_Process_2021__negative regulation of glycoprotein biosynthetic process (GO:0010561),-0.7032835463748267,-1.1261213592602506,0.3220338983050847,1.0,1.0,3/8,15.29%,ITM2A;BACE2;ITM2C
prerank,CellMarker_Augmented_2021__Paneth cell:Large Intestine,-0.4305522621485737,-1.1260785907283093,0.2247191011235955,1.0,1.0,50/231,15.75%,EOLA1;C1QB;SLC37A2;GMFG;LYVE1;ITGB2;HCK;MMP9;TNFRSF1B;LOC100130357;SNN;CPVL;DOCK2;PTAFR;SLCO2B1;HLA-DMA;DAB2;MS4A4A;FCGR3A;PLAU;INPP5D;WAS;LY86;LPAR6;CD37;NFAM1;SOD2;HLA-DPB1;IGSF6;FAM110A;HLA-DRB1;PTPRC;FPR1;CTSZ;SPI1;ATF5;ITGAM;CXCL16;TLR2;EYA2;F13A1;HLA-DPA1;NLRP3;GNL3;OGFRL1;LCP1;ADCY7;IKZF1;FMNL1;CD4
prerank,GO_Biological_Process_2021__cellular response to interleukin-6 (GO:0071354),0.5116931292549662,1.1260366651722593,0.3076923076923077,0.8261581234264239,1.0,7/24,15.86%,SELPLG;PID1;FER;NFKB1;PTPRT;ST3GAL6;PTGIS
prerank,"KEGG_2021_Human__Parathyroid hormone synthesis, secretion and action",0.4150941300331328,1.1260046754967021,0.16,0.8257585118392813,1.0,30/91,21.96%,ITPR2;BCL2;FGFR1;MAFB;MMP17;CREB3L2;CREB3L4;ARRB2;PLCB1;SP1;ADCY2;NR4A2;LRP6;PDE4B;ADCY3;MMP16;ARRB1;MMP24;BRAF;ADCY6;CREB1;GNAQ;PLD2;RAF1;FOS;GNAI2;GNAS;GNA12;GNA11;PDE4D
prerank,Reactome_2022__CDC6 Association With ORC:origin Complex R-HSA-68689,-0.6853164669847933,-1.1259046091640332,0.43333333333333335,1.0,1.0,2/6,20.96%,CDC6;ORC6
prerank,GO_Biological_Process_2021__negative regulation of amyloid precursor protein biosynthetic process (GO:0042985),-0.7333676533322733,-1.1258936071653167,0.34615384615384615,1.0,1.0,3/6,15.29%,ITM2A;BACE2;ITM2C
prerank,GO_Biological_Process_2021__neuron projection arborization (GO:0140058),0.636777081043435,1.1257472028477278,0.38095238095238093,0.8261542606893987,1.0,2/6,7.76%,NLGN1;PHACTR1
prerank,Reactome_2022__Telomere Extension By Telomerase R-HSA-171319,-0.5292610477992803,-1.1257381542100595,0.36764705882352944,1.0,1.0,3/22,10.90%,TERF2IP;TERT;PIF1
prerank,GO_Biological_Process_2021__protein modification by small protein conjugation or removal (GO:0070647),0.5876885323656826,1.1255539277642714,0.3157894736842105,0.8262494284779002,1.0,4/12,28.09%,SENP6;DESI2;SAE1;ATG7
prerank,GO_Biological_Process_2021__regulation of trophoblast cell migration (GO:1901163),-0.6266792528013072,-1.1252794716701875,0.3382352941176471,1.0,1.0,1/13,1.82%,NODAL
prerank,GO_Biological_Process_2021__positive regulation of glucose import (GO:0046326),0.4703119999015837,1.1249151658117087,0.29545454545454547,0.827764774649281,1.0,5/20,14.95%,IRS1;CAPN10;AKT2;IRS2;INSR
prerank,GO_Biological_Process_2021__immune response-regulating cell surface receptor signaling pathway (GO:0002768),-0.6389081462888782,-1.1248377147494992,0.391304347826087,1.0,1.0,1/8,0.36%,MICB
prerank,Reactome_2022__Synthesis Of PIPs At Early Endosome Membrane R-HSA-1660516,0.5958480238445358,1.1246515032251965,0.3684210526315789,0.8281321921963468,1.0,10/16,37.89%,PI4K2B;MTM1;PIK3R4;VAC14;INPP4B;INPP4A;PIK3C3;MTMR12;MTMR10;PIKFYVE
prerank,GO_Biological_Process_2021__regulation of endodeoxyribonuclease activity (GO:0032071),0.6583937034051914,1.124540008549709,0.3157894736842105,0.8280586124718796,1.0,2/7,6.42%,SIRT1;HMGB1
prerank,GO_Biological_Process_2021__cell migration involved in heart development (GO:0060973),0.6890557622779747,1.1242422880633671,0.3170731707317073,0.8285575161205784,1.0,2/5,16.67%,SNAI2;NOTCH1
prerank,GO_Biological_Process_2021__lymphocyte chemotaxis (GO:0048247),-0.5556516728826234,-1.1239188469823551,0.2807017543859649,1.0,1.0,5/15,12.28%,MSMP;CXCL13;GPR183;HSD3B7;CXCL16
prerank,GO_Biological_Process_2021__endoderm formation (GO:0001706),0.48240624729784853,1.123917279238467,0.29545454545454547,0.8290910365194298,1.0,7/29,4.75%,COL8A1;DUSP4;DUSP2;LAMA3;COL12A1;ITGA4;MMP2
prerank,GO_Biological_Process_2021__regulation of glucose transmembrane transport (GO:0010827),0.5814004619418481,1.1238522183573965,0.2619047619047619,0.8288323121220781,1.0,6/15,21.55%,RTN2;NR4A3;CLIP3;BRAF;PRKAG2;OCLN
prerank,GO_Biological_Process_2021__gluconeogenesis (GO:0006094),0.514775221111352,1.1237813236958452,0.20689655172413793,0.8286178446589164,1.0,8/35,11.59%,PER2;FBP2;PC;ENO3;CRY1;G6PC3;SLC25A1;SLC25A12
prerank,GO_Biological_Process_2021__positive regulation of histone H3-K4 methylation (GO:0051571),0.5650219091441917,1.1236197898021076,0.4,0.828614479151287,1.0,2/13,4.97%,AUTS2;DNMT1
prerank,CellMarker_Augmented_2021__Red Blood Cell (erythrocyte):Placenta,-0.5309340597323798,-1.1234798724559736,0.3220338983050847,1.0,1.0,20/40,18.96%,RASGRP4;SLFN14;GYPB;FCGR3A;CA1;SELP;MYO1F;FPR1;ALAS2;ITGA2B;SLC11A1;SPI1;CLEC12A;ADGRE3;HK3;CMTM2;PGLYRP1;SLC4A1;CLEC1B;P2RX1
prerank,GO_Biological_Process_2021__regulation of lipid storage (GO:0010883),0.4990160661118,1.1234185588568473,0.30303030303030304,0.8286462386516227,1.0,5/16,14.09%,APOB;PLIN5;SIRT1;LPL;NFKB1
prerank,GO_Biological_Process_2021__cellular divalent inorganic cation homeostasis (GO:0072503),0.4081584850850474,1.1232363992350638,0.25,0.8286516355531792,1.0,10/86,7.29%,MT1G;CDH5;SLC30A10;RGN;SLC39A8;HTR2C;SLC8A1;DRD5;SLC8A3;DRD4
prerank,Reactome_2022__IRE1alpha Activates Chaperones R-HSA-381070,0.42994699980544643,1.1231758359642587,0.26666666666666666,0.8283588471115105,1.0,12/46,20.34%,EXTL1;PDIA6;CTDSP2;ERN1;ACD;PREB;YIF1A;DNAJC3;CXXC1;EDEM1;ADD1;ACADVL
prerank,"GO_Biological_Process_2021__mitochondrial electron transport, cytochrome c to oxygen (GO:0006123)",-0.6211215239124981,-1.1231275662649043,0.35294117647058826,1.0,1.0,4/12,18.81%,COX6A1;COX6C;COX7C;COX4I1
prerank,"Reactome_2022__Gamma Carboxylation, Hypusine Formation And Arylsulfatase Activation R-HSA-163841",-0.5368562684155047,-1.1230838665399794,0.30666666666666664,1.0,1.0,3/39,1.83%,F8;ARSH;F7
prerank,GO_Biological_Process_2021__positive regulation of actin filament depolymerization (GO:0030836),0.56222081106651,1.1229745157810964,0.34146341463414637,0.8283994653840656,1.0,3/11,8.07%,SEMA5A;WASHC2C;CRACD
prerank,GO_Biological_Process_2021__membrane invagination (GO:0010324),0.6739170255086776,1.1229214651973671,0.38095238095238093,0.8280458495141633,1.0,2/6,27.31%,SMURF1;FNBP1L
prerank,Reactome_2022__Pre-NOTCH Expression And Processing R-HSA-1912422,0.45152422416706417,1.122836213976314,0.29411764705882354,0.8277889478097219,1.0,22/56,20.09%,RFNG;MAML1;H2BC21;ST3GAL3;POFUT1;MOV10;MAMLD1;TNRC6C;H2AX;FURIN;ST3GAL6;TP53;RUNX1;TNRC6A;NOTCH1;AGO3;RBPJ;SIRT6;EP300;KAT2B;H2AJ;AGO2
prerank,GO_Biological_Process_2021__pericardium development (GO:0060039),0.6440971981746222,1.1228194443704167,0.4,0.827383605814368,1.0,3/6,25.69%,LRP6;NOTCH1;BMP2
prerank,CellMarker_Augmented_2021__Thymocyte:Undefined,-0.5010476236102097,-1.1227433075786004,0.2535211267605634,1.0,1.0,12/53,10.28%,GMFG;IRF4;CYTIP;TBC1D10C;ARHGAP9;TAGAP;GPR183;PARVG;WAS;CD37;TRAF3IP3;PTPRC
prerank,GO_Biological_Process_2021__protein localization to microtubule cytoskeleton (GO:0072698),0.6501377874330594,1.1223164112600832,0.4523809523809524,0.8282903890556581,1.0,2/8,9.27%,MID1;MAPRE1
prerank,GO_Biological_Process_2021__modulation by symbiont of entry into host (GO:0052372),-0.626481331270642,-1.1222638840375654,0.34615384615384615,1.0,1.0,3/14,6.02%,TRIM62;TRIM5;TRIM25
prerank,GO_Biological_Process_2021__regulation of interleukin-13 production (GO:0032656),-0.6427678283343037,-1.122197223150435,0.3508771929824561,1.0,1.0,3/11,15.16%,IRF4;LEF1;IL18
prerank,Reactome_2022__TP53 Regulates Transcription Of Genes Involved In G2 Cell Cycle Arrest R-HSA-6804114,0.5877516345477422,1.1220389990975654,0.3235294117647059,0.8287416727410309,1.0,7/18,21.88%,REXO2;RBL1;CARM1;GADD45A;TP53;EP300;TFDP1
prerank,Reactome_2022__Defective CHSY1 Causes TPBS R-HSA-3595177,0.6453317528423601,1.1219461030465436,0.3125,0.8284238257879704,1.0,3/8,10.78%,VCAN;CHSY1;CSPG5
prerank,GO_Biological_Process_2021__wound healing (GO:0042060),0.44869729947041137,1.121898183165457,0.25806451612903225,0.8280365174164682,1.0,13/54,13.81%,FGF10;TSKU;TGFBR1;CFLAR;DCBLD2;ERBB2;NRG1;HPSE;DSP;PLEC;MACF1;DST;NF1
prerank,GO_Biological_Process_2021__regulation of protein K63-linked ubiquitination (GO:1900044),-0.7102439551989923,-1.1218423989463673,0.3275862068965517,1.0,1.0,3/7,21.48%,DDX3X;GPS2;PARP10
prerank,KEGG_2021_Human__Legionellosis,-0.5092990338754445,-1.121685112769141,0.30985915492957744,1.0,1.0,11/41,16.55%,HSPA1L;ITGB2;NFKB2;CASP7;NLRC4;ITGAM;HSPA8;TLR2;IL12A;IL18;NAIP
prerank,GO_Biological_Process_2021__prostaglandin transport (GO:0015732),-0.741358214244924,-1.1216720357554728,0.2909090909090909,1.0,1.0,2/5,14.17%,SLCO2A1;NOS2
prerank,Reactome_2022__Immunoregulatory Interactions Between A Lymphoid And A non-Lymphoid Cell R-HSA-198933,-0.4887470154651104,-1.1215656623945542,0.3230769230769231,1.0,1.0,16/54,19.12%,MICB;ITGB2;KLRB1;CD160;OSCAR;ICAM3;HLA-A;CD300LF;SH2D1B;COLEC12;HLA-F;LAIR2;CD8B;CLEC1B;CD81;CRTAM
prerank,GO_Biological_Process_2021__regulation of leukocyte activation (GO:0002694),-0.6241521263006508,-1.1214449970064224,0.3728813559322034,1.0,1.0,2/11,6.32%,GPER1;PLA2G10
prerank,Reactome_2022__Signaling By FLT3 ITD And TKD Mutants R-HSA-9703648,0.5447152170188054,1.1213982080146416,0.3684210526315789,0.8292723150249475,1.0,4/15,14.95%,NOX4;STAT5B;FLT3;PIK3CA
prerank,PanglaoDB_Augmented_2021__Adrenergic Neurons,0.43738105531554694,1.1212169096087654,0.2962962962962963,0.8293732199887084,1.0,22/95,13.97%,GCK;HGFAC;XKR7;GOLT1A;PLPPR1;CACNG4;HRH3;SEMA6C;PTOV1;REEP6;SYT1;SARDH;ABCC8;PDE9A;WNK2;HID1;EBF4;FAM163B;PRR36;CRABP1;FBLL1;HCN3
prerank,GO_Biological_Process_2021__cellular response to oxidised low-density lipoprotein particle stimulus (GO:0140052),0.7206629879508293,1.1212044713766356,0.40476190476190477,0.8289424664673615,1.0,3/5,27.48%,TICAM1;MIA3;AKT1
prerank,GO_Biological_Process_2021__canonical Wnt signaling pathway (GO:0060070),-0.46964963629478096,-1.1211600648914788,0.3150684931506849,1.0,1.0,10/60,13.80%,TCF7;WNT5A;WNT8B;FZD8;TCF7L1;FRAT1;SFRP4;WNT8A;WNT6;LEF1
prerank,CellMarker_Augmented_2021__Myogenic Endothelial cell:Skeletal Muscle,-0.49783796814881637,-1.1210193459064215,0.24096385542168675,1.0,1.0,19/69,14.86%,C1QB;CYYR1;LYVE1;SLCO2B1;MS4A4A;FCGR3A;CLDN5;ZNF366;P2RY14;VSIG4;SELP;PTPRC;VWF;GPIHBP1;F13A1;HLA-DPA1;TEK;A2M;ADGRF5
prerank,GO_Biological_Process_2021__positive regulation of mitotic nuclear division (GO:0045840),0.5042136869729027,1.1208612286237376,0.30303030303030304,0.8293830858045601,1.0,11/27,26.65%,TGFA;INSR;ESPL1;NSMCE2;ANAPC7;DMRT1;ANAPC4;EDN1;RB1;BTC;PHIP
prerank,GO_Biological_Process_2021__proteoglycan biosynthetic process (GO:0030166),0.5024443315351925,1.1206376058054133,0.34782608695652173,0.8295359721168756,1.0,11/29,13.70%,CSGALNACT1;HS3ST3B1;EXT1;NDST3;CHST12;CHST11;B3GAT3;UGDH;EXT2;FAM20B;CHST8
prerank,Reactome_2022__Translation Initiation Complex Formation R-HSA-72649,-0.4964259709581962,-1.1205432151074606,0.3333333333333333,1.0,1.0,26/52,27.12%,RPS4X;RPS9;FAU;RPS27;RPS21;EIF2S3;RPS16;RPS20;EIF2S2;RPS8;RPS27A;EIF4A2;RPS7;RPS11;RPS14;RPS15;RPS12;RPS13;EIF1AX;RPS3;RPSA;RPS28;RPS19;RPS24;RPS3A;RPS6
prerank,CellMarker_Augmented_2021__Multilymphoid Progenitor cell:Umbilical Cord Blood,0.37847297817789843,1.120358767068765,0.07692307692307693,0.8299322411066784,1.0,98/472,17.15%,IL7R;DGKD;DUSP4;TPM2;DUSP2;GSDMB;BCL6;ABCA9;MAFB;MIDN;RNASET2;BCL2A1;RAB31;AUTS2;EXT1;DDAH2;SPON1;CCDC88B;ADAMTS6;CMYA5;CADM2;NEGR1;GRIK1;SSBP3;ITPKB;ARRB2;MDGA2;HES1;STX6;ANKRD13D;ZBTB4;TMEM106A;TRIM71;MAN1A2;RAPGEF1;KDM7A;ZNF274;ARPP21;WWOX;PIK3C2B;OCIAD2;BDP1;PDE7A;PCDH9;TRIB2;SIPA1;FOXN3;MYO9B;HIVEP3;TENM1;ZNF133;TFE3;PDE9A;PAG1;CROCC;DIPK1A;COTL1;AKAP7;CABLES2;SLC7A6;KDM2A;SLC35E3;EVL;PIM2;AVIL;USP36;DPF1;SGIP1;SMARCA4;JUNB;DPP9;SRSF4;FAM222B;CSMD1;NR3C1;RPS6KA2;YTHDF1;LAIR1;ZC3H13;CXXC5;FURIN;HHLA1;IL23A;ACIN1;SUSD1;FCHSD2;UBE2Z;LSM7;DIP2B;MED13L;WDR53;MINAR1;MPHOSPH8;NOTCH1;ATM;ARID5B;ATN1;HIVEP1
prerank,GO_Biological_Process_2021__negative regulation of cellular amide metabolic process (GO:0034249),0.42951550561941887,1.1202350242858878,0.30303030303030304,0.8298412117270535,1.0,23/82,20.92%,APOE;BIN1;SAMD4A;PCIF1;DHFR;TRIM71;RIDA;EIF2AK3;NANOS3;CNOT9;RTN2;PUS7;MALSU1;SYNCRIP;LSM14A;ABCA7;SAMD4B;EIF4A3;NANOS1;RNF139;FXR2;NTRK2;LARP1
prerank,GO_Biological_Process_2021__regulation of protein kinase A signaling (GO:0010738),0.5676425200867097,1.120084459027445,0.24,0.8297502880726081,1.0,6/16,19.16%,PRKAR2A;AKAP7;ADGRV1;TCIM;IAPP;AKAP12
prerank,GO_Biological_Process_2021__detection of mechanical stimulus involved in sensory perception of sound (GO:0050910),0.6199997170469763,1.1200665338253797,0.3170731707317073,0.8293642329298112,1.0,4/9,14.36%,KIT;WHRN;ADGRV1;PDZD7
prerank,Reactome_2022__Dopamine Neurotransmitter Release Cycle R-HSA-212676,0.526986389742494,1.1199686706216962,0.3,0.8291869073726466,1.0,9/22,21.25%,PPFIA3;SYT1;UNC13B;APBA1;SYN2;SYN1;PPFIA2;LIN7A;CASK
prerank,GO_Biological_Process_2021__rhodopsin mediated signaling pathway (GO:0016056),-0.66622478975671,-1.1199072702976323,0.41379310344827586,1.0,1.0,5/8,23.57%,PDE6B;GNGT1;PDE6A;PDE6G;CNGB1
prerank,PanglaoDB_Augmented_2021__Oligodendrocytes,-0.43144252185873005,-1.1199011105283654,0.1891891891891892,1.0,1.0,9/169,7.24%,GPR62;ENPP2;GJC3;NFE2L3;PPP1R1B;SOX10;SHISA6;SOWAHA;LGI4
prerank,Reactome_2022__HCMV Late Events R-HSA-9610379,0.4632008403776579,1.1196909666637185,0.2413793103448276,0.8294694762473671,1.0,8/67,10.02%,NUP210;IRS1;NUP42;H2BC21;MVB12A;CHMP6;UBAP1;AAAS
prerank,GO_Biological_Process_2021__regulation of extracellular matrix assembly (GO:1901201),-0.6853130069916136,-1.1196668827862213,0.40625,1.0,1.0,3/7,16.15%,TGFB1;AGT;SMAD3
prerank,Reactome_2022__RNA Polymerase III Abortive And Retractive Initiation R-HSA-749476,0.44979025258354005,1.1196566406947175,0.3125,0.8290495814143592,1.0,12/39,22.28%,BDP1;NFIB;SNAPC3;GTF3C4;POLR3G;GTF3C5;POLR3D;POLR3K;POU2F1;POLR3B;NFIX;POLR2F
prerank,GO_Biological_Process_2021__mitotic G2 DNA damage checkpoint signaling (GO:0007095),-0.5497446601393499,-1.1196334865780666,0.328125,1.0,1.0,6/30,12.07%,TICRR;DTL;DONSON;ABRAXAS1;BRCA1;CDKN1A
prerank,GO_Biological_Process_2021__termination of RNA polymerase II transcription (GO:0006369),0.4922945424904489,1.1195323882474162,0.29411764705882354,0.8290026960354101,1.0,5/32,12.78%,CPSF1;LSM10;PCF11;SNRPB;CPSF7
prerank,Reactome_2022__Influenza Viral RNA Transcription And Replication R-HSA-168273,-0.4390635305202071,-1.1193746835406306,0.23170731707317074,1.0,1.0,58/127,27.12%,RPL37A;RPL38;RPL15;RPS4X;RPL3;RPL35A;GNL3;RPS9;FAU;RPS27;RPS21;RPL13A;RPL27A;RPS16;RPL36;RPS20;RPL7A;RPL9;RPS8;RPS27A;RPL21;RPL34;RPL4;RPL32;RPL5;RPL23;RPL41;RPS7;RPS11;NUP93;RPL27;RPL35;RPS14;RPL11;SEC13;RPS15;RPLP1;RPS12;POLR2B;RPL18A;RPS13;RPL29;RPLP2;RPL28;RPL12;RPL18;RPS3;RPL22;RPSA;RPS28;RPS19;NDC1;RPS24;RPL26L1;RPS3A;RPL19;RPL8;RPS6
prerank,GO_Biological_Process_2021__programmed necrotic cell death (GO:0097300),0.5772218721122333,1.119296932141637,0.3103448275862069,0.8291376895651328,1.0,5/14,21.12%,CD14;TICAM2;TICAM1;ITPK1;TRPM7
prerank,GO_Biological_Process_2021__positive regulation of RNA export from nucleus (GO:0046833),0.7424947904498731,1.119192057264891,0.4166666666666667,0.8284472463921216,1.0,3/5,22.12%,KHDRBS1;CPSF6;NRDE2
prerank,GO_Biological_Process_2021__positive regulation of nucleobase-containing compound transport (GO:0032241),0.7424947904498731,1.119192057264891,0.4166666666666667,0.8284472463921216,1.0,3/5,22.12%,KHDRBS1;CPSF6;NRDE2
prerank,GO_Biological_Process_2021__cellular protein complex disassembly (GO:0043624),0.6478781283716228,1.1191100845929027,0.39215686274509803,0.8282538810453322,1.0,3/6,31.62%,ETF1;PEX14;TRMT112
prerank,GO_Biological_Process_2021__RNA polymerase II preinitiation complex assembly (GO:0051123),-0.6583756063643712,-1.1190716983447966,0.3508771929824561,1.0,1.0,2/9,9.14%,TAF7;TAF7L
prerank,GO_Biological_Process_2021__regulation of establishment of cell polarity (GO:2000114),0.6089710754404156,1.1189345996521531,0.3235294117647059,0.8282248670685438,1.0,2/15,9.71%,CDH5;KANK1
prerank,GO_Biological_Process_2021__regulation of fibroblast migration (GO:0010762),-0.5606350554096771,-1.1186370535206493,0.33783783783783783,1.0,1.0,3/21,17.19%,TGFB1;THBS1;RAC1
prerank,CellMarker_Augmented_2021__Cardiovascular Progenitor cell:Heart,0.4179073211917919,1.1185264839295574,0.16666666666666666,0.8288174867409124,1.0,12/73,7.93%,PDLIM3;ADAMTS1;ST6GALNAC3;PCDH17;ADGRL2;CDH5;EPHA7;QRFPR;CGNL1;FGD5;SLIT2;EDNRA
prerank,GO_Biological_Process_2021__regulation of immune effector process (GO:0002697),-0.5339085933995097,-1.118294007806108,0.2903225806451613,1.0,1.0,10/34,14.21%,C1QB;IRF4;VTN;C3AR1;CPB2;CLU;C4BPA;HLA-DRB1;C4BPB;C1S
prerank,GO_Biological_Process_2021__negative regulation of epithelial cell migration (GO:0010633),0.4834685386877653,1.1182299596344558,0.32432432432432434,0.8293317676733162,1.0,10/27,14.40%,APOH;APOE;VASH1;SLIT2;PTPRR;PTPRM;ADIPOR1;EVL;NR2F2;PTPN23
prerank,Reactome_2022__CD28 Dependent PI3K/Akt Signaling R-HSA-389357,0.5161061207869762,1.1181044978674617,0.23076923076923078,0.8292245721515987,1.0,4/20,9.44%,THEM4;MAP3K14;MLST8;AKT2
prerank,"Reactome_2022__Transport Of Bile Salts And Organic Acids, Metal Ions And Amine Compounds R-HSA-425366",-0.45397844138037,-1.1177891278365026,0.2857142857142857,1.0,1.0,17/66,15.86%,SLC22A8;SLC22A6;SLC16A8;SLC14A1;SLC13A4;SLC6A12;SLC39A7;SLC22A7;CP;SLC18A2;SLC11A1;SLC16A3;SLC47A2;SLC14A2;SLC22A3;SLC22A4;RHBG
prerank,GO_Biological_Process_2021__one-carbon compound transport (GO:0019755),-0.7234669627432126,-1.1175798846859544,0.38181818181818183,1.0,1.0,4/6,15.61%,SLC14A1;UPK3A;SLC14A2;AQP11
prerank,GO_Biological_Process_2021__negative regulation of gene silencing by miRNA (GO:0060965),-0.6587296709354524,-1.1174774013560036,0.3333333333333333,1.0,1.0,3/9,10.71%,TGFB1;ESR1;TERT
prerank,GO_Biological_Process_2021__antibacterial humoral response (GO:0019731),-0.6098477068537516,-1.1173870354630058,0.3492063492063492,1.0,1.0,3/13,7.32%,JCHAIN;SFTPD;HLA-A
prerank,Reactome_2022__Regulation Of Signaling By NODAL R-HSA-1433617,-0.691818048467485,-1.1172677533954065,0.3870967741935484,1.0,1.0,1/8,1.82%,NODAL
prerank,CellMarker_Augmented_2021__Muscle Satellite cell:Muscle,0.42193154302385266,1.1172006388516131,0.25925925925925924,0.8316082224281675,1.0,26/84,15.93%,COL22A1;MEGF10;EMP1;MXRA5;RIN2;CHST6;HS3ST1;CAPN2;PTPRZ1;PDLIM4;EFS;TEX26;ADGRA1;CXCL14;VWA2;CDCP1;CAMK1G;HYDIN;RBFOX1;NAV1;TPPP3;WLS;PTPRT;NCAM1;TCN2;C6ORF118
prerank,GO_Biological_Process_2021__male meiosis I (GO:0007141),-0.5786559772673726,-1.117134674130284,0.3076923076923077,1.0,1.0,5/15,17.23%,SLC25A31;BTBD18;MEIOC;SYCP3;MOV10L1
prerank,GO_Biological_Process_2021__cardiolipin biosynthetic process (GO:0032049),0.7011506703060155,1.1171068084024691,0.43902439024390244,0.8314481590379711,1.0,2/5,11.05%,PGS1;CRLS1
prerank,GO_Biological_Process_2021__tetrahydrofolate interconversion (GO:0035999),0.6500727480839693,1.116986207297055,0.40625,0.8314260158186669,1.0,4/9,25.77%,MTHFR;SHMT2;MTHFD1L;MTHFD2L
prerank,Reactome_2022__Leading Strand Synthesis R-HSA-69109,0.6099055248965892,1.1168535924865823,0.35135135135135137,0.8313436732272885,1.0,2/13,6.48%,SLC19A1;POLD3
prerank,CellMarker_Augmented_2021__Endothelial cell:Bladder,-0.4762376310065884,-1.1167469425682959,0.30864197530864196,1.0,1.0,16/64,14.86%,C1QB;CYYR1;GALNT15;LYVE1;ANGPT2;DCN;CLDN5;ASPN;ITGA9;VWF;GPIHBP1;COX7A1;TEK;A2M;GGT5;ADGRF5
prerank,CellMarker_Augmented_2021__Hematopoietic Progenitor cell:Bone Marrow,-0.4762376310065884,-1.1167469425682959,0.30864197530864196,1.0,1.0,16/64,14.86%,C1QB;CYYR1;GALNT15;LYVE1;ANGPT2;DCN;CLDN5;ASPN;ITGA9;VWF;GPIHBP1;COX7A1;TEK;A2M;GGT5;ADGRF5
prerank,CellMarker_Augmented_2021__Progenitor-like Angiogenesis-Promoting cell:Blood,-0.4762376310065884,-1.1167469425682959,0.30864197530864196,1.0,1.0,16/64,14.86%,C1QB;CYYR1;GALNT15;LYVE1;ANGPT2;DCN;CLDN5;ASPN;ITGA9;VWF;GPIHBP1;COX7A1;TEK;A2M;GGT5;ADGRF5
prerank,CellMarker_Augmented_2021__Cardiomyocyte Progenitor cell:Myocardium,-0.4762376310065884,-1.1167469425682959,0.30864197530864196,1.0,1.0,16/64,14.86%,C1QB;CYYR1;GALNT15;LYVE1;ANGPT2;DCN;CLDN5;ASPN;ITGA9;VWF;GPIHBP1;COX7A1;TEK;A2M;GGT5;ADGRF5
prerank,CellMarker_Augmented_2021__Monocyte:Umbilical Cord Blood,-0.4762376310065884,-1.1167469425682959,0.30864197530864196,1.0,1.0,16/64,14.86%,C1QB;CYYR1;GALNT15;LYVE1;ANGPT2;DCN;CLDN5;ASPN;ITGA9;VWF;GPIHBP1;COX7A1;TEK;A2M;GGT5;ADGRF5
prerank,CellMarker_Augmented_2021__Submandibular Gland Stem cell:Submandibular Gland,-0.4762376310065884,-1.1167469425682959,0.30864197530864196,1.0,1.0,16/64,14.86%,C1QB;CYYR1;GALNT15;LYVE1;ANGPT2;DCN;CLDN5;ASPN;ITGA9;VWF;GPIHBP1;COX7A1;TEK;A2M;GGT5;ADGRF5
prerank,CellMarker_Augmented_2021__Dendritic cell:Umbilical Cord Blood,-0.4762376310065884,-1.1167469425682959,0.30864197530864196,1.0,1.0,16/64,14.86%,C1QB;CYYR1;GALNT15;LYVE1;ANGPT2;DCN;CLDN5;ASPN;ITGA9;VWF;GPIHBP1;COX7A1;TEK;A2M;GGT5;ADGRF5
prerank,CellMarker_Augmented_2021__Hematopoietic Stem cell:Peripheral Blood,-0.4762376310065884,-1.1167469425682959,0.30864197530864196,1.0,1.0,16/64,14.86%,C1QB;CYYR1;GALNT15;LYVE1;ANGPT2;DCN;CLDN5;ASPN;ITGA9;VWF;GPIHBP1;COX7A1;TEK;A2M;GGT5;ADGRF5
prerank,CellMarker_Augmented_2021__Keratinocyte:Epithelium,-0.4762376310065884,-1.1167469425682959,0.30864197530864196,1.0,1.0,16/64,14.86%,C1QB;CYYR1;GALNT15;LYVE1;ANGPT2;DCN;CLDN5;ASPN;ITGA9;VWF;GPIHBP1;COX7A1;TEK;A2M;GGT5;ADGRF5
prerank,CellMarker_Augmented_2021__Mature Endothelial cell:Blood,-0.4762376310065884,-1.1167469425682959,0.30864197530864196,1.0,1.0,16/64,14.86%,C1QB;CYYR1;GALNT15;LYVE1;ANGPT2;DCN;CLDN5;ASPN;ITGA9;VWF;GPIHBP1;COX7A1;TEK;A2M;GGT5;ADGRF5
prerank,CellMarker_Augmented_2021__Stromal Vascular Fraction cell:Adipose Tissue,-0.4762376310065884,-1.1167469425682959,0.30864197530864196,1.0,1.0,16/64,14.86%,C1QB;CYYR1;GALNT15;LYVE1;ANGPT2;DCN;CLDN5;ASPN;ITGA9;VWF;GPIHBP1;COX7A1;TEK;A2M;GGT5;ADGRF5
prerank,CellMarker_Augmented_2021__Endothelial Progenitor cell:Adipose Tissue,-0.4762376310065884,-1.1167469425682959,0.30864197530864196,1.0,1.0,16/64,14.86%,C1QB;CYYR1;GALNT15;LYVE1;ANGPT2;DCN;CLDN5;ASPN;ITGA9;VWF;GPIHBP1;COX7A1;TEK;A2M;GGT5;ADGRF5
prerank,CellMarker_Augmented_2021__Hematopoietic Stem cell:Periodontal Ligament,-0.4762376310065884,-1.1167469425682959,0.30864197530864196,1.0,1.0,16/64,14.86%,C1QB;CYYR1;GALNT15;LYVE1;ANGPT2;DCN;CLDN5;ASPN;ITGA9;VWF;GPIHBP1;COX7A1;TEK;A2M;GGT5;ADGRF5
prerank,CellMarker_Augmented_2021__Hematopoietic Progenitor cell:Umbilical Cord Blood,-0.4762376310065884,-1.1167469425682959,0.30864197530864196,1.0,1.0,16/64,14.86%,C1QB;CYYR1;GALNT15;LYVE1;ANGPT2;DCN;CLDN5;ASPN;ITGA9;VWF;GPIHBP1;COX7A1;TEK;A2M;GGT5;ADGRF5
prerank,CellMarker_Augmented_2021__Endothelial cell:Corpus Luteum,-0.4762376310065884,-1.1167469425682959,0.30864197530864196,1.0,1.0,16/64,14.86%,C1QB;CYYR1;GALNT15;LYVE1;ANGPT2;DCN;CLDN5;ASPN;ITGA9;VWF;GPIHBP1;COX7A1;TEK;A2M;GGT5;ADGRF5
prerank,GO_Biological_Process_2021__regulation of establishment of protein localization (GO:0070201),0.61298080426477,1.1166837925071895,0.30303030303030304,0.8314935875855918,1.0,6/12,16.39%,CEP135;CEP120;CEP290;KIAA0586;SPIDR;CORO2B
prerank,Reactome_2022__Termination Of Translesion DNA Synthesis R-HSA-5656169,-0.5208798938852229,-1.1166750004385497,0.3114754098360656,1.0,1.0,9/31,21.63%,PCLAF;RPA3;UBE2L6;TRIM25;POLE2;POLD4;RPS27A;POLE3;ISG15
prerank,Reactome_2022__AMPK Inhibits chREBP Transcriptional Activity R-HSA-163680,0.7218069971375249,1.1164035934679084,0.3617021276595745,0.8318323903559282,1.0,5/7,19.98%,ADIPOR1;MLXIPL;ADIPOR2;PRKAA2;PRKAG2
prerank,GO_Biological_Process_2021__negative regulation of cell differentiation (GO:0045596),0.38413029537960147,1.1162015390440565,0.25,0.8318959647301677,1.0,30/152,10.29%,BAMBI;FOXO1;TSKU;TGFBR1;SPRED3;RORA;TWIST2;IL17RD;PPARG;SIRT1;DTX1;ADAMTS12;RORB;JAG1;USH2A;HES1;WNT9A;ANKRD26;OSR1;GREM1;CDK6;ABCA1;TRIB2;SPRED2;TWIST1;SNAI2;CRIM1;ANP32B;ADIPOR1;BBS12
prerank,GO_Biological_Process_2021__regulation of sterol biosynthetic process (GO:0106118),0.5642667818658061,1.1159151510994594,0.325,0.832285650714016,1.0,4/9,25.25%,SEC14L2;SREBF2;ABCA2;LPCAT3
prerank,GO_Biological_Process_2021__regulation of microtubule binding (GO:1904526),0.7332414224895085,1.115912354837668,0.3953488372093023,0.8318170015855327,1.0,3/5,25.01%,ABL1;MARK2;MAP2
prerank,GO_Biological_Process_2021__membrane fission (GO:0090148),0.5844752562681522,1.1156560798310557,0.39473684210526316,0.8320433808352999,1.0,4/7,28.69%,SPAST;TMCC1;SH3GLB1;CORO1C
prerank,KEGG_2021_Human__Maturity onset diabetes of the young,0.5506286921234446,1.1153634735729114,0.40476190476190477,0.8324922962122863,1.0,2/15,5.56%,GCK;HES1
prerank,GO_Biological_Process_2021__cerebral cortex cell migration (GO:0021795),0.6839322334589705,1.115362415132511,0.4339622641509434,0.8320157694256737,1.0,4/6,29.64%,PEX13;EFHC1;HTR6;FGF13
prerank,Reactome_2022__Miro GTPase Cycle R-HSA-9715370,0.6117387046292214,1.1150984561080657,0.35135135135135137,0.8323957129580035,1.0,4/8,28.22%,TRAK2;RAP1GDS1;MYO19;TRAK1
prerank,GO_Biological_Process_2021__positive regulation of JNK cascade (GO:0046330),0.4450917494169349,1.1150531348797668,0.22727272727272727,0.8320309929496295,1.0,10/58,8.99%,RASSF2;DUSP15;CCN2;TNFRSF19;SH3RF1;HMGB1;CARD9;SH3RF3;PLCB1;MAP3K10
prerank,GO_Biological_Process_2021__early endosome to Golgi transport (GO:0034498),0.56065530091851,1.115047774410462,0.37142857142857144,0.831555546667944,1.0,1/12,5.00%,STX5
prerank,GO_Biological_Process_2021__translesion synthesis (GO:0019985),-0.528887039041233,-1.1149648201503912,0.3188405797101449,1.0,1.0,12/42,21.63%,DTL;PCLAF;RPA3;UBE2L6;TRIM25;POLE2;POLD4;RPS27A;FAAP20;RPA2;PARP10;ISG15
prerank,CellMarker_Augmented_2021__Natural Memory B cell:Undefined,-0.5340075056548013,-1.11494572549515,0.3424657534246575,1.0,1.0,12/40,13.88%,SIRPG;CYTIP;TBC1D10C;ARHGAP9;TAGAP;KLRB1;CD5;CD37;TRAF3IP3;NLRC3;CD27;PSTPIP1
prerank,Reactome_2022__Diseases Associated With O-glycosylation Of Proteins R-HSA-3906995,0.43910175150845127,1.1149087036682743,0.2727272727272727,0.8314993281726052,1.0,9/59,8.68%,ADAMTS1;ADAMTS16;GALNT12;SEMA5A;SPON1;ADAMTS12;ADAMTS6;MUC13;ADAMTS10
prerank,GO_Biological_Process_2021__negative regulation of ERAD pathway (GO:1904293),-0.7082740023929028,-1.114831309693211,0.375,1.0,1.0,4/6,27.87%,SVIP;AQP11;UBXN1;USP14
prerank,GO_Biological_Process_2021__sphingoid metabolic process (GO:0046519),-0.661613020356735,-1.1147414051438873,0.3559322033898305,1.0,1.0,1/11,2.50%,DEGS2
prerank,GO_Biological_Process_2021__stem cell development (GO:0048864),0.5791877848211731,1.1145771391535464,0.358974358974359,0.8318274607707384,1.0,4/13,13.21%,TCOF1;NRG1;SNAI2;CDH2
prerank,GO_Biological_Process_2021__vesicle localization (GO:0051648),-0.7292977991594295,-1.1145579994951569,0.35,1.0,1.0,1/5,5.16%,RAB11A
prerank,CellMarker_Augmented_2021__Natural Regulatory T (Treg) cell:Blood,-0.5346526530381176,-1.1145361550181663,0.35135135135135137,1.0,1.0,12/40,13.88%,SIRPG;TBC1D10C;ARHGAP9;TAGAP;KLRB1;SCML4;ARHGAP15;CD5;TRAF3IP3;PTPRC;NLRC3;PSTPIP1
prerank,GO_Biological_Process_2021__positive regulation of DNA-dependent DNA replication (GO:2000105),-0.6200079200906476,-1.1143985065097481,0.37037037037037035,1.0,1.0,2/9,24.56%,STOML2;CDC7
prerank,GO_Biological_Process_2021__neurotransmitter reuptake (GO:0098810),-0.6630322072345312,-1.114362693722444,0.3050847457627119,1.0,1.0,3/7,24.50%,SLC22A3;SLC6A4;SLC22A1
prerank,GO_Biological_Process_2021__secondary palate development (GO:0062009),-0.6065929943253218,-1.1142289612496963,0.3559322033898305,1.0,1.0,4/12,14.43%,WNT5A;WNT8A;LEF1;TGFB3
prerank,GO_Biological_Process_2021__cardiac muscle cell development (GO:0055013),-0.5897928823890297,-1.1141508796655293,0.328125,1.0,1.0,5/18,14.24%,ACTC1;CSRP3;ALPK2;HEY2;TTN
prerank,PanglaoDB_Augmented_2021__Enterochromaffin Cells,-0.45304947589733,-1.1139587552362342,0.2463768115942029,1.0,1.0,9/87,6.82%,ENPP2;TREH;CLCA1;ANGPTL2;SMLR1;PIEZO2;ALDOB;MASP1;DCN
prerank,CellMarker_Augmented_2021__Pericyte:Subcutaneous Adipose Tissue,-0.4841714108472016,-1.113671115602971,0.2625,1.0,1.0,18/67,14.86%,C1QB;CYYR1;GALNT15;LYVE1;ANGPT2;DCN;CLDN5;ZNF366;VSIG4;SELP;VWF;GPIHBP1;ENG;COX7A1;TEK;A2M;GGT5;ADGRF5
prerank,GO_Biological_Process_2021__histone H3-K36 methylation (GO:0010452),0.6925022161439158,1.1134872059354144,0.3958333333333333,0.8346729961489181,1.0,3/5,16.96%,SETMAR;SETD2;ASH1L
prerank,Reactome_2022__Regulation Of TNFR1 Signaling R-HSA-5357905,0.4885108321382472,1.113486998509962,0.3225806451612903,0.8341971278500875,1.0,6/32,17.08%,CFLAR;SHARPIN;TANK;FADD;OTUD7B;CLIP3
prerank,GO_Biological_Process_2021__nuclear-transcribed mRNA poly(A) tail shortening (GO:0000289),0.5381958379012415,1.113485206845346,0.2608695652173913,0.833730326962788,1.0,6/21,20.81%,SAMD4A;CNOT9;CNOT4;SAMD4B;CNOT6;TUT7
prerank,GO_Biological_Process_2021__negative regulation of complement activation (GO:0045916),-0.6021802133672429,-1.1131496202073778,0.34615384615384615,1.0,1.0,4/11,14.17%,VSIG4;C4BPA;A2M;C4BPB
prerank,GO_Biological_Process_2021__response to alkaloid (GO:0043279),-0.6643853020506255,-1.1129061342683213,0.44642857142857145,1.0,1.0,1/7,8.01%,HTR1B
prerank,GO_Biological_Process_2021__regulation of organelle organization (GO:0033043),0.4386108267471819,1.112821811322617,0.23809523809523808,0.8351044331710927,1.0,19/72,21.29%,STX5;ZEB2;SIRT7;CAPN2;PLXNB1;STX18;AKAP9;CLEC16A;PREB;MIEF2;MYO5A;EP300;STOX1;PDE4DIP;PAK2;MARK2;MTM1;USP6NL;CAMSAP3
prerank,CellMarker_Augmented_2021__Purkinje cell:Undefined,-0.5670219871301586,-1.1127604998460292,0.3230769230769231,1.0,1.0,4/24,8.95%,GAD1;PDE5A;MPZ;CLU
prerank,GO_Biological_Process_2021__definitive hemopoiesis (GO:0060216),-0.732200741283851,-1.112667900354139,0.35294117647058826,1.0,1.0,3/5,16.07%,MFAP5;TEK;HIPK1
prerank,PanglaoDB_Augmented_2021__Oxyphil Cells,0.40289381760074994,1.1126360932995036,0.2692307692307692,0.835225210354693,1.0,14/78,8.65%,ADRA1A;KBTBD12;SMYD1;NT5C1A;CMYA5;CADM2;DTNA;SLC35F1;CTAGE3P;ANO5;HFM1;ACACB;ADCY2;HIF3A
prerank,GO_Biological_Process_2021__positive regulation of organelle assembly (GO:1902117),0.4386213665022531,1.1126115977338569,0.2571428571428571,0.8348522374521434,1.0,14/41,22.99%,SDC4;RALB;CEP120;STX18;CROCC;CCDC88A;ARHGAP35;MARK4;FSCN1;PIP4K2A;LRSAM1;CNOT6;ELAPOR1;ASAP1
prerank,GO_Biological_Process_2021__epithelial cilium movement involved in determination of left/right asymmetry (GO:0060287),-0.7244894797793556,-1.112458411896997,0.35185185185185186,1.0,1.0,1/7,2.89%,CCDC39
prerank,GO_Biological_Process_2021__sensory perception of pain (GO:0019233),-0.6140544401100672,-1.1124373678720785,0.3333333333333333,1.0,1.0,4/16,17.88%,PRDM12;PTGES;OPRM1;TRPA1
prerank,GO_Biological_Process_2021__regulation of protein secretion (GO:0050708),0.4058950881359302,1.112398317870775,0.23076923076923078,0.8349645149601965,1.0,7/98,3.83%,GCK;PER2;LLGL1;ITPR2;APOE;KCNC2;APBB3
prerank,GO_Biological_Process_2021__regulation of peptidyl-threonine phosphorylation (GO:0010799),0.4802288644194603,1.1122884779969042,0.3333333333333333,0.8348131372155012,1.0,6/35,11.02%,IRGM;SPRED3;PARD3;RIPK2;SPRED2;SPRED1
prerank,GO_Biological_Process_2021__superoxide metabolic process (GO:0006801),-0.565992170530958,-1.1122713297147164,0.3382352941176471,1.0,1.0,5/20,10.17%,DUOX1;ALOX12;TAFA4;SOD2;CYBA
prerank,CellMarker_Augmented_2021__Ovarian Germ Stem cell:Ovary,-0.4841951274582558,-1.1122648086714906,0.2777777777777778,1.0,1.0,13/51,17.40%,NODAL;SALL4;SLC7A3;CA14;DAZL;CLDN6;C1ORF94;PIF1;CCDC172;ZNF738;EPHA1;ZNF90;ZNF850
prerank,CellMarker_Augmented_2021__Gonocyte:Gonad,-0.4841951274582558,-1.1122648086714906,0.2777777777777778,1.0,1.0,13/51,17.40%,NODAL;SALL4;SLC7A3;CA14;DAZL;CLDN6;C1ORF94;PIF1;CCDC172;ZNF738;EPHA1;ZNF90;ZNF850
prerank,Reactome_2022__Activation Of BAD And Translocation To Mitochondria R-HSA-111447,0.6149954530077767,1.1122613089927298,0.4375,0.8343815612450194,1.0,4/14,14.12%,BCL2;REXO2;AKT2;BID
prerank,GO_Biological_Process_2021__response to progesterone (GO:0032570),-0.579707045535526,-1.1122379306010084,0.3148148148148148,1.0,1.0,6/17,16.69%,TGFB1;UBE3A;THBS1;TGFB3;YAP1;WBP2
prerank,"Reactome_2022__Defective B4GALT7 Causes EDS, Progeroid Type R-HSA-3560783",0.5767289299522527,1.1122297245223698,0.26666666666666666,0.8339759488749116,1.0,7/19,11.20%,VCAN;GPC4;SDC4;GPC6;GPC5;CSPG5;SDC3
prerank,GO_Biological_Process_2021__phosphatidylglycerol biosynthetic process (GO:0006655),0.6737374084629218,1.112002387757117,0.35,0.834241224369382,1.0,2/7,11.05%,PGS1;CRLS1
prerank,KEGG_2021_Human__Choline metabolism in cancer,0.4077343124959601,1.111901704663127,0.21739130434782608,0.8340990815295671,1.0,23/93,20.53%,DGKD;SLC44A5;PDGFD;SLC22A5;SP1;MAPK8;AKT2;WASF3;CHPT1;PLPP2;WASF2;CHKA;PLA2G4C;PIK3CA;DGKH;EIF4EBP1;SOS1;DGKZ;PLPP3;PLD2;RAF1;HIF1A;FOS
prerank,GO_Biological_Process_2021__positive regulation of cold-induced thermogenesis (GO:0120162),0.42379080351040255,1.1117917711747929,0.16666666666666666,0.8339401461370047,1.0,6/80,3.16%,GPR3;ESRRG;PER2;ELOVL6;HDAC3;ZBTB7B
prerank,PanglaoDB_Augmented_2021__Tuft Cells,-0.4986860034189553,-1.1115771882201495,0.29577464788732394,1.0,1.0,19/48,17.21%,JCHAIN;POU2F3;HCK;ALOX5;PTAFR;FCGR3A;ASIC5;NFAM1;GNAT3;PTPRC;SPI1;ITGAM;KLF3;CD300LF;ADGRE3;HK3;TUBB;RAC2;CD24
prerank,GO_Biological_Process_2021__regulation of cardiac muscle cell action potential involved in regulation of contraction (GO:0098909),-0.6757807329983258,-1.1112494736084924,0.4,1.0,1.0,1/8,2.76%,CAV3
prerank,GO_Biological_Process_2021__positive regulation of non-motile cilium assembly (GO:1902857),0.7552677167235318,1.1111779857207045,0.3684210526315789,0.8352894086179392,1.0,2/5,14.34%,CEP135;SEPTIN9
prerank,GO_Biological_Process_2021__renal system development (GO:0072001),0.42367498792561115,1.1109672061791382,0.16666666666666666,0.8353331926589039,1.0,6/40,9.82%,TGFBR1;IFT88;ITGA8;WNT4;PROX1;CEP290
prerank,GO_Biological_Process_2021__activation of phospholipase C activity (GO:0007202),0.5029482359035383,1.110816536252533,0.34210526315789475,0.8353346150362493,1.0,1/24,0.05%,ADRA1A
prerank,GO_Biological_Process_2021__positive regulation of cholesterol transport (GO:0032376),0.4643411530606839,1.1106600451897541,0.2413793103448276,0.8354375275226492,1.0,3/27,4.59%,APOE;PPARG;SIRT1
prerank,KEGG_2021_Human__Allograft rejection,-0.5469864186490737,-1.1101468345505823,0.3387096774193548,1.0,1.0,11/19,22.43%,HLA-DMA;HLA-A;HLA-DPB1;HLA-DRB1;HLA-DPA1;IL12A;CD80;HLA-F;IL5;CD86;HLA-C
prerank,CellMarker_Augmented_2021__Multipotent Mesenchymal Stroma cell:Adipose Tissue,-0.7708137177022604,-1.1101104255255847,0.4375,1.0,1.0,3/5,16.84%,PTPRC;ENG;NT5E
prerank,GO_Biological_Process_2021__regulation of insulin secretion (GO:0050796),0.40968124941189415,1.1100985597894506,0.2413793103448276,0.8367828948446518,1.0,13/86,10.67%,GCK;PER2;ITPR2;IRS1;MIDN;KCNC2;CAPN10;DOC2B;GLUD1;EFNA5;ABCC8;MCU;IRS2
prerank,GO_Biological_Process_2021__negative regulation of ubiquitin-dependent protein catabolic process (GO:2000059),0.43543038623436897,1.1099617815733345,0.2702702702702703,0.8366483267648839,1.0,6/35,13.41%,FHIT;QRICH2;PML;N4BP1;EIF3H;RYBP
prerank,GO_Biological_Process_2021__positive regulation of leukocyte differentiation (GO:1902107),0.6438014267388611,1.109811615778252,0.38,0.8365645705135556,1.0,4/8,17.42%,LGALS1;HMGB1;LGALS9;LGALS3
prerank,CellMarker_Augmented_2021__Plasmacytoid Dendritic cell:Peripheral Blood,-0.5152525696056024,-1.1098100762408292,0.34375,1.0,1.0,15/47,10.28%,GMFG;ITGB2;CYTIP;TBC1D10C;ARHGAP9;TAGAP;TNFRSF1B;PARVG;CD5;WAS;CD37;IL3RA;TRAF3IP3;MYO1F;PTPRC
prerank,GO_Biological_Process_2021__negative regulation of trophoblast cell migration (GO:1901164),-0.7388344417417638,-1.1098048462382855,0.44642857142857145,1.0,1.0,1/6,1.82%,NODAL
prerank,GO_Biological_Process_2021__regulation of histone H4-K16 acetylation (GO:2000618),0.6849072840413541,1.1096440936051721,0.3888888888888889,0.8365652943631281,1.0,4/5,9.20%,AUTS2;SIRT1;SMARCB1;PIH1D1
prerank,GO_Biological_Process_2021__chromosome condensation (GO:0030261),-0.49371189731495313,-1.1092962594607816,0.31343283582089554,1.0,1.0,7/38,14.24%,BANF2;ERN2;GPER1;H1-0;H1-3;INCENP;TTN
prerank,Reactome_2022__Polo-like Kinase Mediated Events R-HSA-156711,-0.6478495130541125,-1.1091915110115345,0.359375,1.0,1.0,2/14,5.14%,FOXM1;CDC25A
prerank,GO_Biological_Process_2021__response to alcohol (GO:0097305),0.5395262353317835,1.1090605072077888,0.4117647058823529,0.8375865078404716,1.0,5/22,9.93%,GRIN3A;TGFBR1;SDF4;SLIT2;GRIN1
prerank,GO_Biological_Process_2021__positive regulation of macrophage differentiation (GO:0045651),-0.6904258388599335,-1.1089655393995599,0.34375,1.0,1.0,1/9,1.49%,TGFB1
prerank,GO_Biological_Process_2021__regulation of exosomal secretion (GO:1903541),0.5344972242008048,1.1087715805104414,0.3333333333333333,0.8379406753981162,1.0,4/17,9.06%,SDC4;RAB7A;CHMP6;SMPD3
prerank,GO_Biological_Process_2021__neurotransmitter biosynthetic process (GO:0042136),-0.6194844883556443,-1.108700585611112,0.3728813559322034,1.0,1.0,1/11,0.42%,DBH
prerank,GO_Biological_Process_2021__regulation of metal ion transport (GO:0010959),0.5419061913672711,1.1086717324402071,0.2903225806451613,0.8378900773443838,1.0,4/16,9.58%,BCL2;SLC30A10;IL16;EPB41
prerank,GO_Biological_Process_2021__peptidyl-methionine modification (GO:0018206),0.6269380743990641,1.1084852369181322,0.4146341463414634,0.8378732145065572,1.0,1/9,8.12%,METAP1D
prerank,GO_Biological_Process_2021__negative regulation of smooth muscle cell migration (GO:0014912),0.5775870644435634,1.1083493854328064,0.2972972972972973,0.8377133184993302,1.0,6/12,28.25%,SERPINE1;SLIT2;CORO1B;BMPR1A;PRKG1;MEF2C
prerank,CellMarker_Augmented_2021__Germ cell:Gonad,0.4035223190587067,1.108139910660821,0.2916666666666667,0.8377806749931027,1.0,18/58,19.48%,MGAT4C;OR7D2;ZNF99;FLVCR1;ZNF519;TERF1;SUZ12P1;SLC35E3;SAG;C4ORF36;MIPOL1;HHLA1;GYG2P1;ZNF765;ZNF665;ZNF675;ZNF66;NANOGP1
prerank,GO_Biological_Process_2021__cellular response to increased oxygen levels (GO:0036295),0.6336933791352961,1.1080545367100632,0.35,0.8376041998792741,1.0,1/9,0.86%,FOXO1
prerank,Reactome_2022__Late SARS-CoV-2 Infection Events R-HSA-9772573,0.4612754474939496,1.1080373251310047,0.2692307692307692,0.8372515091375966,1.0,6/57,8.35%,MGAT4C;ST6GALNAC3;PRKCSH;GALNT1;ST3GAL3;MAN2A1
prerank,GO_Biological_Process_2021__regulation of hippo signaling (GO:0035330),0.5430587725194127,1.1079790134145777,0.37142857142857144,0.8369663817778484,1.0,11/16,33.79%,MOB3B;MARK3;DLG5;WWC1;IQCJ-SCHIP1;NF2;WWC2;WWC3;LIMD1;VGLL4;NEK8
prerank,GO_Biological_Process_2021__purine-containing compound metabolic process (GO:0072521),0.6466174546285385,1.10792709337233,0.4528301886792453,0.8366731830126489,1.0,1/6,1.49%,FHIT
prerank,GO_Biological_Process_2021__regulation of mitochondrial membrane permeability involved in apoptotic process (GO:1902108),0.6505317558194065,1.107890948782361,0.38095238095238093,0.8362964476393421,1.0,1/6,1.27%,THEM4
prerank,GO_Biological_Process_2021__negative regulation of histone deacetylation (GO:0031064),-0.7149692937268154,-1.1077877317673064,0.3584905660377358,1.0,1.0,1/5,11.29%,USP17L2
prerank,Reactome_2022__APC/C:Cdc20 Mediated Degradation Of Mitotic Proteins R-HSA-176409,-0.47893953078746276,-1.1077711658673741,0.3194444444444444,1.0,1.0,2/66,0.62%,NEK2;PSMB9
prerank,GO_Biological_Process_2021__toll-like receptor 2 signaling pathway (GO:0034134),0.6884769348404742,1.1076750059690563,0.43137254901960786,0.8365068626388661,1.0,2/5,11.29%,RIPK2;LGALS9
prerank,Reactome_2022__Regulation Of Beta-Cell Development R-HSA-186712,0.46033694791896784,1.1075677016699206,0.22857142857142856,0.836306562189718,1.0,13/32,19.29%,FOXO1;FGF10;MAML1;AKT2;MAMLD1;RFX6;MAP4K2;NOTCH1;IAPP;PAX6;RBPJ;EP300;KAT2B
prerank,GO_Biological_Process_2021__regulation of ion transmembrane transport (GO:0034765),-0.49279895177177047,-1.1074804898787387,0.3484848484848485,1.0,1.0,4/33,8.12%,KCNJ15;CASQ2;KCNJ11;KCNQ1
prerank,GO_Biological_Process_2021__regulation of cytoskeleton organization (GO:0051493),0.41631492416575033,1.1072760083027895,0.2692307692307692,0.8367260473187526,1.0,19/99,16.60%,PHLDB2;SORBS3;CAPN2;RHOBTB3;RHOBTB1;CRK;BICD1;EPHA3;ABL1;PLXNB1;EFNA5;MLST8;RND3;CCDC88A;ARHGAP35;MAP6;FSCN1;CORO2B;IQCJ-SCHIP1
prerank,GO_Biological_Process_2021__myelination (GO:0042552),0.45257657587994254,1.106822289257052,0.22727272727272727,0.8375969227410023,1.0,6/44,10.38%,MARVELD1;ADGRG6;PARD3;SLC8A3;ABCD2;ACER3
prerank,Reactome_2022__PIP3 Activates AKT Signaling R-HSA-1257604,0.34889570259099906,1.1067004911597844,0.0625,0.8375217952381012,1.0,49/236,17.44%,FOXO1;FGF10;THEM4;KIT;HDAC3;FGFR1;IRS1;NRG2;PHC2;GATAD2A;FRK;PPARG;FGF17;PSME4;ERBB2;SEM1;NRG1;PSMA1;NRG3;PML;WWP2;FGF18;TGFA;MLST8;SNAI2;MOV10;AKT2;FGFR3;KITLG;IRS2;PPP2R1B;TNRC6C;SCMH1;HDAC1;GATAD2B;CHD4;RNF146;FLT3;OTUD3;INSR;PIK3CA;IRAK4;TP53;TNRC6A;PIP4K2A;NEDD4;ATN1;AGO3;PPP2R5D
prerank,CellMarker_Augmented_2021__CD14+ Endothelial Progenitor cell:Blood,-0.48244767505770264,-1.1066902695396221,0.24691358024691357,1.0,1.0,18/67,14.86%,C1QB;CYYR1;LYVE1;SLCO2B1;MS4A4A;FCGR3A;CLDN5;VSIG4;SELP;ITGA9;VWF;FPR3;GPX3;F13A1;EDNRB;TEK;A2M;ADGRF5
prerank,GO_Biological_Process_2021__reverse cholesterol transport (GO:0043691),0.5892810466340388,1.106602096019141,0.425,0.8373297338056216,1.0,3/11,7.63%,LIPC;APOE;ABCA1
prerank,GO_Biological_Process_2021__intrinsic apoptotic signaling pathway by p53 class mediator (GO:0072332),0.5289098030004723,1.1064677896225747,0.22857142857142856,0.8373300231534718,1.0,6/31,7.66%,FHIT;SIRT1;IFI16;PPP1R13B;PML;ZNF385B
prerank,GO_Biological_Process_2021__covalent chromatin modification (GO:0016569),0.6034843746376435,1.1064152774849096,0.2571428571428571,0.8370547921833559,1.0,4/13,16.78%,SIRT1;SIRT7;HDAC1;CHD1
prerank,GO_Biological_Process_2021__ceramide transport (GO:0035627),-0.6093091235382113,-1.1063680312264275,0.3050847457627119,1.0,1.0,3/13,14.91%,PSAP;ABCB1;ABCA12
prerank,CellMarker_Augmented_2021__Epidermal Transit Amplifying cell:Foreskin,-0.4606788400872069,-1.1062382103258621,0.3055555555555556,1.0,1.0,18/84,25.27%,PLAU;SNRPD2;TXNDC17;SLIRP;DYNLL1;VDAC1;COX7C;HSPE1;PSMA3;NUDT15;COX7A2;PRDX1;TMA7;TXN;NDUFS5;PDCD5;PTMA;MDH1
prerank,GO_Biological_Process_2021__regulation of T cell mediated immune response to tumor cell (GO:0002840),-0.6723379514269995,-1.1060688509789285,0.4067796610169492,1.0,1.0,2/6,10.21%,AHR;HLA-DRB1
prerank,GO_Biological_Process_2021__extrinsic apoptotic signaling pathway in absence of ligand (GO:0097192),0.5080667867903174,1.105926393795077,0.3076923076923077,0.8380815999648764,1.0,4/20,7.93%,BCL2;BCL2A1;DCC;CASP3
prerank,GO_Biological_Process_2021__cellular response to acetylcholine (GO:1905145),0.6183624138991188,1.1058475596431465,0.2926829268292683,0.8379313536350724,1.0,1/8,2.13%,LYPD1
prerank,GO_Biological_Process_2021__transmembrane receptor protein tyrosine phosphatase signaling pathway (GO:0007185),0.6988897470524398,1.1053398291247496,0.4090909090909091,0.8388731776375351,1.0,2/6,15.95%,PTPRF;PTPRD
prerank,CellMarker_Augmented_2021__Smooth Muscle cell:Heart,0.6429648920247233,1.1053380618992705,0.4,0.8384060990308327,1.0,3/7,16.07%,CDH5;CNN1;CALD1
prerank,GO_Biological_Process_2021__icosanoid transport (GO:0071715),-0.6364847515794299,-1.1053182780881228,0.3090909090909091,1.0,1.0,2/9,6.94%,ABCC6;SLCO2A1
prerank,Reactome_2022__GAG Synthesis Requires Tetrasaccharide Linker Sequence R-HSA-1971475,0.5323545681611048,1.1051563612635589,0.27586206896551724,0.8384557435943335,1.0,8/25,11.20%,VCAN;GPC4;SDC4;GPC6;GPC5;CSPG5;B3GAT3;SDC3
prerank,GO_Biological_Process_2021__cell part morphogenesis (GO:0032990),0.522800730153481,1.1049726284638366,0.20588235294117646,0.838555260312845,1.0,4/13,14.06%,PACSIN2;PID1;CSPG5;PNPT1
prerank,GO_Biological_Process_2021__phosphate ion homeostasis (GO:0055062),-0.6581988483466531,-1.104968047293799,0.35714285714285715,1.0,1.0,3/7,20.20%,SFRP4;FGFR4;GCM2
prerank,Reactome_2022__Phase 4 - Resting Membrane Potential R-HSA-5576886,0.585114828641242,1.1047561954040532,0.42424242424242425,0.8386463497917365,1.0,2/14,7.92%,KCNK6;KCNK2
prerank,GO_Biological_Process_2021__presynaptic membrane assembly (GO:0097105),0.6190874137928033,1.1046528179720698,0.40425531914893614,0.838512914500505,1.0,5/10,15.95%,CEL;NLGN1;NLGN4X;NLGN3;PTPRD
prerank,"KEGG_2021_Human__Alanine, aspartate and glutamate metabolism",-0.5109171450131507,-1.1046028789858986,0.3333333333333333,1.0,1.0,2/31,2.41%,ADSS1;GAD1
prerank,CellMarker_Augmented_2021__Pericyte:Skeletal Muscle,-0.46256962325681755,-1.1045618043076046,0.25,1.0,1.0,17/86,15.25%,ENPP2;C1QB;CYYR1;GALNT15;LYVE1;DAAM2;DCN;CLDN5;PTPRC;VWF;GAS7;GPIHBP1;EDNRB;TEK;A2M;ADGRF5;JAM2
prerank,GO_Biological_Process_2021__zinc ion homeostasis (GO:0055069),0.5345027943912721,1.104522848406294,0.3888888888888889,0.8383214758089998,1.0,3/24,3.19%,MT1G;SLC30A10;SLC39A8
prerank,Reactome_2022__DNA Damage Bypass R-HSA-73893,-0.5148598744490115,-1.1044811028665096,0.3333333333333333,1.0,1.0,9/47,18.03%,DTL;PCLAF;RPA3;UBE2L6;TRIM25;POLE2;RBX1;POLD4;RPS27A
prerank,GO_Biological_Process_2021__positive regulation of mitochondrial translation (GO:0070131),-0.597227182412783,-1.1041911469529684,0.3548387096774194,1.0,1.0,2/13,15.75%,MPV17L2;RCC1L
prerank,GO_Biological_Process_2021__regulation of positive chemotaxis (GO:0050926),-0.6439743800081549,-1.104158524840438,0.4098360655737705,1.0,1.0,2/7,3.18%,F7;ANGPT2
prerank,GO_Biological_Process_2021__early endosome to late endosome transport (GO:0045022),0.5101473708094184,1.104045477738301,0.29545454545454547,0.8393590578344824,1.0,8/20,26.17%,RAB7A;STX8;PTPN23;SNF8;RAB5A;KIF16B;HOOK3;WDR81
prerank,CellMarker_Augmented_2021__T cell:Spleen,-0.5228695501512094,-1.103975433424118,0.3055555555555556,1.0,1.0,16/40,18.85%,SIRPG;GMFG;CYTIP;ARHGAP9;TAGAP;KLRB1;PARVG;CD5;TRAF3IP3;PTPRC;PSTPIP1;IKZF1;CD4;TNFSF8;CD8B;SASH3
prerank,GO_Biological_Process_2021__anion transmembrane transport (GO:0098656),0.43738688538811393,1.1039179459952124,0.25,0.8392337474287033,1.0,17/61,19.41%,SLC38A5;SLC39A8;SLC3A2;SLC19A1;SLC16A7;SFXN2;SLC25A1;SLC6A20;SLC25A29;SLC7A8;SLC25A12;ABCC1;SLC25A42;SLC36A4;LRRC8B;SLC25A41;SLC1A3
prerank,GO_Biological_Process_2021__glycogen catabolic process (GO:0005980),-0.5932903425639108,-1.1035886201764997,0.2898550724637681,1.0,1.0,3/13,18.02%,PHKG1;PYGL;CALM1
prerank,GO_Biological_Process_2021__regulation of mast cell activation involved in immune response (GO:0033006),-0.6391059631241027,-1.1035274180634453,0.34615384615384615,1.0,1.0,1/9,2.65%,BLK
prerank,Reactome_2022__Collagen Biosynthesis And Modifying Enzymes R-HSA-1650814,0.44403276935426944,1.1032926035720363,0.2692307692307692,0.8403691960905503,1.0,15/64,12.73%,COL22A1;COL8A1;PCOLCE2;COL9A2;COL12A1;P3H3;P3H2;COLGALT1;PLOD3;COLGALT2;PPIB;COL16A1;TLL1;COL13A1;COL5A3
prerank,"GO_Biological_Process_2021__regulation of DNA-templated transcription, initiation (GO:2000142)",0.426349681795041,1.1032668146507278,0.2222222222222222,0.8400196630118029,1.0,15/57,17.12%,MED17;MITF;CBFB;MED25;CDK4;TWIST1;MOV10;TNRC6C;MED16;CDK8;NFKB1;MECP2;TP53;TNRC6A;AGO3
prerank,GO_Biological_Process_2021__dendrite morphogenesis (GO:0048813),0.4655554967658925,1.1028429132180508,0.3235294117647059,0.8408634661668473,1.0,8/35,19.93%,ARC;PHACTR1;FARP1;MAP6;EPHB2;DCDC2;CTNNA2;PAK3
prerank,GO_Biological_Process_2021__mRNA-containing ribonucleoprotein complex export from nucleus (GO:0071427),0.41757723601665964,1.1027524684214867,0.25806451612903225,0.8406879218980103,1.0,26/90,26.04%,CPSF1;NUP210;NXF5;NUP42;NXT1;NXF1;U2AF1;SRRM1;AAAS;SRSF4;SMG1;SMG5;RANBP2;SMG6;EIF4A3;U2AF2;SYMPK;EIF4E;NUP214;TPR;MAGOHB;SEH1L;THOC1;WDR33;NUP153;RBM8A
prerank,Reactome_2022__Estrogen-dependent Gene Expression R-HSA-9018519,0.4045577080200813,1.1026879628580202,0.2727272727272727,0.8404546453803138,1.0,29/94,20.65%,BCL2;CBFB;H2BC21;NCOA3;NCOA2;NRIP1;MYC;TGFA;MOV10;KANK1;TNRC6C;HDAC1;GREB1;CARM1;H2AX;GTF2F2;CXXC5;RUNX1;TNRC6A;CHD1;PMEPA1;AGO3;EP300;KAT2B;H2AJ;POU2F1;AGO2;FOS;KCTD6
prerank,KEGG_2021_Human__Epithelial cell signaling in Helicobacter pylori infection,0.425604817719523,1.1025077115306665,0.3333333333333333,0.8405441813601139,1.0,7/60,7.93%,ATP6V0D2;TCIRG1;MAP3K14;CSK;PTPRZ1;MAPK8;CASP3
prerank,GO_Biological_Process_2021__protein transmembrane import into intracellular organelle (GO:0044743),-0.5354140313095335,-1.1024808296268596,0.3088235294117647,1.0,1.0,9/29,29.49%,TOMM20;PAM16;TIMM17A;ROMO1;CHCHD4;DNAJC19;TIMM21;PEX1;GRPEL1
prerank,GO_Biological_Process_2021__nucleoside catabolic process (GO:0009164),0.5846367023459892,1.1023498411792871,0.4090909090909091,0.8405509577938625,1.0,3/12,12.76%,NT5C1A;UPP2;NT5C3A
prerank,GO_Biological_Process_2021__membrane depolarization during cardiac muscle cell action potential (GO:0086012),-0.565964562383109,-1.102163371331305,0.323943661971831,1.0,1.0,1/17,1.19%,SCN5A
prerank,GO_Biological_Process_2021__regulation of mitotic cell cycle spindle assembly checkpoint (GO:0090266),0.5562476588196933,1.1020223167347607,0.425,0.840921232601584,1.0,4/13,23.38%,CDK5RAP2;TPR;PCID2;USP44
prerank,KEGG_2021_Human__Collecting duct acid secretion,0.4552662538370133,1.1019969962982574,0.3235294117647059,0.84053971741052,1.0,2/22,1.86%,ATP6V0D2;TCIRG1
prerank,CellMarker_Augmented_2021__CD8+ Regulatory T cell:Undefined,-0.5013511994987816,-1.1019748648162055,0.3472222222222222,1.0,1.0,11/53,10.28%,SIRPG;GMFG;CYTIP;ARHGAP9;TAGAP;KLRB1;SCML4;GPR183;CD5;TRAF3IP3;PTPRC
prerank,GO_Biological_Process_2021__regulation of protein targeting to mitochondrion (GO:1903214),-0.500005519698213,-1.1016375293034015,0.25,1.0,1.0,5/35,13.34%,ARIH2;HSPA1L;PINK1;TOMM7;ATP5IF1
prerank,GO_Biological_Process_2021__regulation of type I interferon-mediated signaling pathway (GO:0060338),-0.5352876331583544,-1.1016304742295702,0.3898305084745763,1.0,1.0,8/27,25.22%,WNT5A;OAS1;CDC37;CACTIN;ISG15;HSP90AB1;USP18;PTPN11
prerank,GO_Biological_Process_2021__I-kappaB kinase/NF-kappaB signaling (GO:0007249),0.4451189692117851,1.1015911267313017,0.23076923076923078,0.8413222091088852,1.0,17/53,20.40%,MAP3K14;TBKBP1;CD14;RIPK2;TICAM2;SHARPIN;TICAM1;TANK;NKIRAS2;TAB3;IRAK1BP1;ZNF675;FAIM;TAB1;ERC1;TAB2;TRAF6
prerank,GO_Biological_Process_2021__regulation of extracellular matrix constituent secretion (GO:0003330),-0.6846050651211473,-1.101552887929359,0.36507936507936506,1.0,1.0,1/7,4.89%,TNFRSF1B
prerank,GO_Biological_Process_2021__female gamete generation (GO:0007292),-0.5425175470293073,-1.1013897674205435,0.36764705882352944,1.0,1.0,1/25,0.57%,IHO1
prerank,GO_Biological_Process_2021__membrane repolarization during atrial cardiac muscle cell action potential (GO:0098914),-0.7005501195650314,-1.1013642026480712,0.34545454545454546,1.0,1.0,2/5,8.12%,KCNA5;KCNQ1
prerank,GO_Biological_Process_2021__atrial cardiac muscle cell membrane repolarization (GO:0099624),-0.7005501195650314,-1.1013642026480712,0.34545454545454546,1.0,1.0,2/5,8.12%,KCNA5;KCNQ1
prerank,GO_Biological_Process_2021__leukotriene transport (GO:0071716),-0.6235586782372302,-1.101231248119356,0.3584905660377358,1.0,1.0,1/7,2.12%,ABCC6
prerank,GO_Biological_Process_2021__negative regulation of leukocyte degranulation (GO:0043301),-0.6661162110526393,-1.1011487983905575,0.3392857142857143,1.0,1.0,3/5,15.53%,CEACAM1;SPI1;HLA-F
prerank,Reactome_2022__HDMs Demethylate Histones R-HSA-3214842,0.5444523283092004,1.1010408652823471,0.2682926829268293,0.8425987081142882,1.0,10/22,32.79%,KDM7A;KDM2A;KDM3B;ARID5B;KDM5B;KDM4C;PHF2;KDM5D;KDM5A;RIOX2
prerank,GO_Biological_Process_2021__pyrimidine nucleoside catabolic process (GO:0046135),0.5945849558249071,1.1009692484206746,0.37209302325581395,0.8423570352212574,1.0,3/11,12.76%,NT5C1A;UPP2;NT5C3A
prerank,"GO_Biological_Process_2021__nuclear-transcribed mRNA catabolic process, deadenylation-independent decay (GO:0031086)",0.5940583240884488,1.1008779569899438,0.4,0.8421156284878004,1.0,1/7,3.60%,DCP1B
prerank,KEGG_2021_Human__Long-term depression,0.4113761914496438,1.1008378156946468,0.2608695652173913,0.8418086137457313,1.0,23/55,28.01%,GRID2;ITPR2;PLCB1;GUCY1A2;PPP2R1B;PLA2G4C;GNAO1;BRAF;GNAQ;RAF1;GNAI2;GNAS;GNA12;GRM1;GNA11;GUCY1A1;CACNA1A;GNA13;PLCB3;PRKG1;GRIA1;NOS1;GNAI1
prerank,KEGG_2021_Human__Fatty acid degradation,0.4637555210636703,1.1006881498281993,0.19444444444444445,0.8418475836001079,1.0,15/37,21.70%,ACADS;ALDH7A1;CYP2U1;ECHS1;CPT1C;ACADM;ACSL1;ADH4;CPT1A;ECI1;ACOX1;HADHB;ACADVL;ALDH1B1;ACOX3
prerank,GO_Biological_Process_2021__positive regulation of endocytosis (GO:0045807),0.44833587795593605,1.10065763933522,0.2926829268292683,0.8414341266678572,1.0,8/44,6.54%,CD151;APOE;NLGN1;HIP1;RAB31;SERPINE1;SNCA;BICD1
prerank,GO_Biological_Process_2021__mitotic metaphase plate congression (GO:0007080),-0.49770472330470944,-1.1005864426002856,0.34285714285714286,1.0,1.0,6/45,9.82%,KIF14;CEP55;RAB11A;ANKRD53;CHMP3;NUF2
prerank,GO_Biological_Process_2021__nucleoside triphosphate catabolic process (GO:0009143),0.6812718178458259,1.100209936928127,0.37777777777777777,0.8424021921429038,1.0,4/5,31.88%,SMPDL3A;ENPP1;ITPA;DCTPP1
prerank,Reactome_2022__Aspirin ADME R-HSA-9749641,0.5526741619844034,1.1001630554484854,0.3409090909090909,0.8421121266795782,1.0,5/22,4.09%,BCHE;GLYATL1;GLYATL2;UGT2B15;BSG
prerank,GO_Biological_Process_2021__positive regulation of catecholamine secretion (GO:0033605),-0.6701587288053098,-1.1000877927452555,0.36666666666666664,1.0,1.0,2/7,25.02%,CARTPT;CHRNB2
prerank,GO_Biological_Process_2021__mRNA splice site selection (GO:0006376),0.5055952917304976,1.1000646373231753,0.3142857142857143,0.8419948236280824,1.0,7/26,15.37%,PRPF39;PUF60;CELF5;CELF4;SFSWAP;CELF2;LUC7L
prerank,GO_Biological_Process_2021__regulation of reactive oxygen species biosynthetic process (GO:1903426),0.48574634722063204,1.1000229863249844,0.3157894736842105,0.841615021589007,1.0,6/21,10.37%,RAB27A;SLC30A10;SNCA;SLC25A33;GRIN1;ABCD2
prerank,GO_Biological_Process_2021__L-serine biosynthetic process (GO:0006564),0.6951600435907389,1.0999759739173587,0.3877551020408163,0.8413422700008036,1.0,4/6,16.43%,PSAT1;SRR;PSPH;SERINC5
prerank,Reactome_2022__RND2 GTPase Cycle R-HSA-9696270,0.42709411499003297,1.0999752156404814,0.1935483870967742,0.8408812605377894,1.0,12/39,16.50%,SCRIB;VANGL1;ANKRD26;MUC13;KTN1;FNBP1;GOLGA3;DST;ARHGAP35;PKP4;DLG5;LRRC1
prerank,GO_Biological_Process_2021__positive regulation of calcineurin-NFAT signaling cascade (GO:0070886),0.6282269796906712,1.0997899909522615,0.3673469387755102,0.8404766718290896,1.0,6/8,31.42%,PTBP1;CAMTA1;AKAP6;CIB1;SPPL3;SLC9A1
prerank,GO_Biological_Process_2021__positive regulation of calcineurin-mediated signaling (GO:0106058),0.6282269796906712,1.0997899909522615,0.3673469387755102,0.8404766718290896,1.0,6/8,31.42%,PTBP1;CAMTA1;AKAP6;CIB1;SPPL3;SLC9A1
prerank,Reactome_2022__Organelle Biogenesis And Maintenance R-HSA-1852241,0.3701640488367705,1.0997683298509835,0.26666666666666666,0.8400823698013468,1.0,75/253,24.52%,PCM1;HDAC3;IFT88;CEP152;CEP135;CNTRL;TFB1M;SCLT1;SMARCD3;ACSS2;BBS9;NCOA2;DYNLT5;GLUD1;ALMS1;DYNC1I2;CNGA4;SDCCAG8;C2CD3;MAPRE1;RPGRIP1L;CEP290;NUDT19;BBS12;AKAP9;CEP250;RAB11FIP3;MKS1;IDH2;GLUD2;CHD9;CARM1;ARL13B;EXOC7;PPARGC1B;MARK4;CEP41;CEP162;GABPA;IFT140;MAPK12;TTC21B;ARL3;APOOL;KIF3B;BBIP1;PDE6D;UNC119B;CREB1;PRKAA2;TMEM67;PRKAG2;EXOC6;CDK5RAP2;TRIP11;WDR19;TBL1X;IQCB1;FBF1;EXOC4;CRTC1;CEP192;CHCHD3;SSTR3;ASAP1;WDR35;IFT57;PLK1;TCTN2;NR1D1;HAUS1;MICOS10;CLUAP1;NRF1;BBS10
prerank,GO_Biological_Process_2021__regulation of digestive system process (GO:0044058),0.6270389799177488,1.099738297607796,0.42,0.839680318748681,1.0,3/6,9.58%,FGF10;SGK1;EPB41
prerank,GO_Biological_Process_2021__superoxide anion generation (GO:0042554),-0.6444560382286031,-1.0996944877536607,0.35,1.0,1.0,4/9,10.17%,DUOX1;ALOX12;TAFA4;CYBA
prerank,GO_Biological_Process_2021__rRNA 5'-end processing (GO:0000967),0.6568682950555188,1.0996192576033306,0.38461538461538464,0.8385911342596704,1.0,3/5,22.56%,NOP9;NOP14;TBL3
prerank,"GO_Biological_Process_2021__endonucleolytic cleavage in 5'-ETS of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000480)",0.6568682950555188,1.0996192576033306,0.38461538461538464,0.8385911342596704,1.0,3/5,22.56%,NOP9;NOP14;TBL3
prerank,"GO_Biological_Process_2021__endonucleolytic cleavage to generate mature 5'-end of SSU-rRNA from (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000472)",0.6568682950555188,1.0996192576033306,0.38461538461538464,0.8385911342596704,1.0,3/5,22.56%,NOP9;NOP14;TBL3
prerank,GO_Biological_Process_2021__positive regulation of receptor internalization (GO:0002092),0.5456071604592686,1.0995640866621157,0.3,0.8382479105033646,1.0,7/19,14.95%,ANGPT1;ARRB2;MAGI2;GREM1;WNT3A;ARRB1;INSR
prerank,GO_Biological_Process_2021__heart morphogenesis (GO:0003007),-0.5098973583821198,-1.0994154870475412,0.36363636363636365,1.0,1.0,9/37,14.24%,TBX1;ACTC1;MYBPC3;ZFPM1;HTR2B;ALPK2;ENG;HEY2;TTN
prerank,KEGG_2021_Human__Phagosome,-0.4334605276817939,-1.0993178878838898,0.325,1.0,1.0,30/117,17.31%,SFTPA1;ITGB2;ATP6V1G2;HLA-DMA;SFTPD;FCGR3A;HLA-A;ACTG1;ATP6V1C2;ATP6V1D;ATP6AP1;HLA-DPB1;THBS1;CYBA;HLA-DRB1;ATP6V0E2;ITGAM;TLR2;TUBA4A;HLA-DPA1;ITGA5;COLEC12;TUBA3D;ATP6V1E1;HLA-F;TUBB;ITGB5;TUBB6;RAC1;TUBB2A
prerank,GO_Biological_Process_2021__protein import into peroxisome matrix (GO:0016558),0.6348146797119926,1.0992923318259755,0.47058823529411764,0.8387045342771419,1.0,1/11,4.55%,PEX13
prerank,CellMarker_Augmented_2021__Mesothelial cell:Undefined,-0.47679994904370054,-1.0992051771619984,0.31666666666666665,1.0,1.0,12/57,13.39%,TMEM184A;PLEKHG6;MISP;ELMO3;DTX2;EPN3;SPINT1;GPR39;LAMC2;ITGB6;BAIAP2L1;DOK7
prerank,GO_Biological_Process_2021__positive regulation of cellular metabolic process (GO:0031325),0.4180629762763039,1.0991896573831672,0.2857142857142857,0.838459464142181,1.0,21/88,15.44%,SCRIB;APOE;ANGPT1;PID1;PPARG;AKR1C3;SNCA;ARRB2;MAGI2;AKR1C1;GREM1;F2;ACACB;WNT3A;LIPT2;ARRB1;STARD4;INSR;NR1H3;GADD45A;TP53
prerank,Reactome_2022__RUNX3 Regulates p14-ARF R-HSA-8951936,-0.644711976990393,-1.0991430980992591,0.4,1.0,1.0,2/9,3.67%,TGFB1;CCND1
prerank,Reactome_2022__FLT3 Signaling Thru SRC Family Kinases R-HSA-9706374,-0.7748585175040499,-1.0990355632470623,0.32727272727272727,1.0,1.0,1/5,2.29%,HCK
prerank,GO_Biological_Process_2021__positive regulation of cell junction assembly (GO:1901890),0.45349151058521747,1.0990145482348115,0.25,0.8385406211128003,1.0,14/46,18.08%,GRID2;NLGN1;CNTNAP2;ABL1;SYNDIG1;COL16A1;LIMS1;NLGN3;CLSTN2;NRXN1;PTPRD;DLG5;EPHB2;SLITRK2
prerank,GO_Biological_Process_2021__receptor-mediated endocytosis of virus by host cell (GO:0019065),-0.7002462745122711,-1.0989720396259761,0.37735849056603776,1.0,1.0,1/7,11.01%,CAV2
prerank,KEGG_2021_Human__Systemic lupus erythematosus,-0.49136671231092793,-1.0989264837006352,0.34177215189873417,1.0,1.0,12/49,15.83%,C1QB;HLA-DMA;FCGR3A;H4C8;H2BC4;HLA-DPB1;HLA-DRB1;H2AZ1;HLA-DPA1;C1S;CD80;ELANE
prerank,Reactome_2022__Processing Of Capped Intronless Pre-mRNA R-HSA-75067,0.4936566472794477,1.0988493972476827,0.2631578947368421,0.8385076657791776,1.0,5/27,12.78%,CPSF1;LSM10;PCF11;SNRPB;CPSF7
prerank,Reactome_2022__Rap1 Signaling R-HSA-392517,0.5645692643989741,1.0988024182947513,0.4117647058823529,0.838214261941859,1.0,7/14,27.45%,SIPA1;RAP1A;RAPGEF3;RAPGEF4;PRKACB;PRKG1;YWHAZ
prerank,Reactome_2022__Late Endosomal Microautophagy R-HSA-9615710,0.45333693794211294,1.098621828035642,0.3611111111111111,0.8383767769536324,1.0,5/29,13.73%,IFT88;MVB12A;CHMP6;UBAP1;ARL13B
prerank,Reactome_2022__MAP2K And MAPK Activation R-HSA-5674135,0.4697979983091441,1.0986200751447337,0.3076923076923077,0.8379292686893312,1.0,8/32,13.66%,KSR1;CSK;IL17RD;ARRB2;CNKSR2;RAP1A;MARK3;ARRB1
prerank,CellMarker_Augmented_2021__Circulating Progenitor cell:Peripheral Blood,-0.46621461742614057,-1.0983517136701675,0.2948717948717949,1.0,1.0,16/70,14.86%,C1QB;CYYR1;LYVE1;ANGPTL2;SLCO2B1;DCN;SLCO2A1;CLDN5;ITGA9;VWF;GPIHBP1;EDNRB;TEK;A2M;C1S;ADGRF5
prerank,Reactome_2022__Activated NTRK2 Signals Thru RAS R-HSA-9026519,0.6531884896935558,1.0980589459835934,0.3023255813953488,0.8391482552634884,1.0,2/6,20.77%,SOS1;NTRK2
prerank,KEGG_2021_Human__Osteoclast differentiation,-0.4418987865141714,-1.0977411240425303,0.30952380952380953,1.0,1.0,19/92,18.74%,LILRB3;SIRPG;TGFB1;TEC;STAT1;FCGR3A;OSCAR;NFKB2;PIK3R3;CYBA;SPI1;BLNK;PIK3CB;FOSL2;IFNGR2;RAC1;TNFRSF11A;NFATC2;CSF1R
prerank,GO_Biological_Process_2021__catecholamine metabolic process (GO:0006584),-0.6134560691800102,-1.0975073975173897,0.39622641509433965,1.0,1.0,1/12,0.42%,DBH
prerank,GO_Biological_Process_2021__positive regulation of pathway-restricted SMAD protein phosphorylation (GO:0010862),-0.5022308014543032,-1.097451568253438,0.36923076923076925,1.0,1.0,8/37,14.43%,TGFB1;NODAL;DAB2;TTK;GDF11;ENG;BMP3;TGFB3
prerank,GO_Biological_Process_2021__cellular response to misfolded protein (GO:0071218),0.5713899273116617,1.0974154110282275,0.41379310344827586,0.8407801637320322,1.0,1/19,0.97%,AUP1
prerank,GO_Biological_Process_2021__SNARE complex assembly (GO:0035493),0.6425359313222462,1.0972163594678113,0.40425531914893614,0.8408597532591441,1.0,2/8,19.22%,SNCA;VAMP8
prerank,GO_Biological_Process_2021__receptor guanylyl cyclase signaling pathway (GO:0007168),-0.7095965947886953,-1.097024475467452,0.3673469387755102,1.0,1.0,3/6,24.71%,GUCY2C;GUCY2F;NPR2
prerank,GO_Biological_Process_2021__neutrophil migration (GO:1990266),-0.5533485592892803,-1.0966427317192187,0.265625,1.0,1.0,3/27,3.57%,UMODL1;ITGB2;CXCL13
prerank,CellMarker_Augmented_2021__T cell:Fetal Liver,-0.4879872050688701,-1.0966264744718321,0.3108108108108108,1.0,1.0,16/56,10.28%,SIRPG;GMFG;ITGB2;CYTIP;TBC1D10C;ARHGAP9;TAGAP;TMC8;KLRB1;PARVG;CD5;WAS;CD37;TRAF3IP3;MYO1F;PTPRC
prerank,KEGG_2021_Human__Terpenoid backbone biosynthesis,0.5623368474014425,1.0965746528952154,0.3548387096774194,0.8423510315672748,1.0,3/20,12.75%,NUS1;PDSS2;FNTA
prerank,GO_Biological_Process_2021__interleukin-23-mediated signaling pathway (GO:0038155),0.6185637389457002,1.0964307262906163,0.325,0.8418598612585603,1.0,3/8,27.93%,IL23A;TYK2;STAT3
prerank,Reactome_2022__Interleukin-23 Signaling R-HSA-9020933,0.6185637389457002,1.0964307262906163,0.325,0.8418598612585603,1.0,3/8,27.93%,IL23A;TYK2;STAT3
prerank,GO_Biological_Process_2021__negative regulation of cell-matrix adhesion (GO:0001953),0.4978343171835036,1.0963606735280593,0.25,0.8415417707548304,1.0,4/28,6.96%,PHLDB2;SERPINE1;JAG1;ACER2
prerank,GO_Biological_Process_2021__positive regulation of cell morphogenesis involved in differentiation (GO:0010770),0.44939956190912805,1.0962615641434206,0.28205128205128205,0.8414021384410757,1.0,10/45,18.57%,CRK;ABL1;FLNA;CASS4;CSPG5;LIMS1;CUX1;CRKL;PTPRD;DOCK1
prerank,CellMarker_Augmented_2021__B cell:Lymphoid Tissue,-0.7114228561066026,-1.0959796930876151,0.44642857142857145,1.0,1.0,3/5,20.41%,CD80;PAX5;CD86
prerank,GO_Biological_Process_2021__spermatid development (GO:0007286),-0.5113712782069533,-1.0957951397353403,0.328125,1.0,1.0,7/28,15.67%,TOPAZ1;SOX30;TNP1;MEIOC;GALNTL5;JAM2;SYCP3
prerank,CellMarker_Augmented_2021__Pyramidal cell:Undefined,0.6074367166988147,1.0957776377938269,0.3870967741935484,0.8422660291256502,1.0,2/12,8.87%,POU3F1;FEZF2
prerank,"Reactome_2022__mRNA Activation Upon Binding Of Cap-Binding Complex And eIFs, Subsequent Binding To 43S R-HSA-72662",-0.4780679140615464,-1.0956260763562689,0.36363636363636365,1.0,1.0,26/53,27.12%,RPS4X;RPS9;FAU;RPS27;RPS21;EIF2S3;RPS16;RPS20;EIF2S2;RPS8;RPS27A;EIF4A2;RPS7;RPS11;RPS14;RPS15;RPS12;RPS13;EIF1AX;RPS3;RPSA;RPS28;RPS19;RPS24;RPS3A;RPS6
prerank,GO_Biological_Process_2021__intracellular cholesterol transport (GO:0032367),0.5589088506840023,1.0955582380800608,0.3333333333333333,0.8425466977197357,1.0,4/14,13.68%,ABCA1;LRP6;LDLR;STARD4
prerank,GO_Biological_Process_2021__regulation of necrotic cell death (GO:0010939),-0.6849869322906406,-1.095502844952622,0.43661971830985913,1.0,1.0,1/7,10.20%,OLFM4
prerank,GO_Biological_Process_2021__positive regulation of DNA ligation (GO:0051106),0.6874756146474746,1.0954287529915994,0.40384615384615385,0.8425522421977071,1.0,1/5,6.42%,HMGB1
prerank,GO_Biological_Process_2021__positive regulation of protein targeting to mitochondrion (GO:1903955),-0.5124317341981165,-1.0954049737988616,0.3333333333333333,1.0,1.0,3/28,5.61%,ARIH2;HSPA1L;PINK1
prerank,GO_Biological_Process_2021__sterol transport (GO:0015918),0.5170069656920895,1.0953501097830685,0.32432432432432434,0.8423800514472647,1.0,4/19,21.85%,APOB;LDLR;NPC2;ABCG8
prerank,Reactome_2022__Budding And Maturation Of HIV Virion R-HSA-162588,0.4817002028745545,1.0952530390305466,0.3170731707317073,0.8421757495791445,1.0,7/27,22.29%,MVB12A;CHMP6;UBAP1;SGIP1;VTA1;MVB12B;TSG101
prerank,GO_Biological_Process_2021__positive regulation of phospholipase activity (GO:0010518),0.512154665647466,1.095112084647826,0.3684210526315789,0.8420765766333806,1.0,4/20,9.62%,KIT;FGFR1;ABL2;FGFR3
prerank,GO_Biological_Process_2021__tyrosine metabolic process (GO:0006570),-0.6204505476071467,-1.0947854806148234,0.41935483870967744,1.0,1.0,1/10,0.88%,IYD
prerank,Reactome_2022__Assembly Of HIV Virion R-HSA-175474,0.5390026647009564,1.0947195501945284,0.375,0.8428082608961063,1.0,9/17,28.07%,MVB12A;UBAP1;SGIP1;FURIN;NMT2;MVB12B;TSG101;VPS37D;PPIA
prerank,Reactome_2022__XBP1(S) Activates Chaperone Genes R-HSA-381038,0.42574665441744824,1.0944195040620464,0.3103448275862069,0.8431844642985633,1.0,11/44,20.34%,EXTL1;PDIA6;CTDSP2;ACD;PREB;YIF1A;DNAJC3;CXXC1;EDEM1;ADD1;ACADVL
prerank,CellMarker_Augmented_2021__Astrocyte:Embryonic Prefrontal Cortex,0.36357918409769385,1.0942576995232984,0.1875,0.843278272774158,1.0,55/320,11.76%,BCHE;PDLIM3;TBC1D10A;MYO10;SEZ6L;ITPR2;ALCAM;AASS;HSPB1;APOE;GRM3;HNMT;RAB31;LRRTM3;BRINP3;SLC3A2;PSAT1;SOAT1;SPON1;SNX5;C1ORF122;HES1;CBS;BCL11A;TNFRSF19;G6PC3;DTNA;LGALS1;OLFM2;PTPRZ1;TIMP1;ETV1;OCIAD2;PNPLA3;LUZP2;IGFBP4;ABHD3;GLUD1;TRIB2;DOK5;SYT1;LRRN3;ABCD3;CXCL14;PLAGL1;P3H4;LRRC17;CSPG5;ELAVL4;SDC3;DDAH1;PLEC;TSPAN3;TSPAN6;RBFOX2
prerank,GO_Biological_Process_2021__TORC2 signaling (GO:0038203),-0.6629405395256667,-1.0940681049622984,0.4426229508196721,1.0,1.0,1/6,5.61%,PINK1
prerank,GO_Biological_Process_2021__cyclic-nucleotide-mediated signaling (GO:0019935),0.4494806877516304,1.0938740610729059,0.32142857142857145,0.8439759188068048,1.0,9/32,11.24%,ADGRG6;KSR1;APOE;HTR2C;PDE7A;ADCY2;PDE9A;CAP2;RIMS2
prerank,CellMarker_Augmented_2021__Epithelial cell:Amniotic Membrane,-0.4554173803335307,-1.093843728518667,0.31343283582089554,1.0,1.0,16/64,19.98%,TMEM184A;PLEKHG6;MARVELD2;TMC4;EPN3;MYO5B;SPINT1;SOWAHB;STAP2;PROM2;EPHA1;TJP3;SCNN1A;CAPN13;CBLC;FAM83F
prerank,GO_Biological_Process_2021__response to cocaine (GO:0042220),-0.6792804901517768,-1.0938122840374347,0.39215686274509803,1.0,1.0,1/5,8.48%,TGM2
prerank,GO_Biological_Process_2021__RNA export from nucleus (GO:0006405),0.41858051792883494,1.0936859359637943,0.2413793103448276,0.8440450560702545,1.0,27/93,26.04%,CPSF1;NUP210;NXF5;NUP42;NXT1;NXF1;U2AF1;SRRM1;AAAS;SRSF4;XPO5;SMG1;SMG5;RANBP2;SMG6;EIF4A3;U2AF2;SYMPK;EIF4E;NUP214;TPR;MAGOHB;SEH1L;THOC1;WDR33;NUP153;RBM8A
prerank,CellMarker_Augmented_2021__Neuroepithelial cell:Undefined,0.6689844641302753,1.093680706415052,0.4444444444444444,0.8435912684057004,1.0,3/5,21.55%,HES1;NOTCH1;OCLN
prerank,GO_Biological_Process_2021__peptidyl-serine modification (GO:0018209),0.362388177701006,1.0932882171890619,0.10526315789473684,0.8442635030220939,1.0,41/161,20.19%,TGFBR1;MAPKAPK2;SBK1;POGLUT3;VRK2;GALNT1;POGLUT2;SGK1;EIF2AK3;LATS1;MAST1;MAST2;MAPK8;MAP3K10;AKT2;GALNT13;DYRK3;PKN2;RPS6KA3;STK32C;SGK2;CAMK1G;MAP3K13;MARK3;RPS6KA4;RPS6KA2;RPS6KA6;CLSPN;MAPK12;SMG1;MARK1;ATM;CSNK1G1;MAST4;ATR;MORC3;PNCK;CDK5;PAK2;MARK2;PRKCE
prerank,GO_Biological_Process_2021__pyroptosis (GO:0070269),-0.6247765582025047,-1.0932424021689469,0.3492063492063492,1.0,1.0,8/11,20.40%,AIM2;GSDMA;GSDME;NLRP9;NLRC4;NAIP;CASP8;APIP
prerank,GO_Biological_Process_2021__regulation of leukocyte adhesion to vascular endothelial cell (GO:1904994),-0.6144470849156889,-1.0931904443651805,0.328125,1.0,1.0,1/10,2.28%,ITGB2
prerank,Reactome_2022__Small Interfering RNA (siRNA) Biogenesis R-HSA-426486,0.5904666526948459,1.0930643008439007,0.35,0.8444529026720017,1.0,3/8,20.09%,AGO3;TARBP2;AGO2
prerank,Reactome_2022__Interactions Of Rev With Host Cellular Proteins R-HSA-177243,0.49263519557428526,1.092984435843991,0.36363636363636365,0.8442244920843639,1.0,11/35,27.98%,NUP210;NUP42;AAAS;RANBP2;XPO1;NUP214;TPR;SEH1L;NUP153;NUP98;NUP37
prerank,GO_Biological_Process_2021__double-strand break repair via classical nonhomologous end joining (GO:0097680),0.6945976723091786,1.0929042441836232,0.4146341463414634,0.8440043531661545,1.0,3/6,21.10%,ERCC8;LIG4;ZBTB7A
prerank,GO_Biological_Process_2021__protein localization to ciliary transition zone (GO:1904491),0.6419289195658888,1.0928152213561038,0.3958333333333333,0.8438165394814003,1.0,1/6,6.20%,SPATA7
prerank,GO_Biological_Process_2021__negative regulation of metabolic process (GO:0009892),0.4572292928012008,1.092629150679533,0.2692307692307692,0.8439576647160375,1.0,15/46,25.87%,LAMA4;NOVA1;ALDH1A1;PLCL2;TFE3;NR1H3;NOTCH1;IP6K1;RBPJ;MAP2K6;CCDC3;NR1D1;PCTP;TLE3;RB1
prerank,Reactome_2022__TAK1-dependent IKK And NF-kappa-B Activation R-HSA-445989,0.41998591337645785,1.092445560923094,0.26666666666666666,0.8439143237615074,1.0,13/40,20.40%,RIPK2;HMGB1;ALPK1;N4BP1;TANK;NKIRAS2;TAB3;NFKB1;TP53;S100B;TAB1;TAB2;TRAF6
prerank,CellMarker_Augmented_2021__Preadipocyte Progenitor cell:Adipose Tissue,-0.4449587697945074,-1.0924422961888147,0.2839506172839506,1.0,1.0,21/80,15.25%,OLFML1;CYYR1;LMOD1;GALNT15;LYVE1;ECM2;ANGPTL2;ADAM33;DAAM2;DCN;ASPN;ITGA9;VWF;COX7A1;EDNRB;TEK;A2M;C1S;ACTA2;ADGRF5;JAM2
prerank,GO_Biological_Process_2021__regulation of hydrogen peroxide metabolic process (GO:0010310),-0.7004353174978707,-1.092352341592633,0.45454545454545453,1.0,1.0,5/5,29.98%,RAC2;RAC1;NOXA1;NOXO1;HDAC6
prerank,Reactome_2022__TRP Channels R-HSA-3295583,0.4964741078021179,1.0923342416739523,0.35714285714285715,0.8436948222758439,1.0,3/24,3.98%,MCOLN3;TRPC3;TRPM2
prerank,GO_Biological_Process_2021__positive regulation of endoplasmic reticulum unfolded protein response (GO:1900103),0.5962911185402235,1.0922372379018448,0.35135135135135137,0.8434675505560082,1.0,2/12,18.39%,ERN1;ATF6
prerank,GO_Biological_Process_2021__presynaptic membrane organization (GO:0097090),0.6145379374192116,1.0922185651652607,0.37777777777777777,0.8430725042693342,1.0,5/11,15.95%,CEL;NLGN1;NLGN4X;NLGN3;PTPRD
prerank,"GO_Biological_Process_2021__phototransduction, visible light (GO:0007603)",-0.616341489163098,-1.0922177302541816,0.4067796610169492,1.0,1.0,7/12,24.01%,PDE6B;GNGT1;RP1;PDE6A;PDE6G;CNGB1;ABCA4
prerank,GO_Biological_Process_2021__protein-DNA complex assembly (GO:0065004),-0.43783064645211506,-1.0918078814104517,0.3076923076923077,1.0,1.0,19/110,22.24%,MCM2;PSMB9;RPA3;MCM3;NAP1L2;GRWD1;CHAF1A;RBX1;PSMA3;RPS27A;CDC6;PSMA7;PSMB6;SMARCA5;H2BC18;ORC6;SOX9;RPA2;PSMA5
prerank,GO_Biological_Process_2021__protein localization to membrane (GO:0072657),0.37010833788382136,1.091761298114759,0.21052631578947367,0.8439893167092407,1.0,47/177,19.26%,MRAP2;FRMPD1;SCRIB;NLGN1;KCNB2;SPTBN4;ABHD17A;BSG;SYNE3;ITGA4;TMEM150A;MAGI2;KCNIP3;PDZD11;FLNA;RAP2A;LRP6;TNIK;DPP10;KCNIP4;TSPAN17;EHD4;RAB3C;RAP1A;ARL5A;TESC;RAB10;BID;SMURF1;NKD2;ANK2;DPP6;NRXN1;WNK3;ARL3;ZDHHC3;RAB11B;TTC7B;BRAF;RAB3D;DLG2;EFR3B;MYO5A;SLMAP;RAB40A;PTCH1;PACS1
prerank,GO_Biological_Process_2021__unsaturated fatty acid metabolic process (GO:0033559),-0.5099643185497522,-1.0916527678447594,0.36619718309859156,1.0,1.0,9/48,9.30%,ELOVL2;ALOX12;CYP1B1;ALOX5;PTGR1;ALOX12B;PLA2G10;ALOX15;CYP2J2
prerank,GO_Biological_Process_2021__nucleotide-binding oligomerization domain containing signaling pathway (GO:0070423),0.5158220535570649,1.091637046182015,0.3684210526315789,0.844049974403798,1.0,7/24,20.40%,IRGM;RIPK2;TAB3;TAB1;TAB2;MAP2K6;TRAF6
prerank,Reactome_2022__PP2A-mediated Dephosphorylation Of Key Metabolic Factors R-HSA-163767,0.6737851627212827,1.0915663740888868,0.4,0.8437511062071854,1.0,3/6,17.44%,PPP2R1B;MLXIPL;PPP2R5D
prerank,GO_Biological_Process_2021__ventricular cardiac muscle tissue morphogenesis (GO:0055010),-0.5427181276846548,-1.0915374167897758,0.40298507462686567,1.0,1.0,6/23,11.81%,PKP2;TGFB1;MYH7;MYBPC3;LRP2;ENG
prerank,CellMarker_Augmented_2021__Endothelial cell:Fetal Gonad,0.3762477936797781,1.091136259924825,0.3,0.8446181862761772,1.0,40/191,14.32%,BCHE;RFWD3;CCNG1;LAMA4;ZNF195;PCDH17;GPR161;FGFR1;HSPB1;CEP152;RCBTB2;ADGRL2;BIN1;DDAH2;IFI16;DNMT1;SH3BGRL3;HMGB1;BCAT1;WWOX;GMDS;SLIT2;ZEB1;LRRN3;SNAI2;COTL1;F2R;FLRT2;ZNF652;CES2;SLC35E3;BRD3;ZBTB44;LIMS1;MAN1A1;IDH2;NFIB;TSPAN12;NR2F2;ANO10
prerank,GO_Biological_Process_2021__heart looping (GO:0001947),-0.5280501024100475,-1.091124941980489,0.36,1.0,1.0,5/25,17.81%,CCDC39;TBX6;ENG;GATA4;MESP1
prerank,GO_Biological_Process_2021__late endosome to vacuole transport via multivesicular body sorting pathway (GO:0032511),0.5500428703109409,1.091111841758215,0.3611111111111111,0.8442076207652016,1.0,3/13,16.49%,CHMP6;VTA1;SNF8
prerank,"GO_Biological_Process_2021__antigen processing and presentation of endogenous peptide antigen via MHC class I via ER pathway, TAP-independent (GO:0002486)",-0.6937537055729086,-1.0910546787425142,0.4,1.0,1.0,3/6,22.43%,HLA-A;HLA-F;HLA-C
prerank,GO_Biological_Process_2021__antigen processing and presentation of endogenous peptide antigen via MHC class I via ER pathway (GO:0002484),-0.6937537055729086,-1.0910546787425142,0.4,1.0,1.0,3/6,22.43%,HLA-A;HLA-F;HLA-C
prerank,CellMarker_Augmented_2021__CD1C+ A Dendritic cell:Blood,0.4914983604498958,1.090875852655744,0.34146341463414637,0.844387661521996,1.0,3/18,8.45%,PTGS1;PID1;NR4A2
prerank,GO_Biological_Process_2021__macropinocytosis (GO:0044351),-0.6926171014522382,-1.0906700366798687,0.41509433962264153,1.0,1.0,3/6,5.45%,RAB34;MAPKAPK3;DOCK2
prerank,GO_Biological_Process_2021__MyD88-independent toll-like receptor signaling pathway (GO:0002756),0.4603875507309769,1.0905749813715078,0.22857142857142856,0.844726930478723,1.0,10/27,25.41%,CD14;TICAM2;TICAM1;TANK;FADD;TNIP3;UBE2D2;IKBKB;TRAF3;UBE2D3
prerank,CellMarker_Augmented_2021__CD1C+ B Dendritic cell:Blood,0.4799859989569761,1.0903243018450424,0.30303030303030304,0.8449782037938386,1.0,7/35,3.92%,CSTA;RAB27A;VCAN;AOAH;HNMT;CD14;PID1
prerank,GO_Biological_Process_2021__carboxylic acid biosynthetic process (GO:0046394),0.5852001548363436,1.0902388694463334,0.40540540540540543,0.8448868213962752,1.0,7/11,25.17%,RGN;FADS1;UGDH;SLC35D1;CYP2C8;PAH;NANP
prerank,GO_Biological_Process_2021__positive regulation of nervous system development (GO:0051962),0.45853503510860794,1.0902295624846605,0.4,0.8444612883593187,1.0,16/39,18.08%,GRID2;NLGN1;CX3CR1;RGS14;SYNDIG1;SPEN;NUMB;NLGN3;CLSTN2;NRXN1;PTPRD;DLG5;LIG4;EPHB2;FAIM;SLITRK2
prerank,GO_Biological_Process_2021__myelination in peripheral nervous system (GO:0022011),0.5910404525398296,1.09021604444211,0.3783783783783784,0.8440521158791686,1.0,2/11,3.01%,ADGRG6;PARD3
prerank,GO_Biological_Process_2021__negative regulation of TOR signaling (GO:0032007),0.4984664214560517,1.0901428132720359,0.29411764705882354,0.8438023747261959,1.0,11/31,21.75%,KPTN;EPM2A;SIRT1;DEPTOR;RNF152;MINAR1;ATM;SESN2;PRKAA2;SZT2;NPRL2
prerank,GO_Biological_Process_2021__embryonic organ development (GO:0048568),0.4605427015575394,1.0901087669990275,0.3125,0.8434654971979033,1.0,4/45,2.94%,TEAD2;KIT;RARB;MFSD2A
prerank,Reactome_2022__VEGFA-VEGFR2 Pathway R-HSA-4420097,0.37384697121378596,1.0901057080057772,0.25,0.8430177978894119,1.0,12/82,11.41%,THEM4;MAPKAPK2;ITPR2;HSPB1;CDH5;CRK;NANOS3;MLST8;AKT2;WASF3;PKN2;WASF2
prerank,GO_Biological_Process_2021__negative regulation of extrinsic apoptotic signaling pathway (GO:2001237),0.40674488417607113,1.0898640022126036,0.14814814814814814,0.8431896730681824,1.0,15/64,18.70%,EYA4;TGFBR1;BCL2;CFLAR;SERPINE1;SH3RF1;SNAI2;HSPA1A;FADD;GPX1;ZMYND11;EYA3;LGALS3;FAIM;ACVR1
prerank,CellMarker_Augmented_2021__Naive T cell:Bone Marrow,-0.48404790244741186,-1.0897442187393653,0.3188405797101449,1.0,1.0,15/54,10.28%,GMFG;ITGB2;DOCK8;CYTIP;ARHGAP9;TAGAP;TNFRSF1B;GPR183;PARVG;CD5;WAS;CD37;TRAF3IP3;MYO1F;PTPRC
prerank,GO_Biological_Process_2021__macrophage chemotaxis (GO:0048246),-0.6791365298346084,-1.089660767206267,0.44,1.0,1.0,3/7,13.30%,SFTPD;TAFA4;EDNRB
prerank,GO_Biological_Process_2021__hydrogen peroxide catabolic process (GO:0042744),-0.6133416030900514,-1.0895519015549282,0.39655172413793105,1.0,1.0,3/10,12.76%,PRDX4;PXDN;GPX3
prerank,GO_Biological_Process_2021__lipopolysaccharide-mediated signaling pathway (GO:0031663),-0.5894269523765695,-1.0892353377943418,0.38596491228070173,1.0,1.0,2/14,2.29%,TGFB1;HCK
prerank,"Reactome_2022__Gamma-carboxylation, Transport, And Amino-Terminal Cleavage Of Proteins R-HSA-159854",-0.6633602933181987,-1.0891843692566234,0.4126984126984127,1.0,1.0,2/9,9.58%,F7;FAM110A
prerank,KEGG_2021_Human__Thyroid cancer,-0.4956912719635202,-1.089177214532861,0.3194444444444444,1.0,1.0,6/37,14.02%,TCF7;CCND1;TCF7L1;CDKN1A;LEF1;RXRG
prerank,GO_Biological_Process_2021__external encapsulating structure organization (GO:0045229),-0.4290482190997667,-1.0890670819640909,0.3058823529411765,1.0,1.0,33/180,12.60%,CD44;ECM2;ITGB2;MMP9;MMP21;MMP19;TGFBI;COL18A1;NID1;COL1A1;COL5A1;COL27A1;LOX;VTN;DCN;HRNR;ICAM3;COL4A4;ITGA9;COL4A3;THBS1;MATN4;VWF;ITGA2B;PXDN;MMP25;LAMC2;FBN2;ITGAM;ITGB6;MARCOL;COL23A1;VIT
prerank,GO_Biological_Process_2021__IMP biosynthetic process (GO:0006188),0.6194659420258242,1.0887544684175627,0.40425531914893614,0.8462568979463257,1.0,3/6,23.09%,AMPD1;HPRT1;AMPD3
prerank,KEGG_2021_Human__Shigellosis,-0.4092520267239617,-1.0886896744641918,0.32926829268292684,1.0,1.0,2/206,1.35%,CD44;HK2
prerank,GO_Biological_Process_2021__response to leptin (GO:0044321),0.6108914221006008,1.088630133924193,0.3953488372093023,0.8462682992177288,1.0,3/9,8.97%,GCK;SIRT1;LEPR
prerank,Reactome_2022__Cell Cycle Checkpoints R-HSA-69620,-0.3948094561737786,-1.0885877169337423,0.25,1.0,1.0,48/238,23.67%,BUB1;ERCC6L;PSMB9;SPC25;RPA3;MCM3;CENPU;ABRAXAS1;CDC25A;ITGB3BP;ZWILCH;H2BC4;BRCA1;NUF2;CENPH;CENPS-CORT;CDKN1A;DYNLL1;RPS27;INCENP;CCNE2;NDEL1;PSMA3;RRAD;CDCA8;CENPN;RPS27A;KIF18A;PKMYT1;CDC6;BUB1B;PSMA7;PSMB6;YWHAG;RMI1;ORC6;TOPBP1;SKA2;SEC13;CENPL;CDKN1B;PSMA5;BLM;DYNLL2;PPP2R5A;RAD9B;CENPM;PSMD6
prerank,GO_Biological_Process_2021__genitalia development (GO:0048806),-0.6556599889184502,-1.0885625409681892,0.4339622641509434,1.0,1.0,1/7,2.54%,WNT5A
prerank,GO_Biological_Process_2021__neurotransmitter loading into synaptic vesicle (GO:0098700),0.688347263100737,1.0885591351790807,0.4583333333333333,0.8460102533470337,1.0,1/5,0.54%,SLC17A6
prerank,CellMarker_Augmented_2021__Endothelial cell:Fetal Liver,-0.45940682415347883,-1.0884542070665921,0.35443037974683544,1.0,1.0,17/77,14.86%,ENPP2;C1QB;CYYR1;LYVE1;ANGPT2;SLCO2B1;DAAM2;DCN;ZNF366;ITGA9;VWF;GPIHBP1;EDNRB;TEK;A2M;COLEC12;ADGRF5
prerank,GO_Biological_Process_2021__phagosome maturation (GO:0090382),0.4548428700982825,1.0884445074320626,0.2857142857142857,0.8458475250726403,1.0,5/33,5.56%,ATP6V0D2;TCIRG1;RAB31;RAB20;RAB7A
prerank,CellMarker_Augmented_2021__Adventitial cell:Skeletal Muscle,-0.4881074121542764,-1.08836281068102,0.3013698630136986,1.0,1.0,19/68,13.10%,C1QB;GMFG;HCK;ARHGAP9;TAGAP;TNFRSF1B;C3AR1;MS4A4A;PARVG;FCGR3A;P2RY14;VSIG4;HLA-DPB1;SELP;MYO1F;PTPRC;SPI1;F13A1;HLA-DPA1
prerank,GO_Biological_Process_2021__negative regulation of osteoblast proliferation (GO:0033689),0.5819010108844008,1.0881711227906787,0.34210526315789475,0.8461361909691428,1.0,2/8,8.27%,GREM1;PLXNB1
prerank,GO_Biological_Process_2021__regulation of vascular endothelial growth factor signaling pathway (GO:1900746),-0.5841562579062523,-1.0881035474497118,0.40298507462686567,1.0,1.0,4/17,14.26%,DCN;CD63;PIK3CB;IL12A
prerank,CellMarker_Augmented_2021__Platelet:Blood,0.4704720352501355,1.0880243163519756,0.26666666666666666,0.8460764240576466,1.0,4/27,4.84%,CD151;CD14;BSG;TNFSF14
prerank,GO_Biological_Process_2021__morphogenesis of a polarized epithelium (GO:0001738),0.5914188284791144,1.0878234108214258,0.36363636363636365,0.8463725716348371,1.0,2/12,2.41%,LAMA3;SCRIB
prerank,GO_Biological_Process_2021__carbohydrate derivative transport (GO:1901264),-0.5728561259720895,-1.087751617078408,0.3380281690140845,1.0,1.0,2/17,6.32%,SLC28A1;PLA2G10
prerank,Reactome_2022__Activation Of ATR In Response To Replication Stress R-HSA-176187,-0.5408555353505188,-1.0876232587256847,0.3968253968253968,1.0,1.0,12/31,27.84%,RPA3;MCM3;CDC25A;RRAD;CDC6;ORC6;RAD9B;CDC7;CHEK1;MCM5;MCM10;MCM6
prerank,GO_Biological_Process_2021__regulation of neutrophil extravasation (GO:2000389),-0.6818914870115445,-1.087442694192721,0.37037037037037035,1.0,1.0,1/6,10.20%,OLFM4
prerank,GO_Biological_Process_2021__regulation of ribonucleoprotein complex localization (GO:2000197),0.7162937576525931,1.087257733579014,0.4666666666666667,0.8470666215584095,1.0,4/6,23.43%,IWS1;SETD2;TPR;NSUN2
prerank,GO_Biological_Process_2021__regulation of mRNA export from nucleus (GO:0010793),0.7162937576525931,1.087257733579014,0.4666666666666667,0.8470666215584095,1.0,4/6,23.43%,IWS1;SETD2;TPR;NSUN2
prerank,KEGG_2021_Human__Thyroid hormone synthesis,-0.4579457750060878,-1.0870946471696714,0.3194444444444444,1.0,1.0,12/62,15.54%,DUOX1;IYD;ASGR2;TSHR;ATP1A4;CGA;LRP2;GPX3;GPX2;ADCY7;ITPR3;TG
prerank,GO_Biological_Process_2021__positive regulation of respiratory burst (GO:0060267),-0.7845325002639633,-1.0870196154556708,0.30434782608695654,1.0,1.0,1/5,1.12%,JCHAIN
prerank,GO_Biological_Process_2021__presynapse assembly (GO:0099054),0.5434292373147653,1.0867057596411445,0.2972972972972973,0.8480170866674398,1.0,8/18,12.52%,CEL;NLGN1;LRRTM3;PCLO;FZD1;WNT3A;NLGN4X;NLGN3
prerank,GO_Biological_Process_2021__negative regulation of cellular protein localization (GO:1903828),-0.5584145304360211,-1.0865985483828853,0.34375,1.0,1.0,5/29,10.89%,CAV3;CTNNA1;LATS2;DNAJA1;SPI1
prerank,Reactome_2022__Regulation Of Actin Dynamics For Phagocytic Cup Formation R-HSA-2029482,0.40795385561152103,1.086550690695282,0.3,0.8479328119642456,1.0,14/52,19.00%,MYO10;CD247;CRK;ABL1;MYO9B;WASF3;WASF2;ARPC3;VAV2;NCK1;LIMK1;MYO5A;DOCK1;ELMO1
prerank,GO_Biological_Process_2021__antigen processing and presentation of endogenous peptide antigen (GO:0002483),-0.5818014806721882,-1.086243609634625,0.3584905660377358,1.0,1.0,5/12,18.50%,HLA-A;ERAP2;HLA-DRB1;HLA-F;ERAP1
prerank,Reactome_2022__Anchoring Fibril Formation R-HSA-2214320,0.614340691304562,1.086048721032703,0.42857142857142855,0.8487083051836133,1.0,2/7,11.42%,LAMA4;TLL1
prerank,CellMarker_Augmented_2021__Proximal Tubular cell:Kidney,-0.4954203363614344,-1.085933943785406,0.37333333333333335,1.0,1.0,13/45,13.04%,SIRPG;JCHAIN;CYTIP;TAGAP;KLRB1;SCML4;ARHGAP15;CD5;SELP;TRAF3IP3;PTPRC;PTGDR;NLRC3
prerank,GO_Biological_Process_2021__RNA catabolic process (GO:0006401),0.4592724373706182,1.0858536365975002,0.3076923076923077,0.8489469502523396,1.0,12/40,21.06%,RNASET2;RIDA;DXO;ERN1;LSM2;HSPA1A;PNPT1;AGO3;XRN2;METTL16;DNA2;LSM6
prerank,GO_Biological_Process_2021__cell morphogenesis involved in differentiation (GO:0000904),0.4163541512809781,1.085583519411764,0.25,0.8492720092162191,1.0,18/65,16.47%,LAMB4;PARVA;ITGA8;ITGA4;USH2A;SRGAP2;NTN4;PROX1;FER;NTNG2;TYRO3;PXN;RILPL1;ARL13B;SIPA1L3;ANTXR1;TMEFF2;SRCIN1
prerank,Reactome_2022__Mitotic Telophase/Cytokinesis R-HSA-68884,0.5798643494692727,1.0854930888868952,0.4358974358974359,0.848951016122016,1.0,5/12,23.92%,PMEPA1;MAU2;NIPBL;PLK1;SMC3
prerank,GO_Biological_Process_2021__regulation of tissue remodeling (GO:0034103),-0.574368829582862,-1.0854289005285982,0.36231884057971014,1.0,1.0,3/16,7.40%,TGFB1;FLT4;CEACAM1
prerank,GO_Biological_Process_2021__nonribosomal peptide biosynthetic process (GO:0019184),0.6296680696324767,1.085425653823377,0.38235294117647056,0.8486854533174832,1.0,2/10,14.02%,CHAC1;BDH2
prerank,Reactome_2022__Regulation Of mRNA Stability By Proteins That Bind AU-rich Elements R-HSA-450531,-0.45608651174218384,-1.085309743007989,0.3235294117647059,1.0,1.0,2/80,0.62%,ENPP2;PSMB9
prerank,GO_Biological_Process_2021__endoplasmic reticulum organization (GO:0007029),0.41604049858829234,1.085054122969166,0.20689655172413793,0.8492303915126698,1.0,16/66,25.25%,TOR1B;STX5;REEP6;SMPD4;EIF2AK3;STX18;MOSPD3;RAB10;MIA3;DOP1B;TMCC1;UBE2J2;SEC61A1;SEC31A;BNIP1;LPCAT3
prerank,CellMarker_Augmented_2021__Myeloid Dendritic cell:Intestine,-0.6168876361962954,-1.0848781017317564,0.3620689655172414,1.0,1.0,7/11,20.41%,PDCD1LG2;ADGRE1;ITGAM;CD80;CD4;ITGAX;CD86
prerank,CellMarker_Augmented_2021__Myeloid Dendritic cell:Skin,-0.6168876361962954,-1.0848781017317564,0.3620689655172414,1.0,1.0,7/11,20.41%,PDCD1LG2;ADGRE1;ITGAM;CD80;CD4;ITGAX;CD86
prerank,CellMarker_Augmented_2021__Myeloid Dendritic cell:Lung,-0.6168876361962954,-1.0848781017317564,0.3620689655172414,1.0,1.0,7/11,20.41%,PDCD1LG2;ADGRE1;ITGAM;CD80;CD4;ITGAX;CD86
prerank,CellMarker_Augmented_2021__Myeloid Dendritic cell:Blood,-0.6168876361962954,-1.0848781017317564,0.3620689655172414,1.0,1.0,7/11,20.41%,PDCD1LG2;ADGRE1;ITGAM;CD80;CD4;ITGAX;CD86
prerank,CellMarker_Augmented_2021__Myeloid Dendritic cell:Stomach,-0.6168876361962954,-1.0848781017317564,0.3620689655172414,1.0,1.0,7/11,20.41%,PDCD1LG2;ADGRE1;ITGAM;CD80;CD4;ITGAX;CD86
prerank,GO_Biological_Process_2021__negative regulation of leukocyte proliferation (GO:0070664),-0.6836309531077213,-1.0848539904313041,0.43478260869565216,1.0,1.0,1/6,2.65%,BLK
prerank,Reactome_2022__MET Receptor Activation R-HSA-6806942,0.675349568788348,1.0847661396542805,0.42857142857142855,0.8494759973060241,1.0,1/6,0.66%,HGFAC
prerank,GO_Biological_Process_2021__regulation of dendritic cell apoptotic process (GO:2000668),-0.6425581758817888,-1.0846190112154768,0.4883720930232558,1.0,1.0,1/7,2.65%,BLK
prerank,Reactome_2022__Nuclear Import Of Rev Protein R-HSA-180746,0.4858178138331484,1.084273673321686,0.35294117647058826,0.8505149998551508,1.0,10/32,27.98%,NUP210;NUP42;AAAS;RANBP2;NUP214;TPR;SEH1L;NUP153;NUP98;NUP37
prerank,GO_Biological_Process_2021__regulation of T cell activation (GO:0050863),-0.5097898940036885,-1.0842615045141795,0.38028169014084506,1.0,1.0,9/35,19.12%,SIRPG;TNFRSF1B;HLA-DPB1;IL27;HLA-DPA1;FGL1;CD4;TNFSF8;CRTAM
prerank,GO_Biological_Process_2021__mitotic spindle elongation (GO:0000022),0.6724357921453836,1.0839060460448344,0.40816326530612246,0.8507371997665265,1.0,3/7,22.16%,MAP10;KIF4B;AURKC
prerank,GO_Biological_Process_2021__mitotic spindle midzone assembly (GO:0051256),0.6724357921453836,1.0839060460448344,0.40816326530612246,0.8507371997665265,1.0,3/7,22.16%,MAP10;KIF4B;AURKC
prerank,GO_Biological_Process_2021__regulation of histone exchange (GO:1900049),-0.6170733485544804,-1.0837990951314311,0.3770491803278688,1.0,1.0,1/9,2.96%,TERF2IP
prerank,GO_Biological_Process_2021__positive regulation of histone exchange (GO:1900051),-0.6170733485544804,-1.0837990951314311,0.3770491803278688,1.0,1.0,1/9,2.96%,TERF2IP
prerank,GO_Biological_Process_2021__serotonin uptake (GO:0051610),-0.7285375748873586,-1.0837914179412003,0.38461538461538464,1.0,1.0,3/5,24.50%,SLC22A3;SLC6A4;SLC22A1
prerank,GO_Biological_Process_2021__serotonin transport (GO:0006837),-0.7285375748873586,-1.0837914179412003,0.38461538461538464,1.0,1.0,3/5,24.50%,SLC22A3;SLC6A4;SLC22A1
prerank,PanglaoDB_Augmented_2021__T Memory Cells,0.41050327222873667,1.0837834836738172,0.3,0.8506990584311733,1.0,9/72,5.09%,IL7R;SELPLG;SKAP1;CD247;TRAC;BCL2;GPR174;IL16;PYHIN1
prerank,GO_Biological_Process_2021__regulation of natural killer cell mediated cytotoxicity directed against tumor cell target (GO:0002858),-0.7074205947293007,-1.0835488777475701,0.4166666666666667,1.0,1.0,3/6,19.12%,CEACAM1;IL12A;CRTAM
prerank,GO_Biological_Process_2021__necroptotic process (GO:0070266),0.6014442437301324,1.0834579986099968,0.42857142857142855,0.8512725936118276,1.0,5/12,21.12%,CD14;TICAM2;TICAM1;ITPK1;TRPM7
prerank,GO_Biological_Process_2021__camera-type eye morphogenesis (GO:0048593),0.5862472405617922,1.0833704524062573,0.4222222222222222,0.8510382771181929,1.0,4/9,17.21%,TENM3;LRP6;NF1;SKI
prerank,GO_Biological_Process_2021__cell junction maintenance (GO:0034331),-0.5737378843513673,-1.0833351300129157,0.3870967741935484,1.0,1.0,5/12,23.48%,CLDN1;DCTN1;F2RL1;CSF1R;PRTN3
prerank,PanglaoDB_Augmented_2021__Paneth Cells,-0.4909027924065913,-1.0832313260601536,0.34285714285714286,1.0,1.0,14/43,15.20%,ST6GALNAC1;CLCA1;ACSL5;GUCY2C;SLC5A1;CEACAM1;CFD;OLFM4;SPINK4;CYP4F12;GPX2;ADAMDEC1;MUC17;TMEM45B
prerank,GO_Biological_Process_2021__negative regulation of T cell differentiation (GO:0045581),-0.6649368574589338,-1.083206230902382,0.4107142857142857,1.0,1.0,2/6,15.95%,IRF1;GLI3
prerank,GO_Biological_Process_2021__sodium ion export across plasma membrane (GO:0036376),-0.6396896961403348,-1.0828702847604017,0.3225806451612903,1.0,1.0,3/10,19.66%,ATP1A4;ATP4A;ATP1A1
prerank,CellMarker_Augmented_2021__Suppressor T cell:Peripheral Blood,-0.4831622233425929,-1.0825297832776228,0.3582089552238806,1.0,1.0,20/49,16.70%,GMFG;ITGB2;HCK;CYTIP;ARHGAP9;TAGAP;PARVG;FCGR3A;CD5;WAS;TRAF3IP3;MYO1F;PTPRC;ITGAM;CD300LF;PSTPIP1;IKZF1;CD4;HK3;TNFSF8
prerank,GO_Biological_Process_2021__N-acetylneuraminate metabolic process (GO:0006054),0.5424156224245551,1.0825235860286058,0.4166666666666667,0.8531228577670946,1.0,2/10,10.69%,NPL;NAGK
prerank,GO_Biological_Process_2021__lamellipodium assembly (GO:0030032),0.5165659483168179,1.082500590536268,0.34210526315789475,0.8527782097087718,1.0,4/25,5.64%,KIT;PTPRO;CDH13;SRGAP2
prerank,GO_Biological_Process_2021__regulation of insulin-like growth factor receptor signaling pathway (GO:0043567),0.5679641869356369,1.082298009738479,0.4222222222222222,0.8529738533189813,1.0,2/12,7.94%,MYORG;IGFBP4
prerank,GO_Biological_Process_2021__oligodendrocyte development (GO:0014003),-0.5845947146623738,-1.0822345823893404,0.3442622950819672,1.0,1.0,5/16,24.47%,SOX10;EIF2B2;PLP1;MYRF;ZNF488
prerank,KEGG_2021_Human__JAK-STAT signaling pathway,0.37938449592280316,1.0821613165219057,0.2777777777777778,0.8528955574312301,1.0,9/106,9.44%,IL7R;BCL2;IL13RA2;STAT5B;CCND3;MYC;EPOR;LEPR;AKT2
prerank,Reactome_2022__Growth Hormone Receptor Signaling R-HSA-982772,0.49739763121986724,1.082087062605596,0.4358974358974359,0.8528017095322442,1.0,3/16,10.67%,IRS1;STAT5B;IRS2
prerank,Reactome_2022__Molecules Associated With Elastic Fibres R-HSA-2129379,-0.508782419190314,-1.0820138359330342,0.3064516129032258,1.0,1.0,7/24,16.22%,TGFB1;VTN;ITGB6;MFAP5;TGFB3;FBLN2;ITGB5
prerank,GO_Biological_Process_2021__negative regulation of ERBB signaling pathway (GO:1901185),-0.5055897880657689,-1.0818646854144391,0.3037974683544304,1.0,1.0,1/36,0.29%,EPN1
prerank,GO_Biological_Process_2021__basic amino acid transport (GO:0015802),-0.6563680871634756,-1.081766140094825,0.4262295081967213,1.0,1.0,2/8,8.28%,SLC7A7;SLC3A1
prerank,GO_Biological_Process_2021__regulation of flagellated sperm motility (GO:1901317),0.641841570180998,1.0816588125450939,0.5,0.8534970555394596,1.0,1/7,0.14%,TACR3
prerank,GO_Biological_Process_2021__cytoplasmic pattern recognition receptor signaling pathway (GO:0002753),0.5021319289009998,1.0816140978648303,0.38235294117647056,0.8532311991037427,1.0,7/23,20.40%,RIPK2;ALPK1;TAB3;TAB1;TAB2;MAP2K6;TRAF6
prerank,GO_Biological_Process_2021__peripheral nervous system axon ensheathment (GO:0032292),0.6503442549937958,1.0812179369726587,0.45,0.8534881795447135,1.0,2/7,3.01%,ADGRG6;PARD3
prerank,GO_Biological_Process_2021__Schwann cell development (GO:0014044),0.6503442549937958,1.0812179369726587,0.45,0.8534881795447135,1.0,2/7,3.01%,ADGRG6;PARD3
prerank,Reactome_2022__Regulation Of Expression Of SLITs And ROBOs R-HSA-9010553,-0.4230354479649759,-1.081167745141165,0.2727272727272727,1.0,1.0,67/151,27.50%,PSMB9;RPL37A;RPL38;RPL15;RPS4X;RPL3;LHX4;RPL35A;RPS9;FAU;RPS27;RPS21;RBX1;RPL13A;PSMA3;RPL27A;RPS16;RPL36;RPS20;RPL7A;RPL9;RPS8;RPS27A;RPL21;RPL34;PSMA7;PSMB6;RPL4;RPL32;RPL5;COL4A5;RPL23;RPL41;RPS7;RPS11;RPL27;RPL35;RPS14;RPL11;RPS15;PSMA5;RPLP1;RPS12;RPL18A;ELOB;PSMD6;RPS13;RPL29;RPLP2;RPL28;RPL12;RPL18;RPS3;RPL22;RPSA;PSMC5;RPS28;RPS19;PSMB4;RPS24;RPL26L1;RPS3A;RPL19;RPL8;RPS6;PSMB7;PSMD8
prerank,GO_Biological_Process_2021__sodium-independent organic anion transport (GO:0043252),-0.6517242351628598,-1.081147210945043,0.4230769230769231,1.0,1.0,3/11,15.91%,SLCO2B1;SLCO2A1;SLCO1A2
prerank,GO_Biological_Process_2021__positive regulation of substrate adhesion-dependent cell spreading (GO:1900026),0.4571315201550268,1.080899742542322,0.2894736842105263,0.8538932462566196,1.0,8/32,18.57%,CRK;ABL1;FLNA;CASS4;CSPG5;LIMS1;CRKL;DOCK1
prerank,GO_Biological_Process_2021__telomere maintenance in response to DNA damage (GO:0043247),-0.6253040080878741,-1.080860656105841,0.3870967741935484,1.0,1.0,4/10,21.55%,TERF2IP;DCLRE1C;DCLRE1A;TFIP11
prerank,GO_Biological_Process_2021__regulation of SMAD protein signal transduction (GO:0060390),-0.5301701967603969,-1.0808022693646062,0.3382352941176471,1.0,1.0,4/20,6.21%,TGFB1;NODAL;PBLD;DAB2
prerank,KEGG_2021_Human__Glycerophospholipid metabolism,0.402310217401494,1.0806034498206765,0.15384615384615385,0.8541654187839981,1.0,31/85,25.25%,DGKD;CHPT1;PGS1;PLPP2;CEPT1;CRLS1;LPCAT2;GPD2;CHKA;GPD1;PLA2G4C;AGPAT5;PLA2G15;ACHE;DGKH;AGPAT2;LPIN2;LCLAT1;PLA2G5;DGKZ;PLPP3;PLD2;ETNPPL;CDS1;PTDSS2;ADPRM;PEMT;PLA2G6;PCYT2;PNPLA6;LPCAT3
prerank,GO_Biological_Process_2021__regulation of small GTPase mediated signal transduction (GO:0051056),-0.42103967056308766,-1.0804926427296206,0.3108108108108108,1.0,1.0,19/126,17.19%,TRIP10;FOXM1;RASGRF2;ARHGAP9;TAGAP;OBSCN;VAV3;ARHGAP15;TGM2;RHOQ;ARHGAP12;ARAP3;ARHGAP28;ARHGDIG;A2M;AKAP13;RAC2;ECT2;RAC1
prerank,KEGG_2021_Human__Longevity regulating pathway,0.38966046730983867,1.080405071522986,0.3333333333333333,0.8542581740965088,1.0,25/91,19.98%,FOXO1;IRS1;PPARG;CREB3L2;SIRT1;CREB3L4;ADCY2;AKT2;ADIPOR1;IRS2;ADCY3;ADIPOR2;HSPA1A;HDAC1;IRS4;NFKB1;INSR;PIK3CA;TP53;EIF4EBP1;ADCY6;SESN2;CREB1;PRKAA2;PRKAG2
prerank,GO_Biological_Process_2021__substrate adhesion-dependent cell spreading (GO:0034446),0.42670853672550985,1.080388651601352,0.26666666666666666,0.8538370640745638,1.0,14/45,16.47%,LAMB4;PARVA;ITGA8;ITGA4;USH2A;SRGAP2;NTN4;FER;NTNG2;TYRO3;PXN;ANTXR1;TMEFF2;SRCIN1
prerank,GO_Biological_Process_2021__negative regulation of ubiquitin protein ligase activity (GO:1904667),-0.6370465499819423,-1.0802787574824746,0.4166666666666667,1.0,1.0,4/9,20.95%,RPL5;RPL23;RPS7;RPL11
prerank,Reactome_2022__Export Of Viral Ribonucleoproteins From Nucleus R-HSA-168274,0.46988616093297275,1.0802263373888508,0.35135135135135137,0.8538365297336228,1.0,13/33,27.98%,NUP210;NUP42;PBRM1;AAAS;HSPA1A;RANBP2;XPO1;NUP214;TPR;SEH1L;NUP153;NUP98;NUP37
prerank,Reactome_2022__Glycogen Breakdown (Glycogenolysis) R-HSA-70221,-0.5843512254681751,-1.0801662378075538,0.4264705882352941,1.0,1.0,5/13,24.35%,PHKG1;PYGL;CALM1;GYG2;PHKA1
prerank,Reactome_2022__Mitotic Anaphase R-HSA-68882,-0.3911510412171771,-1.0800778063690535,0.2823529411764706,1.0,1.0,40/210,23.67%,BUB1;ERCC6L;PSMB9;SPC25;CENPU;ITGB3BP;ZWILCH;NUF2;CENPH;CENPS-CORT;TUBA4A;DYNLL1;RPS27;INCENP;TUBA3D;CC2D1B;NDEL1;TUBB;PSMA3;TUBB6;TUBB2A;CDCA8;CENPN;RPS27A;KIF18A;BUB1B;PSMA7;PSMB6;NUP93;SKA2;TUBB4A;SEC13;CENPL;PSMA5;TUBB4B;DYNLL2;PTTG1;PPP2R5A;CENPM;PSMD6
prerank,PanglaoDB_Augmented_2021__Neuroendocrine Cells,0.3871506119290732,1.0800687286586952,0.24242424242424243,0.8536960228340397,1.0,35/123,19.02%,SPHKAP;GRM3;LRRTM3;KCNC2;LRRC4C;PDE10A;ATXN1;ELAVL3;CADM2;NEGR1;PAK5;KCNIP1;ADGRA1;CELF4;CXCL14;BRINP1;GABRG1;RGS7BP;NXPH1;ELAVL4;RAB3C;DPF1;OLFM3;SNAP91;RBFOX1;SCRT1;VSTM2B;NRXN1;RIT2;PPFIA2;LSAMP;MMD2;ST8SIA3;ADGRB3;GRM5
prerank,GO_Biological_Process_2021__regulation of phospholipid metabolic process (GO:1903725),0.5978437607593382,1.0800453328703121,0.40540540540540543,0.8533224945810114,1.0,5/10,28.52%,MFSD2A;MTMR3;MTMR1;MTMR9;ABCA3
prerank,GO_Biological_Process_2021__regulation of cellular component size (GO:0032535),-0.5314471797446568,-1.0800409806857032,0.31343283582089554,1.0,1.0,5/30,17.52%,RIN3;VAV3;NEB;RAC1;MSN
prerank,CellMarker_Augmented_2021__Mesenchymal Progenitor cell:Bone,0.40575730108028346,1.0800167509265801,0.2916666666666667,0.8508182661370249,1.0,24/94,16.07%,EDIL3;LAMA4;AMOTL1;ADGRL2;PARVA;MID1;COL12A1;RASSF8;RAI14;TENM3;PPFIBP1;SNAI2;CAP2;COL16A1;CHST3;MPDZ;RBFOX2;EFEMP1;NR2F2;MAGI1;WWTR1;ANTXR1;SPRY4;CALD1
prerank,CellMarker_Augmented_2021__Dental Pulp Stem cell:Molar,0.40575730108028346,1.0800167509265801,0.2916666666666667,0.8508182661370249,1.0,24/94,16.07%,EDIL3;LAMA4;AMOTL1;ADGRL2;PARVA;MID1;COL12A1;RASSF8;RAI14;TENM3;PPFIBP1;SNAI2;CAP2;COL16A1;CHST3;MPDZ;RBFOX2;EFEMP1;NR2F2;MAGI1;WWTR1;ANTXR1;SPRY4;CALD1
prerank,CellMarker_Augmented_2021__Mesenchymal Progenitor cell:Adipose Tissue,0.40575730108028346,1.0800167509265801,0.2916666666666667,0.8508182661370249,1.0,24/94,16.07%,EDIL3;LAMA4;AMOTL1;ADGRL2;PARVA;MID1;COL12A1;RASSF8;RAI14;TENM3;PPFIBP1;SNAI2;CAP2;COL16A1;CHST3;MPDZ;RBFOX2;EFEMP1;NR2F2;MAGI1;WWTR1;ANTXR1;SPRY4;CALD1
prerank,CellMarker_Augmented_2021__Tumor-propagating cell:Undefined,0.40575730108028346,1.0800167509265801,0.2916666666666667,0.8508182661370249,1.0,24/94,16.07%,EDIL3;LAMA4;AMOTL1;ADGRL2;PARVA;MID1;COL12A1;RASSF8;RAI14;TENM3;PPFIBP1;SNAI2;CAP2;COL16A1;CHST3;MPDZ;RBFOX2;EFEMP1;NR2F2;MAGI1;WWTR1;ANTXR1;SPRY4;CALD1
prerank,CellMarker_Augmented_2021__Progenitor cell:Fetal Liver,0.40575730108028346,1.0800167509265801,0.2916666666666667,0.8508182661370249,1.0,24/94,16.07%,EDIL3;LAMA4;AMOTL1;ADGRL2;PARVA;MID1;COL12A1;RASSF8;RAI14;TENM3;PPFIBP1;SNAI2;CAP2;COL16A1;CHST3;MPDZ;RBFOX2;EFEMP1;NR2F2;MAGI1;WWTR1;ANTXR1;SPRY4;CALD1
prerank,CellMarker_Augmented_2021__Mesenchymal Progenitor cell:Bone Marrow,0.40575730108028346,1.0800167509265801,0.2916666666666667,0.8508182661370249,1.0,24/94,16.07%,EDIL3;LAMA4;AMOTL1;ADGRL2;PARVA;MID1;COL12A1;RASSF8;RAI14;TENM3;PPFIBP1;SNAI2;CAP2;COL16A1;CHST3;MPDZ;RBFOX2;EFEMP1;NR2F2;MAGI1;WWTR1;ANTXR1;SPRY4;CALD1
prerank,Reactome_2022__Syndecan Interactions R-HSA-3000170,-0.5583835822229793,-1.0800011225265251,0.3387096774193548,1.0,1.0,4/17,9.78%,TGFB1;SDC2;VTN;THBS1
prerank,KEGG_2021_Human__Phosphonate and phosphinate metabolism,0.6641644350774771,1.0798994821597674,0.42424242424242425,0.8507186237156977,1.0,2/6,10.75%,CHPT1;CEPT1
prerank,GO_Biological_Process_2021__DNA strand elongation (GO:0022616),-0.5773016650175966,-1.0796730373773809,0.4305555555555556,1.0,1.0,3/18,10.71%,MCM3;MCMDC2;TERT
prerank,KEGG_2021_Human__Adipocytokine signaling pathway,0.41101409716834575,1.0795980369403189,0.29411764705882354,0.851145409689777,1.0,14/56,14.09%,IRS1;G6PC3;ACACB;MAPK8;CPT1C;LEPR;AKT2;ADIPOR1;IRS2;ACSL1;ADIPOR2;CPT1A;IRS4;NFKB1
prerank,GO_Biological_Process_2021__ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway (GO:0043162),0.5052962184555598,1.079526336858398,0.3870967741935484,0.850929660020104,1.0,8/22,22.29%,UBAP1L;MVB12A;UBAP1;PTPN23;SNF8;NEDD4;MVB12B;TSG101
prerank,GO_Biological_Process_2021__regulation of epidermal cell differentiation (GO:0045604),-0.5479046923661129,-1.0793520067108882,0.3620689655172414,1.0,1.0,4/21,17.25%,AQP3;SFRP4;ABCA12;ZFP36L1
prerank,GO_Biological_Process_2021__response to histamine (GO:0034776),0.6202411268876777,1.079281086664725,0.4666666666666667,0.8512399146412924,1.0,8/9,34.83%,DRD4;HRH1;GABRB2;GABRB1;GABRB3;GABRG2;DIAPH1;DRD3
prerank,GO_Biological_Process_2021__negative regulation of cellular macromolecule biosynthetic process (GO:2000113),0.3476491001687347,1.079160458886183,0.2222222222222222,0.8511943568871433,1.0,118/459,20.92%,CD38;FOXO1;PER2;GMNC;HDAC3;PRICKLE1;BCL6;HDAC10;TSHZ3;TWIST2;MTERF3;KLF10;CIART;SLFN11;PHC2;PRDM5;SAMD4A;HEXIM2;GATAD2A;TLE2;ATXN1;PPARG;WNT4;SIRT1;IFI16;RORB;SFMBT1;CRY1;HIC2;NRG1;HES1;PCIF1;PROX1;DHFR;ZBTB4;TRIM71;FOXP2;IKZF4;ZNF703;RIDA;KDM8;EIF2AK3;PML;PLCB1;WWP2;NANOS3;NKAP;CNOT9;FOXN3;ZEB1;MAP3K10;TWIST1;SPEN;CTBP2;TERF1;TIMELESS;DACH1;DPF1;RBFOX2;LIMS1;SMARCA2;MLXIPL;SMARCA4;SCMH1;MDFIC;KAT6A;DPF2;HDAC1;ASCL1;SMAD2;NR2F2;NR3C1;BCOR;MBTD1;MECP2;ZMYND11;HDAC4;PUS7;MALSU1;SPINDOC;MEN1;TP53;MPHOSPH8;MAGEL2;NOTCH1;ARID5B;ATF7IP;RAD17;PA2G4;SYNCRIP;THAP7;ZHX3;NIPBL;LSM14A;ZNF12;RBPJ;SP3;YAF2;ZNF706;ATR;SAMD4B;SOX13;DPF3;KAT6B;CDK5;KHDRBS1;EIF4A3;POU2F1;HDAC5;NANOS1;TRAF6;RSF1;PCGF6;RNF139;FXR2;HINFP;PRDM16;LARP1
prerank,GO_Biological_Process_2021__cellular response to muramyl dipeptide (GO:0071225),0.6114074936482252,1.078872444872577,0.4186046511627907,0.8516663604899105,1.0,1/8,3.92%,RIPK2
prerank,Reactome_2022__Regulation Of IFNA/IFNB Signaling R-HSA-912694,-0.6495304624918365,-1.0788247658200663,0.4230769230769231,1.0,1.0,1/9,6.09%,STAT1
prerank,GO_Biological_Process_2021__regulation of NLRP3 inflammasome complex assembly (GO:1900225),-0.6042415546193645,-1.0787541871614974,0.45,1.0,1.0,3/11,14.99%,USP50;NLRC3;DDX3X
prerank,GO_Biological_Process_2021__positive regulation of acrosome reaction (GO:2000344),-0.6637437513145521,-1.0786092986140758,0.43859649122807015,1.0,1.0,4/7,16.03%,PLA2G10;POMZP3;ZP3;IQCF1
prerank,PanglaoDB_Augmented_2021__Schwann Cells,-0.44126467333614183,-1.0782463956293347,0.34615384615384615,1.0,1.0,18/128,14.02%,GPR62;TRIL;LMOD1;PPP1R1B;SOX10;GFRA3;SHISA6;CTHRC1;DAAM2;LGI4;MPZ;ART3;AQP4;LRP4;APOD;EDNRB;NDRG1;RXRG
prerank,Reactome_2022__Costimulation By CD28 Family R-HSA-388841,0.4207768051461626,1.0781752791242702,0.27586206896551724,0.8534271351399282,1.0,10/53,11.36%,THEM4;CD247;MAP3K14;CSK;HLA-DRA;MLST8;ICOSLG;AKT2;PKN2;PPP2R1B
prerank,GO_Biological_Process_2021__regulation of T-helper 17 type immune response (GO:2000316),0.6741348061530202,1.0781193971008989,0.4864864864864865,0.8531490360415719,1.0,3/6,22.14%,CARD9;IL23A;SMAD7
prerank,GO_Biological_Process_2021__GDP-mannose metabolic process (GO:0019673),0.648987996623488,1.0780846214883053,0.375,0.8527786778455475,1.0,3/6,28.33%,GMDS;PMM2;GFUS
prerank,GO_Biological_Process_2021__positive regulation of regulatory T cell differentiation (GO:0045591),0.6128517695040998,1.0780426544283717,0.4146341463414634,0.8524703666776052,1.0,3/10,6.51%,BCL6;SOX12;HLA-DRA
prerank,Reactome_2022__Rev-mediated Nuclear Export Of HIV RNA R-HSA-165054,0.5017328272332475,1.077845224725689,0.2903225806451613,0.8526400338834927,1.0,11/33,27.98%,NUP210;NUP42;AAAS;RANBP2;XPO1;NUP214;TPR;SEH1L;NUP153;NUP98;NUP37
prerank,GO_Biological_Process_2021__lipid oxidation (GO:0034440),-0.6443688497644839,-1.0777621455555122,0.375,1.0,1.0,6/12,16.51%,ALOX12;ALOX5;ALOX12B;ALOX15;HAO2;ALOX15B
prerank,GO_Biological_Process_2021__negative regulation of T cell activation (GO:0050868),-0.5240974878863742,-1.0774765173515024,0.3787878787878788,1.0,1.0,7/30,14.67%,PDCD1LG2;SFTPD;CEACAM1;VSIG4;HLA-DRB1;FGL1;CD80
prerank,Reactome_2022__Mitotic Metaphase And Anaphase R-HSA-2555396,-0.39108555833091935,-1.0774410562997316,0.27380952380952384,1.0,1.0,40/211,23.67%,BUB1;ERCC6L;PSMB9;SPC25;CENPU;ITGB3BP;ZWILCH;NUF2;CENPH;CENPS-CORT;TUBA4A;DYNLL1;RPS27;INCENP;TUBA3D;CC2D1B;NDEL1;TUBB;PSMA3;TUBB6;TUBB2A;CDCA8;CENPN;RPS27A;KIF18A;BUB1B;PSMA7;PSMB6;NUP93;SKA2;TUBB4A;SEC13;CENPL;PSMA5;TUBB4B;DYNLL2;PTTG1;PPP2R5A;CENPM;PSMD6
prerank,"GO_Biological_Process_2021__positive regulation of transcription, DNA-templated (GO:0045893)",0.3109816246647907,1.0773862137240462,0.0,0.8535025482448783,1.0,215/966,19.37%,TEAD2;ERG;CD38;BAMBI;POU3F1;ESRRG;FOXO1;FANK1;ZNF496;SKAP1;TGFBR1;HDAC3;MED17;MAFB;MITF;NFATC3;RORA;APOE;RARB;POU3F2;GALR3;KLF10;CDH13;BCL11B;GABPB2;CCN1;AUTS2;ZNF263;RIPK2;PID1;SMARCD3;PPARG;CREB3L2;WNT4;FZD5;TET2;SIRT1;ELOF1;IFI16;ERBB2;MAML1;CREB3L4;PAX3;SNX5;RORB;ZEB2;PYHIN1;SOX12;LHX2;SSBP3;SERPINE1;JAG1;PKD2;SIRT7;HES1;PTOV1;PROX1;STAT5B;HMGB1;LBHD1;ATF3;DLX1;NCOA3;NCOA2;OSR1;SMARCB1;CDCA4;MED25;PCGF5;ETV1;GREM1;KDM8;SEC14L2;EIF2AK3;NRIP1;PML;ABL1;WWOX;NAT14;PLCB1;SP1;RBL1;FZD1;MYC;ZNF462;FSTL3;BCLAF3;TCF20;NR4A2;LRP6;SENP1;ZSCAN21;WNT3A;TWIST1;HIVEP3;HCLS1;TFE3;H1-10;WBP2NL;ATF1;CEP290;GRIN1;PLAGL1;ARID1A;CTBP2;RNF10;RPS6KA3;NPAS4;F2R;NAMPT;RRP1B;NPAS3;SP7;BPTF;TRIM44;PPM1A;CITED4;PIM2;DPF1;NSD1;SMARCA2;ZNF300;MLXIPL;SMARCA4;USP16;BCL9L;GDF6;RET;BICRAL;MDFIC;KAT6A;JUNB;NFIB;FADD;PLSCR1;DPF2;HDAC1;ASCL1;TESC;RYBP;ZXDC;MED16;FOXF2;ARRB1;CDK8;SMAD2;NR2F2;RPS6KA4;RLF;NR3C1;NFKB1;PPARGC1B;NFAT5;MLLT3;ASXL3;WWTR1;TFCP2;THRB;HDAC4;RFX6;NFIC;ETV5;MEN1;HSF1;NR1H3;SERTAD2;HJV;TP53;ZNF609;GABPA;RUNX1;ATAD2B;NR4A3;ZGLP1;NOTCH1;NCK1;ATM;PBX1;LPIN2;ATF7IP;NUFIP1;HIVEP1;GABPB1;BRD4;ICE1;SKI;FOXJ2;MAP2K7;PAX6;RFPL2;IL11;ELF2;ARID1B;TFEB;SATB2;RBPJ;SP3;YAF2;SUPT3H;ATF6;TNIP3;KLF6;NR4A1;RFX5;SPIN1;ACVR1;ASXL1;EP300;CXXC1;DPF3;TCF4;CREB1;KAT2B;QRICH1;KAT6B
prerank,GO_Biological_Process_2021__extracellular transport (GO:0006858),0.6077567226271716,1.0772359107883738,0.4222222222222222,0.8535560657205344,1.0,2/10,7.94%,SPEF2;WWP2
prerank,GO_Biological_Process_2021__negative regulation of potassium ion transmembrane transport (GO:1901380),-0.6670459561542696,-1.0772026259671936,0.3333333333333333,1.0,1.0,2/10,2.76%,CASQ2;CAV3
prerank,GO_Biological_Process_2021__maintenance of protein localization in organelle (GO:0072595),-0.5644734836709615,-1.0769191673853953,0.373134328358209,1.0,1.0,2/17,5.61%,HK2;PINK1
prerank,"Reactome_2022__Unblocking Of NMDA Receptors, Glutamate Binding And Activation R-HSA-438066",0.5337081535881857,1.0768693672280845,0.36666666666666664,0.8541556831861367,1.0,2/21,2.58%,LLGL1;GPRIN1
prerank,GO_Biological_Process_2021__regulation of viral life cycle (GO:1903900),-0.5348601674340374,-1.076821556107063,0.32786885245901637,1.0,1.0,3/18,6.02%,TRIM62;TRIM5;TRIM25
prerank,Reactome_2022__Presynaptic Nicotinic Acetylcholine Receptors R-HSA-622323,-0.5795688156181537,-1.0767943007006828,0.4032258064516129,1.0,1.0,6/11,27.58%,CHRNE;CHRNG;CHRNA5;CHRNA3;CHRNB2;CHRNA6
prerank,GO_Biological_Process_2021__negative regulation by symbiont of host apoptotic process (GO:0033668),-0.6780201643473825,-1.0766354023907774,0.41818181818181815,1.0,1.0,1/7,7.96%,RNF213
prerank,Reactome_2022__Endosomal Sorting Complex Required For Transport (ESCRT) R-HSA-917729,0.47503040964004983,1.0765675279890425,0.28125,0.8545547867403538,1.0,8/29,22.29%,MVB12A;CHMP6;UBAP1;VTA1;SNF8;STAM2;MVB12B;TSG101
prerank,GO_Biological_Process_2021__cell-cell adhesion mediated by integrin (GO:0033631),0.6743615209681627,1.0764324052878993,0.43137254901960786,0.8545769436235703,1.0,1/5,4.73%,ITGA4
prerank,Reactome_2022__RAF/MAP Kinase Cascade R-HSA-5673001,0.3695926780096267,1.0764275048514442,0.35714285714285715,0.8541459295717303,1.0,46/237,13.97%,DUSP4;FGF10;DUSP2;KIT;LLGL1;SPRED3;FGFR1;KSR1;GPRIN1;IRS1;ANGPT1;SPTBN4;NRG2;CSK;ABHD17A;IL17RD;FGF17;PSME4;ERBB2;SEM1;ARRB2;NRG1;RASA2;PPP5C;PSMA1;NRG3;FGF18;TGFA;SPRED2;ABHD17C;FGFR3;KITLG;IRS2;SPRED1;PPP2R1B;CNKSR2;RASAL2;RET;RAP1A;FNTA;ABHD17B;MARK3;ARRB1;NF1;MPP2;FLT3
prerank,GO_Biological_Process_2021__regulation of endothelial cell development (GO:1901550),0.6250383789983716,1.0763456526558826,0.42857142857142855,0.853868888552672,1.0,4/7,31.33%,VCL;IKBKB;ROCK1;ZDHHC21
prerank,Reactome_2022__Glucuronidation R-HSA-156588,0.6396592569665676,1.0762882216033436,0.4090909090909091,0.8535921316782485,1.0,3/8,17.13%,UGT2B15;UGDH;SLC35D1
prerank,GO_Biological_Process_2021__innate immune response (GO:0045087),-0.4037564525692221,-1.0762210295986148,0.3253012048192771,1.0,1.0,31/175,15.41%,CLEC5A;APOL1;JCHAIN;TRIM58;TRIM62;HCK;BLK;SP100;TRIM77;TRIM5;CIITA;SFTPD;TRIM25;RNF39;MASP1;BPIFB1;PTX3;CFD;NLRP9;CYBA;SLC11A1;IFIT1;MASP2;OAS1;CXCL16;TLR2;COLEC12;NOS2;RNF187;DDX3X;IGLL1
prerank,Reactome_2022__Collagen Chain Trimerization R-HSA-8948216,0.4369562282031812,1.0761475138605352,0.3125,0.853637742554006,1.0,4/41,4.22%,COL22A1;COL8A1;COL9A2;COL12A1
prerank,Reactome_2022__Fructose Metabolism R-HSA-5652084,-0.6287924016390838,-1.0761434698786607,0.4444444444444444,1.0,1.0,2/7,5.00%,ALDOB;GLYCTK
prerank,CellMarker_Augmented_2021__Adipose-derived Stromal cell:Visceral Adipose Tissue,0.39162426152565394,1.076121664862027,0.3181818181818182,0.8528171872592636,1.0,24/93,16.39%,FIBIN;EDIL3;MXRA5;BAALC;SEMA5A;TMEM132C;CNTN3;PTPRZ1;KCNIP1;EFS;DOK5;RGS7BP;COL16A1;CAMK1G;SGIP1;PAMR1;RNF180;MAP6;NAV1;PRICKLE2;CDH11;FGF14;PTPRD;CORO2B
prerank,CellMarker_Augmented_2021__Adipose-derived Stem cell:Visceral Adipose Tissue,0.39162426152565394,1.076121664862027,0.3181818181818182,0.8528171872592636,1.0,24/93,16.39%,FIBIN;EDIL3;MXRA5;BAALC;SEMA5A;TMEM132C;CNTN3;PTPRZ1;KCNIP1;EFS;DOK5;RGS7BP;COL16A1;CAMK1G;SGIP1;PAMR1;RNF180;MAP6;NAV1;PRICKLE2;CDH11;FGF14;PTPRD;CORO2B
prerank,GO_Biological_Process_2021__activation of cysteine-type endopeptidase activity (GO:0097202),0.5543302849669849,1.0761126065637745,0.4318181818181818,0.8523960541753431,1.0,4/14,4.79%,TBC1D10A;PERP;RIPK2;IFI16
prerank,GO_Biological_Process_2021__positive regulation of keratinocyte differentiation (GO:0045618),-0.6066983234426828,-1.0760997352792183,0.4426229508196721,1.0,1.0,4/10,14.65%,PLAAT4;ETV4;PRKCH;VDR
prerank,CellMarker_Augmented_2021__Platelet:Undefined,-0.5980818454757593,-1.0760033651887515,0.4666666666666667,1.0,1.0,4/16,10.72%,MPL;TGFB1;GP1BA;ITGA2B
prerank,GO_Biological_Process_2021__positive regulation of B cell differentiation (GO:0045579),-0.6931941135122927,-1.0759108717868495,0.4084507042253521,1.0,1.0,1/6,13.49%,CD27
prerank,CellMarker_Augmented_2021__Mesenchymal Stem cell:Embryo,-0.7410323279212669,-1.0758521743955192,0.45098039215686275,1.0,1.0,3/5,18.10%,ENG;NT5E;ANPEP
prerank,Reactome_2022__Interleukin-6 Signaling R-HSA-1059683,-0.5746133865076879,-1.0758473859734263,0.3333333333333333,1.0,1.0,1/9,6.09%,STAT1
prerank,GO_Biological_Process_2021__resolution of meiotic recombination intermediates (GO:0000712),0.5071598217244926,1.0757840823388,0.32558139534883723,0.8528707502632771,1.0,3/13,7.07%,MSH4;TOP2A;HFM1
prerank,"GO_Biological_Process_2021__regulation of transcription, DNA-templated (GO:0006355)",0.31246320728528215,1.0757765017519174,0.0,0.8524653185313212,1.0,407/1778,18.70%,TEAD2;ERG;CD38;BAMBI;POU3F1;ESRRG;FOXO1;PER2;FANK1;MLF1;ZNF496;ZNF607;ZSCAN4;ZNF808;SKAP1;TGFBR1;TSHZ2;KIT;ZNF408;POU6F2;HDAC3;PKNOX1;PRICKLE1;ZNF239;ZNF347;MKX;ZNF195;OR7D2;ZNF485;ZNF117;BCL6;ZNF212;ZBTB9;DMRT3;NEUROD2;ZNF623;MED17;MAFB;MITF;NFATC3;ZFPL1;RORA;APOE;ZNF518A;HDAC10;TSHZ3;POU3F2;ZNF692;CDK14;TWIST2;MTERF3;ZNF561;URI1;ZBTB7B;KLF10;SLC39A8;ARX;PCGF1;BCL11B;ZNF835;ZNF70;CIART;CBFB;PHC2;PRDM5;HEXIM2;APBB3;TGIF1;GATAD2A;ZNF263;ZNF99;TLE2;ZNF33B;E2F6;ZNF701;SMARCD3;ATXN1;PPARG;CREB3L2;WNT4;ATOH7;SIRT1;ZNF860;IFI16;ERBB2;ZFHX4;CREB3L4;PAX3;SNX5;TULP3;RORB;ZEB2;SFMBT1;BACH2;PYHIN1;SOX12;LHX2;ARID3B;ZNF641;ELP4;CRY1;GPBP1L1;ZBTB20;HIC2;NRG1;HES1;GFI1B;BCL11A;ZNF780B;ZNF534;TOX;ZFP3;PROX1;ZNF470;STAT5B;DHFR;ZBTB40;ZBTB4;CRK;HMGB1;BHLHA9;SMARCAL1;LBHD1;ATF3;TPRX1;DLX1;FOXP2;HIVEP2;NCOA2;SAFB2;OSR1;ZBTB1;HP1BP3;IKZF4;KDM7A;SMARCB1;ZNF703;PCGF5;ETV1;ZNF274;SPIN2B;KDM8;ZNF786;RGS14;SEC14L2;PML;ABL1;POFUT1;NAT14;PLCB1;SP1;FZD1;WWP2;MYC;MGA;NKAP;ZNF251;ZNF215;FSTL3;CTDSP1;TCF20;NR4A2;ZNF33A;TGFA;ZNF688;LRP6;ZSCAN12;FOXN3;SLTM;RFX1;ZEB1;FOXD4L5;HIF3A;ZNF202;ZSCAN21;WNT3A;HDX;RFX7;MAP3K10;TWIST1;SNAI2;HIVEP3;TENM1;SPEN;HCLS1;ZNF845;SRCAP;ZNF133;FADS1;LCORL;TFE3;WBP2NL;ATF1;ZNF2;CEP290;TESMIN;MAMLD1;PLAGL1;ZNF599;ZNF331;ARID1A;CTBP2;CREM;CDK18;ZNF519;RNF10;RPS6KA3;ZNF852;NPAS4;ZNF569;ELOA;ZNF514;F2R;EBF4;NPAS3;BATF2;MSC;KDM2A;ZNF777;ZNF652;SP7;BPTF;ZNF75A;TRIM44;HES6;TIMELESS;ZNF782;PPM1A;PIM2;DACH1;ZFP82;DPF1;RBFOX2;MYT1L;ZNF761;CCNH;NSD1;DMTF1;BRD3;LIMS1;SMARCA2;ZNF41;ZNF300;KDM3B;ZNF846;MLXIPL;SMARCA4;ZNF771;ZNF594;USP16;GDF6;TIAL1;RET;BICRAL;SCMH1;EPC2;ZNF337;MDFIC;KAT6A;ZNF155;JUNB;EFEMP1;ZNF704;NFIB;TEAD4;ZNF311;DPF2;ZNF276;NR3C2;MXI1;ZNF384;HDAC1;ASCL1;TESC;RYBP;CHD4;ZXDC;CDK11A;CARM1;MED16;FOXF2;ARRB1;TCIM;SMAD2;NR2F2;RPS6KA4;RLF;NFYC;ZNF774;NR3C1;NFKB1;PPARGC1B;NFAT5;MLLT3;BCOR;SOX5;ASCC2;ZNF611;MBTD1;CUX1;WWTR1;SCRT1;TFCP2;MECP2;ZMYND11;ZNF438;HDAC4;ZNF69;INSR;RFX6;ZFP62;NFIC;SPINDOC;CDK16;ETV5;MEN1;ZNF131;HSF1;MAGED1;ZNF48;NR1H3;ZNF586;TP53;ZNF165;ZNF609;BAZ1B;HSF4;GABPA;ZFY;RUNX1;NR6A1;ZNF549;BAZ2B;BAZ2A;NR4A3;FUS;TTC21B;ZFP28;MED13L;ZSCAN31;WWC1;SNF8;ZNF765;MPHOSPH8;GMEB1;ZNF708;ZGLP1;MAGEL2;NOTCH1;POLR3G;ZBTB2;CHD1;UBE2L3;ZNF283;PBX1;ZNF665;ARID5B;ATF7IP;ZNF292;KLF12;HIVEP1;ZNF273;BRD4;PA2G4;THAP7;SP2;ZFX;FOXJ2;NR2C1;MAP2K7;PAX6;RFPL2;ZHX3;ZNF646;ZNF675;ZNF322;ELF2;ZNF627;ZNF589;ARID1B;TFEB;NIPBL;ZBTB5;PRMT5;SATB2;ZNF12;ZBTB41;ZNF613;RBPJ;ZNF142;CAMTA1;SP3;NFX1;YAF2;UXT;ZNF706;SUPT3H;ATF6;KLF6;NR4A1;ZNF157;SOX13;RFX5;SPIN1;ZNF445;ERC1;ACVR1
prerank,CellMarker_Augmented_2021__Endothelial Progenitor cell:Blood,-0.45886166131631345,-1.0757682634948806,0.35443037974683544,1.0,1.0,19/64,14.86%,C1QB;CYYR1;LYVE1;ITM2A;SLCO2B1;MS4A4A;CLDN5;VSIG4;HLA-DPB1;SELP;ITGA9;PTPRC;VWF;F13A1;HLA-DPA1;EDNRB;TEK;A2M;ADGRF5
prerank,Reactome_2022__Activation Of APC/C And APC/C:Cdc20 Mediated Degradation Of Mitotic Proteins R-HSA-176814,-0.4749327504487696,-1.0753793306372301,0.373134328358209,1.0,1.0,2/67,0.62%,NEK2;PSMB9
prerank,GO_Biological_Process_2021__plasma membrane tubulation (GO:0097320),0.5482407279997753,1.075357240256071,0.38461538461538464,0.8531382681604368,1.0,6/11,28.72%,PACSIN2;SNX9;BIN3;FNBP1L;SNX33;WHAMM
prerank,Reactome_2022__Uptake And Function Of Diphtheria Toxin R-HSA-5336415,-0.7276899675525306,-1.0751336169878032,0.5,1.0,1.0,2/5,24.26%,EEF2;HSP90AB1
prerank,CellMarker_Augmented_2021__T cell:Tonsil,-0.5042580966106458,-1.0750285186693342,0.3815789473684211,1.0,1.0,16/47,18.85%,SIRPG;GMFG;CYTIP;ARHGAP9;TAGAP;KLRB1;SCML4;CD5;TRAF3IP3;PTPRC;NLRC3;PSTPIP1;IKZF1;TNFSF8;CD8B;SASH3
prerank,CellMarker_Augmented_2021__Memory T cell:Peripheral Blood,-0.5042580966106458,-1.0750285186693342,0.3815789473684211,1.0,1.0,16/47,18.85%,SIRPG;GMFG;CYTIP;ARHGAP9;TAGAP;KLRB1;SCML4;CD5;TRAF3IP3;PTPRC;NLRC3;PSTPIP1;IKZF1;TNFSF8;CD8B;SASH3
prerank,CellMarker_Augmented_2021__Naive T cell:Umbilical Cord Blood,-0.5042580966106458,-1.0750285186693342,0.3815789473684211,1.0,1.0,16/47,18.85%,SIRPG;GMFG;CYTIP;ARHGAP9;TAGAP;KLRB1;SCML4;CD5;TRAF3IP3;PTPRC;NLRC3;PSTPIP1;IKZF1;TNFSF8;CD8B;SASH3
prerank,CellMarker_Augmented_2021__T cell:Brain,-0.5042580966106458,-1.0750285186693342,0.3815789473684211,1.0,1.0,16/47,18.85%,SIRPG;GMFG;CYTIP;ARHGAP9;TAGAP;KLRB1;SCML4;CD5;TRAF3IP3;PTPRC;NLRC3;PSTPIP1;IKZF1;TNFSF8;CD8B;SASH3
prerank,CellMarker_Augmented_2021__Memory T cell:Liver,-0.5042580966106458,-1.0750285186693342,0.3815789473684211,1.0,1.0,16/47,18.85%,SIRPG;GMFG;CYTIP;ARHGAP9;TAGAP;KLRB1;SCML4;CD5;TRAF3IP3;PTPRC;NLRC3;PSTPIP1;IKZF1;TNFSF8;CD8B;SASH3
prerank,GO_Biological_Process_2021__response to leucine (GO:0043201),0.5904161031653451,1.0749816182464058,0.45454545454545453,0.8536114483014324,1.0,5/10,31.49%,KLHL22;SESN2;RRAGD;SESN3;UBR2
prerank,GO_Biological_Process_2021__cellular response to leucine (GO:0071233),0.5904161031653451,1.0749816182464058,0.45454545454545453,0.8536114483014324,1.0,5/10,31.49%,KLHL22;SESN2;RRAGD;SESN3;UBR2
prerank,GO_Biological_Process_2021__negative regulation of protein polymerization (GO:0032272),0.4786516700244462,1.074640993753718,0.4838709677419355,0.8541911816926246,1.0,8/27,17.08%,CDH5;SNCA;SLIT2;MAPRE1;KANK1;KANK4;SSH1;CLIP3
prerank,GO_Biological_Process_2021__dendrite self-avoidance (GO:0070593),0.5866687746880669,1.0745748439494194,0.42424242424242425,0.8539692198344961,1.0,5/15,15.63%,DSCAML1;BSG;DSCAM;EMB;CNTN6
prerank,GO_Biological_Process_2021__RNA destabilization (GO:0050779),0.51575753716229,1.0745519114854891,0.2903225806451613,0.8535797194287884,1.0,7/18,23.53%,RIDA;DXO;LIN28B;YTHDF1;METTL16;RBM24;MEX3D
prerank,GO_Biological_Process_2021__TRIF-dependent toll-like receptor signaling pathway (GO:0035666),0.46898946135029496,1.0745294901761684,0.24242424242424243,0.8532211030186841,1.0,5/26,12.94%,CD14;TICAM2;TICAM1;TANK;FADD
prerank,GO_Biological_Process_2021__catecholamine uptake (GO:0090493),-0.6945353096760523,-1.0743249832551034,0.5,1.0,1.0,2/5,24.50%,SLC22A3;SLC22A1
prerank,Reactome_2022__Platelet Sensitization By LDL R-HSA-432142,0.5438791710175905,1.0742751862268767,0.4,0.8534113411497486,1.0,4/15,17.44%,APOB;PPP2R1B;LRP8;PPP2R5D
prerank,GO_Biological_Process_2021__protein localization to mitochondrion (GO:0070585),-0.5964379361323274,-1.0740548759624198,0.391304347826087,1.0,1.0,3/12,10.70%,HK2;PINK1;DNAJA1
prerank,Reactome_2022__Translation R-HSA-72766,-0.40528081843710617,-1.0738244321746673,0.275,1.0,1.0,80/259,27.12%,RPL37A;NARS1;DARS2;RPL38;RPL15;WARS1;RPS4X;RPL3;RPL35A;RPS9;FAU;RPS27;EEF2;RPS21;MRPL19;SRP14;EIF2B2;RPL13A;MRPL40;YARS2;RPL27A;EIF2S3;RPS16;RPL36;RPS20;RPL7A;RPL9;EIF2S2;MRPS34;RPS8;RPS27A;RPL21;EIF4A2;RPL34;MRPL20;MRPL34;RPL4;RPL32;RPL5;RPL23;RPL41;RPS7;RPS11;SRP19;RPL27;RPL35;MRPS22;SSR4;RPS14;RPL11;RPS15;RPLP1;RPS12;PPA1;MRPS25;RPL18A;MRPS26;RPS13;RPL29;RPLP2;RPL28;RPL12;EIF1AX;RPL18;RPS3;RPL22;EEF1A1;RPSA;RPS28;SPCS2;RPS19;RPS24;MRPS2;GADD45GIP1;RPL26L1;RPS3A;RPL19;SPCS1;RPL8;RPS6
prerank,GO_Biological_Process_2021__positive regulation of cell cycle G1/S phase transition (GO:1902808),0.45541738605020016,1.0736473929050387,0.32432432432432434,0.8546064377277018,1.0,5/30,7.70%,ADAMTS1;FGF10;LSM10;CCND3;PLCB1
prerank,GO_Biological_Process_2021__response to glucagon (GO:0033762),0.5140965791206378,1.072976616266693,0.3888888888888889,0.8561656061253572,1.0,6/17,19.24%,CRY1;ADCY2;PRKAR2A;ADCY3;ADCY6;CREB1
prerank,Reactome_2022__Metabolism Of Steroid Hormones R-HSA-196071,-0.5121321963801725,-1.0727987114433903,0.34285714285714286,1.0,1.0,6/24,22.45%,AKR1B15;CYP21A2;HSD11B1;HSD3B1;CYP17A1;HSD11B2
prerank,GO_Biological_Process_2021__regulation of leukocyte mediated cytotoxicity (GO:0001910),-0.6738093325015191,-1.0727009572817299,0.49122807017543857,1.0,1.0,2/6,20.84%,NOS2;AGER
prerank,GO_Biological_Process_2021__toll-like receptor 4 signaling pathway (GO:0034142),-0.5478950829050928,-1.0726711888066656,0.390625,1.0,1.0,6/18,14.69%,TRIL;ITGB2;SCIMP;ITGAM;OAS1;NR1H4
prerank,GO_Biological_Process_2021__cobalamin transport (GO:0015889),-0.6584890867720581,-1.072589172766589,0.417910447761194,1.0,1.0,3/6,18.59%,TCN1;AMN;CBLIF
prerank,GO_Biological_Process_2021__regulation of defense response to bacterium (GO:1900424),-0.7043713378267109,-1.072555467796171,0.48,1.0,1.0,2/5,15.82%,CYBA;GRN
prerank,GO_Biological_Process_2021__tRNA pseudouridine synthesis (GO:0031119),0.6825967207261772,1.0723147164095954,0.47368421052631576,0.8576775514621933,1.0,2/6,14.89%,PUS10;PUS7
prerank,CellMarker_Augmented_2021__Smooth Muscle cell:Adipose Tissue,-0.4696874680965684,-1.0720924902696027,0.3,1.0,1.0,17/68,14.86%,C1QB;CYYR1;GALNT15;LYVE1;ANGPT2;DCN;CLDN5;ZNF366;VSIG4;SELP;VWF;GPIHBP1;ENG;TEK;A2M;GGT5;ADGRF5
prerank,GO_Biological_Process_2021__astrocyte differentiation (GO:0048708),0.6406575194346342,1.071895872969967,0.4897959183673469,0.8585797663407854,1.0,4/6,31.13%,CDK6;STAT3;DLL1;HES5
prerank,GO_Biological_Process_2021__positive regulation of osteoblast differentiation (GO:0045669),0.435384312823779,1.0717003331842754,0.3235294117647059,0.8586984128061658,1.0,12/38,23.49%,CCN4;CCN1;WNT4;SUCO;WWTR1;ZHX3;ACVR1;ACVR2A;BMPR2;BMP4;LRP3;BMPR1A
prerank,GO_Biological_Process_2021__cytosolic transport (GO:0016482),0.41981729136094853,1.0715668020852955,0.375,0.8586650447001156,1.0,27/110,18.88%,TBC1D10A;KLHL20;SNX5;STX5;RAB7A;STX6;WASHC2C;GBF1;RHOBTB3;STX8;UBE2O;GCC2;GGA1;DENND2A;VPS54;WASHC2A;VTI1A;PTPN23;SNX32;SNF8;MAGEL2;RAB5A;VPS50;MON2;ERC1;ARFRP1;DOP1B
prerank,GO_Biological_Process_2021__mitochondrial DNA metabolic process (GO:0032042),0.6103565664583344,1.0714628303343472,0.42,0.8585633927789754,1.0,4/7,29.63%,PRIMPOL;DNA2;LONP1;LIG3
prerank,GO_Biological_Process_2021__glucan catabolic process (GO:0009251),-0.5826158881503767,-1.071380680180277,0.40298507462686567,1.0,1.0,3/13,18.02%,PHKG1;PYGL;CALM1
prerank,GO_Biological_Process_2021__L-alpha-amino acid transmembrane transport (GO:1902475),0.4746035811091011,1.071323264867604,0.35135135135135137,0.8585225399800246,1.0,6/26,11.59%,SLC38A5;SLC3A2;SLC6A20;SLC25A29;SLC7A8;SLC25A12
prerank,GO_Biological_Process_2021__atrial septum morphogenesis (GO:0060413),-0.6604718564973517,-1.0713169548365786,0.38596491228070173,1.0,1.0,3/8,14.82%,ZFPM1;HEY2;GATA4
prerank,CellMarker_Augmented_2021__CD4+ Regulatory T cell:Undefined,-0.5159850675795687,-1.0711161420343571,0.3333333333333333,1.0,1.0,13/46,10.28%,SIRPG;GMFG;CYTIP;TBC1D10C;ARHGAP9;TAGAP;PARVG;CD5;WAS;CD37;TRAF3IP3;MYO1F;PTPRC
prerank,CellMarker_Augmented_2021__Regulatory T (Treg) cell:Ascites,-0.5159850675795687,-1.0711161420343571,0.3333333333333333,1.0,1.0,13/46,10.28%,SIRPG;GMFG;CYTIP;TBC1D10C;ARHGAP9;TAGAP;PARVG;CD5;WAS;CD37;TRAF3IP3;MYO1F;PTPRC
prerank,GO_Biological_Process_2021__peripheral nervous system development (GO:0007422),0.5237215473085048,1.0705984275289773,0.4375,0.8601803559741906,1.0,2/22,0.91%,NGF;ADGRG6
prerank,GO_Biological_Process_2021__desmosome organization (GO:0002934),-0.6696428574043662,-1.0705434157413274,0.4642857142857143,1.0,1.0,1/6,1.00%,PKP2
prerank,GO_Biological_Process_2021__response to type I interferon (GO:0034340),-0.632326439353372,-1.0705061646571084,0.40384615384615385,1.0,1.0,5/9,21.63%,SP100;IFIT1;TRIM56;MX1;ISG15
prerank,GO_Biological_Process_2021__cytokine-mediated signaling pathway (GO:0019221),-0.3902921840837422,-1.0702955934721368,0.27586206896551724,1.0,1.0,72/436,15.75%,CD44;DUOX1;CRLF1;PSMB9;TGFB1;TRIM62;IL21R;AIM2;ITGB2;HCK;IRF4;MMP9;CXCL13;CCND1;IFNK;SP100;ALOX5;RORC;CARD14;IRF1;TRIM5;TNFRSF1B;TEC;CLCF1;PTAFR;CIITA;TRIM25;STAT1;IL7;OAS2;IFIT3;CA1;INPP5D;HLA-A;CEACAM1;ALOX15;SOD2;HLA-DPB1;IL3RA;ANXA1;EDAR;OSMR;IL27;TXNDC17;GBP1;TRAF3IP2;HLA-DRB1;FPR1;SPI1;ITGAM;HSPA8;CDKN1A;IFIT1;OAS1;IL18BP;CFL1;F13A1;HLA-DPA1;CD300LF;OPRM1;CD27;PIK3CB;NOS2;IL12A;LCP1;CD80;IFNGR2;IL5RA;IL18;HLA-F;RBX1;CD4
prerank,GO_Biological_Process_2021__regulation of ATP metabolic process (GO:1903578),0.4302292897796766,1.0702753284258801,0.34210526315789475,0.8605783257889615,1.0,4/53,5.65%,GCK;NUP210;NUP42;SLC25A33
prerank,GO_Biological_Process_2021__muscle cell development (GO:0055001),-0.5006222242833223,-1.0702505007840688,0.36764705882352944,1.0,1.0,7/27,14.24%,NRAP;CAV3;NEB;ALPK2;ENG;HEY2;TTN
prerank,Reactome_2022__Diseases Of Metabolism R-HSA-5668914,0.35885445730515597,1.0702221581972824,0.23529411764705882,0.8602486466310693,1.0,36/207,11.28%,VCAN;ADAMTS1;GPC4;CYP7B1;ADAMTS16;PAPSS2;GALNT12;SDC4;DPM3;CHST6;EXT1;SEMA5A;GALE;SPON1;CYP2U1;GPC6;ADAMTS12;ADAMTS6;PRELP;CHSY1;SPAM1;G6PC3;ST3GAL3;MUC13;ARSB;GYS1;ADAMTS10;NUS1;ALG12;GPC5;MTR;CSPG5;B3GAT3;CHST3;SDC3;GLB1
prerank,Reactome_2022__RHOH GTPase Cycle R-HSA-9013407,0.49340901044966534,1.0701966474738525,0.4090909090909091,0.8598814429312327,1.0,7/34,11.41%,CSK;VANGL1;RAB7A;SLC4A7;PKN2;MTR;OSBPL11
prerank,Reactome_2022__Amino Acids Regulate mTORC1 R-HSA-9639288,0.4131057834387377,1.0701270190450547,0.2903225806451613,0.8596432635653717,1.0,3/48,2.57%,ATP6V0D2;TCIRG1;KPTN
prerank,KEGG_2021_Human__Central carbon metabolism in cancer,0.399182022690464,1.070070089614953,0.2903225806451613,0.8594053250279898,1.0,13/63,15.44%,GCK;KIT;FGFR1;ERBB2;PFKP;MYC;AKT2;FGFR3;RET;IDH2;FLT3;PIK3CA;TP53
prerank,CellMarker_Augmented_2021__Myeloid cell:Bone Marrow,0.4237388860969639,1.069794229175241,0.375,0.8596136768113751,1.0,5/45,4.73%,CD38;KIT;APOE;CD14;ITGA4
prerank,GO_Biological_Process_2021__miRNA catabolic process (GO:0010587),0.6253377953213966,1.0696920788440103,0.42857142857142855,0.8594666697444484,1.0,4/7,33.72%,LIN28B;LIN28A;TUT4;TENT4B
prerank,Reactome_2022__Androgen Biosynthesis R-HSA-193048,-0.7016956034284073,-1.0696033924713964,0.509090909090909,1.0,1.0,2/6,19.39%,HSD3B1;CYP17A1
prerank,GO_Biological_Process_2021__negative regulation of cAMP-mediated signaling (GO:0043951),0.6098245191555098,1.0695542264259437,0.44,0.8594104415073079,1.0,3/8,21.96%,PDE3B;CDC34;PDE4D
prerank,PanglaoDB_Augmented_2021__Radial Glia Cells,0.3832003661996124,1.0694681960424415,0.35714285714285715,0.8592636853230441,1.0,33/111,19.41%,MEGF10;PCDH17;NOVA1;NLGN1;LRRC4C;PDGFD;SLC35F1;PTPRZ1;KCNIP1;SLIT2;EFS;DOK5;ADGRA1;SYNDIG1;GUCY1A2;PDZRN3;BRINP1;RGS7BP;NPAS3;SNAP91;MAP6;ASXL3;ANK2;PTPRD;CORO2B;MAGEL2;MARK1;CDH4;PAX6;PPFIA2;FAT3;ADGRB3;SLC1A3
prerank,CellMarker_Augmented_2021__Eosinophil:Peripheral Blood,-0.6046378527123303,-1.0694530273999272,0.42028985507246375,1.0,1.0,7/10,19.68%,FCGR3A;IL3RA;CEACAM8;ITGAM;IL5RA;IL5;ITGAX
prerank,Reactome_2022__APC/C-mediated Degradation Of Cell Cycle Proteins R-HSA-174143,-0.44960672712895283,-1.0691261300077306,0.3287671232876712,1.0,1.0,2/76,0.62%,NEK2;PSMB9
prerank,GO_Biological_Process_2021__alpha-linolenic acid metabolic process (GO:0036109),-0.596206559084193,-1.0690889700268293,0.4098360655737705,1.0,1.0,1/12,1.18%,ELOVL2
prerank,GO_Biological_Process_2021__negative regulation of oxidoreductase activity (GO:0051354),0.618873479419087,1.069071058206656,0.42105263157894735,0.8600979163780583,1.0,2/8,5.38%,DRD5;SNCA
prerank,GO_Biological_Process_2021__negative regulation of type I interferon production (GO:0032480),-0.49235708245949855,-1.0689675753302519,0.31746031746031744,1.0,1.0,6/33,21.63%,UBE2L6;TRIM25;NLRC3;CACTIN;DHX58;ISG15
prerank,GO_Biological_Process_2021__glycoside catabolic process (GO:0016139),0.593713578932437,1.0689512772626164,0.43243243243243246,0.860018831652087,1.0,1/8,2.16%,GLA
prerank,PanglaoDB_Augmented_2021__Cardiac Stem And Precursor Cells,0.3825881452043595,1.0687801503798677,0.2962962962962963,0.8600227370754786,1.0,27/97,15.15%,KIT;ADGRL2;PARVA;MID1;COL12A1;RAI14;SLIT2;EDNRA;TENM3;AADAT;SNAI2;KITLG;RND3;CAP2;CHST3;MPDZ;DDAH1;TSPAN6;RBFOX2;LRIG3;TEAD4;TSPAN12;NR2F2;MAGI1;WWTR1;ANTXR1;PTPRF
prerank,CellMarker_Augmented_2021__Cancer Stem cell:Skin,0.4204561467692665,1.0687741976339296,0.3333333333333333,0.8596424290479863,1.0,29/87,16.94%,PLCH1;SLC16A9;MEGF10;GRID2;CACNG4;EPHA7;UNC5D;CXXC4;SLC35F1;PTPRZ1;FGFR3;WNK2;STOX2;NLGN4X;LRRN1;ADGRV1;CRABP1;MAP6;MSI1;ASXL3;PTPRT;ZNF663P;NRXN1;PPP1R9A;C6ORF118;PTPRD;MARK1;PBX1;GRIK3
prerank,GO_Biological_Process_2021__negative regulation of metallopeptidase activity (GO:1905049),-0.6741299261699663,-1.0687039078643494,0.4444444444444444,1.0,1.0,1/5,1.88%,TIMP3
prerank,GO_Biological_Process_2021__negative regulation of cell projection organization (GO:0031345),0.4280972118346362,1.068651284299344,0.3125,0.8596766388872382,1.0,7/47,9.71%,TSKU;APOE;PTPRO;DCC;PTPN9;WNT3A;KANK1
prerank,GO_Biological_Process_2021__positive regulation of ion transport (GO:0043270),-0.5021676096357541,-1.0685645981135368,0.3424657534246575,1.0,1.0,2/40,1.19%,PKP2;SCN5A
prerank,PanglaoDB_Augmented_2021__Ependymal Cells,-0.42983055096621076,-1.068443798762056,0.3888888888888889,1.0,1.0,22/102,16.78%,ANGPTL2;CFAP126;VWA3B;VWA3A;CCDC60;MAP3K19;BPIFB1;DRC1;MS4A8;AKAP14;AQP4;SNTN;CFAP77;FAM81B;APOBEC4;DRC3;CFAP61;DNAH2;CATIP;DNAI1;ADH7;ZBBX
prerank,GO_Biological_Process_2021__poly-N-acetyllactosamine metabolic process (GO:0030309),-0.5968925397431982,-1.068261235203698,0.423728813559322,1.0,1.0,5/10,27.26%,B3GNT9;B4GAT1;B3GNT2;B3GALT2;B3GNT3
prerank,GO_Biological_Process_2021__proline transport (GO:0015824),0.5965224957478633,1.0682496598380995,0.46808510638297873,0.8603730971151157,1.0,3/6,16.71%,SLC6A17;SLC6A20;SLC36A4
prerank,GO_Biological_Process_2021__isoleucine metabolic process (GO:0006549),-0.7080182110972795,-1.0682169494804663,0.45454545454545453,1.0,1.0,2/5,14.94%,SDS;SDSL
prerank,GO_Biological_Process_2021__determination of left/right symmetry (GO:0007368),-0.5135424825988812,-1.068062196593058,0.3939393939393939,1.0,1.0,4/33,2.91%,TBX1;DNAH11;CCDC39;MMP21
prerank,GO_Biological_Process_2021__diol metabolic process (GO:0034311),-0.540194687297369,-1.0679645885935904,0.3783783783783784,1.0,1.0,3/17,18.26%,DEGS2;CALM1;GCHFR
prerank,Reactome_2022__RHOV GTPase Cycle R-HSA-9013424,0.4333803970264578,1.067827975810861,0.27586206896551724,0.8610613328758762,1.0,12/35,21.97%,VANGL1;SH3RF1;TPM4;PKN2;DST;PARD6B;DLG5;NCK1;MYO9A;TPM3;GIT1;NCK2
prerank,GO_Biological_Process_2021__digestive tract development (GO:0048565),0.4732103916349284,1.0678159745411564,0.3409090909090909,0.8606511938703698,1.0,3/26,2.88%,KIT;CLMP;RARB
prerank,GO_Biological_Process_2021__positive regulation of cardiac epithelial to mesenchymal transition (GO:0062043),0.63022868693528,1.0676015109839543,0.4634146341463415,0.8608802079449028,1.0,2/7,5.28%,TGFBR1;JAG1
prerank,Reactome_2022__Class A/1 (Rhodopsin-like Receptors) R-HSA-373076,0.3733276168112963,1.0675990717220398,0.2608695652173913,0.860448039165814,1.0,24/184,7.93%,ADRA1A;TACR3;NTSR2;ADRA1B;CHRM2;PLPPR1;HTR1F;GALR3;HTR2C;HRH3;QRFPR;RIPK2;DRD5;CX3CR1;OPN5;PROKR2;UTS2R;OPRD1;DRD4;RXFP1;S1PR5;NMU;NPW;EDNRA
prerank,GO_Biological_Process_2021__tRNA 3'-end processing (GO:0042780),-0.6335620931896501,-1.0674831904462085,0.44642857142857145,1.0,1.0,2/6,22.93%,TRNT1;PTCD1
prerank,GO_Biological_Process_2021__protection from non-homologous end joining at telomere (GO:0031848),-0.6444173481616524,-1.0674228470789597,0.390625,1.0,1.0,4/7,21.55%,TERF2IP;DCLRE1C;DCLRE1A;TFIP11
prerank,GO_Biological_Process_2021__protein localization to chromosome (GO:0034502),-0.4981650699989334,-1.0674002906861826,0.4,1.0,1.0,8/32,25.72%,TERF2IP;ESR1;FAM47E;BOD1;RPA2;TPP1;SLF1;MRNIP
prerank,GO_Biological_Process_2021__regulation of inflammatory response to wounding (GO:0106014),-0.7481058737842493,-1.067306483052253,0.42857142857142855,1.0,1.0,2/5,15.82%,ALOX5;GRN
prerank,GO_Biological_Process_2021__glycoside metabolic process (GO:0016137),0.6350280918011668,1.0672341271792223,0.4186046511627907,0.8606804831151713,1.0,1/6,2.16%,GLA
prerank,GO_Biological_Process_2021__glycosyl compound catabolic process (GO:1901658),0.6350280918011668,1.0672341271792223,0.4186046511627907,0.8606804831151713,1.0,1/6,2.16%,GLA
prerank,GO_Biological_Process_2021__establishment of protein localization to membrane (GO:0090150),0.4098016831141315,1.067203065122749,0.3333333333333333,0.8603615573389686,1.0,17/65,19.34%,FRMPD1;PARD3;ZDHHC11B;SYNE3;ZDHHC18;ZDHHC12;GOLGA7B;NECTIN3;RAB10;BID;MYO1C;ZDHHC14;ZDHHC3;RAB11B;BRAF;ZDHHC9;ZDHHC11
prerank,GO_Biological_Process_2021__in utero embryonic development (GO:0001701),0.5129109440377767,1.0671232176232133,0.38095238095238093,0.8601478920038998,1.0,5/18,20.83%,TGFBR1;PTPRR;LIG4;ADAM10;HINFP
prerank,GO_Biological_Process_2021__small nucleolar ribonucleoprotein complex assembly (GO:0000491),0.5805957633857604,1.0670960633188882,0.36363636363636365,0.8598070762581156,1.0,5/9,33.96%,PIH1D1;NUFIP1;ZNHIT6;NAF1;RUVBL2
prerank,Reactome_2022__Transcriptional Activity Of SMAD2/SMAD3:SMAD4 Heterotrimer R-HSA-2173793,0.4273652873476293,1.067027551633592,0.3,0.8596088788675063,1.0,16/46,22.14%,TGIF1;SERPINE1;RBL1;MYC;PPM1A;HDAC1;CDK8;SMAD2;WWTR1;MEN1;FURIN;SKI;EP300;E2F5;TFDP1;SMAD7
prerank,CellMarker_Augmented_2021__Red Blood Cell (erythrocyte):Undefined,-0.49191747926957247,-1.0670236285579568,0.35443037974683544,1.0,1.0,27/76,19.97%,GYPE;SP100;SLFN14;DOCK2;GYPB;C3AR1;MS4A4A;FCGR3A;CA1;VSIG4;SOD2;SELP;IGSF6;PTPRC;FPR1;ALAS2;CLEC12A;F13A1;APOL6;PIK3CG;CPQ;CLEC1B;CSF1R;CARD6;TFEC;ITGAX;GAB3
prerank,GO_Biological_Process_2021__bicarbonate transport (GO:0015701),0.4530817191909286,1.06699606158319,0.2926829268292683,0.8592387356390159,1.0,5/28,8.19%,SLC26A7;SLC39A8;CA3;CYB5R4;SLC4A7
prerank,GO_Biological_Process_2021__inorganic anion transport (GO:0015698),-0.5080799707748302,-1.0669892889455295,0.3387096774193548,1.0,1.0,1/40,0.10%,CLIC1
prerank,Reactome_2022__Eicosanoids R-HSA-211979,-0.6194497876852647,-1.066972494799847,0.4411764705882353,1.0,1.0,3/9,17.94%,CYP4F12;TBXAS1;CYP4B1
prerank,GO_Biological_Process_2021__organic hydroxy compound transport (GO:0015850),-0.48532795928263583,-1.0669525253925858,0.3220338983050847,1.0,1.0,11/33,19.10%,SLC51A;SLC16A8;SLCO2B1;CEACAM1;NR1H4;STARD5;SLC10A1;SLCO1A2;GHRL;ABCB11;SLC27A5
prerank,Reactome_2022__CASP8 Activity Is Inhibited R-HSA-5218900,0.5612375954081927,1.0668017213811658,0.4117647058823529,0.8588509802562089,1.0,3/9,12.94%,CFLAR;TANK;FADD
prerank,Reactome_2022__Dimerization Of Procaspase-8 R-HSA-69416,0.5612375954081927,1.0668017213811658,0.4117647058823529,0.8588509802562089,1.0,3/9,12.94%,CFLAR;TANK;FADD
prerank,GO_Biological_Process_2021__molybdopterin cofactor biosynthetic process (GO:0032324),0.6456386601928085,1.0667372602647678,0.4146341463414634,0.8581652159847127,1.0,1/6,8.93%,GPHN
prerank,Reactome_2022__Molybdenum Cofactor Biosynthesis R-HSA-947581,0.6456386601928085,1.0667372602647678,0.4146341463414634,0.8581652159847127,1.0,1/6,8.93%,GPHN
prerank,GO_Biological_Process_2021__protein localization to nucleus (GO:0034504),0.41458123970739624,1.0666607405286344,0.3076923076923077,0.8579460337301807,1.0,23/95,24.20%,CTDNEP1;PRICKLE1;TOR1B;RANBP17;PML;NOL8;NXT1;TAF3;BANP;GBP2;NUTF2;PPP1R10;ABCA7;MORC3;APPL2;IPO8;ZBTB7A;BMP4;NUP214;TPR;BCL3;PLK1;IPO7
prerank,GO_Biological_Process_2021__poly-N-acetyllactosamine biosynthetic process (GO:0030311),-0.6086307708562131,-1.0665832759908758,0.3870967741935484,1.0,1.0,5/9,27.26%,B3GNT9;B4GAT1;B3GNT2;B3GALT2;B3GNT3
prerank,GO_Biological_Process_2021__regulation of epithelial cell apoptotic process (GO:1904035),-0.6536512563608594,-1.0665486683954428,0.43859649122807015,1.0,1.0,3/8,17.25%,TEK;YAP1;ZFP36L1
prerank,GO_Biological_Process_2021__smooth muscle cell migration (GO:0014909),0.6158711239071585,1.0664951377887177,0.4186046511627907,0.8580703280910708,1.0,1/6,3.31%,PARVA
prerank,KEGG_2021_Human__Steroid biosynthesis,0.5201984880577333,1.06620840592999,0.3611111111111111,0.858380958781603,1.0,5/17,15.61%,CEL;SOAT1;SOAT2;SC5D;TM7SF2
prerank,GO_Biological_Process_2021__autophagy of mitochondrion (GO:0000422),-0.4866247448937789,-1.0661949163221234,0.36231884057971014,1.0,1.0,10/38,25.97%,PINK1;ATG14;GABARAPL1;GABARAPL2;MAP1LC3B2;FIS1;FUNDC1;SPATA18;BNIP3;ULK1
prerank,Reactome_2022__Signaling By RAF1 Mutants R-HSA-9656223,0.44084505203831,1.066138650859602,0.2916666666666667,0.8581545419647031,1.0,7/33,13.66%,KSR1;CSK;ARRB2;CNKSR2;RAP1A;MARK3;ARRB1
prerank,KEGG_2021_Human__RNA degradation,0.3758478657957856,1.0661251560003036,0.3125,0.8577942329974668,1.0,24/72,23.05%,DCP1B;ENO3;TENT4A;PFKP;DCPS;EXOSC1;CNOT9;LSM2;TOB2;PNPT1;CNOT4;PATL1;LSM7;DIS3;ZCCHC7;XRN2;CNOT6;EXOSC5;C1D;LSM6;LSM8;ENO1;DIS3L;DCP1A
prerank,CellMarker_Augmented_2021__Induced Regulatory T (Treg) cell:Peripheral Blood,0.45336557782211856,1.065903506251982,0.3448275862068966,0.8580226172599198,1.0,6/46,5.09%,IL7R;SELPLG;CD247;TRAC;IL16;PYHIN1
prerank,GO_Biological_Process_2021__negative regulation of neuron differentiation (GO:0045665),0.4964215067337963,1.0658581965041902,0.4090909090909091,0.8576999502806618,1.0,4/17,13.36%,DTX1;HES1;DLX1;ASCL1
prerank,Reactome_2022__ADORA2B Mediated Anti-Inflammatory Cytokine Production R-HSA-9660821,-0.44585988206663124,-1.0658352980902104,0.35714285714285715,1.0,1.0,12/81,14.93%,C1QTNF1;SCTR;TSHR;GPHB5;GNAT3;PTRH2;GPR27;GNGT1;GPR39;PTGDR;NLRP3;ADCY7
prerank,GO_Biological_Process_2021__regulation of chromatin binding (GO:0035561),0.5907340901736226,1.065793117566515,0.4,0.857437123131873,1.0,2/10,10.73%,MED25;ZNF618
prerank,GO_Biological_Process_2021__positive regulation of receptor-mediated endocytosis (GO:0048260),0.46117337950458825,1.0657688274266208,0.3409090909090909,0.8570853232229575,1.0,9/38,8.91%,DGKD;ANGPT1;HIP1;SERPINE1;ARRB2;MAGI2;BICD1;GREM1;WNT3A
prerank,GO_Biological_Process_2021__positive regulation of protein modification by small protein conjugation or removal (GO:1903322),0.3961641352602846,1.0657253071589405,0.2916666666666667,0.8568081975843906,1.0,15/66,18.56%,HDAC3;PRICKLE1;ANGPT1;RIPK2;COMMD1;CRY1;DCUN1D1;TANK;HSPBP1;HDAC4;MALT1;FBXO4;UBE2L3;RASD2;SPRTN
prerank,GO_Biological_Process_2021__RNA metabolic process (GO:0016070),0.38176021439315266,1.0656803623959041,0.2916666666666667,0.8565090607935689,1.0,27/118,22.28%,NOVA1;RNASET2;ATXN1;HNRNPF;BICD1;RBMS1;HNRNPH1;PCBP3;HNRNPL;ELAVL4;WDR74;RBFOX2;PNPT1;GTF2F2;CELF2;PTBP1;TBRG4;AGO3;NUFIP1;SYNCRIP;PAPOLA;XRN2;AGO2;RBM6;ADAR;LSM8;POLR2F
prerank,GO_Biological_Process_2021__extracellular structure organization (GO:0043062),-0.41566951106894123,-1.0656120283051467,0.3333333333333333,1.0,1.0,32/180,12.60%,CD44;ECM2;ITGB2;MMP9;MMP21;MMP19;TGFBI;COL18A1;NID1;COL1A1;COL5A1;COL27A1;LOX;VTN;DCN;ICAM3;COL4A4;ITGA9;COL4A3;THBS1;MATN4;VWF;ITGA2B;PXDN;MMP25;LAMC2;FBN2;ITGAM;ITGB6;MARCOL;COL23A1;VIT
prerank,GO_Biological_Process_2021__negative regulation of serine-type peptidase activity (GO:1902572),-0.6730172442554652,-1.0655421440157637,0.46296296296296297,1.0,1.0,4/5,32.18%,SPINK6;SPINK5;ANXA8;CR1
prerank,CellMarker_Augmented_2021__Intermediate Progenitor cell:Undefined,0.4046825532654394,1.0654812760694807,0.3,0.8566260263498375,1.0,26/88,17.54%,XKR7;SEZ6L;DMRTC1;SBK1;DSCAML1;BCL11B;KCNH8;ELAVL3;DTX1;GLCCI1;PAK5;CD8A;ABCD2;NXPH1;ELAVL4;EVL;NLGN3;ASCL1;GNAO1;PITPNC1;VSTM2B;JPH4;JAKMIP2;CARMIL3;GRIK3;KIF21B
prerank,GO_Biological_Process_2021__myoblast migration (GO:0051451),0.6418138448819201,1.065451470351081,0.44680851063829785,0.856260483958352,1.0,1/7,1.01%,MEGF10
prerank,GO_Biological_Process_2021__mRNA processing (GO:0006397),0.34385818364132464,1.0653656868143377,0.16666666666666666,0.856058494189003,1.0,72/277,26.51%,CPSF1;SNRPN;NOVA1;PCF11;HNRNPF;TRA2A;RBM41;PUF60;PRPF40B;HNRNPH1;TXNL4A;SNRPB;SPEN;U2AF1;ERN1;SRRM1;HNRNPL;LSM2;ZMAT5;CCNH;GEMIN5;CWC27;SF3B1;CPSF7;SRSF4;GTF2F2;SRRM4;PTBP1;FUS;LSM7;TBRG4;SYNCRIP;AURKAIP1;PAPOLA;ERCC3;RNF113A;RPRD2;EIF4A3;U2AF2;SYMPK;SF3B4;RBM6;CPSF6;GPATCH1;LSM6;PPIH;CDC5L;LSM8;PDCD7;DDX46;DDX41;POLR2F;RALY;PRPF18;MAGOHB;TCERG1;SNRNP48;PSPC1;RBM10;YBX1;THOC1;SNRPF;WDR33;CWF19L1;PABPC1;CCAR1;SF1;SCAF11;SNRPA;RBM8A;SMU1;SON
prerank,Reactome_2022__Signaling By VEGF R-HSA-194138,0.381373736740843,1.0653140859147912,0.3076923076923077,0.8557751499610344,1.0,13/90,11.41%,THEM4;MAPKAPK2;ITPR2;VEGFC;HSPB1;CDH5;CRK;NANOS3;MLST8;AKT2;WASF3;PKN2;WASF2
prerank,GO_Biological_Process_2021__chondroitin sulfate proteoglycan metabolic process (GO:0050654),0.5810842720710919,1.0652506138101419,0.3333333333333333,0.855536548730734,1.0,3/10,11.69%,CSGALNACT1;B3GAT3;DSEL
prerank,GO_Biological_Process_2021__nucleocytoplasmic transport (GO:0006913),0.4636301996109291,1.0652106421277956,0.29411764705882354,0.8552167098397542,1.0,10/36,16.80%,ATXN1;BACH2;RGS14;NXT1;ANP32A;SNRPB;AAAS;GEMIN5;MALT1;NUTF2
prerank,KEGG_2021_Human__Amino sugar and nucleotide sugar metabolism,0.4255849314389692,1.0649664124748113,0.25925925925925924,0.8554672225653078,1.0,9/44,11.98%,GCK;GALE;CYB5R4;GMDS;NPL;NAGK;UAP1;UGDH;GALT
prerank,"GO_Biological_Process_2021__antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent (GO:0002479)",-0.43735581434432985,-1.064816993670992,0.3787878787878788,1.0,1.0,17/60,27.50%,PSMB9;HLA-A;SNAP23;CYBA;HLA-F;PSMA3;ITGB5;PSMA7;PSMB6;PSMA5;HLA-C;PSMD6;NCF2;PSMC5;PSMB4;PSMB7;PSMD8
prerank,GO_Biological_Process_2021__regulation of organelle assembly (GO:1902115),0.37502322966500745,1.0645523431083384,0.21739130434782608,0.8562502437283416,1.0,20/68,22.46%,TBC1D10A;IFT88;TBC1D16;TBC1D12;TRAPPC12;ALMS1;STX18;SDCCAG8;TBC1D22B;IFT140;MTMR3;RAB5A;TBC1D2;DCDC2;TBC1D8;USP6NL;TBC1D5;NPRL2;TSG101;RABEP2
prerank,GO_Biological_Process_2021__presynapse organization (GO:0099172),0.5252034000786179,1.0645006204053578,0.391304347826087,0.8560192751632874,1.0,6/12,12.52%,NLGN1;LRRTM3;FZD1;WNT3A;NLGN4X;NLGN3
prerank,Reactome_2022__Complex I Biogenesis R-HSA-6799198,-0.4946709018950995,-1.0644730259272197,0.42857142857142855,1.0,1.0,11/43,22.05%,TMEM186;NDUFS2;NDUFA2;NDUFB4;NDUFC1;NDUFA1;NDUFB9;NDUFB10;NDUFS5;NDUFB11;NDUFAF5
prerank,GO_Biological_Process_2021__negative regulation of biosynthetic process (GO:0009890),-0.5268628873133054,-1.0644459421893753,0.3888888888888889,1.0,1.0,4/14,10.60%,GPER1;CIITA;CEACAM1;SLC18A2
prerank,Reactome_2022__Transport Of Ribonucleoproteins Into Host Nucleus R-HSA-168271,0.4682840052961684,1.0644073400498602,0.37142857142857144,0.8558920239530166,1.0,4/32,10.02%,NUP210;NUP42;PBRM1;AAAS
prerank,GO_Biological_Process_2021__negative regulation of response to food (GO:0032096),-0.652336076083095,-1.0643201729716227,0.4067796610169492,1.0,1.0,1/5,13.18%,CARTPT
prerank,GO_Biological_Process_2021__positive regulation of ion transmembrane transporter activity (GO:0032414),-0.5263769123128035,-1.064176533390226,0.4,1.0,1.0,5/23,13.21%,STAC;PDZK1;GLRX;ABCB1;COX17
prerank,GO_Biological_Process_2021__ventricular trabecula myocardium morphogenesis (GO:0003222),0.5911918523557407,1.0640061523446254,0.41025641025641024,0.8565037414174911,1.0,2/8,5.50%,TGFBR1;NRG1
prerank,GO_Biological_Process_2021__regulation of regulatory T cell differentiation (GO:0045589),0.4810326319479959,1.0638011149541984,0.2857142857142857,0.8567751549903856,1.0,4/18,8.83%,BCL6;CBFB;SOX12;TNFRSF18
prerank,KEGG_2021_Human__Steroid hormone biosynthesis,0.46880712855965045,1.0637919389219253,0.38461538461538464,0.8563746170312972,1.0,6/30,7.00%,CYP1A2;CYP7B1;UGT2B15;AKR1C3;STS;AKR1C1
prerank,GO_Biological_Process_2021__regulation of cellular component biogenesis (GO:0044087),0.46465678760652496,1.0630842932403206,0.3939393939393939,0.8578926241620302,1.0,5/36,7.67%,IRGM;APOE;SNCAIP;RAPGEF1;LATS1
prerank,GO_Biological_Process_2021__positive regulation of cilium-dependent cell motility (GO:2000155),0.6557541214718442,1.063059087369058,0.4418604651162791,0.856699092814865,1.0,1/6,0.14%,TACR3
prerank,GO_Biological_Process_2021__positive regulation of flagellated sperm motility (GO:1902093),0.6557541214718442,1.063059087369058,0.4418604651162791,0.856699092814865,1.0,1/6,0.14%,TACR3
prerank,GO_Biological_Process_2021__positive regulation of cilium movement (GO:0003353),0.6557541214718442,1.063059087369058,0.4418604651162791,0.856699092814865,1.0,1/6,0.14%,TACR3
prerank,GO_Biological_Process_2021__regulation of macrophage activation (GO:0043030),-0.5311010101533238,-1.063027781275553,0.38461538461538464,1.0,1.0,3/20,9.78%,WNT5A;PLA2G10;THBS1
prerank,GO_Biological_Process_2021__positive regulation of G1/S transition of mitotic cell cycle (GO:1900087),0.4681919340996377,1.0629464407016052,0.34210526315789475,0.8565351931492959,1.0,5/25,7.70%,ADAMTS1;FGF10;LSM10;CCND3;PLCB1
prerank,GO_Biological_Process_2021__ribonucleoside monophosphate biosynthetic process (GO:0009156),-0.5770842785172093,-1.0628340216132897,0.4090909090909091,1.0,1.0,4/13,19.59%,ADSS1;RFK;PAICS;IMPDH2
prerank,PanglaoDB_Augmented_2021__Hepatic Stellate Cells,0.36504303086173345,1.0627813213573043,0.17647058823529413,0.8565407199097164,1.0,21/115,10.72%,FIBIN;TPM2;FGF10;LAMA4;MXRA5;MRGPRF;CCN2;PARVA;CCN1;SLC8A1;COL12A1;PPARG;ADAMTS12;MMP2;TIMP1;PNPLA3;EDNRA;SNAI2;PDZRN3;COLEC11;COL16A1
prerank,CellMarker_Augmented_2021__Mesenchymal Stem cell:Umbilical Vein,-0.43238982639266954,-1.0627528993258901,0.38271604938271603,1.0,1.0,21/83,15.89%,CYYR1;GALNT15;LYVE1;ECM2;ANGPTL2;FILIP1L;DAB2;ADAM33;DCN;ASPN;PTPRC;VWF;ENG;COX7A1;TEK;A2M;C1S;ACTA2;GGT5;ADGRF5;FBLN2
prerank,Reactome_2022__Signaling By MAPK Mutants R-HSA-9652817,-0.5866006814201118,-1.0627133697550342,0.4074074074074074,1.0,1.0,1/7,10.97%,DUSP16
prerank,Reactome_2022__Membrane Binding And Targetting Of GAG Proteins R-HSA-174490,0.5326442604489896,1.0626376987748427,0.375,0.856487395333541,1.0,6/15,22.29%,MVB12A;UBAP1;SGIP1;NMT2;MVB12B;TSG101
prerank,GO_Biological_Process_2021__skin morphogenesis (GO:0043589),-0.6698776555597433,-1.0626033420976049,0.47619047619047616,1.0,1.0,2/5,14.91%,COL1A1;ABCA12
prerank,GO_Biological_Process_2021__regulation of double-strand break repair via nonhomologous end joining (GO:2001032),0.4894666572423983,1.0623905258732993,0.3333333333333333,0.8566546868597411,1.0,11/27,17.85%,SIRT7;SHLD2;SHLD1;SETMAR;KMT5C;SMCHD1;WRAP53;HSF1;KMT5B;USP51;PNKP
prerank,KEGG_2021_Human__Cocaine addiction,0.4460179796142465,1.062285603680013,0.3103448275862069,0.856483782495733,1.0,7/44,11.34%,GRIN3A;GRM3;CREB3L2;CREB3L4;GRM2;GRIN1;GPSM1
prerank,GO_Biological_Process_2021__secretory granule organization (GO:0033363),0.6509001721882015,1.0621250552907717,0.45,0.8564893236418244,1.0,2/6,10.74%,ABCA1;F2R
prerank,GO_Biological_Process_2021__platelet degranulation (GO:0002576),-0.42982510338735064,-1.0620599875403223,0.3132530120481928,1.0,1.0,21/103,14.43%,F8;TGFB1;TIMP3;BLK;PSAP;SELP;CLU;PLG;CFD;THBS1;CD63;VWF;ITGA2B;ITIH3;TUBA4A;F13A1;ITIH4;A2M;F5;TTN;TGFB3
prerank,Reactome_2022__Activated TAK1 Mediates P38 MAPK Activation R-HSA-450302,0.49998971653490765,1.0618739955707106,0.30952380952380953,0.8567224396689408,1.0,7/17,20.40%,MAPKAPK2;RIPK2;TAB3;TAB1;TAB2;MAP2K6;TRAF6
prerank,GO_Biological_Process_2021__positive regulation of synaptic plasticity (GO:0031915),0.688412155258179,1.061829130021041,0.43902439024390244,0.8564049995263623,1.0,1/6,2.34%,NEUROD2
prerank,GO_Biological_Process_2021__positive regulation by host of viral transcription (GO:0043923),0.4836255606527017,1.061818319914174,0.3157894736842105,0.8559998613605547,1.0,6/16,18.84%,SMARCB1;SP1;RRP1B;SMARCA4;CHD1;EP300
prerank,GO_Biological_Process_2021__regulation of cell population proliferation (GO:0042127),0.319551802137803,1.0617670367460232,0.25,0.8557270693720329,1.0,79/604,11.92%,IL7R;ADRA1A;BAMBI;NGF;EGLN3;SMYD2;GRK5;ADAMTS1;FGF10;NOX4;TGFBR1;KIT;DUSP15;TCIRG1;BCL6;VEGFC;BCL2;FGFR1;KSR1;IRS1;POU3F2;KLF10;CDH13;FRK;FGF17;SIRT1;P3H3;AKR1C3;ERBB2;P3H2;JAG1;PKD2;KLHL41;PDGFD;NRG1;HES1;MAGI2;FKTN;SLC25A33;WNT9A;CHRNA10;PROX1;STAT5B;TRIM71;TIMP1;HP1BP3;ACER2;ZNF703;GREM1;CDK6;SGK1;FER;CDK4;PML;MYC;FGF18;TGFA;WNT3A;TENM1;HCLS1;AKT2;FGFR3;KITLG;PBRM1;CTBP2;ACER3;WNK2;ALDH1A2;IRS2;F2R;NAMPT;DDAH1;TIMELESS;PIM2;SGK2;RBFOX2;PPP1R9B;LIMS1;SMARCA2
prerank,GO_Biological_Process_2021__establishment of protein localization to mitochondrion (GO:0072655),-0.481010694307733,-1.0617410417330786,0.3698630136986301,1.0,1.0,9/44,20.23%,HK2;PINK1;TOMM20;TOMM7;PAM16;TIMM17A;ROMO1;FIS1;CHCHD4
prerank,Reactome_2022__STAT5 Activation Downstream Of FLT3 ITD Mutants R-HSA-9702518,0.5816525369521859,1.0617051225278895,0.43902439024390244,0.8554911791646934,1.0,3/10,13.97%,NOX4;STAT5B;FLT3
prerank,GO_Biological_Process_2021__cardiolipin metabolic process (GO:0032048),0.5381796009113762,1.0616822532090333,0.45454545454545453,0.8551383465443261,1.0,6/12,23.88%,PGS1;CRLS1;LCLAT1;PLA2G5;HADHB;PLA2G6
prerank,GO_Biological_Process_2021__complement receptor mediated signaling pathway (GO:0002430),0.5870234488222169,1.0616327805397405,0.4473684210526316,0.8548444171677728,1.0,1/10,0.25%,GPR33
prerank,Reactome_2022__Coenzyme A Biosynthesis R-HSA-196783,0.6099289938583963,1.0615463804325884,0.47368421052631576,0.8547775765680283,1.0,3/8,16.09%,PANK1;PPCS;SLC25A16
prerank,GO_Biological_Process_2021__positive regulation of insulin secretion (GO:0032024),0.47402096189955933,1.0615332927818275,0.40540540540540543,0.8543963596944354,1.0,6/33,10.67%,GCK;CAPN10;DOC2B;GLUD1;MCU;IRS2
prerank,GO_Biological_Process_2021__cellular response to UV-B (GO:0071493),-0.6753766317788649,-1.061377042906406,0.47058823529411764,1.0,1.0,2/6,14.93%,CDKN1A;HYAL1
prerank,GO_Biological_Process_2021__regulation of lamellipodium assembly (GO:0010591),0.4387434863030094,1.061120481698745,0.42105263157894735,0.8551337958455484,1.0,8/30,15.02%,AUTS2;FER;SLIT2;ABI3;WASF2;AVIL;PIK3CA;FSCN1
prerank,Reactome_2022__STAT5 Activation R-HSA-9645135,0.6417493433198613,1.0607803050458164,0.45,0.8557682354823772,1.0,2/6,13.97%,STAT5B;FLT3
prerank,GO_Biological_Process_2021__glomerular visceral epithelial cell development (GO:0072015),0.6531569432014395,1.0607580223632074,0.42857142857142855,0.8554089989424225,1.0,2/7,5.58%,JAG1;MAGI2
prerank,GO_Biological_Process_2021__positive regulation of megakaryocyte differentiation (GO:0045654),-0.6256161792458548,-1.060726779604191,0.40350877192982454,1.0,1.0,3/9,13.14%,SCIN;PITHD1;FAXDC2
prerank,Reactome_2022__WNT5A-dependent Internalization Of FZD4 R-HSA-5099900,-0.6026173144643125,-1.06070336233388,0.48484848484848486,1.0,1.0,1/15,2.54%,WNT5A
prerank,GO_Biological_Process_2021__negative regulation of nucleic acid-templated transcription (GO:1903507),0.33331521201412945,1.060466525426452,0.25,0.855831033881245,1.0,83/384,18.34%,CD38;FOXO1;PER2;HDAC3;PRICKLE1;BCL6;HDAC10;TSHZ3;TWIST2;MTERF3;KLF10;CIART;PHC2;PRDM5;HEXIM2;GATAD2A;TLE2;ATXN1;PPARG;WNT4;SIRT1;IFI16;RORB;SFMBT1;CRY1;HIC2;NRG1;HES1;PROX1;ZBTB4;FOXP2;IKZF4;ZNF703;KDM8;PML;PLCB1;WWP2;NKAP;FOXN3;ZEB1;MAP3K10;TWIST1;SPEN;CTBP2;TIMELESS;DACH1;DPF1;RBFOX2;LIMS1;SMARCA2;MLXIPL;SMARCA4;SCMH1;MDFIC;KAT6A;DPF2;HDAC1;ASCL1;SMAD2;NR2F2;NR3C1;BCOR;MBTD1;MECP2;ZMYND11;HDAC4;SPINDOC;MEN1;TP53;MPHOSPH8;MAGEL2;NOTCH1;ARID5B;ATF7IP;PA2G4;THAP7;ZHX3;NIPBL;ZNF12;RBPJ;SP3;YAF2;ZNF706
prerank,GO_Biological_Process_2021__epithelial cell migration (GO:0010631),0.4351702763314834,1.0604008946837102,0.2972972972972973,0.8556253071697194,1.0,8/35,12.34%,PRSS3;KIT;CDH13;ZEB2;ABL1;KANK1;PKN2;PXN
prerank,GO_Biological_Process_2021__regulation of protein localization to nucleolus (GO:1904749),-0.6360086864358103,-1.0603121599674357,0.4074074074074074,1.0,1.0,1/8,10.71%,TERT
prerank,GO_Biological_Process_2021__natural killer cell activation (GO:0030101),-0.5303562245245603,-1.0602978263001939,0.3333333333333333,1.0,1.0,6/19,20.44%,IL21R;IFNK;PTPRC;AXL;CASP8;PRDX1
prerank,GO_Biological_Process_2021__regulation of ERK1 and ERK2 cascade (GO:0070372),-0.40192058470229436,-1.060165038699202,0.3333333333333333,1.0,1.0,19/180,10.28%,CD44;TGFB1;NODAL;TIMP3;SCIMP;ROS1;GPER1;GPR183;ALKAL2;FLT4;CEACAM1;ALOX15;ATP6AP1;HTR2B;P2RY6;PRXL2C;GBP1;HLA-DRB1;PTPRC
prerank,Reactome_2022__Intra-Golgi And Retrograde Golgi-to-ER Traffic R-HSA-6811442,0.36720002337646923,1.0601641356675169,0.16666666666666666,0.8558937098660802,1.0,46/168,24.87%,KIFC1;KIFC2;GOLIM4;STX5;STX6;RHOBTB3;GOLGA4;GALNT1;BICD1;MAN1A2;DYNC1I2;MAN2A1;STX18;GCC2;TMED3;KIF6;VPS54;MAN1A1;VTI1A;KIF4B;COG7;CUX1;SEC22B;UBE2Z;KIF21B;KIF3B;COG5;ARFRP1;ARFIP2;COG4;CYTH1;TRIP11;KIF21A;USP6NL;KIF16B;GOLGA1;KIF27;CAPZA1;COG2;VPS51;VPS45;COG3;PLA2G6;CYTH3;BNIP1;CAPZB
prerank,Reactome_2022__MAPK1/MAPK3 Signaling R-HSA-5684996,0.36618965041517704,1.0601349759759737,0.38461538461538464,0.8555715504449627,1.0,46/242,13.97%,DUSP4;FGF10;DUSP2;KIT;LLGL1;SPRED3;FGFR1;KSR1;GPRIN1;IRS1;ANGPT1;SPTBN4;NRG2;CSK;ABHD17A;IL17RD;FGF17;PSME4;ERBB2;SEM1;ARRB2;NRG1;RASA2;PPP5C;PSMA1;NRG3;FGF18;TGFA;SPRED2;ABHD17C;FGFR3;KITLG;IRS2;SPRED1;PPP2R1B;CNKSR2;RASAL2;RET;RAP1A;FNTA;ABHD17B;MARK3;ARRB1;NF1;MPP2;FLT3
prerank,Reactome_2022__RUNX1 And FOXP3 Control Development Of Regulatory T Lymphocytes (Tregs) R-HSA-8877330,0.6420361112892627,1.0600466070105252,0.525,0.85542452345529,1.0,3/7,15.67%,CBFB;TNFRSF18;RUNX1
prerank,GO_Biological_Process_2021__pancreas development (GO:0031016),-0.6214780694581542,-1.0600165222587972,0.4444444444444444,1.0,1.0,1/8,2.89%,CCDC39
prerank,GO_Biological_Process_2021__antigen processing and presentation of exogenous peptide antigen via MHC class I (GO:0042590),-0.43530867839704585,-1.0598771288340696,0.3333333333333333,1.0,1.0,17/62,27.50%,PSMB9;HLA-A;SNAP23;CYBA;HLA-F;PSMA3;ITGB5;PSMA7;PSMB6;PSMA5;HLA-C;PSMD6;NCF2;PSMC5;PSMB4;PSMB7;PSMD8
prerank,GO_Biological_Process_2021__negative regulation of osteoclast differentiation (GO:0045671),-0.5701438198556967,-1.0598765932572884,0.4166666666666667,1.0,1.0,1/14,0.34%,LILRB3
prerank,GO_Biological_Process_2021__positive regulation of cellular respiration (GO:1901857),-0.6122047569186527,-1.059749797558226,0.4166666666666667,1.0,1.0,5/10,29.24%,PINK1;IL10RB;ISCU;PARK7;NUPR1
prerank,GO_Biological_Process_2021__positive regulation of protein export from nucleus (GO:0046827),0.5671301491949318,1.0595184776835729,0.6111111111111112,0.8565153363987922,1.0,5/14,24.85%,ANP32B;TP53;RAPGEF3;TPR;GAS6
prerank,GO_Biological_Process_2021__N-acylphosphatidylethanolamine metabolic process (GO:0070292),-0.6334001990386797,-1.0593855712034055,0.4067796610169492,1.0,1.0,1/8,4.67%,PLAAT4
prerank,GO_Biological_Process_2021__organophosphate biosynthetic process (GO:0090407),0.4519969224347623,1.0593618327354701,0.32142857142857145,0.856498979905002,1.0,15/37,31.27%,ITPKB;GPHN;FADS1;AGPAT5;IP6K1;IPPK;IP6K2;PNPO;CPS1;PCYT2;MOCS1;PPIP5K1;PIP5K1A;GK;G6PD
prerank,GO_Biological_Process_2021__skeletal muscle thin filament assembly (GO:0030240),-0.6651567736213441,-1.0593320443565761,0.43137254901960786,1.0,1.0,3/6,14.24%,ACTC1;LMOD3;TTN
prerank,GO_Biological_Process_2021__positive regulation of alpha-beta T cell activation (GO:0046635),0.5440685568434389,1.0592361304352118,0.42857142857142855,0.8564244513878146,1.0,3/16,8.09%,PNP;HLA-DRA;NKAP
prerank,GO_Biological_Process_2021__establishment of planar polarity (GO:0001736),-0.6303067608876166,-1.0591938268415937,0.46551724137931033,1.0,1.0,1/6,17.65%,CELSR1
prerank,GO_Biological_Process_2021__regulation of cyclin-dependent protein kinase activity (GO:1904029),-0.4528717507346241,-1.0590693733187637,0.373134328358209,1.0,1.0,18/52,22.86%,CCNG2;CCND1;CDC25A;CCND2;CDKN2D;CDKN1A;CCNI2;CCNF;CCNE2;CDKN3;CDC37;CDK5R1;PKMYT1;CDC6;GTPBP4;CDKN1B;BLM;CCNI
prerank,GO_Biological_Process_2021__positive regulation of epithelial cell differentiation (GO:0030858),-0.5792588054974219,-1.058888781634021,0.41818181818181815,1.0,1.0,7/14,29.44%,SFRP4;MESP1;BTG1;SOX9;TMEM100;FGF2;ATOH8
prerank,GO_Biological_Process_2021__terpenoid metabolic process (GO:0006721),0.6935623320248921,1.0588137848271504,0.4791666666666667,0.8569824815210944,1.0,1/5,0.59%,CYP1A2
prerank,KEGG_2021_Human__Insulin signaling pathway,0.3831719339278812,1.0587076195386964,0.25,0.8569077905733186,1.0,17/119,10.67%,GCK;FOXO1;FBP2;SH2B2;IRS1;SHC4;G6PC3;CRK;PPP1R3E;RAPGEF1;ACACB;MAPK8;CBLB;GYS1;AKT2;PRKAR2A;IRS2
prerank,GO_Biological_Process_2021__adenosine to inosine editing (GO:0006382),-0.680950916049748,-1.0586238638841245,0.46,1.0,1.0,1/7,3.14%,ADAD2
prerank,PanglaoDB_Augmented_2021__Endothelial Cells (Blood Brain Barrier),0.3893624115150769,1.05860967009021,0.23809523809523808,0.8567678060557086,1.0,24/108,19.14%,ALCAM;TBC1D16;KCNIP3;TNFRSF19;SLC19A1;PLXNB1;FGFR3;CAP2;CHST3;MPDZ;SDC3;DDAH1;RBFOX2;FARP1;TYRO3;KIAA1549L;FOXF2;SRRM3;ANTXR1;PTPRF;ZNRF3;DOCK1;DZIP1;NAV2
prerank,GO_Biological_Process_2021__positive regulation of toll-like receptor 9 signaling pathway (GO:0034165),0.6634626041054228,1.0585788526465352,0.5,0.8564392136450424,1.0,3/5,25.55%,HMGB1;SLC15A4;RSAD2
prerank,GO_Biological_Process_2021__regulation of cell-cell adhesion (GO:0022407),-0.47245300450162053,-1.0584198930742432,0.3880597014925373,1.0,1.0,6/38,7.40%,SIRPG;TGFB1;NODAL;RNASE10;ADA;CEACAM1
prerank,CellMarker_Augmented_2021__Bipolar cell:Retina,0.3985220624617897,1.0583736382459688,0.3181818181818182,0.8566406172777787,1.0,19/79,15.81%,GPRIN1;CACNG4;MANEAL;KIAA1549;HS6ST2;JPH1;LRRC73;TENM3;AADAT;P3H4;AMH;TEAD4;CDH24;FJX1;TRIP13;MPP2;CDK16;PTPRF;EFNA2
prerank,GO_Biological_Process_2021__regulation of superoxide metabolic process (GO:0090322),0.615689676181373,1.0583279432910822,0.4883720930232558,0.8563776761077105,1.0,1/6,6.34%,DHFR
prerank,GO_Biological_Process_2021__positive regulation of T-helper 17 cell differentiation (GO:2000321),0.6590876813911368,1.0581506592602619,0.4418604651162791,0.8564484355828708,1.0,4/6,28.57%,IL23A;MALT1;NFKBID;NFKBIZ
prerank,GO_Biological_Process_2021__positive regulation of non-membrane spanning protein tyrosine kinase activity (GO:1903997),0.6455431308580852,1.0578907505023953,0.5121951219512195,0.8567075046549675,1.0,3/6,27.85%,NTRK2;DOCK3;FYN
prerank,Reactome_2022__Stimuli-sensing Channels R-HSA-2672351,-0.45505033012723634,-1.057823808308699,0.375,1.0,1.0,8/91,7.06%,CLCA2;CLCA1;ANO2;CLCA4;TRPV6;TRDN;TRPC7;ASIC5
prerank,GO_Biological_Process_2021__transmembrane receptor protein tyrosine kinase signaling pathway (GO:0007169),0.3494970564074088,1.057720419706727,0.2857142857142857,0.8568649376539299,1.0,67/354,15.01%,ATP6V0D2;EFNB1;NGF;FOXO1;SH2D6;SH2B2;FGF10;KIT;MAPKAPK2;TCIRG1;VEGFC;FGFR1;IRS1;ANGPT1;EPHA7;FRK;FGF17;SHC4;MMP2;ERBB2;PDGFD;HNRNPF;NRG1;CRK;TRIM71;EPHA3;RAPGEF1;RGS14;EIF2AK3;FER;PLCB1;CASP3;CD8A;EFS;HNRNPH1;ESRP1;EFNA5;FGF18;SPRED2;NUS1;CASS4;AKT2;FGFR3;GRIN1;MPZL1;IRS2;NAMPT;FLRT2;SPRED1;WASF2;RBFOX2;TYRO3;TIAL1;RET;PXN;GAB1;UBASH3B;IRS4;ARPC3;ANOS1;FLT3;GTF2F2;PTPRT;RYK;INSR;PIK3CA;VAV2
prerank,Reactome_2022__Reelin Signaling Pathway R-HSA-8866376,0.6548775481844432,1.0577145583137177,0.5,0.8564576307516492,1.0,1/5,10.50%,SH3KBP1
prerank,GO_Biological_Process_2021__regulation of histone methylation (GO:0031060),0.5427071317991362,1.057678319005519,0.32142857142857145,0.8561230657837001,1.0,4/14,13.71%,AASS;PIH1D1;NSD1;MTHFR
prerank,Reactome_2022__Viral Messenger RNA Synthesis R-HSA-168325,0.43509121242685705,1.057392505774458,0.28125,0.856345634730284,1.0,13/44,27.98%,NUP210;NUP42;PBRM1;AAAS;GTF2F2;RANBP2;NUP214;POLR2F;TPR;SEH1L;NUP153;NUP98;NUP37
prerank,GO_Biological_Process_2021__positive regulation of signal transduction (GO:0009967),0.3712667237454605,1.057388866103664,0.25,0.855931941186936,1.0,28/215,12.52%,IL7R;RSPO3;TGFBR1;IRS1;NLGN1;KLK14;ZBTB7B;SIRT1;MAML1;SNX5;JAG1;PKD2;MYORG;SMARCB1;RSPO2;FLNA;PIH1D1;ERN1;KANK1;GRIN1;CTBP2;GKAP1;RIMS2;TRIM44;MACF1;LIMS1;SMARCA4;NLGN3
prerank,GO_Biological_Process_2021__regulation of potassium ion transmembrane transporter activity (GO:1901016),-0.5295696126177867,-1.0573332851325148,0.3880597014925373,1.0,1.0,3/25,6.54%,CASQ2;CAV3;KCNS2
prerank,Reactome_2022__Positive Epigenetic Regulation Of rRNA Expression R-HSA-5250913,0.41717314070527367,1.0573136325475339,0.39285714285714285,0.8557209281674844,1.0,17/54,22.28%,DDX56;GATAD2A;H2BC21;TAF1B;SF3B1;POLR1H;HDAC1;GATAD2B;CHD4;H2AX;BAZ1B;EP300;KAT2B;H2AJ;RBBP4;MYO1E;POLR2F
prerank,KEGG_2021_Human__Vasopressin-regulated water reabsorption,-0.48184994815255877,-1.0572281224271838,0.37681159420289856,1.0,1.0,6/38,13.36%,AQP3;RAB11A;AQP4;DCTN1;ARHGDIG;DYNLL1
prerank,PanglaoDB_Augmented_2021__Dopaminergic Neurons,0.37726126760648676,1.057226062369732,0.23333333333333334,0.8555173396638042,1.0,25/111,16.94%,SLC17A6;LHFPL4;KCNB2;HRH3;ELAVL3;PAK5;KCNJ6;ERC2;ADGRA1;CASKIN1;NR4A2;CELF5;TENM1;ABCC8;CELF4;NXPH1;RIMS4;OLFM3;PRR36;SNAP91;MSI1;SCRT1;NRXN1;SRCIN1;GRIK3
prerank,Reactome_2022__OAS Antiviral Response R-HSA-8983711,-0.5929882294113675,-1.0571637733956576,0.425531914893617,1.0,1.0,2/8,12.20%,OAS2;OAS1
prerank,CellMarker_Augmented_2021__Epithelial cell:Cornea,0.47674472746454527,1.056714833324158,0.4418604651162791,0.8566635923982194,1.0,1/20,0.04%,ADGRF4
prerank,Reactome_2022__Synthesis Of Bile Acids And Bile Salts R-HSA-192105,0.4314876533529364,1.0566826757591834,0.3793103448275862,0.856394820855495,1.0,8/32,8.63%,CYP7B1;OSBPL3;OSBPL6;AKR1C3;NCOA2;AKR1C1;SLC27A2;OSBPL7
prerank,GO_Biological_Process_2021__nitric oxide mediated signal transduction (GO:0007263),0.5480974285513663,1.0566168133893,0.40476190476190477,0.8561263083696792,1.0,4/11,11.24%,APOE;KCNC2;DDAH2;DDAH1
prerank,GO_Biological_Process_2021__histone mRNA metabolic process (GO:0008334),0.4690926945671507,1.0565677825853432,0.3541666666666667,0.855829226877319,1.0,7/26,26.76%,LSM10;SNRPB;ATM;TUT7;ERI1;SNRPF;XRN1
prerank,Reactome_2022__Constitutive Signaling By AKT1 E17K In Cancer R-HSA-5674400,0.46244946449306107,1.0565354855907871,0.3548387096774194,0.8554820072860225,1.0,6/25,19.24%,FOXO1;MLST8;AKT2;NR4A1;FOXO6;CREB1
prerank,GO_Biological_Process_2021__RNA polyadenylation (GO:0043631),0.46493530500610336,1.0565051339634604,0.24324324324324326,0.8547453910441276,1.0,2/24,4.39%,CPSF1;PCF11
prerank,GO_Biological_Process_2021__mRNA polyadenylation (GO:0006378),0.46493530500610336,1.0565051339634604,0.24324324324324326,0.8547453910441276,1.0,2/24,4.39%,CPSF1;PCF11
prerank,Reactome_2022__GRB2 Events In EGFR Signaling R-HSA-179812,0.6054769056294464,1.056493940931896,0.3783783783783784,0.8543704210740087,1.0,3/8,26.09%,TGFA;SOS1;BTC
prerank,GO_Biological_Process_2021__adrenal gland development (GO:0030325),0.6700002119548754,1.0564116822833798,0.5,0.854182741241595,1.0,2/6,13.81%,WNT4;NF1
prerank,GO_Biological_Process_2021__chemical synaptic transmission (GO:0007268),0.3544421062444037,1.0563526904283207,0.2727272727272727,0.8539090078606664,1.0,39/266,10.36%,GABRE;SLC17A6;CHRM2;GRID2;CEL;GABRA5;NOVA1;GABRR2;APOE;NLGN1;GRM3;HTR1F;GALR3;HTR2C;GABRG3;HRH3;DRD5;GRIK1;SNCA;CACNB4;CHRNA10;DTNA;DRD4;APBA3;PDZD11;PPFIA3;KCND2;ERC2;GRIK2;PDLIM4;SYT1;LRP6;GRM4;GRM7;GRIN1;PRKAR2A;AKAP9;GABRG1;RPS6KA3
prerank,GO_Biological_Process_2021__regulation of T-helper 1 type immune response (GO:0002825),-0.718343833914124,-1.0563293808977325,0.5263157894736842,1.0,1.0,2/5,10.72%,IL27;SLC11A1
prerank,Reactome_2022__NEP/NS2 Interacts With Cellular Export Machinery R-HSA-168333,0.45496850997192345,1.0563211285939873,0.40540540540540543,0.8535565275713023,1.0,12/32,27.98%,NUP210;NUP42;PBRM1;AAAS;RANBP2;XPO1;NUP214;TPR;SEH1L;NUP153;NUP98;NUP37
prerank,GO_Biological_Process_2021__negative regulation of biomineralization (GO:0110150),-0.6313879884956943,-1.0562053814711656,0.453125,1.0,1.0,2/8,14.16%,TGFB1;HEY2
prerank,GO_Biological_Process_2021__receptor-mediated endocytosis (GO:0006898),-0.42769891087083023,-1.0560963543061246,0.37662337662337664,1.0,1.0,20/123,18.80%,AMBP;APOL1;JCHAIN;ITGB2;SFTPD;DAB2;MASP1;PPT1;CAV2;LRP2;HPR;ITGAM;CXCL16;COLEC12;AMN;ASGR1;STAB2;LDLRAP1;HSPH1;CD81
prerank,CellMarker_Augmented_2021__Embryonic Stem cell:Embryo,-0.7091456761486301,-1.0560858283910284,0.509090909090909,1.0,1.0,2/5,16.24%,TERT;CHST10
prerank,CellMarker_Augmented_2021__Hematopoietic cell:Fetal Liver,0.5769202202068324,1.0559497469471064,0.4222222222222222,0.8543243495757588,1.0,2/8,3.69%,KIT;CD14
prerank,Reactome_2022__RHO GTPases Activate Rhotekin And Rhophilins R-HSA-5666185,-0.6690607036080624,-1.0559216578209079,0.4716981132075472,1.0,1.0,3/7,24.14%,RTKN;RHPN2;RHOB
prerank,KEGG_2021_Human__Cell cycle,-0.4400867190835654,-1.0557568744528134,0.32926829268292684,1.0,1.0,19/114,19.26%,BUB1;MCM2;TGFB1;CCND1;MCM3;CDC25A;TTK;CCND2;CDKN2D;CDKN1A;TGFB3;SMC1B;CCNE2;RBX1;SMAD3;PKMYT1;CDC6;BUB1B;YWHAG
prerank,Reactome_2022__EGR2 And SOX10-mediated Initiation Of Schwann Cell Myelination R-HSA-9619665,0.5186414590196242,1.0557061019312886,0.36363636363636365,0.854589128132366,1.0,9/28,15.55%,POU3F1;ADGRG6;UTRN;POU3F2;SCD5;SMARCA4;ADGRV1;WWTR1;PLPPR3
prerank,GO_Biological_Process_2021__glycolipid metabolic process (GO:0006664),0.41514122525314695,1.0556274128030616,0.34615384615384615,0.8544519999234322,1.0,12/46,15.83%,ST6GALNAC3;GLA;ESYT3;STS;SMPD4;SMPD3;ESYT2;NEU4;GLB1;PGAP1;ST3GAL6;NEU3
prerank,GO_Biological_Process_2021__chromatin maintenance (GO:0070827),0.681259353373143,1.0553930293365763,0.4883720930232558,0.8545945916528568,1.0,2/5,13.71%,SIRT1;MTHFR
prerank,Reactome_2022__RHO GTPase Effectors R-HSA-195258,-0.38509133660884054,-1.0551832620987007,0.35714285714285715,1.0,1.0,51/231,24.72%,BUB1;ERCC6L;KIF14;CTNNA1;SPC25;CENPU;ITGB3BP;ZWILCH;ACTG1;WAS;H2BC4;RHOQ;NUF2;CYBA;CENPH;CENPS-CORT;H2AZ1;DYNLL1;PKN3;RPS27;INCENP;NCKIPSD;FMNL1;NDEL1;RAC2;MYL6;CDCA8;IQGAP3;CENPN;RTKN;CALM1;KIF18A;MYL9;BUB1B;YWHAG;NOX1;SKA2;MYH11;SEC13;CENPL;CDKN1B;DYNLL2;BRK1;PPP2R5A;RHPN2;CENPM;RHOB;SPC24;PDZD2;KLC1;NCF2
prerank,GO_Biological_Process_2021__neuromuscular synaptic transmission (GO:0007274),0.4815603008978188,1.0549679997266623,0.325,0.8554106040990644,1.0,5/15,18.70%,DTNA;ERC2;CHRNA1;FCHSD2;ERC1
prerank,GO_Biological_Process_2021__positive regulation of cation transmembrane transport (GO:1904064),-0.4843657346425067,-1.0547231772218095,0.4264705882352941,1.0,1.0,4/38,9.57%,KCNJ15;STAC;KCNQ1;PDZK1
prerank,GO_Biological_Process_2021__snRNA processing (GO:0016180),0.5136581314739616,1.0546790253160359,0.45454545454545453,0.8557603005488852,1.0,3/15,12.58%,INTS11;INTS14;INTS9
prerank,GO_Biological_Process_2021__cellular response to chemical stress (GO:0062197),0.41040225286953425,1.0546634220559477,0.24,0.8554009563832999,1.0,23/86,19.85%,FOXO1;NOX4;HTRA2;PKD2;SNCA;VRK2;SLC25A24;ABL1;ADNP2;HSPA1A;PNPT1;GPX1;PIK3CA;ETV5;ATM;RAD52;SESN2;GSR;STOX1;ERMP1;PRKAA2;VKORC1L1;SLC4A11
prerank,"Reactome_2022__POU5F1 (OCT4), SOX2, NANOG Activate Genes Related To Proliferation R-HSA-2892247",-0.6447741411122832,-1.0545410964165787,0.56,1.0,1.0,2/6,15.56%,SALL4;EPHA1
prerank,KEGG_2021_Human__mRNA surveillance pathway,0.4205119082533213,1.0545369309063168,0.30434782608695654,0.8553639409442108,1.0,22/86,20.63%,CPSF1;NXF5;PCF11;NXT1;NXF1;SRRM1;PPP2R1B;CPSF7;MSI1;ETF1;ACIN1;FUS;SMG1;PPP2R5D;PAPOLA;SMG5;MSI2;PPP1CB;SMG6;EIF4A3;SYMPK;CPSF6
prerank,GO_Biological_Process_2021__negative regulation of telomere maintenance via telomerase (GO:0032211),0.4689213748236934,1.0545356218734818,0.3953488372093023,0.8549550671674687,1.0,4/18,12.82%,CTC1;TERF1;GNL3L;ACD
prerank,GO_Biological_Process_2021__lactation (GO:0007595),0.5975872180518785,1.054367065940259,0.4166666666666667,0.855018377532988,1.0,1/7,3.16%,ZBTB7B
prerank,Reactome_2022__IRAK1 Recruits IKK Complex R-HSA-937039,0.6154142841668598,1.054257986935634,0.5227272727272727,0.8549744528553737,1.0,4/9,24.24%,PELI1;PELI2;TRAF6;IKBKB
prerank,"GO_Biological_Process_2021__DNA-templated transcription, initiation (GO:0006352)",0.35718246370485784,1.0542389492489534,0.3333333333333333,0.8546020582970641,1.0,36/156,18.53%,TEAD2;ESRRG;HDAC3;MED17;RORA;TFB1M;HDAC10;RARB;CCN2;PPARG;MAML1;RORB;TAF1B;NAT14;TAF3;NR4A2;TAF12;CCNH;POLR1H;TEAD4;NR3C2;HDAC1;NR3C1;GTF2F2;WWTR1;THRB;NR1H3;NR6A1;NRBF2;NR4A3;NOTCH1;NR2C1;TAF4;ERCC3;RBPJ;NR4A1
prerank,Reactome_2022__Pyrimidine Catabolism R-HSA-73621,0.5707881949498953,1.0541417331737901,0.42857142857142855,0.8544584400028657,1.0,4/12,18.88%,NT5C1A;UPP2;NT5C3A;AGXT2
prerank,GO_Biological_Process_2021__endochondral bone morphogenesis (GO:0060350),0.5869395509566446,1.0541038091265922,0.4418604651162791,0.8541294551850452,1.0,4/9,21.65%,FGFR3;COL13A1;BMPR2;BMP4
prerank,KEGG_2021_Human__Renin-angiotensin system,-0.5438233116438489,-1.0540462566919426,0.36507936507936506,1.0,1.0,5/15,19.87%,ATP6AP2;REN;AGT;ANPEP;ACE2
prerank,GO_Biological_Process_2021__regulation of stem cell proliferation (GO:0072091),-0.5694476699759912,-1.0538834636521404,0.40350877192982454,1.0,1.0,7/15,26.11%,PTPRC;TERT;YAP1;ZFP36L1;HMGA2;EPCAM;KDM1A
prerank,GO_Biological_Process_2021__pronephros development (GO:0048793),0.573045471626995,1.0534752423607208,0.44,0.8556549347789858,1.0,2/6,9.82%,OSR1;CEP290
prerank,GO_Biological_Process_2021__protein homooligomerization (GO:0051260),0.3627013365285403,1.0532645247023127,0.3157894736842105,0.8557890102596024,1.0,20/106,14.06%,ARC;TDO2;VSTM5;KCNC2;TRPM2;CLYBL;PKD2;HCN1;ZBTB1;IKZF4;CARD9;ACACB;MICU1;SPAST;EHD4;ALDH1A2;USP16;TRMT61B;MPP2;PNPT1
prerank,Reactome_2022__MET Activates RAP1 And RAC1 R-HSA-8875555,0.5771496268436463,1.053200839639938,0.34210526315789475,0.8555738547343661,1.0,5/11,19.27%,CRK;RAPGEF1;RAP1A;CRKL;SOS1
prerank,"GO_Biological_Process_2021__RNA splicing, via transesterification reactions (GO:0000375)",0.5113764884128736,1.0531429912749997,0.4074074074074074,0.8552805711910514,1.0,5/25,12.88%,KHSRP;TXNL4A;SRRM1;SF3B1;SRSF4
prerank,CellMarker_Augmented_2021__Myeloid cell:Peripheral Blood,-0.6124113411741289,-1.0529004352103695,0.3968253968253968,1.0,1.0,5/8,11.77%,FCGR3A;IL3RA;PTPRC;CEACAM8;ITGAM
prerank,GO_Biological_Process_2021__defense response to bacterium (GO:0042742),-0.43421242268333826,-1.0528680940133883,0.34782608695652173,1.0,1.0,25/85,18.13%,JCHAIN;GSDMA;CXCL13;HAMP;SFTPD;OAS2;HLA-A;SELP;LYG2;NLRC4;SLC11A1;OAS1;DEFB109B;TLR2;COLEC12;NOS2;IL12A;IGLL1;ELANE;NAIP;PGLYRP1;LYG1;GBP6;ROMO1;STAB2
prerank,GO_Biological_Process_2021__defense response to fungus (GO:0050832),0.65951229546263,1.0528278576631118,0.4423076923076923,0.855756286789573,1.0,2/7,7.29%,CX3CR1;CARD9
prerank,GO_Biological_Process_2021__protein alkylation (GO:0008213),-0.5468657653324221,-1.0527363998447188,0.4107142857142857,1.0,1.0,5/22,19.01%,BHMT;ETFBKMT;PCMT1;EEF1AKMT2;EEF2KMT
prerank,GO_Biological_Process_2021__peptide antigen assembly with MHC protein complex (GO:0002501),-0.6942890134774204,-1.0527319377343507,0.4909090909090909,1.0,1.0,3/5,10.21%,HLA-DMA;TAPBPL;HLA-DRB1
prerank,GO_Biological_Process_2021__regulation of cytokine production involved in inflammatory response (GO:1900015),-0.49882424485050225,-1.052549090302102,0.3972602739726027,1.0,1.0,6/30,14.93%,PLD4;ALOX5;APOD;NLRC3;NOS2;ADCY7
prerank,Reactome_2022__NRIF Signals Cell Death From Nucleus R-HSA-205043,0.5366817207238663,1.0525336085837207,0.41025641025641024,0.8560892620913829,1.0,2/13,7.84%,NGF;MAPK8
prerank,PanglaoDB_Augmented_2021__T Follicular Helper Cells,-0.45573902391097687,-1.0525206505757372,0.36231884057971014,1.0,1.0,15/58,10.28%,SIRPG;GMFG;ITGB2;CYTIP;TBC1D10C;ARHGAP9;TAGAP;TNFRSF1B;GPR183;PARVG;CD5;CD37;TRAF3IP3;MYO1F;PTPRC
prerank,KEGG_2021_Human__Olfactory transduction,-0.44722130929826154,-1.0523968023639199,0.4,1.0,1.0,25/82,18.70%,OR13A1;ANO2;OR2H2;OR2T6;OR52A5;OR51M1;OR2G6;OR10A2;OR52I2;OR51I2;OR5V1;OR2AJ1;OR52N2;OR7C1;OR2AG1;OR56A3;OR1L8;OR2T12;OR9Q1;OR1L6;OR2M4;GNAL;CALM1;CAMK2A;OR8A1
prerank,Reactome_2022__PECAM1 Interactions R-HSA-210990,-0.5749774866046934,-1.052369759973877,0.42857142857142855,1.0,1.0,1/11,7.17%,INPP5D
prerank,GO_Biological_Process_2021__actin filament-based transport (GO:0099515),-0.5263931011210499,-1.0522596136788513,0.4166666666666667,1.0,1.0,5/19,20.29%,SYNE2;MYO1F;MYO5B;MYO15A;MYO7B
prerank,"GO_Biological_Process_2021__RNA splicing, via transesterification reactions with bulged adenosine as nucleophile (GO:0000377)",0.3356813059807091,1.0520294435769328,0.15789473684210525,0.8570405789782796,1.0,58/234,26.04%,CPSF1;SNRPN;NOVA1;PCF11;HNRNPF;TRA2A;RBM41;PUF60;PRPF40B;HNRNPH1;TXNL4A;SNRPB;SPEN;U2AF1;SRRM1;HNRNPL;LSM2;ZMAT5;GEMIN5;CWC27;SF3B1;CPSF7;SRSF4;GTF2F2;PTBP1;FUS;LSM7;SYNCRIP;PAPOLA;RNF113A;EIF4A3;U2AF2;SYMPK;SF3B4;RBM6;GPATCH1;LSM6;PPIH;CDC5L;LSM8;PDCD7;DDX46;DDX41;POLR2F;RALY;MAGOHB;SNRNP48;PSPC1;RBM10;YBX1;SNRPF;WDR33;CWF19L1;PABPC1;CCAR1;SF1;SNRPA;RBM8A
prerank,GO_Biological_Process_2021__fatty acid derivative biosynthetic process (GO:1901570),-0.47462797258042017,-1.0519936688410654,0.3787878787878788,1.0,1.0,8/31,19.10%,ALOX12;ALOX5;PPT1;GGT5;ACSS3;AWAT1;ALOX5AP;SLC27A5
prerank,GO_Biological_Process_2021__biotin metabolic process (GO:0006768),0.5897389588533829,1.0517661668417735,0.42105263157894735,0.857386843067969,1.0,2/9,7.55%,PC;PDZD11
prerank,Reactome_2022__SHC1 Events In EGFR Signaling R-HSA-180336,0.6053323867019753,1.0516517333830033,0.4411764705882353,0.8571928545950883,1.0,3/9,26.09%,TGFA;SOS1;BTC
prerank,GO_Biological_Process_2021__Golgi to plasma membrane transport (GO:0006893),0.44600901705698415,1.0516007720136662,0.2692307692307692,0.8568854360542039,1.0,16/43,21.50%,LLGL1;RAB31;COMMD1;BLZF1;GOLGA4;GCC2;GGA1;MACF1;CCDC22;RAB10;ARL3;EXOC6B;ARFRP1;EXOC6;RAB26;EXOC4
prerank,Reactome_2022__Glycerophospholipid Catabolism R-HSA-6814848,0.6504758189286375,1.0514747499800592,0.45,0.8567983322794023,1.0,2/7,24.64%,GDPD5;PNPLA6
prerank,KEGG_2021_Human__Circadian entrainment,0.38389134370530487,1.0514515607555235,0.34615384615384615,0.8564346391032793,1.0,20/84,22.39%,PER2;PER3;KCNJ3;KCNJ6;PLCB1;ADCY2;GUCY1A2;GRIN1;ADCY3;GNAO1;GNG7;ADCY6;CREB1;GNAQ;FOS;GNAI2;GNAS;GUCY1A1;CACNA1I;GRIA4
prerank,CellMarker_Augmented_2021__Myoblast:Muscle,-0.672674698064668,-1.0510694335346806,0.46153846153846156,1.0,1.0,4/5,27.41%,ID1;TTN;ID3;PCNA
prerank,GO_Biological_Process_2021__positive regulation of cardiac muscle cell differentiation (GO:2000727),-0.6012682426418398,-1.0509869884630785,0.4098360655737705,1.0,1.0,1/7,1.49%,TGFB1
prerank,Reactome_2022__tRNA Processing In Nucleus R-HSA-6784531,0.4156149196012994,1.0509513491369666,0.3225806451612903,0.8575036305980132,1.0,4/54,4.13%,CPSF1;NUP210;RPP25;NUP42
prerank,Reactome_2022__Activation Of SMO R-HSA-5635838,0.5046643931752102,1.0507480306610102,0.30952380952380953,0.8576431556139461,1.0,6/15,25.76%,ARRB2;ARRB1;PTCH1;GAS1;BOC;SHH
prerank,GO_Biological_Process_2021__negative regulation of interferon-beta production (GO:0032688),-0.6170315733358729,-1.0507334764794811,0.4426229508196721,1.0,1.0,2/7,17.55%,NLRC3;CACTIN
prerank,GO_Biological_Process_2021__telomere maintenance via recombination (GO:0000722),0.5836246013022638,1.0507303549358125,0.5,0.8572866631134071,1.0,4/10,25.52%,SMC5;NSMCE2;SMC6;TPRKB
prerank,Reactome_2022__Disorders Of Developmental Biology R-HSA-9675151,0.5618245894833358,1.0506459603116907,0.42857142857142855,0.8570862839773108,1.0,3/12,14.59%,HDAC3;HDAC1;MECP2
prerank,CellMarker_Augmented_2021__Stem cell:Esophagus,0.37758432893930355,1.0504719045043789,0.2916666666666667,0.857169189412571,1.0,21/100,16.74%,LGR5;MEGF10;ADGRL2;IL17RD;GPC6;SLIT2;TENM3;GUCY1A2;PDZRN3;CAP2;STOX2;MPDZ;RBFOX2;NEO1;MAP6;MAGI1;ANK2;ANTXR1;PTPRD;FRAS1;MARK1
prerank,GO_Biological_Process_2021__mitochondrion transport along microtubule (GO:0047497),0.5423468887380061,1.0502211467529161,0.40540540540540543,0.8575703477404562,1.0,4/13,20.51%,MGARP;SPAST;UXT;HIF1A
prerank,Reactome_2022__Cross-presentation Of Particulate Exogenous Antigens (Phagosomes) R-HSA-1236973,-0.7010096885322712,-1.0502171378270242,0.5294117647058824,1.0,1.0,3/5,24.72%,CYBA;ITGB5;NCF2
prerank,Reactome_2022__Cellular Hexose Transport R-HSA-189200,-0.5409126405701523,-1.0501011201894261,0.43636363636363634,1.0,1.0,4/16,9.89%,SLC5A2;SLC5A1;SLC5A9;SLC5A4
prerank,GO_Biological_Process_2021__positive regulation of chemokine production (GO:0032722),-0.4651541982649843,-1.0500827743842902,0.4722222222222222,1.0,1.0,10/33,20.84%,WNT5A;IL7;OAS1;TLR2;DDX3X;IL18;F2RL1;ALOX15B;CSF1R;AGER
prerank,Reactome_2022__Peroxisomal Lipid Metabolism R-HSA-390918,-0.5296834980000376,-1.04989717806264,0.39655172413793105,1.0,1.0,5/28,14.39%,AMACR;ACOX2;ACOT6;ACOT4;HAO2
prerank,GO_Biological_Process_2021__PML body organization (GO:0030578),0.6981658348532995,1.0498378973076379,0.6136363636363636,0.858423650777351,1.0,1/5,7.51%,PML
prerank,KEGG_2021_Human__Rap1 signaling pathway,0.3411848937450658,1.0498192656171492,0.3888888888888889,0.8581029683006838,1.0,42/182,15.94%,NGF;FGF10;SKAP1;KIT;VEGFC;FGFR1;ANGPT1;PARD3;FGF17;RALB;PDGFD;MAGI2;CRK;RAPGEF1;RGS14;PLCB1;ADCY2;RALA;EFNA5;SIPA1;FGF18;FARP2;AKT2;SIPA1L2;FGFR3;KITLG;GRIN1;F2R;ADCY3;EVL;RAP1A;MAGI1;MAGI3;GNAO1;INSR;PIK3CA;SIPA1L3;VAV2;MAPK12;EFNA2;CRKL;PARD6B
prerank,GO_Biological_Process_2021__macromolecule modification (GO:0043412),0.6006667683409541,1.0498122027011718,0.5106382978723404,0.857697820534725,1.0,4/8,34.38%,CHD1;ST3GAL2;ST3GAL4;SETD5
prerank,Reactome_2022__Early SARS-CoV-2 Infection Events R-HSA-9772572,0.46112430326552933,1.0498099887269892,0.2972972972972973,0.8573001158391632,1.0,8/34,15.21%,GPC4;SDC4;GPC6;CHMP6;GPC5;SDC3;TMPRSS2;FURIN
prerank,GO_Biological_Process_2021__isopentenyl diphosphate biosynthetic process (GO:0009240),0.6473209735731189,1.049646045195117,0.45652173913043476,0.8573968004615958,1.0,3/5,35.00%,MVK;PMVK;MVD
prerank,GO_Biological_Process_2021__regulation of complement activation (GO:0030449),-0.5034214455874999,-1.0496101079690585,0.3870967741935484,1.0,1.0,8/31,14.21%,C1QB;VTN;C3AR1;CPB2;CLU;C4BPA;C4BPB;C1S
prerank,KEGG_2021_Human__NF-kappa B signaling pathway,0.40129674703554186,1.0494153679193616,0.24,0.8577050144333619,1.0,23/78,20.89%,BCL2;CFLAR;MAP3K14;BCL2A1;EDARADD;CD14;TICAM2;CCL4L2;TNFSF14;TNFSF13B;TICAM1;TAB3;NFKB1;IRAK4;GADD45A;LBP;MALT1;ATM;TAB1;ERC1;TAB2;TRAF6;PLCG2
prerank,GO_Biological_Process_2021__regulation of lipid transport (GO:0032368),0.6231382533091819,1.0491852416027763,0.39285714285714285,0.857907177515621,1.0,3/7,33.25%,NR1H3;ITGAV;NR1H2
prerank,KEGG_2021_Human__Insulin secretion,0.3745805925596806,1.0491631359720306,0.2916666666666667,0.8575453603918908,1.0,9/73,11.24%,GCK;CREB3L2;CREB3L4;PCLO;PLCB1;ADCY2;ABCC8;ADCY3;RIMS2
prerank,GO_Biological_Process_2021__positive regulation of cell killing (GO:0031343),-0.5820035247484662,-1.04909100460247,0.45,1.0,1.0,5/12,19.81%,WNT5A;CYBA;NOS2;RAC1;NOX1
prerank,GO_Biological_Process_2021__regulation of transcription involved in G1/S transition of mitotic cell cycle (GO:0000083),0.4901380537039988,1.0490901107151356,0.25,0.8572965888258242,1.0,10/29,25.87%,CDK14;DHFR;CDK18;CDK16;BRD4;CDK5;HINFP;TFDP1;POLA1;RB1
prerank,GO_Biological_Process_2021__regulation of chaperone-mediated autophagy (GO:1904714),0.6572218763286078,1.048761846508835,0.5116279069767442,0.8577732475275167,1.0,2/8,13.92%,SNCA;PLK3
prerank,GO_Biological_Process_2021__positive regulation of endopeptidase activity (GO:0010950),-0.5151723606374069,-1.048710200432857,0.48484848484848486,1.0,1.0,5/25,24.07%,AIM2;USP50;VSIR;AGER;APH1A
prerank,GO_Biological_Process_2021__catecholamine catabolic process (GO:0042424),-0.7020699027478898,-1.0483683678420999,0.4918032786885246,1.0,1.0,1/6,0.42%,DBH
prerank,GO_Biological_Process_2021__receptor clustering (GO:0043113),0.4504417407942097,1.0482784428233691,0.3225806451612903,0.858819489439175,1.0,5/25,8.20%,SCRIB;NLGN1;ITGA4;MAGI2;FLNA
prerank,GO_Biological_Process_2021__negative regulation of interleukin-17 production (GO:0032700),-0.6338936732989792,-1.0479274816471496,0.46774193548387094,1.0,1.0,3/7,24.92%,IL12A;VSIR;TNFSF4
prerank,GO_Biological_Process_2021__antigen processing and presentation of peptide antigen via MHC class I (GO:0002474),-0.4893908856923282,-1.0478930529505854,0.4482758620689655,1.0,1.0,8/28,23.17%,HLA-A;ERAP2;TAPBPL;HLA-F;ERAP1;SEC13;HLA-C;SEC24D
prerank,GO_Biological_Process_2021__negative regulation of appetite (GO:0032099),-0.5786659305174787,-1.04745346860854,0.4444444444444444,1.0,1.0,1/8,13.18%,CARTPT
prerank,GO_Biological_Process_2021__regulation of T-helper cell differentiation (GO:0045622),-0.6878681949897649,-1.04738504766695,0.5,1.0,1.0,3/6,10.21%,IRF4;IL27;HLA-DRB1
prerank,GO_Biological_Process_2021__positive regulation of cell adhesion (GO:0045785),-0.444133935374316,-1.0471886379365194,0.3382352941176471,1.0,1.0,12/64,17.19%,SIRPG;NODAL;ECM2;P2RY12;RNASE10;ALOX15;TGM2;VIT;IL12A;HYAL1;FBLN2;RAC1
prerank,GO_Biological_Process_2021__positive regulation of MAPK cascade (GO:0043410),-0.38808699112597833,-1.04709670439712,0.3924050632911392,1.0,1.0,21/205,10.28%,CD44;TBX1;TGFB1;NODAL;LPAR1;SCIMP;GFRAL;TRIM5;GPER1;ALOX12B;GPR183;GSDME;ALKAL2;FLT4;ALOX15;ATP6AP1;HTR2B;P2RY6;PRXL2C;HLA-DRB1;PTPRC
prerank,Reactome_2022__NR1H2 And NR1H3 Regulate Gene Expression To Control Bile Acid Homeostasis R-HSA-9623433,0.5957753963230654,1.0470502664832142,0.4897959183673469,0.8617569255295687,1.0,5/8,37.69%,NR1H3;RXRA;NR1H2;RXRB;NCOA1
prerank,Reactome_2022__MicroRNA (miRNA) Biogenesis R-HSA-203927,0.45125874885875644,1.0467686019540656,0.42424242424242425,0.8621253540280661,1.0,9/24,31.71%,DGCR8;XPO5;AGO3;TARBP2;AGO2;POLR2F;DROSHA;PRKRA;POLR2C
prerank,GO_Biological_Process_2021__negative regulation of response to endoplasmic reticulum stress (GO:1903573),-0.5043744451936081,-1.0467287390236173,0.391304347826087,1.0,1.0,7/24,22.55%,ALOX5;CLU;WFS1;AQP11;CREB3;HERPUD1;UBXN1
prerank,GO_Biological_Process_2021__fatty acid beta-oxidation using acyl-CoA dehydrogenase (GO:0033539),0.601284383392065,1.0464271039814421,0.4358974358974359,0.8628377844543854,1.0,2/9,10.45%,ACADS;ACADM
prerank,GO_Biological_Process_2021__protein N-linked glycosylation (GO:0006487),0.4073024970628039,1.0464216885223165,0.38461538461538464,0.8624467447158054,1.0,10/63,16.52%,MGAT4C;SLC39A8;DPM3;DERL3;UBE2J1;ALG12;ALG3;GAL3ST1;MGAT2;MOGS
prerank,GO_Biological_Process_2021__phosphatidylethanolamine acyl-chain remodeling (GO:0036152),-0.5347187953070868,-1.0464076747531528,0.4,1.0,1.0,5/17,20.26%,PLAAT4;PLA2G10;PLA2G4A;MBOAT1;PLA2G4D
prerank,GO_Biological_Process_2021__retinoic acid metabolic process (GO:0042573),-0.5968382548883777,-1.0463166321774862,0.43859649122807015,1.0,1.0,6/12,18.49%,CYP26B1;CYP3A5;CYP3A4;ADH7;SCPEP1;ALDH1A3
prerank,Reactome_2022__Beta Oxidation Of lauroyl-CoA To decanoyl-CoA-CoA R-HSA-77310,0.6530642865913832,1.0462855951866303,0.5111111111111111,0.8623720131697402,1.0,2/5,19.84%,ECHS1;HADHB
prerank,GO_Biological_Process_2021__positive regulation of smoothened signaling pathway (GO:0045880),-0.522501315042369,-1.0462719693343283,0.44285714285714284,1.0,1.0,1/18,1.55%,RAB34
prerank,GO_Biological_Process_2021__positive regulation of fibroblast apoptotic process (GO:2000271),-0.6661954287181825,-1.0462469944493735,0.5102040816326531,1.0,1.0,3/7,24.21%,STK17A;BTG1;SFRP1
prerank,CellMarker_Augmented_2021__Monocyte:Peripheral Blood,0.43518489911718666,1.045912262981061,0.4,0.8630131491979288,1.0,4/26,3.69%,CD38;KLRD1;KIT;CD14
prerank,Reactome_2022__Downregulation Of TGF-beta Receptor Signaling R-HSA-2173788,0.42653718829162135,1.0457940508843728,0.3076923076923077,0.8628540501933252,1.0,2/26,1.51%,BAMBI;TGFBR1
prerank,GO_Biological_Process_2021__fatty acid oxidation (GO:0019395),0.4301940302556823,1.0457340255835783,0.3142857142857143,0.8625689014823019,1.0,22/55,20.34%,ACADS;CYP4V2;ACAD10;PEX13;SLC27A2;ECHS1;ABCD3;ADIPOR1;ABCD2;ACADM;MECR;ADIPOR2;ADH4;ACSM1;BDH2;ECI1;ECHDC1;ACOX1;DECR1;HADHB;ECHDC2;ACADVL
prerank,KEGG_2021_Human__Pathogenic Escherichia coli infection,-0.4125101587622961,-1.0454705451904376,0.3717948717948718,1.0,1.0,23/161,17.31%,NLRP4;LPAR1;CLDN1;CLDN6;CLDN5;ACTG1;CLDN2;MYO1F;MYO5B;CASP7;TNFRSF10A;TUBA4A;BAIAP2L1;NLRP3;CLDN18;TUBA3D;IL18;CLDN20;TUBB;TUBB6;NAIP;RAC1;TUBB2A
prerank,GO_Biological_Process_2021__negative regulation of cell activation (GO:0050866),-0.5829830061765775,-1.045359163894103,0.46774193548387094,1.0,1.0,2/11,5.18%,C1QTNF1;GPER1
prerank,Reactome_2022__MAPK6/MAPK4 Signaling R-HSA-5687128,0.3798912394314461,1.0452576100960873,0.21739130434782608,0.8633912461944375,1.0,12/81,11.67%,FOXO1;HSPB1;MMP2;PSME4;SEM1;NCOA3;PSMA1;CCND3;MYC;MOV10;PKN2;TNRC6C
prerank,Reactome_2022__RNA Polymerase III Transcription Initiation From Type 1 Promoter R-HSA-76061,0.43100011292188756,1.0452520025852094,0.42105263157894735,0.8630010457707878,1.0,8/27,22.28%,BDP1;GTF3C4;POLR3G;GTF3C5;POLR3D;POLR3K;POLR3B;POLR2F
prerank,GO_Biological_Process_2021__Notch signaling pathway (GO:0007219),0.42385593277332917,1.0450783831445416,0.3225806451612903,0.8630452851133942,1.0,16/54,19.29%,DTX1;MAML1;JAG1;HES1;POFUT1;GMDS;MYC;SNAI2;ASCL1;WWC1;NOTCH1;PBX1;RBPJ;ADAM10;EP300;KAT2B
prerank,GO_Biological_Process_2021__ruffle assembly (GO:0097178),-0.6782417893140243,-1.045013596956009,0.4117647058823529,1.0,1.0,2/5,18.12%,RAC1;AIF1L
prerank,CellMarker_Augmented_2021__Cancer Stem cell:Uterus,0.3760117016204016,1.0449257053786756,0.3333333333333333,0.8630684892873366,1.0,16/82,12.90%,ERG;EMP1;LAMA4;MXRA5;LAMA3;CDH5;PARVA;COL12A1;NTN4;CFH;PPFIBP1;CRIM1;COL16A1;PTPRB;EFEMP1;NFIB
prerank,GO_Biological_Process_2021__positive regulation of DNA recombination (GO:0045911),0.4353496532574579,1.0448675241447547,0.35714285714285715,0.8627559282443373,1.0,8/27,16.13%,SHLD2;SHLD1;TIMELESS;KMT5C;ARID2;WRAP53;FUS;KMT5B
prerank,GO_Biological_Process_2021__positive regulation of sterol transport (GO:0032373),0.6670455977229702,1.0448251461271816,0.5434782608695652,0.8625135731959549,1.0,4/5,33.25%,NR1H3;ABCA13;LIPG;NR1H2
prerank,"Reactome_2022__Interleukin-3, Interleukin-5 And GM-CSF Signaling R-HSA-512988",-0.469854846514162,-1.0446840709690994,0.37142857142857144,1.0,1.0,8/38,15.09%,HCK;TEC;INPP5D;PIK3R3;IL3RA;BLNK;PIK3CB;IL5RA
prerank,GO_Biological_Process_2021__positive regulation of calcium ion transport into cytosol (GO:0010524),0.5253914048563555,1.0446834408116836,0.3783783783783784,0.8624531357312814,1.0,5/21,10.74%,TRPC3;SNCA;F2;GRIN1;F2R
prerank,GO_Biological_Process_2021__maturation of LSU-rRNA (GO:0000470),-0.49402704516903756,-1.0444547268415918,0.4166666666666667,1.0,1.0,7/25,25.62%,EIF6;LAS1L;RPL7A;WDR12;RPL35;DDX18;NSA2
prerank,CellMarker_Augmented_2021__Endothelial cell:Lymph Node,-0.46719886048649706,-1.0441276651115439,0.36585365853658536,1.0,1.0,17/61,13.10%,C1QB;GMFG;LYVE1;TNFRSF1B;C3AR1;MS4A4A;PARVG;FCGR3A;ZNF366;VSIG4;HLA-DPB1;SELP;PTPRC;VWF;SPI1;F13A1;HLA-DPA1
prerank,CellMarker_Augmented_2021__Mature Endothelial cell:Subcutaneous Adipose Tissue,-0.46719886048649706,-1.0441276651115439,0.36585365853658536,1.0,1.0,17/61,13.10%,C1QB;GMFG;LYVE1;TNFRSF1B;C3AR1;MS4A4A;PARVG;FCGR3A;ZNF366;VSIG4;HLA-DPB1;SELP;PTPRC;VWF;SPI1;F13A1;HLA-DPA1
prerank,CellMarker_Augmented_2021__Inflammatory cell:Muscle,-0.46719886048649706,-1.0441276651115439,0.36585365853658536,1.0,1.0,17/61,13.10%,C1QB;GMFG;LYVE1;TNFRSF1B;C3AR1;MS4A4A;PARVG;FCGR3A;ZNF366;VSIG4;HLA-DPB1;SELP;PTPRC;VWF;SPI1;F13A1;HLA-DPA1
prerank,CellMarker_Augmented_2021__Immature Endothelial cell:Subcutaneous Adipose Tissue,-0.46719886048649706,-1.0441276651115439,0.36585365853658536,1.0,1.0,17/61,13.10%,C1QB;GMFG;LYVE1;TNFRSF1B;C3AR1;MS4A4A;PARVG;FCGR3A;ZNF366;VSIG4;HLA-DPB1;SELP;PTPRC;VWF;SPI1;F13A1;HLA-DPA1
prerank,PanglaoDB_Augmented_2021__B Cells Naive,-0.4381180378982194,-1.043996334154623,0.33783783783783783,1.0,1.0,18/90,10.28%,GMFG;BLK;DOCK8;CYTIP;TBC1D10C;ARHGAP9;TAGAP;STAG3;TMC8;PARVG;WAS;LY86;P2RY14;CD37;TRAF3IP3;PSG2;MYO1F;PTPRC
prerank,Reactome_2022__RUNX1 Regulates Transcription Of Genes Involved In WNT Signaling R-HSA-8939256,0.6377950103959735,1.0439836346028293,0.41304347826086957,0.8638106813267029,1.0,2/6,3.64%,RSPO3;CBFB
prerank,Reactome_2022__Activation Of TFAP2 (AP-2) Family Of Transcription Factors R-HSA-8866907,-0.6440470803154029,-1.0439444329270309,0.48148148148148145,1.0,1.0,1/8,1.02%,TFAP2E
prerank,GO_Biological_Process_2021__positive regulation of membrane depolarization (GO:1904181),-0.6938373179971326,-1.0438391062697148,0.5,1.0,1.0,1/5,6.82%,DCN
prerank,CellMarker_Augmented_2021__Mesenchymal Stem cell:Umbilical Cord Blood,0.39868015079401314,1.0437487497041442,0.3548387096774194,0.864084811830993,1.0,5/71,4.79%,IL7R;SELPLG;SLFN11;IL16;IFI16
prerank,GO_Biological_Process_2021__ion homeostasis (GO:0050801),0.4732237720824157,1.043720803827158,0.38235294117647056,0.8637236572656969,1.0,7/27,22.90%,SLC4A7;RHCG;WNK2;KLHL3;WNK3;SLC4A11;WNK1
prerank,GO_Biological_Process_2021__neuron projection fasciculation (GO:0106030),0.5250842872885848,1.0436030513787071,0.39473684210526316,0.8636488181807482,1.0,7/10,29.44%,SEMA5A;ARHGAP35;EPHB2;NRCAM;EPHB3;CNTN4;EPHA4
prerank,CellMarker_Augmented_2021__Zymogenic Chief cell:Gastric Epithelium,-0.4764086075622575,-1.0436026682815491,0.43478260869565216,1.0,1.0,19/64,18.80%,TMEM150B;RIN3;ASGR2;SLC7A7;TGFBI;C3AR1;DAB2;OSCAR;CTSZ;ENG;TLR2;CD300LF;ITGA5;KCNE3;GRN;HK3;CPQ;ANPEP;CARD6
prerank,CellMarker_Augmented_2021__Thecal cell:Ovary,-0.4764086075622575,-1.0436026682815491,0.43478260869565216,1.0,1.0,19/64,18.80%,TMEM150B;RIN3;ASGR2;SLC7A7;TGFBI;C3AR1;DAB2;OSCAR;CTSZ;ENG;TLR2;CD300LF;ITGA5;KCNE3;GRN;HK3;CPQ;ANPEP;CARD6
prerank,Reactome_2022__Mitotic Prometaphase R-HSA-68877,-0.3906742617786959,-1.043496039878951,0.379746835443038,1.0,1.0,35/173,23.94%,NEK2;BUB1;ERCC6L;SPC25;CENPU;ITGB3BP;ZWILCH;NUF2;CENPH;DCTN1;CENPS-CORT;TUBA4A;CEP72;DYNLL1;RPS27;INCENP;NDEL1;TUBB;CEP76;CDCA8;CENPN;KIF18A;BUB1B;YWHAG;NCAPH;SKA2;TUBB4A;SEC13;CENPL;TUBB4B;DYNLL2;PPP2R5A;CENPM;MZT2B;CSNK2A2
prerank,GO_Biological_Process_2021__regulation of exocytosis (GO:0017157),0.4107924955118561,1.0432793570198138,0.3055555555555556,0.8641945426862353,1.0,11/47,17.53%,RAB27A;SNCA;RALA;SYT1;CHMP6;RAB27B;RIMS2;RAB3C;RAB10;RAB5A;RAB3D
prerank,GO_Biological_Process_2021__positive regulation of T-helper cell differentiation (GO:0045624),-0.5694249720916525,-1.0432647252057778,0.3898305084745763,1.0,1.0,6/12,24.92%,ANXA1;NLRP3;CD80;IL18;CD86;TNFSF4
prerank,Reactome_2022__Recycling Of eIF2:GDP R-HSA-72731,-0.5990413758354358,-1.0432505379203207,0.43103448275862066,1.0,1.0,3/8,17.84%,EIF2B2;EIF2S3;EIF2S2
prerank,CellMarker_Augmented_2021__Myoepithelial cell:Salivary Gland,0.3973938196926262,1.043218264344171,0.37037037037037035,0.8639174647769772,1.0,19/85,12.82%,ADGRF4;VEGFC;ARSJ;DCBLD2;COL12A1;ADAMTS12;MMP2;P3H2;SERPINE1;RAI14;EDNRA;PDLIM4;SNAI2;RND3;CHST3;TWSG1;TMTC3;LRIG3;EFEMP1
prerank,GO_Biological_Process_2021__negative regulation of transcription by RNA polymerase II (GO:0000122),0.31546258083022455,1.0429821446397256,0.2222222222222222,0.8641212539673166,1.0,166/567,21.94%,SMYD2;PER2;HDAC3;ZNF239;BCL6;AASS;MITF;NFATC3;HDAC10;RARB;ZNF692;URI1;ZBTB7B;KLF10;PCGF1;CBFB;PRDM5;HEXIM2;TGIF1;GATAD2A;ZNF263;E2F6;FRK;ATXN1;PPARG;SIRT1;IFI16;ZEB2;CRY1;SNCA;PER3;SIRT7;HES1;GFI1B;KCNIP3;BCL11A;PROX1;ZBTB4;HMGB1;ATF3;DLX1;FOXP2;MIER2;OSR1;ZBTB1;MED25;ZNF274;NRIP1;WWOX;WWP2;MYC;NKAP;TAF3;NR4A2;ZNF688;ZEB1;ZNF202;TWIST1;SNAI2;SPEN;ZNF133;FHL2;ZNF599;CTBP2;CREM;BPTF;ZNF75A;PPM1A;DACH1;MYT1L;NSD1;SMARCA2;ZNF846;SMARCA4;SAP130;ZNF337;HSPA1A;NFIB;DPF2;MXI1;HDAC1;GATAD2B;ASCL1;SMAD2;NR2F2;PLK3;NR3C1;NFKB1;NCOA5;BCOR;CUX1;SCRT1;MECP2;OTUD7B;THRB;HDAC4;ZNF69;NFIC;CXXC5;ETV5;MEN1;HSF1;NR1H3;HJV;GADD45A;TP53;HSF4;RUNX1;NR6A1;NR4A3;WWC1;ZGLP1;NOTCH1;NEDD4;ZBTB2;ARID5B;ATN1;KLF12;HIVEP1;THAP7;SKI;SP2;ZMYM5;NR2C1;PAX6;ZNF675;ZNF589;NIPBL;ZBTB5;NOC2L;MACROH2A2;RBPJ;NFX1;UXT;IMPACT;SOX13;SIRT6;EP300;SLA2;AEBP1;PTCH1;ZNF79;SREBF2;RNF2;BRMS1L;ZNF596;HDAC5;IGBP1;TRAF6;JAZF1;TBL1X;ZNF764;ZNF778;PRDM16;ZNF785;ZBTB7A;MTDH;NFIX;DLG1;MDM4;BMP4;MLIP;ZNF25;SUV39H2;ZNF268;ZNF3
prerank,GO_Biological_Process_2021__protein polymerization (GO:0051258),-0.44684509876335354,-1.0429212681927307,0.34782608695652173,1.0,1.0,7/49,13.88%,CASQ2;WAS;CHMP3;GAS7;VIL1;CATIP;PSTPIP1
prerank,Reactome_2022__Synthesis Of diphthamide-EEF2 R-HSA-5358493,0.5720889050880107,1.0425562210228894,0.4594594594594595,0.8647286557768761,1.0,3/8,9.34%,DNAJC24;DPH1;DPH5
prerank,GO_Biological_Process_2021__postsynaptic density assembly (GO:0097107),0.650615103067722,1.0424579304513144,0.45454545454545453,0.8646465644250783,1.0,4/6,25.84%,ZDHHC12;NRXN1;PTEN;NLGN2
prerank,Reactome_2022__NCAM Signaling For Neurite Out-Growth R-HSA-375165,0.421368597875154,1.042426967032486,0.35714285714285715,0.864341969085481,1.0,5/55,5.94%,FGFR1;SPTBN4;COL9A2;CACNB4;ST8SIA4
prerank,GO_Biological_Process_2021__regulation of embryonic development (GO:0045995),0.4719770129308243,1.0424182027482007,0.36363636363636365,0.8639750852026331,1.0,5/30,17.89%,PHLDB2;PLCB1;RPS6KA6;INSR;NIPBL
prerank,GO_Biological_Process_2021__negative regulation of focal adhesion assembly (GO:0051895),0.5627398636362461,1.0423920481918012,0.36363636363636365,0.8632145556081257,1.0,1/15,0.53%,PHLDB2
prerank,GO_Biological_Process_2021__negative regulation of cell-substrate junction organization (GO:0150118),0.5627398636362461,1.0423920481918012,0.36363636363636365,0.8632145556081257,1.0,1/15,0.53%,PHLDB2
prerank,GO_Biological_Process_2021__regulation of steroid biosynthetic process (GO:0050810),0.5329496331260702,1.0423793006713782,0.4,0.8628487056302087,1.0,3/12,4.75%,WNT4;SIRT1;AKR1C3
prerank,GO_Biological_Process_2021__dicarboxylic acid metabolic process (GO:0043648),0.42967834523440007,1.0423521756055916,0.2916666666666667,0.8624970740387641,1.0,11/47,18.77%,SLC19A1;DHFR;ALDH18A1;AADAT;OGDH;IDH2;GLUD2;MTHFR;ME3;FPGS;SHMT2
prerank,GO_Biological_Process_2021__cellular response to interleukin-15 (GO:0071350),0.5371707369064178,1.0423491096860555,0.40625,0.8617046585719254,1.0,3/12,15.73%,STAT5B;PLCB1;IL2RB
prerank,GO_Biological_Process_2021__interleukin-15-mediated signaling pathway (GO:0035723),0.5371707369064178,1.0423491096860555,0.40625,0.8617046585719254,1.0,3/12,15.73%,STAT5B;PLCB1;IL2RB
prerank,GO_Biological_Process_2021__regulation of phospholipase A2 activity (GO:0032429),-0.6566874023902638,-1.0422257926995937,0.5454545454545454,1.0,1.0,1/5,8.67%,ANXA1
prerank,GO_Biological_Process_2021__regulation of ossification (GO:0030278),-0.4887643235929783,-1.0421892165706905,0.4084507042253521,1.0,1.0,5/32,14.29%,NOTUM;WNT5A;SMAD6;LRP4;SGMS2
prerank,GO_Biological_Process_2021__synapse pruning (GO:0098883),-0.6718999113592141,-1.0419193999997916,0.4807692307692308,1.0,1.0,2/5,11.77%,C1QB;ITGAM
prerank,PanglaoDB_Augmented_2021__Sebocytes,-0.46017265442161925,-1.041901021970472,0.391304347826087,1.0,1.0,22/64,21.24%,AQP3;PLEKHG6;TCN1;CYP24A1;RDH12;SERPINB5;ST6GALNAC2;SPINT1;CXCL16;TRIM29;VDR;IL18;TMEM45B;TJP3;PRRG4;F2RL1;SCNN1A;ANGPTL4;FAM3D;CBLC;COL17A1;CNR2
prerank,Reactome_2022__Keratinization R-HSA-6805567,-0.480479766126233,-1.0416110143769088,0.3968253968253968,1.0,1.0,3/35,1.89%,KRTAP5-1;PKP2;FLG
prerank,GO_Biological_Process_2021__purine nucleoside monophosphate biosynthetic process (GO:0009127),-0.5861152297745236,-1.0415270254519888,0.40625,1.0,1.0,1/11,1.23%,ADSS1
prerank,Reactome_2022__Synthesis Of Dolichyl-phosphate R-HSA-446199,0.6570435546153524,1.0414968963408007,0.5348837209302325,0.8634884427742567,1.0,1/5,8.69%,NUS1
prerank,GO_Biological_Process_2021__regulation of microglial cell activation (GO:1903978),-0.6238605560869965,-1.041391982320121,0.4915254237288136,1.0,1.0,3/9,15.82%,TAFA3;PTPRC;GRN
prerank,GO_Biological_Process_2021__regulation of neuron projection arborization (GO:0150011),0.4984214860657569,1.0413634605046127,0.3684210526315789,0.8634142323007736,1.0,6/15,11.93%,GRIP1;MFSD2A;MOV10;NTNG2;MACF1;MAP3K13
prerank,GO_Biological_Process_2021__enzyme-directed rRNA pseudouridine synthesis (GO:0000455),0.6056898331286545,1.04122155190496,0.4772727272727273,0.8632500856878345,1.0,1/6,13.19%,RPUSD1
prerank,GO_Biological_Process_2021__pinocytosis (GO:0006907),-0.6022245153481384,-1.041075026592463,0.40384615384615385,1.0,1.0,4/9,9.22%,RAB34;MAPKAPK3;DOCK2;PPT1
prerank,GO_Biological_Process_2021__aminoglycan metabolic process (GO:0006022),-0.5990994277092911,-1.0409839057986885,0.39285714285714285,1.0,1.0,3/10,17.62%,CHST9;XYLT2;B3GALT6
prerank,CellMarker_Augmented_2021__Regulatory T (Treg) cell:Colorectum,-0.5937795800228116,-1.0409782595972936,0.48214285714285715,1.0,1.0,2/7,7.00%,SIRPG;CD5
prerank,GO_Biological_Process_2021__regulation of ERBB signaling pathway (GO:1901184),0.5354610851858598,1.0409654116013323,0.43243243243243246,0.8635566676117611,1.0,4/16,8.16%,CDH13;ERBB2;FER;MVB12A
prerank,Reactome_2022__Inflammasomes R-HSA-622312,-0.5508246267587247,-1.040962287217792,0.4827586206896552,1.0,1.0,6/18,15.44%,AIM2;NFKB2;NLRC4;NLRP3;PSTPIP1;TXNIP
prerank,Reactome_2022__Activated NTRK3 Signals Thru PI3K R-HSA-9603381,0.6585034779622528,1.0409177414190485,0.5,0.863316519418092,1.0,2/5,14.95%,IRS1;PIK3CA
prerank,Reactome_2022__Sensory Perception R-HSA-9709957,-0.3905172178136424,-1.0408636988297577,0.3411764705882353,1.0,1.0,58/224,19.01%,CHRNA9;OR13A1;ANO2;OR2H2;OR2T6;OR52A5;OR51M1;OR2G6;PDE6B;GRK7;LRP10;SDC2;OR10A2;OR52I2;OR51I2;GRXCR2;RDH12;OR5V1;SLC24A1;OTOG;GPC3;GNAT3;OR2AJ1;GNGT1;OR52N2;OR7C1;OR2AG1;GPIHBP1;APOM;LRP2;OR56A3;MYO3B;TMC2;SLC17A8;FSCN2;BCO1;OR1L8;STRC;OR2T12;ITPR3;PDE6A;PLB1;OR9Q1;USH1C;GRXCR1;OR1L6;SCNN1A;SLC26A5;OR2M4;MSN;SCNN1G;MYO15A;GNAL;CALM1;GUCY2F;OR8A1;NMT1;TMC1
prerank,GO_Biological_Process_2021__positive regulation of T-helper 17 type immune response (GO:2000318),0.630581551855499,1.0407427505262352,0.4722222222222222,0.8634706826028113,1.0,5/8,28.57%,CARD9;IL23A;MALT1;NFKBID;NFKBIZ
prerank,GO_Biological_Process_2021__phosphatidylserine acyl-chain remodeling (GO:0036150),-0.5479575368910204,-1.0406645685049492,0.3968253968253968,1.0,1.0,4/14,20.26%,PLA2G10;PLA2G4A;MBOAT1;PLA2G4D
prerank,GO_Biological_Process_2021__regulation of neurogenesis (GO:0050767),0.4123796990006465,1.0406491370894813,0.28125,0.863286081220464,1.0,14/47,17.75%,PER2;PCM1;CX3CR1;HES1;RGS14;WNT3A;SPEN;NUMB;HES6;ASCL1;LIG4;NOTCH1;PAX6;FAIM
prerank,Reactome_2022__Processive Synthesis On C-strand Of Telomere R-HSA-174414,-0.520489318654019,-1.0404910229818403,0.4153846153846154,1.0,1.0,2/18,4.30%,TERF2IP;RPA3
prerank,PanglaoDB_Augmented_2021__Vascular Smooth Muscle Cells,0.34181024214871575,1.0404898450984956,0.2,0.8632743369335687,1.0,17/93,12.06%,FIBIN;ADAMTS1;LAMA4;MXRA5;MRGPRF;ITGA11;ITGA8;COL12A1;SSC5D;MMP2;CNN1;SLIT2;EDNRA;COL16A1;RBMS3;MSRB3;PAMR1
prerank,GO_Biological_Process_2021__dolichyl diphosphate biosynthetic process (GO:0006489),0.6309192976083616,1.0404882096523513,0.45454545454545453,0.8624917605808988,1.0,1/6,8.69%,NUS1
prerank,GO_Biological_Process_2021__dolichyl diphosphate metabolic process (GO:0046465),0.6309192976083616,1.0404882096523513,0.45454545454545453,0.8624917605808988,1.0,1/6,8.69%,NUS1
prerank,Reactome_2022__MET Receptor Recycling R-HSA-8875656,0.5523474767159733,1.0404291626059483,0.40540540540540543,0.8623010530468281,1.0,3/9,19.27%,CRK;CRKL;SOS1
prerank,GO_Biological_Process_2021__cGMP biosynthetic process (GO:0006182),-0.6440875408311252,-1.0403969874248862,0.48148148148148145,1.0,1.0,3/7,24.71%,GUCY2C;GUCY2F;NPR2
prerank,GO_Biological_Process_2021__regulation of TORC1 signaling (GO:1903432),0.4631488710387708,1.0403360417491845,0.37777777777777777,0.8621105212800699,1.0,13/32,23.62%,KPTN;SIK3;TELO2;RNF152;PIH1D1;DYRK3;CLEC16A;KLHL22;ATM;SESN2;SZT2;RRAGD;SEH1L
prerank,GO_Biological_Process_2021__positive regulation of acute inflammatory response (GO:0002675),-0.6165738480496764,-1.0402627498451815,0.42857142857142855,1.0,1.0,2/7,13.45%,OSMR;PTGER3
prerank,GO_Biological_Process_2021__negative regulation of actin filament depolymerization (GO:0030835),-0.6448191680839734,-1.0402425729826639,0.5,1.0,1.0,2/6,11.76%,SCIN;VIL1
prerank,GO_Biological_Process_2021__glial cell differentiation (GO:0010001),0.47004112202789267,1.0402067261244596,0.30303030303030304,0.8621062370816197,1.0,6/26,13.21%,ADGRG6;FGF10;SLC8A3;PTPRZ1;NFIB;CDH2
prerank,GO_Biological_Process_2021__regulation of miRNA metabolic process (GO:2000628),0.6573227938511229,1.0401283092499116,0.47619047619047616,0.8619228588370246,1.0,4/5,29.31%,NFKB1;RC3H1;RC3H2;RELA
prerank,GO_Biological_Process_2021__R-loop disassembly (GO:0062176),0.6595997461526449,1.0401234711215488,0.5365853658536586,0.8615537485856304,1.0,3/5,23.99%,SIRT7;PRIMPOL;SRPK2
prerank,Reactome_2022__Ion Transport By P-type ATPases R-HSA-936837,-0.4827800537557366,-1.0398698468272134,0.3972602739726027,1.0,1.0,13/44,25.20%,ATP1A4;ATP10B;ATP13A5;ATP4A;PLN;ATP8B3;CALM1;CAMK2A;FXYD6-FXYD2;CUTC;ATP11C;ATP2A2;ATP11A
prerank,GO_Biological_Process_2021__apoptotic nuclear changes (GO:0030262),-0.5485435409156347,-1.0398131489382583,0.453125,1.0,1.0,5/21,11.87%,ERN2;GPER1;H1-0;ENDOG;DNASE2
prerank,GO_Biological_Process_2021__astral microtubule organization (GO:0030953),-0.6250890223307207,-1.039727939156656,0.423728813559322,1.0,1.0,1/8,5.16%,RAB11A
prerank,Reactome_2022__Gene Silencing By RNA R-HSA-211000,0.4094242899773242,1.0396965533286089,0.23076923076923078,0.8623824541170124,1.0,21/86,22.33%,PLD6;NUP210;NUP42;H2BC21;PIWIL1;AAAS;TNRC6C;DGCR8;H2AX;XPO5;TNRC6A;AGO3;RANBP2;TARBP2;H2AJ;AGO2;PIWIL2;IPO8;NUP214;POLR2F;TPR
prerank,GO_Biological_Process_2021__protein autoubiquitination (GO:0051865),0.39732647065448684,1.0395438301270468,0.2413793103448276,0.862364295004851,1.0,20/60,21.64%,MARCHF5;ERCC8;SH3RF1;TRIM71;SH3RF3;WWP2;RNF10;UBE3D;KLHL24;UBE2A;RNF146;CNOT4;RNF185;NFX1;LRSAM1;MARCHF7;RNF122;RNF19B;TRAF6;UBE2D2
prerank,GO_Biological_Process_2021__branched-chain amino acid catabolic process (GO:0009083),0.5430046765134731,1.0394368353860675,0.4666666666666667,0.8618194571330128,1.0,10/19,27.46%,BCKDK;BCAT1;ECHS1;HIBADH;HIBCH;BCKDHB;MCCC1;DBT;ACADSB;AUH
prerank,GO_Biological_Process_2021__branched-chain amino acid metabolic process (GO:0009081),0.5430046765134731,1.0394368353860675,0.4666666666666667,0.8618194571330128,1.0,10/19,27.46%,BCKDK;BCAT1;ECHS1;HIBADH;HIBCH;BCKDHB;MCCC1;DBT;ACADSB;AUH
prerank,GO_Biological_Process_2021__glyceraldehyde-3-phosphate metabolic process (GO:0019682),-0.6097255763448409,-1.0392995997289405,0.4745762711864407,1.0,1.0,2/7,5.00%,ALDOB;GLYCTK
prerank,GO_Biological_Process_2021__regulation of aerobic respiration (GO:1903715),-0.5386006543905402,-1.039236387726824,0.3793103448275862,1.0,1.0,5/14,18.44%,PINK1;ACTN3;COX7A1;COX7A2;NOP53
prerank,GO_Biological_Process_2021__box C/D snoRNP assembly (GO:0000492),0.6036947370927204,1.0390975619680214,0.42424242424242425,0.8623373953506001,1.0,2/7,17.13%,PIH1D1;NUFIP1
prerank,Reactome_2022__Signaling By CSF3 (G-CSF) R-HSA-9674555,-0.5234808195942402,-1.0390546152298483,0.38333333333333336,1.0,1.0,2/26,6.09%,HCK;STAT1
prerank,GO_Biological_Process_2021__regulation of neutrophil chemotaxis (GO:0090022),0.4675446625257566,1.0388911339550582,0.4,0.8624703478718858,1.0,3/20,10.27%,DAPK2;SLIT2;MCU
prerank,CellMarker_Augmented_2021__T Helper cell:Bone Marrow,-0.4823740246224454,-1.038755231952227,0.352112676056338,1.0,1.0,8/44,10.28%,SIRPG;CYTIP;TAGAP;KLRB1;SCML4;CD5;TRAF3IP3;PTPRC
prerank,GO_Biological_Process_2021__positive regulation of GTPase activity (GO:0043547),0.36568381566726865,1.0385855589674269,0.2631578947368421,0.8628159346981158,1.0,41/161,18.20%,TBC1D10A;SNX18;SCRIB;TBC1D16;RGS16;ERBB2;TBC1D12;ASAP3;SYDE2;SRGAP2;RAPGEF1;PLXNB1;SIPA1;SIPA1L2;RALGAPA2;ARHGAP42;TBC1D22B;F2R;EVI5L;LIMS1;TBC1D4;RAP1A;RGS7;SNX9;DOCK9;RAP1GDS1;NF1;RGS6;PKP4;SIPA1L3;BCR;DOCK11;RSU1;TBC1D8B;ARHGAP27;SLC27A4;CCDC125;TBC1D2;TBCK;ARHGEF16;RAPGEF3
prerank,GO_Biological_Process_2021__basement membrane assembly (GO:0070831),0.6489340721971953,1.0385120919007405,0.5142857142857142,0.8626192678543946,1.0,3/8,10.36%,LAMB4;NTN4;NTNG2
prerank,Reactome_2022__Phase 3 - Rapid Repolarisation R-HSA-5576890,-0.6304587125504904,-1.038301314911796,0.4482758620689655,1.0,1.0,3/8,14.89%,KCNA5;KCNQ1;KCNE3
prerank,Reactome_2022__Signal Transduction R-HSA-162582,0.29644365605394474,1.0382610215447363,0.0,0.8629507560395091,1.0,362/2043,16.23%,ADRA1A;TACR3;NTSR2;ARC;ATP6V0D2;LGR5;ADRA1B;BAMBI;RSPO3;NGF;PLEKHG2;HGFAC;DGKD;FOXO1;CHRM2;DUSP4;GRK5;SH2B2;FGF10;DUSP2;GREM2;THEM4;LAMA4;TGFBR1;KIT;LLGL1;HDAC3;PRICKLE1;MAPKAPK2;TCIRG1;ITPR2;SPRED3;GPR161;VEGFC;IFT88;BCL2;CFLAR;CRHR2;FGFR1;SCRIB;HSPB1;KSR1;GPRIN1;RORA;IRS1;AMOTL1;APOE;GRM3;HDAC10;PLPPR1;HTR1F;ANGPT1;CDH5;RARB;GALR3;PARD3;TRPC3;SPTBN4;COL9A2;NRG2;FGD4;ALDH1A1;HTR2C;GABRG3;BCL11B;HRH3;RFNG;PLEKHG4B;CBFB;PHC2;ITGA8;PDE10A;CSK;ABHD17A;TGIF1;GATAD2A;QRFPR;RIPK2;TLE2;KCNH8;FRK;DRD5;CX3CR1;KLKB1;IL17RD;PPARG;WNT4;TPH1;FGF17;DTX1;SPOPL;RGS16;MMP2;AKR1C3;PCDH7;OPN5;PSME4;ERBB2;MAML1;VANGL1;SEM1;PROKR2;LMNB1;RALB;STX5;TULP3;CXXC4;SERPINE1;JAG1;SYDE2;PDGFD;PRPF38B;ARRB2;HNRNPF;NRG1;RAB7A;PRKCSH;SRGAP2;UTS2R;RHOBTB3;RRAS2;SH3RF1;GRM8;WNT9A;RHOBTB1;ANKRD26;STAT5B;VRK2;H2BC21;CRK;RGS11;ST3GAL3;REXO2;RASA2;NCOA3;PTPRZ1;MUC13;NCOA2;RAPGEF1;OPRD1;PPP5C;DRD4;SGK1;RGS14;PSMA1;RXFP1;FGD5;S1PR5;NRG3;FER;NRIP1;CDK4;PML;NMU;TAS2R8;LTBP1;ABL1;CCND3;WWOX;ABCA1;POFUT1;LATS1;ARHGAP20;PLCB1;PDE1A;RBL1;RSPO2;RBBP6;MAPK8;FZD1;PDE7A;NPW;CASP3;EDNRA;WWP2;ADCY2;NANOS3;MYC;KHDRBS2;SLC4A7;FLNA;FSTL3;PLXNB1;DYNC1I2;RALA;HNRNPH1;ESRP1;FGD1;FGF18;TGFA;LRP6;EPOR;SPRED2;SENP1;MYO9B;MLST8;ABHD17C;PGRMC2;ABL2;GRM4;WNT3A;ABCD3;INSL5;SNAI2;NSMAF;SMPD3;NHS;MOV10;GRM2;FARP2;MAPRE1;GPC5;TPM4;KTN1;AKT2;RPGRIP1L;PAG1;ITGA3;FGFR3;ZFYVE16;WASF3;KANK1;KITLG;SRRM1;GRM7;MAMLD1;NUMB;AAAS;RND3;PRKAR2A;PKN2;CTBP2;MTR;PDE4B;RGR;ARHGAP42;RPS6KA3;TRAK2;SH3KBP1;ALDH1A2;SGO2;IRS2;SHARPIN;F2R;UCN;FLRT2;AMH;SPRED1;GPSM1;PPP2R1B;OSBPL11;WASF2;PPM1A;EVL;TAC3;TNRC6C;RBFOX2;FARP1;CNKSR2;MKS1;SMARCA4;RASAL2;BCL9L;TIAL1;RET;SCMH1;RAP1A;ARHGAP21;TANK;RGS7;CRABP1;FNTA;CPSF7;CPT1A;GPSM3;FNBP1;ABHD17B;FADD;CCDC88A;KCTD3;MARK3;HDAC1;GOLGA3;DST;GATAD2B;GREB1;TAB3;ARHGAP35;ASCL1;IRS4;CHD4;RNF146;ARPC3;DOCK9;CARM1;ANOS1;ARRB1;H2AX;ARL13B;RAP1GDS1;CDK8;NF1;SMAD2;MPP2;FLT3;WLS;NR3C1;EEF2K;NFKB1;GNAO1;CYSLTR1;SMURF1;GTF2F2;RPS6KA2;RGS6;WWTR1;MOB1A;OTUD3;RYK;OTUD7B;HDAC4;COL9A1;PKP4;INSR;PIK3CA;IRAK4;VAV2;CXXC5;MEN1;FURIN;MAGED1;ST3GAL6;HTR1E;FAM135A;NCAM1;NR1H3;TP53;PLPPR3;IFT140;HDAC11;SKA1;CGN;RUNX1;MAPK12;MATK;IL2RB;TNRC6A;CRKL;CLIP1;PARD6B;PTBP1;S1PR1;SLK;DLG5;AMIGO2;TTC21B;DGKH;SRFBP1;COL6A3;PTCH2;ZNRF3;ADORA1
prerank,GO_Biological_Process_2021__positive regulation of transcription from RNA polymerase II promoter involved in cellular response to chemical stimulus (GO:1901522),0.5233943897098986,1.0381297142490236,0.4074074074074074,0.8629666715146916,1.0,10/20,29.31%,NOTCH1;RBPJ;SESN2;EP300;HIF1A;CARF;SMAD5;NFE2L2;BMP2;RELA
prerank,GO_Biological_Process_2021__negative regulation of collateral sprouting (GO:0048671),0.6799372764387824,1.038035335621903,0.5111111111111111,0.8628318606231083,1.0,1/5,6.21%,DCC
prerank,GO_Biological_Process_2021__cellular response to alkaloid (GO:0071312),-0.5281521947650176,-1.038003386769643,0.4576271186440678,1.0,1.0,4/17,9.49%,CASQ2;HTR1B;TGM2;CASP7
prerank,GO_Biological_Process_2021__regulation of interferon-gamma-mediated signaling pathway (GO:0060334),0.44518210972075156,1.0376410869026444,0.4864864864864865,0.8635736404242591,1.0,2/19,4.33%,IRGM;PPARG
prerank,GO_Biological_Process_2021__lamellipodium organization (GO:0097581),0.49581597968932933,1.0376383002008909,0.34375,0.8631785930132689,1.0,3/28,3.26%,KIT;PTPRO;CDH13
prerank,Reactome_2022__Signaling By MST1 R-HSA-8852405,-0.7002216239349514,-1.037555977869178,0.5294117647058824,1.0,1.0,1/5,10.88%,SPINT1
prerank,Reactome_2022__Inhibition Of Replication Initiation Of Damaged DNA By RB1/E2F1 R-HSA-113501,0.5819024919006314,1.037485480546384,0.40540540540540543,0.8631943752013576,1.0,4/11,25.87%,PPP2R1B;TFDP1;POLA1;RB1
prerank,Reactome_2022__Generic Transcription Pathway R-HSA-212436,0.301772338407341,1.037394585767608,0.0,0.8630460306711091,1.0,269/1022,21.94%,TEAD2;RSPO3;SMYD2;ESRRG;FOXO1;ZNF804B;ZNF496;ZNF607;CCNG1;KIT;HDAC3;ZNF347;ZNF195;ZNF485;BCL6;ZNF212;MED17;GPRIN1;RORA;APOE;HDAC10;RARB;ZNF692;TWIST2;TRPC3;ZNF561;CCN2;PERP;ZNF70;CBFB;PHC2;TGIF1;GATAD2A;ZNF263;ZNF99;ZNF33B;E2F6;ZNF701;SMARCD3;PPARG;SIRT1;ZNF860;ABCA6;ELOF1;ITGA4;PSME4;ERBB2;MAML1;SEM1;RORB;SERPINE1;JAG1;ZNF641;TP53AIP1;ZNF470;PPP1R13B;H2BC21;REXO2;SMARCB1;ZNF703;MED25;PCGF5;TACO1;ZNF274;ZNF786;CDK6;SGK1;PSMA1;CDK4;PML;ABL1;CCND3;WWOX;RBL1;MYC;MGA;ZNF215;TAF3;NR4A2;ZNF33A;TGFA;ZNF688;CNOT9;MLST8;ZNF202;RBM14-RBM4;TNFRSF18;TWIST1;HIVEP3;TAF12;MOV10;ZNF133;AKT2;CTSV;UBE2E1;PBRM1;MAMLD1;PLAGL1;ZNF599;ZNF331;ARID1A;ZNF519;ZNF569;ELOA;ZNF514;ANAPC16;ZNF777;SP7;PPP2R1B;ZNF75A;ZNF782;PPM1A;CITED4;BANP;TNRC6C;ZNF761;CCNH;SMARCA2;ZNF41;ZNF300;SMARCA4;ZNF771;SCMH1;ZNF337;KAT6A;ZNF155;DPY30;COX19;ZNF704;TEAD4;ZNF311;ARID2;NR3C2;DGCR8;HDAC1;GATAD2B;RYBP;CRADD;CHD4;RBFOX1;CARM1;MED16;H2AX;ZNF839;CDK8;SMAD2;PLK3;NFYC;ZNF774;NR3C1;NFKB1;BID;PPARGC1B;SMURF1;GTF2F2;AIFM2;ZNF611;WWTR1;MECP2;THRB;HDAC4;CDC26;MEN1;FURIN;CNOT4;NR1H3;ZNF586;GADD45A;TP53;HDAC11;MAP4K2;RUNX1;NR6A1;ZNF549;TNRC6A;EXO1;NRBF2;NR4A3;ZFP28;PIP4K2A;ZNF708;NOTCH1;ATM;ZNF665;RAD17;AGO3;ZNF273;SKI;NR2C1;LGALS3;ZNF675;PLXNA4;TAF4;ELF2;ZNF627;ZNF589;ARID1B;PRMT5;NOC2L;SATB2;ERCC3;ZNF12;ZNF613;RBPJ;YAF2;UXT;RAD9A;MDC1;ZNF706;ANAPC7;NR4A1;ZNF157;ZNF445;SESN2;GSR;EP300;PCBP4;OPRK1;CXXC1;FOXO6;ZNF287;CREB1;ZNF717;KAT2B;H2AJ;CDK5;ZNF79;PRKAA2;TFAP2D;RNF2;MAP2K6;PRKAG2;ZNF324B;ZNF596;HDAC5;AGO2;KMT2C;ZNF500;E2F5;DNA2;PCGF6;FOS;ZNF595;KCTD6;CNOT6;SOCS4;TBL1X;ZNF764;ZNF778;PSMD4;ZNF785;BNIP3L;FZR1;ZNF441;MED27;RBBP4;ZNF664;ZNF28;MDM4;HDAC7;OCLN;RRM2B;ZNF415;CUL1;ZNF34;ZNF25;ZNF268;TFDP1;ZNF3
prerank,Reactome_2022__NADE Modulates Death Signaling R-HSA-205025,0.673835152273511,1.037322854980738,0.47058823529411764,0.8628363076818867,1.0,2/5,7.93%,NGF;CASP3
prerank,PanglaoDB_Augmented_2021__T Cytotoxic Cells,-0.47892829481298055,-1.0372958202327667,0.38028169014084506,1.0,1.0,8/36,10.28%,SIRPG;CYTIP;TBC1D10C;TAGAP;KLRB1;CD5;TRAF3IP3;PTPRC
prerank,GO_Biological_Process_2021__regulation of supramolecular fiber organization (GO:1902903),0.45213311731496114,1.0372261747797042,0.3611111111111111,0.8627565798013981,1.0,7/22,21.29%,APOE;ABL1;GPX1;PIK3CA;GBA2;AEBP1;CAMSAP3
prerank,GO_Biological_Process_2021__mitochondrial DNA repair (GO:0043504),0.6390508943696286,1.0372004470626328,0.45454545454545453,0.8623969500767953,1.0,3/5,29.63%,PRIMPOL;DNA2;LIG3
prerank,GO_Biological_Process_2021__cellular response to oxidative stress (GO:0034599),0.3696231506021188,1.0370375159389338,0.2608695652173913,0.8624062273202473,1.0,28/107,20.53%,FOXO1;NOX4;HTRA2;AKR1C3;PKD2;SNCA;VRK2;SLC25A24;FER;ABL1;MAPK8;ADNP2;PXN;HSPA1A;PNPT1;GPX1;ETV5;TP53;RAD52;ERCC6L2;SESN2;GSR;ERMP1;PRKAA2;VKORC1L1;SLC4A11;HIF1A;FOS
prerank,Reactome_2022__RHOU GTPase Cycle R-HSA-9013420,0.43857496562795617,1.0370111537812206,0.2857142857142857,0.8620948422862083,1.0,10/37,21.97%,VANGL1;SRGAP2;WWP2;PKN2;DST;DLG5;NCK1;STAM2;GIT1;NCK2
prerank,GO_Biological_Process_2021__negative regulation of cation channel activity (GO:2001258),-0.5263756137055241,-1.0369970176046777,0.36764705882352944,1.0,1.0,3/23,6.40%,CASQ2;MMP9;TRDN
prerank,Reactome_2022__Neuronal System R-HSA-112316,0.32844751510058834,1.0369583946224197,0.25,0.8618246569759177,1.0,71/355,18.10%,GRIN3A;KCNK6;BCHE;SLITRK6;LLGL1;GABRA5;GABRR2;GPRIN1;NLGN1;CACNG4;KCNB2;LRRTM3;IL1RAPL2;GABRG3;KCNC2;PPFIBP2;KCNH8;DLGAP4;GRIK1;NRG1;CACNB4;HCN1;KCNH7;KCNJ3;KCNG1;NCALD;KCNJ6;APBA3;PPFIA3;PLCB1;KCND2;KCNK2;ADCY2;SYT1;PPFIBP1;CACNG2;ABCC8;EPB41;PRKAR2A;EPB41L5;RPS6KA3;SHARPIN;SYT12;NLGN4X;UNC13B;KCNH4;APBA1;NLGN3;KCNH5;KCNQ5;GRIP2;MPP2;HCN3;SYN2;RPS6KA2;RPS6KA6;PTPRF;ACHE;NRXN1;CHRNA1;PTPRD;KCNK10;KCND3;GABRB2;GRIK3;SYN1;GABRA2;GNG7;ADCY6;SLITRK2;PPFIA2
prerank,"GO_Biological_Process_2021__neurotransmitter receptor transport, endosome to plasma membrane (GO:0099639)",0.5664937022817336,1.0369195995853007,0.4473684210526316,0.8615274530269317,1.0,2/7,2.69%,SCRIB;GRIP1
prerank,Reactome_2022__RNA Polymerase II Transcription R-HSA-73857,0.3024697332462356,1.0369106800358512,0.0,0.8611555756402701,1.0,292/1135,21.99%,TEAD2;RSPO3;SMYD2;ESRRG;FOXO1;ZNF804B;ZNF496;ZNF607;CCNG1;CPSF1;KIT;INTS11;HDAC3;ZNF347;ZNF195;LSM10;ZNF485;BCL6;ZNF212;MED17;GPRIN1;RORA;APOE;HDAC10;RARB;ZNF692;TWIST2;TRPC3;ZNF561;CCN2;PERP;ZNF70;CBFB;PHC2;TGIF1;GATAD2A;ZNF263;ZNF99;ZNF33B;E2F6;ZNF701;SMARCD3;PPARG;PCF11;SIRT1;ZNF860;ABCA6;ELOF1;ITGA4;PSME4;ERBB2;MAML1;SEM1;RORB;SERPINE1;IWS1;JAG1;ZNF641;TP53AIP1;ZNF470;PPP1R13B;H2BC21;REXO2;SMARCB1;ZNF703;MED25;PCGF5;TACO1;ZNF274;ZNF786;CDK6;SGK1;PSMA1;CDK4;PML;ABL1;CCND3;WWOX;RBL1;MYC;MGA;ZNF215;TAF3;NR4A2;ZNF33A;TGFA;ZNF688;CNOT9;MLST8;ZNF202;RBM14-RBM4;TNFRSF18;SNRPB;TWIST1;HIVEP3;TAF12;MOV10;ZNF133;AKT2;U2AF1;CTSV;UBE2E1;SRRM1;PBRM1;MAMLD1;PLAGL1;ZNF599;ZNF331;ARID1A;ZNF519;ZNF569;ELOA;ZNF514;ANAPC16;ZNF777;SP7;PPP2R1B;ZNF75A;ZNF782;PPM1A;CITED4;BANP;TNRC6C;ZNF761;CCNH;SMARCA2;ZNF41;ZNF300;SMARCA4;INTS14;ZNF771;SCMH1;ZNF337;KAT6A;ZNF155;INTS9;DPY30;CPSF7;COX19;ZNF704;SRSF4;TEAD4;ZNF311;ARID2;NR3C2;DGCR8;HDAC1;GATAD2B;RYBP;CRADD;CHD4;RBFOX1;CARM1;MED16;H2AX;ZNF839;CDK8;SMAD2;PLK3;NFYC;ZNF774;NR3C1;NFKB1;BID;PPARGC1B;SMURF1;MLLT3;GTF2F2;AIFM2;ZNF611;WWTR1;MECP2;THRB;HDAC4;CDC26;SNAPC3;MEN1;FURIN;CNOT4;NR1H3;ZNF586;GADD45A;TP53;HDAC11;MAP4K2;RUNX1;NR6A1;ZNF549;TNRC6A;EXO1;NRBF2;NR4A3;ZFP28;PIP4K2A;ZNF708;NOTCH1;ATM;ZNF665;RAD17;AGO3;ZNF273;ICE1;SKI;NR2C1;LGALS3;PAPOLA;ZNF675;PLXNA4;TAF4;ELF2;ZNF627;ZNF589;ARID1B;PRMT5;NOC2L;SATB2;ERCC3;ZNF12;ZNF613;RBPJ;YAF2;UXT;RAD9A;MDC1;ZNF706;ANAPC7;RPRD2;NR4A1;ZNF157;ZNF445;SESN2;GSR;EP300;PCBP4;OPRK1;CXXC1;FOXO6;ZNF287;CREB1;ZNF717;KAT2B;H2AJ;CDK5;ZNF79;EIF4A3;PRKAA2;TFAP2D;RNF2;MAP2K6;PRKAG2;ZNF324B;U2AF2;POU2F1;ZNF596;HDAC5;SYMPK;AGO2;KMT2C;ZNF500;E2F5;DNA2;PCGF6;FOS;ZNF595;CPSF6;KCTD6;CNOT6;SOCS4;TBL1X;ZNF764;ZNF778;PSMD4;ZNF785;BNIP3L;FZR1;ZNF441;MED27;RBBP4;ZNF664;ZNF28;MDM4;HDAC7;OCLN;RRM2B;ZNF415;CUL1;ZNF34;ZNF25;ZNF268;TFDP1;ZNF3;ICE2
prerank,GO_Biological_Process_2021__RNA methylation (GO:0001510),0.3928090372039106,1.0368933614079066,0.375,0.8607908467858857,1.0,15/57,19.85%,TRDMT1;TFB1M;METTL1;METTL8;PCIF1;MTO1;FBLL1;TRMT61B;ZC3H13;TRMT61A;FBL;ZCCHC4;BUD23;NSUN4;METTL16
prerank,GO_Biological_Process_2021__regulation of myeloid leukocyte mediated immunity (GO:0002886),-0.6298148166631397,-1.0368757551912209,0.49056603773584906,1.0,1.0,1/9,2.65%,BLK
prerank,Reactome_2022__Membrane Trafficking R-HSA-199991,0.333240800096986,1.036656285094931,0.0,0.8609233536523309,1.0,75/539,13.66%,IL7R;CHRM2;RAB27A;TBC1D10A;KIFC1;SNX18;GJB6;TOR1B;APOB;PACSIN2;HIP1;RAB31;TBC1D16;KIAA0319;SPTBN4;KIFC2;RIN2;BIN1;GOLIM4;ACBD3;SNX5;STX5;ARRB2;RAB7A;STX6;RIN1;RHOBTB3;GOLGA4;CCZ1B;GALNT1;BICD1;REXO2;MAN1A2;TRAPPC1;SEC24C;TRAPPC12;SEC22A;CNIH3;MVB12A;DYNC1I2;RALA;MAN2A1;SYT1;TGFA;STX18;CHMP6;UBAP1;GCC2;AKT2;RALGAPA2;GGA1;DENND1B;LDLR;TMED3;DENND2A;SH3KBP1;BET1;SYT12;RAB35;RAB27B;KIF6;VPS54;SGIP1;TBC1D4;MAN1A1;VTI1A;KIF4B;FNBP1;PREB;SNX9;SNAP91;COG7;ARPC3;ARRB1;RAB10
prerank,GO_Biological_Process_2021__postsynaptic density protein 95 clustering (GO:0097119),0.6806173935302817,1.0366544110450202,0.475,0.8605318468976003,1.0,2/5,15.58%,NLGN1;NRXN1
prerank,GO_Biological_Process_2021__deoxyribonucleotide metabolic process (GO:0009262),0.6646753372346477,1.0366306171566175,0.4583333333333333,0.8602155039112983,1.0,2/5,21.59%,SAMHD1;RRM2B
prerank,GO_Biological_Process_2021__negative regulation of lipid metabolic process (GO:0045833),-0.545068764272196,-1.0365245588886483,0.45454545454545453,1.0,1.0,3/13,12.51%,GPER1;CEACAM1;APOD
prerank,GO_Biological_Process_2021__positive regulation of toll-like receptor 3 signaling pathway (GO:0034141),-0.6200903512289557,-1.0362614213071588,0.4418604651162791,1.0,1.0,2/5,24.64%,F2RL1;FLOT1
prerank,GO_Biological_Process_2021__tRNA modification (GO:0006400),0.37342801504924367,1.0361237147716362,0.3333333333333333,0.8612861636948312,1.0,24/62,29.49%,TRDMT1;METTL1;PUS10;CTU1;TRMT9B;MTO1;TRMT61B;PUS7;CDKAL1;TRMT61A;ANKRD16;DTWD1;THUMPD1;THG1L;NSUN2;ADAT2;TRMT1;TPRKB;ELP5;ALKBH8;QTRT1;THADA;QTRT2;PUSL1
prerank,Reactome_2022__Cristae Formation R-HSA-8949613,-0.5058586168544366,-1.03595474707568,0.4393939393939394,1.0,1.0,6/26,22.78%,ATP5F1E;ATP5MC3;ATP5PF;ATP5ME;ATP5PB;ATP5F1A
prerank,Reactome_2022__Signaling By ALK Fusions And Activated Point Mutants R-HSA-9725370,0.4298822306904049,1.0358076025700023,0.3333333333333333,0.8618666443659198,1.0,17/52,22.77%,IRS1;HIP1;BCL2A1;BCL11A;EIF2AK3;PPFIBP1;GCC2;TPM4;MECP2;PIK3CA;RANBP2;VCL;TFG;TPM3;CUL1;TPR;SEC31A
prerank,GO_Biological_Process_2021__polyphosphate metabolic process (GO:0006797),0.669739044919908,1.0356820489478025,0.5789473684210527,0.8618014100247143,1.0,4/6,33.00%,BNIP2;BNIPL;MINPP1;PRUNE2
prerank,KEGG_2021_Human__Wnt signaling pathway,0.3632507588100232,1.035652999743975,0.3684210526315789,0.8615054302510876,1.0,23/144,8.91%,LGR5;BAMBI;RSPO3;CCN4;GPC4;PRICKLE1;NFATC3;PRICKLE3;TLE2;WNT4;FZD5;VANGL1;CXXC4;WNT9A;NKD1;CCND3;PLCB1;RSPO2;MAPK8;FZD1;MYC;LRP6;WNT3A
prerank,CellMarker_Augmented_2021__Mesenchymal Stem cell:Corneal Endothelium,0.3786092647370796,1.0356203746911488,0.4375,0.8611554365973847,1.0,21/87,11.33%,COL8A1;TPM2;EMP1;CLMP;VEGFC;ARSJ;TWIST2;ADAMTS12;MMP2;SERPINE1;PKD2;CAPN2;LGALS1;TIMP1;FLNA;ANTXR2;CRIM1;TPM4;F2R;TWSG1;MSRB3
prerank,GO_Biological_Process_2021__chloride transmembrane transport (GO:1902476),0.39652956642726617,1.0355753686655171,0.4230769230769231,0.860860017990111,1.0,10/47,12.59%,GABRE;GABRA5;GABRR2;SLC12A1;GABRG3;ANO5;SLC12A9;GABRG1;ANO7;ANO4
prerank,GO_Biological_Process_2021__regulation of phosphorylation (GO:0042325),0.3860238557127266,1.035546921341576,0.39285714285714285,0.8605784253812482,1.0,11/112,10.02%,GCK;NUP210;HSPB1;CDH5;NUP42;SIRT1;DSCAM;FER;PML;BTBD10;AAAS
prerank,GO_Biological_Process_2021__regulation of podosome assembly (GO:0071801),-0.6611143725109425,-1.0354636807157218,0.46938775510204084,1.0,1.0,4/8,19.69%,HCK;LCP1;IL5;KIF9
prerank,GO_Biological_Process_2021__negative regulation of membrane protein ectodomain proteolysis (GO:0051045),-0.6710423350366679,-1.0354338774623613,0.5,1.0,1.0,2/6,9.20%,TIMP3;TIMP4
prerank,GO_Biological_Process_2021__regulation of transposition (GO:0010528),0.5215594304543753,1.0353162784336127,0.3783783783783784,0.8607781890679533,1.0,4/15,14.43%,SMYD5;SIRT7;PIWIL1;TEX15
prerank,CellMarker_Augmented_2021__Effector Regulatory T (Treg) cell:Peripheral Blood,-0.43942647511647687,-1.035272435179536,0.43661971830985913,1.0,1.0,15/62,10.28%,GMFG;ITGB2;CYTIP;ARHGAP9;TAGAP;TNFRSF1B;ARHGAP15;DOCK2;GPR183;PARVG;WAS;CD37;TRAF3IP3;MYO1F;PTPRC
prerank,GO_Biological_Process_2021__vasculogenesis (GO:0001570),-0.5132665128138181,-1.0351935150799543,0.4057971014492754,1.0,1.0,3/22,14.16%,TGFB1;ENG;HEY2
prerank,GO_Biological_Process_2021__negative regulation of microglial cell activation (GO:1903979),-0.633746223861167,-1.0351659373903714,0.4393939393939394,1.0,1.0,3/7,15.82%,TAFA3;PTPRC;GRN
prerank,GO_Biological_Process_2021__fibrinolysis (GO:0042730),-0.5939131634689367,-1.035137913509572,0.4576271186440678,1.0,1.0,5/9,13.43%,GP1BA;PLAU;CPB2;PLG;PLAT
prerank,GO_Biological_Process_2021__benzene-containing compound metabolic process (GO:0042537),0.5696171416871978,1.0351311096129512,0.4888888888888889,0.8608964958171095,1.0,4/8,20.00%,KYAT1;AADAT;ACSM1;KYAT3
prerank,CellMarker_Augmented_2021__Natural Killer cell:Lymph Node,0.409261054142941,1.0351283212631215,0.43333333333333335,0.8605069498914004,1.0,9/64,5.07%,GPRIN3;RASSF2;KLRD1;SEZ6L;CD247;AOAH;CX3CR1;ZEB2;BACH2
prerank,GO_Biological_Process_2021__protein sulfation (GO:0006477),0.6198804093440793,1.0350925576068681,0.4375,0.8602327932884958,1.0,2/5,7.81%,HS3ST5;UST
prerank,GO_Biological_Process_2021__glycolipid transport (GO:0046836),-0.6830167154014248,-1.035075040171082,0.48333333333333334,1.0,1.0,1/6,8.35%,PSAP
prerank,KEGG_2021_Human__Pathways in cancer,0.31469361043990135,1.0349897055088988,0.1,0.8601550353572677,1.0,56/448,9.84%,IL7R;EGLN3;FOXO1;FGF10;LAMA4;LAMB4;TGFBR1;KIT;VEGFC;LAMA3;BCL2;FGFR1;MITF;RARB;DAPK2;PPARG;WNT4;FGF17;FZD5;MMP2;ERBB2;RALB;GSTM5;JAG1;HES1;WNT9A;DCC;STAT5B;CRK;NCOA3;CDK6;F2;CDK4;PML;ABL1;CCND3;PLCB1;SP1;MAPK8;FZD1;CASP3;EDNRA;ADCY2;GSTO2;MYC;RALA;FGF18;TGFA;LRP6;EPOR;WNT3A;AKT2;ITGA3;FGFR3;KITLG;GSTM2
prerank,GO_Biological_Process_2021__mRNA stabilization (GO:0048255),-0.5083205478414143,-1.0346211860671983,0.37681159420289856,1.0,1.0,5/39,10.72%,TENT5B;BOLL;DAZL;MEIOC;SLC11A1
prerank,CellMarker_Augmented_2021__Natural Killer T (NKT) cell:Peripheral Blood,-0.6355995555041999,-1.0344498833830647,0.45161290322580644,1.0,1.0,3/6,10.28%,KLRB1;FCGR3A;PTPRC
prerank,GO_Biological_Process_2021__negative regulation of apoptotic process (GO:0043066),-0.3849755904389957,-1.0344216929981036,0.45555555555555555,1.0,1.0,49/381,14.99%,CD44;TBX1;CRLF1;CLEC5A;FGF20;KIF14;PRAME;ALOX12;HCK;MMP9;WNT5A;CARD14;BCL2L2;CLCF1;PINK1;DAB2;IL7;IFIT3;FLT4;RNF213;SOD2;BEX3;ANXA1;CCND2;HTR2B;PTRH2;PPT1;THBS1;SMAD6;DNAJA1;COPS5;ATF5;LRP2;CDKN2D;PRKCH;WFS1;TAF9B;CFL1;NAA38;CD27;TEK;FOXB1;VDAC1;ITGA5;LEF1;TGFB3;NR1H4;GATA4;DDX3X
prerank,GO_Biological_Process_2021__amino acid transmembrane transport (GO:0003333),0.43323548210377455,1.0344035166453478,0.25806451612903225,0.8614565435472759,1.0,9/42,11.59%,SLC38A5;SLC3A2;SLC7A9;SFXN2;SLC6A20;SLC7A11;SLC7A6;SLC7A8;SLC25A12
prerank,CellMarker_Augmented_2021__Stem cell:Molar,0.37873284445704586,1.034348637774399,0.2916666666666667,0.8612566643396676,1.0,15/86,9.01%,TPM2;EMP1;MXRA5;CLMP;VEGFC;MRGPRF;TWIST2;COL12A1;SSC5D;ADAMTS12;MMP2;SERPINE1;ECM1;IGFBP4;SNAI2
prerank,CellMarker_Augmented_2021__Idiopathic Pulmonary Fibrosis cell:Lung,-0.6107816547948877,-1.0342835642429196,0.4098360655737705,1.0,1.0,2/10,7.28%,COL1A1;MUC5B
prerank,KEGG_2021_Human__Tyrosine metabolism,-0.5171853617396511,-1.0342173951315103,0.4411764705882353,1.0,1.0,1/25,0.42%,DBH
prerank,GO_Biological_Process_2021__negative regulation of lyase activity (GO:0051350),0.5249540749123243,1.0341583970923924,0.36585365853658536,0.8614014532408737,1.0,3/13,12.22%,GRM3;GRM2;ADGRV1
prerank,GO_Biological_Process_2021__hyperosmotic response (GO:0006972),0.6473132877718586,1.0340432973245772,0.5217391304347826,0.8613233082932974,1.0,1/5,8.86%,ICOSLG
prerank,Reactome_2022__Activated NOTCH1 Transmits Signal To Nucleus R-HSA-2122948,0.44584397700538586,1.034020254795229,0.40625,0.861002285468805,1.0,11/28,22.85%,DTX1;JAG1;ARRB2;NUMB;ARRB1;NOTCH1;MIB2;ADAM10;CNTN1;JAG2;MIB1
prerank,GO_Biological_Process_2021__negative regulation of protein kinase B signaling (GO:0051898),0.44019167843119045,1.0339555936666767,0.42105263157894735,0.8607962260106421,1.0,4/35,5.58%,THEM4;SIRT1;ARRB2;MAGI2
prerank,GO_Biological_Process_2021__negative regulation of hemostasis (GO:1900047),0.5948350659285457,1.0338293123291684,0.42424242424242425,0.8607589143600054,1.0,3/11,5.25%,APOH;APOE;SERPINE1
prerank,GO_Biological_Process_2021__intermediate filament organization (GO:0045109),-0.5715027904242389,-1.0333885351355927,0.4838709677419355,1.0,1.0,1/12,1.00%,PKP2
prerank,CellMarker_Augmented_2021__Primordial Germ cell:Germ,0.4079437033226174,1.0333760256514444,0.43478260869565216,0.8616449404575204,1.0,16/78,10.44%,PCDH15;VWC2L;SLC17A6;ZNF804B;GRM3;CNTN5;KCNC2;OPN5;PAK5;ERC2;RALYL;TEX26;CELF4;GRM7;GABRG1;NXPH1
prerank,GO_Biological_Process_2021__response to forskolin (GO:1904321),-0.5924366578027194,-1.0333010930810953,0.4918032786885246,1.0,1.0,1/9,1.39%,AHR
prerank,GO_Biological_Process_2021__cellular response to forskolin (GO:1904322),-0.5924366578027194,-1.0333010930810953,0.4918032786885246,1.0,1.0,1/9,1.39%,AHR
prerank,"GO_Biological_Process_2021__positive regulation of DNA damage response, signal transduction by p53 class mediator (GO:0043517)",0.5368589296616645,1.0332649739591813,0.4090909090909091,0.8615601253914756,1.0,6/11,18.39%,SPRED3;PYHIN1;SPRED2;SPRED1;ATM;ATR
prerank,GO_Biological_Process_2021__protein deneddylation (GO:0000338),-0.6202572239045365,-1.033255396893947,0.4864864864864865,1.0,1.0,4/10,24.30%,COPS5;COPS4;TOR1A;COPS7A
prerank,Reactome_2022__Metabolism Of Cofactors R-HSA-8978934,0.46716052607782266,1.033193180675814,0.3333333333333333,0.8613272523038584,1.0,5/19,17.97%,DHFR;NANOS3;PDSS2;COQ2;COQ9
prerank,"KEGG_2021_Human__Glycine, serine and threonine metabolism",-0.4809713144838845,-1.0331650270155026,0.39705882352941174,1.0,1.0,12/35,16.64%,BHMT;GLYCTK;PIPOX;CHDH;DAO;ALAS2;PGAM1;GLDC;SDS;SDSL;GNMT;PGAM2
prerank,PanglaoDB_Augmented_2021__Glomus Cells,0.3495298678327442,1.0330536714824325,0.45454545454545453,0.8613032296147998,1.0,24/122,15.10%,FIBIN;EDIL3;ADGRL2;GPC6;CBS;SLIT2;EDNRA;TENM3;SYNDIG1;ABCC8;GUCY1A2;PDZRN3;CAP2;COL16A1;CHST3;MPDZ;SDC3;RBFOX2;MAP6;MAGI1;ANK2;PRICKLE2;SRRM3;ANTXR1
prerank,Reactome_2022__Defective B3GALT6 Causes EDSP2 And SEMDJL1 R-HSA-4420332,0.5571158083503095,1.0328890322726794,0.34615384615384615,0.8614810482767123,1.0,7/19,11.20%,VCAN;GPC4;SDC4;GPC6;GPC5;CSPG5;SDC3
prerank,GO_Biological_Process_2021__membrane organization (GO:0061024),0.3654016047103694,1.0327176767469763,0.38461538461538464,0.8615645668818719,1.0,26/216,13.66%,IL7R;CTDNEP1;CHRM2;TOR1B;APOB;PACSIN2;HIP1;KIAA0319;BIN1;ARRB2;UBXN2A;SYT1;TGFA;STX18;CHMP6;SPAST;LDLR;SH3KBP1;LPCAT2;SGIP1;FNBP1;CCDC88A;MOSPD3;SNX9;ARPC3;ARRB1
prerank,GO_Biological_Process_2021__regulation of integrin activation (GO:0033623),-0.5552912019302887,-1.032593460627733,0.417910447761194,1.0,1.0,3/14,8.55%,KIF14;CXCL13;SELP
prerank,GO_Biological_Process_2021__protein kinase C-activating G protein-coupled receptor signaling pathway (GO:0007205),0.5554408098159148,1.0325584046741618,0.36585365853658536,0.8616278466060214,1.0,2/11,3.01%,DGKD;PARD3
prerank,GO_Biological_Process_2021__regulation of mitochondrial membrane potential (GO:0051881),0.44094533388940593,1.0325397246798644,0.3103448275862069,0.8612745372241581,1.0,6/38,9.44%,BCL2;PID1;SLC25A33;OPRD1;ABL1;AKT2
prerank,KEGG_2021_Human__AGE-RAGE signaling pathway in diabetic complications,0.36059310534135686,1.0325222565661905,0.375,0.8609618364790096,1.0,13/86,9.44%,FOXO1;NOX4;TGFBR1;VEGFC;BCL2;MMP2;SERPINE1;STAT5B;CDK4;PLCB1;MAPK8;CASP3;AKT2
prerank,GO_Biological_Process_2021__proteasomal ubiquitin-independent protein catabolic process (GO:0010499),-0.5119782702261726,-1.0322893459778293,0.4153846153846154,1.0,1.0,5/17,19.11%,PSMB9;ENC1;PSMA3;PSMA7;PSMB6
prerank,Reactome_2022__Translation Of Structural Proteins R-HSA-9683701,0.4457593024511465,1.0322445728377239,0.3939393939393939,0.8612602296457832,1.0,4/29,6.55%,ST6GALNAC3;PRKCSH;GALNT1;ST3GAL3
prerank,Reactome_2022__Removal Of Flap Intermediate From C-strand R-HSA-174437,-0.5420567017216901,-1.0321647487024532,0.421875,1.0,1.0,2/16,4.30%,TERF2IP;RPA3
prerank,Reactome_2022__SUMOylation R-HSA-2990846,0.35291376450975925,1.031979685568477,0.3793103448275862,0.8614510076033353,1.0,36/153,18.84%,NUP210;MITF;RORA;PHC2;NUP42;PPARG;DNMT1;RNF168;TOP2A;NCOA2;NRIP1;PML;NR4A2;SENP1;AAAS;SCMH1;NR3C2;HDAC1;SMC5;CASP8AP2;NR3C1;THRB;HDAC4;HERC2;ZNF131;NR1H3;TP53;RAD52;PMEPA1;NR2C1;NSMCE2;SATB2;SP3;RANBP2;MDC1;EP300
prerank,GO_Biological_Process_2021__phospholipid metabolic process (GO:0006644),-0.438258463859995,-1.0319533370522709,0.35294117647058826,1.0,1.0,3/62,6.32%,ENPP2;PLAAT4;PLA2G10
prerank,Reactome_2022__NR1H2 And NR1H3 Regulate Gene Expression To Limit Cholesterol Uptake R-HSA-9031525,0.6479606321567144,1.031928830943391,0.5283018867924528,0.8612191228508039,1.0,5/5,35.22%,NR1H3;RXRA;NR1H2;RXRB;MYLIP
prerank,GO_Biological_Process_2021__regulation of chemokine production (GO:0032642),-0.5010990949915662,-1.0318740851893298,0.43333333333333335,1.0,1.0,9/26,20.84%,WNT5A;IL7;TLR2;IL18;ELANE;F2RL1;ALOX15B;CSF1R;AGER
prerank,GO_Biological_Process_2021__aspartate family amino acid catabolic process (GO:0009068),0.513806791281009,1.0318455152743171,0.42105263157894735,0.8610611812194813,1.0,5/17,12.14%,HYKK;AASS;ALDH7A1;AADAT;OGDH
prerank,Reactome_2022__EGFR Interacts With Phospholipase C-gamma R-HSA-212718,0.6634745755955203,1.0315778448443427,0.5581395348837209,0.8613790960138905,1.0,1/5,8.52%,TGFA
prerank,Reactome_2022__SUMO E3 Ligases SUMOylate Target Proteins R-HSA-3108232,0.35120527588040606,1.0315257739296244,0.3870967741935484,0.8611743436912627,1.0,35/148,18.84%,NUP210;MITF;RORA;PHC2;NUP42;PPARG;DNMT1;RNF168;TOP2A;NCOA2;NRIP1;PML;NR4A2;AAAS;SCMH1;NR3C2;HDAC1;SMC5;CASP8AP2;NR3C1;THRB;HDAC4;HERC2;ZNF131;NR1H3;TP53;RAD52;PMEPA1;NR2C1;NSMCE2;SATB2;SP3;RANBP2;MDC1;EP300
prerank,Reactome_2022__Insulin Receptor Recycling R-HSA-77387,0.45381806687128307,1.0314874442381683,0.375,0.8609229150868316,1.0,2/22,1.86%,ATP6V0D2;TCIRG1
prerank,GO_Biological_Process_2021__neurotransmitter transport (GO:0006836),-0.44689839518682395,-1.031447474378533,0.4084507042253521,1.0,1.0,2/65,2.41%,SLC28A2;GAD1
prerank,Reactome_2022__Interleukin-10 Signaling R-HSA-6783783,-0.5528857750655439,-1.0313792858805682,0.38333333333333336,1.0,1.0,8/20,20.41%,TNFRSF1B;PTAFR;FPR1;IL12A;CD80;IL18;IL10RB;CD86
prerank,CellMarker_Augmented_2021__Regulatory T (Treg) cell:Undefined,-0.5148738973907998,-1.031286852776717,0.4520547945205479,1.0,1.0,5/23,16.84%,TGFB1;ADA;CD4;SMAD3;NT5E
prerank,GO_Biological_Process_2021__regulation of reactive oxygen species metabolic process (GO:2000377),-0.45051132019995377,-1.031177018185709,0.4788732394366197,1.0,1.0,14/52,17.63%,FOXM1;CYP1B1;ALOX5;PINK1;EIF6;BRCA1;STK17A;THBS1;UCP1;CDKN1A;AGT;RAC2;RAC1;ROMO1
prerank,GO_Biological_Process_2021__positive regulation of nitrogen compound metabolic process (GO:0051173),0.53711128774879,1.031039945325214,0.36363636363636365,0.8617088506623257,1.0,3/15,14.09%,TMEM106A;MAPK8;NFKB1
prerank,GO_Biological_Process_2021__mesodermal cell differentiation (GO:0048333),0.6334912016780909,1.0310205874729717,0.47619047619047616,0.8613503962286625,1.0,3/8,12.90%,ITGA8;ITGA3;ITGB4
prerank,Reactome_2022__Regulation Of RUNX3 Expression And Activity R-HSA-8941858,-0.4578151233317108,-1.0310191810553029,0.37142857142857144,1.0,1.0,2/48,1.49%,PSMB9;TGFB1
prerank,GO_Biological_Process_2021__regulation of nucleotide-binding oligomerization domain containing signaling pathway (GO:0070424),0.6153307335586206,1.0308200778378003,0.5111111111111111,0.8614201175902574,1.0,3/5,34.60%,SLC15A4;XIAP;SLC15A2
prerank,Reactome_2022__Dectin-2 Family R-HSA-5621480,-0.5480485042600731,-1.0307910043960369,0.46774193548387094,1.0,1.0,6/17,18.18%,CLEC4C;MUCL1;MUC5B;MUC4;MUC17;MUC15
prerank,GO_Biological_Process_2021__cellular macromolecule biosynthetic process (GO:0034645),-0.3861028324314532,-1.0307474143700037,0.3626373626373626,1.0,1.0,98/283,27.27%,TICRR;MCM2;RPL37A;DONSON;PCLAF;RPA3;MCM3;BRCA1;GRWD1;RPL38;RPL15;ALAS2;TERT;PIF1;COPS5;WARS1;RPS4X;RPL3;RPL35A;RAD1;RPS9;RPS27;EEF2;GCNT1;POLE2;RPS21;RPL13A;YARS2;RPL27A;RPS16;RPL36;RPS20;RPL7A;RPL9;ABCF1;RPL13;RPS8;RPS27A;RPL21;CDC6;RPL34;MRPL34;RPL4;RPL32;INHA;RPL5;RECQL4;RPL23;RPL41;RPS7;RPS11;SET;RPL27;RPL35;RPS14;RMI1;RPL11;ORC6;TOPBP1;POLE3;ASMT;DRG1;RPA2;RPS15;PTMS;RPLP1;BLM;RPS12;RPL24;RAD9B;POLR2B;RPL18A;RPS13;RPL29;RPLP2;PTMA;CDC7;RPL28;RPL12;IGF2BP3;CHEK1;GAL3ST4;RPL18;RPS3;RPL22;EEF1A1;RPSA;RMI2;RPS28;MCM5;RPS19;RPS24;RPS3A;RPL19;CREBL2;RPL8;RPS6;RPL10
prerank,GO_Biological_Process_2021__regulation of cortisol biosynthetic process (GO:2000064),0.5655813373678982,1.0305551216066517,0.3611111111111111,0.8617570669031038,1.0,2/7,6.20%,WNT4;H6PD
prerank,Reactome_2022__Josephin Domain DUBs R-HSA-5689877,-0.5519684456381299,-1.030516776761015,0.46875,1.0,1.0,5/11,33.37%,RPS27A;JOSD2;UBB;UBC;RAD23B
prerank,GO_Biological_Process_2021__membrane depolarization during action potential (GO:0086010),-0.49596053004951535,-1.0304923017473773,0.3870967741935484,1.0,1.0,1/25,1.19%,SCN5A
prerank,Reactome_2022__Cell-cell Junction Organization R-HSA-421270,0.4038433666917096,1.0303068927370826,0.4,0.8620068848244601,1.0,18/49,17.39%,CDH19;CDH12;CDH5;PARD3;CDH13;SDK1;CADM2;CADM1;CDH6;CLDN12;CDH2;CDH24;NECTIN3;CDH10;CDH11;PARD6B;CLDN15;CDH4
prerank,GO_Biological_Process_2021__regulation of osteoclast development (GO:2001204),-0.6774771727460223,-1.0302782636809922,0.5161290322580645,1.0,1.0,2/5,22.73%,ATP6AP1;SIGLEC15
prerank,Reactome_2022__Butyrate Response Factor 1 Binds And Destabilizes mRNA R-HSA-450385,0.49437312752313495,1.030233524177996,0.43902439024390244,0.8618425496822356,1.0,2/16,5.98%,MAPKAPK2;EXOSC1
prerank,Reactome_2022__Activation Of Kainate Receptors Upon Glutamate Binding R-HSA-451326,0.47697997335192976,1.030161050956856,0.40540540540540543,0.8616716878226363,1.0,4/25,7.70%,LLGL1;GRIK1;NCALD;PLCB1
prerank,GO_Biological_Process_2021__myofibril assembly (GO:0030239),-0.4871722944415233,-1.0301556641829412,0.4782608695652174,1.0,1.0,6/34,10.22%,LMOD1;ACTC1;OBSCN;TMOD4;CSRP3;LMOD3
prerank,GO_Biological_Process_2021__embryonic cranial skeleton morphogenesis (GO:0048701),-0.5600375326358689,-1.0298749763011255,0.45901639344262296,1.0,1.0,1/10,0.55%,TBX1
prerank,GO_Biological_Process_2021__regulation of leukocyte migration (GO:0002685),-0.5188753090981892,-1.0297712146148597,0.47761194029850745,1.0,1.0,7/15,21.70%,ANXA1;ZP3;RAC2;RAC1;CD81;BST1;TNFSF18
prerank,GO_Biological_Process_2021__regulation of telomere maintenance via telomerase (GO:0032210),-0.44318720142015444,-1.0297635667717087,0.49230769230769234,1.0,1.0,1/49,0.37%,NEK2
prerank,GO_Biological_Process_2021__negative regulation of protein binding (GO:0032091),-0.4477688214105223,-1.0297253213154167,0.39705882352941174,1.0,1.0,10/63,14.41%,DISC1;LRPAP1;TMC8;DAB2;ZFPM1;CTSZ;CDKN1A;IFIT1;MITD1;EFHB
prerank,PanglaoDB_Augmented_2021__B Cells Memory,-0.43821054734935416,-1.0294973943846841,0.4189189189189189,1.0,1.0,27/86,16.84%,GMFG;AIM2;BLK;CYTIP;TBC1D10C;ZBTB32;ARHGAP9;TAGAP;TMC8;ALOX5;IL7;PARVG;CLCA3P;WAS;LY86;CD37;TRAF3IP3;PTPRC;TMEM156;HVCN1;CXCR5;CD27;CD80;IKZF1;ADAM28;NAPSB;NT5E
prerank,CellMarker_Augmented_2021__Mesenchymal Stromal cell:Nasal Concha,0.6221976217669143,1.0291841102791295,0.4166666666666667,0.8640423775177957,1.0,1/5,3.69%,CD14
prerank,Reactome_2022__SCF(Skp2)-mediated Degradation Of P27/P21 R-HSA-187577,-0.43783089786926843,-1.029167181862088,0.3380281690140845,1.0,1.0,17/53,27.50%,PSMB9;CCND1;CDKN1A;CCNE2;CKS1B;PSMA3;RPS27A;PSMA7;PSMB6;CDKN1B;PSMA5;PSMD6;SKP1;PSMC5;PSMB4;PSMB7;PSMD8
prerank,GO_Biological_Process_2021__embryonic digestive tract morphogenesis (GO:0048557),0.6052579971014732,1.0291099245429298,0.5,0.8638373507930832,1.0,3/5,37.93%,NIPBL;PDGFRA;FGFR2
prerank,Reactome_2022__Chromosome Maintenance R-HSA-73886,-0.4127536407812954,-1.0290655073533599,0.40540540540540543,1.0,1.0,20/96,23.42%,TERF2IP;RPA3;CENPU;ITGB3BP;H2BC4;OIP5;CENPH;TERT;PIF1;CENPS-CORT;H2AZ1;RBBP7;POLD4;CENPN;SMARCA5;CENPL;BLM;NOP10;POLR2B;CENPM
prerank,GO_Biological_Process_2021__semaphorin-plexin signaling pathway involved in neuron projection guidance (GO:1902285),-0.5560341052565988,-1.029038711066757,0.44776119402985076,1.0,1.0,2/12,7.50%,SEMA3F;SEMA3A
prerank,GO_Biological_Process_2021__cellular response to laminar fluid shear stress (GO:0071499),0.629704327882197,1.028541868747253,0.5428571428571428,0.8650520232218846,1.0,2/6,22.74%,SREBF2;NFE2L2
prerank,CellMarker_Augmented_2021__Microglial cell:Undefined,-0.6496322255056015,-1.0285373518081333,0.4339622641509434,1.0,1.0,4/8,11.77%,P2RY12;ADGRE1;PTPRC;ITGAM
prerank,"Reactome_2022__Defective CHST14 Causes EDS, Musculocontractural Type R-HSA-3595174",0.5931177381998611,1.0285020377105063,0.43333333333333335,0.8647334852357634,1.0,2/7,10.78%,VCAN;CSPG5
prerank,GO_Biological_Process_2021__postsynaptic density organization (GO:0097106),0.6008679806865602,1.0284907920953694,0.46153846153846156,0.8643619630533169,1.0,4/8,25.84%,NLGN1;NRXN1;PTEN;NLGN2
prerank,GO_Biological_Process_2021__mitochondrial respiratory chain complex III assembly (GO:0034551),0.5909958736576464,1.028460766149832,0.45454545454545453,0.8636731302038576,1.0,2/8,18.62%,SLC25A33;UQCC3
prerank,GO_Biological_Process_2021__respiratory chain complex III assembly (GO:0017062),0.5909958736576464,1.028460766149832,0.45454545454545453,0.8636731302038576,1.0,2/8,18.62%,SLC25A33;UQCC3
prerank,Reactome_2022__Signaling By FGFR2 R-HSA-5654738,0.3784357328366377,1.0281304091764742,0.37037037037037035,0.8641470721959804,1.0,12/62,17.32%,FGF10;FGF17;HNRNPF;HNRNPH1;ESRP1;FGF18;RBFOX2;TIAL1;GTF2F2;PIK3CA;PTBP1;BRAF
prerank,GO_Biological_Process_2021__endochondral ossification (GO:0001958),0.6039834289205633,1.028093034182206,0.4883720930232558,0.8638296437793648,1.0,4/6,28.25%,FGFR3;COL13A1;BMP4;MEF2C
prerank,Reactome_2022__Transferrin Endocytosis And Recycling R-HSA-917977,0.4441475246952974,1.0279807490972053,0.3793103448275862,0.8637118077144429,1.0,2/28,1.86%,ATP6V0D2;TCIRG1
prerank,Reactome_2022__RNA Polymerase III Transcription Initiation From Type 2 Promoter R-HSA-76066,0.4310486128533663,1.0277203556300547,0.45,0.8640921312012669,1.0,8/26,22.28%,BDP1;GTF3C4;POLR3G;GTF3C5;POLR3D;POLR3K;POLR3B;POLR2F
prerank,CellMarker_Augmented_2021__Intestinal Epithelial Stem cell:Intestine,0.38813344196137206,1.0275904855593712,0.2903225806451613,0.8640539366768865,1.0,21/82,15.43%,DUSP4;MYO10;EMP1;ARSJ;SDC4;PARVA;DCBLD2;SERPINE1;RAI14;PPFIBP1;CRIM1;ITGA3;RND3;CHST3;SPRED1;FJX1;NECTIN3;HRH1;WWTR1;ETV5;SPRY4
prerank,GO_Biological_Process_2021__positive regulation of endothelial cell migration (GO:0010595),0.3760751952224851,1.0274985209134224,0.48148148148148145,0.8639361579136485,1.0,13/77,8.69%,FGFR1;HSPB1;ANGPT1;RIN2;SEMA5A;ANXA3;SIRT1;PROX1;HMGB1;ABL1;SP1;FGF18;NUS1
prerank,"GO_Biological_Process_2021__RNA phosphodiester bond hydrolysis, exonucleolytic (GO:0090503)",0.6281635708052382,1.0274949560574151,0.5098039215686274,0.8635731031946788,1.0,2/5,26.76%,TOE1;XRN1
prerank,GO_Biological_Process_2021__histone mRNA catabolic process (GO:0071044),0.48673089644541456,1.0273730179495717,0.3877551020408163,0.863515302511531,1.0,7/14,33.72%,ATM;TUT7;ERI1;XRN1;TUT4;EXOSC10;TENT4B
prerank,CellMarker_Augmented_2021__Progenitor cell:Prostate,0.3853055273058069,1.0272166298703027,0.3333333333333333,0.8635304393298885,1.0,4/57,3.43%,ADGRF4;LAMA3;SDC4;PERP
prerank,KEGG_2021_Human__Oxytocin signaling pathway,0.3644705624504515,1.0271555251892248,0.3333333333333333,0.8633005082477176,1.0,27/133,20.72%,CD38;ITPR2;NFATC3;CACNG4;TRPM2;CACNB4;KCNJ3;KCNJ6;PLCB1;ADCY2;CACNG2;GUCY1A2;ADCY3;CAMK1G;PLA2G4C;EEF2K;GNAO1;PIK3R5;ADCY6;PPP1CB;PRKAA2;PRKAG2;GNAQ;RAF1;FOS;GNAI2;GNAS
prerank,GO_Biological_Process_2021__regulation of multicellular organism growth (GO:0040014),0.5578315017739579,1.0270728679928407,0.48484848484848486,0.8630906411363797,1.0,3/13,10.61%,MFSD2A;STAT5B;PPIB
prerank,GO_Biological_Process_2021__pteridine-containing compound metabolic process (GO:0042558),-0.5606548656555008,-1.0270187006218772,0.463768115942029,1.0,1.0,3/12,18.26%,FTCD;CALM1;GCHFR
prerank,Reactome_2022__Cooperation Of Prefoldin And TriC/CCT In Actin And Tubulin Folding R-HSA-389958,-0.5139987752169464,-1.0268942486096269,0.43548387096774194,1.0,1.0,14/27,29.61%,TUBA4A;CCT6B;TUBA3D;TUBB;TUBB6;TUBB2A;TUBB4A;TUBB4B;PFDN6;CCT6A;CCT8;CCT7;CCT2;VBP1
prerank,Reactome_2022__Transport Of Mature Transcript To Cytoplasm R-HSA-72202,0.4015475801075168,1.0264430460693543,0.3793103448275862,0.8644095411864393,1.0,25/74,27.98%,CPSF1;NUP210;NUP42;NXT1;NXF1;U2AF1;SRRM1;AAAS;SRSF4;RANBP2;EIF4A3;U2AF2;SYMPK;EIF4E;NUP214;TPR;MAGOHB;SEH1L;THOC1;WDR33;NUP153;RBM8A;NUP98;DDX39A;NUP37
prerank,GO_Biological_Process_2021__regulation of membrane tubulation (GO:1903525),0.6566947876928722,1.0264103507762539,0.4473684210526316,0.8641067689965569,1.0,4/6,30.03%,ATP10A;ASAP1;SH3GLB1;DNM2
prerank,Reactome_2022__SUMOylation Of RNA Binding Proteins R-HSA-4570464,0.41598141116581305,1.0263166180485288,0.4857142857142857,0.8640554971286704,1.0,11/43,23.71%,NUP210;PHC2;NUP42;AAAS;SCMH1;RANBP2;RNF2;NUP214;TPR;SEH1L;NOP58
prerank,GO_Biological_Process_2021__regulation of autophagy (GO:0010506),0.3509478516054263,1.0262566365059271,0.2608695652173913,0.8638456673316277,1.0,56/210,21.78%,ATP6V0D2;IRGM;FOXO1;BCL2;HSPB1;DAPK2;HTRA2;FZD5;IFI16;SNX5;TRIM8;HMGB1;ACER2;ABL1;DHRSX;MAPK8;CASP3;MTMR8;OSBPL7;MLST8;RNF152;ABL2;LEPR;ERN1;TRIM65;PIM2;USP36;DAPL1;TICAM1;TAB3;KLHL22;IL10RA;EXOC7;SNX32;DEPP1;MTMR3;PIP4K2A;NEDD4;ATM;TFEB;ATF6;EP300;CDK5;PRKAA2;SREBF2;TAB2;PRKAG2;MID2;TRIM14;RASIP1;DRAM2;MTDH;RUBCN;EXOC4;NPRL2;EIF4E
prerank,GO_Biological_Process_2021__ncRNA catabolic process (GO:0034661),-0.49977310728783375,-1.0261378120288946,0.5370370370370371,1.0,1.0,2/27,5.36%,ERN2;SLFN14
prerank,GO_Biological_Process_2021__osteoclast differentiation (GO:0030316),-0.5138947841638412,-1.02610331817289,0.4307692307692308,1.0,1.0,4/17,18.74%,GPR183;OSCAR;TNFRSF11A;CSF1R
prerank,GO_Biological_Process_2021__chondroitin sulfate catabolic process (GO:0030207),0.5566406319831853,1.0260830773258915,0.41379310344827586,0.8638540059631473,1.0,3/11,10.78%,VCAN;ARSB;CSPG5
prerank,Reactome_2022__Metabolism Of Amino Acids And Derivatives R-HSA-71291,-0.382393470726742,-1.0260629072511516,0.4,1.0,1.0,73/318,20.62%,SQOR;DBH;DUOX1;PSMB9;BHMT;IYD;VSIG2;SERINC2;RPL37A;ACMSD;INMT;PIPOX;NQO1;FTCD;CHDH;DAO;SLC6A12;AZIN1;RPL38;RPL15;CKB;PDHX;CYP21A2;NAT8L;ARG2;CKMT2;RPS4X;RPL3;TMLHE;RPL35A;HAAO;GLDC;RPS9;FAU;OAZ2;RPS27;UROC1;RPS21;SDSL;RPL13A;PSMA3;SERINC1;RPL27A;GNMT;RPS16;SMOX;RPL36;RPS20;RPL7A;RPL9;SLC6A7;PRODH2;MCCC2;RPS8;RPS27A;RPL21;RPL34;TYR;SERINC3;PSMA7;PSMB6;RPL4;RPL32;RPL5;RPL23;RPL41;RPS7;RPS11;RPL27;RPL35;APIP;RPS14;BBOX1
prerank,GO_Biological_Process_2021__modulation by symbiont of host defense response (GO:0052031),-0.641803413222781,-1.0260558793617731,0.5357142857142857,1.0,1.0,2/7,18.03%,TLR2;RPS27A
prerank,GO_Biological_Process_2021__response to host defenses (GO:0052200),-0.641803413222781,-1.0260558793617731,0.5357142857142857,1.0,1.0,2/7,18.03%,TLR2;RPS27A
prerank,Reactome_2022__Modulation By Mtb Of Host Immune System R-HSA-9637628,-0.641803413222781,-1.0260558793617731,0.5357142857142857,1.0,1.0,2/7,18.03%,TLR2;RPS27A
prerank,GO_Biological_Process_2021__negative regulation of telomere maintenance (GO:0032205),-0.546288417728764,-1.0259942324288491,0.390625,1.0,1.0,1/15,2.96%,TERF2IP
prerank,GO_Biological_Process_2021__negative regulation of amyloid precursor protein catabolic process (GO:1902992),0.4953584277166088,1.0258752899954924,0.3333333333333333,0.8640340057417811,1.0,2/19,3.49%,APOE;BIN1
prerank,GO_Biological_Process_2021__positive regulation of histone H4 acetylation (GO:0090240),0.6018513069361604,1.0258181668635602,0.5116279069767442,0.8638508619894387,1.0,4/6,13.66%,AUTS2;SMARCB1;PIH1D1;ARRB1
prerank,KEGG_2021_Human__Kaposi sarcoma-associated herpesvirus infection,-0.39661469683542094,-1.0257721643632,0.4074074074074074,1.0,1.0,23/147,18.10%,MICB;TCF7;HCK;ANGPT2;CCND1;TCF7L1;STAT1;HLA-A;PIK3R3;GNGT1;CDKN1A;ATG14;PIK3CB;LEF1;GABARAPL1;ITPR3;HLA-F;GABARAPL2;RAC1;PIK3CG;CALM1;RPS27A;NFATC2
prerank,CellMarker_Augmented_2021__Interstitial cell:Dorsolateral Prefrontal Cortex,-0.43218396926137614,-1.0255958076560494,0.45714285714285713,1.0,1.0,9/76,12.25%,PSMB9;APOL1;SP100;FMO4;MPPE1;TAPBPL;GLRX;OAS1;SP110
prerank,GO_Biological_Process_2021__negative regulation of cell migration (GO:0030336),0.37164128121115375,1.025505791247931,0.2692307692307692,0.8642945769223899,1.0,23/118,16.01%,PHLDB2;MITF;SERPINE1;JAG1;MAGI2;SRGAP2;TIMP1;SLIT2;PTPRR;RAP2A;NAV3;KANK1;ADIPOR1;EVL;DACH1;ARID2;NF1;NEXMIF;ADAM15;PTPN23;PTPRT;TMEFF2;DLG5
prerank,GO_Biological_Process_2021__cellular iron ion homeostasis (GO:0006879),-0.454014545334544,-1.0254475836084258,0.4507042253521127,1.0,1.0,9/46,12.97%,HAMP;NUBP1;ATP6AP1;ABCG2;CP;ALAS2;SLC11A1;FTH1;FRRS1
prerank,GO_Biological_Process_2021__regulation of metallopeptidase activity (GO:1905048),0.6171603956657,1.0254336108842186,0.4807692307692308,0.8640587285209549,1.0,1/6,6.75%,TIMP1
prerank,Reactome_2022__Acrosome Reaction And Sperm:Oocyte Membrane Binding R-HSA-1300645,-0.6850559967461762,-1.0253845165819107,0.5166666666666667,1.0,1.0,1/5,9.85%,IZUMO1
prerank,GO_Biological_Process_2021__carboxylic acid metabolic process (GO:0019752),0.4428186974895229,1.0253419003375908,0.4411764705882353,0.8639351349202568,1.0,6/33,8.06%,CYP1A2;CSGALNACT1;CARNMT1;CYP2S1;GSTO2;GLUD1
prerank,GO_Biological_Process_2021__mRNA 3'-end processing by stem-loop binding and cleavage (GO:0006398),-0.6924487641491205,-1.0252156637950431,0.52,1.0,1.0,2/5,21.91%,ZNF473;CPSF2
prerank,GO_Biological_Process_2021__positive regulation of trophoblast cell migration (GO:1901165),0.6307088747919867,1.0251870515862376,0.47368421052631576,0.8639565883214376,1.0,4/6,35.01%,AGO2;ACVR1B;APELA;SMURF2
prerank,GO_Biological_Process_2021__'de novo' posttranslational protein folding (GO:0051084),-0.4849247211052579,-1.0251523506605025,0.47619047619047616,1.0,1.0,10/29,24.55%,HSPA1L;HSPA8;HSPE1;SDF2L1;DNAJB1;CHCHD4;HSPA5;ENTPD5;HSPA2;HSPA13
prerank,GO_Biological_Process_2021__histone H3-K4 monomethylation (GO:0097692),0.639218744505632,1.025137799722062,0.45098039215686275,0.8637080297054457,1.0,5/7,33.36%,KMT2C;KMT2B;KMT2A;SETD4;KMT2D
prerank,CellMarker_Augmented_2021__Cardiomyocyte:Pluripotent Stem Cell,-0.4221300292125703,-1.0250773815540797,0.43373493975903615,1.0,1.0,23/78,19.46%,CLEC5A;C1QB;HCK;LPAR1;TGFBI;NID1;ARHGEF40;MS4A4A;OSCAR;VSIG4;PSAP;RHOQ;SPI1;GAS7;TLR2;CD300LF;IFNGR2;HK3;COL8A2;ANPEP;CSF1R;ARHGAP31;TFEC
prerank,PanglaoDB_Augmented_2021__Epiblast Cells,0.3994613001033953,1.0250237102493676,0.42857142857142855,0.8635979181201001,1.0,22/81,16.63%,GRID2;EPHA7;IGDCC3;PLEKHG4B;IL17RD;UNC5D;CNTNAP2;BCL11A;TRIM71;GRM4;LIN28B;NLGN4X;RIMS4;ADAMTS19;CRABP1;MSI1;SYT6;ZNF663P;MYO3A;WNK3;FRAS1;MAGEL2
prerank,CellMarker_Augmented_2021__Responder T cell:Blood,-0.45017621188186346,-1.0249809267859011,0.4507042253521127,1.0,1.0,17/61,10.89%,GMFG;ITGB2;HCK;CYTIP;ARHGAP9;TAGAP;TNFRSF1B;C3AR1;GPR183;PARVG;FCGR3A;LY86;CD37;HLA-DPB1;MYO1F;PTPRC;SPI1
prerank,GO_Biological_Process_2021__positive regulation of lamellipodium assembly (GO:0010592),0.44644107760695384,1.0249606289564208,0.4358974358974359,0.8633760534662853,1.0,7/23,22.12%,AUTS2;WASF2;AVIL;PIK3CA;FSCN1;OCLN;CARMIL2
prerank,GO_Biological_Process_2021__regulation of pathway-restricted SMAD protein phosphorylation (GO:0060393),-0.4513026687047961,-1.0248070536041596,0.4722222222222222,1.0,1.0,9/46,14.43%,TGFB1;NODAL;DAB2;TTK;SMAD6;GDF11;ENG;BMP3;TGFB3
prerank,GO_Biological_Process_2021__regulation of inclusion body assembly (GO:0090083),0.558936619655727,1.0247427329381111,0.42857142857142855,0.863588433819726,1.0,3/9,16.02%,SNCAIP;HSPA1A;SACS
prerank,CellMarker_Augmented_2021__Radial Glial cell:Undefined,0.5897575058447345,1.0245299806410775,0.4418604651162791,0.8638532165476873,1.0,4/10,19.41%,HES1;CDH2;PAX6;SLC1A3
prerank,Reactome_2022__Other Interleukin Signaling R-HSA-449836,0.49098989824318906,1.0244656818567421,0.5,0.8636512442994291,1.0,4/19,11.76%,IL16;PTPRZ1;CASP3;TXLNA
prerank,GO_Biological_Process_2021__gastrulation (GO:0007369),-0.5629521000435356,-1.0244403415183085,0.48214285714285715,1.0,1.0,2/12,8.55%,WNT8B;GPC3
prerank,GO_Biological_Process_2021__tRNA export from nucleus (GO:0006409),0.4726364937848867,1.0243896005627329,0.4,0.8630377524457509,1.0,11/33,27.98%,NUP210;NUP42;AAAS;RANBP2;NUP214;TPR;SEH1L;XPOT;NUP153;NUP98;NUP37
prerank,GO_Biological_Process_2021__tRNA-containing ribonucleoprotein complex export from nucleus (GO:0071431),0.4726364937848867,1.0243896005627329,0.4,0.8630377524457509,1.0,11/33,27.98%,NUP210;NUP42;AAAS;RANBP2;NUP214;TPR;SEH1L;XPOT;NUP153;NUP98;NUP37
prerank,GO_Biological_Process_2021__iron ion transport (GO:0006826),0.3690939830912654,1.0242690688841227,0.32,0.8630463905664868,1.0,3/45,4.24%,ATP6V0D2;TCIRG1;REP15
prerank,GO_Biological_Process_2021__digestive tract morphogenesis (GO:0048546),0.5801341865349884,1.0242599631285196,0.46,0.8626877050431864,1.0,4/8,37.93%,NIPBL;EPHB3;PDGFRA;FGFR2
prerank,GO_Biological_Process_2021__regulation of stress-activated protein kinase signaling cascade (GO:0070302),0.5507048220197117,1.024190537629053,0.55,0.8624342353399019,1.0,1/10,7.18%,GREM1
prerank,GO_Biological_Process_2021__cellular response to amyloid-beta (GO:1904646),0.47051046131737734,1.024142920323095,0.38095238095238093,0.862141666869894,1.0,9/26,29.44%,ITGA4;GRIN1;ABCC1;GRM5;CDK5;CACNA1A;FYN;CACNB1;EPHA4
prerank,GO_Biological_Process_2021__positive regulation of isomerase activity (GO:0010912),-0.6384225496550952,-1.023874306841101,0.4838709677419355,1.0,1.0,2/7,11.77%,ITGB2;ITGAM
prerank,GO_Biological_Process_2021__negative regulation of release of sequestered calcium ion into cytosol (GO:0051280),-0.5960255210856207,-1.0237364387142671,0.48484848484848486,1.0,1.0,2/10,6.40%,CASQ2;TRDN
prerank,GO_Biological_Process_2021__negative regulation of ryanodine-sensitive calcium-release channel activity (GO:0060315),-0.5960255210856207,-1.0237364387142671,0.48484848484848486,1.0,1.0,2/10,6.40%,CASQ2;TRDN
prerank,Reactome_2022__Orexin And Neuropeptides FF And QRFP Bind To Their Respective Receptors R-HSA-389397,-0.6365670556070117,-1.0236752737934114,0.5555555555555556,1.0,1.0,1/6,1.36%,NPFFR1
prerank,Reactome_2022__RAC3 GTPase Cycle R-HSA-9013423,0.3962752774177356,1.0236251086162118,0.375,0.8632446324117639,1.0,17/83,16.10%,VANGL1;JAG1;RAB7A;SRGAP2;VRK2;NCOA3;RAPGEF1;PGRMC2;ABL2;NHS;PKN2;ARHGAP42;WASF2;ARHGAP21;ARHGAP35;VAV2;AMIGO2
prerank,GO_Biological_Process_2021__neural crest cell differentiation (GO:0014033),0.5015554205371296,1.0235628021086633,0.45454545454545453,0.8629977994928911,1.0,5/15,13.21%,TCOF1;NRG1;LRP6;SNAI2;CDH2
prerank,GO_Biological_Process_2021__regulation of execution phase of apoptosis (GO:1900117),0.5908555549913694,1.0234424755895588,0.43902439024390244,0.8629278939900733,1.0,7/11,27.83%,TP53;PTGIS;FAP;DFFA;BCL2L1;DLC1;FZD3
prerank,Reactome_2022__Phospholipase C-mediated Cascade; FGFR4 R-HSA-5654228,-0.5611701224545863,-1.0234348350814044,0.43548387096774194,1.0,1.0,1/11,0.93%,FGF20
prerank,GO_Biological_Process_2021__reelin-mediated signaling pathway (GO:0038026),0.6344378372123259,1.0231989414338993,0.5531914893617021,0.8632440280494456,1.0,1/5,13.60%,LRP8
prerank,KEGG_2021_Human__Tryptophan metabolism,0.42993743144020286,1.0231042244123139,0.34146341463414637,0.8630629105193458,1.0,9/39,9.39%,CYP1A2;TDO2;ALDH7A1;TPH1;DHTKD1;KYAT1;ECHS1;AADAT;AANAT
prerank,GO_Biological_Process_2021__skin development (GO:0043588),-0.44962179451340023,-1.022800257627773,0.3787878787878788,1.0,1.0,10/54,8.67%,FLG;ALOX12;WNT5A;FLG2;CLDN1;COL1A1;COL5A1;ALOX12B;HRNR;ANXA1
prerank,GO_Biological_Process_2021__regulation of blood-brain barrier permeability (GO:1905603),0.5737764269779444,1.0227045715489258,0.40476190476190477,0.8639473667110809,1.0,1/7,2.81%,ANGPT1
prerank,GO_Biological_Process_2021__central nervous system development (GO:0007417),0.3395075074496974,1.0226160613972495,0.3125,0.8638314345970478,1.0,50/225,19.70%,VCAN;KLHL17;POU6F2;ROBO2;ADGRL2;EPHA7;MFSD2A;DSCAML1;DNAJC30;IL1RAPL2;PITPNM1;CX3CR1;ATXN1;CNTNAP2;SOX12;GRIK1;SLC8A3;PKD2;JHY;PROX1;PTPRZ1;MAST1;NR4A2;SLC6A17;SNTG2;GRIN1;RPS6KA3;BPTF;NFIB;CDH2;UTP3;CHST8;NF1;SMG9;RPS6KA6;CNTN6;AMIGO2;MDGA1;LIG4;PBX1;ATN1;PAX6;NIPBL;MACROH2A2;S100B;GBA2;PTCH1;CDK5;SH3GL1;NRCAM
prerank,GO_Biological_Process_2021__MyD88-dependent toll-like receptor signaling pathway (GO:0002755),0.44587979361549007,1.022494072288837,0.40625,0.863852745978281,1.0,8/24,22.67%,CD14;MAP3K1;TAB3;IRAK4;TAB1;TAB2;TRAF6;TLR5
prerank,"GO_Biological_Process_2021__DNA-templated transcription, elongation (GO:0006354)",0.39437747850441573,1.0224878270386712,0.42424242424242425,0.8634889023462131,1.0,9/64,18.01%,ELOF1;IWS1;ELP4;ELOA;CCNH;MLLT3;GTF2F2;SETD2;ERCC3
prerank,PanglaoDB_Augmented_2021__Principal Cells,-0.4071307732365823,-1.0224269127547991,0.43283582089552236,1.0,1.0,22/95,19.93%,AQP3;SMIM22;TMC4;PTGES;SLC5A1;EPN3;SLCO2A1;MYO5B;AQP4;SOWAHB;ITGB6;TRIM29;TMEM45B;PROM2;SCNN1A;SCNN1G;CAPN13;ADGRG1;SLC44A3;FAM3D;ACE2;CBLC
prerank,GO_Biological_Process_2021__protein import (GO:0017038),0.39497909817331334,1.0224175732318692,0.3076923076923077,0.8632950231816063,1.0,8/80,10.37%,PRICKLE1;APOE;RANBP17;PEX13;GDAP1;NXT1;ABCD3;ABCD2
prerank,GO_Biological_Process_2021__cAMP-mediated signaling (GO:0019933),0.4735813105847848,1.022222596654583,0.34375,0.8634600255093688,1.0,6/22,11.24%,ADGRG6;KSR1;PDE7A;ADCY2;CAP2;RIMS2
prerank,GO_Biological_Process_2021__negative regulation of transforming growth factor beta production (GO:0071635),0.5933130413762158,1.0222028501594567,0.5208333333333334,0.8631163862186008,1.0,1/7,1.32%,TSKU
prerank,GO_Biological_Process_2021__receptor catabolic process (GO:0032801),-0.5147049077098023,-1.0221713664777945,0.4492753623188406,1.0,1.0,1/21,1.49%,TGFB1
prerank,CellMarker_Augmented_2021__Cancer Stem-Like cell:Brain,-0.4517887573032462,-1.0217649900063466,0.45454545454545453,1.0,1.0,16/61,14.89%,C1QB;LYVE1;TNFRSF1B;SLCO2B1;DAB2;MS4A4A;ZNF366;VSIG4;SELP;VWF;ENG;FPR3;TEK;GGT5;ADGRF5;KCNE3
prerank,Reactome_2022__MET Activates PTK2 Signaling R-HSA-8874081,0.45091794440707045,1.021747613364988,0.41379310344827586,0.8640437371513786,1.0,2/17,9.59%,LAMA4;ITGA3
prerank,GO_Biological_Process_2021__actin filament organization (GO:0007015),-0.40070649507603484,-1.0216125752558076,0.4605263157894737,1.0,1.0,24/140,17.90%,NRAP;LMOD1;ACTC1;ELMO3;TMOD4;FHOD1;NLRP5;WAS;NEB;MYO1F;MYO5B;ARHGAP12;LMOD3;SVIL;SCIN;VIL1;BAIAP2L1;TTN;LCP1;RAC2;GHRL;RAC1;MYO15A;BAIAP2L2
prerank,GO_Biological_Process_2021__megakaryocyte differentiation (GO:0030219),0.5831119910694912,1.0215714134042952,0.44642857142857145,0.8639737110664416,1.0,1/8,1.53%,KIT
prerank,KEGG_2021_Human__Oxidative phosphorylation,-0.42913610150484344,-1.0214502569519326,0.44871794871794873,1.0,1.0,23/94,16.73%,COX6A1;ATP6V1G2;ATP6V1C2;ATP6V1D;ATP6AP1;ATP5F1E;NDUFS2;COX6C;ATP6V0E2;ATP5MC3;ATP5PF;COX17;COX7A1;NDUFA2;NDUFB4;NDUFC1;COX7C;ATP6V1E1;NDUFA1;NDUFB9;ATP5ME;ATP4A;COX7A2
prerank,GO_Biological_Process_2021__negative regulation of signaling (GO:0023057),-0.575270969849117,-1.0209862962124698,0.5333333333333333,1.0,1.0,2/16,3.51%,HHIP;NLRP12
prerank,Reactome_2022__Glycerophospholipid Biosynthesis R-HSA-1483206,0.35740261737130014,1.0208978245065152,0.37037037037037035,0.8653426088994651,1.0,29/112,18.48%,BCHE;PLD6;SLC44A5;MFSD2A;PITPNM1;CPNE7;PRKCSH;PNPLA3;ABHD3;CHPT1;PGS1;CEPT1;CRLS1;AWAT2;LPCAT2;GPD2;CHKA;GPD1;CPNE6;PLA2G4C;AGPAT5;PLA2G15;ACHE;AGPAT2;LPIN2;LCLAT1;ABHD4;PLA2G5;CPNE1
prerank,GO_Biological_Process_2021__positive regulation of early endosome to late endosome transport (GO:2000643),-0.6057684323346773,-1.0204521428590583,0.4666666666666667,1.0,1.0,2/8,17.52%,DAB2;MSN
prerank,GO_Biological_Process_2021__toll-like receptor 3 signaling pathway (GO:0034138),-0.5824512025826263,-1.020421548492637,0.46551724137931033,1.0,1.0,5/11,19.41%,SCIMP;OAS1;COLEC12;SCARA3;CASP8
prerank,GO_Biological_Process_2021__positive regulation of chromatin binding (GO:0035563),0.6127371253219952,1.0203900978860905,0.4772727272727273,0.8663263521159642,1.0,2/7,10.73%,MED25;ZNF618
prerank,GO_Biological_Process_2021__regulation of DNA methylation (GO:0044030),0.6290518038981272,1.0203743756806898,0.4897959183673469,0.8659757086074606,1.0,3/6,16.55%,MYC;MECP2;MPHOSPH8
prerank,Reactome_2022__Processing Of Capped Intron-Containing Pre-mRNA R-HSA-72203,0.33754541611045874,1.0203512768781493,0.38461538461538464,0.8656643830958509,1.0,56/229,26.04%,CPSF1;NUP210;SNRPN;NUP42;PCF11;HNRNPF;PUF60;NXT1;HNRNPH1;NXF1;TXNL4A;SNRPB;U2AF1;SRRM1;HNRNPL;AAAS;LSM2;ZMAT5;CWC27;SF3B1;CPSF7;SRSF4;GTF2F2;PTBP1;FUS;LSM7;PAPOLA;RANBP2;EIF4A3;U2AF2;SYMPK;SF3B4;CPSF6;LSM6;PPIH;CDC5L;EIF4E;NUP214;LSM8;PDCD7;DDX46;POLR2F;TPR;MAGOHB;SEH1L;SNRNP48;YBX1;THOC1;SNRPF;WDR33;CCAR1;SF1;SNRPA;PPIL6;NUP153;RBM8A
prerank,GO_Biological_Process_2021__dolichol-linked oligosaccharide biosynthetic process (GO:0006488),0.4908146446273548,1.0203345590043524,0.4146341463414634,0.8653208311714815,1.0,3/16,15.03%,NUS1;ALG12;ALG3
prerank,Reactome_2022__SUMOylation Of DNA Replication Proteins R-HSA-4615885,0.42110536272620913,1.0202628530743563,0.4,0.8652179502056465,1.0,4/41,10.02%,NUP210;NUP42;TOP2A;AAAS
prerank,CellMarker_Augmented_2021__Hair Follicle cell:Hair Follicle,-0.4587532844853859,-1.0201858460860476,0.379746835443038,1.0,1.0,15/75,10.59%,CD44;APOL1;CMAHP;ELK3;SP100;IRF1;CIITA;C3AR1;MS4A4A;OAS2;SELP;ERAP2;TAPBPL;GBP1;VWF
prerank,GO_Biological_Process_2021__ventricular septum development (GO:0003281),0.488287487647187,1.0201661719065067,0.42424242424242425,0.8650437274363825,1.0,5/28,7.88%,TGFBR1;ROBO2;HES1;PROX1;SLIT2
prerank,GO_Biological_Process_2021__mRNA catabolic process (GO:0006402),0.44560291208864783,1.019968160682459,0.3793103448275862,0.8651682381573351,1.0,13/42,21.06%,NBDY;RIDA;DXO;ERN1;LSM2;HSPA1A;PNPT1;AGO3;RC3H1;XRN2;METTL16;TUT7;LSM6
prerank,GO_Biological_Process_2021__response to acetylcholine (GO:1905144),-0.6881275762986246,-1.01991411763592,0.5185185185185185,1.0,1.0,2/5,25.02%,CHRNA3;CHRNB2
prerank,Reactome_2022__FOXO-mediated Transcription Of Cell Death Genes R-HSA-9614657,0.5022571865854533,1.0198551982644997,0.3333333333333333,0.8651823431010496,1.0,2/15,2.05%,FOXO1;BCL6
prerank,GO_Biological_Process_2021__negative regulation of mitochondrial fusion (GO:0010637),-0.635037439152487,-1.0196392657671904,0.5,1.0,1.0,2/7,24.34%,BNIP3;ADCK1
prerank,GO_Biological_Process_2021__transforming growth factor beta receptor signaling pathway (GO:0007179),0.37424549284631636,1.0196294406176585,0.35,0.8654299063599485,1.0,15/77,15.63%,BAMBI;TGFBR1;DUSP15;CDH5;PARD3;SIRT1;ARRB2;TWSG1;PXN;FNTA;SMAD2;LTBP2;SMURF1;FURIN;CGN
prerank,GO_Biological_Process_2021__negative regulation of cell communication (GO:0010648),-0.5972474617001096,-1.0195772299874426,0.5737704918032787,1.0,1.0,2/14,3.51%,HHIP;NLRP12
prerank,GO_Biological_Process_2021__negative regulation of transposition (GO:0010529),0.4946841706162936,1.0194302139859264,0.425,0.8656124302631664,1.0,5/20,14.43%,SMYD5;SIRT7;MOV10;PIWIL1;TEX15
prerank,GO_Biological_Process_2021__response to increased oxygen levels (GO:0036296),-0.7011188707022108,-1.0194096880662096,0.5217391304347826,1.0,1.0,1/5,8.37%,ATP6AP1
prerank,GO_Biological_Process_2021__regulation of vascular associated smooth muscle cell apoptotic process (GO:1905459),0.5937818069940709,1.0192653959089366,0.5,0.8657170399630587,1.0,2/7,4.97%,PPARG;DNMT1
prerank,Reactome_2022__RHO GTPases Activate NADPH Oxidases R-HSA-5668599,-0.5137468908497602,-1.0192429286989835,0.43548387096774194,1.0,1.0,9/18,30.71%,CYBA;RAC2;NOX1;PDZD2;NCF2;NOXA1;RNASE1;NOXO1;MAPK3
prerank,PanglaoDB_Augmented_2021__Sertoli Cells,-0.4011984268223294,-1.0192206616875066,0.45569620253164556,1.0,1.0,21/128,19.37%,C1QTNF1;LMOD1;TIMP3;TMEM184A;DOCK6;ACOX2;COL18A1;SLCO2A1;CLU;SLC16A3;WNT6;GPX3;C1S;GATA4;AGT;YAP1;ITGB5;AARD;EPAS1;INHA;ANGPTL4
prerank,GO_Biological_Process_2021__positive regulation of wound healing (GO:0090303),-0.4780570881257491,-1.0188395646796213,0.44594594594594594,1.0,1.0,7/33,10.38%,DUOX1;CLDN1;VTN;ACTG1;ANXA1;THBS1;ENPP4
prerank,GO_Biological_Process_2021__cristae formation (GO:0042407),-0.49839276669418203,-1.0187190008561704,0.3709677419354839,1.0,1.0,6/25,22.78%,ATP5F1E;ATP5MC3;ATP5PF;ATP5ME;ATP5PB;ATP5F1A
prerank,GO_Biological_Process_2021__regulation of keratinocyte proliferation (GO:0010837),0.504749811134201,1.0186592727752772,0.4222222222222222,0.8668708120976609,1.0,2/18,9.01%,FGF10;SNAI2
prerank,Reactome_2022__Glycogen Storage Diseases R-HSA-3229121,0.49805164425844684,1.0185155163036885,0.47368421052631576,0.8669294682727977,1.0,2/13,8.39%,G6PC3;GYS1
prerank,Reactome_2022__rRNA Processing In Nucleus And Cytosol R-HSA-8868773,-0.3900338795296681,-1.0185104115106076,0.45121951219512196,1.0,1.0,68/178,27.12%,RPL37A;RPP38;DIMT1;NOL12;SENP3;RPL38;PWP2;EMG1;RPL15;NOB1;RPS4X;RPL3;RPL35A;GNL3;RPS9;FAU;RPS27;RPS21;RPL13A;RPL27A;RPS16;RPL36;LAS1L;RPS20;RPL7A;RPL9;RPS8;RPS27A;RPL21;WDR12;EXOSC8;RPL34;RPL4;RPL32;RPL5;RPL23;RPL41;RPS7;RPS11;RPL27;RPL35;RPS14;RPL11;RPS15;EXOSC2;RPLP1;RPS12;NOP10;RPL18A;RPS13;RPL29;RPLP2;PDCD11;RPL28;RPL12;RPL18;EBNA1BP2;RPS3;RPL22;RPSA;RPS28;RPS19;RPS24;RPL26L1;RPS3A;RPL19;RPL8;RPS6
prerank,GO_Biological_Process_2021__alpha-beta T cell activation (GO:0046631),-0.6467048791331376,-1.0183751572505007,0.55,1.0,1.0,3/6,9.90%,HLA-A;ANXA1;STOML2
prerank,GO_Biological_Process_2021__positive regulation of nucleic acid-templated transcription (GO:1903508),0.324735392828857,1.0182685824926894,0.3333333333333333,0.8672339818752467,1.0,69/421,14.23%,TEAD2;CD38;BAMBI;POU3F1;ESRRG;FOXO1;FANK1;ZNF496;SKAP1;TGFBR1;MED17;MAFB;MITF;RORA;APOE;SMARCD3;PPARG;CREB3L2;WNT4;PAX3;SNX5;RORB;PYHIN1;LHX2;HES1;LBHD1;KDM8;SEC14L2;PML;NAT14;PLCB1;SP1;FZD1;MYC;LRP6;WNT3A;HIVEP3;TFE3;WBP2NL;CEP290;ARID1A;RNF10;F2R;NPAS3;TRIM44;PPM1A;PIM2;NSD1;SMARCA2;MLXIPL;SMARCA4;USP16;GDF6;RET;BICRAL;MDFIC;KAT6A;NFIB;HDAC1;TESC;RYBP;ZXDC;MED16;FOXF2;SMAD2;NR2F2;RLF;NFKB1;MLLT3
prerank,GO_Biological_Process_2021__microtubule polymerization or depolymerization (GO:0031109),-0.517660645408638,-1.0180652507479953,0.4098360655737705,1.0,1.0,5/24,21.21%,KIF14;STMN4;KIF18A;STMN1;STMND1
prerank,Reactome_2022__N-glycan Trimming And Elongation In cis-Golgi R-HSA-964739,0.620121331498456,1.0180524908908284,0.43902439024390244,0.8674282681849702,1.0,2/5,12.41%,MAN1A2;MAN1A1
prerank,GO_Biological_Process_2021__UV protection (GO:0009650),0.5772125272272752,1.0178617238834926,0.4634146341463415,0.8676547149443815,1.0,2/6,14.37%,SDF4;GPX1
prerank,GO_Biological_Process_2021__plasminogen activation (GO:0031639),0.6356936564860098,1.0177067642078275,0.5,0.8676289136915012,1.0,3/6,6.11%,APOH;KLKB1;F11
prerank,CellMarker_Augmented_2021__Decidual cell:Placenta,0.3767516865839612,1.0176011203351274,0.32432432432432434,0.8675191535371504,1.0,15/71,10.09%,ADRA1B;NGF;ADGRG6;VEGFC;ARSJ;PARVA;DCBLD2;EXT1;SERPINE1;NTN4;F2;IGFBP4;FSTL3;SNAI2;RND3
prerank,Reactome_2022__FGFR3 Ligand Binding And Activation R-HSA-190239,-0.5723141910694047,-1.0175807010523736,0.5555555555555556,1.0,1.0,1/10,0.93%,FGF20
prerank,GO_Biological_Process_2021__regulation of single stranded viral RNA replication via double stranded DNA intermediate (GO:0045091),0.5503913164642437,1.0174594424129026,0.4358974358974359,0.8675321768797596,1.0,3/12,16.55%,TOP2A;RESF1;MPHOSPH8
prerank,GO_Biological_Process_2021__lens fiber cell development (GO:0070307),0.6509140158357302,1.0174190440392268,0.45652173913043476,0.8672289176477292,1.0,1/6,6.26%,PROX1
prerank,GO_Biological_Process_2021__peptidyl-serine phosphorylation (GO:0018105),0.3410610875310357,1.0172618549309682,0.4117647058823529,0.8672678618492268,1.0,38/151,20.19%,TGFBR1;MAPKAPK2;SBK1;VRK2;SGK1;EIF2AK3;LATS1;MAST1;MAST2;MAPK8;MAP3K10;AKT2;ERN1;DYRK3;PKN2;RPS6KA3;STK32C;SGK2;CAMK1G;MAP3K13;MARK3;RPS6KA4;RPS6KA2;RPS6KA6;CLSPN;MAPK12;SMG1;MARK1;ATM;CSNK1G1;MAST4;ATR;MORC3;PNCK;CDK5;PAK2;MARK2;PRKCE
prerank,GO_Biological_Process_2021__vesicle tethering to Golgi (GO:0099041),0.6437231260386637,1.017069618596299,0.5555555555555556,0.8673712620067547,1.0,2/5,24.25%,TRIP11;C17ORF75
prerank,GO_Biological_Process_2021__negative regulation of tumor necrosis factor production (GO:0032720),-0.47299245527537415,-1.0170022943684154,0.47619047619047616,1.0,1.0,6/29,17.55%,ARG2;NLRC3;NR1H4;GHRL;VSIR;CACTIN
prerank,GO_Biological_Process_2021__cytoplasmic sequestering of transcription factor (GO:0042994),0.5038156215795491,1.0169208225627544,0.5,0.8674101113212371,1.0,6/12,30.26%,PKD2;CCDC22;FAF1;SUFU;PSMD10;PKD1
prerank,CellMarker_Augmented_2021__Endothelial cell:Liver,-0.4282787662958464,-1.0168301547329102,0.4696969696969697,1.0,1.0,12/64,18.63%,F8;OIT3;KLHL28;PTPRC;VWF;ENG;DCLRE1C;TSPAN7;CD4;BTNL9;STAB2;CLEC1B
prerank,GO_Biological_Process_2021__regulation of axon extension (GO:0030516),0.45090068479469286,1.016622428112709,0.3333333333333333,0.8677453234913538,1.0,9/35,19.70%,APOE;KIAA0319;GOLGA4;ABL1;MACF1;MAP3K13;DIP2B;LIMK1;NRCAM
prerank,GO_Biological_Process_2021__extrinsic apoptotic signaling pathway via death domain receptors (GO:0008625),0.48078461385654525,1.0166216095340381,0.45714285714285713,0.8673717783671647,1.0,7/24,16.58%,NGF;BCL2;FADD;CRADD;CASP8AP2;BID;ZDHHC3
prerank,GO_Biological_Process_2021__cellular response to sterol depletion (GO:0071501),0.5675233028370411,1.0165894108522955,0.5111111111111111,0.8670822468008759,1.0,6/9,36.03%,SREBF2;ARHGEF10L;ERLIN1;INSIG1;ERLIN2;SCAP
prerank,Reactome_2022__Cell-Cell Communication R-HSA-1500931,0.36155089610987073,1.016452943694493,0.3333333333333333,0.8670246273232539,1.0,30/105,17.39%,LAMA4;CDH19;CDH12;CD151;CDH5;PARD3;CDH13;PARVA;SDK1;CADM2;MAGI2;CADM1;CDH6;FLNA;PLEC;CLDN12;LIMS1;ITGB4;DST;CDH2;CDH24;NECTIN3;CDH10;PIK3CA;CDH11;PARD6B;NCK1;CLDN15;RSU1;CDH4
prerank,Reactome_2022__Processing And Activation Of SUMO R-HSA-3215018,0.5790318754744357,1.0163851927034104,0.5,0.8668319787207516,1.0,4/8,31.31%,SENP1;SENP5;SAE1;SUMO1
prerank,GO_Biological_Process_2021__central nervous system neuron axonogenesis (GO:0021955),0.5563806887339474,1.01637888682679,0.45,0.8664658977546658,1.0,4/12,22.04%,SPTBN4;ARHGAP35;EPHB2;PTEN
prerank,CellMarker_Augmented_2021__Erythroid cell:Umbilical Cord Blood,-0.416448911842777,-1.0162804005110917,0.3670886075949367,1.0,1.0,17/84,22.48%,POLQ;KIF14;GYPE;GYPB;CA1;BRCA1;FRRS1;POLE2;ATAD5;ZGRF1;CEP76;KIF18A;CCDC18;TOPBP1;SDE2;CENPL;ALG10
prerank,GO_Biological_Process_2021__regulation of I-kappaB phosphorylation (GO:1903719),0.6557836857343448,1.0162295314202103,0.46808510638297873,0.8664536048242752,1.0,1/6,4.29%,CX3CR1
prerank,GO_Biological_Process_2021__anterograde trans-synaptic signaling (GO:0098916),0.3395252800469234,1.016190005590317,0.3157894736842105,0.8661393929440392,1.0,37/211,12.71%,GABRE;CHRM2;CEL;GABRA5;NOVA1;GABRR2;NLGN1;GRM3;HTR1F;GALR3;HTR2C;GABRG3;HRH3;DRD5;GRIK1;SNCA;CACNB4;CHRNA10;DTNA;DRD4;APBA3;KCND2;GRIK2;SYT1;LRP6;GRM4;GRM7;GRIN1;PRKAR2A;AKAP9;GABRG1;RPS6KA3;NLGN4X;UNC13B;APBA1;NLGN3;CPNE6
prerank,GO_Biological_Process_2021__calcium ion transmembrane import into cytosol (GO:0097553),0.42869237605167165,1.0161147251564082,0.3870967741935484,0.8659795613724321,1.0,8/37,10.74%,ITPR2;HTR2C;TRPM2;SLC8A1;SLC8A3;PKD2;GRIN1;F2R
prerank,GO_Biological_Process_2021__regulation of systemic arterial blood pressure (GO:0003073),0.5750254553424851,1.0157180011814126,0.4857142857142857,0.8666286004845254,1.0,5/11,30.06%,DDAH1;ACE;BMPR2;PLCB3;GPR37L1
prerank,GO_Biological_Process_2021__regulation of ruffle assembly (GO:1900027),0.44747602355802,1.0157091465659103,0.4634146341463415,0.866263391638108,1.0,8/21,13.00%,NLGN1;DEF8;PLEKHM1;KANK1;ABI3;EVL;EPS8L2;EPS8
prerank,GO_Biological_Process_2021__negative regulation of toll-like receptor signaling pathway (GO:0034122),0.42966378119908144,1.0156657516104142,0.46153846153846156,0.8660267562295306,1.0,8/26,15.37%,CD14;TICAM2;SARM1;NLRP2B;TYRO3;TICAM1;GPR108;MFHAS1
prerank,GO_Biological_Process_2021__protein localization to microtubule plus-end (GO:1904825),0.6524084413740892,1.0156039437345457,0.56,0.8654643881205131,1.0,5/5,34.77%,MAPRE1;MAPRE3;MAPRE2;GAS2L1;GAS2L2
prerank,GO_Biological_Process_2021__protein localization to microtubule end (GO:1905725),0.6524084413740892,1.0156039437345457,0.56,0.8654643881205131,1.0,5/5,34.77%,MAPRE1;MAPRE3;MAPRE2;GAS2L1;GAS2L2
prerank,KEGG_2021_Human__Diabetic cardiomyopathy,-0.3971046447366651,-1.0155963256171703,0.5121951219512195,1.0,1.0,29/153,17.19%,COX6A1;TGFB1;MMP9;SLC25A31;COL1A1;PIK3R3;ATP5F1E;NDUFS2;COX6C;CYBA;ATP5MC3;ATP5PF;COX7A1;PIK3CB;VDAC1;NDUFA2;NDUFB4;TGFB3;NDUFC1;COX7C;NDUFA1;REN;AGT;NDUFB9;SMAD3;RAC2;COX7A2;PLN;RAC1
prerank,GO_Biological_Process_2021__regulation of spindle assembly (GO:0090169),-0.4799245430367428,-1.0155905733563497,0.4852941176470588,1.0,1.0,4/21,21.25%,GPSM2;CHMP3;EML3;DRG1
prerank,GO_Biological_Process_2021__regulation of neurotransmitter receptor activity (GO:0099601),0.36921394384894585,1.0155219804437996,0.4444444444444444,0.8653436847244579,1.0,7/56,10.32%,NLGN1;CACNG4;DLGAP4;CNIH3;CACNG2;GRIN1;AKAP9
prerank,KEGG_2021_Human__Arrhythmogenic right ventricular cardiomyopathy,-0.42419984132610816,-1.0153625612722494,0.44,1.0,1.0,12/71,13.80%,TCF7;PKP2;CTNNA1;CTNNA3;TCF7L1;ACTG1;ITGA9;ACTN3;ITGA2B;ITGB6;ITGA5;LEF1
prerank,GO_Biological_Process_2021__neuron apoptotic process (GO:0051402),0.5023497558103039,1.015291041518536,0.4146341463414634,0.8654407540320961,1.0,5/18,19.39%,BCL2;BID;LIG4;ATN1;CDK5
prerank,GO_Biological_Process_2021__negative regulation of amyloid-beta formation (GO:1902430),0.5053344450950659,1.0152528583747948,0.36585365853658536,0.8651473828146626,1.0,6/17,22.98%,APOE;BIN1;RTN2;ABCA7;NTRK2;RTN1
prerank,Reactome_2022__Glycosphingolipid Metabolism R-HSA-1660662,0.40183930971650156,1.015222785350162,0.3333333333333333,0.8648478658818787,1.0,10/41,11.28%,ESYT3;ARSJ;GLB1L;STS;SMPD4;ARSB;SMPD3;ESYT2;NEU4;GLB1
prerank,Reactome_2022__p38MAPK Events R-HSA-171007,0.5425834331285376,1.0150809272150465,0.5,0.8648363274587691,1.0,3/12,8.31%,MAPKAPK2;RALB;RALA
prerank,GO_Biological_Process_2021__positive regulation of cytokine production involved in immune response (GO:0002720),-0.4663692913997222,-1.0150542887457101,0.4393939393939394,1.0,1.0,7/24,16.13%,WNT5A;SCIMP;CD160;HLA-A;LACC1;HLA-F;F2RL1
prerank,GO_Biological_Process_2021__multinuclear osteoclast differentiation (GO:0072674),-0.6705536429497917,-1.0150092036781453,0.49019607843137253,1.0,1.0,3/5,29.55%,TNFRSF11A;CD81;DCSTAMP
prerank,GO_Biological_Process_2021__regulation of MAPK cascade (GO:0043408),0.3637677410742078,1.0148571999205107,0.38095238095238093,0.8650229230667006,1.0,14/143,7.18%,ADRA1A;ADRA1B;FGF10;KIT;FGFR1;KSR1;EPHA7;CCN1;ERBB2;PAK5;VRK2;TMEM106A;HMGB1;GREM1
prerank,CellMarker_Augmented_2021__Neuroendocrine cell:Pancreas,-0.4177090633542403,-1.0148267979358991,0.484375,1.0,1.0,26/94,26.32%,BEX1;ATP6V1G2;ENO2;TMEM179;PHF21B;TCEAL5;GDF11;TMEM35A;NEFM;SULT4A1;PNMA2;SALL2;CAMKV;NUDT11;PIANP;NEFL;TCEAL2;TMEM59L;TCEAL7;ZCCHC12;USP11;PCDH10;SYT11;NUDT10;CHN1;ADGRB2
prerank,GO_Biological_Process_2021__regulation of pinocytosis (GO:0048548),-0.5672002047743897,-1.0147947841979963,0.45614035087719296,1.0,1.0,3/9,18.95%,PPT1;PROM2;AXL
prerank,CellMarker_Augmented_2021__Muscle cell:Embryoid Body,-0.41925641916532147,-1.01474008799723,0.45714285714285713,1.0,1.0,9/85,6.40%,TRIL;LMOD1;MYH7;CASQ2;ACTC1;ANGPTL2;CTNNA3;FBXL7;TRDN
prerank,Reactome_2022__SLC-mediated Transmembrane Transport R-HSA-425407,-0.38119099749496055,-1.0146515726529957,0.3625,1.0,1.0,34/204,13.81%,SLC28A2;SLC28A1;SLC22A8;SLC22A6;SLC28A3;SLC16A8;SLC7A7;SLC5A2;SLC7A3;SLCO2B1;SLC5A1;SLCO2A1;SLC14A1;SLC5A9;SLC13A4;SLC24A1;SLC6A12;SLC3A1;SLC39A7;SLC5A4;SLC24A5;SLC22A7;CP;SLC9A2;SLC18A2;SLC11A1;SLC16A3;SLC25A18;SLC17A8;APOD;SLC47A2;SLC14A2;NLRP3;SLC22A3
prerank,CellMarker_Augmented_2021__Epithelial Progenitor cell:Corneal Epithelium,0.3529950486127316,1.0146409157642948,0.41379310344827586,0.8641662836891967,1.0,9/93,10.82%,TEAD2;DUSP15;ADGRL2;TBC1D16;ASAP3;PLXNB1;EFS;FGFR3;EBF4
prerank,CellMarker_Augmented_2021__Mesenchymal Stromal cell:Liver,0.3529950486127316,1.0146409157642948,0.41379310344827586,0.8641662836891967,1.0,9/93,10.82%,TEAD2;DUSP15;ADGRL2;TBC1D16;ASAP3;PLXNB1;EFS;FGFR3;EBF4
prerank,CellMarker_Augmented_2021__Epithelial Stem cell:Laryngeal Squamous Epithelium,0.3529950486127316,1.0146409157642948,0.41379310344827586,0.8641662836891967,1.0,9/93,10.82%,TEAD2;DUSP15;ADGRL2;TBC1D16;ASAP3;PLXNB1;EFS;FGFR3;EBF4
prerank,CellMarker_Augmented_2021__Epithelial Stem cell:Corneal Epithelium,0.3529950486127316,1.0146409157642948,0.41379310344827586,0.8641662836891967,1.0,9/93,10.82%,TEAD2;DUSP15;ADGRL2;TBC1D16;ASAP3;PLXNB1;EFS;FGFR3;EBF4
prerank,CellMarker_Augmented_2021__Hemangioblast:Germ,0.5670660203831231,1.0145945470912785,0.4878048780487805,0.8639701183539766,1.0,1/9,2.83%,CDH5
prerank,GO_Biological_Process_2021__negative regulation of protein-containing complex assembly (GO:0031333),-0.4595441650089527,-1.0144966129103947,0.4625,1.0,1.0,12/43,21.55%,KIF14;TMC8;CLU;SMAD6;SVIP;NLRC3;DDX3X;RPL13A;THRA;NOP53;HSPA5;TFIP11
prerank,Reactome_2022__Choline Catabolism R-HSA-6798163,-0.644778227185941,-1.0144610450246372,0.4807692307692308,1.0,1.0,2/6,7.84%,BHMT;CHDH
prerank,GO_Biological_Process_2021__choline catabolic process (GO:0042426),-0.644778227185941,-1.0144610450246372,0.4807692307692308,1.0,1.0,2/6,7.84%,BHMT;CHDH
prerank,GO_Biological_Process_2021__mitochondrial genome maintenance (GO:0000002),0.5660890039318122,1.0143892578440614,0.45454545454545453,0.8641183574265955,1.0,6/12,31.83%,SLC25A33;LONP1;AKT3;MEF2A;MPV17;SLC25A36
prerank,GO_Biological_Process_2021__positive regulation of Notch signaling pathway (GO:0045747),0.44339039990093393,1.0143883072554531,0.3939393939393939,0.8637630783737216,1.0,3/36,5.28%,ROBO2;MAML1;JAG1
prerank,GO_Biological_Process_2021__cellular response to cAMP (GO:0071320),0.41792372081393486,1.0141285999096188,0.34210526315789475,0.8640386660945407,1.0,8/30,13.97%,SLC26A3;PKD2;HCN1;RAPGEF1;AANAT;AKAP9;RAP1A;HCN3
prerank,GO_Biological_Process_2021__glucose metabolic process (GO:0006006),0.3997710308375869,1.0141093927755727,0.34285714285714286,0.8637346563244552,1.0,9/51,11.59%,PER2;FBP2;PC;ENO3;CRY1;G6PC3;SLC25A1;IRS2;SLC25A12
prerank,"GO_Biological_Process_2021__negative regulation of blood coagulation, intrinsic pathway (GO:2000267)",-0.6891806706568302,-1.013987485641097,0.5689655172413793,1.0,1.0,1/5,0.35%,F8
prerank,"GO_Biological_Process_2021__regulation of blood coagulation, intrinsic pathway (GO:2000266)",-0.6891806706568302,-1.013987485641097,0.5689655172413793,1.0,1.0,1/5,0.35%,F8
prerank,GO_Biological_Process_2021__response to ketone (GO:1901654),-0.5143241740019531,-1.013703107415593,0.43636363636363634,1.0,1.0,7/21,17.21%,TGFB1;UBE3A;THBS1;TGFB3;YAP1;WBP2;HSD3B1
prerank,GO_Biological_Process_2021__negative regulation of nucleocytoplasmic transport (GO:0046823),-0.5513355514328424,-1.0134944382547793,0.3898305084745763,1.0,1.0,2/13,12.51%,SP100;APOD
prerank,CellMarker_Augmented_2021__Endocrine cell:Embryonic Stem Cell,-0.42383863430302193,-1.0132977464854316,0.4027777777777778,1.0,1.0,12/74,14.18%,DUOX1;CYYR1;MACC1;RARRES1;B3GNT5;FUT2;GPRIN2;SPINT1;LAMC2;NSUN7;TEK;MUC4
prerank,CellMarker_Augmented_2021__Endocrine cell:Undefined,-0.42383863430302193,-1.0132977464854316,0.4027777777777778,1.0,1.0,12/74,14.18%,DUOX1;CYYR1;MACC1;RARRES1;B3GNT5;FUT2;GPRIN2;SPINT1;LAMC2;NSUN7;TEK;MUC4
prerank,GO_Biological_Process_2021__sulfur compound transport (GO:0072348),-0.48403267978299297,-1.013215098607861,0.38461538461538464,1.0,1.0,3/26,8.58%,MGST1;SLC13A4;ABCG2
prerank,Reactome_2022__Activation Of BH3-only Proteins R-HSA-114452,0.4961508936669118,1.0130636819478247,0.4166666666666667,0.8662692124942698,1.0,7/26,15.44%,BCL2;PPP1R13B;REXO2;MAPK8;AKT2;BID;TP53
prerank,GO_Biological_Process_2021__protein localization to microtubule (GO:0035372),0.638210075235973,1.0130335421422634,0.4878048780487805,0.8660472086304141,1.0,2/8,9.27%,MID1;MAPRE1
prerank,GO_Biological_Process_2021__positive regulation of dendrite morphogenesis (GO:0050775),0.5331883404062712,1.01293072511127,0.45,0.8659716391619828,1.0,6/18,30.46%,LRP8;CUX1;PTPRD;CUL7;DBNL;IL1RAPL1
prerank,GO_Biological_Process_2021__negative regulation of pri-miRNA transcription by RNA polymerase II (GO:1902894),0.5058417223926832,1.012904668860324,0.40540540540540543,0.8656736806394133,1.0,3/13,12.90%,NFATC3;PPARG;NFIB
prerank,PanglaoDB_Augmented_2021__Hepatocytes,-0.38721914591939516,-1.0128675146121033,0.4444444444444444,1.0,1.0,35/139,15.90%,AMBP;AQP3;SLC28A1;AHR;F7;ITIH2;SMLR1;NR1I3;HAMP;ALDOB;SDC2;C3P1;OIT3;PON3;CYP2A6;GPC3;CPB2;CYP3A4;SLC22A7;CP;APOM;PON1;HPR;MASP2;FOXA3;HSD11B1;NOS2;FGL1;HAO2;VDR;NR1H4;CYP2E1;FGFR4;SLC10A1;PRRG4
prerank,GO_Biological_Process_2021__negative regulation of transport (GO:0051051),0.4221979828740517,1.0127673459829722,0.3333333333333333,0.8657063368048662,1.0,16/42,24.06%,SNCA;NRG1;RAB7A;EPHA3;WWP2;PXK;PLSCR1;NR1H3;LGALS3;ABCA7;LRSAM1;PIP4P2;RUBCN;PTEN;CTTNBP2NL;ERBB3
prerank,CellMarker_Augmented_2021__Regulatory T (Treg) cell:Brain,-0.4538600373554098,-1.0126983206061864,0.4411764705882353,1.0,1.0,15/54,10.28%,GMFG;ITGB2;CYTIP;ARHGAP9;TAGAP;TNFRSF1B;GPR183;PARVG;CD5;WAS;LY86;CD37;TRAF3IP3;MYO1F;PTPRC
prerank,"GO_Biological_Process_2021__negative regulation of transcription, DNA-templated (GO:0045892)",0.2979196703749508,1.0126472534318227,0.25,0.8656437090688245,1.0,216/787,21.94%,CD38;SMYD2;FOXO1;PER2;HDAC3;PRICKLE1;ZNF239;BCL6;AASS;MITF;HDAC10;TSHZ3;RARB;ZNF692;TWIST2;MTERF3;URI1;ZBTB7B;KLF10;PCGF1;CIART;CBFB;PHC2;PRDM5;HEXIM2;TGIF1;GATAD2A;ZNF263;TLE2;E2F6;FRK;ATXN1;PPARG;WNT4;SIRT1;IFI16;RORB;ZEB2;SFMBT1;CRY1;SNCA;PER3;SIRT7;HIC2;NRG1;HES1;GFI1B;KCNIP3;BCL11A;PROX1;ZBTB4;HMGB1;ATF3;DLX1;FOXP2;MIER2;OSR1;ZBTB1;IKZF4;ZNF703;MED25;ZNF274;KDM8;NRIP1;PML;WWOX;PLCB1;WWP2;MYC;NKAP;FLNA;TAF3;NR4A2;ZNF688;FOXN3;ZEB1;ZNF202;MAP3K10;TWIST1;SNAI2;SPEN;ZNF133;FHL2;ZNF599;CTBP2;CREM;KDM2A;BPTF;ZNF75A;TIMELESS;PPM1A;DACH1;DPF1;RBFOX2;MYT1L;NSD1;LIMS1;SMARCA2;ZNF846;MLXIPL;SMARCA4;SCMH1;SAP130;ZNF337;MDFIC;KAT6A;DPF2;MXI1;HDAC1;GATAD2B;ASCL1;SMAD2;NR2F2;PLK3;NR3C1;NFKB1;NCOA5;BCOR;MBTD1;CUX1;SCRT1;MECP2;OTUD7B;ZMYND11;THRB;HDAC4;ZNF69;NFIC;SPINDOC;CXXC5;ETV5;MEN1;HSF1;NR1H3;HJV;GADD45A;TP53;HSF4;RUNX1;NR6A1;NR4A3;WWC1;MPHOSPH8;ZGLP1;MAGEL2;NOTCH1;ZBTB2;ARID5B;ATN1;ATF7IP;KLF12;HIVEP1;PA2G4;THAP7;SKI;SP2;ZMYM5;NR2C1;PAX6;ZHX3;ZNF675;ZNF589;NIPBL;ZBTB5;NOC2L;MACROH2A2;ZNF12;RBPJ;SP3;NFX1;YAF2;UXT;ZNF706;IMPACT;SOX13;SIRT6;EP300;SLA2;AEBP1;DPF3;PTCH1;CREB1;KAT6B;CDK5;KHDRBS1;ZNF79;SREBF2;RNF2;BRMS1L;POU2F1;ZNF596;HDAC5;IGBP1;TRAF6;RSF1;JAZF1;PCGF6;TBL1X;ZNF764;ZNF778;HINFP;PRDM16;ZNF785;ZBTB7A;MTDH;NFIX;DLG1;MDM4;RCOR2;BAHD1;BMP4;MLIP;ZNF25;SUV39H2;ZNF268;ZNF3
prerank,Reactome_2022__Recognition Of DNA Damage By PCNA-containing Replication Complex R-HSA-110314,-0.4822547091429553,-1.012329988502488,0.47761194029850745,1.0,1.0,7/30,21.10%,DTL;RPA3;POLE2;RBX1;POLD4;RPS27A;POLE3
prerank,KEGG_2021_Human__Gastric cancer,-0.40539913050708254,-1.0121830423843412,0.38666666666666666,1.0,1.0,24/127,16.15%,TCF7;FGF20;TGFB1;WNT5A;WNT8B;CTNNA1;CCND1;CTNNA3;FZD8;TCF7L1;PIK3R3;FRAT1;TERT;WNT8A;CDKN1A;WNT6;ABCB1;PIK3CB;LEF1;RXRG;TGFB3;FGF22;CCNE2;SMAD3
prerank,Reactome_2022__RNA Polymerase III Transcription Termination R-HSA-73980,0.4563988055973725,1.0121744593303839,0.4857142857142857,0.8665332921309918,1.0,7/21,22.28%,NFIB;POLR3G;POLR3D;POLR3K;POLR3B;NFIX;POLR2F
prerank,Reactome_2022__Formation Of Apoptosome R-HSA-111458,-0.5593312763733498,-1.0121052348769581,0.5084745762711864,1.0,1.0,4/10,25.10%,UACA;CARD8;APIP;APAF1
prerank,GO_Biological_Process_2021__mRNA destabilization (GO:0061157),0.4571009659653893,1.0118990440364537,0.2903225806451613,0.8668510683553017,1.0,10/36,20.81%,DCPS;TRIM71;RIDA;KHSRP;MOV10;YTHDF1;RC3H1;METTL16;RBM24;TUT7
prerank,GO_Biological_Process_2021__membrane protein intracellular domain proteolysis (GO:0031293),-0.5337765194655617,-1.011565714354344,0.4461538461538462,1.0,1.0,1/17,1.49%,TGFB1
prerank,CellMarker_Augmented_2021__Dendritic cell:Undefined,-0.565208952603661,-1.011456434338559,0.4745762711864407,1.0,1.0,9/17,20.41%,CLEC4C;CLU;PTPRC;ITGAM;CD80;ANPEP;CD302;ITGAX;CD86
prerank,Reactome_2022__Signaling By FGFR In Disease R-HSA-1226099,0.3796844558640039,1.0111620459030426,0.43333333333333335,0.8683736190048059,1.0,10/56,14.95%,FGF10;FGFR1;CNTRL;FGF17;STAT5B;FGF18;FGFR3;GTF2F2;CUX1;PIK3CA
prerank,GO_Biological_Process_2021__regulation of DNA recombination at telomere (GO:0072695),-0.5156820919438584,-1.0111341795961524,0.463768115942029,1.0,1.0,1/20,2.96%,TERF2IP
prerank,GO_Biological_Process_2021__negative regulation of DNA recombination at telomere (GO:0048239),-0.5156820919438584,-1.0111341795961524,0.463768115942029,1.0,1.0,1/20,2.96%,TERF2IP
prerank,Reactome_2022__Repression Of WNT Target Genes R-HSA-4641265,-0.5482152069219973,-1.011121438621994,0.484375,1.0,1.0,2/14,5.29%,TCF7;TCF7L1
prerank,GO_Biological_Process_2021__regulation of chemokine (C-C motif) ligand 5 production (GO:0071649),-0.6441027161113111,-1.0111145595462625,0.48,1.0,1.0,1/6,14.99%,DDX3X
prerank,Reactome_2022__Apoptotic Factor-Mediated Response R-HSA-111471,-0.5165505868698566,-1.0109895689739317,0.44642857142857145,1.0,1.0,5/18,20.40%,UACA;GSDME;CASP7;CARD8;APIP
prerank,CellMarker_Augmented_2021__Cardiomyocyte:Embryonic Stem Cell,-0.40727947035431233,-1.010829583564128,0.4375,1.0,1.0,9/93,6.21%,ENPP2;PDCD1LG2;LPAR1;TGFBI;NID1;SDC2;GLIS3;ARHGEF40;DAB2
prerank,CellMarker_Augmented_2021__Cardiac Progenitor cell:Embryonic Stem Cell,-0.40727947035431233,-1.010829583564128,0.4375,1.0,1.0,9/93,6.21%,ENPP2;PDCD1LG2;LPAR1;TGFBI;NID1;SDC2;GLIS3;ARHGEF40;DAB2
prerank,GO_Biological_Process_2021__negative regulation of endopeptidase activity (GO:0010951),-0.46530065462384473,-1.010625444442956,0.43283582089552236,1.0,1.0,11/40,17.92%,TIMP3;SERPIND1;VTN;SERPINB5;SERPINA10;TIMP4;SERPINE3;SPOCK3;AGT;SERPINB7;SERPINF1
prerank,GO_Biological_Process_2021__negative regulation of histone methylation (GO:0031061),0.5163613851500711,1.0105934635715832,0.42857142857142855,0.8694257453625249,1.0,2/12,4.97%,AASS;DNMT1
prerank,Reactome_2022__Nef Mediated CD8 Down-regulation R-HSA-182218,-0.6131198097677011,-1.0105425285083844,0.5,1.0,1.0,1/7,17.98%,CD8B
prerank,PanglaoDB_Augmented_2021__Oligodendrocyte Progenitor Cells,-0.3906386056345033,-1.0102655306106476,0.4520547945205479,1.0,1.0,8/122,10.63%,GPR62;TRIL;SOX10;LRRTM1;TMEM179;TCEAL5;MATN4;AQP4
prerank,GO_Biological_Process_2021__ameboidal-type cell migration (GO:0001667),-0.4643814708219514,-1.010241453079487,0.47297297297297297,1.0,1.0,8/49,9.35%,TBX1;SOX10;PDXDC1;SEMA3F;SEMA3A;GPC3;HTR2B;FAT2
prerank,Reactome_2022__Signal Amplification R-HSA-392518,-0.5052358689574421,-1.0102277347737254,0.47540983606557374,1.0,1.0,7/28,23.05%,P2RY12;GNAT3;GNGT1;PLA2G4A;GNA15;GNG13;GNG12
prerank,GO_Biological_Process_2021__phosphatidylinositol phosphate biosynthetic process (GO:0046854),0.44567469141360083,1.0101277474298516,0.46875,0.8703312303066815,1.0,17/34,24.78%,PI4KB;ITPKB;TMEM150A;PIK3C2B;PI4K2B;PIK3CA;SMG1;PIP4K2A;TTC7B;IP6K1;EFR3B;SLA2;SOCS7;SOCS4;IP6K2;EFR3A;PIK3CD
prerank,GO_Biological_Process_2021__cellular response to iron ion (GO:0071281),-0.6332277120375148,-1.0099976026369857,0.5254237288135594,1.0,1.0,3/5,35.86%,B2M;TFR2;BMP6
prerank,CellMarker_Augmented_2021__Paneth cell:Pyloric Gland,-0.4962694606923119,-1.0099567726002068,0.43478260869565216,1.0,1.0,16/32,19.87%,CLCA1;MEP1B;ALDOB;LRRC19;C17ORF78;RBP2;MS4A8;OLFM4;SPINK4;ADAMDEC1;MUC17;GBA3;LGALS4;ADGRG7;FAM3D;ACE2
prerank,GO_Biological_Process_2021__embryonic digit morphogenesis (GO:0042733),0.5070080396563345,1.0099054642254395,0.4,0.8705581805225134,1.0,3/14,13.17%,OSR1;TWIST1;HDAC1
prerank,GO_Biological_Process_2021__positive regulation of protein binding (GO:0032092),0.41176937448591827,1.009871606437324,0.47368421052631576,0.8702657474574056,1.0,7/53,9.58%,BAMBI;APOE;RIPK2;RALB;ABL1;WNT3A;EPB41
prerank,GO_Biological_Process_2021__regulation of cell communication by electrical coupling involved in cardiac conduction (GO:1901844),-0.6388628995978319,-1.0098691546452447,0.5,1.0,1.0,2/7,18.02%,TRDN;CALM1
prerank,CellMarker_Augmented_2021__Kupffer cell:Liver,-0.6500175914166127,-1.0095161378070492,0.5087719298245614,1.0,1.0,3/6,11.77%,ITGB2;VSIG4;ITGAM
prerank,Reactome_2022__Gap Junction Assembly R-HSA-190861,0.5904484116824155,1.009367546742852,0.5102040816326531,0.8711380833702066,1.0,1/7,1.92%,GJB6
prerank,GO_Biological_Process_2021__myeloid dendritic cell differentiation (GO:0043011),0.5877866217242437,1.0093579473434067,0.5675675675675675,0.870801368685144,1.0,1/6,10.94%,BATF2
prerank,GO_Biological_Process_2021__regulation of cell motility (GO:2000145),-0.40997706027956476,-1.0093091440862225,0.4864864864864865,1.0,1.0,8/109,7.51%,ENPP2;DUOX1;FGF20;KIF14;TGFB1;CAVIN1;CEACAM1;WAS
prerank,Reactome_2022__Activation Of AP-1 Family Of Transcription Factors R-HSA-450341,0.5530773326382643,1.009120475563909,0.4358974358974359,0.8711225900845554,1.0,2/10,20.53%,MAPK8;FOS
prerank,Reactome_2022__RNA Polymerase III Transcription Initiation R-HSA-76046,0.41963337661118527,1.0090177137344332,0.3939393939393939,0.8710390024583143,1.0,10/35,22.28%,BDP1;SNAPC3;GTF3C4;POLR3G;GTF3C5;POLR3D;POLR3K;POU2F1;POLR3B;POLR2F
prerank,GO_Biological_Process_2021__regulation of fertilization (GO:0080154),0.6371822586557709,1.0089429435749344,0.6,0.8708417572745327,1.0,2/5,7.70%,LHFPL2;PLCB1
prerank,CellMarker_Augmented_2021__Epithelial cell:Mammary Epithelium,-0.4125498567185403,-1.0087388781908515,0.45454545454545453,1.0,1.0,9/64,12.97%,SERINC2;MISP;ELMO3;EPN3;SPINT1;GPR39;LAMC2;SOWAHB;BAIAP2L1
prerank,GO_Biological_Process_2021__positive regulation of epithelial cell apoptotic process (GO:1904037),-0.5391188647765744,-1.0084981832121438,0.4714285714285714,1.0,1.0,4/15,9.78%,GPER1;CD160;SFRP4;THBS1
prerank,GO_Biological_Process_2021__regulation of cell adhesion mediated by integrin (GO:0033628),-0.49290608916624945,-1.0084578466280603,0.5,1.0,1.0,4/28,7.11%,P2RY12;CYP1B1;PLAU;ADA
prerank,CellMarker_Augmented_2021__T cell:Lymph Node,-0.6326344649029443,-1.0083709045751317,0.5344827586206896,1.0,1.0,3/5,15.75%,CD5;PTPRC;CD4
prerank,GO_Biological_Process_2021__T-helper 1 type immune response (GO:0042088),-0.6167337824206998,-1.008346015679919,0.4807692307692308,1.0,1.0,4/7,15.16%,HLA-DRB1;IL18BP;LEF1;IL18
prerank,GO_Biological_Process_2021__negative regulation of protein autophosphorylation (GO:0031953),-0.6404715250796412,-1.0083238864352437,0.46774193548387094,1.0,1.0,3/9,19.94%,NLRP12;ENG;MVP
prerank,GO_Biological_Process_2021__regulation of glutamate receptor signaling pathway (GO:1900449),0.6301136814133991,1.0082979931036575,0.5348837209302325,0.8720783115949754,1.0,2/6,27.85%,FRRS1L;FYN
prerank,GO_Biological_Process_2021__negative regulation of reproductive process (GO:2000242),-0.5371881980431011,-1.0079935376361233,0.4714285714285714,1.0,1.0,3/15,16.00%,NODAL;ZP3;SPINK13
prerank,Reactome_2022__GPCR Ligand Binding R-HSA-500792,0.320393525409111,1.0079138442621967,0.3333333333333333,0.8726446551152428,1.0,35/264,9.22%,ADRA1A;TACR3;NTSR2;ADRA1B;CHRM2;CRHR2;GRM3;PLPPR1;HTR1F;GALR3;HTR2C;HRH3;QRFPR;RIPK2;DRD5;CX3CR1;WNT4;OPN5;PROKR2;UTS2R;GRM8;WNT9A;OPRD1;DRD4;RXFP1;S1PR5;NMU;TAS2R8;FZD1;NPW;EDNRA;GRM4;WNT3A;INSL5;GRM2
prerank,GO_Biological_Process_2021__positive regulation of TORC1 signaling (GO:1904263),0.5342855453509536,1.0077164106681054,0.47058823529411764,0.8728319067226449,1.0,5/15,13.33%,SIK3;TELO2;PIH1D1;CLEC16A;KLHL22
prerank,GO_Biological_Process_2021__cellular response to decreased oxygen levels (GO:0036294),0.3796756115715118,1.0077061252366695,0.3333333333333333,0.8724891640480391,1.0,11/58,9.00%,EGLN3;CPEB1;RORA;SIRT1;SLC8A3;HP1BP3;OPRD1;MGARP;KCND2;MYC;TWIST1
prerank,GO_Biological_Process_2021__dicarboxylic acid catabolic process (GO:0043649),-0.5772234503759949,-1.0075754863486395,0.4461538461538462,1.0,1.0,2/13,9.32%,GAD1;ACOT4
prerank,GO_Biological_Process_2021__positive regulation of membrane invagination (GO:1905155),0.574929988591022,1.0074764853539895,0.46,0.8726321889354144,1.0,1/7,3.06%,RAB31
prerank,PanglaoDB_Augmented_2021__T Cells Naive,-0.4726492198641638,-1.007455287968645,0.43478260869565216,1.0,1.0,14/51,10.28%,SIRPG;GMFG;ITGB2;CYTIP;TBC1D10C;ARHGAP9;TAGAP;KLRB1;PARVG;CD5;WAS;CD37;TRAF3IP3;PTPRC
prerank,GO_Biological_Process_2021__SCF complex assembly (GO:0010265),-0.6376956940363538,-1.0074279886567834,0.5964912280701754,1.0,1.0,2/6,15.72%,FBXL7;RBX1
prerank,GO_Biological_Process_2021__regulation of toll-like receptor 9 signaling pathway (GO:0034163),0.5732654952761039,1.0074073030871467,0.5454545454545454,0.8724410734295034,1.0,3/8,25.55%,HMGB1;SLC15A4;RSAD2
prerank,Reactome_2022__Nucleotide Catabolism R-HSA-8956319,0.4489463409797063,1.00737734428139,0.3953488372093023,0.8721556247326119,1.0,9/32,19.66%,NT5C1A;UPP2;NUDT18;NT5C3A;DNPH1;SAMHD1;NUDT5;AGXT2;ENTPD2
prerank,Reactome_2022__Formation Of Editosome R-HSA-75094,-0.6614103715075085,-1.0073305274763285,0.5833333333333334,1.0,1.0,1/5,12.26%,APOBEC4
prerank,GO_Biological_Process_2021__positive regulation of response to external stimulus (GO:0032103),-0.4045192986559296,-1.007272966381839,0.4142857142857143,1.0,1.0,18/94,16.13%,TGFB1;WNT5A;P2RY12;NLRP12;SCIMP;IFNK;LY86;PLG;THBS1;CYBA;USP17L2;TLR2;SH2D1B;IL18;ZP3;AGT;GRN;F2RL1
prerank,GO_Biological_Process_2021__dopaminergic neuron differentiation (GO:0071542),0.5526342213492398,1.0070615212957497,0.5151515151515151,0.8726953177239158,1.0,3/11,14.61%,NR4A2;LRP6;RYK
prerank,GO_Biological_Process_2021__rRNA 3'-end processing (GO:0031125),-0.5800878037562689,-1.0070092952139,0.49122807017543857,1.0,1.0,4/9,22.14%,RPS21;ERI2;EXOSC8;EXOSC2
prerank,Reactome_2022__FGFR3 Mutant Receptor Activation R-HSA-2033514,-0.5836589497064988,-1.0067017409426897,0.5357142857142857,1.0,1.0,1/9,0.93%,FGF20
prerank,Reactome_2022__Interleukin-12 Family Signaling R-HSA-447115,-0.4503502815535535,-1.0064845429136768,0.4305555555555556,1.0,1.0,4/45,9.32%,CRLF1;STAT1;CA1;IL27
prerank,Reactome_2022__Diseases Associated With Visual Transduction R-HSA-2474795,-0.6006719611653828,-1.0062290720554259,0.47540983606557374,1.0,1.0,3/8,24.01%,RDH12;RBP1;ABCA4
prerank,GO_Biological_Process_2021__generation of neurons (GO:0048699),0.3576110416261546,1.0061821055789104,0.42857142857142855,0.874581538578428,1.0,37/148,16.74%,PER2;NEUROD2;FGFR1;POU3F2;KIAA0319;AUTS2;CX3CR1;WNT4;PEX13;FZD5;ATOH7;ERBB2;LHX2;HES1;SH3RF1;WNT9A;CDK6;FZD1;CASP3;NR4A2;SDCCAG8;WNT3A;TAFA1;ADNP2;NLGN4X;HES6;MYT1L;ASCL1;FUT9;ANOS1;NAV1;SNPH;RYK;RUNX1;PTPRD;MDGA1;MARK1
prerank,GO_Biological_Process_2021__negative regulation of leukocyte mediated cytotoxicity (GO:0001911),0.5292822286616496,1.0061742394506825,0.4375,0.874238924929975,1.0,4/10,11.29%,KLRD1;CX3CR1;ARRB2;LGALS9
prerank,GO_Biological_Process_2021__regulation of cardiac muscle cell differentiation (GO:2000725),-0.5772044479000694,-1.0060873293590347,0.48214285714285715,1.0,1.0,1/10,1.49%,TGFB1
prerank,GO_Biological_Process_2021__embryonic hemopoiesis (GO:0035162),0.5682224426162015,1.0060468098096098,0.47058823529411764,0.8741544489963233,1.0,2/9,9.81%,KIT;KITLG
prerank,GO_Biological_Process_2021__cellular response to arsenic-containing substance (GO:0071243),0.5202955208555544,1.0059931941996372,0.5161290322580645,0.8738625937016494,1.0,3/13,15.27%,ATF3;GSTO2;HSF1
prerank,Reactome_2022__SUMOylation Of Transcription Cofactors R-HSA-3899300,0.4121754399301362,1.0059300139043974,0.41379310344827586,0.8736463883684462,1.0,9/40,21.39%,PHC2;NCOA2;NRIP1;SCMH1;CASP8AP2;ZNF131;EP300;RNF2;MRTFA
prerank,KEGG_2021_Human__Primary bile acid biosynthesis,-0.5382430959998954,-1.0059039457372805,0.47058823529411764,1.0,1.0,3/15,8.93%,AMACR;ACOX2;HSD3B7
prerank,GO_Biological_Process_2021__negative regulation of protein targeting to membrane (GO:0090315),-0.6228650391631765,-1.0058731169414845,0.5625,1.0,1.0,1/6,11.29%,USP17L2
prerank,Reactome_2022__Signaling By FGFR1 R-HSA-5654736,0.4001405435792834,1.0058709354450106,0.4666666666666667,0.8734052401839036,1.0,9/45,14.95%,FGF10;FGFR1;FGF17;FGF18;SPRED2;FLRT2;SPRED1;ANOS1;PIK3CA
prerank,GO_Biological_Process_2021__cellular protein metabolic process (GO:0044267),-0.3749911383718512,-1.0057118406078356,0.4945054945054945,1.0,1.0,105/355,26.43%,NOTUM;SFTPA1;APOL1;RPL37A;ITIH2;PIGH;SERPIND1;SDC2;LOX;UBE2L6;SFTPD;PAPPA2;PAPPA;PHEX;PRSS23;GPC3;RPL38;SERPINA10;PLG;RPL15;STOML2;USP6;CP;COPS5;WARS1;RPS4X;RPL3;RPL35A;WFS1;MFGE8;PLAT;RPS9;F5;RPS27;RPS21;PCMT1;RPL13A;YARS2;RPL27A;GNMT;RPS16;RPL36;PARP4;RPS20;RPL7A;RABGGTB;RABGGTA;RPL9;ABCF1;RPL13;RPS8;RPS27A;RPL21;RPL34;AMBN;MRPL34;RPL4;RPL32;CHGB;RPL5;RPL23;RPL41;RPS7;RPS11;GGCX;FN1;RPL27;RPL35;CSF2RA;RPS14;LAMB2;RPL11;ASMT;RPS15;ALB;IGFBP3;RPLP1;RPS12;RPL24;TGOLN2;RPL18A;RPS13;RPL29;RPLP2;APH1A;FBXO2;KNG1;RPL28;RPL12;IGF2BP3;RPL18;RPS3;FUCA2;RPL22;EEF1A1;RPSA;UBE2M;DENND3;RPS28;UBL5;SPCS2;RPS19;PROC;RPS24;SCG3
prerank,GO_Biological_Process_2021__positive regulation of epithelial to mesenchymal transition involved in endocardial cushion formation (GO:1905007),0.6355077160225427,1.0056222357713391,0.5116279069767442,0.8737481911877081,1.0,1/5,1.51%,TGFBR1
prerank,Reactome_2022__Major Pathway Of rRNA Processing In Nucleolus And Cytosol R-HSA-6791226,-0.38450471789102036,-1.0055347282881208,0.4880952380952381,1.0,1.0,66/169,27.12%,RPL37A;RPP38;NOL12;SENP3;RPL38;PWP2;EMG1;RPL15;NOB1;RPS4X;RPL3;RPL35A;GNL3;RPS9;FAU;RPS27;RPS21;RPL13A;RPL27A;RPS16;RPL36;LAS1L;RPS20;RPL7A;RPL9;RPS8;RPS27A;RPL21;WDR12;EXOSC8;RPL34;RPL4;RPL32;RPL5;RPL23;RPL41;RPS7;RPS11;RPL27;RPL35;RPS14;RPL11;RPS15;EXOSC2;RPLP1;RPS12;RPL18A;RPS13;RPL29;RPLP2;PDCD11;RPL28;RPL12;RPL18;EBNA1BP2;RPS3;RPL22;RPSA;RPS28;RPS19;RPS24;RPL26L1;RPS3A;RPL19;RPL8;RPS6
prerank,GO_Biological_Process_2021__progesterone receptor signaling pathway (GO:0050847),-0.6340098362444003,-1.0055087426438947,0.5098039215686274,1.0,1.0,3/7,16.69%,UBE3A;YAP1;WBP2
prerank,GO_Biological_Process_2021__regulation of leukocyte degranulation (GO:0043300),-0.6363167245396953,-1.005446263836844,0.5384615384615384,1.0,1.0,1/8,2.65%,BLK
prerank,GO_Biological_Process_2021__polyphosphate catabolic process (GO:0006798),0.6995322474331429,1.0053254222776433,0.6666666666666666,0.8742477501462012,1.0,2/5,22.25%,BNIP2;BNIPL
prerank,GO_Biological_Process_2021__photoreceptor cell differentiation (GO:0046530),0.5724738927342671,1.0053203785762648,0.5333333333333333,0.8739000088303821,1.0,2/7,6.24%,RP1L1;NKD1
prerank,GO_Biological_Process_2021__monosaccharide transmembrane transport (GO:0015749),-0.5116796056167242,-1.005274531607422,0.453125,1.0,1.0,3/14,7.85%,SLC5A2;SLC5A1;SLC5A9
prerank,Reactome_2022__Synthesis Of Substrates In N-glycan Biosythesis R-HSA-446219,0.37656636711467273,1.0052487485351935,0.45161290322580644,0.8737344054153068,1.0,12/56,11.28%,ST6GALNAC3;DPM3;ST6GAL2;ST8SIA4;ST3GAL3;GMDS;NPL;NUS1;NAGK;UAP1;NEU4;GLB1
prerank,Reactome_2022__GAB1 Signalosome R-HSA-180292,0.5223343550031571,1.0051337122368513,0.46153846153846156,0.8737632468668635,1.0,4/13,14.95%,CSK;TGFA;PAG1;PIK3CA
prerank,Reactome_2022__Intraflagellar Transport R-HSA-5620924,0.4079100240423199,1.0050247336378928,0.4117647058823529,0.8736667578763384,1.0,15/35,30.32%,IFT88;DYNLT5;IFT140;TTC21B;KIF3B;TRIP11;WDR19;WDR35;IFT57;CLUAP1;DYNC2I2;IFT52;DYNC2I1;IFT172;IFT74
prerank,GO_Biological_Process_2021__positive regulation of protein polymerization (GO:0032273),-0.4473685628483686,-1.005001340987993,0.4492753623188406,1.0,1.0,13/59,17.90%,LMOD1;HCK;CAV3;C15ORF62;PINK1;ALOX15;ANKRD53;DCTN1;BAIAP2L1;VASP;RAC1;CDK5R1;BAIAP2L2
prerank,Reactome_2022__Constitutive Signaling By NOTCH1 t(7;9)(NOTCH1:M1580 K2555) Translocation Mutant R-HSA-2660826,0.668685802129103,1.0049139476852385,0.5294117647058824,0.873658027348322,1.0,4/7,21.76%,JAG1;NOTCH1;ADAM10;JAG2
prerank,PanglaoDB_Augmented_2021__Noradrenergic Neurons,-0.4512592593933394,-1.004765811952704,0.4262295081967213,1.0,1.0,14/51,14.69%,AMBP;DBH;F7;ALDOB;C3P1;FTCD;DAO;SLC22A7;SHD;SLC18A2;UROC1;FGL1;HAO2;NR1H4
prerank,GO_Biological_Process_2021__regulation of peptidase activity (GO:0052547),0.5171766938346145,1.004688743555028,0.4090909090909091,0.8738621465536923,1.0,5/16,15.70%,CSTA;ECM1;HDAC1;FURIN;MAPK12
prerank,GO_Biological_Process_2021__positive regulation of neurogenesis (GO:0050769),0.390169253170383,1.0045868867830683,0.46153846153846156,0.8737845096247331,1.0,16/64,17.75%,NGF;ROBO2;SMARCD3;CX3CR1;RGS14;SLIT2;PLXNB1;DCT;SPEN;NUMB;MAP6;CUX1;PTPRD;LIG4;PLXNA4;FAIM
prerank,GO_Biological_Process_2021__embryo development ending in birth or egg hatching (GO:0009792),0.5087047801908644,1.0044300388150516,0.40425531914893614,0.8737819956562796,1.0,4/13,15.19%,FGFR1;CELF4;STOX2;RAI2
prerank,CellMarker_Augmented_2021__Hematopoietic Precursor cell:Fetal Liver,0.5773736444922755,1.004361918879303,0.5098039215686274,0.8735981693098048,1.0,2/7,3.69%,KIT;CD14
prerank,KEGG_2021_Human__B cell receptor signaling pathway,-0.43196479923390657,-1.0042031390396364,0.5,1.0,1.0,12/61,21.57%,LILRB3;VAV3;INPP5D;PIK3R3;BLNK;PIK3CB;RAC2;RAC1;NFATC2;CD81;PIK3AP1;MAP2K1
prerank,GO_Biological_Process_2021__ATP transport (GO:0015867),-0.5416706697455768,-1.0041872260542108,0.5,1.0,1.0,1/11,2.12%,ABCC6
prerank,GO_Biological_Process_2021__positive regulation of lymphocyte proliferation (GO:0050671),0.3831726104015767,1.0041591359922994,0.5666666666666667,0.873758225184658,1.0,5/54,4.79%,PNP;CD38;FGF10;BCL2;CCDC88B
prerank,CellMarker_Augmented_2021__B1 cell:Salivary Gland,-0.4763415511381571,-1.004072239796438,0.47297297297297297,1.0,1.0,7/31,10.28%,SIRPG;TBC1D10C;TAGAP;KLRB1;CD5;TRAF3IP3;PTPRC
prerank,CellMarker_Augmented_2021__T cell:Salivary Gland,-0.4763415511381571,-1.004072239796438,0.47297297297297297,1.0,1.0,7/31,10.28%,SIRPG;TBC1D10C;TAGAP;KLRB1;CD5;TRAF3IP3;PTPRC
prerank,GO_Biological_Process_2021__histone H3-K4 dimethylation (GO:0044648),0.6256390392102167,1.0039586951570627,0.56,0.8740368404458986,1.0,4/6,33.36%,KMT2B;KMT2A;SETD4;KMT2D
prerank,GO_Biological_Process_2021__positive regulation of cyclin-dependent protein serine/threonine kinase activity (GO:0045737),-0.5187534582129396,-1.0039368444898271,0.47368421052631576,1.0,1.0,3/17,8.75%,SPDYA;CCND1;CCND2
prerank,GO_Biological_Process_2021__negative regulation of cell cycle G2/M phase transition (GO:1902750),-0.434373003685768,-1.0038632752268135,0.47761194029850745,1.0,1.0,18/51,29.05%,PSMB9;FBXL7;ATF5;RBX1;PSMA3;PSMA7;PSMB6;RFPL1;PSMA5;AURKA;PSMD6;SKP1;PSMC5;PSMB4;PSMB7;PSMD8;GPR132;PSMD3
prerank,GO_Biological_Process_2021__low-density lipoprotein particle remodeling (GO:0034374),0.55345517636096,1.0038608146180301,0.5526315789473685,0.8738718710886425,1.0,2/9,2.65%,LIPC;APOB
prerank,"GO_Biological_Process_2021__positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay (GO:1900153)",0.5037829751973824,1.003819788081704,0.45454545454545453,0.8732179074128692,1.0,8/14,29.72%,NANOS3;TNRC6C;AGO2;NANOS1;PABPC1;TNRC6B;TOB1;ZFP36L2
prerank,"GO_Biological_Process_2021__regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay (GO:1900151)",0.5037829751973824,1.003819788081704,0.45454545454545453,0.8732179074128692,1.0,8/14,29.72%,NANOS3;TNRC6C;AGO2;NANOS1;PABPC1;TNRC6B;TOB1;ZFP36L2
prerank,GO_Biological_Process_2021__response to ATP (GO:0033198),-0.546991980636586,-1.003810631968789,0.4107142857142857,1.0,1.0,2/14,6.95%,P2RY12;KCNJ11
prerank,GO_Biological_Process_2021__phosphatidylethanolamine metabolic process (GO:0046337),-0.4952404086523491,-1.0037787714271325,0.5072463768115942,1.0,1.0,3/26,7.49%,PLAAT4;PLA2G10;ALOX15
prerank,GO_Biological_Process_2021__regulation of cellular amine metabolic process (GO:0033238),-0.4431662166423797,-1.0037486623498828,0.4411764705882353,1.0,1.0,7/43,19.11%,PSMB9;NQO1;AZIN1;OAZ2;PSMA3;PSMA7;PSMB6
prerank,GO_Biological_Process_2021__cellular response to transforming growth factor beta stimulus (GO:0071560),0.3655054445710209,1.0036333243256685,0.2857142857142857,0.8733466052757697,1.0,22/99,15.84%,BAMBI;TGFBR1;DUSP15;CDH5;PARD3;WNT4;SIRT1;ARRB2;DLX1;WWOX;TWSG1;LIMS1;PXN;FNTA;SMAD2;LTBP2;NR3C1;SMURF1;SOX5;FURIN;CGN;CRKL
prerank,GO_Biological_Process_2021__negative regulation of adenylate cyclase activity (GO:0007194),0.5367731853318476,1.0036256321672918,0.3902439024390244,0.872631582339796,1.0,3/11,12.22%,GRM3;GRM2;ADGRV1
prerank,GO_Biological_Process_2021__negative regulation of cyclase activity (GO:0031280),0.5367731853318476,1.0036256321672918,0.3902439024390244,0.872631582339796,1.0,3/11,12.22%,GRM3;GRM2;ADGRV1
prerank,GO_Biological_Process_2021__ERBB signaling pathway (GO:0038127),0.4089837689047346,1.0035813510705516,0.5,0.8723617205484765,1.0,11/59,15.71%,DGKD;SLC30A10;NRG2;ERBB2;NRG1;PTPRR;TGFA;GAB1;EFEMP1;PIK3CA;MATK
prerank,GO_Biological_Process_2021__negative regulation of viral process (GO:0048525),-0.42624848783896296,-1.0034333083065146,0.4393939393939394,1.0,1.0,8/52,12.20%,TRIM62;TRIM5;STAT1;OAS2;CHMP3;PTX3;IFIT1;OAS1
prerank,Reactome_2022__Mitochondrial Fatty Acid Beta-Oxidation R-HSA-77289,0.42297551469610245,1.003336044241525,0.36363636363636365,0.8726835728371923,1.0,7/35,11.57%,ACADS;THEM4;ACAD10;ECHS1;ACOT9;ACADM;MECR
prerank,Reactome_2022__Signaling By ERBB2 ECD Mutants R-HSA-9665348,0.48525667836297287,1.0033202821725105,0.4594594594594595,0.8723392305489563,1.0,3/15,19.27%,ERBB2;PIK3CA;SOS1
prerank,GO_Biological_Process_2021__negative regulation of response to stimulus (GO:0048585),-0.4562456008768097,-1.0032438595367272,0.5373134328358209,1.0,1.0,7/52,12.92%,AMBP;HHIP;NLRP12;ALOX5;CLU;TERT;WFS1
prerank,GO_Biological_Process_2021__negative regulation of fibroblast migration (GO:0010764),-0.6117942156408023,-1.0031903214052575,0.509090909090909,1.0,1.0,3/6,30.66%,RAC1;FGF2;HAS1
prerank,GO_Biological_Process_2021__L-amino acid transport (GO:0015807),0.4644816814866907,1.0028751997007286,0.42857142857142855,0.8730714123377226,1.0,6/28,11.59%,SLC38A5;SLC3A2;SLC7A9;SLC6A20;SLC7A8;SLC25A12
prerank,GO_Biological_Process_2021__CRD-mediated mRNA stabilization (GO:0070934),0.6419414845949664,1.0028705274644396,0.5128205128205128,0.8727271950890028,1.0,3/5,31.79%,SYNCRIP;YBX1;HNRNPU
prerank,CellMarker_Augmented_2021__Mesenchymal Stem cell:Peripheral Blood,0.39621744538994536,1.0025387238420425,0.37037037037037035,0.8732721315735315,1.0,12/74,7.60%,ERG;TPM2;EMP1;LAMA4;MRGPRF;CDH5;SSC5D;MMP2;SERPINE1;ECM1;OLFML2B;CFH
prerank,Reactome_2022__FCERI Mediated NF-kB Activation R-HSA-2871837,-0.42229112301915783,-1.002265267260796,0.4411764705882353,1.0,1.0,2/70,0.78%,PSMB9;RASGRP4
prerank,GO_Biological_Process_2021__regulation of phospholipid transport (GO:2001138),0.6180177954802568,1.0018149921795647,0.5128205128205128,0.8748915123469491,1.0,1/5,28.52%,ABCA3
prerank,CellMarker_Augmented_2021__Lake Et al.Science.In3:Brain,-0.5304214329216244,-1.001691006631845,0.5081967213114754,1.0,1.0,2/12,6.27%,SCTR;SYT2
prerank,GO_Biological_Process_2021__phosphate-containing compound metabolic process (GO:0006796),0.33844242887505976,1.0015102429948384,0.3181818181818182,0.8753233054268552,1.0,24/182,11.55%,GCK;PLCH1;DUSP4;FBP2;DUSP15;EPHX2;PLPPR1;EPHA7;DUSP23;BCKDK;PFKP;ITPKB;G6PC3;PLCB1;ACYP2;INPP1;LPL;PLPP2;PSPH;PLCH2;GPD2;DUSP18;PPM1A;PTPRB
prerank,GO_Biological_Process_2021__regulation of translational termination (GO:0006449),0.5613148667119499,1.001485626157163,0.5454545454545454,0.875009765700585,1.0,3/8,14.49%,JMJD4;MTRF1;ETF1
prerank,GO_Biological_Process_2021__DNA dealkylation (GO:0035510),0.5615177296730715,1.001467983137323,0.4666666666666667,0.8743338424143967,1.0,5/10,32.49%,ASCC2;MGMT;ALKBH3;ASCC3;FTO
prerank,GO_Biological_Process_2021__DNA dealkylation involved in DNA repair (GO:0006307),0.5615177296730715,1.001467983137323,0.4666666666666667,0.8743338424143967,1.0,5/10,32.49%,ASCC2;MGMT;ALKBH3;ASCC3;FTO
prerank,GO_Biological_Process_2021__negative regulation of cytosolic calcium ion concentration (GO:0051481),0.6150063032530578,1.0014437711454705,0.5,0.8740397037631819,1.0,1/6,3.99%,SLC8A1
prerank,GO_Biological_Process_2021__regulation of defense response (GO:0031347),-0.44433868411752475,-1.0013850367000114,0.463768115942029,1.0,1.0,25/61,25.59%,HCK;WNT5A;ALOX5;IRF1;PTGES;LRRC19;ALOX15;ANXA1;LACC1;GRN;SPATA2;ERAP1;CASP8;ACE2;DHX58;PIK3AP1;BST1;SEMA7A;TMSB4X;IL1R1;TKFC;TNFSF4;USP18;PARK7;UFL1
prerank,GO_Biological_Process_2021__collagen-activated tyrosine kinase receptor signaling pathway (GO:0038063),-0.6348606523571612,-1.001198214828399,0.5161290322580645,1.0,1.0,3/7,17.85%,COL1A1;COL4A6;OTOL1
prerank,GO_Biological_Process_2021__regulation of cellular metabolic process (GO:0031323),-0.4446793767148085,-1.00105925944237,0.43661971830985913,1.0,1.0,5/43,9.40%,FOXM1;CYP1B1;PINK1;EIF6;STK17A
prerank,CellMarker_Augmented_2021__Myeloid Conventional Dendritic cell:Bone Marrow,-0.5963787274875246,-1.001004481449171,0.5081967213114754,1.0,1.0,2/8,11.77%,XCR1;ITGAM
prerank,GO_Biological_Process_2021__cell-substrate junction assembly (GO:0007044),0.42031925254490105,1.0009619941039196,0.4166666666666667,0.8747808470399203,1.0,6/31,15.02%,CD151;LAMA3;PLEC;ITGB4;DST;BCR
prerank,KEGG_2021_Human__Natural killer cell mediated cytotoxicity,-0.4230649097398426,-1.0008507314195894,0.4,1.0,1.0,14/75,18.10%,MICB;ITGB2;VAV3;FCGR3A;HLA-A;PIK3R3;SH3BP2;TNFRSF10A;PIK3CB;SH2D1B;IFNGR2;RAC2;RAC1;NFATC2
prerank,Reactome_2022__DNA Damage Reversal R-HSA-73942,0.5743087732467955,1.0005333380924126,0.5666666666666667,0.8756081102762441,1.0,5/8,32.49%,ASCC2;MGMT;ALKBH3;ASCC3;FTO
prerank,Reactome_2022__Glycosaminoglycan Metabolism R-HSA-1630316,-0.40714664791177313,-1.0003374686066533,0.4805194805194805,1.0,1.0,5/106,5.23%,CD44;LYVE1;CHST9;OGN;SDC2
prerank,GO_Biological_Process_2021__attachment of GPI anchor to protein (GO:0016255),0.6242134860524734,1.000333958657109,0.5263157894736842,0.8757782621656109,1.0,3/5,37.05%,PGAP1;PIGU;PIGK
prerank,GO_Biological_Process_2021__protein localization to nucleolus (GO:1902570),0.656546214385281,1.000262361568335,0.5434782608695652,0.8756016253666934,1.0,1/6,7.64%,NOL8
prerank,KEGG_2021_Human__Cardiac muscle contraction,-0.4272117854935793,-1.0002578928620898,0.4507042253521127,1.0,1.0,6/65,6.59%,COX6A1;MYH7;CASQ2;ACTC1;TRDN;ATP1A4
prerank,CellMarker_Augmented_2021__1-Cell Stage Cell (Blastomere):Embryo,0.410340228379421,1.0001677283163681,0.40540540540540543,0.8754498849929846,1.0,12/38,24.79%,SDCCAG8;RNF10;INTS9;DPF2;ZSWIM3;ARHGEF16;SHMT2;DCLK2;PPIL2;ACVR1B;BNIP1;STK38
prerank,GO_Biological_Process_2021__embryonic digestive tract development (GO:0048566),0.5311862690373808,1.0001637644695813,0.4594594594594595,0.8750941643173527,1.0,1/12,2.88%,RARB
prerank,"Reactome_2022__TICAM1,TRAF6-dependent Induction Of TAK1 Complex R-HSA-9014325",0.5065528217303186,1.0001205250032128,0.43902439024390244,0.8748191096994329,1.0,5/10,20.40%,TICAM1;TAB3;TAB1;TAB2;TRAF6
prerank,CellMarker_Augmented_2021__Natural Killer T (NKT) cell:Fetal Kidney,0.24991324613494018,1.0,1.0,0.8744426479886181,1.0,756/4122,19.51%,IL7R;GPRIN3;NXPH4;SELPLG;CD38;PHLDB2;BAMBI;DGKD;CTDNEP1;SMYD2;DUSP4;RAB27A;AUP1;TBC1D10A;SLX4IP;PCM1;DUSP2;SLC10A3;ELOVL6;THEM4;HPS3;CCNG1;ZNF808;KLRD1;KIFC1;SKAP1;FHIT;KIT;HDAC3;CD247;SAMSN1;TCIRG1;UTRN;BTN3A2;GJB6;RHEBL1;ZNF195;KLHL20;NUP210;YDJC;CD151;ANKRD36B;SNRPN;IFT88;LINGO2;INO80D;CCDC97;CFLAR;MED17;PRR14;AOAH;TCOF1;NFATC3;ZFPL1;NAALADL1;KPTN;RORA;TOR1B;CEP135;SBK1;CNTRL;SIMC1;TFB1M;HDAC10;MIDN;SAMD9;HIP1;UBE2E3;URI1;KLF10;SLC39A8;SLC25A39;SDC4;PIGQ;STAMBPL1;DPM3;METRNL;AGTRAP;PERP;BCL11B;ADGRG3;BIN1;SLC3A2;CARNMT1;PUS7L;CBFB;PTAR1;PITPNM1;EYS;VPS16;CSK;ABHD17A;AK3;BAALC;GATAD2A;AUTS2;ZNF263;EXT1;PPP1R35;SCLT1;ZNF701;BSG;DLGAP4;SLC25A37;IL16;CCL3L3;SPON1;COMMD1;CNPPD1;ZNRF1;SDF4;PEX13;MOB2;TET2;CCL4L2;ACBD3;RGS16;ITGA4;AKR1C3;IFI16;CCDC88B;PSME4;C4ORF33;PI4KB;TNFSF14;CREB3L4;LMNB1;CMC1;DNMT1;COMMD6;STX5;SFMBT1;RAD54L2;PYHIN1;SSBP3;GTPBP6;SLFN5;IWS1;JAG1;GTF2I;ZNF641;CRY1;GPBP1L1;RNF168;ZBTB20;PDGFD;PRPF38B;ARRB2;HNRNPF;SIRT7;CHST12;CAPN2;RAB7A;PRKCSH;PDIA6;TRA2A;GLCCI1;DCPS;RRAS2;ST8SIA4;GOLGA4;EXOSC1;EIF1AY;TOX;CHCHD5;CCZ1B;PCIF1;UBE2J1;SH3BGRL3;LGALS1;STAT5B;DHFR;JAGN1;RIC8A;IMMP1L;HMGB1;METTL15;EBPL;C5ORF63;FANCL;UBXN2A;RASA2;PRPF39;MAN1A2;SAFB2;RBMS1;ZBTB1;HP1BP3;NCALD;SAMD3;KDM7A;DCUN1D1;CDCA4;SLC35E2B;ZNF274;PRRC2C;RIOK1;PPP5C;TASOR2;ZNF786;TRAPPC1;SMPD4;RGS14;SLC27A2;PSMA1;S1PR5;PMS1;APBA3;PLCL2;RALGPS2;PML;BOD1L1;STX8;PDZD11;CCND3;SOAT2;CFH;TSSC4;FKRP;PLCB1;OCIAD2;PUF60;SEC22A;GMDS;RBBP6;TMEM175;MAPK8;NXT1;CBLB;BDP1;CNNM2;PDE7A;PCDH9;CASP3;ABHD3;ECHS1;CD8A;PTPRR;MYC;GLUD1;URB2;NKAP;METAP1D;POLM;FLNA;TAF3;TRIB2;DYNC1I2;RALA;CTDSP1;HNRNPH1;SCD5;NR4A2;SIPA1;ANP32A;FOXN3;SLTM;OSBPL7;NXF1;TELO2;PGRMC2;STX18;TMEM222;TNFRSF18;PTPN9;MAEA;SNRPB;GPHN;ALG12;HIVEP3;CHMP6;TTC17;HCLS1;TAF12;UBAP1;PIH1D1;TNIK;GRM2;MAPRE1;GCC2;ANP32B;NOC3L;DPH5;TPM4;KTN1;AKT2;APOL3;ACYP2;U2AF1;H1-10;FAM167A;RPGRIP1L;INPP1;ERN1;EPB41;ZDHHC18;DCAF13;PNISR;ATF1;GGA1;BTBD10;MCMBP;TRMT2A;DENND1B;IRAG2;SRRM1;MPC1;LIN52;PBRM1;BNIP2;GTF2IRD2B;KCNIP4;HNRNPL;TMED3;ARIH2OS;ZNF331;CTC1;PRKAR2A;ARID1A;CTBP2;TSPAN17;CREM;NSRP1;RPGR;SAAL1;PDE4B;TERF1;AKAP9;RNF10;RPS6KA3;RSPRY1;ACADM;LSM2;CHST11;SH3KBP1;CEP250;MPLKIP;COTL1;PPIB;ISOC1;ZNF569;PHF3;GPATCH8;AKAP7;IRS2;SHARPIN;UAP1;CAMKMT;STARD3NL;NAMPT;ABI3;ANAPC16;RAB35;PI4K2B;ABTB1;SLC7A6;B3GAT3;FHL3;WDR74;GAN;TTC14;EEFSEC;KDM2A;TRIM65;CCDC50;DPP3;N4BP1;POGK;RNF166;BPTF;ZNF75A;TRIM44;WASF2;FASTK;DUSP18;PPM1A;ODC1;SLC35E3;PTPRB;EVL;HECA;SLC25A12;PIM2;BANP;PGLS;TNRC6C;USP36;FAM177A1;DNAAF10;ZMAT5;CCNH;NSD1;DMTF1;BRD3;MACF1;ZBTB44;SMARCA2;PPP1R18;NOA1;GALT;KLHL24;POLG;TOB2;SMARCA4;ADIPOR2;KMT5C;USP16;ZDHHC12;FAM184A;TIAL1;ZNF277;ANKRD44;OXR1;OLA1;PXN;C9ORF85;TICAM1;RAP1A;EPC2;MDFIC;EIF3H;NGLY1;CFAP410;KAT6A;UBASH3B;IDH2;TANK;WDR89;INTS9;JUNB;QSOX1;DPY30;VTI1A;SF3B1;RESF1;HGH1;POLR1H;FNTA;REV3L;NT5C3A;CPSF7;SREK1;ACD;COX19;GPSM3;FNBP1;DPP9;SRSF4;ABHD17B;SC5D;PLSCR1;PPP1R15B;SPIRE2;DPF2;ZNF276;FAM20B;NEO1;KCNQ5;ARID2;MARK3;HDAC1;ARL5A;SMC5;ARHGAP35;EIF3E;RYBP;CHD9;CHD4;COG7;ARPC3;CDK11A;SAMD12;H2AX;RAP1GDS1;TECR;PCED1B;SMAD2;GBP4;CCDC107;EXOC7;RLF;CASP8AP2;PUM3;NR3C1;SMCHD1;NFKB1;BID;NFAT5;AP5Z1;SMC2;NTAQ1;SUCO;KIAA0586;MLLT3;ASCC2;ZNF638;HSPBP1;PITPNC1;GMPS;ETF1;MOB1A;ESCO1;RPF1;CYB5B;MECP2;RYK;OTUD7B;ZMYND11;CELF2;EMB;DCAF5;ANKRD36;AGPAT5;NKTR;NCBP3;CDC26;GPR108;VOPP1;ZC3H13;SH3YL1;DNPH1;FAM89B;CXXC5;HERC2;LYRM1;SLC25A42;FURIN;ZNF131;CA2;MGAT2;CNPY3;HSF1;EIF3M;SHPRH;LUC7L;NCAM1;MIEN1;CNOT4;ETHE1;ZNF586;TP53;GBP2;BAZ1B;CLSPN;B3GALNT2;FLNB;ZC3H14;PPP1R9A;ACIN1;BRAP;ZFY;ATG2A;LRRC45;MATK;IL2RB;TNRC6A;WDR3;NMRK1;NRBF2;ATAD2B;BAZ2B;ADNP;PTBP1;S1PR1;SLK;DLG5;BAZ2A;MGMT;NR4A3;FUS;PATL1;MALT1;PTPRE;SRFBP1;COL6A3;CTSC;EIF3K;DOCK11;FBXO4;LSM7;FBL;HPRT1;SMG1;SETD2;UBALD2;SNF8;OTUD5;CLINT1;MOGS;DNAJC3;PIP4K2A;ELOVL1;MPHOSPH8;ZDHHC3;GMEB1;ZNF708;CERS4;NOTCH1;SSR2;MPHOSPH9;DAP3;NCK1;ARIH1;CHD1;RAB5A;NUTF2;UBE2L3;RAB11B;ATM;KLHL6;TM2D1;LPIN2;ASH1L;ARID5B;PSMG2;RPIA;DIS3;ATF7IP;RAD17;ZNF292;KLF12;UNC13C;RAB11FIP1;RSU1;AGO3;GOLGB1;NUFIP1;CCNDBP1;HIVEP1;GABPB1;BRD4;PA2G4;SYNCRIP;ICE1;SKI;FAM98C;STIM2;SPOP;ZMYM5;CSNK1G1;R3HCC1L;ZFX;BRAF;TSC22D2;HMOX2;MAP2K7;AURKAIP1;BRAT1;DTYMK;KIF21B;PAPOLA;SYAP1;NSMCE2;ARHGAP10;ZNF831;FAIM;ELF2;NUDT5;NT5DC1;PNKP;IP6K1;NIPBL;POLR3D;RC3H1;NOC2L;COQ9;LSM14A;ERCC3;RNF113A;MIA3;PAM;ACOX1;PPP1R10;UBE4B;ZFAND6;ZNF142;CD320;CAMTA1;SP3;ABCA7;SLMAP;YAF2;UXT;RAD9A;ITPK1;ZNF706;SUPT3H;APRT;SIKE1;FAM118A;RSRP1;RASSF1;ATR;MIB2;LY9;MORC3;CPNE1;KLF6;NR4A1;AP4B1;DECR1;SPRTN;NOP14;FPGS;NSUN4;DNAJC1;PPP1CB;PDE6D;NASP;ADAM10;SMG6;ZFYVE28;SMYD4;SHMT2;ARFRP1;ASXL1;BIN3;ERMP1;PDE3B;SLA2;TMEM131;EMC4;ARAP2;STAMBP;PSMG3;LENG1;JADE2;ELMO1;RAB40A;RASSF5;CXXC1;CALCOCO2;EEF1D;ITIH5;VAMP8;PRPSAP1;ZCCHC7;CREB1;PACS1;ADD1;CSGALNACT2;KAT2B;QRICH1;CCDC152;H2AJ;HM13;KAT6B;COG4;RNF40;YIPF5;RO60;XRN2;DGKZ;BTF3L4;KHDRBS1;YIPF3
prerank,GO_Biological_Process_2021__regulation of transcription by RNA polymerase II (GO:0006357),0.30443273921853836,1.0,1.0,0.8744426479886181,1.0,394/1744,18.84%,TEAD2;ERG;SMYD2;POU3F1;ESRRG;FOXO1;PER2;ZNF496;ZNF607;ZSCAN4;ZNF808;SKAP1;TSHZ2;KIT;ZNF408;POU6F2;HDAC3;PKNOX1;ZNF239;ZNF347;MKX;ZNF485;BCL6;ZNF212;ZBTB9;DMRT3;NEUROD2;AASS;ZNF623;MED17;MAFB;MITF;NFATC3;RORA;APOE;ZNF518A;HDAC10;TSHZ3;RARB;POU3F2;GALR3;ZNF692;TWIST2;ZNF561;URI1;ZBTB7B;KLF10;ARX;CDH13;PCGF1;BCL11B;ZNF835;ZNF70;GABPB2;CBFB;PRDM5;HEXIM2;CCN1;TGIF1;GATAD2A;AUTS2;ZNF263;ZNF99;RIPK2;PID1;ZNF33B;E2F6;ZNF701;SMARCD3;FRK;ATXN1;PPARG;CREB3L2;FZD5;TET2;ATOH7;SIRT1;ZNF860;IFI16;ERBB2;MAML1;ZFHX4;CREB3L4;PAX3;RORB;ZEB2;BACH2;SOX12;LHX2;SSBP3;ARID3B;SERPINE1;JAG1;ZNF641;ELP4;PKD2;CRY1;SNCA;ZBTB20;PER3;SIRT7;HIC2;HES1;GFI1B;PTOV1;KCNIP3;BCL11A;ZNF780B;ZNF534;TOX;ZFP3;PROX1;ZNF470;STAT5B;ZBTB40;ZBTB4;CRK;HMGB1;BHLHA9;SMARCAL1;ATF3;TPRX1;DLX1;FOXP2;NCOA3;MIER2;HIVEP2;NCOA2;SAFB2;OSR1;ZBTB1;IKZF4;KDM7A;SMARCB1;MED25;PCGF5;ETV1;ZNF274;GREM1;ZNF786;NRIP1;CDK4;ABL1;WWOX;SP1;RBL1;WWP2;MYC;MGA;NKAP;ZNF251;ZNF462;ZNF215;TAF3;FSTL3;BCLAF3;CTDSP1;TCF20;NR4A2;ZNF33A;TGFA;ZNF688;LRP6;ZSCAN12;SLTM;RFX1;ZEB1;FOXD4L5;HIF3A;SENP1;ZNF202;ZSCAN21;WNT3A;HDX;RFX7;TWIST1;SNAI2;HIVEP3;SPEN;HCLS1;MOV10;ZNF845;SRCAP;ZNF133;LCORL;TFE3;FHL2;ATF1;ZNF2;GRIN1;MAMLD1;PLAGL1;ZNF599;ARID1A;CTBP2;CREM;RNF10;RPS6KA3;ZNF852;NPAS4;ZNF569;ELOA;ZNF514;NAMPT;RRP1B;EBF4;NPAS3;BATF2;MSC;KDM2A;ZNF777;ZNF652;SP7;BPTF;ZNF75A;HES6;ZNF782;PPM1A;CITED4;DACH1;ZFP82;TNRC6C;DPF1;MYT1L;ZNF761;CCNH;NSD1;DMTF1;BRD3;SMARCA2;ZNF41;ZNF300;KDM3B;ZNF846;MLXIPL;SMARCA4;ZNF771;ZNF594;USP16;BCL9L;TIAL1;SAP130;EPC2;ZNF337;KAT6A;ZNF155;JUNB;ZNF704;NFIB;TEAD4;ZNF311;FADD;PLSCR1;DPF2;ZNF276;NR3C2;MXI1;ZNF384;HDAC1;GATAD2B;ASCL1;CHD4;ZXDC;MED16;FOXF2;ARRB1;CDK8;SMAD2;NR2F2;RPS6KA4;RLF;PLK3;NFYC;ZNF774;NR3C1;NFKB1;NCOA5;PPARGC1B;NFAT5;BCOR;SOX5;ASXL3;ZNF611;CUX1;WWTR1;SCRT1;TFCP2;MECP2;OTUD7B;THRB;ZNF438;HDAC4;ZNF69;RFX6;ZFP62;NFIC;CXXC5;ETV5;MEN1;ZNF131;HSF1;ZNF48;NR1H3;HJV;ZNF586;GADD45A;TP53;ZNF165;ZNF609;BAZ1B;HSF4;GABPA;ZFY;RUNX1;NR6A1;ZNF549;TNRC6A;ATAD2B;BAZ2B;NR4A3;FUS;TTC21B;ZFP28;MED13L;ZSCAN31;WWC1;SNF8;ZNF765;GMEB1;ZGLP1;NOTCH1;NCK1;ZBTB2;CHD1;ZNF283;ATM;PBX1;ZNF665;LPIN2;ARID5B;ATN1;ZNF292;KLF12;AGO3;NUFIP1;HIVEP1;GABPB1;BRD4;THAP7;SKI;SP2;ZMYM5;ZFX;FOXJ2;NR2C1;PAX6;IL11;ZHX3;ZNF675;ZNF322;ELF2;ZNF627;ZNF589;ARID1B;TFEB;NIPBL;ZBTB5;NOC2L;SATB2;MACROH2A2;ZNF12;ZBTB41;ZNF613;RBPJ;ZNF142;CAMTA1;SP3;NFX1;UXT;SUPT3H;ATF6;TNIP3;IMPACT;KLF6;NR4A1;ZNF157;SOX13;RFX5;ZNF445;ACVR1;DBX2;ASXL1;SIRT6;EP300
prerank,GO_Biological_Process_2021__protein localization to cilium (GO:0061512),-0.4700689187099055,-0.999988095148051,0.4852941176470588,1.0,1.0,5/32,14.38%,TULP1;ROPN1B;ATP6V1D;TULP2;FSIP2
prerank,GO_Biological_Process_2021__motor neuron axon guidance (GO:0008045),-0.5615570813887655,-0.9997247875341115,0.5245901639344263,1.0,1.0,5/12,17.19%,SEMA3A;LAMC2;NTN1;RAC2;RAC1
prerank,CellMarker_Augmented_2021__Macrophage:Bone Marrow,-0.6380293535937747,-0.999462533499346,0.4915254237288136,1.0,1.0,3/7,11.77%,ITGB2;ADGRE1;ITGAM
prerank,GO_Biological_Process_2021__mitochondrion disassembly (GO:0061726),-0.4563509994696352,-0.9993724896273681,0.4696969696969697,1.0,1.0,8/34,25.97%,PINK1;GABARAPL1;GABARAPL2;MAP1LC3B2;FIS1;FUNDC1;BNIP3;ULK1
prerank,GO_Biological_Process_2021__anterograde dendritic transport (GO:0098937),0.6169528049436839,0.9991947902012422,0.5581395348837209,0.8760542768688613,1.0,1/5,18.08%,KIF3B
prerank,GO_Biological_Process_2021__anterograde dendritic transport of neurotransmitter receptor complex (GO:0098971),0.6169528049436839,0.9991947902012422,0.5581395348837209,0.8760542768688613,1.0,1/5,18.08%,KIF3B
prerank,"GO_Biological_Process_2021__retrograde transport, endosome to Golgi (GO:0042147)",0.4056514330351964,0.999120623242046,0.34615384615384615,0.8758225814901223,1.0,15/83,12.65%,TBC1D10A;SNX5;STX5;RAB7A;STX6;WASHC2C;GBF1;RHOBTB3;UBE2O;GCC2;GGA1;DENND2A;VPS54;WASHC2A;VTI1A
prerank,CellMarker_Augmented_2021__Limbal Stem cell:Limbal Epithelium,0.4023039253680866,0.9990202164279498,0.34615384615384615,0.8757020863019302,1.0,2/33,2.22%,ADGRF4;LAMA3
prerank,GO_Biological_Process_2021__ion transport (GO:0006811),0.3645600382401707,0.9990153898649484,0.4090909090909091,0.8753659281627688,1.0,8/104,5.32%,SLC5A8;SLC17A6;SLC26A3;SLC26A7;CNGA3;SLC12A1;SLC8A1;SLC8A3
prerank,GO_Biological_Process_2021__spinal cord development (GO:0021510),0.5503594395132176,0.99895797123902,0.5,0.8752210719206829,1.0,3/11,13.81%,SOX12;PKD2;NF1
prerank,GO_Biological_Process_2021__positive regulation of monocyte differentiation (GO:0045657),-0.5973478936032357,-0.9989214001081425,0.4642857142857143,1.0,1.0,3/10,17.25%,HLA-DRB1;CD4;ZFP36L1
prerank,CellMarker_Augmented_2021__Cancer Stem cell:Eye,-0.4041384117314996,-0.9989090376826859,0.4411764705882353,1.0,1.0,20/66,23.31%,PKP2;MISP;MARVELD2;GPRIN2;EPN3;MYO5B;SPINT1;SOWAHB;BAIAP2L1;TOM1L1;CD24;SCNN1A;CAPN13;SLC44A3;CBLC;LSR;HSD11B2;C6ORF132;RAB17;RHPN2
prerank,GO_Biological_Process_2021__posttranscriptional regulation of gene expression (GO:0010608),0.43044987264257933,0.9987561078180575,0.4666666666666667,0.8752796004227651,1.0,16/42,27.15%,TCOF1;PCIF1;TRIM71;NANOS3;GEMIN5;PUM3;RC3H1;GRM5;METTL16;NANOS1;LARP1;EIF4E;MEX3D;ZC3H7B;FOXO3;ATXN2
prerank,Reactome_2022__Phospholipase C-mediated Cascade; FGFR3 R-HSA-5654227,-0.5836567653593898,-0.9986268144664174,0.42105263157894735,1.0,1.0,1/10,0.93%,FGF20
prerank,Reactome_2022__Platelet Homeostasis R-HSA-418346,0.358904040394212,0.9985203131275436,0.45454545454545453,0.8756336179510553,1.0,11/71,11.36%,ITPR2;APOB;TRPC3;PDE10A;SLC8A1;SLC8A3;PDE1A;NANOS3;GUCY1A2;PDE9A;PPP2R1B
prerank,GO_Biological_Process_2021__depyrimidination (GO:0045008),-0.5640412976725175,-0.9983379343127214,0.4444444444444444,1.0,1.0,2/8,19.05%,SMUG1;OGG1
prerank,CellMarker_Augmented_2021__Beige Adipogenic Precursor cell:Adipose Tissue,0.35690367796043754,0.9983221522462634,0.5172413793103449,0.8753995294825558,1.0,15/91,9.44%,FIBIN;PDLIM3;FGF10;LAMA4;NOVA1;ITGA8;IL17RD;ZFHX4;PAX3;EPHA3;SLIT2;EDNRA;DOK5;GUCY1A2;PDZRN3
prerank,CellMarker_Augmented_2021__Brown Adipogenic Precursor cell:Adipose Tissue,0.35690367796043754,0.9983221522462634,0.5172413793103449,0.8753995294825558,1.0,15/91,9.44%,FIBIN;PDLIM3;FGF10;LAMA4;NOVA1;ITGA8;IL17RD;ZFHX4;PAX3;EPHA3;SLIT2;EDNRA;DOK5;GUCY1A2;PDZRN3
prerank,GO_Biological_Process_2021__fructose catabolic process (GO:0006001),-0.6297838092972285,-0.9982072760417086,0.5094339622641509,1.0,1.0,2/5,5.00%,ALDOB;GLYCTK
prerank,Reactome_2022__Fructose Catabolism R-HSA-70350,-0.6297838092972285,-0.9982072760417086,0.5094339622641509,1.0,1.0,2/5,5.00%,ALDOB;GLYCTK
prerank,GO_Biological_Process_2021__fructose catabolic process to hydroxyacetone phosphate and glyceraldehyde-3-phosphate (GO:0061624),-0.6297838092972285,-0.9982072760417086,0.5094339622641509,1.0,1.0,2/5,5.00%,ALDOB;GLYCTK
prerank,GO_Biological_Process_2021__positive regulation of I-kappaB phosphorylation (GO:1903721),0.6562010874546834,0.9981959143507098,0.5555555555555556,0.8754332906792013,1.0,1/5,4.29%,CX3CR1
prerank,CellMarker_Augmented_2021__Progenitor cell:Undefined,0.36846600073187463,0.9979646727313518,0.3333333333333333,0.8756575782387994,1.0,10/92,10.61%,MARVELD1;IFRD2;ALCAM;METTL1;PDIA6;CDK4;POFUT1;ALDH18A1;SNRPB;PPIB
prerank,Reactome_2022__G-protein Activation R-HSA-202040,-0.5044536189363332,-0.9977188484523597,0.515625,1.0,1.0,7/19,26.22%,PDYN;GNGT1;OPRM1;GNA15;GNG13;GNG12;GNG4
prerank,CellMarker_Augmented_2021__Enterocyte:Large Intestine,-0.46411496558662146,-0.9977133082110522,0.5151515151515151,1.0,1.0,9/37,18.10%,CDHR5;RARRES1;CYP3A5;IGF2BP2;STEAP1;NR1H4;TMEM45B;GPANK1;ANPEP
prerank,GO_Biological_Process_2021__negative regulation of transcription by competitive promoter binding (GO:0010944),0.605836566538468,0.99760316763531,0.5405405405405406,0.8760905905731902,1.0,4/6,22.14%,KDM2A;DACH1;CREB1;SMAD7
prerank,GO_Biological_Process_2021__mitotic DNA damage checkpoint signaling (GO:0044773),-0.4354808311163606,-0.9975906069759066,0.5138888888888888,1.0,1.0,6/53,8.63%,TICRR;DTL;CCND1;DONSON;ABRAXAS1;BRCA1
prerank,GO_Biological_Process_2021__regulation of protein localization to centrosome (GO:1904779),0.5000097373126763,0.997584584002866,0.4358974358974359,0.8757862242124271,1.0,4/9,19.79%,BICD1;CEP250;MARK4;UBXN2B
prerank,GO_Biological_Process_2021__amino sugar biosynthetic process (GO:0046349),0.464364331402003,0.99757350110571,0.4878048780487805,0.8754821076394037,1.0,6/12,27.39%,NAGK;UAP1;GNPNAT1;UAP1L1;NANP;GFPT2
prerank,Reactome_2022__Translesion Synthesis By Y Family DNA Polymerases Bypasses Lesions On DNA Template R-HSA-110313,-0.47094152295845454,-0.9975352729722112,0.49230769230769234,1.0,1.0,9/38,21.63%,PCLAF;RPA3;UBE2L6;TRIM25;POLE2;POLD4;RPS27A;POLE3;ISG15
prerank,Reactome_2022__SUMO Is Proteolytically Processed R-HSA-3065679,0.5979065989762214,0.9971678971100665,0.5510204081632653,0.8762399106536484,1.0,2/5,21.20%,SENP1;SENP5
prerank,Reactome_2022__Formation Of Tubulin Folding Intermediates By CCT/TriC R-HSA-389960,-0.512498885115752,-0.996821830006758,0.5161290322580645,1.0,1.0,12/22,29.23%,TUBA4A;CCT6B;TUBA3D;TUBB;TUBB6;TUBB2A;TUBB4A;TUBB4B;CCT6A;CCT8;CCT7;CCT2
prerank,GO_Biological_Process_2021__apical junction assembly (GO:0043297),-0.4494186386318485,-0.9966246129255173,0.47297297297297297,1.0,1.0,6/45,7.49%,MARVELD2;CTNNA1;CLDN1;CLDN6;CLDN5;CLDN2
prerank,GO_Biological_Process_2021__negative regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway (GO:2001268),-0.6463339551096935,-0.9965945823736758,0.5434782608695652,1.0,1.0,1/5,2.53%,MMP9
prerank,GO_Biological_Process_2021__phosphorylation (GO:0016310),0.31596076550379476,0.9965883383762177,0.4166666666666667,0.8774878366876231,1.0,88/362,20.31%,ERG;DGKD;GRK5;TGFBR1;MAPKAPK2;LMTK3;FGFR1;EPHA7;CDK14;DAPK2;CSK;FRK;BCKDK;ERBB2;MAML1;PAK5;CILK1;VRK2;CDK6;SGK1;EIF2AK3;FER;CDK4;ABL1;LATS1;MAST1;MAST2;MAPK8;MAP3K1;TRIB2;SIK3;TNIK;ERN1;MAP3K9;DYRK3;PKN2;CDK18;WNK2;MAP3K21;FASTK;PIM2;SGK2;MAP3K13;RET;PXK;FAM20B;MARK3;CDK11A;CDK8;RPS6KA4;MARK4;RYK;INSR;PIK3CA;BCR;CDK16;TSSK4;MAP4K2;MATK;WNK3;DGKH;NEK1;EPHB2;MARK1;ATM;BRAF;TBCK;PNKP;LIMK1;SIK2;MORC3;ADAM10;ACVR1;CLK2;PPP4R1;CREB1;CDK5;PDK1;DGKZ;PRKAA2;NIM1K;PAK3;XYLB;PRKAG2;PAK2;MARK2;PRKCE;ACVR2A
prerank,GO_Biological_Process_2021__regulation of interleukin-6 production (GO:0032675),-0.4136629841453515,-0.996586274241434,0.49295774647887325,1.0,1.0,12/67,16.67%,EOLA1;WNT5A;NLRP12;SCIMP;CYBA;TLR2;NLRC3;C1QTNF4;NOS2;AFAP1L2;F2RL1;GHRL
prerank,Reactome_2022__Biological Oxidations R-HSA-211859,0.3497443426479794,0.9965771949738753,0.42857142857142855,0.8771588694812745,1.0,33/142,15.86%,CYP1A2;PTGS1;GLYATL1;CYP7B1;CYP4V2;PODXL2;GLYATL2;PAPSS2;UGT2B15;ALDH1A1;CYP2U1;ACSS2;GSTM5;BPHL;CYP2S1;NCOA2;CHAC1;CMBL;GSTO2;GSTM2;MTR;UGDH;MAT2A;CES2;ACSM2A;ACSM1;AKR7L;GSTA4;CYB5B;GSTZ1;SULT2A1;NQO2;PTGIS
prerank,GO_Biological_Process_2021__negative regulation of tumor necrosis factor superfamily cytokine production (GO:1903556),-0.4674466490811446,-0.9965552608231695,0.49206349206349204,1.0,1.0,6/30,17.55%,ARG2;NLRC3;NR1H4;GHRL;VSIR;CACTIN
prerank,GO_Biological_Process_2021__positive regulation of biosynthetic process (GO:0009891),0.40704536961162574,0.996511903644156,0.40625,0.8769650159531229,1.0,10/35,15.67%,RAB27A;APOE;WNT4;ZBTB20;F2;GRIN1;F2R;MLXIPL;SUCO;RUNX1
prerank,CellMarker_Augmented_2021__Tumor Endothelial cell:Colon,-0.49298349816939757,-0.9964873149928517,0.44776119402985076,1.0,1.0,4/21,1.89%,CLCA2;TMPRSS11F;PNLIPRP3;FLG
prerank,CellMarker_Augmented_2021__Tumor Endothelial cell:Kidney,-0.49298349816939757,-0.9964873149928517,0.44776119402985076,1.0,1.0,4/21,1.89%,CLCA2;TMPRSS11F;PNLIPRP3;FLG
prerank,GO_Biological_Process_2021__negative regulation of fibrinolysis (GO:0051918),0.6159804518672033,0.9964378670614928,0.4864864864864865,0.8767897014990803,1.0,3/7,7.30%,APOH;SERPINE1;F2
prerank,GO_Biological_Process_2021__gland development (GO:0048732),0.3968317237689294,0.9963839171960297,0.45161290322580644,0.8765655364776181,1.0,13/47,13.81%,FGF10;TGFBR1;WNT4;PKD2;NRG1;HES1;PRKCSH;PROX1;ZBTB1;COBL;FADD;ARHGAP35;NF1
prerank,KEGG_2021_Human__Cortisol synthesis and secretion,0.37704109189263535,0.9963770711187026,0.4,0.8762129980300574,1.0,19/56,22.92%,ITPR2;CREB3L2;CREB3L4;PLCB1;SP1;KCNK2;ADCY2;LDLR;ADCY3;PBX1;ADCY6;NR4A1;CREB1;GNAQ;GNAS;GNA11;CACNA1I;SCARB1;CREB3L1
prerank,GO_Biological_Process_2021__cellular monovalent inorganic cation homeostasis (GO:0030004),-0.5178943719178722,-0.996328554988089,0.4927536231884058,1.0,1.0,5/16,19.66%,ATP1A4;ATP6AP1;LACC1;ATP4A;ATP1A1
prerank,Reactome_2022__FGFR4 Ligand Binding And Activation R-HSA-190322,-0.5611721767971953,-0.9962906617354782,0.5172413793103449,1.0,1.0,1/10,0.93%,FGF20
prerank,Reactome_2022__Cohesin Loading Onto Chromatin R-HSA-2470946,0.556731628468889,0.9961808451193581,0.48717948717948717,0.8764359576262585,1.0,5/10,30.51%,PMEPA1;MAU2;NIPBL;SMC3;PDS5A
prerank,GO_Biological_Process_2021__positive regulation of stress-activated MAPK cascade (GO:0032874),0.3741019342655253,0.9961703906830849,0.47368421052631576,0.8760959939117415,1.0,17/80,16.19%,RASSF2;DUSP15;CCN2;MID1;TNFRSF19;SH3RF1;HMGB1;CARD9;SH3RF3;PLCB1;MAP3K10;GDF6;KLHDC10;MFHAS1;GADD45A;MAP4K2;RELL1
prerank,GO_Biological_Process_2021__cardiac muscle tissue development (GO:0048738),-0.4400875871410887,-0.9959778726866981,0.4266666666666667,1.0,1.0,10/40,19.50%,SCN5A;ACTC1;CSRP3;ZFPM1;HEY2;TTN;GATA4;AKAP13;MESP1;SGCG
prerank,GO_Biological_Process_2021__positive regulation of interleukin-4 production (GO:0032753),-0.5555862147327124,-0.9956277765079259,0.5522388059701493,1.0,1.0,4/14,20.41%,IRF4;NLRP3;ZP3;CD86
prerank,Reactome_2022__PINK1-PRKN Mediated Mitophagy R-HSA-5205685,-0.5142666007557068,-0.9956072265174634,0.4716981132075472,1.0,1.0,5/20,18.03%,PINK1;TOMM20;TOMM7;VDAC1;RPS27A
prerank,GO_Biological_Process_2021__negative regulation of receptor signaling pathway via JAK-STAT (GO:0046426),0.5415805506154054,0.9954621881031519,0.5294117647058824,0.8777067539248063,1.0,4/12,23.79%,ADIPOR1;PIBF1;BCL3;NF2
prerank,GO_Biological_Process_2021__RNA 3'-end processing (GO:0031123),0.3939285506038435,0.995395752927474,0.2413793103448276,0.8775499014236522,1.0,15/62,20.81%,CPSF1;PCF11;TENT4A;U2AF1;SRRM1;LIN28B;CPSF7;SRSF4;PNPT1;PAPOLA;RPRD2;EIF4A3;U2AF2;SYMPK;TUT7
prerank,GO_Biological_Process_2021__positive regulation of glucose metabolic process (GO:0010907),0.5085216948480158,0.9952229052546541,0.47058823529411764,0.8776680935871671,1.0,4/13,10.67%,IRS1;SIRT1;AKT2;IRS2
prerank,GO_Biological_Process_2021__histone deubiquitination (GO:0016578),0.44095049490275806,0.9951756744838317,0.3870967741935484,0.8774564240368644,1.0,7/19,22.04%,BRCC3;USP36;USP16;USP51;SUPT3H;USP15;ATXN7
prerank,Reactome_2022__Chromatin Modifying Enzymes R-HSA-3247509,0.33818106206651366,0.995109478896389,0.3684210526315789,0.8772205101195859,1.0,56/206,22.22%,SMYD2;HDAC3;HDAC10;JADE3;GATAD2A;SMARCD3;PAX3;H2BC21;NCOA2;KDM7A;SMARCB1;CDK4;TAF12;PBRM1;ARID1A;MSL2;KDM2A;NSD1;SMARCA2;KDM3B;SMARCA4;KMT5C;SAP130;KAT6A;DPY30;ARID2;HDAC1;GATAD2B;CHD4;CARM1;H2AX;NFKB1;KMT5B;SETD2;ASH1L;ARID5B;ATF7IP;ARID1B;PRMT5;SUPT3H;EP300;JADE2;KAT14;KAT2B;H2AJ;KAT6B;BRMS1L;KMT2C;TBL1X;PRDM16;RBBP4;BRWD1;SUV39H2;ATXN7;ELP3;SETD7
prerank,GO_Biological_Process_2021__positive regulation of neutrophil migration (GO:1902624),0.46868213164124684,0.9950270166335283,0.5135135135135135,0.8771007224951229,1.0,5/17,22.57%,DAPK2;MCU;MOSPD2;ADAM8;THBS4
prerank,GO_Biological_Process_2021__somite development (GO:0061053),-0.5788206665011152,-0.9949407316642095,0.5714285714285714,1.0,1.0,1/9,6.15%,PPP2R3A
prerank,GO_Biological_Process_2021__regulation of cyclic-nucleotide phosphodiesterase activity (GO:0051342),-0.6458310808324729,-0.9946955719135914,0.4918032786885246,1.0,1.0,3/5,28.29%,CALM1;CALM3;RACK1
prerank,GO_Biological_Process_2021__alditol phosphate metabolic process (GO:0052646),0.6794214304151376,0.9945679727907373,0.5869565217391305,0.878017912687188,1.0,1/5,12.29%,GPD1
prerank,CellMarker_Augmented_2021__Nucleus Pulposus cell:Intervertebral Disc,0.3600817676236278,0.9944832910057386,0.4,0.8779344786065381,1.0,26/88,16.17%,FIBIN;PDLIM3;ADAMTS1;MYO10;LAMA4;PARVA;ITGA8;PDE10A;COL12A1;PCDH7;ARHGAP20;SLIT2;EDNRA;SNAI2;GUCY1A2;PDZRN3;RBMS3;RNF150;PAMR1;FOXF2;BMPER;NR2F2;CDH11;ANTXR1;CALD1;COL6A3
prerank,GO_Biological_Process_2021__stress granule disassembly (GO:0035617),0.5900429784335202,0.9944217939892904,0.5151515151515151,0.8777475089524835,1.0,1/5,9.86%,DYRK3
prerank,Reactome_2022__Extracellular Matrix Organization R-HSA-1474244,-0.37748766498035136,-0.9944120923630744,0.4588235294117647,1.0,1.0,40/243,12.27%,CD44;TGFB1;ITGB2;MMP9;CAPN8;MMP19;SCUBE3;COL18A1;NID1;COL1A1;SDC2;COL5A1;P4HA3;COL27A1;CAPN12;LOX;VTN;DCN;ICAM3;ASPN;CEACAM1;COL4A4;ITGA9;TNXB;COL4A3;PLG;FBN3;LOXL4;THBS1;MATN4;ITGA2B;CEACAM8;PXDN;LRP4;LAMC2;FBN2;ITGAM;COL6A6;ITGB6;COL23A1
prerank,GO_Biological_Process_2021__positive regulation of protein kinase B signaling (GO:0051897),0.35012490003308644,0.9943250032628449,0.38095238095238093,0.8776216100010763,1.0,24/133,9.81%,FGF10;THEM4;TGFBR1;KIT;FGFR1;IRS1;ANGPT1;HIP1;NRG2;SEMA5A;CX3CR1;FGF17;AKR1C3;ERBB2;NRG1;HPSE;MYORG;FGF18;TGFA;CASS4;HCLS1;AKT2;FGFR3;KITLG
prerank,GO_Biological_Process_2021__antiviral innate immune response (GO:0140374),-0.5818509108253742,-0.994245694446302,0.5362318840579711,1.0,1.0,4/11,26.42%,IFIT1;OAS1;MX1;RNF135
prerank,CellMarker_Augmented_2021__Sertoli cell:Seminal Plasma,-0.4235140348194359,-0.994199729226171,0.4626865671641791,1.0,1.0,19/66,16.59%,AMBP;F7;ITIH2;SMLR1;SERPIND1;VTN;DAO;CPB2;SLC22A7;CP;AQP4;PON1;HPR;ITIH3;SLC25A18;FGL1;CYP2E1;AGT;ANGPTL3
prerank,Reactome_2022__Alpha-protein Kinase 1 Signaling Pathway R-HSA-9645460,0.5177322616461304,0.9940812183464094,0.5277777777777778,0.8778733541825731,1.0,5/11,20.40%,ALPK1;TAB3;TAB1;TAB2;TRAF6
prerank,CellMarker_Augmented_2021__Gonadal Mitotic Phase Fetal Germ cell:Fetal Gonad,0.32878628713725333,0.9936129834315377,0.42857142857142855,0.8788187987564726,1.0,23/255,9.04%,COL22A1;PNP;TEAD2;RASSF2;ELOVL6;ACADS;KIT;CFLAR;APOE;SLC3A2;MMP2;PRELP;FAM162B;BPHL;CYP2S1;DHTKD1;NANOS3;MVB12A;FLNA;ESRP1;CATSPERG;SNRPB;NSMAF
prerank,GO_Biological_Process_2021__detection of bacterium (GO:0016045),-0.563764096785507,-0.9935626688309805,0.46808510638297873,1.0,1.0,5/9,16.86%,HLA-A;HLA-DRB1;NLRC4;NAIP;PGLYRP1
prerank,GO_Biological_Process_2021__regulation of mitochondrial membrane permeability (GO:0046902),0.5180325783925156,0.993249221400025,0.4375,0.8792828057664606,1.0,2/16,2.31%,THEM4;BCL2
prerank,GO_Biological_Process_2021__skeletal system morphogenesis (GO:0048705),0.43824724707114976,0.9930980559684526,0.43902439024390244,0.8793754372386344,1.0,7/22,9.62%,TGFBR1;FGFR1;DSCAML1;SPEF2;WWOX;LRP6;FGFR3
prerank,GO_Biological_Process_2021__SREBP signaling pathway (GO:0032933),0.570215251951818,0.9930177584193773,0.5714285714285714,0.8792308941809911,1.0,6/8,36.03%,SREBF2;ARHGEF10L;ERLIN1;INSIG1;ERLIN2;SCAP
prerank,Reactome_2022__Regulation Of Gene Expression In Early Pancreatic Precursor Cells R-HSA-210747,0.6436297586046985,0.9929339826298227,0.56,0.8790803915439309,1.0,1/5,1.19%,FGF10
prerank,GO_Biological_Process_2021__regulation of integrin-mediated signaling pathway (GO:2001044),0.5203888909229389,0.9927224511144846,0.48717948717948717,0.8792276631523454,1.0,4/12,11.91%,TIMP1;FLNA;PHACTR4;LIMS1
prerank,GO_Biological_Process_2021__positive regulation of protein ubiquitination (GO:0031398),0.3982261625657584,0.9926939520778876,0.48148148148148145,0.8789436985356736,1.0,7/69,7.00%,HDAC3;PRICKLE1;ANGPT1;RIPK2;COMMD1;CRY1;DCUN1D1
prerank,GO_Biological_Process_2021__regulation of cellular carbohydrate metabolic process (GO:0010675),0.5112180430304586,0.9926319675659093,0.4318181818181818,0.8787024515351105,1.0,4/15,10.25%,RORA;BCKDK;SIRT1;ADIPOR1
prerank,Reactome_2022__GP1b-IX-V Activation Signaling R-HSA-430116,-0.6084959823841254,-0.9925866341858184,0.5423728813559322,1.0,1.0,2/6,10.59%,GP1BA;VWF
prerank,GO_Biological_Process_2021__L-ornithine transmembrane transport (GO:1903352),-0.6460998869351163,-0.9924734313656307,0.5833333333333334,1.0,1.0,1/5,5.15%,SLC7A3
prerank,Reactome_2022__Synthesis Of 15-Eicosatetraenoic Acid Derivatives R-HSA-2142770,-0.6240516204091004,-0.9923179635095432,0.6,1.0,1.0,3/6,16.51%,ALOX15;GPX2;ALOX15B
prerank,CellMarker_Augmented_2021__Mesenchymal Stem cell:Oral Mucosa,0.35710908823415066,0.9922439587034713,0.5,0.8793290014102303,1.0,10/77,7.37%,ERG;FIBIN;LAMA4;MXRA5;MRGPRF;CDH5;SSC5D;MMP2;OLFML2B;FGD5
prerank,Reactome_2022__SUMOylation Of Intracellular Receptors R-HSA-4090294,0.41562243389210163,0.9921413761219909,0.4,0.879227281493507,1.0,9/25,17.36%,RORA;PPARG;NR4A2;NR3C2;NR3C1;THRB;HDAC4;NR1H3;NR2C1
prerank,CellMarker_Augmented_2021__Corneal Epithelial Stem cell:Eye,0.4274480970480544,0.9921085508115616,0.4418604651162791,0.8789255905916677,1.0,1/25,0.04%,ADGRF4
prerank,CellMarker_Augmented_2021__Endothelial cell:Embryonic Brain,-0.43890883496800603,-0.9918520568279937,0.5301204819277109,1.0,1.0,17/58,14.86%,C1QB;LYVE1;TNFRSF1B;SLCO2B1;MS4A4A;FCGR3A;CLDN5;ZNF366;VSIG4;SELP;VWF;GPIHBP1;FPR3;F13A1;A2M;GGT5;ADGRF5
prerank,GO_Biological_Process_2021__sympathetic nervous system development (GO:0048485),-0.5658209293129897,-0.9917267883094013,0.5084745762711864,1.0,1.0,2/12,7.50%,SEMA3F;SEMA3A
prerank,GO_Biological_Process_2021__positive regulation of amyloid-beta formation (GO:1902004),0.5093903105391383,0.9916948863067088,0.4444444444444444,0.8796664244090581,1.0,3/16,7.93%,LRRTM3;SP1;CASP3
prerank,CellMarker_Augmented_2021__Plasmablast:Blood,-0.44886668666082513,-0.9915640255208151,0.4647887323943662,1.0,1.0,12/60,10.28%,SIRPG;GMFG;CYTIP;ARHGAP9;TAGAP;KLRB1;SCML4;ARHGAP15;PARVG;CD5;TRAF3IP3;PTPRC
prerank,GO_Biological_Process_2021__aorta morphogenesis (GO:0035909),-0.5462511938881627,-0.9915313438543698,0.5806451612903226,1.0,1.0,3/14,14.16%,TBX1;ENG;HEY2
prerank,CellMarker_Augmented_2021__Regulatory T (Treg) cell:Peripheral Blood,0.3896242947646842,0.9913915562464519,0.46153846153846156,0.8801037925585924,1.0,2/42,0.98%,SELPLG;FANK1
prerank,GO_Biological_Process_2021__cellular response to amino acid starvation (GO:0034198),0.3763784437973054,0.9913866519139851,0.5,0.8797476194333159,1.0,7/68,8.73%,ATP6V0D2;TCIRG1;KPTN;EIF2AK3;MAPK8;MLST8;RNF152
prerank,GO_Biological_Process_2021__positive regulation of integrin activation (GO:0033625),-0.5676112530337287,-0.9912755457897817,0.5142857142857142,1.0,1.0,2/11,3.57%,P2RY12;CXCL13
prerank,GO_Biological_Process_2021__cellular response to oxygen-containing compound (GO:1901701),0.30529382030582564,0.9911687181613793,0.5,0.879918294605724,1.0,39/247,10.68%,IRGM;SLC26A3;FOXO1;CPEB1;RORA;IRS1;BRINP3;KCNC2;CD14;HTRA2;PID1;TICAM2;DRD5;CX3CR1;AKR1C3;RORB;SERPINE1;PKD2;CAPN2;WNT9A;HCN1;HMGB1;NCOA3;EPHA3;RAPGEF1;ZNF703;FER;NRIP1;MAPK8;SLIT2;ABL2;WNT3A;AANAT;LPL;BRINP1;MTR;PDE4B;AKAP9;ADNP2
prerank,GO_Biological_Process_2021__plasma membrane bounded cell projection organization (GO:0120036),0.34199629135083615,0.9908974984095775,0.38095238095238093,0.8802703307845361,1.0,21/112,16.01%,GPRIN3;TTC29;GPRIN1;APOE;NLGN1;CNTNAP2;PKD2;SAMD14;HMGB1;FAM161B;PTPRM;TTC17;RAB35;PPP1R9B;MNS1;MARK4;RYK;CDK16;PPP1R9A;BICDL1;FRY
prerank,GO_Biological_Process_2021__positive regulation of NK T cell activation (GO:0051135),-0.6207064084630802,-0.990855003687583,0.5294117647058824,1.0,1.0,3/5,18.62%,IL12A;IL18;HSPH1
prerank,Reactome_2022__VEGF Binds To VEGFR Leading To Receptor Dimerization R-HSA-195399,0.5705471958009418,0.9904527200874522,0.5625,0.8811361217863027,1.0,1/6,2.12%,VEGFC
prerank,GO_Biological_Process_2021__DNA geometric change (GO:0032392),-0.4995688292658216,-0.9904385395844606,0.5230769230769231,1.0,1.0,7/26,22.47%,HMGB3;ANXA1;PIF1;DDX1;RECQL4;DDX11;BLM
prerank,GO_Biological_Process_2021__positive regulation of sodium ion transmembrane transporter activity (GO:2000651),0.4666557657692188,0.9904178067631524,0.4411764705882353,0.8808707833773347,1.0,7/13,24.81%,DRD4;WNK2;TESC;WNK3;DMD;WNK1;ANK3
prerank,CellMarker_Augmented_2021__Cholinergic neuron:Undefined,0.3506318581585367,0.9903334791493549,0.37142857142857144,0.8807385973233283,1.0,18/91,16.63%,XKR7;TRIM67;DUSP15;HRH3;ELAVL3;KCNIP1;ADGRA1;ELAVL4;OLFM3;CRABP1;FBLL1;ASCL1;SNAP91;MSI1;SCRT1;ACHE;EFNA2;MAGEL2
prerank,GO_Biological_Process_2021__ventricular compact myocardium morphogenesis (GO:0003223),0.6593048586510951,0.9903213618529529,0.6086956521739131,0.8804253120577458,1.0,2/5,6.95%,TGFBR1;DSP
prerank,GO_Biological_Process_2021__nucleus organization (GO:0006997),0.3902347907095123,0.9903144508773721,0.3793103448275862,0.8800941663638394,1.0,5/42,11.72%,CTDNEP1;BIN1;CHMP6;IRAG2;USP36
prerank,GO_Biological_Process_2021__positive regulation of triglyceride lipase activity (GO:0061365),0.6592485666745929,0.990143220651979,0.54,0.8799515047942322,1.0,1/5,1.08%,APOH
prerank,GO_Biological_Process_2021__positive regulation of lipoprotein lipase activity (GO:0051006),0.6592485666745929,0.990143220651979,0.54,0.8799515047942322,1.0,1/5,1.08%,APOH
prerank,Reactome_2022__Amino Acid Transport Across Plasma Membrane R-HSA-352230,0.4132453556483811,0.99011697349713,0.4444444444444444,0.8796571332511446,1.0,9/29,11.22%,SLC38A5;SLC3A2;SLC7A9;SLC16A10;SLC6A20;SLC7A11;SLC7A6;SLC25A29;SLC7A8
prerank,Reactome_2022__Mitophagy R-HSA-5205647,-0.4693000961670948,-0.9899601491911717,0.515625,1.0,1.0,9/25,25.97%,PINK1;TOMM20;TOMM7;VDAC1;RPS27A;FUNDC1;PGAM5;CSNK2A2;ULK1
prerank,GO_Biological_Process_2021__peptidyl-proline hydroxylation (GO:0019511),0.5577689232538594,0.9899063761753361,0.42857142857142855,0.8799416898001063,1.0,2/9,4.82%,EGLN3;P3H2
prerank,Reactome_2022__KSRP (KHSRP) Binds And Destabilizes mRNA R-HSA-450604,0.46920634609703843,0.9898872444010036,0.42105263157894735,0.879617431307717,1.0,7/16,27.48%,EXOSC1;KHSRP;DIS3;EXOSC5;EXOSC9;YWHAZ;AKT1
prerank,GO_Biological_Process_2021__acetyl-CoA biosynthetic process (GO:0006085),0.5629325804214429,0.9897032855748579,0.4857142857142857,0.8797030099008598,1.0,4/9,28.32%,PPCS;PDHA1;DLAT;MLYCD
prerank,Reactome_2022__Signaling By High-Kinase Activity BRAF Mutants R-HSA-6802948,0.44280785276374934,0.9895980123844929,0.35714285714285715,0.8796199385402448,1.0,7/28,13.66%,KSR1;CSK;ARRB2;CNKSR2;RAP1A;MARK3;ARRB1
prerank,Reactome_2022__Cellular Response To Starvation R-HSA-9711097,-0.3879327093897124,-0.9895888688810798,0.475,1.0,1.0,66/139,27.12%,RPL37A;ATP6V1G2;ATP6V1C2;ATP6V1D;RPL38;DEPDC5;RPL15;ATP6V0E2;RPS4X;RPL3;RRAGA;RPL35A;RPS9;FAU;RPS27;RPS21;ATP6V1E1;RPL13A;RPL27A;EIF2S3;RPS16;RPL36;RPS20;RPL7A;RPL9;EIF2S2;RPS8;RPS27A;RPL21;RPL34;RPL4;RPL32;RPL5;RPL23;RPL41;RPS7;RPS11;RPL27;RPL35;RPS14;RPL11;SEC13;RPS15;WDR24;RPLP1;RPS12;RPL18A;RPS13;RPL29;RPLP2;RPL28;RPL12;RPL18;RPS3;RPL22;RPSA;RPS28;RPS19;RPS24;ATP6V0D1;RPL26L1;LAMTOR1;RPS3A;RPL19;RPL8;RPS6
prerank,GO_Biological_Process_2021__positive regulation of epidermal growth factor-activated receptor activity (GO:0045741),0.6024323332199661,0.9893617345288686,0.4634146341463415,0.8800424738073164,1.0,1/6,8.52%,TGFA
prerank,"GO_Biological_Process_2021__negative regulation of gene expression, epigenetic (GO:0045814)",0.4293109219891149,0.98934221694314,0.5555555555555556,0.8797367440490969,1.0,2/27,4.97%,SMYD5;DNMT1
prerank,GO_Biological_Process_2021__UDP-N-acetylglucosamine biosynthetic process (GO:0006048),0.44680689495511683,0.9892546970910363,0.5777777777777777,0.8795515299147936,1.0,5/11,27.39%,NAGK;UAP1;GNPNAT1;UAP1L1;GFPT2
prerank,GO_Biological_Process_2021__regulation of type B pancreatic cell proliferation (GO:0061469),0.604348866788053,0.9892253031974478,0.5365853658536586,0.8792823095287093,1.0,3/6,23.83%,NR4A3;NR4A1;NR1D1
prerank,Reactome_2022__Protein Methylation R-HSA-8876725,-0.5547728868784301,-0.9891114329579949,0.5303030303030303,1.0,1.0,7/17,19.01%,HSPA8;ETFBKMT;EEF2;ETFB;CALM1;EEF1AKMT2;EEF2KMT
prerank,GO_Biological_Process_2021__DNA-dependent DNA replication (GO:0006261),-0.380149141498466,-0.9890976162710584,0.475,1.0,1.0,22/117,22.47%,MCM2;PSMB9;RPA3;MCM3;CDK2AP1;MCMDC2;POLE2;PSMA3;POLD4;RPS27A;CDC6;PSMA7;PSMB6;RECQL4;HMGA1;ORC6;TOPBP1;POLE3;RPA2;PSMA5;BAZ1A;BLM
prerank,GO_Biological_Process_2021__negative regulation of smooth muscle cell proliferation (GO:0048662),-0.5227365581420191,-0.9887288496192648,0.5151515151515151,1.0,1.0,7/23,14.43%,OGN;GPER1;SOD2;CDKN1A;APOD;IL12A;TGFB3
prerank,GO_Biological_Process_2021__regulation of cell cycle G1/S phase transition (GO:1902806),-0.4779778974684765,-0.9884612545235847,0.4264705882352941,1.0,1.0,2/30,12.07%,KIF14;CDKN1A
prerank,Reactome_2022__Butyrophilin (BTN) Family Interactions R-HSA-8851680,0.48960884965737966,0.9883961652958557,0.4222222222222222,0.8811283547272979,1.0,1/11,1.91%,BTN3A2
prerank,GO_Biological_Process_2021__regulation of cell death (GO:0010941),0.3677932722652247,0.9882341163529368,0.4482758620689655,0.8811289987710539,1.0,18/85,13.33%,CCN4;CCN2;SLFN11;CCN1;RIPK2;AKR1C3;SNCA;SRGAP2;RRAS2;SARM1;DCC;ACER2;SLC25A24;ACER3;ADNP2;NOA1;HSPA1A;RILPL1
prerank,GO_Biological_Process_2021__organic cyclic compound biosynthetic process (GO:1901362),-0.4756145632277498,-0.9881620315516515,0.5,1.0,1.0,4/26,19.39%,ALOX5;CYP21A2;HSD3B1;CYP17A1
prerank,GO_Biological_Process_2021__response to mitochondrial depolarisation (GO:0098780),-0.6679806016215499,-0.9881589529321988,0.5614035087719298,1.0,1.0,2/5,18.76%,ATG14;GPS2
prerank,GO_Biological_Process_2021__epidermal cell differentiation (GO:0009913),0.4147785292542412,0.988158727448491,0.5,0.8809795462842834,1.0,7/34,7.93%,CSTA;AKR1C3;JAG1;USH2A;DSP;LORICRIN;CASP3
prerank,GO_Biological_Process_2021__negative regulation of B cell differentiation (GO:0045578),-0.6707449090563896,-0.9880400376642522,0.5490196078431373,1.0,1.0,4/5,32.18%,INHA;SFRP1;INHBA;CR1
prerank,GO_Biological_Process_2021__melanocyte differentiation (GO:0030318),0.5355164217135162,0.9880049309440082,0.47368421052631576,0.8811362867407869,1.0,3/10,9.70%,KIT;MITF;LRMDA
prerank,GO_Biological_Process_2021__regulation of cysteine-type endopeptidase activity (GO:2000116),-0.5201867745519617,-0.9880039132871994,0.5238095238095238,1.0,1.0,5/18,9.30%,PSMB9;AIM2;NLRP12;BEX3;USP50
prerank,GO_Biological_Process_2021__positive regulation of macrophage proliferation (GO:0120041),-0.671637543582969,-0.9878445735066227,0.6226415094339622,1.0,1.0,2/5,30.71%,CSF1R;MAPK3
prerank,GO_Biological_Process_2021__branching involved in ureteric bud morphogenesis (GO:0001658),0.560996509627478,0.987826470345613,0.5,0.881238910269998,1.0,5/12,25.76%,PKD2;MYC;BMP4;BMP2;SHH
prerank,GO_Biological_Process_2021__regulation of IRE1-mediated unfolded protein response (GO:1903894),-0.5753722829992121,-0.9877818753369325,0.5362318840579711,1.0,1.0,4/14,26.06%,COPS5;HSPA5;UFL1;DDRGK1
prerank,GO_Biological_Process_2021__negative regulation of cell cycle (GO:0045786),0.38246456027388354,0.9877413031975615,0.36363636363636365,0.8810955900544101,1.0,16/67,15.21%,GMNC;SCRIB;BRINP3;HTRA2;HEXIM2;TRIM35;PPP1R13B;CDK6;LATS1;SIPA1;BRINP1;NLRP2B;HECA;NR2F2;RPS6KA2;MEN1
prerank,CellMarker_Augmented_2021__T Helper17 (Th17) cell:Undefined,-0.5416239278074529,-0.9876783272112097,0.48333333333333334,1.0,1.0,4/16,3.99%,AHR;IL21R;IRF4;KLRB1
prerank,Reactome_2022__Gene And Protein Expression By JAK-STAT Signaling After Interleukin-12 Stimulation R-HSA-8950505,0.4183462033051739,0.9876625474280707,0.4411764705882353,0.8809943442117817,1.0,4/27,10.13%,LMNB1;HNRNPF;RALA;PKN2
prerank,GO_Biological_Process_2021__regulation of lipid metabolic process (GO:0019216),0.3864400064484195,0.9873587582746551,0.4117647058823529,0.8814204594856737,1.0,16/78,15.72%,ELOVL6;HDAC3;RORA;SMARCD3;PPARG;NCOA2;ACACB;SP1;ADIPOR1;IRS2;SC5D;CHD9;CARM1;NFYC;TM7SF2;OPA3
prerank,PanglaoDB_Augmented_2021__Pericytes,-0.3903777929156519,-0.9873172759049867,0.5128205128205128,1.0,1.0,24/124,14.86%,C1QTNF1;LMOD1;TIMP3;ECM2;ANGPTL2;ANGPT2;COL1A1;PDE5A;VTN;ADAM33;DAAM2;DCN;ASPN;P2RY14;GPIHBP1;ATP13A5;STEAP4;HSD11B1;MFGE8;COX7A1;TEK;C1S;ACTA2;ADGRF5
prerank,GO_Biological_Process_2021__negative regulation of cellular metabolic process (GO:0031324),-0.4606506549662593,-0.9872988587082097,0.4461538461538462,1.0,1.0,6/31,13.30%,RIN3;LRPAP1;PINK1;BRCA1;PTX3;EDNRB
prerank,Reactome_2022__SUMOylation Of Chromatin Organization Proteins R-HSA-4551638,0.42312597759131765,0.9871547263255245,0.43333333333333335,0.8816006673829592,1.0,13/50,23.62%,NUP210;PHC2;NUP42;AAAS;SCMH1;HDAC1;HDAC4;SATB2;RANBP2;RNF2;NUP214;TPR;SEH1L
prerank,GO_Biological_Process_2021__positive regulation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0043280),0.3618143216203525,0.9871516260770172,0.43478260869565216,0.8812658470726492,1.0,21/96,14.12%,NGF;EGLN3;CFLAR;HIP1;HTRA2;PPARG;SIRT1;SNCA;HMGB1;ACER2;CARD9;EIF2AK3;MYC;SENP1;ANP32B;F2R;LGALS9;FADD;CRADD;CASP8AP2;BID
prerank,CellMarker_Augmented_2021__Myofibroblast:Lung,0.33177553329488924,0.987127617844121,0.5416666666666666,0.8809791716446334,1.0,11/84,7.93%,FIBIN;TPM2;LAMA4;MXRA5;MRGPRF;COL12A1;SSC5D;ADAMTS12;MMP2;CNN1;EDNRA
prerank,GO_Biological_Process_2021__negative regulation of G2/M transition of mitotic cell cycle (GO:0010972),-0.42011845713558776,-0.9871241084200749,0.46153846153846156,1.0,1.0,19/56,29.05%,PSMB9;FBXL7;RBX1;PSMA3;PSMA7;PSMB6;RFPL1;PSMA5;AURKA;PSMD6;CHEK1;SKP1;PSMC5;PSMB4;PSMB7;PSMD8;GPR132;VPS4A;PSMD3
prerank,Reactome_2022__Nef-mediated Downmodulation Of Cell Surface Receptors By Recruitment To Clathrin Adapters R-HSA-164938,-0.5122862613987528,-0.9871187434888242,0.49230769230769234,1.0,1.0,3/19,17.98%,HLA-A;CD4;CD8B
prerank,CellMarker_Augmented_2021__Enteroendocrine cell:Large Intestine,0.36007115494812003,0.9870385771816934,0.5,0.8807884412310464,1.0,31/88,23.49%,FRK;BMS1P1;FAM228B;FER;AKAP9;GAN;MFSD11;SLC35E3;C4ORF36;MIPOL1;PTGR2;SHPRH;ZC3H14;FRAS1;NEDD4;TMEM45A;TBC1D8B;LCLAT1;ASTN2;RASEF;TMEM67;TRIP11;MYO9A;CFAP69;ABCC9;BRWD1;LRRTM4;ZNF268;EFHC1;ADAM32;BMPR1A
prerank,"GO_Biological_Process_2021__regulation of retrograde transport, endosome to Golgi (GO:1905279)",0.6160899364642909,0.9870368334158273,0.5116279069767442,0.8804364074815535,1.0,3/6,31.78%,ARFIP1;ATP9A;EIPR1
prerank,"GO_Biological_Process_2021__nucleotide-excision repair, preincision complex assembly (GO:0006294)",-0.4561472572898326,-0.9869692430926903,0.4857142857142857,1.0,1.0,6/26,24.92%,RPA3;RBX1;RPS27A;RPA2;DDB1;CDK7
prerank,Reactome_2022__Biotin Transport And Metabolism R-HSA-196780,0.5185646565725853,0.9869354496662877,0.4838709677419355,0.8803895052422913,1.0,5/10,24.93%,ACACB;PDZD11;PCCA;MCCC1;ACACA
prerank,GO_Biological_Process_2021__regulation of synaptic vesicle recycling (GO:1903421),0.6705787880468782,0.9866665574434673,0.5806451612903226,0.8806593190766578,1.0,3/5,27.48%,SNCA;CDK5;ROCK1
prerank,GO_Biological_Process_2021__positive regulation of immune response (GO:0050778),-0.4257640450089226,-0.9866629812444201,0.4931506849315068,1.0,1.0,15/52,18.85%,ITGB2;IFNK;GPR151;CYBA;HLA-DRB1;PTPRC;ITGAM;NLRP3;SH2D1B;ZP3;GRN;F2RL1;IFI35;CD81;SASH3
prerank,Reactome_2022__Iron Uptake And Transport R-HSA-917937,0.37548577002037437,0.9865486977169272,0.43333333333333335,0.8806243106634085,1.0,4/51,5.23%,ATP6V0D2;TCIRG1;ACO1;FLVCR1
prerank,GO_Biological_Process_2021__negative regulation of leukocyte chemotaxis (GO:0002689),-0.5528968619195198,-0.98643711519428,0.5423728813559322,1.0,1.0,1/10,2.49%,RIN3
prerank,GO_Biological_Process_2021__membrane protein proteolysis (GO:0033619),-0.47076101354651767,-0.9863873746938332,0.5068493150684932,1.0,1.0,2/32,6.25%,TGFB1;BACE2
prerank,GO_Biological_Process_2021__regulation of T cell receptor signaling pathway (GO:0050856),-0.4641160520833013,-0.9862264853966063,0.56,1.0,1.0,4/29,12.99%,CD160;CEACAM1;GBP1;TESPA1
prerank,GO_Biological_Process_2021__negative regulation of stress fiber assembly (GO:0051497),0.443016871846697,0.9862240091971354,0.45652173913043476,0.8811983007425949,1.0,3/22,11.41%,PHLDB2;CGNL1;WASF2
prerank,GO_Biological_Process_2021__limb development (GO:0060173),0.4889367797894796,0.9861641042582449,0.4,0.8809840677246304,1.0,6/24,19.29%,FGF10;GREM1;RSPO2;ZNRF3;PTCH1;KAT2B
prerank,GO_Biological_Process_2021__regulation of dopamine metabolic process (GO:0042053),-0.5993931542413975,-0.9859569862887841,0.5084745762711864,1.0,1.0,2/6,11.77%,ITGB2;ITGAM
prerank,GO_Biological_Process_2021__regulation of B cell proliferation (GO:0030888),-0.44167913421296506,-0.9858272708815125,0.4927536231884058,1.0,1.0,6/33,6.30%,AHR;BLK;VAV3;CLCF1;GPR183;IL7
prerank,GO_Biological_Process_2021__mitochondrial fusion (GO:0008053),0.5128698893149912,0.9856007938160859,0.5151515151515151,0.882267355718038,1.0,2/18,4.88%,PLD6;GDAP1
prerank,CellMarker_Augmented_2021__Hepatocyte:Fetal Liver,0.35077469184482846,0.985583016688275,0.5714285714285714,0.8819514936487348,1.0,21/84,15.15%,ADGRG6;SDC4;PARVA;PERP;MID1;ERBB2;NTN4;DSP;RAI14;RND3;RNF128;DDAH1;TSPAN6;EPS8L2;LRIG3;TEAD4;NR2F2;MAGI1;WWTR1;BCAM;PTPRF
prerank,GO_Biological_Process_2021__negative regulation of vascular endothelial growth factor receptor signaling pathway (GO:0030948),-0.5480313613764553,-0.9855051432640173,0.5074626865671642,1.0,1.0,1/10,5.54%,CNMD
prerank,Reactome_2022__Cilium Assembly R-HSA-5617833,0.34805878221583064,0.9854863800151868,0.3333333333333333,0.881856432311621,1.0,52/171,24.52%,PCM1;IFT88;CEP152;CEP135;CNTRL;SCLT1;BBS9;DYNLT5;ALMS1;DYNC1I2;CNGA4;SDCCAG8;C2CD3;MAPRE1;RPGRIP1L;CEP290;NUDT19;BBS12;AKAP9;CEP250;RAB11FIP3;MKS1;ARL13B;EXOC7;MARK4;CEP41;CEP162;IFT140;TTC21B;ARL3;KIF3B;BBIP1;PDE6D;UNC119B;TMEM67;EXOC6;CDK5RAP2;TRIP11;WDR19;IQCB1;FBF1;EXOC4;CEP192;SSTR3;ASAP1;WDR35;IFT57;PLK1;TCTN2;HAUS1;CLUAP1;BBS10
prerank,GO_Biological_Process_2021__relaxation of cardiac muscle (GO:0055119),0.5076677568046973,0.9852273102914532,0.5714285714285714,0.8820951177202182,1.0,3/13,14.95%,SLC8A1;GSTM2;PIK3CA
prerank,GO_Biological_Process_2021__cellular response to angiotensin (GO:1904385),0.610080921212053,0.9851007888382477,0.5555555555555556,0.882137063796842,1.0,3/7,15.23%,SLC30A10;NFKB1;CA2
prerank,CellMarker_Augmented_2021__pro-Natural Killer Cell (pro-NK cell):Peripheral Blood,0.3790406720212087,0.9847189733776359,0.5,0.8828219727612097,1.0,8/56,4.95%,GPRIN3;CD247;AOAH;CD14;CX3CR1;CCL3L3;CCL4L2;C1ORF162
prerank,GO_Biological_Process_2021__regulation of actin filament length (GO:0030832),-0.6049643779898145,-0.9845182830698201,0.47692307692307695,1.0,1.0,2/6,7.99%,WAS;NEB
prerank,GO_Biological_Process_2021__positive regulation of interleukin-13 production (GO:0032736),-0.615857363656498,-0.9844676332851827,0.5818181818181818,1.0,1.0,2/9,15.16%,IRF4;IL18
prerank,Reactome_2022__SHC-mediated cascade:FGFR3 R-HSA-5654704,-0.555377412046371,-0.9844487730774019,0.578125,1.0,1.0,1/14,0.93%,FGF20
prerank,GO_Biological_Process_2021__positive regulation of filopodium assembly (GO:0051491),0.4213999301777541,0.9842934618929793,0.5161290322580645,0.8835063368497105,1.0,10/24,24.95%,NLGN1;RALA;TENM1;FSCN1;MIEN1;DOCK11;PLPPR5;PALM;GPM6A;TENM2
prerank,Reactome_2022__COPI-dependent Golgi-to-ER Retrograde Traffic R-HSA-6811434,0.37611644129868393,0.9842393627747582,0.5,0.8833335101230035,1.0,13/73,21.22%,KIFC1;KIFC2;STX18;TMED3;KIF6;KIF4B;SEC22B;UBE2Z;KIF21B;KIF3B;KIF21A;KIF16B;KIF27
prerank,GO_Biological_Process_2021__positive regulation of T cell apoptotic process (GO:0070234),0.5730369707565811,0.9841763461589438,0.4418604651162791,0.8832500193315287,1.0,3/8,22.36%,LGALS9;TP53;ADAM8
prerank,Reactome_2022__Calcineurin Activates NFAT R-HSA-2025928,0.5651316767967814,0.9841097710882051,0.5348837209302325,0.883077431766908,1.0,1/7,2.55%,NFATC3
prerank,CellMarker_Augmented_2021__Trophoblast cell:Placenta,0.3520652882957758,0.9840077894978351,0.5,0.8830059926836213,1.0,19/85,10.94%,TPM2;EMP1;CLMP;VEGFC;ARSJ;TWIST2;EXT1;COL12A1;ADAMTS12;MMP2;SERPINE1;RAI14;PDLIM4;FSTL3;SNAI2;CRIM1;ITGA3;RND3;CHST3
prerank,Reactome_2022__Transport Of Mature mRNA Derived From An Intron-Containing Transcript R-HSA-159236,0.3910359245090937,0.9839225395993307,0.4827586206896552,0.8828039415813191,1.0,21/65,27.98%,NUP210;NUP42;NXT1;NXF1;U2AF1;SRRM1;AAAS;SRSF4;RANBP2;EIF4A3;U2AF2;NUP214;TPR;MAGOHB;SEH1L;THOC1;NUP153;RBM8A;NUP98;DDX39A;NUP37
prerank,Reactome_2022__Leishmania Infection R-HSA-9658195,-0.36816531339875036,-0.9838066768419839,0.4659090909090909,1.0,1.0,26/176,15.44%,C1QTNF1;HCK;WNT5A;SCTR;VAV3;TSHR;GPHB5;C3AR1;NFKB2;ACTG1;WAS;GNAT3;PTRH2;GPR27;GNGT1;CYBA;GPR39;PTGDR;NLRP3;PSTPIP1;NCKIPSD;GGT5;ADCY7;ITPR3;IL18;TXNIP
prerank,KEGG_2021_Human__Hematopoietic cell lineage,-0.41292051998119544,-0.9835737919001087,0.4647887323943662,1.0,1.0,8/59,8.44%,CD44;HLA-DMA;IL7;GP1BA;CD5;CD37;HLA-DPB1;IL3RA
prerank,GO_Biological_Process_2021__regulation of leukocyte chemotaxis (GO:0002688),-0.5417701974700788,-0.9835597783713982,0.532258064516129,1.0,1.0,4/15,17.87%,F7;ZNF580;F2RL1;MTUS1
prerank,GO_Biological_Process_2021__calcium ion transmembrane transport (GO:0070588),0.3532356882138436,0.9831882237548522,0.41379310344827586,0.8843000703619806,1.0,9/82,10.27%,MCOLN3;TRPC3;TRPM2;SLC8A1;SLC8A3;PKD2;MICU1;GRIN1;MCU
prerank,CellMarker_Augmented_2021__Endothelial cell:Bone Marrow,0.5590889628909528,0.9831026522695304,0.48484848484848486,0.8841510792201229,1.0,3/13,7.37%,KIT;CDH5;S1PR5
prerank,GO_Biological_Process_2021__depurination (GO:0045007),-0.5838189047366734,-0.9830731335368578,0.4642857142857143,1.0,1.0,1/8,2.96%,TERF2IP
prerank,GO_Biological_Process_2021__atrioventricular valve formation (GO:0003190),-0.5785254414851042,-0.9826653392996609,0.5245901639344263,1.0,1.0,5/7,27.75%,ZFPM1;GATA4;HEY1;DCHS1;OLFM1
prerank,KEGG_2021_Human__Glycolysis / Gluconeogenesis,0.37444745437490584,0.9824368611723228,0.6,0.8856098928465272,1.0,7/52,5.96%,GCK;FBP2;ALDH7A1;ACSS2;ENO3;PFKP;G6PC3
prerank,GO_Biological_Process_2021__protein localization to perinuclear region of cytoplasm (GO:1905719),-0.6271715963802528,-0.9822218206996647,0.475,1.0,1.0,2/6,16.96%,RNF26;HOOK2
prerank,GO_Biological_Process_2021__negative regulation of coagulation (GO:0050819),0.5086126121452703,0.9822203383228291,0.5,0.8859230462427874,1.0,4/13,6.16%,APOH;APOE;SERPINE1;HS3ST5
prerank,GO_Biological_Process_2021__positive regulation of actin cytoskeleton reorganization (GO:2000251),-0.5099989133789611,-0.9822096338532649,0.546875,1.0,1.0,5/16,18.22%,HCK;BAIAP2L1;TEK;BAIAP2L2;NTRK3
prerank,GO_Biological_Process_2021__negative regulation of cardiac muscle cell differentiation (GO:2000726),0.6468250461592895,0.9821327608624257,0.6326530612244898,0.8857617337286103,1.0,4/5,34.50%,FZD7;BMP2;FRS2;SMAD4
prerank,GO_Biological_Process_2021__monoacylglycerol biosynthetic process (GO:0006640),-0.6135416438276188,-0.9819584304106443,0.4838709677419355,1.0,1.0,2/6,17.74%,DGAT2L6;PLA2G4A
prerank,GO_Biological_Process_2021__response to metal ion (GO:0010038),-0.4488066320022993,-0.9819383549315196,0.42857142857142855,1.0,1.0,10/57,15.12%,AQP3;ZACN;TRPV6;HAMP;THBS1;HVCN1;HAAO;NDRG1;TTN;ITPR3
prerank,GO_Biological_Process_2021__regulation of muscle contraction (GO:0006937),-0.48851100816270676,-0.981783416519995,0.53125,1.0,1.0,3/22,4.08%,MYBPH;NMUR2;MYBPC3
prerank,GO_Biological_Process_2021__chromatin silencing at telomere (GO:0006348),-0.5960483077899994,-0.9816770183784769,0.6037735849056604,1.0,1.0,1/8,4.80%,DYDC2
prerank,Reactome_2022__HSP90 Chaperone Cycle For Steroid Hormone Receptors (SHR) In Presence Of Ligand R-HSA-3371497,-0.46721409845168754,-0.9815656442228693,0.4857142857142857,1.0,1.0,11/34,26.16%,HSPA1L;DNAJA1;DCTN1;HSPA8;DYNLL1;DNAJB1;DYNLL2;HSPA2;HSP90AB1;FKBP4;DCTN2
prerank,Reactome_2022__WNT Ligand Biogenesis And Trafficking R-HSA-3238698,-0.46409587139034497,-0.9814490492791529,0.5166666666666667,1.0,1.0,4/22,12.38%,WNT5A;WNT8B;WNT8A;WNT6
prerank,GO_Biological_Process_2021__positive regulation of cell adhesion mediated by integrin (GO:0033630),-0.5334191364340661,-0.9814163864631072,0.48484848484848486,1.0,1.0,2/14,3.57%,P2RY12;CXCL13
prerank,GO_Biological_Process_2021__chaperone cofactor-dependent protein refolding (GO:0051085),-0.4790388171227387,-0.9813520760353223,0.49230769230769234,1.0,1.0,8/24,24.55%,HSPA1L;HSPA8;HSPE1;SDF2L1;DNAJB1;HSPA5;HSPA2;HSPA13
prerank,GO_Biological_Process_2021__regulation of mitotic metaphase/anaphase transition (GO:0030071),0.42788459245484106,0.9812014556227854,0.45161290322580644,0.8878758927988103,1.0,14/25,35.89%,ESPL1;NSMCE2;ANAPC7;CDK5RAP2;USP44;PLK1;ANAPC4;RB1;HECW2;DLGAP5;CDC16;ANAPC15;ANAPC11;CENPE
prerank,GO_Biological_Process_2021__regulation of rhodopsin mediated signaling pathway (GO:0022400),-0.46854210611339986,-0.9811388756665638,0.5,1.0,1.0,8/21,23.57%,PDE6B;GRK7;PDE6A;CALM1;GUCY2F;NMT1;PDE6G;CNGB1
prerank,GO_Biological_Process_2021__serine family amino acid metabolic process (GO:0009069),0.4544787596197922,0.9808769008230486,0.475,0.8883062377836082,1.0,4/16,13.08%,SRR;CBS;PSPH;THNSL2
prerank,GO_Biological_Process_2021__heart development (GO:0007507),-0.3916313884579959,-0.9807926178459194,0.5066666666666667,1.0,1.0,25/120,19.91%,TBX1;PKP2;TGFB1;MYH7;MMP21;MYBPC3;CSRP3;ZFPM1;GPC3;HTR2B;HEG1;POPDC2;ALPK2;CDKN1A;TEK;GATA4;AKAP13;MESP1;NTRK3;LDB3;MESP2;CASP8;DAND5;SGCG;FN1
prerank,GO_Biological_Process_2021__cardiac ventricle development (GO:0003231),-0.5332011791111002,-0.9807023966446392,0.46875,1.0,1.0,4/14,14.82%,SCN5A;ENG;HEY2;GATA4
prerank,GO_Biological_Process_2021__antifungal innate immune response (GO:0061760),0.6622040530520268,0.9806843097838599,0.5660377358490566,0.8884106045036118,1.0,2/5,7.29%,CX3CR1;CARD9
prerank,Reactome_2022__GPCR Downstream Signaling R-HSA-388396,0.3154337799536755,0.9800554613667819,0.35714285714285715,0.8895091702481311,1.0,53/423,10.36%,ADRA1A;TACR3;NTSR2;ADRA1B;PLEKHG2;DGKD;CHRM2;GRK5;ITPR2;CRHR2;GRM3;HTR1F;GALR3;TRPC3;FGD4;HTR2C;PDE10A;QRFPR;RIPK2;DRD5;CX3CR1;RGS16;OPN5;PROKR2;PRPF38B;ARRB2;UTS2R;GRM8;RGS11;OPRD1;DRD4;RGS14;RXFP1;S1PR5;NMU;TAS2R8;PLCB1;PDE1A;PDE7A;NPW;EDNRA;ADCY2;PLXNB1;FGD1;GRM4;INSL5;GRM2;AKT2;GRM7;PRKAR2A;PDE4B;RGR;RPS6KA3
prerank,GO_Biological_Process_2021__extracellular matrix organization (GO:0030198),-0.36879734384063,-0.9799451756167076,0.5393258426966292,1.0,1.0,38/251,12.60%,CD44;TGFB1;ECM2;ITGB2;MMP9;MMP21;CYP1B1;MMP19;SCUBE3;TGFBI;COL18A1;NID1;COL1A1;COL5A1;P4HA3;COL27A1;LOX;VTN;DCN;ICAM3;COL4A4;ITGA9;COL4A3;PLG;LOXL4;THBS1;MATN4;VWF;ITGA2B;PXDN;MMP25;LAMC2;FBN2;ITGAM;ITGB6;MARCOL;COL23A1;VIT
prerank,GO_Biological_Process_2021__regulation of glomerular filtration (GO:0003093),0.6247669431141043,0.9799375947839584,0.5454545454545454,0.8894177506901576,1.0,2/6,10.74%,PTPRO;F2R
prerank,GO_Biological_Process_2021__ubiquitin-dependent ERAD pathway (GO:0030433),0.37621000487318923,0.9797807201817016,0.4666666666666667,0.8894210220291586,1.0,15/71,22.28%,AUP1;DERL3;UBE2J1;MAN1A1;FBXO27;RHBDD2;TMUB2;RNF185;UBE4B;EDEM1;TMEM67;UBXN4;UBE2J2;BAG6;FBXO17
prerank,GO_Biological_Process_2021__positive regulation of circadian rhythm (GO:0042753),0.5683210015062068,0.9797183796824885,0.4782608695652174,0.8892410396216173,1.0,2/7,2.68%,RORA;NLGN1
prerank,GO_Biological_Process_2021__regulation of receptor-mediated endocytosis (GO:0048259),-0.43440262161706256,-0.9794544126704025,0.4153846153846154,1.0,1.0,9/32,18.30%,LRPAP1;VTN;CLU;PPT1;PIK3CB;RSPO1;PROM2;RAC1;LDLRAP1
prerank,CellMarker_Augmented_2021__Progenitor cell:Bone Marrow,-0.39061798161069283,-0.9793919764059349,0.5185185185185185,1.0,1.0,17/93,15.25%,ENPP2;TRIL;CYYR1;ANGPTL2;TSPAN11;SHISA6;FBXL7;ITGA9;TCEAL5;VWF;AQP4;EDNRB;TEK;A2M;ADGRF5;TSPAN7;JAM2
prerank,GO_Biological_Process_2021__development of primary male sexual characteristics (GO:0046546),0.4319133662384605,0.9792299391402068,0.53125,0.8900125472763808,1.0,6/27,9.97%,LHFPL2;KIT;WNT4;AKR1C3;KITLG;MAMLD1
prerank,GO_Biological_Process_2021__positive regulation of embryonic development (GO:0040019),0.4869971538659386,0.9789793076642189,0.5121951219512195,0.8903168195991975,1.0,4/15,8.91%,WNT4;OSR1;PLCB1;WNT3A
prerank,GO_Biological_Process_2021__hexose transmembrane transport (GO:0008645),-0.5053265198709047,-0.9786890804973176,0.5,1.0,1.0,3/18,7.85%,SLC5A2;SLC5A1;SLC5A9
prerank,Reactome_2022__Interleukin-4 And Interleukin-13 Signaling R-HSA-6785807,-0.424618040462808,-0.9785886310676776,0.5,1.0,1.0,18/73,15.16%,TGFB1;ITGB2;IRF4;MMP9;CCND1;ALOX5;RORC;TNFRSF1B;STAT1;ALOX15;ANXA1;ITGAM;HSPA8;CDKN1A;F13A1;OPRM1;IL12A;IL18
prerank,GO_Biological_Process_2021__positive regulation of plasma membrane bounded cell projection assembly (GO:0120034),0.3511654599609189,0.9783916929710859,0.3611111111111111,0.8915596401410422,1.0,19/76,16.30%,NLGN1;AUTS2;DEF8;CEP120;PLEKHM1;RALA;TENM1;CROCC;WASF2;AVIL;EPS8L2;EPS8;CCDC88A;ARHGAP35;MARK4;PIK3CA;FSCN1;MIEN1;DOCK11
prerank,Reactome_2022__Nef Mediated Downregulation Of MHC Class I Complex Cell Surface Expression R-HSA-164940,-0.5459637702181851,-0.978294818550518,0.5423728813559322,1.0,1.0,1/10,7.32%,HLA-A
prerank,GO_Biological_Process_2021__aminoglycan catabolic process (GO:0006026),0.44065437942626706,0.9780394644452783,0.43333333333333335,0.892146358125863,1.0,7/25,11.28%,GPC4;SDC4;GPC6;HPSE;GPC5;SDC3;GLB1
prerank,GO_Biological_Process_2021__positive regulation of protein tyrosine kinase activity (GO:0061098),0.45137945015050995,0.9779545395042614,0.5142857142857142,0.8920423516624276,1.0,13/34,26.35%,NOX4;TGFA;CASS4;LRP8;SRCIN1;GRM5;NTRK2;ACE;ERBB3;GAS6;DLG3;BTC;DOCK3
prerank,GO_Biological_Process_2021__regulation of stress fiber assembly (GO:0051492),0.3789256277646506,0.9779539334172306,0.42424242424242425,0.8916966359426709,1.0,12/67,13.07%,PHLDB2;TGFBR1;CCN2;SORBS3;ASAP3;CGNL1;ABL1;ALMS1;WASF2;EVL;PXN;CCDC88A
prerank,GO_Biological_Process_2021__regulation of fibroblast apoptotic process (GO:2000269),-0.5886286273824944,-0.9777373597795178,0.56,1.0,1.0,3/8,24.21%,STK17A;BTG1;SFRP1
prerank,GO_Biological_Process_2021__regulation of cell communication by electrical coupling (GO:0010649),-0.5949829700656819,-0.9776505851395249,0.5357142857142857,1.0,1.0,2/10,6.40%,CASQ2;TRDN
prerank,GO_Biological_Process_2021__positive regulation of cytoplasmic transport (GO:1903651),-0.5579501368595257,-0.9776169975803395,0.4642857142857143,1.0,1.0,2/11,17.52%,DAB2;MSN
prerank,GO_Biological_Process_2021__regulation of blood coagulation (GO:0030193),0.41369525895539067,0.9775765690928894,0.4473684210526316,0.8922708163817726,1.0,7/24,10.85%,APOH;APOE;SERPINE1;HPSE;F2;F2R;F12
prerank,GO_Biological_Process_2021__protein transport (GO:0015031),0.33113150078677644,0.9775384140176339,0.47058823529411764,0.8920018881315048,1.0,46/317,14.00%,ATP6V0D2;TBC1D10A;TCIRG1;APOB;APOE;RAB31;TBC1D16;TICAM2;REP15;PPARG;STX5;BLZF1;TBC1D12;RAB28;RAB20;SCFD2;RAB7A;STX6;TOM1;GOLGA4;OLFM2;SCAMP4;STX8;ABCA1;SYNDIG1;GCC2;GGA1;CEP290;TMED3;RPGR;TBC1D22B;EVI5L;RAB3C;TVP23B;MACF1;TBC1D4;ACD;ARL5A;PREB;SNX9;COG7;IL10RA;RAB10;LTBP2;LRP1B;WLS
prerank,Reactome_2022__Nervous System Development R-HSA-9675108,0.2925470981339869,0.977436023505004,0.4444444444444444,0.8918804311893017,1.0,78/506,16.17%,EFNB1;POU3F1;ADGRG6;MYO10;LLGL1;UTRN;ROBO2;FGFR1;ALCAM;GPRIN1;EPHA7;POU3F2;TRPC3;DSCAML1;SPTBN4;COL9A2;RPL3L;UNC5C;SEMA5A;UNC5D;MMP2;PSME4;ERBB2;SEM1;LHX2;SRGAP2;CACNB4;NTN4;ST8SIA4;DCC;EPHA3;DSCAM;PSMA1;ABL1;MAPK8;SLIT2;PLXNB1;DOK5;EFNA5;SCD5;MYO9B;ABL2;FARP2;DOK6;SEMA4A;NUMB;PRKAR2A;PKN2;RPS6KA3;SH3KBP1;IRS2;EVL;SMARCA4;ADGRV1;RET;SCN7A;KIF4B;NEO1;ARHGAP35;ARPC3;RPS6KA4;MSI1;RPS6KA2;WWTR1;ETF1;ANK2;RPS6KA6;COL9A1;PIK3CA;VAV2;NCAM1;HJV;PLPPR3;CNTN6;MAPK12;EFNA2;ITGA10;COL6A3
prerank,Reactome_2022__Signaling By PDGFRA Extracellular Domain Mutants R-HSA-9673770,-0.5603056314016717,-0.9771224818549613,0.5,1.0,1.0,2/10,13.53%,STAT1;PIK3CB
prerank,Reactome_2022__Methylation R-HSA-156581,0.5227009835422728,0.9769760339388048,0.4117647058823529,0.8926481675097636,1.0,3/11,11.33%,CYP1A2;MTR;MAT2A
prerank,GO_Biological_Process_2021__neuron development (GO:0048666),0.3251627908727784,0.9769038033761922,0.47619047619047616,0.8924618086625539,1.0,28/129,16.89%,GPRIN3;RP1L1;GPRIN1;APOE;NLGN1;POU3F2;CNTNAP2;SAMD14;HMGB1;ETV1;TENM3;TENM1;PTPRM;RAB35;UGDH;MYT1L;PPP1R9B;ASCL1;RYK;CDK16;SRRM4;PPP1R9A;RUNX1;BICDL1;FRY;ARL3;NEDD4;PBX1
prerank,GO_Biological_Process_2021__negative regulation of epithelial cell differentiation (GO:0030857),0.49327287066627834,0.9768967828470049,0.5714285714285714,0.8921755780170054,1.0,5/12,11.02%,SPRED3;OSR1;ZEB1;SPRED2;SPRED1
prerank,Reactome_2022__PI-3K cascade:FGFR3 R-HSA-5654710,-0.5185444282178067,-0.9766455316189129,0.4918032786885246,1.0,1.0,1/15,0.93%,FGF20
prerank,GO_Biological_Process_2021__Rac protein signal transduction (GO:0016601),0.45133073917414435,0.9765854626703069,0.46153846153846156,0.8925188522927249,1.0,4/18,19.00%,CDH13;FARP2;EPS8;ELMO1
prerank,GO_Biological_Process_2021__protein phosphorylation (GO:0006468),0.29518828934965524,0.9764225745685445,0.5555555555555556,0.8926325832271919,1.0,115/446,20.31%,ERG;GRK5;TGFBR1;KIT;MAPKAPK2;LMTK3;FGFR1;SBK1;CDK14;DAPK2;CSK;FRK;BCKDK;ERBB2;MAML1;CRY1;PAK5;CILK1;VRK2;EPHA3;CDK6;SGK1;EIF2AK3;FER;CDK4;ABL1;LATS1;MAST1;MAST2;MAPK8;MAP3K1;TRIB2;SIK3;ABL2;MAP3K10;TNIK;AKT2;ERN1;FGFR3;MAP3K9;DYRK3;PKN2;CDK18;RPS6KA3;STK32C;WNK2;ABI3;MAP3K21;FASTK;PIM2;SGK2;CCNH;CAMK1G;MAP3K13;TYRO3;GDF6;RET;PXK;EFEMP1;FAM20B;MARK3;CDK11A;CDK8;SMAD2;RPS6KA4;FLT3;EEF2K;RPS6KA2;MARK4;RYK;RPS6KA6;INSR;BCR;CDK16;TSSK4;MYO3A;BAZ1B;CLSPN;MAP4K2;MAPK12;MATK;WNK3;SLK;NEK1;SMG1;EPHB2;MARK1;ATM;CSNK1G1;BRAF;MAST4;TBCK;LIMK1;SIK2;ATR;MORC3;ADAM10;ERC1;ACVR1;CLK2;PPP4R1;PNCK;CREB1;CDK5;PDK1;PRKAA2;NIM1K;MAP2K6;PAK3;USP15;PRKAG2;PAK2;MARK2;PRKCE;ACVR2A
prerank,GO_Biological_Process_2021__carbohydrate derivative biosynthetic process (GO:1901137),-0.46020534671703284,-0.9763968538240834,0.484375,1.0,1.0,2/24,14.50%,B3GNT5;GCNT1
prerank,GO_Biological_Process_2021__regulation of cell-matrix adhesion (GO:0001952),0.38336907324617375,0.9763654578445358,0.4230769230769231,0.8924230172853687,1.0,12/60,14.18%,SKAP1;UTRN;CDH13;JAG1;EPHA3;ACER2;CDK6;EFNA5;MACF1;NF1;NEXMIF;ADAM15
prerank,GO_Biological_Process_2021__regulation of protein kinase B signaling (GO:0051896),0.33703589545811835,0.9762933274518526,0.5789473684210527,0.8922194900960082,1.0,28/173,9.81%,FGF10;THEM4;TGFBR1;KIT;FGFR1;IRS1;ANGPT1;HIP1;NRG2;SEMA5A;CX3CR1;FGF17;SIRT1;AKR1C3;ERBB2;ARRB2;NRG1;MAGI2;HPSE;MYORG;FGF18;TGFA;CASS4;HCLS1;GRM2;AKT2;FGFR3;KITLG
prerank,GO_Biological_Process_2021__positive regulation of aspartic-type peptidase activity (GO:1905247),-0.5873173935102014,-0.9761248605320603,0.4897959183673469,1.0,1.0,2/8,20.84%,GRN;AGER
prerank,Reactome_2022__Downstream Signaling Of Activated FGFR3 R-HSA-5654708,-0.49593235404379266,-0.9759662641064426,0.5072463768115942,1.0,1.0,1/21,0.93%,FGF20
prerank,GO_Biological_Process_2021__triglyceride metabolic process (GO:0006641),0.42400355713896054,0.975943024072772,0.40625,0.8928969058620193,1.0,7/40,9.91%,APOH;LIPC;APOB;APOE;SIRT1;PNPLA3;LPL
prerank,PanglaoDB_Augmented_2021__Hepatoblasts,-0.40442742250049657,-0.9758166227309051,0.5,1.0,1.0,15/67,14.90%,AMBP;PKP2;FOXM1;SMLR1;CLDN1;CLDN2;MYO5B;HNF1A;SOWAHB;FOXA3;BAIAP2L1;FGL1;NR1H4;TOM1L1;FGFR4
prerank,Reactome_2022__SHC-mediated cascade:FGFR4 R-HSA-5654719,-0.534947615496568,-0.9756828893568062,0.49230769230769234,1.0,1.0,1/15,0.93%,FGF20
prerank,GO_Biological_Process_2021__negative regulation of telomere maintenance via telomere lengthening (GO:1904357),0.4260390405573174,0.9755878174874836,0.45714285714285713,0.8934153113342698,1.0,4/23,12.82%,CTC1;TERF1;GNL3L;ACD
prerank,GO_Biological_Process_2021__negative regulation of antigen receptor-mediated signaling pathway (GO:0050858),-0.5020087520903258,-0.9754790389501958,0.4857142857142857,1.0,1.0,3/18,10.00%,CD160;CEACAM1;GBP1
prerank,GO_Biological_Process_2021__positive regulation of T cell activation (GO:0050870),-0.4199812307670103,-0.9754431195131075,0.5138888888888888,1.0,1.0,11/49,15.80%,SIRPG;DOCK8;PDCD1LG2;IL7;HLA-A;HLA-DPB1;ANXA1;PTPRC;HLA-DPA1;CD80;ZP3
prerank,GO_Biological_Process_2021__cellular response to cadmium ion (GO:0071276),0.46623019429928086,0.9753154749389016,0.525,0.8937338226054679,1.0,5/20,15.27%,MT1G;AKR1C3;MAPK8;MT4;HSF1
prerank,GO_Biological_Process_2021__positive regulation of nitric oxide metabolic process (GO:1904407),0.4674042253959127,0.9752595450105683,0.42424242424242425,0.8935066407790554,1.0,6/18,18.88%,DDAH2;PKD2;TMEM106A;DDAH1;INSR;AGXT2
prerank,GO_Biological_Process_2021__positive regulation of vascular endothelial growth factor signaling pathway (GO:1900748),0.5918768260357359,0.9752202386682287,0.6341463414634146,0.8932444608883076,1.0,2/6,25.82%,MYO1C;JCAD
prerank,GO_Biological_Process_2021__bile acid metabolic process (GO:0008206),0.4036323425972058,0.975040538270911,0.41379310344827586,0.8934044343253379,1.0,6/29,8.63%,CYP7B1;OSBPL3;OSBPL6;AKR1C1;SLC27A2;OSBPL7
prerank,Reactome_2022__GPVI-mediated Activation Cascade R-HSA-114604,-0.47996744702249106,-0.9750054172879582,0.5384615384615384,1.0,1.0,9/29,26.02%,VAV3;PIK3R3;PIK3CB;RAC2;PIK3CG;CLEC1B;RHOB;PTPN11;RNASE1
prerank,GO_Biological_Process_2021__apoptotic cell clearance (GO:0043277),0.43735130896480595,0.9748650208698644,0.5,0.893529133928887,1.0,7/24,12.05%,MEGF10;XKR7;RHOBTB1;HMGB1;XKR6;XKR4;TYRO3
prerank,Reactome_2022__Epigenetic Regulation Of Gene Expression R-HSA-212165,0.35954354168038144,0.9747543554468749,0.45454545454545453,0.8934604944990481,1.0,25/94,22.28%,DDX56;GATAD2A;TET2;SIRT1;DNMT1;H2BC21;TAF1B;CCNH;SAP130;SF3B1;POLR1H;HDAC1;GATAD2B;CHD4;H2AX;BAZ1B;BAZ2A;ERCC3;EP300;KAT2B;H2AJ;RBBP4;MYO1E;PHF1;POLR2F
prerank,Reactome_2022__Transport Of RCbl Within Body R-HSA-9758890,-0.5749986422702531,-0.9745711013748857,0.5161290322580645,1.0,1.0,3/8,18.30%,TCN1;LRP2;LDLRAP1
prerank,GO_Biological_Process_2021__intra-Golgi vesicle-mediated transport (GO:0006891),-0.46891899088290123,-0.9745495793882101,0.5138888888888888,1.0,1.0,6/29,21.60%,RAB6D;RAB6B;GABARAPL2;RAB6C;TRAPPC3L;COG8
prerank,Reactome_2022__Platelet Aggregation (Plug Formation) R-HSA-76009,-0.4740393857001715,-0.9743662021147853,0.5135135135135135,1.0,1.0,4/29,10.72%,MPL;GP1BA;VWF;ITGA2B
prerank,GO_Biological_Process_2021__negative regulation of RNA catabolic process (GO:1902369),-0.5700035536041541,-0.9743476910350344,0.5245901639344263,1.0,1.0,3/8,21.61%,SLIRP;PHAX;ZCCHC17
prerank,Reactome_2022__HDL Assembly R-HSA-8963896,0.5777454470353987,0.9742088540059328,0.5740740740740741,0.8945333431574481,1.0,1/6,7.63%,ABCA1
prerank,Reactome_2022__PCP/CE Pathway R-HSA-4086400,0.3520942698735291,0.9739698957106528,0.4642857142857143,0.8947861818092663,1.0,10/78,7.87%,PRICKLE1;SCRIB;RORA;WNT4;PSME4;SEM1;ARRB2;NCOA3;PSMA1;FZD1
prerank,GO_Biological_Process_2021__regulation of G protein-coupled receptor signaling pathway (GO:0008277),0.3464127385685575,0.9739153365313568,0.5142857142857142,0.894565059202643,1.0,16/76,13.10%,MRAP2;GRK5;FRMPD1;KLK14;RGS16;TULP3;CRY1;KCTD8;RGS11;RGS14;PLCB1;RPGRIP1L;CAMKMT;PPP1R9B;FNTA;SAG
prerank,GO_Biological_Process_2021__steroid metabolic process (GO:0008202),-0.39365966240684747,-0.9738859524852006,0.4810126582278481,1.0,1.0,13/68,14.77%,SLC22A24;AMACR;CYP26B1;CYP1B1;CYP3A5;CYP24A1;CYP2A6;CYP3A4;CYP21A2;LRP2;HSD11B1;VDR;CYP2E1
prerank,GO_Biological_Process_2021__regulation of dopamine secretion (GO:0014059),-0.47544723449260984,-0.9738210982065434,0.578125,1.0,1.0,3/24,6.27%,FGF20;SYT10;SYT2
prerank,Reactome_2022__TP53 Regulates Transcription Of Cell Cycle Genes R-HSA-6791312,0.4180397220514729,0.9737923902068852,0.4482758620689655,0.8945428954264032,1.0,13/46,21.88%,REXO2;RBL1;CNOT9;PLAGL1;CARM1;PLK3;CNOT4;GADD45A;TP53;EP300;PCBP4;CNOT6;TFDP1
prerank,GO_Biological_Process_2021__positive regulation of execution phase of apoptosis (GO:1900119),0.5628598351998502,0.9737385481924159,0.5217391304347826,0.8943220406055595,1.0,4/7,27.01%,TP53;PTGIS;FAP;DLC1
prerank,GO_Biological_Process_2021__negative regulation of protein localization to nucleus (GO:1900181),-0.5069174519049365,-0.9733338812765657,0.4393939393939394,1.0,1.0,3/16,12.51%,CTNNA1;LATS2;APOD
prerank,GO_Biological_Process_2021__carboxylic acid transmembrane transport (GO:1905039),0.426324414614118,0.9731790801166171,0.30434782608695654,0.8955034578124758,1.0,8/39,12.82%,SLC38A5;SLC19A1;SLC7A9;SLC16A7;SLC7A11;SLC7A6;SLC7A8;ABCC1
prerank,Reactome_2022__VEGFR2 Mediated Vascular Permeability R-HSA-5218920,0.4162134445229048,0.9730778200485259,0.43333333333333335,0.8954283955026547,1.0,6/26,10.13%,THEM4;CDH5;NANOS3;MLST8;AKT2;PKN2
prerank,GO_Biological_Process_2021__calcineurin-NFAT signaling cascade (GO:0033173),0.5331261377939585,0.9730529873981281,0.5135135135135135,0.8947882858752711,1.0,2/9,14.18%,NFATC3;NFAT5
prerank,GO_Biological_Process_2021__calcineurin-mediated signaling (GO:0097720),0.5331261377939585,0.9730529873981281,0.5135135135135135,0.8947882858752711,1.0,2/9,14.18%,NFATC3;NFAT5
prerank,GO_Biological_Process_2021__sequestering of actin monomers (GO:0042989),-0.6042221691015183,-0.9730210859316929,0.5970149253731343,1.0,1.0,3/8,23.39%,SCIN;TMSB10;TMSB4X
prerank,GO_Biological_Process_2021__regulation of osteoclast differentiation (GO:0045670),-0.5038066600409568,-0.9729763096491423,0.582089552238806,1.0,1.0,1/22,0.34%,LILRB3
prerank,GO_Biological_Process_2021__relaxation of muscle (GO:0090075),0.5077832179793192,0.9728948951761248,0.5428571428571428,0.8948769133653603,1.0,3/12,14.95%,SLC8A1;GSTM2;PIK3CA
prerank,GO_Biological_Process_2021__protein insertion into mitochondrial inner membrane (GO:0045039),0.4889758321563203,0.9728202757202997,0.42857142857142855,0.8947847201443031,1.0,1/10,5.26%,TIMM29
prerank,PanglaoDB_Augmented_2021__Peri-islet Schwann Cells,0.34431324573471334,0.9726687371640245,0.4482758620689655,0.8949607063684559,1.0,27/109,15.10%,SLITRK6;EDIL3;ADGRL2;PARVA;ALDH7A1;IL17RD;GPC6;PCDH7;ASAP3;SLIT2;EDNRA;TENM3;EFS;PDZRN3;DENND2A;CAP2;COL16A1;CHST3;MPDZ;SDC3;RBFOX2;FARP1;MAGI1;ANK2;PRICKLE2;CDH11;ANTXR1
prerank,GO_Biological_Process_2021__regulation of RIG-I signaling pathway (GO:0039535),-0.5128234547568427,-0.9726199208502223,0.4915254237288136,1.0,1.0,4/17,20.83%,USP17L2;NOP53;DHX58;DDX60
prerank,Reactome_2022__Serotonin Neurotransmitter Release Cycle R-HSA-181429,0.5038296859381437,0.9725851990146718,0.45161290322580644,0.8948452476921346,1.0,6/17,18.10%,PPFIA3;SYT1;UNC13B;SYN2;SYN1;PPFIA2
prerank,GO_Biological_Process_2021__regulation of actin polymerization or depolymerization (GO:0008064),0.4635325707091551,0.9725437763266966,0.5,0.8946366966791542,1.0,8/24,19.93%,PLEKHG2;LATS1;HCLS1;COTL1;ARHGAP35;FCHSD2;GBA2;PAK3
prerank,GO_Biological_Process_2021__long-term synaptic depression (GO:0060292),-0.6298713435317389,-0.9725338469394728,0.5357142857142857,1.0,1.0,1/7,7.99%,SLC24A1
prerank,CellMarker_Augmented_2021__Dopaminergic neuron:Midbrain,-0.4032343513488013,-0.9725018063005288,0.4857142857142857,1.0,1.0,20/70,23.31%,S100A13;MISP;CTNNA1;SEMA3F;MYO5B;GPR39;ITGB6;TRIM29;PPIC;TOM1L1;YAP1;SCARA3;SCNN1A;SLC44A3;LAMB2;SEMA3B;MUC16;GNG12;RAB17;RHPN2
prerank,CellMarker_Augmented_2021__Epithelial cell:Uterus,-0.4032343513488013,-0.9725018063005288,0.4857142857142857,1.0,1.0,20/70,23.31%,S100A13;MISP;CTNNA1;SEMA3F;MYO5B;GPR39;ITGB6;TRIM29;PPIC;TOM1L1;YAP1;SCARA3;SCNN1A;SLC44A3;LAMB2;SEMA3B;MUC16;GNG12;RAB17;RHPN2
prerank,GO_Biological_Process_2021__regulation of signal transduction (GO:0009966),0.31748160512938606,0.9724783905124623,0.3333333333333333,0.8944341295854985,1.0,39/171,15.67%,RSPO3;GRK5;FRMPD1;LLGL1;RORA;RFNG;CBFB;CSK;SEMA5A;SIRT1;DTX1;RGS16;AKR1C3;TULP3;SLC8A3;CRK;KCTD8;RGS11;TIMP1;RGS14;POFUT1;PLCB1;IGFBP4;DOK5;ITGA3;VWA2;SHARPIN;PXN;MDFIC;UBASH3B;PLSCR1;TSPAN12;FRRS1L;ANKRD54;RGS6;WWTR1;NCAM1;BRAP;RUNX1
prerank,CellMarker_Augmented_2021__Secretory Progenitor cell:Esophagus,-0.4094631995414626,-0.9723877619648392,0.547945205479452,1.0,1.0,9/55,12.62%,MACC1;TMPRSS11D;LIPH;CEACAM1;TGM2;ATP10B;OAS1;STEAP4;BLNK
prerank,GO_Biological_Process_2021__formation of translation preinitiation complex (GO:0001731),0.5569405890911215,0.9723678711310845,0.5106382978723404,0.8943422878813161,1.0,1/10,2.38%,EIF2S3B
prerank,GO_Biological_Process_2021__positive regulation of metabolic process (GO:0009893),0.3683593003749478,0.9723186797680321,0.5,0.8941748953470782,1.0,17/91,15.97%,GPR3;ESRRG;PER2;ELOVL6;HDAC3;ZBTB7B;ACACB;ALMS1;LEPR;ADIPOR1;ACSL1;ADIPOR2;PPARGC1B;INSR;HSF1;ACHE;PIGA
prerank,Reactome_2022__Signaling By FGFR3 In Disease R-HSA-5655332,-0.5095999924310839,-0.9722063033722311,0.5223880597014925,1.0,1.0,1/18,0.93%,FGF20
prerank,GO_Biological_Process_2021__negative regulation of blood pressure (GO:0045776),0.5340491688993141,0.9721822326157755,0.40476190476190477,0.8941820779796685,1.0,1/10,1.73%,RNLS
prerank,GO_Biological_Process_2021__cilium organization (GO:0044782),0.3371965931267417,0.972150684626115,0.4117647058823529,0.8939276891110791,1.0,62/202,21.50%,PCM1;TTC29;IFT88;DZIP1L;PARVA;SCLT1;PKD2;FHDC1;GBF1;CILK1;BBS9;SPAG16;FLNA;CNGA4;FAM161B;TTC17;CEP290;EHD4;RPGR;CEP250;RAB11FIP3;AVIL;MKS1;MNS1;CFAP410;CEP20;TTC36;RILPL1;PIBF1;ARL13B;EXOC7;KIAA0586;RP2;PTPN23;MARK4;CEP41;CEP162;CDC14B;IFT140;NEK1;ARL3;NOTCH1;CFAP70;DCDC2;KIF3B;BBIP1;CFAP221;PDE6D;DZIP1;UNC119B;CFAP43;TMEM67;PTPDC1;EXOC6;TMEM138;WDR19;TTC39C;IQCB1;POC1B;FBF1;KIF27;EXOC4
prerank,Reactome_2022__Displacement Of DNA Glycosylase By APEX1 R-HSA-110357,-0.569358686442277,-0.9721010847446905,0.6101694915254238,1.0,1.0,2/8,19.05%,SMUG1;OGG1
prerank,GO_Biological_Process_2021__activation of GTPase activity (GO:0090630),0.35116862779974145,0.9720424359544068,0.4782608695652174,0.893900100255178,1.0,24/81,21.10%,TBC1D10A;SCRIB;TBC1D16;TBC1D12;SYDE2;SIPA1;SIPA1L2;RALGAPA2;ARHGAP42;TBC1D22B;EVI5L;TBC1D4;SIPA1L3;BCR;TBC1D8B;SLC27A4;CCDC125;TBC1D2;TBCK;ARHGEF16;TBC1D8;TBC1D26;USP6NL;TBC1D5
prerank,GO_Biological_Process_2021__regulation of TOR signaling (GO:0032006),0.36345964614915305,0.9719093820223194,0.5142857142857142,0.8939189973242876,1.0,24/64,27.57%,HDAC3;EPM2A;SIRT1;DEPTOR;MLST8;TELO2;PIH1D1;DYRK3;PIK3CA;MINAR1;TBCK;PRKAA2;GNA12;NPRL2;RRAGD;SEH1L;PKHD1;HTR6;LAMTOR4;GAS6;LIN28A;GPAT3;TMEM127;C9ORF72
prerank,CellMarker_Augmented_2021__Hematopoietic Stem cell:Breast,-0.3952448286229084,-0.9718749061708155,0.5185185185185185,1.0,1.0,6/81,4.94%,ENPP2;TRIL;CYYR1;LYVE1;TSPAN11;SHISA6
prerank,CellMarker_Augmented_2021__Hematopoietic Stem cell:Corneal Endothelium,-0.3952448286229084,-0.9718749061708155,0.5185185185185185,1.0,1.0,6/81,4.94%,ENPP2;TRIL;CYYR1;LYVE1;TSPAN11;SHISA6
prerank,GO_Biological_Process_2021__macrophage differentiation (GO:0030225),-0.5519374321006857,-0.9718306922628015,0.5362318840579711,1.0,1.0,5/13,19.41%,MMP9;HLA-DRB1;CD4;CSF1R;CASP8
prerank,GO_Biological_Process_2021__cellular response to interferon-alpha (GO:0035457),0.5616893735090157,0.9717379410273266,0.5434782608695652,0.8939901320114086,1.0,4/7,24.85%,PYHIN1;RO60;TPR;GAS6
prerank,CellMarker_Augmented_2021__Chondrocyte:Cartilage,0.35736246337741356,0.971390064843676,0.42857142857142855,0.894450049849602,1.0,23/93,15.10%,FIBIN;MXRA5;FGFR1;ADGRL2;PARVA;COL12A1;IL17RD;GPC6;ADAMTS12;ASAP3;SLIT2;EDNRA;TENM3;EFS;PDZRN3;COL16A1;CHST3;FARP1;LRIG3;MAGI1;ANK2;CDH11;ANTXR1
prerank,Reactome_2022__Acyl Chain Remodelling Of PE R-HSA-1482839,-0.4810227257628992,-0.9710888986616097,0.4782608695652174,1.0,1.0,5/20,20.26%,PLAAT4;PLA2G10;PLA2G4A;MBOAT1;PLA2G4D
prerank,GO_Biological_Process_2021__snRNA metabolic process (GO:0016073),0.4971971280342154,0.9710761755679934,0.5,0.8949212136380097,1.0,1/15,1.54%,INTS11
prerank,GO_Biological_Process_2021__ureteric bud morphogenesis (GO:0060675),0.5734144580567605,0.9709498691653031,0.5,0.894962881862506,1.0,5/11,25.76%,PKD2;MYC;BMP4;BMP2;SHH
prerank,PanglaoDB_Augmented_2021__Thymocytes,-0.431065286436258,-0.9709253305098927,0.5428571428571428,1.0,1.0,16/60,10.28%,SIRPG;GMFG;ITGB2;CYTIP;TBC1D10C;ARHGAP9;TAGAP;TMC8;TSHR;PARVG;CD5;WAS;CD37;TRAF3IP3;MYO1F;PTPRC
prerank,GO_Biological_Process_2021__heterochromatin organization (GO:0070828),0.4942258070460486,0.9706260210495352,0.4666666666666667,0.8956827447512253,1.0,6/14,22.22%,SIRT1;HP1BP3;SMCHD1;PRDM16;BAHD1;SETD7
prerank,GO_Biological_Process_2021__cellular response to low-density lipoprotein particle stimulus (GO:0071404),0.48352591154478475,0.9706131064811345,0.48717948717948717,0.8953474389404302,1.0,5/12,9.94%,CDH13;PPARG;ABCA1;LPL;LDLR
prerank,Reactome_2022__Gene Expression (Transcription) R-HSA-74160,0.3086227110071827,0.9704396219858917,1.0,0.8955163248668587,1.0,322/1265,21.94%,TEAD2;RSPO3;SMYD2;ESRRG;FOXO1;ZNF804B;DDX56;ZNF496;ZNF607;CCNG1;CPSF1;KIT;INTS11;PLD6;HDAC3;ZNF347;ZNF195;LSM10;ZNF485;NUP210;BCL6;ZNF212;MED17;GPRIN1;RORA;APOE;HDAC10;RARB;ZNF692;TWIST2;TRPC3;ZNF561;CCN2;PERP;ZNF70;CBFB;PHC2;TGIF1;GATAD2A;ZNF263;ZNF99;ZNF33B;E2F6;ZNF701;SMARCD3;NUP42;PPARG;PCF11;TET2;SIRT1;ZNF860;ABCA6;ELOF1;ITGA4;PSME4;ERBB2;MAML1;SEM1;DNMT1;RORB;SERPINE1;IWS1;JAG1;ZNF641;TP53AIP1;ZNF470;PPP1R13B;H2BC21;REXO2;SMARCB1;ZNF703;MED25;PCGF5;TACO1;ZNF274;ZNF786;CDK6;SGK1;PSMA1;CDK4;PML;ABL1;CCND3;WWOX;TAF1B;RBL1;BDP1;MYC;MGA;ZNF215;TAF3;NR4A2;ZNF33A;TGFA;ZNF688;CNOT9;MLST8;ZNF202;RBM14-RBM4;TNFRSF18;SNRPB;TWIST1;HIVEP3;TAF12;MOV10;ZNF133;AKT2;U2AF1;PIWIL1;CTSV;UBE2E1;SRRM1;PBRM1;MAMLD1;AAAS;PLAGL1;ZNF599;ZNF331;ARID1A;ZNF519;ZNF569;ELOA;ZNF514;ANAPC16;ZNF777;SP7;PPP2R1B;ZNF75A;ZNF782;PPM1A;CITED4;BANP;TNRC6C;ZNF761;CCNH;SMARCA2;ZNF41;ZNF300;SMARCA4;INTS14;ZNF771;SCMH1;SAP130;ZNF337;KAT6A;ZNF155;INTS9;DPY30;SF3B1;POLR1H;CPSF7;COX19;ZNF704;SRSF4;NFIB;TEAD4;ZNF311;ARID2;NR3C2;DGCR8;HDAC1;GATAD2B;RYBP;CRADD;CHD4;RBFOX1;CARM1;MED16;H2AX;ZNF839;CDK8;SMAD2;PLK3;NFYC;ZNF774;NR3C1;NFKB1;BID;PPARGC1B;SMURF1;MLLT3;GTF2F2;AIFM2;ZNF611;WWTR1;MECP2;THRB;HDAC4;CDC26;SNAPC3;GTF3C4;XPO5;MEN1;FURIN;CNOT4;NR1H3;ZNF586;GADD45A;TP53;BAZ1B;HDAC11;MAP4K2;RUNX1;NR6A1;ZNF549;TNRC6A;EXO1;NRBF2;BAZ2A;NR4A3;ZFP28;PIP4K2A;ZNF708;NOTCH1;POLR3G;ATM;ZNF665;RAD17;GTF3C5;AGO3;ZNF273;ICE1;SKI;NR2C1;LGALS3;PAPOLA;ZNF675;PLXNA4;TAF4;ELF2;ZNF627;ZNF589;ARID1B;PRMT5;POLR3D;NOC2L;SATB2;ERCC3;ZNF12;ZNF613;RBPJ;RANBP2;YAF2;UXT;RAD9A;MDC1;ZNF706;ANAPC7;RPRD2;NR4A1;ZNF157;TARBP2;ZNF445;SESN2;GSR;EP300;PCBP4;OPRK1;CXXC1;FOXO6;ZNF287;CREB1;ZNF717;KAT2B;H2AJ;CDK5;ZNF79;EIF4A3;PRKAA2;POLR3K;TFAP2D;RNF2;MAP2K6;PRKAG2;ZNF324B;U2AF2;POU2F1;ZNF596;HDAC5;SYMPK;AGO2;KMT2C;ZNF500;E2F5;DNA2;PCGF6;FOS;ZNF595;CPSF6;KCTD6;CNOT6;PIWIL2;SOCS4;TBL1X;POLR3B;IPO8;ZNF764;ZNF778;PSMD4;ZNF785;BNIP3L;FZR1;ZNF441;MED27;RBBP4;ZNF664;NFIX;ZNF28;MYO1E;MDM4;HDAC7;PHF1;OCLN;RRM2B;ZNF415;CUL1;ZNF34;ZNF25;ZNF268;TFDP1;NUP214;ZNF3
prerank,GO_Biological_Process_2021__negative regulation of DNA metabolic process (GO:0051053),-0.4704755188840936,-0.9704247845002065,0.5072463768115942,1.0,1.0,10/26,26.77%,TERF2IP;H1-0;CDKN1A;H1-3;MSH6;BLM;H1-2;RPS3;ZNF93;ZRANB3
prerank,GO_Biological_Process_2021__negative regulation of interferon-gamma production (GO:0032689),-0.47670229391488184,-0.9702350025833355,0.5384615384615384,1.0,1.0,6/20,19.28%,PDCD1LG2;HLA-DRB1;NR1H4;VSIR;AXL;INHA
prerank,GO_Biological_Process_2021__neuron projection regeneration (GO:0031102),0.5325491518259166,0.9702257605941865,0.5526315789473685,0.8957835114624112,1.0,4/9,21.69%,DHFR;MTR;NREP;RTN4RL2
prerank,GO_Biological_Process_2021__histone lysine methylation (GO:0034968),0.4473727016506566,0.970167598330308,0.45161290322580644,0.8956627059473139,1.0,14/31,25.86%,SMYD2;PRDM5;SMYD1;SETMAR;DPY30;MEN1;CXXC1;SUV39H2;DYDC1;KMT2B;WDR5B;EZH2;KMT2A;SMYD3
prerank,CellMarker_Augmented_2021__Hematopoietic cell:Bone Marrow,0.5821590554797624,0.9701666454705741,0.5217391304347826,0.895316355326298,1.0,3/9,8.00%,CD38;KIT;CD8A
prerank,Reactome_2022__Synthesis Of Epoxy (EET) And Dihydroxyeicosatrienoic Acids (DHET) R-HSA-2142670,0.6010356034320822,0.9701038614116038,0.4883720930232558,0.8951437734800881,1.0,2/5,2.43%,CYP1A2;EPHX2
prerank,CellMarker_Augmented_2021__Mesenchymal cell:Fetal Liver,0.3377440822196357,0.9699031317366869,0.5,0.8952892872864511,1.0,14/88,9.44%,FIBIN;LAMA4;MXRA5;MRGPRF;ITGA11;COL12A1;SEMA5A;SSC5D;ADAMTS12;MMP2;CNN1;EDNRA;EFS;PDZRN3
prerank,GO_Biological_Process_2021__regulation of autophagosome assembly (GO:2000785),0.4166757334952156,0.9698790247091666,0.5526315789473685,0.895018607924159,1.0,11/33,22.88%,IFT88;RALB;TBC1D12;SEC22B;MTMR3;PIP4K2A;RAB5A;LRSAM1;MTM1;NPRL2;ELAPOR1
prerank,GO_Biological_Process_2021__ribosomal small subunit assembly (GO:0000028),-0.5175486523685592,-0.9698014965845467,0.4461538461538462,1.0,1.0,8/17,26.26%,PWP2;RPS27;RPS14;RPS15;RPSA;RPS28;RPS19;ABT1
prerank,CellMarker_Augmented_2021__Lymphoid cell:Peripheral Blood,-0.4039085358645114,-0.9697108348204113,0.5714285714285714,1.0,1.0,13/65,12.55%,LINGO3;HCK;BLK;ARHGAP9;TAGAP;PARVG;LY86;CD37;NFAM1;KLHL14;SPI1;GAS7;HVCN1
prerank,Reactome_2022__Acyl Chain Remodelling Of PS R-HSA-1482801,-0.5130057292131146,-0.9696055126439036,0.5147058823529411,1.0,1.0,4/14,20.26%,PLA2G10;PLA2G4A;MBOAT1;PLA2G4D
prerank,CellMarker_Augmented_2021__Abnormal Plasma cell:Peripheral Blood,0.34758340688087025,0.9695991093909655,0.5172413793103449,0.8954124544237407,1.0,29/95,15.95%,CD38;VCAN;MEGF10;CYP7B1;SEZ6L;PCDH17;LRRC4C;BAALC;AUTS2;SLC8A1;TMEM132C;CADM1;PROX1;NCALD;KCNIP1;PARM1;CXCL14;SETBP1;ELAVL4;PDZRN4;MAP6;TPPP3;ASXL3;PTPRT;INSR;NCAM1;UBE2QL1;NRXN1;PTPRD
prerank,GO_Biological_Process_2021__regulation of actomyosin structure organization (GO:0110020),-0.5358141976434662,-0.9694993563421206,0.5362318840579711,1.0,1.0,5/12,17.19%,FHOD1;ACTG1;WAS;AKAP13;RAC1
prerank,Reactome_2022__FRS-mediated FGFR4 Signaling R-HSA-5654712,-0.5129303063598483,-0.9694106191296241,0.546875,1.0,1.0,1/17,0.93%,FGF20
prerank,GO_Biological_Process_2021__small GTPase mediated signal transduction (GO:0007264),0.36755675297340706,0.9689763801205049,0.5217391304347826,0.896625967205759,1.0,21/101,20.93%,RHEBL1;KSR1;RIN2;RALB;DNMT1;RRAS2;RALA;CCDC88A;NF1;BCR;TP53;BRAP;CRKL;ARL3;RIT2;ARHGAP33;RASSF1;ARFIP2;SOS1;PLD2;SHOC2
prerank,GO_Biological_Process_2021__defense response to Gram-positive bacterium (GO:0050830),-0.4827937103343687,-0.968962889132092,0.4927536231884058,1.0,1.0,10/26,19.90%,HLA-A;LYG2;TLR2;IL12A;PGLYRP1;LYG1;GBP6;ROMO1;STAB2;DEFB119
prerank,GO_Biological_Process_2021__regulation of natural killer cell mediated cytotoxicity (GO:0042269),0.46285547586229503,0.9688862486091335,0.5128205128205128,0.8964589852314593,1.0,4/19,11.29%,KLRD1;ARRB2;CADM1;LGALS9
prerank,GO_Biological_Process_2021__lipid droplet organization (GO:0034389),0.48486485259180057,0.9687920490574939,0.47368421052631576,0.8963729118390725,1.0,3/17,7.75%,AUP1;PLIN5;PNPLA3
prerank,GO_Biological_Process_2021__regulation of clathrin-dependent endocytosis (GO:2000369),0.47253085959595476,0.9687632819294965,0.47619047619047616,0.896102336475338,1.0,1/14,0.67%,DGKD
prerank,GO_Biological_Process_2021__regulation of response to endoplasmic reticulum stress (GO:1905897),-0.5534458463830094,-0.9686048010622916,0.48148148148148145,1.0,1.0,4/12,15.61%,ALOX5;CLU;WFS1;AQP11
prerank,"GO_Biological_Process_2021__fructose 1,6-bisphosphate metabolic process (GO:0030388)",0.6005336114513793,0.9685862780469912,0.5555555555555556,0.896247088370472,1.0,2/6,5.03%,FBP2;PFKP
prerank,GO_Biological_Process_2021__nitric oxide biosynthetic process (GO:0006809),-0.5277078461996232,-0.9683236662773287,0.4861111111111111,1.0,1.0,5/13,18.26%,CYP1B1;NQO1;ARG2;NOS2;GCHFR
prerank,"KEGG_2021_Human__Neomycin, kanamycin and gentamicin biosynthesis",0.6312730101963464,0.9682600182051722,0.6086956521739131,0.8967951609285357,1.0,1/5,0.16%,GCK
prerank,GO_Biological_Process_2021__regulation of epithelial cell proliferation (GO:0050678),-0.39889130382578686,-0.9681671544486855,0.47435897435897434,1.0,1.0,5/76,5.72%,TBX1;SCN5A;TGFB1;NODAL;FUT2
prerank,GO_Biological_Process_2021__positive regulation by host of viral process (GO:0044794),0.5392500105400411,0.9680613239478244,0.4857142857142857,0.896818551517674,1.0,3/11,10.61%,PC;APOE;PPIB
prerank,GO_Biological_Process_2021__cellular response to organic substance (GO:0071310),0.355290925883554,0.9680370837346058,0.42424242424242425,0.896525185691745,1.0,20/99,14.40%,TGFBR1;ROBO2;URI1;HTRA2;PID1;ERBB2;DCPS;STAT5B;NCOA3;NCOA2;MAPK8;SLIT2;KHSRP;PTPN9;HCLS1;PTPN20;NDOR1;FLT3;NFAT5;PTPN23
prerank,GO_Biological_Process_2021__positive regulation of neuron death (GO:1901216),-0.4421258092726633,-0.9679691871534758,0.4264705882352941,1.0,1.0,8/35,17.67%,ITGB2;WNT5A;CLU;REST;ITGAM;GRN;DDIT4;CDK5R1
prerank,GO_Biological_Process_2021__positive regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress (GO:1990440),0.5181684428245346,0.9677111973911493,0.4883720930232558,0.8970207086342836,1.0,5/11,28.03%,ATF3;TP53;ATF6;CREB3L1;CREB3L3
prerank,"Reactome_2022__Tetrahydrobiopterin (BH4) Synthesis, Recycling, Salvage And Regulation R-HSA-1474151",0.4813375636528432,0.9676783336580564,0.5384615384615384,0.8967907896743428,1.0,2/10,8.00%,DHFR;NANOS3
prerank,KEGG_2021_Human__Ovarian steroidogenesis,-0.4564306675021307,-0.9675014139090498,0.5151515151515151,1.0,1.0,12/38,20.26%,CYP1B1;ALOX5;CYP2J2;ACOT4;CGA;ACOT1;ACOT2;ADCY7;HSD3B1;PLA2G4A;CYP17A1;PLA2G4D
prerank,GO_Biological_Process_2021__adenylate cyclase-activating dopamine receptor signaling pathway (GO:0007191),0.572113666328048,0.9674616143415019,0.52,0.8970614921998096,1.0,1/7,4.25%,DRD5
prerank,Reactome_2022__Reproduction R-HSA-1474165,-0.40210077345140044,-0.9674549892801174,0.4714285714285714,1.0,1.0,17/79,15.80%,KCNU1;SYCP1;TERF2IP;STAG3;RPA3;SYNE2;ADAM21;H2BC4;BRCA1;IZUMO1;PSMC3IP;HVCN1;H2AZ1;SYCE2;SMC1B;SYCP3;ZP3
prerank,Reactome_2022__Na+/Cl- Dependent Neurotransmitter Transporters R-HSA-442660,-0.5219497865835729,-0.9673482328806942,0.5362318840579711,1.0,1.0,3/12,17.66%,SLC6A12;SLC18A2;SLC6A7
prerank,GO_Biological_Process_2021__lipoprotein catabolic process (GO:0042159),-0.5614046676955367,-0.9673465761944742,0.5636363636363636,1.0,1.0,1/10,0.22%,NOTUM
prerank,"GO_Biological_Process_2021__regulation of CD8-positive, alpha-beta T cell activation (GO:2001185)",-0.5992980584290638,-0.9673273506248224,0.5714285714285714,1.0,1.0,2/8,7.32%,IRF1;HLA-A
prerank,CellMarker_Augmented_2021__Memory B cell:Undefined,-0.6497231106692424,-0.9673022355186,0.6231884057971014,1.0,1.0,3/5,20.09%,TLR2;CD27;PAX5
prerank,GO_Biological_Process_2021__hepatocyte growth factor receptor signaling pathway (GO:0048012),-0.5583080724621042,-0.9673017664637036,0.5909090909090909,1.0,1.0,3/11,22.57%,RAC1;STMN1;MST1
prerank,KEGG_2021_Human__SNARE interactions in vesicular transport,0.40035283495592355,0.9672980860973857,0.4838709677419355,0.8971077355938444,1.0,7/30,15.70%,STX5;STX6;STX8;STX18;BET1;VTI1A;SEC22B
prerank,Reactome_2022__NOSTRIN Mediated eNOS Trafficking R-HSA-203641,-0.6505763490218894,-0.967279725142859,0.5490196078431373,1.0,1.0,1/5,3.81%,NOSTRIN
prerank,GO_Biological_Process_2021__positive regulation of cell population proliferation (GO:0008284),0.30699266147635335,0.967218350064363,0.6363636363636364,0.8969757610944449,1.0,48/366,10.78%,IL7R;BAMBI;MEGF10;CCN4;GRK5;FGF10;TGFBR1;TCIRG1;VEGFC;BCL2;FGFR1;IRS1;POU3F2;CDH13;CCN1;PID1;FGF17;SIRT1;AKR1C3;ERBB2;PDGFD;NRG1;HES1;SLC25A33;HPSE;TOX;PROX1;TIMP1;OSR1;ACER2;ZNF703;GREM1;CDK6;FER;CDK4;MYC;FGF18;TGFA;WNT3A;HCLS1;AKT2;FGFR3;KITLG;SAAL1;ACER3;IRS2;F2R;NAMPT
prerank,GO_Biological_Process_2021__regulation of glycolytic process (GO:0006110),0.4010285426109428,0.9672012038297771,0.4444444444444444,0.8966715196326096,1.0,19/66,22.33%,GCK;NUP210;NUP42;ZBTB20;AAAS;MLXIPL;HDAC4;INSR;RANBP2;EP300;PFKFB4;PRKAA2;PRKAG2;HIF1A;PFKFB3;ZBTB7A;GIT1;NUP214;TPR
prerank,GO_Biological_Process_2021__regulation of protein localization to Cajal body (GO:1904869),-0.5488516892444164,-0.9671970094335868,0.6,1.0,1.0,4/11,29.23%,CCT6A;CCT8;CCT7;CCT2
prerank,GO_Biological_Process_2021__positive regulation of protein localization to Cajal body (GO:1904871),-0.5488516892444164,-0.9671970094335868,0.6,1.0,1.0,4/11,29.23%,CCT6A;CCT8;CCT7;CCT2
prerank,Reactome_2022__PI-3K cascade:FGFR4 R-HSA-5654720,-0.5006508978526253,-0.9671562984997321,0.5238095238095238,1.0,1.0,1/16,0.93%,FGF20
prerank,CellMarker_Augmented_2021__Natural Killer T (NKT) cell:Liver,-0.46769335322748745,-0.9670312096761599,0.4520547945205479,1.0,1.0,7/30,10.28%,SIRPG;TAGAP;KLRB1;SCML4;CD5;TRAF3IP3;PTPRC
prerank,CellMarker_Augmented_2021__Cytokine Induced Killer cell:Blood,-0.46769335322748745,-0.9670312096761599,0.4520547945205479,1.0,1.0,7/30,10.28%,SIRPG;TAGAP;KLRB1;SCML4;CD5;TRAF3IP3;PTPRC
prerank,GO_Biological_Process_2021__bone morphogenesis (GO:0060349),-0.5544777034109581,-0.9669527919237579,0.5614035087719298,1.0,1.0,2/9,9.05%,CYP26B1;SFRP4
prerank,GO_Biological_Process_2021__axo-dendritic transport (GO:0008088),-0.6365232023011247,-0.9668655233912457,0.53125,1.0,1.0,2/6,11.92%,DCTN1;HSPA8
prerank,Reactome_2022__FRS-mediated FGFR3 Signaling R-HSA-5654706,-0.5317119511738252,-0.9664677853385027,0.625,1.0,1.0,1/16,0.93%,FGF20
prerank,Reactome_2022__Canonical Retinoid Cycle In Rods (Twilight Vision) R-HSA-2453902,0.47436091091116034,0.9663729853035519,0.45714285714285713,0.8985385189326212,1.0,1/15,1.24%,CYP4V2
prerank,GO_Biological_Process_2021__cortical cytoskeleton organization (GO:0030865),0.38796917782676843,0.9663224538349444,0.40540540540540543,0.8983487353134081,1.0,5/39,10.09%,LLGL1;NLGN1;RHOBTB3;RHOBTB1;RND3
prerank,GO_Biological_Process_2021__mitral valve morphogenesis (GO:0003183),-0.5501349504146162,-0.9661540969765745,0.5606060606060606,1.0,1.0,2/9,9.85%,ZFPM1;SMAD6
prerank,GO_Biological_Process_2021__negative regulation of exocytosis (GO:0045920),0.5497291328639221,0.9660216779693314,0.5531914893617021,0.8988018651881917,1.0,2/9,5.56%,SNCA;RAB7A
prerank,Reactome_2022__Signaling By Activated Point Mutants Of FGFR1 R-HSA-1839122,-0.5459217942804234,-0.9660204194988494,0.55,1.0,1.0,1/9,0.93%,FGF20
prerank,Reactome_2022__BH3-only Proteins Associate With And Inactivate Anti-Apoptotic BCL-2 Members R-HSA-111453,0.6280110390146245,0.9658865831881135,0.6041666666666666,0.8987842300889801,1.0,2/7,14.12%,BCL2;BID
prerank,CellMarker_Augmented_2021__Lymphoid-primed Multipotent Progenitor cell:Umbilical Cord Blood,-0.41190400803738353,-0.9658706318129171,0.547945205479452,1.0,1.0,9/66,11.08%,LY6G5C;PRAME;CYTIP;SSC4D;PROX2;OAS2;RNF213;FAM210B;GAS7
prerank,CellMarker_Augmented_2021__Liver Stem cell:Fetal Liver,0.343139277295177,0.9658108180174889,0.45161290322580644,0.8986691203133905,1.0,16/92,12.82%,MXRA5;ADGRL2;MRGPRF;PARVA;COL12A1;ADAMTS12;MMP2;RAI14;EDNRA;SNAI2;RND3;COL16A1;CHST3;MPDZ;RBFOX2;EFEMP1
prerank,KEGG_2021_Human__Cholinergic synapse,0.35473358634559526,0.9656561868361169,0.3888888888888889,0.898691676405577,1.0,37/102,28.03%,CHRM2;ITPR2;BCL2;CREB3L2;CREB3L4;KCNJ3;KCNJ6;PLCB1;ADCY2;AKT2;ADCY3;KCNQ5;GNAO1;PIK3CA;ACHE;GNG7;PIK3R5;ADCY6;CREB1;GNAQ;FOS;GNAI2;GNA11;CREB3L1;CACNA1A;CACNA1B;PIK3CD;PRKACB;CHRM3;PLCB3;KCNQ2;AKT3;ADCY9;AKT1;FYN;GNAI1;CREB3L3
prerank,GO_Biological_Process_2021__cardiac epithelial to mesenchymal transition (GO:0060317),0.4328472879339392,0.965629044152816,0.4146341463414634,0.8984219746598497,1.0,6/16,21.72%,TGFBR1;SNAI2;NOTCH1;RBPJ;BMP4;SPRY1
prerank,GO_Biological_Process_2021__tight junction assembly (GO:0120192),-0.43621360431152867,-0.9655479203074165,0.5753424657534246,1.0,1.0,6/41,7.49%,MARVELD2;CLDN1;CLDN6;CLDN5;ACTG1;CLDN2
prerank,Reactome_2022__Creatine Metabolism R-HSA-71288,-0.5578319457926337,-0.9655268559792193,0.6229508196721312,1.0,1.0,4/10,17.66%,SLC6A12;CKB;CKMT2;SLC6A7
prerank,GO_Biological_Process_2021__positive regulation of programmed cell death (GO:0043068),0.311473299626307,0.9655164318765731,0.5555555555555556,0.8984102400206556,1.0,48/246,18.01%,NGF;PLEKHG2;RASSF2;FOXO1;FANK1;BCL6;SCRIB;FGD4;BIN1;DAPK2;HTRA2;SIRT1;SNCA;TRIM35;TOP2A;HMGB1;ABL1;LATS1;MAPK8;SLIT2;CASP3;FGD1;MAP3K10;RRP1B;CALHM2;NLRP2B;UNC13B;FADD;RYBP;CRADD;NF1;BID;AIFM2;RPS6KA2;MARK4;VAV2;GADD45A;TP53;UBE2Z;ATM;GPLD1;CLIP3;IAPP;PAWR;SLC27A4;ARHGEF16;FAF1;ERCC3
prerank,Reactome_2022__Synthesis Of Leukotrienes (LT) And Eoxins (EX) R-HSA-2142691,-0.5060312707243656,-0.9654295541887054,0.5166666666666667,1.0,1.0,6/16,17.94%,ALOX5;PTGR1;ALOX15;GGT5;ALOX5AP;CYP4B1
prerank,GO_Biological_Process_2021__peptidyl-lysine dimethylation (GO:0018027),0.46461489812820705,0.9653778903256159,0.39473684210526316,0.898558837355124,1.0,8/18,25.60%,SMYD2;SETMAR;SETD2;ASH1L;SUV39H2;SETD7;KMT2B;KMT2A
prerank,GO_Biological_Process_2021__regulation of intracellular transport (GO:0032386),0.411943434809392,0.9653439929937545,0.42105263157894735,0.8983123904781213,1.0,12/34,21.89%,DNAJC30;CAPN10;REEP6;AAAS;ATPSCKMT;TTC21B;WWC1;RAB11B;MLC1;RNF139;GAS1;NUP214
prerank,Reactome_2022__Loss Of Nlp From Mitotic Centrosomes R-HSA-380259,0.3740069315861848,0.9652990829943766,0.5,0.8980661320882133,1.0,11/64,10.51%,PCM1;CEP152;CEP135;CNTRL;ALMS1;DYNC1I2;SDCCAG8;MAPRE1;CEP290;AKAP9;CEP250
prerank,GO_Biological_Process_2021__regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis (GO:1903587),-0.5539160367778606,-0.9652746412961051,0.5079365079365079,1.0,1.0,2/9,14.26%,THBS1;IL12A
prerank,GO_Biological_Process_2021__response to amino acid starvation (GO:1990928),0.37244281448273986,0.9651422577738836,0.5384615384615384,0.8981346209849824,1.0,7/69,8.73%,ATP6V0D2;TCIRG1;KPTN;EIF2AK3;MAPK8;MLST8;RNF152
prerank,GO_Biological_Process_2021__phosphatidylcholine metabolic process (GO:0046470),-0.40964630010849684,-0.965123662231008,0.4788732394366197,1.0,1.0,3/59,6.32%,ENPP2;PLAAT4;PLA2G10
prerank,GO_Biological_Process_2021__positive regulation of neural precursor cell proliferation (GO:2000179),0.4402735511181065,0.9648506148304635,0.4772727272727273,0.8984488915247393,1.0,5/20,8.37%,SMARCD3;CX3CR1;TOX;PROX1;DCT
prerank,GO_Biological_Process_2021__omega-hydroxylase P450 pathway (GO:0097267),0.6389566352832211,0.964815450821097,0.625,0.898174288757798,1.0,2/6,4.45%,CYP1A2;CYP2U1
prerank,GO_Biological_Process_2021__positive regulation of autophagy (GO:0010508),0.3799758210208005,0.9643077533971746,0.4666666666666667,0.8992023921043784,1.0,23/79,21.75%,IRGM;FOXO1;EPM2A;SIRT1;TRIM8;HMGB1;DHRSX;RNF152;TRIM65;GPSM1;PIM2;TICAM1;PLK3;TFEB;ATF6;SESN2;PRKAA2;MID2;TRIM14;LARP1;BNIP3L;MTDH;NPRL2
prerank,GO_Biological_Process_2021__negative regulation of RIG-I signaling pathway (GO:0039536),-0.610382985797847,-0.9642504371750088,0.5172413793103449,1.0,1.0,2/6,31.08%,DHX58;SEC14L1
prerank,GO_Biological_Process_2021__cell proliferation in forebrain (GO:0021846),0.47327425765604686,0.9641942917614846,0.48717948717948717,0.8991390007185865,1.0,4/10,9.99%,PCM1;CEP120;WNT3A;NUMB
prerank,GO_Biological_Process_2021__xenobiotic transport (GO:0042908),-0.5108099632458019,-0.964160543532255,0.5517241379310345,1.0,1.0,9/18,26.84%,ABCG2;ABCB1;SLC22A3;SLC22A4;SLC47A1;ABCC11;SLC22A1;ABCC2;ABCC3
prerank,GO_Biological_Process_2021__cellular response to nitrogen levels (GO:0043562),-0.5798275557567996,-0.9638295263982601,0.5357142857142857,1.0,1.0,3/9,18.31%,GABARAPL1;GABARAPL2;MAP1LC3B2
prerank,GO_Biological_Process_2021__cellular response to nitrogen starvation (GO:0006995),-0.5798275557567996,-0.9638295263982601,0.5357142857142857,1.0,1.0,3/9,18.31%,GABARAPL1;GABARAPL2;MAP1LC3B2
prerank,Reactome_2022__B-WICH Complex Positively Regulates rRNA Expression R-HSA-5250924,0.38966190329258865,0.9637752592787838,0.45714285714285713,0.8998234508194527,1.0,12/40,22.28%,DDX56;H2BC21;TAF1B;SF3B1;POLR1H;H2AX;BAZ1B;EP300;KAT2B;H2AJ;MYO1E;POLR2F
prerank,GO_Biological_Process_2021__transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0007178),0.32887860204728403,0.9637545410729874,0.45,0.8995202118963621,1.0,31/113,22.14%,BAMBI;TGFBR1;DUSP15;CDH5;PARD3;SIRT1;ARRB2;ZFYVE16;AMH;TWSG1;GDF6;PXN;FNTA;SMAD2;LTBP2;SMURF1;FURIN;HJV;CGN;HIVEP1;SKI;ACVR1;USP15;APPL2;ACVR2A;ZFYVE9;FOS;BMPR2;BMP4;SMAD5;SMAD7
prerank,CellMarker_Augmented_2021__Monocyte Derived Dendritic cell:Peripheral Blood,-0.5902978835071064,-0.9636789128852898,0.5932203389830508,1.0,1.0,4/7,11.77%,FCGR3A;IL3RA;CEACAM8;ITGAM
prerank,GO_Biological_Process_2021__cellular response to estradiol stimulus (GO:0071392),-0.5216645157683623,-0.9634203805165223,0.5517241379310345,1.0,1.0,5/16,12.91%,ESR1;GPER1;FAM210B;H2AZ1;SSTR1
prerank,CellMarker_Augmented_2021__Immature Myeloid cell:Peripheral Blood,-0.5966001485932825,-0.963412138378583,0.5714285714285714,1.0,1.0,4/6,11.77%,FCGR3A;IL3RA;CEACAM8;ITGAM
prerank,CellMarker_Augmented_2021__Classical monocyte:Peripheral Blood,-0.5966001485932825,-0.963412138378583,0.5714285714285714,1.0,1.0,4/6,11.77%,FCGR3A;IL3RA;CEACAM8;ITGAM
prerank,CellMarker_Augmented_2021__Intermediate monocyte:Peripheral Blood,-0.5966001485932825,-0.963412138378583,0.5714285714285714,1.0,1.0,4/6,11.77%,FCGR3A;IL3RA;CEACAM8;ITGAM
prerank,CellMarker_Augmented_2021__CD16+ Dendritic cell:Peripheral Blood,-0.5966001485932825,-0.963412138378583,0.5714285714285714,1.0,1.0,4/6,11.77%,FCGR3A;IL3RA;CEACAM8;ITGAM
prerank,CellMarker_Augmented_2021__Suppressive monocyte:Peripheral Blood,-0.5966001485932825,-0.963412138378583,0.5714285714285714,1.0,1.0,4/6,11.77%,FCGR3A;IL3RA;CEACAM8;ITGAM
prerank,CellMarker_Augmented_2021__Non-classical monocyte:Peripheral Blood,-0.5966001485932825,-0.963412138378583,0.5714285714285714,1.0,1.0,4/6,11.77%,FCGR3A;IL3RA;CEACAM8;ITGAM
prerank,GO_Biological_Process_2021__positive regulation of cellular amide metabolic process (GO:0034250),0.3529401438639329,0.9634017872769575,0.46875,0.9001526588530674,1.0,24/74,24.77%,PRR16;LRRTM3;SAMD4A;ERBB2;PCIF1;SP1;CASP3;NSMAF;SMPD3;EIF3E;YTHDF1;ZCCHC4;GSAP;EIF4A3;PIWIL2;FXR2;NIBAN1;LARP4B;BCL3;ABCA2;PLA2G6;PRKCD;SLC2A13;UPF3A
prerank,Reactome_2022__APC/C:Cdc20 Mediated Degradation Of Cyclin B R-HSA-174048,0.4318213083954028,0.9633630140681243,0.5,0.8999407546860905,1.0,7/21,28.54%,UBE2E1;ANAPC16;CDC26;ANAPC7;ANAPC4;ANAPC2;CDK1
prerank,GO_Biological_Process_2021__regulation of dopamine receptor signaling pathway (GO:0060159),-0.5360513778806554,-0.9632525962029428,0.5087719298245614,1.0,1.0,2/8,18.98%,CAV2;RGS8
prerank,GO_Biological_Process_2021__negative regulation of transcription elongation from RNA polymerase II promoter (GO:0034244),0.5183376623272803,0.9632022017017751,0.4523809523809524,0.9000652910814212,1.0,1/12,5.39%,RNF168
prerank,GO_Biological_Process_2021__positive regulation of chemotaxis (GO:0050921),-0.4533285785876547,-0.9631809524070478,0.5616438356164384,1.0,1.0,3/33,2.75%,TGFB1;F7;P2RY12
prerank,GO_Biological_Process_2021__negative regulation of DNA biosynthetic process (GO:2000279),0.416226042958245,0.9628908166746107,0.5333333333333333,0.9004290265986347,1.0,7/25,15.44%,CTC1;TERF1;GNL3L;DACH1;ACD;MEN1;TP53
prerank,GO_Biological_Process_2021__retinoid metabolic process (GO:0001523),0.3782264355162439,0.9627300683618634,0.45454545454545453,0.9004735480211238,1.0,17/61,12.24%,CYP1A2;GPC4;CYP4V2;APOB;APOE;SDC4;ALDH1A1;GPC6;AKR1C3;CYP2S1;AKR1C1;GPC5;LPL;ALDH1A2;AWAT2;SDC3;ADH4
prerank,GO_Biological_Process_2021__positive regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway (GO:2001269),0.5727528834627174,0.9627081110121725,0.5365853658536586,0.9001536746324391,1.0,2/8,11.29%,HTRA2;LGALS9
prerank,GO_Biological_Process_2021__positive regulation of macroautophagy (GO:0016239),0.41049260573670915,0.9625604411693212,0.42424242424242425,0.9001242842598768,1.0,14/49,22.88%,IRGM;EPM2A;SIRT1;RALB;GPSM1;PIP4K2A;LRSAM1;SESN2;CALCOCO2;PRKAA2;LARP1;BNIP3L;STING1;ELAPOR1
prerank,GO_Biological_Process_2021__negative regulation of JNK cascade (GO:0046329),-0.45407598800901794,-0.9624562518465023,0.578125,1.0,1.0,3/32,10.70%,AMBP;PINK1;DNAJA1
prerank,GO_Biological_Process_2021__negative regulation of calcium ion-dependent exocytosis (GO:0045955),-0.5977255369894057,-0.9624055616293045,0.5666666666666667,1.0,1.0,1/5,9.69%,REST
prerank,"GO_Biological_Process_2021__nucleotide-binding domain, leucine rich repeat containing receptor signaling pathway (GO:0035872)",0.4731869573927749,0.962373925846925,0.5151515151515151,0.9002769581615371,1.0,6/21,20.40%,RIPK2;TAB3;TAB1;TAB2;MAP2K6;TRAF6
prerank,CellMarker_Augmented_2021__Endothelial Precursor cell:Fetal Liver,0.33057062291193723,0.96234712389077,0.43478260869565216,0.8999461509335315,1.0,12/86,8.34%,ERG;FREM1;MXRA5;PCDH17;ADGRL2;CDH5;SNCAIP;MMP2;FAM162B;CGNL1;FGD5;DOK5
prerank,Reactome_2022__Golgi Cisternae Pericentriolar Stack Reorganization R-HSA-162658,0.46249287409004236,0.9622550218517424,0.4523809523809524,0.8998657125210989,1.0,1/14,5.15%,BLZF1
prerank,GO_Biological_Process_2021__negative regulation of actin filament bundle assembly (GO:0032232),0.4337945796952967,0.9622370050319905,0.45454545454545453,0.8995807713869831,1.0,3/25,11.41%,PHLDB2;CGNL1;WASF2
prerank,Reactome_2022__RHOF GTPase Cycle R-HSA-9035034,0.4444935583792348,0.9622246492511115,0.5454545454545454,0.8992506052403968,1.0,9/37,12.46%,VANGL1;LMNB1;RAB7A;SRGAP2;SLC4A7;SENP1;MYO9B;FARP1;ARHGAP21
prerank,GO_Biological_Process_2021__central nervous system neuron development (GO:0021954),0.5054442608777094,0.9622037337299634,0.5128205128205128,0.8989604358022619,1.0,5/13,25.01%,ARHGAP35;GBA2;NTRK2;PTEN;MAP2
prerank,GO_Biological_Process_2021__negative regulation of stem cell differentiation (GO:2000737),0.4967278437391527,0.9619819578647124,0.4594594594594595,0.8992891554151772,1.0,2/11,5.56%,JAG1;HES1
prerank,GO_Biological_Process_2021__positive regulation of cell-substrate adhesion (GO:0010811),0.3568742237730711,0.9619473927551465,0.45161290322580644,0.8990445811055277,1.0,10/61,11.91%,SKAP1;UTRN;CDH13;CRK;CDK6;ABL1;FLNA;CASS4;CSPG5;LIMS1
prerank,GO_Biological_Process_2021__lung development (GO:0030324),0.42077769312247904,0.9618629863916626,0.5,0.8989533242924219,1.0,3/25,9.59%,FGF10;PROX1;ITGA3
prerank,GO_Biological_Process_2021__insulin secretion involved in cellular response to glucose stimulus (GO:0035773),0.5969672781991608,0.961725225760371,0.6304347826086957,0.8989811942307575,1.0,2/6,31.40%,RAB11B;RAB11FIP2
prerank,Reactome_2022__RNA Polymerase II Transcription Termination R-HSA-73856,0.3698775700915063,0.9616413648440588,0.4838709677419355,0.8989070323465984,1.0,8/59,12.88%,CPSF1;LSM10;PCF11;SNRPB;U2AF1;SRRM1;CPSF7;SRSF4
prerank,GO_Biological_Process_2021__positive regulation of response to stimulus (GO:0048584),-0.4513921612727042,-0.9613866243733915,0.5373134328358209,1.0,1.0,8/34,19.73%,WNT5A;ACOX2;GPR151;ARG2;CD80;IER5;HMGA2;HMGA1
prerank,Reactome_2022__Metabolism Of Carbohydrates R-HSA-71387,-0.35557700009886134,-0.9611390132605536,0.5609756097560976,1.0,1.0,14/249,6.83%,CD44;SLC37A2;LYVE1;CHST9;PHKG1;ALDOB;OGN;GLYCTK;TAC4;PKLR;SDC2;FUT2;DCN;ENO2
prerank,GO_Biological_Process_2021__regulation of sodium ion transmembrane transport (GO:1902305),-0.4977375793347477,-0.9610433275039414,0.45161290322580644,1.0,1.0,2/23,2.76%,SCN5A;CAV3
prerank,GO_Biological_Process_2021__regulation of protein autophosphorylation (GO:0031952),0.3933380081304117,0.9608987578349139,0.44,0.9004361543756214,1.0,4/34,8.46%,RASSF2;EPHA7;PDGFD;RAP2A
prerank,Reactome_2022__Aggrephagy R-HSA-9646399,0.4628397280147544,0.9608738928218716,0.5555555555555556,0.9001406420405494,1.0,4/22,15.27%,IFT88;DYNC1I2;ARL13B;HSF1
prerank,Reactome_2022__Defective C1GALT1C1 Causes TNPS R-HSA-5083632,-0.5205396479077306,-0.9606965802948749,0.5714285714285714,1.0,1.0,5/14,18.18%,MUCL1;MUC5B;MUC4;MUC17;MUC15
prerank,Reactome_2022__Negative Regulation Of FGFR4 Signaling R-HSA-5654733,-0.4507713889456665,-0.9606792589143894,0.4411764705882353,1.0,1.0,1/26,0.93%,FGF20
prerank,Reactome_2022__Ion Channel Transport R-HSA-983712,-0.3895487460223044,-0.9606237515007184,0.573170731707317,1.0,1.0,18/154,11.74%,CLCA2;CLCA1;ANO2;CLCA4;ATP6V1G2;TRPV6;TRDN;ATP1A4;TRPC7;ASIC5;ATP6V1C2;ATP6V1D;ATP6AP1;ATP10B;ATP6V0E2;SLC9C1;SLC9B1;ATP13A5
prerank,GO_Biological_Process_2021__endothelial cell proliferation (GO:0001935),0.501827209716402,0.9606017146917448,0.5263157894736842,0.9005020094704558,1.0,8/15,26.50%,SEMA5A;ERN1;BMPER;DLG1;BMPR2;BMP4;THAP1;CD34
prerank,Reactome_2022__Developmental Biology R-HSA-1266738,0.29050026747575103,0.9605799221703648,0.6666666666666666,0.9002236718258125,1.0,127/775,15.81%,EFNB1;CSTA;POU3F1;FOXO1;ADGRG6;MYO10;FGF10;LLGL1;HDAC3;PKNOX1;UTRN;ROBO2;FGFR1;ALCAM;MED17;MAFB;GPRIN1;CACNG4;RARB;EPHA7;POU3F2;KLK14;TRPC3;DSCAML1;SPTBN4;COL9A2;RPL3L;PERP;CBFB;UNC5C;SMARCD3;SEMA5A;PPARG;WNT4;UNC5D;MMP2;PSME4;ERBB2;MAML1;SEM1;LHX2;SRGAP2;CACNB4;NTN4;ST8SIA4;DCC;H2BC21;NCOA3;NCOA2;EPHA3;MED25;DSCAM;PSMA1;CDK4;PML;LORICRIN;ABL1;CCND3;MAPK8;SLIT2;MYC;PLXNB1;DOK5;EFNA5;SCD5;CNOT9;HIF3A;MYO9B;ABL2;CACNG2;LIPJ;FARP2;DOK6;AKT2;SEMA4A;LPL;BNIP2;MAMLD1;NUMB;PRKAR2A;PKN2;RPS6KA3;SH3KBP1;IRS2;AMH;EVL;SMARCA4;ADGRV1;RET;SCN7A;KIF4B;NEO1;CDH2;ARHGAP35;CHD9;ARPC3;CARM1;MED16;H2AX;CDK8;SMAD2;NR2F2;RPS6KA4;MSI1;NFKB1;RPS6KA2;ZNF638;WWTR1;ETF1;ANK2;RPS6KA6;COL9A1;PKP4;PIK3CA;RFX6;VAV2;CFC1;FURIN;NCAM1;HJV;PLPPR3;CNTN6;MAP4K2;RUNX1;MAPK12;NR6A1;EFNA2
prerank,"GO_Biological_Process_2021__mRNA splicing, via spliceosome (GO:0000398)",0.3157287512761535,0.9605797628595741,0.5625,0.8998833226115116,1.0,65/257,26.04%,CPSF1;SNRPN;NOVA1;PCF11;HNRNPF;TRA2A;DCPS;RBM41;PUF60;PRPF40B;HNRNPH1;TXNL4A;SNRPB;SPEN;CELF4;U2AF1;SRRM1;HNRNPL;LSM2;ZMAT5;GEMIN5;CWC27;SF3B1;CPSF7;SRSF4;GTF2F2;PTBP1;FUS;LSM7;SYNCRIP;PAPOLA;PRMT5;RNF113A;EIF4A3;U2AF2;SYMPK;SF3B4;RBM6;GPATCH1;LSM6;PPIH;CDC5L;LSM8;PDCD7;DDX46;DDX41;POLR2F;RALY;MAGOHB;SNRNP48;SRPK2;CLNS1A;PSPC1;RBM10;YBX1;CDK13;SNRPF;WDR33;CWF19L1;PABPC1;CCAR1;SF1;SCAF11;SNRPA;RBM8A
prerank,CellMarker_Augmented_2021__Cholinergic neuron:Spinal Cord,0.36820263529005354,0.9604667667447447,0.4482758620689655,0.8998655320611839,1.0,17/76,15.20%,SLC17A6;XKR7;TRIM67;CNGA3;KCNB2;ELAVL3;PAK5;DCC;KCNIP1;NPAS4;ELAVL4;OLFM3;ASCL1;SNAP91;GPR149;SCRT1;SRRM4
prerank,GO_Biological_Process_2021__positive regulation of epidermis development (GO:0045684),-0.5844806440997196,-0.9602005594634769,0.5555555555555556,1.0,1.0,2/7,13.52%,SFRP4;TMEM79
prerank,GO_Biological_Process_2021__establishment of protein localization to plasma membrane (GO:0061951),0.4368268344514974,0.9601635646458168,0.4642857142857143,0.9002716755414776,1.0,10/32,13.66%,RAB31;BLZF1;RAB7A;GOLGA4;GCC2;GGA1;MACF1;RILPL1;NECTIN3;RAB10
prerank,GO_Biological_Process_2021__bile acid and bile salt transport (GO:0015721),-0.45581379589662224,-0.9600439203581055,0.5254237288135594,1.0,1.0,9/23,19.10%,SLC51A;SLCO2B1;CEACAM1;NR1H4;STARD5;SLC10A1;SLCO1A2;ABCB11;SLC27A5
prerank,GO_Biological_Process_2021__carbohydrate homeostasis (GO:0033500),0.39436435436690886,0.9598547998597938,0.4594594594594595,0.9006266610071508,1.0,13/55,14.99%,GCK;IRS1;PPARG;CRY1;CYB5R4;LEPR;ADIPOR1;MCU;MLXIPL;ADIPOR2;ACSM2A;INSR;RFX6
prerank,Reactome_2022__Tight Junction Interactions R-HSA-420029,-0.49001575845381173,-0.9597273086410155,0.53125,1.0,1.0,6/21,15.91%,CLDN1;CLDN6;CLDN5;CLDN2;CLDN18;CLDN20
prerank,GO_Biological_Process_2021__protein palmitoylation (GO:0018345),0.430647856375395,0.9596088573632465,0.5454545454545454,0.9009136023736909,1.0,13/31,20.96%,ZDHHC11B;ZDHHC16;ZDHHC18;ZDHHC12;GOLGA7B;ZDHHC14;ZDHHC3;ZDHHC13;CLIP3;ZDHHC9;ZDHHC11;ZDHHC5;ZDHHC23
prerank,CellMarker_Augmented_2021__Granulocyte-monocyte progenitor:Undefined,0.5951969371295878,0.9595631981699461,0.5365853658536586,0.9003580864737735,1.0,1/6,0.51%,CD38
prerank,CellMarker_Augmented_2021__Megakaryocyte-erythroid progenitor:Undefined,0.5951969371295878,0.9595631981699461,0.5365853658536586,0.9003580864737735,1.0,1/6,0.51%,CD38
prerank,GO_Biological_Process_2021__negative regulation of angiogenesis (GO:0016525),-0.42282430499380325,-0.9595313994958513,0.5128205128205128,1.0,1.0,13/65,13.55%,EPN1;ALOX5;CNMD;STAT1;CD160;DCN;CLDN5;COL4A3;ISM1;THBS1;FOXO4;PIK3CB;TEK
prerank,Reactome_2022__Negative Regulation Of FGFR3 Signaling R-HSA-5654732,-0.4652858077869919,-0.9594686380861943,0.5409836065573771,1.0,1.0,1/25,0.93%,FGF20
prerank,GO_Biological_Process_2021__telomere maintenance via telomerase (GO:0007004),-0.4475319153935314,-0.9593988162413183,0.5555555555555556,1.0,1.0,3/28,10.90%,TERF2IP;TERT;PIF1
prerank,GO_Biological_Process_2021__positive regulation of cyclin-dependent protein kinase activity (GO:1904031),-0.4856976868240048,-0.959248896866627,0.5806451612903226,1.0,1.0,3/20,8.75%,SPDYA;CCND1;CCND2
prerank,PanglaoDB_Augmented_2021__Hemangioblasts,-0.43331061714617913,-0.9591938871602813,0.463768115942029,1.0,1.0,9/47,10.72%,GMFG;SLFN14;GYPB;ICAM3;FRAT1;FAM110A;MFSD2B;ALAS2;ITGA2B
prerank,GO_Biological_Process_2021__cellular triglyceride homeostasis (GO:0035356),0.5941804705241261,0.9590813546348019,0.6285714285714286,0.9013330819008104,1.0,1/5,4.59%,SIRT1
prerank,GO_Biological_Process_2021__iron ion homeostasis (GO:0055072),-0.42439896407463734,-0.9590765500868941,0.5507246376811594,1.0,1.0,9/49,12.97%,HAMP;NUBP1;ATP6AP1;ABCG2;CP;ALAS2;SLC11A1;FTH1;FRRS1
prerank,Reactome_2022__Metabolism Of Vitamins And Cofactors R-HSA-196854,0.3338695405180519,0.9588228484224914,0.5,0.901624963856977,1.0,27/164,11.20%,SLC5A8;CD38;GPC4;PRSS3;RNLS;APOB;APOE;SDC4;GPC6;AKR1C3;PANK1;SLC19A1;DHFR;AKR1C1;ACACB;PDZD11;NANOS3;GSTO2;GPHN;GPC5;LPL;LDLR;MTR;PDSS2;NAMPT;PPCS;SDC3
prerank,GO_Biological_Process_2021__positive regulation of vesicle fusion (GO:0031340),0.615822635576978,0.9586860503406434,0.525,0.901617845433415,1.0,3/6,9.44%,DOC2B;SNCA;AKT2
prerank,GO_Biological_Process_2021__catecholamine biosynthetic process (GO:0042423),-0.5837501620314498,-0.9586693049428308,0.5333333333333333,1.0,1.0,2/9,8.03%,DBH;DAO
prerank,KEGG_2021_Human__beta-Alanine metabolism,0.4003690183159968,0.9586164364587749,0.4864864864864865,0.9014247693472345,1.0,3/28,7.98%,ACADS;ALDH7A1;ECHS1
prerank,KEGG_2021_Human__Small cell lung cancer,0.3604077615889658,0.9585080877280672,0.4482758620689655,0.9013050692288569,1.0,12/87,9.59%,LAMA4;LAMB4;FHIT;LAMA3;BCL2;RARB;CDK6;CDK4;CASP3;MYC;AKT2;ITGA3
prerank,Reactome_2022__EPH-Ephrin Signaling R-HSA-2682334,0.34595571233055816,0.9584873320849254,0.47368421052631576,0.9010165291710944,1.0,14/83,18.66%,EFNB1;GPRIN1;EPHA7;MMP2;EPHA3;EFNA5;PKN2;ARPC3;VAV2;EFNA2;EPHB2;EPHA6;LIMK1;ADAM10
prerank,GO_Biological_Process_2021__macrophage activation (GO:0042116),-0.46187247189091934,-0.9584533255417254,0.5161290322580645,1.0,1.0,4/27,11.77%,ITGB2;CLU;SLC11A1;ITGAM
prerank,CellMarker_Augmented_2021__MKI67+ Progenitor cell:Large Intestine,-0.4217217849547408,-0.9579316816845033,0.5466666666666666,1.0,1.0,19/81,15.48%,CYYR1;TRAIP;SLCO2A1;CLDN5;INPP5D;HEG1;NUF2;ARAP3;VWF;DIPK2B;ENG;APOLD1;PALMD;TFPI;ADGRF5;TK1;TSPAN7;JAM2;CDKN3
prerank,PanglaoDB_Augmented_2021__Endothelial Cells (Aorta),-0.3811838319465558,-0.9577608384007323,0.5063291139240507,1.0,1.0,29/153,14.21%,SQOR;C1QTNF1;LMOD1;TIMP3;ANGPTL2;CYP1B1;PROCR;COL1A1;COL5A1;LOX;BACE2;UACA;DCN;SLCO2A1;COL4A4;ITGA9;COL4A3;ITGBL1;SMAD6;ENPP4;AFAP1L1;PPIC;COX7A1;TEK;PKN3;NTN1;ITGA5;HEY2;C1S
prerank,KEGG_2021_Human__Fc epsilon RI signaling pathway,-0.4122437960476194,-0.9577462610322455,0.5131578947368421,1.0,1.0,12/55,21.57%,VAV3;ALOX5;INPP5D;PIK3R3;PIK3CB;RAC2;RAC1;PLA2G4A;ALOX5AP;IL5;PLA2G4D;MAP2K1
prerank,Reactome_2022__Signaling By Non-Receptor Tyrosine Kinases R-HSA-9006927,0.37252434851289445,0.9577215483208931,0.6,0.9026420263960657,1.0,14/46,21.13%,NRG2;ERBB2;NRG1;CRK;NRG3;CDK4;KHDRBS2;ARHGAP35;NR3C1;DOCK1;ELMO1;KHDRBS1;HIF1A;KHDRBS3
prerank,"GO_Biological_Process_2021__base-excision repair, AP site formation (GO:0006285)",-0.5088922424620557,-0.9575942968198573,0.55,1.0,1.0,3/15,19.05%,TERF2IP;SMUG1;OGG1
prerank,KEGG_2021_Human__Apelin signaling pathway,0.31638371226165535,0.9575215526326664,0.47619047619047616,0.9027920883062689,1.0,26/112,20.57%,TGFBR1;ITPR2;CCN2;SLC8A1;SERPINE1;JAG1;SLC8A3;RRAS2;PLCB1;ADCY2;AKT2;ADCY3;MYL3;SMAD2;HDAC4;GNG7;PIK3R5;ADCY6;PDE3B;PRKAA2;PRKAG2;HDAC5;PRKCE;GNAQ;RAF1;GNAI2
prerank,GO_Biological_Process_2021__positive regulation of cardiac muscle hypertrophy (GO:0010613),0.5157223145032999,0.9574927115811134,0.5,0.9025089392905121,1.0,7/16,28.81%,TRPC3;PDE9A;NR4A3;AKAP6;EDN1;ROCK1;MEF2A
prerank,GO_Biological_Process_2021__positive regulation of positive chemotaxis (GO:0050927),0.4936183642806821,0.9572565989889442,0.5128205128205128,0.9027882567768112,1.0,3/13,4.19%,VEGFC;CDH13;IL16
prerank,Reactome_2022__RNA Polymerase III Transcription Initiation From Type 3 Promoter R-HSA-76071,0.41568259436672833,0.9570082369786206,0.5609756097560976,0.903005539735685,1.0,8/27,22.28%,BDP1;SNAPC3;POLR3G;POLR3D;POLR3K;POU2F1;POLR3B;POLR2F
prerank,GO_Biological_Process_2021__positive regulation of extrinsic apoptotic signaling pathway via death domain receptors (GO:1902043),-0.6478486146456116,-0.9570062086787855,0.6545454545454545,1.0,1.0,2/5,9.78%,TIMP3;THBS1
prerank,GO_Biological_Process_2021__action potential (GO:0001508),-0.4486083497324138,-0.9569822193514013,0.45161290322580644,1.0,1.0,3/41,8.12%,SCN5A;GPER1;KCNQ1
prerank,GO_Biological_Process_2021__glycerophospholipid biosynthetic process (GO:0046474),0.3296988076300088,0.9569623294055839,0.5833333333333334,0.9028349958301071,1.0,52/164,23.90%,DGKD;PLD6;SLC44A5;MFSD2A;PITPNM1;PI4KB;CPNE7;PIK3C2B;PNPLA3;ABHD3;MTMR8;CHPT1;PGS1;CEPT1;PI4K2B;CRLS1;LPCAT2;CHKA;GPD1;CPNE6;PLSCR1;PLA2G4C;AGPAT5;PIK3CA;ACHE;DGKH;MTMR3;PIP4K2A;AGPAT2;RAB5A;LPIN2;LCLAT1;ABHD4;PIK3R5;HDHD5;PLA2G5;MTMR14;CPNE1;DGKZ;MTMR1;MTM1;PLD2;PLCG2;PIK3R4;ETNPPL;PTEN;CDS1;SLC44A2;PTDSS2;VAC14;PEMT;PCTP
prerank,Reactome_2022__Regulation Of Signaling By CBL R-HSA-912631,-0.48810170157572164,-0.9569010687503624,0.5333333333333333,1.0,1.0,4/17,13.53%,HCK;PIK3R3;BLNK;PIK3CB
prerank,CellMarker_Augmented_2021__Primordial Germ cell:Ovary,-0.42880735577637097,-0.956707184583869,0.4696969696969697,1.0,1.0,9/37,15.91%,TOPAZ1;SLC25A31;TRIM77;DAZL;CCDC172;WNT8A;GALNTL5;TRIM51FP;SLCO1A2
prerank,GO_Biological_Process_2021__regulation of small molecule metabolic process (GO:0062012),0.4582175895762447,0.9566403074373695,0.6,0.9033329083786948,1.0,5/27,4.59%,EPHX2;RORA;APOE;BCKDK;SIRT1
prerank,"GO_Biological_Process_2021__negative regulation of mRNA splicing, via spliceosome (GO:0048025)",0.46758264351927087,0.9566066123426679,0.45652173913043476,0.9030613158606062,1.0,5/13,20.02%,SFSWAP;SRSF4;PTBP1;PCBP4;U2AF2
prerank,GO_Biological_Process_2021__regulation of myeloid leukocyte differentiation (GO:0002761),0.5724963856305443,0.9565221115123883,0.5263157894736842,0.9029133909115734,1.0,1/6,12.54%,UBASH3B
prerank,GO_Biological_Process_2021__regulation of anatomical structure morphogenesis (GO:0022603),0.34511140051493705,0.9564013678071313,0.42857142857142855,0.9028441153209391,1.0,21/111,13.85%,ARC;PHLDB2;BCL6;LRRC4C;PID1;MARCHF5;ERBB2;LZTS3;SARM1;VASH1;EFNA5;RAP2A;TNIK;ABI3;PDZD8;BCL9L;CDH2;ARHGAP35;TSPAN12;NF1;BMPER
prerank,Reactome_2022__Metabolism Of Polyamines R-HSA-351202,-0.4141101807851509,-0.9563903261612603,0.547945205479452,1.0,1.0,8/48,19.11%,PSMB9;NQO1;AZIN1;OAZ2;PSMA3;SMOX;PSMA7;PSMB6
prerank,GO_Biological_Process_2021__fructose metabolic process (GO:0006000),0.5836462856437997,0.9563421664439831,0.5652173913043478,0.9026178736783107,1.0,1/6,1.09%,FBP2
prerank,GO_Biological_Process_2021__positive regulation of lipid storage (GO:0010884),0.4487306019792471,0.9561817670151511,0.4878048780487805,0.9026889028214341,1.0,5/17,14.09%,APOB;PLIN5;LPL;OSBPL11;NFKB1
prerank,GO_Biological_Process_2021__positive regulation of adenylate cyclase activity (GO:0045762),0.5242095442373005,0.9561810875148279,0.42857142857142855,0.9023508170900404,1.0,2/7,13.81%,DRD5;NF1
prerank,GO_Biological_Process_2021__embryonic organ morphogenesis (GO:0048562),-0.4602942856322364,-0.9561302994207512,0.5645161290322581,1.0,1.0,5/21,18.49%,TBX1;FBN2;MFAP5;MESP1;ALDH1A3
prerank,Reactome_2022__IkBA Variant Leads To EDA-ID R-HSA-5603029,-0.5618986556435942,-0.9558376302022604,0.5510204081632653,1.0,1.0,1/7,7.07%,NFKB2
prerank,CellMarker_Augmented_2021__T Helper17 (Th17) cell:Umbilical Cord Blood,-0.44079412326396405,-0.9556837727578612,0.4788732394366197,1.0,1.0,8/35,11.33%,SIRPG;TAGAP;KLRB1;SCML4;CD5;TRAF3IP3;PTPRC;PTGDR
prerank,GO_Biological_Process_2021__cellular response to calcium ion (GO:0071277),0.35453242782028405,0.9555035641404122,0.47058823529411764,0.9035870022388895,1.0,15/63,12.71%,NEUROD2;NLGN1;CPNE4;TRPM2;AKR1C3;CPNE7;ITPKB;SYT3;PKD2;SYT17;SLC25A24;SYT1;SYT12;ADGRV1;CPNE6
prerank,"GO_Biological_Process_2021__negative regulation of DNA-templated transcription, elongation (GO:0032785)",0.5096733866049781,0.9554602422839042,0.5121951219512195,0.9033160261331385,1.0,1/13,5.39%,RNF168
prerank,GO_Biological_Process_2021__regulation of hematopoietic stem cell proliferation (GO:1902033),0.6094584824801632,0.9552750652041421,0.6046511627906976,0.903403479684377,1.0,4/6,37.42%,ACE;PDCD2;N4BP2L2;EIF2AK2
prerank,Reactome_2022__FGFR3b Ligand Binding And Activation R-HSA-190371,-0.596607300730306,-0.9551785761892677,0.5102040816326531,1.0,1.0,1/6,0.93%,FGF20
prerank,Reactome_2022__Processing Of Intronless Pre-mRNAs R-HSA-77595,0.4475636410943502,0.9551709929333273,0.5526315789473685,0.9033901541860223,1.0,6/19,20.63%,CPSF1;PCF11;CPSF7;PAPOLA;SYMPK;CPSF6
prerank,GO_Biological_Process_2021__DNA replication-dependent nucleosome assembly (GO:0006335),-0.5757592680343906,-0.9551524971420455,0.6,1.0,1.0,2/7,13.13%,HAT1;CHAF1A
prerank,GO_Biological_Process_2021__DNA replication-dependent nucleosome organization (GO:0034723),-0.5757592680343906,-0.9551524971420455,0.6,1.0,1.0,2/7,13.13%,HAT1;CHAF1A
prerank,GO_Biological_Process_2021__ciliary basal body-plasma membrane docking (GO:0097711),0.35648125780438783,0.9550790187447797,0.42857142857142855,0.9032593833297499,1.0,18/90,14.82%,PCM1;CEP152;CEP135;CNTRL;SCLT1;ALMS1;DYNC1I2;SDCCAG8;C2CD3;MAPRE1;RPGRIP1L;CEP290;AKAP9;CEP250;MKS1;MARK4;CEP41;CEP162
prerank,GO_Biological_Process_2021__negative regulation of programmed cell death (GO:0043069),-0.3562249795515243,-0.9549214041784274,0.6292134831460674,1.0,1.0,31/304,13.80%,CD44;CLEC5A;KIF14;PRAME;HCK;MMP9;WNT5A;CARD14;BCL2L2;DAB2;IL7;IFIT3;FLT4;ANXA1;CCND2;HTR2B;PPT1;THBS1;SMAD6;DNAJA1;COPS5;ATF5;LRP2;WFS1;TAF9B;CFL1;NAA38;CD27;TEK;VDAC1;LEF1
prerank,GO_Biological_Process_2021__cellular lipid biosynthetic process (GO:0097384),0.6114916693929957,0.9546472908783974,0.625,0.9037246958601103,1.0,1/5,16.45%,DHRS7B
prerank,GO_Biological_Process_2021__glycerol ether biosynthetic process (GO:0046504),0.6114916693929957,0.9546472908783974,0.625,0.9037246958601103,1.0,1/5,16.45%,DHRS7B
prerank,Reactome_2022__FRS-mediated FGFR1 Signaling R-HSA-5654693,0.45432980024898234,0.954625789325433,0.4634146341463415,0.9034486886088678,1.0,3/19,4.51%,FGF10;FGFR1;FGF17
prerank,Reactome_2022__Glucagon-like Peptide-1 (GLP1) Regulates Insulin Secretion R-HSA-381676,0.392312420217202,0.9546035364918097,0.5333333333333333,0.9031393788532084,1.0,9/35,22.48%,ITPR2;KCNC2;PRKAR2A;RAP1A;GNG7;ADCY6;RAPGEF3;GNAS;RAPGEF4
prerank,GO_Biological_Process_2021__negative regulation of protein localization to cell surface (GO:2000009),-0.5852207053269324,-0.9542216254098754,0.546875,1.0,1.0,1/9,2.76%,CAV3
prerank,GO_Biological_Process_2021__negative regulation of B cell apoptotic process (GO:0002903),0.5775085228020874,0.9542083199313847,0.5434782608695652,0.9039077563187847,1.0,3/6,17.93%,BCL6;IRS2;NOC2L
prerank,GO_Biological_Process_2021__positive regulation of glial cell differentiation (GO:0045687),-0.5283663452150975,-0.9540964586093188,0.5454545454545454,1.0,1.0,3/16,5.44%,TGFB1;TNFRSF1B;CLCF1
prerank,CellMarker_Augmented_2021__Beta cell:Pancreatic Islet,0.3523409284629337,0.9539731256191736,0.3181818181818182,0.9041844683717548,1.0,23/86,14.50%,MRAP2;ROBO2;ALCAM;LRRTM3;EDARADD;SEMA5A;WNT4;CYP2U1;RGS16;CADM1;VAT1L;GREM1;WSCD2;SUSD4;SCD5;ELOVL4;CTSV;GPSM1;RNF130;FAM76A;OXLD1;CGRRF1;NTPCR
prerank,GO_Biological_Process_2021__protein localization to Golgi apparatus (GO:0034067),0.46801489579431566,0.9538275222983226,0.53125,0.9041987839876795,1.0,5/25,18.79%,GBF1;GCC2;ARL5A;COG7;ARFRP1
prerank,GO_Biological_Process_2021__regulation of anion channel activity (GO:0010359),-0.5655465807467233,-0.9538221172157588,0.6,1.0,1.0,1/6,12.73%,ABCB1
prerank,GO_Biological_Process_2021__peptidyl-tyrosine autophosphorylation (GO:0038083),-0.4931368366989838,-0.953809618639232,0.5344827586206896,1.0,1.0,4/13,19.74%,TEC;TXK;BMX;NTRK1
prerank,GO_Biological_Process_2021__organophosphate ester transport (GO:0015748),0.4607175215690999,0.9538074208053965,0.525,0.9039342672654744,1.0,12/24,28.52%,PITPNM1;LDLR;PITPNC1;PRELID2;OSBPL8;NPC2;SCARB1;PCTP;PITPNB;PRELID3A;PRELID3B;ABCA3
prerank,GO_Biological_Process_2021__response to gamma radiation (GO:0010332),0.4559394070472412,0.9534606410839622,0.5,0.9045172497126552,1.0,7/22,18.39%,MYC;MEN1;HSF1;TP53;LIG4;ATM;ATR
prerank,GO_Biological_Process_2021__mitotic cytokinetic process (GO:1902410),-0.48811806025550386,-0.9534406160601786,0.5285714285714286,1.0,1.0,4/16,18.85%,CEP55;CHMP3;MITD1;KLHDC8B
prerank,GO_Biological_Process_2021__aggrephagy (GO:0035973),0.41877756180448544,0.9534178711961875,0.42105263157894735,0.9042862450915882,1.0,3/26,13.73%,IFT88;DYNC1I2;ARL13B
prerank,CellMarker_Augmented_2021__Effector Memory T cell:Undefined,-0.6176030019680032,-0.9533254081206628,0.5490196078431373,1.0,1.0,1/5,0.01%,CD44
prerank,CellMarker_Augmented_2021__Endometrial Stromal Stem cell:Endometrium Stroma,-0.3942542083936599,-0.9531333514077293,0.547945205479452,1.0,1.0,11/83,6.82%,CYYR1;LMOD1;ANGPTL2;NID1;COL1A1;COL5A1;LOX;DAB2;ADAM33;GP1BA;DCN
prerank,GO_Biological_Process_2021__cellular response to catecholamine stimulus (GO:0071870),0.4476933624712335,0.9530046389955162,0.4166666666666667,0.9049243644574856,1.0,7/23,18.06%,DRD5;SNCA;ABL1;PDE4B;GABPA;NR4A3;ADCY6
prerank,GO_Biological_Process_2021__cellular response to cGMP (GO:0071321),0.5850715598142417,0.9530033748138437,0.5454545454545454,0.9042621897597042,1.0,4/5,40.85%,HCN2;RAPGEF2;PDE3A;PDE2A
prerank,GO_Biological_Process_2021__response to cGMP (GO:0070305),0.5850715598142417,0.9530033748138437,0.5454545454545454,0.9042621897597042,1.0,4/5,40.85%,HCN2;RAPGEF2;PDE3A;PDE2A
prerank,GO_Biological_Process_2021__endothelial cell chemotaxis (GO:0035767),-0.5772761384415218,-0.9529420341849247,0.5614035087719298,1.0,1.0,1/8,3.57%,CXCL13
prerank,GO_Biological_Process_2021__monocarboxylic acid transport (GO:0015718),-0.41407465848503033,-0.9529161371600043,0.48484848484848486,1.0,1.0,13/50,15.91%,SLC51A;SLC16A8;SLCO2B1;SLCO2A1;CEACAM1;SLC6A12;ABCG2;SLC16A3;SLC16A4;NR1H4;STARD5;SLC10A1;SLCO1A2
prerank,CellMarker_Augmented_2021__Neutrophil:Blood,-0.5236900681128105,-0.9529120361122133,0.5294117647058824,1.0,1.0,6/12,19.68%,FCGR3A;CEACAM8;ITGAM;TLR2;ANPEP;ITGAX
prerank,Reactome_2022__Pyruvate Metabolism R-HSA-70268,-0.4647680698985298,-0.9528860332904634,0.4794520547945205,1.0,1.0,6/28,13.77%,SLC16A8;PLPP6;LDHAL6A;PDHX;SLC16A3;VDAC1
prerank,GO_Biological_Process_2021__regulation of interferon-beta production (GO:0032648),-0.44416908738097116,-0.9527555252294037,0.5522388059701493,1.0,1.0,13/39,26.42%,IRF1;OAS2;OAS1;TLR2;NLRC3;DDX3X;CACTIN;DHX58;TRIM56;ISG15;FLOT1;PTPN11;RNF135
prerank,Reactome_2022__RAF Activation R-HSA-5673000,0.41703046150836653,0.9525430202218397,0.6,0.9051166017816711,1.0,7/30,20.93%,KSR1;PPP2R1B;MARK3;BRAF;PPP2R5D;PPP1CB;SHOC2
prerank,Reactome_2022__Anti-inflammatory Response Favoring Leishmania Infection R-HSA-9662851,-0.38492907425664896,-0.9525318796193626,0.6,1.0,1.0,15/106,15.12%,C1QTNF1;HCK;SCTR;TSHR;GPHB5;GNAT3;PTRH2;GPR27;GNGT1;GPR39;PTGDR;NLRP3;GGT5;ADCY7;ITPR3
prerank,Reactome_2022__rRNA Processing R-HSA-72312,-0.3658786901861139,-0.9525162944544735,0.6172839506172839,1.0,1.0,68/186,27.12%,RPL37A;RPP38;DIMT1;NOL12;SENP3;RPL38;PWP2;EMG1;RPL15;NOB1;RPS4X;RPL3;RPL35A;GNL3;RPS9;FAU;RPS27;RPS21;RPL13A;RPL27A;RPS16;RPL36;LAS1L;RPS20;RPL7A;RPL9;RPS8;RPS27A;RPL21;WDR12;EXOSC8;RPL34;RPL4;RPL32;RPL5;RPL23;RPL41;RPS7;RPS11;RPL27;RPL35;RPS14;RPL11;RPS15;EXOSC2;RPLP1;RPS12;NOP10;RPL18A;RPS13;RPL29;RPLP2;PDCD11;RPL28;RPL12;RPL18;EBNA1BP2;RPS3;RPL22;RPSA;RPS28;RPS19;RPS24;RPL26L1;RPS3A;RPL19;RPL8;RPS6
prerank,GO_Biological_Process_2021__regulation of translation (GO:0006417),0.30999659230718235,0.9525124616470348,0.6,0.9048301845080547,1.0,39/170,22.51%,PRR16;HSPB1;TCOF1;SAMD4A;ERBB2;PCIF1;DHFR;TRIM71;RIDA;EIF2AK3;NANOS3;CNOT9;RPS6KA3;GEMIN5;EIF3H;MTRF1;EIF3E;PUM3;ETF1;YTHDF1;PUS7;MALSU1;ZCCHC4;SYNCRIP;LSM14A;IMPACT;SAMD4B;SHMT2;GRM5;EIF4A3;NANOS1;RNF139;PIWIL2;FXR2;LARP1;EIF4E;NIBAN1;LARP4B;NEMF
prerank,"GO_Biological_Process_2021__mitochondrial electron transport, ubiquinol to cytochrome c (GO:0006122)",0.4734997662575677,0.9524989327659514,0.5116279069767442,0.9045328603943305,1.0,3/11,27.38%,UQCC3;UQCRC2;UQCRHL
prerank,GO_Biological_Process_2021__cyclic nucleotide transport (GO:0070729),0.5884187366103423,0.9524637990291709,0.5111111111111111,0.9042635461251173,1.0,1/5,6.04%,SLC19A1
prerank,Reactome_2022__Xenobiotics R-HSA-211981,-0.4883673301889032,-0.9524509964757473,0.5172413793103449,1.0,1.0,5/13,9.84%,AHR;CYP3A5;CYP2A6;CYP2J2;CYP3A4
prerank,GO_Biological_Process_2021__positive regulation of SMAD protein signal transduction (GO:0060391),-0.5264444789959469,-0.9524163906051534,0.48333333333333334,1.0,1.0,3/13,6.21%,TGFB1;NODAL;DAB2
prerank,GO_Biological_Process_2021__negative regulation of androgen receptor signaling pathway (GO:0060766),-0.5607066290183079,-0.9524005967664483,0.5833333333333334,1.0,1.0,2/12,6.21%,NODAL;DAB2
prerank,GO_Biological_Process_2021__chromatin remodeling (GO:0006338),0.3510761147645668,0.9521374955741077,0.36363636363636365,0.9047444549026382,1.0,30/95,22.08%,SMARCD3;SIRT1;ZBTB1;SMARCB1;MYC;PIH1D1;SRCAP;PBRM1;ARID1A;BPTF;SMARCA2;SMARCA4;HDAC1;GATAD2B;CHD4;HDAC4;BAZ1B;BAZ2B;BAZ2A;NUDT5;ARID1B;SATB2;KAT2B;HDAC5;RSF1;ZBTB7A;RBBP4;BAHD1;SUV39H2;SMARCAD1
prerank,GO_Biological_Process_2021__response to cAMP (GO:0051591),-0.4328244750756491,-0.9520909377613359,0.515625,1.0,1.0,4/35,8.12%,DUOX1;AHR;STAT1;KCNQ1
prerank,CellMarker_Augmented_2021__T cell:Eye,-0.42640639956211646,-0.9520824998240193,0.5797101449275363,1.0,1.0,11/58,10.28%,GMFG;CYTIP;ARHGAP9;TAGAP;ARHGAP15;GPR183;PARVG;CD5;CD37;TRAF3IP3;PTPRC
prerank,GO_Biological_Process_2021__cellular response to caffeine (GO:0071313),-0.5770529311610567,-0.9520189883571444,0.5862068965517241,1.0,1.0,1/7,1.74%,CASQ2
prerank,GO_Biological_Process_2021__response to caffeine (GO:0031000),-0.5770529311610567,-0.9520189883571444,0.5862068965517241,1.0,1.0,1/7,1.74%,CASQ2
prerank,GO_Biological_Process_2021__tricuspid valve morphogenesis (GO:0003186),-0.6582221090392797,-0.9519443219626331,0.6363636363636364,1.0,1.0,2/5,14.16%,ZFPM1;HEY2
prerank,KEGG_2021_Human__Lysosome,0.3244978376441072,0.9518471252363095,0.5238095238095238,0.9051528090269051,1.0,8/113,11.28%,ATP6V0D2;TCIRG1;GLA;SPAM1;ARSB;CTSV;GGA1;GLB1
prerank,GO_Biological_Process_2021__microtubule bundle formation (GO:0001578),0.4172989881384957,0.9517569439285833,0.4411764705882353,0.9050001481816629,1.0,12/37,20.33%,RP1L1;JHY;SPAG16;SPAST;AAAS;NAV1;TPPP3;MARK4;CLIP1;NCKAP5L;CFAP46;CDK5RAP2
prerank,Reactome_2022__Ca2+ Activated K+ Channels R-HSA-1296052,-0.5609637536163953,-0.9517368071883076,0.5517241379310345,1.0,1.0,4/8,39.93%,KCNN3;KCNMB1;KCNN1;KCNN2
prerank,GO_Biological_Process_2021__regulation of bone mineralization (GO:0030500),-0.43417149814272843,-0.9517245924104498,0.5068493150684932,1.0,1.0,3/48,4.10%,NOTUM;TGFB1;ALOX5
prerank,Reactome_2022__Constitutive Signaling By NOTCH1 HD Domain Mutants R-HSA-2691232,0.4860419636820057,0.9517006762815222,0.5,0.9048476005863062,1.0,6/15,22.85%,JAG1;NOTCH1;MIB2;ADAM10;JAG2;MIB1
prerank,Reactome_2022__Synthesis Of (16-20)-Hydroxyeicosatetraenoic Acids (HETE) R-HSA-2142816,0.641939734003754,0.9516577022957369,0.6170212765957447,0.9046230487925357,1.0,2/5,4.45%,CYP1A2;CYP2U1
prerank,GO_Biological_Process_2021__embryonic appendage morphogenesis (GO:0035113),-0.552426004744473,-0.951617022572385,0.5757575757575758,1.0,1.0,1/10,2.44%,CYP26B1
prerank,GO_Biological_Process_2021__regulation of transcription by RNA polymerase III (GO:0006359),0.4477344493198286,0.9516084783007602,0.4857142857142857,0.9043931180265448,1.0,10/21,36.49%,TENM1;POLR3G;ICE1;ICE2;CEBPA;NAB2;ZNF345;CHD8;BRF2;ZC3H8
prerank,GO_Biological_Process_2021__snRNA transcription by RNA polymerase III (GO:0042796),0.5211419093424419,0.951605654817601,0.6,0.9040580335070831,1.0,3/8,21.99%,SNAPC3;ICE1;ICE2
prerank,GO_Biological_Process_2021__ncRNA export from nucleus (GO:0097064),0.43197769139789943,0.9515069087407781,0.5483870967741935,0.9039836393539511,1.0,11/37,27.98%,NUP210;NUP42;AAAS;RANBP2;NUP214;TPR;SEH1L;XPOT;NUP153;NUP98;NUP37
prerank,Reactome_2022__EGFR Transactivation By Gastrin R-HSA-2179392,0.552666151949017,0.9514161266946869,0.5476190476190477,0.9039093002871971,1.0,4/6,40.98%,SOS1;HRAS;PRKCA;GRB2
prerank,GO_Biological_Process_2021__negative regulation of defense response (GO:0031348),0.33524339079129484,0.9513308322181542,0.5789473684210527,0.903779644037519,1.0,7/67,4.79%,AOAH;RORA;APOE;CDH5;METRNL;PPARG;IFI16
prerank,Reactome_2022__DEx/H-box Helicases Activate Type I IFN And Inflammatory Cytokines Production R-HSA-3134963,-0.6432301147641504,-0.9512917082096489,0.625,1.0,1.0,1/5,7.07%,NFKB2
prerank,CellMarker_Augmented_2021__Hematopoietic Stem cell:Bone Marrow,-0.44979029078224236,-0.9511647616611985,0.5147058823529411,1.0,1.0,2/39,1.38%,CD44;MPL
prerank,"GO_Biological_Process_2021__regulation of CD8-positive, alpha-beta T cell proliferation (GO:2000564)",-0.5935334389068266,-0.9511250165530432,0.5932203389830508,1.0,1.0,3/7,17.08%,IRF1;HLA-A;VSIR
prerank,GO_Biological_Process_2021__negative regulation of insulin secretion (GO:0046676),0.4641366174069971,0.9511049525221389,0.5370370370370371,0.9039932644035056,1.0,2/15,2.85%,IRS1;MIDN
prerank,Reactome_2022__Paradoxical Activation Of RAF Signaling By Kinase Inactive BRAF R-HSA-6802955,0.391781227855743,0.9510628879085627,0.44,0.9037640767473459,1.0,7/36,13.66%,KSR1;CSK;ARRB2;CNKSR2;RAP1A;MARK3;ARRB1
prerank,GO_Biological_Process_2021__positive regulation of calcium ion transport (GO:0051928),0.41286990939604756,0.9509105631581548,0.4857142857142857,0.9038779854885818,1.0,7/25,17.42%,TRPC3;GRIN1;F2R;ANK2;WNK3;STIM2;LGALS3
prerank,GO_Biological_Process_2021__positive regulation of branching involved in ureteric bud morphogenesis (GO:0090190),-0.618274179935605,-0.9505016918154217,0.65625,1.0,1.0,5/9,31.28%,AGT;SIX4;SOX9;PAX2;PAX8
prerank,GO_Biological_Process_2021__detection of calcium ion (GO:0005513),-0.562392622707762,-0.9504722175064693,0.5645161290322581,1.0,1.0,4/12,22.40%,CASQ2;CASR;CALM1;KCNMB2
prerank,GO_Biological_Process_2021__regulation of cholesterol efflux (GO:0010874),0.3636534429661916,0.9503685500789387,0.6,0.9048488105755759,1.0,3/29,4.59%,APOE;PPARG;SIRT1
prerank,GO_Biological_Process_2021__protein glycosylation (GO:0006486),0.3164928688119548,0.9503378114429589,0.6,0.9045532369456902,1.0,22/118,16.85%,MGAT4C;GALNT7;SLC39A8;DPM3;TET2;FKTN;ST8SIA4;GALNT1;ST3GAL3;PLOD3;POFUT1;NUS1;ALG12;COG7;FUT9;ALG3;GAL3ST1;MGAT2;ST3GAL6;B3GALNT2;MOGS;POMT2
prerank,GO_Biological_Process_2021__regulation of hormone secretion (GO:0046883),-0.5603799701936841,-0.9503267456217591,0.5740740740740741,1.0,1.0,1/8,8.67%,ANXA1
prerank,GO_Biological_Process_2021__rRNA processing (GO:0006364),-0.36897972678511326,-0.9503221961572078,0.5333333333333333,1.0,1.0,58/165,27.27%,RPL37A;EIF6;SENP3;RPL38;PWP2;EMG1;RPL15;NOB1;RPL3;RPL35A;RPS9;RPS27;RPL13A;RPL27A;RPS16;RPL36;LAS1L;RPL7A;RPL9;RPL13;RPL21;WDR12;NOP53;EXOSC8;RPL34;RPL4;RPL32;RPL5;RPL23;RPL41;RPS7;RPL27;RPL35;RPS14;RPL11;RPS15;EXOSC2;RPLP1;RPL24;SBDS;RPL18A;RPL29;RPLP2;PDCD11;RPL28;RPL12;RPL18;EBNA1BP2;RPL22;IMP3;NSA2;RPS28;RPS19;RPS24;RPL19;RPL8;RPS6;RPL10
prerank,GO_Biological_Process_2021__histone modification (GO:0016570),0.3718811972497352,0.9502925510052708,0.5263157894736842,0.9043297059914223,1.0,29/106,22.16%,EYA4;HDAC10;PRDM5;SIRT1;SIRT7;MIER2;USP36;NSD1;USP16;KAT6A;UBE2A;HDAC1;CARM1;RPS6KA4;HDAC4;EYA3;BAZ1B;HDAC11;BAZ2A;USP51;SUPT3H;EP300;KAT6B;BRMS1L;HDAC5;TBL1X;RCOR2;ATXN7;AURKC
prerank,GO_Biological_Process_2021__smooth muscle cell differentiation (GO:0051145),-0.5498133928677933,-0.9501352382659869,0.6166666666666667,1.0,1.0,3/10,14.16%,TMEM204;EDNRB;HEY2
prerank,PanglaoDB_Augmented_2021__Trigeminal Neurons,0.32518684142372234,0.949806599843476,0.5806451612903226,0.90508389562227,1.0,37/139,19.46%,SLC17A6;SPHKAP;NOVA1;LRRTM3;ELAVL3;NKAIN2;GDAP1;CADM2;MAGI2;PAK5;LRFN5;ERC2;ADGRA1;PARM1;BRINP1;RGS7BP;ELAVL4;RAB3C;AVIL;OLFM3;SCN7A;SNAP91;MAP6;RBFOX1;ASXL3;ANK2;NRXN1;PTPRD;DGKH;DLG2;PPFIA2;LSAMP;MMD2;ST8SIA3;ADGRB3;GRM5;DGKZ
prerank,GO_Biological_Process_2021__kinetochore assembly (GO:0051382),0.49117019498176623,0.9497691318422589,0.43243243243243246,0.9048382503213873,1.0,5/9,40.37%,POGZ;DLGAP5;CENPE;CENPT;CENPC
prerank,CellMarker_Augmented_2021__Corneal Endothelial cell:Eye,0.339986084467784,0.9497183394295263,0.6896551724137931,0.9046479746247081,1.0,23/95,16.63%,FREM1;MEGF10;GPC4;LRRC4C;TMEM132C;SLC35F1;KCNIP1;KCND2;EFS;DOK5;SYNDIG1;PARM1;PDZRN3;BRINP1;RGS7BP;NLGN4X;LRRN1;CRABP1;ANOS1;SYT6;ZNF663P;PTPRD;MAGEL2
prerank,GO_Biological_Process_2021__regulation of skeletal muscle cell differentiation (GO:2001014),0.592336525490395,0.9496445613111922,0.5641025641025641,0.9044909400693377,1.0,1/8,5.36%,KLHL41
prerank,GO_Biological_Process_2021__chondrocyte development (GO:0002063),0.5540402469765238,0.9496035670434984,0.6170212765957447,0.9042623292702515,1.0,3/6,21.51%,EIF2AK3;SULF2;BMPR2
prerank,CellMarker_Augmented_2021__Lymphoblast:Fetal Liver,-0.5019363079477513,-0.9495917945815691,0.532258064516129,1.0,1.0,3/17,7.00%,TCF7;SIRPG;CD5
prerank,GO_Biological_Process_2021__positive regulation of transmembrane transport (GO:0034764),-0.5006904768120954,-0.9492873299186235,0.5636363636363636,1.0,1.0,2/13,8.70%,ACSL5;AZIN1
prerank,GO_Biological_Process_2021__regulation of focal adhesion assembly (GO:0051893),0.37776603810560466,0.949209337055584,0.6153846153846154,0.9050151542837694,1.0,7/50,11.91%,PHLDB2;EPHA3;ABL1;EFNA5;COL16A1;MACF1;LIMS1
prerank,CellMarker_Augmented_2021__Retinoid Acid Signaling-Responsive Fetal Germ cell:Fetal Gonad,-0.3542292210311149,-0.9490999577178111,0.5897435897435898,1.0,1.0,36/188,18.21%,ELOVL2;LY6G5C;DOCK8;CCND1;PDE6B;AGBL5;DAZL;ADA;CDK2AP1;NOL12;ATP6V1D;MYO1F;CASP7;NT5DC2;STRA8;TRMT10A;FBN2;CDKN2D;ABHD14A;TMEM52;COX7A1;NEXN;SYTL1;SPOCK3;LEF1;TUBA3D;SMC1B;CDKN3;UROS;ATOX1;GPATCH11;PDCL2;CD24;A1BG;NUDT8;SDF2L1
prerank,Reactome_2022__Telomere C-strand Synthesis Initiation R-HSA-174430,-0.506251305669116,-0.9489122930550585,0.5087719298245614,1.0,1.0,1/11,2.96%,TERF2IP
prerank,GO_Biological_Process_2021__positive regulation of leukocyte migration (GO:0002687),-0.49898635297464317,-0.9487155741665521,0.5633802816901409,1.0,1.0,4/23,16.13%,F7;ZNF580;ZP3;F2RL1
prerank,GO_Biological_Process_2021__phosphatidylinositol 3-kinase signaling (GO:0014065),0.3826924890768399,0.9485392720021016,0.5365853658536586,0.9062964526421693,1.0,7/31,14.95%,NYAP2;IRS1;ERBB2;PIK3C2B;TYRO3;NF1;PIK3CA
prerank,GO_Biological_Process_2021__DNA strand elongation involved in DNA replication (GO:0006271),-0.5068395428432008,-0.9485134779089981,0.4714285714285714,1.0,1.0,2/18,8.41%,MCM3;MCMDC2
prerank,CellMarker_Augmented_2021__Endocrine cell:Pancreatic Islet,-0.4026386590099163,-0.9484142095338484,0.5526315789473685,1.0,1.0,4/89,5.99%,CLIC1;RIN3;LRP10;CMTM3
prerank,CellMarker_Augmented_2021__Eosinophil:Sinonasal Mucosa,-0.4149012345470088,-0.9483034694206663,0.5072463768115942,1.0,1.0,16/50,20.31%,GMFG;TMC8;RAB44;DOCK2;PARVG;WAS;SPI1;IKZF1;IGLL1;ELANE;RAC2;PIK3CG;LAT2;P2RX1;GAB3;GNA15
prerank,Reactome_2022__PI-3K cascade:FGFR1 R-HSA-5654689,0.4460890438545951,0.9482866949149836,0.5277777777777778,0.9065797366844994,1.0,3/18,4.51%,FGF10;FGFR1;FGF17
prerank,Reactome_2022__Cargo Concentration In ER R-HSA-5694530,-0.4347869636277742,-0.9482501496717065,0.5135135135135135,1.0,1.0,4/27,14.62%,F8;CTSZ;F5;MCFD2
prerank,GO_Biological_Process_2021__regulation of cell aging (GO:0090342),-0.530684025656631,-0.9482247032178633,0.5714285714285714,1.0,1.0,1/10,1.41%,FOXM1
prerank,Reactome_2022__AURKA Activation By TPX2 R-HSA-8854518,0.3687135583798567,0.9479606054852328,0.5652173913043478,0.9070445316811965,1.0,11/67,10.51%,PCM1;CEP152;CEP135;CNTRL;ALMS1;DYNC1I2;SDCCAG8;MAPRE1;CEP290;AKAP9;CEP250
prerank,GO_Biological_Process_2021__basement membrane organization (GO:0071711),0.46702352237263334,0.9479575847786094,0.5454545454545454,0.9067218232962067,1.0,4/14,10.95%,LAMB4;NTN4;NTNG2;FLRT2
prerank,GO_Biological_Process_2021__negative regulation of anion transmembrane transport (GO:1903960),-0.5609161457024724,-0.9479373435283273,0.5660377358490566,1.0,1.0,4/5,39.62%,TCAF2;ARL6IP5;GOPC;SLC43A1
prerank,"GO_Biological_Process_2021__positive regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043372)",0.5739654962877992,0.9476539181037009,0.5434782608695652,0.9071752189483346,1.0,2/7,6.51%,ZBTB7B;HLA-DRA
prerank,GO_Biological_Process_2021__error-free translesion synthesis (GO:0070987),-0.4850167980460416,-0.9476143521604786,0.5774647887323944,1.0,1.0,3/22,21.44%,RPA3;RPS27A;RPA2
prerank,Reactome_2022__DAP12 Interactions R-HSA-2172127,-0.485694882972401,-0.947561725219883,0.6119402985074627,1.0,1.0,2/26,4.02%,CLEC5A;VAV3
prerank,Reactome_2022__Opsins R-HSA-419771,0.6158718820117874,0.947427975103736,0.6304347826086957,0.9073972569687864,1.0,3/6,17.01%,OPN5;RGR;OPN3
prerank,GO_Biological_Process_2021__negative regulation of neuron death (GO:1901215),-0.39355229210529485,-0.9472910850294453,0.625,1.0,1.0,15/82,16.55%,CRLF1;FGF20;KIF14;TNFRSF1B;CLCF1;PINK1;SOD2;PPT1;REST;WFS1;FOXB1;TGFB3;HLA-F;GRN;NAIP
prerank,GO_Biological_Process_2021__negative regulation of mRNA processing (GO:0050686),0.4538410319719157,0.9472315434147239,0.5652173913043478,0.9075256563354676,1.0,5/14,20.02%,SFSWAP;SRSF4;PTBP1;PCBP4;U2AF2
prerank,GO_Biological_Process_2021__L-arginine transmembrane transport (GO:1903400),-0.5749716209986222,-0.9471963434521014,0.5686274509803921,1.0,1.0,1/6,5.15%,SLC7A3
prerank,GO_Biological_Process_2021__negative regulation of double-strand break repair via homologous recombination (GO:2000042),-0.5091318781231353,-0.947193234239457,0.5409836065573771,1.0,1.0,1/17,0.77%,POLQ
prerank,GO_Biological_Process_2021__intracellular distribution of mitochondria (GO:0048312),0.5374098564677686,0.9469142361084449,0.5208333333333334,0.9080936842298553,1.0,3/5,43.94%,CLUH;LRRK2;MAPT
prerank,GO_Biological_Process_2021__acetyl-CoA biosynthetic process from pyruvate (GO:0006086),-0.5925118316534592,-0.9468876321067864,0.6349206349206349,1.0,1.0,1/5,10.04%,PDHX
prerank,GO_Biological_Process_2021__positive regulation of small GTPase mediated signal transduction (GO:0051057),0.41229623029370177,0.9468482748280804,0.5128205128205128,0.9079415131490141,1.0,5/27,10.67%,NGF;FGF10;RAPGEF1;EPOR;IRS2
prerank,KEGG_2021_Human__Purine metabolism,0.33989527279787995,0.9466567777297805,0.5555555555555556,0.9081464663096275,1.0,19/118,12.76%,PNP;FHIT;PAPSS2;NME1-NME2;PDE10A;AK3;NT5C1A;AMPD1;PDE1A;PDE7A;ADCY2;IMPDH1;GUCY1A2;PDE9A;ALLC;PDE4B;ADCY3;AK9;NT5C3A
prerank,GO_Biological_Process_2021__negative regulation of intracellular transport (GO:0032387),-0.6108652928095262,-0.9466195578658313,0.6271186440677966,1.0,1.0,2/5,20.55%,PLN;MRLN
prerank,GO_Biological_Process_2021__negative regulation of proteolysis (GO:0045861),0.4172493327947061,0.9466044649866587,0.41935483870967744,0.9079724256058594,1.0,5/34,7.30%,CSTA;ECM1;TIMP1;CHAC1;F2
prerank,GO_Biological_Process_2021__negative regulation of histone H3-K9 methylation (GO:0051573),0.5729321382212447,0.9463646006192651,0.5454545454545454,0.9081827055279773,1.0,3/6,9.20%,DNMT1;SMARCB1;PIH1D1
prerank,GO_Biological_Process_2021__cGMP-mediated signaling (GO:0019934),0.5022231079801671,0.9462358825690234,0.5428571428571428,0.9081788593720679,1.0,4/12,9.46%,APOE;HTR2C;KCNC2;PDE9A
prerank,GO_Biological_Process_2021__regulation of interleukin-12 production (GO:0032655),0.38332469962543303,0.9459058082010453,0.48,0.9086576473468686,1.0,8/34,15.56%,RIPK2;IL16;HMGB1;PLCB1;MAST2;LGALS9;PIBF1;IL23A
prerank,Reactome_2022__Serotonin Receptors R-HSA-390666,0.5122499865551275,0.9458631613649844,0.56,0.9084398149306283,1.0,2/10,3.39%,HTR1F;HTR2C
prerank,GO_Biological_Process_2021__regulation of glial cell migration (GO:1903975),-0.6451335066051086,-0.9458437365925507,0.6666666666666666,1.0,1.0,2/5,6.26%,P2RY12;GPR183
prerank,Reactome_2022__Alpha-oxidation Of Phytanate R-HSA-389599,0.6161517073597245,0.9458411745013209,0.625,0.9081673378105192,1.0,3/5,23.83%,SLC27A2;PECR;SLC25A17
prerank,KEGG_2021_Human__Synthesis and degradation of ketone bodies,0.5596893563306478,0.9457867077741001,0.4883720930232558,0.9079608012989467,1.0,2/8,23.72%,BDH2;HMGCLL1
prerank,GO_Biological_Process_2021__negative regulation of gene silencing by RNA (GO:0060967),-0.6266182099112568,-0.9456622865992097,0.6111111111111112,1.0,1.0,1/5,1.49%,TGFB1
prerank,GO_Biological_Process_2021__negative regulation of posttranscriptional gene silencing (GO:0060149),-0.6266182099112568,-0.9456622865992097,0.6111111111111112,1.0,1.0,1/5,1.49%,TGFB1
prerank,GO_Biological_Process_2021__negative regulation of immune response (GO:0050777),-0.38475225841710015,-0.9456216059016596,0.5797101449275363,1.0,1.0,17/116,15.79%,AMBP;HCK;SCTR;TSHR;GPHB5;FCGR3A;ALOX15;GPR27;CGA;HLA-DRB1;SPI1;GPR39;PTGDR;NLRC3;GGT5;ADCY7;RNF26
prerank,Reactome_2022__Activated NTRK2 Signals Thru PI3K R-HSA-9028335,0.6032864445742107,0.9455427303255269,0.5945945945945946,0.9081761000773653,1.0,3/5,30.11%,PIK3CA;NTRK2;PIGU
prerank,Reactome_2022__Formation Of beta-catenin:TCF Transactivating Complex R-HSA-201722,-0.4384654535456456,-0.9454255489517227,0.4861111111111111,1.0,1.0,6/40,13.80%,TCF7;TCF7L1;H2BC4;TERT;H2AZ1;LEF1
prerank,GO_Biological_Process_2021__negative regulation of cell cycle process (GO:0010948),-0.4179968277101897,-0.9453850262492414,0.5394736842105263,1.0,1.0,7/59,14.75%,NEK2;GPER1;BRCA1;MAX;FOXO4;RBBP7;TOM1L1
prerank,Reactome_2022__ROS And RNS Production In Phagocytes R-HSA-1222556,0.3811104587956686,0.9453051014092052,0.5555555555555556,0.9084240877786816,1.0,2/29,1.86%,ATP6V0D2;TCIRG1
prerank,GO_Biological_Process_2021__negative regulation of ion transport (GO:0043271),-0.4595266424793076,-0.945183654778007,0.515625,1.0,1.0,3/21,8.01%,CASQ2;CAV3;HTR1B
prerank,GO_Biological_Process_2021__isoprenoid metabolic process (GO:0006720),0.5246304993937501,0.9450364712258725,0.5128205128205128,0.908857956030962,1.0,2/7,24.00%,PDSS2;MVK
prerank,Reactome_2022__Establishment Of Sister Chromatid Cohesion R-HSA-2468052,0.5092797886984954,0.9449995630300508,0.5588235294117647,0.9085967649751231,1.0,4/11,23.92%,ESCO1;PMEPA1;ESCO2;SMC3
prerank,Reactome_2022__DNA Double Strand Break Response R-HSA-5693606,0.38545043573737314,0.9449762965303489,0.5161290322580645,0.9083193596174547,1.0,13/47,16.83%,EYA4;BRCC3;RNF168;H2BC21;PPP5C;ABL1;MAPK8;H2AX;HERC2;EYA3;TP53;BAZ1B;ATM
prerank,KEGG_2021_Human__Influenza A,-0.3775882981100194,-0.9449626745838711,0.5443037974683544,1.0,1.0,22/118,15.16%,TMPRSS11D;SLC25A31;RAB11A;HLA-DMA;CIITA;TRIM25;STAT1;OAS2;ACTG1;PIK3R3;HLA-DPB1;PLG;HLA-DRB1;OAS1;TNFRSF10A;HLA-DPA1;NLRP3;PIK3CB;VDAC1;IL12A;IFNGR2;IL18
prerank,KEGG_2021_Human__Alcoholism,0.3508713091687995,0.9448913696798701,0.5,0.9081514852146647,1.0,27/111,20.77%,GRIN3A;HDAC3;HDAC10;PKIA;CREB3L2;SHC4;CREB3L4;H2BC21;H3C6;GRIN1;HDAC1;H2AX;GNAO1;HDAC4;HDAC11;BRAF;GNG7;MACROH2A2;PPP1CB;CREB1;SOS1;H2AJ;HDAC5;RAF1;GNAI2;GNAS;NTRK2
prerank,GO_Biological_Process_2021__telomere organization (GO:0032200),-0.42893707849788043,-0.9448720090210474,0.5753424657534246,1.0,1.0,4/42,10.71%,TERF2IP;SP100;RPA3;TERT
prerank,GO_Biological_Process_2021__attachment of mitotic spindle microtubules to kinetochore (GO:0051315),-0.536478403142984,-0.9448459511734059,0.5423728813559322,1.0,1.0,2/10,21.14%,NUF2;BOD1
prerank,CellMarker_Augmented_2021__Germ cell:Ovary,-0.5608337315159839,-0.9447478278104425,0.6379310344827587,1.0,1.0,4/10,8.55%,SALL4;DAZL;NLRP5;GPC3
prerank,Reactome_2022__Downstream Signaling Of Activated FGFR4 R-HSA-5654716,-0.4795151923142007,-0.9446601259079987,0.5606060606060606,1.0,1.0,1/22,0.93%,FGF20
prerank,GO_Biological_Process_2021__positive regulation of translational initiation (GO:0045948),-0.5271597648110128,-0.9446399623744582,0.5873015873015873,1.0,1.0,3/18,14.99%,BOLL;DAZL;DDX3X
prerank,GO_Biological_Process_2021__positive regulation of phosphate metabolic process (GO:0045937),0.42174025284539296,0.9446081424406677,0.5135135135135135,0.9086012124302297,1.0,3/23,9.76%,SNCA;DSCAM;BTBD10
prerank,GO_Biological_Process_2021__mitochondrial protein processing (GO:0034982),0.5439176849903984,0.9445922348080165,0.5161290322580645,0.9083241092881937,1.0,2/10,6.40%,IMMP2L;IMMP1L
prerank,GO_Biological_Process_2021__RNA stabilization (GO:0043489),-0.44351934766233725,-0.9445282772763041,0.5230769230769231,1.0,1.0,3/33,10.72%,TENT5B;MEIOC;SLC11A1
prerank,Reactome_2022__Negative Regulation Of FGFR1 Signaling R-HSA-5654726,0.39588917885433555,0.9444637368317722,0.5625,0.9082547046463697,1.0,3/29,4.51%,FGF10;FGFR1;FGF17
prerank,GO_Biological_Process_2021__regulation of macroautophagy (GO:0016241),0.33976776999446645,0.9443819986267461,0.42105263157894735,0.9081307662952752,1.0,25/104,21.50%,ATP6V0D2;EPM2A;SIRT1;SNX5;MAPK8;CASP3;MTMR8;MLST8;ERN1;GPSM1;USP36;CLEC16A;QSOX1;EXOC7;PIK3CA;SNX32;SMG1;NEDD4;SESN2;CDK5;PRKAA2;PRKAG2;LARP1;BNIP3L;EXOC4
prerank,Reactome_2022__Recruitment And ATM-mediated Phosphorylation Of Repair And Signal Proteins At DNA Double Strand Breaks R-HSA-5693565,0.38759734244901917,0.9442102147981424,0.5,0.908159698788311,1.0,13/46,16.83%,EYA4;BRCC3;RNF168;H2BC21;PPP5C;ABL1;MAPK8;H2AX;HERC2;EYA3;TP53;BAZ1B;ATM
prerank,"GO_Biological_Process_2021__neurotransmitter receptor transport, endosome to postsynaptic membrane (GO:0098887)",0.5741272348418764,0.9442101791657722,0.5263157894736842,0.9078286161420157,1.0,2/6,2.69%,SCRIB;GRIP1
prerank,Reactome_2022__Caspase Activation Via Death Receptors In Presence Of Ligand R-HSA-140534,0.48484208540159524,0.9441230379569299,0.5161290322580645,0.9078194703882189,1.0,4/13,12.94%,CFLAR;TICAM1;TANK;FADD
prerank,GO_Biological_Process_2021__regulation of endothelial cell proliferation (GO:0001936),0.36349493973821984,0.9439745284369766,0.5,0.9077994303357805,1.0,13/75,9.08%,APOH;TGFBR1;VEGFC;APOE;ANGPT1;CDH13;SEMA5A;SIRT1;PROX1;ECM1;VASH1;FGF18;PTPRM
prerank,GO_Biological_Process_2021__positive regulation of protein processing (GO:0010954),0.40829706776223895,0.943824780833984,0.43333333333333335,0.9079156172848313,1.0,8/17,22.36%,KLKB1;RHBDD1;F12;ASTL;NKD2;PLGRKT;ENO1;ADAM8
prerank,CellMarker_Augmented_2021__Endothelial Progenitor cell:Blood Vessel,0.3504329888959359,0.9438194610355745,0.47619047619047616,0.9072602789791798,1.0,8/75,7.37%,ERG;FREM1;MXRA5;KIT;CDH5;TMEM132C;CGNL1;FGD5
prerank,CellMarker_Augmented_2021__Circulating Progenitor cell:Blood,0.3504329888959359,0.9438194610355745,0.47619047619047616,0.9072602789791798,1.0,8/75,7.37%,ERG;FREM1;MXRA5;KIT;CDH5;TMEM132C;CGNL1;FGD5
prerank,GO_Biological_Process_2021__cellular response to bacterial lipopeptide (GO:0071221),0.5863399879637864,0.9437166407578588,0.631578947368421,0.9072187013018091,1.0,1/5,3.69%,CD14
prerank,GO_Biological_Process_2021__cellular response to zinc ion (GO:0071294),0.4829699175054201,0.9435763031073803,0.5116279069767442,0.9072859652855813,1.0,1/12,0.75%,MT1G
prerank,GO_Biological_Process_2021__amino acid transport (GO:0006865),0.38317397414780396,0.9435736252949669,0.48148148148148145,0.9069724788248877,1.0,10/45,11.22%,SLC38A5;SLC3A2;SLC7A9;SLC16A10;SLC6A17;SLC6A20;SLC7A11;SLC7A6;SLC25A29;SLC7A8
prerank,GO_Biological_Process_2021__negative regulation of cell size (GO:0045792),-0.6420314533965112,-0.9433249551272437,0.6666666666666666,1.0,1.0,1/5,2.76%,CAV3
prerank,GO_Biological_Process_2021__high-density lipoprotein particle assembly (GO:0034380),0.5386173142154138,0.9432120334374303,0.6046511627906976,0.9074910226260937,1.0,2/9,7.63%,APOE;ABCA1
prerank,GO_Biological_Process_2021__negative regulation of interleukin-1 production (GO:0032692),-0.4754942083640907,-0.9431183505654998,0.46774193548387094,1.0,1.0,5/21,18.68%,NLRP12;CEACAM1;NLRP3;GHRL;CARD8
prerank,Reactome_2022__Pre-NOTCH Transcription And Translation R-HSA-1912408,0.38596618975603436,0.9430619967644721,0.5555555555555556,0.9075255065382668,1.0,17/43,20.09%,MAML1;H2BC21;MOV10;MAMLD1;TNRC6C;H2AX;TP53;RUNX1;TNRC6A;NOTCH1;AGO3;RBPJ;SIRT6;EP300;KAT2B;H2AJ;AGO2
prerank,GO_Biological_Process_2021__regulation of epithelial cell differentiation (GO:0030856),-0.4847824192835458,-0.9430356133009747,0.578125,1.0,1.0,5/14,21.32%,CEACAM1;APOLD1;ALOX15B;CD24;SOX9
prerank,Reactome_2022__Signaling By EGFR R-HSA-177929,-0.4305392919905953,-0.9430003448485054,0.6029411764705882,1.0,1.0,1/45,0.29%,EPN1
prerank,Reactome_2022__Biosynthesis Of Maresins R-HSA-9018682,0.5723812437663133,0.9429570065195626,0.5555555555555556,0.9074567446951848,1.0,2/6,2.43%,CYP1A2;EPHX2
prerank,Reactome_2022__HIV Transcription Initiation R-HSA-167161,-0.42891197063734177,-0.9428206207742852,0.6119402985074627,1.0,1.0,11/43,24.92%,GTF2E1;TAF7;TAF7L;TAF9B;TAF10;TAF6;TAF13;TBP;POLR2B;TAF5;CDK7
prerank,GO_Biological_Process_2021__regulation of G2/M transition of mitotic cell cycle (GO:0010389),-0.3709597026481227,-0.9427722065160695,0.6024096385542169,1.0,1.0,8/136,5.75%,NEK2;PSMB9;KIF14;DTL;CCND1;CDC25A;RAB11A;FBXL7
prerank,GO_Biological_Process_2021__gamma-aminobutyric acid metabolic process (GO:0009448),-0.607642437516935,-0.9427024422379869,0.6326530612244898,1.0,1.0,1/5,2.41%,GAD1
prerank,GO_Biological_Process_2021__regulation of B cell differentiation (GO:0045577),-0.4998806995424924,-0.9426873245423899,0.5217391304347826,1.0,1.0,4/15,24.21%,CD27;ZFP36L1;INHA;SFRP1
prerank,GO_Biological_Process_2021__RNA-dependent DNA biosynthetic process (GO:0006278),-0.43876238698973774,-0.9426466888896458,0.6065573770491803,1.0,1.0,3/29,10.90%,TERF2IP;TERT;PIF1
prerank,GO_Biological_Process_2021__cellular response to brain-derived neurotrophic factor stimulus (GO:1990416),0.6134824147975213,0.9426391828950764,0.6428571428571429,0.9078822262103133,1.0,2/5,30.67%,NTRK2;TMEM108
prerank,KEGG_2021_Human__Sphingolipid metabolism,0.367748715131683,0.9426390806888895,0.5588235294117647,0.9075528059540685,1.0,11/43,16.63%,GLA;ACER2;SMPD4;SMPD3;PLPP2;ACER3;NEU4;GLB1;GAL3ST1;NEU3;CERS4
prerank,KEGG_2021_Human__Ras signaling pathway,0.3342002619766046,0.9424108619633178,0.6,0.9077988609710511,1.0,37/189,15.81%,NGF;FGF10;KIT;VEGFC;FGFR1;KSR1;ANGPT1;FGF17;SHC4;RALB;PDGFD;RIN1;PAK5;RRAS2;RASA2;ABL1;MAPK8;RALA;EFNA5;FGF18;TGFA;ABL2;AKT2;FGFR3;KITLG;GRIN1;RASAL2;RAP1A;GAB1;PLA2G4C;NF1;FLT3;NFKB1;INSR;PIK3CA;BRAP;EFNA2
prerank,GO_Biological_Process_2021__positive regulation of kinase activity (GO:0033674),0.33769626781315737,0.9423804604787674,0.5652173913043478,0.9075565064638934,1.0,26/101,21.15%,RASSF2;KIT;FGFR1;EPHA7;CCN1;ERBB2;EPHA3;DRD4;F2;FGFR3;TYRO3;RET;RAP1A;SNX9;FLT3;RYK;INSR;EPHB2;ROR1;EPHA6;DUSP19;MMD2;TAB2;PRKAG2;NTRK2;CACUL1
prerank,Reactome_2022__Biosynthesis Of N-glycan Precursor (Dolichol LLO) And Transfer To Protein R-HSA-446193,0.3606205160655475,0.9423161955431899,0.5833333333333334,0.9074065156428117,1.0,13/70,11.28%,ST6GALNAC3;DPM3;ST6GAL2;ST8SIA4;ST3GAL3;GMDS;NPL;NUS1;ALG12;NAGK;UAP1;NEU4;GLB1
prerank,"GO_Biological_Process_2021__positive regulation of phagocytosis, engulfment (GO:0060100)",0.5336549112279845,0.942212176130235,0.46938775510204084,0.9073162629589312,1.0,3/8,20.03%,RAB31;ABCA7;APPL2
prerank,Reactome_2022__Diseases Associated With N-glycosylation Of Proteins R-HSA-3781860,0.43118867242584347,0.9421983732382982,0.5675675675675675,0.9070147387250442,1.0,7/20,29.09%,ALG12;GLB1;ALG3;MOGS;ALG13;B4GALT1;EGFL7
prerank,Reactome_2022__Phospholipase C-mediated Cascade: FGFR1 R-HSA-5654219,0.48561574782068495,0.9420793210587133,0.46511627906976744,0.9070817843144541,1.0,3/13,4.51%,FGF10;FGFR1;FGF17
prerank,GO_Biological_Process_2021__homeostasis of number of cells (GO:0048872),0.500548993816605,0.9420747087138531,0.53125,0.9067643182836775,1.0,4/11,10.74%,CX3CR1;CARD9;OCIAD2;F2R
prerank,GO_Biological_Process_2021__regulation of translational elongation (GO:0006448),0.5737629311563748,0.9419631388673181,0.5681818181818182,0.9067718628066,1.0,2/6,19.02%,USP16;GRM5
prerank,GO_Biological_Process_2021__regulation of mitochondrial gene expression (GO:0062125),0.526792927498295,0.9419613019146471,0.5227272727272727,0.9064547384950168,1.0,2/8,23.39%,SHMT2;METTL4
prerank,CellMarker_Augmented_2021__Peritubular Myoid cell:Testis,-0.38522667007399825,-0.9417689292655447,0.55,1.0,1.0,10/83,9.05%,OLFML1;LMOD1;ECM2;ANGPTL2;FILIP1L;COL1A1;ADAM33;DCN;ASPN;SFRP4
prerank,CellMarker_Augmented_2021__Fibroblast:Corneal Endothelium,-0.38522667007399825,-0.9417689292655447,0.55,1.0,1.0,10/83,9.05%,OLFML1;LMOD1;ECM2;ANGPTL2;FILIP1L;COL1A1;ADAM33;DCN;ASPN;SFRP4
prerank,CellMarker_Augmented_2021__Mesenchymal cell:Undefined,-0.38522667007399825,-0.9417689292655447,0.55,1.0,1.0,10/83,9.05%,OLFML1;LMOD1;ECM2;ANGPTL2;FILIP1L;COL1A1;ADAM33;DCN;ASPN;SFRP4
prerank,CellMarker_Augmented_2021__Myofibroblast:Undefined,-0.38522667007399825,-0.9417689292655447,0.55,1.0,1.0,10/83,9.05%,OLFML1;LMOD1;ECM2;ANGPTL2;FILIP1L;COL1A1;ADAM33;DCN;ASPN;SFRP4
prerank,CellMarker_Augmented_2021__Smooth Muscle cell:Blood Vessel,-0.38522667007399825,-0.9417689292655447,0.55,1.0,1.0,10/83,9.05%,OLFML1;LMOD1;ECM2;ANGPTL2;FILIP1L;COL1A1;ADAM33;DCN;ASPN;SFRP4
prerank,CellMarker_Augmented_2021__T cell:Optic Nerve,-0.4450356815259724,-0.9416094329593137,0.5733333333333334,1.0,1.0,6/28,10.28%,SIRPG;KLRB1;SCML4;CD5;TRAF3IP3;PTPRC
prerank,CellMarker_Augmented_2021__T cell:Colorectum,-0.4450356815259724,-0.9416094329593137,0.5733333333333334,1.0,1.0,6/28,10.28%,SIRPG;KLRB1;SCML4;CD5;TRAF3IP3;PTPRC
prerank,CellMarker_Augmented_2021__T cell:Bone Marrow,-0.4450356815259724,-0.9416094329593137,0.5733333333333334,1.0,1.0,6/28,10.28%,SIRPG;KLRB1;SCML4;CD5;TRAF3IP3;PTPRC
prerank,CellMarker_Augmented_2021__T cell:Synovium,-0.4450356815259724,-0.9416094329593137,0.5733333333333334,1.0,1.0,6/28,10.28%,SIRPG;KLRB1;SCML4;CD5;TRAF3IP3;PTPRC
prerank,GO_Biological_Process_2021__negative regulation of receptor binding (GO:1900121),0.5692091809069609,0.9416030907280614,0.5652173913043478,0.907062799587612,1.0,2/6,15.15%,ADAM15;PTPRF
prerank,"GO_Biological_Process_2021__DNA damage response, signal transduction by p53 class mediator (GO:0030330)",-0.42352859785758873,-0.9415489096921762,0.5606060606060606,1.0,1.0,3/68,4.03%,GML;FOXM1;SP100
prerank,GO_Biological_Process_2021__metanephric mesenchyme development (GO:0072075),0.4872940582964658,0.9412128989698314,0.4444444444444444,0.9076596068806176,1.0,3/8,6.85%,WNT4;PKD2;OSR1
prerank,GO_Biological_Process_2021__positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway (GO:1900740),0.46624286465752346,0.9410968318599462,0.5263157894736842,0.9072957952521472,1.0,5/21,15.44%,BCL2;PPP1R13B;MAPK8;BID;TP53
prerank,GO_Biological_Process_2021__regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway (GO:1900739),0.46624286465752346,0.9410968318599462,0.5263157894736842,0.9072957952521472,1.0,5/21,15.44%,BCL2;PPP1R13B;MAPK8;BID;TP53
prerank,GO_Biological_Process_2021__cellular component maintenance (GO:0043954),-0.529524783277977,-0.9410747489510316,0.5833333333333334,1.0,1.0,1/11,4.19%,CLDN1
prerank,GO_Biological_Process_2021__peptidyl-proline hydroxylation to 4-hydroxy-L-proline (GO:0018401),0.5995271086074382,0.9409753093245715,0.6444444444444445,0.9071843032053324,1.0,1/6,0.67%,EGLN3
prerank,CellMarker_Augmented_2021__Luminal Progenitor cell:Breast,-0.40957846889742494,-0.940880184641623,0.5666666666666667,1.0,1.0,15/60,19.93%,MISP;EPN3;MYO5B;LAMC2;SOWAHB;ITGB6;TRIM29;TJP3;CD24;SCNN1A;CAPN13;SLC44A3;FAM3D;ACE2;CBLC
prerank,GO_Biological_Process_2021__regulation of mast cell degranulation (GO:0043304),-0.5371723932421579,-0.9408281176044467,0.5471698113207547,1.0,1.0,1/12,2.65%,BLK
prerank,GO_Biological_Process_2021__BMP signaling pathway (GO:0030509),-0.406447344667206,-0.940816388047936,0.5915492957746479,1.0,1.0,7/54,17.20%,TGFB1;NODAL;SMAD6;ENG;TGFB3;SMAD3;GDF15
prerank,Reactome_2022__Metabolism Of RNA R-HSA-8953854,-0.33113219060606286,-0.9407764011750245,0.6847826086956522,1.0,1.0,74/620,20.13%,CD44;NLRP4;ENPP2;PSMB9;RPL37A;RPP38;DIMT1;NOL12;SNRPD2;IGF2BP2;SENP3;RPL38;PWP2;EMG1;RPL15;SNRNP27;DHX38;TRMT10A;FIP1L1;HSPA8;DDX20;NOB1;RPS4X;RPL3;APOBEC4;RPL35A;GNL3;RPS9;FAU;COLEC12;RPS27;RPS21;METTL14;GEMIN4;RPL13A;PSMA3;WBP11;RPL27A;CDC40;RPS16;RPL36;LAS1L;RPS20;RPL7A;ZFP36L1;RPL9;CSTF2T;RPS8;RPS27A;SRSF9;SRSF5;RPL21;EIF4A2;WDR12;EXOSC8;RPL34;DDX1;PRCC;ZNF473;PSMA7;PSMB6;RPL4;RPL32;RPL5;RPL23;RNMT;RPL41;RPS7;RPS11;SET;NUP93;RPL27;RPL35;DUS2
prerank,KEGG_2021_Human__Hepatocellular carcinoma,-0.37005370527292364,-0.9406700519719952,0.6049382716049383,1.0,1.0,21/148,15.05%,TCF7;MGST1;TGFB1;WNT5A;WNT8B;CCND1;FZD8;ACTL6A;TCF7L1;NQO1;ACTG1;PIK3R3;FRAT1;TERT;WNT8A;CDKN1A;WNT6;PIK3CB;LEF1;TGFB3;SMARCE1
prerank,GO_Biological_Process_2021__cellular response to drug (GO:0035690),-0.47421412460688744,-0.9406160259044862,0.5161290322580645,1.0,1.0,4/22,9.69%,AIM2;HTR1B;KCNQ1;REST
prerank,"Reactome_2022__Metabolism Of Ingested SeMet, Sec, MeSec Into H2Se R-HSA-2408508",-0.6403825311773836,-0.9405184351367808,0.5964912280701754,1.0,1.0,1/5,1.05%,VSIG2
prerank,Reactome_2022__Regulation Of Cytoskeletal Remodeling And Cell Spreading By IPP Complex Components R-HSA-446388,0.5138334108682268,0.9404925621692791,0.5,0.9081365615735492,1.0,3/8,17.11%,PARVA;LIMS1;RSU1
prerank,GO_Biological_Process_2021__glutamine family amino acid catabolic process (GO:0009065),-0.5133494850739984,-0.9402736982957399,0.5833333333333334,1.0,1.0,4/12,17.77%,GAD1;DAO;NOS2;PRODH2
prerank,Reactome_2022__Peroxisomal Protein Import R-HSA-9033241,-0.4079604053533276,-0.9401629336435575,0.5217391304347826,1.0,1.0,7/56,14.71%,AMACR;ACOX2;PIPOX;DAO;ACOT4;HAO2;ACOT2
prerank,KEGG_2021_Human__Arachidonic acid metabolism,-0.4347903654791095,-0.940157655214634,0.5507246376811594,1.0,1.0,15/43,17.74%,ALOX12;ALOX5;ALOX12B;PTGES;PLA2G10;ALOX15;CYP2J2;GPX3;GPX2;GGT5;CYP2E1;PLB1;ALOX15B;TBXAS1;PLA2G4A
prerank,Reactome_2022__SHC-related Events Triggered By IGF1R R-HSA-2428933,0.5644576698492751,0.9400183345556107,0.5813953488372093,0.9090449537506216,1.0,5/7,40.98%,SOS1;HRAS;IGF1;IGF1R;GRB2
prerank,GO_Biological_Process_2021__neurotransmitter receptor transport to postsynaptic membrane (GO:0098969),0.5149745072458142,0.9399924806222854,0.5945945945945946,0.9087710881727794,1.0,2/9,2.69%,SCRIB;GRIP1
prerank,GO_Biological_Process_2021__nitric oxide metabolic process (GO:0046209),-0.509723367754186,-0.9399298865637531,0.527027027027027,1.0,1.0,5/14,18.26%,CYP1B1;NQO1;ARG2;NOS2;GCHFR
prerank,GO_Biological_Process_2021__activation of Janus kinase activity (GO:0042976),0.6036180481603753,0.9397271696606015,0.6341463414634146,0.9090637376087404,1.0,2/6,23.80%,PIBF1;PRLR
prerank,GO_Biological_Process_2021__negative regulation of myeloid leukocyte differentiation (GO:0002762),-0.47524278404665604,-0.9395589191342959,0.5757575757575758,1.0,1.0,3/21,8.28%,LILRB3;CEACAM1;ZFPM1
prerank,Reactome_2022__Regulation Of IGF Transport And Uptake By IGFBPs R-HSA-381426,-0.3828002025535095,-0.9395271079935261,0.527027027027027,1.0,1.0,15/96,13.89%,NOTUM;APOL1;ITIH2;SERPIND1;SDC2;PAPPA2;PAPPA;PRSS23;GPC3;SERPINA10;PLG;CP;WFS1;MFGE8;F5
prerank,CellMarker_Augmented_2021__Stem cell:Ovarian Cortex,0.3710206872573176,0.939522881497837,0.5714285714285714,0.9093346098982403,1.0,13/64,10.31%,GRID2;ANKRD18CP;IGDCC3;PCDH11X;CHST6;CNTNAP2;FLVCR1;TRIM71;PTPRZ1;ADCY2;GRM4;ZNF519;TERF1
prerank,GO_Biological_Process_2021__icosanoid biosynthetic process (GO:0046456),-0.47465054588213806,-0.9394105100030492,0.546875,1.0,1.0,3/11,17.79%,ALOX5;PLA2G4A;ALOX5AP
prerank,GO_Biological_Process_2021__positive regulation of tau-protein kinase activity (GO:1902949),-0.6149113362996111,-0.9391601195729423,0.5319148936170213,1.0,1.0,1/5,8.95%,CLU
prerank,GO_Biological_Process_2021__positive regulation of apoptotic process (GO:0043065),0.31397576668112726,0.939123940112454,0.5882352941176471,0.909998728914,1.0,50/264,18.01%,NGF;PLEKHG2;RASSF2;FOXO1;FANK1;TGFBR1;BCL6;SCRIB;EPHA7;FGD4;BIN1;DAPK2;HTRA2;SIRT1;SNCA;TRIM35;TOP2A;HMGB1;ABL1;LATS1;MAPK8;SLIT2;CASP3;FGD1;MAP3K10;RRP1B;CALHM2;NLRP2B;UNC13B;FADD;RYBP;CRADD;NF1;BID;AIFM2;RPS6KA2;VAV2;GADD45A;TP53;PTGIS;UBE2Z;ATM;GPLD1;CLIP3;IAPP;PAWR;SLC27A4;ARHGEF16;FAF1;ERCC3
prerank,GO_Biological_Process_2021__monoacylglycerol metabolic process (GO:0046462),-0.5386884090342339,-0.9389852391368126,0.6363636363636364,1.0,1.0,2/11,17.74%,DGAT2L6;PLA2G4A
prerank,GO_Biological_Process_2021__protein deglutamylation (GO:0035608),-0.5651126099896078,-0.938827640562745,0.5178571428571429,1.0,1.0,3/8,22.42%,AGBL5;FOLH1B;FOLH1
prerank,GO_Biological_Process_2021__negative regulation of epidermal growth factor receptor signaling pathway (GO:0042059),-0.4523002280791123,-0.9386608592982942,0.6301369863013698,1.0,1.0,1/39,0.29%,EPN1
prerank,GO_Biological_Process_2021__negative regulation of stress-activated MAPK cascade (GO:0032873),-0.4418227768740038,-0.9386336295481851,0.5645161290322581,1.0,1.0,3/36,5.61%,AMBP;FOXM1;PINK1
prerank,GO_Biological_Process_2021__positive regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway (GO:1901030),0.44119797976111297,0.938543990379001,0.5897435897435898,0.9111203219183498,1.0,5/29,15.44%,BCL2;PPP1R13B;MAPK8;BID;TP53
prerank,GO_Biological_Process_2021__phospholipase C-activating dopamine receptor signaling pathway (GO:0060158),0.5563791170692395,0.9385121499995931,0.5434782608695652,0.910862359390054,1.0,1/7,4.25%,DRD5
prerank,CellMarker_Augmented_2021__Bile Duct cell:Liver,-0.3940661982328397,-0.9383536097850437,0.5714285714285714,1.0,1.0,13/66,13.06%,SERINC2;MISP;CCND1;CLDN1;SEMA3F;SH2D4A;EPN3;GPR39;LAMC2;ITGB6;BAIAP2L1;TRIM29;PPIC
prerank,Reactome_2022__PIWI-interacting RNA (piRNA) Biogenesis R-HSA-5601884,0.41757377391004324,0.9383240420345604,0.5714285714285714,0.9110675890172251,1.0,2/29,9.58%,PLD6;PIWIL1
prerank,GO_Biological_Process_2021__positive regulation of mRNA processing (GO:0050685),0.45521479732938275,0.9381259268094849,0.4878048780487805,0.911186561238107,1.0,8/20,32.71%,TRA2A;CELF4;SF3B4;NUP98;LEO1;DAZAP1;CDC73;TRA2B
prerank,GO_Biological_Process_2021__ribosome biogenesis (GO:0042254),-0.35387139341261314,-0.9380464896663167,0.5555555555555556,1.0,1.0,59/184,27.27%,RPL37A;EIF6;SENP3;RPL38;PWP2;EMG1;RPL15;NOB1;RPL3;RPL35A;RPS9;RPS27;RPL13A;RPL27A;RPS16;RPL36;LAS1L;RPL7A;RPL9;RPL13;RPL21;WDR12;NOP53;EXOSC8;RPL34;RPL4;RPL32;RPL5;RPL23;RPL41;RPS7;RPL27;RPL35;RPS14;RPL11;RPS15;EXOSC2;RPLP1;SURF6;RPL24;SBDS;RPL18A;RPL29;RPLP2;PDCD11;RPL28;RPL12;RPL18;EBNA1BP2;RPL22;IMP3;RPS28;RPS19;RPS24;RPL26L1;RPL19;RPL8;RPS6;RPL10
prerank,GO_Biological_Process_2021__beta-catenin-TCF complex assembly (GO:1904837),-0.45819295817125566,-0.937879367180183,0.5441176470588235,1.0,1.0,4/29,13.80%,TCF7;TCF7L1;TERT;LEF1
prerank,GO_Biological_Process_2021__somatic recombination of immunoglobulin genes involved in immune response (GO:0002204),0.554193143580316,0.9376751369978747,0.575,0.9119348990901883,1.0,2/6,16.35%,RNF168;LIG4
prerank,CellMarker_Augmented_2021__Mucosal-associated Invariant T cell:Liver,0.3674752707823053,0.9376362397645506,0.5925925925925926,0.9116770146614398,1.0,5/57,9.53%,PNP;RORA;NRIP1;APOL3;ERN1
prerank,GO_Biological_Process_2021__protein localization to organelle (GO:0033365),0.3371570516847968,0.9375492069509133,0.3157894736842105,0.9115859733727125,1.0,26/125,16.34%,CTDNEP1;AUP1;TOR1B;PACSIN2;FAM83H;CNTLN;MARCHF5;STX5;TULP3;WASHC2C;GBF1;BBS9;BICD1;GCC2;CROCC;TSPAN17;CEP250;RAB35;BANP;WASHC2A;COG7;ANK2;GBP2;IFT140;TTC21B;ARL3
prerank,Reactome_2022__SHC-mediated cascade:FGFR1 R-HSA-5654688,0.46882223050372357,0.9374666934055423,0.5428571428571428,0.9114896233598248,1.0,3/17,4.51%,FGF10;FGFR1;FGF17
prerank,GO_Biological_Process_2021__negative regulation of T cell migration (GO:2000405),-0.6467228440597244,-0.9374480387651658,0.6037735849056604,1.0,1.0,1/5,12.51%,APOD
prerank,Reactome_2022__O-linked Glycosylation R-HSA-5173105,0.33028397704922396,0.9374195344216706,0.5652173913043478,0.9113020151778729,1.0,11/91,6.71%,ADAMTS1;ADAMTS16;ST6GALNAC3;GALNT12;SEMA5A;SPON1;ADAMTS12;ADAMTS6;GALNT1;ST3GAL3;MUC13
prerank,GO_Biological_Process_2021__positive regulation of cytosolic calcium ion concentration (GO:0007204),0.33545203685853237,0.9370689456008185,0.5,0.9118663793957335,1.0,13/103,7.93%,ADRA1A;GPR33;ADRA1B;TRPC3;GPR174;HTR2C;SLC8A1;CX3CR1;JPH1;CHRNA10;HMGB1;ABL1;EDNRA
prerank,GO_Biological_Process_2021__pyrimidine nucleobase catabolic process (GO:0006208),0.5552423510605625,0.9370024416374864,0.5652173913043478,0.9117163490590646,1.0,5/8,35.79%,DPYSL2;DPYSL5;DPYS;ALDH6A1;DPYSL4
prerank,GO_Biological_Process_2021__cellular response to retinoic acid (GO:0071300),-0.3847304694382022,-0.9369788815566182,0.582089552238806,1.0,1.0,3/39,2.81%,TBX1;WNT5A;WNT8B
prerank,GO_Biological_Process_2021__cannabinoid signaling pathway (GO:0038171),-0.6174097444928552,-0.9369612938746994,0.6181818181818182,1.0,1.0,3/5,28.32%,ALOX15B;CNR2;CNR1
prerank,GO_Biological_Process_2021__positive regulation of interferon-beta production (GO:0032728),-0.46200211938719926,-0.9369422273306506,0.5238095238095238,1.0,1.0,11/29,26.42%,IRF1;OAS2;OAS1;TLR2;DDX3X;DHX58;TRIM56;ISG15;FLOT1;PTPN11;RNF135
prerank,Reactome_2022__Ca2+ Pathway R-HSA-4086398,-0.428234087187672,-0.9368597703257382,0.6025641025641025,1.0,1.0,10/53,18.38%,TCF7;WNT5A;PDE6B;TCF7L1;GNGT1;LEF1;ITPR3;PDE6A;CALM1;CAMK2A
prerank,GO_Biological_Process_2021__RNA splicing (GO:0008380),0.3553907933785856,0.9368584104208023,0.6153846153846154,0.9117274188586422,1.0,30/92,26.93%,SNRPN;NOVA1;KHSRP;TXNL4A;SNRPB;U2AF1;SRRM1;ZMAT5;PPP1R9B;SF3B1;SRSF4;PTBP1;FUS;SYNCRIP;RNF113A;SF3B4;LSM6;YJU2;NRDE2;PDCD7;PRPF18;MAGOHB;TCERG1;SNRNP48;SRPK2;SNRPF;SCAF11;RBM8A;SMU1;RP9
prerank,GO_Biological_Process_2021__regulation of protein localization to membrane (GO:1905475),0.4121184941497097,0.9367769746959655,0.5454545454545454,0.9115560879621499,1.0,4/27,9.31%,GPC4;GPC6;STX8;GPC5
prerank,GO_Biological_Process_2021__Wnt signaling pathway (GO:0016055),-0.38489031199311563,-0.9365208444544909,0.5714285714285714,1.0,1.0,15/85,18.03%,TCF7;WNT5A;WNT8B;FZD8;TCF7L1;FRAT1;SFRP4;WNT8A;WNT6;LEF1;DDX3X;RBX1;WNT10A;CD24;RPS27A
prerank,GO_Biological_Process_2021__positive regulation of amyloid precursor protein catabolic process (GO:1902993),0.46750621190216185,0.9364874041057208,0.53125,0.9119801251670071,1.0,3/20,7.93%,LRRTM3;SP1;CASP3
prerank,GO_Biological_Process_2021__T cell mediated immunity (GO:0002456),0.4916194524527173,0.9360680045199189,0.4358974358974359,0.9127254974359822,1.0,4/15,8.00%,BTN3A2;JAG1;CADM1;CD8A
prerank,GO_Biological_Process_2021__carbohydrate catabolic process (GO:0016052),-0.44202584554023194,-0.9359150282179932,0.6285714285714286,1.0,1.0,7/35,8.97%,HK2;ENO4;ALDOB;PKLR;ENOSF1;ENO2;GAPDHS
prerank,GO_Biological_Process_2021__outflow tract septum morphogenesis (GO:0003148),-0.4884369796387142,-0.9358419684838518,0.5614035087719298,1.0,1.0,4/19,11.81%,TBX1;SMAD6;LRP2;ENG
prerank,CellMarker_Augmented_2021__Adipose-derived Stromal cell:Subcutaneous Adipose Tissue,0.363805541668329,0.9358320027048664,0.5333333333333333,0.912939821625503,1.0,7/68,3.92%,CSTA;PTGS1;BCL6;MAFB;RIN2;CD14;PID1
prerank,GO_Biological_Process_2021__negative regulation of intracellular steroid hormone receptor signaling pathway (GO:0033144),-0.487558244478736,-0.9357753811382966,0.6351351351351351,1.0,1.0,4/26,8.63%,NODAL;DAB2;ZNF366;BRCA1
prerank,CellMarker_Augmented_2021__Acinar cell:Pancreas,0.34548315417142855,0.9357171224900596,0.5625,0.9128593677865433,1.0,32/87,31.43%,URI1;CBFB;ABCD3;TMEM267;SUCO;ZMYND11;GABPA;LIG4;RAD17;ZBTB41;SOCS4;MTDH;ZNF664;ZNF800;APPBP2;FBXL17;ATP11B;GPR180;RB1;DNAJB14;NR1D2;CD2AP;EDEM3;PRELID3B;PRKAA1;MANEA;SLC10A7;VPS13A;PDS5A;CAPN7;TBL1XR1;PDIK1L
prerank,GO_Biological_Process_2021__regulation of cell-substrate junction assembly (GO:0090109),0.41045613074393156,0.9357160447933317,0.45161290322580644,0.9125380013595044,1.0,11/21,28.69%,EPHA3;EFNA5;MACF1;SLK;VCL;CAMSAP3;PTPRA;PEAK1;ROCK1;GPM6B;CORO1C
prerank,KEGG_2021_Human__Peroxisome,-0.40756473147643013,-0.9356935745480548,0.6428571428571429,1.0,1.0,7/74,8.33%,AMACR;ACOX2;ACSL5;PIPOX;MPV17L2;DAO;SOD2
prerank,GO_Biological_Process_2021__excitatory synapse assembly (GO:1904861),0.548886296643215,0.9354915903537112,0.6097560975609756,0.9127146917490365,1.0,2/8,2.68%,GRID2;NLGN1
prerank,CellMarker_Augmented_2021__Pancreatic Polypeptide cell:Pancreas,-0.4893029254855279,-0.9353527996036156,0.5614035087719298,1.0,1.0,1/16,0.34%,AQP3
prerank,GO_Biological_Process_2021__sulfate transport (GO:0008272),0.5038778305031161,0.9353490786393184,0.5121951219512195,0.9126986175020175,1.0,1/13,1.67%,SLC26A7
prerank,GO_Biological_Process_2021__proteolysis involved in cellular protein catabolic process (GO:0051603),0.36016185317207566,0.9353422357890182,0.5454545454545454,0.9123883515364888,1.0,17/61,24.67%,ADAMTS12;CAPN2;RHBDD1;CTSV;RSPRY1;NGLY1;OTUD7B;MALT1;CTSC;HM13;FAP;ZER1;OTUD7A;BAG6;LONP1;NR1D1;FBXL17
prerank,CellMarker_Augmented_2021__Astrocyte:Undefined,0.5693639025830517,0.935223413236837,0.52,0.9123777526502084,1.0,4/6,34.79%,S100B;SLC1A3;SLC1A2;GFAP
prerank,GO_Biological_Process_2021__positive regulation of protein serine/threonine kinase activity (GO:0071902),0.34685092604193135,0.9351862130888474,0.5483870967741935,0.9121640389062916,1.0,16/91,9.20%,IRGM;KIT;FGFR1;SIRT1;ERBB2;RALB;DIPK2A;PKD2;SNCA;PDGFD;PROX1;CCND3;FGF18;TELO2;TENM1;PIH1D1
prerank,GO_Biological_Process_2021__aorta development (GO:0035904),-0.5346614242430499,-0.9351771239025857,0.5535714285714286,1.0,1.0,1/11,0.55%,TBX1
prerank,GO_Biological_Process_2021__negative regulation of protein serine/threonine kinase activity (GO:0071901),0.39819475582152414,0.9351254780631745,0.6086956521739131,0.9120039119959039,1.0,16/70,15.44%,APOE;HEXIM2;PKIA;SLC8A1;SIRT1;SLC8A3;RGS14;ABL1;LATS1;LRP6;PRKAR2A;NF1;NR2F2;MEN1;SPRY4;GADD45A
prerank,GO_Biological_Process_2021__regulation of histone H3-K4 methylation (GO:0051569),0.4495406116156786,0.9350321735123354,0.46875,0.9119614126499171,1.0,4/18,14.25%,AUTS2;DNMT1;PIH1D1;BCOR
prerank,CellMarker_Augmented_2021__Cardiac Progenitor cell:Undefined,-0.39286550756990907,-0.9350006128985042,0.5,1.0,1.0,8/83,6.82%,ENPP2;C1QB;CYYR1;LYVE1;KCNA5;NID1;DAAM2;DCN
prerank,GO_Biological_Process_2021__negative regulation of mitochondrion organization (GO:0010823),-0.47647753865222725,-0.934747370371428,0.5857142857142857,1.0,1.0,3/27,11.86%,PINK1;CLU;ACAA2
prerank,GO_Biological_Process_2021__negative regulation of tumor necrosis factor-mediated signaling pathway (GO:0010804),-0.4962622158424932,-0.9347324506713769,0.5230769230769231,1.0,1.0,4/15,18.76%,TRAIP;F2RL1;CARD8;GPS2
prerank,Reactome_2022__Signaling By GPCR R-HSA-372790,0.30349760071376247,0.9346764571331084,0.6666666666666666,0.9124475644431136,1.0,59/470,10.36%,ADRA1A;TACR3;NTSR2;ADRA1B;PLEKHG2;DGKD;CHRM2;GRK5;ITPR2;CRHR2;GRM3;PLPPR1;HTR1F;GALR3;TRPC3;FGD4;HTR2C;HRH3;PDE10A;QRFPR;RIPK2;DRD5;CX3CR1;WNT4;RGS16;OPN5;PROKR2;PRPF38B;ARRB2;UTS2R;GRM8;WNT9A;RGS11;OPRD1;DRD4;RGS14;RXFP1;S1PR5;NMU;TAS2R8;PLCB1;PDE1A;FZD1;PDE7A;NPW;EDNRA;ADCY2;PLXNB1;FGD1;GRM4;WNT3A;INSL5;GRM2;AKT2;GRM7;PRKAR2A;PDE4B;RGR;RPS6KA3
prerank,Reactome_2022__ATF4 Activates Genes In Response To Endoplasmic Reticulum Stress R-HSA-380994,0.4228412508636728,0.9345385988655992,0.5641025641025641,0.9124476387365703,1.0,7/22,20.74%,EXOSC1;ATF3;KHSRP;NFYC;DIS3;ATF6;EXOSC5
prerank,Reactome_2022__SARS-CoV-2 Targets Host Intracellular Signaling And Regulatory Pathways R-HSA-9755779,0.4843478545608979,0.9344988995633468,0.5227272727272727,0.9122129379741355,1.0,2/12,9.44%,REXO2;AKT2
prerank,Reactome_2022__Uptake And Function Of Anthrax Toxins R-HSA-5210891,0.5096775744709533,0.9344785217198618,0.6,0.9119410673033403,1.0,5/11,19.92%,ANTXR2;ANTXR1;FURIN;MAP2K7;MAP2K6
prerank,CellMarker_Augmented_2021__Parietal Progenitor cell:Stomach,0.6113605147371379,0.934403139685247,0.5294117647058824,0.9117973582279433,1.0,3/5,7.60%,H6PD;FGD5;CFH
prerank,GO_Biological_Process_2021__myeloid leukocyte differentiation (GO:0002573),0.35191912672820097,0.9343261287016695,0.7272727272727273,0.9116271010816356,1.0,10/57,11.29%,MT1G;KIT;PPARG;SIRT1;IFI16;CDK4;PML;FARP2;BATF2;LGALS9
prerank,Reactome_2022__SUMOylation Of DNA Damage Response And Repair Proteins R-HSA-3108214,0.35667905850845333,0.9342578312687666,0.6060606060606061,0.9113930268650356,1.0,21/70,23.92%,NUP210;PHC2;NUP42;RNF168;PML;AAAS;SCMH1;SMC5;HERC2;RAD52;PMEPA1;NSMCE2;RANBP2;MDC1;RNF2;SMC6;HDAC7;NUP214;TPR;SEH1L;SMC3
prerank,GO_Biological_Process_2021__coronary artery morphogenesis (GO:0060982),-0.5849686358998426,-0.934239185762918,0.5833333333333334,1.0,1.0,1/5,0.55%,TBX1
prerank,Reactome_2022__Centrosome Maturation R-HSA-380287,0.35739933606817526,0.9338802334700406,0.6086956521739131,0.912096547728879,1.0,11/76,10.51%,PCM1;CEP152;CEP135;CNTRL;ALMS1;DYNC1I2;SDCCAG8;MAPRE1;CEP290;AKAP9;CEP250
prerank,GO_Biological_Process_2021__negative regulation of intracellular estrogen receptor signaling pathway (GO:0033147),-0.5762299066289118,-0.9338179736190705,0.559322033898305,1.0,1.0,2/10,8.63%,ZNF366;BRCA1
prerank,Reactome_2022__Recruitment Of NuMA To Mitotic Centrosomes R-HSA-380320,0.36304697249319684,0.933617932191793,0.5833333333333334,0.9124534817125488,1.0,11/75,10.51%,PCM1;CEP152;CEP135;CNTRL;ALMS1;DYNC1I2;SDCCAG8;MAPRE1;CEP290;AKAP9;CEP250
prerank,GO_Biological_Process_2021__regulation of toll-like receptor 3 signaling pathway (GO:0034139),-0.5604171882360514,-0.933600440633736,0.5106382978723404,1.0,1.0,2/6,24.64%,F2RL1;FLOT1
prerank,GO_Biological_Process_2021__cyclooxygenase pathway (GO:0019371),0.5390676759113792,0.9335876214048782,0.5945945945945946,0.9122193633273327,1.0,2/10,4.75%,PTGS1;AKR1C3
prerank,Reactome_2022__Heme Degradation R-HSA-189483,-0.5361058463370185,-0.9335615879405773,0.59375,1.0,1.0,5/9,24.67%,SLCO2B1;ABCG2;ALB;BLVRB;ABCC2
prerank,GO_Biological_Process_2021__supramolecular fiber organization (GO:0097435),0.3042033261779246,0.9331563717678792,0.7,0.9129005573129355,1.0,50/302,14.07%,COL22A1;COL8A1;TPM2;PCM1;TGFBR1;CD151;LAMA3;LOXL1;HIP1;SNCAIP;COL9A2;COL12A1;CCDC88B;P3H2;KLHL41;SNCA;RHOBTB3;SAMD14;RHOBTB1;COLGALT1;CGNL1;DSP;GREM1;PLOD3;MAP10;COLGALT2;SPAST;TPM4;GGA1;P3H4;RND3;PPIB;COL16A1;PLEC;TLL1;EVL;AVIL;PPP1R9B;KLHL24;CLIP2;COL13A1;COL5A3;ITGB4;CCDC88A;DST;NF1;LTBP2;PLK3;TPPP3;MAP7D3
prerank,GO_Biological_Process_2021__regulation of toll-like receptor 2 signaling pathway (GO:0034135),-0.5378792157141982,-0.9329115563940127,0.543859649122807,1.0,1.0,3/7,24.74%,CYBA;F2RL1;PJA2
prerank,GO_Biological_Process_2021__negative regulation of extrinsic apoptotic signaling pathway in absence of ligand (GO:2001240),0.4713518419509678,0.9325741719642586,0.4594594594594595,0.9137723441246761,1.0,5/16,15.10%,EYA4;BCL2;SNAI2;HSPA1A;EYA3
prerank,GO_Biological_Process_2021__negative regulation of signal transduction in absence of ligand (GO:1901099),0.4713518419509678,0.9325741719642586,0.4594594594594595,0.9137723441246761,1.0,5/16,15.10%,EYA4;BCL2;SNAI2;HSPA1A;EYA3
prerank,CellMarker_Augmented_2021__Dental Pulp Stem cell:Deciduous Tooth,-0.4062488383561498,-0.9324015892219003,0.575,1.0,1.0,18/69,14.86%,C1QB;LYVE1;ANGPT2;MS4A4A;DCN;CLDN5;ZNF366;VSIG4;HLA-DPB1;SELP;PTPRC;VWF;GPIHBP1;HLA-DPA1;TEK;A2M;GGT5;ADGRF5
prerank,GO_Biological_Process_2021__regulation of microglial cell migration (GO:1904139),-0.6089833096547702,-0.9323295471194429,0.5606060606060606,1.0,1.0,1/5,2.75%,P2RY12
prerank,GO_Biological_Process_2021__negative regulation of cell-substrate adhesion (GO:0010812),0.4039327469285344,0.9320086387011124,0.5675675675675675,0.9148296215748056,1.0,10/36,16.67%,PTPRO;JAG1;ACER2;EFNA5;KANK1;NEXMIF;ADAM15;SPRY4;CORO2B;NOTCH1
prerank,"GO_Biological_Process_2021__mRNA cis splicing, via spliceosome (GO:0045292)",0.45892391264186944,0.9319958405010782,0.6206896551724138,0.9145260053322569,1.0,3/15,12.12%,DCPS;PRPF39;SFSWAP
prerank,GO_Biological_Process_2021__regulation of immunoglobulin production (GO:0002637),-0.4859319824420411,-0.9319100372744116,0.5970149253731343,1.0,1.0,9/19,32.18%,CLCF1;PTPRC;SASH3;CD86;TNFSF4;TNFRSF4;SUPT6H;PHB2;CR1
prerank,KEGG_2021_Human__Pentose phosphate pathway,0.43046236649256714,0.9319015408515509,0.5769230769230769,0.9144456738605066,1.0,4/26,6.20%,FBP2;RGN;PFKP;H6PD
prerank,GO_Biological_Process_2021__mitotic intra-S DNA damage checkpoint signaling (GO:0031573),0.4605940990570856,0.9318369503655265,0.5116279069767442,0.9142485950888547,1.0,5/13,24.57%,RAD17;RAD9A;MDC1;EME2;MUS81
prerank,Reactome_2022__Oncogene Induced Senescence R-HSA-2559585,0.3439661266036128,0.9316481243549415,0.6333333333333333,0.9144284817918175,1.0,10/31,21.88%,CDK6;CDK4;MOV10;TNRC6C;ETF1;TP53;TNRC6A;AGO3;MDM4;TFDP1
prerank,GO_Biological_Process_2021__positive regulation of cytokine production (GO:0001819),-0.3482406812187381,-0.9313034700701428,0.6551724137931034,1.0,1.0,46/250,16.51%,TGFB1;NODAL;S100A13;IRF4;WNT5A;CYP1B1;SCIMP;IRF1;IL7;NFKB2;POLR1C;HLA-A;FLT4;NFAM1;ZFPM1;HLA-DPB1;BRCA1;ANXA1;HTR2B;IL27;NLRP9;STOML2;CYBA;PTPRC;SLC11A1;LACC1;TLR2;TXK;HLA-DPA1;C1QTNF4;NLRP3;ZNF580;POLR3H;NOS2;IL12A;CD80;NR1H4;GATA4;AFAP1L2;IL18;CD4;ZP3;AGT;ELANE;F2RL1;ALOX15B
prerank,GO_Biological_Process_2021__lipid catabolic process (GO:0016042),0.41561998135256095,0.9311812583457131,0.5,0.9152024593239312,1.0,5/22,5.81%,CYP1A2;LIPC;GLYATL2;CEL;STS
prerank,CellMarker_Augmented_2021__Plasmacytoid Dendritic cell:Blood,0.321960084763973,0.9311083209980261,0.45454545454545453,0.9150212327900563,1.0,74/288,22.06%,EGLN3;TPM2;SEL1L3;MAPKAPK2;ITPR2;TRDMT1;ANKRD36B;SNRPN;CEP135;MFSD2A;RNASET2;STAMBPL1;ARL6IP6;SLC3A2;DAPK2;DERL3;CREB3L2;ITGA4;PFKP;BCL11A;DCPS;UBE2J1;DHTKD1;CD8A;PPFIBP1;SMPD3;CRIM1;ERN1;KANK1;SLC7A11;SETBP1;CCDC50;TSPAN3;TBC1D4;GAB1;MDFIC;NGLY1;LRP8;CYSLTR1;EMB;ANKRD36;LAIR1;MAGED1;SERTAD2;FLNB;SUSD1;FCHSD2;PLXNA4;GNG7;SIDT1;KIRREL3;NFX1;ABCA7;LY9;SLA2;ST3GAL2;TCF4;SP4;EIF4A3;MAP2K6;SIVA1;PHLPP2;NPC2;PTK7;SMC6;N4BP2L1;MILR1;SULF2;MYO1E;SEC61A1;OCLN;ASPH;EFHC1;POLB
prerank,GO_Biological_Process_2021__Notch signaling involved in heart development (GO:0061314),0.502984424377445,0.9310307926893531,0.6,0.9148666435014915,1.0,4/10,18.15%,JAG1;SNAI2;NOTCH1;RBPJ
prerank,KEGG_2021_Human__Rheumatoid arthritis,-0.40517818520520055,-0.930996003872958,0.6419753086419753,1.0,1.0,17/56,15.32%,TGFB1;ITGB2;ATP6V1G2;HLA-DMA;ATP6V1C2;ATP6V1D;ATP6AP1;HLA-DPB1;HLA-DRB1;ATP6V0E2;TLR2;HLA-DPA1;TEK;TGFB3;CD80;IL18;ATP6V1E1
prerank,GO_Biological_Process_2021__cellular metal ion homeostasis (GO:0006875),0.32913734418158913,0.9309718306309365,0.5806451612903226,0.9146114659509462,1.0,8/82,7.29%,LETM2;CDH5;RGN;HTR2C;SLC8A1;DRD5;SLC8A3;DRD4
prerank,CellMarker_Augmented_2021__Endothelial cell:Blood Vessel,-0.4053101727835565,-0.9306146507834627,0.5714285714285714,1.0,1.0,16/62,18.80%,LYVE1;ITGB2;PROCR;TNFRSF1B;CD160;FLT4;A4GALT;SELP;ENG;TNFRSF10A;TEK;COLEC12;ACKR2;ANPEP;STAB2;CD81
prerank,GO_Biological_Process_2021__B cell receptor signaling pathway (GO:0050853),0.3941699886004161,0.9304708226615819,0.6363636363636364,0.915410772434515,1.0,3/26,2.31%,CD38;SH2B2;BCL2
prerank,GO_Biological_Process_2021__ERK1 and ERK2 cascade (GO:0070371),0.4679106912997793,0.9302262121004398,0.6190476190476191,0.9157222689670076,1.0,3/19,11.29%,FGF10;MYC;LGALS9
prerank,GO_Biological_Process_2021__neural crest cell development (GO:0014032),-0.425620360744114,-0.930216830002445,0.5735294117647058,1.0,1.0,5/40,8.81%,TBX1;SOX10;SEMA3F;SEMA3A;HTR2B
prerank,GO_Biological_Process_2021__cellular response to cytokine stimulus (GO:0071345),-0.3455898017178878,-0.9300882760432804,0.6627906976744186,1.0,1.0,53/341,15.16%,DUOX1;CRLF1;TCF7;TGFB1;AIM2;ITGB2;HCK;IRF4;MMP9;WNT5A;DOCK8;NLRP12;CCND1;IFNK;ALOX5;RORC;IRF1;TNFRSF1B;TEC;GPER1;CLCF1;PTAFR;STAT1;IL7;GSDME;INPP5D;ALOX15;IL3RA;BRCA1;ANXA1;OSMR;GBP1;FPR1;AQP4;ITGAM;HSPA8;CDKN1A;IFIT1;OAS1;IL18BP;TLR2;F13A1;HLA-DPA1;OPRM1;PIK3CB;LEF1;NOS2;IL12A;CD80;IFNGR2;HYAL1;IL5RA;IL18
prerank,GO_Biological_Process_2021__pulmonary valve morphogenesis (GO:0003184),0.516405467440832,0.9297511916821048,0.475,0.9165047339332723,1.0,3/12,7.88%,ROBO2;JAG1;SLIT2
prerank,GO_Biological_Process_2021__sodium ion transmembrane transport (GO:0035725),-0.38399162535652936,-0.929720053092864,0.5694444444444444,1.0,1.0,14/75,17.66%,SCN5A;SLC5A2;SLC5A1;ATP1A4;ASIC5;SLC24A1;SLC6A12;SLC9A2;SLC9C1;SLC6A4;ATP4A;SCNN1A;SCNN1G;SLC6A7
prerank,GO_Biological_Process_2021__negative regulation of phosphoprotein phosphatase activity (GO:0032515),0.4585383001992559,0.9296848444633299,0.525,0.9163922323738956,1.0,3/20,8.23%,PPP1R14D;BOD1L1;STYXL1
prerank,Reactome_2022__Keratan Sulfate/Keratin Metabolism R-HSA-1638074,0.4363665249189079,0.9294020115454416,0.5555555555555556,0.916856476289346,1.0,7/27,11.28%,CHST6;PRELP;GLB1L;ST3GAL3;B4GALT2;B4GALT3;GLB1
prerank,GO_Biological_Process_2021__positive regulation of cell communication (GO:0010647),0.45209071976924303,0.9291096337080766,0.5,0.9171405781441497,1.0,7/23,14.40%,NMU;GRIK2;SYT1;RIMS2;CLSTN2;WLS;PTPN23
prerank,CellMarker_Augmented_2021__SLC16A7+ cell:Lung,0.27798880001474396,0.9290632209837986,1.0,0.9169539563273581,1.0,187/874,18.93%,NIPAL1;GOLGA6L10;MLPH;RAB27A;FANK1;NYAP2;IBA57;NOX4;THEM4;TSHZ2;CLMP;UTRN;BTN3A2;GSDMB;ANKRD36B;ABCA9;CFLAR;SLC2A11;CNTRL;UGT2B15;HIP1;ZNF692;MANEAL;ZNF561;KIAA0319;PCDH11X;DZIP1L;ST6GAL2;PLEKHG4B;PTAR1;TMPRSS7;AK3;QRFPR;ZNF33B;METTL8;MID1;SEMA5A;GOLGA6L4;ANKRD18A;HSCB;VWDE;BLZF1;FLVCR1;PRELP;RASSF8;CHST12;CLASRP;SPEF2;GLB1L;NAA40;RBM41;NKD1;KCNJ3;CNTN3;FADS6;IKZF4;SLC16A7;CNTROB;TASOR2;SLC22A5;CMBL;USP54;PMS1;DYNLT5;UTP23;WWOX;ZNF251;PLXNB1;ANKS6;ABL2;ALPK1;KPNA6;LEPR;CCDC30;MOV10;SRCAP;PHACTR4;ICA1L;ZFYVE16;MAP3K9;GGA1;SLC6A20;CEP290;LIN52;CROCC;ARIH2OS;GOLGA6L9;ZNF519;MCU;AKAP9;ACER3;ZNF514;SLC7A6;EVI5L;SLC25A29;TTC14;TRIM65;ABCF3;MSRB3;MFSD11;DSEL;DNAAF10;ZNF761;DMTF1;EPS8L2;SFSWAP;ZNF277;UBIAD1;CFAP410;C3ORF62;KANK4;SREK1;COX19;RNF207;FNBP1;DPP9;FBXL20;AASDH;GREB1;ANKLE1;KLHL22;LPP;TRIP13;MTHFR;FAM76A;GBP4;NCR3LG1;PNPT1;MAGI3;NFAT5;ANKRD36;UBN2;LAIR1;CEP162;SSH1;MFHAS1;CDC14B;ACIN1;OPA3;ZNF549;TNRC6A;NMRK1;CDHR3;SLC7A14;SRFBP1;FRAS1;ANKRD62;MDGA1;DOP1A;SMG1;SRCIN1;PRELID2;GMEB1;ATG16L2;CSAD;ATM;ZNF665;ZNF273;DZANK1;ZMYM5;ANKRD16;NR2C1;AP4S1;ERCC6L2;CCDC125;QRSL1;TDRD3;IP6K1;CEP85L;RC3H1;SIDT1;MYO5A;LRRC8B;BTBD9;RAD9A;RSRP1;ATR;TNIP3;FAAH2;SAMD4B;DCAF10;ZNF445;ERC1;SMYD4;C5AR1;BIN3;RASEF
prerank,GO_Biological_Process_2021__positive regulation of actin filament polymerization (GO:0030838),-0.43822315108282983,-0.929048199015141,0.5540540540540541,1.0,1.0,7/40,12.97%,LMOD1;HCK;C15ORF62;ALOX15;LMOD3;SCIN;BAIAP2L1
prerank,CellMarker_Augmented_2021__Activated B cell:Peripheral Blood,-0.43161838912949385,-0.928998891948226,0.6,1.0,1.0,6/40,7.01%,PSMB9;SIRPG;TBC1D10C;IRF1;CD5;ICAM3
prerank,CellMarker_Augmented_2021__Megakaryocyte:Umbilical Cord Blood,-0.4279745238405604,-0.9289459926818961,0.5945945945945946,1.0,1.0,13/47,13.05%,TRIM58;P2RY12;SLFN14;CLDN5;DYTN;SELP;FPR1;VWF;ALAS2;ITGA2B;PTP4A2P2;CLEC12A;F13A1
prerank,Reactome_2022__RAC1 GTPase Cycle R-HSA-9013149,-0.363606415524667,-0.9288887071510816,0.6296296296296297,1.0,1.0,18/164,11.10%,RASGRF2;PLEKHG6;DOCK6;DOCK8;ARHGAP9;TAGAP;PLEKHG3;VAV3;ARHGAP15;DOCK2;WAS;PIK3R3;MPZ;SNAP23;CYBA;ARHGAP12;ARAP3;DEF6
prerank,Reactome_2022__Oxidative Stress Induced Senescence R-HSA-2559580,0.3520138633305654,0.9288549742623801,0.45,0.9171162701890663,1.0,22/70,21.88%,MAPKAPK2;PHC2;H2BC21;CDK6;CDK4;MAPK8;MOV10;TNIK;TNRC6C;SCMH1;H2AX;TP53;TNRC6A;AGO3;MAP2K7;H2AJ;RNF2;MAP2K6;FOS;RBBP4;MDM4;TFDP1
prerank,GO_Biological_Process_2021__lymphocyte migration (GO:0072676),-0.5616433091985064,-0.9288496937612056,0.6271186440677966,1.0,1.0,1/10,1.65%,MSMP
prerank,GO_Biological_Process_2021__acylglycerol catabolic process (GO:0046464),-0.4494928349811361,-0.9288141589832845,0.5522388059701493,1.0,1.0,3/24,7.72%,LIPI;LIPH;PNPLA4
prerank,GO_Biological_Process_2021__regulation of activated T cell proliferation (GO:0046006),0.4045351111675349,0.9287543767686134,0.4444444444444444,0.9170512986817008,1.0,8/28,17.93%,CLC;SCRIB;HMGB1;ICOSLG;LGALS9;FADD;IL23A;RC3H1
prerank,GO_Biological_Process_2021__maturation of 5.8S rRNA (GO:0000460),-0.4589289963332577,-0.9286539351082951,0.5740740740740741,1.0,1.0,3/17,18.37%,EIF6;LAS1L;WDR12
prerank,GO_Biological_Process_2021__regulation of protein targeting to membrane (GO:0090313),-0.4441298593514102,-0.9286378692117776,0.5833333333333334,1.0,1.0,4/28,11.77%,ITGB2;PDZK1;USP17L2;ITGAM
prerank,CellMarker_Augmented_2021__Endothelial cell:Lung,-0.5655182238840337,-0.928606599849245,0.6129032258064516,1.0,1.0,2/8,10.59%,LYVE1;VWF
prerank,Reactome_2022__Deactivation Of Beta-Catenin Transactivating Complex R-HSA-3769402,-0.4285761063433815,-0.9283314077870567,0.5833333333333334,1.0,1.0,2/38,5.29%,TCF7;TCF7L1
prerank,Reactome_2022__FBXL7 Down-Regulates AURKA During Mitotic Entry And In Early Mitosis R-HSA-8854050,-0.3938474850660814,-0.9283276544545243,0.5507246376811594,1.0,1.0,16/48,27.50%,PSMB9;FBXL7;RBX1;PSMA3;RPS27A;FBXL18;PSMA7;PSMB6;PSMA5;AURKA;PSMD6;SKP1;PSMC5;PSMB4;PSMB7;PSMD8
prerank,GO_Biological_Process_2021__recombinational repair (GO:0000725),-0.39312919926580536,-0.9283212883986739,0.527027027027027,1.0,1.0,5/71,8.63%,POLQ;MEIOB;RPA3;RAD51AP2;BRCA1
prerank,GO_Biological_Process_2021__regulation of homotypic cell-cell adhesion (GO:0034110),-0.5566469500066848,-0.9283105579221117,0.603448275862069,1.0,1.0,1/12,2.65%,BLK
prerank,CellMarker_Augmented_2021__Endometrial Stem cell:Uterus,-0.3964265558772602,-0.9279550824974763,0.5897435897435898,1.0,1.0,11/80,12.28%,APOL1;TGFBI;LRP10;DRAM1;CLCF1;NFKB2;HSD3B7;CTSZ;ENG;SLC16A3;CXCL16
prerank,GO_Biological_Process_2021__plus-end-directed organelle transport along microtubule (GO:0072386),0.5574863777880615,0.9278021777913446,0.6,0.9189879386163896,1.0,4/6,39.02%,KIF3B;FYCO1;KIF13A;KIFAP3
prerank,GO_Biological_Process_2021__positive regulation of monocyte chemotaxis (GO:0090026),0.5379698077248574,0.9276798535594647,0.574468085106383,0.91893291115132,1.0,2/11,6.42%,SERPINE1;HMGB1
prerank,GO_Biological_Process_2021__glycosphingolipid biosynthetic process (GO:0006688),0.4659440208676455,0.9274969013878016,0.475,0.9190784656048486,1.0,2/15,5.94%,ST6GALNAC3;ST8SIA4
prerank,GO_Biological_Process_2021__positive regulation of blood-brain barrier permeability (GO:1905605),0.5753599104770747,0.9274159888985913,0.5813953488372093,0.9189495867783508,1.0,1/5,2.81%,ANGPT1
prerank,GO_Biological_Process_2021__rRNA transport (GO:0051029),0.585329418687864,0.927324086930527,0.6585365853658537,0.9188524411846657,1.0,4/5,35.74%,PNPT1;TST;TSC1;MRPL18
prerank,PanglaoDB_Augmented_2021__Glycinergic Neurons,0.349268127584771,0.9271842421819877,0.6060606060606061,0.9188660733480678,1.0,25/97,19.12%,HRH3;ELAVL3;NGB;PPFIA3;ADGRA1;CASKIN1;GRIN1;BRINP1;B4GALNT4;NXPH1;CSPG5;RIMS4;PRR36;FBLL1;SNAP91;MAP6;MPP2;SCRT1;VSTM2B;SRRM3;CLIP3;SYN1;MMD2;GRM5;PNCK
prerank,GO_Biological_Process_2021__bicellular tight junction assembly (GO:0070830),-0.4284378918671642,-0.9271392895620469,0.5694444444444444,1.0,1.0,8/38,17.06%,MARVELD2;CLDN1;CLDN6;CLDN5;CLDN2;CLDN18;CLDN20;ECT2
prerank,PanglaoDB_Augmented_2021__Chondrocytes,0.3057382883926551,0.9271373038491124,0.75,0.9186794353640159,1.0,19/124,11.20%,FIBIN;EMP1;LAMA4;MXRA5;MATN1;MRGPRF;COL12A1;SEMA5A;CREB3L2;ADAMTS12;MMP2;OLFML2B;EDNRA;EFS;FGF18;SNAI2;PDZRN3;COL16A1;SDC3
prerank,Reactome_2022__DNA Strand Elongation R-HSA-69190,-0.45314240735583944,-0.9271111144374238,0.5692307692307692,1.0,1.0,2/27,4.42%,RPA3;MCM3
prerank,GO_Biological_Process_2021__regulation of MAP kinase activity (GO:0043405),0.33270497281261213,0.9269565460852158,0.5161290322580645,0.9187932138596865,1.0,10/83,9.05%,KIT;FGFR1;KSR1;APOE;ERBB2;PDGFD;RGS14;TRIB2;FGF18;TENM1
prerank,GO_Biological_Process_2021__regulation of mitotic nuclear division (GO:0007088),-0.4174554643964122,-0.9267885147069334,0.5492957746478874,1.0,1.0,5/44,18.33%,NEK2;CAV2;TOM1L1;BORA;PKMYT1
prerank,Reactome_2022__Synthesis Of Very Long-Chain Fatty acyl-CoAs R-HSA-75876,-0.43986388612682925,-0.9267226659466009,0.6031746031746031,1.0,1.0,3/21,5.09%,ELOVL2;ACSL5;TECRL
prerank,GO_Biological_Process_2021__chordate embryonic development (GO:0043009),-0.4399299336053814,-0.9266387982042998,0.5846153846153846,1.0,1.0,5/44,8.63%,TBX1;TGFB1;WNT5A;COL1A1;BRCA1
prerank,GO_Biological_Process_2021__positive regulation of pinocytosis (GO:0048549),-0.5820893723199231,-0.9263147740276352,0.6833333333333333,1.0,1.0,2/7,18.95%,PPT1;AXL
prerank,KEGG_2021_Human__Huntington disease,-0.3502745544353078,-0.9262961012919549,0.6703296703296703,1.0,1.0,62/260,25.14%,DNAH11;COX6A1;SLC25A31;SOD2;ATP5F1E;TGM2;REST;NDUFS2;COX6C;DCTN1;DNAH17;ATP5MC3;UCP1;GPX3;ATP5PF;TUBA4A;COX7A1;ATG14;DNAH3;DNAH2;VDAC1;NDUFA2;GPX2;TBPL1;NDUFB4;NDUFC1;TUBA3D;DNAI1;COX7C;NDUFA1;NDUFB9;TUBB;PSMA3;DNAH10;TUBB6;COX7A2;TUBB2A;COX4I1;PSMA7;PSMB6;CASP8;BBC3;CREB3;NDUFB10;TUBB4A;NDUFS5;ATP5PB;NDUFB11;DLG4;PSMA5;TUBB4B;TBP;ATP5F1A;SDHC;POLR2B;PSMD6;PLCB2;KLC1;NDUFB2;ACTR1B;APAF1;DNAH12
prerank,GO_Biological_Process_2021__regulation of myelination (GO:0031641),-0.44163041098315836,-0.9261929559459273,0.5211267605633803,1.0,1.0,8/24,20.21%,KIF14;TNFRSF1B;LGI4;JAM2;EGR2;MYRF;ITGAX;NCMAP
prerank,GO_Biological_Process_2021__chromatin organization involved in regulation of transcription (GO:0034401),0.47694094092790557,0.9260176629124913,0.4878048780487805,0.9207185209519627,1.0,5/13,17.84%,ELOF1;CDCA4;ARID1A;SERTAD2;ARID1B
prerank,GO_Biological_Process_2021__regulation of telomerase activity (GO:0051972),-0.39979210243516444,-0.9258694845506761,0.5161290322580645,1.0,1.0,1/43,0.37%,NEK2
prerank,GO_Biological_Process_2021__regulation of cellular macromolecule biosynthetic process (GO:2000112),0.2968370122583271,0.9258133394175757,0.7692307692307693,0.9209104686654417,1.0,98/396,19.38%,TEAD2;ESRRG;MLF1;TGFBR1;POU6F2;ZNF195;OR7D2;ZNF117;ZNF212;MAFB;TCOF1;MITF;ZFPL1;RORA;HDAC10;SLC39A8;PCGF1;APBB3;ZNF263;ATXN1;TULP3;RORB;SOX12;GPBP1L1;PCIF1;ZBTB4;NCOA2;HP1BP3;ZNF703;ZNF274;SPIN2B;PML;ABL1;POFUT1;SP1;RBBP6;NANOS3;ZNF33A;FOXN3;ZSCAN21;SNAI2;HCLS1;FADS1;ZNF2;TESMIN;ZNF331;CREM;ZNF519;MSC;HES6;NSD1;DMTF1;SMARCA2;GEMIN5;MLXIPL;EFEMP1;CCDC88A;RYBP;CDK11A;CARM1;RPS6KA4;NFYC;PUM3;NR3C1;PPARGC1B;ASCC2;WWTR1;SCRT1;ESCO1;INSR;MAGED1;TP53;DSCC1;BAZ2A;FUS;WWC1;ZNF708;NOTCH1;UBE2L3;ZNF273;THAP7;ZNF646;ZNF675;TFEB;PRMT5;SP3;NFX1;YAF2;SUPT3H;SOX13;SPIN1;ERC1;EP300;GRM5;CXXC1;ZNF280B;KAT6B;ZNF66
prerank,GO_Biological_Process_2021__regulation of nucleobase-containing compound metabolic process (GO:0019219),0.4410194696555809,0.9256029498257422,0.5609756097560976,0.9211338569446644,1.0,4/11,18.92%,NOVA1;PCBP3;ZNF445;PCBP4
prerank,GO_Biological_Process_2021__intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator (GO:0042771),0.4676277074684191,0.9255999404558336,0.575,0.9208467954599707,1.0,8/19,25.18%,SIRT1;IFI16;PML;TP53;EP300;BAG6;BCL3;DYRK2
prerank,Reactome_2022__Ubiquitin-dependent Degradation Of Cyclin D R-HSA-75815,-0.4037427197681537,-0.925568229910689,0.5857142857142857,1.0,1.0,2/45,3.67%,PSMB9;CCND1
prerank,GO_Biological_Process_2021__positive regulation of mast cell activation (GO:0033005),0.5807257799983799,0.9254980080698073,0.6,0.9207334794775858,1.0,4/6,36.70%,NR4A3;HAVCR1;NECTIN2;CRLF2
prerank,GO_Biological_Process_2021__regulation of PERK-mediated unfolded protein response (GO:1903897),0.5418348849890646,0.9250458086377273,0.5434782608695652,0.9215086849533952,1.0,3/9,18.26%,PPP1R15B;NCK1;ABCA7
prerank,GO_Biological_Process_2021__rRNA transcription (GO:0009303),0.4187956771836665,0.9249293335556416,0.5428571428571428,0.92151083061363,1.0,7/17,20.13%,TCOF1;SIRT7;TAF1B;GTF3C4;GTF3C5;SPIN1;MARS1
prerank,Reactome_2022__PTK6 Regulates Cell Cycle R-HSA-8849470,-0.6191645878332006,-0.9248391146343427,0.6363636363636364,1.0,1.0,1/5,3.67%,CCND1
prerank,GO_Biological_Process_2021__histone H3-K4 trimethylation (GO:0080182),0.4702370685436675,0.9248365258980107,0.625,0.9214079075575347,1.0,1/12,4.57%,TET2
prerank,GO_Biological_Process_2021__peroxisome proliferator activated receptor signaling pathway (GO:0035357),0.5551076077715198,0.9247342700086979,0.625,0.9213733264685942,1.0,2/6,17.58%,PPARG;FAM120B
prerank,GO_Biological_Process_2021__membrane repolarization during cardiac muscle cell action potential (GO:0086013),-0.5077835981801286,-0.9246681523696564,0.6031746031746031,1.0,1.0,2/15,8.12%,KCNA5;KCNQ1
prerank,GO_Biological_Process_2021__plus-end-directed vesicle transport along microtubule (GO:0072383),0.5784949212937845,0.9246103568295952,0.625,0.9213335199731759,1.0,4/5,39.02%,KIF3B;FYCO1;KIF13A;KIFAP3
prerank,GO_Biological_Process_2021__positive regulation of cell motility (GO:2000147),-0.34997025320061437,-0.9245952029400665,0.575,1.0,1.0,30/188,17.08%,DUOX1;TGFB1;F7;MMP9;SMIM22;CLDN1;COL1A1;SEMA3F;GPER1;DAB2;SYNE2;CAVIN1;PLAU;ACTG1;SEMA3A;PIK3R3;SOD2;CGA;THBS1;LAMC2;VIL1;CXCL16;NTN1;LEF1;EPHA1;GRN;PLET1;F2RL1;ANGPTL3;VSIR
prerank,GO_Biological_Process_2021__regulation of Rho protein signal transduction (GO:0035023),0.342869511779987,0.9243560167344227,0.5428571428571428,0.9216296026864254,1.0,16/62,17.67%,APOE;GPR174;ABL1;ABCA1;MYO9B;ABL2;ITGA3;KANK1;F2R;EPS8L2;EPS8;ARHGAP35;ARRB1;BCR;RIT2;CCDC125
prerank,GO_Biological_Process_2021__positive regulation of non-canonical Wnt signaling pathway (GO:2000052),0.48488972125327257,0.9242595847299862,0.6190476190476191,0.9214638304271319,1.0,2/9,6.24%,RSPO3;NKD1
prerank,GO_Biological_Process_2021__chloride transport (GO:0006821),-0.39936576575969157,-0.9241908888883844,0.6301369863013698,1.0,1.0,5/64,6.81%,CLIC1;APOL1;ANO2;SLC5A1;GLRA2
prerank,CellMarker_Augmented_2021__Endothelial cell:White Adipose Tissue,-0.39400685591763784,-0.9240687963814083,0.6388888888888888,1.0,1.0,16/69,14.86%,CYYR1;LYVE1;ANGPTL2;DAB2;DCN;SLCO2A1;CLDN5;VWF;AFAP1L1;GPIHBP1;ENG;COX7A1;EDNRB;TEK;GGT5;ADGRF5
prerank,GO_Biological_Process_2021__glomerular visceral epithelial cell migration (GO:0090521),0.6142859740405571,0.9240334011748554,0.6744186046511628,0.921801613136608,1.0,3/5,30.72%,KANK1;ROCK1;TESK1
prerank,"GO_Biological_Process_2021__protein alpha-1,2-demannosylation (GO:0036508)",0.4241577554283169,0.923838951623157,0.5833333333333334,0.9219347088032125,1.0,5/23,20.56%,MAN1A2;MAN1A1;RNF185;EDEM1;RNF139
prerank,Reactome_2022__FGFR1c Ligand Binding And Activation R-HSA-190373,-0.515255244751998,-0.9237078634597954,0.5714285714285714,1.0,1.0,1/10,0.93%,FGF20
prerank,GO_Biological_Process_2021__negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway (GO:1902176),0.4560167797951614,0.9236595899452469,0.6052631578947368,0.9220939136333423,1.0,3/17,4.59%,HSPB1;HTRA2;SIRT1
prerank,CellMarker_Augmented_2021__Fibroblast:Lung,-0.5830502697552296,-0.9234410418892178,0.6111111111111112,1.0,1.0,2/8,28.30%,ACTA2;VIM
prerank,GO_Biological_Process_2021__keratinocyte differentiation (GO:0030216),0.42409001817558273,0.923216093489617,0.6153846153846154,0.9228344965906815,1.0,6/26,7.93%,CSTA;AKR1C3;JAG1;DSP;LORICRIN;CASP3
prerank,GO_Biological_Process_2021__adenosine 5'-(hexahydrogen pentaphosphate) metabolic process (GO:1901910),0.5429455646630184,0.9231638750469711,0.5384615384615384,0.920693145936798,1.0,1/5,5.02%,NUDT4B
prerank,GO_Biological_Process_2021__diadenosine hexaphosphate metabolic process (GO:1901908),0.5429455646630184,0.9231638750469711,0.5384615384615384,0.920693145936798,1.0,1/5,5.02%,NUDT4B
prerank,GO_Biological_Process_2021__diadenosine pentaphosphate catabolic process (GO:1901907),0.5429455646630184,0.9231638750469711,0.5384615384615384,0.920693145936798,1.0,1/5,5.02%,NUDT4B
prerank,GO_Biological_Process_2021__diphosphoinositol polyphosphate metabolic process (GO:0071543),0.5429455646630184,0.9231638750469711,0.5384615384615384,0.920693145936798,1.0,1/5,5.02%,NUDT4B
prerank,GO_Biological_Process_2021__adenosine 5'-(hexahydrogen pentaphosphate) catabolic process (GO:1901911),0.5429455646630184,0.9231638750469711,0.5384615384615384,0.920693145936798,1.0,1/5,5.02%,NUDT4B
prerank,GO_Biological_Process_2021__diadenosine pentaphosphate metabolic process (GO:1901906),0.5429455646630184,0.9231638750469711,0.5384615384615384,0.920693145936798,1.0,1/5,5.02%,NUDT4B
prerank,GO_Biological_Process_2021__diadenosine hexaphosphate catabolic process (GO:1901909),0.5429455646630184,0.9231638750469711,0.5384615384615384,0.920693145936798,1.0,1/5,5.02%,NUDT4B
prerank,GO_Biological_Process_2021__retinoic acid receptor signaling pathway (GO:0048384),-0.5488065193678402,-0.9230398655931125,0.5692307692307692,1.0,1.0,1/10,0.55%,TBX1
prerank,GO_Biological_Process_2021__positive regulation of endothelial cell apoptotic process (GO:2000353),-0.5134806675670592,-0.9227230518971229,0.6290322580645161,1.0,1.0,3/11,9.78%,GPER1;CD160;THBS1
prerank,GO_Biological_Process_2021__negative regulation of systemic arterial blood pressure (GO:0003085),-0.5804803865209435,-0.9224709316846287,0.6101694915254238,1.0,1.0,1/6,8.33%,SOD2
prerank,GO_Biological_Process_2021__positive regulation of protein secretion (GO:0050714),0.3647619890251693,0.9224093517162016,0.6071428571428571,0.9221478389785066,1.0,12/55,15.91%,GCK;CAPN10;APBB3;DOC2B;GLUD1;MCU;IRS2;UNC13B;WLS;PTPN23;ACHE;FRMD4A
prerank,GO_Biological_Process_2021__myeloid cell development (GO:0061515),0.4798121710373103,0.9223605199995011,0.5384615384615384,0.9219460827082543,1.0,1/16,1.53%,KIT
prerank,KEGG_2021_Human__Bacterial invasion of epithelial cells,-0.39171350661951587,-0.9223601689450469,0.618421052631579,1.0,1.0,10/73,13.78%,CAV3;CTNNA1;CTNNA3;ELMO3;ACTG1;PIK3R3;SEPTIN12;CAV2;PIK3CB;ITGA5
prerank,GO_Biological_Process_2021__regulation of smooth muscle cell migration (GO:0014910),0.45189723745390326,0.922304216750597,0.5555555555555556,0.9217810097970446,1.0,3/19,7.88%,CCN4;SERPINE1;SLIT2
prerank,Reactome_2022__Transport Of Nucleotide Sugars R-HSA-727802,0.5228168627783624,0.9219844386514391,0.6170212765957447,0.9222370589827688,1.0,2/8,20.61%,SLC35D1;SLC35B2
prerank,GO_Biological_Process_2021__regulation of cellular ketone metabolic process (GO:0010565),-0.40314956161840165,-0.9219018718413375,0.5285714285714286,1.0,1.0,17/54,27.50%,PSMB9;NQO1;AZIN1;OAZ2;NR1H4;FGFR4;PSMA3;PSMA7;PSMB6;PANK2;PSMA5;PSMD6;PDK4;PSMC5;PSMB4;PSMB7;PSMD8
prerank,Reactome_2022__EPHA-mediated Growth Cone Collapse R-HSA-3928663,-0.4716446564509362,-0.9218970001836069,0.546875,1.0,1.0,4/15,27.71%,MYL6;MYL9;MYH11;YES1
prerank,GO_Biological_Process_2021__scaRNA localization to Cajal body (GO:0090666),0.6197007189069103,0.9217731418839281,0.5957446808510638,0.9221000071298774,1.0,1/5,14.52%,WRAP53
prerank,GO_Biological_Process_2021__RNA localization to Cajal body (GO:0090670),0.6197007189069103,0.9217731418839281,0.5957446808510638,0.9221000071298774,1.0,1/5,14.52%,WRAP53
prerank,GO_Biological_Process_2021__regulation of cardiac muscle cell membrane potential (GO:0086036),-0.5917331007192784,-0.9213455255281134,0.6666666666666666,1.0,1.0,3/6,23.97%,TRDN;PLN;ATP2A2
prerank,Reactome_2022__mRNA Splicing R-HSA-72172,0.30766919163109735,0.9213314715083947,0.6470588235294118,0.9230090073611541,1.0,44/182,26.04%,CPSF1;SNRPN;PCF11;HNRNPF;PUF60;HNRNPH1;TXNL4A;SNRPB;U2AF1;SRRM1;HNRNPL;LSM2;ZMAT5;CWC27;SF3B1;CPSF7;SRSF4;GTF2F2;PTBP1;FUS;LSM7;PAPOLA;EIF4A3;U2AF2;SYMPK;SF3B4;CPSF6;LSM6;PPIH;CDC5L;LSM8;PDCD7;DDX46;POLR2F;MAGOHB;SNRNP48;YBX1;SNRPF;WDR33;CCAR1;SF1;SNRPA;PPIL6;RBM8A
prerank,CellMarker_Augmented_2021__DCLK1+ Progenitor cell:Large Intestine,-0.37823906244452876,-0.9211308777739684,0.6142857142857143,1.0,1.0,12/85,7.34%,OLFML1;PDGFRL;PIEZO2;LPAR1;OGN;COL1A1;CTHRC1;COL5A1;LOX;DCN;IFIT3;ASPN
prerank,KEGG_2021_Human__Pyruvate metabolism,0.4067891831092722,0.9210471947632757,0.6216216216216216,0.9233754017592863,1.0,6/40,12.24%,PC;ALDH7A1;ACSS2;ACACB;ACYP2;ADH4
prerank,CellMarker_Augmented_2021__Semilunar Valve cell:Heart,0.37521541184728785,0.9210371985294985,0.46153846153846156,0.923085148981458,1.0,3/48,2.22%,ADGRF4;SLITRK6;LAMA3
prerank,Reactome_2022__RHOJ GTPase Cycle R-HSA-9013409,0.35720006315742997,0.9210031225301024,0.52,0.9228575900265422,1.0,10/51,13.73%,SCRIB;VANGL1;RAB7A;WWP2;SLC4A7;PKN2;ARHGAP21;FNBP1;ARHGAP35;ARL13B
prerank,GO_Biological_Process_2021__regulation of muscle cell differentiation (GO:0051147),0.4335019756353128,0.9206770451823192,0.4878048780487805,0.9233485946993736,1.0,6/27,15.98%,MEGF10;ABL1;BNIP2;CDH2;MAPK12;PTBP1
prerank,GO_Biological_Process_2021__pyrimidine-containing compound metabolic process (GO:0072527),-0.49989027044512807,-0.9206344732265399,0.6071428571428571,1.0,1.0,4/11,22.60%,ERH;SLC25A19;SLC19A3;DCK
prerank,GO_Biological_Process_2021__regulation of amyloid precursor protein biosynthetic process (GO:0042984),-0.520026235129312,-0.9204530034267434,0.6440677966101694,1.0,1.0,3/11,15.29%,ITM2A;BACE2;ITM2C
prerank,GO_Biological_Process_2021__epithelial cilium movement involved in extracellular fluid movement (GO:0003351),-0.45898882006825104,-0.9204183284968476,0.5344827586206896,1.0,1.0,2/16,10.63%,CCDC39;AQP4
prerank,CellMarker_Augmented_2021__Hepatic Progenitor-Like cell:Pluripotent Stem Cell,-0.4135556827842188,-0.920331138763596,0.6056338028169014,1.0,1.0,13/59,11.63%,CYYR1;RARRES1;GUCY2C;TGFBI;ALDOB;NID1;DAB2;SLC5A9;ITGA9;MS4A8;OLFM4;CP;NSUN7
prerank,GO_Biological_Process_2021__positive regulation of vascular permeability (GO:0043117),-0.5157216555320188,-0.9201039542571513,0.6140350877192983,1.0,1.0,1/12,1.49%,TGFB1
prerank,Reactome_2022__Defective GALNT3 Causes HFTC R-HSA-5083625,-0.5139267210138089,-0.9196547922206018,0.5901639344262295,1.0,1.0,5/13,18.18%,MUCL1;MUC5B;MUC4;MUC17;MUC15
prerank,GO_Biological_Process_2021__neuron migration (GO:0001764),0.356412489236035,0.9194643074337236,0.6296296296296297,0.9257959710421396,1.0,21/46,23.59%,FGFR1;KIAA0319;AUTS2;PEX13;SH3RF1;NR4A2;SDCCAG8;NAV1;MDGA1;MARK1;DCDC2;CEP85L;ASTN2;CDK5;NRCAM;MARK2;NTRK2;ELP3;ADGRL3;GPM6A;TUBB2B
prerank,GO_Biological_Process_2021__protein import into nucleus (GO:0006606),0.3646749578754131,0.9192993128986348,0.5172413793103449,0.9259734796688219,1.0,17/69,25.97%,PRICKLE1;RANBP17;NXT1;CBLB;KPNA6;NUTF2;PPP1R10;RANBP2;RGPD5;APPL2;IPO8;NUP214;TPR;IPO7;RGPD8;FAM53A;NUP153
prerank,KEGG_2021_Human__Th1 and Th2 cell differentiation,0.35092265726740596,0.9192335456204931,0.5,0.9257764356005831,1.0,8/70,7.84%,CD247;NFATC3;HLA-DQB1;MAML1;JAG1;STAT5B;HLA-DRA;MAPK8
prerank,GO_Biological_Process_2021__positive regulation of cell migration (GO:0030335),-0.3415240892937309,-0.9191778912909639,0.5833333333333334,1.0,1.0,32/237,16.59%,ENPP2;TGFB1;F7;MMP9;SMIM22;CLDN1;COL1A1;RAB11A;SEMA3F;GPER1;VTN;DAB2;SYNE2;PLAU;ACTG1;SEMA3A;PIK3R3;SOD2;CGA;THBS1;PTPRC;LAMC2;VIL1;CXCL16;LEF1;HYAL1;EPHA1;ZP3;GRN;PLET1;F2RL1;ANGPTL3
prerank,CellMarker_Augmented_2021__Fat Cell (adipocyte):Adipose Tissue,0.4312744649199139,0.9190783344394406,0.4864864864864865,0.9258446570607474,1.0,7/19,17.52%,PPARG;SLC27A2;ADIPOR1;DLK2;ADIPOR2;VSTM2B;SLC27A4
prerank,GO_Biological_Process_2021__atrial septum development (GO:0003283),-0.5611233165680152,-0.9190331474153591,0.6101694915254238,1.0,1.0,4/9,19.47%,ZFPM1;HEY2;GATA4;DAND5
prerank,Reactome_2022__Regulation Of Ornithine Decarboxylase (ODC) R-HSA-350562,-0.4142966251909941,-0.9189286031874558,0.5652173913043478,1.0,1.0,7/43,19.11%,PSMB9;NQO1;AZIN1;OAZ2;PSMA3;PSMA7;PSMB6
prerank,GO_Biological_Process_2021__regulation of synaptic vesicle priming (GO:0010807),0.5393993450749808,0.9189020296604651,0.5957446808510638,0.9258712567744598,1.0,1/5,11.79%,UNC13B
prerank,Reactome_2022__Vesicle-mediated Transport R-HSA-5653656,0.2955328546068862,0.9187926727547466,1.0,0.9259082279957593,1.0,78/571,13.66%,IL7R;CHRM2;RAB27A;TBC1D10A;KIFC1;SNX18;GJB6;TOR1B;APOB;APOE;PACSIN2;HIP1;RAB31;TBC1D16;KIAA0319;SPTBN4;KIFC2;RIN2;BIN1;GOLIM4;SSC5D;ACBD3;SNX5;STX5;ARRB2;RAB7A;STX6;RIN1;RHOBTB3;GOLGA4;CCZ1B;GALNT1;BICD1;REXO2;MAN1A2;TRAPPC1;SEC24C;TRAPPC12;SEC22A;CNIH3;MVB12A;DYNC1I2;RALA;MAN2A1;SYT1;TGFA;STX18;CHMP6;UBAP1;GCC2;AKT2;RALGAPA2;GGA1;DENND1B;COLEC11;LDLR;TMED3;DENND2A;SH3KBP1;BET1;SYT12;RAB35;RAB27B;KIF6;VPS54;SGIP1;TBC1D4;MAN1A1;VTI1A;KIF4B;FNBP1;PREB;SNX9;SNAP91;COG7;ARPC3;ARRB1;RAB10
prerank,Reactome_2022__Estrogen-dependent Nuclear Events Downstream Of ESR-membrane Signaling R-HSA-9634638,0.4183949373413352,0.9187828382389982,0.5428571428571428,0.9256180027947322,1.0,4/20,9.44%,BCL2;KCNH8;TGFA;AKT2
prerank,GO_Biological_Process_2021__sphingolipid metabolic process (GO:0006665),-0.3827663592992506,-0.9186757426915385,0.581081081081081,1.0,1.0,16/101,16.91%,ENPP2;ELOVL2;DEGS2;PDXDC1;ALOX12B;PRKD3;PSAP;PPT1;ORMDL3;SGMS2;HACD4;ABCA12;CERS3;GBA3;SERINC1;SUMF1
prerank,GO_Biological_Process_2021__regulation of epinephrine secretion (GO:0014060),-0.6173061904217563,-0.9183604944204162,0.6470588235294118,1.0,1.0,1/5,13.18%,CARTPT
prerank,CellMarker_Augmented_2021__Cancer Stem cell:Gastrointestinal Tract,0.32652170621824694,0.9182267063264129,0.5789473684210527,0.9259469130169312,1.0,18/93,13.00%,PAPSS2;ALCAM;ARSJ;SDC4;DCBLD2;EXT1;JAG1;PKD2;SH3RF1;RAI14;CRIM1;ITGA3;KITLG;RND3;DDAH1;RASAL2;TMTC3;EPS8
prerank,CellMarker_Augmented_2021__Cancer Stem cell:Intestine,0.32652170621824694,0.9182267063264129,0.5789473684210527,0.9259469130169312,1.0,18/93,13.00%,PAPSS2;ALCAM;ARSJ;SDC4;DCBLD2;EXT1;JAG1;PKD2;SH3RF1;RAI14;CRIM1;ITGA3;KITLG;RND3;DDAH1;RASAL2;TMTC3;EPS8
prerank,CellMarker_Augmented_2021__Mucous Acinar cell:Salivary Gland,0.32652170621824694,0.9182267063264129,0.5789473684210527,0.9259469130169312,1.0,18/93,13.00%,PAPSS2;ALCAM;ARSJ;SDC4;DCBLD2;EXT1;JAG1;PKD2;SH3RF1;RAI14;CRIM1;ITGA3;KITLG;RND3;DDAH1;RASAL2;TMTC3;EPS8
prerank,KEGG_2021_Human__Pentose and glucuronate interconversions,0.49447937569097955,0.9180091729077948,0.575,0.926170489448168,1.0,5/16,25.79%,UGT2B15;UGDH;XYLB;CRPPA;GUSB
prerank,PanglaoDB_Augmented_2021__Pancreatic Stellate Cells,-0.3874738860115021,-0.9179191266213096,0.6621621621621622,1.0,1.0,10/96,6.82%,C1QTNF1;LMOD1;TGFB1;TIMP3;ANGPTL2;COL1A1;COL5A1;LOX;FBXL7;DCN
prerank,GO_Biological_Process_2021__regulation of MHC class II biosynthetic process (GO:0045346),-0.5481690672506322,-0.917911130891371,0.6833333333333333,1.0,1.0,2/9,5.93%,TAF7;CIITA
prerank,CellMarker_Augmented_2021__Mitotic Arrest Phase Fetal Germ cell:Fetal Gonad,0.2842406175962626,0.9178915573080773,1.0,0.926124333091425,1.0,155/836,15.62%,SMYD2;IRGM;ADGRG6;DUSP4;GPC4;MLF1;NBPF8;PLD6;GPR161;IFT88;EPHX2;HSPB1;ZNF518A;CNTRL;PCOLCE2;PARD3;C9ORF43;UBE2E3;NAALAD2;KLF10;CIART;PHC2;CCDC112;NDUFAF6;GOLIM4;SMARCD3;ACSS2;SHC4;CNTNAP2;PI4KB;CXXC4;SSBP3;TBC1D12;ARID3B;RAB28;ZBTB20;PER3;NRG1;HES1;JPH1;PTOV1;BCL11A;CACNB4;FAM228B;GLCCI1;RBM44;CADM1;CNN1;B4GALT2;MAN1A2;TOP1MT;TASOR2;CDK6;NRIP1;RALGPS2;STX8;NMU;LTBP1;ARHGAP20;GMDS;NPW;CNIH3;CRACD;AADAT;IMPDH1;SIK3;ERICH5;B4GALT3;EFNA5;CYRIA;TWIST1;PTPRM;KTN1;ELOVL4;SLC25A1;PDZRN3;INPP1;ZFYVE16;WASF3;DENND1B;COLEC11;EPB41L5;TBC1D22B;ALDH1A2;COTL1;COBL;UAP1;ACSL1;MPDZ;KDM2A;ZNF652;TSPAN3;UBE2E2;ODC1;DACH1;MYT1L;CABLES1;FARP1;TOM1L2;RASAL2;TBC1D4;OXR1;AK9;ARHGAP21;NGLY1;TANK;RGS7;SPATA33;REV3L;CSMD3;ABCC1;SLC41A3;EPS8;NEO1;HYDIN;CCDC88A;NR3C2;MXI1;ARHGAP35;TESC;SNAP91;MAP6;CFAP92;PELI1;RAP1GDS1;TSPAN12;PSTK;MPP2;MSI1;TMEM39B;NR3C1;MAP7D3;NFKB1;BID;MLLT3;ANO10;HSPBP1;TEX15;GMPS;RYK;ZMYND11;EMB;PELI2;COL9A1;BANK1;RFX6;NFIC;HERC2;CA8;MFHAS1;GBP2;MB21D2;CSRP2;NRXN1;PPP1R9A
prerank,GO_Biological_Process_2021__single strand break repair (GO:0000012),0.5036690998827338,0.9177998399449715,0.6052631578947368,0.9259486488672514,1.0,2/8,5.17%,SIRT1;ERCC8
prerank,GO_Biological_Process_2021__protein methylation (GO:0006479),-0.4146830177905396,-0.9177842768864272,0.6197183098591549,1.0,1.0,6/38,19.01%,BHMT;ETFBKMT;CTCFL;PCMT1;EEF1AKMT2;EEF2KMT
prerank,GO_Biological_Process_2021__sulfur amino acid metabolic process (GO:0000096),-0.43894900182325153,-0.9176868688508383,0.5507246376811594,1.0,1.0,1/23,0.65%,BHMT
prerank,GO_Biological_Process_2021__negative regulation of cell aging (GO:0090344),0.4636609022757392,0.9176490132318034,0.5666666666666667,0.9259544072818684,1.0,6/15,9.00%,SLC30A10;SIRT1;MARCHF5;CDK6;RBL1;TWIST1
prerank,GO_Biological_Process_2021__phospholipid efflux (GO:0033700),0.6164442530453627,0.91750034510417,0.6666666666666666,0.9259705193221169,1.0,2/6,7.63%,APOE;ABCA1
prerank,GO_Biological_Process_2021__heterocycle biosynthetic process (GO:0018130),-0.513724134961784,-0.9173627013799517,0.582089552238806,1.0,1.0,1/13,4.10%,ALOX5
prerank,CellMarker_Augmented_2021__Germinal Center B cell:Undefined,0.5877288541802286,0.9171615438344438,0.6129032258064516,0.9265405607168059,1.0,2/6,5.07%,BCL6;BACH2
prerank,GO_Biological_Process_2021__sphingosine-1-phosphate receptor signaling pathway (GO:0003376),-0.5851930422433198,-0.916982805672291,0.6451612903225806,1.0,1.0,3/6,17.46%,PIK3CB;RAC1;PIK3CG
prerank,GO_Biological_Process_2021__positive regulation of T cell mediated immune response to tumor cell (GO:0002842),-0.6074571686962114,-0.9166811476018644,0.6349206349206349,1.0,1.0,1/5,10.21%,HLA-DRB1
prerank,GO_Biological_Process_2021__peptidyl-threonine modification (GO:0018210),0.34669433641535863,0.9165717637040066,0.52,0.9277415850015732,1.0,7/62,9.86%,TGFBR1;SBK1;GALNT1;MAPK8;MAP3K10;GALNT13;DYRK3
prerank,GO_Biological_Process_2021__pentose-phosphate shunt (GO:0006098),0.45556531658461125,0.9163485146870392,0.45161290322580644,0.9278657044656067,1.0,3/12,17.03%,H6PD;PGLS;RPIA
prerank,GO_Biological_Process_2021__positive regulation of cell death (GO:0010942),-0.4064616616658581,-0.9162944018467443,0.5633802816901409,1.0,1.0,7/51,11.77%,ITGB2;WNT5A;CIDEB;ACOX2;CLU;HPR;ITGAM
prerank,GO_Biological_Process_2021__histone H4 deacetylation (GO:0070933),0.5269579268873559,0.9162838710646818,0.6571428571428571,0.9277259841987258,1.0,3/9,14.76%,HDAC3;HDAC1;HDAC4
prerank,KEGG_2021_Human__Melanoma,0.35182526282598475,0.91623603183449,0.6129032258064516,0.9275294920463919,1.0,9/64,9.44%,FGF10;FGFR1;MITF;FGF17;PDGFD;CDK6;CDK4;FGF18;AKT2
prerank,GO_Biological_Process_2021__response to morphine (GO:0043278),0.6290987145354668,0.9162019556088208,0.68,0.9272917910578544,1.0,1/5,11.85%,PPP1R9B
prerank,GO_Biological_Process_2021__negative regulation of cellular component movement (GO:0051271),-0.5051331709596948,-0.9161285196987203,0.5964912280701754,1.0,1.0,3/13,13.74%,SP100;WAS;SPOCK3
prerank,"GO_Biological_Process_2021__positive regulation of CD4-positive, alpha-beta T cell activation (GO:2000516)",0.4837509047021123,0.9160848600469869,0.6382978723404256,0.9272350743146053,1.0,3/10,11.29%,ZBTB7B;HLA-DRA;LGALS9
prerank,GO_Biological_Process_2021__semaphorin-plexin signaling pathway (GO:0071526),0.37066760884499383,0.9158364046186178,0.5714285714285714,0.9275915571173131,1.0,6/32,9.68%,SEMA6C;SEMA5A;FLNA;PLXNB1;FARP2;SEMA4A
prerank,Reactome_2022__Metabolic Disorders Of Biological Oxidation Enzymes R-HSA-5579029,-0.4788781604425744,-0.9152484475406409,0.6818181818181818,1.0,1.0,4/21,10.49%,CYP26B1;CYP1B1;CYP24A1;CYP21A2
prerank,KEGG_2021_Human__Non-small cell lung cancer,0.3719217688198127,0.9151424003253132,0.55,0.929016477517242,1.0,18/70,20.89%,FHIT;RARB;ERBB2;STAT5B;CDK6;CDK4;TGFA;AKT2;RET;PIK3CA;GADD45A;TP53;BRAF;RASSF1;RASSF5;SOS1;RAF1;PLCG2
prerank,GO_Biological_Process_2021__autophagy of nucleus (GO:0044804),0.4616841322835922,0.915111765933671,0.6410256410256411,0.9287527868651261,1.0,5/16,29.77%,ATG2A;ATG2B;ATG12;ATG7;ATG3
prerank,GO_Biological_Process_2021__negative regulation of T cell mediated immunity (GO:0002710),-0.5232585661576572,-0.9150426389397053,0.6721311475409836,1.0,1.0,4/10,15.53%,AHR;CEACAM1;PTPRC;HLA-F
prerank,Reactome_2022__PKMTs Methylate Histone Lysines R-HSA-3214841,0.3674984298194699,0.9148685851013962,0.5526315789473685,0.9290413084336028,1.0,22/43,29.31%,SMYD2;NSD1;KMT5C;DPY30;NFKB1;KMT5B;SETD2;ASH1L;ATF7IP;KMT2C;PRDM16;RBBP4;SUV39H2;SETD7;KMT2B;EZH2;KMT2A;SMYD3;KMT5A;NSD2;NSD3;RELA
prerank,Reactome_2022__Killing Mechanisms R-HSA-9664420,-0.5323798636959655,-0.9145140924712926,0.6551724137931034,1.0,1.0,2/11,10.17%,WNT5A;CYBA
prerank,Reactome_2022__TNFR1-induced Proapoptotic Signaling R-HSA-5357786,0.5066187419608776,0.9144829838030178,0.696969696969697,0.9296236019715062,1.0,3/11,14.61%,TANK;FADD;OTUD7B
prerank,Reactome_2022__Signaling By Cytosolic FGFR1 Fusion Mutants R-HSA-1839117,0.42685818689717053,0.9144263489427633,0.5555555555555556,0.9294476200197251,1.0,7/16,24.05%,CNTRL;STAT5B;CUX1;PIK3CA;CPSF6;MYO18A;LRRFIP1
prerank,GO_Biological_Process_2021__regulation of potassium ion transport (GO:0043266),-0.4463014933112154,-0.9144096305000551,0.5507246376811594,1.0,1.0,2/30,2.14%,CASQ2;KCNA5
prerank,GO_Biological_Process_2021__unsaturated fatty acid biosynthetic process (GO:0006636),-0.5613608515388171,-0.9143884119037393,0.631578947368421,1.0,1.0,2/9,7.49%,ALOX12;ALOX15
prerank,"GO_Biological_Process_2021__RNA phosphodiester bond hydrolysis, endonucleolytic (GO:0090502)",-0.5172214737831409,-0.9141800712232568,0.6666666666666666,1.0,1.0,1/13,5.36%,SLFN14
prerank,Reactome_2022__Inwardly Rectifying K+ Channels R-HSA-1296065,-0.4397920877591678,-0.9141446874736726,0.6065573770491803,1.0,1.0,4/30,14.00%,KCNJ15;KCNJ11;GNGT1;KCNJ4
prerank,GO_Biological_Process_2021__positive regulation of granulocyte chemotaxis (GO:0071624),0.4518157696076155,0.9141306340592235,0.47058823529411764,0.9299932956130412,1.0,4/15,22.57%,DAPK2;MCU;MOSPD2;THBS4
prerank,GO_Biological_Process_2021__isotype switching (GO:0045190),0.5302326180209269,0.9141204512486729,0.5757575757575758,0.9297091143798671,1.0,2/7,16.35%,RNF168;LIG4
prerank,Reactome_2022__mRNA Decay By 3 To 5 Exoribonuclease R-HSA-429958,0.45914389160146907,0.9141015675117065,0.5675675675675675,0.9294457299263915,1.0,2/14,5.98%,DCPS;EXOSC1
prerank,KEGG_2021_Human__Basal transcription factors,-0.4026382948455329,-0.9140722003921707,0.5416666666666666,1.0,1.0,11/40,23.44%,GTF2E1;TAF7;TAF7L;TAF9B;TBPL1;TAF10;TAF6;TAF6L;TAF13;TBP;TAF5
prerank,CellMarker_Augmented_2021__Bulge Stem cell:Scalp,0.3413513289225875,0.9138170709420954,0.5714285714285714,0.9298003479662514,1.0,31/93,19.40%,CDH20;SEZ6L;SNRPN;LRRC4C;KCNH8;TMEM132C;TOX;WSCD2;PHACTR1;KHDRBS2;DOK5;LRRN3;PDE4B;ELAVL4;NLGN4X;ZMAT1;RAB3C;CNKSR2;KLHL3;CELF2;NRXN1;JPH4;S1PR1;JAKMIP2;MAGEL2;GALNT8;ST8SIA3;ELMO1;AEBP1;TCF4;CTNNA2
prerank,Reactome_2022__Downregulation Of SMAD2/3:SMAD4 Transcriptional Activity R-HSA-2173795,0.3862273119222971,0.9137447667014456,0.5483870967741935,0.9296657818138785,1.0,7/29,17.21%,TGIF1;SERPINE1;PPM1A;HDAC1;SMAD2;WWTR1;SKI
prerank,GO_Biological_Process_2021__negative regulation of execution phase of apoptosis (GO:1900118),0.5179561981242746,0.9136700860057272,0.5777777777777777,0.9295364531797117,1.0,4/7,27.83%,PAK2;DFFA;BCL2L1;FZD3
prerank,GO_Biological_Process_2021__regulation of triglyceride metabolic process (GO:0090207),-0.577759675713544,-0.9134057552397568,0.5925925925925926,1.0,1.0,3/5,35.38%,PANK2;C3;FITM2
prerank,KEGG_2021_Human__Proteasome,-0.39539837466243083,-0.9133680840487324,0.6571428571428571,1.0,1.0,1/39,0.62%,PSMB9
prerank,GO_Biological_Process_2021__microglial cell activation (GO:0001774),-0.47136287641906793,-0.9130713523544943,0.5671641791044776,1.0,1.0,4/16,15.82%,ITGB2;CLU;ITGAM;GRN
prerank,GO_Biological_Process_2021__anion transport (GO:0006820),-0.42693847349218056,-0.9129843904882883,0.6447368421052632,1.0,1.0,9/31,13.81%,SLC22A25;SLC22A24;SLC22A6;SLCO2B1;SLC13A4;ABCG2;SLC17A8;VDAC1;SLC22A3
prerank,GO_Biological_Process_2021__regulation of cell communication (GO:0010646),-0.43050096384547665,-0.9129612862360499,0.6323529411764706,1.0,1.0,5/32,11.97%,CASQ2;GRK7;TRDN;ANXA1;MTCH1
prerank,GO_Biological_Process_2021__inorganic cation import across plasma membrane (GO:0098659),-0.38090639061254367,-0.912948436783247,0.5714285714285714,1.0,1.0,9/71,11.21%,KCNJ15;TRPV6;SLC5A2;SLC5A1;ATP1A4;KCNJ11;SLC24A1;SLC9A2;SLC9C1
prerank,"Reactome_2022__SUMO Is Transferred From E1 To E2 (UBE2I, UBC9) R-HSA-3065678",0.6018277234587892,0.9127558288254307,0.5777777777777777,0.9313153408963458,1.0,3/5,37.40%,SAE1;SUMO1;SUMO2
prerank,Reactome_2022__Death Receptor Signaling R-HSA-73887,0.34136815970242307,0.9126666361783204,0.6666666666666666,0.9311701099894187,1.0,21/124,15.28%,NGF;PLEKHG2;HDAC3;CFLAR;FGD4;RIPK2;PRPF38B;MAPK8;CASP3;FGD1;NSMAF;SMPD3;SHARPIN;TANK;FADD;HDAC1;TAB3;NFKB1;OTUD7B;VAV2;MAGED1
prerank,GO_Biological_Process_2021__mesenchyme development (GO:0060485),0.5203810998110915,0.9126256689902069,0.5434782608695652,0.9309221855232427,1.0,2/12,5.34%,TGFBR1;PKD2
prerank,GO_Biological_Process_2021__cellular response to prostaglandin stimulus (GO:0071379),0.5013886684435301,0.9125345052387075,0.6,0.9308593958070499,1.0,2/9,18.06%,AKR1C3;ADCY6
prerank,KEGG_2021_Human__Antigen processing and presentation,-0.4181256524364616,-0.9124238477829273,0.6515151515151515,1.0,1.0,18/47,24.45%,HSPA1L;HLA-DMA;CIITA;HLA-A;HLA-DPB1;HLA-DRB1;HSPA8;NFYB;HLA-DPA1;HLA-F;CD4;CD8B;HSPA4;HSPA5;HLA-C;HSPA2;HSP90AB1;RFXANK
prerank,Reactome_2022__Fanconi Anemia Pathway R-HSA-6783310,-0.41470284531772955,-0.9123547257222457,0.6197183098591549,1.0,1.0,8/35,22.72%,RPA3;FANCF;CENPS-CORT;RPS27A;DCLRE1A;FAAP20;FANCC;FANCI
prerank,GO_Biological_Process_2021__lipid import into cell (GO:0140354),0.5028316545650616,0.9122215393481664,0.4888888888888889,0.9313513521287852,1.0,3/8,17.52%,SLC27A2;ACSL1;SLC27A4
prerank,GO_Biological_Process_2021__positive regulation of ossification (GO:0045778),-0.40848789781560413,-0.9121714572105108,0.6176470588235294,1.0,1.0,3/34,4.10%,TGFB1;WNT5A;ALOX5
prerank,GO_Biological_Process_2021__atrioventricular valve morphogenesis (GO:0003181),-0.47863538059794125,-0.9120042241954317,0.6268656716417911,1.0,1.0,4/18,14.82%,ZFPM1;SMAD6;HEY2;GATA4
prerank,GO_Biological_Process_2021__cellular response to organic cyclic compound (GO:0071407),-0.3375152845418835,-0.9117963418758549,0.625,1.0,1.0,19/127,15.16%,AHR;TGFB1;P2RY12;CTNNA1;CYP1B1;RORC;ESR1;GPER1;KCNQ1;TGM2;BRCA1;P2RY6;CASP7;FAM210B;H2AZ1;SSTR1;TFPI;NR1H4;IL18
prerank,GO_Biological_Process_2021__regulation of Wnt signaling pathway (GO:0030111),-0.3710566791447172,-0.91178104105798,0.5692307692307692,1.0,1.0,14/94,14.06%,NOTUM;DISC1;ESR1;HIC1;TCF7L1;SOX30;DAAM2;ATP6V1C2;GPC3;SFRP4;TERT;TLR2;RSPO1;ATP6AP2
prerank,Reactome_2022__PI5P Regulates TP53 Acetylation R-HSA-6811555,0.5130710868711527,0.9115320229924585,0.5853658536585366,0.9326850084066688,1.0,4/9,19.92%,TP53;PIP4K2A;EP300;MAP2K6
prerank,Reactome_2022__Phase I - Functionalization Of Compounds R-HSA-211945,0.34369756486681785,0.9114793044058334,0.6666666666666666,0.9324933632120128,1.0,11/68,7.26%,CYP1A2;PTGS1;CYP7B1;CYP4V2;ALDH1A1;CYP2U1;ACSS2;BPHL;CYP2S1;NCOA2;CMBL
prerank,GO_Biological_Process_2021__embryonic axis specification (GO:0000578),0.44318614294958447,0.9114456074366732,0.5609756097560976,0.9322761951906053,1.0,4/12,13.82%,FZD5;CXXC4;COBL;SMAD2
prerank,GO_Biological_Process_2021__negative regulation of protein kinase activity (GO:0006469),0.35039704042362224,0.9114070859756619,0.4838709677419355,0.9320335305914966,1.0,24/82,20.34%,HSPB1;PTPRO;SLC8A1;CEP85;SLC8A3;SNCA;DEPTOR;ABL1;TRIB2;LRP6;SPRED1;PTPRB;UBASH3B;NF1;PTPRT;WWTR1;GADD45A;SRCIN1;DUSP19;TAB1;TARBP2;PRKAG2;PAK2;GNAQ
prerank,GO_Biological_Process_2021__positive regulation of T-helper 1 type immune response (GO:0002827),-0.5580824275794034,-0.9113924523473269,0.6730769230769231,1.0,1.0,3/7,24.13%,SLC11A1;IL18;IL1R1
prerank,GO_Biological_Process_2021__glial cell-derived neurotrophic factor receptor signaling pathway (GO:0035860),-0.6090590097866646,-0.9113382024706624,0.6333333333333333,1.0,1.0,2/5,17.20%,GFRAL;GDF15
prerank,GO_Biological_Process_2021__CD40 signaling pathway (GO:0023035),-0.5440655032714934,-0.9113150009148493,0.5932203389830508,1.0,1.0,4/6,31.80%,ITGA5;CD86;TNIP2;PHB2
prerank,GO_Biological_Process_2021__tubulin complex assembly (GO:0007021),-0.5748304714578175,-0.9112704404072006,0.6610169491525424,1.0,1.0,3/6,30.54%,TBCC;VBP1;TBCE
prerank,CellMarker_Augmented_2021__Schwann cell:Undefined,-0.6047309841199708,-0.9112110056904252,0.6551724137931034,1.0,1.0,1/6,8.31%,MPZ
prerank,GO_Biological_Process_2021__regulation of heart contraction (GO:0008016),-0.409403710870367,-0.911207777579307,0.5694444444444444,1.0,1.0,13/69,19.87%,CASQ2;CAV3;TRDN;ATP1A4;KCNJ11;KCNQ1;CYP2J2;ITPR3;AGT;PLN;CALM1;ATP1A1;ACE2
prerank,Reactome_2022__Immune System R-HSA-168256,-0.3188927486923459,-0.9111004984452148,0.8383838383838383,1.0,1.0,182/1484,16.23%,CD44;NLRP4;MICB;CRLF1;PSMB9;ARIH2;RASGRP4;CLEC5A;C1QB;MGST1;TGFB1;GMFG;TRIM62;IL21R;AIM2;ITGB2;HCK;IRF4;TCN1;MMP9;BLK;TRAIP;TBC1D10C;FLG2;ARHGAP9;CHIT1;PDCD1LG2;ATP6V1G2;PLD4;PRDX4;CCND1;KLRB1;VAV3;SP100;ALOX5;RORC;MAPKAPK3;RAB44;IRF1;TRIM5;TNFRSF1B;TEC;CLCF1;DOCK2;CLEC4C;PTAFR;UBE2L6;HLA-DMA;FBXL7;MUCL1;VTN;CIITA;TRIM25;STAT1;C3AR1;IL7;CD160;MASP1;GSDME;HRNR;OAS2;OSCAR;ICAM3;NFKB2;PLAU;IFIT3;CA1;INPP5D;MUC5B;HLA-A;ACTG1;CEACAM1;ALOX15;WAS;LY86;FBXL13;ASB14;ATP6V1C2;RNF213;NFAM1;ATP6V1D;PIK3R3;BPIFB1;IL3RA;UBE2U;UBE3A;ANXA1;CPB2;EDAR;CLU;ERAP2;PTX3;SNAP23;OSMR;IL27;C4BPA;GBP1;CYBA;OLFM4;HLA-DRB1;PTPRC;FPR1;ENPP4;CD63;NLRC4;PDAP1;SLC11A1;ATP6V0E2;CEACAM8;CTSZ;FTH1;DCTN1;BTN3A3;PYGL;CLEC12A;ITGAM;SVIP;ACP3;HSPA8;CDKN1A;IFIT1;MASP2;OAS1;IL18BP;DEFB109B;TLR2;HVCN1;BLNK;TRIM29;TXK;NLRC3;F13A1;HLA-DPA1;ORMDL3;NLRP3;GNL3;DYNLL1;ATG14;CD300LF;OPRM1;CD27;PIK3CB;SH2D1B;ADGRE3;ASB5;PSTPIP1;COLEC12;ATP6AP2;NCKIPSD;NDUFA2;POLR3H;C4BPB;MUC4;C1S;IL12A;EEF2;MUC17;CD80;FBXO40;IFNGR2;DDX3X;ORAI1;IL5RA;ITPR3;IL18;CCNF;ITM2C;ATP6V1E1;TXNIP;HLA-F;KLHL2;SRP14;RBX1;CD4;SIAH1;GRN;ELANE;TUBB;SMAD3;PSMA3;ITGB5;CYSTM1
prerank,GO_Biological_Process_2021__myeloid cell activation involved in immune response (GO:0002275),-0.5124869906179047,-0.9107944530204573,0.6190476190476191,1.0,1.0,2/12,18.67%,DOCK2;IFI35
prerank,PanglaoDB_Augmented_2021__Satellite Glial Cells,-0.3705487001001694,-0.9106901291646672,0.6538461538461539,1.0,1.0,15/97,13.87%,ENPP2;C1QB;GALNT15;LYVE1;P2RY12;SHISA6;SLCO2B1;FCGR3A;VSIG4;VWF;AQP4;GAS7;SSTR1;EDNRB;A2M
prerank,GO_Biological_Process_2021__positive regulation of hormone metabolic process (GO:0032352),0.5395885683186015,0.9106307709400103,0.5909090909090909,0.9336266191171643,1.0,2/6,26.74%,HIF1A;EGR1
prerank,KEGG_2021_Human__Mineral absorption,0.37886374962455355,0.9105921852774436,0.5641025641025641,0.9334041604748317,1.0,4/42,5.32%,MT1G;SLC26A3;SLC8A1;SLC8A3
prerank,GO_Biological_Process_2021__mature ribosome assembly (GO:0042256),-0.5937295877463442,-0.9105824578000238,0.6415094339622641,1.0,1.0,2/5,14.99%,EIF6;DDX3X
prerank,CellMarker_Augmented_2021__Cardiac Progenitor cell:Heart,0.5468398306199527,0.9104859093380695,0.5217391304347826,0.9333663119216438,1.0,3/8,9.81%,KIT;CASP3;KITLG
prerank,GO_Biological_Process_2021__regulation of amyloid fibril formation (GO:1905906),0.4585333099497769,0.9102586446519078,0.5588235294117647,0.9336460577117451,1.0,3/13,17.11%,APOE;LDLR;IAPP
prerank,CellMarker_Augmented_2021__Late Transit-Amplifying Prostate Epithelial cell:Prostate,-0.40401865215226135,-0.9102518021140013,0.6521739130434783,1.0,1.0,9/46,7.34%,CLCA2;SERINC2;TMEM184A;MISP;PTGES;NQO1;SH2D4A;EPN3;SERPINB5
prerank,CellMarker_Augmented_2021__Early Transit-Amplifying Prostate Epithelial cell:Prostate,-0.40401865215226135,-0.9102518021140013,0.6521739130434783,1.0,1.0,9/46,7.34%,CLCA2;SERINC2;TMEM184A;MISP;PTGES;NQO1;SH2D4A;EPN3;SERPINB5
prerank,PanglaoDB_Augmented_2021__Myoblasts,-0.3676410067067602,-0.9102220417493139,0.684931506849315,1.0,1.0,11/101,6.32%,C1QTNF1;LMOD1;ACTC1;TIMP3;ANGPTL2;ANGPT2;SYNC;COL1A1;COL5A1;FBXL7;UACA
prerank,CellMarker_Augmented_2021__CD4-CD28- T cell:Peripheral Blood,-0.5486506527196043,-0.9102048950496998,0.6551724137931034,1.0,1.0,2/7,10.28%,ITGB2;PTPRC
prerank,CellMarker_Augmented_2021__CD4-CD28+ T cell:Peripheral Blood,-0.5486506527196043,-0.9102048950496998,0.6551724137931034,1.0,1.0,2/7,10.28%,ITGB2;PTPRC
prerank,GO_Biological_Process_2021__regulation of axon regeneration (GO:0048679),-0.508258645844047,-0.9101786192744653,0.5862068965517241,1.0,1.0,1/10,15.82%,GRN
prerank,CellMarker_Augmented_2021__Naive T cell:Peripheral Blood,-0.5773608411929866,-0.9101440924846249,0.639344262295082,1.0,1.0,4/6,17.98%,PTPRC;CD27;CD4;CD8B
prerank,GO_Biological_Process_2021__water-soluble vitamin metabolic process (GO:0006767),0.324820966560984,0.9099348771573231,0.7241379310344828,0.9340484996701438,1.0,14/64,18.77%,PRSS3;PC;SLC19A1;DHFR;PDZD11;GSTO2;MTR;ABCC1;MTHFR;TCN2;PCCA;CD320;FPGS;SHMT2
prerank,Reactome_2022__Role Of Phospholipids In Phagocytosis R-HSA-2029485,0.43366995794168384,0.9098675966659073,0.5641025641025641,0.9338722682223959,1.0,3/20,5.62%,CD247;ITPR2;PRKCSH
prerank,GO_Biological_Process_2021__macromolecule catabolic process (GO:0009057),-0.4550159172920034,-0.9098298285322788,0.65,1.0,1.0,5/24,18.74%,TGFB1;PPT1;SIAH1;ELANE;CLN8
prerank,Reactome_2022__DNA Double-Strand Break Repair R-HSA-5693532,0.32519230670809385,0.9095640652874489,0.5384615384615384,0.9342590071006491,1.0,29/128,18.82%,EYA4;BRCC3;SEM1;RNF168;SLC19A1;H2BC21;POLD3;PPP5C;ABL1;MAPK8;POLM;TIMELESS;LRIG3;H2AX;SPIDR;HERC2;EYA3;TP53;BAZ1B;CLSPN;EXO1;LIG4;ATM;RAD52;RAD17;RAD9A;MDC1;EME2;SIRT6
prerank,Reactome_2022__Apoptotic Cleavage Of Cell Adhesion Proteins R-HSA-351906,0.49375498340190155,0.9095515167086156,0.5384615384615384,0.9339805228469787,1.0,4/9,21.55%,CASP3;TJP2;FZR1;OCLN
prerank,GO_Biological_Process_2021__rRNA modification (GO:0000154),0.4151017305784128,0.9094312048535607,0.5853658536585366,0.9340090280693407,1.0,7/20,21.19%,TFB1M;FBLL1;FBL;ZCCHC4;BUD23;NSUN4;THUMPD1
prerank,GO_Biological_Process_2021__negative regulation of protein localization to membrane (GO:1905476),-0.4510446780708222,-0.909411341764541,0.6,1.0,1.0,6/24,12.29%,TGFB1;DAB2;RHOQ;GBP1;USP17L2;MRAP
prerank,GO_Biological_Process_2021__mesoderm formation (GO:0001707),0.4849169011851172,0.9093836362078842,0.5277777777777778,0.9337614889374248,1.0,4/15,13.82%,ITGA8;ITGA3;ITGB4;SMAD2
prerank,GO_Biological_Process_2021__erythrocyte differentiation (GO:0030218),0.3843705760618909,0.9091838610613173,0.4722222222222222,0.9338666968862401,1.0,8/38,15.64%,KIT;FLVCR1;CASP3;HCLS1;DYRK3;ABCB10;MFHAS1;ACIN1
prerank,GO_Biological_Process_2021__cytoplasmic microtubule organization (GO:0031122),0.36650945796543516,0.9091151865285589,0.4857142857142857,0.933777725900199,1.0,11/53,17.08%,PCM1;CCDC88B;MAP10;SPAST;CLIP2;CCDC88A;DST;PLK3;CLIP1;SLK;CLIP3
prerank,Reactome_2022__P75 NTR Receptor-Mediated Signaling R-HSA-193704,0.3324126835617298,0.9090282161765147,0.59375,0.9336224332498784,1.0,9/86,8.44%,NGF;PLEKHG2;HDAC3;FGD4;RIPK2;PRPF38B;MAPK8;CASP3;FGD1
prerank,Reactome_2022__Glycogen Metabolism R-HSA-8982491,-0.44178211207945023,-0.9090000859063923,0.6111111111111112,1.0,1.0,5/22,20.63%,PHKG1;PYGL;CALM1;RPS27A;GYG2
prerank,Reactome_2022__Cytokine Signaling In Immune System R-HSA-1280215,-0.3243746565311593,-0.9089466656803425,0.7608695652173914,1.0,1.0,56/534,13.53%,CD44;CRLF1;PSMB9;TGFB1;TRIM62;IL21R;ITGB2;HCK;IRF4;MMP9;CCND1;SP100;ALOX5;RORC;MAPKAPK3;IRF1;TRIM5;TNFRSF1B;TEC;CLCF1;PTAFR;UBE2L6;CIITA;TRIM25;STAT1;IL7;OAS2;NFKB2;IFIT3;CA1;INPP5D;HLA-A;ALOX15;PIK3R3;IL3RA;ANXA1;EDAR;OSMR;IL27;GBP1;HLA-DRB1;FPR1;ITGAM;HSPA8;CDKN1A;IFIT1;OAS1;IL18BP;BLNK;TRIM29;F13A1;HLA-DPA1;GNL3;OPRM1;CD27;PIK3CB
prerank,GO_Biological_Process_2021__positive regulation of protein localization to cell cortex (GO:1904778),-0.5915060241074971,-0.9088897193207879,0.6607142857142857,1.0,1.0,1/5,5.55%,GPSM2
prerank,GO_Biological_Process_2021__oxidative RNA demethylation (GO:0035513),0.5491482775967346,0.9088819452501999,0.5777777777777777,0.9336254890386984,1.0,2/5,32.49%,ALKBH3;FTO
prerank,Reactome_2022__Diseases Of Mismatch Repair (MMR) R-HSA-5423599,-0.5787419400857521,-0.9088350653514725,0.5925925925925926,1.0,1.0,3/5,29.76%,MSH6;MLH1;PMS2
prerank,KEGG_2021_Human__Cytokine-cytokine receptor interaction,0.3169664414558366,0.9084893468122217,0.5238095238095238,0.9342919138832966,1.0,10/151,6.05%,IL7R;NGF;TGFBR1;IL16;CX3CR1;CCL3L3;CCL4L2;TNFSF14;TNFRSF19;IL13RA2
prerank,GO_Biological_Process_2021__negative regulation of protein secretion (GO:0050709),0.40130454219267175,0.9084802694257743,0.6285714285714286,0.9339835713082524,1.0,6/33,11.66%,IRS1;APOE;MIDN;DRD4;F2R;RAB11FIP3
prerank,PanglaoDB_Augmented_2021__Parietal Cells,0.345972429032892,0.9083711469126228,0.5,0.9339508052497988,1.0,33/106,19.68%,ZSWIM5;PLPPR1;DSCAML1;ZDHHC11B;ASAP3;PPP1R13B;USP54;PIK3C2B;PLXNB1;KIAA1671;PDE9A;FGFR3;WNK2;HID1;COBL;EBF4;SGK2;ZNF704;NEO1;PTPRT;TMPRSS2;RAI2;RALGPS1;PPP1R9A;CGN;SRCIN1;MYRIP;EPB41L4B;PTCH1;TMEM125;NDRG2;PCDH1;HDC
prerank,GO_Biological_Process_2021__protein localization to nuclear envelope (GO:0090435),0.49777478329444946,0.9082380945208517,0.6,0.9339792331878665,1.0,5/6,38.45%,NUTF2;PLK1;TOR1AIP2;NUP54;INTS13
prerank,KEGG_2021_Human__C-type lectin receptor signaling pathway,0.337182371273717,0.9082105076448405,0.6071428571428571,0.9337426548149242,1.0,16/77,16.08%,MAPKAPK2;ITPR2;KSR1;NFATC3;MAP3K14;RRAS2;CARD9;MAPK8;CBLB;AKT2;PLK3;NFKB1;PIK3CA;IL23A;MAPK12;MALT1
prerank,GO_Biological_Process_2021__positive regulation of hydrolase activity (GO:0051345),0.3308568753296131,0.9080200397546544,0.75,0.9338933942919445,1.0,27/113,18.20%,SNX18;PLIN5;RGS16;ERBB2;ASAP3;SRGAP2;RAPGEF1;MAPK8;PLXNB1;F2R;EVI5L;LIMS1;RAP1A;RGS7;FNTA;SNX9;DOCK9;RAP1GDS1;NF1;RGS6;PKP4;MAPK12;DOCK11;RSU1;ARHGAP27;TBC1D2;RAPGEF3
prerank,GO_Biological_Process_2021__axon extension (GO:0048675),0.43143586080791724,0.9079980599132399,0.6470588235294118,0.9336111742783924,1.0,5/24,12.52%,ALCAM;AUTS2;SEMA5A;SLIT2;NLGN3
prerank,GO_Biological_Process_2021__interleukin-6-mediated signaling pathway (GO:0070102),-0.4589394827207961,-0.9078430040871155,0.603448275862069,1.0,1.0,6/16,26.68%,STAT1;SPI1;YAP1;PTPN11;IL6R;ST18
prerank,GO_Biological_Process_2021__MAPK cascade (GO:0000165),0.2861948783040243,0.9077659321149183,0.6666666666666666,0.9338229443267819,1.0,45/264,15.73%,FGF10;KIT;MAPKAPK2;FGFR1;KSR1;IRS1;ANGPT1;SPTBN4;NRG2;ABHD17A;IL17RD;FGF17;PSME4;ERBB2;NRG1;RASA2;PPP5C;PSMA1;MAPK8;MYC;FGF18;TGFA;ABHD17C;TNIK;FGFR3;KITLG;GRIN1;IRS2;SPRED1;LGALS9;RASAL2;RET;FNTA;ABHD17B;MARK3;NF1;FLT3;NFKB1;PIK3CA;MEN1;HSF1;NCAM1;BRAP;MAPK12;IL2RB
prerank,GO_Biological_Process_2021__negative regulation of smooth muscle cell differentiation (GO:0051151),0.5205766084000255,0.907670660676857,0.5882352941176471,0.9337902997728633,1.0,1/8,2.55%,NFATC3
prerank,GO_Biological_Process_2021__regulation of anion transport (GO:0044070),-0.5567458102959515,-0.9076476751804532,0.6166666666666667,1.0,1.0,2/6,12.73%,PDZK1;ABCB1
prerank,KEGG_2021_Human__Th17 cell differentiation,-0.3813597800808624,-0.9075900991805123,0.625,1.0,1.0,14/83,16.15%,AHR;TGFB1;IL21R;IRF4;RORC;HLA-DMA;STAT1;HLA-DPB1;HLA-DRB1;HLA-DPA1;RXRG;IFNGR2;CD4;SMAD3
prerank,GO_Biological_Process_2021__calcium ion import (GO:0070509),0.38929670314253484,0.9075606007595219,0.5833333333333334,0.9337271539830625,1.0,8/26,23.81%,SLC8A1;MICU1;MCU;SLC25A23;TRPC4;CACNA1I;CACNA1A;CACNA1B
prerank,GO_Biological_Process_2021__regulation of membrane protein ectodomain proteolysis (GO:0051043),-0.4558576814694283,-0.9074511569771746,0.5909090909090909,1.0,1.0,3/18,9.20%,TIMP3;TNFRSF1B;TIMP4
prerank,GO_Biological_Process_2021__lipid droplet formation (GO:0140042),0.5055391358178425,0.9073767995788782,0.6,0.9338928990737351,1.0,1/8,0.97%,AUP1
prerank,Reactome_2022__Post-translational Protein Phosphorylation R-HSA-8957275,-0.37506837711544444,-0.907348558022269,0.6666666666666666,1.0,1.0,12/87,13.89%,NOTUM;APOL1;ITIH2;SERPIND1;SDC2;PRSS23;GPC3;SERPINA10;CP;WFS1;MFGE8;F5
prerank,GO_Biological_Process_2021__negative regulation of reactive oxygen species biosynthetic process (GO:1903427),0.4945754920153191,0.9073244402818176,0.5454545454545454,0.9337179181287227,1.0,2/9,10.37%,SLC30A10;ABCD2
prerank,Reactome_2022__Cytochrome P450 - Arranged By Substrate Type R-HSA-211897,-0.4054100614077077,-0.9072551700731715,0.5970149253731343,1.0,1.0,12/41,14.77%,AHR;CYP26B1;CYP1B1;CYP3A5;CYP24A1;CYP2A6;CYP2J2;CYP3A4;CYP21A2;CYP4F12;NR1H4;CYP2E1
prerank,GO_Biological_Process_2021__negative regulation of peptide hormone secretion (GO:0090278),0.4528764254915252,0.9071678346466208,0.6382978723404256,0.9338225690950746,1.0,2/16,2.85%,IRS1;MIDN
prerank,GO_Biological_Process_2021__organic substance transport (GO:0071702),-0.37740832565830285,-0.9068126954556829,0.7162162162162162,1.0,1.0,19/111,15.91%,SLC22A25;SLC22A24;TCN1;SLC22A6;SLCO2B1;SLCO2A1;CHMP3;ABCG2;PPT1;MFSD2B;SLC18A2;LRP2;SLC22A3;SLC6A4;SLC22A4;ABCA12;TXNIP;AMN;SLCO1A2
prerank,GO_Biological_Process_2021__regulation of vesicle fusion (GO:0031338),0.4975278937673787,0.9067290081989736,0.5869565217391305,0.9344250212908755,1.0,2/8,9.44%,DOC2B;AKT2
prerank,GO_Biological_Process_2021__cellular response to metal ion (GO:0071248),0.31174409140014175,0.9064769185169212,0.72,0.9346461691070611,1.0,15/111,8.41%,MT1G;NEUROD2;NLGN1;CPNE4;TRPM2;AKR1C3;CPNE7;ITPKB;SYT3;PKD2;SNCA;SYT17;SLC25A24;MAPK8;SYT1
prerank,GO_Biological_Process_2021__retinal metabolic process (GO:0042574),-0.49481833752348064,-0.9063874735828104,0.6376811594202898,1.0,1.0,4/14,13.40%,CYP1B1;RDH13;DHRS13;BCO1
prerank,GO_Biological_Process_2021__purine nucleotide biosynthetic process (GO:0006164),-0.5373129331321431,-0.9062754161376615,0.6714285714285714,1.0,1.0,2/10,18.18%,ADA;PRPS1
prerank,GO_Biological_Process_2021__cell differentiation in spinal cord (GO:0021515),0.5561771629829559,0.9062258774564547,0.6976744186046512,0.9349534738303518,1.0,4/7,18.55%,ZC4H2;MDGA2;MDGA1;SOX13
prerank,GO_Biological_Process_2021__coronary vasculature morphogenesis (GO:0060977),-0.5368543102656017,-0.9060954847630609,0.6491228070175439,1.0,1.0,1/8,0.55%,TBX1
prerank,Reactome_2022__Orc1 Removal From Chromatin R-HSA-68949,-0.39257945199570493,-0.9060793645999112,0.6666666666666666,1.0,1.0,18/59,27.84%,PSMB9;MCM3;RBX1;PSMA3;RPS27A;CDC6;PSMA7;PSMB6;ORC6;PSMA5;PSMD6;SKP1;PSMC5;MCM5;PSMB4;PSMB7;PSMD8;MCM6
prerank,GO_Biological_Process_2021__positive regulation of phosphatase activity (GO:0010922),0.43792017551138185,0.9060516064348754,0.6341463414634146,0.9349865114491738,1.0,6/15,28.25%,MAGI2;PPP1R15B;GPLD1;BMP2;MTMR9;MEF2C
prerank,GO_Biological_Process_2021__negative regulation of protein catabolic process (GO:0042177),-0.43113504687116744,-0.9060499111324726,0.6323529411764706,1.0,1.0,3/35,9.20%,TIMP3;AZIN1;TIMP4
prerank,GO_Biological_Process_2021__sarcoplasmic reticulum calcium ion transport (GO:0070296),-0.6063781887830721,-0.9059904300677876,0.6885245901639344,1.0,1.0,1/6,6.40%,TRDN
prerank,GO_Biological_Process_2021__nucleic acid metabolic process (GO:0090304),0.36147918107361277,0.9059802823372011,0.5263157894736842,0.9348419563085464,1.0,15/65,22.28%,HNRNPF;DXO;HNRNPH1;HNRNPL;WDR74;SETMAR;RBFOX2;POLG;ANKLE1;GTF2F2;PTBP1;XRN2;DNA2;LSM8;POLR2F
prerank,GO_Biological_Process_2021__ribosome assembly (GO:0042255),-0.3903392032494247,-0.9059507652590951,0.6363636363636364,1.0,1.0,21/46,28.06%,EIF6;MPV17L2;PWP2;RPL3;RPS27;DDX3X;BRIX1;NOP53;MRPL20;RPL5;RPS14;RPL11;RPS15;RPL24;SBDS;RPSA;RPS28;RPS19;MRPS2;RPL10;DHX37
prerank,GO_Biological_Process_2021__nucleoside diphosphate phosphorylation (GO:0006165),0.47328281391115035,0.9057355074185005,0.5405405405405406,0.9350119457407742,1.0,1/8,12.44%,AK9
prerank,GO_Biological_Process_2021__triglyceride catabolic process (GO:0019433),-0.48547176946199677,-0.9056474937349015,0.6060606060606061,1.0,1.0,3/15,7.72%,LIPI;LIPH;PNPLA4
prerank,GO_Biological_Process_2021__glutathione derivative biosynthetic process (GO:1901687),-0.44284198900914035,-0.9055986637442413,0.5357142857142857,1.0,1.0,1/17,1.47%,MGST1
prerank,GO_Biological_Process_2021__glutathione derivative metabolic process (GO:1901685),-0.44284198900914035,-0.9055986637442413,0.5357142857142857,1.0,1.0,1/17,1.47%,MGST1
prerank,GO_Biological_Process_2021__ephrin receptor signaling pathway (GO:0048013),0.3377243483180748,0.9052530130626418,0.5909090909090909,0.9358206399922827,1.0,7/75,9.93%,EFNB1;EPHA7;MMP2;CRK;EPHA3;EFNA5;GRIN1
prerank,GO_Biological_Process_2021__embryonic heart tube morphogenesis (GO:0003143),-0.42911458640130395,-0.9052307481202638,0.6133333333333333,1.0,1.0,5/29,17.81%,CCDC39;TBX6;ENG;GATA4;MESP1
prerank,GO_Biological_Process_2021__positive regulation of peptidase activity (GO:0010952),-0.4589133274183366,-0.905050090908001,0.6811594202898551,1.0,1.0,5/17,26.06%,PINK1;GRN;VSIR;APH1A;DDRGK1
prerank,PanglaoDB_Augmented_2021__T Regulatory Cells,-0.40948291030119877,-0.905040371123268,0.6428571428571429,1.0,1.0,12/64,10.28%,SIRPG;ITGB2;CYTIP;TAGAP;KLRB1;TNFRSF1B;GPR183;PARVG;CD5;HLA-DPB1;TRAF3IP3;PTPRC
prerank,Reactome_2022__O-linked Glycosylation Of Mucins R-HSA-913709,-0.40583765032236946,-0.9050395940516023,0.6756756756756757,1.0,1.0,14/48,19.27%,GCNT7;B3GNT5;MUCL1;MUC5B;B3GNT9;ST6GALNAC2;GALNTL5;CHST4;MUC4;MUC17;GCNT1;GALNT6;MUC15;GALNT5
prerank,GO_Biological_Process_2021__organic heteropentacyclic compound metabolic process (GO:1901376),-0.4815865511945969,-0.9049937427656989,0.5918367346938775,1.0,1.0,3/10,9.84%,MGST1;CYP3A5;CYP3A4
prerank,GO_Biological_Process_2021__mycotoxin metabolic process (GO:0043385),-0.4815865511945969,-0.9049937427656989,0.5918367346938775,1.0,1.0,3/10,9.84%,MGST1;CYP3A5;CYP3A4
prerank,GO_Biological_Process_2021__aflatoxin metabolic process (GO:0046222),-0.4815865511945969,-0.9049937427656989,0.5918367346938775,1.0,1.0,3/10,9.84%,MGST1;CYP3A5;CYP3A4
prerank,GO_Biological_Process_2021__negative regulation of lymphocyte apoptotic process (GO:0070229),0.5534936048767243,0.9049616254821766,0.575,0.9361777091843714,1.0,3/7,17.93%,BCL6;IRS2;NOC2L
prerank,GO_Biological_Process_2021__GTP metabolic process (GO:0046039),0.44714969205158506,0.9047478432403987,0.6428571428571429,0.9364028058146557,1.0,3/14,12.30%,AK3;IMPDH1;EFL1
prerank,Reactome_2022__Cytosolic tRNA Aminoacylation R-HSA-379716,-0.45680020222897194,-0.9047476600697755,0.6065573770491803,1.0,1.0,2/23,11.99%,NARS1;WARS1
prerank,GO_Biological_Process_2021__L-phenylalanine catabolic process (GO:0006559),0.560265991239637,0.9046708482986532,0.65,0.9359766192781364,1.0,2/5,22.16%,GSTZ1;IL4I1
prerank,GO_Biological_Process_2021__erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222),0.560265991239637,0.9046708482986532,0.65,0.9359766192781364,1.0,2/5,22.16%,GSTZ1;IL4I1
prerank,GO_Biological_Process_2021__cellular response to acid chemical (GO:0071229),0.41138678040565113,0.9046537196987996,0.5714285714285714,0.9357105973184328,1.0,2/28,5.55%,CPEB1;CAPN2
prerank,Reactome_2022__Nef Mediated CD4 Down-regulation R-HSA-167590,-0.5624414881291787,-0.9046272533698236,0.6,1.0,1.0,1/8,15.75%,CD4
prerank,GO_Biological_Process_2021__neurotransmitter secretion (GO:0007269),0.37866315348319574,0.9046224501213399,0.5806451612903226,0.93545487471118,1.0,12/41,17.37%,HRH3;PCLO;SNCA;PDZD11;PPFIA3;SYT1;GRM4;RIMS2;SNPH;SYN2;NRXN1;SYN1
prerank,"GO_Biological_Process_2021__regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043370)",0.5107991453729129,0.9045836709366781,0.5531914893617021,0.9352701370377225,1.0,5/10,6.51%,ZBTB7B;CBFB;SH3RF1;HMGB1;HLA-DRA
prerank,GO_Biological_Process_2021__negative regulation of mitochondrial membrane potential (GO:0010917),0.5322528709263803,0.9045638758838603,0.625,0.9349995672501987,1.0,2/7,32.87%,RNF122;HEBP2
prerank,Reactome_2022__FGFR1 Ligand Binding And Activation R-HSA-190242,0.4648515333243484,0.9044601151497961,0.5121951219512195,0.9349364182517929,1.0,3/13,4.51%,FGF10;FGFR1;FGF17
prerank,Reactome_2022__cGMP Effects R-HSA-418457,-0.4809683184328817,-0.9043946504976601,0.609375,1.0,1.0,2/14,5.05%,IRAG1;PDE5A
prerank,GO_Biological_Process_2021__regulation of viral transcription (GO:0046782),-0.446723852552252,-0.9043946354341428,0.5942028985507246,1.0,1.0,1/38,1.82%,TRIM62
prerank,GO_Biological_Process_2021__positive regulation of lipoprotein particle clearance (GO:0010986),-0.5629529328303846,-0.9043508387322274,0.5849056603773585,1.0,1.0,2/5,18.30%,GPIHBP1;LDLRAP1
prerank,GO_Biological_Process_2021__organelle transport along microtubule (GO:0072384),0.39606967556595923,0.904345167762986,0.46153846153846156,0.934888470540086,1.0,11/31,30.73%,BICD1;TRAK2;ARHGAP21;BICDL1;UXT;PEX14;LRPPRC;TRAK1;RAB6A;NDE1;BICDL2
prerank,KEGG_2021_Human__Neutrophil extracellular trap formation,-0.3618210994036204,-0.904200514115694,0.6582278481012658,1.0,1.0,20/107,13.77%,ITGB2;SLC25A31;FCGR3A;GP1BA;ACTG1;HAT1;H4C8;H2BC4;PIK3R3;SELP;CYBA;FPR1;VWF;ITGA2B;ITGAM;TLR2;H2AZ1;FPR3;PIK3CB;VDAC1
prerank,GO_Biological_Process_2021__positive regulation of protein acetylation (GO:1901985),-0.5232212171836031,-0.904059118198355,0.6612903225806451,1.0,1.0,2/12,14.99%,TERF2IP;DDX3X
prerank,Reactome_2022__TGF-beta Receptor Signaling Activates SMADs R-HSA-2173789,0.36563122575108337,0.9038812768315546,0.6666666666666666,0.9356992543962784,1.0,13/41,20.98%,BAMBI;TGFBR1;ITGA8;LTBP1;SMAD2;SMURF1;FURIN;SRFBP1;PMEPA1;PPP1CB;USP15;ZFYVE9;XPO1
prerank,GO_Biological_Process_2021__phospholipid transport (GO:0015914),0.3298973212857029,0.9038525600377644,0.6111111111111112,0.935444053449021,1.0,22/51,28.52%,APOE;MFSD2A;PITPNM1;ABCA1;LDLR;ABCC1;PITPNC1;PRELID2;ABCA7;ATP8A2;ATP10A;OSBPL8;NPC2;SCARB1;PCTP;ATP11B;PITPNB;PRELID3A;ABCG1;ATP8B1;PRELID3B;ABCA3
prerank,GO_Biological_Process_2021__regulation of double-strand break repair via homologous recombination (GO:0010569),-0.40958346493767817,-0.9036627760239111,0.64,1.0,1.0,3/43,7.51%,POLQ;TERF2IP;WAS
prerank,GO_Biological_Process_2021__response to UV-A (GO:0070141),-0.5005700961824557,-0.9035262644468063,0.5818181818181818,1.0,1.0,2/11,3.67%,MMP9;CCND1
prerank,GO_Biological_Process_2021__positive regulation of transport (GO:0051050),-0.38480215063999534,-0.9034259259489316,0.6557377049180327,1.0,1.0,11/75,11.61%,SIRPG;TULP1;DOCK2;SFTPD;DAB2;GPC3;ANXA1;CYBA;SLC11A1;SCIN;PON1
prerank,GO_Biological_Process_2021__regulation of T cell differentiation (GO:0045580),-0.43601774197456195,-0.9034166770226717,0.6666666666666666,1.0,1.0,2/27,6.30%,TCF7;IL7
prerank,KEGG_2021_Human__Thiamine metabolism,0.5169378792873169,0.9034144200494777,0.6296296296296297,0.9362086729036022,1.0,2/11,21.09%,NTPCR;ALPL
prerank,GO_Biological_Process_2021__positive regulation of cellular protein catabolic process (GO:1903364),0.4051888550722343,0.9033423948605616,0.5757575757575758,0.9360897159329554,1.0,4/17,18.00%,APOE;RNF128;CTSC;FAF1
prerank,GO_Biological_Process_2021__posttranslational protein targeting to endoplasmic reticulum membrane (GO:0006620),-0.5104768715607457,-0.9032073070001412,0.6271186440677966,1.0,1.0,4/11,26.68%,SEC62;HSPA5;SGTB;CHMP4B
prerank,CellMarker_Augmented_2021__Granulosa cell:Fetal Gonad,0.29478133287513425,0.9031434039103681,0.8461538461538461,0.9362634120341312,1.0,22/152,10.62%,VCAN;CCNG1;GOLT1A;RPP25;ALDH1A1;HLA-DQB1;CD14;SEMA5A;TMEM132C;MMP2;IFI16;DIPK2A;ZBTB20;HLA-DRA;CCND3;FSTL3;HIF3A;LRRN3;PLAGL1;RND3;CDCP1;ISOC1
prerank,GO_Biological_Process_2021__regulation of sodium ion transport (GO:0002028),-0.44215987396068085,-0.9027878948191475,0.5972222222222222,1.0,1.0,2/31,1.19%,PKP2;SCN5A
prerank,GO_Biological_Process_2021__regulation of systemic arterial blood pressure by renin-angiotensin (GO:0003081),-0.571151704262016,-0.9027850568166903,0.6,1.0,1.0,2/5,19.87%,AGT;ACE2
prerank,Reactome_2022__Transport Of Small Molecules R-HSA-382551,-0.32619252907298235,-0.9027034520768572,0.7582417582417582,1.0,1.0,96/599,18.03%,SLC28A2;CLCA2;AQP3;SLC28A1;SLC22A8;PSMB9;CLCA1;ANO2;ABCC6;CLCA4;SLC22A6;SLC28A3;ATP6V1G2;SLC16A8;TRPV6;SLC7A7;SLC5A2;SLC7A3;RAB11A;SLCO2B1;SLC5A1;TRDN;ATP1A4;TRPC7;SLCO2A1;KCNJ11;ASIC5;CA1;SLC14A1;SLC5A9;SLC13A4;ATP6V1C2;SLC24A1;SLC6A12;ATP6V1D;SLC3A1;ATP6AP1;ABCG2;MYO5B;SLC39A7;MCUB;ATP10B;GNGT1;SLC5A4;STOML2;SLC24A5;SLC22A7;CP;SLC9A2;SLC18A2;AQP4;SLC11A1;ATP6V0E2;FTH1;SLC9C1;GPIHBP1;SLC9B1;ATP13A5;SLC16A3;SLC25A18;SLC17A8;APOD;SLC47A2;ABCB1;SLC14A2;ERLEC1;NLRP3;VDAC1;SLC22A3;SLC22A4;ABCA12;ADCY7;CA4;ATP6V1E1;AQP11;AMN;RHBG;SLCO1A2;PSMA3;STEAP2;EIF2S3;ANGPTL3;ATP4A;PLN;SCNN1A;ABCF1;SLC25A22;SCNN1G;SLC6A7;ATP8B3;EIF2S2;TRPA1;SLC5A10;SLC4A1;CALM1;RPS27A
prerank,CellMarker_Augmented_2021__Adipose Multilineage-Differentiating Stress-Enduring cell:Adipose Tissue,-0.3692824415364229,-0.9024446576342482,0.6493506493506493,1.0,1.0,14/80,15.89%,LMOD1;TIMP3;ANGPTL2;COL1A1;COL5A1;FBXL7;ADAM33;DCN;ENG;COX7A1;TEK;C1S;ACTA2;FBLN2
prerank,Reactome_2022__Anchoring Of Basal Body To Plasma Membrane R-HSA-5620912,0.34769375719275986,0.9024281061930539,0.5238095238095238,0.9376623573005133,1.0,18/92,14.82%,PCM1;CEP152;CEP135;CNTRL;SCLT1;ALMS1;DYNC1I2;SDCCAG8;C2CD3;MAPRE1;RPGRIP1L;CEP290;AKAP9;CEP250;MKS1;MARK4;CEP41;CEP162
prerank,GO_Biological_Process_2021__actin-mediated cell contraction (GO:0070252),-0.5534439844049961,-0.9024060246161506,0.6181818181818182,1.0,1.0,1/9,1.81%,ACTC1
prerank,GO_Biological_Process_2021__regulation of bile acid biosynthetic process (GO:0070857),0.5074848676160431,0.9023612462853995,0.5319148936170213,0.9375027030998802,1.0,3/7,13.68%,SIRT1;PROX1;STARD4
prerank,PanglaoDB_Augmented_2021__Neurons,0.32733858660650694,0.9023233136622979,0.5555555555555556,0.9373179601337378,1.0,74/267,20.45%,SLC17A6;LHFPL4;RORA;GRM3;LRRTM3;RESP18;ELAVL3;CNTNAP2;CADM2;PCLO;CACNB4;RIN1;PAK5;PROX1;SAFB2;NCALD;PDE1A;LUZP2;ERC2;ADGRA1;CACNG2;CELF5;CELF4;SLC6A17;PNISR;BRINP1;RGS7BP;NXPH1;GPATCH8;CTTNBP2;ELAVL4;GNL3L;RAB3C;OLFM3;SGIP1;SFSWAP;CPNE6;TESC;SNAP91;RBFOX1;FRRS1L;NWD2;RHBDD2;SCRT1;CSPP1;MECP2;ZMYND11;VSTM2B;SRRM4;NRXN1;HDAC11;PPP1R9A;MATK;SACS;SLC36A4;RIT2;DZANK1;SYN1;PPFIA2;MYO5A;ZNF445;MMD2;ST8SIA3;ADGRB3;CHODL;GRM5;PNCK;ZCCHC7;CDK5;CTNNA2;UNC79;KMT2C;HPCA;TRIP11
prerank,GO_Biological_Process_2021__cellular biogenic amine biosynthetic process (GO:0042401),-0.5050720008722416,-0.9019941876470463,0.6119402985074627,1.0,1.0,1/13,0.42%,DBH
prerank,Reactome_2022__Vitamin C (Ascorbate) Metabolism R-HSA-196836,0.505346809072403,0.9019860179864776,0.5384615384615384,0.9377680748734863,1.0,1/7,8.03%,GSTO2
prerank,Reactome_2022__Transcriptional Regulation By Small RNAs R-HSA-5578749,0.3782231219575095,0.9018000142076709,0.5925925925925926,0.9378200528545705,1.0,17/56,26.74%,NUP210;NUP42;H2BC21;AAAS;H2AX;TNRC6A;RANBP2;H2AJ;AGO2;IPO8;NUP214;POLR2F;TPR;SEH1L;H2BC26;NUP153;NUP98
prerank,Reactome_2022__NS1 Mediated Effects On Host Pathways R-HSA-168276,0.3708420503842064,0.9016574494760667,0.5757575757575758,0.9378367566262207,1.0,3/39,10.02%,NUP210;NUP42;AAAS
prerank,GO_Biological_Process_2021__positive regulation of transcription elongation from RNA polymerase II promoter (GO:0032968),-0.4768774830951362,-0.9015187414026317,0.5964912280701754,1.0,1.0,1/11,7.26%,BTBD18
prerank,CellMarker_Augmented_2021__Stromal cell:Undefined,0.4225829523024991,0.9013750058374559,0.6285714285714286,0.9382912751432742,1.0,4/23,6.75%,KIT;ITGA4;MMP2;TIMP1
prerank,GO_Biological_Process_2021__chromosome organization (GO:0051276),0.33272639713919544,0.9012500597335144,0.5151515151515151,0.9383027784440193,1.0,8/89,8.03%,RFWD3;HDAC3;HDAC10;SIRT1;TOP2A;ABL1;LATS1;MYC
prerank,CellMarker_Augmented_2021__Merkel cell:Skin,-0.36849371098416706,-0.9011774090656123,0.6338028169014085,1.0,1.0,13/74,16.36%,CLCA1;PKP2;PTPRH;MISP;GPRIN2;MYO5B;GPR39;SOWAHB;C1ORF226;BCO1;TOM1L1;YAP1;USH1C
prerank,GO_Biological_Process_2021__positive regulation of vacuole organization (GO:0044090),0.4856877316807098,0.9009208149163512,0.5416666666666666,0.9387467765576675,1.0,4/11,22.88%,RALB;PIP4K2A;LRSAM1;ELAPOR1
prerank,GO_Biological_Process_2021__vitamin transport (GO:0051180),-0.4749340482492122,-0.9008675952970658,0.6031746031746031,1.0,1.0,7/24,22.95%,TCN1;ABCG2;AMN;CBLIF;SLC23A1;SLC52A2;GC
prerank,GO_Biological_Process_2021__regulation of cellular component organization (GO:0051128),0.32713554217579643,0.9006924716304596,0.6,0.9390949555051945,1.0,27/123,16.92%,IRGM;APOE;PACSIN2;HIP1;SNCAIP;URI1;CDH13;PAK5;RAPGEF1;SGK1;NRG3;ABL1;LATS1;ABL2;WNT3A;ZFYVE16;CHPT1;SGK2;RAP1A;CD22;CDK11A;MLLT3;MARK4;PTCH2;NEDD4;RAB5A;RIT2
prerank,GO_Biological_Process_2021__regulation of ion transport (GO:0043269),-0.3604941268877948,-0.9005872121041193,0.6447368421052632,1.0,1.0,7/72,9.57%,FGF20;KCNJ15;KCNA5;SYT10;SYT2;KCNJ11;PDZK1
prerank,GO_Biological_Process_2021__prostanoid metabolic process (GO:0006692),0.45702814727734536,0.9005659728019635,0.5641025641025641,0.9391212544128107,1.0,5/14,11.49%,PTGS1;AKR1C3;CYP2S1;AKR1C1;CES2
prerank,GO_Biological_Process_2021__positive regulation of smooth muscle cell proliferation (GO:0048661),0.3826858827410562,0.9005286553790096,0.5675675675675675,0.9389214541677781,1.0,5/39,4.97%,CCN4;ADAMTS1;CDH13;MMP2;DNMT1
prerank,GO_Biological_Process_2021__positive regulation of cellular process (GO:0048522),0.28064361353788486,0.900387299193306,1.0,0.9389829500871419,1.0,56/486,10.78%,IL7R;BAMBI;RAB27A;GRK5;FGF10;TGFBR1;TCIRG1;VEGFC;BCL2;FGFR1;IRS1;POU3F2;MFSD2A;PARD3;TRPC3;CCN2;SLFN11;CAPN10;RIPK2;FGF17;SIRT1;AKR1C3;ERBB2;PDGFD;NRG1;HES1;SLC25A33;PROX1;DLX1;TIMP1;ACER2;ZNF703;GREM1;ACACB;FER;CDK4;MAPK8;MYC;FGF18;TGFA;LRP6;TNFRSF18;WNT3A;HCLS1;TFE3;AKT2;FGFR3;KITLG;GRIN1;RNF10;RPS6KA3;ACER3;IRS2;ADNP2;F2R;NAMPT
prerank,GO_Biological_Process_2021__spindle assembly (GO:0051225),-0.38165337944095373,-0.9003678894355539,0.6428571428571429,1.0,1.0,4/68,5.16%,NEK2;MISP;ABRAXAS1;RAB11A
prerank,GO_Biological_Process_2021__piecemeal microautophagy of the nucleus (GO:0034727),0.5024191833192735,0.9002795848680715,0.5853658536585366,0.938629015328669,1.0,3/7,28.09%,ATG2A;ATG2B;ATG7
prerank,GO_Biological_Process_2021__lysosomal microautophagy (GO:0016237),0.5024191833192735,0.9002795848680715,0.5853658536585366,0.938629015328669,1.0,3/7,28.09%,ATG2A;ATG2B;ATG7
prerank,GO_Biological_Process_2021__positive regulation of extracellular matrix assembly (GO:1901203),0.479809801383154,0.9001094103197312,0.5833333333333334,0.9387206512127942,1.0,1/9,0.53%,PHLDB2
prerank,Reactome_2022__Fertilization R-HSA-1187000,-0.5148904093899268,-0.9000583370327526,0.660377358490566,1.0,1.0,5/17,15.80%,KCNU1;ADAM21;IZUMO1;HVCN1;ZP3
prerank,GO_Biological_Process_2021__peptidyl-lysine methylation (GO:0018022),0.4176225113929336,0.9000273442938557,0.5777777777777777,0.9385714762814791,1.0,2/25,4.06%,SMYD2;SMYD1
prerank,KEGG_2021_Human__Signaling pathways regulating pluripotency of stem cells,-0.3591639426489783,-0.9000036501009504,0.6829268292682927,1.0,1.0,15/111,16.93%,TCF7;NODAL;WNT5A;WNT8B;FZD8;PIK3R3;REST;ID1;WNT8A;WNT6;PIK3CB;FGFR4;HESX1;SMAD3;WNT10A
prerank,Reactome_2022__Packaging Of Telomere Ends R-HSA-171306,-0.4658438130196195,-0.8999643337888555,0.5857142857142857,1.0,1.0,3/16,12.66%,TERF2IP;H2BC4;H2AZ1
prerank,GO_Biological_Process_2021__positive regulation of proteolysis (GO:0045862),0.3607584439534115,0.8999433926048698,0.4827586206896552,0.9384173874021824,1.0,14/47,17.39%,TBC1D10A;APOE;PERP;RHBDD1;ASTL;TANK;FADD;SNX9;NKD2;FURIN;MAPK12;CTSC;GPLD1;AURKAIP1
prerank,Reactome_2022__Meiotic Recombination R-HSA-912446,0.39086110488312525,0.899805290922319,0.6285714285714286,0.938368659045896,1.0,6/32,14.43%,MSH4;H2BC21;CDK4;HID1;H2AX;TEX15
prerank,Reactome_2022__SUMOylation Of DNA Methylation Proteins R-HSA-4655427,0.4506181581142174,0.8996618901771768,0.6744186046511628,0.9384301959309956,1.0,3/14,12.33%,PHC2;DNMT1;SCMH1
prerank,CellMarker_Augmented_2021__Trophectoderm cell:Embryo,-0.3750097459700265,-0.8995600084204561,0.676056338028169,1.0,1.0,13/81,18.46%,OLFML1;SLC28A3;TCF7L1;PTGES;DAB2;ABCG2;PPT1;LRP2;C4BPB;SLC19A3;CD24;BASP1;FBXL18
prerank,GO_Biological_Process_2021__negative regulation of inflammatory response to antigenic stimulus (GO:0002862),-0.3691958504949425,-0.8993854754404275,0.6714285714285714,1.0,1.0,12/85,14.93%,HCK;SCTR;TSHR;GPHB5;FCGR3A;GPR27;CGA;HLA-DRB1;GPR39;PTGDR;GGT5;ADCY7
prerank,Reactome_2022__Ubiquitin Mediated Degradation Of Phosphorylated Cdc25A R-HSA-69601,-0.39272812074648167,-0.8992319894359736,0.6338028169014085,1.0,1.0,2/45,5.14%,PSMB9;CDC25A
prerank,GO_Biological_Process_2021__mitochondrial outer membrane permeabilization (GO:0097345),-0.49339063819413803,-0.8990694676933269,0.6,1.0,1.0,3/10,23.60%,MOAP1;BLOC1S2;BNIP3
prerank,Reactome_2022__Smooth Muscle Contraction R-HSA-445355,-0.41528775634820847,-0.8989222735311932,0.6060606060606061,1.0,1.0,10/42,18.23%,LMOD1;CAV3;PDE5A;ANXA1;PXDN;ACTA2;ITGB5;MYL6;CALM1;MYL9
prerank,Reactome_2022__Phosphorylation Of Emi1 R-HSA-176417,0.5801416580984857,0.8989147070988507,0.6170212765957447,0.9399392623912584,1.0,3/5,28.54%,FZR1;PLK1;CDK1
prerank,GO_Biological_Process_2021__negative regulation of calcium ion transmembrane transporter activity (GO:1901020),-0.43187581386242896,-0.8988858681208226,0.5921052631578947,1.0,1.0,2/23,6.40%,CASQ2;TRDN
prerank,"Reactome_2022__WNT5A-dependent Internalization Of FZD2, FZD5 And ROR2 R-HSA-5140745",-0.5355142695886146,-0.898815051207696,0.6190476190476191,1.0,1.0,1/10,2.54%,WNT5A
prerank,CellMarker_Augmented_2021__Ureteric Bud cell:Fetal Kidney,0.3657110747677996,0.8984999757924069,0.5517241379310345,0.9406461637125578,1.0,19/77,13.94%,TEAD2;GPR161;IGDCC3;PLEKHG4B;HS6ST2;MID1;IL17RD;RAI14;NMU;TENM3;CTSV;PRTG;B4GALNT4;LIN28B;TSPAN6;TYRO3;TEAD4;IRS4;MSI1
prerank,GO_Biological_Process_2021__regulation of ERAD pathway (GO:1904292),-0.5150979973835408,-0.8984949428429488,0.625,1.0,1.0,4/11,22.55%,USP13;AQP11;HERPUD1;UBXN1
prerank,KEGG_2021_Human__Progesterone-mediated oocyte maturation,-0.36990233447657206,-0.8980146990133467,0.6794871794871795,1.0,1.0,6/87,8.19%,BUB1;SPDYA;SPDYE3;CDC25A;SPDYE1;PIK3R3
prerank,GO_Biological_Process_2021__axon regeneration (GO:0031103),0.5029512551267958,0.8979961271478869,0.6410256410256411,0.9415327916114333,1.0,4/8,21.69%,DHFR;MTR;NREP;RTN4RL2
prerank,Reactome_2022__RHO GTPases Activate IQGAPs R-HSA-5626467,-0.5372389831416982,-0.8979773674295919,0.6949152542372882,1.0,1.0,3/11,18.02%,CTNNA1;IQGAP3;CALM1
prerank,GO_Biological_Process_2021__amino acid import (GO:0043090),0.4202258736690636,0.8979773470364475,0.5428571428571428,0.9412579286594278,1.0,5/19,19.41%,SFXN2;SLC6A20;SLC7A8;SLC16A2;SLC1A3
prerank,CellMarker_Augmented_2021__Stromal cell:Embryoid Body,-0.36792222414301323,-0.8979632854928612,0.5657894736842105,1.0,1.0,12/85,9.78%,C1QTNF1;LMOD1;TIMP3;ANGPTL2;COL1A1;COL5A1;LOX;ADAM33;DCN;HEG1;ITGBL1;THBS1
prerank,GO_Biological_Process_2021__elastic fiber assembly (GO:0048251),-0.59412767008234,-0.8978829899916871,0.6909090909090909,1.0,1.0,2/6,21.40%,TNXB;MYH11
prerank,GO_Biological_Process_2021__defense response to Gram-negative bacterium (GO:0050829),0.4245842196286724,0.8978017330417278,0.6470588235294118,0.9414434516066961,1.0,4/26,7.30%,IRGM;SERPINE1;GALP;F2
prerank,GO_Biological_Process_2021__positive regulation of DNA binding (GO:0043388),0.40597816548508264,0.897797319430536,0.5581395348837209,0.9411387990965597,1.0,6/24,9.00%,NGF;PPARG;PYHIN1;HES1;HMGB1;TWIST1
prerank,Reactome_2022__Phosphorylation Of CD3 And TCR Zeta Chains R-HSA-202427,0.49030290558638745,0.8977763925263903,0.6086956521739131,0.9408693421425528,1.0,4/12,9.57%,CD247;CSK;HLA-DRA;PAG1
prerank,GO_Biological_Process_2021__positive regulation of telomerase RNA localization to Cajal body (GO:1904874),-0.5007587527938722,-0.8977386215594941,0.6153846153846154,1.0,1.0,5/15,29.23%,NOP10;CCT6A;CCT8;CCT7;CCT2
prerank,GO_Biological_Process_2021__negative regulation of neuron apoptotic process (GO:0043524),-0.3985758445240147,-0.8975773097847332,0.6911764705882353,1.0,1.0,12/59,16.55%,CRLF1;FGF20;KIF14;CLCF1;PINK1;SOD2;PPT1;WFS1;FOXB1;TGFB3;GRN;NAIP
prerank,PanglaoDB_Augmented_2021__T Helper Cells,-0.42139936265763384,-0.8975753300440945,0.6575342465753424,1.0,1.0,11/62,10.28%,SIRPG;AHR;GMFG;IRF4;CYTIP;TAGAP;KLRB1;RORC;CD5;TRAF3IP3;PTPRC
prerank,GO_Biological_Process_2021__regulation of cyclin-dependent protein serine/threonine kinase activity (GO:0000079),-0.3667088643600054,-0.8974990768316616,0.5735294117647058,1.0,1.0,22/79,22.88%,CCNG2;SPDYA;CCND1;CDC25A;LATS2;CCND2;CDKN2D;CDKN1A;CCNI2;CCNF;CCNE2;CDKN3;CDC37;CDK5R1;PKMYT1;CDC6;INCA1;GTPBP4;CDKN1B;BLM;CCNI;PSRC1
prerank,Reactome_2022__Neurotoxicity Of Clostridium Toxins R-HSA-168799,0.470456063449777,0.8972314369480267,0.6153846153846154,0.9418893388087428,1.0,2/9,8.41%,SV2C;SYT1
prerank,GO_Biological_Process_2021__regulation of phosphatidylinositol 3-kinase activity (GO:0043551),-0.40523393895686366,-0.8971631632371286,0.625,1.0,1.0,6/28,16.76%,TGFB1;P2RY12;PIK3R3;ATG14;TEK;TNFAIP8L3
prerank,Reactome_2022__Degradation Of Beta-Catenin By Destruction Complex R-HSA-195253,-0.36668138685991536,-0.8970460457038152,0.6712328767123288,1.0,1.0,10/77,19.11%,PSMB9;TCF7;TCF7L1;FRAT1;LEF1;RBX1;PSMA3;RPS27A;PSMA7;PSMB6
prerank,Reactome_2022__Post-chaperonin Tubulin Folding Pathway R-HSA-389977,-0.47760460050480613,-0.8968837522641386,0.6619718309859155,1.0,1.0,8/18,24.89%,TUBA4A;TUBA3D;TUBB;TUBB6;TUBB2A;TUBB4A;TUBB4B;TBCC
prerank,GO_Biological_Process_2021__regulation of synapse organization (GO:0050807),0.3991233733944947,0.8968780095717273,0.5483870967741935,0.9423491565417296,1.0,9/24,19.40%,ABHD17A;ABL1;ABHD17C;WNT3A;ABHD17B;MDGA1;NEDD4;SLITRK2;CTNNA2
prerank,GO_Biological_Process_2021__positive regulation of toll-like receptor 2 signaling pathway (GO:0034137),-0.5537911745876319,-0.8968577293655741,0.6440677966101694,1.0,1.0,3/6,24.74%,CYBA;F2RL1;PJA2
prerank,Reactome_2022__Regulation Of TP53 Activity Thru Phosphorylation R-HSA-6804756,-0.36650234480803856,-0.8968370363728351,0.6111111111111112,1.0,1.0,23/81,25.69%,TAF7;RPA3;BRCA1;TAF7L;TAF9B;TAF10;TAF6;HIPK1;RRAD;CDK5R1;RPS27A;RMI1;TOPBP1;BLM;TAF13;TBP;RAD9B;TAF5;AURKA;CSNK2A2;PDZD2;CHEK1;RMI2
prerank,Reactome_2022__Endosomal/Vacuolar Pathway R-HSA-1236977,-0.4918332852767162,-0.8967407039701073,0.576271186440678,1.0,1.0,3/10,22.43%,HLA-A;HLA-F;HLA-C
prerank,Reactome_2022__Cell-extracellular Matrix Interactions R-HSA-446353,0.4498785324341493,0.8967123196639232,0.5882352941176471,0.9423592209392658,1.0,4/16,17.11%,PARVA;FLNA;LIMS1;RSU1
prerank,GO_Biological_Process_2021__positive regulation of interleukin-2 production (GO:0032743),0.39990189794747555,0.8966185039561756,0.6111111111111112,0.942244474060599,1.0,1/21,0.17%,PNP
prerank,GO_Biological_Process_2021__negative regulation of epithelial cell proliferation (GO:0050680),-0.37434973335931543,-0.8965535429985005,0.6571428571428571,1.0,1.0,12/59,16.67%,TGFB1;ALOX5;CNMD;STAT1;CEACAM1;THBS1;CAV2;NLRC3;ATP5IF1;VDR;AQP11;GHRL
prerank,GO_Biological_Process_2021__organonitrogen compound biosynthetic process (GO:1901566),0.30749222616948013,0.8964778569182386,0.782608695652174,0.9423294244198688,1.0,48/137,25.25%,ELOVL6;SLC44A5;APOE;MFSD2A;GSTM5;ACER2;ABHD3;GSTO2;HACD1;GPHN;ELOVL4;GSTM2;CHPT1;PLPP2;ACER3;CEPT1;LPCAT2;CHKA;PLA2G4C;GSTA4;GSTZ1;FURIN;PPM1L;ACHE;ELOVL1;CERS4;LPIN2;SAMD8;PAM;FA2H;ST3GAL2;ELOVL5;ASL;PLPP3;DMD;CPS1;ESD;CERS5;SLC44A2;LARGE1;PEMT;PCTP;CSNK1G2;ELOVL7;PAH;GSTT2B;NANP;LPCAT3
prerank,GO_Biological_Process_2021__negative regulation of telomere capping (GO:1904354),0.5310139843313314,0.8964291491795567,0.675,0.9421698643216362,1.0,3/7,27.18%,ATM;SMG6;NBN
prerank,GO_Biological_Process_2021__adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains (GO:0002460),0.44259067748625824,0.8963785409176557,0.55,0.9419555515044582,1.0,4/16,8.00%,BTN3A2;BACH2;JAG1;CD8A
prerank,Reactome_2022__Downstream Signaling Of Activated FGFR1 R-HSA-5654687,0.40711706253481017,0.8963621960172068,0.59375,0.941691526231179,1.0,3/27,4.51%,FGF10;FGFR1;FGF17
prerank,Reactome_2022__NOTCH3 Activation And Transmission Of Signal To Nucleus R-HSA-9013507,0.4137787428094418,0.8960514675658752,0.5161290322580645,0.9421204344587063,1.0,7/23,24.84%,JAG1;WWP2;MIB2;ADAM10;JAG2;MIB1;YBX1
prerank,CellMarker_Augmented_2021__Epithelial cell:Kidney,-0.47030376919091615,-0.8960203310959886,0.5517241379310345,1.0,1.0,3/14,18.10%,CLDN1;TEK;ANPEP
prerank,GO_Biological_Process_2021__regulation of catecholamine secretion (GO:0050433),-0.42345600238677017,-0.8959763343022412,0.6153846153846154,1.0,1.0,3/28,6.27%,FGF20;SYT10;SYT2
prerank,GO_Biological_Process_2021__protein insertion into membrane (GO:0051205),0.38958885215383054,0.8959396655011437,0.6296296296296297,0.9420657828565715,1.0,1/26,5.00%,STX5
prerank,GO_Biological_Process_2021__lens fiber cell differentiation (GO:0070306),-0.6213472567405462,-0.8959143949746263,0.6296296296296297,1.0,1.0,3/5,28.07%,MAF;WNT5B;BFSP1
prerank,GO_Biological_Process_2021__positive regulation of DNA biosynthetic process (GO:2000573),-0.4060382567851929,-0.8958836295212488,0.7213114754098361,1.0,1.0,1/57,0.37%,NEK2
prerank,Reactome_2022__Tryptophan Catabolism R-HSA-71240,0.44278689790880704,0.8957465237993602,0.6153846153846154,0.9421705452236993,1.0,4/14,8.21%,TDO2;SLC3A2;KYAT1;AADAT
prerank,GO_Biological_Process_2021__steroid catabolic process (GO:0006706),0.48762472016577835,0.8957097879354051,0.6382978723404256,0.9419565887736373,1.0,2/12,5.81%,CYP1A2;STS
prerank,Reactome_2022__Sperm Motility And Taxes R-HSA-1300642,-0.5597477109540069,-0.8956329571435891,0.6037735849056604,1.0,1.0,2/7,12.55%,KCNU1;HVCN1
prerank,PanglaoDB_Augmented_2021__Pinealocytes,0.3245558970568319,0.8953906351147858,0.7741935483870968,0.9425441096309076,1.0,29/87,17.09%,ADRA1B;MGAT4C;RP1L1;SLC2A11;CDH7;SV2C;GABRG3;PDE10A;TPH1;HCN1;KCNJ6;OPRD1;DRD4;CATSPER2;CATSPERG;AANAT;CREM;RGR;MYT1L;XKR4;SAG;FRRS1L;ZNF774;PDZD7;SRRM4;AP3B2;SLC7A14;PMEPA1;UNC13C
prerank,Reactome_2022__SARS-CoV-1 Infection R-HSA-9678108,0.36164160167031467,0.895319416878619,0.6451612903225806,0.9423749514795644,1.0,5/50,9.04%,ST6GALNAC3;PRKCSH;GALNT1;ST3GAL3;CHMP6
prerank,GO_Biological_Process_2021__negative regulation of leukocyte activation (GO:0002695),-0.5161079729359496,-0.8953032345747347,0.6140350877192983,1.0,1.0,3/10,15.82%,GPER1;CD300LF;GRN
prerank,Reactome_2022__mRNA Splicing - Major Pathway R-HSA-72163,0.3022641476260435,0.8952961594511782,0.5625,0.9421412447570747,1.0,41/174,26.04%,CPSF1;SNRPN;PCF11;HNRNPF;PUF60;HNRNPH1;TXNL4A;SNRPB;U2AF1;SRRM1;HNRNPL;LSM2;CWC27;SF3B1;CPSF7;SRSF4;GTF2F2;PTBP1;FUS;LSM7;PAPOLA;EIF4A3;U2AF2;SYMPK;SF3B4;CPSF6;LSM6;PPIH;CDC5L;LSM8;DDX46;POLR2F;MAGOHB;YBX1;SNRPF;WDR33;CCAR1;SF1;SNRPA;PPIL6;RBM8A
prerank,GO_Biological_Process_2021__autophagosome maturation (GO:0097352),-0.4419988275573197,-0.8951009558734663,0.5972222222222222,1.0,1.0,11/29,23.97%,CHMP3;ATG14;GABARAPL1;GABARAPL2;CALM1;MAP1LC3B2;RUBCNL;LIX1;VAMP7;LAMP2;ATP2A2
prerank,GO_Biological_Process_2021__Golgi ribbon formation (GO:0090161),0.49099159628668476,0.8950655378317356,0.5476190476190477,0.9423502257050235,1.0,7/13,22.91%,STX6;FHDC1;GCC2;VTI1A;PRMT5;TRIP11;MYO18A
prerank,CellMarker_Augmented_2021__Plasmacytoid Dendritic cell:Lung,-0.37817998893502097,-0.8950412913046419,0.6666666666666666,1.0,1.0,18/89,14.29%,TIMP3;PDCD1LG2;LPAR1;MMP19;FILIP1L;TGFBI;DAB2;PLAU;PRSS23;TGM2;ITGBL1;THBS1;SVIL;CAV2;AOX1;ITGA5;FOSL2;SGMS2
prerank,GO_Biological_Process_2021__neurogenesis (GO:0022008),-0.4165117878292503,-0.8950210224145041,0.6216216216216216,1.0,1.0,9/37,21.27%,LPAR1;PRDM12;ANXA1;NDUFS2;METTL14;ROGDI;MESP1;GCM2;SIX4
prerank,GO_Biological_Process_2021__protein O-linked glycosylation (GO:0006493),0.3330255096353384,0.8949666383424261,0.7083333333333334,0.9422807129926065,1.0,14/91,7.66%,GALNT7;GALNT12;DPM3;TMTC2;TET2;POGLUT3;FKTN;GALNT1;ST3GAL3;MUC13;POGLUT2;PLOD3;FKRP;POFUT1
prerank,Reactome_2022__Retrograde Transport At Trans-Golgi-Network R-HSA-6811440,0.33883882736788434,0.8945611301117014,0.46153846153846156,0.9428522436670725,1.0,16/44,23.28%,STX6;RHOBTB3;GOLGA4;GCC2;VPS54;VTI1A;COG7;COG5;ARFRP1;ARFIP2;COG4;USP6NL;GOLGA1;COG2;VPS51;COG3
prerank,Reactome_2022__Ketone Body Metabolism R-HSA-74182,0.5174149546597904,0.8944298091101118,0.5365853658536586,0.9428322836484989,1.0,2/8,14.02%,SOAT1;BDH2
prerank,GO_Biological_Process_2021__multivesicular body organization (GO:0036257),0.37386653972384704,0.8942435056330016,0.5882352941176471,0.9429762040650854,1.0,6/28,18.80%,RAB27A;MVB12A;CHMP6;VTA1;SNF8;STAM2
prerank,GO_Biological_Process_2021__mRNA cleavage involved in mRNA processing (GO:0098787),0.49637717532592324,0.8942410196108974,0.6111111111111112,0.9426683027268552,1.0,3/13,12.78%,CPSF1;ERN1;CPSF7
prerank,GO_Biological_Process_2021__polyamine metabolic process (GO:0006595),0.4421511294868883,0.893988521308499,0.5,0.9429312791419271,1.0,5/10,24.22%,HDAC10;ODC1;SAT1;SMS;SRM
prerank,GO_Biological_Process_2021__regulation of histone deacetylation (GO:0031063),0.45499885505343085,0.8937626270888254,0.5945945945945946,0.9431742382375732,1.0,1/13,3.16%,ZBTB7B
prerank,GO_Biological_Process_2021__regulation of interleukin-10 production (GO:0032653),-0.42258458901975976,-0.8937497882292295,0.640625,1.0,1.0,7/29,21.63%,IRF4;PDCD1LG2;HLA-DRB1;F2RL1;VSIR;AGER;ISG15
prerank,GO_Biological_Process_2021__Golgi to plasma membrane protein transport (GO:0043001),0.375841140035576,0.8937326798386466,0.5142857142857142,0.9429459228456715,1.0,7/25,13.66%,RAB31;BLZF1;GOLGA4;GCC2;GGA1;MACF1;RAB10
prerank,CellMarker_Augmented_2021__Alveolar Epithelial Progenitor cell:Lung,0.32976727816482776,0.8936630550220211,0.7142857142857143,0.9428218651125537,1.0,21/86,15.31%,ADGRG6;EMP1;LAMA3;ARSJ;SDC4;PARVA;COL12A1;SERPINE1;NTN4;SNAI2;CRIM1;ITGA3;RND3;CHST3;DDAH1;EFEMP1;NFIB;EPS8;NR2F2;WWTR1;PLSCR4
prerank,GO_Biological_Process_2021__regulation of leukocyte tethering or rolling (GO:1903236),-0.5324235450161624,-0.8936436769881682,0.6,1.0,1.0,1/7,8.55%,SELP
prerank,CellMarker_Augmented_2021__Eosinophil:Undefined,-0.4940978000268797,-0.8935042963704526,0.5967741935483871,1.0,1.0,7/19,20.22%,C3AR1;IL3RA;ADGRE1;PTPRC;IL5RA;CD24;CSF2RA
prerank,GO_Biological_Process_2021__actin polymerization or depolymerization (GO:0008154),-0.4083150382615274,-0.893454263994078,0.6285714285714286,1.0,1.0,10/47,17.19%,WAS;SVIL;SCIN;GAS7;VIL1;CFL1;CATIP;PSTPIP1;GHRL;RAC1
prerank,GO_Biological_Process_2021__positive regulation of cation channel activity (GO:2001259),0.3833888453561177,0.8933898546011787,0.7027027027027027,0.9431686908925886,1.0,7/31,14.65%,ARC;PKD2;GSTM2;ATPSCKMT;NLGN3;STAC2;ANK2
prerank,GO_Biological_Process_2021__response to magnesium ion (GO:0032026),-0.5443597325613021,-0.8933815131865347,0.6428571428571429,1.0,1.0,2/8,9.78%,SLFN14;THBS1
prerank,Reactome_2022__Signaling By Hippo R-HSA-2028269,0.45564244569224727,0.893289401078893,0.5918367346938775,0.9430991373397531,1.0,8/20,22.33%,AMOTL1;LATS1;CASP3;WWTR1;MOB1A;WWC1;TJP2;SAV1
prerank,Reactome_2022__TRAF6-mediated Induction Of TAK1 Complex Within TLR4 Complex R-HSA-937072,0.4352398323983204,0.8932854757736194,0.6486486486486487,0.9428067663186401,1.0,6/15,20.40%,SARM1;TICAM1;TAB3;TAB1;TAB2;TRAF6
prerank,GO_Biological_Process_2021__sensory perception of sound (GO:0007605),0.33068441325954445,0.8932720211763276,0.6129032258064516,0.9425244905600426,1.0,9/75,5.33%,PCDH15;LHFPL3;KIT;LHFPL4;SPTBN4;ALDH7A1;PAX3;WHRN;USH2A
prerank,GO_Biological_Process_2021__response to cadmium ion (GO:0046686),0.4223600675266307,0.8930575292154106,0.7142857142857143,0.9426828844469698,1.0,5/21,15.27%,MT1G;AKR1C3;MAPK8;MT4;HSF1
prerank,GO_Biological_Process_2021__positive regulation of peptidyl-threonine phosphorylation (GO:0010800),0.41307074894736273,0.8929084016519314,0.5833333333333334,0.9427669594359591,1.0,2/21,3.92%,IRGM;RIPK2
prerank,GO_Biological_Process_2021__regulation of JNK cascade (GO:0046328),0.32990856228909987,0.892867845249798,0.6785714285714286,0.9425591663860388,1.0,13/90,8.99%,RASSF2;HDAC3;DUSP15;CCN2;FKTN;TNFRSF19;SH3RF1;HMGB1;CARD9;SH3RF3;PLCB1;RAP2A;MAP3K10
prerank,GO_Biological_Process_2021__regulation of oxidative phosphorylation (GO:0002082),-0.45908832406998523,-0.8927122520835178,0.6086956521739131,1.0,1.0,4/15,16.73%,PINK1;ACTN3;COX7A1;COX7A2
prerank,GO_Biological_Process_2021__fatty acid biosynthetic process (GO:0006633),-0.3812670732626967,-0.892616392449928,0.7183098591549296,1.0,1.0,11/64,10.54%,ELOVL2;ALOX12;LIPI;ACSM6;ALOX5;TECRL;LIPH;ALOX15;CYP3A4;OLAH;ACSM3
prerank,GO_Biological_Process_2021__calcium-mediated signaling (GO:0019722),-0.3795630608603532,-0.8925632869921097,0.6212121212121212,1.0,1.0,9/69,13.30%,NMUR2;XCR1;P2RY12;ACKR4;SELP;HTR2B;PTPRC;CXCR5;EDNRB
prerank,GO_Biological_Process_2021__regulation of nucleic acid-templated transcription (GO:1903506),0.28770025822484274,0.89251701726796,0.7857142857142857,0.9431524936367397,1.0,88/359,19.38%,TEAD2;ESRRG;MLF1;TGFBR1;POU6F2;ZNF195;OR7D2;ZNF117;ZNF212;MAFB;MITF;ZFPL1;RORA;HDAC10;SLC39A8;PCGF1;APBB3;ZNF263;ATXN1;TULP3;RORB;SOX12;GPBP1L1;ZBTB4;NCOA2;HP1BP3;ZNF703;ZNF274;SPIN2B;PML;ABL1;POFUT1;SP1;ZNF33A;FOXN3;ZSCAN21;SNAI2;HCLS1;FADS1;ZNF2;TESMIN;ZNF331;CREM;ZNF519;MSC;HES6;NSD1;DMTF1;SMARCA2;MLXIPL;EFEMP1;RYBP;CDK11A;CARM1;RPS6KA4;NFYC;NR3C1;PPARGC1B;ASCC2;WWTR1;SCRT1;INSR;MAGED1;TP53;BAZ2A;FUS;WWC1;ZNF708;NOTCH1;UBE2L3;ZNF273;THAP7;ZNF646;ZNF675;TFEB;PRMT5;SP3;NFX1;YAF2;SUPT3H;SOX13;SPIN1;ERC1;EP300;CXXC1;ZNF280B;KAT6B;ZNF66
prerank,Reactome_2022__Downstream Signal Transduction R-HSA-186763,0.3669251941623561,0.892194901010998,0.6785714285714286,0.9436070331000591,1.0,8/27,21.97%,STAT5B;CRK;RAPGEF1;PIK3CA;CRKL;NCK1;SOS1;NCK2
prerank,GO_Biological_Process_2021__cellular amino acid catabolic process (GO:0009063),0.3542673606622283,0.8920719953582887,0.6,0.9435424596188401,1.0,19/78,14.94%,HYKK;AASS;TDO2;HNMT;ALDH7A1;CARNMT1;BCKDK;CBS;KYAT1;BCAT1;ECHS1;GLUD1;AADAT;SARDH;DDAH1;OGDH;GLUD2;GSTZ1;HIBADH
prerank,GO_Biological_Process_2021__embryonic skeletal system morphogenesis (GO:0048704),-0.4535801909522606,-0.8920426259102697,0.5862068965517241,1.0,1.0,1/12,0.55%,TBX1
prerank,CellMarker_Augmented_2021__Myeloid-derived Suppressor cell:Peripheral Blood,-0.4459588895423239,-0.8920345260353837,0.6290322580645161,1.0,1.0,8/22,19.68%,GP1BA;CEACAM1;SELP;ITGAM;ITGA5;CD24;CD81;ITGAX
prerank,GO_Biological_Process_2021__negative regulation of organelle assembly (GO:1902116),-0.4325438383457082,-0.8919979499732174,0.6229508196721312,1.0,1.0,4/32,8.63%,CAV3;PINK1;TCHP;BRCA1
prerank,GO_Biological_Process_2021__positive regulation of neutrophil chemotaxis (GO:0090023),0.4521130636573901,0.8919663897223569,0.5142857142857142,0.9435569598507914,1.0,4/14,22.57%,DAPK2;MCU;MOSPD2;THBS4
prerank,CellMarker_Augmented_2021__Extravillous Trophoblast cell:Placenta,-0.3793982755884506,-0.8919243429994814,0.5925925925925926,1.0,1.0,13/74,14.04%,ENPP2;CYYR1;PDCD1LG2;PSG3;TGFBI;PAPPA2;HLA-A;PSG6;GBP1;LAMC2;TEK;PSG11;GABARAPL1
prerank,GO_Biological_Process_2021__regulation of transport (GO:0051049),-0.4362159014481273,-0.8917971066284545,0.6774193548387096,1.0,1.0,5/30,10.70%,RAB11A;PINK1;ACTG1;USP6;DNAJA1
prerank,GO_Biological_Process_2021__regulation of Rab protein signal transduction (GO:0032483),0.5296770963797871,0.8916007935253212,0.6571428571428571,0.9440997964054985,1.0,4/7,25.37%,DENND4A;DENND4B;DENND1A;SGSM3
prerank,GO_Biological_Process_2021__negative regulation of interleukin-12 production (GO:0032695),-0.534782162288704,-0.8915493248469097,0.6451612903225806,1.0,1.0,1/8,9.78%,THBS1
prerank,Reactome_2022__L1CAM Interactions R-HSA-373760,0.3226566696038181,0.8915318721064637,0.6521739130434783,0.9439610815179936,1.0,17/95,16.57%,LLGL1;FGFR1;ALCAM;SPTBN4;NUMB;RPS6KA3;SCN7A;KIF4B;RPS6KA4;RPS6KA2;ANK2;RPS6KA6;VAV2;NCAM1;CNTN6;ITGA10;EPHB2
prerank,CellMarker_Augmented_2021__Smooth Muscle cell:Undefined,-0.3741720605211959,-0.8914599956057212,0.6231884057971014,1.0,1.0,16/74,15.89%,OLFML1;LMOD1;CASQ2;ACTC1;ANGPTL2;COL1A1;ADAM33;DCN;ASPN;SFRP4;COX7A1;TEK;C1S;ACTA2;JPH2;FBLN2
prerank,Reactome_2022__GLI Proteins Bind Promoters Of Hh Responsive Genes To Promote Transcription R-HSA-5635851,-0.6216055881635665,-0.8914596230884072,0.75,1.0,1.0,2/6,15.95%,HHIP;GLI3
prerank,GO_Biological_Process_2021__toll-like receptor signaling pathway (GO:0002224),-0.36695688903868046,-0.8911550249908743,0.6575342465753424,1.0,1.0,11/76,14.69%,SFTPA1;TRIL;ITGB2;SCIMP;MAPKAPK3;SFTPD;ITGAM;OAS1;TLR2;COLEC12;NR1H4
prerank,GO_Biological_Process_2021__negative regulation of cell adhesion (GO:0007162),0.3286974782000828,0.8911486140562116,0.5666666666666667,0.9445725104850274,1.0,11/65,9.01%,ANGPT1;PTPRO;CDH13;SEMA5A;SERPINE1;JAG1;ACER2;DSCAM;PLXNB1;SIPA1;SNAI2
prerank,Reactome_2022__Assembly Of Active LPL And LIPC Lipase Complexes R-HSA-8963889,0.4438632346790078,0.8910025165612475,0.6341463414634146,0.9445866519791632,1.0,3/13,15.21%,LIPC;LPL;FURIN
prerank,GO_Biological_Process_2021__regulation of activin receptor signaling pathway (GO:0032925),-0.4714926270935653,-0.8908818681748168,0.6557377049180327,1.0,1.0,1/12,1.82%,NODAL
prerank,GO_Biological_Process_2021__autophagosome assembly (GO:0000045),0.3410044013988444,0.8908700789980221,0.6176470588235294,0.9445514711300619,1.0,15/53,26.43%,IRGM;RAB7A;UBXN2A;SMURF1;ATG2A;ATG16L2;UBXN2B;ATG2B;STING1;ELAPOR1;ATG12;VMP1;TP53INP1;TRAPPC8;AMBRA1
prerank,GO_Biological_Process_2021__positive regulation of transforming growth factor beta production (GO:0071636),-0.48679950468426175,-0.890826716604087,0.6065573770491803,1.0,1.0,2/9,14.06%,THBS1;ATP6AP2
prerank,GO_Biological_Process_2021__modified amino acid transport (GO:0072337),-0.4922220308006383,-0.8907730435414933,0.6557377049180327,1.0,1.0,1/12,1.47%,MGST1
prerank,KEGG_2021_Human__Breast cancer,-0.3507072269024436,-0.8907644730842899,0.6266666666666667,1.0,1.0,19/128,14.16%,TCF7;FGF20;WNT5A;WNT8B;CCND1;FZD8;ESR1;TCF7L1;NFKB2;FLT4;PIK3R3;FRAT1;BRCA1;WNT8A;CDKN1A;WNT6;PIK3CB;LEF1;HEY2
prerank,GO_Biological_Process_2021__long-chain fatty-acyl-CoA biosynthetic process (GO:0035338),-0.44087963135628727,-0.8907140100949205,0.6212121212121212,1.0,1.0,2/16,4.18%,ELOVL2;ACSL5
prerank,GO_Biological_Process_2021__macromolecule depalmitoylation (GO:0098734),0.49650097015207506,0.8906420836010653,0.6052631578947368,0.944431898423526,1.0,3/8,12.91%,ABHD17A;ABHD17C;ABHD17B
prerank,GO_Biological_Process_2021__protein depalmitoylation (GO:0002084),0.49650097015207506,0.8906420836010653,0.6052631578947368,0.944431898423526,1.0,3/8,12.91%,ABHD17A;ABHD17C;ABHD17B
prerank,Reactome_2022__TRAIL Signaling R-HSA-75158,0.5141894048901754,0.8906160094400078,0.6578947368421053,0.9441701874613824,1.0,2/6,12.94%,CFLAR;FADD
prerank,Reactome_2022__Interaction Between L1 And Ankyrins R-HSA-445095,-0.4423885442777431,-0.8905432597511692,0.676056338028169,1.0,1.0,1/27,1.19%,SCN5A
prerank,Reactome_2022__Response To Elevated Platelet Cytosolic Ca2+ R-HSA-76005,-0.36092351248276955,-0.8905051712541606,0.6547619047619048,1.0,1.0,15/109,14.43%,F8;TGFB1;TIMP3;CLU;PLG;THBS1;CD63;VWF;ITGA2B;ITIH3;TUBA4A;F13A1;ITIH4;F5;TGFB3
prerank,GO_Biological_Process_2021__positive regulation of histone methylation (GO:0031062),0.40915329293739855,0.890364525318921,0.6666666666666666,0.9443863552925058,1.0,3/24,4.97%,AUTS2;SIRT1;DNMT1
prerank,GO_Biological_Process_2021__regulation of protein serine/threonine kinase activity (GO:0071900),0.33648408354265114,0.8902136007144168,0.52,0.9444152996883021,1.0,15/99,9.20%,IRGM;CCNG1;KSR1;SLC8A1;CNPPD1;SIRT1;RALB;SLC8A3;SNCA;ABL1;CCND3;TRIB2;LRP6;TELO2;PIH1D1
prerank,GO_Biological_Process_2021__cellular protein modification process (GO:0006464),0.2592687688540427,0.8901511140603809,1.0,0.9442522838394511,1.0,161/908,16.83%,ERG;CSTA;EGLN3;CTDNEP1;DUSP4;VCAN;GRK5;DUSP2;ASB18;TGFBR1;CD247;MAPKAPK2;KLHL20;CEL;LMTK3;FGFR1;APOB;LOXL1;APOE;PTPRO;CDK14;PTAR1;DAPK2;CCN1;CSK;FRK;JMJD4;COMMD1;BCKDK;SIRT1;PSME4;ERBB2;MAML1;ERCC8;KLHL41;SIRT7;PRKCSH;PDIA6;PAK5;ST8SIA4;HS3ST5;CILK1;LGALS1;VRK2;ST3GAL3;FBXO15;PTPRZ1;TIMP1;DSP;DCUN1D1;PPP5C;CDK6;SGK1;PSMA1;EIF2AK3;FER;CDK4;LORICRIN;LTBP1;ABL1;LATS1;MAST1;MAST2;UST;MAPK8;WWP2;IGFBP4;PTPRR;METAP1D;CTDSP2;MAP3K1;FSTL3;TRIB2;SIK3;CTDSP1;MAN2A1;HIF3A;NUS1;ABL2;PTPN9;PTPRM;TNIK;RHBDD1;KTN1;AKT2;ERN1;ANO8;DCAF13;MAP3K9;UBE2E1;DYRK3;WDTC1;PKN2;CDK18;WNK2;PGGT1B;GAN;MAP3K21;PPP2R1B;UBE2E2;FASTK;FBXL14;PPM1A;PTPRB;PIM2;SGK2;MAP3K13;KLHL3;RET;NGLY1;PXK;QSOX1;KLHL42;CCDC22;FBXL20;FAM20B;MARK3;CDH2;KLHL22;COG7;FUT9;CDK11A;ASB7;FBXO27;CDK8;RPS6KA4;SENP8;NTAQ1;PGAP1;PTPRT;MARK4;RYK;DCAF5;INSR;BCR;ALG3;CDK16;TSSK4;PTPRF;SSH1;MEN1;ST3GAL6;PPM1L;CDC14B;B3GALNT2;KLHL5;MAP4K2;MATK;WNK3;PTPRD;PTPRE;MTMR3;NEK1;FBXO4;DNAJC3;ASB6;MARK1;RAB5A;UBE2L3;RAB11B;ATM
prerank,Reactome_2022__Zinc Influx Into Cells By SLC39 Gene Family R-HSA-442380,0.5238330555181987,0.890055981795301,0.5897435897435898,0.9441090550061396,1.0,1/7,3.19%,SLC39A8
prerank,GO_Biological_Process_2021__positive regulation of gluconeogenesis (GO:0045722),0.5452257180773727,0.8900460647536849,0.5526315789473685,0.9438134520005222,1.0,1/6,4.59%,SIRT1
prerank,CellMarker_Augmented_2021__T cell:Kidney,-0.432562938792309,-0.8899293850598634,0.6521739130434783,1.0,1.0,6/29,10.28%,SIRPG;KLRB1;SCML4;CD5;TRAF3IP3;PTPRC
prerank,GO_Biological_Process_2021__pharyngeal system development (GO:0060037),-0.5165452555429286,-0.8896411826331501,0.6229508196721312,1.0,1.0,1/11,0.55%,TBX1
prerank,PanglaoDB_Augmented_2021__Olfactory Epithelial Cells,0.2830777274708247,0.8895397952964478,0.8571428571428571,0.9447128055743927,1.0,45/201,19.11%,MLF1;PCOLCE2;SPTBN4;CNPPD1;PCLO;NRG1;SPEF2;H2BC21;LRRC73;NAT14;ABHD3;FSTL5;IMPDH1;MORN4;CASKIN1;EFNA5;CNGA4;CAP2;FGF12;RNF128;CSPG5;PRR36;GOLGA7B;CLSTN2;TESC;MAP6;OSCP1;MPP2;SRRM3;FAM81A;PTPRF;IFT140;KLHL5;LRRC45;ARL3;SRCIN1;MARK1;LRRIQ1;TTC21A;FAIM;DCDC2;RIC8B;TRIM66;CFAP43;EPB41L4B
prerank,KEGG_2021_Human__Prion disease,-0.3393037930566264,-0.8895394497407279,0.75,1.0,1.0,53/212,24.72%,C1QB;COX6A1;HSPA1L;SLC25A31;CAV3;PIK3R3;ATP5F1E;NDUFS2;COX6C;CYBA;CAV2;ATP5MC3;HSPA8;ATP5PF;TUBA4A;COX7A1;PIK3CB;VDAC1;NDUFA2;NDUFB4;NDUFC1;TUBA3D;ITPR3;COX7C;NDUFA1;NDUFB9;TUBB;PSMA3;TUBB6;RAC2;COX7A2;RAC1;TUBB2A;COX4I1;PSMA7;PSMB6;CREB3;NDUFB10;HSPA5;TUBB4A;NDUFS5;ATP5PB;NDUFB11;PSMA5;TUBB4B;ATP5F1A;SDHC;PSMD6;CSNK2A2;HSPA2;KLC1;NDUFB2;NCF2
prerank,GO_Biological_Process_2021__cellular response to virus (GO:0098586),0.4114051887849944,0.8893478493482013,0.6829268292682927,0.944849727428075,1.0,4/27,11.29%,IRGM;GBF1;RRP1B;LGALS9
prerank,GO_Biological_Process_2021__lipid homeostasis (GO:0055088),0.3403512952697952,0.8893037794005253,0.6333333333333333,0.9446573556605602,1.0,13/57,18.13%,APOE;PPARG;SIRT1;ZBTB20;ABCA1;PNPLA3;IRS2;TLCD3B;MLXIPL;NR1H3;TLCD3A;ABHD4;ACOX1
prerank,Reactome_2022__Transcription Of HIV Genome R-HSA-167172,-0.38953860017268205,-0.8891054820385369,0.6901408450704225,1.0,1.0,14/64,25.58%,GTF2E1;TAF7;TAF7L;TAF9B;TAF10;TAF6;RNMT;TAF13;TBP;POLR2B;ELOB;TAF5;CDK7;CDK9
prerank,GO_Biological_Process_2021__defense response to protozoan (GO:0042832),-0.533419061503482,-0.8890866909385517,0.6065573770491803,1.0,1.0,3/9,17.49%,IRF4;SLC11A1;GBP6
prerank,GO_Biological_Process_2021__prostaglandin biosynthetic process (GO:0001516),0.46618317678614807,0.8889402230116842,0.5675675675675675,0.9452804814208431,1.0,2/16,4.75%,PTGS1;AKR1C3
prerank,GO_Biological_Process_2021__regulation of cholesterol esterification (GO:0010872),0.5213637996913755,0.8888778771967302,0.6086956521739131,0.9451568382317639,1.0,2/7,13.68%,APOE;STARD4
prerank,GO_Biological_Process_2021__receptor signaling pathway via STAT (GO:0097696),-0.4679728231850502,-0.8888673398828381,0.6764705882352942,1.0,1.0,2/21,6.09%,CLCF1;STAT1
prerank,GO_Biological_Process_2021__positive regulation of leukocyte apoptotic process (GO:2000108),-0.5292389844795092,-0.8887419786494241,0.660377358490566,1.0,1.0,3/10,13.53%,BLK;ANXA1;PIK3CB
prerank,GO_Biological_Process_2021__positive regulation of lipid localization (GO:1905954),0.48520990987427126,0.8887198798524794,0.6388888888888888,0.945303252021538,1.0,4/9,14.09%,APOB;PLIN5;LPL;NFKB1
prerank,GO_Biological_Process_2021__establishment of epithelial cell apical/basal polarity (GO:0045198),0.44182229422643454,0.8887073385538194,0.5588235294117647,0.9450226571287254,1.0,3/9,21.29%,RAP2A;MYO9A;CAMSAP3
prerank,GO_Biological_Process_2021__negative regulation of IRE1-mediated unfolded protein response (GO:1903895),-0.5984202743458354,-0.8886025761237527,0.7272727272727273,1.0,1.0,3/5,26.06%,HSPA5;UFL1;DDRGK1
prerank,CellMarker_Augmented_2021__Natural Killer cell:Kidney,-0.5757064742613219,-0.8885422917593045,0.6617647058823529,1.0,1.0,3/5,6.58%,KLRB1;CD160;FCGR3A
prerank,Reactome_2022__Visual Phototransduction R-HSA-2187338,0.3136287617181377,0.8885179804401955,0.7916666666666666,0.9451297754392891,1.0,14/75,11.20%,GPC4;CYP4V2;APOB;APOE;SDC4;GPC6;AKR1C3;AKR1C1;GPC5;LPL;LDLR;CAMKMT;AWAT2;SDC3
prerank,PanglaoDB_Augmented_2021__Crypt Cells,0.318043038375385,0.8884801876094998,0.7777777777777778,0.944888651943226,1.0,25/98,16.89%,LGR5;FREM1;GPC4;TMEM132C;SPON1;TNFRSF19;PARM1;PDZRN3;PDE9A;VWA2;WNK2;HID1;COBL;LRRN1;ZNF704;NEO1;TPPP3;MSI1;ASXL3;PTPRT;RAI2;RALGPS1;PPP1R9A;EPHB2;PBX1
prerank,Reactome_2022__PTK6 Promotes HIF1A Stabilization R-HSA-8857538,0.5640779962435616,0.8884420121905099,0.6862745098039216,0.944662393112599,1.0,1/5,20.51%,HIF1A
prerank,KEGG_2021_Human__Vibrio cholerae infection,0.3456814823079069,0.8883510659762538,0.6071428571428571,0.944598002722444,1.0,2/45,1.86%,ATP6V0D2;TCIRG1
prerank,GO_Biological_Process_2021__intracellular protein transport (GO:0006886),0.3209529762185571,0.8881297201137608,0.75,0.9448373930004035,1.0,65/298,21.29%,TBC1D10A;PRICKLE1;NLGN1;RAB31;TBC1D16;TICAM2;NUP42;RANBP17;STX5;TBC1D12;RAB28;RAB20;SCFD2;RAB7A;STX6;STX8;NXT1;SYNDIG1;AKT2;GGA1;TMED3;RPGR;TRAK2;TBC1D22B;EVI5L;TBC1D4;ACD;XPO7;ARL5A;PREB;ANKLE1;SNX9;COG7;LTBP2;WLS;SMURF1;RTN2;MYO1C;XPO5;HERC2;RASSF9;SNF8;RAB5A;NUTF2;CLIP3;TBC1D8B;ARFIP1;VPS26C;AP4S1;TBC1D2;TBCK;TECPR2;PPP1R10;AP4B1;ARFRP1;ARFIP2;TBC1D8;TBC1D26;APPL2;USP6NL;IPO8;LAPTM5;XPO1;TBC1D5;CAMSAP3
prerank,PanglaoDB_Augmented_2021__Ductal Cells,-0.3644113941710224,-0.8881127910918182,0.6666666666666666,1.0,1.0,14/75,14.23%,AMBP;SERINC2;TMEM184A;MISP;CLDN1;CLDN2;SLC3A1;MYO5B;GPR39;LAMC2;SOWAHB;ITGB6;TRIM29;GPX2
prerank,PanglaoDB_Augmented_2021__Distal Tubule Cells,-0.35968131897949057,-0.8879828648286682,0.6811594202898551,1.0,1.0,26/112,18.18%,SLC22A8;IYD;MACC1;SLC22A6;TMEM213;CYP3A5;SLC5A1;SLC3A1;MYO5B;ATP10B;SCIN;ITGB6;ATP5MK;UROC1;MUC4;SGMS2;VDR;PIK3C2G;NPHS2;ADGRF5;PROM2;PGAM2;SCNN1A;SCNN1G;COL28A1;MUC15
prerank,GO_Biological_Process_2021__negative regulation of amyloid fibril formation (GO:1905907),0.46079313287151646,0.887892588624734,0.6052631578947368,0.94507662655805,1.0,3/10,17.11%,APOE;LDLR;IAPP
prerank,GO_Biological_Process_2021__DNA protection (GO:0042262),0.5313407241723058,0.8878229126660415,0.6170212765957447,0.9448848729810824,1.0,1/5,5.66%,CBS
prerank,GO_Biological_Process_2021__amyloid-beta metabolic process (GO:0050435),-0.5075123807679984,-0.8877931279297782,0.6296296296296297,1.0,1.0,1/13,6.25%,BACE2
prerank,GO_Biological_Process_2021__negative regulation of cell cycle phase transition (GO:1901988),-0.5650573504023028,-0.8877590579013782,0.6666666666666666,1.0,1.0,2/6,17.25%,ATF5;ZFP36L1
prerank,GO_Biological_Process_2021__copper ion homeostasis (GO:0055070),0.48003714560064115,0.8877048701401606,0.6,0.9448694360708378,1.0,3/14,12.94%,COMMD1;COX19;CCDC22
prerank,GO_Biological_Process_2021__positive regulation of receptor signaling pathway via JAK-STAT (GO:0046427),0.4014951413885161,0.8876541548029776,0.5675675675675675,0.9446485200588817,1.0,7/22,13.71%,KIT;HES1;F2;OCIAD2;F2R;IL10RA;PIBF1
prerank,GO_Biological_Process_2021__negative regulation of autophagy (GO:0010507),0.3507244161900415,0.887630654501413,0.6285714285714286,0.9444032934809977,1.0,16/53,21.78%,BCL2;SNCA;MTMR8;LEPR;USP36;DAPL1;QSOX1;TAB3;KLHL22;IL10RA;PIK3CA;SMG1;TAB2;RASIP1;RUBCN;EIF4E
prerank,GO_Biological_Process_2021__negative regulation of lipid localization (GO:1905953),0.5472675835579915,0.8876239063536338,0.6363636363636364,0.944119111964565,1.0,4/5,33.25%,NR1H3;ITGAV;PTPN2;NR1H2
prerank,GO_Biological_Process_2021__regulation of ATP biosynthetic process (GO:2001169),0.47397306018481483,0.887477442218684,0.5625,0.9441479356372708,1.0,3/14,12.32%,DNAJC30;PID1;ATPSCKMT
prerank,GO_Biological_Process_2021__leukocyte cell-cell adhesion (GO:0007159),-0.44412763816901923,-0.8873843459628499,0.6617647058823529,1.0,1.0,4/22,17.52%,ITGB2;SELP;NT5E;MSN
prerank,GO_Biological_Process_2021__regulation of nephron tubule epithelial cell differentiation (GO:0072182),0.4967626067429184,0.8873786216505162,0.6428571428571429,0.9440448128519073,1.0,1/6,6.85%,OSR1
prerank,GO_Biological_Process_2021__plasma membrane repair (GO:0001778),-0.4787607102579066,-0.8870884070408445,0.6417910447761194,1.0,1.0,1/13,11.55%,AHNAK2
prerank,Reactome_2022__RNA Polymerase I Transcription Initiation R-HSA-73762,0.3949242615509513,0.8870380734659994,0.631578947368421,0.9447037570810115,1.0,11/44,22.28%,GATAD2A;TAF1B;CCNH;POLR1H;HDAC1;GATAD2B;CHD4;ERCC3;KAT2B;RBBP4;POLR2F
prerank,CellMarker_Augmented_2021__Neural Crest cell:Undefined,0.45013832000998755,0.8869800833230991,0.5897435897435898,0.9445126258598182,1.0,6/16,16.67%,ITGA4;PAX3;SNAI2;NUMB;ASCL1;NOTCH1
prerank,GO_Biological_Process_2021__regulation of inflammatory response to antigenic stimulus (GO:0002861),-0.36209689929358535,-0.886855969313829,0.676056338028169,1.0,1.0,12/86,14.93%,HCK;SCTR;TSHR;GPHB5;FCGR3A;GPR27;CGA;HLA-DRB1;GPR39;PTGDR;GGT5;ADCY7
prerank,GO_Biological_Process_2021__regulation of neuroblast proliferation (GO:1902692),-0.4798088639871554,-0.8865916228098281,0.6557377049180327,1.0,1.0,2/16,3.26%,DISC1;TAFA3
prerank,CellMarker_Augmented_2021__LGR5+ Stem cell:Large Intestine,-0.40123704826926765,-0.8865753372807228,0.6060606060606061,1.0,1.0,13/42,17.20%,PKP2;MGST1;PPP1R1B;ZNF296;CLDN2;ATP10B;HNF1A;OLFM4;PTGDR;GPX2;F2RL1;C16ORF89;GDF15
prerank,GO_Biological_Process_2021__purine ribonucleoside monophosphate biosynthetic process (GO:0009168),-0.47149235392822786,-0.886513476687466,0.6521739130434783,1.0,1.0,1/15,1.23%,ADSS1
prerank,Reactome_2022__RND1 GTPase Cycle R-HSA-9696273,0.3660877275543889,0.8863638989511681,0.6052631578947368,0.9458104542821664,1.0,11/38,16.01%,VANGL1;RRAS2;ANKRD26;MUC13;RASAL2;CCDC88A;DST;ARHGAP35;PKP4;FAM135A;DLG5
prerank,GO_Biological_Process_2021__regulation of cardiac muscle hypertrophy (GO:0010611),-0.4326712377303591,-0.8863621301557247,0.6619718309859155,1.0,1.0,1/22,2.76%,CAV3
prerank,GO_Biological_Process_2021__tumor necrosis factor-mediated signaling pathway (GO:0033209),-0.36089027924232797,-0.8861714649262197,0.6666666666666666,1.0,1.0,7/96,9.33%,PSMB9;AIM2;CARD14;TNFRSF1B;STAT1;EDAR;TXNDC17
prerank,GO_Biological_Process_2021__cilium assembly (GO:0060271),0.2946941951726535,0.8861458956658849,0.7857142857142857,0.9460045936564568,1.0,72/283,21.22%,PCM1;RP1L1;IFT88;CEP152;CEP135;CNTRL;DZIP1L;PARVA;SCLT1;FHDC1;GBF1;JHY;CILK1;BBS9;ALMS1;SPAG16;FLNA;DYNC1I2;CNGA4;SDCCAG8;C2CD3;MAPRE1;RPGRIP1L;CEP290;EHD4;RPGR;AKAP9;CEP250;RAB11FIP3;AVIL;MKS1;CFAP410;CEP20;TTC36;RILPL1;PIBF1;ARL13B;EXOC7;KIAA0586;RP2;PTPN23;MARK4;CEP41;CEP162;CDC14B;IFT140;TTC21B;NEK1;ARL3;NOTCH1;CFAP70;DCDC2;KIF3B;BBIP1;CFAP221;PDE6D;DZIP1;UNC119B;CFAP43;TMEM67;PTPDC1;CFAP46;EXOC6;CDK5RAP2;TMEM138;TRIP11;WDR19;TTC39C;IQCB1;POC1B;FBF1;KIF27
prerank,Reactome_2022__Platelet Degranulation R-HSA-114608,-0.362163450039195,-0.8860100958968532,0.6829268292682927,1.0,1.0,15/104,14.43%,F8;TGFB1;TIMP3;CLU;PLG;THBS1;CD63;VWF;ITGA2B;ITIH3;TUBA4A;F13A1;ITIH4;F5;TGFB3
prerank,Reactome_2022__Signaling By NOTCH R-HSA-157118,0.321861619956793,0.8859986624119269,0.7058823529411765,0.9460522591481484,1.0,53/169,21.88%,HDAC3;HDAC10;RFNG;TLE2;DTX1;MAML1;SEM1;JAG1;ARRB2;H2BC21;ST3GAL3;PSMA1;POFUT1;WWP2;MYC;MOV10;MAMLD1;NUMB;TNRC6C;HDAC1;ARRB1;H2AX;CDK8;HDAC4;FURIN;ST3GAL6;TP53;HDAC11;RUNX1;TNRC6A;WWC1;NOTCH1;PBX1;AGO3;RBPJ;MIB2;ADAM10;SIRT6;EP300;CREB1;KAT2B;H2AJ;CNTN1;HDAC5;AGO2;HIF1A;TBL1X;NBEA;PSMD4;HDAC7;CUL1;JAG2;TFDP1
prerank,GO_Biological_Process_2021__positive regulation of MHC class II biosynthetic process (GO:0045348),0.4964667748286845,0.8857063507121229,0.5833333333333334,0.9463681094684524,1.0,2/7,6.37%,SIRT1;TMEM106A
prerank,GO_Biological_Process_2021__protein-DNA complex subunit organization (GO:0071824),0.5606818044989338,0.8855654569830853,0.6521739130434783,0.9463961251949592,1.0,3/6,19.15%,MYC;SETD2;TCF4
prerank,Reactome_2022__Golgi-to-ER Retrograde Transport R-HSA-8856688,0.31457507082204617,0.8855335704268338,0.6551724137931034,0.9461658284539283,1.0,17/106,21.44%,KIFC1;KIFC2;GALNT1;BICD1;DYNC1I2;STX18;TMED3;KIF6;KIF4B;SEC22B;UBE2Z;KIF21B;KIF3B;KIF21A;KIF16B;KIF27;CAPZA1
prerank,GO_Biological_Process_2021__positive regulation of transcription by RNA polymerase II (GO:0045944),0.256363245028963,0.8854961896062534,1.0,0.9459892724717758,1.0,142/735,17.52%,ERG;FOXO1;SKAP1;HDAC3;MED17;MITF;NFATC3;RORA;RARB;POU3F2;GALR3;KLF10;CDH13;BCL11B;GABPB2;CCN1;AUTS2;ZNF263;RIPK2;PID1;SMARCD3;PPARG;FZD5;TET2;SIRT1;IFI16;MAML1;CREB3L4;PAX3;RORB;ZEB2;SOX12;SSBP3;SERPINE1;JAG1;PKD2;SIRT7;HES1;PTOV1;PROX1;STAT5B;HMGB1;ATF3;DLX1;NCOA3;NCOA2;OSR1;SMARCB1;MED25;PCGF5;ETV1;GREM1;NRIP1;ABL1;WWOX;SP1;RBL1;MYC;ZNF462;FSTL3;BCLAF3;TCF20;NR4A2;LRP6;SENP1;ZSCAN21;WNT3A;TWIST1;HCLS1;TFE3;ATF1;GRIN1;PLAGL1;CTBP2;RNF10;RPS6KA3;NPAS4;NAMPT;RRP1B;SP7;BPTF;CITED4;DPF1;SMARCA2;ZNF300;MLXIPL;SMARCA4;USP16;BCL9L;KAT6A;JUNB;NFIB;FADD;PLSCR1;DPF2;HDAC1;ASCL1;MED16;FOXF2;ARRB1;CDK8;SMAD2;NR2F2;RPS6KA4;RLF;NR3C1;NFKB1;PPARGC1B;NFAT5;ASXL3;WWTR1;TFCP2;THRB;HDAC4;RFX6;NFIC;ETV5;MEN1;HSF1;NR1H3;HJV;TP53;ZNF609;GABPA;RUNX1;ATAD2B;NR4A3;WWC1;ZGLP1;NOTCH1;NCK1;ATM;PBX1;LPIN2;NUFIP1;HIVEP1;GABPB1;BRD4;SKI;FOXJ2;PAX6;IL11
prerank,CellMarker_Augmented_2021__Endothelial cell:Embryoid Body,0.30516775187118983,0.8854797953985273,0.8260869565217391,0.9457300362849014,1.0,8/73,7.93%,ERG;RSPO3;LAMA4;CDH5;MMP2;FAM162B;FGD5;EDNRA
prerank,GO_Biological_Process_2021__protein retention in Golgi apparatus (GO:0045053),0.5572475187913449,0.8854271861567804,0.6727272727272727,0.9455732118962051,1.0,4/5,43.65%,VPS13A;SORL1;VPS13C;VPS13D
prerank,GO_Biological_Process_2021__regulation of neurotransmitter transport (GO:0051588),0.43873946898316735,0.8853381542541447,0.5952380952380952,0.9455089650907635,1.0,1/14,2.99%,SNCAIP
prerank,GO_Biological_Process_2021__glucose homeostasis (GO:0042593),0.35435167899194764,0.8849199108706464,0.6333333333333333,0.9461356683745588,1.0,13/70,12.69%,GCK;FOXO1;IRS1;PPARG;SIRT1;CRY1;CYB5R4;LEPR;ADIPOR1;MCU;MLXIPL;ADIPOR2;ACSM2A
prerank,CellMarker_Augmented_2021__Mesenchymal Progenitor cell:Muscle,0.3348768104121984,0.884904084290492,0.6956521739130435,0.9458475378850214,1.0,24/89,16.21%,FIBIN;TPM2;EDIL3;EMP1;LAMA4;MRGPRF;PARVA;COL12A1;SSC5D;MMP2;SERPINE1;IGFBP4;SNAI2;CRIM1;COL16A1;SYNPO;EFEMP1;LTBP2;CDH11;ANTXR1;PLSCR4;CALD1;COL6A3;CLEC14A
prerank,CellMarker_Augmented_2021__CD4+ T cell:Peripheral Blood,-0.5869112012146942,-0.8849038507586786,0.6851851851851852,1.0,1.0,2/5,27.30%,CD4;SLC2A1
prerank,GO_Biological_Process_2021__regulation of stem cell differentiation (GO:2000736),0.3224228672597852,0.8848952812002864,0.6071428571428571,0.9455498698978241,1.0,7/75,7.57%,SMYD5;CBFB;PSME4;JAG1;HES1;PSMA1;ABL1
prerank,GO_Biological_Process_2021__neuron remodeling (GO:0016322),0.5314449333709047,0.8848862527961566,0.6744186046511628,0.9452572561362973,1.0,2/9,18.97%,FARP2;ADGRB3
prerank,GO_Biological_Process_2021__exogenous drug catabolic process (GO:0042738),0.4904180354051313,0.8848646131997217,0.5869565217391305,0.9449939878282811,1.0,3/12,6.53%,CYP1A2;CYP2U1;CYP2S1
prerank,KEGG_2021_Human__Long-term potentiation,0.3311642465295532,0.8847767222068376,0.6923076923076923,0.9448669047522514,1.0,15/59,21.59%,ITPR2;PLCB1;GRIN1;RPS6KA3;RAP1A;RPS6KA2;RPS6KA6;BRAF;RAPGEF3;PPP1CB;EP300;GRM5;GNAQ;RAF1;GRM1
prerank,GO_Biological_Process_2021__positive regulation of cell division (GO:0051781),-0.4194371515934623,-0.884713240624276,0.6229508196721312,1.0,1.0,6/31,18.65%,KIF14;HTR2B;SVIL;CXCR5;ECT2;CDC6
prerank,GO_Biological_Process_2021__positive regulation of protein kinase C activity (GO:1900020),-0.565856005046708,-0.8845249771424323,0.6595744680851063,1.0,1.0,1/5,2.54%,WNT5A
prerank,GO_Biological_Process_2021__regulation of protein kinase C activity (GO:1900019),-0.565856005046708,-0.8845249771424323,0.6595744680851063,1.0,1.0,1/5,2.54%,WNT5A
prerank,CellMarker_Augmented_2021__PDX1+ Pancreatic Progenitor cell:Embryonic Stem Cell,-0.3656441861313133,-0.8845205379782577,0.7101449275362319,1.0,1.0,14/67,19.93%,PKP2;MISP;GPRIN2;MYO5B;SOWAHB;FOXA3;BAIAP2L1;TOM1L1;TJP3;USH1C;CD24;SCNN1A;SLC44A3;CBLC
prerank,"Reactome_2022__BMAL1:CLOCK,NPAS2 Activates Circadian Gene Expression R-HSA-1368108",0.3960541800658485,0.8844936910328509,0.6666666666666666,0.9451672388727224,1.0,7/26,13.63%,SMARCD3;BMAL2;SERPINE1;NCOA2;NAMPT;CHD9;CARM1
prerank,GO_Biological_Process_2021__negative regulation of cellular process (GO:0048523),0.2745027949566799,0.884342642223876,0.9166666666666666,0.9451858170667411,1.0,58/464,12.09%,ADRA1A;NGF;SMYD2;CCN4;ADAMTS1;NOX4;SMYD5;GMNC;BCL6;BCL2;ANGPT1;CCN2;KLF10;CDH13;DCBLD2;HTRA2;CCN1;FRK;SEMA5A;SIRT1;P3H3;MARCHF5;P3H2;PKD2;SIRT7;MAGI2;FKTN;DACT3;SRGAP2;WNT9A;PROX1;PPP1R13B;ST7L;CDK6;DSCAM;EIF2AK3;PML;SLIT2;MYC;PLXNB1;SIPA1;TENM1;ANP32B;PIWIL1;PBRM1;BRINP1;CTBP2;WNK2;ALDH1A2;ADNP2;F2R;ASTL;DDAH1;NLRP2B;PIM2;PPP1R9B;SMARCA2;SMARCA4
prerank,GO_Biological_Process_2021__negative regulation of toll-like receptor 4 signaling pathway (GO:0034144),-0.5574662577771156,-0.8843099795368697,0.6666666666666666,1.0,1.0,1/6,8.36%,BPIFB1
prerank,GO_Biological_Process_2021__negative regulation of axon extension (GO:0030517),0.35578952701932476,0.884096997980637,0.5405405405405406,0.9454227648755456,1.0,4/29,9.68%,KIAA0319;SEMA6C;SEMA5A;SEMA4A
prerank,GO_Biological_Process_2021__gene silencing by miRNA (GO:0035195),0.3810231021970127,0.883982050474532,0.6129032258064516,0.9453151130050329,1.0,10/30,21.64%,TRIM71;MOV10;TNRC6C;XPO5;TNRC6A;AGO3;TARBP2;AGO2;CNOT6;ADAR
prerank,"Reactome_2022__Antigen Presentation: Folding, Assembly, Peptide Loading Of Class I MHC R-HSA-983170",-0.42863573163651664,-0.8838289185401669,0.6451612903225806,1.0,1.0,9/26,23.17%,HLA-A;ERAP2;ATG14;HLA-F;ERAP1;HSPA5;SEC13;HLA-C;SEC24D
prerank,CellMarker_Augmented_2021__Cancer Stem cell:Mammary Gland,-0.36560139251097545,-0.8838205130439029,0.6666666666666666,1.0,1.0,19/81,18.64%,TGFB1;RIN3;TGFBI;LRP10;SELP;ANXA1;ARAP3;SVIL;PYGL;ITGA5;RRAS;GRN;PARP4;VASP;BMX;MSN;ANPEP;MYL9;TMEM256-PLSCR3
prerank,GO_Biological_Process_2021__ectoderm development (GO:0007398),0.5039993848462694,0.8835573391897745,0.5813953488372093,0.945978645910988,1.0,2/7,14.19%,ZBTB7B;SMURF1
prerank,GO_Biological_Process_2021__nucleobase catabolic process (GO:0046113),0.5464859664437431,0.8835190544541723,0.6739130434782609,0.9457205892228748,1.0,5/7,40.71%,DPYSL2;DPYSL5;DPYS;DPYSL4;CRMP1
prerank,GO_Biological_Process_2021__glycosylceramide biosynthetic process (GO:0046476),0.501268260147063,0.8834927812642139,0.625,0.9454966261880989,1.0,3/7,19.09%,B4GALT3;GAL3ST1;FA2H
prerank,GO_Biological_Process_2021__lipid biosynthetic process (GO:0008610),-0.37584836756950785,-0.8834703667912535,0.6521739130434783,1.0,1.0,8/67,10.54%,LIPI;ACSM6;ALOX5;ACSL5;LIPH;OLAH;CYP21A2;ACSM3
prerank,GO_Biological_Process_2021__Rho protein signal transduction (GO:0007266),-0.40072530851460897,-0.8834671783547315,0.640625,1.0,1.0,10/49,18.94%,C15ORF62;ROPN1B;WAS;ARHGDIG;CFL1;NTN1;PLEKHG7;CELSR1;RTKN;ADGRG1
prerank,GO_Biological_Process_2021__myotube differentiation (GO:0014902),-0.46642035187239117,-0.8834479229507486,0.5892857142857143,1.0,1.0,3/16,21.27%,ERVW-1;JAM2;SIX4
prerank,GO_Biological_Process_2021__positive regulation of cell development (GO:0010720),-0.43541327150294645,-0.8834251149900156,0.6615384615384615,1.0,1.0,6/24,13.43%,GPER1;ATP6AP1;TGM2;LMOD3;LRP2;OPRM1
prerank,GO_Biological_Process_2021__sphingomyelin metabolic process (GO:0006684),0.4844769233698777,0.8833405194989015,0.625,0.9455295968223504,1.0,6/10,27.00%,SMPD4;SMPD3;SAMD8;ABCA2;SMPDL3A;ABCA8
prerank,Reactome_2022__Synthesis Of Ketone Bodies R-HSA-77111,0.5178200171337668,0.8832278088090967,0.5652173913043478,0.945475363114492,1.0,2/7,14.02%,SOAT1;BDH2
prerank,GO_Biological_Process_2021__very long-chain fatty acid metabolic process (GO:0000038),-0.39816177485421933,-0.883178080494201,0.6,1.0,1.0,8/31,14.71%,ELOVL2;ACOX2;TECRL;ACOT4;ACOT1;CYP4F12;ACOT2;HACD4
prerank,GO_Biological_Process_2021__regulation of histone phosphorylation (GO:0033127),0.5015865623153688,0.8828731722582163,0.6538461538461539,0.9460893511592715,1.0,2/9,13.88%,TWIST1;RPS6KA4
prerank,GO_Biological_Process_2021__negative regulation of Wnt signaling pathway (GO:0030178),-0.32876781633236124,-0.8825294583506977,0.7236842105263158,1.0,1.0,13/162,11.14%,NOTUM;PSMB9;WNT5A;SHISA6;HIC1;DAB2;SOX30;LATS2;RNF213;SFRP4;ALPK2;DRAXIN;LRP4
prerank,GO_Biological_Process_2021__vesicle transport along actin filament (GO:0030050),-0.44526875085229456,-0.8825067771862954,0.5901639344262295,1.0,1.0,4/17,20.29%,MYO1F;MYO5B;MYO15A;MYO7B
prerank,GO_Biological_Process_2021__regulation of vascular wound healing (GO:0061043),-0.5852748856199498,-0.8825049607463672,0.6153846153846154,1.0,1.0,1/5,4.10%,ALOX5
prerank,GO_Biological_Process_2021__RNA phosphodiester bond hydrolysis (GO:0090501),0.40292879988046143,0.8824995663140456,0.6222222222222222,0.9468336318055304,1.0,3/23,9.53%,PCF11;POP1;ERN1
prerank,Reactome_2022__Regulation Of Gene Expression By Hypoxia-inducible Factor R-HSA-1234158,0.5320779528435113,0.8823481909833527,0.6470588235294118,0.9468370945769131,1.0,4/9,20.51%,HIF3A;MIA3;EP300;HIF1A
prerank,Reactome_2022__Signaling By Interleukins R-HSA-449147,0.28094460841322993,0.8820696050144587,0.9166666666666666,0.9471307892632068,1.0,61/346,15.98%,IL7R;FOXO1;DUSP4;MAPKAPK2;BCL6;BCL2;RORA;IRS1;RIPK2;KCNH8;IL16;MMP2;PSME4;SEM1;LMNB1;HNRNPF;IL13RA2;STAT5B;CRK;HMGB1;PTPRZ1;TIMP1;RAPGEF1;OPRD1;PSMA1;MAPK8;CASP3;MYC;RALA;ZEB1;ALPK1;PTPN9;TWIST1;PKN2;RPS6KA3;IRS2;N4BP1;LGALS9;PPP2R1B;PTPN20;TXLNA;SMARCA4;TANK;NKIRAS2;TAB3;IL10RA;PELI1;NFKB1;RPS6KA2;PTPN23;PELI2;IL20RB;PIK3CA;IRAK4;FSCN1;TP53;LBP;IL23A;IL2RB;CRKL;S1PR1
prerank,GO_Biological_Process_2021__positive regulation of T cell proliferation (GO:0042102),0.34267453199516257,0.8820607898031354,0.7272727272727273,0.9468633560944452,1.0,4/45,8.86%,PNP;CCDC88B;HMGB1;ICOSLG
prerank,GO_Biological_Process_2021__positive regulation of macrophage cytokine production (GO:0060907),-0.5409277804561563,-0.8820064018303773,0.6481481481481481,1.0,1.0,1/7,2.54%,WNT5A
prerank,GO_Biological_Process_2021__N-acetylglucosamine metabolic process (GO:0006044),0.395054119516865,0.8817691417721657,0.6923076923076923,0.9472438664901474,1.0,3/15,10.94%,CHST6;NAGK;CHST3
prerank,GO_Biological_Process_2021__regulated exocytosis (GO:0045055),-0.3439583732995492,-0.881701217898223,0.6470588235294118,1.0,1.0,26/153,14.91%,F8;TGFB1;TIMP3;BLK;SYT10;SYT2;PSAP;SELP;CLU;PLG;CFD;THBS1;CD63;VWF;ITGA2B;SCIN;ITIH3;TUBA4A;F13A1;TMEM79;ITIH4;A2M;F5;TTN;TGFB3;ABCA12
prerank,Reactome_2022__Striated Muscle Contraction R-HSA-390522,-0.44086933099949577,-0.8816773973609829,0.6323529411764706,1.0,1.0,5/22,8.67%,MYH8;TMOD4;MYBPC3;NEB;ACTN3
prerank,CellMarker_Augmented_2021__Plasma cell:Undefined,0.49331984072649115,0.8816223392473547,0.6,0.9472858526721709,1.0,1/9,0.51%,CD38
prerank,GO_Biological_Process_2021__nuclear-transcribed mRNA catabolic process (GO:0000956),-0.3405302130974057,-0.8816012539412165,0.7307692307692307,1.0,1.0,58/160,27.27%,RPL37A;RPL38;RPL15;RPS4X;RPL3;RPL35A;RPS9;RPS27;RPS21;RPL13A;RPL27A;RPS16;RPL36;RPS20;RPL7A;ZFP36L1;RPL9;RPL13;RPS8;RPS27A;RPL21;EXOSC8;RPL34;RPL4;RPL32;RPL5;RPL23;RPL41;RPS7;RPS11;RPL27;RPL35;RPS14;RPL11;RPS15;RPLP1;PNLDC1;RPS12;RPL24;RPL18A;RPS13;RPL29;RPLP2;RPL28;RPL12;RPL18;RPS3;RPL22;RPSA;RPS28;CNOT11;RPS19;RPS24;RPS3A;RPL19;RPL8;RPS6;RPL10
prerank,GO_Biological_Process_2021__amyloid precursor protein metabolic process (GO:0042982),0.42817814807029986,0.8815863509467514,0.6571428571428571,0.9470814313388661,1.0,3/16,18.66%,APOE;ACHE;ADAM10
prerank,GO_Biological_Process_2021__negative regulation of immune effector process (GO:0002698),0.42780831769752925,0.8815496732740039,0.6046511627906976,0.9468868008331743,1.0,4/12,21.96%,FER;LGALS3;RC3H1;CD55
prerank,GO_Biological_Process_2021__collecting duct development (GO:0072044),0.5708297671468563,0.8815110225516154,0.6808510638297872,0.946391737637587,1.0,4/5,30.26%,PTCH1;BMP4;SHH;PKD1
prerank,GO_Biological_Process_2021__metanephric collecting duct development (GO:0072205),0.5708297671468563,0.8815110225516154,0.6808510638297872,0.946391737637587,1.0,4/5,30.26%,PTCH1;BMP4;SHH;PKD1
prerank,GO_Biological_Process_2021__positive regulation of potassium ion transmembrane transporter activity (GO:1901018),0.49904677737926495,0.8814734469175878,0.5833333333333334,0.9461637445361979,1.0,3/10,22.98%,AKAP9;ANK2;GAL
prerank,Reactome_2022__Signaling By FGFR4 R-HSA-5654743,-0.4092485730025517,-0.8814614968086214,0.676056338028169,1.0,1.0,1/35,0.93%,FGF20
prerank,GO_Biological_Process_2021__negative regulation of cell motility (GO:2000146),0.34254268830750756,0.8814022803655267,0.5833333333333334,0.9460564784664617,1.0,27/90,22.47%,MITF;SERPINE1;JAG1;MAGI2;SRGAP2;CRK;SLIT2;RAP2A;NAV3;KANK1;DACH1;FRMD5;ARID2;NF1;ADAM15;PTPRT;TMEFF2;DLG5;CCDC125;MIA3;RECK;VCL;SRGAP2B;PTPRJ;PTEN;SMAD7;SCAI
prerank,"GO_Biological_Process_2021__regulation of CD4-positive, alpha-beta T cell activation (GO:2000514)",0.506960090338715,0.8812643199238854,0.6666666666666666,0.9460987525907186,1.0,3/7,11.12%,SH3RF1;HLA-DRA;TWSG1
prerank,Reactome_2022__Negative Regulation Of NOTCH4 Signaling R-HSA-9604323,-0.38534412294624404,-0.8812534494242076,0.647887323943662,1.0,1.0,20/48,31.83%,PSMB9;RBX1;PSMA3;RPS27A;PSMA7;PSMB6;PSMA5;PSMD6;SKP1;PSMC5;PSMB4;PSMB7;PSMD8;PSMD3;TACC3;UBB;PSMC1;PSMD7;PSME3;UBC
prerank,GO_Biological_Process_2021__mitophagy (GO:0000423),-0.5189859017857912,-0.8810965545484765,0.559322033898305,1.0,1.0,1/8,13.40%,ATG14
prerank,CellMarker_Augmented_2021__Microglial cell:Embryonic Prefrontal Cortex,-0.32112535837313383,-0.8807497512469901,0.7954545454545454,1.0,1.0,73/410,18.95%,CRYBB1;C1QB;GMFG;ITGB2;HCK;P2RY12;DOCK8;ARHGAP9;TAGAP;BEX1;SLC7A7;PLD4;CCND1;B3GNT5;SP100;ALOX5;TNFRSF1B;CPVL;DOCK2;PTAFR;SLCO2B1;C3AR1;DAB2;GPR183;PARVG;FCGR3A;SYNE2;INPP5D;WAS;LY86;LPAR6;VSIG4;CD37;RNF213;PSAP;ABCG2;MYO1F;IGSF6;PPT1;CYBA;ARHGAP12;PTPRC;FPR1;CD63;ITGAM;OAS1;CXCL16;HVCN1;BLNK;A2M;LCP1;ITM2C;IKZF1;ADAM28;CD4;GRN;PNMA1;NAIP;CD24;EGR3;ZFP36L1;POLD4;MSN;TBXAS1;ALOX5AP;SERPINF1;EGR2;DNAJB1;LAT2;CSF1R;CD81;SASH3;AXL
prerank,KEGG_2021_Human__Cytosolic DNA-sensing pathway,-0.3891016927294828,-0.8807394285411383,0.5970149253731343,1.0,1.0,4/37,15.16%,AIM2;POLR1C;POLR3H;IL18
prerank,GO_Biological_Process_2021__regulation of protein localization to cell periphery (GO:1904375),-0.4687119741583165,-0.8807129038273603,0.6619718309859155,1.0,1.0,2/18,10.00%,MISP;GBP1
prerank,CellMarker_Augmented_2021__Macrophage:Lung,-0.5065398484736284,-0.8806857812987611,0.7096774193548387,1.0,1.0,5/11,20.41%,FCGR3A;ITGAM;CD80;ITGAX;CD86
prerank,Reactome_2022__Acetylcholine Regulates Insulin Secretion R-HSA-399997,0.4713417927387016,0.880597473796471,0.6,0.9474376046639915,1.0,6/10,27.09%,PLCB1;GNAQ;GNA11;CHRM3;PLCB3;GNA14
prerank,Reactome_2022__Signaling By NODAL R-HSA-1181150,-0.4596748489253639,-0.8805660415974149,0.6615384615384615,1.0,1.0,1/18,1.82%,NODAL
prerank,GO_Biological_Process_2021__regulation of anoikis (GO:2000209),0.4048711834250886,0.8804269234616897,0.625,0.9475516848704205,1.0,4/18,16.67%,BCL2;SNAI2;PIK3CA;NOTCH1
prerank,GO_Biological_Process_2021__negative regulation of protein phosphorylation (GO:0001933),0.3044676497284502,0.880359839941603,0.6956521739130435,0.9473863062045067,1.0,44/140,22.14%,RASSF2;SAMSN1;SPRED3;HSPB1;PARD3;PID1;CEP85;SNCA;DEPTOR;GREM1;SLIT2;TRIB2;LRP6;SPRED2;TWIST1;SPRED1;NLRP2B;MLXIPL;UBASH3B;PPP1R15B;NF1;WWTR1;MEN1;CRKL;DNAJC3;EPHB2;NCK1;PMEPA1;DUSP19;TAB1;IMPACT;TARBP2;PRKAG2;PAK2;GNAQ;PLPP3;EMILIN1;OCLN;DMD;NIBAN1;PDE4D;NCK2;PTEN;SMAD7
prerank,GO_Biological_Process_2021__regulation of cytosolic calcium ion concentration (GO:0051480),-0.3525535213753564,-0.8802567892182808,0.6533333333333333,1.0,1.0,28/111,17.21%,CHRNA9;C1QTNF1;NMUR2;XCR1;WNT5A;CAV3;CXCL13;LPAR1;ESR1;TAC4;ACKR4;GPER1;C3AR1;TRPC7;FPR1;CAV2;PTGDR;CALB2;FPR3;CXCR5;PTGER3;ITPR3;ACKR2;F2RL1;SMAD3;GHRL;PLN;CD24
prerank,"GO_Biological_Process_2021__nucleotide-excision repair, DNA incision (GO:0033683)",-0.4065917051803814,-0.880174350725478,0.6470588235294118,1.0,1.0,7/36,23.78%,RPA3;RBX1;POLD4;RPS27A;OGG1;RPA2;DDB1
prerank,"Reactome_2022__Base-Excision Repair, AP Site Formation R-HSA-73929",-0.42297859592485637,-0.8799212887608848,0.6338028169014085,1.0,1.0,5/25,19.05%,TERF2IP;H2BC4;H2AZ1;SMUG1;OGG1
prerank,GO_Biological_Process_2021__regulation of gene expression (GO:0010468),0.2659358960182589,0.8797383308462653,1.0,0.9485500953061504,1.0,138/857,14.76%,TEAD2;NGF;POU3F1;ESRRG;RAB27A;CCN4;MLF1;FGF10;TSKU;TGFBR1;POU6F2;ZNF804A;PC;BTN3A2;ZNF195;OR7D2;ZNF117;BCL6;ZNF212;NOVA1;EPHX2;MAFB;MITF;ZFPL1;RORA;APOE;HDAC10;ANGPT1;CDH5;ZBTB7B;SLC39A8;PCGF1;PRDM5;APBB3;ZNF263;PID1;SLC8A1;ATXN1;WNT4;FGF17;CIAO3;SIRT1;IFI16;DNMT1;TULP3;RBM20;RORB;SOX12;GPBP1L1;HNRNPF;UBAP2;PROX1;ZBTB4;TRIM71;NCOA2;OSR1;HP1BP3;ZNF703;ZNF274;OPRD1;SPIN2B;CDK6;EIF2AK3;CDK4;PML;ABL1;POFUT1;SP1;RBL1;MAPK8;WWP2;MYC;NKAP;ZNF462;HNRNPH1;ESRP1;ZNF33A;FGF18;FOXN3;KHSRP;ZSCAN21;ICOSLG;FEZF2;WNT3A;PCBP3;TWIST1;SNAI2;HCLS1;MOV10;FADS1;ZNF2;TESMIN;HNRNPL;ZNF331;CREM;ZNF519;ADNP2;RRP1B;AMH;RBMS3;MSC;RIMS2;LGALS9;TRIM44;FASTK;HES6;TNRC6C;USP36;NSD1;DMTF1;LIMS1;SMARCA2;TOB2;MLXIPL;TICAM1;HSPA1A;EFEMP1;RNF207;PLSCR1;HDAC1;ASCL1;TESC;RYBP;CDK11A;CARM1;RPS6KA4;NFYC;NR3C1;NFKB1;PPARGC1B;ASCC2;GPX1;WWTR1;SCRT1;TRIM4;MECP2;ANK2;HDAC4
prerank,GO_Biological_Process_2021__regulation of DNA binding (GO:0051101),0.37950528720141896,0.8796639462721452,0.5757575757575758,0.9484230129439725,1.0,7/38,7.84%,NGF;PPARG;IFI16;PYHIN1;HES1;HMGB1;MAPK8
prerank,GO_Biological_Process_2021__regulation of B cell receptor signaling pathway (GO:0050855),-0.452673678767858,-0.8795681093251828,0.6333333333333333,1.0,1.0,6/18,20.09%,BLK;NFAM1;PRKCH;GPS2;CD81;PAX5
prerank,Reactome_2022__Integration Of Energy Metabolism R-HSA-163685,0.30971848309166133,0.8794315526151784,0.8,0.9486376886004888,1.0,28/92,25.33%,ITPR2;KCNC2;ACACB;PLCB1;ADCY2;ABCC8;PRKAR2A;ADIPOR1;PPP2R1B;MLXIPL;ADIPOR2;RAP1A;PPP2R5D;GNG7;ADCY6;RAPGEF3;PRKAA2;PRKAG2;GNAQ;GNAI2;GNAS;GNA11;RAPGEF4;CACNA1A;ACACA;PRKACB;CHRM3;PLCB3
prerank,GO_Biological_Process_2021__DNA modification (GO:0006304),-0.4409546362142509,-0.8793201301627632,0.6857142857142857,1.0,1.0,3/21,19.05%,TERF2IP;SMUG1;OGG1
prerank,GO_Biological_Process_2021__xenobiotic transport across blood-brain barrier (GO:1990962),-0.5849193508138583,-0.8791471530986064,0.6470588235294118,1.0,1.0,4/6,24.67%,ABCG2;ABCB1;SLC22A1;ABCC2
prerank,GO_Biological_Process_2021__P-body assembly (GO:0033962),0.48007082546304336,0.8790938488682181,0.7222222222222222,0.9489965500344548,1.0,5/12,32.02%,PATL1;RC3H1;LSM14A;ATXN2;LIMD1
prerank,GO_Biological_Process_2021__negative regulation of transcription from RNA polymerase II promoter in response to stress (GO:0097201),0.4404567638263294,0.8788024735970421,0.625,0.9492782327949725,1.0,3/10,18.47%,HSPA1A;NCK1;IMPACT
prerank,GO_Biological_Process_2021__protein localization to cell periphery (GO:1990778),0.31588750937135407,0.8787347464833626,0.85,0.9491078104765623,1.0,39/127,21.42%,MRAP2;KCNB2;SPTBN4;BSG;TMEM150A;KCNIP3;PDZD11;FLNA;RAP2A;LRP6;TNIK;DPP10;KCNIP4;TSPAN17;EHD4;RAB3C;RAP1A;TESC;RAB10;SMURF1;NKD2;ANK2;DPP6;WNK3;ARL3;ZDHHC3;TTC7B;RAB3D;EFR3B;MYO5A;SLMAP;RAB40A;PTCH1;PACS1;WDR19;LIN7A;JUP;ZDHHC23;DLG1
prerank,GO_Biological_Process_2021__negative regulation of cellular response to vascular endothelial growth factor stimulus (GO:1902548),-0.5203422268537576,-0.8783770144367579,0.6923076923076923,1.0,1.0,3/10,14.26%,DCN;PIK3CB;IL12A
prerank,GO_Biological_Process_2021__response to testosterone (GO:0033574),-0.5785889066709528,-0.8783078614594121,0.6909090909090909,1.0,1.0,2/5,21.60%,MSN;AR
prerank,GO_Biological_Process_2021__cellular response to testosterone stimulus (GO:0071394),-0.5785889066709528,-0.8783078614594121,0.6909090909090909,1.0,1.0,2/5,21.60%,MSN;AR
prerank,GO_Biological_Process_2021__pre-mRNA cleavage required for polyadenylation (GO:0098789),0.4668126111452425,0.8783031066993293,0.5853658536585366,0.9498122184507974,1.0,1/12,1.41%,CPSF1
prerank,GO_Biological_Process_2021__regulation of cholesterol metabolic process (GO:0090181),0.4108902915750233,0.8782876641591446,0.6,0.9495456418119612,1.0,3/20,7.37%,EPHX2;APOE;SEC14L2
prerank,CellMarker_Augmented_2021__CD1C-CD141- Dendritic cell:Blood,-0.3335043427106196,-0.8782196200576465,0.7261904761904762,1.0,1.0,53/260,18.96%,RASGRP4;HCK;CYTIP;SLC7A7;SCIMP;ALOX5;IRF1;TNFRSF1B;C3AR1;CABP4;MS4A4A;FCGR3A;IFIT3;NFAM1;SOD2;PSAP;HEG1;FAM110A;SH3BP2;CFD;CKB;GBP1;PTPRC;FPR1;SLC11A1;SVIL;FTH1;PYGL;ARL4A;CLEC12A;DNASE2;WARS1;OAS1;CXCL16;KLF3;TLR2;CD300LF;SYTL1;SH2D1B;APOL6;IFNGR2;TXNIP;HK3;ERICH1;VASP;SCPEP1;MSN;TBXAS1;IFIT2;DNAJB1;CSF1R;RNF144B;P2RX1
prerank,GO_Biological_Process_2021__embryonic heart tube development (GO:0035050),0.5113524426676138,0.878216087847456,0.6590909090909091,0.9493993131407855,1.0,2/9,18.70%,HES1;ACVR1
prerank,GO_Biological_Process_2021__negative regulation of neuron migration (GO:2001223),0.5835350285867158,0.8781714586395472,0.6956521739130435,0.9491858569562565,1.0,3/5,22.41%,SRGAP2;NEXMIF;TNN
prerank,GO_Biological_Process_2021__positive regulation of mitochondrion organization (GO:0010822),-0.36219242980801886,-0.8781245112668614,0.7213114754098361,1.0,1.0,7/52,13.03%,MMP9;CIDEB;GPER1;PINK1;DCN;BIK;MOAP1
prerank,GO_Biological_Process_2021__organic hydroxy compound biosynthetic process (GO:1901617),0.3720392445559901,0.8781133389837054,0.6521739130434783,0.9490013376777927,1.0,8/45,8.63%,PER2;CYP7B1;OSBPL3;OSBPL6;PSAT1;AKR1C3;SLC27A2;OSBPL7
prerank,GO_Biological_Process_2021__brain morphogenesis (GO:0048854),0.4127173074569451,0.8778483991573608,0.5897435897435898,0.949349564832789,1.0,4/12,22.35%,SPEF2;CTNNA2;PTEN;VPS51
prerank,GO_Biological_Process_2021__monocyte chemotaxis (GO:0002548),-0.4975507618601739,-0.8775806499683255,0.5892857142857143,1.0,1.0,2/12,8.67%,MSMP;ANXA1
prerank,CellMarker_Augmented_2021__4-Cell Stage Cell (Blastomere):Embryo,-0.41185255153494216,-0.8774426131228871,0.625,1.0,1.0,5/31,13.65%,NLRP11;TRAF3IP2;ARG2;CDCA7L;CRYBG1
prerank,GO_Biological_Process_2021__positive regulation of oligodendrocyte differentiation (GO:0048714),-0.554637608288912,-0.8774289686650516,0.6779661016949152,1.0,1.0,1/6,4.89%,TNFRSF1B
prerank,GO_Biological_Process_2021__negative regulation of protein K63-linked ubiquitination (GO:1900045),-0.5447098779199793,-0.8773398238266056,0.6515151515151515,1.0,1.0,3/7,21.48%,GPS2;OTUB1;PARP10
prerank,GO_Biological_Process_2021__inclusion body assembly (GO:0070841),-0.5545835865866329,-0.8772818121768116,0.6376811594202898,1.0,1.0,2/5,30.48%,HDAC6;BAG3
prerank,GO_Biological_Process_2021__regulation of response to cytokine stimulus (GO:0060759),-0.45352329470694364,-0.8772152428895301,0.6,1.0,1.0,1/17,2.54%,WNT5A
prerank,CellMarker_Augmented_2021__Leydig Precursor cell:Fetal Gonad,0.29831354381954117,0.8770698899473942,0.5882352941176471,0.9506665450544236,1.0,37/199,11.24%,LHFPL2;BCHE;TPM2;ADAMTS1;TSHZ2;NLGN1;ITGA11;ARX;GOLIM4;SEMA5A;MMP2;IFI16;NEGR1;GSTM5;CHSY1;RNF24;OSR1;CCND3;CFH;PCDH9;EDNRA;IGFBP4;FSTL5;SYT1;HIF3A;LRRN3;SNAI2;GSTM2;COLEC11;PLAGL1;RND3;LRRC17;CERCAM;FLRT2;RBMS3;MSC;RIMS2
prerank,Reactome_2022__Negative Regulators Of DDX58/IFIH1 Signaling R-HSA-936440,-0.38926130925901486,-0.8768337818998133,0.6551724137931034,1.0,1.0,2/31,6.02%,UBE2L6;TRIM25
prerank,Reactome_2022__Cleavage Of Damaged Pyrimidine R-HSA-110329,-0.4230019702359515,-0.8766172038650069,0.6111111111111112,1.0,1.0,5/24,19.05%,TERF2IP;H2BC4;H2AZ1;SMUG1;OGG1
prerank,KEGG_2021_Human__TNF signaling pathway,0.3209700587245207,0.8766100877735113,0.5714285714285714,0.9514120314085809,1.0,22/89,20.53%,VEGFC;CFLAR;MAP3K14;CREB3L2;CREB3L4;JAG1;MAPK8;CASP3;AKT2;JUNB;FADD;TAB3;RPS6KA4;NFKB1;PIK3CA;MAPK12;MAP2K7;TAB1;CREB1;TAB2;MAP2K6;FOS
prerank,GO_Biological_Process_2021__regulation of cell-substrate adhesion (GO:0010810),-0.39397533754670255,-0.8765590796305402,0.7272727272727273,1.0,1.0,8/40,17.19%,ECM2;ALOX15;PLG;VIT;PIK3CB;FBLN2;RAC2;RAC1
prerank,GO_Biological_Process_2021__negative regulation of secretion (GO:0051048),0.4416682790527421,0.8764314530622179,0.6521739130434783,0.9514859026194435,1.0,4/10,24.06%,NRG1;NR1H3;VAMP8;ERBB3
prerank,Reactome_2022__Negative Regulation Of TCF-dependent Signaling By WNT Ligand Antagonists R-HSA-3772470,0.4209527629752242,0.8764154988171524,0.5777777777777777,0.9512626037079285,1.0,4/12,8.91%,WNT4;WNT9A;LRP6;WNT3A
prerank,GO_Biological_Process_2021__calcium-ion regulated exocytosis (GO:0017156),0.40132127367862896,0.8763854471196301,0.6578947368421053,0.9510442385679352,1.0,8/24,14.25%,DOC2B;SDF4;SYT3;SYT17;SYT1;SYT12;RIMS2;SYT6
prerank,GO_Biological_Process_2021__protein localization to plasma membrane (GO:0072659),0.3104701595165693,0.8763392590721807,0.7391304347826086,0.9508547486373261,1.0,34/123,19.26%,MRAP2;KCNB2;SPTBN4;BSG;TMEM150A;KCNIP3;FLNA;RAP2A;LRP6;TNIK;DPP10;KCNIP4;TSPAN17;EHD4;RAB3C;RAP1A;CCDC88A;TESC;NECTIN3;RAB10;SMURF1;NKD2;ANK2;DPP6;WNK3;ZDHHC3;TTC7B;RAB3D;EFR3B;MYO5A;SLMAP;RAB40A;PTCH1;PACS1
prerank,Reactome_2022__Signaling By FGFR3 R-HSA-5654741,-0.41521502957475,-0.8762250325484009,0.6571428571428571,1.0,1.0,1/35,0.93%,FGF20
prerank,Reactome_2022__Reversal Of Alkylation Damage By DNA Dioxygenases R-HSA-73943,0.5303621325849204,0.8761997005446549,0.65625,0.9508568880844567,1.0,4/7,32.49%,ASCC2;ALKBH3;ASCC3;FTO
prerank,Reactome_2022__GSK3B And BTRC:CUL1-mediated-degradation Of NFE2L2 R-HSA-9762114,-0.38217889144482936,-0.8758801723388464,0.6428571428571429,1.0,1.0,19/46,31.83%,PSMB9;RBX1;PSMA3;RPS27A;PSMA7;PSMB6;PSMA5;PSMD6;SKP1;PSMC5;PSMB4;PSMB7;PSMD8;PSMD3;UBB;PSMC1;PSMD7;PSME3;UBC
prerank,GO_Biological_Process_2021__pyrimidine nucleobase metabolic process (GO:0006206),0.45430021334843557,0.8755477445425515,0.6222222222222222,0.9521656508539345,1.0,7/12,35.79%,CTPS2;CDA;DPYSL2;DPYSL5;DPYS;ALDH6A1;DPYSL4
prerank,GO_Biological_Process_2021__phagosome-lysosome fusion (GO:0090385),-0.5174537202328906,-0.8752505217620535,0.6333333333333333,1.0,1.0,1/10,1.55%,RAB34
prerank,GO_Biological_Process_2021__regulation of transcription initiation from RNA polymerase II promoter (GO:0060260),0.3303807887930802,0.8752062327003244,0.7,0.9526027719918464,1.0,14/59,17.12%,MED17;CBFB;MED25;CDK4;MOV10;TNRC6C;MED16;CDK8;NFKB1;MECP2;TP53;TNRC6A;ATF7IP;AGO3
prerank,GO_Biological_Process_2021__regulation of endoplasmic reticulum tubular network organization (GO:1903371),-0.5769957029310012,-0.8752047161024382,0.6851851851851852,1.0,1.0,2/5,40.04%,TMEM33;RAB3GAP2
prerank,GO_Biological_Process_2021__negative regulation of DNA binding (GO:0043392),0.3810927852304832,0.8751277063476078,0.5952380952380952,0.9524704234531717,1.0,2/24,4.79%,PER2;IFI16
prerank,GO_Biological_Process_2021__negative regulation of cell population proliferation (GO:0008285),0.2812873645568174,0.8750162289816682,0.8333333333333334,0.95242422798851,1.0,30/303,10.74%,ADRA1A;NGF;SMYD2;PER2;ADAMTS1;NOX4;KLF10;CDH13;FRK;PPARG;P3H3;P3H2;PKD2;HES1;MAGI2;FKTN;WNT9A;PROX1;MED25;GREM1;CDK6;PML;MYC;PLXNB1;TENM1;PBRM1;CTBP2;WNK2;ALDH1A2;F2R
prerank,KEGG_2021_Human__Viral carcinogenesis,0.310243749233824,0.8749906724524898,0.7727272727272727,0.9521916399155396,1.0,15/158,7.93%,ATP6V0D2;HDAC3;MAPKAPK2;SCRIB;HDAC10;CREB3L2;CREB3L4;STAT5B;H2BC21;RASA2;CDK6;CDK4;CCND3;RBL1;CASP3
prerank,GO_Biological_Process_2021__glycoprotein biosynthetic process (GO:0009101),-0.34766130229902065,-0.8746836854426001,0.6388888888888888,1.0,1.0,11/71,17.62%,ST6GALNAC1;CHST9;B3GNT5;FUT2;B3GNT9;ST6GALNAC2;GALNTL5;GCNT1;ALG1L2;CHST10;B3GALT6
prerank,CellMarker_Augmented_2021__Embryonic Stem cell:Undefined,0.46185669932645756,0.8746283779433394,0.6052631578947368,0.9527428789779904,1.0,1/16,1.53%,KIT
prerank,Reactome_2022__TGF-beta Receptor Signaling In EMT (Epithelial To Mesenchymal Transition) R-HSA-2173791,0.3960155579348708,0.8745178612447722,0.5277777777777778,0.95269186376883,1.0,2/15,3.01%,TGFBR1;PARD3
prerank,Reactome_2022__Cytochrome C-Mediated Apoptotic Response R-HSA-111461,-0.47825043628297903,-0.8744275015258661,0.6,1.0,1.0,4/12,20.40%,UACA;CASP7;CARD8;APIP
prerank,GO_Biological_Process_2021__negative regulation of glycogen biosynthetic process (GO:0045719),0.5375171079513881,0.8744060188420932,0.627906976744186,0.9522700761260087,1.0,2/6,36.83%,ENPP1;GSK3B
prerank,GO_Biological_Process_2021__negative regulation of glycogen metabolic process (GO:0070874),0.5375171079513881,0.8744060188420932,0.627906976744186,0.9522700761260087,1.0,2/6,36.83%,ENPP1;GSK3B
prerank,GO_Biological_Process_2021__positive regulation of erythrocyte differentiation (GO:0045648),0.3751564458044701,0.8743788375904988,0.59375,0.9520140460240207,1.0,12/24,27.93%,RHEX;STAT5B;HSPA1A;ANKRD54;ABCB10;ACVR2A;HIF1A;ACVR1B;ZNF16;FOXO3;ETS1;STAT3
prerank,GO_Biological_Process_2021__regulation of smooth muscle contraction (GO:0006940),0.4463722820303231,0.8743248699466385,0.6578947368421053,0.9518774519316592,1.0,5/17,10.74%,CHRM2;KCNB2;CNN1;NMU;F2R
prerank,Reactome_2022__Constitutive Signaling By Overexpressed ERBB2 R-HSA-9634285,0.48141084828741465,0.8741173785886098,0.6052631578947368,0.9519698755565037,1.0,3/10,24.19%,ERBB2;SOS1;PTPN12
prerank,GO_Biological_Process_2021__tRNA transcription by RNA polymerase III (GO:0042797),0.5119791063040431,0.8739054741864221,0.6888888888888889,0.9521432940359116,1.0,2/7,17.07%,GTF3C4;GTF3C5
prerank,GO_Biological_Process_2021__regulation of extrinsic apoptotic signaling pathway (GO:2001236),0.31133861756105424,0.8735497035935781,0.7333333333333333,0.9526025829840687,1.0,7/57,7.59%,TGFBR1;CFLAR;FGFR1;SH3RF1;DEPTOR;PML;WWOX
prerank,Reactome_2022__Formation Of Cornified Envelope R-HSA-6809371,0.380316523665081,0.873501237855433,0.7142857142857143,0.9524040326563878,1.0,5/27,9.22%,CSTA;KLK14;PERP;LORICRIN;LIPJ
prerank,Reactome_2022__Axonal Growth Inhibition (RHOA Activation) R-HSA-193634,-0.5103252217834546,-0.8732301396745864,0.6229508196721312,1.0,1.0,2/7,21.82%,OMG;MAG
prerank,GO_Biological_Process_2021__positive regulation of Rho protein signal transduction (GO:0035025),-0.428037375536844,-0.8731223333841571,0.6461538461538462,1.0,1.0,8/25,22.21%,LPAR1;LPAR6;AKAP13;F2RL1;RAC1;ADGRG1;GPR18;SYNPO2L
prerank,GO_Biological_Process_2021__regulation of extrinsic apoptotic signaling pathway via death domain receptors (GO:1902041),-0.4220234073601933,-0.8731000238163201,0.6323529411764706,1.0,1.0,6/32,14.99%,TMC8;SP100;BRCA1;THBS1;TNFRSF10A;DDX3X
prerank,Reactome_2022__PTEN Regulation R-HSA-6807070,0.29927826438087074,0.8729000594092164,0.9,0.9535107569087282,1.0,26/128,17.12%,HDAC3;PHC2;GATAD2A;FRK;PPARG;PSME4;SEM1;PSMA1;PML;WWP2;MLST8;SNAI2;MOV10;AKT2;TNRC6C;SCMH1;HDAC1;GATAD2B;CHD4;RNF146;OTUD3;TP53;TNRC6A;NEDD4;ATN1;AGO3
prerank,Reactome_2022__Signaling By WNT R-HSA-195721,0.28458194194026,0.8727634301628004,0.7857142857142857,0.9535215630529963,1.0,36/247,14.61%,LGR5;RSPO3;PRICKLE1;ITPR2;SCRIB;RORA;TLE2;WNT4;PSME4;SEM1;CXXC4;ARRB2;WNT9A;H2BC21;NCOA3;PSMA1;PLCB1;RSPO2;FZD1;MYC;LRP6;WNT3A;MOV10;AKT2;CTBP2;PPP2R1B;TNRC6C;SMARCA4;BCL9L;HDAC1;RNF146;H2AX;WLS;GNAO1;SMURF1;RYK
prerank,GO_Biological_Process_2021__peptidyl-S-diacylglycerol-L-cysteine biosynthetic process from peptidyl-cysteine (GO:0018231),0.4046637182270786,0.8726891365884352,0.6052631578947368,0.9530577602518117,1.0,10/23,20.96%,ZDHHC11B;ZDHHC18;ZDHHC12;GOLGA7B;ZDHHC14;ZDHHC3;CLIP3;ZDHHC9;ZDHHC11;ZDHHC23
prerank,GO_Biological_Process_2021__peptidyl-L-cysteine S-palmitoylation (GO:0018230),0.4046637182270786,0.8726891365884352,0.6052631578947368,0.9530577602518117,1.0,10/23,20.96%,ZDHHC11B;ZDHHC18;ZDHHC12;GOLGA7B;ZDHHC14;ZDHHC3;CLIP3;ZDHHC9;ZDHHC11;ZDHHC23
prerank,GO_Biological_Process_2021__regulation of protein binding (GO:0043393),-0.3399018108722163,-0.8726781223973332,0.6521739130434783,1.0,1.0,13/105,14.41%,DISC1;LRPAP1;TMC8;VTN;DAB2;CLDN5;ZFPM1;TERT;CTSZ;CDKN1A;IFIT1;MITD1;EFHB
prerank,GO_Biological_Process_2021__positive regulation of defense response to bacterium (GO:1900426),-0.5740343060864124,-0.8725816208872215,0.711864406779661,1.0,1.0,3/5,15.82%,PGC;CYBA;GRN
prerank,GO_Biological_Process_2021__regulation of intracellular pH (GO:0051453),0.3839389578812217,0.8724355867398139,0.6875,0.9532637476280158,1.0,6/33,15.67%,SLC26A3;SLC4A7;GPR89A;SLC9C2;CA2;GPR89B
prerank,GO_Biological_Process_2021__regulation of mitochondrial translation (GO:0070129),-0.4250555142721574,-0.8723206073318719,0.734375,1.0,1.0,2/20,15.75%,MPV17L2;RCC1L
prerank,Reactome_2022__Activation Of G Protein Gated Potassium Channels R-HSA-1296041,-0.44988521373734514,-0.8722778164516536,0.7288135593220338,1.0,1.0,3/24,14.00%,KCNJ15;GNGT1;KCNJ4
prerank,GO_Biological_Process_2021__positive regulation of focal adhesion disassembly (GO:0120183),0.5213163552598146,0.8722415879945137,0.6739130434782609,0.95307154208317,1.0,3/6,32.28%,IQSEC1;MAP4K4;MAPRE2
prerank,GO_Biological_Process_2021__regulation of focal adhesion disassembly (GO:0120182),0.5213163552598146,0.8722415879945137,0.6739130434782609,0.95307154208317,1.0,3/6,32.28%,IQSEC1;MAP4K4;MAPRE2
prerank,CellMarker_Augmented_2021__CD8+ T cell:Lymphoid Tissue,-0.4359207788201077,-0.8722226406396144,0.6666666666666666,1.0,1.0,6/29,8.72%,SIRPG;CYTIP;KLRB1;SCML4;CD5;TRAF3IP3
prerank,GO_Biological_Process_2021__visual system development (GO:0150063),-0.4118127945974384,-0.8721664491920141,0.6666666666666666,1.0,1.0,5/31,17.48%,MAB21L1;FREM2;ITGAM;HIPK1;SALL2
prerank,GO_Biological_Process_2021__adult heart development (GO:0007512),-0.5364915189155715,-0.8721642364968301,0.7083333333333334,1.0,1.0,1/5,1.51%,MYH7
prerank,GO_Biological_Process_2021__regulation of ER-associated ubiquitin-dependent protein catabolic process (GO:1903069),-0.5154947042599868,-0.8721003241249288,0.6481481481481481,1.0,1.0,3/9,27.87%,SVIP;HERPUD1;USP14
prerank,Reactome_2022__Reversible Hydration Of Carbon Dioxide R-HSA-1475029,-0.4807453313952711,-0.8720776304867448,0.6607142857142857,1.0,1.0,3/11,15.13%,CA14;CA1;CA4
prerank,GO_Biological_Process_2021__negative regulation of anoikis (GO:2000811),0.4146092052301616,0.8720747821677456,0.6486486486486487,0.9531014780433585,1.0,4/14,16.67%,BCL2;SNAI2;PIK3CA;NOTCH1
prerank,GO_Biological_Process_2021__hemopoiesis (GO:0030097),-0.3592231324895439,-0.8719031767959603,0.7222222222222222,1.0,1.0,12/77,16.07%,ARIH2;RASGRP4;TGFB1;WNT5A;PLD4;FLT4;ZFPM1;PTPRC;MFAP5;TEK;RRAS;HIPK1
prerank,CellMarker_Augmented_2021__Enterocyte Progenitor cell:Small Intestine,-0.3398912120574607,-0.8718129633263516,0.726027397260274,1.0,1.0,15/95,11.31%,TREH;MGST1;RARRES1;SLC7A7;PIGH;ALDOB;VTN;C17ORF78;SLC5A9;TGM2;RBP2;MS4A8;CYP2J2;ENPP4;GLRX
prerank,GO_Biological_Process_2021__defense response to symbiont (GO:0140546),-0.3425905663308791,-0.8716124196452597,0.6805555555555556,1.0,1.0,23/84,21.63%,IRF1;TRIM5;AGBL5;STAT1;PLA2G10;OAS2;IFIT3;NLRP9;PTPRC;IFIT1;OAS1;TLR2;F2RL1;DDIT4;IFIT2;SERINC3;IFI27;IFIT1B;TRIM56;MLKL;MX1;IFI6;ISG15
prerank,KEGG_2021_Human__Starch and sucrose metabolism,0.3930664578488804,0.8716028990943233,0.6060606060606061,0.9539105939695486,1.0,4/27,8.39%,GCK;GANC;G6PC3;GYS1
prerank,GO_Biological_Process_2021__negative regulation of cardiac muscle hypertrophy (GO:0010614),0.4862855373274368,0.8714771296630203,0.6,0.9539544936719948,1.0,1/11,0.86%,FOXO1
prerank,GO_Biological_Process_2021__TOR signaling (GO:0031929),0.38216192242666336,0.8712885850247643,0.6129032258064516,0.9540980776600716,1.0,6/23,17.57%,RHEBL1;MLST8;CCDC88A;SMG1;EIF4EBP1;SYAP1
prerank,GO_Biological_Process_2021__positive regulation of natural killer cell mediated immune response to tumor cell (GO:0002857),-0.6051125191739922,-0.8712833226653075,0.6949152542372882,1.0,1.0,2/5,19.12%,IL12A;CRTAM
prerank,GO_Biological_Process_2021__positive regulation of natural killer cell mediated cytotoxicity directed against tumor cell target (GO:0002860),-0.6051125191739922,-0.8712833226653075,0.6949152542372882,1.0,1.0,2/5,19.12%,IL12A;CRTAM
prerank,CellMarker_Augmented_2021__CD8+ T cell:Liver,-0.4263987432625154,-0.8711778095971203,0.6086956521739131,1.0,1.0,5/25,8.72%,SIRPG;KLRB1;SCML4;CD5;TRAF3IP3
prerank,CellMarker_Augmented_2021__Cytotoxic T cell:Liver,-0.4263987432625154,-0.8711778095971203,0.6086956521739131,1.0,1.0,5/25,8.72%,SIRPG;KLRB1;SCML4;CD5;TRAF3IP3
prerank,CellMarker_Augmented_2021__CD8+ Cytotoxic T cell:Peripheral Blood,-0.4263987432625154,-0.8711778095971203,0.6086956521739131,1.0,1.0,5/25,8.72%,SIRPG;KLRB1;SCML4;CD5;TRAF3IP3
prerank,GO_Biological_Process_2021__galactose catabolic process (GO:0019388),0.550940034767954,0.8710658121606685,0.6590909090909091,0.9543365043654107,1.0,2/6,11.98%,GALE;GALT
prerank,GO_Biological_Process_2021__sialylation (GO:0097503),-0.5481176701130795,-0.8710441519828129,0.6727272727272727,1.0,1.0,1/6,8.60%,ST6GALNAC2
prerank,Reactome_2022__Potassium Channels R-HSA-1296071,0.3063040814815756,0.870872010218708,0.782608695652174,0.9545510539040495,1.0,12/89,9.13%,KCNK6;KCNB2;KCNC2;KCNH8;HCN1;KCNH7;KCNJ3;KCNG1;KCNJ6;KCND2;KCNK2;ABCC8
prerank,GO_Biological_Process_2021__glycolipid biosynthetic process (GO:0009247),-0.4247696140719468,-0.8707504348966204,0.71875,1.0,1.0,6/36,14.30%,PIGH;B3GNT5;MPPE1;A4GALT;PIGC;PIGL
prerank,GO_Biological_Process_2021__calcium ion-regulated exocytosis of neurotransmitter (GO:0048791),0.46842811459937134,0.8707431576770857,0.6888888888888889,0.9545757201438128,1.0,5/11,17.09%,DOC2B;SYT1;RIMS2;UNC13B;UNC13C
prerank,GO_Biological_Process_2021__enzyme linked receptor protein signaling pathway (GO:0007167),0.3080489128539394,0.8706998192886128,0.5416666666666666,0.9543822305731507,1.0,23/125,15.15%,NGF;SH2D6;KIT;FGFR1;EPHA7;FRK;SHC4;ERBB2;EPHA3;RAPGEF1;FER;CD8A;EFS;CASS4;FGFR3;MPZL1;TYRO3;RET;FLT3;PTPRT;RYK;INSR;PTPRF
prerank,GO_Biological_Process_2021__positive regulation of interleukin-12 production (GO:0032735),0.39808603993895564,0.8706993521033661,0.7,0.9540798280919806,1.0,5/22,11.29%,RIPK2;IL16;HMGB1;PLCB1;LGALS9
prerank,CellMarker_Augmented_2021__Plasma cell:Kidney,-0.473624448420477,-0.8705143601156059,0.6346153846153846,1.0,1.0,4/15,17.47%,JCHAIN;IL5RA;IGLL1;PKHD1L1
prerank,GO_Biological_Process_2021__protein K6-linked ubiquitination (GO:0085020),-0.5140546673141609,-0.8704550802047375,0.6296296296296297,1.0,1.0,1/8,8.63%,BRCA1
prerank,"GO_Biological_Process_2021__DNA-templated transcription, termination (GO:0006353)",0.3239441914188588,0.8704254548305316,0.6774193548387096,0.9544363622987536,1.0,14/67,20.71%,CPSF1;LSM10;PCF11;TAF1B;SNRPB;CCNH;POLR1H;CPSF7;PAPOLA;PRMT5;ERCC3;POLR3K;SYMPK;MTERF2
prerank,Reactome_2022__Sensory Perception Of Salty Taste R-HSA-9730628,-0.5785294583113518,-0.8702432367759569,0.64,1.0,1.0,2/5,17.65%,SCNN1A;SCNN1G
prerank,GO_Biological_Process_2021__secondary alcohol biosynthetic process (GO:1902653),-0.43033802368688,-0.8701385213924574,0.6714285714285714,1.0,1.0,2/28,11.86%,PLPP6;ACAA2
prerank,GO_Biological_Process_2021__acute inflammatory response (GO:0002526),-0.44127920923473174,-0.870101288746859,0.671875,1.0,1.0,5/16,25.47%,HPR;ITIH4;ELANE;TNFSF4;IL6R
prerank,GO_Biological_Process_2021__negative regulation of centriole replication (GO:0046600),-0.5525109441442448,-0.8700832306952158,0.6875,1.0,1.0,1/6,8.63%,BRCA1
prerank,GO_Biological_Process_2021__exonucleolytic trimming involved in rRNA processing (GO:0000459),-0.5050062525842669,-0.8699631967125342,0.6779661016949152,1.0,1.0,3/8,22.14%,ERI2;EXOSC8;EXOSC2
prerank,"GO_Biological_Process_2021__exonucleolytic trimming to generate mature 3'-end of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000467)",-0.5050062525842669,-0.8699631967125342,0.6779661016949152,1.0,1.0,3/8,22.14%,ERI2;EXOSC8;EXOSC2
prerank,GO_Biological_Process_2021__inorganic cation transmembrane transport (GO:0098662),0.27534132457958743,0.8697881165314179,0.8666666666666667,0.9556501894812438,1.0,24/234,10.28%,KCNK6;MCOLN3;SLC12A1;KCNB2;SLC30A10;TRPC3;SLC39A8;KCNC2;TRPM2;SLC8A1;KCNH8;SLC39A11;SLC8A3;PKD2;HCN1;KCNH7;KCNG1;TMEM175;KCND2;KCNK2;ABCC8;SLC6A17;SLC6A20;RHCG
prerank,KEGG_2021_Human__Amyotrophic lateral sclerosis,-0.33044099277821404,-0.8694065025393486,0.8,1.0,1.0,78/301,27.26%,DNAH11;COX6A1;TNFRSF1B;PINK1;NUP210L;ACTG1;ATP5F1E;NDUFS2;COX6C;DCTN1;DNAH17;ATP5MC3;GPX3;ATP5PF;TUBA4A;COX7A1;ATG14;DNAH3;DNAH2;VDAC1;GABARAPL1;NDUFA2;NOS2;GPX2;NDUFB4;NDUFC1;TUBA3D;DNAI1;ITPR3;COX7C;NDUFA1;NEFM;RAB8A;NDUFB9;TUBB;PSMA3;DNAH10;TUBB6;COX7A2;GABARAPL2;RAC1;TUBB2A;COX4I1;PSMA7;PSMB6;NUP93;NDUFB10;NEFL;HSPA5;TUBB4A;SEC13;NDUFS5;ATP5PB;NDUFB11;PSMA5;TUBB4B;ATP5F1A;OPTN;SDHC;PSMD6;KLC1;RAE1;NDUFB2;ACTR1B;APAF1;DNAH12;GRIN2D;PSMC5;ULK1;NDC1;DCTN2;PSMB4;COX6B1;GRIN2C;DAXX;NDUFS6;RAB1A;PSMB7
prerank,GO_Biological_Process_2021__peptidyl-cysteine modification (GO:0018198),-0.5558693546015687,-0.869328225002429,0.6481481481481481,1.0,1.0,3/7,25.54%,NOS2;CHCHD4;PARK7
prerank,GO_Biological_Process_2021__bile acid biosynthetic process (GO:0006699),0.38470516191191284,0.8692667163935451,0.6296296296296297,0.956560133100807,1.0,5/25,8.63%,CYP7B1;OSBPL3;OSBPL6;SLC27A2;OSBPL7
prerank,GO_Biological_Process_2021__purine ribonucleotide metabolic process (GO:0009150),-0.37027647281579745,-0.8691860143643061,0.6575342465753424,1.0,1.0,10/65,14.71%,ADSS1;ACSM6;ACOT6;RHOQ;HINT1;ACOT4;ACSM3;ACOT1;ABHD14B;ACOT2
prerank,GO_Biological_Process_2021__positive regulation of nuclear division (GO:0051785),0.42862885009204077,0.8689403225076029,0.6052631578947368,0.9570907268664496,1.0,11/18,37.01%,TGFA;INSR;DMRT1;EDN1;BTC;PHIP;EDN3;DRD3;SIRT2;NPM2;IGF1
prerank,GO_Biological_Process_2021__regulation of protein glycosylation (GO:0060049),0.49690042321237704,0.8688459287445761,0.6590909090909091,0.9569914724566512,1.0,1/7,5.59%,FKTN
prerank,GO_Biological_Process_2021__keratan sulfate biosynthetic process (GO:0018146),0.4057524743327854,0.8688278478040653,0.6,0.9564147372302595,1.0,5/23,8.40%,CHST6;PRELP;ST3GAL3;B4GALT2;B4GALT3
prerank,Reactome_2022__Keratan Sulfate Biosynthesis R-HSA-2022854,0.4057524743327854,0.8688278478040653,0.6,0.9564147372302595,1.0,5/23,8.40%,CHST6;PRELP;ST3GAL3;B4GALT2;B4GALT3
prerank,KEGG_2021_Human__Estrogen signaling pathway,0.3103086369470044,0.8685833756828952,0.7727272727272727,0.9566467987805186,1.0,15/95,9.44%,ITPR2;BCL2;CREB3L2;SHC4;MMP2;CREB3L4;KCNJ3;NCOA3;NCOA2;KCNJ6;PLCB1;SP1;ADCY2;TGFA;AKT2
prerank,CellMarker_Augmented_2021__Effector CD8+ Memory T (Tem) cell:Peripheral Blood,0.3330997508076544,0.8684692966056777,0.6486486486486487,0.9565950820175191,1.0,10/65,12.34%,KLRD1;CX3CR1;ZEB2;CAPN2;LGALS1;SAMD3;S1PR5;FLNA;RNF166;PXN
prerank,GO_Biological_Process_2021__alkaloid metabolic process (GO:0009820),0.5539079296923332,0.8684408729524327,0.6610169491525424,0.9563260156601149,1.0,1/5,0.59%,CYP1A2
prerank,CellMarker_Augmented_2021__Neutrophil:Peripheral Blood,-0.5290134183987452,-0.8683325009854652,0.6909090909090909,1.0,1.0,5/8,11.77%,FCGR3A;IL3RA;FPR1;CEACAM8;ITGAM
prerank,Reactome_2022__Signaling By Rho GTPases R-HSA-194315,-0.3052109097312596,-0.8681240524056355,0.8526315789473684,1.0,1.0,74/580,18.23%,BUB1;ERCC6L;TRIP10;KIF14;RASGRF2;ACTC1;PLEKHG6;DOCK6;DOCK8;ARHGAP9;TAGAP;CTNNA1;PLEKHG3;OBSCN;VAV3;SPC25;CCDC187;CENPU;PDE5A;ARHGAP15;DOCK2;ARMCX3;ITGB3BP;ARHGEF40;ZWILCH;UACA;CAVIN1;ACTG1;WAS;H2BC4;PIK3R3;MPZ;ATP6AP1;RHOQ;WDR6;SNAP23;NUF2;CKB;CYBA;ARHGAP12;CENPH;ARAP3;DEF6;CENPS-CORT;ARHGAP28;ARHGDIG;H2AZ1;BAIAP2L1;DYNLL1;PKN3;RPS27;INCENP;NCKIPSD;FMNL1;HSPE1;NDEL1;AKAP13;RAC2;CDC37;RNF20;ECT2;MYL6;COPS4;CDCA8;IQGAP3;CENPN;BAIAP2L2;RTKN;CALM1;BASP1;ARHGEF39;KIF18A;EGR2;MYL9
prerank,PanglaoDB_Augmented_2021__Microfold Cells,-0.35375604764263946,-0.8681105003326376,0.7464788732394366,1.0,1.0,15/91,16.86%,APOL1;AHR;LRP10;DTX2;CYBA;CTSZ;SPINT1;OAS1;CXCL16;MFGE8;FOSL2;VDR;GRN;RAC2;PGLYRP1
prerank,GO_Biological_Process_2021__maintenance of DNA repeat elements (GO:0043570),-0.554409883719656,-0.8679822113372689,0.6862745098039216,1.0,1.0,3/6,31.99%,MSH6;RMI2;TCF7L2
prerank,GO_Biological_Process_2021__positive regulation of transcription of Notch receptor target (GO:0007221),0.4139161520287633,0.8678871584066242,0.7096774193548387,0.9573043104588559,1.0,7/16,19.29%,MAML1;WWC1;NOTCH1;PBX1;RBPJ;EP300;KAT2B
prerank,GO_Biological_Process_2021__positive regulation of protein modification process (GO:0031401),-0.31969087345593344,-0.8676121972702553,0.76,1.0,1.0,25/182,15.75%,TBX1;FGF20;TGFB1;MMP9;TERF2IP;CCND1;CARD14;GPER1;PINK1;DAB2;FLT4;CDK2AP1;PIK3R3;CCND2;HLA-DRB1;SVIP;ENG;FAXDC2;ATG14;TEK;RSPO1;DDX3X;FGF22;PROM2;CD4
prerank,GO_Biological_Process_2021__positive regulation of developmental process (GO:0051094),0.30859332957998453,0.8675358026887096,0.7222222222222222,0.9577861022567342,1.0,30/153,16.13%,PHLDB2;PLD6;NEUROD2;FGFR1;APOE;NLGN1;GRIP1;CCN2;SIRT1;MARCHF5;DLX1;NCOA3;ZNF703;PLCB1;RALA;SHLD2;SHLD1;MCU;RPS6KA3;COBL;MAP3K13;KMT5C;MIEF2;LRP8;SOX5;INSR;NRXN1;ELAPOR2;DLG5;KMT5B
prerank,CellMarker_Augmented_2021__Luminal cell:Prostate,0.32068477677217005,0.8675265486349352,0.8636363636363636,0.95751691478189,1.0,21/78,18.06%,MLPH;ADGRG6;TSKU;GOLT1A;PARVA;PERP;ERBB2;DSP;ESRP1;TSPAN6;EPS8L2;LRIG3;TEAD4;NR2F2;BCAM;PTPRF;CGN;WWC1;PAWR;ARHGEF16;ADCY6
prerank,Reactome_2022__Transcriptional Regulation By RUNX3 R-HSA-8878159,-0.352475878992411,-0.867311960347664,0.7466666666666667,1.0,1.0,6/89,5.29%,PSMB9;TCF7;TGFB1;CCND1;RORC;TCF7L1
prerank,GO_Biological_Process_2021__negative regulation of dephosphorylation (GO:0035305),0.4386007726179191,0.8672342992326897,0.7142857142857143,0.9578237052228044,1.0,2/18,3.96%,URI1;PPP1R35
prerank,CellMarker_Augmented_2021__Granulocyte-monocyte progenitor:Umbilical Cord Blood,-0.34632861791468644,-0.8671712215807654,0.7012987012987013,1.0,1.0,20/88,15.83%,MGST1;RAB44;NQO1;TTK;SHCBP1;ANXA1;ERAP2;USP13;NUF2;CP;PYGL;CLEC12A;F13A1;VDAC1;GCNT1;KCNE3;IGLL1;CCNE2;CDKN3;ELANE
prerank,GO_Biological_Process_2021__regulation of interferon-gamma production (GO:0032649),-0.3641711586598258,-0.8669670303591036,0.6753246753246753,1.0,1.0,18/60,19.28%,PDCD1LG2;HLA-A;ZFPM1;HLA-DPB1;IL27;HLA-DRB1;SLC11A1;TXK;HLA-DPA1;IL12A;NR1H4;IL18;ZP3;F2RL1;VSIR;AXL;CRTAM;INHA
prerank,PanglaoDB_Augmented_2021__Epsilon Cells,-0.36097009913285083,-0.8669019300230566,0.6515151515151515,1.0,1.0,15/102,10.05%,AMBP;SLC28A1;BHMT;ELOVL2;F7;SMLR1;ACOX2;ALDOB;VTN;OIT3;MASP1;CLDN2;PON3;CYP3A4;HNF1A
prerank,GO_Biological_Process_2021__negative regulation of chromosome organization (GO:2001251),-0.5111575977578159,-0.8667147458655504,0.7164179104477612,1.0,1.0,1/8,2.96%,TERF2IP
prerank,Reactome_2022__Crosslinking Of Collagen Fibrils R-HSA-2243919,-0.4792434120796853,-0.8664508282040405,0.6470588235294118,1.0,1.0,3/10,11.05%,LOX;LOXL4;PXDN
prerank,Reactome_2022__Regulation Of PTEN Gene Transcription R-HSA-8943724,0.3456973707221877,0.8663466798032534,0.5666666666666667,0.9597628166540512,1.0,17/57,22.04%,HDAC3;PHC2;GATAD2A;PPARG;MLST8;SNAI2;SCMH1;HDAC1;GATAD2B;CHD4;TP53;ATN1;RNF2;HDAC5;RBBP4;HDAC7;PTEN
prerank,GO_Biological_Process_2021__embryonic skeletal system development (GO:0048706),-0.4507239995250854,-0.8663169558966687,0.6515151515151515,1.0,1.0,2/16,5.00%,WNT5A;COL1A1
prerank,GO_Biological_Process_2021__glomerular epithelial cell differentiation (GO:0072311),0.5409791310719726,0.8660657337454019,0.6326530612244898,0.9598368603158107,1.0,1/5,2.84%,PTPRO
prerank,GO_Biological_Process_2021__renal filtration cell differentiation (GO:0061318),0.5409791310719726,0.8660657337454019,0.6326530612244898,0.9598368603158107,1.0,1/5,2.84%,PTPRO
prerank,KEGG_2021_Human__Toll-like receptor signaling pathway,0.33100957486849497,0.8660530235245314,0.7,0.9595627369898878,1.0,19/68,20.53%,CD14;TICAM2;CCL3L3;CCL4L2;MAPK8;AKT2;TICAM1;FADD;NFKB1;PIK3CA;IRAK4;LBP;MAPK12;MAP2K7;TAB1;TAB2;MAP2K6;TRAF6;FOS
prerank,Reactome_2022__Signaling By Nuclear Receptors R-HSA-9006931,0.29755055354164955,0.8660274107257276,0.7777777777777778,0.9593311970914944,1.0,50/210,20.98%,HDAC3;BCL2;APOE;RARB;ALDH1A1;CBFB;KCNH8;MMP2;AKR1C3;H2BC21;NCOA3;NCOA2;PPP5C;NRIP1;ABCA1;NANOS3;MYC;TGFA;MOV10;AKT2;KANK1;ALDH1A2;TNRC6C;CRABP1;CPT1A;HDAC1;GREB1;CARM1;H2AX;GTF2F2;PIK3CA;CXXC5;NR1H3;RUNX1;TNRC6A;CHD1;PMEPA1;AGO3;GNG7;EP300;CREB1;KAT2B;H2AJ;POU2F1;AGO2;FOS;GNAI2;KCTD6;TBL1X;XPO1
prerank,GO_Biological_Process_2021__actomyosin structure organization (GO:0031032),-0.37506676866985206,-0.8658576642456649,0.7,1.0,1.0,6/67,10.22%,LMOD1;ACTC1;OBSCN;TMOD4;CSRP3;LMOD3
prerank,GO_Biological_Process_2021__lipid modification (GO:0030258),-0.3950790300528744,-0.8658239511567364,0.6615384615384615,1.0,1.0,7/41,9.84%,ALOX12;CYP3A5;ALOX5;ALOX12B;ALOX15;PLPP6;CYP3A4
prerank,GO_Biological_Process_2021__galactolipid biosynthetic process (GO:0019375),0.5050930030637079,0.8657982595320364,0.6,0.9592264643541925,1.0,3/6,19.09%,B4GALT3;GAL3ST1;FA2H
prerank,GO_Biological_Process_2021__galactosylceramide biosynthetic process (GO:0006682),0.5050930030637079,0.8657982595320364,0.6,0.9592264643541925,1.0,3/6,19.09%,B4GALT3;GAL3ST1;FA2H
prerank,GO_Biological_Process_2021__positive regulation of interleukin-8 production (GO:0032757),0.36023645383267444,0.8657810518668738,0.5588235294117647,0.958976417410416,1.0,8/37,15.48%,CD14;SERPINE1;HMGB1;F2R;LGALS9;HSPA1A;FADD;LBP
prerank,Reactome_2022__COPI-mediated Anterograde Transport R-HSA-6807878,0.3240955687595435,0.8657373646263998,0.625,0.9588018298010588,1.0,19/72,24.87%,SPTBN4;STX5;DYNC1I2;TMED3;BET1;COG7;ANK2;GOLGB1;COG5;COG4;TMEM115;CAPZA1;CD55;COG2;ANK1;COG3;SPTB;ANK3;CAPZB
prerank,GO_Biological_Process_2021__positive regulation of cyclase activity (GO:0031281),0.4471167772951013,0.8656537554962689,0.6410256410256411,0.9586838107523589,1.0,3/12,13.81%,DRD5;MAPK8;NF1
prerank,GO_Biological_Process_2021__calcium ion homeostasis (GO:0055074),0.320958596317907,0.865628723828645,0.7666666666666667,0.9584341702199104,1.0,9/74,7.29%,CDH5;RGN;HTR2C;TMTC2;SLC8A1;DRD5;SLC8A3;SNCA;DRD4
prerank,GO_Biological_Process_2021__negative regulation of gene expression (GO:0010629),0.27444789064159686,0.8656260347805677,1.0,0.9581470710815377,1.0,65/272,21.65%,SMYD5;PC;APOE;SAMD4A;WNT4;SIRT1;DNMT1;PCIF1;DHFR;TRIM71;OPRD1;RIDA;EIF2AK3;RBL1;WWP2;NANOS3;DXO;CNOT9;MOV10;ERN1;LSM2;RBMS3;TWSG1;N4BP1;LGALS9;TNRC6C;HSPA1A;HDAC1;RPS6KA4;PNPT1;NFKB1;MECP2;PUS7;MALSU1;RUNX1;TNRC6A;CRKL;PTBP1;MPHOSPH8;NOTCH1;AGO3;SYNCRIP;MACROH2A2;LSM14A;SAMD4B;CPNE1;ADAM10;STOX1;KAT2B;EIF4A3;PRKAA2;METTL16;AGO2;NANOS1;HIF1A;RNF139;EMILIN1;FXR2;HINFP;LARP1;LSM6;RBBP4;PHF1;OCLN;BMP4
prerank,CellMarker_Augmented_2021__Blast cell:Bone Marrow,-0.3840432781941838,-0.86554101992799,0.7215189873417721,1.0,1.0,16/63,14.75%,C1QB;LYVE1;C3AR1;DAB2;MS4A4A;DCN;ZNF366;VSIG4;SELP;VWF;ENG;FPR3;F13A1;TEK;A2M;GGT5
prerank,PanglaoDB_Augmented_2021__Cholinergic Neurons,0.31808629967251173,0.8655359486598952,0.7741935483870968,0.9580481708196501,1.0,18/89,16.63%,CACNG4;POU3F2;KCNB2;IGDCC3;GRM8;CASKIN1;LIN28B;CSPG5;RIMS4;RHBDL3;CRABP1;FBLL1;SNAP91;MPP2;MSI1;ACHE;EFNA2;MAGEL2
prerank,PanglaoDB_Augmented_2021__Spermatozoa,-0.3833797391438292,-0.8654016189561282,0.7272727272727273,1.0,1.0,19/82,15.45%,C1QB;ANKUB1;FMO5;CPM;SLCO2B1;MAP3K19;VSIG4;SOD2;HLA-DPB1;CP;GAS7;APOBEC4;HVCN1;FPR3;HLA-DPA1;APOL6;OMG;KCNE3;ADAM28
prerank,GO_Biological_Process_2021__purine ribonucleoside bisphosphate metabolic process (GO:0034035),-0.45043356050547356,-0.8653147192798363,0.7192982456140351,1.0,1.0,5/13,26.56%,ABHD14B;SULT4A1;SULT1C3;SULT1C2;BPNT2
prerank,GO_Biological_Process_2021__positive regulation of dopamine receptor signaling pathway (GO:0060161),-0.5608803232438908,-0.8652764651296331,0.6730769230769231,1.0,1.0,1/5,11.01%,CAV2
prerank,GO_Biological_Process_2021__negative regulation of fatty acid metabolic process (GO:0045922),-0.46363154370006265,-0.865178448760499,0.6060606060606061,1.0,1.0,2/13,8.63%,CEACAM1;BRCA1
prerank,Reactome_2022__Sensory Processing Of Sound By Outer Hair Cells Of Cochlea R-HSA-9662361,-0.39023095655419293,-0.865008605934713,0.7272727272727273,1.0,1.0,13/51,19.01%,CHRNA9;GRXCR2;OTOG;MYO3B;TMC2;FSCN2;STRC;USH1C;GRXCR1;SLC26A5;MSN;MYO15A;TMC1
prerank,PanglaoDB_Augmented_2021__Choroid Plexus Cells,0.29465511600611705,0.864803651790316,0.8333333333333334,0.9594999979797225,1.0,21/109,15.15%,ADGRL2;APOE;HTR2C;GPC6;CGNL1;PLXNB1;EFS;PDZRN3;FGFR3;RNF128;COBL;MPDZ;DDAH1;UNC13B;FARP1;NEO1;MAP6;MAGI1;BCAM;PRICKLE2;PTPRF
prerank,GO_Biological_Process_2021__positive regulation of ryanodine-sensitive calcium-release channel activity (GO:0060316),-0.5467744175042544,-0.8646558367745388,0.6774193548387096,1.0,1.0,3/7,18.02%,TRDN;JPH2;CALM1
prerank,GO_Biological_Process_2021__response to peptide hormone (GO:0043434),0.3537297806776195,0.8644497875922623,0.6388888888888888,0.9600161089038268,1.0,5/41,6.32%,IRS1;ZBTB7B;SIRT1;CRY1;STAT5B
prerank,CellMarker_Augmented_2021__Fibroblast:Peripheral Blood,-0.3666933363109809,-0.864438262880634,0.72,1.0,1.0,13/86,11.05%,LMOD1;TIMP3;ANGPTL2;WNT5A;COL1A1;COL5A1;LOX;FBXL7;ADAM33;DCN;PAPPA;ITGBL1;PXDN
prerank,GO_Biological_Process_2021__intracellular protein transmembrane transport (GO:0065002),-0.3977735189677789,-0.8644042171702142,0.6923076923076923,1.0,1.0,12/41,29.49%,TOMM20;SEC62;PAM16;TIMM17A;ROMO1;CHCHD4;HSPA5;DNAJC19;TIMM21;PEX1;SRP54;GRPEL1
prerank,GO_Biological_Process_2021__error-prone translesion synthesis (GO:0042276),-0.4256976161268774,-0.8642917554090693,0.6231884057971014,1.0,1.0,4/21,21.44%,RPA3;POLE2;RPS27A;RPA2
prerank,GO_Biological_Process_2021__cellular response to glucagon stimulus (GO:0071377),0.42049927122169906,0.8642378128740279,0.6857142857142857,0.960250133682228,1.0,4/15,18.06%,ADCY2;PRKAR2A;ADCY3;ADCY6
prerank,GO_Biological_Process_2021__regulation of Arp2/3 complex-mediated actin nucleation (GO:0034315),-0.47746263992863175,-0.8642069890860986,0.6666666666666666,1.0,1.0,1/17,1.65%,GMFG
prerank,Reactome_2022__Purine Catabolism R-HSA-74259,0.4210672267376243,0.8641022284156935,0.6170212765957447,0.9602821454116643,1.0,4/15,17.82%,NT5C1A;NUDT18;DNPH1;NUDT5
prerank,CellMarker_Augmented_2021__Erythroid precursor:Bone Marrow,0.31188027640770577,0.864032181892541,0.75,0.960145185821629,1.0,6/75,8.48%,PNP;TCIRG1;CSK;DCPS;RGS14;SIPA1
prerank,GO_Biological_Process_2021__NIK/NF-kappaB signaling (GO:0038061),-0.362987083388235,-0.8640275770737647,0.6911764705882353,1.0,1.0,3/63,7.07%,PSMB9;CARD14;NFKB2
prerank,GO_Biological_Process_2021__positive regulation of extrinsic apoptotic signaling pathway (GO:2001238),0.3860563870361517,0.8639608403529702,0.6590909090909091,0.9600270785996515,1.0,7/22,14.12%,HTRA2;PML;WWOX;PPP2R1B;RET;FADD;BID
prerank,GO_Biological_Process_2021__NADH dehydrogenase complex assembly (GO:0010257),-0.3898882529563261,-0.8638847399261542,0.7246376811594203,1.0,1.0,14/50,27.00%,NDUFS2;TMEM126A;NDUFA2;NDUFB4;NDUFC1;NDUFA1;NDUFB9;NDUFB10;NDUFS5;NDUFB11;NDUFAF5;NDUFB2;TIMM21;NDUFS6
prerank,GO_Biological_Process_2021__mitochondrial respiratory chain complex I assembly (GO:0032981),-0.3898882529563261,-0.8638847399261542,0.7246376811594203,1.0,1.0,14/50,27.00%,NDUFS2;TMEM126A;NDUFA2;NDUFB4;NDUFC1;NDUFA1;NDUFB9;NDUFB10;NDUFS5;NDUFB11;NDUFAF5;NDUFB2;TIMM21;NDUFS6
prerank,GO_Biological_Process_2021__glycerol-3-phosphate metabolic process (GO:0006072),0.5697858746893135,0.8638702680218943,0.7111111111111111,0.9599559469014478,1.0,4/5,35.48%,GPD1;GK;GK5;GPAM
prerank,Reactome_2022__Meiosis R-HSA-1500620,-0.36630860057388986,-0.863445311756,0.7611940298507462,1.0,1.0,12/62,15.67%,SYCP1;TERF2IP;STAG3;RPA3;SYNE2;H2BC4;BRCA1;PSMC3IP;H2AZ1;SYCE2;SMC1B;SYCP3
prerank,GO_Biological_Process_2021__glycolytic process (GO:0006096),-0.43760772062162284,-0.8631715934818168,0.7,1.0,1.0,6/25,8.97%,HK2;ENO4;ALDOB;PKLR;ENO2;GAPDHS
prerank,Reactome_2022__Translocation Of ZAP-70 To Immunological Synapse R-HSA-202430,0.48768566988566764,0.8631696806457246,0.6666666666666666,0.9611601801287559,1.0,2/9,6.51%,CD247;HLA-DRA
prerank,GO_Biological_Process_2021__cellular response to corticosteroid stimulus (GO:0071384),-0.4981623997998236,-0.8630301033354354,0.65,1.0,1.0,3/12,9.69%,GPER1;ANXA1;REST
prerank,GO_Biological_Process_2021__galactose metabolic process (GO:0006012),0.508835697477829,0.8628211505182659,0.6521739130434783,0.9616418286615405,1.0,2/9,11.98%,GALE;GALT
prerank,GO_Biological_Process_2021__peptidyl-lysine trimethylation (GO:0018023),0.40250932129013206,0.8626262629480212,0.5806451612903226,0.9618701454963632,1.0,6/28,16.47%,SMYD5;TET2;KMT5C;ATPSCKMT;KMT5B;SETD2
prerank,Reactome_2022__Zinc Transporters R-HSA-435354,0.4371095783234064,0.862613001546921,0.5238095238095238,0.9615924177905711,1.0,1/14,3.19%,SLC39A8
prerank,GO_Biological_Process_2021__peptide metabolic process (GO:0006518),0.32741185431260245,0.8625581532241412,0.6785714285714286,0.9614412997444585,1.0,19/66,21.57%,NAALADL1;CPN1;CARNMT1;GSTM5;TRHDE;GSTM2;GSTA4;GPX1;GSTZ1;THOP1;FURIN;ETHE1;ADAMTS13;GSR;AEBP1;HM13;GSTT2;ACE;DMD
prerank,PanglaoDB_Augmented_2021__NK Cells,-0.36812944106461776,-0.8625296807969455,0.726027397260274,1.0,1.0,20/81,13.88%,SIRPG;AHR;TGFB1;GMFG;CYTIP;ARHGAP9;TAGAP;KLRB1;DOCK2;PARVG;FCGR3A;CD5;TRAF3IP3;MYO1F;PTPRC;ITGAM;HSD11B1;TXK;CD27;PSTPIP1
prerank,CellMarker_Augmented_2021__Germinal Center B cell:Tonsil,0.30837600743192356,0.8624883146471981,0.7916666666666666,0.9613230456628536,1.0,6/74,3.43%,ADGRG6;EMP1;CD151;LAMA3;SDC4;PERP
prerank,GO_Biological_Process_2021__acyl-CoA biosynthetic process (GO:0071616),0.42123074563614027,0.8624728768207184,0.6888888888888889,0.9610551094566644,1.0,3/14,11.15%,SCD5;SLC25A1;PPCS
prerank,CellMarker_Augmented_2021__Neural Stem cell:Brain,0.40497923516769974,0.8623244809511731,0.75,0.961138221927888,1.0,5/19,16.67%,SLITRK6;ASCL1;MSI1;NCAM1;NOTCH1
prerank,CellMarker_Augmented_2021__Pericyte:Brain,-0.3614193261005653,-0.8622040435637947,0.7638888888888888,1.0,1.0,9/85,6.82%,C1QTNF1;LMOD1;TIMP3;ANGPTL2;SYNC;COL1A1;COL5A1;ADAM33;DCN
prerank,KEGG_2021_Human__African trypanosomiasis,-0.4251911331184491,-0.8621298922303117,0.5942028985507246,1.0,1.0,5/23,16.13%,APOL1;HPR;IL12A;IL18;F2RL1
prerank,GO_Biological_Process_2021__positive regulation of Golgi to plasma membrane protein transport (GO:0042998),-0.5578902769257043,-0.862064866239866,0.7321428571428571,1.0,1.0,3/5,28.29%,ACSL3;CNST;RACK1
prerank,Reactome_2022__Muscle Contraction R-HSA-397014,-0.34009204308108176,-0.8619848860198768,0.7195121951219512,1.0,1.0,32/163,18.52%,SCN5A;LMOD1;MYH8;KCNA5;CAV3;TMOD4;MYBPC3;PDE5A;TRDN;ATP1A4;KCNJ11;NEB;KCNQ1;ACTN3;ANXA1;PXDN;KCNK13;KCNJ4;ACTA2;GATA4;KCNE3;ORAI1;ITPR3;HIPK1;ITGB5;PLN;MYL6;MYBPC1;CALM1;MYL9;CAMK2A;KCNK7
prerank,Reactome_2022__N-glycan Trimming In ER And Calnexin/Calreticulin Cycle R-HSA-532668,0.3653921634902972,0.8618426062611722,0.6764705882352942,0.9619181483410699,1.0,6/34,20.56%,PRKCSH;NGLY1;MOGS;RNF185;EDEM1;RNF139
prerank,GO_Biological_Process_2021__positive regulation of RIG-I signaling pathway (GO:1900246),-0.5046359761856558,-0.8618138239307352,0.6885245901639344,1.0,1.0,3/9,20.83%,USP17L2;DHX58;DDX60
prerank,CellMarker_Augmented_2021__Luteinizing Granulosa cell:Ovarian Follicle,0.33389175693139433,0.8618034067635986,0.6571428571428571,0.9617297606995088,1.0,11/75,5.58%,PCDH15;FREM1;FGF10;NOX4;SPHKAP;GRID2;PLCXD3;PRDM5;SMYD1;UNC5D;MAGI2
prerank,PanglaoDB_Augmented_2021__Intercalated Cells,-0.34909611842575133,-0.8617788845956499,0.7272727272727273,1.0,1.0,27/90,18.18%,SLC22A8;SLC22A6;TMEM213;VWA3B;WDR93;CCDC60;P2RY14;ATP6V1C2;BPIFB1;RP1;NEK5;SCIN;ZNF750;SNTN;ATP13A5;CFAP61;DNAH2;RERG;NPHS2;ADGRF5;PROM2;RHBG;SCNN1G;SLC4A1;CYP4B1;COL28A1;MUC15
prerank,GO_Biological_Process_2021__negative regulation of tyrosine phosphorylation of STAT protein (GO:0042532),0.4919049131716287,0.8617445217222893,0.6578947368421053,0.9616022531559154,1.0,3/7,31.55%,PIBF1;NF2;PTPN2
prerank,Reactome_2022__DNA Damage Recognition In GG-NER R-HSA-5696394,-0.41391902070636993,-0.8616520510750959,0.5970149253731343,1.0,1.0,6/34,18.03%,ACTL6A;TFPT;COPS5;RBX1;COPS4;RPS27A
prerank,GO_Biological_Process_2021__regulation of cardiac muscle cell apoptotic process (GO:0010665),-0.5371105802721821,-0.8615973282486482,0.6923076923076923,1.0,1.0,3/9,18.38%,ENG;GATA4;CAMK2A
prerank,KEGG_2021_Human__Fluid shear stress and atherosclerosis,-0.3318890191532537,-0.8615916014407171,0.7721518987341772,1.0,1.0,12/110,13.53%,MGST1;MMP9;CAV3;SDC2;NQO1;ACTG1;PIK3R3;CYBA;ITGA2B;CAV2;PLAT;PIK3CB
prerank,Reactome_2022__mRNA Splicing - Minor Pathway R-HSA-72165,0.33887755128368313,0.8613308668940064,0.6666666666666666,0.9622878525162384,1.0,11/46,25.16%,TXNL4A;SNRPB;ZMAT5;SF3B1;GTF2F2;SF3B4;PDCD7;POLR2F;SNRNP48;YBX1;SNRPF
prerank,GO_Biological_Process_2021__positive regulation of pattern recognition receptor signaling pathway (GO:0062208),-0.4797600174118952,-0.8613295851682935,0.6229508196721312,1.0,1.0,4/12,20.83%,USP17L2;TLR2;DHX58;DDX60
prerank,GO_Biological_Process_2021__aromatic compound catabolic process (GO:0019439),0.5403475059385499,0.86122153553738,0.6458333333333334,0.9622396592480553,1.0,2/6,4.57%,EPHX2;TET2
prerank,GO_Biological_Process_2021__integrin-mediated signaling pathway (GO:0007229),-0.368508329216979,-0.8611849259448273,0.7105263157894737,1.0,1.0,12/67,16.59%,ITGB2;HCK;TEC;DAB2;CEACAM1;ITGBL1;ITGA2B;ITGB6;TXK;ITGA5;ITGB5;ANGPTL3
prerank,Reactome_2022__TICAM1-dependent Activation Of IRF3/IRF7 R-HSA-9013973,0.41415270629037293,0.8609887424270776,0.6904761904761905,0.9624016304821537,1.0,2/10,12.57%,TICAM1;TANK
prerank,Reactome_2022__Signaling By ROBO Receptors R-HSA-376176,-0.3314777264393321,-0.8609717239017116,0.7439024390243902,1.0,1.0,70/190,27.50%,PSMB9;RPL37A;RPL38;RPL15;RPS4X;RPL3;LHX4;RPL35A;NTN1;RPS9;FAU;RPS27;RPS21;RBX1;RPL13A;PSMA3;RPL27A;RPS16;RPL36;RPS20;RPL7A;VASP;RPL9;RPS8;RPS27A;RPL21;RPL34;PSMA7;PSMB6;RPL4;RPL32;RPL5;COL4A5;RPL23;RPL41;RPS7;RPS11;RPL27;RPL35;RPS14;RPL11;RPS15;PSMA5;RPLP1;RPS12;RPL18A;ELOB;PSMD6;RPS13;RPL29;RPLP2;RPL28;RPL12;RPL18;RPS3;RPL22;RPSA;PSMC5;RPS28;RNASE1;RPS19;PSMB4;RPS24;RPL26L1;RPS3A;RPL19;RPL8;RPS6;PSMB7;PSMD8
prerank,GO_Biological_Process_2021__substantia nigra development (GO:0021762),0.35937073838242545,0.8608232714600605,0.5806451612903226,0.962498145887416,1.0,1/39,0.42%,SYPL2
prerank,GO_Biological_Process_2021__positive regulation of neuron migration (GO:2001224),-0.4676927052084203,-0.8607095690298823,0.7272727272727273,1.0,1.0,1/13,7.50%,SEMA3A
prerank,GO_Biological_Process_2021__negative regulation of autophagosome assembly (GO:1902902),-0.45650362354935464,-0.8606665017154108,0.6290322580645161,1.0,1.0,3/12,20.04%,PINK1;PHF23;FEZ1
prerank,GO_Biological_Process_2021__positive regulation of viral transcription (GO:0050434),0.38296746671027215,0.8605233062482543,0.6363636363636364,0.9628419383398011,1.0,4/25,22.28%,MDFIC;GTF2F2;RSF1;POLR2F
prerank,Reactome_2022__Regulation Of RUNX1 Expression And Activity R-HSA-8934593,0.4372605624853978,0.8605225283234048,0.6896551724137931,0.962551037561173,1.0,9/17,17.12%,CBFB;CDK6;PML;CCND3;MOV10;TNRC6C;RUNX1;TNRC6A;AGO3
prerank,GO_Biological_Process_2021__regulation of GTPase activity (GO:0043087),0.30693249766610226,0.8604958715550637,0.8823529411764706,0.9623116202858458,1.0,33/150,18.20%,SNX18;FGD4;RGS16;ERBB2;ASAP3;SRGAP2;CRK;EPHA3;RAPGEF1;FGD5;PLXNB1;EFNA5;FGD1;F2R;RRP1B;EVI5L;GPSM1;LIMS1;RAP1A;RGS7;SNX9;DOCK9;RAP1GDS1;NF1;RGS6;PKP4;VAV2;DOCK11;RSU1;ARHGAP27;PLXNA4;TBC1D2;RAPGEF3
prerank,Reactome_2022__Fatty Acid Metabolism R-HSA-8978868,-0.3300974532151133,-0.8604545577389493,0.7625,1.0,1.0,35/157,17.94%,ELOVL2;AMACR;ALOX12;CYP1B1;ACSM6;ALOX5;ACOX2;ACSL5;PTGR1;TECRL;ACOT6;ALOX12B;PTGES;ALOX15;PON3;PPT1;CYP2J2;ACOT4;OLAH;ACSM3;PON1;ACAA2;ACOT1;GPX2;HAO2;ACOT2;HACD4;GGT5;AWAT1;ACSL3;ALOX15B;TBXAS1;PLA2G4A;ALOX5AP;CYP4B1
prerank,GO_Biological_Process_2021__negative regulation of interleukin-10 production (GO:0032693),-0.47763013872790294,-0.8602249525559487,0.6956521739130435,1.0,1.0,1/11,3.04%,PDCD1LG2
prerank,"GO_Biological_Process_2021__posttranslational protein targeting to membrane, translocation (GO:0031204)",-0.5124492402737011,-0.8601515546817013,0.6935483870967742,1.0,1.0,2/7,21.19%,SEC62;HSPA5
prerank,CellMarker_Augmented_2021__CD141+CLEC9A+ Dendritic cell:Blood,0.3355523427029823,0.8597736708455717,0.7241379310344828,0.9635876250399206,1.0,17/89,13.97%,KCNK6;CD38;DUSP2;BCL6;OSBPL3;HLA-DQB1;ACSS2;CADM1;NCALD;APOL3;DENND1B;EHD4;CSRP1;FNBP1;DST;NAV1;FLT3
prerank,Reactome_2022__Cleavage Of Damaged Purine R-HSA-110331,-0.4363569372720159,-0.8597605237866103,0.6376811594202898,1.0,1.0,3/18,12.66%,TERF2IP;H2BC4;H2AZ1
prerank,GO_Biological_Process_2021__cadmium ion transport (GO:0015691),0.5547245161598867,0.8597471551636451,0.6923076923076923,0.963071316419998,1.0,1/5,3.19%,SLC39A8
prerank,GO_Biological_Process_2021__cadmium ion transmembrane transport (GO:0070574),0.5547245161598867,0.8597471551636451,0.6923076923076923,0.963071316419998,1.0,1/5,3.19%,SLC39A8
prerank,GO_Biological_Process_2021__response to muscle stretch (GO:0035994),-0.47141621970471714,-0.8597200079605193,0.7049180327868853,1.0,1.0,3/14,14.24%,CAV3;CSRP3;TTN
prerank,GO_Biological_Process_2021__bone resorption (GO:0045453),-0.535714328212735,-0.8596803697943595,0.7230769230769231,1.0,1.0,1/7,6.30%,IL7
prerank,CellMarker_Augmented_2021__Liver Bud Hepatic cell:Liver,-0.341039460510196,-0.8596427841300891,0.7945205479452054,1.0,1.0,33/162,14.94%,AMBP;APOL1;LECT2;ITIH2;CLDN1;FILIP1L;TGFBI;CPM;PTRH1;PON3;SOD2;TGM2;RHOQ;CPB2;OSMR;CYP2J2;P2RY6;CASP7;GBP1;ALAS2;FTH1;SVIP;CHCHD2;MASP2;SP110;TUBA4A;F5;PRG4;PALMD;C1S;ABHD14B;NR1H4;SDSL
prerank,GO_Biological_Process_2021__rRNA methylation (GO:0031167),0.40578861830117907,0.8595603941606322,0.7352941176470589,0.963153438921869,1.0,8/19,19.85%,TFB1M;METTL15;FBLL1;FBL;ZCCHC4;BUD23;NSUN4;METTL16
prerank,Reactome_2022__Dissolution Of Fibrin Clot R-HSA-75205,-0.486301748709469,-0.8595242350449921,0.6307692307692307,1.0,1.0,3/11,13.43%,PLAU;PLG;PLAT
prerank,Reactome_2022__Aflatoxin Activation And Detoxification R-HSA-5423646,-0.44946923916848636,-0.8592813728758599,0.58,1.0,1.0,4/13,14.75%,MGST1;CYP3A5;CYP3A4;GGT5
prerank,GO_Biological_Process_2021__signal release from synapse (GO:0099643),0.3631003114478276,0.8592469937096989,0.6060606060606061,0.9635800967434754,1.0,13/40,20.61%,HRH3;PCLO;SNCA;PDZD11;PPFIA3;SYT1;GRM4;SNPH;SYN2;NRXN1;SYN1;CDK5;LIN7A
prerank,GO_Biological_Process_2021__positive regulation of striated muscle cell differentiation (GO:0051155),0.4196987153103154,0.8591847837866613,0.7105263157894737,0.9634152882343898,1.0,6/21,8.91%,SMYD1;MAML1;NRG1;PROX1;GREM1;WNT3A
prerank,GO_Biological_Process_2021__long-chain fatty acid metabolic process (GO:0001676),-0.3702917593078401,-0.859160668902181,0.7391304347826086,1.0,1.0,18/74,16.51%,ELOVL2;ALOX12;CYP1B1;ALOX5;ACSL5;ALOX12B;PLA2G10;ALOX15;CYP2J2;ACOT4;CYP3A4;ACOT1;CYP4F12;ACOT2;CYP2E1;AWAT1;ACSL3;ALOX15B
prerank,CellMarker_Augmented_2021__Pluripotent Stem cell:Skin,0.31255923980446554,0.8591336369955693,0.64,0.9632273138664615,1.0,13/87,9.07%,TPM2;EMP1;MXRA5;PAPSS2;MRGPRF;PARVA;MMP2;SERPINE1;JAG1;NTN4;OLFML2B;IGFBP4;CRIM1
prerank,Reactome_2022__Defective RIPK1-mediated Regulated Necrosis R-HSA-9693928,0.5460806471456946,0.8588811742743466,0.631578947368421,0.9635046793656583,1.0,2/5,12.94%,TANK;FADD
prerank,Reactome_2022__Activated PKN1 Stimulates Transcription Of Androgen Receptor Regulated KLK2 And KLK3 R-HSA-5625886,0.40322126479055564,0.8587322768465474,0.6428571428571429,0.9636144442201501,1.0,3/16,6.80%,KLKB1;H2BC21;NCOA2
prerank,GO_Biological_Process_2021__chromatin organization (GO:0006325),0.3184610181768882,0.8586275198625348,0.5555555555555556,0.963533517985169,1.0,36/122,22.22%,HDAC3;HDAC10;SMARCD3;SIRT1;HIRIP3;ZBTB1;HP1BP3;SMARCB1;MYC;PIH1D1;PBRM1;ARID1A;BPTF;SMARCA2;SMARCA4;HDAC1;HDAC4;BAZ1B;HDAC11;BAZ2B;BAZ2A;SETD2;CHD1;NUDT5;SATB2;KAT2B;HDAC5;RSF1;PRDM16;ZBTB7A;RBBP4;PHF1;BRWD1;SUV39H2;SMARCAD1;SETD7
prerank,GO_Biological_Process_2021__inositol phosphate metabolic process (GO:0043647),0.33852545022813296,0.8584940211065296,0.6388888888888888,0.9635270083338165,1.0,6/47,11.09%,PLCH1;NUDT4B;ITPKB;PLCB1;INPP1;PLCH2
prerank,KEGG_2021_Human__Human cytomegalovirus infection,0.29741085348373175,0.8584836555474834,0.85,0.9632463621456872,1.0,51/177,26.11%,ITPR2;NFATC3;CCL3L3;CREB3L2;CCL4L2;CREB3L4;CRK;CDK6;CDK4;PLCB1;SP1;CASP3;ADCY2;MYC;AKT2;ADCY3;PXN;FADD;IL10RA;NFKB1;BID;GNAO1;PIK3CA;TP53;MAPK12;CRKL;EIF4EBP1;GNG7;ADCY6;CREB1;SOS1;MAP2K6;GNAQ;RAF1;GNAI2;GNAS;GNA12;GNA11;STING1;CREB3L1;IKBKB;PPP3CC;PIK3CD;GNA13;PRKACB;PLCB3;TAPBP;ARHGEF11;RPS6KB1;RB1;AKT3
prerank,GO_Biological_Process_2021__non-motile cilium assembly (GO:1905515),0.4131947455971152,0.8584552788031369,0.7222222222222222,0.9630216303133633,1.0,8/27,13.73%,PCM1;IFT88;C2CD3;RPGRIP1L;CEP290;CEP250;PIBF1;ARL13B
prerank,GO_Biological_Process_2021__pore complex assembly (GO:0046931),0.40636396953235016,0.8583649882348535,0.5609756097560976,0.9629409885348833,1.0,6/17,26.74%,PDZD11;ADAM10;TPR;NUP153;AFDN;NUP98
prerank,Reactome_2022__FCGR3A-mediated Phagocytosis R-HSA-9664422,0.3271387942936702,0.8582139631466157,0.6551724137931034,0.9629625235598854,1.0,13/51,19.00%,MYO10;CD247;CRK;ABL1;MYO9B;WASF3;WASF2;ARPC3;VAV2;NCK1;MYO5A;DOCK1;ELMO1
prerank,Reactome_2022__Axon Guidance R-HSA-422475,0.2649516631782866,0.8581298039290659,1.0,0.9628309025981789,1.0,69/481,16.17%,EFNB1;MYO10;LLGL1;ROBO2;FGFR1;ALCAM;GPRIN1;EPHA7;TRPC3;DSCAML1;SPTBN4;COL9A2;RPL3L;UNC5C;SEMA5A;UNC5D;MMP2;PSME4;ERBB2;SEM1;LHX2;SRGAP2;CACNB4;NTN4;ST8SIA4;DCC;EPHA3;DSCAM;PSMA1;ABL1;MAPK8;SLIT2;PLXNB1;DOK5;EFNA5;MYO9B;ABL2;FARP2;DOK6;SEMA4A;NUMB;PRKAR2A;PKN2;RPS6KA3;SH3KBP1;IRS2;EVL;RET;SCN7A;KIF4B;NEO1;ARHGAP35;ARPC3;RPS6KA4;MSI1;RPS6KA2;ETF1;ANK2;RPS6KA6;COL9A1;PIK3CA;VAV2;NCAM1;HJV;CNTN6;MAPK12;EFNA2;ITGA10;COL6A3
prerank,GO_Biological_Process_2021__receptor internalization (GO:0031623),-0.38595487502929043,-0.8580970192863159,0.6231884057971014,1.0,1.0,3/40,7.40%,ITGB2;CAV3;CEACAM1
prerank,PanglaoDB_Augmented_2021__Peritubular Myoid Cells,-0.34667708241009654,-0.8578675189772355,0.7228915662650602,1.0,1.0,10/105,7.34%,C1QTNF1;LMOD1;TIMP3;ANGPTL2;CYP1B1;COL1A1;UACA;ADAM33;DCN;ASPN
prerank,GO_Biological_Process_2021__semaphorin-plexin signaling pathway involved in axon guidance (GO:1902287),0.47225076861667703,0.8578610448760685,0.6363636363636364,0.963144730946024,1.0,2/8,17.65%,PLXNB1;PLXNA4
prerank,GO_Biological_Process_2021__inhibitory synapse assembly (GO:1904862),-0.48521638295593533,-0.8577942190662939,0.7169811320754716,1.0,1.0,1/11,2.54%,WNT5A
prerank,GO_Biological_Process_2021__ganglion development (GO:0061548),-0.5008748087462552,-0.8574277064958272,0.6785714285714286,1.0,1.0,2/9,7.50%,SEMA3F;SEMA3A
prerank,KEGG_2021_Human__Fructose and mannose metabolism,-0.41068958566333136,-0.8573531333783626,0.6615384615384615,1.0,1.0,3/28,6.15%,HK2;ALDOB;ENOSF1
prerank,GO_Biological_Process_2021__N-terminal peptidyl-methionine acetylation (GO:0017196),0.5038760553915637,0.8572299476129299,0.6829268292682927,0.9642189653472365,1.0,1/5,31.69%,NAA16
prerank,Reactome_2022__Activation Of RAC1 Downstream Of NMDARs R-HSA-9619229,-0.5003512553675541,-0.8572020141381157,0.6724137931034483,1.0,1.0,5/7,32.43%,CALM1;CAMKK2;RNASE1;CAMKK1;ARHGEF7
prerank,GO_Biological_Process_2021__regulation of actin filament bundle assembly (GO:0032231),-0.4294070536679237,-0.8571807222678847,0.65625,1.0,1.0,4/24,11.76%,FHOD1;ACTG1;WAS;VIL1
prerank,GO_Biological_Process_2021__cellular response to lipopolysaccharide (GO:0071222),-0.38040681556764877,-0.8571195582848344,0.7323943661971831,1.0,1.0,6/69,4.89%,TGFB1;HCK;WNT5A;PDCD1LG2;CXCL13;TNFRSF1B
prerank,GO_Biological_Process_2021__protein sialylation (GO:1990743),-0.5485934888575816,-0.8570984261280449,0.6833333333333333,1.0,1.0,1/5,8.60%,ST6GALNAC2
prerank,GO_Biological_Process_2021__visual perception (GO:0007601),-0.37010199373465563,-0.8568974036681614,0.6811594202898551,1.0,1.0,20/72,19.32%,CRYBB1;TULP1;ROM1;COL18A1;COL1A1;CABP4;RDH12;SLC24A1;GPR179;CRYBA4;TULP2;FSCN2;WFS1;PDE6C;RABGGTB;RABGGTA;CRYBG3;GUCY2F;TYR;PRPH2
prerank,Reactome_2022__Synthesis Of IP3 And IP4 In Cytosol R-HSA-1855204,0.3715037406877867,0.8567829293421113,0.6666666666666666,0.9649077151398738,1.0,4/26,11.09%,PLCH1;ITPKB;PLCB1;PLCH2
prerank,PanglaoDB_Augmented_2021__Satellite Cells,0.2907188092449903,0.8564773291178396,0.9523809523809523,0.9652623228675732,1.0,23/115,15.67%,SCRIB;PARVA;COL12A1;ERBB2;PAX3;NTN4;EDNRA;SNAI2;KITLG;RND3;CDCP1;CAP2;COL16A1;CHST3;DDAH1;RBFOX2;LRIG3;EFEMP1;NR2F2;WWTR1;ANTXR1;NCAM1;RUNX1
prerank,GO_Biological_Process_2021__regulation of sarcomere organization (GO:0060297),-0.5722132158690192,-0.8564065882215525,0.7592592592592593,1.0,1.0,1/5,2.76%,CAV3
prerank,GO_Biological_Process_2021__membrane lipid biosynthetic process (GO:0046467),-0.38165935796349204,-0.8563496677022637,0.7076923076923077,1.0,1.0,4/52,6.68%,ELOVL2;DEGS2;B3GNT5;PRKD3
prerank,GO_Biological_Process_2021__3'-UTR-mediated mRNA destabilization (GO:0061158),0.474355193297361,0.8563477951544087,0.7027027027027027,0.9652413974775128,1.0,5/14,20.80%,TRIM71;KHSRP;MOV10;RC3H1;RBM24
prerank,Reactome_2022__DAG And IP3 Signaling R-HSA-1489509,0.36305072099275015,0.8562149890964984,0.7037037037037037,0.9652621736312713,1.0,11/37,25.03%,ITPR2;PDE1A;ADCY2;PRKAR2A;ADCY6;CREB1;PRKCE;NBEA;PDE1B;PRKCD;PRKACB
prerank,GO_Biological_Process_2021__membrane repolarization during ventricular cardiac muscle cell action potential (GO:0098915),-0.566653186918454,-0.8559654887614855,0.7307692307692307,1.0,1.0,1/5,8.12%,KCNQ1
prerank,CellMarker_Augmented_2021__Mesenchymal Stem cell:Endometrium,0.5294531517328043,0.855897787485529,0.7380952380952381,0.9656348649247034,1.0,2/7,3.69%,ALCAM;CD14
prerank,GO_Biological_Process_2021__RNA biosynthetic process (GO:0032774),-0.41823475226849605,-0.8558580936542718,0.7384615384615385,1.0,1.0,10/30,23.44%,TAF7;TERT;TBPL1;TAF10;TCEA2;TAF6;SMARCA5;TAF13;TBP;TAF5
prerank,GO_Biological_Process_2021__protein poly-ADP-ribosylation (GO:0070212),-0.48039169424651995,-0.8556963687703226,0.6571428571428571,1.0,1.0,5/10,29.66%,PARP10;PARP15;PARP14;PARP9;PARP2
prerank,GO_Biological_Process_2021__regulation of kinase activity (GO:0043549),0.32480607320969007,0.8556838148847227,0.7368421052631579,0.9658684496272419,1.0,18/87,17.66%,KIT;FGFR1;EPHA7;ERBB2;EPHA3;DRD4;RBL1;FGFR3;IRS2;TYRO3;RET;FLT3;ANKRD54;RYK;INSR;EPHB2;ROR1;EPHA6
prerank,GO_Biological_Process_2021__thymus development (GO:0048538),0.47081766095898975,0.8555640470687547,0.7352941176470589,0.9658473626457189,1.0,4/10,6.88%,FGF10;TGFBR1;HES1;ZBTB1
prerank,GO_Biological_Process_2021__caveola assembly (GO:0070836),-0.5366193400241572,-0.8555253305439545,0.72,1.0,1.0,2/5,11.01%,CAV3;CAV2
prerank,GO_Biological_Process_2021__positive regulation of amyloid-beta clearance (GO:1900223),-0.5142353347659507,-0.8554608247746109,0.7142857142857143,1.0,1.0,1/6,2.65%,LRPAP1
prerank,GO_Biological_Process_2021__negative regulation of macrophage activation (GO:0043031),-0.4759300855765454,-0.8554474869179209,0.6417910447761194,1.0,1.0,3/12,15.82%,TAFA3;PTPRC;GRN
prerank,GO_Biological_Process_2021__negative regulation of establishment of protein localization (GO:1904950),0.4423106318754428,0.8554468343180671,0.6842105263157895,0.9657846516809577,1.0,3/10,16.39%,WWP2;TERF1;CORO2B
prerank,GO_Biological_Process_2021__endothelin receptor signaling pathway (GO:0086100),-0.5678188154324082,-0.8554377150548421,0.7021276595744681,1.0,1.0,1/5,13.30%,EDNRB
prerank,GO_Biological_Process_2021__positive regulation of cellular component organization (GO:0051130),0.3117574951961448,0.8553641083048961,0.6923076923076923,0.9656526058977544,1.0,22/93,18.20%,TGFBR1;CD151;NEUROD2;APOE;CDH5;SNCA;NRG1;PIH1D1;GNL3L;FRMPD4;BID;GPX1;PTPN23;SPIDR;INSR;NRXN1;RUNX1;CLIP3;ICE1;LGALS3;FAF1;RAPGEF3
prerank,Reactome_2022__Mitochondrial Fatty Acid Beta-Oxidation Of Saturated Fatty Acids R-HSA-77286,0.43251280235455153,0.8552424804922697,0.631578947368421,0.9656547225496894,1.0,4/11,11.57%,ACADS;ECHS1;ACADM;MECR
prerank,GO_Biological_Process_2021__termination of RNA polymerase I transcription (GO:0006363),-0.3882821229657162,-0.8551933277372897,0.7058823529411765,1.0,1.0,3/29,10.93%,CAVIN1;POLR1C;POLR1G
prerank,GO_Biological_Process_2021__positive regulation of dendrite development (GO:1900006),0.4758754339128362,0.8551814360997134,0.7105263157894737,0.965495066200178,1.0,2/10,13.60%,COBL;LRP8
prerank,KEGG_2021_Human__Glycosphingolipid biosynthesis,0.35512508204528215,0.855036864661966,0.75,0.9654556446095683,1.0,8/36,15.32%,ST6GALNAC3;GLA;ST3GAL3;B4GALT2;B4GALT3;GLB1;FUT9;ST3GAL6
prerank,KEGG_2021_Human__ABC transporters,0.32768587618312994,0.8548888789300186,0.6857142857142857,0.9655086312486492,1.0,18/42,23.46%,ABCA9;ABCA6;ABCA1;ABCD3;ABCC8;ABCD2;ABCC1;ABCC10;ABCB10;ABCA10;ABCA7;ABCC9;ABCG8;ABCA13;ABCG4;ABCC5;ABCB9;ABCA2
prerank,GO_Biological_Process_2021__autophagosome-lysosome fusion (GO:0061909),0.4951688757921359,0.8546473098812489,0.675,0.9657232070849835,1.0,2/8,16.53%,PLEKHM1;PIP4K2A
prerank,GO_Biological_Process_2021__sulfur compound catabolic process (GO:0044273),0.37570258781761523,0.85457871503761,0.68,0.9656191227775996,1.0,6/33,11.28%,VCAN;PRELP;CHAC1;ARSB;CSPG5;GLB1
prerank,Reactome_2022__Extra-nuclear Estrogen Signaling R-HSA-9009391,-0.36035642117533506,-0.8545709177977677,0.75,1.0,1.0,7/61,11.01%,MMP9;CCND1;ESR1;PIK3R3;GNAT3;GNGT1;CAV2
prerank,GO_Biological_Process_2021__negative regulation of transcription by RNA polymerase I (GO:0016479),0.5192706249773418,0.8545505014937319,0.627906976744186,0.9653489655601595,1.0,2/5,17.99%,FLNA;MACROH2A2
prerank,GO_Biological_Process_2021__phagolysosome assembly (GO:0001845),-0.4816473994332387,-0.8545194974903981,0.65,1.0,1.0,1/12,1.55%,RAB34
prerank,Reactome_2022__Gluconeogenesis R-HSA-70263,-0.41472090676294004,-0.8544868051871234,0.671875,1.0,1.0,4/27,8.97%,SLC37A2;ALDOB;ENO2;GAPDHS
prerank,GO_Biological_Process_2021__tRNA aminoacylation for mitochondrial protein translation (GO:0070127),-0.532722290467583,-0.854388165666614,0.6935483870967742,1.0,1.0,2/8,16.15%,DARS2;YARS2
prerank,Reactome_2022__Asymmetric Localization Of PCP Proteins R-HSA-4608870,-0.3634489807524962,-0.8542732455421458,0.6567164179104478,1.0,1.0,3/54,4.31%,PSMB9;WNT5A;FZD8
prerank,GO_Biological_Process_2021__tRNA transcription (GO:0009304),0.4859270505207919,0.8541569491694888,0.7894736842105263,0.966029355325805,1.0,2/8,17.07%,GTF3C4;GTF3C5
prerank,Reactome_2022__Regulation Of PLK1 Activity At G2/M Transition R-HSA-2565942,0.31912351073326406,0.854113047106716,0.7142857142857143,0.9658422555539244,1.0,11/81,10.51%,PCM1;CEP152;CEP135;CNTRL;ALMS1;DYNC1I2;SDCCAG8;MAPRE1;CEP290;AKAP9;CEP250
prerank,GO_Biological_Process_2021__cellular response to hypoxia (GO:0071456),0.2907783812055612,0.8540692267388664,0.8214285714285714,0.9656552710977739,1.0,14/111,9.00%,EGLN3;CPEB1;RORA;SIRT1;PSME4;SLC8A3;HP1BP3;OPRD1;PSMA1;MGARP;KCND2;MYC;HIF3A;TWIST1
prerank,GO_Biological_Process_2021__autophagosome organization (GO:1905037),0.33875842797123046,0.8540401060500854,0.6388888888888888,0.9654223095197867,1.0,3/51,6.64%,IRGM;RAB7A;UBXN2A
prerank,GO_Biological_Process_2021__cellular response to alcohol (GO:0097306),-0.38747042664635567,-0.8539289702441759,0.7164179104477612,1.0,1.0,4/43,8.63%,AHR;CTNNA1;GLRA2;BRCA1
prerank,KEGG_2021_Human__Viral protein interaction with cytokine and cytokine receptor,-0.41408767730337565,-0.8538875754635538,0.7230769230769231,1.0,1.0,9/36,18.74%,XCR1;CXCL13;TNFRSF1B;ACKR4;TNFRSF10A;CXCR5;IL18;IL10RB;CSF1R
prerank,GO_Biological_Process_2021__regulation of astrocyte differentiation (GO:0048710),0.4978210384224767,0.8538586092541209,0.6176470588235294,0.9655212540117691,1.0,3/10,7.30%,BIN1;HES1;F2
prerank,Reactome_2022__Sphingolipid De Novo Biosynthesis R-HSA-1660661,-0.39891523484818886,-0.8538382672454569,0.6363636363636364,1.0,1.0,5/40,15.78%,DEGS2;PRKD3;ORMDL3;SGMS2;CERS3
prerank,GO_Biological_Process_2021__glucosamine-containing compound metabolic process (GO:1901071),0.3923803364340663,0.8538019053236447,0.6829268292682927,0.9653483602781644,1.0,3/13,10.94%,CHST6;NAGK;CHST3
prerank,KEGG_2021_Human__Focal adhesion,0.2791537889730065,0.8537636050198751,0.8421052631578947,0.9651387331565485,1.0,22/187,9.59%,LAMA4;LAMB4;VEGFC;LAMA3;BCL2;ITGA11;COL9A2;PARVA;ITGA8;SHC4;ITGA4;ERBB2;PDGFD;CAPN2;PAK5;CRK;RAPGEF1;CCND3;MAPK8;FLNA;AKT2;ITGA3
prerank,Reactome_2022__Cross-presentation Of Soluble Exogenous Antigens (Endosomes) R-HSA-1236978,-0.3893559076092073,-0.8537585412815417,0.7272727272727273,1.0,1.0,1/40,0.62%,PSMB9
prerank,GO_Biological_Process_2021__regulation of intestinal cholesterol absorption (GO:0030300),0.535430095501816,0.8535737303954771,0.6346153846153846,0.9652745020509933,1.0,2/5,25.25%,ABCG8;LPCAT3
prerank,GO_Biological_Process_2021__late nucleophagy (GO:0044805),0.468017327155357,0.8535550206227408,0.6190476190476191,0.9650190051680966,1.0,3/7,28.09%,ATG2A;ATG2B;ATG7
prerank,GO_Biological_Process_2021__positive regulation of epithelial to mesenchymal transition (GO:0010718),0.3649658974193439,0.853468690425354,0.65625,0.9649522953054895,1.0,8/36,14.49%,BAMBI;TGFBR1;JAG1;ZNF703;TWIST1;BCL9L;SMAD2;WWTR1
prerank,CellMarker_Augmented_2021__Migration Phase Fetal Germ cell:Fetal Gonad,-0.33990831892603607,-0.8533840777183981,0.7560975609756098,1.0,1.0,34/131,21.67%,MGST1;ACTC1;S100A13;HMGB3;RPA3;ARMCX3;NQO1;SNRPD2;NLRP9;SLIRP;TCEAL8;TPD52L1;TOMM7;H2AZ1;BEX2;TMSB10;TP53I3;ETFB;CYSTM1;COX7A2;MYL6;BEX4;NTRK3;MYL9;MRPL34;PSMB6;CPNE8;CARHSP1;TXN;RPS14;SKA2;ZNF486;NDUFS5;NDUFB11
prerank,GO_Biological_Process_2021__sno(s)RNA 3'-end processing (GO:0031126),0.4323652146815047,0.8533096369969589,0.6363636363636364,0.965101794246994,1.0,3/11,20.74%,FBLL1;FBL;EXOSC5
prerank,GO_Biological_Process_2021__positive regulation of extracellular matrix organization (GO:1903055),-0.46992510614896943,-0.8533042193727784,0.6,1.0,1.0,1/16,1.49%,TGFB1
prerank,GO_Biological_Process_2021__hematopoietic stem cell migration (GO:0035701),0.5360860177773675,0.8530882873413588,0.6875,0.9652879845121717,1.0,1/5,3.45%,BCL11B
prerank,GO_Biological_Process_2021__cardiac atrium morphogenesis (GO:0003209),-0.49346834956668345,-0.8530490336821255,0.7213114754098361,1.0,1.0,5/12,17.81%,ZFPM1;ENG;HEY2;GATA4;MESP1
prerank,GO_Biological_Process_2021__oligosaccharide-lipid intermediate biosynthetic process (GO:0006490),0.42408581617681335,0.852712604310742,0.631578947368421,0.9657406567179189,1.0,2/12,15.03%,ALG12;ALG3
prerank,GO_Biological_Process_2021__neuron projection extension (GO:1990138),0.386082380750432,0.852674632502513,0.71875,0.965522169630742,1.0,3/32,4.26%,ALCAM;AUTS2;SEMA5A
prerank,GO_Biological_Process_2021__regulation of vasculature development (GO:1901342),-0.4233772618767435,-0.8521700214572188,0.75,1.0,1.0,3/20,11.99%,CXCL13;SP100;WARS1
prerank,"GO_Biological_Process_2021__G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger (GO:0007187)",0.3629772346518765,0.851733216004611,0.7142857142857143,0.9673020614819455,1.0,7/37,7.29%,CHRM2;HTR1F;GALR3;HTR2C;HRH3;OPRD1;DRD4
prerank,GO_Biological_Process_2021__defense response to virus (GO:0051607),-0.3342413485197908,-0.8516564815237572,0.7468354430379747,1.0,1.0,23/91,21.63%,IRF1;TRIM5;AGBL5;STAT1;PLA2G10;OAS2;IFIT3;NLRP9;PTPRC;IFIT1;OAS1;TLR2;F2RL1;DDIT4;IFIT2;SERINC3;IFI27;IFIT1B;TRIM56;MLKL;MX1;IFI6;ISG15
prerank,KEGG_2021_Human__Protein processing in endoplasmic reticulum,0.2935283426368789,0.8515791340123644,0.9354838709677419,0.9673633568927466,1.0,32/161,21.68%,BCL2;DERL3;CAPN2;PRKCSH;PDIA6;UBE2J1;UBXN2A;MAN1A2;SEC24C;EIF2AK3;MAPK8;ERN1;UBE2D4;MAN1A1;HSPA1A;NGLY1;PREB;HSPBP1;MOGS;DNAJC3;SSR2;RNF185;MAP2K7;UBE4B;ATF6;DNAJC1;EDEM1;UBXN4;UBE2J2;SEC61A1;UBE2D2;CUL1
prerank,CellMarker_Augmented_2021__Leydig cell:Testis,-0.3461101058876987,-0.8514846554370348,0.7536231884057971,1.0,1.0,4/72,8.82%,RHOXF2;MEIOB;CA14;C17ORF99
prerank,GO_Biological_Process_2021__endosome to lysosome transport via multivesicular body sorting pathway (GO:0032510),-0.501846182500167,-0.8513994599822763,0.6507936507936508,1.0,1.0,1/7,7.97%,CHMP3
prerank,GO_Biological_Process_2021__negative regulation of TORC1 signaling (GO:1904262),0.44548662812888423,0.8511727686747321,0.6458333333333334,0.9679112444781267,1.0,5/12,20.11%,KPTN;RNF152;ATM;SESN2;SZT2
prerank,GO_Biological_Process_2021__regulation of response to biotic stimulus (GO:0002831),-0.42643413132146873,-0.8511649467408017,0.7,1.0,1.0,2/25,4.81%,IRF1;TRIM5
prerank,"GO_Biological_Process_2021__regulation of Wnt signaling pathway, planar cell polarity pathway (GO:2000095)",0.5185499418582954,0.8511641403276458,0.7317073170731707,0.9676281075049488,1.0,2/7,6.24%,RSPO3;NKD1
prerank,CellMarker_Augmented_2021__Follicular Helper (Tfh) T cell:Salivary Gland,-0.40822117716168327,-0.851050161266718,0.7285714285714285,1.0,1.0,7/34,10.28%,SIRPG;TAGAP;KLRB1;SCML4;CD5;TRAF3IP3;PTPRC
prerank,"GO_Biological_Process_2021__nucleotide-excision repair, DNA duplex unwinding (GO:0000717)",-0.411439062321842,-0.8508534891083822,0.7014925373134329,1.0,1.0,8/20,33.37%,RBX1;RPS27A;DDB1;UBB;CETN2;UBC;GTF2H5;RAD23B
prerank,KEGG_2021_Human__Asthma,-0.47939875720925756,-0.8507111368386525,0.6379310344827587,1.0,1.0,4/11,13.10%,HLA-DMA;HLA-DPB1;HLA-DRB1;HLA-DPA1
prerank,Reactome_2022__Myogenesis R-HSA-525793,-0.42714107630201986,-0.8506377860835521,0.6612903225806451,1.0,1.0,2/22,5.29%,CTNNA1;TCF7L1
prerank,GO_Biological_Process_2021__intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress (GO:0070059),0.4024848676091889,0.8506312648198658,0.7096774193548387,0.9685013281138226,1.0,4/26,9.53%,BCL2;TMEM117;CHAC1;ERN1
prerank,"Reactome_2022__Signaling By Rho GTPases, Miro GTPases And RHOBTB3 R-HSA-9716542",-0.2981779182520378,-0.8503044466399506,0.9157894736842105,1.0,1.0,74/595,18.23%,BUB1;ERCC6L;TRIP10;KIF14;RASGRF2;ACTC1;PLEKHG6;DOCK6;DOCK8;ARHGAP9;TAGAP;CTNNA1;PLEKHG3;OBSCN;VAV3;SPC25;CCDC187;CENPU;PDE5A;ARHGAP15;DOCK2;ARMCX3;ITGB3BP;ARHGEF40;ZWILCH;UACA;CAVIN1;ACTG1;WAS;H2BC4;PIK3R3;MPZ;ATP6AP1;RHOQ;WDR6;SNAP23;NUF2;CKB;CYBA;ARHGAP12;CENPH;ARAP3;DEF6;CENPS-CORT;ARHGAP28;ARHGDIG;H2AZ1;BAIAP2L1;DYNLL1;PKN3;RPS27;INCENP;NCKIPSD;FMNL1;HSPE1;NDEL1;AKAP13;RAC2;CDC37;RNF20;ECT2;MYL6;COPS4;CDCA8;IQGAP3;CENPN;BAIAP2L2;RTKN;CALM1;BASP1;ARHGEF39;KIF18A;EGR2;MYL9
prerank,Reactome_2022__Synthesis Of PG R-HSA-1483148,0.5083929389015435,0.8502500561208767,0.7317073170731707,0.9690300164605348,1.0,3/7,9.93%,PLD6;PRKCSH;PGS1
prerank,KEGG_2021_Human__Prostate cancer,0.3214365586989612,0.8502375890128867,0.8421052631578947,0.9687651378145082,1.0,11/88,9.44%,ERG;FOXO1;BCL2;FGFR1;CREB3L2;ERBB2;CREB3L4;PDGFD;TGFA;ZEB1;AKT2
prerank,Reactome_2022__Metal Ion SLC Transporters R-HSA-425410,0.39280814355486504,0.8502174306185748,0.75,0.9685004214715734,1.0,2/22,3.19%,SLC30A10;SLC39A8
prerank,GO_Biological_Process_2021__regulation of T cell proliferation (GO:0042129),0.33409265940894534,0.8502146200267277,0.631578947368421,0.9682083728189449,1.0,4/51,4.79%,PNP;CLC;SDC4;CCDC88B
prerank,GO_Biological_Process_2021__regulation of RNA metabolic process (GO:0051252),0.33634994579930066,0.8501873292117628,0.6666666666666666,0.9679439890533775,1.0,17/61,18.92%,NOVA1;MITF;RBM20;HNRNPF;HNRNPH1;ESRP1;PCBP3;HNRNPL;RRP1B;FASTK;USP36;SRRM4;PTBP1;FUS;RC3H1;CLK2;PCBP4
prerank,PanglaoDB_Augmented_2021__Transient Cells,0.29698911299864134,0.8500709003513719,0.7368421052631579,0.9678492125364137,1.0,31/112,23.29%,SDC4;PERP;ERBB2;TMEM117;DSP;PTGFRN;PLXNB1;PARM1;RNF128;HID1;COBL;UNC13B;OGDH;BCAM;PTPRF;HDAC11;TMEM63B;ARHGEF16;ADCY6;DOCK1;EPB41L4B;TMEM125;PCDH1;JUP;CAMSAP3;ARHGEF10L;GNA11;SYT7;ST14;CDS1;PTPN21
prerank,CellMarker_Augmented_2021__T cell:Liver,-0.5399954144766164,-0.8499854771616925,0.7796610169491526,1.0,1.0,3/7,15.75%,PTPRC;CD27;CD4
prerank,GO_Biological_Process_2021__cellular response to glucocorticoid stimulus (GO:0071385),-0.4948592533642894,-0.8498610017032618,0.6610169491525424,1.0,1.0,3/13,17.25%,ANXA1;REST;ZFP36L1
prerank,GO_Biological_Process_2021__nucleus localization (GO:0051647),-0.5072586929067241,-0.8497044546279958,0.703125,1.0,1.0,2/10,11.15%,SYNE2;DCTN1
prerank,GO_Biological_Process_2021__negative regulation of RNA splicing (GO:0033119),0.39837343828313165,0.8496683402074651,0.625,0.9685373669045076,1.0,5/18,20.02%,SFSWAP;SRSF4;PTBP1;PCBP4;U2AF2
prerank,CellMarker_Augmented_2021__Astrocyte:Brain,0.32697328272887743,0.8496533036738252,0.72,0.9682822787334614,1.0,22/151,10.09%,EGLN3;TBC1D10A;LYPD1;MAFB;APOE;HNMT;SLC30A10;ST6GAL2;GRAMD2B;SLC39A11;SPON1;LHFPL6;CBS;DTNA;KCNH7;ATF3;ABCA1;DOK5;HIF3A;FGFR3;LPL;RND3
prerank,GO_Biological_Process_2021__adenosine metabolic process (GO:0046085),-0.5118130228106641,-0.8495481924397755,0.7142857142857143,1.0,1.0,2/6,11.90%,ADA;ACP3
prerank,Reactome_2022__NOTCH2 Activation And Transmission Of Signal To Nucleus R-HSA-2979096,0.41073542526716494,0.849543346120172,0.696969696969697,0.9682789937922343,1.0,6/19,22.85%,JAG1;MIB2;ADAM10;CNTN1;JAG2;MIB1
prerank,GO_Biological_Process_2021__muscle contraction (GO:0006936),-0.3521627215081211,-0.8494402952024653,0.7215189873417721,1.0,1.0,15/104,8.67%,LMOD1;MYH4;MYH7;CASQ2;ACTC1;MYH8;CAV3;MYOT;TMOD4;MYBPC3;TRDN;LTB4R;CHRNE;NEB;ACTN3
prerank,GO_Biological_Process_2021__positive regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains (GO:0002824),0.4990129808305275,0.8493925199500338,0.6111111111111112,0.9683305989205744,1.0,3/7,15.56%,ZBTB1;CARD9;IL23A
prerank,GO_Biological_Process_2021__actin filament depolymerization (GO:0030042),-0.48378867333114967,-0.8492061305869247,0.6666666666666666,1.0,1.0,2/11,13.00%,VIL1;CFL1
prerank,GO_Biological_Process_2021__phospholipid translocation (GO:0045332),0.35128272819046424,0.8491210361026154,0.7333333333333333,0.9686199480779462,1.0,8/28,19.88%,MFSD2A;ABCA1;ABCC1;PLSCR1;PLSCR4;ABCA7;ATP8A2;ATP10A
prerank,GO_Biological_Process_2021__artery development (GO:0060840),0.40351951662482943,0.8490554018237059,0.76,0.968456570626209,1.0,4/17,5.56%,TGFBR1;ROBO2;PKD2;HES1
prerank,GO_Biological_Process_2021__positive regulation of osteoclast differentiation (GO:0045672),-0.5359494366552198,-0.8487115017767778,0.75,1.0,1.0,1/5,8.37%,ATP6AP1
prerank,GO_Biological_Process_2021__internal protein amino acid acetylation (GO:0006475),-0.5469926512547107,-0.8486261481201042,0.7735849056603774,1.0,1.0,1/7,7.60%,HAT1
prerank,GO_Biological_Process_2021__DNA metabolic process (GO:0006259),-0.317513267043419,-0.8483226798459588,0.8157894736842105,1.0,1.0,27/252,19.40%,TICRR;MCM2;POLQ;HMGB3;TERF2IP;SP100;RPA3;MCM3;UBE2U;BRCA1;ENDOG;TERT;DNASE2;REXO4;RAD1;POLE2;NUDT15;PARP4;NT5E;POLD4;SMUG1;RPS27A;NOP53;CDC6;RAD54L;OGG1;RECQL4
prerank,GO_Biological_Process_2021__regulation of proteasomal protein catabolic process (GO:0061136),0.3196914257234717,0.8481323246669619,0.7037037037037037,0.9702263242481927,1.0,6/50,14.37%,APOE;COMMD1;OSBPL7;TMTC3;FOXF2;GPX1
prerank,CellMarker_Augmented_2021__FOXN4+ cell:Lung,0.3092345373904187,0.848045212560096,0.7727272727272727,0.9701493560242057,1.0,6/66,7.93%,BAMBI;SLFN11;DPY19L1;POGLUT3;DHFR;CASP3
prerank,GO_Biological_Process_2021__modulation by symbiont of host process (GO:0044003),-0.5078746175192372,-0.8479433521459244,0.711864406779661,1.0,1.0,5/10,31.83%,TLR2;RPS27A;UBB;PGK1;UBC
prerank,GO_Biological_Process_2021__epoxygenase P450 pathway (GO:0019373),0.45803160063476644,0.8478494771854929,0.7027027027027027,0.9702322806295305,1.0,3/10,6.53%,CYP1A2;EPHX2;CYP2S1
prerank,GO_Biological_Process_2021__positive regulation of protein targeting to membrane (GO:0090314),-0.41917459522971706,-0.8478424161741014,0.703125,1.0,1.0,3/23,11.77%,ITGB2;PDZK1;ITGAM
prerank,CellMarker_Augmented_2021__Ciliated cell:Lung,-0.3179330321446002,-0.8478306984791129,0.8333333333333334,1.0,1.0,39/211,20.44%,SMIM22;SPC25;DNAAF8;RPA3;CCDC81;VWA3B;AGBL5;NQO1;CCDC60;ERICH2;DRC1;AZIN1;ENDOG;CKB;AKAP14;LXN;SNTN;DALRD3;FAM81B;AHSA1;ANKRD65;APOBEC4;RRAGA;DYNLL1;PNMA1;HIPK1;CYSTM1;RRAD;PLEKHB1;CYB561A3;CYP4B1;CALM1;BASP1;PRPS1;CIBAR2;EFCAB10;KIF9;IFI27;PRDX1
prerank,GO_Biological_Process_2021__actin filament polymerization (GO:0030041),-0.41158834645915726,-0.8476559886703922,0.7213114754098361,1.0,1.0,6/27,17.19%,WAS;GAS7;VIL1;CATIP;PSTPIP1;RAC1
prerank,GO_Biological_Process_2021__calcium ion import across plasma membrane (GO:0098703),0.41336200138434,0.847589589619407,0.6222222222222222,0.9702793078803709,1.0,3/14,5.32%,TRPM2;SLC8A1;SLC8A3
prerank,GO_Biological_Process_2021__calcium ion import into cytosol (GO:1902656),0.41336200138434,0.847589589619407,0.6222222222222222,0.9702793078803709,1.0,3/14,5.32%,TRPM2;SLC8A1;SLC8A3
prerank,GO_Biological_Process_2021__negative regulation of mitotic cell cycle (GO:0045930),-0.3708337857582745,-0.8475703796211532,0.6944444444444444,1.0,1.0,3/42,6.24%,BUB1;TGFB1;ZWILCH
prerank,GO_Biological_Process_2021__regulation of apoptotic cell clearance (GO:2000425),-0.5162705248215609,-0.8475125278104783,0.7555555555555555,1.0,1.0,2/5,13.42%,TGM2;CD300LF
prerank,GO_Biological_Process_2021__phenol-containing compound biosynthetic process (GO:0046189),-0.5481245695116151,-0.8473108053164002,0.72,1.0,1.0,1/7,0.42%,DBH
prerank,GO_Biological_Process_2021__regulation of cellular response to growth factor stimulus (GO:0090287),0.40114792308674413,0.8472127286621671,0.7045454545454546,0.9707864616237837,1.0,5/14,11.12%,SLIT2;FSTL3;DOK5;ITGA3;TWSG1
prerank,GO_Biological_Process_2021__hematopoietic stem cell differentiation (GO:0060218),0.48563118337002875,0.8470845503241962,0.6326530612244898,0.9708371606807866,1.0,4/8,21.17%,SP7;MLLT3;TP53;ACE
prerank,GO_Biological_Process_2021__response to calcium ion (GO:0051592),-0.35093459451581716,-0.8468833567363959,0.7215189873417721,1.0,1.0,8/95,7.49%,AQP3;SCN5A;CASQ2;WNT5A;TRPV6;SYT10;SYT2;ALOX15
prerank,GO_Biological_Process_2021__ribonucleoside bisphosphate metabolic process (GO:0033875),-0.40150274968104904,-0.8468253118715715,0.7361111111111112,1.0,1.0,6/28,14.71%,ACSM6;ACOT6;ACOT4;ACSM3;ACOT1;ACOT2
prerank,GO_Biological_Process_2021__purine nucleoside bisphosphate metabolic process (GO:0034032),-0.40150274968104904,-0.8468253118715715,0.7361111111111112,1.0,1.0,6/28,14.71%,ACSM6;ACOT6;ACOT4;ACSM3;ACOT1;ACOT2
prerank,GO_Biological_Process_2021__TRAIL-activated apoptotic signaling pathway (GO:0036462),-0.5241607403502805,-0.8466886808262487,0.7241379310344828,1.0,1.0,3/6,19.41%,SPI1;TNFRSF10A;CASP8
prerank,Reactome_2022__Asparagine N-linked Glycosylation R-HSA-446203,0.28223947879699646,0.8466811503632027,0.8461538461538461,0.9714304764729227,1.0,50/260,19.40%,MGAT4C;ST6GALNAC3;SPTBN4;DPM3;ST6GAL2;STX5;PRKCSH;ST8SIA4;ST3GAL3;B4GALT2;MAN1A2;TRAPPC1;SEC24C;SEC22A;GMDS;CNIH3;NPL;DYNC1I2;MAN2A1;B4GALT3;TGFA;NUS1;ALG12;TMED3;BET1;NAGK;UAP1;NEU4;GLB1;MAN1A1;NGLY1;PREB;COG7;CHST8;ANK2;ALG3;ST3GAL6;SEC22B;NEU3;CTSC;MOGS;GOLGB1;RNF185;MIA3;COG5;ST8SIA3;EDEM1;ST3GAL2;COG4;TMEM115
prerank,Reactome_2022__Formation Of RNA Pol II Elongation Complex R-HSA-112382,0.350049781811078,0.8466613981643396,0.7857142857142857,0.9711527238239541,1.0,15/55,31.71%,IWS1;ELOA;CCNH;MLLT3;GTF2F2;ERCC3;POLR2F;DMAP1;SSRP1;LEO1;ERCC2;AFF4;CDC73;CCNT1;POLR2C
prerank,Reactome_2022__IRAK2 Mediated Activation Of TAK1 Complex R-HSA-937042,0.43167565881149195,0.8465091393901661,0.6666666666666666,0.9712169368476175,1.0,4/10,20.40%,TAB3;TAB1;TAB2;TRAF6
prerank,GO_Biological_Process_2021__pyrimidine nucleoside metabolic process (GO:0006213),0.4154181949545054,0.8464599631254411,0.6818181818181818,0.9710168686523005,1.0,3/15,12.76%,NT5C1A;UPP2;NT5C3A
prerank,GO_Biological_Process_2021__positive regulation of toll-like receptor 4 signaling pathway (GO:0034145),0.48032908941200586,0.8461580022832619,0.7209302325581395,0.9713998997502049,1.0,3/8,15.48%,TICAM2;NR1H3;LBP
prerank,Reactome_2022__Norepinephrine Neurotransmitter Release Cycle R-HSA-181430,0.41856516005278777,0.8460047429754695,0.5714285714285714,0.971432107049744,1.0,4/17,18.10%,PPFIA3;SYT1;UNC13B;PPFIA2
prerank,GO_Biological_Process_2021__positive regulation of NF-kappaB transcription factor activity (GO:0051092),-0.34522580683762777,-0.8459687203162969,0.8,1.0,1.0,25/120,22.02%,TRIM62;AIM2;WNT5A;TERF2IP;CARD14;TRIM5;TRIM25;NFKB2;CLU;NLRC4;TLR2;PRKCH;NLRP3;IL18;AGT;TNFRSF11A;RPS27A;CAMK2A;NTRK1;TRIM68;ALK;AGER;AR;TNFSF18;TRIM22
prerank,GO_Biological_Process_2021__body fluid secretion (GO:0007589),0.4515599549960088,0.8459436961949998,0.5277777777777778,0.9712867768775657,1.0,1/11,3.16%,ZBTB7B
prerank,GO_Biological_Process_2021__negative regulation of muscle cell apoptotic process (GO:0010656),0.5328903961056822,0.845914865044655,0.7804878048780488,0.9710459776290241,1.0,3/7,8.53%,APOH;DIPK2A;LRP6
prerank,GO_Biological_Process_2021__negative regulation of NIK/NF-kappaB signaling (GO:1901223),-0.43572701097685435,-0.8457658833785034,0.6507936507936508,1.0,1.0,6/19,14.99%,NLRP12;UACA;SPI1;NLRC3;NLRP3;DDX3X
prerank,GO_Biological_Process_2021__negative regulation of myoblast differentiation (GO:0045662),-0.47673245520230106,-0.8457469561482499,0.676923076923077,1.0,1.0,1/11,1.49%,TGFB1
prerank,GO_Biological_Process_2021__regulation of canonical Wnt signaling pathway (GO:0060828),0.29154300681971523,0.8456940934662436,0.8636363636363636,0.9712147323348885,1.0,36/225,14.49%,LGR5;BAMBI;FGF10;PRICKLE1;APOE;PTPRO;CDK14;TLE2;SEMA5A;PSME4;ZEB2;DACT3;NKD1;ZNF703;GREM1;PSMA1;LATS1;IGFBP4;LRP6;WNT3A;SNAI2;LZTS2;GPC5;KANK1;WNK2;RBMS3;PPM1A;HDAC1;TMEM131L;RNF146;TPBGL;WLS;NFKB1;MLLT3;NKD2;WWTR1
prerank,GO_Biological_Process_2021__positive regulation of MAP kinase activity (GO:0043406),0.33176348741260103,0.8455204318973271,0.7272727272727273,0.9712969802469656,1.0,7/58,9.05%,KIT;FGFR1;ERBB2;PDGFD;FGF18;MAP3K10;TENM1
prerank,GO_Biological_Process_2021__regulation of interferon-alpha production (GO:0032647),-0.44566049279128245,-0.845413880855476,0.6774193548387096,1.0,1.0,3/16,14.99%,STAT1;NLRC3;DDX3X
prerank,GO_Biological_Process_2021__positive regulation of intracellular signal transduction (GO:1902533),0.27122802171964167,0.8452734090067037,0.9333333333333333,0.9715473878727566,1.0,86/441,15.06%,ADRA1A;ADRA1B;FGF10;THEM4;TGFBR1;KIT;HDAC3;BCL2;CFLAR;NEUROD2;FGFR1;KSR1;IRS1;NLGN1;ANGPT1;MAP3K14;HIP1;CDH13;NRG2;CD14;RIPK2;TICAM2;SEMA5A;CX3CR1;FGF17;SIRT1;AKR1C3;ERBB2;TNFSF14;PDGFD;NRG1;TNFRSF19;HPSE;TRIM8;LGALS1;TMEM106A;HMGB1;ECM1;MYORG;PPP5C;CARD9;FLNA;STYXL1;PLXNB1;FGF18;TGFA;EPOR;MLST8;GRM4;ALPK1;CASS4;HCLS1;AKT2;APOL3;FGFR3;KITLG;IRS2;SHARPIN;F2R;LGALS9;TRIM44;PPM1A;PIM2;TSPAN6;GPR89A;LIMS1;ADGRV1;RET;TICAM1;GAB1;FADD;CCDC22;NR3C2;TAB3;PELI1;TCIM;FLT3;WLS;BID;NFAT5;RYK;PELI2;INSR;PIK3CA;IRAK4;CXXC5
prerank,GO_Biological_Process_2021__regulation of epithelial to mesenchymal transition involved in endocardial cushion formation (GO:1905005),-0.49160030350991846,-0.845200909467819,0.7384615384615385,1.0,1.0,3/7,14.43%,TGFB1;ENG;TGFB3
prerank,GO_Biological_Process_2021__transcription initiation from RNA polymerase I promoter (GO:0006361),-0.3846413116045664,-0.8446936758791435,0.7428571428571429,1.0,1.0,3/31,10.93%,CAVIN1;POLR1C;POLR1G
prerank,Reactome_2022__Arachidonic Acid Metabolism R-HSA-2142753,-0.3722306431785922,-0.8444088661169106,0.7536231884057971,1.0,1.0,18/50,17.94%,ALOX12;CYP1B1;ALOX5;PTGR1;ALOX12B;PTGES;ALOX15;PON3;CYP2J2;PON1;GPX2;GGT5;AWAT1;ALOX15B;TBXAS1;PLA2G4A;ALOX5AP;CYP4B1
prerank,GO_Biological_Process_2021__protein monoubiquitination (GO:0006513),-0.3885781462553498,-0.8443343216134662,0.7301587301587301,1.0,1.0,5/35,16.68%,DTL;TRIM25;ATXN7L3;RBX1;RNF20
prerank,GO_Biological_Process_2021__positive regulation of inositol phosphate biosynthetic process (GO:0060732),-0.5531357340093315,-0.8442903837913679,0.7,1.0,1.0,2/6,9.43%,GPER1;P2RY6
prerank,GO_Biological_Process_2021__substrate-dependent cell migration (GO:0006929),0.4024704553210331,0.8442688561193591,0.7,0.9734201466233986,1.0,2/14,3.01%,VEGFC;ITGA11
prerank,GO_Biological_Process_2021__regulation of glial cell apoptotic process (GO:0034350),-0.5742232820437712,-0.8440291581029818,0.7735849056603774,1.0,1.0,1/5,12.91%,PRKCH
prerank,Reactome_2022__Antigen Processing: Ubiquitination And Proteasome Degradation R-HSA-983168,0.26837105965660246,0.8439112878120169,0.9166666666666666,0.973942364226941,1.0,68/278,22.37%,ASB18;RNF182;KLHL20;UBE2E3;ZNRF1;PSME4;SEM1;KLHL41;TRIM69;SH3RF1;UBE2J1;TRIM71;FBXO15;PSMA1;RBBP6;CBLB;UBE2O;UBE2E1;UBE2D4;ANAPC13;GAN;UBE2E2;FBXL14;UBE3D;RNF217;KLHL3;UBE2A;KLHL42;RNF130;FBXL20;KLHL22;ASB7;FBXO27;SMURF1;TRIM4;CDC26;HERC2;THOP1;KLHL5;UBE2Z;FBXO4;ASB6;NEDD4;UBE2L3;LONRF1;HERC5;LRSAM1;MIB2;ANAPC7;FBXO11;FBXL22;FBXO31;RNF19B;CDC34;UBE2J2;FBXO30;RNF19A;KCTD6;HECTD3;FBXO41;TRIM9;PSMD4;FZR1;UBE2D2;CUL1;ASB13;FBXO17;RNF25
prerank,CellMarker_Augmented_2021__Oligodendrocyte:Brain,0.3108333341599834,0.8438780714993559,0.76,0.9737011974034576,1.0,20/141,11.72%,LHFPL3;GRM3;PLPPR1;HIP1;CDH13;BIN1;PID1;KCNH8;SHC4;ZEB2;KCNIP3;SGK1;GRIK2;CDK18;RGR;IFITM10;NXPH1;CDHR1;NEU4;LRRN1
prerank,GO_Biological_Process_2021__positive regulation of supramolecular fiber organization (GO:1902905),-0.3510155900115851,-0.8438631134521136,0.725,1.0,1.0,15/79,17.90%,LMOD1;HCK;CAV3;C15ORF62;ALOX15;ANKRD53;CLU;DCTN1;VIL1;BAIAP2L1;F2RL1;VASP;RAC1;CDK5R1;BAIAP2L2
prerank,GO_Biological_Process_2021__cellular protein localization (GO:0034613),0.31618297858606825,0.8437956466915731,0.7692307692307693,0.9735600721240452,1.0,48/290,17.92%,TBC1D10A;FGF10;GRID2;SEPTIN10;ANGPT1;RAB31;TBC1D16;CNTLN;ABHD17A;TICAM2;CNTNAP2;STX5;TBC1D12;RAB28;RAB20;SCFD2;STX6;BICD1;STX8;FLNA;RAP2A;SYNDIG1;GGA1;TMED3;CROCC;RPGR;TBC1D22B;CEP250;EVI5L;TBC1D4;ACD;ARL5A;SNX9;COG7;WLS;SMURF1;SEPTIN9;SEPTIN8;ANK2;HERC2;RAB5A;TBC1D8B;ARFIP1;VPS26C;TBC1D2;TBCK;NIPBL;CEP68
prerank,Reactome_2022__Reactions Specific To Complex N-glycan Synthesis Pathway R-HSA-975578,0.5096255004077738,0.8437878902456943,0.7272727272727273,0.9732646958885707,1.0,2/8,13.70%,MAN2A1;CHST8
prerank,Reactome_2022__Defensins R-HSA-1461973,0.47861415625392034,0.8436486406198275,0.6666666666666666,0.9732463128473555,1.0,1/8,1.28%,PRSS3
prerank,Reactome_2022__ABC Transporter Disorders R-HSA-5619084,-0.3470175540198784,-0.8435662242043679,0.7162162162162162,1.0,1.0,10/70,19.11%,PSMB9;ABCC6;KCNJ11;ERLEC1;ABCA12;PSMA3;RPS27A;ABCB11;PSMA7;PSMB6
prerank,CellMarker_Augmented_2021__Placenta cell:Placenta,-0.37067356241677646,-0.8435375316075319,0.6865671641791045,1.0,1.0,12/42,18.43%,CLCA1;MISP;SOWAHA;HNF1A;SPINK4;FOXA3;NOS2;MUC17;FGFR4;USH1C;LGALS4;ADGRG7
prerank,GO_Biological_Process_2021__aspartate family amino acid metabolic process (GO:0009066),0.4030584688868728,0.8435196976763941,0.6388888888888888,0.9732324775128479,1.0,3/18,13.71%,NAALAD2;SLC25A12;MTHFR
prerank,GO_Biological_Process_2021__morphogenesis of an epithelium (GO:0002009),-0.41705941587973183,-0.8434663258345607,0.7,1.0,1.0,4/24,10.18%,FLG2;SOX10;ACTG1;ARHGAP12
prerank,GO_Biological_Process_2021__long-chain fatty-acyl-CoA metabolic process (GO:0035336),-0.41923335780972454,-0.843327381112993,0.765625,1.0,1.0,2/22,4.18%,ELOVL2;ACSL5
prerank,GO_Biological_Process_2021__vascular associated smooth muscle contraction (GO:0014829),0.4817126352874588,0.8433046648756727,0.5813953488372093,0.9734590152958175,1.0,2/7,7.93%,SLC8A1;EDNRA
prerank,KEGG_2021_Human__Adherens junction,-0.3553033605980233,-0.8432608726451036,0.7702702702702703,1.0,1.0,6/68,7.51%,TCF7;CTNNA1;CTNNA3;TCF7L1;ACTG1;WAS
prerank,CellMarker_Augmented_2021__Osteoblast:Bone Marrow,0.3284970400438041,0.8432223618694333,0.696969696969697,0.9730278541148986,1.0,5/68,3.48%,NLRP9P1;VCAN;CLC;TSHZ3;ADGRG3
prerank,CellMarker_Augmented_2021__Pluripotent Stem cell:Embryoid Body,0.3284970400438041,0.8432223618694333,0.696969696969697,0.9730278541148986,1.0,5/68,3.48%,NLRP9P1;VCAN;CLC;TSHZ3;ADGRG3
prerank,GO_Biological_Process_2021__positive regulation of neutrophil extravasation (GO:2000391),0.5405557934829489,0.8430907843752753,0.7291666666666666,0.973018632763041,1.0,1/5,22.36%,ADAM8
prerank,GO_Biological_Process_2021__negative regulation of alcohol biosynthetic process (GO:1902931),0.4315182637418512,0.8430632227667835,0.6829268292682927,0.9727784027342519,1.0,2/11,14.09%,APOE;NFKB1
prerank,Reactome_2022__Polymerase Switching On C-strand Of Telomere R-HSA-174411,0.3665050736250089,0.8430388775559163,0.6486486486486487,0.9725564314048014,1.0,6/23,15.95%,SLC19A1;POLD3;CTC1;TERF1;ACD;DSCC1
prerank,Reactome_2022__ESR-mediated Signaling R-HSA-8939211,0.30153887767640386,0.8429726440659266,0.8181818181818182,0.9724251334052894,1.0,39/151,20.98%,BCL2;CBFB;KCNH8;MMP2;H2BC21;NCOA3;NCOA2;PPP5C;NRIP1;NANOS3;MYC;TGFA;MOV10;AKT2;KANK1;TNRC6C;HDAC1;GREB1;CARM1;H2AX;GTF2F2;PIK3CA;CXXC5;RUNX1;TNRC6A;CHD1;PMEPA1;AGO3;GNG7;EP300;CREB1;KAT2B;H2AJ;POU2F1;AGO2;FOS;GNAI2;KCTD6;XPO1
prerank,GO_Biological_Process_2021__pyruvate metabolic process (GO:0006090),-0.388908141845131,-0.8428732700237095,0.7763157894736842,1.0,1.0,14/47,16.64%,HK2;ENO4;SLC16A8;ALDOB;PKLR;ENO2;GAPDHS;PDHX;SLC16A3;PGAM1;VDAC1;SDS;HK3;PGAM2
prerank,Reactome_2022__GRB2:SOS Provides Linkage To MAPK Signaling For Integrins R-HSA-354194,-0.4991581063007311,-0.8428302610438484,0.696969696969697,1.0,1.0,3/11,19.91%,VWF;ITGA2B;FN1
prerank,CellMarker_Augmented_2021__Corneal Endothelial cell:Corneal Endothelium,-0.3573144143907183,-0.842733939131322,0.7285714285714285,1.0,1.0,6/85,2.72%,TRIL;CYYR1;LMOD1;TIMP3;ANGPTL2;TSPAN11
prerank,CellMarker_Augmented_2021__Central Memory T cell:Peripheral Blood,-0.5651678647056826,-0.8427109518298428,0.7540983606557377,1.0,1.0,3/5,15.75%,PTPRC;CD27;CD4
prerank,CellMarker_Augmented_2021__Effector T cell:Peripheral Blood,-0.5651678647056826,-0.8427109518298428,0.7540983606557377,1.0,1.0,3/5,15.75%,PTPRC;CD27;CD4
prerank,CellMarker_Augmented_2021__Effector Memory T cell:Peripheral Blood,-0.5651678647056826,-0.8427109518298428,0.7540983606557377,1.0,1.0,3/5,15.75%,PTPRC;CD27;CD4
prerank,GO_Biological_Process_2021__regulation of peptidyl-lysine acetylation (GO:2000756),0.4963466463862032,0.8426005832134932,0.5897435897435898,0.9729003426839615,1.0,3/9,19.55%,SIRT1;DIP2B;PRKAA2
prerank,Reactome_2022__NRAGE Signals Death Thru JNK R-HSA-193648,0.35022141420127717,0.84253345070539,0.7272727272727273,0.9727599716706729,1.0,6/51,8.44%,NGF;PLEKHG2;FGD4;PRPF38B;MAPK8;FGD1
prerank,GO_Biological_Process_2021__endomembrane system organization (GO:0010256),0.294350652822226,0.8424307325213491,0.7727272727272727,0.9726422997490483,1.0,41/179,25.99%,CTDNEP1;TOR1B;TICAM2;BLZF1;GBF1;UBXN2A;REEP6;SMPD4;EIF2AK3;TRAPPC12;TMED3;PI4K2B;ARHGAP21;COG7;FAM174B;GOLGB1;MIA3;DOP1B;TMCC1;COG4;UBXN2B;TRIP11;USP6NL;SEC61A1;TRAPPC11;COG2;VPS51;SEC31A;MYO18A;COG3;VMP1;BNIP1;ANK3;HOOK3;ZNF501;GOLGA8H;CUL7;SYNE1;TRAPPC8;DNAJC28;SEC23IP
prerank,GO_Biological_Process_2021__ERAD pathway (GO:0036503),0.3233349768681938,0.8423604443769116,0.9333333333333333,0.9724659197360156,1.0,18/84,22.28%,AUP1;DERL3;UBE2J1;RHBDD1;MAN1A1;FBXO27;RHBDD2;TMUB2;POMT2;RNF185;UBE4B;EDEM1;TMEM67;UBXN4;UBE2J2;RNF139;BAG6;FBXO17
prerank,GO_Biological_Process_2021__regulation of striated muscle cell differentiation (GO:0051153),0.5326679897783368,0.8422967593235366,0.6037735849056604,0.9723303273047897,1.0,3/6,20.80%,NRG1;HDAC5;RBM24
prerank,GO_Biological_Process_2021__regulation of lipid catabolic process (GO:0050994),-0.48009287528899647,-0.8422429275083392,0.6842105263157895,1.0,1.0,3/10,20.42%,ANGPTL3;ABCB11;ALK
prerank,CellMarker_Augmented_2021__Osteoclast:Bone,0.48203031707036487,0.8421287717757947,0.6976744186046512,0.9724523853451155,1.0,2/6,15.38%,THNSL2;NCAM1
prerank,GO_Biological_Process_2021__protein sumoylation (GO:0016925),0.3344648791157606,0.8420650322200155,0.8285714285714286,0.9723620527042419,1.0,14/51,27.98%,NUP210;NUP42;BCL11A;AAAS;RNF212;NSMCE2;RANBP2;NUP214;TPR;SEH1L;NUP153;NUP98;SAE1;NUP37
prerank,GO_Biological_Process_2021__neuron differentiation (GO:0030182),0.32833331448486175,0.8420166588840414,0.8947368421052632,0.9721633901418282,1.0,29/120,15.95%,TGFBR1;NEUROD2;POU3F2;WNT4;FZD5;ATOH7;ERBB2;RORB;LHX2;USH2A;WNT9A;FZD1;CASP3;TENM3;NR4A2;LRP6;WNT3A;TENM1;ADNP2;NLGN4X;UGDH;MYT1L;ASCL1;FUT9;ANOS1;SNPH;RYK;RUNX1;PTPRD
prerank,GO_Biological_Process_2021__positive regulation of pri-miRNA transcription by RNA polymerase II (GO:1902895),-0.42877850164881726,-0.8420019751084653,0.7538461538461538,1.0,1.0,5/25,16.15%,TGFB1;TERT;SPI1;GNL3;SMAD3
prerank,Reactome_2022__Defective B4GALT1 Causes B4GALT1-CDG (CDG-2d) R-HSA-3656244,-0.5571220131084332,-0.8419802968463914,0.7241379310344828,1.0,1.0,2/5,10.43%,OGN;OMD
prerank,GO_Biological_Process_2021__proteoglycan metabolic process (GO:0006029),0.3786291244653443,0.8418680083582644,0.6666666666666666,0.9721950949384164,1.0,8/23,13.70%,CSGALNACT1;ADAMTS12;CHST12;HPSE;CHST11;HS3ST4;FAM20B;CHST8
prerank,Reactome_2022__Neddylation R-HSA-8951664,0.2554644872367866,0.8417305034958807,1.0,0.9721726210751961,1.0,25/210,13.89%,ASB18;KLHL20;COMMD4;COMMD1;PSME4;SEM1;COMMD6;ERCC8;KLHL41;FBXO15;DCUN1D1;PSMA1;HIF3A;DCAF13;WDTC1;GAN;FBXL14;KLHL3;KLHL42;CCDC22;FBXL20;KLHL22;ASB7;FBXO27;SENP8
prerank,GO_Biological_Process_2021__prostaglandin metabolic process (GO:0006693),0.3887543356614901,0.8416087646802117,0.6571428571428571,0.9721185772340658,1.0,8/24,18.13%,PTGS1;AKR1C3;CYP2S1;AKR1C1;CES2;PTGR2;PTGIS;ACOX1
prerank,GO_Biological_Process_2021__regulation of axon extension involved in axon guidance (GO:0048841),0.36400799647724813,0.8416004923787563,0.7058823529411765,0.9718480584749349,1.0,4/23,9.68%,SEMA6C;SEMA5A;DSCAM;SEMA4A
prerank,GO_Biological_Process_2021__positive regulation of calcium ion transmembrane transporter activity (GO:1901021),-0.4614328935012282,-0.8413382054328082,0.7627118644067796,1.0,1.0,5/20,18.02%,STAC;TRDN;P2RY6;JPH2;CALM1
prerank,CellMarker_Augmented_2021__Dental Pulp Stem cell:Premolar,-0.5185392933602482,-0.8413116139813314,0.7,1.0,1.0,5/8,18.10%,PTPRC;ITGAM;ENG;NT5E;ANPEP
prerank,Reactome_2022__Formation Of Incision Complex In GG-NER R-HSA-5696395,-0.3851755781972545,-0.8412513159175751,0.7575757575757576,1.0,1.0,14/39,34.67%,RPA3;RBX1;RPS27A;DDB1;CDK7;PARP2;UBB;CETN2;ERCC4;UBC;GTF2H5;RAD23B;UBE2V2;RNF111
prerank,GO_Biological_Process_2021__negative regulation of ERK1 and ERK2 cascade (GO:0070373),0.36108261898583216,0.8412495506184701,0.6944444444444444,0.9724615086376959,1.0,7/43,11.02%,DUSP4;SPRED3;RGS14;PTPRR;SPRED2;WNK2;SPRED1
prerank,GO_Biological_Process_2021__regulation of lymphocyte proliferation (GO:0050670),-0.46851514661112836,-0.8412047402630364,0.7333333333333333,1.0,1.0,5/15,16.70%,AHR;TNFRSF1B;IL27;IL12A;TNFSF8
prerank,Reactome_2022__Phospholipid Metabolism R-HSA-1483257,0.28623727758829753,0.8411705914159946,0.8571428571428571,0.9722992380862961,1.0,45/190,20.45%,BCHE;PLD6;SLC44A5;MFSD2A;PITPNM1;PI4KB;CPNE7;PRKCSH;PIK3C2B;PNPLA3;ABHD3;CHPT1;PGS1;CEPT1;PI4K2B;CRLS1;AWAT2;LPCAT2;GPD2;CHKA;GPD1;CPNE6;PLA2G4C;AGPAT5;PIK3CA;PLA2G15;ACHE;MTMR3;PIP4K2A;AGPAT2;RAB5A;LPIN2;LCLAT1;GDPD5;ABHD4;PIK3R5;PLA2G5;MTMR14;CPNE1;SBF2;MTMR1;HADHB;OSBPL8;MTM1;PLD2
prerank,Reactome_2022__Synthesis Of UDP-N-acetyl-glucosamine R-HSA-446210,0.4600201237207471,0.8408711021451051,0.7073170731707317,0.9726417929724608,1.0,3/8,20.23%,NAGK;UAP1;GNPNAT1
prerank,GO_Biological_Process_2021__parallel actin filament bundle assembly (GO:0030046),0.48774464720603594,0.8406190349674062,0.6829268292682927,0.9728489873560798,1.0,3/6,15.74%,SPIRE2;FSCN1;ESPN
prerank,GO_Biological_Process_2021__regulation of neuron apoptotic process (GO:0043523),0.32819846187730833,0.8401579495763793,0.7894736842105263,0.9735829997336907,1.0,7/77,3.00%,NGF;EGLN3;GRID2;BCL2;APOE;EPHA7;SLC30A10
prerank,CellMarker_Augmented_2021__Exhausted T cell:Undefined,-0.5064242991372894,-0.8400660726359963,0.7666666666666667,1.0,1.0,2/8,15.75%,CD160;CD4
prerank,Reactome_2022__Insertion Of Tail-Anchored Proteins Into Endoplasmic Reticulum Membrane R-HSA-9609523,0.3786670915249187,0.8399865050629054,0.6764705882352942,0.9736862303134476,1.0,3/18,21.95%,STX5;UBE2J2;BAG6
prerank,Reactome_2022__Maturation Of Spike Protein R-HSA-9683686,0.5503786918169712,0.8399294259343141,0.7142857142857143,0.9734968289579701,1.0,2/5,16.52%,PRKCSH;MOGS
prerank,GO_Biological_Process_2021__modulation by host of viral process (GO:0044788),0.4712968522712102,0.8398737524897558,0.6842105263157895,0.9733165409691057,1.0,2/9,2.66%,PC;APOE
prerank,GO_Biological_Process_2021__nuclear polyadenylation-dependent tRNA catabolic process (GO:0071038),-0.519699030816152,-0.8397925557817556,0.7068965517241379,1.0,1.0,2/5,22.14%,EXOSC8;EXOSC2
prerank,GO_Biological_Process_2021__nuclear polyadenylation-dependent rRNA catabolic process (GO:0071035),-0.519699030816152,-0.8397925557817556,0.7068965517241379,1.0,1.0,2/5,22.14%,EXOSC8;EXOSC2
prerank,GO_Biological_Process_2021__nuclear polyadenylation-dependent ncRNA catabolic process (GO:0071046),-0.519699030816152,-0.8397925557817556,0.7068965517241379,1.0,1.0,2/5,22.14%,EXOSC8;EXOSC2
prerank,GO_Biological_Process_2021__tRNA surveillance (GO:0106354),-0.519699030816152,-0.8397925557817556,0.7068965517241379,1.0,1.0,2/5,22.14%,EXOSC8;EXOSC2
prerank,GO_Biological_Process_2021__response to molecule of bacterial origin (GO:0002237),0.34514132474340786,0.8395294331233579,0.8,0.9738650969428265,1.0,12/49,16.50%,MAPKAPK2;CD14;FZD5;SRR;SNCA;FER;RPS6KA3;F2R;LGALS9;PELI1;LBP;OTUD5
prerank,GO_Biological_Process_2021__potassium ion transmembrane transport (GO:0071805),0.2927149372576727,0.8393542524221924,0.9375,0.9740355738526293,1.0,16/120,9.13%,KCNK6;SLC12A1;KCNB2;KCNC2;KCNH8;PKD2;HCN1;KCNH7;KCNJ3;KCNG1;SLC12A9;KCNJ6;TMEM175;KCND2;KCNK2;ABCC8
prerank,GO_Biological_Process_2021__regulation of amyloid-beta clearance (GO:1900221),-0.4694171391902707,-0.8391460051420881,0.6176470588235294,1.0,1.0,2/12,8.95%,LRPAP1;CLU
prerank,GO_Biological_Process_2021__negative regulation of protein localization to cell periphery (GO:1904376),-0.426156683133179,-0.8390885487601888,0.6666666666666666,1.0,1.0,5/19,12.29%,TGFB1;DAB2;RHOQ;GBP1;MRAP
prerank,GO_Biological_Process_2021__positive regulation of cellular component movement (GO:0051272),-0.44448412189344494,-0.8390884141046316,0.7301587301587301,1.0,1.0,2/21,6.86%,DUOX1;CAVIN1
prerank,Reactome_2022__PLC Beta Mediated Events R-HSA-112043,0.3399311650179292,0.8389853067741919,0.8461538461538461,0.9744532098463702,1.0,16/45,27.09%,ITPR2;PLCB1;PDE1A;ADCY2;PRKAR2A;ADCY6;CREB1;GNAQ;NBEA;GNA11;PDE1B;PRKCD;PRKACB;PLCB3;ADCY9;GNA14
prerank,GO_Biological_Process_2021__cellular response to amino acid stimulus (GO:0071230),0.3623497257420861,0.8387838067834442,0.6923076923076923,0.9745649815939516,1.0,2/33,5.55%,CPEB1;CAPN2
prerank,GO_Biological_Process_2021__regulation of protein localization to nucleus (GO:1900180),-0.37100044158048023,-0.8386295737273908,0.7419354838709677,1.0,1.0,3/37,7.54%,TGFB1;CTNNA1;LATS2
prerank,Reactome_2022__FCGR3A-mediated IL10 Synthesis R-HSA-9664323,0.36264495772668054,0.8385959124182737,0.7037037037037037,0.9745958128565465,1.0,4/29,10.12%,CD247;ITPR2;ADCY2;PRKAR2A
prerank,CellMarker_Augmented_2021__Meiotic Prophase Fetal Germ cell:Fetal Gonad,0.2577986493830516,0.8383913452046867,1.0,0.9747029830679091,1.0,232/930,21.40%,MSH4;GLIPR1L2;ADGRG6;PCM1;MLF1;NBPF8;SKAP1;RNF182;SLC26A7;KLHL20;NUP210;C16ORF95;IFT88;AASS;ADGRL2;CNTRL;SIMC1;C9ORF43;UBE2E3;URI1;KLF10;CNTLN;GABPB2;AK3;JADE3;CCDC112;RANBP17;PCF11;TBCCD1;ACSS2;SPOPL;ACBD3;RAB28;CRY1;SYDE2;SRR;SAMD15;FAM228B;HIRIP3;GLCCI1;RBM44;KRCC1;SH3RF1;RBM41;IL13RA2;PPP1R13B;RIC8A;CEP120;FANCL;FBXO15;RASA2;PRPF39;DUT;HFM1;SCAF4;TASOR2;CETN3;RALGPS2;NOL8;LATS1;ARHGAP20;TMEM175;MAP10;MGA;NKAP;RUNDC3B;SPAG16;SENP1;STX18;TUBE1;TAF12;FARP2;LCORL;C11ORF24;ZFYVE16;ATF1;BTBD10;DENND1B;COLEC11;UBE2D4;NSRP1;TERF1;RPS6KA3;ACER3;CEP250;ALDH1A2;ADNP2;UAP1;GKAP1;ZMAT1;KDM2A;ZNF652;SLC35G2;AGBL4;DDAH1;TRIM44;OSBPL11;GPR89A;DSEL;TXLNA;MACF1;CNKSR2;OXR1;MNS1;AK9;ARHGAP21;NGLY1;TANK;ENKD1;CSMD3;FBXL20;SPESP1;HYDIN;CCDC88A;ARID2;MXI1;MARK3;RNF212;EMC2;SNX9;CHD9;SNAP91;MMS22L;TRIP13;NF1;MPP2;NR3C1;NCOA5;NFAT5;SUCO;RP2;TEX15;TRIM4;CSPP1;ANKRD36;NKTR;RPS6KA6;HERC2;EYA3;LYRM1;ZNF131;FAM135A;MYO3A;URGCP;B3GALNT2;KLHL5;GPR89B;FLYWCH2;WDR3;ATAD2B;PARD6B;ZFC3H1;ANKRD62;FBXO4;MED13L;HPRT1;SMG1;SETD2;ELOVL1;ZNF346;ZDHHC13;MARK1;CSAD;TM2D1;GABRB2;ASH1L;RAD17;AGO3;THAP7;ZMYM5;PAWR;TSC22D2;HMOX2;PAX6;HERC5;CFAP70;NIPBL;RC3H1;ERCC3;BBIP1;LRSAM1;SLMAP;RSRP1;IMPACT;CEP350;DECR1;DNAJC1;PDE6D;DCAF10;ZNF445;DZIP1;ARFRP1;UNC119B;ARHGAP5;FBXO11;ZNF280B;ZCCHC7;ADD1;WDR31;CCDC152;COG4;GSAP;SH3GL1;ATF7IP2;ANKRD7;PTPDC1;RNF19B;CCDC181;JMJD1C;OSBPL8;SOCS7;ACVR2A;HLTF;KIF21A;RNF19A;ZNF595;FXR2;GNAS;C1D;HINFP;IQCB1;PHLPP2;NPC2;ZER1;ESCO2;GOLGA1;MTDH;ZNF441;USP42;ZNF664;AFTPH;ABCC9
prerank,CellMarker_Augmented_2021__Stem cell:Lacrimal Gland,0.3249631825824034,0.8382730028634378,0.8571428571428571,0.9740547920521336,1.0,14/80,11.24%,ADGRG6;PC;GOLT1A;PAPSS2;SDC4;PPARG;NTN4;DSP;CRIM1;KITLG;ARHGAP42;RNF128;COBL;DDAH1
prerank,CellMarker_Augmented_2021__Stem cell:Limbal Epithelium,0.3249631825824034,0.8382730028634378,0.8571428571428571,0.9740547920521336,1.0,14/80,11.24%,ADGRG6;PC;GOLT1A;PAPSS2;SDC4;PPARG;NTN4;DSP;CRIM1;KITLG;ARHGAP42;RNF128;COBL;DDAH1
prerank,CellMarker_Augmented_2021__Corneal Epithelial Progenitor cell:Embryonic Stem Cell,0.3249631825824034,0.8382730028634378,0.8571428571428571,0.9740547920521336,1.0,14/80,11.24%,ADGRG6;PC;GOLT1A;PAPSS2;SDC4;PPARG;NTN4;DSP;CRIM1;KITLG;ARHGAP42;RNF128;COBL;DDAH1
prerank,GO_Biological_Process_2021__myotube cell development (GO:0014904),-0.46708310508960293,-0.8380937078867279,0.6935483870967742,1.0,1.0,2/8,11.01%,LMOD3;CAV2
prerank,GO_Biological_Process_2021__camera-type eye photoreceptor cell differentiation (GO:0060219),0.5357747342335196,0.8379503698593239,0.7058823529411765,0.9745298666510188,1.0,2/5,21.34%,DSCAM;SDK2
prerank,GO_Biological_Process_2021__histone monoubiquitination (GO:0010390),0.4199793203088261,0.8378462909596137,0.5555555555555556,0.9744261064892092,1.0,7/23,19.89%,PCGF1;RNF168;UBE2E1;RYBP;BCOR;RNF40;RNF2
prerank,KEGG_2021_Human__Butanoate metabolism,-0.4036102752808094,-0.8377460620501086,0.7123287671232876,1.0,1.0,3/24,10.54%,GAD1;ACSM6;ACSM3
prerank,GO_Biological_Process_2021__regulation of stem cell population maintenance (GO:2000036),-0.43119852967145444,-0.8371605078890874,0.6774193548387096,1.0,1.0,4/19,18.89%,NODAL;REST;HMGA2;TAF6L
prerank,GO_Biological_Process_2021__acylglycerol acyl-chain remodeling (GO:0036155),-0.5271424627480394,-0.8371468812313695,0.7384615384615385,1.0,1.0,1/7,4.57%,DGAT2L6
prerank,Reactome_2022__Acyl Chain Remodeling Of DAG And TAG R-HSA-1482883,-0.5271424627480394,-0.8371468812313695,0.7384615384615385,1.0,1.0,1/7,4.57%,DGAT2L6
prerank,GO_Biological_Process_2021__mRNA pseudouridine synthesis (GO:1990481),0.4818874044871232,0.8371172906431903,0.6744186046511628,0.975667470304666,1.0,1/7,14.89%,PUS7
prerank,GO_Biological_Process_2021__NLS-bearing protein import into nucleus (GO:0006607),0.3810152080969535,0.8370846891188715,0.7368421052631579,0.9754558588011324,1.0,4/19,19.62%,CBLB;KPNA6;RANBP2;RGPD5
prerank,GO_Biological_Process_2021__negative regulation of biomineral tissue development (GO:0070168),-0.4459833151184091,-0.8369051299313619,0.696969696969697,1.0,1.0,3/18,14.16%,TGFB1;ASPN;HEY2
prerank,GO_Biological_Process_2021__regulation of t-circle formation (GO:1904429),-0.5637300262183939,-0.8368700276469693,0.75,1.0,1.0,2/5,40.35%,ERCC1;SLX4
prerank,GO_Biological_Process_2021__regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion (GO:0010881),-0.46266797506870583,-0.8368531234006431,0.7428571428571429,1.0,1.0,1/15,1.74%,CASQ2
prerank,GO_Biological_Process_2021__protein K11-linked deubiquitination (GO:0035871),0.4549337385868565,0.836542701965192,0.6578947368421053,0.9763152980929922,1.0,3/8,21.91%,OTUD3;OTUD7B;OTUD7A
prerank,Reactome_2022__FOXO-mediated Transcription R-HSA-9614085,0.34054084389941613,0.8365371747119117,0.8148148148148148,0.9760319471478383,1.0,17/54,19.29%,FOXO1;BCL6;SIRT1;ABCA6;REXO2;AKT2;HDAC1;SMAD2;NFYC;NR3C1;GADD45A;MAP4K2;PLXNA4;EP300;PCBP4;FOXO6;KAT2B
prerank,GO_Biological_Process_2021__regulation of intracellular protein transport (GO:0033157),0.34624449438981714,0.8364992038161553,0.84375,0.9757935475371003,1.0,7/29,13.92%,PCM1;SIRT7;TENM1;GCC2;CEP290;B3GAT3;PLK3
prerank,GO_Biological_Process_2021__dendrite arborization (GO:0140059),-0.4938165203937498,-0.8364703320477078,0.6935483870967742,1.0,1.0,1/6,7.50%,SEMA3A
prerank,GO_Biological_Process_2021__positive regulation of phosphatidylinositol 3-kinase signaling (GO:0014068),0.32240159659857026,0.8364562812341859,0.8181818181818182,0.9755866284152006,1.0,16/62,18.04%,KIT;FGFR1;SIRT1;PDGFD;PLXNB1;EPOR;HCLS1;IRS2;F2R;GAB1;FLT3;INSR;PIK3CA;NEDD4;ROR1;PIK3R5
prerank,PanglaoDB_Augmented_2021__Smooth Muscle Cells,-0.3283552241178566,-0.8363316209708559,0.75,1.0,1.0,26/147,15.89%,LMOD1;ACTC1;TIMP3;ANGPTL2;HHIP;IRAG1;OBSCN;OGN;COL1A1;COL5A1;LOX;FBXL7;ADAM33;DAAM2;DCN;ITGA9;PRXL2C;COX7A1;MFAP5;NEXN;TEK;C1S;ADAMDEC1;ACTA2;JPH2;FBLN2
prerank,GO_Biological_Process_2021__cGMP metabolic process (GO:0046068),-0.497159118447178,-0.8362709895295365,0.7368421052631579,1.0,1.0,1/9,4.38%,GUCY2C
prerank,GO_Biological_Process_2021__negative regulation of proteolysis involved in cellular protein catabolic process (GO:1903051),0.3747587831108836,0.8362172244098763,0.7560975609756098,0.9758050048508796,1.0,2/25,7.51%,QRICH2;PML
prerank,KEGG_2021_Human__Dopaminergic synapse,0.32017464190826556,0.8362006084373621,0.782608695652174,0.975540042057514,1.0,33/116,26.11%,ITPR2;DRD5;CREB3L2;CREB3L4;ARRB2;KCNJ3;KCNJ6;DRD4;PLCB1;MAPK8;AKT2;PPP2R1B;ARRB1;GNAO1;MAPK12;PPP2R5D;GNG7;PPP1CB;CREB1;GNAQ;FOS;GNAI2;GNAS;PPP2R2B;GRIA4;CREB3L1;CACNA1A;CACNA1B;PPP3CC;PRKACB;PLCB3;COMT;AKT3
prerank,KEGG_2021_Human__Cushing syndrome,-0.3321241125985424,-0.8361922426811774,0.7710843373493976,1.0,1.0,21/135,17.21%,TCF7;AHR;WNT5A;WNT8B;CCND1;FZD8;TCF7L1;AIPL1;CYP21A2;WNT8A;CDKN1A;MRAP;WNT6;LEF1;ADCY7;ORAI1;ITPR3;CCNE2;AGT;WNT10A;HSD3B1
prerank,GO_Biological_Process_2021__negative regulation of cell morphogenesis involved in differentiation (GO:0010771),0.4202164834081307,0.8358770009483483,0.6571428571428571,0.9757260283294383,1.0,3/12,15.43%,EFNA5;KANK1;SPRY4
prerank,GO_Biological_Process_2021__negative regulation of substrate adhesion-dependent cell spreading (GO:1900025),0.4202164834081307,0.8358770009483483,0.6571428571428571,0.9757260283294383,1.0,3/12,15.43%,EFNA5;KANK1;SPRY4
prerank,Reactome_2022__GPER1 Signaling R-HSA-9634597,-0.378861097804839,-0.8358179418353401,0.6666666666666666,1.0,1.0,5/37,14.93%,GPER1;GNAT3;GNGT1;ITGA5;ADCY7
prerank,Reactome_2022__Formation Of Early Elongation Complex R-HSA-113418,0.34216417573078606,0.8357766964863624,0.6410256410256411,0.9756401323691998,1.0,4/31,22.28%,CCNH;GTF2F2;ERCC3;POLR2F
prerank,GO_Biological_Process_2021__negative regulation of cell death (GO:0060548),0.30460017274705375,0.8357570884050132,0.8518518518518519,0.9753889418086817,1.0,7/78,5.87%,CCN4;CCN2;HTRA2;CCN1;SNCA;SRGAP2;DCPS
prerank,Reactome_2022__Role Of Nef In HIV-1 Replication And Disease Pathogenesis R-HSA-164952,-0.4365221964796334,-0.8357315140677355,0.7258064516129032,1.0,1.0,3/26,7.32%,HCK;DOCK2;HLA-A
prerank,Reactome_2022__Activation Of Arylsulfatases R-HSA-1663150,-0.48066284812845195,-0.8356895078235765,0.7246376811594203,1.0,1.0,1/13,0.56%,ARSH
prerank,CellMarker_Augmented_2021__Tuft Progenitor cell:Small Intestine,0.4871117736347604,0.8356874399021726,0.7096774193548387,0.9752138483165393,1.0,2/7,8.67%,TPM2;TUBA8
prerank,GO_Biological_Process_2021__nucleic acid phosphodiester bond hydrolysis (GO:0090305),-0.35617502737619455,-0.8354692702281342,0.6933333333333334,1.0,1.0,8/63,19.05%,IHO1;RPA3;REXO4;RBX1;POLD4;RPS27A;DDX1;OGG1
prerank,GO_Biological_Process_2021__negative regulation of phosphatase activity (GO:0010923),0.3691612127014764,0.8353485974742055,0.6410256410256411,0.9755971269189961,1.0,4/24,8.23%,URI1;PPP1R35;BOD1L1;STYXL1
prerank,Reactome_2022__NOTCH4 Activation And Transmission Of Signal To Nucleus R-HSA-9013700,0.48771459830606434,0.8352612709591344,0.7058823529411765,0.9755203015724642,1.0,5/9,32.10%,JAG1;ADAM10;YWHAZ;NOTCH4;NCSTN
prerank,Reactome_2022__Transport To Golgi And Subsequent Modification R-HSA-948021,0.293540112363173,0.8350510952593234,0.875,0.9756443784721927,1.0,45/150,26.00%,MGAT4C;SPTBN4;STX5;B4GALT2;MAN1A2;TRAPPC1;SEC24C;SEC22A;CNIH3;DYNC1I2;MAN2A1;B4GALT3;TGFA;TMED3;BET1;MAN1A1;PREB;COG7;CHST8;ANK2;SEC22B;CTSC;GOLGB1;MIA3;COG5;ST8SIA3;COG4;TMEM115;TFG;CAPZA1;PPP6R3;CD55;COG2;SEC31A;ANK1;COG3;CNIH2;SPTB;B4GALT4;ANK3;CAPZB;SEC24B;COPB1;SEC23IP;ANKRD28
prerank,GO_Biological_Process_2021__positive regulation of nitric oxide biosynthetic process (GO:0045429),0.4132613239901975,0.8349246629818998,0.65625,0.9755631227136419,1.0,5/17,18.88%,DDAH2;PKD2;DDAH1;INSR;AGXT2
prerank,Reactome_2022__Regulation Of RAS By GAPs R-HSA-5658442,0.2993543953200072,0.8347973695716185,0.7857142857142857,0.9755399059920107,1.0,9/57,13.81%,SPRED3;PSME4;SEM1;RASA2;PSMA1;SPRED2;SPRED1;RASAL2;NF1
prerank,CellMarker_Augmented_2021__Hematopoietic Stem cell:Embryo,-0.37574492108315993,-0.8347558126944116,0.7307692307692307,1.0,1.0,13/57,14.75%,C1QB;LYVE1;SLCO2B1;MS4A4A;ZNF366;VSIG4;KCNQ1;VWF;ENG;FPR3;A2M;ADAMDEC1;GGT5
prerank,GO_Biological_Process_2021__response to steroid hormone (GO:0048545),-0.42145642449385196,-0.8347283766147845,0.65,1.0,1.0,8/28,16.69%,TGFB1;SOX30;UBE3A;THBS1;TGFB3;TFPI;YAP1;WBP2
prerank,"GO_Biological_Process_2021__regulation of gene expression, epigenetic (GO:0040029)",0.31470522660205097,0.8346913768384052,0.8095238095238095,0.9754141349659795,1.0,19/75,22.28%,SMYD5;IFI16;DNMT1;TAF1B;SF3B1;POLR1H;GPX1;MECP2;HDAC4;MYO1C;BAZ1B;MPHOSPH8;MACROH2A2;EP300;KAT2B;HDAC5;RBBP4;PHF1;POLR2F
prerank,GO_Biological_Process_2021__negative regulation of inflammatory response (GO:0050728),-0.3132000780928406,-0.8346863377554082,0.8378378378378378,1.0,1.0,23/146,16.67%,HCK;NLRP12;SCTR;ALOX5;TNFRSF1B;TSHR;GPER1;GPHB5;FCGR3A;GPR27;CGA;HLA-DRB1;GPR39;PTGDR;NLRC3;NLRP3;TEK;NR1H4;GGT5;ADCY7;GRN;ELANE;GHRL
prerank,GO_Biological_Process_2021__regulation of epidermal growth factor receptor signaling pathway (GO:0042058),-0.3632190569477504,-0.8346466996490054,0.7721518987341772,1.0,1.0,5/61,7.40%,EPN1;MMP9;GPER1;PDE6H;CEACAM1
prerank,Reactome_2022__Fatty acyl-CoA Biosynthesis R-HSA-75105,-0.38835641603902354,-0.8345712655047078,0.7096774193548387,1.0,1.0,7/32,15.67%,ELOVL2;ACSL5;TECRL;PPT1;OLAH;HACD4;ACSL3
prerank,Reactome_2022__FGFR2 Mutant Receptor Activation R-HSA-1839126,-0.3730843418495547,-0.8345466187234799,0.704225352112676,1.0,1.0,1/29,0.93%,FGF20
prerank,CellMarker_Augmented_2021__Exhausted CD8+ T cell:Liver,0.29196695212506635,0.8345159098415569,0.7894736842105263,0.9754890559008613,1.0,55/221,18.74%,CD38;DUSP4;RAB27A;SEL1L3;SAMSN1;OSBPL3;GOLIM4;JMJD4;ATXN1;TET2;IFI16;PFKP;WHRN;GTF2I;CHST12;TOX;HLA-DRA;ETV1;GMDS;CBLB;CASP3;NR4A2;SARDH;TTYH3;SEMA4A;CREM;LSM2;COTL1;GPD2;LIMS1;TBC1D4;SUSD6;UBASH3B;PLSCR1;SNX9;PELI1;STARD4;GBP4;NFAT5;RHBDD2;SSH1;GBP2;IL2RB;PTGIS;DGKH;ARL3;ARID5B;ZMYM5;NUDT5;PAM;RBPJ;LIMK1;RFX5;NASP;IFI27L2
prerank,GO_Biological_Process_2021__regulation of protein modification by small protein conjugation or removal (GO:1903320),0.41876582773732446,0.8345004758293011,0.7391304347826086,0.9752341269491825,1.0,3/18,12.47%,TGFBR1;DCUN1D1;HSPA1A
prerank,GO_Biological_Process_2021__positive regulation of potassium ion transport (GO:0043268),-0.3750864667007142,-0.8344729752888604,0.7285714285714285,1.0,1.0,3/37,14.00%,KCNJ15;KCNQ1;KCNJ4
prerank,GO_Biological_Process_2021__monocarboxylic acid biosynthetic process (GO:0072330),-0.3525952243181447,-0.8343804356315202,0.7397260273972602,1.0,1.0,9/56,10.54%,AMACR;LIPI;ACMSD;ACSM6;ALOX5;ACOX2;LIPH;HSD3B7;ACSM3
prerank,GO_Biological_Process_2021__lipid transport (GO:0006869),0.29999026901996967,0.8343503500122876,0.8148148148148148,0.9752065803562029,1.0,14/97,12.00%,SLC10A3;ABCA9;APOE;MFSD2A;PITPNM1;ABCA6;NCOA2;AKR1C1;ABCA1;ABCD3;LDLR;ABCD2;ACSL1;CHKA
prerank,GO_Biological_Process_2021__regulation of cell junction assembly (GO:1901888),0.38253953927775464,0.8343332029055083,0.8,0.9749296164179955,1.0,6/23,15.67%,CBFB;RAPGEF1;SNAI2;RAP1A;MYO1C;RUNX1
prerank,Reactome_2022__mRNA Editing R-HSA-75072,-0.5132487337942262,-0.8343215482833722,0.673469387755102,1.0,1.0,1/7,12.26%,APOBEC4
prerank,Reactome_2022__G Alpha (S) Signaling Events R-HSA-418555,-0.3436863695315062,-0.8342941215636449,0.8333333333333334,1.0,1.0,14/103,14.93%,C1QTNF1;SCTR;TSHR;GPER1;GPHB5;GNAT3;PTRH2;GPR27;GNGT1;GPR39;PTGDR;NLRP3;ITGA5;ADCY7
prerank,Reactome_2022__Antigen processing-Cross Presentation R-HSA-1236975,-0.3375755543413329,-0.8342723394470392,0.7333333333333333,1.0,1.0,12/83,19.11%,PSMB9;HLA-A;SNAP23;CYBA;TLR2;NDUFA2;HLA-F;PSMA3;ITGB5;RPS27A;PSMA7;PSMB6
prerank,Reactome_2022__NR1H2 And NR1H3 Regulate Gene Expression Linked To Lipogenesis R-HSA-9029558,0.44355897005667494,0.8342316760843302,0.6341463414634146,0.9748398369722676,1.0,2/9,15.39%,NRIP1;NR1H3
prerank,GO_Biological_Process_2021__positive regulation of Ras protein signal transduction (GO:0046579),0.33305053076137014,0.8341768301519172,0.7142857142857143,0.9746521774327656,1.0,8/54,10.74%,NGF;FGF10;GPR174;AUTS2;RAPGEF1;EPOR;IRS2;F2R
prerank,Reactome_2022__Condensation Of Prometaphase Chromosomes R-HSA-2514853,-0.4813991227277429,-0.8341142603488226,0.7121212121212122,1.0,1.0,4/9,31.95%,NCAPH;CSNK2A2;NCAPG;CCNB1
prerank,Reactome_2022__Signaling By SCF-KIT R-HSA-1433557,0.3352821907607652,0.8339837898599777,0.8333333333333334,0.9747805936917393,1.0,5/38,9.81%,SH2B2;KIT;STAT5B;FER;KITLG
prerank,Reactome_2022__Receptor Mediated Mitophagy R-HSA-8934903,-0.5073365891603643,-0.8336856343516189,0.6607142857142857,1.0,1.0,5/9,30.92%,FUNDC1;PGAM5;CSNK2A2;ULK1;MAP1LC3B
prerank,GO_Biological_Process_2021__photoreceptor cell development (GO:0042461),0.45617719936354617,0.833661242392138,0.5454545454545454,0.9750913375045922,1.0,5/12,10.84%,RP1L1;MFSD2A;RORB;CEP290;CDHR1
prerank,KEGG_2021_Human__Type II diabetes mellitus,0.3683846670873759,0.8334584143455208,0.7352941176470589,0.9752106517618214,1.0,8/37,14.95%,GCK;IRS1;MAPK8;ABCC8;IRS2;IRS4;INSR;PIK3CA
prerank,KEGG_2021_Human__Ribosome biogenesis in eukaryotes,-0.3501338288942832,-0.8334215214693469,0.7714285714285715,1.0,1.0,8/72,13.35%,SNORD3A;RPP38;REXO5;EIF6;PWP2;EMG1;NOB1;GNL3
prerank,GO_Biological_Process_2021__positive regulation of stress fiber assembly (GO:0051496),0.3421753465081273,0.8333327610058762,0.7105263157894737,0.9751387071287062,1.0,7/39,13.07%,TGFBR1;CCN2;SORBS3;ABL1;EVL;PXN;CCDC88A
prerank,GO_Biological_Process_2021__positive regulation of apoptotic signaling pathway (GO:2001235),0.35694949010039667,0.8331636171797016,0.6486486486486487,0.9752134873085341,1.0,9/46,15.44%,TGFBR1;BCL2;PML;WWOX;STYXL1;FADD;CRADD;BID;TP53
prerank,"GO_Biological_Process_2021__positive regulation of Wnt signaling pathway, planar cell polarity pathway (GO:2000096)",0.5206976391953091,0.8331342419307639,0.7142857142857143,0.9749905024770171,1.0,2/5,6.24%,RSPO3;NKD1
prerank,KEGG_2021_Human__Parkinson disease,-0.3199603348284164,-0.8330676397003447,0.8352941176470589,1.0,1.0,61/199,28.18%,COX6A1;SLC25A31;PINK1;UBE2L6;ATP5F1E;NDUFS2;COX6C;SLC18A2;ATP5MC3;ATP5PF;TUBA4A;COX7A1;VDAC1;NDUFA2;NDUFB4;NDUFC1;TUBA3D;ITPR3;COX7C;NDUFA1;NDUFB9;TUBB;PSMA3;TUBB6;COX7A2;TUBB2A;GNAL;CALM1;RPS27A;CAMK2A;COX4I1;PSMA7;PSMB6;NDUFB10;TXN;HSPA5;TUBB4A;NDUFS5;ATP5PB;NDUFB11;PSMA5;TUBB4B;ATP5F1A;SDHC;PSMD6;KLC1;NDUFB2;UCHL1;APAF1;PARK7;PSMC5;PSMB4;VDAC3;COX6B1;DAXX;NDUFS6;PSMB7;PSMD8;KLC4;ITPR1;CALM3
prerank,GO_Biological_Process_2021__cellular component assembly (GO:0022607),0.2862640729995303,0.832970886056909,0.75,0.9749675522798336,1.0,41/238,16.07%,TEAD2;LLGL1;CD247;RP1L1;QRICH2;MATN1;MITF;NLGN1;PARD3;LRRTM3;PARVA;FSCN3;PCLO;HES1;JHY;SLC7A9;PML;FZD1;SPAG16;FLNA;WNT3A;WASF3;CEP290;P3H4;NLGN4X;LIMS1;GEMIN5;NLGN3;QSOX1;ACD;EPS8;SNX9;TRIP13;MAGI1;YTHDF1;FSCN1;TP53;IL2RB;ESPN;PARD6B;CALD1
prerank,GO_Biological_Process_2021__heart process (GO:0003015),-0.4307536959205409,-0.8329536345335243,0.676923076923077,1.0,1.0,2/12,6.40%,ACTC1;TRDN
prerank,GO_Biological_Process_2021__regulation of cell size (GO:0008361),-0.4248826740385994,-0.8327929953285278,0.6461538461538462,1.0,1.0,2/22,4.02%,CAV3;VAV3
prerank,Reactome_2022__Post NMDA Receptor Activation Events R-HSA-438064,0.32635183536180323,0.8327807655685239,0.7777777777777778,0.9751311357327686,1.0,14/58,22.41%,LLGL1;GPRIN1;NRG1;PRKAR2A;RPS6KA3;MPP2;RPS6KA2;RPS6KA6;CREB1;PRKAA2;PRKAG2;DLG1;GIT1;LRRC7
prerank,Reactome_2022__G1/S DNA Damage Checkpoints R-HSA-69615,-0.3612259089746004,-0.8325838146731396,0.7538461538461538,1.0,1.0,16/60,27.50%,PSMB9;CDC25A;CDKN1A;CCNE2;PSMA3;RPS27A;PSMA7;PSMB6;CDKN1B;PSMA5;PSMD6;CHEK1;PSMC5;PSMB4;PSMB7;PSMD8
prerank,"GO_Biological_Process_2021__nucleotide-excision repair, DNA incision, 5'-to lesion (GO:0006296)",-0.39029352730833883,-0.8325303852354166,0.746268656716418,1.0,1.0,6/34,23.78%,RPA3;RBX1;POLD4;RPS27A;RPA2;DDB1
prerank,GO_Biological_Process_2021__regulation of establishment of protein localization to telomere (GO:0070203),0.474878164680651,0.8323976809954877,0.7441860465116279,0.9756586721903096,1.0,2/11,14.52%,TERF1;WRAP53
prerank,GO_Biological_Process_2021__regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum (GO:0010880),-0.4431309431559471,-0.8323380099263451,0.7230769230769231,1.0,1.0,4/21,18.02%,CASQ2;TRDN;DHRS7C;CALM1
prerank,GO_Biological_Process_2021__regulation of protein deubiquitination (GO:0090085),0.5107058447895794,0.8321247377000879,0.7567567567567568,0.9758840900253669,1.0,1/5,12.57%,TANK
prerank,Reactome_2022__Regulation Of Pyruvate Dehydrogenase (PDH) Complex R-HSA-204174,-0.4421655120994745,-0.8321029447540128,0.7164179104477612,1.0,1.0,5/15,24.93%,PLPP6;PDHX;LDHD;PDK4;PDK3
prerank,CellMarker_Augmented_2021__Gonadal Endothelial cell:Fetal Gonad,0.284137481160405,0.832078801889251,1.0,0.9756612369617741,1.0,91/414,16.67%,PNP;PHLDB2;LHFPL2;BCHE;EGLN3;EDIL3;LAMA4;KIT;TCIRG1;UTRN;PCDH17;GPR161;HSPB1;AMOTL1;ANGPT1;MIDN;RARB;RAB31;CCN2;ITGA8;CCN1;RALB;DNMT1;CHST12;VASH1;RBMS1;POGLUT2;KDM7A;IGFBP4;TSPAN18;CTDSP2;RALA;MAN2A1;EFNA5;RAP2A;ZEB1;PTPRM;H1-10;CHPF2;RALGAPA2;NAV3;MCMBP;PGS1;PDE4B;COTL1;CTTNBP2;F2R;FLRT2;MPDZ;CSRP1;TRIM44;TIMELESS;LIMS1;MMP16;PXN;MAN1A1;GAB1;IDH2;LRIG3;FNBP1;NFIB;SLC41A3;MMS22L;PELI1;ASB7;DOCK9;ARRB1;NAV1;NR2F2;NFKB1;BID;NFAT5;ADAM15;RPS6KA2;WWTR1;PELI2;FSCN1;SSH1;FAM171A1;ST3GAL6;TP53;CSRP2;MAP4K2;NMRK1;FRMD4A;PTPRE;DIXDC1;DIP2B;PIP4K2A;ELOVL1;NOTCH1
prerank,GO_Biological_Process_2021__negative regulation of natural killer cell mediated cytotoxicity (GO:0045953),0.4315442161655098,0.8319203735668113,0.6521739130434783,0.9757179642884596,1.0,3/11,11.29%,KLRD1;ARRB2;LGALS9
prerank,Reactome_2022__DNA Replication Pre-Initiation R-HSA-69002,-0.33601553782279164,-0.8315080873534466,0.7671232876712328,1.0,1.0,23/95,27.84%,PSMB9;RPA3;MCM3;H2BC4;H2AZ1;POLE2;PSMA3;RPS27A;CDC6;PSMA7;PSMB6;ORC6;POLE3;PSMA5;PSMD6;CDC7;PSMC5;MCM5;PSMB4;PSMB7;PSMD8;MCM10;MCM6
prerank,GO_Biological_Process_2021__apoptotic process (GO:0006915),0.2885794294841868,0.8314073462493111,0.8666666666666667,0.976528501204369,1.0,32/194,14.28%,ADRA1A;EGLN3;FOXO1;BCL2;CFLAR;HIP1;DAPK2;CD14;TNFSF14;PAX3;TNFRSF19;PAK5;TP53AIP1;DCC;CASP3;MYC;EFNA5;RNF152;MAP3K10;BNIP2;PLAGL1;DPF1;GDF6;FADD;PLSCR1;DPF2;CDK11A;PLK3;BID;MAGI3;ADAM15;AIFM2
prerank,CellMarker_Augmented_2021__Stem cell:Placenta,-0.347115776759195,-0.8313475660050932,0.8,1.0,1.0,16/89,14.21%,C1QTNF1;TIMP3;ANGPTL2;PDCD1LG2;TGFBI;COL1A1;COL5A1;LOX;DCN;HEG1;ITGBL1;ENG;COX7A1;PLAT;TEK;C1S
prerank,CellMarker_Augmented_2021__Mesenchymal Stem cell:Breast,-0.347115776759195,-0.8313475660050932,0.8,1.0,1.0,16/89,14.21%,C1QTNF1;TIMP3;ANGPTL2;PDCD1LG2;TGFBI;COL1A1;COL5A1;LOX;DCN;HEG1;ITGBL1;ENG;COX7A1;PLAT;TEK;C1S
prerank,GO_Biological_Process_2021__positive regulation of actin filament bundle assembly (GO:0032233),0.32911914681343873,0.8310024485569579,0.6842105263157895,0.9770681412661053,1.0,8/45,13.07%,TGFBR1;CCN2;SORBS3;ABL1;EVL;SYNPO;PXN;CCDC88A
prerank,GO_Biological_Process_2021__detection of visible light (GO:0009584),-0.47030339934648546,-0.8309146947323337,0.7419354838709677,1.0,1.0,3/15,9.71%,TULP1;PDE6B;RP1
prerank,GO_Biological_Process_2021__regulation of peroxisome proliferator activated receptor signaling pathway (GO:0035358),0.45658888908377426,0.8308463134660591,0.6153846153846154,0.9770446300389422,1.0,2/9,4.59%,PLIN5;SIRT1
prerank,KEGG_2021_Human__Chemical carcinogenesis,-0.3168166827162601,-0.830648834156523,0.8795180722891566,1.0,1.0,21/171,15.41%,CHRNA9;FGF20;AHR;MGST1;CCND1;CYP1B1;NR1I3;CYP3A5;ESR1;CDC25A;CYP2A6;PIK3R3;AIPL1;CYP3A4;HSD11B1;PIK3CB;RXRG;VDR;CYP2E1;ADCY7;FGF22
prerank,GO_Biological_Process_2021__positive regulation of ruffle assembly (GO:1900029),0.4445905097449131,0.83046563664067,0.675,0.9775527846391938,1.0,5/11,13.00%,NLGN1;DEF8;PLEKHM1;EPS8L2;EPS8
prerank,GO_Biological_Process_2021__regulation of platelet-derived growth factor receptor signaling pathway (GO:0010640),-0.4880723611348199,-0.8304058714286598,0.7142857142857143,1.0,1.0,2/10,12.51%,F7;APOD
prerank,"GO_Biological_Process_2021__regulation of retrograde protein transport, ER to cytosol (GO:1904152)",0.436134912242911,0.8303565916550236,0.6041666666666666,0.9774892817729918,1.0,2/13,6.23%,DERL3;UBE2J1
prerank,GO_Biological_Process_2021__antigen receptor-mediated signaling pathway (GO:0050851),0.27203576892935843,0.8303140263616643,1.0,0.9772929821878049,1.0,16/153,10.30%,CD38;SH2B2;SKAP1;CD247;BTN3A2;BCL2;HLA-DQB1;CSK;RIPK2;PSME4;HLA-DRA;PSMA1;ICOSLG;PAG1;DENND1B;PDE4B
prerank,GO_Biological_Process_2021__positive regulation of unsaturated fatty acid biosynthetic process (GO:2001280),-0.5458596058330709,-0.830266443381738,0.75,1.0,1.0,1/5,8.67%,ANXA1
prerank,GO_Biological_Process_2021__regulation of cGMP-mediated signaling (GO:0010752),0.49708704051441494,0.8302109475457394,0.6818181818181818,0.9772428732624614,1.0,1/5,3.75%,PDE10A
prerank,GO_Biological_Process_2021__positive regulation of cytoplasmic translation (GO:2000767),0.5531688098293411,0.8301918984075646,0.7441860465116279,0.977006935958235,1.0,1/6,25.92%,LIN28A
prerank,CellMarker_Augmented_2021__Multipotent Mesenchymal Stroma cell:Bone Marrow,-0.5028454741766835,-0.8300828787545551,0.6379310344827587,1.0,1.0,4/7,16.84%,PTPRC;ITGAM;ENG;NT5E
prerank,Reactome_2022__Neurotransmitter Receptors And Postsynaptic Signal Transmission R-HSA-112314,0.27612658318624306,0.830040314686169,0.875,0.9770277233647395,1.0,17/167,10.36%,GRIN3A;LLGL1;GABRA5;GABRR2;GPRIN1;CACNG4;GABRG3;GRIK1;NRG1;KCNJ3;NCALD;KCNJ6;PLCB1;ADCY2;CACNG2;PRKAR2A;RPS6KA3
prerank,GO_Biological_Process_2021__granulocyte chemotaxis (GO:0071621),-0.4254820633119723,-0.8299133000948951,0.7384615384615385,1.0,1.0,3/25,8.67%,ITGB2;CXCL13;ANXA1
prerank,GO_Biological_Process_2021__cellular response to ionizing radiation (GO:0071479),0.3562473851399022,0.8298595535788837,0.6296296296296297,0.9770706113560458,1.0,13/45,19.16%,SIRT1;IFI16;TANK;SPIDR;HSF1;GADD45A;TP53;LIG4;ATM;NIPBL;RAD9A;ATR;EEF1D
prerank,GO_Biological_Process_2021__negative regulation of centrosome duplication (GO:0010826),-0.4839997773965353,-0.8297672920659067,0.7037037037037037,1.0,1.0,2/10,15.21%,BRCA1;CCNF
prerank,GO_Biological_Process_2021__negative regulation of cilium assembly (GO:1902018),-0.45486489425598475,-0.8296553161844874,0.7741935483870968,1.0,1.0,3/11,21.02%,TCHP;YAP1;TBC1D7
prerank,GO_Biological_Process_2021__regulation of cell cycle (GO:0051726),0.2824858688286728,0.8295798904981686,0.8823529411764706,0.9773566437354084,1.0,50/256,16.83%,PER2;GRK5;MLF1;FGF10;TGFBR1;GMNC;BIN1;HTRA2;SIRT1;PKD2;MAGI2;GBF1;PROX1;PPP1R13B;ZNF703;MED25;CDK6;CDK4;PML;ABL1;NANOS3;MYC;SIPA1;LRP6;MAEA;PHACTR4;AKT2;ERN1;LIN52;BRINP1;PLAGL1;SETMAR;NLRP2B;PIM2;PPP1R9B;MLXIPL;JUNB;CDK11A;PNPT1;RPS6KA2;CDC26;MEN1;GADD45A;TP53;CDC14B;MAPK12;USP51;TBRG4;NOTCH1;ATM
prerank,Reactome_2022__Antimicrobial Peptides R-HSA-6803157,-0.4225686056793724,-0.8295699918612035,0.7142857142857143,1.0,1.0,12/22,23.56%,BPIFB1;CLU;SLC11A1;DEFB109B;TLR2;CD4;ELANE;ATOX1;PGLYRP1;DEFB119;PRTN3;PGLYRP2
prerank,GO_Biological_Process_2021__eye photoreceptor cell development (GO:0042462),-0.4580139345181397,-0.8293723667038201,0.6911764705882353,1.0,1.0,3/13,16.36%,TULP1;RP1;USH1C
prerank,Reactome_2022__Assembly Of Collagen Fibrils And Other Multimeric Structures R-HSA-2022090,-0.36991561998303596,-0.829349784919436,0.7638888888888888,1.0,1.0,12/51,11.85%,MMP9;COL18A1;COL1A1;COL5A1;COL27A1;LOX;COL4A4;COL4A3;LOXL4;PXDN;LAMC2;COL6A6
prerank,GO_Biological_Process_2021__tyrosine catabolic process (GO:0006572),0.5305294652823881,0.8293149930734318,0.7,0.9775496879173752,1.0,2/5,22.16%,GSTZ1;IL4I1
prerank,GO_Biological_Process_2021__membrane repolarization (GO:0086009),-0.4622908821972039,-0.8292962227697246,0.7313432835820896,1.0,1.0,4/14,22.70%,KCNQ1;KCNE3;ATP1A1;KCNE4
prerank,GO_Biological_Process_2021__lysosome localization (GO:0032418),-0.4101366748699639,-0.829183333675958,0.71875,1.0,1.0,2/32,1.95%,RAB34;S100A13
prerank,GO_Biological_Process_2021__arachidonic acid metabolic process (GO:0019369),-0.37143970456549236,-0.8290480164904465,0.7746478873239436,1.0,1.0,15/44,17.74%,ALOX12;CYP1B1;ALOX5;ALOX12B;PTGES;PLA2G10;ALOX15;CYP2A6;CYP2J2;CYP4F12;CYP2E1;AWAT1;ALOX15B;TBXAS1;PLA2G4A
prerank,Reactome_2022__Cyclin E Associated Events During G1/S Transition R-HSA-69202,-0.34414313435056576,-0.829045090873054,0.8125,1.0,1.0,11/74,19.11%,PSMB9;CCND1;CDC25A;CDKN1A;MAX;CCNE2;CKS1B;PSMA3;RPS27A;PSMA7;PSMB6
prerank,GO_Biological_Process_2021__global genome nucleotide-excision repair (GO:0070911),-0.4050577509098724,-0.8289940677981492,0.7575757575757576,1.0,1.0,10/24,34.67%,RBX1;RPS27A;DDB1;UBB;CETN2;ERCC4;UBC;GTF2H5;RAD23B;RNF111
prerank,Reactome_2022__Wax And Plasmalogen Biosynthesis R-HSA-8848584,0.44443432340430444,0.8289417675014915,0.7222222222222222,0.978104947900897,1.0,3/7,19.82%,AWAT2;DHRS7B;FAR2
prerank,GO_Biological_Process_2021__positive regulation of T cell mediated cytotoxicity (GO:0001916),-0.42333320232103977,-0.8288489546365466,0.6875,1.0,1.0,4/18,15.53%,HLA-A;HLA-DRB1;IL12A;HLA-F
prerank,GO_Biological_Process_2021__positive regulation of membrane potential (GO:0045838),-0.5047741405922459,-0.8285697704336183,0.6721311475409836,1.0,1.0,2/8,11.31%,STOML2;GLRX
prerank,GO_Biological_Process_2021__regulation of ceramide biosynthetic process (GO:2000303),0.415543044581578,0.8285064810503577,0.7560975609756098,0.9787658964511085,1.0,5/13,24.44%,NSMAF;SMPD3;SAMD8;PLA2G6;PRKCD
prerank,GO_Biological_Process_2021__myoblast fusion (GO:0007520),-0.4658345688800296,-0.828384882705328,0.6885245901639344,1.0,1.0,3/12,18.80%,ERVW-1;JAM2;CD81
prerank,CellMarker_Augmented_2021__Lymphoid Stem cell:Peripheral Blood,-0.329286775004895,-0.8283571941936514,0.8354430379746836,1.0,1.0,33/96,33.43%,RPA3;TEX30;SNRPD2;ERH;CDKN3;STRAP;HSPE1;CHCHD4;POLE3;PSMA5;PDCD5;CHAC2;PSMC5;CACYBP;PSMG1;CCT8;RPL26L1;PCNA;UCHL5;MRPL21;RAN;YEATS4;VBP1;MZT1;MED10;SNRPE;CKS2;POLR2K;SNRPA1;CDC123;MAGOH;UTP4;THOC7
prerank,GO_Biological_Process_2021__regulation of phosphatidylinositol biosynthetic process (GO:0010511),0.4998683793103091,0.8283569459640193,0.6538461538461539,0.978786127870325,1.0,1/5,3.39%,HTR2C
prerank,GO_Biological_Process_2021__negative regulation of developmental growth (GO:0048640),0.3748387710659127,0.8281969031583312,0.5666666666666667,0.9788593242894925,1.0,7/29,19.18%,KIAA0319;DCC;NKD1;FGFR3;DIP2B;WWC1;PTCH1
prerank,GO_Biological_Process_2021__positive regulation of T cell receptor signaling pathway (GO:0050862),-0.4428443957511145,-0.8281169862027701,0.765625,1.0,1.0,4/13,28.45%,TESPA1;CD81;RPS3;PRKD2
prerank,GO_Biological_Process_2021__regulation of protein phosphorylation (GO:0001932),0.2697598891449231,0.8280726545614207,0.9230769230769231,0.9788044876876041,1.0,31/230,9.44%,IRGM;FGF10;HDAC3;VEGFC;HSPB1;ANGPT1;CDH5;EPHA7;SPTBN4;CCN1;PID1;FGF17;SIRT1;ERBB2;RALB;ATF3;F2;EIF2AK3;FER;PML;ABL1;CCND3;SLIT2;EFNA5;RAP2A;FGF18;LRP6;WNT3A;LEPR;TNIK;AKT2
prerank,PanglaoDB_Augmented_2021__Merkel Cells,-0.3404916857161199,-0.8280080393714314,0.7428571428571429,1.0,1.0,15/55,19.93%,CLCA1;MISP;PIEZO2;VIL1;FOXA3;BCO1;NOS2;GPX2;NR1H4;USH1C;LGALS4;ADGRG7;SLC44A3;ACE2;CBLC
prerank,Reactome_2022__Metabolism Of Lipids R-HSA-556833,0.2491602958180088,0.8279545594539391,1.0,0.9787629198516022,1.0,132/648,18.71%,BCHE;CYP1A2;PTGS1;CYP7B1;ELOVL6;ACADS;THEM4;PLD6;HDAC3;MAPKAPK2;SLC44A5;ESYT3;ARSJ;EPHX2;MED17;RORA;MFSD2A;OSBPL3;ACAD10;OSBPL6;PITPNM1;SOAT1;SMARCD3;PPARG;CYP2U1;AKR1C3;PI4KB;CPNE7;PRKCSH;GLB1L;STS;NCOA3;NCOA2;ACER2;AKR1C1;MED25;SLC22A5;SMPD4;SEC24C;SLC27A2;ACACB;SOAT2;PIK3C2B;ABCA1;PNPLA3;ABHD3;ECHS1;ARSB;HACD1;ACOT9;SCD5;OSBPL7;SMPD3;ELOVL4;SLC25A1;FHL2;CHPT1;PGS1;ESYT2;PLPP2;NUDT19;ACER3;ACADM;ACBD4;STARD3NL;CEPT1;ACSL1;NEU4;PI4K2B;CRLS1;AWAT2;LPCAT2;GLB1;GPD2;MECR;CHKA;GPD1;CPNE6;CPT1A;ABCC1;SC5D;PLA2G4C;CHD9;CARM1;MED16;STARD4;TECR;CDK8;NFYC;BDH2;PPARGC1B;GPX1;AGPAT5;PIK3CA;ECI1;PTGR2;PPM1L;SULT2A1;NR1H3;PLA2G15;ACHE;TM7SF2;NEU3;PTGIS;MTMR3;MED13L;DHRS7B;PIP4K2A;ELOVL1;CERS4;AGPAT2;MED9;RAB5A;PCCA;LPIN2;SAMD8;LCLAT1;FAM120B;GDPD5;ABHD4;LTC4S;PIK3R5;MIA3;ACOX1;PLA2G5;MTMR14;FAAH2;CPNE1;SBF2;DECR1;PPP1CB;GBA2
prerank,GO_Biological_Process_2021__regulation of transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0090092),-0.3906468235559127,-0.8278643434072129,0.7205882352941176,1.0,1.0,4/25,11.81%,TGFB1;LATS2;SFRP4;ENG
prerank,CellMarker_Augmented_2021__Retinal Progenitor cell:Retina,-0.3461454162653856,-0.8276047063818918,0.7631578947368421,1.0,1.0,6/89,8.75%,ENPP2;CYYR1;ITM2A;SHISA6;ITGA9;CCND2
prerank,CellMarker_Augmented_2021__Embryonic Stem cell:Periodontal Ligament,-0.3461454162653856,-0.8276047063818918,0.7631578947368421,1.0,1.0,6/89,8.75%,ENPP2;CYYR1;ITM2A;SHISA6;ITGA9;CCND2
prerank,GO_Biological_Process_2021__cell junction organization (GO:0034330),-0.3536758476763954,-0.8275354353713062,0.8266666666666667,1.0,1.0,10/68,17.12%,TGFB1;MARVELD2;MYOT;CLDN1;ACTG1;LRP4;TGFB3;TJP3;SMAD3;VASP
prerank,Reactome_2022__Regulation Of Insulin Secretion R-HSA-422356,0.30068110936904396,0.8272960469509,0.7777777777777778,0.9797755673807198,1.0,18/67,25.33%,ITPR2;KCNC2;PLCB1;ABCC8;PRKAR2A;RAP1A;GNG7;ADCY6;RAPGEF3;GNAQ;GNAI2;GNAS;GNA11;RAPGEF4;CACNA1A;PRKACB;CHRM3;PLCB3
prerank,GO_Biological_Process_2021__organelle assembly (GO:0070925),0.28039913606484274,0.8272555859614843,0.9285714285714286,0.9795529466887686,1.0,94/372,23.26%,IRGM;AUP1;PCM1;HDAC3;IFT88;DZIP1L;PARVA;SCLT1;KLHL41;RAB7A;FHDC1;GBF1;STARD9;CILK1;BBS9;BICD1;UBXN2A;PRRC2C;MVB12A;SPAG16;FLNA;CNGA4;CHMP6;FARP2;MAPRE1;CEP290;EHD4;RPGR;CEP250;RAB11FIP3;AVIL;MKS1;SYNPO;CFAP410;CEP20;TTC36;SAC3D1;PLA2G4C;RILPL1;PIBF1;ARL13B;EXOC7;VTA1;KIAA0586;RP2;PTPN23;YTHDF1;CEP41;CEP162;CDC14B;IFT140;ATG2A;PATL1;NEK1;ARL3;SNF8;ATG16L2;NOTCH1;CFAP70;DCDC2;RC3H1;LSM14A;KIF3B;BBIP1;CFAP221;PDE6D;DZIP1;STAM2;UNC119B;CFAP43;TMEM67;PTPDC1;UBXN2B;EXOC6;TMEM138;WDR19;TTC39C;IQCB1;POC1B;FBF1;KIF27;EXOC4;ATG2B;TSG101;STING1;CDS1;SSTR3;ELAPOR1;ASAP1;ATG12;CORO1A;FAM161A;POGZ;WDR35
prerank,GO_Biological_Process_2021__dopamine metabolic process (GO:0042417),-0.44949639048002143,-0.8272043050415582,0.7333333333333333,1.0,1.0,2/16,8.03%,DBH;DAO
prerank,GO_Biological_Process_2021__protein tetramerization (GO:0051262),0.3092853337254577,0.8267091790560793,0.7741935483870968,0.9805162740649901,1.0,17/61,20.63%,TDO2;TRPM2;PKD2;SNCA;HCN1;ACACB;GRIN1;ALDH1A2;USP16;CPSF7;HPRT1;SAMHD1;SHMT2;KCNC3;APPL2;CRYZ;CPSF6
prerank,GO_Biological_Process_2021__establishment of spindle orientation (GO:0051294),-0.4021318050810567,-0.8266867066626203,0.71875,1.0,1.0,4/28,15.88%,MISP;GPSM2;DCTN1;NDEL1
prerank,Reactome_2022__RMTs Methylate Histone Arginines R-HSA-3214858,0.33672171704003506,0.826657878083977,0.8076923076923077,0.980377298255763,1.0,13/35,19.36%,SMARCD3;SMARCB1;CDK4;PBRM1;ARID1A;SMARCA2;SMARCA4;ARID2;CARM1;H2AX;ARID1B;PRMT5;H2AJ
prerank,GO_Biological_Process_2021__regulation of interleukin-17 production (GO:0032660),-0.4180618276841796,-0.8266328609043367,0.7323943661971831,1.0,1.0,5/19,17.08%,TGFB1;IL12A;NR1H4;IL18;VSIR
prerank,KEGG_2021_Human__TGF-beta signaling pathway,0.321925716248088,0.8263415197226094,0.7777777777777778,0.9806745631546976,1.0,16/80,14.19%,BAMBI;GREM2;TGFBR1;TGIF1;GREM1;LTBP1;SP1;RBL1;MYC;ZFYVE16;AMH;PPP2R1B;GDF6;NEO1;SMAD2;SMURF1
prerank,"GO_Biological_Process_2021__transcription, DNA-templated (GO:0006351)",0.2838922202399087,0.8263268761244128,1.0,0.980403492127145,1.0,36/198,18.26%,MLF1;PKNOX1;ZBTB7B;CBFB;TEFM;DTX1;IWS1;ARRB2;SLC25A33;PPP5C;TAF1B;NAT14;TAF3;NR4A2;TAF12;ELOA;CCNH;MED16;TRIP13;NFKB1;MLLT3;GTF2F2;SOX5;THRB;SNAPC3;GTF3C4;NFIC;HSF1;TP53;BAZ2A;POLR3G;GTF3C5;TAF4;PRMT5;ERCC3;NFX1
prerank,GO_Biological_Process_2021__epidermal growth factor receptor signaling pathway (GO:0007173),0.35311264225683525,0.8263194237388459,0.71875,0.9801237745430222,1.0,11/40,22.39%,DGKD;SLC30A10;TGFA;GAB1;EFEMP1;PIK3CA;BRAF;SOS1;KIF16B;NCK2;SHC3
prerank,GO_Biological_Process_2021__positive regulation of double-strand break repair (GO:2000781),0.3342958078744473,0.826290423956277,0.7037037037037037,0.979888239112934,1.0,14/37,17.85%,SHLD2;SHLD1;SETMAR;TIMELESS;KMT5C;SPIRE2;ARID2;SMCHD1;WRAP53;SPIDR;MGMT;FUS;KMT5B;PNKP
prerank,GO_Biological_Process_2021__glycolytic process through glucose-6-phosphate (GO:0061620),0.37403859725714955,0.8261928849675697,0.6451612903225806,0.9798024579394924,1.0,3/23,5.03%,GCK;ENO3;PFKP
prerank,CellMarker_Augmented_2021__Eosinophil:Sputum,-0.346388031446461,-0.8261866970553352,0.7662337662337663,1.0,1.0,6/67,5.17%,SERINC2;S100A13;CTNNA1;CCND1;CLDN1;SEMA3F
prerank,GO_Biological_Process_2021__blood vessel endothelial cell migration (GO:0043534),0.37506094370424,0.8260297805898105,0.6756756756756757,0.979861899757361,1.0,6/20,18.53%,CDH5;GREM1;SLIT2;GPLD1;MIA3;NR4A1
prerank,GO_Biological_Process_2021__very long-chain fatty acid biosynthetic process (GO:0042761),-0.43140345697870824,-0.8259567869395344,0.6833333333333333,1.0,1.0,2/12,5.09%,ELOVL2;TECRL
prerank,GO_Biological_Process_2021__negative regulation of multicellular organismal process (GO:0051241),0.2705630740292936,0.8259504552564838,1.0,0.9797014128816365,1.0,35/168,18.34%,LAMA4;TNNT1;SPRED3;NOVA1;PTPRO;ALDH1A1;IL17RD;SFMBT1;CHSY1;HS3ST5;DLX1;TIMP1;PLCL2;PTPRR;SPRED2;TFE3;ADIPOR1;F2R;SPRED1;TWSG1;N4BP1;EVL;RAB11FIP3;NFIB;RPS6KA4;PTPN23;RPS6KA6;NR1H3;ELAPOR2;WWC1;NOTCH1;RAB11FIP1;IP6K1;RBPJ;ZNF706
prerank,GO_Biological_Process_2021__T-tubule organization (GO:0033292),-0.5401619506404826,-0.8259329854542389,0.746268656716418,1.0,1.0,1/6,2.76%,CAV3
prerank,GO_Biological_Process_2021__protein targeting to membrane (GO:0006612),0.3294422761514449,0.8259054135959234,0.8,0.9795058476658107,1.0,21/78,24.64%,PARD3;ZDHHC11B;PEX13;GDAP1;ABCD3;ZDHHC18;ABCD2;ZDHHC12;GOLGA7B;MYO1C;ZDHHC14;ZDHHC3;SSR2;ZDHHC9;ZDHHC11;ZDHHC23;SEC61A1;SLC25A17;ZDHHC20;PEX3;PEX14
prerank,Reactome_2022__RHOQ GTPase Cycle R-HSA-9013406,-0.37123867214728157,-0.8258361162923942,0.7532467532467533,1.0,1.0,5/56,9.16%,TRIP10;PLEKHG3;OBSCN;RHOQ;SNAP23
prerank,GO_Biological_Process_2021__limb morphogenesis (GO:0035108),-0.43356937447322397,-0.8258053689070773,0.7205882352941176,1.0,1.0,1/16,2.44%,CYP26B1
prerank,Reactome_2022__Synthesis Of PIPs At Plasma Membrane R-HSA-1660499,-0.3577314925963138,-0.8254121873089743,0.7887323943661971,1.0,1.0,8/50,17.52%,PLEKHA4;INPP5D;PIK3R3;PLEKHA2;PIK3CB;PIK3C2G;PIK3CG;BMX
prerank,GO_Biological_Process_2021__cell cycle G1/S phase transition (GO:0044843),-0.370825274535519,-0.8251721212695091,0.7972972972972973,1.0,1.0,10/60,15.48%,SPDYA;CCND1;CRLF3;CDC25A;LATS2;CDKN2D;CDKN1A;MAX;CCNE2;CDKN3
prerank,GO_Biological_Process_2021__positive regulation of Wnt signaling pathway (GO:0030177),0.28678793670492575,0.8251606880990394,0.9047619047619048,0.9807037046071874,1.0,19/139,14.09%,LGR5;BAMBI;RSPO3;FGF10;SEMA5A;PSME4;ZEB2;PSMA1;RSPO2;WNT3A;GPC5;KANK1;WNK2;PPM1A;MACF1;SMARCA4;RNF146;WLS;NFKB1
prerank,GO_Biological_Process_2021__regulation of apoptotic process (GO:0042981),-0.2968252559015924,-0.8251509980698566,0.9325842696629213,1.0,1.0,78/602,17.35%,CD44;CLEC5A;KIF14;RASGRF2;PRAME;HCK;MMP9;WNT5A;CIDEB;CYP1B1;OBSCN;VAV3;CARD14;BCL2L2;GPER1;BCL2L14;PINK1;ITGB3BP;STAT1;DAB2;IL7;IFIT3;FLT4;LATS2;TGM2;ACTN3;ANXA1;CCND2;HTR2B;CLU;SFRP4;PPT1;STK17A;REST;THBS1;SMAD6;OLFM4;ALPK2;NLRC4;PXT1;DNAJA1;TFPT;SCIN;USP17L2;COPS5;ATF5;LRP2;DDX20;MTCH1;TNFRSF10A;WFS1;TAF9B;CFL1;MOAP1;NAA38;NDRG1;CD27;TEK;VDAC1;LEF1;TGFB3;BEX2;NR1H4;DDX3X;TP53I3;ANP32E;SIAH1;AGT;PNMA1;AKAP13;NAIP;GHRL;ECT2;RABGGTB;RABGGTA;PNMA2;EGR3;PAX7
prerank,Reactome_2022__Telomere C-strand (Lagging Strand) Synthesis R-HSA-174417,-0.384805606500669,-0.8251298849077214,0.7538461538461538,1.0,1.0,2/30,4.30%,TERF2IP;RPA3
prerank,GO_Biological_Process_2021__peptidyl-lysine oxidation (GO:0018057),-0.5109840085212811,-0.8250964136009139,0.7551020408163265,1.0,1.0,2/5,9.75%,LOX;LOXL4
prerank,Reactome_2022__Signaling By RNF43 Mutants R-HSA-5340588,-0.5331233888835434,-0.8250859931113247,0.7692307692307693,1.0,1.0,1/6,4.31%,FZD8
prerank,GO_Biological_Process_2021__positive regulation of ubiquitin protein ligase activity (GO:1904668),0.4361229103341441,0.8250391191497597,0.7608695652173914,0.9806705379089427,1.0,6/10,27.79%,CDC14B;FZR1;PTEN;PLK1;BTRC;GORASP1
prerank,Reactome_2022__Inhibition Of DNA Recombination At Telomere R-HSA-9670095,-0.40179505100940793,-0.8246699538599339,0.8169014084507042,1.0,1.0,3/31,12.66%,TERF2IP;H2BC4;H2AZ1
prerank,GO_Biological_Process_2021__regulation of steroid metabolic process (GO:0019218),0.4047694774067039,0.8245806969729932,0.6875,0.981397329535422,1.0,3/20,2.66%,EPHX2;RORA;APOE
prerank,GO_Biological_Process_2021__renal absorption (GO:0070293),0.3718898035730161,0.8245645874079972,0.7714285714285715,0.9811356248375355,1.0,3/12,12.21%,AKR1C3;SGK1;KLHL3
prerank,GO_Biological_Process_2021__chromatin assembly or disassembly (GO:0006333),0.4339529210674446,0.8242577664498765,0.7333333333333333,0.9814535711765604,1.0,5/11,21.85%,HIRIP3;TP53;NOC2L;RBBP4;SUV39H2
prerank,CellMarker_Augmented_2021__FGFR1HighNME5- Epithelial cell:Esophagus,0.28129834839962153,0.8241774737875793,1.0,0.9813148911620585,1.0,33/174,17.63%,GRK5;ADAMTS1;ELOVL6;FGFR1;P3H3;MMP2;ZFHX4;DDX31;STARD9;STAT5B;PCDH9;ACOT9;SYT1;SDHAF4;COL16A1;FLRT2;TRIM65;ZNF761;GALT;PAMR1;COL5A3;METTL25;XPNPEP2;NOMO1;FKBP7;FURIN;CA2;CRKL;DOCK11;FBXO4;CSAD;TBC1D8B;ARHGAP10
prerank,KEGG_2021_Human__Renal cell carcinoma,0.3163536984888939,0.8241032924312106,0.8076923076923077,0.9812070053864139,1.0,18/64,20.51%,EGLN3;PAK5;CRK;RAPGEF1;TGFA;TFE3;AKT2;RAP1A;GAB1;PIK3CA;CRKL;BRAF;EP300;SOS1;PAK3;PAK2;RAF1;HIF1A
prerank,GO_Biological_Process_2021__cellular response to macrophage colony-stimulating factor stimulus (GO:0036006),0.4587733701193578,0.8239584891099598,0.6585365853658537,0.9809212637836667,1.0,1/5,7.46%,FER
prerank,GO_Biological_Process_2021__response to macrophage colony-stimulating factor (GO:0036005),0.4587733701193578,0.8239584891099598,0.6585365853658537,0.9809212637836667,1.0,1/5,7.46%,FER
prerank,GO_Biological_Process_2021__chromatin organization involved in negative regulation of transcription (GO:0097549),0.496899960327436,0.8238576399191242,0.7142857142857143,0.9807829022653415,1.0,3/6,21.53%,SIRT1;SMCHD1;BAHD1
prerank,GO_Biological_Process_2021__negative regulation of fibroblast proliferation (GO:0048147),0.37841146547012455,0.8238320805813072,0.7073170731707317,0.9805701207183595,1.0,6/17,18.46%,MED25;MYC;NF1;TP53;SKI;MORC3
prerank,GO_Biological_Process_2021__beta-catenin destruction complex disassembly (GO:1904886),-0.4059252960136517,-0.8237247099620865,0.7058823529411765,1.0,1.0,3/19,11.84%,WNT8B;FRAT1;WNT8A
prerank,GO_Biological_Process_2021__negative regulation of supramolecular fiber organization (GO:1902904),0.31985007585990655,0.8237056413699393,0.8260869565217391,0.980537090257559,1.0,13/69,17.11%,APOE;CDH5;SNCA;SLIT2;MAPRE1;NAV3;KANK1;LDLR;KANK4;PIK3CA;SSH1;CLIP3;IAPP
prerank,GO_Biological_Process_2021__response to amino acid (GO:0043200),0.3870631967354481,0.823602765658212,0.75,0.9804383813720894,1.0,3/32,9.93%,CPEB1;CAPN2;GRIN1
prerank,GO_Biological_Process_2021__fatty acid beta-oxidation (GO:0006635),0.3417700588200159,0.8234222722850496,0.8787878787878788,0.9805849301317987,1.0,16/50,20.34%,ACADS;ACAD10;SLC27A2;ECHS1;ABCD3;ABCD2;ACADM;MECR;BDH2;ECI1;ECHDC1;ACOX1;DECR1;HADHB;ECHDC2;ACADVL
prerank,GO_Biological_Process_2021__autophagosome membrane docking (GO:0016240),-0.5044874565899216,-0.8234042045648832,0.6666666666666666,1.0,1.0,3/7,23.97%,ATG14;CALM1;ATP2A2
prerank,Reactome_2022__SARS-CoV-2-host Interactions R-HSA-9705683,-0.3264907495952503,-0.8233174364849782,0.8421052631578947,1.0,1.0,46/161,26.42%,NLRP12;SFTPD;TRIM25;STAT1;MASP1;HLA-A;SNRPD2;DDX20;RPS4X;MASP2;TLR2;NLRP3;ATG14;RPS9;FAU;RPS27;RPS21;GEMIN4;HLA-F;RPS16;RPS20;RPS8;RPS27A;YWHAG;RPS7;RPS11;NUP93;RPS14;SEC13;ISG15;RPS15;HLA-C;RPS12;SEC24D;RPS13;VPS18;HSP90AB1;TKFC;RPS3;PTPN11;RPSA;RPS28;RPS19;NDC1;RPS24;RNF135
prerank,GO_Biological_Process_2021__constitutive secretory pathway (GO:0045054),0.533678064923382,0.8233053949316211,0.7391304347826086,0.9805738107696423,1.0,2/5,21.56%,RAB11B;TRAPPC11
prerank,CellMarker_Augmented_2021__Myofibroblast:Liver,0.28824829881815717,0.823240510180408,0.9545454545454546,0.9803832815924842,1.0,10/92,8.34%,FIBIN;LAMA4;MXRA5;MRGPRF;ADAMTS12;MMP2;CNN1;OLFML2B;EDNRA;DOK5
prerank,GO_Biological_Process_2021__cellular response to gonadotropin stimulus (GO:0071371),0.5342690918416215,0.8229239539907728,0.7027027027027027,0.980748454324553,1.0,2/5,30.19%,NOTCH1;FSHR
prerank,Reactome_2022__Signaling By KIT In Disease R-HSA-9669938,0.37434576134628017,0.8228958981414426,0.65625,0.9805229978891912,1.0,2/18,6.32%,KIT;STAT5B
prerank,Reactome_2022__Tie2 Signaling R-HSA-210993,-0.44481683195296173,-0.8228890403430226,0.703125,1.0,1.0,3/15,13.55%,ANGPT2;PIK3CB;TEK
prerank,Reactome_2022__SCF-beta-TrCP Mediated Degradation Of Emi1 R-HSA-174113,-0.3483863412859426,-0.8228852812149824,0.704225352112676,1.0,1.0,1/47,0.62%,PSMB9
prerank,GO_Biological_Process_2021__brown fat cell differentiation (GO:0050873),0.5124891938055832,0.8228634231258145,0.6888888888888889,0.9803107897369352,1.0,1/6,3.38%,METRNL
prerank,Reactome_2022__Sodium/Proton Exchangers R-HSA-425986,-0.5162350902799426,-0.8226799054858559,0.7058823529411765,1.0,1.0,1/6,10.46%,SLC9A2
prerank,KEGG_2021_Human__Riboflavin metabolism,-0.5301118762102787,-0.8225793319529636,0.7796610169491526,1.0,1.0,3/7,24.32%,RFK;BLVRB;ACP2
prerank,GO_Biological_Process_2021__negative regulation of endoplasmic reticulum calcium ion concentration (GO:0032471),-0.5463282623828543,-0.8224138094646599,0.7377049180327869,1.0,1.0,2/5,18.81%,TGM2;FIS1
prerank,GO_Biological_Process_2021__establishment of centrosome localization (GO:0051660),-0.5099079830883564,-0.8222631656209819,0.8035714285714286,1.0,1.0,1/7,2.29%,MISP
prerank,Reactome_2022__TP53 Regulates Transcription Of Genes Involved In G1 Cell Cycle Arrest R-HSA-6804116,-0.45239799334723335,-0.8222356034073071,0.75,1.0,1.0,3/12,22.07%,CDKN1A;CCNE2;CDKN1B
prerank,GO_Biological_Process_2021__positive regulation of maintenance of mitotic sister chromatid cohesion (GO:0034184),0.5441776283958644,0.8221485630318834,0.8367346938775511,0.9809329912194287,1.0,2/5,17.60%,SMC5;NSMCE2
prerank,GO_Biological_Process_2021__regulation of maintenance of mitotic sister chromatid cohesion (GO:0034182),0.5441776283958644,0.8221485630318834,0.8367346938775511,0.9809329912194287,1.0,2/5,17.60%,SMC5;NSMCE2
prerank,GO_Biological_Process_2021__positive regulation of maintenance of sister chromatid cohesion (GO:0034093),0.5441776283958644,0.8221485630318834,0.8367346938775511,0.9809329912194287,1.0,2/5,17.60%,SMC5;NSMCE2
prerank,GO_Biological_Process_2021__protein kinase A signaling (GO:0010737),-0.5155975514718175,-0.8220145093001406,0.7704918032786885,1.0,1.0,2/10,14.57%,TTN;LCP1
prerank,Reactome_2022__Neurotransmitter Release Cycle R-HSA-112310,-0.37602834095171966,-0.8219398068186895,0.7162162162162162,1.0,1.0,4/45,11.92%,GAD1;SLC6A12;SLC18A2;HSPA8
prerank,GO_Biological_Process_2021__5S class rRNA transcription by RNA polymerase III (GO:0042791),0.5136744423986905,0.8218756198013312,0.7083333333333334,0.9812231238327325,1.0,2/6,17.07%,GTF3C4;GTF3C5
prerank,Reactome_2022__Signaling By Activin R-HSA-1502540,0.38066777300493027,0.8218477992879946,0.7777777777777778,0.9809891920334445,1.0,4/13,24.13%,FSTL3;SMAD2;ACVR2A;ACVR1B
prerank,CellMarker_Augmented_2021__Premeiotic Germ cell:Gonad,-0.5171782761386592,-0.8217395605673613,0.7377049180327869,1.0,1.0,3/8,18.70%,PRAME;CCDC144NL;OR8A1
prerank,CellMarker_Augmented_2021__Premeiotic Germ cell:Testis,-0.5171782761386592,-0.8217395605673613,0.7377049180327869,1.0,1.0,3/8,18.70%,PRAME;CCDC144NL;OR8A1
prerank,CellMarker_Augmented_2021__Primordial Germ cell:Testis,-0.5171782761386592,-0.8217395605673613,0.7377049180327869,1.0,1.0,3/8,18.70%,PRAME;CCDC144NL;OR8A1
prerank,Reactome_2022__Interleukin-9 Signaling R-HSA-8985947,-0.5051914457674582,-0.8217294250759097,0.6885245901639344,1.0,1.0,1/6,6.09%,STAT1
prerank,GO_Biological_Process_2021__cellular response to interleukin-9 (GO:0071355),-0.5051914457674582,-0.8217294250759097,0.6885245901639344,1.0,1.0,1/6,6.09%,STAT1
prerank,GO_Biological_Process_2021__interleukin-9-mediated signaling pathway (GO:0038113),-0.5051914457674582,-0.8217294250759097,0.6885245901639344,1.0,1.0,1/6,6.09%,STAT1
prerank,GO_Biological_Process_2021__regulation of erythrocyte differentiation (GO:0045646),0.3571853436258901,0.8216830943408175,0.6666666666666666,0.980934341990228,1.0,7/33,14.74%,RHEX;MAFB;STAT5B;CDK6;HSPA1A;ANKRD54;ABCB10
prerank,Reactome_2022__RNA Polymerase III Chain Elongation R-HSA-73780,0.38503743313466016,0.8215183895070354,0.7317073170731707,0.9809973315817008,1.0,5/17,22.28%,POLR3G;POLR3D;POLR3K;POLR3B;POLR2F
prerank,Reactome_2022__Transcriptional Regulation By AP-2 (TFAP2) Family Of Transcription Factors R-HSA-8864260,0.3732966982828835,0.8214303077441245,0.7878787878787878,0.9808988914084973,1.0,7/29,11.54%,KIT;APOE;ERBB2;WWOX;MYC;TGFA;CITED4
prerank,GO_Biological_Process_2021__positive regulation of protein metabolic process (GO:0051247),-0.33404957981261396,-0.8213513171322762,0.7567567567567568,1.0,1.0,14/94,15.80%,TGFB1;DTL;WNT5A;PLA2G10;GPC3;CLU;C4BPA;WFS1;ASB5;OAZ2;C4BPB;CD80;IL18;AGT
prerank,GO_Biological_Process_2021__keratan sulfate metabolic process (GO:0042339),0.38781084204621996,0.8212358804700014,0.5769230769230769,0.9809574939118789,1.0,6/27,11.28%,CHST6;PRELP;ST3GAL3;B4GALT2;B4GALT3;GLB1
prerank,GO_Biological_Process_2021__potassium ion transport (GO:0006813),0.2781883453835555,0.821167465597023,0.8695652173913043,0.9807850123683802,1.0,14/109,9.13%,KCNK6;KCNB2;KCNC2;KCNH8;PKD2;HCN1;KCNH7;KCNJ3;KCNG1;KCNJ6;TMEM175;KCND2;KCNK2;ABCC8
prerank,GO_Biological_Process_2021__establishment of vesicle localization (GO:0051650),0.44225450083457546,0.8211667050856101,0.7586206896551724,0.980499319093586,1.0,1/17,0.97%,RAB27A
prerank,GO_Biological_Process_2021__replication fork processing (GO:0031297),0.3454463949517913,0.8211210908179465,0.8108108108108109,0.9803183576422906,1.0,10/34,18.58%,RFWD3;SMARCAL1;BOD1L1;SETMAR;MMS22L;PRIMPOL;SAMHD1;FBH1;ATR;EME2
prerank,GO_Biological_Process_2021__mitotic G1/S transition checkpoint signaling (GO:0044819),0.41294075331666463,0.8210893162042289,0.7297297297297297,0.9801287903050051,1.0,1/11,0.99%,RFWD3
prerank,GO_Biological_Process_2021__positive regulation of natural killer cell mediated cytotoxicity (GO:0045954),0.4249796164880617,0.8210477237302098,0.7142857142857143,0.9799175615246104,1.0,2/13,5.92%,KLRD1;CADM1
prerank,PanglaoDB_Augmented_2021__Gastric Chief Cells,-0.3368359356275664,-0.8210324907475968,0.7611940298507462,1.0,1.0,20/80,19.93%,PLEKHG3;PPP1R1B;TMC4;GPRIN2;SLCO2A1;SLC5A9;KCNQ1;SPINT1;SOWAHB;CYP4F12;TMEM45B;TJP3;CD24;SCNN1A;ANPEP;CAPN13;SLC44A3;FAM3D;ACE2;CBLC
prerank,CellMarker_Augmented_2021__Pluripotent Very Small Embryonic-Like cell:Ovary,0.33660878586455556,0.820703797219093,0.6206896551724138,0.9803550660822518,1.0,18/61,15.72%,PLCH1;IGDCC3;PLEKHG4B;CHST6;UNC5D;FZD5;TRIM71;ESRP1;TERF1;LRRN1;CRABP1;SYT6;TMPRSS2;COL9A1;HHLA1;ZNF663P;CGN;NR6A1
prerank,GO_Biological_Process_2021__cellular response to organonitrogen compound (GO:0071417),-0.320915901628056,-0.8206842903258069,0.8571428571428571,1.0,1.0,9/94,9.43%,AHR;P2RY12;CTNNA1;TSHR;GLRA2;HTR1B;KCNQ1;BRCA1;P2RY6
prerank,GO_Biological_Process_2021__regulation of angiogenesis (GO:0045765),-0.3216892933590385,-0.8206671921884753,0.813953488372093,1.0,1.0,28/157,16.67%,HK2;NODAL;WNT5A;CXCL13;CYP1B1;SP100;ALOX5;CNMD;STAT1;CD160;DCN;CLDN5;CEACAM1;BRCA1;COL4A3;ISM1;THBS1;WARS1;FOXO4;TEK;GATA4;HYAL1;RRAS;EPHA1;GRN;HIPK1;ANGPTL3;GHRL
prerank,GO_Biological_Process_2021__skeletal muscle fiber development (GO:0048741),-0.4742653263824704,-0.8205350211312109,0.7301587301587301,1.0,1.0,2/7,11.01%,LMOD3;CAV2
prerank,GO_Biological_Process_2021__cellular response to topologically incorrect protein (GO:0035967),-0.3890151083498602,-0.8204259666972016,0.7464788732394366,1.0,1.0,7/29,24.55%,HSPA1L;HSPA8;STUB1;HSPA5;OPTN;HSPA2;HSPA13
prerank,GO_Biological_Process_2021__cellular response to estrogen stimulus (GO:0071391),-0.46542804328211285,-0.8204078452257114,0.7586206896551724,1.0,1.0,5/14,28.50%,WBP2;AR;SFRP1;SRA1;RARA
prerank,GO_Biological_Process_2021__ATP-dependent chromatin remodeling (GO:0043044),0.3371199269646339,0.8201005480908424,0.7916666666666666,0.981358053238498,1.0,13/40,22.08%,SMARCB1;SRCAP;PBRM1;ARID1A;SMARCA2;SMARCA4;HDAC1;GATAD2B;CHD4;ARID1B;NASP;RBBP4;SMARCAD1
prerank,GO_Biological_Process_2021__regulation of non-canonical Wnt signaling pathway (GO:2000050),-0.4259423434323697,-0.820086398975643,0.7058823529411765,1.0,1.0,4/13,9.05%,DAAM2;RNF213;GPC3;SFRP4
prerank,CellMarker_Augmented_2021__Regulatory T (Treg) cell:Skin,-0.4977375533442565,-0.8200751060562823,0.6666666666666666,1.0,1.0,1/5,16.84%,NT5E
prerank,GO_Biological_Process_2021__regulation of mast cell chemotaxis (GO:0060753),-0.5405934092989546,-0.8199832774938886,0.7758620689655172,1.0,1.0,1/5,2.49%,RIN3
prerank,GO_Biological_Process_2021__regulation of Golgi to plasma membrane protein transport (GO:0042996),0.48596201477241774,0.8198839184373379,0.75,0.981542552097415,1.0,1/7,3.81%,CSK
prerank,GO_Biological_Process_2021__plasma membrane raft assembly (GO:0044854),-0.5115770888267707,-0.8198699067419701,0.76,1.0,1.0,2/6,11.01%,CAV3;CAV2
prerank,GO_Biological_Process_2021__long-chain fatty acid biosynthetic process (GO:0042759),0.37230111343816097,0.8198487983977697,0.7777777777777778,0.9813529044235687,1.0,3/27,2.43%,CYP1A2;ELOVL6;EPHX2
prerank,GO_Biological_Process_2021__positive regulation of microtubule polymerization or depolymerization (GO:0031112),-0.4183325466914621,-0.8196495824663652,0.8,1.0,1.0,7/25,22.88%,CAV3;ANKRD53;DCTN1;RAC1;CDK5R1;DRG1;PSRC1
prerank,Reactome_2022__SLC Transporter Disorders R-HSA-5619102,0.2941937601117997,0.8194322174688963,0.8333333333333334,0.981867747810149,1.0,10/76,10.02%,SLC26A3;NUP210;SLC12A1;SLC3A2;BSG;NUP42;SLC7A9;SLC22A5;SLC6A20;AAAS
prerank,GO_Biological_Process_2021__negative regulation of type I interferon-mediated signaling pathway (GO:0060339),-0.4240479208741685,-0.8189789779350515,0.6984126984126984,1.0,1.0,4/16,25.13%,OAS1;CACTIN;ISG15;USP18
prerank,GO_Biological_Process_2021__pyrimidine deoxyribonucleotide catabolic process (GO:0009223),0.42938208864228766,0.8188416553007553,0.7352941176470589,0.9827256866045555,1.0,2/13,10.42%,DUT;UPP2
prerank,GO_Biological_Process_2021__positive regulation of histone ubiquitination (GO:0033184),-0.5029259794815809,-0.8187458880036032,0.75,1.0,1.0,3/5,26.11%,RNF20;CDK9;KDM1A
prerank,KEGG_2021_Human__Yersinia infection,0.30200237503277133,0.818717863723474,0.9545454545454546,0.9826792621777654,1.0,32/117,20.53%,ACTR3C;NFATC3;ITGA4;CRK;MAPK8;CD8A;AKT2;PKN2;RPS6KA3;WASF2;PXN;TICAM1;ARPC3;NFKB1;RPS6KA2;RPS6KA6;PIK3CA;IRAK4;VAV2;MAPK12;CRKL;MAP2K7;LIMK1;TAB1;DOCK1;SKAP2;ELMO1;TAB2;MAP2K6;GNAQ;TRAF6;FOS
prerank,GO_Biological_Process_2021__negative regulation of axon regeneration (GO:0048681),0.48611826147467513,0.818602204669496,0.6666666666666666,0.9826241762258808,1.0,2/6,35.49%,EPHA4;PTPRS
prerank,KEGG_2021_Human__Tuberculosis,0.29196485673489925,0.8186012532573127,0.85,0.9823389442443929,1.0,24/122,16.08%,ATP6V0D2;TCIRG1;BCL2;KSR1;HLA-DQB1;CD14;RIPK2;RAB7A;HLA-DRA;CARD9;MAPK8;CASP3;AKT2;FADD;IL10RA;PLK3;NFYC;NFKB1;BID;IRAK4;LBP;IL23A;MAPK12;MALT1
prerank,Reactome_2022__Sensory Processing Of Sound R-HSA-9659379,-0.34696099001662434,-0.8185905857953789,0.7564102564102564,1.0,1.0,14/70,19.01%,CHRNA9;GRXCR2;OTOG;MYO3B;TMC2;SLC17A8;FSCN2;STRC;USH1C;GRXCR1;SLC26A5;MSN;MYO15A;TMC1
prerank,Reactome_2022__Cyclin A:Cdk2-associated Events At S Phase Entry R-HSA-69656,-0.3391679715270525,-0.8185847657975867,0.8354430379746836,1.0,1.0,11/76,19.11%,PSMB9;CCND1;CDC25A;CDKN1A;MAX;CCNE2;CKS1B;PSMA3;RPS27A;PSMA7;PSMB6
prerank,GO_Biological_Process_2021__regulation of cell migration (GO:0030334),-0.29798116052856083,-0.8185798663507042,0.9560439560439561,1.0,1.0,50/348,18.74%,ENPP2;FGF20;KIF14;TGFB1;F7;MMP9;CYP1B1;SMIM22;CLDN1;COL1A1;SEMA3F;GPER1;DAB2;SYNE2;CLDN5;PLAU;ACTG1;CEACAM1;SEMA3A;PIK3R3;SOD2;ANXA1;CGA;IGSF10;THBS1;USP17L2;LAMC2;VIL1;ENG;CXCL16;NEXN;LEF1;TMSB10;FGF22;EPHA1;GRN;PLET1;F2RL1;DUSP22;ALOX15B;ANGPTL3;RNF20;VSIR;RAC1;BEX4;ARHGEF39;NTRK3;CAMK2A;PLXNA3;CSF1R
prerank,GO_Biological_Process_2021__endothelial cell migration (GO:0043542),0.37690615726937376,0.8185412197276964,0.6388888888888888,0.9821797877163307,1.0,11/32,21.33%,PRSS3;CDH5;CDH13;ABL1;PXN;PIK3CA;NR4A1;CORO1B;FAP;LGALS8;FSTL1
prerank,Reactome_2022__Pyroptosis R-HSA-5620971,-0.41052548226435964,-0.8184121308208928,0.7258064516129032,1.0,1.0,4/18,15.83%,IRF1;GSDME;IL18;ELANE
prerank,GO_Biological_Process_2021__regulation of long-chain fatty acid import across plasma membrane (GO:0010746),-0.5088390050176234,-0.8183802641690506,0.7586206896551724,1.0,1.0,2/6,9.78%,ACSL5;THBS1
prerank,GO_Biological_Process_2021__innate immune response in mucosa (GO:0002227),-0.5198126222407878,-0.8183515393035816,0.7096774193548387,1.0,1.0,2/5,14.17%,BPIFB1;NOS2
prerank,GO_Biological_Process_2021__response to lipopolysaccharide (GO:0032496),0.2859436569052884,0.8181236227745388,0.9230769230769231,0.9827065164432957,1.0,20/100,15.48%,IRGM;MAPKAPK2;CD14;TICAM2;CX3CR1;SERPINE1;SRR;SNCA;HMGB1;FER;MAPK8;PDE4B;RPS6KA3;F2R;LGALS9;TICAM1;PELI1;NFKB1;NR1H3;LBP
prerank,Reactome_2022__DNA Damage/Telomere Stress Induced Senescence R-HSA-2559586,-0.37091771728240663,-0.8181168776623162,0.7846153846153846,1.0,1.0,9/41,19.73%,TERF2IP;H1-0;H2BC4;CDKN1A;H2AZ1;H1-3;CCNE2;HMGA2;HMGA1
prerank,KEGG_2021_Human__Retinol metabolism,-0.3791541064383885,-0.8180590193023213,0.796875,1.0,1.0,9/34,13.40%,CYP26B1;CYP3A5;RDH12;RDH13;PNPLA4;CYP2A6;CYP3A4;AOX1;BCO1
prerank,GO_Biological_Process_2021__tRNA aminoacylation (GO:0043039),-0.381377968754786,-0.8180327042170985,0.75,1.0,1.0,4/36,16.15%,NARS1;DARS2;WARS1;YARS2
prerank,GO_Biological_Process_2021__histone H3-K14 acetylation (GO:0044154),0.47480256977801094,0.8179141419112018,0.6739130434782609,0.9828944818386696,1.0,3/7,30.14%,BRPF1;BRPF3;ING5
prerank,CellMarker_Augmented_2021__Memory B cell:Peripheral Blood,-0.41092492760612764,-0.8177251131687507,0.6363636363636364,1.0,1.0,6/21,13.49%,SIRPG;TBC1D10C;CD5;TRAF3IP3;TAPBPL;CD27
prerank,CellMarker_Augmented_2021__Plasma cell:Sinonasal Mucosa,-0.41092492760612764,-0.8177251131687507,0.6363636363636364,1.0,1.0,6/21,13.49%,SIRPG;TBC1D10C;CD5;TRAF3IP3;TAPBPL;CD27
prerank,CellMarker_Augmented_2021__Non-switched B cell:Blood,-0.41092492760612764,-0.8177251131687507,0.6363636363636364,1.0,1.0,6/21,13.49%,SIRPG;TBC1D10C;CD5;TRAF3IP3;TAPBPL;CD27
prerank,CellMarker_Augmented_2021__Switched Memory B cell:Blood,-0.41092492760612764,-0.8177251131687507,0.6363636363636364,1.0,1.0,6/21,13.49%,SIRPG;TBC1D10C;CD5;TRAF3IP3;TAPBPL;CD27
prerank,CellMarker_Augmented_2021__Memory B cell:Liver,-0.41092492760612764,-0.8177251131687507,0.6363636363636364,1.0,1.0,6/21,13.49%,SIRPG;TBC1D10C;CD5;TRAF3IP3;TAPBPL;CD27
prerank,KEGG_2021_Human__cAMP signaling pathway,0.28172211551290766,0.817668334822937,0.9473684210526315,0.9832341662951012,1.0,39/177,20.72%,GRIN3A;CHRM2;CNGA3;HTR1F;PDE10A;DRD5;CREB3L2;CREB3L4;RRAS2;MAPK8;EDNRA;ADCY2;CNGA4;AKT2;GRIN1;PDE4B;F2R;AMH;ADCY3;RAP1A;NFKB1;PIK3CA;VAV2;HTR1E;ADORA1;BRAF;ADCY6;ACOX1;RAPGEF3;PPP1CB;EP300;PDE3B;PTCH1;CREB1;PLD2;RAF1;FOS;GNAI2;GNAS
prerank,Reactome_2022__Neurofascin Interactions R-HSA-447043,0.4613717669740543,0.8176055611039027,0.6521739130434783,0.9830532513759853,1.0,4/7,29.25%,CNTN1;NRCAM;ANK1;SDCBP
prerank,GO_Biological_Process_2021__cellular response to tumor necrosis factor (GO:0071356),-0.3287375299962961,-0.8175846925040109,0.8289473684210527,1.0,1.0,20/138,19.11%,PSMB9;AIM2;CARD14;TNFRSF1B;GPER1;STAT1;GSDME;BRCA1;EDAR;TXNDC17;GBP1;CD27;HYAL1;PSMA3;TNFSF8;ZFP36L1;CACTIN;TNFRSF11A;PSMA7;PSMB6
prerank,GO_Biological_Process_2021__cellular response to sterol (GO:0036315),0.41249133171543684,0.8174733886644866,0.6388888888888888,0.9829938333585619,1.0,9/13,26.64%,RORA;LRP6;OSBPL7;GPLD1;PTCH1;MLC1;GRAMD1B;GRAMD1A;INSIG1
prerank,GO_Biological_Process_2021__maintenance of blood-brain barrier (GO:0035633),0.35223014712134976,0.8174274802529541,0.71875,0.9828174270528336,1.0,3/28,2.94%,GJB6;CDH5;MFSD2A
prerank,Reactome_2022__Apoptotic Cleavage Of Cellular Proteins R-HSA-111465,0.3457180631896897,0.8172376776953257,0.8285714285714286,0.982892432247162,1.0,11/35,21.55%,LMNB1;CASP3;PLEC;GAS2;FNTA;CLSPN;ACIN1;ADD1;TJP2;FZR1;OCLN
prerank,GO_Biological_Process_2021__neutrophil chemotaxis (GO:0030593),-0.4381415886197988,-0.817232303596477,0.7419354838709677,1.0,1.0,2/22,3.57%,ITGB2;CXCL13
prerank,Reactome_2022__Hedgehog Off State R-HSA-5610787,0.2934755579643177,0.8171458985252323,0.9090909090909091,0.9828071224084719,1.0,11/89,11.98%,GPR161;IFT88;PSME4;SEM1;TULP3;PSMA1;ADCY2;RPGRIP1L;NUMB;PRKAR2A;MKS1
prerank,GO_Biological_Process_2021__regulation of transforming growth factor beta1 production (GO:0032908),0.5159968147183988,0.8168568591884319,0.675,0.9830682948478796,1.0,1/5,1.32%,TSKU
prerank,GO_Biological_Process_2021__regulation of skeletal muscle tissue development (GO:0048641),-0.487525134996417,-0.8167894013210888,0.6666666666666666,1.0,1.0,1/5,1.49%,TGFB1
prerank,GO_Biological_Process_2021__regulation of ubiquitin-dependent protein catabolic process (GO:2000058),0.3092626026920294,0.816670178302787,0.7857142857142857,0.9831691372934981,1.0,15/41,23.61%,QRICH2;COMMD1;PYHIN1;PML;LATS1;CCDC22;FOXF2;SMURF1;RNF139;LAPTM5;XPO1;GNA12;PTEN;AXIN1;PDCL3
prerank,Reactome_2022__Metabolism Of Water-Soluble Vitamins And Cofactors R-HSA-196849,0.28393785333910737,0.8164561201351389,0.9523809523809523,0.983369463233422,1.0,14/110,11.15%,SLC5A8;CD38;PRSS3;RNLS;PANK1;SLC19A1;DHFR;ACACB;PDZD11;GSTO2;GPHN;MTR;NAMPT;PPCS
prerank,Reactome_2022__Histidine Catabolism R-HSA-70921,0.49211400855255816,0.8164182246250685,0.7941176470588235,0.9831846010765316,1.0,3/7,11.58%,HNMT;CARNMT1;HECA
prerank,GO_Biological_Process_2021__regulation of acute inflammatory response (GO:0002673),-0.4721190038996117,-0.8163643884097433,0.7288135593220338,1.0,1.0,3/11,13.31%,PTGES;OSMR;NLRP3
prerank,Reactome_2022__CD163 Mediating An Anti-Inflammatory Response R-HSA-9662834,0.49139012223915846,0.816265921809413,0.7948717948717948,0.9832463938056654,1.0,1/7,15.21%,FURIN
prerank,GO_Biological_Process_2021__negative regulation of glial cell differentiation (GO:0045686),0.459405098175649,0.8162311876772932,0.6818181818181818,0.9830487016146197,1.0,4/8,16.67%,HES1;F2;NF1;NOTCH1
prerank,GO_Biological_Process_2021__regulation of mitochondrial depolarization (GO:0051900),0.4573654074727943,0.8161337338049492,0.7435897435897436,0.9829894565905322,1.0,1/8,2.31%,BCL2
prerank,PanglaoDB_Augmented_2021__Enteric Glia Cells,-0.32870740541522075,-0.8159581526926307,0.7922077922077922,1.0,1.0,17/102,15.22%,TRIL;TSPAN11;PPP1R1B;SOX10;GFRA3;SHISA6;DAAM2;LGI4;MPZ;TCEAL5;SLC18A2;AQP4;APOD;EDNRB;RXRG;NOS2;TSPAN7
prerank,Reactome_2022__Synthesis Of Prostaglandins (PG) And Thromboxanes (TX) R-HSA-2162123,0.47324259173814,0.8159443324350489,0.696969696969697,0.983025322208881,1.0,2/14,4.75%,PTGS1;AKR1C3
prerank,GO_Biological_Process_2021__negative regulation of transferase activity (GO:0051348),0.36019714678878084,0.8159296812573545,0.6857142857142857,0.982780340636125,1.0,8/27,22.14%,ABL1;TERF1;IRS2;MEN1;TP53;LIMK1;NPRL2;SMAD7
prerank,CellMarker_Augmented_2021__T cell:Placenta,-0.390981228326712,-0.8158282341464476,0.7313432835820896,1.0,1.0,5/28,8.72%,SIRPG;KLRB1;SCML4;CD5;TRAF3IP3
prerank,KEGG_2021_Human__Sphingolipid signaling pathway,0.2923422130424403,0.8156678620061034,0.8888888888888888,0.9830235656007232,1.0,28/105,22.67%,BCL2;ACER2;OPRD1;S1PR5;PLCB1;MAPK8;NSMAF;AKT2;PPP2R1B;ABCC1;NFKB1;BID;PIK3CA;TP53;MAPK12;S1PR1;ADORA1;CERS4;PPP2R5D;PRKCE;GNAQ;PLD2;RAF1;GNAI2;GNA12;PTEN;PPP2R2B;CERS5
prerank,GO_Biological_Process_2021__positive regulation of type I interferon production (GO:0032481),-0.36395589771902326,-0.8155857033209307,0.765625,1.0,1.0,9/67,14.99%,IRF1;STAT1;OAS2;NFKB2;POLR1C;OAS1;TLR2;POLR3H;DDX3X
prerank,GO_Biological_Process_2021__regulation of telomerase RNA localization to Cajal body (GO:1904872),-0.4308830204099085,-0.8154990998770021,0.7254901960784313,1.0,1.0,5/18,29.23%,NOP10;CCT6A;CCT8;CCT7;CCT2
prerank,Reactome_2022__Prevention Of Phagosomal-Lysosomal Fusion R-HSA-9636383,0.46970319930944976,0.8153881728751994,0.723404255319149,0.983249378521314,1.0,3/8,23.14%,RAB7A;RAB5A;CORO1A
prerank,CellMarker_Augmented_2021__Basal cell:Salivary Gland,-0.4057429732222121,-0.8153260761497128,0.7258064516129032,1.0,1.0,16/32,17.99%,CLCA2;DUOX1;PNLIPRP3;DUOXA1;SERPINB5;FAT2;GPR87;ZNF750;ITGB6;TRIM29;ABCA12;CERS3;ADH7;GBP6;CYP4B1;DSG3
prerank,CellMarker_Augmented_2021__Buccal Epithelial Stem cell:Oral Mucosa,-0.4057429732222121,-0.8153260761497128,0.7258064516129032,1.0,1.0,16/32,17.99%,CLCA2;DUOX1;PNLIPRP3;DUOXA1;SERPINB5;FAT2;GPR87;ZNF750;ITGB6;TRIM29;ABCA12;CERS3;ADH7;GBP6;CYP4B1;DSG3
prerank,CellMarker_Augmented_2021__Basal cell:Submandibular Gland,-0.4057429732222121,-0.8153260761497128,0.7258064516129032,1.0,1.0,16/32,17.99%,CLCA2;DUOX1;PNLIPRP3;DUOXA1;SERPINB5;FAT2;GPR87;ZNF750;ITGB6;TRIM29;ABCA12;CERS3;ADH7;GBP6;CYP4B1;DSG3
prerank,GO_Biological_Process_2021__positive regulation of phosphorylation (GO:0042327),0.26693800160931125,0.8152700777346686,0.8695652173913043,0.9831599443898226,1.0,29/220,9.76%,IRGM;FGF10;KIT;HDAC3;VEGFC;FGFR1;ANGPT1;EPHA7;CCN1;FGF17;SIRT1;ERBB2;RALB;ZBTB20;EPHA3;DRD4;F2;DSCAM;ABL1;CCND3;EFNA5;RAP2A;FGF18;WNT3A;LEPR;TNIK;AKT2;FGFR3;BTBD10
prerank,GO_Biological_Process_2021__positive regulation of nitric-oxide synthase activity (GO:0051000),0.3725847561957025,0.8151820276776404,0.6875,0.9830015150861457,1.0,3/15,8.69%,APOE;DHFR;NUS1
prerank,CellMarker_Augmented_2021__Microglial cell:Brain,0.41465869410690437,0.815178904253656,0.6571428571428571,0.9827180659756826,1.0,5/16,9.66%,BCL2A1;BIN1;CD14;HLA-DRA;NAV3
prerank,GO_Biological_Process_2021__epidermis development (GO:0008544),0.3226114156560711,0.8148191471581717,0.7666666666666667,0.9831119110389305,1.0,8/49,8.37%,EMP1;LAMA3;KLK14;CCN2;STS;KLK7;DSP;DCT
prerank,GO_Biological_Process_2021__negative regulation of peptidase activity (GO:0010466),-0.38078464620027064,-0.814815430673905,0.7424242424242424,1.0,1.0,12/41,18.22%,TIMP3;SERPIND1;VTN;SERPINB5;SERPINA10;TIMP4;SERPINE3;SPOCK3;AGT;SERPINB7;SERPINF1;SPINK6
prerank,GO_Biological_Process_2021__cellular response to BMP stimulus (GO:0071773),-0.34941150172350965,-0.8147427725935219,0.7142857142857143,1.0,1.0,8/58,17.20%,TGFB1;NODAL;SMAD6;ENG;VSTM2A;TGFB3;SMAD3;GDF15
prerank,GO_Biological_Process_2021__ornithine transport (GO:0015822),-0.5159378261988702,-0.8143743240717646,0.7213114754098361,1.0,1.0,1/5,5.15%,SLC7A3
prerank,Reactome_2022__Vif-mediated Degradation Of APOBEC3G R-HSA-180585,-0.35870997239039165,-0.8143451261281538,0.7794117647058824,1.0,1.0,21/47,31.83%,PSMB9;RBX1;PSMA3;RPS27A;PSMA7;PSMB6;PSMA5;ELOB;PSMD6;PSMC5;PSMB4;PSMB7;PSMD8;APOBEC3G;PSMD3;UBB;PSMC1;PSMD7;PSMA8;PSME3;UBC
prerank,GO_Biological_Process_2021__protein modification process (GO:0036211),-0.35038507088383714,-0.8141023699825983,0.7721518987341772,1.0,1.0,10/70,17.11%,PIGH;LOX;UBE2L6;PHEX;USP6;PLAT;GNMT;PARP4;RABGGTB;RABGGTA
prerank,Reactome_2022__G Beta:Gamma Signaling Thru CDC42 R-HSA-8964616,-0.4348278228554032,-0.8140260254300032,0.6825396825396826,1.0,1.0,5/16,29.93%,GNGT1;GNG13;GNG12;GNG4;GNG3
prerank,GO_Biological_Process_2021__flavin-containing compound metabolic process (GO:0042726),-0.5375459281273088,-0.8140187278208207,0.7627118644067796,1.0,1.0,2/5,22.38%,RFK;SLC52A2
prerank,GO_Biological_Process_2021__riboflavin metabolic process (GO:0006771),-0.5375459281273088,-0.8140187278208207,0.7627118644067796,1.0,1.0,2/5,22.38%,RFK;SLC52A2
prerank,Reactome_2022__Vitamin B2 (Riboflavin) Metabolism R-HSA-196843,-0.5375459281273088,-0.8140187278208207,0.7627118644067796,1.0,1.0,2/5,22.38%,RFK;SLC52A2
prerank,GO_Biological_Process_2021__peptidyl-tyrosine modification (GO:0018212),0.31706953501891877,0.8139674041728608,0.7407407407407407,0.9844368545367549,1.0,12/53,14.95%,KIT;FGFR1;ERBB2;EPHA3;FER;ABL1;ABL2;FGFR3;ABI3;EFEMP1;FLT3;INSR
prerank,GO_Biological_Process_2021__retinal rod cell development (GO:0046548),0.4634938971353359,0.8138035528518368,0.8085106382978723,0.9844851415101619,1.0,2/6,9.51%,RORB;RPGRIP1L
prerank,GO_Biological_Process_2021__actin filament network formation (GO:0051639),-0.468132607411054,-0.8135981361466945,0.7627118644067796,1.0,1.0,2/11,14.57%,FHOD1;LCP1
prerank,GO_Biological_Process_2021__apoptotic DNA fragmentation (GO:0006309),-0.44568941224666925,-0.8134962460702886,0.7205882352941176,1.0,1.0,3/14,11.87%,H1-0;ENDOG;DNASE2
prerank,Reactome_2022__RNA Polymerase I Promoter Clearance R-HSA-73854,0.32201101834502177,0.8134600306036355,0.6956521739130435,0.984951393857438,1.0,14/58,22.28%,GATAD2A;H2BC21;TAF1B;CCNH;POLR1H;HDAC1;GATAD2B;CHD4;H2AX;ERCC3;KAT2B;H2AJ;RBBP4;POLR2F
prerank,Reactome_2022__DNA Replication Initiation R-HSA-68952,-0.49720148883016974,-0.8133847477546485,0.6792452830188679,1.0,1.0,2/7,21.10%,POLE2;POLE3
prerank,GO_Biological_Process_2021__G protein-coupled serotonin receptor signaling pathway (GO:0098664),0.45103902052025724,0.8133094178029132,0.6888888888888889,0.9849176534898096,1.0,2/9,3.39%,HTR1F;HTR2C
prerank,GO_Biological_Process_2021__regulation of cell-cell adhesion mediated by integrin (GO:0033632),-0.4835776741605289,-0.813180398596422,0.7377049180327869,1.0,1.0,2/9,7.11%,CXCL13;ADA
prerank,Reactome_2022__Peptide Hormone Biosynthesis R-HSA-209952,-0.5462415726875349,-0.8130860072364289,0.7636363636363637,1.0,1.0,2/5,29.67%,INHA;INHBA
prerank,GO_Biological_Process_2021__membrane protein ectodomain proteolysis (GO:0006509),-0.4368702295904777,-0.8130592546323238,0.7761194029850746,1.0,1.0,4/19,24.07%,BACE2;ERAP1;PRTN3;APH1A
prerank,GO_Biological_Process_2021__cellular biogenic amine catabolic process (GO:0042402),-0.4817633783336736,-0.812920570435787,0.8367346938775511,1.0,1.0,2/10,7.84%,BHMT;CHDH
prerank,CellMarker_Augmented_2021__Epiblast cell:Embryo,-0.3570315820550978,-0.8128436847130401,0.7625,1.0,1.0,13/70,18.30%,TENT5B;NODAL;DOCK6;ARGFX;NLRP9;LRP4;ETV4;HEY2;MUC4;DND1;RRAD;CAMKV;LDLRAP1
prerank,Reactome_2022__RAS Processing R-HSA-9648002,0.4176733505941971,0.812817022008831,0.7941176470588235,0.9855859290965494,1.0,6/18,19.01%,ABHD17A;ABHD17C;FNTA;ABHD17B;PDE6D;ZDHHC9
prerank,GO_Biological_Process_2021__protein-containing complex disassembly (GO:0032984),-0.35454445357674835,-0.8128058000999527,0.7894736842105263,1.0,1.0,12/49,20.22%,WNT8B;CHMP3;FRAT1;WNT8A;HSPA8;GABARAPL1;GABARAPL2;MAP1LC3B2;RUBCNL;LIX1;RPL23;VAMP7
prerank,Reactome_2022__Processing Of SMDT1 R-HSA-8949664,-0.45031199824259194,-0.8127065426792783,0.6901408450704225,1.0,1.0,2/15,9.90%,MCUB;STOML2
prerank,Reactome_2022__Fcgamma Receptor (FCGR) Dependent Phagocytosis R-HSA-2029480,0.2993218677607302,0.812653536511474,0.7692307692307693,0.9856725792104746,1.0,21/75,21.45%,MYO10;CD247;ITPR2;PRKCSH;CRK;ABL1;MYO9B;WASF3;WASF2;ARPC3;PIK3CA;VAV2;NCK1;LIMK1;MYO5A;DOCK1;ELMO1;PRKCE;PLD2;PLCG2;MYO1E
prerank,GO_Biological_Process_2021__regulation of microtubule motor activity (GO:2000574),0.46918138954554717,0.8124900988990534,0.6458333333333334,0.9857204412242898,1.0,3/6,35.06%,MAP2;CFAP100;FBXW11
prerank,GO_Biological_Process_2021__nose development (GO:0043584),0.4714746645764671,0.8124433961453652,0.7631578947368421,0.9855143980348406,1.0,3/6,17.21%,PROX1;SMCHD1;SKI
prerank,Reactome_2022__Disease R-HSA-1643685,0.24632501601734988,0.8123124303998793,1.0,0.9855063549419382,1.0,162/1448,11.41%,MGAT4C;SLC26A3;FOXO1;VCAN;ADAMTS1;GPC4;MYO10;FGF10;CYP7B1;NOX4;TGFBR1;KIT;ADAMTS16;HDAC3;CD247;ITPR2;ST6GALNAC3;SPRED3;NUP210;PAPSS2;CRHR2;FGFR1;KSR1;IRS1;SLC12A1;CNTRL;HDAC10;SV2C;HIP1;BCL2A1;NRG2;GALNT12;SDC4;RPL3L;DPM3;AGTRAP;SLC3A2;KIAA1549;CHST6;VPS16;CSK;GATAD2A;RIPK2;EXT1;KCNH8;BSG;DERL3;NUP42;DRD5;SEMA5A;KLKB1;GALE;SPON1;CYP2U1;FGF17;GPC6;TENT4A;ITGA4;ADAMTS12;PSME4;ERBB2;MAML1;SEM1;ADAMTS6;LMNB1;DNMT1;PRELP;JAG1;USH2A;ARRB2;CHSY1;SPAM1;NRG1;CAPN2;RAB7A;PRKCSH;BCL11A;G6PC3;GOLGA4;SLC7A9;STAT5B;H2BC21;CRK;HMGB1;GALNT1;ST3GAL3;REXO2;MUC13;KDM7A;DUT;SLC22A5;CDK6;SEC24C;PSMA1;RXFP1;EIF2AK3;NRG3;CDK4;PML;ABL1;CCND3;ABCA1;MAPK8;ERC2;ADCY2;MYC;MVB12A;ARSB;TAF3;DYNC1I2;MAN2A1;GYS1;SYT1;ESRP1;PPFIBP1;FGF18;TGFA;LRP6;SPRED2;MYO9B;MLST8;ADAMTS10;NUS1;ANTXR2;SNRPB;WNT3A;ALG12;CHMP6;ABCC8;TAF12;UBAP1;GCC2;GPC5;TPM4;AKT2;FGFR3;WASF3;KANK1;UBE2E1;KITLG;SLC6A20;PBRM1;MAMLD1;AAAS;PRKAR2A;PKN2;CTBP2;MTR;AKAP9;SH3KBP1;IRS2;ELOA;CSPG5;ANAPC16;F12;B3GAT3;CHST3;SPRED1;SDC3;GLB1;PPP2R1B;WASF2
prerank,GO_Biological_Process_2021__negative regulation of secretion by cell (GO:1903531),0.34112428526249905,0.8120233954409044,0.7941176470588235,0.9858767637899531,1.0,5/32,9.91%,APOE;HRH3;SNCA;DRD4;GRM7
prerank,GO_Biological_Process_2021__DNA-dependent DNA replication maintenance of fidelity (GO:0045005),0.34457343809581564,0.8118742151007006,0.8333333333333334,0.9859245121162298,1.0,11/38,18.58%,RFWD3;SLFN11;SMARCAL1;BOD1L1;SETMAR;TIMELESS;MMS22L;PRIMPOL;FBH1;ATR;EME2
prerank,GO_Biological_Process_2021__positive regulation of interleukin-1 production (GO:0032732),-0.3572181465155913,-0.8115313918804993,0.7910447761194029,1.0,1.0,6/36,10.45%,S100A13;AIM2;WNT5A;NLRP12;USP50;NLRC4
prerank,Reactome_2022__RAB GEFs Exchange GTP For GDP On RABs R-HSA-8876198,-0.33395035796211886,-0.8112350135733117,0.8271604938271605,1.0,1.0,2/84,2.49%,DENND1C;RIN3
prerank,CellMarker_Augmented_2021__Pit Progenitor cell:Stomach,0.3262149720759862,0.8111557384039412,0.8214285714285714,0.9870553458502833,1.0,5/49,8.31%,RSPO3;BCL2;BCL11A;CNN1;HACD1
prerank,GO_Biological_Process_2021__regulation of interleukin-8 production (GO:0032677),0.3149496825635634,0.8110826035278541,0.6896551724137931,0.9869523391360397,1.0,11/50,15.48%,CD14;SSC5D;SERPINE1;HMGB1;F2R;LGALS9;HSPA1A;FADD;ARRB1;OTUD7B;LBP
prerank,GO_Biological_Process_2021__arginine catabolic process (GO:0006527),-0.5242800417607677,-0.8110689902306543,0.7719298245614035,1.0,1.0,2/6,14.17%,ARG2;NOS2
prerank,PanglaoDB_Augmented_2021__Enteroendocrine Cells,0.2907463778404342,0.8110475107988556,0.8148148148148148,0.9867205236059039,1.0,26/123,15.58%,SLC17A6;CNGA3;ALCAM;LHFPL4;PLPPR1;KCNB2;ARX;UNC5D;ELAVL3;PAK5;KCNIP1;ADGRA1;INSL5;ABCC8;CELF4;ELAVL4;RAB3C;OLFM3;VWA5B2;SNAP91;ASXL3;PTPRT;SCRT1;RFX6;CFC1;NRXN1
prerank,GO_Biological_Process_2021__positive regulation of protein depolymerization (GO:1901881),0.3875099498160448,0.8110393430044294,0.6585365853658537,0.9864458974915734,1.0,1/10,4.26%,SEMA5A
prerank,Reactome_2022__G Beta:Gamma Signaling Thru BTK R-HSA-8964315,-0.460240455396397,-0.8110091621732259,0.7627118644067796,1.0,1.0,5/14,29.93%,GNGT1;GNG13;GNG12;GNG4;GNG3
prerank,GO_Biological_Process_2021__myoblast differentiation (GO:0045445),0.4173329348251375,0.8109793108429802,0.6909090909090909,0.9862615847877612,1.0,2/14,5.50%,JAG1;NRG1
prerank,KEGG_2021_Human__Regulation of lipolysis in adipocytes,0.3198821007044198,0.8109687315913642,0.8275862068965517,0.9859915397869381,1.0,14/46,20.72%,PTGS1;IRS1;ADCY2;AKT2;IRS2;ADCY3;IRS4;INSR;PIK3CA;ADORA1;ADCY6;PDE3B;GNAI2;GNAS
prerank,Reactome_2022__Post-translational Modification: Synthesis Of GPI-anchored Proteins R-HSA-163125,0.31731230231963153,0.8108999992207765,0.8928571428571429,0.9859104392077191,1.0,20/64,21.69%,LYPD1;CNTN5;PIGQ;DPM3;NEGR1;MDGA2;CNTN3;NTNG2;TECTA;XPNPEP2;PGAP1;PIGA;MDGA1;GPLD1;ULBP2;LSAMP;RECK;PIGF;ALPL;RTN4RL2
prerank,GO_Biological_Process_2021__negative regulation of lipase activity (GO:0060192),0.5100363444311201,0.8107927705359724,0.6744186046511628,0.9858122273666313,1.0,1/6,4.35%,PLIN5
prerank,GO_Biological_Process_2021__regulation of endothelial cell migration (GO:0010594),0.3074913945810444,0.8107450808458386,0.9047619047619048,0.9855940018957872,1.0,10/74,9.08%,APOH;APOE;ANGPT1;RIN2;ANXA3;PROX1;VASH1;ABL1;SLIT2;PTPRM
prerank,GO_Biological_Process_2021__positive regulation of activated T cell proliferation (GO:0042104),0.3780251592428183,0.810634160891149,0.8372093023255814,0.9856073985640453,1.0,4/16,15.56%,HMGB1;ICOSLG;FADD;IL23A
prerank,GO_Biological_Process_2021__regulation of calcium ion import (GO:0090279),-0.41528514048318615,-0.8105274570072951,0.734375,1.0,1.0,1/17,2.76%,CAV3
prerank,GO_Biological_Process_2021__postsynapse assembly (GO:0099068),0.41795652323949856,0.8105126223158764,0.6111111111111112,0.9855265009477426,1.0,5/11,15.58%,CEL;NLGN1;NLGN4X;NLGN3;NRXN1
prerank,GO_Biological_Process_2021__cellular amino acid biosynthetic process (GO:0008652),-0.4817982614398779,-0.8103360713976409,0.7222222222222222,1.0,1.0,1/6,2.41%,GAD1
prerank,GO_Biological_Process_2021__fructose 6-phosphate metabolic process (GO:0006002),0.42483859228973775,0.8098151037509843,0.8,0.9865596268599255,1.0,2/10,5.03%,FBP2;PFKP
prerank,GO_Biological_Process_2021__mitochondrial fragmentation involved in apoptotic process (GO:0043653),-0.4691287691160145,-0.8097555442316873,0.7368421052631579,1.0,1.0,4/9,35.21%,FIS1;BNIP3;VPS35;CCAR2
prerank,CellMarker_Augmented_2021__B cell:Kidney,0.2532387436931799,0.8097111827663722,1.0,0.9864913528562351,1.0,99/582,16.34%,NXPH4;DGKD;IFRD2;SH2B2;SEL1L3;CCSER1;MOXD1;SLC2A11;TCOF1;CDK14;RNASET2;CCN2;ACAD10;HLA-DQB1;LRRC4C;TEFM;JADE3;NDUFAF6;METTL8;DERL3;DDAH2;PLIN5;ZNF860;ACBD3;MOB3B;BACH2;PTOV1;BCL11A;CACNB4;RRAS2;EIF1AY;UBE2J1;SLC7A9;HLA-DRA;BICD1;CEP120;NCOA3;DHTKD1;AKR1C1;SMARCB1;SCAF4;RALGPS2;PHACTR1;GMDS;PCDH9;IGFBP4;MYC;KHDRBS2;NUS1;NOC3L;RHBDD1;C11ORF24;PNISR;IRAG2;CHPT1;RHCG;MPZL1;SETBP1;LSM12;CEPT1;TTC14;CCDC50;TSPAN3;ODC1;SYNPO;ANKRD44;GPD1;KIZ;MAN1A1;NGLY1;PXK;DPY30;ACSM2A;NPIPB15;SC5D;CD22;NR3C2;SAC3D1;METTL25;XPNPEP2;TMEM154;SMCHD1;CYSLTR1;SUCO;ANK2;VOPP1;BANK1;SIPA1L3;CXXC5;CA2;CNPY3;SHPRH;SERTAD2;KLHL5;TMUB2;FCHSD2;LSM7;FBL;ARL3
prerank,Reactome_2022__mRNA 3-End Processing R-HSA-72187,0.31611547975945886,0.809598312072563,0.84375,0.9864017075574131,1.0,11/51,20.63%,CPSF1;PCF11;U2AF1;SRRM1;CPSF7;SRSF4;PAPOLA;EIF4A3;U2AF2;SYMPK;CPSF6
prerank,GO_Biological_Process_2021__regulation of Fc-gamma receptor signaling pathway involved in phagocytosis (GO:1905449),-0.5549384371397427,-0.8095340192270865,0.7241379310344828,1.0,1.0,1/5,10.28%,PTPRC
prerank,KEGG_2021_Human__Herpes simplex virus 1 infection,0.26663777244697956,0.8094358404152446,0.9375,0.9863977305571275,1.0,74/399,18.63%,ZNF607;ZNF808;ZNF347;ZNF195;ZNF212;BCL2;ZNF623;ZNF561;HLA-DQB1;ZNF99;ZNF33B;NXF5;ZNF701;ZNF860;TNFSF14;ZNF641;ZNF780B;ZNF534;ZNF470;HLA-DRA;ZNF786;CARD9;EIF2AK3;PML;CASP3;ZNF251;ZNF559-ZNF177;ZNF33A;ZNF688;NXF1;ZNF845;ZNF133;AKT2;ZNF2;ZNF599;ZNF331;ZNF519;ZNF569;ZNF514;ZNF777;ZNF782;ZFP82;ZNF761;ZNF41;ZNF300;ZNF846;TICAM1;ZNF337;ZNF155;SRSF4;ZNF311;FADD;NFKB1;BID;ZNF611;PIK3CA;IRAK4;TP53;ZNF549;ZFP28;ZNF765;ZNF708;ZNF283;ZNF665;ZNF273;EIF4EBP1;ZNF675;ZNF627;ZNF589;ZNF12;ZNF613;TAB1;ZNF157;PPP1CB
prerank,GO_Biological_Process_2021__regulation of cardiac conduction (GO:1903779),-0.37502543508612085,-0.8089744785512124,0.7391304347826086,1.0,1.0,4/43,6.95%,CASQ2;TRDN;ATP1A4;KCNJ11
prerank,Reactome_2022__Transmission Across Chemical Synapses R-HSA-112315,0.27585935958233054,0.8086948031761861,1.0,0.9875749324614389,1.0,19/225,8.83%,GRIN3A;BCHE;LLGL1;GABRA5;GABRR2;GPRIN1;CACNG4;GABRG3;GRIK1;NRG1;CACNB4;KCNJ3;NCALD;KCNJ6;PPFIA3;PLCB1;ADCY2;SYT1;CACNG2
prerank,GO_Biological_Process_2021__membrane repolarization during action potential (GO:0086011),-0.4690841766091999,-0.8086628472539007,0.75,1.0,1.0,4/12,22.70%,KCNQ1;KCNE3;ATP1A1;KCNE4
prerank,CellMarker_Augmented_2021__Epidermal Stem cell:Foreskin,0.32142006501506476,0.8083494092972594,0.8148148148148148,0.988071195236362,1.0,42/89,32.90%,SPOPL;GPBP1L1;ABHD3;ZNF33A;TTC17;PKN2;CEPT1;VPS54;CLINT1;RAB11FIP1;ARFIP1;MON2;SP3;ADAM10;UBXN4;AFTPH;COG3;ZDHHC20;VMP1;ATP11B;STK38;RBM39;MPZL3;SCAF11;TRAPPC8;COPB1;NHLRC3;XRN1;NCOA4;CD2AP;EDEM3;BROX;PRKAA1;EFCAB14;TMEM260;UBR2;PDCD6IP;CMTM6;PCMTD1;LMBRD1;PTBP3;STT3B
prerank,Reactome_2022__Acyl Chain Remodelling Of PI R-HSA-1482922,-0.46373582965164095,-0.8081987785214142,0.7540983606557377,1.0,1.0,3/11,20.26%,PLA2G10;PLA2G4A;PLA2G4D
prerank,GO_Biological_Process_2021__phosphatidylglycerol acyl-chain remodeling (GO:0036148),-0.4812446916169427,-0.8081730160851028,0.734375,1.0,1.0,3/10,20.26%,PLA2G10;PLA2G4A;PLA2G4D
prerank,Reactome_2022__PERK Regulates Gene Expression R-HSA-381042,0.3545012217592491,0.8080770221622221,0.8055555555555556,0.9883490381633269,1.0,8/27,20.74%,EXOSC1;ATF3;EIF2AK3;KHSRP;NFYC;DIS3;ATF6;EXOSC5
prerank,GO_Biological_Process_2021__cellular response to lipoteichoic acid (GO:0071223),0.5008103523805725,0.8080396282188276,0.7567567567567568,0.9878270146290604,1.0,2/6,15.48%,CD14;LBP
prerank,GO_Biological_Process_2021__response to lipoteichoic acid (GO:0070391),0.5008103523805725,0.8080396282188276,0.7567567567567568,0.9878270146290604,1.0,2/6,15.48%,CD14;LBP
prerank,GO_Biological_Process_2021__positive regulation of dephosphorylation (GO:0035306),-0.4030627193083133,-0.8077815164426094,0.75,1.0,1.0,1/23,1.49%,TGFB1
prerank,GO_Biological_Process_2021__regulation of phosphatidylinositol 3-kinase signaling (GO:0014066),0.2859825753873949,0.8077433079868244,0.8857142857142857,0.9881346038131807,1.0,19/88,18.04%,KIT;FGFR1;SIRT1;DIPK2A;PDGFD;PLXNB1;EPOR;TWIST1;HCLS1;IRS2;F2R;GAB1;FLT3;INSR;PIK3CA;PIP4K2A;NEDD4;ROR1;PIK3R5
prerank,GO_Biological_Process_2021__epithelial structure maintenance (GO:0010669),-0.45121246242897584,-0.8076634825689581,0.75,1.0,1.0,3/10,15.51%,PBLD;MUC4;STRAP
prerank,Reactome_2022__Pentose Phosphate Pathway R-HSA-71336,0.36331792675218755,0.8073808251888579,0.6904761904761905,0.988655631990334,1.0,4/12,25.49%,PGLS;RPIA;PGM2;PHGDH
prerank,GO_Biological_Process_2021__glucose catabolic process to pyruvate (GO:0061718),0.3789190832297442,0.8072713231964087,0.7096774193548387,0.9883517919632283,1.0,3/22,5.03%,GCK;ENO3;PFKP
prerank,GO_Biological_Process_2021__canonical glycolysis (GO:0061621),0.3789190832297442,0.8072713231964087,0.7096774193548387,0.9883517919632283,1.0,3/22,5.03%,GCK;ENO3;PFKP
prerank,Reactome_2022__Degradation Of AXIN R-HSA-4641257,-0.34690126759322204,-0.8070754133473265,0.7313432835820896,1.0,1.0,1/48,0.62%,PSMB9
prerank,Reactome_2022__FCGR Activation R-HSA-2029481,-0.48746274859262817,-0.8069234963975822,0.7419354838709677,1.0,1.0,1/7,2.29%,HCK
prerank,KEGG_2021_Human__Graft-versus-host disease,-0.4072028276941197,-0.8069038130636114,0.6896551724137931,1.0,1.0,7/17,15.53%,HLA-DMA;HLA-A;HLA-DPB1;HLA-DRB1;HLA-DPA1;CD80;HLA-F
prerank,CellMarker_Augmented_2021__Stem cell:Fetal Liver,0.2931461200302588,0.8068366940797124,0.9310344827586207,0.9887912081247383,1.0,20/93,17.08%,FREM1;FGFR1;GPC6;ADAMTS12;MMP2;VAT1L;EFS;DOK5;PDZRN3;BRINP1;NLGN4X;MPDZ;CDH2;MAP6;ANK2;CDH11;NREP;PTPRD;MAGEL2;CLIP3
prerank,GO_Biological_Process_2021__positive regulation of cytoskeleton organization (GO:0051495),-0.34594389587828905,-0.8066774921788339,0.8227848101265823,1.0,1.0,12/67,18.22%,LMOD1;HCK;C15ORF62;GPSM2;ALOX15;VIL1;BAIAP2L1;TEK;F2RL1;VASP;BAIAP2L2;NTRK3
prerank,GO_Biological_Process_2021__cell projection assembly (GO:0030031),0.36201902495175553,0.8066258256724654,0.7027027027027027,0.9888889801095587,1.0,2/22,3.31%,QRICH2;PARVA
prerank,GO_Biological_Process_2021__intracellular steroid hormone receptor signaling pathway (GO:0030518),-0.37708585146192336,-0.8065719009275181,0.7419354838709677,1.0,1.0,5/34,16.69%,ESR1;GPER1;UBE3A;YAP1;WBP2
prerank,GO_Biological_Process_2021__autophagy of peroxisome (GO:0030242),0.44347650061675314,0.8064770312305997,0.6590909090909091,0.9889141709010973,1.0,4/12,31.32%,ATM;PIK3R4;TRAPPC8;PIK3C3
prerank,GO_Biological_Process_2021__adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway (GO:0007193),0.3295882008377543,0.8064646574242166,0.8,0.9886450633016153,1.0,10/51,11.15%,CHRM2;HTR1F;HRH3;GRM8;DRD4;ADCY2;FLNA;GRM4;GRM7;ADCY3
prerank,GO_Biological_Process_2021__Fc receptor mediated stimulatory signaling pathway (GO:0002431),-0.3506708833933588,-0.8063913906099875,0.8115942028985508,1.0,1.0,6/62,7.51%,HCK;BLK;VAV3;FCGR3A;ACTG1;WAS
prerank,Reactome_2022__CRMPs In Sema3A Signaling R-HSA-399956,-0.4442725759115391,-0.8063585717886126,0.6440677966101694,1.0,1.0,3/16,18.53%,SEMA3A;CDK5R1;PLXNA3
prerank,CellMarker_Augmented_2021__Cytotrophoblast:Placenta,-0.33893244587890403,-0.8063238171812097,0.8690476190476191,1.0,1.0,8/81,6.94%,CLCA2;TIMP3;WNT5A;CLDN1;COL1A1;SEMA3F;COL5A1;SLCO2A1
prerank,GO_Biological_Process_2021__regulation of alpha-beta T cell proliferation (GO:0046640),-0.5038715937574952,-0.806234503325482,0.75,1.0,1.0,1/7,4.73%,IRF1
prerank,GO_Biological_Process_2021__regulation of protein localization (GO:0032880),0.32249395469622194,0.8061438121132343,0.7586206896551724,0.9890028833451051,1.0,5/54,9.82%,TRIM67;DZIP1L;STX6;MAPK8;CEP290
prerank,KEGG_2021_Human__Non-alcoholic fatty liver disease,-0.31957299857073834,-0.806091944480686,0.8571428571428571,1.0,1.0,18/121,17.19%,COX6A1;TGFB1;PKLR;PIK3R3;CASP7;NDUFS2;COX6C;COX7A1;PIK3CB;NDUFA2;NDUFB4;NDUFC1;CYP2E1;COX7C;NDUFA1;NDUFB9;COX7A2;RAC1
prerank,Reactome_2022__Activation Of GABAB Receptors R-HSA-991365,-0.39012810243114215,-0.805840552455689,0.7903225806451613,1.0,1.0,6/36,18.00%,KCNJ15;GNAT3;GNGT1;KCNJ4;ADCY7;GNAL
prerank,Reactome_2022__Translation Of Replicase And Assembly Of Replication Transcription Complex R-HSA-9679504,0.4331932885063055,0.8055674384482242,0.7073170731707317,0.9897782299648265,1.0,4/11,32.47%,CHMP6;PIK3R4;PIK3C3;CHMP7
prerank,GO_Biological_Process_2021__ribosomal small subunit biogenesis (GO:0042274),-0.37004913523457394,-0.8055201308617175,0.7391304347826086,1.0,1.0,14/39,27.12%,PWP2;EMG1;NOB1;RPS27;RPS16;RPS7;RPS14;RPS15;SURF6;RPSA;RPS28;RPS19;RPS24;RPS6
prerank,GO_Biological_Process_2021__regulation of mitotic spindle checkpoint (GO:1903504),0.4799880293335728,0.8054929246050775,0.7209302325581395,0.9893636794273687,1.0,2/6,23.38%,CDK5RAP2;USP44
prerank,GO_Biological_Process_2021__regulation of mitotic sister chromatid segregation (GO:0033047),0.4799880293335728,0.8054929246050775,0.7209302325581395,0.9893636794273687,1.0,2/6,23.38%,CDK5RAP2;USP44
prerank,KEGG_2021_Human__Oocyte meiosis,-0.33589854082662285,-0.8054029626342493,0.8648648648648649,1.0,1.0,16/107,19.26%,BUB1;SPDYA;STAG3;SPDYE3;SPDYE1;ADCY7;SMC1B;ITPR3;CCNE2;RBX1;SPDYE18;SPDYE5;CALM1;PKMYT1;CAMK2A;YWHAG
prerank,Reactome_2022__G1/S Transition R-HSA-69206,-0.32366810291808934,-0.8053947840893847,0.8875,1.0,1.0,33/114,27.84%,PSMB9;CCND1;RPA3;MCM3;CDC25A;CDKN1A;MAX;POLE2;TK1;CCNE2;CKS1B;PSMA3;RPS27A;CDC6;PSMA7;PSMB6;ORC6;POLE3;CDKN1B;PSMA5;PSMD6;CDC7;CDK7;SKP1;PSMC5;MCM5;PSMB4;LIN54;PSMB7;PCNA;PSMD8;MCM10;MCM6
prerank,GO_Biological_Process_2021__piRNA biosynthetic process (GO:1990511),-0.5121738126809526,-0.8052610912621481,0.7538461538461538,1.0,1.0,1/6,7.26%,BTBD18
prerank,GO_Biological_Process_2021__regulation of skeletal muscle contraction (GO:0014819),-0.5389334557831033,-0.805255900085935,0.7692307692307693,1.0,1.0,2/6,14.42%,CAV3;C12ORF57
prerank,GO_Biological_Process_2021__amyloid precursor protein catabolic process (GO:0042987),0.4230321528652785,0.8052265146434209,0.7878787878787878,0.9895377541153808,1.0,6/12,33.04%,ABCA7;ADAM10;DYRK1A;ABCG1;NCSTN;CLN3
prerank,GO_Biological_Process_2021__fatty acid metabolic process (GO:0006631),-0.3271166100906693,-0.8050554594049238,0.8356164383561644,1.0,1.0,26/111,18.26%,ALOX12;LIPI;ACSM6;ALOX5;ACOX2;ACSL5;ACOT6;ALOX12B;LIPH;ALOX15;PON3;CYP2J2;ACOT4;ACSM3;PON1;ACOT1;CYP4F12;HAO2;ACOT2;GGT5;ACSL3;ALOX15B;ANGPTL3;ALOX5AP;CYP4B1;ABCB11
prerank,GO_Biological_Process_2021__B cell activation involved in immune response (GO:0002312),-0.486108020154683,-0.805000863441297,0.71875,1.0,1.0,2/8,8.82%,GPR183;C17ORF99
prerank,Reactome_2022__Suppression Of Phagosomal Maturation R-HSA-9637687,0.454316009942494,0.804932288009259,0.6829268292682927,0.9897926260978643,1.0,3/11,23.14%,RAB7A;RAB5A;CORO1A
prerank,"GO_Biological_Process_2021__CD4-positive, alpha-beta T cell activation (GO:0035710)",0.5185536849601668,0.8048915989259916,0.782608695652174,0.9896004213631073,1.0,2/5,6.42%,CDH26;HMGB1
prerank,Reactome_2022__Processive Synthesis On Lagging Strand R-HSA-69183,-0.4303102898340516,-0.8048554102957423,0.7017543859649122,1.0,1.0,1/13,4.30%,RPA3
prerank,GO_Biological_Process_2021__regulation of cardiac muscle contraction by calcium ion signaling (GO:0010882),-0.4375031385687503,-0.8048382348072869,0.7536231884057971,1.0,1.0,1/18,1.74%,CASQ2
prerank,GO_Biological_Process_2021__cytoplasmic translational initiation (GO:0002183),0.4035010422843353,0.804805667750205,0.6595744680851063,0.9894636446226,1.0,1/18,2.38%,EIF2S3B
prerank,CellMarker_Augmented_2021__Embryonic Stem cell:Hair Follicle,-0.3461072187170061,-0.8046393976004143,0.7671232876712328,1.0,1.0,15/60,17.40%,SALL4;TUNAR;CA14;USHBP1;TPTEP1;HLA-DPB2;DRAXIN;CCDC172;ZNF814;ADGRG2;ZNF738;CTCFL;ZNF90;LCTL;ZNF850
prerank,CellMarker_Augmented_2021__Amnion Epithelial cell:Amniotic Membrane,-0.3461072187170061,-0.8046393976004143,0.7671232876712328,1.0,1.0,15/60,17.40%,SALL4;TUNAR;CA14;USHBP1;TPTEP1;HLA-DPB2;DRAXIN;CCDC172;ZNF814;ADGRG2;ZNF738;CTCFL;ZNF90;LCTL;ZNF850
prerank,GO_Biological_Process_2021__cellular response to epinephrine stimulus (GO:0071872),0.4411686097698455,0.8046151538031616,0.6829268292682927,0.9892541173553524,1.0,2/8,10.30%,SNCA;PDE4B
prerank,GO_Biological_Process_2021__response to epinephrine (GO:0071871),0.4411686097698455,0.8046151538031616,0.6829268292682927,0.9892541173553524,1.0,2/8,10.30%,SNCA;PDE4B
prerank,Reactome_2022__FGFR2 Ligand Binding And Activation R-HSA-190241,-0.41742897808497403,-0.8045682043074486,0.7222222222222222,1.0,1.0,1/14,0.93%,FGF20
prerank,GO_Biological_Process_2021__regulation of glial cell proliferation (GO:0060251),0.4741268717683612,0.8038734397785621,0.6444444444444445,0.9902527472630248,1.0,2/5,16.67%,HES1;NOTCH1
prerank,KEGG_2021_Human__Hepatitis B,0.2722480452376214,0.8037399187539844,0.95,0.9902944593713572,1.0,31/134,20.53%,TGFBR1;BCL2;NFATC3;TICAM2;CREB3L2;CREB3L4;STAT5B;MAPK8;CASP3;MYC;MAP3K1;AKT2;TICAM1;FADD;NFKB1;BID;PIK3CA;IRAK4;TP53;MAPK12;BRAF;MAP2K7;TAB1;EP300;CREB1;SOS1;TAB2;MAP2K6;TRAF6;RAF1;FOS
prerank,GO_Biological_Process_2021__organic acid transport (GO:0015849),-0.3321177250518184,-0.8036045130836605,0.8157894736842105,1.0,1.0,10/85,8.58%,SLC51A;SLC22A6;SLC16A8;SLC7A7;SLC7A3;SLCO2B1;CEACAM1;SLC6A12;SLC3A1;ABCG2
prerank,GO_Biological_Process_2021__regulation of cellular catabolic process (GO:0031329),0.3041999193664967,0.8033394904162702,0.7837837837837838,0.9907653209288123,1.0,7/63,8.76%,HSPB1;DAPK2;IFI16;ACER2;ABL1;OSBPL7;ABL2
prerank,GO_Biological_Process_2021__negative regulation of canonical Wnt signaling pathway (GO:0090090),-0.30910353628980874,-0.80332141595131,0.8591549295774648,1.0,1.0,9/143,11.14%,NOTUM;PSMB9;WNT5A;SHISA6;DAB2;LATS2;SFRP4;DRAXIN;LRP4
prerank,GO_Biological_Process_2021__negative chemotaxis (GO:0050919),0.33125820134870715,0.8032927120921001,0.8421052631578947,0.9905392377650937,1.0,5/31,9.68%,EPHA7;SEMA6C;UNC5C;SLIT2;SEMA4A
prerank,GO_Biological_Process_2021__mitochondrial fission (GO:0000266),0.4055211713413945,0.8030659496903859,0.7222222222222222,0.9906190544743138,1.0,1/17,4.88%,GDAP1
prerank,CellMarker_Augmented_2021__B cell:Peripheral Blood,0.42072769201997356,0.8030325691467528,0.8205128205128205,0.9903888955053008,1.0,1/9,0.51%,CD38
prerank,Reactome_2022__Metalloprotease DUBs R-HSA-5689901,0.35582446812743473,0.8029464168931468,0.7741935483870968,0.9902649775530034,1.0,2/21,3.34%,BRCC3;STAMBPL1
prerank,CellMarker_Augmented_2021__Oocyte:Embryo,0.3087915958125024,0.8029301564964109,0.8636363636363636,0.9900138334851993,1.0,23/84,23.09%,PER3;MFAP3L;GRM8;REXO2;RAI14;WASF3;IRAG2;EPB41L5;PPM1A;CLSTN2;DNAJC3;RFESD;RPIA;SP2;LONRF1;DUSP19;TMEM131;TMCC1;CREB1;TFG;POLB;METTL9;AMPD3
prerank,Reactome_2022__Vpu Mediated Degradation Of CD4 R-HSA-180534,-0.3482431441159835,-0.8029093634881396,0.7205882352941176,1.0,1.0,20/45,31.83%,PSMB9;CD4;PSMA3;RPS27A;PSMA7;PSMB6;PSMA5;PSMD6;SKP1;PSMC5;PSMB4;PSMB7;PSMD8;PSMD3;UBB;PSMC1;PSMD7;PSMA8;PSME3;UBC
prerank,GO_Biological_Process_2021__liver development (GO:0001889),0.36781624427167126,0.802807821664194,0.813953488372093,0.989945238276377,1.0,6/24,13.81%,WNT4;PKD2;PRKCSH;PROX1;COBL;NF1
prerank,KEGG_2021_Human__Ubiquinone and other terpenoid-quinone biosynthesis,-0.46236785897109733,-0.8027627301958575,0.7301587301587301,1.0,1.0,1/9,6.51%,NQO1
prerank,GO_Biological_Process_2021__oxoacid metabolic process (GO:0043436),-0.3911214495446899,-0.8027626576458591,0.75,1.0,1.0,9/23,26.85%,DAO;ABHD14B;GNMT;SULT4A1;SULT1C3;PPA1;SULT1C2;BPNT2;LIAS
prerank,CellMarker_Augmented_2021__CD8+ T cell:Lung,0.2874394177570037,0.8026748756879748,0.8888888888888888,0.9899275716497801,1.0,6/73,7.36%,GLA;HSCB;CMC1;COMMD6;EXOSC1;PSMA1
prerank,GO_Biological_Process_2021__positive regulation of extracellular matrix disassembly (GO:0090091),0.48879950792775706,0.8025626430940752,0.775,0.9898166436967977,1.0,4/7,34.77%,FSCN1;CARMIL2;CLASP2;CLASP1
prerank,GO_Biological_Process_2021__organic acid catabolic process (GO:0016054),0.43594913225831633,0.8025329299766237,0.7346938775510204,0.9895743880288252,1.0,1/9,1.76%,GLYATL2
prerank,Reactome_2022__Disassembly Of Destruction Complex And Recruitment Of AXIN To Membrane R-HSA-4641262,-0.37930521105463955,-0.8023905528679055,0.7076923076923077,1.0,1.0,3/26,11.84%,WNT8B;FRAT1;WNT8A
prerank,GO_Biological_Process_2021__regulation of growth hormone secretion (GO:0060123),-0.5148659458346769,-0.8023299640377535,0.7884615384615384,1.0,1.0,1/5,16.67%,GHRL
prerank,GO_Biological_Process_2021__regulation of macrophage derived foam cell differentiation (GO:0010743),0.3684282617760752,0.8022708106961666,0.7428571428571429,0.9898025993255393,1.0,7/22,18.24%,APOB;PPARG;ABCA1;LPL;NFKB1;NR1H3;PLA2G5
prerank,Reactome_2022__Other Semaphorin Interactions R-HSA-416700,0.3999108384425123,0.8022025728065816,0.75,0.9896536769276048,1.0,3/16,17.65%,SEMA5A;SEMA4A;PLXNA4
prerank,GO_Biological_Process_2021__adherens junction maintenance (GO:0034334),0.5259160121095625,0.8019166696046502,0.725,0.9899283194627962,1.0,3/5,38.81%,CAMSAP3;TJP1;KIFC3
prerank,GO_Biological_Process_2021__negative regulation of apoptotic signaling pathway (GO:2001234),0.31542751431094695,0.8018927081888505,0.8518518518518519,0.9896863063944011,1.0,8/70,9.20%,TGFBR1;BCL2;CFLAR;URI1;CX3CR1;SH3RF1;NR4A2;PIH1D1
prerank,GO_Biological_Process_2021__regulation of actin cytoskeleton organization (GO:0032956),0.34190919131571706,0.8016481196374865,0.7142857142857143,0.9899099953900709,1.0,17/83,16.39%,TRPM2;RHOBTB3;RHOBTB1;CRK;EPHA3;ABL1;EFNA5;MLST8;ABL2;RND3;ABI3;EPS8;CCDC88A;ARHGAP35;PIK3CA;FSCN1;CORO2B
prerank,GO_Biological_Process_2021__ribosomal large subunit biogenesis (GO:0042273),-0.3413048976908963,-0.801553343520709,0.796875,1.0,1.0,17/53,27.27%,EIF6;RPL3;RPL35A;BRIX1;LAS1L;RPL7A;WDR12;NOP53;MRPL20;RPL5;RPL11;SURF6;RPL24;EBNA1BP2;NSA2;RPL26L1;RPL10
prerank,GO_Biological_Process_2021__regulation of cellular response to transforming growth factor beta stimulus (GO:1903844),-0.3887406943005486,-0.8015172853443405,0.782608695652174,1.0,1.0,4/21,16.15%,TGFB1;LATS2;ENG;SMAD3
prerank,GO_Biological_Process_2021__receptor signaling pathway via JAK-STAT (GO:0007259),-0.39330897383989755,-0.8014865464519032,0.7205882352941176,1.0,1.0,2/25,6.09%,CLCF1;STAT1
prerank,GO_Biological_Process_2021__folic acid-containing compound metabolic process (GO:0006760),0.373876780869137,0.8014549451086338,0.7027027027027027,0.989900841126929,1.0,5/18,18.77%,SLC19A1;DHFR;MTHFR;FPGS;SHMT2
prerank,GO_Biological_Process_2021__regulation of megakaryocyte differentiation (GO:0045652),-0.36982447307848887,-0.8014019179626752,0.7671232876712328,1.0,1.0,8/47,13.14%,EIF6;GP1BA;ZFPM1;THBS1;ITGA2B;SCIN;PITHD1;FAXDC2
prerank,Reactome_2022__Cellular Senescence R-HSA-2559583,0.2676159889572301,0.8013284880395836,0.8235294117647058,0.9898620819200638,1.0,36/132,22.30%,MAPKAPK2;PHC2;LMNB1;H2BC21;CDK6;CDK4;MAPK8;MOV10;TNIK;UBE2E1;TERF1;RPS6KA3;ANAPC16;TNRC6C;SCMH1;ACD;H2AX;NFKB1;RPS6KA2;ETF1;CDC26;TP53;TNRC6A;ATM;AGO3;MAP2K7;ANAPC7;H2AJ;RNF2;MAP2K6;FOS;FZR1;RBBP4;MDM4;TFDP1;ASF1A
prerank,PanglaoDB_Augmented_2021__Parathyroid Chief Cells,0.28786847901991663,0.8013282528425149,0.92,0.989582301795157,1.0,20/89,17.37%,GPC4;DUSP15;FGFR1;SPTBN4;DNAJB5;KCNIP1;SPRED2;ABCC8;PDZRN3;NPAS4;SLC7A8;CAMK1G;PRR36;ANK2;RFX6;CFC1;WWC1;MAGEL2;ATN1;SYN1
prerank,GO_Biological_Process_2021__regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway (GO:1902235),0.39723631995542813,0.801182960020925,0.6216216216216216,0.9895351992473669,1.0,6/19,27.28%,EIF2AK3;HSPA1A;NCK1;CREB3L1;BCL2L1;TXNDC12
prerank,GO_Biological_Process_2021__nuclear mRNA surveillance (GO:0071028),0.4413218886716126,0.8011753699400249,0.7291666666666666,0.9892641223948334,1.0,5/10,26.76%,DXO;EXOSC5;PCID2;EXOSC9;XRN1
prerank,CellMarker_Augmented_2021__Adipose Progenitor cell:Abdominal Adipose Tissue,-0.3363327436770873,-0.8011315986688824,0.7941176470588235,1.0,1.0,8/72,9.70%,ACTC1;BEX1;SLC7A3;LRRTM1;CLDN6;GPC3;RTL1;FBN3
prerank,CellMarker_Augmented_2021__Adipose-derived Stromal cell:Abdominal Adipose Tissue,-0.3363327436770873,-0.8011315986688824,0.7941176470588235,1.0,1.0,8/72,9.70%,ACTC1;BEX1;SLC7A3;LRRTM1;CLDN6;GPC3;RTL1;FBN3
prerank,GO_Biological_Process_2021__regulation of blood circulation (GO:1903522),-0.39993786908758877,-0.8010172297677324,0.6935483870967742,1.0,1.0,9/23,22.96%,CAV3;KCNQ1;CYP2J2;AGT;PLN;ACE2;AGER;KCNMB2;KCNG2
prerank,Reactome_2022__FCERI Mediated MAPK Activation R-HSA-2871796,0.34784621359192397,0.800974359942483,0.918918918918919,0.989360794426607,1.0,8/27,20.89%,MAPK8;MAP3K1;PKN2;VAV2;MAP2K7;SOS1;FOS;PLCG2
prerank,GO_Biological_Process_2021__protein stabilization (GO:0050821),0.28957994851737284,0.8009564433634767,1.0,0.9891194881988622,1.0,31/161,22.14%,RASSF2;IRGM;HIP1;PARVA;PYHIN1;PER3;FLNA;TELO2;PPIB;TRIM44;PIM2;USP36;CCNH;HSPA1A;TESC;COG7;OTUD3;ANK2;ATF7IP;MORC3;EP300;CREB1;MARCHF7;SWSAP1;GNAQ;PLPP3;TBL1X;MDM4;BAG6;PTEN;SMAD7
prerank,GO_Biological_Process_2021__regulation of innate immune response (GO:0045088),-0.35209870843443286,-0.8009224288125159,0.8115942028985508,1.0,1.0,16/52,26.42%,IFNK;IRF1;NLRC3;SH2D1B;CDC37;CACTIN;ERAP1;IFI35;CASP8;DHX58;HSP90AB1;TKFC;USP18;PTPN11;CCL5;RNF135
prerank,Reactome_2022__UCH Proteinases R-HSA-5689603,-0.3361037721126109,-0.8007874050468251,0.8441558441558441,1.0,1.0,3/74,4.98%,PSMB9;TGFB1;ACTL6A
prerank,Reactome_2022__Autodegradation Of E3 Ubiquitin Ligase COP1 R-HSA-349425,-0.35016743866013217,-0.8007175505329485,0.7681159420289855,1.0,1.0,1/45,0.62%,PSMB9
prerank,CellMarker_Augmented_2021__Neuroendocrine cell:Fetal Pancreas,-0.32378377972950095,-0.8005862532764657,0.8064516129032258,1.0,1.0,19/95,26.32%,ATP6V1G2;ENO2;ATP6V0E2;CA11;RAB6B;MAGEE1;NEFM;PNMA1;SALL2;PIANP;NEFL;TUBB4A;DLG4;TCEAL2;TMEM59L;USP11;CALY;CHN1;ADGRB2
prerank,KEGG_2021_Human__T cell receptor signaling pathway,0.32555235715161573,0.8001348213998395,0.7142857142857143,0.9903225341503791,1.0,23/85,21.97%,CD247;NFATC3;MAP3K14;PAK5;CDK4;MAPK8;CBLB;CD8A;AKT2;NFKB1;PIK3CA;VAV2;MAPK12;MALT1;NCK1;MAP2K7;SOS1;PAK3;PAK2;RAF1;FOS;DLG1;NCK2
prerank,CellMarker_Augmented_2021__Oogenesis Phase Fetal Germ cell:Fetal Gonad,-0.2831415128623593,-0.8001279496922139,0.9895833333333334,1.0,1.0,91/770,16.23%,NLRP4;AMBP;EPN1;DNAH11;SERINC2;RASGRF2;HIPK4;DISC1;TEKT5;MAT2B;GAD1;DEGS2;ITIH2;PDGFRL;STAG3;ASGR2;NLRP11;NOSTRIN;VAV3;FAM184B;TRIM77;FSD2;ARHGAP15;CAPN12;CLEC4C;NR2E3;STAT1;FAM227B;SH2D4A;FTCD;NLRP5;NFKB2;ADA;C19ORF38;H1-0;NOL12;CHRNE;PHEX;ITGA9;POMZP3;MYO5B;LDHAL6A;ACOT4;FAT2;ITGBL1;CFD;PHF21B;LMOD3;SHD;GLRX;DNAH17;PON1;ARG2;SVIP;COL6A6;MYO3B;CALB2;TMC3;MAX;GPX3;TUBA4A;WFS1;EYA2;BAIAP2L1;PPIC;NLRP14;BCO1;DNAH3;PSMG4;NTN1;SPOCK3;STRC;PSTPIP1;ZIM2;HEY2;C1S;SGMS2;CCNI2;GLB1L2;ACOT2;TTC32;PCMT1;ZP3;EI24;JPH2;FBLN2;DNAH10;DUSP22;IRF2BPL;ITGB5;CYSTM1
prerank,GO_Biological_Process_2021__insulin metabolic process (GO:1901142),-0.5307225202827334,-0.8000835141231352,0.7868852459016393,1.0,1.0,1/5,7.40%,CEACAM1
prerank,PanglaoDB_Augmented_2021__Mesothelial Cells,0.2732239078911394,0.7999885002724336,0.95,0.9903512791059447,1.0,25/117,15.45%,FIBIN;MXRA5;LAMA3;MRGPRF;SDC4;PARVA;COL12A1;NTN4;OSR1;DSP;FZD1;EDNRA;SNAI2;MIR22HG;RND3;COL16A1;CRLS1;TWSG1;LRIG3;EFEMP1;WWTR1;PRICKLE2;CDH11;PLSCR4;GBP2
prerank,KEGG_2021_Human__Regulation of actin cytoskeleton,0.2604031152867158,0.7999665466919124,1.0,0.9901267795683442,1.0,29/192,16.53%,CHRM2;FGF10;ACTR3C;FGFR1;ITGA11;ITGA8;FGF17;ITGA4;PDGFD;PAK5;RRAS2;CRK;F2;FGD1;FGF18;ITGA3;FGFR3;F2R;WASF2;PXN;ITGB4;ARHGAP35;ARPC3;PIK3CA;VAV2;SSH1;CRKL;ITGA10;PIP4K2A
prerank,CellMarker_Augmented_2021__Lymphocyte:Undefined,-0.3694380724835828,-0.799769120855959,0.8055555555555556,1.0,1.0,7/50,4.89%,SIRPG;GMFG;CYTIP;TAGAP;KLRB1;IRF1;TNFRSF1B
prerank,GO_Biological_Process_2021__regulation of transforming growth factor beta receptor signaling pathway (GO:0017015),0.28485116370169106,0.7997563225480295,0.8888888888888888,0.9902272912936617,1.0,21/85,17.21%,BAMBI;TGFBR1;SPRED3;IL17RD;SIRT1;ZEB2;ZNF703;LATS1;SPRED2;ITGA3;SPRED1;PPM1A;BCL9L;HSPA1A;SMAD2;SMURF1;FAM89B;MEN1;NREP;PMEPA1;SKI
prerank,GO_Biological_Process_2021__negative regulation of hippo signaling (GO:0035331),0.4511546537971396,0.7997226781392117,0.6666666666666666,0.9900071713888571,1.0,7/12,32.82%,MARK3;DLG5;WWC1;WWC2;WWC3;LIMD1;VGLL4
prerank,GO_Biological_Process_2021__auditory receptor cell stereocilium organization (GO:0060088),0.5368059231020165,0.7997106326627278,0.7777777777777778,0.9894619108560704,1.0,2/5,14.36%,WHRN;PDZD7
prerank,GO_Biological_Process_2021__auditory receptor cell morphogenesis (GO:0002093),0.5368059231020165,0.7997106326627278,0.7777777777777778,0.9894619108560704,1.0,2/5,14.36%,WHRN;PDZD7
prerank,Reactome_2022__Sensory Processing Of Sound By Inner Hair Cells Of Cochlea R-HSA-9662360,0.321101914794053,0.7997104752640556,0.75,0.9891831891910405,1.0,13/62,21.45%,PCDH15;PCLO;WHRN;CTBP2;EPS8L2;EPS8;MYO3A;ESPN;SYN1;TPRN;CASK;CAPZA1;MYO1E
prerank,GO_Biological_Process_2021__response to sterol (GO:0036314),-0.4733619607731624,-0.7996680494658593,0.7627118644067796,1.0,1.0,2/9,4.14%,TGFB1;RORC
prerank,Reactome_2022__Regulation Of Activated PAK-2p34 By Proteasome Mediated Degradation R-HSA-211733,-0.3527096522156692,-0.7995028429353228,0.7681159420289855,1.0,1.0,1/43,0.62%,PSMB9
prerank,"Reactome_2022__TICAM1, RIP1-mediated IKK Complex Recruitment R-HSA-168927",0.39556543540123124,0.7990792118712496,0.6857142857142857,0.9900759330515184,1.0,5/16,25.41%,TICAM1;TRAF6;UBE2D2;IKBKB;UBE2D3
prerank,GO_Biological_Process_2021__positive regulation of catabolic process (GO:0009896),-0.3477686417485932,-0.7989202824252613,0.7746478873239436,1.0,1.0,10/54,17.08%,DTL;WNT5A;GPC3;ACTN3;C4BPA;ASB5;OAZ2;C4BPB;ANGPTL3;VSIR
prerank,GO_Biological_Process_2021__positive regulation of canonical Wnt signaling pathway (GO:0090263),0.28824871244931854,0.7988315849007196,0.9130434782608695,0.9902647445402347,1.0,15/119,14.09%,LGR5;BAMBI;FGF10;SEMA5A;PSME4;ZEB2;PSMA1;WNT3A;GPC5;KANK1;WNK2;PPM1A;RNF146;WLS;NFKB1
prerank,Reactome_2022__Citric Acid Cycle (TCA Cycle) R-HSA-71403,0.3675230931252965,0.7986528252118567,0.8285714285714286,0.9903565974734532,1.0,3/18,12.54%,LDLR;OGDH;IDH2
prerank,PanglaoDB_Augmented_2021__Stromal Cells,-0.3164196781575965,-0.7986149369001341,0.8823529411764706,1.0,1.0,16/104,14.70%,LMOD1;TIMP3;ANGPTL2;MMP9;COL1A1;COL5A1;DAB2;ADAM33;DCN;ICAM3;LAMC2;CALB2;TLR2;TEK;C1S;ACTA2
prerank,GO_Biological_Process_2021__nucleobase-containing compound catabolic process (GO:0034655),0.38715847703496725,0.7984769165932162,0.7058823529411765,0.990355783479285,1.0,6/33,19.66%,RNASET2;NUDT18;PNPT1;NUDT5;XRN2;ENTPD2
prerank,GO_Biological_Process_2021__regulation of chemokine (C-X-C motif) ligand 2 production (GO:2000341),0.4145336640342413,0.7983437816541376,0.7142857142857143,0.9903970559364196,1.0,2/10,9.91%,HMGB1;LPL
prerank,Reactome_2022__Endogenous Sterols R-HSA-211976,0.3575242065633776,0.7982606412915648,0.7272727272727273,0.9902279343899313,1.0,3/19,6.80%,CYP7B1;CYP4V2;NCOA2
prerank,GO_Biological_Process_2021__dendritic cell migration (GO:0036336),-0.44897152942638835,-0.7982290623282634,0.7755102040816326,1.0,1.0,2/8,6.26%,ALOX5;GPR183
prerank,GO_Biological_Process_2021__negative regulation of plasma membrane bounded cell projection assembly (GO:0120033),0.3473671145040258,0.7980114106449829,0.7419354838709677,0.990315488146253,1.0,5/22,11.56%,SLIT2;KANK1;ABI3;EVI5L;EVL
prerank,Reactome_2022__Erythrocytes Take Up Carbon Dioxide And Release Oxygen R-HSA-1237044,-0.47170435152382884,-0.7979958954751671,0.6949152542372882,1.0,1.0,3/7,17.94%,CA1;CA4;SLC4A1
prerank,PanglaoDB_Augmented_2021__Trophoblast Stem Cells,-0.3348560732875354,-0.7979085518249363,0.8028169014084507,1.0,1.0,21/62,24.91%,CCND1;SEMA3F;PTGES;SH2D4A;EPN3;BAIAP2L1;TRIM29;PPIC;TOM1L1;ABCA12;YAP1;CELSR1;ALDH1A3;SIX4;KLRG2;C6ORF132;GNG12;LYPD6;TPBG;GRHL2;TMEM54
prerank,GO_Biological_Process_2021__positive regulation of immunoglobulin mediated immune response (GO:0002891),0.39714816048052476,0.7977920388200742,0.6666666666666666,0.990411402788962,1.0,4/14,16.13%,SHLD2;SHLD1;KMT5C;KMT5B
prerank,GO_Biological_Process_2021__regulation of microtubule-based movement (GO:0060632),-0.48636323686495586,-0.797784320155513,0.7846153846153846,1.0,1.0,1/8,8.44%,DRC1
prerank,Reactome_2022__Elevation Of Cytosolic Ca2+ Levels R-HSA-139853,0.4613495485258805,0.7974131514722727,0.8,0.9908015343789798,1.0,2/13,3.05%,ITPR2;TRPC3
prerank,GO_Biological_Process_2021__neural tube closure (GO:0001843),0.33011585702247304,0.7972503069157114,0.875,0.9908090021511986,1.0,6/33,13.71%,PRICKLE1;SCRIB;LRP6;PHACTR4;COBL;MTHFR
prerank,GO_Biological_Process_2021__immune response-activating cell surface receptor signaling pathway (GO:0002429),-0.4177189701538848,-0.7969777690818418,0.8095238095238095,1.0,1.0,5/18,12.70%,MICB;BLK;C3AR1;FPR1;FPR3
prerank,KEGG_2021_Human__Pathways of neurodegeneration,-0.29175712231270456,-0.7969622947634647,0.9545454545454546,1.0,1.0,93/397,25.63%,DNAH11;COX6A1;WNT5A;SLC25A31;WNT8B;FZD8;TNFRSF1B;PINK1;UBE2L6;PDYN;ATP5F1E;FRAT1;CASP7;NDUFS2;COX6C;DCTN1;DNAH17;ATP5MC3;WNT8A;WNT6;GPX3;ATP5PF;TUBA4A;COX7A1;ATG14;DNAH3;DNAH2;VDAC1;GABARAPL1;NDUFA2;NOS2;GPX2;NDUFB4;NDUFC1;TUBA3D;DNAI1;ITPR3;COX7C;NDUFA1;NEFM;RAB8A;NDUFB9;TUBB;PSMA3;DNAH10;TUBB6;COX7A2;GABARAPL2;WNT10A;RAC1;TUBB2A;CDK5R1;CALM1;RPS27A;CAMK2A;COX4I1;PSMA7;PSMB6;CASP8;NOX1;NDUFB10;AGER;DKK2;NEFL;HSPA5;TUBB4A;MAP2K1;NDUFS5;ATP5PB;NDUFB11;DLG4;PSMA5;TUBB4B;ATP5F1A;OPTN;SDHC;PSMD6;PLCB2;CSNK2A2;PPID;ATP2A2;WNT9B;KLC1;NDUFB2;UCHL1;ACTR1B;APAF1;DNAH12;WNT5B;KRAS;GRIN2D;PARK7;PSMC5
prerank,GO_Biological_Process_2021__negative regulation of nervous system process (GO:0031645),0.47255415951912044,0.7969218771161571,0.74,0.9910979667774735,1.0,1/6,7.38%,EIF2AK3
prerank,GO_Biological_Process_2021__detection of mechanical stimulus involved in sensory perception (GO:0050974),0.39639752029927006,0.7969131047994381,0.7272727272727273,0.9908281254452168,1.0,4/13,14.36%,KIT;WHRN;ADGRV1;PDZD7
prerank,Reactome_2022__Phase 0 - Rapid Depolarisation R-HSA-5576892,-0.4006303842718747,-0.7968594837708213,0.8181818181818182,1.0,1.0,1/30,1.19%,SCN5A
prerank,GO_Biological_Process_2021__microtubule polymerization (GO:0046785),0.3688741515864671,0.7968420583766421,0.78125,0.9906760117752016,1.0,9/28,29.79%,AKAP9;TPPP3;MAP7D3;TPPP;CCDC57;ZNF207;NDE1;FGF13;CLASP2
prerank,GO_Biological_Process_2021__potassium ion import across plasma membrane (GO:1990573),-0.358686209452109,-0.7968197822327131,0.7671232876712328,1.0,1.0,6/38,16.95%,KCNJ15;ATP1A4;KCNJ11;KCNJ4;ATP4A;KCNJ13
prerank,GO_Biological_Process_2021__integrated stress response signaling (GO:0140467),0.4204559693635425,0.7968128251675116,0.6571428571428571,0.9904484199783155,1.0,6/11,29.74%,EIF2AK3;IMPACT;QRICH1;NFE2L2;EIF2S1;EIF2AK4
prerank,GO_Biological_Process_2021__vascular endothelial growth factor receptor signaling pathway (GO:0048010),0.30658298461300393,0.7967216101325375,0.8,0.9903090885368347,1.0,13/57,20.06%,MAPKAPK2;VEGFC;HSPB1;CRK;WASF2;PXN;PIK3CA;VAV2;CLEC14A;NCK1;DOCK1;ELMO1;PAK2
prerank,GO_Biological_Process_2021__regulation of branching involved in ureteric bud morphogenesis (GO:0090189),-0.49554221331132897,-0.7965569299830848,0.7424242424242424,1.0,1.0,5/10,31.28%,AGT;SIX4;SOX9;PAX2;PAX8
prerank,CellMarker_Augmented_2021__Astroglial Progenitor cell:Embryo,0.30705075751357336,0.7965541313172364,0.8214285714285714,0.9902957037532522,1.0,10/73,10.88%,SELPLG;TRAC;CNPPD1;MOB2;ITPKB;CTDSP2;CTDSP1;APOL3;WDTC1;ABTB1
prerank,CellMarker_Augmented_2021__Lymphocyte:Blood,-0.3579637895189157,-0.7965390855929022,0.8309859154929577,1.0,1.0,18/58,19.76%,HCK;C3AR1;FCGR3A;OSCAR;LY86;GBP1;FPR1;NLRC4;CLEC12A;TLR2;CD300LF;ADGRE3;HK3;LITAF;ALOX5AP;CPQ;CSF1R;TMEM71
prerank,GO_Biological_Process_2021__T cell differentiation (GO:0030217),-0.3883073466222995,-0.7965379517233838,0.7971014492753623,1.0,1.0,7/35,17.25%,TCF7;ANXA1;PTPRC;SPI1;CD4;GLI3;ZFP36L1
prerank,GO_Biological_Process_2021__forebrain neuron development (GO:0021884),-0.5238457809428017,-0.7965064289176388,0.7962962962962963,1.0,1.0,1/6,2.54%,WNT5A
prerank,GO_Biological_Process_2021__cellular response to purine-containing compound (GO:0071415),-0.4539346915918514,-0.796288321080778,0.7692307692307693,1.0,1.0,2/9,9.43%,CASQ2;P2RY6
prerank,GO_Biological_Process_2021__endosome organization (GO:0007032),0.33193630659559276,0.7962716400930593,0.7941176470588235,0.9905633540137978,1.0,1/38,0.97%,RAB27A
prerank,GO_Biological_Process_2021__positive regulation of cytokinesis (GO:0032467),-0.3923248521888978,-0.7962085671535549,0.7540983606557377,1.0,1.0,5/26,18.65%,KIF14;SVIL;CXCR5;ECT2;CDC6
prerank,GO_Biological_Process_2021__histidine catabolic process (GO:0006548),0.5068087910459762,0.7961100326400049,0.78125,0.9902891311291834,1.0,2/7,3.54%,HNMT;CARNMT1
prerank,GO_Biological_Process_2021__histidine metabolic process (GO:0006547),0.5068087910459762,0.7961100326400049,0.78125,0.9902891311291834,1.0,2/7,3.54%,HNMT;CARNMT1
prerank,Reactome_2022__Peptide Ligand-Binding Receptors R-HSA-375276,0.32419851244560205,0.7959528306077869,0.8571428571428571,0.9903637761719225,1.0,14/100,8.98%,TACR3;NTSR2;GALR3;QRFPR;RIPK2;CX3CR1;PROKR2;UTS2R;OPRD1;RXFP1;NMU;NPW;EDNRA;INSL5
prerank,GO_Biological_Process_2021__aromatic compound biosynthetic process (GO:0019438),-0.5075776154789122,-0.7957695851469008,0.7407407407407407,1.0,1.0,1/7,2.55%,ACMSD
prerank,GO_Biological_Process_2021__response to peptide (GO:1901652),-0.37589707434246233,-0.7955947907169217,0.8095238095238095,1.0,1.0,3/29,8.67%,MMP9;STAT1;ANXA1
prerank,Reactome_2022__RHO GTPase Cycle R-HSA-9012999,-0.288987243753142,-0.7955373647803571,0.9775280898876404,1.0,1.0,32/410,10.48%,TRIP10;KIF14;RASGRF2;ACTC1;PLEKHG6;DOCK6;DOCK8;ARHGAP9;TAGAP;PLEKHG3;OBSCN;VAV3;CCDC187;PDE5A;ARHGAP15;DOCK2;ARMCX3;ARHGEF40;UACA;CAVIN1;ACTG1;WAS;PIK3R3;MPZ;ATP6AP1;RHOQ;WDR6;SNAP23;CKB;CYBA;ARHGAP12;ARAP3
prerank,GO_Biological_Process_2021__extracellular exosome biogenesis (GO:0097734),0.49846263151163267,0.7954459739954715,0.7,0.9908824921185232,1.0,1/5,0.97%,RAB27A
prerank,GO_Biological_Process_2021__sterol biosynthetic process (GO:0016126),-0.3838345551730825,-0.7953115520735518,0.7205882352941176,1.0,1.0,3/32,13.14%,PLPP6;ACAA2;FAXDC2
prerank,GO_Biological_Process_2021__androgen receptor signaling pathway (GO:0030521),0.42722456144470355,0.7952483765943864,0.8055555555555556,0.9909234206953637,1.0,2/11,16.94%,ARID1A;PMEPA1
prerank,GO_Biological_Process_2021__glycerophospholipid metabolic process (GO:0006650),0.28912136624463236,0.7952250010275059,0.9565217391304348,0.99068377074156,1.0,16/67,18.48%,PIGQ;CPNE7;SMPD4;PLCB1;PNPLA3;ABHD3;CRLS1;CPNE6;PLA2G4C;PLA2G15;PIGA;DGKH;SERINC5;GPLD1;HDHD5;CPNE1
prerank,PanglaoDB_Augmented_2021__Juxtaglomerular Cells,-0.3248780673965205,-0.7952164630753783,0.7631578947368421,1.0,1.0,8/81,7.34%,LMOD1;TIMP3;ANGPTL2;COL1A1;ADAM33;DCN;SLCO2A1;ASPN
prerank,KEGG_2021_Human__Cysteine and methionine metabolism,-0.35151317123207493,-0.7952057759961437,0.7916666666666666,1.0,1.0,2/44,2.36%,BHMT;MAT2B
prerank,PanglaoDB_Augmented_2021__Pulmonary Alveolar Type I Cells,-0.322160178713832,-0.7952019231045993,0.8902439024390244,1.0,1.0,22/117,19.16%,AQP3;CRLF1;CLDN1;COL1A1;SEMA3F;SLCO2A1;A4GALT;COL4A4;OSMR;COL4A3;LAMC2;ITGB6;TRIM29;PPIC;CLDN18;YAP1;SCARA3;SCNN1A;SCNN1G;CYP4B1;EPAS1;SLC44A3
prerank,GO_Biological_Process_2021__protein-DNA complex disassembly (GO:0032986),0.38876767149236896,0.7950353487665803,0.8108108108108109,0.9907121733397506,1.0,6/16,13.07%,SMARCD3;SMARCB1;MYC;ARID1A;SMARCA4;ARID2
prerank,PanglaoDB_Augmented_2021__Pulmonary Vascular Smooth Muscle Cells,-0.33248886196572197,-0.7950146603018037,0.8481012658227848,1.0,1.0,9/86,6.82%,LMOD1;GALNT15;ANGPTL2;COL1A1;COL5A1;DAB2;ADAM33;DAAM2;DCN
prerank,GO_Biological_Process_2021__transcription preinitiation complex assembly (GO:0070897),-0.43162905594782136,-0.7949276964095565,0.7627118644067796,1.0,1.0,2/12,9.14%,TAF7;TAF7L
prerank,GO_Biological_Process_2021__protein deglycosylation involved in glycoprotein catabolic process (GO:0035977),0.49749605338446856,0.7946759358673275,0.7083333333333334,0.9905839673982904,1.0,3/5,28.07%,MAN1A1;EDEM1;EDEM3
prerank,GO_Biological_Process_2021__mannose trimming involved in glycoprotein ERAD pathway (GO:1904382),0.49749605338446856,0.7946759358673275,0.7083333333333334,0.9905839673982904,1.0,3/5,28.07%,MAN1A1;EDEM1;EDEM3
prerank,GO_Biological_Process_2021__ubiquitin-dependent glycoprotein ERAD pathway (GO:0097466),0.49749605338446856,0.7946759358673275,0.7083333333333334,0.9905839673982904,1.0,3/5,28.07%,MAN1A1;EDEM1;EDEM3
prerank,GO_Biological_Process_2021__nicotinamide nucleotide biosynthetic process (GO:0019359),-0.44430704570146845,-0.7946680178129183,0.6779661016949152,1.0,1.0,2/7,23.62%,HAAO;QPRT
prerank,GO_Biological_Process_2021__alpha-amino acid catabolic process (GO:1901606),0.3684485230797145,0.794616288158311,0.7352941176470589,0.9904200150338034,1.0,7/25,14.77%,TDO2;CBS;KYAT1;AADAT;SARDH;THNSL2;GSTZ1
prerank,Reactome_2022__Synthesis Of PA R-HSA-1483166,-0.3756720638931409,-0.794456048927251,0.7391304347826086,1.0,1.0,4/32,9.22%,LIPI;LIPH;PLA2G10;DDHD2
prerank,GO_Biological_Process_2021__positive regulation of macromolecule metabolic process (GO:0010604),0.2603187727464473,0.7942674612661786,1.0,0.9909375558011821,1.0,55/290,17.45%,NGF;POU3F1;RAB27A;FGF10;TGFBR1;ZNF804A;SCRIB;EPHX2;MITF;ANGPT1;CDH5;ZBTB7B;PID1;FGF17;DNMT1;SNCA;ARRB2;MAGI2;OSR1;GREM1;EIF2AK3;SP1;MAPK8;MYC;FGF18;WNT3A;TWIST1;MOV10;AMH;RBMS3;RIMS2;LGALS9;TNRC6C;LIMS1;TICAM1;HSPA1A;RESF1;RNF207;PLSCR1;TESC;ARRB1;ANK2;INSR;TP53;GABPA;TNRC6A;SNF8;MPHOSPH8;EPHB2;NOTCH1;ATM;ATF7IP;AGO3;BRAF;PAX6
prerank,GO_Biological_Process_2021__quaternary ammonium group transport (GO:0015697),0.4239765414877446,0.7942493465369784,0.7045454545454546,0.9907025496979959,1.0,3/8,10.93%,SLC22A5;SLC6A20;SLC25A29
prerank,GO_Biological_Process_2021__regulation of striated muscle tissue development (GO:0016202),-0.47752581327492627,-0.793854042016783,0.7333333333333333,1.0,1.0,1/8,1.49%,TGFB1
prerank,Reactome_2022__NR1H2 And NR1H3 Regulate Gene Expression Linked To Triglyceride Lipolysis In Adipose R-HSA-9031528,0.4969165018481444,0.793802040048606,0.7547169811320755,0.9911821201353122,1.0,4/5,35.21%,NR1H3;RXRA;NR1H2;RXRB
prerank,GO_Biological_Process_2021__purine ribonucleoside triphosphate metabolic process (GO:0009205),0.41461114858470866,0.7936747759728797,0.7045454545454546,0.9911142520202464,1.0,2/12,12.30%,AK3;EFL1
prerank,CellMarker_Augmented_2021__Ciliated Epithelial cell:Esophagus,-0.2911421288737081,-0.7935831841481706,0.9655172413793104,1.0,1.0,37/356,12.11%,PLEKHS1;ECT2L;DNAH11;POLQ;CHST9;CFAP126;CCDC39;ANKUB1;PZP;CCDC81;DYDC2;VWA3B;SYT10;AGBL5;VWA3A;PTRH1;TEKT3;CCDC60;ERICH2;ATP6V1C2;ODAD1;BPIFB1;DRC1;ST6GALNAC2;MS4A8;ITGBL1;ENDOG;C11ORF16;AKAP14;ENPP4;CP;NEK5;SNTN;DALRD3;FAM81B;WARS1;CFAP20DC
prerank,GO_Biological_Process_2021__positive regulation of alpha-beta T cell proliferation (GO:0046641),-0.4233383756087422,-0.7935731907036929,0.7538461538461538,1.0,1.0,3/12,18.80%,HLA-A;IL18;CD81
prerank,Reactome_2022__Senescence-Associated Secretory Phenotype (SASP) R-HSA-2559582,0.32460803405078303,0.7935455447948806,0.8947368421052632,0.9911341117086012,1.0,14/55,21.20%,H2BC21;CDK6;CDK4;UBE2E1;RPS6KA3;ANAPC16;H2AX;NFKB1;RPS6KA2;CDC26;ANAPC7;H2AJ;FOS;FZR1
prerank,GO_Biological_Process_2021__peptide cross-linking (GO:0018149),0.37302763953680673,0.7935107445752968,0.7674418604651163,0.9909285348640591,1.0,4/17,7.52%,CSTA;CD247;DSP;LORICRIN
prerank,GO_Biological_Process_2021__regulation of intracellular steroid hormone receptor signaling pathway (GO:0033143),0.36372678311389306,0.7934582166532718,0.6551724137931034,0.9907397662304644,1.0,8/30,20.65%,CBFB;NCOA2;SAFB2;LATS1;CARM1;RUNX1;EP300;KCTD6
prerank,GO_Biological_Process_2021__DNA replication-independent nucleosome organization (GO:0034724),-0.4513242269448529,-0.7934484592808937,0.7540983606557377,1.0,1.0,1/11,7.60%,HAT1
prerank,"Reactome_2022__Platelet Activation, Signaling And Aggregation R-HSA-76002",-0.3087063561790393,-0.7934434037799825,0.8809523809523809,1.0,1.0,26/219,15.12%,F8;MPL;TGFB1;TIMP3;P2RY12;VAV3;GP1BA;TRPC7;PIK3R3;GNAT3;CLU;PLG;GNGT1;THBS1;CD63;VWF;ITGA2B;ITIH3;TUBA4A;PRKCH;F13A1;PIK3CB;ITIH4;F5;TGFB3;ITPR3
prerank,CellMarker_Augmented_2021__Lake Et al.Science.Ex2:Brain,-0.46739812025275335,-0.7934393012869575,0.7254901960784313,1.0,1.0,1/10,5.09%,SYT10
prerank,Reactome_2022__Regulation Of TP53 Activity R-HSA-5633007,0.29197768383081096,0.7932396330376736,0.9090909090909091,0.990838985859944,1.0,37/142,22.84%,SMYD2;CCNG1;GATAD2A;PPP1R13B;SGK1;PML;TAF3;MLST8;TAF12;AKT2;PPP2R1B;BANP;KAT6A;HDAC1;GATAD2B;CHD4;PLK3;TP53;EXO1;PIP4K2A;ATM;RAD17;TAF4;PRMT5;NOC2L;RAD9A;EP300;CDK5;PRKAA2;MAP2K6;PRKAG2;DNA2;RBBP4;MDM4;ATRIP;TTC5;BRIP1
prerank,PanglaoDB_Augmented_2021__Mesangial Cells,-0.3156283678092676,-0.7930804176360122,0.9125,1.0,1.0,14/137,7.54%,LMOD1;TIMP3;ANGPTL2;ANGPT2;NOSTRIN;FILIP1L;COL1A1;COL5A1;FBXL7;DAB2;ADAM33;DCN;PLAU;LATS2
prerank,GO_Biological_Process_2021__regulation of protein kinase activity (GO:0045859),0.299076872411737,0.7930318975500238,0.7391304347826086,0.9909882028154381,1.0,25/95,20.34%,RASSF2;HSPB1;CCN1;CEP85;SIRT1;SNCA;DEPTOR;TRIB2;LRP6;SPRED1;RAP1A;UBASH3B;SNX9;NF1;ANKRD54;WWTR1;DUSP19;TAB1;TARBP2;MMD2;C5AR1;TAB2;PRKAG2;PAK2;GNAQ
prerank,Reactome_2022__Phospholipase C-mediated Cascade; FGFR2 R-HSA-5654221,-0.41887802942446817,-0.7930258423202055,0.8,1.0,1.0,1/14,0.93%,FGF20
prerank,GO_Biological_Process_2021__positive regulation of lymphocyte differentiation (GO:0045621),-0.4138108700154929,-0.7930010833852291,0.7727272727272727,1.0,1.0,3/17,18.95%,IL7;CD27;AXL
prerank,GO_Biological_Process_2021__negative regulation of endocytosis (GO:0045806),0.37381546732734067,0.792994140567879,0.8,0.9907995753852852,1.0,6/19,21.39%,EPHA3;NR1H3;LGALS3;ABCA7;LRSAM1;RUBCN
prerank,GO_Biological_Process_2021__peptidyl-threonine phosphorylation (GO:0018107),0.29249311735092237,0.7929940010468767,0.9310344827586207,0.9905235097471171,1.0,5/56,9.86%,TGFBR1;SBK1;MAPK8;MAP3K10;DYRK3
prerank,CellMarker_Augmented_2021__Spermatogonial Stem cell:Embryo,-0.33529313413960704,-0.7929847952091928,0.8289473684210527,1.0,1.0,9/93,6.82%,LMOD1;ANGPTL2;TSPAN11;COL1A1;COL5A1;FBXL7;ADAM33;RGS4;DCN
prerank,CellMarker_Augmented_2021__Fibroblast:Synovium,-0.33529313413960704,-0.7929847952091928,0.8289473684210527,1.0,1.0,9/93,6.82%,LMOD1;ANGPTL2;TSPAN11;COL1A1;COL5A1;FBXL7;ADAM33;RGS4;DCN
prerank,CellMarker_Augmented_2021__Retinal Ganglion cell:Embryonic Stem Cell,-0.33529313413960704,-0.7929847952091928,0.8289473684210527,1.0,1.0,9/93,6.82%,LMOD1;ANGPTL2;TSPAN11;COL1A1;COL5A1;FBXL7;ADAM33;RGS4;DCN
prerank,CellMarker_Augmented_2021__Mesenchymal cell:Pancreas,-0.33529313413960704,-0.7929847952091928,0.8289473684210527,1.0,1.0,9/93,6.82%,LMOD1;ANGPTL2;TSPAN11;COL1A1;COL5A1;FBXL7;ADAM33;RGS4;DCN
prerank,CellMarker_Augmented_2021__Fibroblast:Embryonic Stem Cell,-0.33529313413960704,-0.7929847952091928,0.8289473684210527,1.0,1.0,9/93,6.82%,LMOD1;ANGPTL2;TSPAN11;COL1A1;COL5A1;FBXL7;ADAM33;RGS4;DCN
prerank,CellMarker_Augmented_2021__Mesenchymal Stromal cell:Blood Vessel,-0.33529313413960704,-0.7929847952091928,0.8289473684210527,1.0,1.0,9/93,6.82%,LMOD1;ANGPTL2;TSPAN11;COL1A1;COL5A1;FBXL7;ADAM33;RGS4;DCN
prerank,CellMarker_Augmented_2021__Testis Somatic cell:Testis,-0.33529313413960704,-0.7929847952091928,0.8289473684210527,1.0,1.0,9/93,6.82%,LMOD1;ANGPTL2;TSPAN11;COL1A1;COL5A1;FBXL7;ADAM33;RGS4;DCN
prerank,Reactome_2022__RHOG GTPase Cycle R-HSA-9013408,0.312178852232642,0.7928867810183161,0.68,0.990397630369198,1.0,15/71,19.12%,VANGL1;STX5;RAB7A;PRKCSH;VRK2;PGRMC2;KTN1;PKN2;ARHGAP21;ARHGAP35;VAV2;ARHGEF16;DOCK1;SHMT2;ARHGAP5
prerank,GO_Biological_Process_2021__monocarboxylic acid metabolic process (GO:0032787),-0.3209992171055186,-0.7925180370835618,0.8181818181818182,1.0,1.0,28/116,18.49%,AMACR;ALOX12;CYP26B1;SLC16A8;CYP3A5;PTGR1;ACOT6;CYP2J2;ACOT4;CYP3A4;CKB;PDHX;CKMT2;SLC16A3;ACOT1;CYP4F12;VDAC1;ACOT2;GGT5;ACSL3;ADH7;ANGPTL3;SCPEP1;PRODH2;MCCC2;CYP4B1;ABCB11;ALDH1A3
prerank,GO_Biological_Process_2021__positive regulation of nucleocytoplasmic transport (GO:0046824),0.3165261198295321,0.792496193764571,0.9024390243902439,0.9908717838319436,1.0,16/41,25.94%,HDAC3;FLNA;HCLS1;ANP32B;TP53;NEDD4;RAPGEF3;KHDRBS1;CPSF6;JUP;NRDE2;TPR;UBR5;PRKCD;GAS6;DMAP1
prerank,GO_Biological_Process_2021__transition metal ion transport (GO:0000041),0.33146311340348994,0.7921810772966984,0.8648648648648649,0.9911582371316332,1.0,3/33,3.19%,SLC30A10;TRPC3;SLC39A8
prerank,GO_Biological_Process_2021__double-strand break repair via nonhomologous end joining (GO:0006303),0.30497935098426776,0.7921751030724568,0.9354838709677419,0.9908865430969847,1.0,16/58,18.33%,BRCC3;ERCC8;RNF168;HMGB1;SMARCAL1;POLM;SETMAR;KDM2A;SMC5;H2AX;PAXX;HERC2;LIG4;ATM;NSMCE2;MDC1
prerank,Reactome_2022__Infection With Mycobacterium Tuberculosis R-HSA-9635486,-0.4076390296667916,-0.7921016542600865,0.864406779661017,1.0,1.0,4/22,18.03%,RNF213;DUSP16;TLR2;RPS27A
prerank,Reactome_2022__Aberrant Regulation Of Mitotic G1/S Transition In Cancer Due To RB1 Defects R-HSA-9659787,-0.43397351968840303,-0.7920286064169959,0.7164179104477612,1.0,1.0,4/15,15.42%,CCND1;CCND2;CDKN1A;CCNE2
prerank,GO_Biological_Process_2021__regulation of adipose tissue development (GO:1904177),0.4795850123565754,0.7918127730264288,0.7333333333333333,0.9912977207854659,1.0,1/6,4.59%,SIRT1
prerank,Reactome_2022__ERCC6 (CSB) And EHMT2 (G9a) Positively Regulate rRNA Expression R-HSA-427389,0.36762860758705446,0.791798905904333,0.7307692307692307,0.9910386244187821,1.0,6/26,13.73%,GATAD2A;H2BC21;HDAC1;GATAD2B;CHD4;H2AX
prerank,GO_Biological_Process_2021__peptidyl-tyrosine phosphorylation (GO:0018108),0.2916918182287434,0.791793791232583,0.9545454545454546,0.9907671903103896,1.0,13/64,14.95%,KIT;FGFR1;ERBB2;EPHA3;FER;ABL1;ABL2;FGFR3;ABI3;EFEMP1;PIBF1;FLT3;INSR
prerank,"GO_Biological_Process_2021__negative regulation of retrograde protein transport, ER to cytosol (GO:1904153)",0.47367336019516715,0.7915731554476974,0.7659574468085106,0.9909284907626623,1.0,2/9,6.23%,DERL3;UBE2J1
prerank,GO_Biological_Process_2021__regulation of interleukin-1 beta production (GO:0032651),0.32645691216233247,0.7915485339913154,0.7380952380952381,0.9906946628626152,1.0,11/50,11.44%,HSPB1;RIPK2;CX3CR1;FZD5;IFI16;PYHIN1;TMEM106A;LPL;F2R;LGALS9;NLRP2B
prerank,GO_Biological_Process_2021__peroxisome organization (GO:0007031),0.35740874488682706,0.7914742751459776,0.71875,0.9905524221284108,1.0,11/24,37.32%,ABCD3;ABCD2;PEX3;PEX14;ACOT8;MFF;PEX16;LONP2;PEX12;ABCD4;PEX7
prerank,GO_Biological_Process_2021__negative regulation of Rho protein signal transduction (GO:0035024),0.3683665262254438,0.791307748784835,0.75,0.9905889680661399,1.0,7/16,22.47%,ABL2;ITGA3;KANK1;ARHGAP35;CCDC125;RASIP1;SCAI
prerank,KEGG_2021_Human__Necroptosis,0.28527675615646103,0.7912300865816944,0.96,0.990438526008688,1.0,17/103,14.12%,BCL2;CFLAR;TICAM2;CAPN2;STAT5B;HMGB1;MAPK8;GLUD1;CHMP6;SHARPIN;SPATA2L;TICAM1;FADD;GLUD2;PLA2G4C;H2AX;BID
prerank,GO_Biological_Process_2021__nucleosome positioning (GO:0016584),-0.464117831454787,-0.79118407004351,0.7692307692307693,1.0,1.0,6/10,27.21%,H1-0;H1-3;SMARCA5;PAF1;H1-2;LIN54
prerank,GO_Biological_Process_2021__ncRNA processing (GO:0034470),-0.2996679750499781,-0.7910429361335196,0.8875,1.0,1.0,58/192,27.27%,RPL37A;INTS5;SENP3;RPL38;PWP2;EMG1;RPL15;NOB1;RPL3;RPL35A;RPS9;RPS27;RPL13A;SMAD3;RPL27A;RPS16;RPL36;LAS1L;RPL7A;RPL9;RPL13;RPL21;WDR12;NOP53;EXOSC8;RPL34;RPL4;RPL32;RPL5;RPL23;RPL41;RPS7;RPL27;RPL35;RPS14;RPL11;RPS15;EXOSC2;RPLP1;RPL24;SBDS;RPL18A;RPL29;RPLP2;PDCD11;RPL28;RPL12;RPL18;EBNA1BP2;RPL22;IMP3;RPS28;RPS19;RPS24;RPL19;RPL8;RPS6;RPL10
prerank,PanglaoDB_Augmented_2021__Keratinocytes,-0.3568368327428736,-0.7910163066110101,0.7536231884057971,1.0,1.0,5/47,7.34%,CLCA2;AQP3;FLG;DUOXA1;SERPINB5
prerank,GO_Biological_Process_2021__peptidyl-amino acid modification (GO:0018193),0.43529052595016104,0.7909717500521408,0.6956521739130435,0.9906370769600709,1.0,2/7,14.66%,METAP1D;FKBP7
prerank,GO_Biological_Process_2021__positive regulation of RNA metabolic process (GO:0051254),0.31800505786415545,0.7908784385162746,0.8275862068965517,0.990515772779304,1.0,10/43,15.44%,RBM20;SIRT7;RIOK1;DXO;ERN1;LIN28B;HSPA1A;PNPT1;NFKB1;TP53
prerank,GO_Biological_Process_2021__protein localization to cytoplasmic stress granule (GO:1903608),-0.5192382202958374,-0.7908752273972957,0.7543859649122807,1.0,1.0,2/6,18.78%,DDX3X;DDX1
prerank,GO_Biological_Process_2021__synaptic vesicle exocytosis (GO:0016079),0.30745971873092925,0.7906139415070847,0.896551724137931,0.9907640086638164,1.0,7/34,14.19%,DOC2B;PCLO;SNCA;SYT1;RIMS2;UNC13B;SNPH
prerank,GO_Biological_Process_2021__O-glycan processing (GO:0016266),-0.34496891612039987,-0.7904572491540096,0.8051948051948052,1.0,1.0,10/50,15.93%,GALNT15;B3GNT5;MUCL1;MUC5B;ST6GALNAC2;CHST4;MUC4;MUC17;GCNT1;GALNT6
prerank,Reactome_2022__SHC-mediated cascade:FGFR2 R-HSA-5654699,-0.4039344384251028,-0.7903262127428237,0.7540983606557377,1.0,1.0,1/18,0.93%,FGF20
prerank,Reactome_2022__ER-Phagosome Pathway R-HSA-1236974,-0.3306378947518752,-0.7903219914851792,0.7536231884057971,1.0,1.0,10/73,19.11%,PSMB9;HLA-A;SNAP23;TLR2;NDUFA2;HLA-F;PSMA3;RPS27A;PSMA7;PSMB6
prerank,GO_Biological_Process_2021__negative regulation of cellular catabolic process (GO:0031330),0.3089627377240932,0.7901688746827654,0.8846153846153846,0.9912611204891316,1.0,10/58,13.52%,BCL2;MFSD2A;PLIN5;TIMP1;MTMR8;LEPR;DAPL1;TAB3;KLHL22;IL10RA
prerank,GO_Biological_Process_2021__protein processing (GO:0016485),0.32861106671405904,0.789953878651815,0.7619047619047619,0.991421881386704,1.0,5/82,4.29%,HGFAC;PRSS3;CPN1;HTRA2;KLKB1
prerank,GO_Biological_Process_2021__3'-UTR-mediated mRNA stabilization (GO:0070935),-0.4603834598965812,-0.789772594029255,0.8307692307692308,1.0,1.0,2/13,6.10%,BOLL;DAZL
prerank,GO_Biological_Process_2021__negative regulation of neuron projection regeneration (GO:0070571),0.45237539839883817,0.7897528779701667,0.717948717948718,0.991528630102378,1.0,2/7,35.49%,EPHA4;PTPRS
prerank,Reactome_2022__Non-integrin membrane-ECM Interactions R-HSA-3000171,-0.3669969005416101,-0.7896276554276416,0.7971014492753623,1.0,1.0,5/37,11.45%,TGFB1;SDC2;VTN;THBS1;LAMC2
prerank,GO_Biological_Process_2021__dehydroascorbic acid transport (GO:0070837),-0.5122413511461087,-0.7895715077252319,0.7407407407407407,1.0,1.0,2/5,30.03%,SLC23A1;SLC2A2
prerank,"Reactome_2022__Cell Cycle, Mitotic R-HSA-69278",-0.2784466730892196,-0.7895325952137962,0.9888888888888889,1.0,1.0,58/461,19.26%,NEK2;BUB1;ERCC6L;PSMB9;FOXM1;CCND1;SPC25;RPA3;MCM3;CENPU;CDC25A;FBXL7;ITGB3BP;ZWILCH;H2BC4;CCND2;FKBPL;NUF2;CENPH;DCTN1;CENPS-CORT;CDKN2D;CDKN1A;MAX;H2AZ1;TUBA4A;CEP72;DYNLL1;RPS27;INCENP;POLE2;TUBA3D;TK1;CCNE2;BORA;RAB8A;RBX1;CKS1B;CC2D1B;NDEL1;TUBB;PSMA3;TUBB6;CEP76;TUBB2A;POLD4;ARPP19;CDCA8;CENPN;RPS27A;KIF18A;PKMYT1;FBXL18;CDC6;BUB1B;PSMA7;PSMB6;YWHAG
prerank,GO_Biological_Process_2021__regulation of double-strand break repair (GO:2000779),-0.3534081416622528,-0.7894372999008444,0.7972972972972973,1.0,1.0,3/40,7.51%,FOXM1;TERF2IP;WAS
prerank,GO_Biological_Process_2021__negative regulation of DNA recombination (GO:0045910),-0.349086983120166,-0.7892443800392352,0.8055555555555556,1.0,1.0,3/50,7.35%,POLQ;TERF2IP;H1-0
prerank,GO_Biological_Process_2021__negative regulation of lipid biosynthetic process (GO:0051055),-0.398133056189342,-0.7891313081308016,0.8194444444444444,1.0,1.0,3/18,8.63%,GPER1;CEACAM1;BRCA1
prerank,PanglaoDB_Augmented_2021__Loop Of Henle Cells,-0.3083029189659562,-0.7890529364540358,0.8571428571428571,1.0,1.0,19/121,14.86%,C1QTNF1;CYYR1;LMOD1;TIMP3;ANGPTL2;PPP1R1B;DRAM1;DCN;SLCO2A1;ENC1;THBS1;VWF;GPX3;SLC14A2;EDNRB;TEK;HEY2;C1S;ADGRF5
prerank,GO_Biological_Process_2021__activation of protein kinase B activity (GO:0032148),-0.3808606514505703,-0.7888802911121912,0.765625,1.0,1.0,2/26,5.61%,WNT5A;PINK1
prerank,GO_Biological_Process_2021__negative regulation of transforming growth factor beta receptor signaling pathway (GO:0030512),0.30536378244421314,0.7887570319137189,0.8928571428571429,0.9931074254032932,1.0,14/59,15.05%,BAMBI;TGFBR1;SPRED3;IL17RD;SIRT1;LTBP1;SPRED2;SPRED1;PPM1A;BCL9L;HSPA1A;SMAD2;SMURF1;FAM89B
prerank,Reactome_2022__Nuclear Receptor Transcription Pathway R-HSA-383280,0.3314606944953232,0.788700492725445,0.8333333333333334,0.9929441821175796,1.0,13/46,16.04%,ESRRG;RORA;RARB;PPARG;RORB;NR4A2;NR3C2;NR3C1;THRB;NR1H3;NR6A1;NRBF2;NR4A3
prerank,Reactome_2022__TRAF3-dependent IRF Activation Pathway R-HSA-918233,-0.4384351646701195,-0.7886933645371811,0.7666666666666667,1.0,1.0,1/12,6.02%,TRIM25
prerank,GO_Biological_Process_2021__ESCRT complex disassembly (GO:1904896),0.45846282732768096,0.7886337730525717,0.775,0.9925475301512052,1.0,1/9,14.10%,VTA1
prerank,GO_Biological_Process_2021__ESCRT III complex disassembly (GO:1904903),0.45846282732768096,0.7886337730525717,0.775,0.9925475301512052,1.0,1/9,14.10%,VTA1
prerank,GO_Biological_Process_2021__regulation of endothelial cell differentiation (GO:0045601),-0.466295176850877,-0.7885249667555818,0.7058823529411765,1.0,1.0,3/9,21.09%,CEACAM1;APOLD1;BTG1
prerank,KEGG_2021_Human__alpha-Linolenic acid metabolism,-0.4185903399119981,-0.7883111468569823,0.7627118644067796,1.0,1.0,4/16,20.26%,PLA2G10;PLB1;PLA2G4A;PLA2G4D
prerank,GO_Biological_Process_2021__cytochrome complex assembly (GO:0017004),-0.48752536457445944,-0.7882799386998905,0.7419354838709677,1.0,1.0,1/6,10.17%,CYBA
prerank,GO_Biological_Process_2021__tube closure (GO:0060606),0.33470949610844425,0.7880699021774222,0.8333333333333334,0.9929753839044828,1.0,6/30,13.71%,PRICKLE1;SCRIB;LRP6;PHACTR4;COBL;MTHFR
prerank,GO_Biological_Process_2021__primary neural tube formation (GO:0014020),0.33470949610844425,0.7880699021774222,0.8333333333333334,0.9929753839044828,1.0,6/30,13.71%,PRICKLE1;SCRIB;LRP6;PHACTR4;COBL;MTHFR
prerank,GO_Biological_Process_2021__sphingolipid biosynthetic process (GO:0030148),-0.3375671489469644,-0.7879525211538249,0.8055555555555556,1.0,1.0,5/68,8.09%,ELOVL2;DEGS2;ALOX12B;PRKD3;A4GALT
prerank,Reactome_2022__PKA Activation In Glucagon Signaling R-HSA-164378,0.3909031420241498,0.787906114339,0.71875,0.9929365997712621,1.0,7/14,29.07%,ADCY2;PRKAR2A;ADCY6;GNAS;PRKACB;ADCY9;ADCY5
prerank,GO_Biological_Process_2021__positive regulation of myoblast differentiation (GO:0045663),0.4516247085361602,0.7877756766181796,0.7,0.9928688658659227,1.0,2/14,7.70%,SMYD1;PLCB1
prerank,Reactome_2022__G2/M Transition R-HSA-69275,-0.30314248372877906,-0.7877412962406284,0.9036144578313253,1.0,1.0,23/166,19.26%,NEK2;PSMB9;FOXM1;CDC25A;FBXL7;FKBPL;DCTN1;CDKN1A;TUBA4A;CEP72;DYNLL1;BORA;RAB8A;RBX1;TUBB;PSMA3;CEP76;RPS27A;PKMYT1;FBXL18;PSMA7;PSMB6;YWHAG
prerank,Reactome_2022__Metabolism R-HSA-1430728,-0.27424709015660687,-0.7877350081228724,1.0,1.0,1.0,263/1769,19.66%,CD44;ENPP2;SQOR;DBH;ARSH;DUOX1;PSMB9;BHMT;IYD;SLC51A;VSIG2;SERINC2;ELOVL2;ADSS1;COX6A1;SLC37A2;AHR;MGST1;AMACR;LYVE1;RPL37A;ALOX12;LIPI;MAT2B;TCN1;CYP26B1;DEGS2;ACMSD;TMEM186;INMT;CHST9;ARHGAP9;SLC16A8;PLD4;CYP1B1;NOSTRIN;ACSM6;CYP3A5;ALOX5;ACOX2;ACSL5;PHKG1;CYP24A1;PTGR1;DGAT2L6;PLAAT4;ALDOB;OGN;LRP10;GLYCTK;TAC4;FMO4;TECRL;PIPOX;PKLR;SDC2;ACOT6;ALOX12B;LIPH;SLCO2B1;FUT2;PTGES;CA14;NUDT13;PLA2G10;NQO1;FTCD;PRKD3;DCN;ENO2;PLEKHA4;KCNJ11;ADA;CA1;INPP5D;ARF3;ALOX15;PNPLA4;CHDH;PON3;DAO;CYP2A6;SLC6A12;PIK3R3;ATP5F1E;GLYATL3;GPC3;ABCG2;PLPP6;AZIN1;RPL38;HSD3B7;GAPDHS;AKR1B15;DDHD2;PPT1;LDHAL6A;CYP2J2;ACOT4;GNGT1;CYP3A4;RPL15;NDUFS2;CKB;COX6C;PDHX;OLAH;OMD;CYP21A2;ACSM3;RFK;ALAS2;NAT8L;PYGL;CHST7;GLRX;AOX1;GPIHBP1;APOM;ATP5MC3;LRP2;PON1;ARG2;UCP1;ACAA2;CKMT2;RPS4X;PLEKHA2;SLC16A3;RPL3;ACOT1;TMLHE;HSD11B1;RPL35A;HAAO;ATP5PF;NFYB;GLDC;CYP4F12;ORMDL3;HSD17B13;BCO1;PIK3CB;RPS9;VDAC1;FAU;OAZ2;RPS27;UROC1;NDUFA2;GPX2;SGMS2;NDUFB4;HAO2;ABHD14B;NDUFC1;RPS21;VDR;PIK3C2G;NR1H4;ACOT2;HACD4;GGT5;CYP2E1;ADCY7;TK1;SDSL;SLC25A19;ITPR3;CA4;ACSS3;COX7C;ETFB;AWAT1;NDUFA1;STARD5;SLC10A1;AMN;ACSL3;PLB1;XYLT2;CERS3;RPL13A;SLCO1A2;UROS;B4GALNT2;NDUFB9;PSMA3;GBA3;ATP5ME;SERINC1;RPL27A;NUDT15;ADH7;SLC19A3;GNMT;ALOX15B;RPS16;SMOX;PGAM2;RPL36;TNFAIP8L3;PARP4;NT5E;RPS20;RPL7A;SUMF1;HOOK2;COX20;SULT4A1;HSD3B1;PAICS;RPL9;PIK3CG;BMX;ARSF;B3GALT6;SLC6A7;TBXAS1;PLA2G4A;PRODH2;ALOX5AP;MBOAT1;IDH3G;MCCC2;CYP4B1;RPS8;CALM1;RPS27A;STAB2;IMPA2;RPL21;ABCB11;GCHFR;LDLRAP1;PKMYT1;CBLIF;RPL34;TYR;GPS2;COX4I1;UGT8;SERINC3;PSMA7;B4GAT1;NNT;PFKFB2;SLC27A5;PSMB6;RPL4;SLC44A3;RPL32;HS3ST3A1;ANGPTL4;NUDT11;CYP17A1;RPL5;DAND5;RPL23;IMPDH2;RPL41;MOGAT1;RPS7
prerank,GO_Biological_Process_2021__regulation of collagen biosynthetic process (GO:0032965),-0.4066681508200165,-0.7876157062014625,0.7777777777777778,1.0,1.0,2/17,5.93%,TGFB1;CIITA
prerank,GO_Biological_Process_2021__sensory perception of light stimulus (GO:0050953),-0.32725479801241336,-0.7875957455433018,0.8767123287671232,1.0,1.0,21/73,19.32%,CRYBB1;TULP1;ROM1;COL18A1;COL1A1;CABP4;RDH12;SLC24A1;GPR179;CRYBA4;TULP2;FSCN2;WFS1;PDE6C;USH1C;RABGGTB;RABGGTA;CRYBG3;GUCY2F;TYR;PRPH2
prerank,GO_Biological_Process_2021__negative regulation of T cell mediated cytotoxicity (GO:0001915),0.48852689766922475,0.7874796320650309,0.7111111111111111,0.993173553649011,1.0,1/5,1.42%,KLRD1
prerank,CellMarker_Augmented_2021__Cancer cell:Esophagus,-0.3282132344502696,-0.7874618881621351,0.8611111111111112,1.0,1.0,23/82,19.91%,RARRES1;SYNC;PTGR1;TGFBI;DAB2;PLAU;A4GALT;PRSS23;TGM2;OSMR;THBS1;CAV2;AFAP1L1;PLAT;C1S;SGMS2;ADGRF5;NT5E;MYL9;AXL;EPAS1;ANGPTL4;FN1
prerank,GO_Biological_Process_2021__peptidyl-asparagine modification (GO:0018196),0.3511246451862263,0.7873367502664892,0.8444444444444444,0.9931637021055417,1.0,3/30,6.23%,DPM3;DERL3;UBE2J1
prerank,GO_Biological_Process_2021__positive regulation of B cell activation (GO:0050871),0.30693495814682664,0.7871344235536882,0.8571428571428571,0.9932282916827456,1.0,8/42,12.12%,CD38;BCL2;SHLD2;SHLD1;SH3KBP1;IRS2;TNFSF13B;KMT5C
prerank,GO_Biological_Process_2021__positive regulation of protein localization to endosome (GO:1905668),-0.5004351564714327,-0.7870509380942359,0.7857142857142857,1.0,1.0,3/7,35.87%,MSN;EGF;EZR
prerank,GO_Biological_Process_2021__regulation of protein localization to early endosome (GO:1902965),-0.5004351564714327,-0.7870509380942359,0.7857142857142857,1.0,1.0,3/7,35.87%,MSN;EGF;EZR
prerank,GO_Biological_Process_2021__positive regulation of protein localization to early endosome (GO:1902966),-0.5004351564714327,-0.7870509380942359,0.7857142857142857,1.0,1.0,3/7,35.87%,MSN;EGF;EZR
prerank,KEGG_2021_Human__Mucin type O-glycan biosynthesis,-0.36472910305999073,-0.7870307114334388,0.7948717948717948,1.0,1.0,2/32,1.33%,ST6GALNAC1;GALNT15
prerank,GO_Biological_Process_2021__monovalent inorganic cation homeostasis (GO:0055067),0.36220338586303386,0.786944627873075,0.7575757575757576,0.9933011139104398,1.0,2/22,6.91%,SLC12A1;SLC12A9
prerank,GO_Biological_Process_2021__marginal zone B cell differentiation (GO:0002315),0.4857149917804183,0.7868859300728039,0.76,0.9931052489182405,1.0,3/5,32.66%,DOCK11;DLL1;DOCK10
prerank,Reactome_2022__Acyl Chain Remodelling Of PG R-HSA-1482925,-0.4650296383955693,-0.7867996830641875,0.7571428571428571,1.0,1.0,3/10,20.26%,PLA2G10;PLA2G4A;PLA2G4D
prerank,Reactome_2022__Activated Point Mutants Of FGFR2 R-HSA-2033519,-0.418879377537399,-0.7867108260977645,0.7735849056603774,1.0,1.0,1/13,0.93%,FGF20
prerank,CellMarker_Augmented_2021__Unrestricted Somatic Stem cell:Embryo,0.45609658469780145,0.7866905931860867,0.7209302325581395,0.9931863286824129,1.0,1/6,2.39%,ALCAM
prerank,Reactome_2022__Cargo Trafficking To Periciliary Membrane R-HSA-5620920,0.3132410878836296,0.7865606792978623,0.825,0.9931103952373572,1.0,15/46,22.99%,BBS9;CNGA4;NUDT19;BBS12;RAB11FIP3;ARL13B;EXOC7;ARL3;BBIP1;PDE6D;UNC119B;EXOC6;EXOC4;SSTR3;ASAP1
prerank,GO_Biological_Process_2021__regulation of fat cell differentiation (GO:0045598),-0.33577227089088557,-0.7864818787391393,0.8311688311688312,1.0,1.0,6/66,8.28%,TGFB1;WNT5A;ALOX5;RORC;GPER1;ZFPM1
prerank,"GO_Biological_Process_2021__Wnt signaling pathway, planar cell polarity pathway (GO:0060071)",0.30323058049697693,0.7864803298466382,0.8,0.9930097260603261,1.0,8/75,7.87%,PRICKLE1;FZD5;PSME4;VANGL1;ARRB2;MAGI2;PSMA1;FZD1
prerank,KEGG_2021_Human__Endocrine and other factor-regulated calcium reabsorption,-0.35361731645749006,-0.7863954993618963,0.8194444444444444,1.0,1.0,3/45,6.59%,ESR1;RAB11A;ATP1A4
prerank,GO_Biological_Process_2021__vasculature development (GO:0001944),0.3933204029942788,0.7863748976036847,0.8292682926829268,0.9929297547838335,1.0,1/11,2.83%,CDH5
prerank,Reactome_2022__Hh Mutants Are Degraded By ERAD R-HSA-5362768,-0.3413740553564703,-0.7862882260611915,0.7763157894736842,1.0,1.0,1/49,0.62%,PSMB9
prerank,GO_Biological_Process_2021__negative regulation of calcium ion transmembrane transport (GO:1903170),0.43500318538388005,0.7862422587166998,0.725,0.9928622096189191,1.0,1/9,3.49%,BIN1
prerank,Reactome_2022__Extension Of Telomeres R-HSA-180786,-0.35688136829716244,-0.786208988986985,0.7580645161290323,1.0,1.0,4/46,10.90%,TERF2IP;RPA3;TERT;PIF1
prerank,GO_Biological_Process_2021__positive regulation of tyrosine phosphorylation of STAT protein (GO:0042531),-0.34793800207084125,-0.7861178860265705,0.8181818181818182,1.0,1.0,5/37,15.16%,CRLF1;CLCF1;STAP2;IL12A;IL18
prerank,GO_Biological_Process_2021__positive regulation of phosphatidylinositol 3-kinase activity (GO:0043552),-0.3979026619804976,-0.7860880615375048,0.7962962962962963,1.0,1.0,5/22,16.76%,TGFB1;P2RY12;ATG14;TEK;TNFAIP8L3
prerank,Reactome_2022__Mitotic G2-G2/M Phases R-HSA-453274,-0.30201625825058226,-0.7860090032919195,0.9294117647058824,1.0,1.0,23/168,19.26%,NEK2;PSMB9;FOXM1;CDC25A;FBXL7;FKBPL;DCTN1;CDKN1A;TUBA4A;CEP72;DYNLL1;BORA;RAB8A;RBX1;TUBB;PSMA3;CEP76;RPS27A;PKMYT1;FBXL18;PSMA7;PSMB6;YWHAG
prerank,Reactome_2022__Biosynthesis Of Specialized Proresolving Mediators (SPMs) R-HSA-9018678,-0.4401569304771523,-0.7858194986933023,0.7884615384615384,1.0,1.0,5/16,9.84%,ALOX12;ALOX5;PTGR1;ALOX15;CYP3A4
prerank,GO_Biological_Process_2021__regulation of neural precursor cell proliferation (GO:2000177),0.384473631398886,0.785723023874186,0.75,0.9935497947676661,1.0,5/19,9.20%,TOX;PROX1;TRIM71;PTPRZ1;TAFA1
prerank,Reactome_2022__FRS-mediated FGFR2 Signaling R-HSA-5654700,-0.3911171715097504,-0.7857090205159288,0.8253968253968254,1.0,1.0,1/20,0.93%,FGF20
prerank,GO_Biological_Process_2021__regulation of T cell mediated cytotoxicity (GO:0001914),-0.39370586119652873,-0.7854686357460104,0.7580645161290323,1.0,1.0,6/19,15.53%,HLA-A;CEACAM1;HLA-DRB1;PTPRC;IL12A;HLA-F
prerank,GO_Biological_Process_2021__regulation of NMDA receptor activity (GO:2000310),0.3317795310737867,0.7854464799001724,0.9411764705882353,0.9937461193494479,1.0,10/29,28.25%,NLGN1;GRIN1;EPHB2;DLG2;DLG1;GRIA4;LRRC7;DLG3;GRIA1;MEF2C
prerank,Reactome_2022__Metabolism Of Non-Coding RNA R-HSA-194441,0.323494898540873,0.7853639021785258,0.8709677419354839,0.9936165462659386,1.0,14/48,26.74%,NUP210;NUP42;SNRPB;AAAS;GEMIN5;PRMT5;RANBP2;NUP214;TPR;SEH1L;CLNS1A;SNRPF;NUP153;NUP98
prerank,GO_Biological_Process_2021__negative regulation of DNA-binding transcription factor activity (GO:0043433),-0.3230131958254205,-0.7853016281857459,0.7922077922077922,1.0,1.0,13/114,13.31%,AIM2;NLRP12;CYP1B1;SP100;ESR1;TBX6;PLA2G10;SFRP4;ID1;SPI1;WFS1;NLRC3;NLRP3
prerank,GO_Biological_Process_2021__prostanoid biosynthetic process (GO:0046457),0.4277818025816094,0.7851848067555252,0.7142857142857143,0.9936560785950452,1.0,1/12,1.16%,PTGS1
prerank,Reactome_2022__Carboxyterminal Post-Translational Modifications Of Tubulin R-HSA-8955332,-0.3769058474149221,-0.7851557998723646,0.8,1.0,1.0,9/34,23.60%,AGBL5;TUBA3D;TTLL4;TUBB;TUBB6;TUBB2A;TUBB4A;TUBB4B;TPGS1
prerank,CellMarker_Augmented_2021__Mast cell:Kidney,0.28527161187334216,0.785137549867632,0.9523809523809523,0.9934400471653912,1.0,4/82,1.53%,VWC2;MLPH;PTGS1;KIT
prerank,Reactome_2022__G Alpha (I) Signaling Events R-HSA-418594,-0.3037858455059405,-0.7850240489829072,0.9358974358974359,1.0,1.0,39/199,19.08%,NMUR2;P2RY12;CXCL13;LPAR1;PPP1R1B;ACKR4;GPER1;GPSM2;C3AR1;GPR183;RGS4;P2RY14;HTR1B;PDYN;GNAT3;ANXA1;RGSL1;GNGT1;FPR1;CXCL16;FPR3;SSTR1;RGS21;CXCR5;OPRM1;PTGER3;ADCY7;ITPR3;HRH4;RRH;HTR5A;CASR;PLA2G4A;GNAL;CALM1;CAMK2A;MCHR2;RGS8;PDE4A
prerank,KEGG_2021_Human__Glycosylphosphatidylinositol (GPI)-anchor biosynthesis,-0.41430914105006117,-0.7849663633854124,0.8591549295774648,1.0,1.0,4/23,14.30%,PIGH;MPPE1;PIGC;PIGL
prerank,GO_Biological_Process_2021__regulation of cell migration involved in sprouting angiogenesis (GO:0090049),-0.38933112883727533,-0.784912997631826,0.7868852459016393,1.0,1.0,2/24,9.78%,ANXA1;THBS1
prerank,GO_Biological_Process_2021__positive regulation of cytosolic calcium ion concentration involved in phospholipase C-activating G protein-coupled signaling pathway (GO:0051482),-0.38829036819637397,-0.7847999002804107,0.7681159420289855,1.0,1.0,3/21,7.64%,LPAR1;C3AR1;LPAR6
prerank,Reactome_2022__Post-translational Protein Modification R-HSA-597592,0.23871395433176743,0.7847458955118767,1.0,0.9938586932188891,1.0,229/1190,19.40%,MGAT4C;RAB27A;VCAN;ADAMTS1;ASB18;TGFBR1;ADAMTS16;ST6GALNAC3;BRCC3;KLHL20;NUP210;LYPD1;INO80D;ARSJ;MITF;RORA;APOB;APOE;COMMD4;UBE2E3;RAB31;CNTN5;SPTBN4;GALNT12;PIGQ;STAMBPL1;DPM3;ST6GAL2;PHC2;RIPK2;NUP42;SEMA5A;PPARG;SPON1;COMMD1;PEX13;ADAMTS12;PSME4;SEM1;ADAMTS6;DNMT1;COMMD6;STX5;NEGR1;ERCC8;RAB20;KLHL41;RNF168;ARRB2;MDGA2;RAB7A;PRKCSH;PDIA6;STS;ST8SIA4;TOP2A;LGALS1;H2BC21;GALNT1;ST3GAL3;CNTN3;FBXO15;MUC13;B4GALT2;TIMP1;VASH1;MAN1A2;NCOA2;DCUN1D1;TRAPPC1;SEC24C;DNAJC24;PSMA1;NRIP1;PML;LTBP1;SEC22A;GMDS;USP12;IGFBP4;MYC;CNIH3;ARSB;FSTL3;NPL;DYNC1I2;MAN2A1;B4GALT3;NR4A2;TGFA;HIF3A;SENP1;ADAMTS10;NUS1;RNF152;USP26;ALG12;DPH1;DPH5;KTN1;ANO8;DCAF13;UBE2E1;WDTC1;TMED3;AAAS;NTNG2;RNF128;BET1;NAGK;UAP1;CAMKMT;RAB35;NEU4;GAN;RAB27B;AGBL4;GLB1;FBXL14;RAB3C;DMTF1;KLHL3;SCMH1;MAN1A1;NGLY1;TANK;ADAMTS19;QSOX1;UBE2A;KLHL42;TECTA;CCDC22;FBXL20;METTL22;TTLL9;NR3C2;HDAC1;CDH2;PREB;KLHL22;SMC5;COG7;RNF146;ASB7;XPNPEP2;ARRB1;RAB10;FBXO27;CHST8;SMAD2;SENP8;CASP8AP2;NR3C1;PGAP1;MUC7;OTUD3;TRIM4;OTUD7B;THRB;DCAF5;ANK2;HDAC4;ALG3;HERC2;MEN1;FURIN;ZNF131;ST3GAL6;SHPRH;NR1H3;TP53;CLSPN;B3GALNT2;KLHL5;SEC22B;NEU3;PIGA;UBE2Z;CTSC;MDGA1;FBXO4;OTUD5;MOGS;DNAJC3;ASB6;RAB5A;UBE2L3;POMT2;ADAMTS13;RAD52;PMEPA1;GPLD1;TTLL1;GOLGB1;NR2C1;RNF185;RAB3D;NSMCE2;ULBP2;THSD7B;GALNT8;SATB2;MIA3;SP3;RANBP2;MDC1;WDR20;TNIP3;TAB1;COG5;DCAF10;ADAM10;LSAMP;STAM2;ASXL1;EP300;ST8SIA3;STAMBP;RAB40A;CXXC1;EDEM1;ST3GAL2;FBXO11;FBXL22;KAT2B;FBXO31;COG4;RNF40;TMEM115
prerank,Reactome_2022__Oxygen-dependent Proline Hydroxylation Of Hypoxia-inducible Factor Alpha R-HSA-1234176,0.2975038173663559,0.7847416370374676,0.8484848484848485,0.9935850537108444,1.0,5/56,8.65%,EGLN3;PSME4;SEM1;PSMA1;HIF3A
prerank,GO_Biological_Process_2021__mitotic cell cycle phase transition (GO:0044772),-0.30747354964161006,-0.7847324054938649,0.926829268292683,1.0,1.0,27/197,16.36%,NEK2;CCNG2;FOXM1;SPDYA;CCND1;CRLF3;CDC25A;FBXL7;LATS2;CCND2;DCTN1;TPD52L1;CDKN2D;CDKN1A;MAX;ABCB1;TUBA4A;CEP72;DYNLL1;CCNI2;CCNF;CCNE2;CDKN3;BORA;TUBB;CEP76;USH1C
prerank,GO_Biological_Process_2021__T cell proliferation (GO:0042098),-0.4368871727547473,-0.7847234266570492,0.7540983606557377,1.0,1.0,9/14,27.40%,DOCK8;SLC11A1;PIK3CG;MSN;CRTAM;TNFSF18;RASGRP1;CTPS1;TNFRSF4
prerank,Reactome_2022__Pyruvate Metabolism And Citric Acid (TCA) Cycle R-HSA-71406,-0.36314868450938426,-0.7845735412980734,0.8169014084507042,1.0,1.0,13/47,24.93%,SLC16A8;PLPP6;LDHAL6A;PDHX;SLC16A3;VDAC1;IDH3G;NNT;LDHB;LDHD;LDHC;PDK4;PDK3
prerank,Reactome_2022__Regulation Of HSF1-mediated Heat Shock Response R-HSA-3371453,-0.3286544702225612,-0.7845515253459582,0.8,1.0,1.0,13/75,21.43%,GML;HSPA1L;RPA3;CRYBA4;HSPA8;COL4A6;DNAJB1;HSPH1;NUP93;DNAJC2;HSPA4;HSPA5;SEC13
prerank,Reactome_2022__NCAM1 Interactions R-HSA-419037,0.3198143012067599,0.7844348683156275,0.8648648648648649,0.9937728078693634,1.0,6/36,16.17%,COL9A2;CACNB4;ST8SIA4;COL9A1;NCAM1;COL6A3
prerank,GO_Biological_Process_2021__succinyl-CoA metabolic process (GO:0006104),-0.508755978964214,-0.7842436069389079,0.803921568627451,1.0,1.0,1/5,9.32%,ACOT4
prerank,GO_Biological_Process_2021__negative regulation of leukocyte cell-cell adhesion (GO:1903038),0.39339009774811123,0.7840551798163682,0.7297297297297297,0.9941127916936338,1.0,6/16,27.48%,PAG1;MIA3;LAPTM5;IL4I1;WNK1;AKT1
prerank,GO_Biological_Process_2021__inorganic anion transmembrane transport (GO:0098661),-0.334206764744212,-0.7839752196501578,0.8607594936708861,1.0,1.0,5/62,6.81%,APOL1;SLC37A2;ANO2;SLC5A1;GLRA2
prerank,Reactome_2022__Interleukin-12 Signaling R-HSA-9020591,0.3343902077192757,0.7839492564493468,0.9259259259259259,0.994069802742908,1.0,4/35,10.13%,LMNB1;HNRNPF;RALA;PKN2
prerank,GO_Biological_Process_2021__mitral valve development (GO:0003174),-0.4953631750812215,-0.7834252223988302,0.75,1.0,1.0,1/6,9.85%,SMAD6
prerank,GO_Biological_Process_2021__transition metal ion homeostasis (GO:0055076),-0.37646821157880084,-0.7834104638965088,0.75,1.0,1.0,3/26,10.72%,TMC8;CP;SLC11A1
prerank,GO_Biological_Process_2021__regulation of cytokinesis (GO:0032465),-0.32973723789346754,-0.7832289606069254,0.8450704225352113,1.0,1.0,8/67,18.65%,KIF14;RAB11A;ANKRD53;SVIL;CXCR5;ECT2;CALM1;CDC6
prerank,GO_Biological_Process_2021__cardiac cell development (GO:0055006),0.42488322366147213,0.7832023612917784,0.6388888888888888,0.9949897107964499,1.0,4/10,16.94%,SLC8A1;JAG1;NOTCH1;ALPK3
prerank,GO_Biological_Process_2021__protein ubiquitination (GO:0016567),0.25184702596727204,0.7831110226136175,1.0,0.9948642301344266,1.0,111/461,20.98%,RFWD3;RNF182;LZTR1;KLHL20;BCL2;NEUROD2;UBE2E3;CBFB;COMMD1;ZNRF1;PEX13;SIRT1;DTX1;MARCHF5;PSME4;ERCC8;KLHL41;RNF168;ARRB2;TRIM69;SH3RF1;UBE2J1;TRIM35;TRIM71;FANCL;FBXO15;PSMA1;SH3RF3;RBBP6;WWP2;UBE2O;HIF3A;RNF152;PDZRN3;UBE2E1;UBE2D4;TSPAN17;RNF10;KLHL18;ANAPC16;MSL2;GAN;RNF166;UBE2E2;TRIM44;FBXL14;MARCHF8;UBE3D;RNF38;RNF217;KLHL24;KLHL3;FBXO28;UBE2A;KLHL42;CCDC22;FBXL20;KLHL22;RNF146;PELI1;ARRB1;FBXO27;SMURF1;TRIM4;PELI2;HERC2;THOP1;SHPRH;CNOT4;UBE2QL1;BRAP;UBE2Z;MARCHF3;ZNRF3;FBXO4;NEDD4;ARIH1;UBE2L3;SPOP;RNF185;LONRF1;FBH1;HERC5;RC3H1;RNF113A;UBE4B;NFX1;LRSAM1;TRIM47;MIB2;ANAPC7;FBXO11;FBXL22;FBXO31;RNF40;MARCHF7;RNF122;RNF19B;CDC34;UBE2J2;TRPC4AP;TRIM14;FBXO30;TRAF6;HLTF;RNF19A;HIF1A;RNF139;FBXO41;PSMD4;TRIM26
prerank,GO_Biological_Process_2021__regulation of stress-activated MAPK cascade (GO:0032872),0.3312172652205534,0.7830483917991895,0.7741935483870968,0.9947182555494035,1.0,7/46,11.29%,FOXO1;MID1;GREM1;CARD9;MYC;RAP2A;LGALS9
prerank,GO_Biological_Process_2021__regulation of oligodendrocyte differentiation (GO:0048713),-0.39997649311629335,-0.7829657128618981,0.765625,1.0,1.0,2/16,6.70%,TNFRSF1B;DAAM2
prerank,GO_Biological_Process_2021__regulation of mitotic spindle assembly (GO:1901673),-0.39840388877143285,-0.7828078294159799,0.7580645161290323,1.0,1.0,3/16,21.25%,CHMP3;EML3;DRG1
prerank,KEGG_2021_Human__Colorectal cancer,-0.3310085045656446,-0.7827552153605353,0.8611111111111112,1.0,1.0,12/81,17.19%,TCF7;TGFB1;CCND1;TCF7L1;PIK3R3;CDKN1A;PIK3CB;LEF1;TGFB3;SMAD3;RAC2;RAC1
prerank,"GO_Biological_Process_2021__positive regulation of DNA-templated transcription, elongation (GO:0032786)",-0.3707624573680327,-0.782750164302609,0.734375,1.0,1.0,1/22,7.26%,BTBD18
prerank,GO_Biological_Process_2021__epithelium development (GO:0060429),-0.337208157893367,-0.7826543203637214,0.8157894736842105,1.0,1.0,8/89,8.63%,TBX1;TGFB1;SOX10;UPK1B;STAT1;PPP2R3A;UPK1A;UPK3A
prerank,GO_Biological_Process_2021__neuron maturation (GO:0042551),-0.4265971914059413,-0.782363631465861,0.7796610169491526,1.0,1.0,2/16,11.97%,LGI4;MTCH1
prerank,GO_Biological_Process_2021__vitamin A metabolic process (GO:0006776),-0.4681993411509737,-0.7821302696495336,0.7666666666666667,1.0,1.0,2/7,13.40%,RBP2;BCO1
prerank,Reactome_2022__Degradation Of DVL R-HSA-4641258,-0.34526811393100665,-0.7820287859714675,0.765625,1.0,1.0,1/49,0.62%,PSMB9
prerank,Reactome_2022__Metabolism Of Porphyrins R-HSA-189445,-0.37996323206602495,-0.7817619942086341,0.8405797101449275,1.0,1.0,7/20,24.67%,SLCO2B1;ABCG2;ALAS2;UROS;ALB;BLVRB;ABCC2
prerank,Reactome_2022__Base Excision Repair R-HSA-73884,-0.3363450702907712,-0.7815443407708557,0.7702702702702703,1.0,1.0,8/52,19.05%,TERF2IP;RPA3;H2BC4;H2AZ1;POLE2;POLD4;SMUG1;OGG1
prerank,CellMarker_Augmented_2021__Serotonergic neuron:Undefined,-0.3453200376671349,-0.7815150854070148,0.8205128205128205,1.0,1.0,4/53,9.97%,CLCA1;MYT1;TMEM179;CKB
prerank,KEGG_2021_Human__Cell adhesion molecules,-0.3069242540682109,-0.7814699121921472,0.8732394366197183,1.0,1.0,25/116,15.91%,CD99L2;ITGB2;PDCD1LG2;CLDN1;SDC2;HLA-DMA;CLDN6;ICAM3;CLDN5;HLA-A;CLDN2;MPZ;HLA-DPB1;SELP;ITGA9;HLA-DRB1;PTPRC;ITGAM;HLA-DPA1;CLDN18;CD80;JAM2;HLA-F;CD4;CLDN20
prerank,GO_Biological_Process_2021__transcription by RNA polymerase III (GO:0006383),0.34022885769908395,0.7814628618216454,0.7837837837837838,0.9971831326558283,1.0,8/28,21.99%,SNAPC3;GTF3C4;POLR3G;GTF3C5;ICE1;RO60;POLR3K;ICE2
prerank,Reactome_2022__GLI3 Is Processed To GLI3R By Proteasome R-HSA-5610785,-0.33385233266346187,-0.781361360587859,0.8059701492537313,1.0,1.0,21/52,31.83%,PSMB9;RBX1;GLI3;PSMA3;RPS27A;PSMA7;PSMB6;PSMA5;PSMD6;SKP1;PSMC5;PSMB4;PSMB7;PSMD8;PSMD3;UBB;PSMC1;PSMD7;PSMA8;PSME3;UBC
prerank,GO_Biological_Process_2021__cellular response to radiation (GO:0071478),0.35828291424254316,0.7811795131330616,0.75,0.9973941991950566,1.0,12/37,19.16%,SIRT1;OPN5;IFI16;RGR;TANK;SPIDR;GADD45A;TP53;LIG4;OPN3;RAD9A;EEF1D
prerank,Reactome_2022__Erythropoietin Activates Phosphoinositide-3-kinase (PI3K) R-HSA-9027276,0.4053720135263,0.7811574342344614,0.7142857142857143,0.9971613569833563,1.0,4/12,18.04%,EPOR;IRS2;PIK3CA;PIK3R5
prerank,GO_Biological_Process_2021__protein oxidation (GO:0018158),-0.45614255253620983,-0.7811535179994384,0.7659574468085106,1.0,1.0,4/10,20.23%,LOX;LOXL4;SUMF1;CHCHD4
prerank,CellMarker_Augmented_2021__Naive CD8+ T cell:Peripheral Blood,-0.3267121545644968,-0.7810951348330293,0.8208955223880597,1.0,1.0,19/83,21.07%,TCF7;SCML4;GPR183;TMEM204;TOMM7;TXK;LEF1;EEF2;TNFSF8;NT5E;PLEKHB1;BEX4;RPS8;LDLRAP1;EXOSC8;TMEM123;LDHB;LRRC75A;ARHGEF18
prerank,GO_Biological_Process_2021__pathway-restricted SMAD protein phosphorylation (GO:0060389),-0.4334846051136411,-0.7810337106555767,0.7936507936507936,1.0,1.0,1/11,1.49%,TGFB1
prerank,GO_Biological_Process_2021__hair cell differentiation (GO:0035315),0.4330918452812408,0.7809875886492715,0.7,0.9972120990820733,1.0,2/7,18.01%,USH2A;ERCC3
prerank,KEGG_2021_Human__Mitophagy,0.30414544290357975,0.780839921972156,0.8387096774193549,0.9972217439558135,1.0,7/64,9.43%,MITF;RAB7A;RRAS2;EIF2AK3;SP1;MAPK8;TFE3
prerank,GO_Biological_Process_2021__regulation of mammary gland epithelial cell proliferation (GO:0033599),0.47540560473462695,0.7806554262807375,0.8125,0.997276547442969,1.0,3/8,23.14%,ZNF703;GPX1;DEAF1
prerank,GO_Biological_Process_2021__regulation of nucleocytoplasmic transport (GO:0046822),-0.4437367113330242,-0.7804927867308695,0.8103448275862069,1.0,1.0,1/13,1.49%,TGFB1
prerank,KEGG_2021_Human__Arginine and proline metabolism,-0.3421273266532937,-0.7804689841717519,0.7333333333333333,1.0,1.0,8/44,17.77%,P4HA3;DAO;CKB;ARG2;CKMT2;NOS2;SMOX;PRODH2
prerank,Reactome_2022__Melanin Biosynthesis R-HSA-5662702,0.4988790102395774,0.7802978733711897,0.7719298245614035,0.9975899159077122,1.0,3/5,23.55%,DCT;TYRP1;OCA2
prerank,GO_Biological_Process_2021__regulation of mRNA catabolic process (GO:0061013),0.2716371365178457,0.7802310895029038,1.0,0.997418892690509,1.0,38/112,28.15%,MAPKAPK2;HSPB1;SAMD4A;PSME4;EXOSC1;PSMA1;ANP32A;KHSRP;CSDC2;MOV10;HSPA1A;PNPT1;YTHDF1;ZC3H14;DIS3;RC3H1;SAMD4B;PCBP4;FXR2;EXOSC5;RBM24;PSMD4;XPO1;NUP214;DCP1A;PCID2;PRKCD;PSMB2;PABPC1;EXOSC9;PSMD5;PSMF1;XRN1;RC3H2;YWHAZ;AKT1;PSMD10;PSMD13
prerank,Reactome_2022__HDR Thru Homologous Recombination (HRR) Or Single Strand Annealing (SSA) R-HSA-5693567,0.283525579996732,0.7801239585044553,0.8823529411764706,0.9973710362310835,1.0,22/96,20.40%,BRCC3;SEM1;RNF168;SLC19A1;H2BC21;POLD3;ABL1;TIMELESS;H2AX;SPIDR;HERC2;CLSPN;EXO1;ATM;RAD52;RAD17;RAD9A;MDC1;EME2;SIRT6;RAD51B;DNA2
prerank,GO_Biological_Process_2021__hypotonic response (GO:0006971),0.48312701552454207,0.7799859365841135,0.75,0.9973724217016449,1.0,3/6,32.65%,SLC4A11;STK39;SLC12A5
prerank,GO_Biological_Process_2021__regulation of calcium ion-dependent exocytosis (GO:0017158),-0.37429331853205655,-0.7799500065186223,0.803030303030303,1.0,1.0,4/29,9.69%,TRPV6;SYT10;SYT2;REST
prerank,GO_Biological_Process_2021__positive regulation of ion transmembrane transport (GO:0034767),-0.486279996135229,-0.7799278446778697,0.8360655737704918,1.0,1.0,1/6,9.57%,PDZK1
prerank,Reactome_2022__Stabilization Of P53 R-HSA-69541,-0.34084383945482244,-0.7796943941863682,0.7910447761194029,1.0,1.0,1/50,0.62%,PSMB9
prerank,GO_Biological_Process_2021__import into nucleus (GO:0051170),0.3161485048625052,0.7795264245768989,0.8,0.997833026996999,1.0,16/67,25.97%,PRICKLE1;RANBP17;BACH2;NXT1;SNRPB;GEMIN5;NUTF2;PPP1R10;APPL2;IPO8;NUP214;TPR;IPO7;SNRPF;FAM53A;NUP153
prerank,GO_Biological_Process_2021__regulation of neuron death (GO:1901214),-0.3215543585498519,-0.7795208598406331,0.8656716417910447,1.0,1.0,8/72,11.77%,KIF14;ITGB2;WNT5A;TNFRSF1B;CLU;REST;CTSZ;ITGAM
prerank,GO_Biological_Process_2021__tRNA transport (GO:0051031),0.3539222145629767,0.7793063273268191,0.7741935483870968,0.997949058828162,1.0,12/35,27.98%,NUP210;NUP42;AAAS;RANBP2;NUP214;TPR;SEH1L;XPOT;YBX1;NUP153;NUP98;NUP37
prerank,Reactome_2022__HDL Clearance R-HSA-8964011,-0.5205380510782598,-0.7792755862109744,0.7843137254901961,1.0,1.0,1/5,15.63%,AMN
prerank,Reactome_2022__Deregulated CDK5 Triggers Neurodegenerative Pathways In Alzheimers Disease Models R-HSA-8862803,0.3802130269015609,0.7792660193138268,0.8043478260869565,0.9977535838304408,1.0,3/18,7.86%,LMNB1;CAPN2;ERC2
prerank,GO_Biological_Process_2021__regulation of cellular biosynthetic process (GO:0031326),0.3535710886000191,0.7791982102713411,0.7631578947368421,0.997562312699268,1.0,6/26,12.11%,MITF;CX3CR1;SIRT1;ADIPOR1;AVIL;ADIPOR2
prerank,GO_Biological_Process_2021__negative regulation of protein exit from endoplasmic reticulum (GO:0070862),0.45618106907854544,0.7789632414821918,0.7608695652173914,0.9976824190416391,1.0,2/10,6.23%,DERL3;UBE2J1
prerank,PanglaoDB_Augmented_2021__Adipocyte Progenitor Cells,-0.32075195085109254,-0.7789313170290237,0.8194444444444444,1.0,1.0,9/87,6.32%,LMOD1;TIMP3;CYP26B1;PDGFRL;COL1A1;COL5A1;TCF7L1;LOX;UACA
prerank,PanglaoDB_Augmented_2021__Decidual Cells,-0.37809981249543395,-0.7788218903159505,0.7704918032786885,1.0,1.0,4/28,7.00%,SIRPG;CYTIP;KLRB1;CD5
prerank,GO_Biological_Process_2021__cellular defense response (GO:0006968),-0.39632566790756907,-0.7788170834102102,0.71875,1.0,1.0,1/25,0.82%,CLEC5A
prerank,PanglaoDB_Augmented_2021__Myofibroblasts,-0.31968521205672545,-0.7787223506796458,0.8831168831168831,1.0,1.0,9/89,6.82%,LMOD1;TIMP3;ANGPTL2;COL1A1;COL5A1;FBXL7;ADAM33;DAAM2;DCN
prerank,Reactome_2022__Hh Mutants Abrogate Ligand Secretion R-HSA-5387390,-0.3378296941843531,-0.7786537526779637,0.7866666666666666,1.0,1.0,1/50,0.62%,PSMB9
prerank,GO_Biological_Process_2021__regulation of Ras protein signal transduction (GO:0046578),-0.3327323743743833,-0.7786004893252975,0.8701298701298701,1.0,1.0,3/76,1.41%,RASGRP4;KIF14;FOXM1
prerank,GO_Biological_Process_2021__positive regulation of protein localization to cell surface (GO:2000010),-0.4544197831493841,-0.7783389289823233,0.7368421052631579,1.0,1.0,3/11,25.49%,TMEM35A;HSP90AB1;GPD1L
prerank,GO_Biological_Process_2021__positive regulation of cell migration involved in sprouting angiogenesis (GO:0090050),-0.4386336771174857,-0.7782444200452039,0.7307692307692307,1.0,1.0,1/12,8.67%,ANXA1
prerank,GO_Biological_Process_2021__positive regulation of protein localization to cell periphery (GO:1904377),-0.3513377481457786,-0.7782313974129015,0.7368421052631579,1.0,1.0,3/48,5.55%,STAC;GPER1;GPSM2
prerank,Reactome_2022__Calnexin/calreticulin Cycle R-HSA-901042,0.3521348632531521,0.7778190938958661,0.7894736842105263,0.9993911540636478,1.0,4/25,20.56%,PRKCSH;RNF185;EDEM1;RNF139
prerank,GO_Biological_Process_2021__negative regulation of developmental process (GO:0051093),-0.3284503355643297,-0.777624631866685,0.7945205479452054,1.0,1.0,5/64,5.61%,TBX1;FOXM1;TGFB1;PRAME;PINK1
prerank,GO_Biological_Process_2021__carnitine metabolic process (GO:0009437),0.44399721000254255,0.777620302815479,0.6666666666666666,0.9995270681292768,1.0,3/11,12.79%,CPT1C;ACADM;CPT1A
prerank,Reactome_2022__PI-3K cascade:FGFR2 R-HSA-5654695,-0.3838590263679035,-0.7775682653781232,0.7704918032786885,1.0,1.0,1/19,0.93%,FGF20
prerank,GO_Biological_Process_2021__negative regulation of catalytic activity (GO:0043086),0.34674628350418546,0.7774466409684833,0.8387096774193549,0.9995278608439129,1.0,5/22,16.67%,SIRT1;TIMP1;APBA3;TP53;NOTCH1
prerank,KEGG_2021_Human__Chronic myeloid leukemia,0.31668930380621685,0.7774007581713265,0.7916666666666666,0.9993200011964932,1.0,18/74,15.84%,TGFBR1;SHC4;STAT5B;CRK;CDK6;CDK4;ABL1;MYC;AKT2;CTBP2;HDAC1;NFKB1;PIK3CA;BCR;GADD45A;TP53;RUNX1;CRKL
prerank,Reactome_2022__Synthesis Of Bile Acids And Bile Salts Via 24-Hydroxycholesterol R-HSA-193775,-0.4199387133408341,-0.7773457851356479,0.75,1.0,1.0,2/13,8.93%,AMACR;HSD3B7
prerank,GO_Biological_Process_2021__regulation of inflammatory response (GO:0050727),-0.29726452254409275,-0.7771531180974871,0.8888888888888888,1.0,1.0,22/141,15.83%,HCK;MMP9;WNT5A;NLRP12;ALOX5;TNFRSF1B;GPER1;PTGES;LRRC19;ALOX15;ANXA1;LACC1;TLR2;NLRC3;NLRP3;TEK;NR1H4;IL18;ZP3;AGT;GRN;ELANE
prerank,Reactome_2022__Gain-of-function MRAS Complexes Activate RAF Signaling R-HSA-9726842,0.44040517159375686,0.7769660208007341,0.7428571428571429,0.9997584903408497,1.0,4/7,28.52%,BRAF;PPP1CB;SHOC2;PPP1CC
prerank,KEGG_2021_Human__Drug metabolism,0.3021784843146887,0.7767551511242462,0.875,0.9997796640483366,1.0,14/67,14.49%,CYP1A2;NME1-NME2;UGT2B15;GSTM5;DUT;GSTO2;IMPDH1;GSTM2;UPP2;CES2;ADH4;UCK2;GSTA4;GMPS
prerank,GO_Biological_Process_2021__negative regulation of smoothened signaling pathway (GO:0045879),-0.377264287860358,-0.7767297715868319,0.8676470588235294,1.0,1.0,3/23,8.55%,HHIP;RFX4;GPC3
prerank,GO_Biological_Process_2021__regulation of T cell mediated immunity (GO:0002709),0.4737790831979322,0.7766442193874074,0.8205128205128205,0.9997108932472221,1.0,3/7,6.88%,CLC;HMGB1;ZBTB1
prerank,GO_Biological_Process_2021__DNA biosynthetic process (GO:0071897),0.3661323901180247,0.7766108655960468,0.7419354838709677,0.9994991239673378,1.0,2/17,6.48%,SIRT1;POLD3
prerank,CellMarker_Augmented_2021__Neuron:Brain,-0.36494572201744846,-0.7765504046734931,0.7538461538461538,1.0,1.0,3/30,6.83%,GLRA2;DCN;ENO2
prerank,GO_Biological_Process_2021__negative regulation of intrinsic apoptotic signaling pathway (GO:2001243),0.3019045087956752,0.7765495139361603,0.9166666666666666,0.9993405835123776,1.0,6/58,5.52%,BCL2;HSPB1;URI1;HTRA2;SIRT1;ARMC10
prerank,Reactome_2022__Autodegradation Of Cdh1 By Cdh1:APC/C R-HSA-174084,-0.332896799991089,-0.7765314469344595,0.8194444444444444,1.0,1.0,1/56,0.62%,PSMB9
prerank,Reactome_2022__Glutathione Conjugation R-HSA-156590,-0.3406165381223027,-0.7763120919585477,0.8307692307692308,1.0,1.0,1/27,1.47%,MGST1
prerank,GO_Biological_Process_2021__positive regulation of vascular associated smooth muscle cell proliferation (GO:1904707),0.3684225758597997,0.7762553825264147,0.7837837837837838,0.9995905809074985,1.0,4/20,9.53%,ADAMTS1;MMP2;DNMT1;ERN1
prerank,Reactome_2022__Transcriptional Regulation By VENTX R-HSA-8853884,0.31821128279040134,0.77620095270999,0.875,0.9994280186330325,1.0,10/35,18.43%,MOV10;UBE2E1;ANAPC16;TNRC6C;NFKB1;CDC26;TP53;TNRC6A;AGO3;ANAPC7
prerank,GO_Biological_Process_2021__endocrine system development (GO:0035270),-0.46168766164837516,-0.7760709229968875,0.7551020408163265,1.0,1.0,1/12,0.55%,TBX1
prerank,CellMarker_Augmented_2021__Mesenchymal Stem cell:Tooth,0.45378430780599766,0.7759739473157282,0.7142857142857143,0.9994941529698499,1.0,1/9,2.39%,ALCAM
prerank,KEGG_2021_Human__Hypertrophic cardiomyopathy,-0.32714639916520744,-0.7759444446797024,0.875,1.0,1.0,13/75,16.22%,TGFB1;MYH7;ACTC1;MYBPC3;ACTG1;ITGA9;ITGA2B;ITGB6;ITGA5;TTN;TGFB3;AGT;ITGB5
prerank,GO_Biological_Process_2021__mitotic sister chromatid segregation (GO:0000070),-0.31238654007220856,-0.775927708577306,0.8732394366197183,1.0,1.0,5/93,7.97%,KIF14;CEP55;RAB11A;ANKRD53;CHMP3
prerank,GO_Biological_Process_2021__protein localization to phagophore assembly site (GO:0034497),0.3942171571950526,0.7758352133713748,0.7142857142857143,0.9995112771821865,1.0,3/11,34.42%,TRAPPC8;PACS2;ATG9B
prerank,GO_Biological_Process_2021__cellular response to pH (GO:0071467),-0.4289853613229275,-0.7756523366344561,0.8235294117647058,1.0,1.0,4/15,20.24%,HVCN1;GPR68;HYAL1;PKD1L3
prerank,"Reactome_2022__Synthesis, Secretion, And Inactivation Of Glucagon-like Peptide-1 (GLP-1) R-HSA-381771",-0.42997141858569476,-0.7756064021095738,0.7796610169491526,1.0,1.0,4/16,27.08%,GNAT3;GNG13;SPCS2;SPCS1
prerank,Reactome_2022__Basigin Interactions R-HSA-210991,0.35349391021993504,0.7754772328937329,0.7428571428571429,0.9998180761332665,1.0,7/24,11.22%,SLC3A2;BSG;SLC7A9;ITGA3;SLC7A11;SLC7A6;SLC7A8
prerank,CellMarker_Augmented_2021__T Helper1 (Th1) cell:Undefined,-0.4269035858977469,-0.7754216796694189,0.8591549295774648,1.0,1.0,4/14,15.75%,STAT1;IL27;IL18;CD4
prerank,KEGG_2021_Human__Hippo signaling pathway,-0.29125515321897094,-0.7753731107057202,0.8902439024390244,1.0,1.0,13/149,8.75%,TCF7;TGFB1;ITGB2;WNT5A;WNT8B;CTNNA1;CCND1;CTNNA3;FZD8;TCF7L1;ACTG1;LATS2;CCND2
prerank,GO_Biological_Process_2021__mitotic sister chromatid cohesion (GO:0007064),0.3867475527448814,0.7752468414797657,0.8372093023255814,0.9998799710940887,1.0,8/15,33.39%,DSCC1;MAU2;NIPBL;POGZ;RB1;PDS5A;NAA50;RAD21L1
prerank,GO_Biological_Process_2021__receptor recycling (GO:0001881),0.4404644052226881,0.7752096623203091,0.75,0.9996971623132145,1.0,2/9,16.83%,REP15;RAB11B
prerank,Reactome_2022__Degradation Of GLI2 By Proteasome R-HSA-5610783,-0.33000755788215785,-0.7751411258280603,0.8059701492537313,1.0,1.0,1/52,0.62%,PSMB9
prerank,GO_Biological_Process_2021__polyol metabolic process (GO:0019751),0.30042451457431224,0.7750933538785436,0.7894736842105263,0.9995633738225947,1.0,5/45,11.09%,PLCH1;ITPKB;PLCB1;INPP1;PLCH2
prerank,Reactome_2022__Telomere Maintenance R-HSA-157579,-0.32632162711263,-0.7749457421168925,0.8194444444444444,1.0,1.0,6/71,12.66%,TERF2IP;RPA3;H2BC4;TERT;PIF1;H2AZ1
prerank,GO_Biological_Process_2021__positive regulation of chondrocyte differentiation (GO:0032332),0.43287560058674374,0.7747839517104999,0.675,0.9996945729834438,1.0,2/9,14.26%,GDF6;SOX5
prerank,PanglaoDB_Augmented_2021__Chromaffin Cells,0.2821808740453613,0.774740309733828,0.9523809523809523,0.9994915915367896,1.0,38/117,25.35%,PCDH17;DOC2B;UNC5D;PCLO;SERPINE1;KCNIP1;ERC2;ADGRA1;GUCY1A2;BRINP1;RGS7BP;ELAVL4;RAB3C;DST;SNAP91;MAP6;RBFOX1;ASXL3;ANK2;NRXN1;PTPRD;LSAMP;ST8SIA3;ADGRB3;AKAP12;CNTN1;PLD2;TMEM196;GRIA4;SHC3;RAPGEF4;PLPPR4;CACNA1B;CDC42BPA;CADPS;MAP2;TAGLN3;NCS1
prerank,"GO_Biological_Process_2021__DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest (GO:0006977)",-0.3657609646329556,-0.7746419310200929,0.8615384615384616,1.0,1.0,1/51,0.47%,GML
prerank,Reactome_2022__Activation Of IRF3/IRF7 Mediated By TBK1/IKK Epsilon R-HSA-936964,0.38795274685898995,0.7742801914097704,0.8571428571428571,0.9999241698458219,1.0,3/15,12.57%,SARM1;TICAM1;TANK
prerank,GO_Biological_Process_2021__circulatory system development (GO:0072359),-0.31553390789546126,-0.7742216726437028,0.8513513513513513,1.0,1.0,10/94,14.16%,TBX1;PKP2;TGFB1;FLT4;ZFPM1;HEG1;POPDC2;CDKN1A;TEK;HEY2
prerank,GO_Biological_Process_2021__regulation of tyrosine phosphorylation of STAT protein (GO:0042509),-0.33845033593087304,-0.7741954213230766,0.8289473684210527,1.0,1.0,5/43,15.16%,CRLF1;CLCF1;STAP2;IL12A;IL18
prerank,GO_Biological_Process_2021__stress-induced premature senescence (GO:0090400),0.45125409611797723,0.7741039087754576,0.7,0.999945212011361,1.0,2/6,15.44%,SIRT1;TP53
prerank,GO_Biological_Process_2021__stem cell differentiation (GO:0048863),0.3289512594897992,0.7740932696760475,0.84375,0.9996731180761197,1.0,7/35,16.47%,KIT;OSR1;LRP6;SP7;MLLT3;TP53;SETD2
prerank,GO_Biological_Process_2021__regulation of fatty acid biosynthetic process (GO:0042304),-0.3773924068915926,-0.7740881615233143,0.847457627118644,1.0,1.0,3/23,8.63%,EIF6;CEACAM1;BRCA1
prerank,GO_Biological_Process_2021__telomere capping (GO:0016233),-0.4090237934311384,-0.7736832868177832,0.7313432835820896,1.0,1.0,4/16,21.55%,TERF2IP;DCLRE1C;DCLRE1A;TFIP11
prerank,GO_Biological_Process_2021__regulation of catecholamine uptake involved in synaptic transmission (GO:0051940),-0.49573062108958016,-0.7736768926269975,0.7321428571428571,1.0,1.0,2/5,32.79%,TOR1A;DRD2
prerank,GO_Biological_Process_2021__positive regulation of tumor necrosis factor production (GO:0032760),-0.33567584590497934,-0.7736395421677109,0.8615384615384616,1.0,1.0,9/50,13.20%,WNT5A;OAS2;CLU;THBS1;CYBA;PTPRC;OAS1;TLR2;C1QTNF4
prerank,GO_Biological_Process_2021__endodermal cell differentiation (GO:0035987),-0.3768565490812344,-0.7735582543455237,0.8153846153846154,1.0,1.0,4/29,5.82%,NODAL;ITGB2;MMP9;VTN
prerank,Reactome_2022__Downstream Signaling Of Activated FGFR2 R-HSA-5654696,-0.37117539852750003,-0.773531205153995,0.8,1.0,1.0,1/25,0.93%,FGF20
prerank,GO_Biological_Process_2021__positive regulation of leukocyte mediated cytotoxicity (GO:0001912),-0.3851689514508132,-0.7734231210599676,0.796875,1.0,1.0,8/28,15.53%,CD160;HLA-A;HLA-DRB1;SPI1;ITGAM;NOS2;IL12A;HLA-F
prerank,Reactome_2022__Factors Involved In Megakaryocyte Development And Platelet Production R-HSA-983231,0.28833125991410696,0.7733682498242965,0.9,1.0,1.0,27/105,21.44%,SH2B2;KIFC1;KIFC2;AK3;ABL1;PRKAR2A;CABLES2;CABLES1;KIF6;KIF4B;HDAC1;DOCK9;TP53;DOCK11;RAB5A;MICAL1;KIF21B;KIF3B;ITPK1;DOCK1;CDK5;RAD51B;JMJD1C;KIF21A;KIF16B;KIF27;CAPZA1
prerank,GO_Biological_Process_2021__fatty-acyl-CoA biosynthetic process (GO:0046949),-0.36978096487176454,-0.7733360602032165,0.7903225806451613,1.0,1.0,3/25,9.22%,ELOVL2;ACSL5;PPT1
prerank,GO_Biological_Process_2021__cellular response to lipid (GO:0071396),-0.2945213406184864,-0.7731302593059945,0.9512195121951219,1.0,1.0,11/154,5.18%,TBX1;AHR;MGST1;WNT5A;WNT8B;PDCD1LG2;CXCL13;RORC;ESR1;TNFRSF1B;GPER1
prerank,GO_Biological_Process_2021__regulation of short-term neuronal synaptic plasticity (GO:0048172),-0.4313520357766054,-0.7730001496219757,0.7936507936507936,1.0,1.0,1/13,4.94%,SHISA6
prerank,GO_Biological_Process_2021__positive regulation of lymphocyte activation (GO:0051251),-0.38361059899811806,-0.7729108076103846,0.8333333333333334,1.0,1.0,5/23,15.41%,SIRPG;HLA-DPB1;HLA-DPA1;IL12A;IGLL1
prerank,GO_Biological_Process_2021__positive regulation of NIK/NF-kappaB signaling (GO:1901224),-0.3529048004976766,-0.7728773388573474,0.8243243243243243,1.0,1.0,10/40,20.84%,TERF2IP;NLRP12;LRRC19;TLR2;C1QTNF4;CD27;DDX3X;IFI35;CD86;AGER
prerank,CellMarker_Augmented_2021__Villous Stromal cell:Placenta,-0.3251562077812522,-0.7728646103876254,0.9154929577464789,1.0,1.0,11/78,14.21%,C1QTNF1;LMOD1;TIMP3;ANGPTL2;COL1A1;DCN;ITGBL1;AOX1;PPIC;COX7A1;C1S
prerank,GO_Biological_Process_2021__positive regulation of granulocyte differentiation (GO:0030854),0.4637806337896512,0.7727482897519486,0.7142857142857143,1.0,1.0,3/5,15.67%,HCLS1;TESC;RUNX1
prerank,GO_Biological_Process_2021__regulation of dephosphorylation (GO:0035303),-0.3902172570817305,-0.7723593352464561,0.8214285714285714,1.0,1.0,1/14,5.77%,PPP1R17
prerank,CellMarker_Augmented_2021__Basal cell:Airway Epithelium,-0.3233133890746062,-0.7721753200064668,0.8961038961038961,1.0,1.0,5/80,6.59%,TRIP10;SERINC2;S100A13;CCND1;TSPAN4
prerank,Reactome_2022__CLEC7A (Dectin-1) Signaling R-HSA-5607764,0.2745377448909333,0.7718781804163684,0.9130434782608695,1.0,1.0,7/86,7.36%,ITPR2;NFATC3;MAP3K14;PSME4;SEM1;CARD9;PSMA1
prerank,Reactome_2022__Negative Regulation Of FGFR2 Signaling R-HSA-5654727,-0.3535315691326448,-0.7718719091041224,0.8095238095238095,1.0,1.0,1/29,0.93%,FGF20
prerank,Reactome_2022__Removal Of Flap Intermediate R-HSA-69166,-0.4322182130169566,-0.7717801798208601,0.711864406779661,1.0,1.0,1/12,4.30%,RPA3
prerank,GO_Biological_Process_2021__negative regulation of protein localization to plasma membrane (GO:1903077),-0.3880511897443346,-0.7717190582960777,0.7631578947368421,1.0,1.0,5/19,12.29%,TGFB1;DAB2;RHOQ;GBP1;MRAP
prerank,GO_Biological_Process_2021__regulation of protein-containing complex disassembly (GO:0043244),0.3966041244323299,0.7716811295981107,0.6666666666666666,1.0,1.0,4/15,14.95%,CLEC16A;MTRF1;ETF1;INSR
prerank,GO_Biological_Process_2021__immunoglobulin mediated immune response (GO:0016064),-0.4790334192620838,-0.7716598731561168,0.7761194029850746,1.0,1.0,3/5,18.80%,CD27;ZP3;CD81
prerank,GO_Biological_Process_2021__negative regulation of histone acetylation (GO:0035067),-0.4431620796411381,-0.7716169695411982,0.7681159420289855,1.0,1.0,3/12,10.89%,TAF7;BRCA1;SPI1
prerank,GO_Biological_Process_2021__negative regulation of T-helper cell differentiation (GO:0045623),-0.45472876864462064,-0.7714856467087763,0.7846153846153846,1.0,1.0,1/8,8.67%,ANXA1
prerank,Reactome_2022__PI Metabolism R-HSA-1483255,-0.3241698927557921,-0.7713321078585131,0.9104477611940298,1.0,1.0,10/79,17.52%,PLEKHA4;INPP5D;ARF3;PIK3R3;PLEKHA2;PIK3CB;PIK3C2G;TNFAIP8L3;PIK3CG;BMX
prerank,Reactome_2022__Regulation Of PTEN Localization R-HSA-8948747,0.4335001077942291,0.7711183122759002,0.7872340425531915,1.0,1.0,3/9,22.04%,PML;NEDD4;PTEN
prerank,GO_Biological_Process_2021__negative regulation of oxidative stress-induced cell death (GO:1903202),0.35944194748934133,0.7711023370625807,0.8823529411764706,1.0,1.0,3/25,4.59%,HSPB1;HTRA2;SIRT1
prerank,GO_Biological_Process_2021__regulation of nuclear cell cycle DNA replication (GO:0033262),-0.4579616321957934,-0.7710811918140619,0.782608695652174,1.0,1.0,2/8,24.56%,NUGGC;CDC7
prerank,GO_Biological_Process_2021__aminophospholipid transport (GO:0015917),0.4602334064306241,0.7709963980129327,0.6595744680851063,1.0,1.0,2/5,24.74%,ATP8A2;ATP11B
prerank,GO_Biological_Process_2021__stress-activated protein kinase signaling cascade (GO:0031098),0.3193529547960793,0.7709854877431949,0.8297872340425532,1.0,1.0,7/27,27.53%,MAPK8;NFKB1;MAP2K7;CUL1;IKBKB;TAOK2;BTRC
prerank,GO_Biological_Process_2021__negative regulation of protein processing (GO:0010955),-0.3979883654095995,-0.7708622036732825,0.8135593220338984,1.0,1.0,4/14,17.79%,THBS1;CTSZ;USP17L2;ACP4
prerank,GO_Biological_Process_2021__intrinsic apoptotic signaling pathway (GO:0097193),-0.30955705614618134,-0.7708573669712309,0.8955223880597015,1.0,1.0,10/86,13.03%,ERN2;CIDEB;CYP1B1;BCL2L2;TNFRSF1B;HIC1;BRCA1;HINT1;CDKN1A;MOAP1
prerank,GO_Biological_Process_2021__positive regulation of myoblast fusion (GO:1901741),-0.4774759460982595,-0.77085669559226,0.7540983606557377,1.0,1.0,2/8,25.20%,FLOT1;EHD2
prerank,GO_Biological_Process_2021__negative regulation of cellular respiration (GO:1901856),-0.516107763903858,-0.7708222577002721,0.7543859649122807,1.0,1.0,1/5,8.67%,ACTN3
prerank,GO_Biological_Process_2021__positive regulation of histone H3-K9 acetylation (GO:2000617),0.4615504480996564,0.7708049280481725,0.6904761904761905,1.0,1.0,2/5,9.20%,SMARCB1;PIH1D1
prerank,GO_Biological_Process_2021__positive regulation of biomineral tissue development (GO:0070169),-0.3435854568650662,-0.7706719918889454,0.8133333333333334,1.0,1.0,6/34,16.65%,TGFB1;ALOX5;FBN2;WNT6;TGFB3;ODAPH
prerank,Reactome_2022__ADP Signaling Thru P2Y Purinoceptor 1 R-HSA-418592,-0.408498154409292,-0.7706491461597771,0.8360655737704918,1.0,1.0,6/20,26.22%,GNGT1;PLA2G4A;GNA15;GNG13;GNG12;GNG4
prerank,GO_Biological_Process_2021__retinol metabolic process (GO:0042572),0.3954993560725024,0.7705828810301315,0.7560975609756098,1.0,1.0,1/15,0.59%,CYP1A2
prerank,"Reactome_2022__Cell Death Signaling Via NRAGE, NRIF And NADE R-HSA-204998",0.30497159973915583,0.7705808482156208,0.896551724137931,1.0,1.0,7/66,8.44%,NGF;PLEKHG2;FGD4;PRPF38B;MAPK8;CASP3;FGD1
prerank,CellMarker_Augmented_2021__Endothelial Stem cell:Blood Vessel,0.4021824405495844,0.770574189991991,0.8125,1.0,1.0,3/17,4.73%,KIT;CD14;ITGA4
prerank,GO_Biological_Process_2021__protein localization to endoplasmic reticulum (GO:0070972),0.38085959790255586,0.7705695823623478,0.6944444444444444,1.0,1.0,4/15,23.42%,GBF1;ANK2;MIA3;UBAC2
prerank,Reactome_2022__Synthesis Of DNA R-HSA-69239,-0.3009703383981086,-0.7705141168782857,0.8987341772151899,1.0,1.0,24/104,27.84%,PSMB9;RPA3;MCM3;POLE2;CCNE2;RBX1;PSMA3;POLD4;RPS27A;CDC6;PSMA7;PSMB6;ORC6;POLE3;PSMA5;PSMD6;SKP1;PSMC5;MCM5;PSMB4;PSMB7;PCNA;PSMD8;MCM6
prerank,GO_Biological_Process_2021__cellular amide metabolic process (GO:0043603),0.26692793914008744,0.7703843703310211,1.0,1.0,1.0,21/97,19.05%,THEM4;PC;CPN1;SLC19A1;DHFR;PDZD11;ACOT9;NSMAF;SMPD3;PLPP2;ACSM2A;ACSM1;MTHFR;THOP1;OXSM;PLA2G15;PCCA;ABHD4;FPGS;SHMT2;AEBP1
prerank,GO_Biological_Process_2021__positive regulation of cell-cell adhesion mediated by integrin (GO:0033634),0.4827048346024579,0.7703171005403178,0.8048780487804879,1.0,1.0,1/5,1.48%,SKAP1
prerank,GO_Biological_Process_2021__negative regulation of cytokine-mediated signaling pathway (GO:0001960),-0.32877487035873315,-0.770130101347562,0.8636363636363636,1.0,1.0,13/47,26.21%,TRAIP;PTPRC;OAS1;PALM3;F2RL1;CACTIN;CARD8;GPS2;ISG15;OTUD4;PELI3;USP18;RFFL
prerank,GO_Biological_Process_2021__creatine metabolic process (GO:0006600),-0.4734530033027191,-0.7699797793407646,0.7833333333333333,1.0,1.0,2/7,11.93%,CKB;CKMT2
prerank,KEGG_2021_Human__Chagas disease,0.28743255374066523,0.7697427333113036,0.9259259259259259,1.0,1.0,17/77,15.70%,TGFBR1;CD247;CFLAR;CCL3L3;SERPINE1;PLCB1;MAPK8;AKT2;PPP2R1B;TICAM1;FADD;SMAD2;NFKB1;GNAO1;PIK3CA;IRAK4;MAPK12
prerank,CellMarker_Augmented_2021__Goblet cell:Large Intestine,-0.35921023141465175,-0.7696966628520306,0.8064516129032258,1.0,1.0,6/32,17.22%,ERN2;CAPN8;MUC5B;MUC4;HLA-F;SCNN1A
prerank,GO_Biological_Process_2021__regulation of toll-like receptor signaling pathway (GO:0034121),-0.38594182150461165,-0.7696623136885454,0.7746478873239436,1.0,1.0,6/21,24.93%,IRF1;TLR2;CACTIN;GPS2;FLOT1;OTUD4
prerank,GO_Biological_Process_2021__negative regulation of protein kinase activity by regulation of protein phosphorylation (GO:0044387),0.45474933147826546,0.7695977164435904,0.7692307692307693,1.0,1.0,3/6,29.95%,ADAR;CORO1C;PPM1F
prerank,Reactome_2022__G Alpha (Z) Signaling Events R-HSA-418597,-0.36563411902434406,-0.7692261086465114,0.8636363636363636,1.0,1.0,6/41,14.93%,RGS4;GNAT3;RGSL1;GNGT1;PRKCH;ADCY7
prerank,GO_Biological_Process_2021__cellular response to molecule of bacterial origin (GO:0071219),0.3055097973591947,0.7692205403737852,0.8888888888888888,1.0,1.0,13/65,15.48%,IRGM;CD14;TICAM2;CX3CR1;FZD5;SERPINE1;HMGB1;MAPK8;PDE4B;TICAM1;NFKB1;NR1H3;LBP
prerank,Reactome_2022__Fatty Acids Bound To GPR40 (FFAR1) Regulate Insulin Secretion R-HSA-434316,0.45925705409807427,0.7691302235148669,0.7659574468085106,1.0,1.0,5/7,27.09%,PLCB1;GNAQ;GNA11;PLCB3;GNA14
prerank,GO_Biological_Process_2021__protein N-linked glycosylation via asparagine (GO:0018279),0.3512154903066795,0.7691109095974649,0.8837209302325582,1.0,1.0,3/29,6.23%,DPM3;DERL3;UBE2J1
prerank,Reactome_2022__NF-kB Activation Thru FADD/RIP-1 Pathway Mediated By Caspase-8 And -10 R-HSA-933543,-0.39985026755042885,-0.7690875481411064,0.7301587301587301,1.0,1.0,1/12,6.02%,TRIM25
prerank,"GO_Biological_Process_2021__phagocytosis, engulfment (GO:0006911)",0.32726129355296124,0.7689765787024142,0.8529411764705882,1.0,1.0,5/29,11.80%,MEGF10;XKR7;RHOBTB1;XKR6;XKR4
prerank,GO_Biological_Process_2021__multivesicular body assembly (GO:0036258),-0.3649053325143379,-0.7689181857674865,0.7971014492753623,1.0,1.0,2/27,7.97%,RAB11A;CHMP3
prerank,KEGG_2021_Human__Human T-cell leukemia virus 1 infection,-0.3011338295247128,-0.7688146277398706,0.9146341463414634,1.0,1.0,29/186,18.78%,TGFB1;ITGB2;SLC25A31;CCND1;HLA-DMA;NFKB2;HLA-A;PIK3R3;HLA-DPB1;CCND2;HLA-DRB1;TERT;SPI1;CDKN1A;NFYB;HLA-DPA1;PIK3CB;VDAC1;TBPL1;TGFB3;ADCY7;CCNE2;HLA-F;CD4;SMAD3;NFATC2;EGR2;GPS2;BUB1B
prerank,Reactome_2022__Deubiquitination R-HSA-5688426,-0.2923670986908547,-0.7687902696244364,0.9310344827586207,1.0,1.0,19/224,13.77%,PSMB9;TGFB1;MAT2B;ESR1;ACTL6A;ABRAXAS1;CDC25A;TRIM25;TOMM20;H2BC4;BRCA1;PTRH2;USP13;TFPT;USP17L2;FOXO4;TAF9B;NLRP3;VDAC1
prerank,KEGG_2021_Human__Acute myeloid leukemia,0.28467214869013857,0.7687835109886868,0.9,1.0,1.0,15/62,17.32%,PER2;KIT;BCL2A1;CD14;STAT5B;PML;MYC;AKT2;PIM2;FLT3;NFKB1;PIK3CA;RUNX1;EIF4EBP1;BRAF
prerank,Reactome_2022__Loss Of Function Of TGFBR1 In Cancer R-HSA-3656534,-0.4612949782820685,-0.7687660243529162,0.71875,1.0,1.0,1/6,1.49%,TGFB1
prerank,Reactome_2022__SMAD2/3 Phosphorylation Motif Mutants In Cancer R-HSA-3304356,-0.4612949782820685,-0.7687660243529162,0.71875,1.0,1.0,1/6,1.49%,TGFB1
prerank,GO_Biological_Process_2021__positive regulation of muscle cell differentiation (GO:0051149),0.37505356267438106,0.7687198915284826,0.8,1.0,1.0,6/22,15.70%,NRG1;OLFM2;ABL1;BNIP2;CDH2;MAPK12
prerank,GO_Biological_Process_2021__monoubiquitinated protein deubiquitination (GO:0035520),0.46300151203189777,0.7686493616063156,0.8181818181818182,1.0,1.0,1/6,19.95%,USP15
prerank,GO_Biological_Process_2021__regulation of primary metabolic process (GO:0080090),0.29956067463664887,0.7685681169227405,0.875,1.0,1.0,20/114,15.72%,ELOVL6;HDAC3;APOE;SMARCD3;PPARG;PSME4;NCOA2;PSMA1;ACACB;SP1;LDLR;ADIPOR1;IRS2;ODC1;SC5D;CHD9;CARM1;NFYC;TM7SF2;OPA3
prerank,GO_Biological_Process_2021__ER overload response (GO:0006983),0.4292555568054798,0.7685525536089801,0.7692307692307693,1.0,1.0,2/8,15.44%,EIF2AK3;TP53
prerank,GO_Biological_Process_2021__gliogenesis (GO:0042063),-0.4237256735698617,-0.7685354473330572,0.803921568627451,1.0,1.0,5/15,20.20%,ANXA1;NDUFS2;METRN;METTL14;GCM2
prerank,Reactome_2022__HDACs Deacetylate Histones R-HSA-3214815,0.35643259558969603,0.7684881487443682,0.6521739130434783,1.0,1.0,7/38,13.45%,HDAC3;HDAC10;GATAD2A;H2BC21;HDAC1;GATAD2B;CHD4
prerank,Reactome_2022__GABA Receptor Activation R-HSA-977443,0.2957217195825965,0.7684462589495223,0.9166666666666666,1.0,1.0,6/51,7.95%,GABRA5;GABRR2;GABRG3;KCNJ3;KCNJ6;ADCY2
prerank,GO_Biological_Process_2021__peptidyl-proline modification (GO:0018208),0.35545297392610103,0.7683224675981689,0.8809523809523809,1.0,1.0,5/24,14.70%,P3H2;PPIB;CWC27;FKBP7;NKTR
prerank,GO_Biological_Process_2021__positive regulation of IRE1-mediated unfolded protein response (GO:1903896),-0.5009438606625802,-0.7682752248351067,0.8095238095238095,1.0,1.0,4/7,41.28%,BAK1;TMEM33;BCL2L11;AGR2
prerank,GO_Biological_Process_2021__lipoprotein biosynthetic process (GO:0042158),0.4347116035430514,0.7681693542043654,0.7843137254901961,1.0,1.0,1/11,2.66%,APOE
prerank,GO_Biological_Process_2021__inner ear auditory receptor cell differentiation (GO:0042491),0.44733001161134783,0.7680036867985278,0.7857142857142857,1.0,1.0,3/6,21.76%,SLC4A7;PDZD7;JAG2
prerank,GO_Biological_Process_2021__positive regulation of reactive oxygen species metabolic process (GO:2000379),-0.3615084639020202,-0.7680024589462295,0.8857142857142857,1.0,1.0,9/38,17.63%,TGFB1;ITGB2;THBS1;CYBA;ITGAM;CDKN1A;AGT;F2RL1;ROMO1
prerank,GO_Biological_Process_2021__negative regulation of proteasomal protein catabolic process (GO:1901799),0.29922569918866043,0.7676663909554995,0.9333333333333333,1.0,1.0,4/34,13.41%,FHIT;N4BP1;EIF3H;RYBP
prerank,Reactome_2022__Loss Of Function Of SMAD2/3 In Cancer R-HSA-3304349,-0.45726153459097707,-0.7676479622562158,0.703125,1.0,1.0,1/7,1.49%,TGFB1
prerank,Reactome_2022__Signaling By TGF-beta Receptor Complex In Cancer R-HSA-3304351,-0.45726153459097707,-0.7676479622562158,0.703125,1.0,1.0,1/7,1.49%,TGFB1
prerank,GO_Biological_Process_2021__positive regulation of cell-substrate junction organization (GO:0150117),0.3236996990502319,0.7675954944651981,0.7575757575757576,1.0,1.0,7/21,27.48%,ABL1;COL16A1;LIMS1;IQSEC1;PTPRJ;MAP4K4;ROCK1
prerank,Reactome_2022__SARS-CoV-2 Activates/Modulates Innate And Adaptive Immune Responses R-HSA-9705671,-0.3207099497764753,-0.7675950699423878,0.9054054054054054,1.0,1.0,10/94,13.40%,NLRP12;SFTPD;TRIM25;STAT1;MASP1;HLA-A;MASP2;TLR2;NLRP3;ATG14
prerank,GO_Biological_Process_2021__apoptotic mitochondrial changes (GO:0008637),-0.36439345840573445,-0.7675286205908809,0.7746478873239436,1.0,1.0,9/30,21.33%,HK2;SOD2;CLU;BIK;IFIT2;CAMK2A;FIS1;BBC3;IFI6
prerank,GO_Biological_Process_2021__morphogenesis of an epithelial sheet (GO:0002011),0.43736016821404894,0.7674277234692997,0.8108108108108109,1.0,1.0,3/8,16.67%,LRP6;PHACTR4;NOTCH1
prerank,GO_Biological_Process_2021__positive regulation of cellular response to transforming growth factor beta stimulus (GO:1903846),-0.394012560230075,-0.7673653755694335,0.7213114754098361,1.0,1.0,2/18,9.78%,DAB2;THBS1
prerank,GO_Biological_Process_2021__positive regulation of transforming growth factor beta receptor signaling pathway (GO:0030511),-0.394012560230075,-0.7673653755694335,0.7213114754098361,1.0,1.0,2/18,9.78%,DAB2;THBS1
prerank,KEGG_2021_Human__Glyoxylate and dicarboxylate metabolism,0.35380760180769755,0.7673641227916511,0.7837837837837838,1.0,1.0,2/25,4.47%,ACO1;ACSS2
prerank,Reactome_2022__Transcriptional Regulation Of Testis Differentiation R-HSA-9690406,0.4668055508837431,0.7673225222945863,0.7446808510638298,1.0,1.0,2/7,10.99%,WNT4;AMH
prerank,Reactome_2022__TCF Dependent Signaling In Response To WNT R-HSA-201681,0.25397281311400133,0.7672780587429611,1.0,1.0,1.0,22/160,13.73%,LGR5;RSPO3;TLE2;WNT4;PSME4;SEM1;CXXC4;WNT9A;H2BC21;PSMA1;RSPO2;FZD1;MYC;LRP6;WNT3A;AKT2;PPP2R1B;SMARCA4;BCL9L;HDAC1;RNF146;H2AX
prerank,Reactome_2022__Cell Cycle R-HSA-1640170,-0.26955122285281435,-0.7672257429071045,1.0,1.0,1.0,76/582,19.80%,NEK2;BUB1;ERCC6L;PSMB9;FOXM1;SYCP1;TERF2IP;STAG3;CCND1;SPC25;RPA3;MCM3;CENPU;ABRAXAS1;CDC25A;FBXL7;ITGB3BP;ZWILCH;SYNE2;H2BC4;BRCA1;CCND2;OIP5;FKBPL;NUF2;CENPH;TERT;PIF1;DCTN1;CENPS-CORT;CDKN2D;CDKN1A;PSMC3IP;MAX;H2AZ1;TUBA4A;CEP72;DYNLL1;SYCE2;RPS27;INCENP;RBBP7;POLE2;TUBA3D;TK1;SMC1B;CCNE2;BORA;RAB8A;SYCP3;RBX1;CKS1B;CC2D1B;NDEL1;TUBB;PSMA3;TUBB6;CEP76;TUBB2A;RRAD;POLD4;ARPP19;CDCA8;CENPN;RPS27A;KIF18A;PKMYT1;FBXL18;CDC6;BUB1B;PSMA7;PSMB6;YWHAG;SMARCA5;SET;NUP93
prerank,GO_Biological_Process_2021__negative regulation of signal transduction (GO:0009968),0.2615321962787368,0.7672084951574725,1.0,1.0,1.0,45/215,16.76%,TSKU;BCL2;IRS1;KLK14;KCTD21;PID1;CX3CR1;PLIN5;ADAMTS12;ERBB2;TULP3;CXXC4;CRY1;SNCA;DACT3;DCC;NKD1;CHAC1;RGS14;WWOX;WWP2;FSTL3;NR4A2;BEND6;SNAI2;PHACTR4;RPGRIP1L;KANK1;NLGN4X;DLK2;NLRP2B;TYRO3;UBASH3B;ARRB1;TCIM;NKD2;PTPRT;GPR108;SPRY4;BRAP;PTPRE;PTCH2;PIP4K2A;NEDD4;NCK1
prerank,GO_Biological_Process_2021__negative regulation of ossification (GO:0030279),0.36496684453215,0.7671868320235152,0.696969696969697,1.0,1.0,6/19,18.15%,CHSY1;ECM1;GREM1;BCOR;NOTCH1;RBPJ
prerank,Reactome_2022__Cholesterol Biosynthesis R-HSA-191273,0.3637253888489521,0.7671147748050445,0.8076923076923077,1.0,1.0,7/24,24.00%,SOAT2;SC5D;TM7SF2;SREBF2;NSDHL;SH3D19;MVK
prerank,GO_Biological_Process_2021__negative regulation of blood vessel endothelial cell migration (GO:0043537),-0.37194233678167965,-0.7670953645745789,0.8769230769230769,1.0,1.0,3/26,9.78%,TGFB1;ANGPT2;THBS1
prerank,GO_Biological_Process_2021__retinal rod cell differentiation (GO:0060221),0.4080338022474316,0.7670797960290106,0.75,1.0,1.0,2/8,9.51%,RORB;RPGRIP1L
prerank,GO_Biological_Process_2021__renal tubule development (GO:0061326),-0.47865317848574185,-0.7669631780682737,0.7166666666666667,1.0,1.0,1/5,6.09%,STAT1
prerank,Reactome_2022__ChREBP Activates Metabolic Gene Expression R-HSA-163765,-0.48167863378071885,-0.7669092172350207,0.803030303030303,1.0,1.0,1/7,5.22%,PKLR
prerank,GO_Biological_Process_2021__cellular calcium ion homeostasis (GO:0006874),0.27434717241582596,0.7667724564193014,0.9545454545454546,1.0,1.0,15/114,11.41%,BCL2;CDH5;RGN;TRPC3;HTR2C;SLC8A1;DRD5;SLC8A3;DRD4;F2;PML;MICU1;WBP2NL;MCU;PDZD8
prerank,GO_Biological_Process_2021__positive regulation of astrocyte differentiation (GO:0048711),0.4592250792182515,0.7667517810720053,0.7714285714285715,1.0,1.0,2/8,5.56%,BIN1;HES1
prerank,"GO_Biological_Process_2021__DNA catabolic process, endonucleolytic (GO:0000737)",-0.39570599480963986,-0.7666501067099921,0.7571428571428571,1.0,1.0,4/21,12.35%,H1-0;ENDOG;DNASE2;REXO4
prerank,GO_Biological_Process_2021__positive regulation of melanin biosynthetic process (GO:0048023),0.46465958321247636,0.7666156125799128,0.7631578947368421,0.9997265194249126,1.0,3/7,22.58%,ZEB2;OPN3;TYRP1
prerank,GO_Biological_Process_2021__positive regulation of secondary metabolite biosynthetic process (GO:1900378),0.46465958321247636,0.7666156125799128,0.7631578947368421,0.9997265194249126,1.0,3/7,22.58%,ZEB2;OPN3;TYRP1
prerank,KEGG_2021_Human__Bladder cancer,-0.3514022403915499,-0.7662032734973477,0.8529411764705882,1.0,1.0,5/37,12.07%,MMP9;CCND1;UPK3A;THBS1;CDKN1A
prerank,GO_Biological_Process_2021__negative regulation of cytoskeleton organization (GO:0051494),-0.39260989260998536,-0.7661432708904302,0.8275862068965517,1.0,1.0,2/29,6.64%,CAV3;KANK3
prerank,GO_Biological_Process_2021__protein targeting to mitochondrion (GO:0006626),0.3414606473799186,0.7661363594857361,0.75,1.0,1.0,5/50,7.64%,GDAP1;TIMM29;IMMP2L;IMMP1L;MGARP
prerank,GO_Biological_Process_2021__regulation of actin filament-based process (GO:0032970),0.31637557127954147,0.7661258833646175,0.9,0.9999410171870606,1.0,12/64,16.39%,RHOBTB3;RHOBTB1;CRK;EPHA3;ABL1;EFNA5;MLST8;RND3;CCDC88A;ARHGAP35;FSCN1;CORO2B
prerank,CellMarker_Augmented_2021__CD4+ Cytotoxic T cell:Liver,-0.32562663826887805,-0.7661143572853574,0.8260869565217391,1.0,1.0,6/65,8.84%,PZP;PLEKHG3;FCGR3A;SYNE2;PRSS23;MYO1F
prerank,GO_Biological_Process_2021__response to fructose (GO:0009750),-0.4917235656317417,-0.7659018910997986,0.7857142857142857,1.0,1.0,2/5,31.93%,GCKR;SLC26A6
prerank,GO_Biological_Process_2021__positive regulation of viral release from host cell (GO:1902188),0.40792322704916856,0.765850841448761,0.8409090909090909,1.0,1.0,1/11,1.79%,PC
prerank,GO_Biological_Process_2021__negative regulation of peptidyl-tyrosine phosphorylation (GO:0050732),0.36962530815678196,0.7658079160386729,0.8,0.9999102104916224,1.0,1/25,1.76%,SAMSN1
prerank,Reactome_2022__RUNX2 Regulates Bone Development R-HSA-8941326,0.3671221483475318,0.765713824890103,0.6923076923076923,0.9997662906203015,1.0,7/27,14.76%,HDAC3;CBFB;ABL1;RBM14-RBM4;SP7;WWTR1;HDAC4
prerank,PanglaoDB_Augmented_2021__Plasma Cells,0.30741739796492223,0.7656992317523569,0.9032258064516129,0.9995341080773958,1.0,5/57,4.74%,IGLL3P;CD38;HTRA2;IL16;AMPD1
prerank,GO_Biological_Process_2021__regulation of regulated secretory pathway (GO:1903305),0.332839559479544,0.7656332532040087,0.9090909090909091,0.9993462082396471,1.0,11/34,17.53%,RAB27A;SYT3;SYT17;SYT1;SYT12;RIMS2;RIMS4;SYT6;RAB5A;SYN1;RAB3D
prerank,GO_Biological_Process_2021__positive regulation of calcium ion transmembrane transport (GO:1904427),0.3812190861988656,0.7654784400821893,0.75,0.9992988745961188,1.0,4/18,14.65%,SNCA;F2;F2R;ANK2
prerank,Reactome_2022__EPHB-mediated Forward Signaling R-HSA-3928662,-0.36633678227493893,-0.7653746153006695,0.8405797101449275,1.0,1.0,2/30,7.39%,SDC2;ACTG1
prerank,Reactome_2022__Cardiac Conduction R-HSA-5576891,0.2829727305299006,0.7653601123946927,0.9523809523809523,0.9992355174569426,1.0,12/104,10.49%,KCNK6;ITPR2;CACNG4;SLC8A1;SLC8A3;KCNIP3;KCNIP1;KCND2;KCNK2;KCNIP4;AKAP9;FGF12
prerank,Reactome_2022__Golgi Associated Vesicle Biogenesis R-HSA-432722,0.2990599014543829,0.7653401712706196,0.8125,0.9990197707815688,1.0,10/48,19.86%,ACBD3;SNX5;SNX9;ARRB1;CLINT1;GOLGB1;TBC1D8B;AP4B1;VAMP8;AP1B1
prerank,PanglaoDB_Augmented_2021__Leydig Cells,-0.3083077181777334,-0.7649626817699634,0.926829268292683,1.0,1.0,18/119,14.86%,C1QTNF1;LMOD1;TIMP3;ANGPTL2;CYP26B1;COL1A1;DCN;SLCO2A1;ADAM21;CFD;CALB2;VIT;TEK;SLC22A3;C1S;GATA4;MLANA;ADGRF5
prerank,GO_Biological_Process_2021__associative learning (GO:0008306),0.39220957036106185,0.7649340466400792,0.6923076923076923,0.9994297106548665,1.0,1/9,11.15%,ADCY3
prerank,GO_Biological_Process_2021__negative regulation of intracellular signal transduction (GO:1902532),0.2612670282702125,0.7649156082637957,0.9130434782608695,0.9991979915833499,1.0,48/172,22.11%,DGKD;THEM4;BCL2;RORA;URI1;EPM2A;ADGRG3;PDE10A;SIRT1;ARRB2;MAGI2;DEPTOR;CGNL1;SLIT2;TWIST1;ADIPOR1;SPRED1;PPM1A;TSPAN6;TANK;CCDC22;CD22;MARK3;NF1;OTUD3;OTUD7B;ZMYND11;BANK1;DLG5;WWC1;MINAR1;NOC2L;ABCA7;TNIP3;CPNE1;PDE3B;SLA2;STAMBP;PRKAA2;CDC34;PHLPP2;HDAC7;PTPRJ;NPRL2;OTUD7A;PDE4D;PTEN;ARHGAP25
prerank,GO_Biological_Process_2021__Wnt signaling pathway involved in midbrain dopaminergic neuron differentiation (GO:1904953),-0.4412081545407655,-0.764873026441546,0.8269230769230769,1.0,1.0,1/9,2.54%,WNT5A
prerank,Reactome_2022__Sphingolipid Metabolism R-HSA-428157,0.2875462188461902,0.7647299085534497,0.9259259259259259,0.9991948481787465,1.0,13/81,11.28%,ESYT3;ARSJ;GLB1L;STS;ACER2;SMPD4;ARSB;SMPD3;ESYT2;PLPP2;ACER3;NEU4;GLB1
prerank,GO_Biological_Process_2021__positive regulation of keratinocyte migration (GO:0051549),0.41492079653548236,0.7646958716354054,0.7872340425531915,0.9989873572069767,1.0,1/10,1.19%,FGF10
prerank,GO_Biological_Process_2021__axoneme assembly (GO:0035082),-0.3731099892224253,-0.7645206861149586,0.8260869565217391,1.0,1.0,4/26,9.71%,CCDC39;CFAP74;DRC1;RP1
prerank,Reactome_2022__Nef And Signal Transduction R-HSA-164944,-0.4976274059512674,-0.7644675092695419,0.8,1.0,1.0,2/8,5.45%,HCK;DOCK2
prerank,Reactome_2022__Regulation Of Apoptosis R-HSA-169911,-0.3399587384015849,-0.7644371765909416,0.8507462686567164,1.0,1.0,1/45,0.62%,PSMB9
prerank,Reactome_2022__Activation Of PUMA And Translocation To Mitochondria R-HSA-139915,0.4602419602593044,0.7643899366776964,0.7906976744186046,0.9992486530482597,1.0,3/8,21.88%,PPP1R13B;TP53;TFDP1
prerank,Reactome_2022__Signaling By NOTCH3 R-HSA-9012852,0.3275711902166772,0.7643678497970348,0.8148148148148148,0.9990332493451718,1.0,14/45,22.85%,MAML1;JAG1;WWP2;MAMLD1;WWC1;NOTCH1;PBX1;RBPJ;MIB2;ADAM10;EP300;KAT2B;JAG2;MIB1
prerank,GO_Biological_Process_2021__negative regulation of endothelial cell migration (GO:0010596),-0.3692842426531664,-0.7642592057335065,0.8648648648648649,1.0,1.0,5/28,9.78%,TGFB1;ANGPT2;SP100;DCN;THBS1
prerank,GO_Biological_Process_2021__negative regulation of axonogenesis (GO:0050771),0.34390065518133417,0.7642106458111209,0.7857142857142857,0.9990942114921036,1.0,2/25,6.21%,KIAA0319;DCC
prerank,CellMarker_Augmented_2021__Mesenchymal Stem cell:Whartons Jelly,-0.3442065163908142,-0.7642085227668098,0.8181818181818182,1.0,1.0,18/72,18.75%,RIN3;PDCD1LG2;MMP19;PLAC9;TGFBI;HIC1;DAB2;TMEM204;VWF;CTSZ;ENG;ITGA5;RRAS;GRN;COL8A2;ANPEP;CSF1R;ARHGAP31
prerank,CellMarker_Augmented_2021__Epithelial cell:Bone,-0.3442065163908142,-0.7642085227668098,0.8181818181818182,1.0,1.0,18/72,18.75%,RIN3;PDCD1LG2;MMP19;PLAC9;TGFBI;HIC1;DAB2;TMEM204;VWF;CTSZ;ENG;ITGA5;RRAS;GRN;COL8A2;ANPEP;CSF1R;ARHGAP31
prerank,Reactome_2022__Homology Directed Repair R-HSA-5693538,0.2854420364409694,0.7641461646178191,0.9032258064516129,0.9989350002015128,1.0,23/100,20.40%,BRCC3;SEM1;RNF168;SLC19A1;H2BC21;POLD3;ABL1;TIMELESS;LRIG3;H2AX;SPIDR;HERC2;CLSPN;EXO1;ATM;RAD52;RAD17;RAD9A;MDC1;EME2;SIRT6;RAD51B;DNA2
prerank,Reactome_2022__Role Of Second Messengers In Netrin-1 Signaling R-HSA-418890,0.4053991546727129,0.7640799375044449,0.7441860465116279,0.9988358964215323,1.0,2/10,6.21%,TRPC3;DCC
prerank,GO_Biological_Process_2021__estrogen metabolic process (GO:0008210),0.4096471527016279,0.7639060968900412,0.7631578947368421,0.9988488573970228,1.0,2/17,2.75%,CYP1A2;UGT2B15
prerank,GO_Biological_Process_2021__sensory perception of mechanical stimulus (GO:0050954),-0.3074222355032084,-0.7636976276242947,0.9154929577464789,1.0,1.0,16/72,17.28%,TBX1;PIEZO2;MARVELD2;COL1A1;EYA1;GSDME;GRXCR2;KCNQ1;COL4A3;LRP2;MYO3B;WFS1;NDUFB9;USH1C;GRXCR1;SLC26A5
prerank,GO_Biological_Process_2021__protein kinase B signaling (GO:0043491),-0.38744938897335635,-0.7636805254269625,0.7796610169491526,1.0,1.0,2/17,8.19%,TGFB1;PIK3R3
prerank,Reactome_2022__Signaling By Hedgehog R-HSA-5358351,-0.2992357601993823,-0.7636464356435746,0.9259259259259259,1.0,1.0,3/123,2.89%,NOTUM;PSMB9;HHIP
prerank,GO_Biological_Process_2021__negative regulation of proteasomal ubiquitin-dependent protein catabolic process (GO:0032435),0.32254415265911396,0.7635975486203607,0.9090909090909091,0.9990937737788576,1.0,4/28,13.41%,FHIT;N4BP1;EIF3H;RYBP
prerank,GO_Biological_Process_2021__regulation of intrinsic apoptotic signaling pathway in response to DNA damage (GO:1902229),-0.3843399997558419,-0.7635695130739965,0.7391304347826086,1.0,1.0,2/16,11.88%,CLU;CDKN2D
prerank,GO_Biological_Process_2021__regulation of myosin-light-chain-phosphatase activity (GO:0035507),0.5209125594700892,0.7634997221488944,0.8372093023255814,0.9990067018667768,1.0,3/6,29.59%,IKBKB;ROCK1;NUAK1
prerank,CellMarker_Augmented_2021__Regulatory T (Treg) cell:Liver,0.25490652857399654,0.7632693067309799,1.0,0.9990715705980623,1.0,76/362,18.66%,PLEKHG2;FOXO1;DUSP4;FANK1;SAMSN1;ACTR3C;HSPB1;COL9A2;SDC4;STAMBPL1;NDUFC2-KCTD14;SLC3A2;EDARADD;METTL8;CREB3L2;SDF4;TET2;WHRN;TRIM69;PDIA6;CADM1;TOM1;HPSE;TOX;FANCL;NCOA3;MAN1A2;IKZF4;OCIAD2;DYNC1I2;HACD1;ACOT9;TNFRSF18;SMPD3;TTYH3;INPP1;CREM;ISOC1;NAMPT;ADCY3;CCDC50;PIM2;VPS54;TBC1D4;RAP1A;HSPA1A;CCDC22;SNX9;PELI1;GBP4;TMEM154;NFAT5;GPX1;RHBDD2;DNPH1;SSH1;GADD45A;GBP2;IL2RB;CLIP1;CTSC;HPRT1;OTUD5;ARID5B;ZNF292;RAB11FIP1;GABPB1;LGALS3;MAST4;NUDT5;RBPJ;MYO5A;TNIP3;RFX5;PPP1CB;ADAM10
prerank,Reactome_2022__Switching Of Origins To A Post-Replicative State R-HSA-69052,-0.3141212013992582,-0.7631022387612694,0.8513513513513513,1.0,1.0,19/78,27.84%,PSMB9;MCM3;CCNE2;RBX1;PSMA3;RPS27A;CDC6;PSMA7;PSMB6;ORC6;PSMA5;PSMD6;SKP1;PSMC5;MCM5;PSMB4;PSMB7;PSMD8;MCM6
prerank,Reactome_2022__Glutathione Synthesis And Recycling R-HSA-174403,0.4104208738867158,0.7630814631529479,0.7906976744186046,0.9991803622832931,1.0,1/9,6.86%,CHAC1
prerank,GO_Biological_Process_2021__regulation of cation transmembrane transport (GO:1904062),-0.37075518341042235,-0.7629747571618769,0.8285714285714286,1.0,1.0,3/27,10.40%,SCN5A;PDZK1;CD63
prerank,GO_Biological_Process_2021__branching involved in blood vessel morphogenesis (GO:0001569),-0.4371558248477241,-0.7628380119806698,0.8208955223880597,1.0,1.0,6/12,34.07%,ENG;DLL4;COL4A1;SFRP2;NRP1;TGFBR2
prerank,KEGG_2021_Human__Endocytosis,0.2731783597308728,0.7627523996387291,1.0,0.9994568891844072,1.0,42/229,17.45%,GRK5;TGFBR1;ACTR3C;PARD3;RAB31;BIN1;SNX5;ASAP3;ARRB2;RAB7A;WASHC2C;GBF1;PML;CBLB;MVB12A;CHMP6;FGFR3;ZFYVE16;LDLR;EHD4;SH3KBP1;RAB35;RAB11FIP3;ACAP3;WASHC2A;HSPA1A;ARPC3;ARRB1;RAB10;SMAD2;VTA1;SMURF1;SNX32;IL2RB;PARD6B;SNF8;AGAP4;NEDD4;RAB5A;RAB11B;RAB11FIP1;IQSEC1
prerank,GO_Biological_Process_2021__establishment of spindle localization (GO:0051293),0.40197684245287263,0.7626518346088506,0.8333333333333334,0.9993418552268826,1.0,1/14,1.59%,LLGL1
prerank,GO_Biological_Process_2021__negative regulation of cardiocyte differentiation (GO:1905208),-0.4604586115387893,-0.7625614001336587,0.7142857142857143,1.0,1.0,1/6,14.16%,HEY2
prerank,GO_Biological_Process_2021__regulation of cellular amide metabolic process (GO:0034248),0.34486643314265886,0.762410770945252,0.8333333333333334,0.9994784383011688,1.0,12/30,27.48%,TCOF1;PCIF1;NANOS3;GEMIN5;PUM3;SAMD8;GRM5;EIF4E;PRKCD;FOXO3;ATXN2;ROCK1
prerank,GO_Biological_Process_2021__negative regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002924),-0.4750132754898711,-0.7622164531519321,0.8333333333333334,1.0,1.0,2/7,14.17%,C4BPA;C4BPB
prerank,"GO_Biological_Process_2021__negative regulation of complement activation, classical pathway (GO:0045959)",-0.4750132754898711,-0.7622164531519321,0.8333333333333334,1.0,1.0,2/7,14.17%,C4BPA;C4BPB
prerank,"GO_Biological_Process_2021__regulation of complement activation, classical pathway (GO:0030450)",-0.4750132754898711,-0.7622164531519321,0.8333333333333334,1.0,1.0,2/7,14.17%,C4BPA;C4BPB
prerank,CellMarker_Augmented_2021__Pancreatic Progenitor cell:Pancreas,0.2864833778479585,0.7621446002750882,0.90625,0.9980212542673673,1.0,20/76,16.89%,FREM1;ESRRG;PLCH1;UNC5D;PTPRZ1;CFAP65;VWA2;WNK2;COBL;TSPAN6;LRRN1;ASXL3;PTPRT;TMPRSS2;ZNF663P;PPP1R9A;CGN;PTPRD;FRAS1;PBX1
prerank,CellMarker_Augmented_2021__Progenitor cell:Embryonic Stem Cell,0.2864833778479585,0.7621446002750882,0.90625,0.9980212542673673,1.0,20/76,16.89%,FREM1;ESRRG;PLCH1;UNC5D;PTPRZ1;CFAP65;VWA2;WNK2;COBL;TSPAN6;LRRN1;ASXL3;PTPRT;TMPRSS2;ZNF663P;PPP1R9A;CGN;PTPRD;FRAS1;PBX1
prerank,CellMarker_Augmented_2021__Neural Stem cell:Bone Marrow,0.2864833778479585,0.7621446002750882,0.90625,0.9980212542673673,1.0,20/76,16.89%,FREM1;ESRRG;PLCH1;UNC5D;PTPRZ1;CFAP65;VWA2;WNK2;COBL;TSPAN6;LRRN1;ASXL3;PTPRT;TMPRSS2;ZNF663P;PPP1R9A;CGN;PTPRD;FRAS1;PBX1
prerank,CellMarker_Augmented_2021__Cancer Stem cell:Larynx,0.2864833778479585,0.7621446002750882,0.90625,0.9980212542673673,1.0,20/76,16.89%,FREM1;ESRRG;PLCH1;UNC5D;PTPRZ1;CFAP65;VWA2;WNK2;COBL;TSPAN6;LRRN1;ASXL3;PTPRT;TMPRSS2;ZNF663P;PPP1R9A;CGN;PTPRD;FRAS1;PBX1
prerank,CellMarker_Augmented_2021__Early Hematopoietic cell:Blood,0.2864833778479585,0.7621446002750882,0.90625,0.9980212542673673,1.0,20/76,16.89%,FREM1;ESRRG;PLCH1;UNC5D;PTPRZ1;CFAP65;VWA2;WNK2;COBL;TSPAN6;LRRN1;ASXL3;PTPRT;TMPRSS2;ZNF663P;PPP1R9A;CGN;PTPRD;FRAS1;PBX1
prerank,CellMarker_Augmented_2021__Dermal Papilla cell:Hair Follicle,0.2864833778479585,0.7621446002750882,0.90625,0.9980212542673673,1.0,20/76,16.89%,FREM1;ESRRG;PLCH1;UNC5D;PTPRZ1;CFAP65;VWA2;WNK2;COBL;TSPAN6;LRRN1;ASXL3;PTPRT;TMPRSS2;ZNF663P;PPP1R9A;CGN;PTPRD;FRAS1;PBX1
prerank,CellMarker_Augmented_2021__Ductal cell:Pancreas,0.2864833778479585,0.7621446002750882,0.90625,0.9980212542673673,1.0,20/76,16.89%,FREM1;ESRRG;PLCH1;UNC5D;PTPRZ1;CFAP65;VWA2;WNK2;COBL;TSPAN6;LRRN1;ASXL3;PTPRT;TMPRSS2;ZNF663P;PPP1R9A;CGN;PTPRD;FRAS1;PBX1
prerank,CellMarker_Augmented_2021__LGR5+ Stem cell:Small Intestine,-0.31873210503836014,-0.7618612748360009,0.881578947368421,1.0,1.0,9/90,6.82%,LMOD1;TIMP3;ANGPTL2;COL1A1;COL5A1;LOX;FBXL7;UACA;DCN
prerank,GO_Biological_Process_2021__proteasome assembly (GO:0043248),0.44856534464115433,0.7618218045833789,0.717948717948718,0.9982734467916954,1.0,5/10,28.15%,PSMG2;PSMD4;PSMD5;PSMD10;PSMD13
prerank,GO_Biological_Process_2021__activation of protein kinase activity (GO:0032147),-0.31904286443450486,-0.7617561099557931,0.8961038961038961,1.0,1.0,15/96,18.22%,KIF14;WNT5A;CARD14;PINK1;SLC11A1;STRADB;TNFRSF10A;STRADA;TOM1L1;ADCY7;IL18;BORA;ECT2;PRRC1;NTRK3
prerank,GO_Biological_Process_2021__tRNA aminoacylation for protein translation (GO:0006418),-0.3628975196570383,-0.761691552531754,0.8059701492537313,1.0,1.0,5/40,16.58%,NARS1;DARS2;WARS1;YARS2;TARS3
prerank,Reactome_2022__Mitochondrial Protein Import R-HSA-1268020,-0.3317005944425883,-0.7616098521612129,0.8493150684931506,1.0,1.0,15/58,25.59%,TOMM20;CHCHD2;TOMM7;COX17;VDAC1;PAM16;TIMM17A;IDH3G;CHCHD4;ATP5F1A;CCNI;LDHD;DNAJC19;CHCHD7;TIMM21
prerank,CellMarker_Augmented_2021__EBV+ B Lymphoma cell:Kidney,0.2697846871247236,0.7615970489120707,1.0,0.9978865977857032,1.0,30/95,25.44%,TOR1B;MIDN;PHC2;CUEDC1;NOP9;TTYH3;UBE2E1;CTBP2;MPZL1;RAB35;CARM1;SMURF1;YTHDF1;PATL1;PPP4R1;RNF19B;ZDHHC5;BAG6;MEX3D;PVR;PBX2;GOLM1;ACVR1B;PTPN12;GNS;YBX1;PLAGL2;CANT1;PLCB3;ARHGEF11
prerank,CellMarker_Augmented_2021__EBV+ B Lymphoma cell:Liver,0.2697846871247236,0.7615970489120707,1.0,0.9978865977857032,1.0,30/95,25.44%,TOR1B;MIDN;PHC2;CUEDC1;NOP9;TTYH3;UBE2E1;CTBP2;MPZL1;RAB35;CARM1;SMURF1;YTHDF1;PATL1;PPP4R1;RNF19B;ZDHHC5;BAG6;MEX3D;PVR;PBX2;GOLM1;ACVR1B;PTPN12;GNS;YBX1;PLAGL2;CANT1;PLCB3;ARHGEF11
prerank,CellMarker_Augmented_2021__EBV+ B Lymphoma cell:Lymph,0.2697846871247236,0.7615970489120707,1.0,0.9978865977857032,1.0,30/95,25.44%,TOR1B;MIDN;PHC2;CUEDC1;NOP9;TTYH3;UBE2E1;CTBP2;MPZL1;RAB35;CARM1;SMURF1;YTHDF1;PATL1;PPP4R1;RNF19B;ZDHHC5;BAG6;MEX3D;PVR;PBX2;GOLM1;ACVR1B;PTPN12;GNS;YBX1;PLAGL2;CANT1;PLCB3;ARHGEF11
prerank,GO_Biological_Process_2021__positive regulation of reactive oxygen species biosynthetic process (GO:1903428),0.4375703770574878,0.761357164738412,0.76,0.9979873101828933,1.0,2/8,9.93%,RAB27A;GRIN1
prerank,Reactome_2022__Ras Activation Upon Ca2+ Influx Thru NMDA Receptor R-HSA-442982,0.37920753694550224,0.7612362026843456,0.76,0.9978850328121569,1.0,2/19,2.58%,LLGL1;GPRIN1
prerank,Reactome_2022__RUNX3 Regulates Immune Response And Cell Migration R-HSA-8949275,0.4858868317412548,0.7610183859655241,0.7333333333333333,0.9979538674042592,1.0,2/5,4.73%,CBFB;ITGA4
prerank,GO_Biological_Process_2021__positive regulation of dendritic spine morphogenesis (GO:0061003),0.45739656901965553,0.7606752188073712,0.825,0.9981618613007722,1.0,1/9,13.60%,LRP8
prerank,Reactome_2022__G1/S-Specific Transcription R-HSA-69205,0.3562419104270335,0.760530949341833,0.8518518518518519,0.9981232345840951,1.0,5/26,13.17%,E2F6;DHFR;RBL1;LIN52;HDAC1
prerank,GO_Biological_Process_2021__vesicle transport along microtubule (GO:0047496),0.33721669684600336,0.7604382499434075,0.7407407407407407,0.9980250047042519,1.0,11/23,35.47%,TRAK2;BICDL1;KIF3B;TRAK1;NDE1;BICDL2;CLN3;FYCO1;KIF13A;FBXW11;KIF1C
prerank,GO_Biological_Process_2021__positive regulation of vascular associated smooth muscle cell apoptotic process (GO:1905461),0.4501535134465645,0.7602722501554805,0.7272727272727273,0.9980142518533134,1.0,1/5,4.33%,PPARG
prerank,GO_Biological_Process_2021__urea cycle (GO:0000050),-0.48398777365217904,-0.7601075114188194,0.8135593220338984,1.0,1.0,1/7,11.64%,ARG2
prerank,Reactome_2022__Response Of EIF2AK1 (HRI) To Heme Deficiency R-HSA-9648895,0.37604685534047577,0.7599701273228058,0.8,0.9981187159578297,1.0,2/14,6.86%,ATF3;CHAC1
prerank,Reactome_2022__Formation Of HIV-1 Elongation Complex Containing HIV-1 Tat R-HSA-167200,0.30761290133105706,0.7599140614874402,0.7878787878787878,0.9979530458091774,1.0,9/40,31.71%,ELOA;CCNH;GTF2F2;ERCC3;POLR2F;SSRP1;ERCC2;CCNT1;POLR2C
prerank,GO_Biological_Process_2021__receptor metabolic process (GO:0043112),-0.33431734506642075,-0.7596848253314487,0.8227848101265823,1.0,1.0,2/49,2.28%,TGFB1;ITGB2
prerank,GO_Biological_Process_2021__regulation of protein autoubiquitination (GO:1902498),-0.48348175583650266,-0.7595828179439441,0.8070175438596491,1.0,1.0,1/6,15.72%,RBX1
prerank,GO_Biological_Process_2021__ribosomal subunit export from nucleus (GO:0000054),-0.40565123605254755,-0.7595739059392749,0.7164179104477612,1.0,1.0,1/13,5.98%,EIF6
prerank,GO_Biological_Process_2021__negative regulation of vascular associated smooth muscle cell proliferation (GO:1904706),-0.4214635961136118,-0.759572748529042,0.8064516129032258,1.0,1.0,4/14,14.43%,GPER1;SOD2;CDKN1A;TGFB3
prerank,GO_Biological_Process_2021__histone H2A acetylation (GO:0043968),-0.4001718856103249,-0.7595065426161667,0.8028169014084507,1.0,1.0,1/16,4.98%,ACTL6A
prerank,GO_Biological_Process_2021__translational readthrough (GO:0006451),0.4628781307652464,0.7594636719385548,0.7321428571428571,0.9980149635416395,1.0,1/7,11.03%,EEFSEC
prerank,GO_Biological_Process_2021__selenocysteine incorporation (GO:0001514),0.4628781307652464,0.7594636719385548,0.7321428571428571,0.9980149635416395,1.0,1/7,11.03%,EEFSEC
prerank,GO_Biological_Process_2021__integrin activation (GO:0033622),0.46356000991302776,0.7594150038716256,0.7317073170731707,0.9978375469874021,1.0,1/7,10.72%,COL16A1
prerank,GO_Biological_Process_2021__cellular response to steroid hormone stimulus (GO:0071383),0.3913067722439536,0.7591137601558481,0.8529411764705882,0.998021270120593,1.0,5/17,16.80%,URI1;AKR1C3;MGARP;NR3C1;UBE2L3
prerank,GO_Biological_Process_2021__protein deacylation (GO:0035601),-0.3792723962572788,-0.7590796152453576,0.8088235294117647,1.0,1.0,1/23,0.22%,NOTUM
prerank,KEGG_2021_Human__PPAR signaling pathway,-0.3132517952373187,-0.7589624551774786,0.88,1.0,1.0,3/60,4.18%,PLIN4;ACOX2;ACSL5
prerank,Reactome_2022__Defective Intrinsic Pathway For Apoptosis R-HSA-9734009,0.3515836740089763,0.7587602837578827,0.8085106382978723,0.9983873540181384,1.0,3/21,7.86%,LMNB1;CAPN2;ERC2
prerank,KEGG_2021_Human__Relaxin signaling pathway,0.26388277342091254,0.7586936321339129,0.9642857142857143,0.9981901526788464,1.0,29/112,20.72%,TGFBR1;VEGFC;CREB3L2;SHC4;MMP2;CREB3L4;ARRB2;RXFP1;PLCB1;MAPK8;ADCY2;INSL5;AKT2;ADCY3;ARRB1;SMAD2;NFKB1;GNAO1;PIK3CA;MAPK12;MAP2K7;GNG7;ADCY6;CREB1;SOS1;RAF1;FOS;GNAI2;GNAS
prerank,KEGG_2021_Human__HIF-1 signaling pathway,-0.32105215613453697,-0.7586025836334639,0.8846153846153846,1.0,1.0,15/93,16.09%,HK2;ENO4;ANGPT2;ALDOB;ENO2;PIK3R3;LDHAL6A;CDKN1A;PIK3CB;TEK;NOS2;IFNGR2;EIF4E1B;RBX1;HK3
prerank,GO_Biological_Process_2021__response to glucocorticoid (GO:0051384),-0.405510330749287,-0.7585700925450654,0.8181818181818182,1.0,1.0,4/18,17.25%,ANXA1;REST;HSD3B1;ZFP36L1
prerank,Reactome_2022__Activation Of NF-kappaB In B Cells R-HSA-1169091,-0.31320995327225765,-0.7585297444245183,0.8918918918918919,1.0,1.0,1/60,0.62%,PSMB9
prerank,GO_Biological_Process_2021__ribosomal large subunit export from nucleus (GO:0000055),0.3932979170772809,0.7584494656428655,0.7674418604651163,0.9983260637763287,1.0,2/7,27.54%,XPO1;RRS1
prerank,GO_Biological_Process_2021__detection of mechanical stimulus (GO:0050982),-0.4039282519041742,-0.7584063706730991,0.8,1.0,1.0,4/18,7.95%,PKD2L2;CAV3;PIEZO2;CSRP3
prerank,GO_Biological_Process_2021__phosphatidylinositol acyl-chain remodeling (GO:0036149),-0.4400327446017358,-0.7582268838084605,0.7678571428571429,1.0,1.0,3/12,20.26%,PLA2G10;PLA2G4A;PLA2G4D
prerank,GO_Biological_Process_2021__protein K69-linked ufmylation (GO:1990592),-0.5101589142316769,-0.758107576267051,0.8,1.0,1.0,2/5,26.06%,UFL1;DDRGK1
prerank,GO_Biological_Process_2021__protein polyufmylation (GO:1990564),-0.5101589142316769,-0.758107576267051,0.8,1.0,1.0,2/5,26.06%,UFL1;DDRGK1
prerank,GO_Biological_Process_2021__protein ufmylation (GO:0071569),-0.5101589142316769,-0.758107576267051,0.8,1.0,1.0,2/5,26.06%,UFL1;DDRGK1
prerank,GO_Biological_Process_2021__telencephalon cell migration (GO:0022029),0.45267544925964964,0.7580596530143761,0.7818181818181819,0.9986481793765547,1.0,1/6,4.55%,PEX13
prerank,"Reactome_2022__PTK6 Regulates RHO GTPases, RAS GTPase And MAP Kinases R-HSA-8849471",0.4008317722090909,0.758024166945441,0.8235294117647058,0.9984114428339432,1.0,4/13,19.00%,CRK;ARHGAP35;DOCK1;ELMO1
prerank,GO_Biological_Process_2021__muscle organ development (GO:0007517),-0.346588629733584,-0.7580059372974821,0.8208955223880597,1.0,1.0,3/44,7.99%,TBX1;CAV3;NEB
prerank,GO_Biological_Process_2021__histone-threonine phosphorylation (GO:0035405),0.4684470243859561,0.757926024108296,0.7804878048780488,0.9982817848934892,1.0,3/5,40.91%,DCAF1;PKN1;PRKCA
prerank,GO_Biological_Process_2021__regulation of sodium ion transmembrane transporter activity (GO:2000649),0.3461226360727989,0.7577262200212014,0.7428571428571429,0.9983422843661032,1.0,12/33,22.90%,UTRN;OSR1;WNK2;FGF12;FGF14;WNK3;NEDD4;NETO1;SLMAP;PRKCE;DMD;WNK1
prerank,Reactome_2022__Integrin Signaling R-HSA-354192,0.3294266623840939,0.7576206704373993,0.75,0.9982364681557856,1.0,6/23,22.48%,CSK;CRK;RAP1A;RAPGEF3;SOS1;RAPGEF4
prerank,GO_Biological_Process_2021__regulation of keratinocyte migration (GO:0051547),0.4006255901626576,0.7575635189658343,0.7755102040816326,0.9980673785333487,1.0,1/11,1.19%,FGF10
prerank,Reactome_2022__Drug-mediated Inhibition Of CDK4/CDK6 Activity R-HSA-9754119,-0.48654151078823216,-0.7575361681377977,0.7833333333333333,1.0,1.0,2/5,8.75%,CCND1;CCND2
prerank,GO_Biological_Process_2021__protein insertion into ER membrane (GO:0045048),0.28592775506078966,0.7574684155322191,0.8620689655172413,0.997993347327889,1.0,6/32,22.95%,STX5;EMC2;EMC4;UBE2J2;BAG6;EMC8
prerank,GO_Biological_Process_2021__respiratory tube development (GO:0030323),-0.36805237288207204,-0.7571399495803743,0.7941176470588235,1.0,1.0,1/23,2.89%,CCDC39
prerank,CellMarker_Augmented_2021__Cancer Stem cell:Bone Marrow,0.28721035821819113,0.7569354037773987,0.9523809523809523,0.9985562703623426,1.0,16/67,16.15%,CSTA;CFLAR;SAMD9;TET2;FAM151B;HPSE;CYB5R4;ALPK1;NAMPT;LPCAT2;SLC2A9;TMEM154;KIAA0825;DDX60L;RUNX1;PTPRE
prerank,Reactome_2022__Detoxification Of Reactive Oxygen Species R-HSA-3299685,0.3408232495065741,0.7568838598640948,0.8823529411764706,0.998379320397686,1.0,1/25,1.21%,NOX4
prerank,Reactome_2022__Signaling By FGFR2 In Disease R-HSA-5655253,-0.34085682878335416,-0.7568639750080792,0.8428571428571429,1.0,1.0,1/38,0.93%,FGF20
prerank,Reactome_2022__Collagen Degradation R-HSA-1442490,-0.3734519903063803,-0.7568350092104772,0.8082191780821918,1.0,1.0,3/29,4.68%,MMP9;MMP19;COL18A1
prerank,GO_Biological_Process_2021__positive regulation of focal adhesion assembly (GO:0051894),0.34796054845694346,0.7567927854144637,0.8571428571428571,0.9982459568962858,1.0,3/16,11.91%,ABL1;COL16A1;LIMS1
prerank,GO_Biological_Process_2021__response to cholesterol (GO:0070723),0.3616047369412318,0.7566296319311085,0.7857142857142857,0.9982391553466594,1.0,10/15,25.35%,TGFBR1;LRP6;OSBPL7;SMAD2;GPLD1;PTCH1;MLC1;ABCA2;GRAMD1B;GRAMD1A
prerank,GO_Biological_Process_2021__transcription-coupled nucleotide-excision repair (GO:0006283),-0.33100722952476697,-0.7564185116862217,0.8701298701298701,1.0,1.0,19/70,30.31%,RPA3;UVSSA;COPS5;RBX1;POLD4;COPS4;RPS27A;RPA2;XRCC1;POLR2B;DDB1;COPS7A;CDK7;PRPF19;PCNA;TCEA1;UBB;COPS7B;ERCC4
prerank,GO_Biological_Process_2021__establishment of protein localization to organelle (GO:0072594),-0.3209584987500555,-0.7563418066396419,0.8831168831168831,1.0,1.0,4/67,8.88%,HK2;RAB11A;PINK1;RANBP6
prerank,CellMarker_Augmented_2021__Follicular B cell:Undefined,0.3554992692335067,0.7562890009324424,0.7741935483870968,0.9985050326077082,1.0,2/17,2.05%,FOXO1;BCL6
prerank,GO_Biological_Process_2021__T cell differentiation in thymus (GO:0033077),-0.429620991988671,-0.7562229700041825,0.7910447761194029,1.0,1.0,3/12,17.25%,PTPRC;GLI3;ZFP36L1
prerank,CellMarker_Augmented_2021__Mesangial cell:Kidney,0.5157099247580929,0.7561653395545329,0.7894736842105263,0.9983954461863529,1.0,1/5,3.71%,ITGA8
prerank,GO_Biological_Process_2021__regulation of mitotic cell cycle (GO:0007346),-0.28865825832475095,-0.7561297603100974,0.9186046511627907,1.0,1.0,3/150,1.49%,NEK2;PSMB9;TGFB1
prerank,Reactome_2022__Inositol Phosphate Metabolism R-HSA-1483249,0.2961795307232163,0.7561117508549806,0.8888888888888888,0.9982266717009144,1.0,5/47,11.09%,PLCH1;ITPKB;PLCB1;INPP1;PLCH2
prerank,GO_Biological_Process_2021__positive regulation of protein transport (GO:0051222),0.299912004124492,0.7560445434791072,0.8846153846153846,0.9980619349878724,1.0,10/55,17.20%,PCM1;APBB3;TENM1;CEP290;B3GAT3;UNC13B;PLK3;ACHE;FRMD4A;ICE1
prerank,Reactome_2022__CaMK IV-mediated Phosphorylation Of CREB R-HSA-111932,-0.4507474802936248,-0.7560346767422853,0.8387096774193549,1.0,1.0,5/10,31.53%,CALM1;CAMK2A;CAMKK2;CAMKK1;KPNA2
prerank,Reactome_2022__RUNX2 Regulates Osteoblast Differentiation R-HSA-8940973,0.3767791065689824,0.7560214154717249,0.7317073170731707,0.9978222799717373,1.0,5/21,14.49%,HDAC3;CBFB;ABL1;SP7;WWTR1
prerank,GO_Biological_Process_2021__histone H3-K4 methylation (GO:0051568),0.33997799241401394,0.7559506196203618,0.7941176470588235,0.9976656300448822,1.0,11/27,25.60%,TET2;SETMAR;DPY30;MEN1;CXXC1;KMT2C;DYDC1;TET3;KMT2B;WDR5B;KMT2A
prerank,Reactome_2022__Formation Of Senescence-Associated Heterochromatin Foci (SAHF) R-HSA-2559584,-0.3882813763247376,-0.7557611388541018,0.7058823529411765,1.0,1.0,5/15,19.73%,H1-0;CDKN1A;H1-3;HMGA2;HMGA1
prerank,GO_Biological_Process_2021__organic cation transport (GO:0015695),-0.35767934148760194,-0.755581796114625,0.8363636363636363,1.0,1.0,4/17,15.08%,PDZK1;SLC22A3;SLC22A4;SLC25A19
prerank,GO_Biological_Process_2021__positive regulation of epithelial cell proliferation (GO:0050679),-0.3174847100184467,-0.7555103714070771,0.8421052631578947,1.0,1.0,7/95,8.81%,TBX1;SCN5A;NODAL;WNT5A;CLDN1;FLT4;HTR2B
prerank,GO_Biological_Process_2021__erythrocyte development (GO:0048821),-0.42061527338237137,-0.7554004523166682,0.7692307692307693,1.0,1.0,1/10,10.62%,ALAS2
prerank,GO_Biological_Process_2021__positive regulation of establishment of protein localization to mitochondrion (GO:1903749),-0.3414723618292147,-0.75536294431974,0.835820895522388,1.0,1.0,3/48,5.61%,ARIH2;HSPA1L;PINK1
prerank,GO_Biological_Process_2021__regulation of antigen receptor-mediated signaling pathway (GO:0050854),-0.43869602832802823,-0.7551892481312558,0.8245614035087719,1.0,1.0,2/10,10.28%,BLK;PTPRC
prerank,GO_Biological_Process_2021__positive regulation of fibroblast growth factor receptor signaling pathway (GO:0045743),-0.5016594000253889,-0.7551568908773967,0.8076923076923077,1.0,1.0,3/5,35.10%,PRKD2;SMOC2;NPTN
prerank,GO_Biological_Process_2021__cellular response to peptide (GO:1901653),0.29723163522200946,0.7550882479375051,0.9736842105263158,0.9986690579312737,1.0,8/44,19.39%,RIPK2;ITGA4;GRIN1;TIMELESS;ABCC1;TP53;GRM5;CDK5
prerank,"GO_Biological_Process_2021__nucleotide-excision repair, DNA gap filling (GO:0006297)",-0.3730707625284201,-0.7549298184087149,0.7746478873239436,1.0,1.0,5/24,22.81%,RPA3;POLD4;RPS27A;RPA2;XRCC1
prerank,Reactome_2022__RHO GTPases Activate CIT R-HSA-5625900,-0.4015810627871327,-0.7549229045059369,0.8688524590163934,1.0,1.0,1/19,1.34%,KIF14
prerank,GO_Biological_Process_2021__positive regulation of histone acetylation (GO:0035066),0.339558557299525,0.7548367439069101,0.9142857142857143,0.9988475516970738,1.0,4/20,13.88%,SMARCB1;PIH1D1;ARRB1;RPS6KA4
prerank,GO_Biological_Process_2021__positive regulation of interleukin-6 production (GO:0032755),-0.3226156180861627,-0.754712625100117,0.8611111111111112,1.0,1.0,7/46,16.13%,WNT5A;SCIMP;CYBA;TLR2;C1QTNF4;NOS2;F2RL1
prerank,KEGG_2021_Human__Fatty acid biosynthesis,-0.4024203388470121,-0.7544612736170152,0.8382352941176471,1.0,1.0,3/15,15.67%,ACSL5;OLAH;ACSL3
prerank,GO_Biological_Process_2021__response to reactive oxygen species (GO:0000302),0.31583557641469606,0.7543398044157719,0.896551724137931,0.9992862211810255,1.0,9/51,14.37%,APOE;SIRT1;AKR1C3;PKD2;FER;MAPK8;PXN;PLK3;GPX1
prerank,GO_Biological_Process_2021__actin filament capping (GO:0051693),-0.3922321762622376,-0.7542009207423737,0.7936507936507936,1.0,1.0,3/18,11.76%,SVIL;SCIN;VIL1
prerank,GO_Biological_Process_2021__barbed-end actin filament capping (GO:0051016),-0.3922321762622376,-0.7542009207423737,0.7936507936507936,1.0,1.0,3/18,11.76%,SVIL;SCIN;VIL1
prerank,GO_Biological_Process_2021__response to interferon-beta (GO:0035456),0.40905752485002367,0.7540915493962094,0.7272727272727273,0.999334357639347,1.0,4/17,5.09%,IRGM;HTRA2;IFI16;PYHIN1
prerank,GO_Biological_Process_2021__regulation of nitric-oxide synthase activity (GO:0050999),0.31660059435499194,0.7540278191270768,0.8888888888888888,0.9991735743092588,1.0,6/33,11.24%,GLA;APOE;DDAH2;DHFR;NUS1;DDAH1
prerank,KEGG_2021_Human__Hepatitis C,-0.3003915375579402,-0.7539345161010128,0.9594594594594594,1.0,1.0,22/118,22.49%,CCND1;CLDN1;STAT1;CLDN6;OAS2;CLDN5;CLDN2;PIK3R3;CDKN1A;IFIT1;OAS1;PIK3CB;CLDN18;CLDN20;CD81;YWHAG;CASP8;IFIT1B;MX1;MAP2K1;CLDN10;CLDN9
prerank,GO_Biological_Process_2021__protein ADP-ribosylation (GO:0006471),-0.3791543709336709,-0.7537311130071781,0.8472222222222222,1.0,1.0,5/28,21.48%,ART1;ART3;PARP4;ART4;PARP10
prerank,GO_Biological_Process_2021__cellular response to epidermal growth factor stimulus (GO:0071364),0.33654419533582236,0.7537074076055815,0.8378378378378378,0.9993517471660671,1.0,3/26,9.01%,ERBB2;STAT5B;SNAI2
prerank,Reactome_2022__Mitotic G1 Phase And G1/S Transition R-HSA-453279,-0.2946153555071531,-0.7534634801333441,0.9512195121951219,1.0,1.0,18/130,19.11%,PSMB9;CCND1;RPA3;MCM3;CDC25A;CCND2;CDKN2D;CDKN1A;MAX;POLE2;TK1;CCNE2;CKS1B;PSMA3;RPS27A;CDC6;PSMA7;PSMB6
prerank,GO_Biological_Process_2021__dorsal aorta morphogenesis (GO:0035912),-0.5104673596892794,-0.7534442176877991,0.8,1.0,1.0,2/6,14.16%,ENG;HEY2
prerank,GO_Biological_Process_2021__dorsal aorta development (GO:0035907),-0.5104673596892794,-0.7534442176877991,0.8,1.0,1.0,2/6,14.16%,ENG;HEY2
prerank,KEGG_2021_Human__Human immunodeficiency virus 1 infection,0.27548342067879705,0.7532146570106344,0.95,0.9998292151842445,1.0,38/166,21.72%,CD247;ITPR2;BCL2;NFATC3;PAK5;CRK;MAPK8;CASP3;AKT2;PXN;FADD;NFKB1;BID;GNAO1;PIK3CA;IRAK4;MAPK12;CRKL;ATM;SAMHD1;MAP2K7;GNG7;LIMK1;ATR;TAB1;AP1B1;TAB2;MAP2K6;PAK3;PAK2;GNAQ;TRAF6;RAF1;FOS;GNAI2;PLCG2;CUL1;GNA11
prerank,GO_Biological_Process_2021__regulation of voltage-gated calcium channel activity (GO:1901385),-0.36808458155456053,-0.7531311806961944,0.8484848484848485,1.0,1.0,1/21,2.13%,STAC
prerank,GO_Biological_Process_2021__negative regulation of cholesterol transport (GO:0032375),-0.4768166552528313,-0.7530922546769944,0.7796610169491526,1.0,1.0,1/7,6.32%,PLA2G10
prerank,GO_Biological_Process_2021__response to interleukin-1 (GO:0070555),0.2907174176161887,0.7530728167488515,0.9655172413793104,0.99979839219202,1.0,12/51,20.51%,ADAMTS12;SNCA;LGALS9;TANK;NFKB1;HDAC4;GBP2;PTGIS;RC3H1;IGBP1;TRAF6;HIF1A
prerank,GO_Biological_Process_2021__positive regulation of tumor necrosis factor superfamily cytokine production (GO:1903557),-0.32121425403909165,-0.7529552776323472,0.8787878787878788,1.0,1.0,9/53,13.20%,WNT5A;OAS2;CLU;THBS1;CYBA;PTPRC;OAS1;TLR2;C1QTNF4
prerank,GO_Biological_Process_2021__response to X-ray (GO:0010165),0.39629666632891647,0.7529197992833506,0.7567567567567568,0.9997242756126776,1.0,4/13,17.89%,BRCC3;LIG4;ATM;NIPBL
prerank,GO_Biological_Process_2021__stress granule assembly (GO:0034063),0.35756040137253775,0.752594408559136,0.8461538461538461,1.0,1.0,4/20,18.00%,BICD1;PRRC2C;YTHDF1;LSM14A
prerank,CellMarker_Augmented_2021__Ito Cell (Hepatic Stellate cell):Liver,-0.4807436998861343,-0.7525833935002393,0.8431372549019608,1.0,1.0,1/5,14.70%,ACTA2
prerank,GO_Biological_Process_2021__protein targeting (GO:0006605),0.2932859076965965,0.7522592407796075,0.9615384615384616,1.0,1.0,21/114,19.34%,NLGN1;PARD3;ZDHHC11B;GDAP1;MGARP;ZDHHC18;TRAK2;ZDHHC12;MAN1A1;GOLGA7B;LTBP2;MYO1C;ZDHHC14;RASSF9;ZDHHC3;AP4S1;ZFAND6;AP4B1;ZDHHC9;EDEM1;ZDHHC11
prerank,GO_Biological_Process_2021__maintenance of gastrointestinal epithelium (GO:0030277),-0.43622236341282683,-0.7522367083139585,0.8059701492537313,1.0,1.0,4/9,21.32%,PBLD;MUC4;STRAP;SOX9
prerank,CellMarker_Augmented_2021__Clara cell:Undefined,-0.3037831098142336,-0.7520450502277698,0.918918918918919,1.0,1.0,1/94,0.47%,CD99L2
prerank,GO_Biological_Process_2021__regulation of protein acetylation (GO:1901983),-0.4352092501668161,-0.7517899815619258,0.8412698412698413,1.0,1.0,1/11,2.96%,TERF2IP
prerank,CellMarker_Augmented_2021__AXL+SIGLEC6+ Dendritic cell:Blood,-0.31616560023510387,-0.7516978787581208,0.9,1.0,1.0,10/66,13.33%,IRF4;DAB2;ADAM33;CD5;UPK3A;ATF5;ACP3;CDKN1A;RAD1;NDRG1
prerank,GO_Biological_Process_2021__cellular biogenic amine metabolic process (GO:0006576),0.4137909796004752,0.7516973645022623,0.6756756756756757,1.0,1.0,2/9,11.53%,HNMT;ODC1
prerank,GO_Biological_Process_2021__negative regulation of plasminogen activation (GO:0010757),-0.4961054583079283,-0.7516361176671719,0.8431372549019608,1.0,1.0,2/5,10.87%,THBS1;CTSZ
prerank,GO_Biological_Process_2021__regulation of telomere maintenance (GO:0032204),-0.36234610781688426,-0.7515369352376537,0.7941176470588235,1.0,1.0,3/25,13.35%,TERF2IP;PIF1;GNL3
prerank,GO_Biological_Process_2021__smooth muscle tissue development (GO:0048745),0.404798461517526,0.7515117905092341,0.7941176470588235,1.0,1.0,5/9,25.76%,PROX1;NF1;PTCH1;BMP4;SHH
prerank,CellMarker_Augmented_2021__HES1High Progenitor cell:Stomach,-0.3174901648295203,-0.7513625393386046,0.88,1.0,1.0,18/91,16.28%,LMOD1;GALNT15;ECM2;BACE2;ADAM33;DCN;ASPN;OSMR;OMD;VWF;AHNAK2;APOD;COX7A1;PALMD;C1S;ADGRF5;ADIRF;STEAP2
prerank,Reactome_2022__Formation Of HIV Elongation Complex In Absence Of HIV Tat R-HSA-167152,0.3049477403153962,0.7513401327523535,0.8387096774193549,1.0,1.0,9/42,31.71%,ELOA;CCNH;GTF2F2;ERCC3;POLR2F;SSRP1;ERCC2;CCNT1;POLR2C
prerank,GO_Biological_Process_2021__positive regulation of interleukin-1 beta production (GO:0032731),-0.3388352232810603,-0.7512730401985677,0.8787878787878788,1.0,1.0,10/32,20.84%,AIM2;WNT5A;NLRP12;USP50;NLRC4;NLRP3;F2RL1;CARD8;CASP8;AGER
prerank,GO_Biological_Process_2021__positive regulation of immunoglobulin production (GO:0002639),-0.371927524767928,-0.7512184600895973,0.8194444444444444,1.0,1.0,3/26,10.28%,CLCF1;C17ORF99;PTPRC
prerank,Reactome_2022__Signaling By FGFR1 In Disease R-HSA-5655302,-0.34177709220888397,-0.7511393655752758,0.8783783783783784,1.0,1.0,2/33,6.09%,FGF20;STAT1
prerank,GO_Biological_Process_2021__nucleoside metabolic process (GO:0009116),0.421874294297026,0.7511045759945866,0.8372093023255814,1.0,1.0,4/10,17.33%,NT5C1A;UPP2;NT5C3A;MACROD2
prerank,CellMarker_Augmented_2021__Dental Pulp cell:Dental Pulp,-0.32131405511436134,-0.7507453635997081,0.9078947368421053,1.0,1.0,16/89,14.21%,TIMP3;ANGPTL2;PDCD1LG2;LPAR1;TGFBI;COL1A1;LOX;RGS4;HEG1;OSMR;ITGBL1;THBS1;AOX1;ENG;PLAT;C1S
prerank,CellMarker_Augmented_2021__Mesenchymal Stromal cell:Amniotic Membrane,-0.32131405511436134,-0.7507453635997081,0.9078947368421053,1.0,1.0,16/89,14.21%,TIMP3;ANGPTL2;PDCD1LG2;LPAR1;TGFBI;COL1A1;LOX;RGS4;HEG1;OSMR;ITGBL1;THBS1;AOX1;ENG;PLAT;C1S
prerank,GO_Biological_Process_2021__negative regulation of extrinsic apoptotic signaling pathway via death domain receptors (GO:1902042),0.3388665751567837,0.7507341083014845,0.8888888888888888,1.0,1.0,5/25,17.75%,CFLAR;SERPINE1;FADD;GPX1;FAIM
prerank,GO_Biological_Process_2021__epithelial tube formation (GO:0072175),0.4886932728300599,0.7506906295306722,0.8222222222222222,1.0,1.0,1/5,9.82%,CEP290
prerank,GO_Biological_Process_2021__regulation of endothelial cell chemotaxis to fibroblast growth factor (GO:2000544),0.4357008425418506,0.7506726990269355,0.8695652173913043,1.0,1.0,2/5,8.49%,FGFR1;FGF18
prerank,GO_Biological_Process_2021__actin crosslink formation (GO:0051764),0.4237366949833302,0.7505178700667221,0.8297872340425532,1.0,1.0,4/11,13.00%,FLNA;GAS2L3;GAS2;EPS8
prerank,Reactome_2022__G2/M Checkpoints R-HSA-69481,-0.2986348062938131,-0.7503063753804257,0.922077922077922,1.0,1.0,34/123,28.04%,PSMB9;RPA3;MCM3;ABRAXAS1;CDC25A;H2BC4;BRCA1;PSMA3;RRAD;RPS27A;PKMYT1;CDC6;PSMA7;PSMB6;YWHAG;RMI1;ORC6;TOPBP1;PSMA5;BLM;RAD9B;PSMD6;CDC7;CHEK1;RNF8;PSMC5;RMI2;MCM5;PSMB4;PSMB7;PSMD8;MCM10;MCM6;KAT5
prerank,GO_Biological_Process_2021__positive regulation of cysteine-type endopeptidase activity (GO:2001056),-0.33297495267399524,-0.750275798166356,0.8787878787878788,1.0,1.0,8/50,10.45%,NODAL;AIM2;CIDEB;GPER1;UACA;USP50;REST;NLRC4
prerank,Reactome_2022__Gap Junction Trafficking And Regulation R-HSA-157858,0.36867150153179,0.7494730025353881,0.875,1.0,1.0,1/18,1.92%,GJB6
prerank,GO_Biological_Process_2021__regulation of natural killer cell activation (GO:0032814),0.3926427242681055,0.7494579092925399,0.6923076923076923,1.0,1.0,3/9,15.56%,TICAM1;PIBF1;IL23A
prerank,GO_Biological_Process_2021__cellular response to UV (GO:0034644),0.3118821974492152,0.749407086860317,0.8571428571428571,1.0,1.0,15/65,18.84%,SIRT1;MMP2;OPN5;TIMP1;ZBTB1;MYC;RHBDD1;N4BP1;TP53;NEDD4;OPN3;NOC2L;ATR;IMPACT;EP300
prerank,GO_Biological_Process_2021__COPII vesicle coating (GO:0048208),-0.320039235012466,-0.7493684560140884,0.8961038961038961,1.0,1.0,1/58,0.35%,F8
prerank,"GO_Biological_Process_2021__vesicle targeting, rough ER to cis-Golgi (GO:0048207)",-0.320039235012466,-0.7493684560140884,0.8961038961038961,1.0,1.0,1/58,0.35%,F8
prerank,GO_Biological_Process_2021__vesicle coating (GO:0006901),-0.320039235012466,-0.7493684560140884,0.8961038961038961,1.0,1.0,1/58,0.35%,F8
prerank,GO_Biological_Process_2021__regulation of hydrolase activity (GO:0051336),-0.3340890178933057,-0.7491635619490362,0.8918918918918919,1.0,1.0,10/66,18.53%,ARHGAP9;VAV3;ARHGAP15;PPP1R17;ARHGAP12;ATP5IF1;PROM2;EPHA1;CAMK2A;PLXNA3
prerank,CellMarker_Augmented_2021__Bipolar cell:Eye,0.28297232013630014,0.7491260476090209,1.0,1.0,1.0,26/94,20.63%,DPY19L1;NEGR1;PCDH9;ZEB1;BEND6;CSDC2;DOK6;NAV3;MACF1;FRMPD4;ARHGAP21;RGS7;CCDC88A;CDH2;NECTIN3;SNPH;SACS;SLC7A14;CLIP3;ZHX3;SATB2;KIRREL3;NALCN;ANKH;DCLK2;PDE7B
prerank,GO_Biological_Process_2021__translocation of molecules into host (GO:0044417),0.42843578380768166,0.7487246698558058,0.8571428571428571,1.0,1.0,2/7,33.91%,THOC1;ALYREF
prerank,GO_Biological_Process_2021__viral mRNA export from host cell nucleus (GO:0046784),0.42843578380768166,0.7487246698558058,0.8571428571428571,1.0,1.0,2/7,33.91%,THOC1;ALYREF
prerank,KEGG_2021_Human__Amoebiasis,-0.3254466637581888,-0.7486690641966558,0.8947368421052632,1.0,1.0,22/69,20.93%,TGFB1;ITGB2;COL1A1;PIK3R3;COL4A4;COL4A3;LAMC2;ARG2;ITGAM;TLR2;PIK3CB;NOS2;IL12A;TGFB3;COL4A6;GNAL;COL4A5;FN1;GNA15;PRDX1;LAMB2;LAMC3
prerank,GO_Biological_Process_2021__response to light stimulus (GO:0009416),-0.33064205593023394,-0.7485464995624365,0.9014084507042254,1.0,1.0,8/50,16.30%,DTL;PCLAF;UVSSA;GPR88;SLC24A1;CDKN2D;ELANE;RRH
prerank,KEGG_2021_Human__Intestinal immune network for IgA production,-0.3684966184262013,-0.7485179960414484,0.8636363636363636,1.0,1.0,6/26,14.67%,TGFB1;HLA-DMA;HLA-DPB1;HLA-DRB1;HLA-DPA1;CD80
prerank,GO_Biological_Process_2021__positive regulation of cellular senescence (GO:2000774),0.3784602841409794,0.748484084531948,0.775,1.0,1.0,2/9,10.79%,SIRT1;ABI3
prerank,GO_Biological_Process_2021__regulation of cellular response to stress (GO:0080135),0.26619707618104826,0.7484203849822119,1.0,1.0,1.0,21/112,18.84%,MAPKAPK2;NUP210;NUP42;SIRT1;ATF3;VASH1;ABL1;MLST8;DYRK3;AAAS;HSPA1A;PNPT1;AIFM2;HSF1;USP51;CORO2B;SMG1;ATM;RANBP2;ATR;EP300
prerank,GO_Biological_Process_2021__cholesterol biosynthetic process (GO:0006695),-0.36823989526034995,-0.7480848665375559,0.8088235294117647,1.0,1.0,2/29,11.86%,PLPP6;ACAA2
prerank,Reactome_2022__Translesion Synthesis By POLH R-HSA-110320,-0.39832355427295574,-0.7479165283786657,0.7887323943661971,1.0,1.0,1/19,4.30%,RPA3
prerank,GO_Biological_Process_2021__regulation of chaperone-mediated protein folding (GO:1903644),-0.4819891439031054,-0.7478574123901254,0.7894736842105263,1.0,1.0,2/5,22.91%,SGTB;PDCD5
prerank,Reactome_2022__Assembly Of Pre-Replicative Complex R-HSA-68867,-0.3016774086040371,-0.7477776831418795,0.9135802469135802,1.0,1.0,9/82,19.11%,PSMB9;MCM3;H2BC4;H2AZ1;PSMA3;RPS27A;CDC6;PSMA7;PSMB6
prerank,GO_Biological_Process_2021__chromatin disassembly (GO:0031498),0.3652900565335323,0.7477404761010051,0.8571428571428571,1.0,1.0,5/14,13.07%,SMARCD3;SMARCB1;ARID1A;SMARCA4;ARID2
prerank,GO_Biological_Process_2021__nucleosome disassembly (GO:0006337),0.3652900565335323,0.7477404761010051,0.8571428571428571,1.0,1.0,5/14,13.07%,SMARCD3;SMARCB1;ARID1A;SMARCA4;ARID2
prerank,CellMarker_Augmented_2021__Oligodendrocyte Progenitor cell:Brain,-0.3182298473112798,-0.7476844286581595,0.8648648648648649,1.0,1.0,8/97,6.70%,LMOD1;TIMP3;ANGPTL2;LPAR1;NID1;SDC2;FBXL7;DAAM2
prerank,Reactome_2022__CREB1 Phosphorylation Thru NMDA Receptor-Mediated Activation Of RAS Signaling R-HSA-442742,0.35239288957529197,0.7474915107501552,0.8260869565217391,1.0,1.0,6/27,14.79%,LLGL1;GPRIN1;RPS6KA3;MPP2;RPS6KA2;RPS6KA6
prerank,Reactome_2022__Nucleotide Salvage R-HSA-8956321,0.32500060958272914,0.7474647663226791,0.8125,1.0,1.0,6/21,18.59%,AMPD1;UPP2;UCK2;HPRT1;APRT;PUDP
prerank,GO_Biological_Process_2021__cellular response to UV-A (GO:0071492),0.43435825048637944,0.74738743161769,0.7346938775510204,1.0,1.0,3/8,6.75%,MMP2;OPN5;TIMP1
prerank,GO_Biological_Process_2021__heme biosynthetic process (GO:0006783),-0.38437846636908257,-0.7473225923935741,0.8208955223880597,1.0,1.0,6/19,21.90%,ABCG2;ALAS2;ATP5IF1;UROS;PGRMC1;ALB
prerank,GO_Biological_Process_2021__mitochondrial transport (GO:0006839),0.331890056045254,0.7472375907371961,0.9032258064516129,1.0,1.0,5/52,7.64%,BCL2;GDAP1;FLVCR1;SLC25A24;MGARP
prerank,GO_Biological_Process_2021__histone ubiquitination (GO:0016574),-0.393513657645818,-0.7471953262837668,0.8307692307692308,1.0,1.0,3/20,16.68%,ATXN7L3;UBE2U;RNF20
prerank,GO_Biological_Process_2021__negative regulation of cyclin-dependent protein serine/threonine kinase activity (GO:0045736),0.36827720568297956,0.7470695057328186,0.8461538461538461,1.0,1.0,8/19,24.20%,HEXIM2;LATS1;NR2F2;MEN1;PTEN;TFAP4;PLK1;IPO7
prerank,GO_Biological_Process_2021__negative regulation of histone H4 acetylation (GO:0090241),-0.5051651468570136,-0.746788906171706,0.7868852459016393,1.0,1.0,2/5,10.89%,TAF7;SPI1
prerank,GO_Biological_Process_2021__sodium ion homeostasis (GO:0055078),0.3536932396214123,0.7466812287592751,0.9117647058823529,1.0,1.0,2/19,3.99%,SLC12A1;SLC8A1
prerank,GO_Biological_Process_2021__aspartate transmembrane transport (GO:0015810),-0.4966381177443569,-0.7466455506606454,0.7547169811320755,1.0,1.0,2/6,17.64%,SLC25A18;SLC25A22
prerank,GO_Biological_Process_2021__regulation of smoothened signaling pathway (GO:0008589),-0.3226659600611411,-0.746491983202482,0.8641975308641975,1.0,1.0,3/46,8.55%,RAB34;HHIP;GPC3
prerank,Reactome_2022__Pexophagy R-HSA-9664873,-0.4133434847482334,-0.7464915675558094,0.8214285714285714,1.0,1.0,6/11,33.34%,RPS27A;EPAS1;UBB;MAP1LC3B;UBC;PEX5
prerank,GO_Biological_Process_2021__extrinsic apoptotic signaling pathway (GO:0097191),0.28030927742315237,0.7463548749305122,0.9230769230769231,1.0,1.0,10/63,14.12%,NGF;BCL2;BCL2A1;DCC;CASP3;FGFR3;FADD;CRADD;CASP8AP2;BID
prerank,GO_Biological_Process_2021__ribosome disassembly (GO:0032790),0.4027840888851164,0.7463176064812292,0.7777777777777778,1.0,1.0,1/7,12.15%,MRRF
prerank,Reactome_2022__Serine Biosynthesis R-HSA-977347,-0.4550796615464348,-0.7461885889898797,0.8148148148148148,1.0,1.0,1/8,1.08%,SERINC2
prerank,GO_Biological_Process_2021__negative regulation of viral release from host cell (GO:1902187),-0.4050627990322852,-0.7461496351155316,0.7377049180327869,1.0,1.0,2/11,7.97%,TRIM5;CHMP3
prerank,Reactome_2022__Regulation Of RUNX2 Expression And Activity R-HSA-8939902,-0.3118147574530402,-0.7461433041403841,0.9054054054054054,1.0,1.0,3/62,6.09%,PSMB9;ESR1;STAT1
prerank,"Reactome_2022__Regulation Of Glycolysis By Fructose 2,6-Bisphosphate Metabolism R-HSA-9634600",0.44870544945720675,0.746045278279602,0.7857142857142857,1.0,1.0,5/10,25.03%,PPP2R1B;PPP2R5D;PFKFB4;PFKFB3;PRKACB
prerank,Reactome_2022__Signaling By PDGFR In Disease R-HSA-9671555,-0.3809466770268829,-0.7460428079827286,0.835820895522388,1.0,1.0,3/17,13.53%,STAT1;FIP1L1;PIK3CB
prerank,CellMarker_Augmented_2021__Lake Et al.Science.Ex1:Brain,0.4015509743264107,0.7458236663737552,0.875,1.0,1.0,2/14,5.40%,JAG1;PDGFD
prerank,Reactome_2022__ECM Proteoglycans R-HSA-3000178,-0.3395117204760074,-0.7454019826507261,0.8701298701298701,1.0,1.0,10/47,12.14%,TGFB1;VTN;DCN;ASPN;ITGA9;TNXB;MATN4;ITGA2B;LRP4;ITGB6
prerank,CellMarker_Augmented_2021__Stromal cell:Amniotic Membrane,0.28208020753222385,0.7453856093184569,0.8636363636363636,1.0,1.0,16/89,12.45%,TSHZ3;ITGA4;MMP2;IFI16;ZEB2;LGALS1;TIMP1;OLFML2B;SH3RF3;ZEB1;ADAMTS10;ANTXR2;CHST11;MSC;PPP1R18;MDFIC
prerank,GO_Biological_Process_2021__porphyrin-containing compound biosynthetic process (GO:0006779),-0.3754052087133787,-0.7453668986137187,0.828125,1.0,1.0,6/21,21.90%,ABCG2;ALAS2;ATP5IF1;UROS;PGRMC1;ALB
prerank,GO_Biological_Process_2021__foam cell differentiation (GO:0090077),-0.5085434842772447,-0.7453395221244711,0.8545454545454545,1.0,1.0,2/6,6.09%,TGFB1;STAT1
prerank,GO_Biological_Process_2021__macrophage derived foam cell differentiation (GO:0010742),-0.5085434842772447,-0.7453395221244711,0.8545454545454545,1.0,1.0,2/6,6.09%,TGFB1;STAT1
prerank,GO_Biological_Process_2021__primary alcohol metabolic process (GO:0034308),0.3544994931866355,0.7452557905424104,0.8421052631578947,1.0,1.0,1/24,0.59%,CYP1A2
prerank,GO_Biological_Process_2021__mitochondrial calcium ion transmembrane transport (GO:0006851),0.3454994844173314,0.7452418052670378,0.8484848484848485,1.0,1.0,3/19,10.27%,SLC8A3;MICU1;MCU
prerank,Reactome_2022__CTNNB1 S33 Mutants Not Phosphorylated R-HSA-5358747,0.35078760379258406,0.745241630855465,0.8333333333333334,1.0,1.0,7/14,36.83%,PPP2R1B;PPP2R5D;AXIN1;PPP2R5B;PPP2R5E;PPP2R5C;GSK3B
prerank,Reactome_2022__Regulation Of BACH1 Activity R-HSA-9708530,-0.42323972039067526,-0.7451982215225134,0.8103448275862069,1.0,1.0,6/11,31.83%,RBX1;RPS27A;MAFK;SKP1;UBB;UBC
prerank,GO_Biological_Process_2021__skeletal muscle organ development (GO:0060538),-0.3634821366759047,-0.7451653371607596,0.8133333333333334,1.0,1.0,6/19,21.27%,CSRP3;POPDC2;SVIL;MYL6;BASP1;SIX4
prerank,GO_Biological_Process_2021__regulation of secretion (GO:0051046),0.3942759198764293,0.7450627323770292,0.7560975609756098,1.0,1.0,3/13,7.31%,FGF10;NRG1;SGK1
prerank,PanglaoDB_Augmented_2021__Melanocytes,-0.3066917640553055,-0.7448402825744249,0.9305555555555556,1.0,1.0,10/121,6.32%,AHR;TIMP3;FLG;ANGPTL2;CCND1;SYNC;FILIP1L;COL1A1;LOX;UACA
prerank,GO_Biological_Process_2021__import into cell (GO:0098657),0.30385088257015624,0.7447259134732956,0.8823529411764706,1.0,1.0,7/34,19.41%,SLC19A1;SLC6A20;SLC7A8;IL10RA;LRSAM1;SLC16A2;SLC1A3
prerank,GO_Biological_Process_2021__regulation of RNA polymerase II transcription preinitiation complex assembly (GO:0045898),-0.39086403723196017,-0.7446645416466219,0.7741935483870968,1.0,1.0,2/10,16.77%,ESR1;THRA
prerank,GO_Biological_Process_2021__nuclear RNA surveillance (GO:0071027),0.4115726586480835,0.7446338204575297,0.7333333333333333,1.0,1.0,4/9,26.76%,DXO;EXOSC5;EXOSC9;XRN1
prerank,GO_Biological_Process_2021__positive regulation of protein maturation (GO:1903319),-0.42645474570252606,-0.744622651545143,0.765625,1.0,1.0,2/10,10.45%,TNP1;NLRC4
prerank,GO_Biological_Process_2021__phosphatidic acid biosynthetic process (GO:0006654),0.31932905158065666,0.7444650989101325,0.8666666666666667,1.0,1.0,12/41,20.45%,DGKD;PLD6;PNPLA3;GPD1;AGPAT5;DGKH;AGPAT2;LCLAT1;ABHD4;PLA2G5;DGKZ;PLD2
prerank,GO_Biological_Process_2021__negative regulation of cell-cell adhesion (GO:0022408),-0.34195081412958417,-0.7444397523804319,0.8571428571428571,1.0,1.0,2/35,9.60%,TGFB1;PLG
prerank,GO_Biological_Process_2021__positive regulation of type 2 immune response (GO:0002830),-0.45566636564325785,-0.7442797951408227,0.8846153846153846,1.0,1.0,6/11,28.50%,NLRP3;IL18;CD81;CD86;TNFSF4;RARA
prerank,GO_Biological_Process_2021__negative regulation of monooxygenase activity (GO:0032769),0.45502952266360264,0.7442491809854992,0.8974358974358975,1.0,1.0,2/6,5.38%,GLA;SNCA
prerank,GO_Biological_Process_2021__cation transport (GO:0006812),-0.2936003064574981,-0.7442425796468628,0.9753086419753086,1.0,1.0,11/152,7.85%,PANX3;KCNJ15;SCN5A;KCNA5;PIEZO2;TAF7;SLC5A2;SLC5A1;KCNS2;ATP1A4;SLC5A9
prerank,GO_Biological_Process_2021__N-acylethanolamine metabolic process (GO:0070291),0.49734016308868423,0.7442383699277803,0.8695652173913043,1.0,1.0,1/5,24.65%,NAPEPLD
prerank,GO_Biological_Process_2021__ethanolamine-containing compound metabolic process (GO:0042439),0.49734016308868423,0.7442383699277803,0.8695652173913043,1.0,1.0,1/5,24.65%,NAPEPLD
prerank,GO_Biological_Process_2021__ribosomal small subunit export from nucleus (GO:0000056),0.43299194254252404,0.744206328512167,0.7272727272727273,1.0,1.0,2/7,20.98%,NOP9;XPO1
prerank,CellMarker_Augmented_2021__Neutrophil:Kidney,-0.33801914313977355,-0.7441792319217078,0.796875,1.0,1.0,6/45,10.36%,KCNJ15;MMP9;SOD2;DRC1;IGSF6;FPR1
prerank,Reactome_2022__Disorders Of Transmembrane Transporters R-HSA-5619115,-0.2859378621804035,-0.7441730059922369,0.922077922077922,1.0,1.0,15/146,13.31%,PSMB9;ABCC6;SLC7A7;SLC5A2;TAC4;SLC5A1;SLCO2A1;KCNJ11;SLC24A1;SLC3A1;SLC24A5;CP;SLC17A8;ERLEC1;NLRP3
prerank,Reactome_2022__RNA Polymerase II Pre-transcription Events R-HSA-674695,-0.311924974378053,-0.7441529962815691,0.8701298701298701,1.0,1.0,15/75,25.58%,GTF2E1;TAF7;TAF7L;TAF9B;TAF10;TAF6;RTF1;TAF13;TBP;POLR2B;ELOB;TAF5;PAF1;CDK7;CDK9
prerank,CellMarker_Augmented_2021__Primitive Streak cell:Primitive Streak,-0.3438393290229522,-0.7440876953051286,0.8615384615384616,1.0,1.0,16/71,21.23%,SALL4;SPC25;SLC7A3;CLDN6;FBN3;PHF21B;DRAXIN;PIF1;WNT8A;FOXB1;CCNF;ARHGEF39;HMGA2;STMN1;ORC6;CHRNA5
prerank,CellMarker_Augmented_2021__Cancer Stem cell:Venous Blood,-0.29194083319665853,-0.7439881533374665,0.9594594594594594,1.0,1.0,14/84,17.53%,VSIG2;ZDHHC19;KCNQ1;DHRS13;SPINT1;NSUN7;FOXA3;ORMDL3;NOS2;ITM2C;TJP3;ROGDI;CD24;PLEKHB1
prerank,GO_Biological_Process_2021__regulation of defense response to virus (GO:0050688),-0.3997505286261718,-0.7438426514561329,0.7931034482758621,1.0,1.0,2/14,15.79%,USP17L2;RNF26
prerank,Reactome_2022__DCC Mediated Attractive Signaling R-HSA-418885,0.38074020640159856,0.7437663940198895,0.7674418604651163,1.0,1.0,3/14,18.57%,DCC;NCK1;DOCK1
prerank,Reactome_2022__Tyrosine Catabolism R-HSA-8963684,0.4829357423444457,0.7436587490753461,0.8333333333333334,1.0,1.0,1/5,14.77%,GSTZ1
prerank,GO_Biological_Process_2021__regulation of protein tyrosine kinase activity (GO:0061097),0.32501627289510704,0.7435132934791439,0.9487179487179487,1.0,1.0,10/35,25.20%,NOX4;CASS4;LRP8;SRCIN1;GRM5;ACE;NCK2;ERBB3;GAS6;DLG3
prerank,Reactome_2022__CDC42 GTPase Cycle R-HSA-9013148,-0.29539907229469753,-0.7434701544491419,0.9647058823529412,1.0,1.0,12/137,12.47%,RASGRF2;DOCK6;DOCK8;ARHGAP9;TAGAP;PLEKHG3;VAV3;WAS;SNAP23;ARAP3;DEF6;ARHGDIG
prerank,GO_Biological_Process_2021__antimicrobial humoral immune response mediated by antimicrobial peptide (GO:0061844),0.38164966387881516,0.7433704169565074,0.8484848484848485,1.0,1.0,5/15,14.45%,GALP;H2BC21;F2;CXCL14;MUC7
prerank,GO_Biological_Process_2021__regulation of receptor signaling pathway via JAK-STAT (GO:0046425),0.3518194993792273,0.7432428161539462,0.7894736842105263,1.0,1.0,7/31,13.52%,KIT;HES1;F2;OCIAD2;ADIPOR1;F2R;IL10RA
prerank,Reactome_2022__Rab Regulation Of Trafficking R-HSA-9007101,-0.30078899568628314,-0.7432350479281027,0.9605263157894737,1.0,1.0,4/113,5.16%,DENND1C;RIN3;TBC1D10C;RAB11A
prerank,CellMarker_Augmented_2021__Natural Killer cell:Peripheral Blood,-0.43805777323241646,-0.7430540594304608,0.828125,1.0,1.0,4/10,10.28%,KLRB1;CD160;FCGR3A;PTPRC
prerank,KEGG_2021_Human__PD-L1 expression and PD-1 checkpoint pathway in cancer,0.2786790777925495,0.7429150484197323,0.8421052631578947,1.0,1.0,14/73,20.53%,CD247;NFATC3;TICAM2;AKT2;BATF2;TICAM1;NFKB1;PIK3CA;MAPK12;MAP2K6;TRAF6;RAF1;HIF1A;FOS
prerank,"GO_Biological_Process_2021__positive regulation of gene expression, epigenetic (GO:0045815)",0.2857541929294891,0.7426921573167545,0.88,1.0,1.0,14/53,19.29%,ELOF1;CDCA4;TAF1B;H1-10;ARID1A;SF3B1;POLR1H;MYO1C;SERTAD2;BAZ1B;ATAD2B;ARID1B;EP300;KAT2B
prerank,GO_Biological_Process_2021__miRNA mediated inhibition of translation (GO:0035278),0.36725098180118754,0.7426866934574916,0.7692307692307693,1.0,1.0,5/11,20.09%,TRIM71;TNRC6C;TNRC6A;AGO3;AGO2
prerank,"GO_Biological_Process_2021__negative regulation of translation, ncRNA-mediated (GO:0040033)",0.36725098180118754,0.7426866934574916,0.7692307692307693,1.0,1.0,5/11,20.09%,TRIM71;TNRC6C;TNRC6A;AGO3;AGO2
prerank,Reactome_2022__Transcriptional Regulation By TP53 R-HSA-3700989,0.23469801206948473,0.742533975087496,1.0,1.0,1.0,71/323,22.49%,SMYD2;CCNG1;BCL6;PERP;GATAD2A;TP53AIP1;PPP1R13B;REXO2;TACO1;SGK1;PML;RBL1;TAF3;CNOT9;MLST8;TAF12;MOV10;AKT2;PLAGL1;ELOA;PPP2R1B;BANP;TNRC6C;CCNH;KAT6A;COX19;HDAC1;GATAD2B;CRADD;CHD4;CARM1;PLK3;BID;GTF2F2;AIFM2;CNOT4;GADD45A;TP53;TNRC6A;EXO1;PIP4K2A;ATM;RAD17;AGO3;TAF4;PRMT5;NOC2L;ERCC3;RAD9A;MDC1;SESN2;GSR;EP300;PCBP4;CDK5;PRKAA2;MAP2K6;PRKAG2;AGO2;DNA2;FOS;CNOT6;BNIP3L;RBBP4;MDM4;RRM2B;TFDP1;PTEN;POLR2F;ATRIP;TTC5
prerank,GO_Biological_Process_2021__drug catabolic process (GO:0042737),0.40351494088357803,0.7424956465210497,0.7777777777777778,1.0,1.0,3/13,6.53%,CYP1A2;CYP2U1;CYP2S1
prerank,GO_Biological_Process_2021__inner mitochondrial membrane organization (GO:0007007),-0.3329550813375825,-0.7423856543458269,0.8405797101449275,1.0,1.0,7/44,22.78%,ATP5F1E;ATP5MC3;ATP5PF;ATP5ME;ROMO1;ATP5PB;ATP5F1A
prerank,GO_Biological_Process_2021__regulation of protein localization to plasma membrane (GO:1903076),-0.32543609875728513,-0.7422832416339886,0.926829268292683,1.0,1.0,8/72,12.91%,TGFB1;STAC;GPER1;DAB2;RHOQ;GBP1;MRAP;PRKCH
prerank,GO_Biological_Process_2021__regulation of programmed cell death (GO:0043067),0.2695445489818858,0.742270634693683,1.0,1.0,1.0,28/151,16.10%,FANK1;BCL6;HIP1;PERP;DAPK2;SIRT1;DCPS;TP53AIP1;LGALS1;PPP1R13B;ACER2;SGK1;ABL1;ANP32A;ANP32B;ACER3;USP36;CRADD;LRP8;FLT3;BID;AIFM2;MARK4;MAGED1;TP53;SLK;MALT1;AMIGO2
prerank,GO_Biological_Process_2021__positive regulation of natural killer cell mediated immunity (GO:0002717),0.37599739994199144,0.7422034089035975,0.8285714285714286,1.0,1.0,2/15,5.92%,KLRD1;CADM1
prerank,GO_Biological_Process_2021__negative regulation of stress-activated protein kinase signaling cascade (GO:0070303),0.4292849877990079,0.7420755679476079,0.7857142857142857,1.0,1.0,2/7,8.03%,FOXO1;MYC
prerank,"GO_Biological_Process_2021__fatty acid elongation, saturated fatty acid (GO:0019367)",-0.46619873971351256,-0.7419921214197676,0.8135593220338984,1.0,1.0,1/6,1.18%,ELOVL2
prerank,"GO_Biological_Process_2021__fatty acid elongation, monounsaturated fatty acid (GO:0034625)",-0.46619873971351256,-0.7419921214197676,0.8135593220338984,1.0,1.0,1/6,1.18%,ELOVL2
prerank,"GO_Biological_Process_2021__fatty acid elongation, polyunsaturated fatty acid (GO:0034626)",-0.46619873971351256,-0.7419921214197676,0.8135593220338984,1.0,1.0,1/6,1.18%,ELOVL2
prerank,"GO_Biological_Process_2021__fatty acid elongation, unsaturated fatty acid (GO:0019368)",-0.46619873971351256,-0.7419921214197676,0.8135593220338984,1.0,1.0,1/6,1.18%,ELOVL2
prerank,GO_Biological_Process_2021__mRNA 3'-end processing (GO:0031124),0.28395840257747107,0.741980958524611,0.9259259259259259,1.0,1.0,12/71,20.63%,CPSF1;PCF11;U2AF1;SRRM1;CPSF7;SRSF4;PAPOLA;RPRD2;EIF4A3;U2AF2;SYMPK;CPSF6
prerank,GO_Biological_Process_2021__response to zinc ion (GO:0010043),-0.35783019640148234,-0.7414491258695921,0.7936507936507936,1.0,1.0,4/22,12.80%,ZACN;GLRA2;HVCN1;HAAO
prerank,GO_Biological_Process_2021__protein-containing complex assembly (GO:0065003),0.24192607460535998,0.7414046203432044,1.0,1.0,1.0,37/243,16.20%,TEAD2;LLGL1;CD247;MATN1;MITF;PARD3;TLE2;STX5;HES1;SLC7A9;TRAPPC1;SEC24C;PML;PDZD11;MYC;CNIH3;TGFA;FARP2;WASF3;MCU;BET1;COL16A1;GEMIN5;SMARCA4;BCL9L;FADD;HDAC1;PREB;SNX9;MAGI1;MEN1;HSF1;TP53;SEC22B;IL2RB;PARD6B;CTSC
prerank,Reactome_2022__Nonhomologous End-Joining (NHEJ) R-HSA-5693571,0.31195342268395715,0.7413518986282784,0.9696969696969697,1.0,1.0,9/39,18.33%,BRCC3;RNF168;H2BC21;POLM;H2AX;HERC2;LIG4;ATM;MDC1
prerank,GO_Biological_Process_2021__negative regulation of T cell apoptotic process (GO:0070233),0.46317103148870975,0.7413383336054551,0.7659574468085106,1.0,1.0,2/5,21.65%,FADD;BMP4
prerank,GO_Biological_Process_2021__negative regulation of phosphorylation (GO:0042326),-0.3095992095166926,-0.7412667101543321,0.8271604938271605,1.0,1.0,8/82,13.40%,TGFB1;TERF2IP;ACTN3;CDKN2D;WARS1;CDKN1A;DYNLL1;ATG14
prerank,"GO_Biological_Process_2021__alternative mRNA splicing, via spliceosome (GO:0000380)",0.3953523154964066,0.7410873886703327,0.8444444444444444,1.0,1.0,2/14,9.29%,PUF60;CELF4
prerank,Reactome_2022__Regulated Proteolysis Of p75NTR R-HSA-193692,0.4225833360498625,0.7410402357076298,0.8292682926829268,1.0,1.0,4/8,32.10%,NFKB1;TRAF6;RELA;NCSTN
prerank,GO_Biological_Process_2021__response to UV (GO:0009411),-0.30570468209718094,-0.7410274590446104,0.8974358974358975,1.0,1.0,5/85,6.08%,DTL;CCND1;PCLAF;CDC25A;UVSSA
prerank,GO_Biological_Process_2021__macroautophagy (GO:0016236),0.26559714711012045,0.7409894459357893,1.0,1.0,1.0,23/108,23.08%,TCIRG1;HDAC10;MTERF3;VPS16;TMEM74;PLEKHM1;MVB12A;CHMP6;KLHL3;VTA1;MTMR3;SNF8;PIP4K2A;MTMR14;STAM2;VAMP8;PRKAA2;PRKAG2;TBC1D5;PIK3R4;TSG101;LIX1L;ATG12
prerank,GO_Biological_Process_2021__negative regulation of calcineurin-NFAT signaling cascade (GO:0070885),-0.43729738912907135,-0.7408147402437595,0.875,1.0,1.0,1/9,8.67%,ACTN3
prerank,GO_Biological_Process_2021__negative regulation of calcineurin-mediated signaling (GO:0106057),-0.43729738912907135,-0.7408147402437595,0.875,1.0,1.0,1/9,8.67%,ACTN3
prerank,GO_Biological_Process_2021__positive regulation of neuron projection arborization (GO:0150012),-0.45902401097449136,-0.7407330804522658,0.8983050847457628,1.0,1.0,1/8,2.54%,WNT5A
prerank,GO_Biological_Process_2021__dendritic cell chemotaxis (GO:0002407),0.4446792771852154,0.7405939724462933,0.7592592592592593,1.0,1.0,2/6,6.42%,TRPM2;HMGB1
prerank,GO_Biological_Process_2021__protein localization to vacuole (GO:0072665),0.3927983776187094,0.7405149363612508,0.8611111111111112,1.0,1.0,2/14,10.59%,KPTN;RNF128
prerank,Reactome_2022__Gap Junction Trafficking R-HSA-190828,0.3740071240918879,0.7404719956461318,0.8787878787878788,1.0,1.0,1/16,1.92%,GJB6
prerank,GO_Biological_Process_2021__regulation of RNA polymerase II regulatory region sequence-specific DNA binding (GO:1903025),0.39582445982079695,0.7404408956465554,0.775,1.0,1.0,2/8,18.84%,NSD1;EP300
prerank,Reactome_2022__Apoptotic Execution Phase R-HSA-75153,0.3006015555343394,0.7403674135799333,0.9696969696969697,1.0,1.0,14/47,21.55%,LMNB1;HMGB1;CASP3;PKN2;PLEC;GAS2;FNTA;CLSPN;ACIN1;ADD1;TJP2;FZR1;DFFA;OCLN
prerank,GO_Biological_Process_2021__positive regulation of protein localization to nucleus (GO:1900182),0.2845325570697165,0.7401490941121884,0.975609756097561,1.0,1.0,6/58,9.14%,HDAC3;PYHIN1;F2;EIF2AK3;FLNA;HCLS1
prerank,GO_Biological_Process_2021__regulation of miRNA mediated inhibition of translation (GO:1905616),0.43067101591204576,0.7400626588816639,0.717948717948718,0.9996965144528365,1.0,3/7,28.89%,AGO2;STAT3;TNRC6B
prerank,GO_Biological_Process_2021__positive regulation of miRNA mediated inhibition of translation (GO:1905618),0.43067101591204576,0.7400626588816639,0.717948717948718,0.9996965144528365,1.0,3/7,28.89%,AGO2;STAT3;TNRC6B
prerank,GO_Biological_Process_2021__keratan sulfate catabolic process (GO:0042340),-0.4584553730487215,-0.7398990590477159,0.8059701492537313,1.0,1.0,2/8,10.43%,OGN;OMD
prerank,GO_Biological_Process_2021__skeletal myofibril assembly (GO:0014866),-0.4437922554361252,-0.7398718018131263,0.8,1.0,1.0,3/8,14.24%,ACTC1;LMOD3;TTN
prerank,GO_Biological_Process_2021__purine ribonucleoside metabolic process (GO:0046128),-0.49262085728870814,-0.7396933816685495,0.875,1.0,1.0,3/5,16.50%,ENPP4;ACP3;GNMT
prerank,GO_Biological_Process_2021__chondrocyte differentiation (GO:0002062),0.3253947857850023,0.7396158552393558,0.9444444444444444,1.0,1.0,11/29,21.65%,CREB3L2;OSR1;EIF2AK3;FGFR3;NFIB;SOX5;RUNX1;GPLD1;SULF2;BMPR2;BMP4
prerank,GO_Biological_Process_2021__serine family amino acid catabolic process (GO:0009071),-0.45193880589110214,-0.7396060038035549,0.8666666666666667,1.0,1.0,3/8,14.01%,DAO;GLDC;SDS
prerank,GO_Biological_Process_2021__cortical actin cytoskeleton organization (GO:0030866),-0.38201664625157605,-0.739507344256474,0.7666666666666667,1.0,1.0,4/18,15.68%,FHOD1;RHOQ;LCP1;FMNL1
prerank,Reactome_2022__Chaperone Mediated Autophagy R-HSA-9613829,0.34231723528157343,0.7393505974035766,0.8378378378378378,1.0,1.0,1/19,2.21%,IFT88
prerank,GO_Biological_Process_2021__positive regulation of protein polyubiquitination (GO:1902916),-0.4748184928411772,-0.7393482432836203,0.9019607843137255,1.0,1.0,1/7,14.99%,DDX3X
prerank,GO_Biological_Process_2021__adipose tissue development (GO:0060612),-0.44652656248206024,-0.7393279736567888,0.84375,1.0,1.0,1/12,4.14%,RORC
prerank,GO_Biological_Process_2021__cell projection organization (GO:0030030),-0.3486670713894681,-0.7393230867331951,0.835820895522388,1.0,1.0,6/30,17.19%,P2RY12;PARVG;RHOQ;SCIN;RAC2;RAC1
prerank,Reactome_2022__Nitric Oxide Stimulates Guanylate Cyclase R-HSA-392154,-0.3712878829859434,-0.7390597683291907,0.7692307692307693,1.0,1.0,2/19,5.05%,IRAG1;PDE5A
prerank,GO_Biological_Process_2021__glycine metabolic process (GO:0006544),-0.4303318862261316,-0.7390078188215241,0.8208955223880597,1.0,1.0,3/10,14.94%,GLDC;SDS;SDSL
prerank,GO_Biological_Process_2021__negative regulation of release of cytochrome c from mitochondria (GO:0090201),-0.43174936926435276,-0.7388929899503922,0.8275862068965517,1.0,1.0,1/14,8.95%,CLU
prerank,GO_Biological_Process_2021__hematopoietic progenitor cell differentiation (GO:0002244),0.3206491119752117,0.7388491879267751,0.926829268292683,1.0,1.0,9/26,15.44%,MLF1;KIT;PRRC2C;FSTL3;ARMC6;SP7;FLT3;MLLT3;TP53
prerank,CellMarker_Augmented_2021__Ionocyte cell:Lung,0.26745033188242273,0.7387619182401837,1.0,1.0,1.0,68/253,23.41%,ATP6V0D2;ACADS;ITPR2;BCL2;DDAH2;PI4KB;ITPKB;TRIM8;CGNL1;NCALD;SMARCB1;EIF2AK3;UST;PTGFRN;RALA;MAN2A1;MPC1;AKAP7;CSPG5;ACSL1;TWSG1;PPP1R18;TMTC3;TBC1D4;RET;CEP20;QSOX1;ZNF704;SC5D;FAM174B;LTBP2;CCDC107;WLS;STAC2;BCOR;CELF2;ANK2;HDAC4;BCR;FAM89B;SNTB1;DOCK11;ZDHHC3;AGPAT2;USP53;TRIM47;ACVR1;PCBP4;KLHL23;SLC25A23;UBXN2B;PRKAG2;PRDM4;C1D;PLCG2;PLXDC2;KHDRBS3;TFG;RRM2B;GNA11;DUSP6;SAV1;SYT7;ST14;CHST15;ZNF493;ATP6V0A4;AXIN1
prerank,GO_Biological_Process_2021__positive regulation of muscle hypertrophy (GO:0014742),0.37305286911463936,0.7385177115255592,0.7804878048780488,1.0,1.0,6/14,31.42%,PDE9A;NR4A3;EDN1;ROCK1;MEF2A;SLC9A1
prerank,GO_Biological_Process_2021__apical protein localization (GO:0045176),-0.42693643341949417,-0.73846646308648,0.8070175438596491,1.0,1.0,2/9,27.25%,CELSR1;SHROOM3
prerank,GO_Biological_Process_2021__mitotic G1 DNA damage checkpoint signaling (GO:0031571),-0.3290673611094529,-0.7384561852891065,0.8450704225352113,1.0,1.0,2/59,3.67%,GML;CCND1
prerank,Reactome_2022__DNA Replication R-HSA-69306,-0.28299947672940795,-0.7384011186439677,0.9390243902439024,1.0,1.0,28/121,27.84%,PSMB9;RPA3;MCM3;H2BC4;H2AZ1;POLE2;CCNE2;RBX1;PSMA3;POLD4;RPS27A;CDC6;PSMA7;PSMB6;ORC6;POLE3;PSMA5;PSMD6;CDC7;SKP1;PSMC5;MCM5;PSMB4;PSMB7;PCNA;PSMD8;MCM10;MCM6
prerank,Reactome_2022__Infectious Disease R-HSA-5663205,-0.26301300645681064,-0.7383947875172336,1.0,1.0,1.0,191/794,26.47%,PSMB9;C1QTNF1;TGFB1;RPL37A;HCK;GTF2E1;WNT5A;NLRP12;SCTR;TAF7;VAV3;GUCY2C;TSHR;SDC2;DOCK2;GPHB5;SFTPD;TRIM25;STAT1;C3AR1;SYT2;ATP1A4;MASP1;NFKB2;HLA-A;ACTG1;WAS;SNRPD2;H2BC4;RNF213;GPC3;ST6GALNAC2;GNAT3;RPL38;PTRH2;TAF7L;GPR27;REST;GNGT1;RPL15;CYBA;DUSP16;GPR39;PTGDR;SAP30;DDX20;RPS4X;RPL3;MASP2;TLR2;BLNK;RPL35A;TAF9B;NLRP3;GNL3;DYNLL1;ATG14;RPS9;FAU;PSTPIP1;RPS27;NCKIPSD;RBBP7;EEF2;RPS21;GGT5;IFNGR2;TAF10;ADCY7;ITPR3;IL18;SAP30L;GEMIN4;TXNIP;HLA-F;RBX1;CD4;RPL13A;TAF6;TUBB;PSMA3;RPL27A;RPS16;RPL36;PARP4;NT5E;RPS20;RPL7A;RPL9;RPS8;CD8B;CALM1;RPS27A;RPL21;RPL34;GPS2;NMT1;PSMA7;PSMB6;RPL4;FXYD6-FXYD2;RPL32;YWHAG;RPL5;RPL23;RNMT;IMPDH2;RPL41;MOGAT1;RPS7;HMGA1;RPS11;CHURC1-FNTB;NUP93;NOX1;ACE2;SUDS3;RPL27;RPL35;H2BC18;RPS14;RPL11;SEC13;PARP10;MAP2K1;ISG15;RPS15;SRPK1;SAP18;PSMA5;GNG13;RPLP1;HLA-C;TAF13;DYNLL2;TBP;RPS12;GPR83;BRK1;MAN1B1;GNG12;SEC24D;MTA2;ISCU;POLR2B;RPL18A;ELOB;TAF5;ADRB1;ENTPD5;PSMD6;RPS13;RPL29;RPLP2;ZCRB1;VPS18;IL1R1;ADCY1;HSP90AB1;MGAT4B;PTH2R;TKFC;RPL28;KPNA7;RPL12;FKBP4;CDK7;RPL18;RPS3;PTPN11;SKP1;RPL22;IL6R;RPSA;CDK9;PSMC5;KPNA5;GANAB;RPS28;NOXA1;RNASE1;RPS19;KDM1A;NDC1;PSMB4;GNG4;XRCC6;RPS24;RNF135;VPS36;PRKAR1A
prerank,GO_Biological_Process_2021__positive regulation of ATP metabolic process (GO:1903580),-0.35106595943657704,-0.7381432487801788,0.875,1.0,1.0,4/30,9.50%,PINK1;ACTN3;GAPDHS;PRXL2C
prerank,GO_Biological_Process_2021__cellular hypotonic response (GO:0071476),0.470926940724893,0.7380436392932257,0.7894736842105263,1.0,1.0,2/6,27.08%,SLC4A11;STK39
prerank,GO_Biological_Process_2021__cell differentiation involved in metanephros development (GO:0072202),0.44003080296487024,0.7380418595273497,0.7804878048780488,1.0,1.0,2/7,6.85%,WNT4;OSR1
prerank,Reactome_2022__IKK Complex Recruitment Mediated By RIP1 R-HSA-937041,0.3451302414808193,0.7378798706722899,0.9142857142857143,1.0,1.0,6/20,25.41%,SARM1;TICAM1;TRAF6;UBE2D2;IKBKB;UBE2D3
prerank,GO_Biological_Process_2021__negative regulation of double-strand break repair (GO:2000780),-0.3775438403319542,-0.7377595094783411,0.84375,1.0,1.0,1/31,0.77%,POLQ
prerank,GO_Biological_Process_2021__regulation of smooth muscle cell proliferation (GO:0048660),0.31987905158151403,0.7376885472867242,0.8181818181818182,1.0,1.0,3/38,4.33%,CCN4;CDH13;PPARG
prerank,GO_Biological_Process_2021__establishment of protein localization to chromosome (GO:0070199),0.4073150933934799,0.7375414771993105,0.8409090909090909,1.0,1.0,4/11,17.99%,PIH1D1;ACD;NIPBL;MACROH2A2
prerank,GO_Biological_Process_2021__regulation of histone H3-K9 methylation (GO:0051570),0.43413175313917635,0.7375045931111234,0.8125,1.0,1.0,3/11,7.10%,SIRT1;DNMT1;ZNF274
prerank,CellMarker_Augmented_2021__Periosteum-derived Progenitor cell:Periosteum,-0.3076638279028697,-0.7371877572318467,0.96,1.0,1.0,10/89,10.86%,C1QB;ANGPTL2;RARRES1;PDCD1LG2;LPAR1;TGFBI;DCN;PTPRC;VWF;LACC1
prerank,GO_Biological_Process_2021__sodium ion transport (GO:0006814),-0.3057131730383248,-0.7371661321666003,0.9285714285714286,1.0,1.0,9/77,9.89%,SCN5A;SLC5A2;SLC5A1;ATP1A4;ASIC5;SLC5A9;SLC24A1;SLC6A12;SLC5A4
prerank,GO_Biological_Process_2021__fusion of virus membrane with host plasma membrane (GO:0019064),-0.42770252398157416,-0.7370465550883333,0.7678571428571429,1.0,1.0,1/6,15.75%,CD4
prerank,GO_Biological_Process_2021__membrane fusion involved in viral entry into host cell (GO:0039663),-0.42770252398157416,-0.7370465550883333,0.7678571428571429,1.0,1.0,1/6,15.75%,CD4
prerank,Reactome_2022__FGFR1 Mutant Receptor Activation R-HSA-1839124,-0.3576110566630112,-0.7369547869258414,0.84375,1.0,1.0,2/27,6.09%,FGF20;STAT1
prerank,CellMarker_Augmented_2021__Hematopoietic Progenitor cell:Undefined,-0.3262078929550472,-0.7369196753941619,0.8513513513513513,1.0,1.0,12/74,14.86%,CYYR1;LYVE1;ANGPTL2;SCTR;ALDOB;SLCO2A1;ITGA9;VWF;GPX3;EDNRB;TEK;ADGRF5
prerank,GO_Biological_Process_2021__response to granulocyte macrophage colony-stimulating factor (GO:0097012),-0.4839565487799995,-0.736824393641899,0.8235294117647058,1.0,1.0,2/5,24.71%,CD4;NPR2
prerank,GO_Biological_Process_2021__cellular response to granulocyte macrophage colony-stimulating factor stimulus (GO:0097011),-0.4839565487799995,-0.736824393641899,0.8235294117647058,1.0,1.0,2/5,24.71%,CD4;NPR2
prerank,GO_Biological_Process_2021__modification-dependent macromolecule catabolic process (GO:0043632),-0.4082589298395004,-0.7366589275635054,0.8305084745762712,1.0,1.0,4/9,31.83%,RPS27A;ISG15;UBB;UBC
prerank,GO_Biological_Process_2021__regulation of intrinsic apoptotic signaling pathway (GO:2001242),-0.32659722797191504,-0.7365384647511326,0.8615384615384616,1.0,1.0,4/42,6.85%,MMP9;BCL2L2;PINK1;GSDME
prerank,GO_Biological_Process_2021__regulation of tau-protein kinase activity (GO:1902947),-0.44726261469198497,-0.7364124996855318,0.7755102040816326,1.0,1.0,1/8,8.95%,CLU
prerank,GO_Biological_Process_2021__adenine nucleotide transport (GO:0051503),-0.3989962251674889,-0.7362371416432117,0.8148148148148148,1.0,1.0,1/15,2.12%,ABCC6
prerank,GO_Biological_Process_2021__cellular response to interferon-beta (GO:0035458),0.4274496765973468,0.7361563940519337,0.8421052631578947,1.0,1.0,4/12,5.09%,IRGM;HTRA2;IFI16;PYHIN1
prerank,Reactome_2022__tRNA Aminoacylation R-HSA-379724,-0.34967227917078436,-0.7360505459266905,0.8656716417910447,1.0,1.0,4/39,16.15%,NARS1;DARS2;WARS1;YARS2
prerank,CellMarker_Augmented_2021__Natural Killer cell:Blood,0.45800786626118906,0.7360490734819876,0.7804878048780488,1.0,1.0,1/5,1.42%,KLRD1
prerank,Reactome_2022__Synthesis Of Glycosylphosphatidylinositol (GPI) R-HSA-162710,-0.40265340969685065,-0.7359221920815321,0.8289473684210527,1.0,1.0,3/16,14.30%,PIGH;PIGC;PIGL
prerank,GO_Biological_Process_2021__positive regulation of cartilage development (GO:0061036),0.36378267685125826,0.7358756500657018,0.7906976744186046,1.0,1.0,7/16,32.18%,GDF6;SOX5;BMPR2;BMP4;BMP2;ZBTB16;BMPR1B
prerank,CellMarker_Augmented_2021__Lake Et al.Science.In5:Brain,0.42185091132653135,0.735747999168813,0.8043478260869565,1.0,1.0,2/7,6.12%,PDGFD;TOX
prerank,GO_Biological_Process_2021__COPII-coated vesicle budding (GO:0090114),-0.3112436619587137,-0.7356975334775834,0.9041095890410958,1.0,1.0,1/65,0.35%,F8
prerank,GO_Biological_Process_2021__negative regulation of telomerase activity (GO:0051974),0.39486803181539976,0.7356774550097672,0.8372093023255814,1.0,1.0,3/9,15.44%,TERF1;MEN1;TP53
prerank,Reactome_2022__Laminin Interactions R-HSA-3000157,-0.36954469958034764,-0.7355560973015742,0.8714285714285714,1.0,1.0,3/22,11.45%,COL18A1;NID1;LAMC2
prerank,GO_Biological_Process_2021__striated muscle tissue development (GO:0014706),-0.344704163619793,-0.7354665284172992,0.8205128205128205,1.0,1.0,6/23,21.27%,CSRP3;POPDC2;SVIL;MYL6;SGCG;SIX4
prerank,Reactome_2022__Maturation Of Nucleoprotein R-HSA-9683610,-0.4156394192051754,-0.7354443024996582,0.8333333333333334,1.0,1.0,4/11,29.37%,PARP4;PARP10;PARP14;PARP9
prerank,GO_Biological_Process_2021__regulation of chromosome separation (GO:1905818),0.4905104074296658,0.7354080148892489,0.84,1.0,1.0,3/5,28.70%,PLSCR1;TPR;NUMA1
prerank,Reactome_2022__Phase 2 - Plateau Phase R-HSA-5576893,0.3592793072030616,0.7353616926196753,0.7941176470588235,1.0,1.0,2/14,10.32%,CACNG4;AKAP9
prerank,GO_Biological_Process_2021__regulation of cell killing (GO:0031341),-0.40780218974931604,-0.7352284248700601,0.8490566037735849,1.0,1.0,4/16,19.81%,WNT5A;CYBA;RAC1;NOX1
prerank,Reactome_2022__p53-Dependent G1 DNA Damage Response R-HSA-69563,-0.31671609268161793,-0.7351857432669414,0.890625,1.0,1.0,14/58,27.50%,PSMB9;CDKN1A;CCNE2;PSMA3;RPS27A;PSMA7;PSMB6;CDKN1B;PSMA5;PSMD6;PSMC5;PSMB4;PSMB7;PSMD8
prerank,GO_Biological_Process_2021__telomere maintenance (GO:0000723),-0.3209527675667336,-0.735174011995314,0.9154929577464789,1.0,1.0,3/49,4.30%,TERF2IP;SP100;RPA3
prerank,"Reactome_2022__Activation Of NIMA Kinases NEK9, NEK6, NEK7 R-HSA-2980767",0.40070781179191817,0.7351729485658752,0.7555555555555555,1.0,1.0,5/7,42.39%,PLK1;CDK1;CCNB2;NEK7;NEK9
prerank,GO_Biological_Process_2021__regulation of centrosome duplication (GO:0010824),0.3200433296932569,0.7351465880319739,0.8275862068965517,1.0,1.0,3/27,8.10%,SIRT1;CEP120;ALMS1
prerank,GO_Biological_Process_2021__regulation of autophagy of mitochondrion (GO:1903146),0.343088073265546,0.7348359746172692,0.8571428571428571,1.0,1.0,3/19,11.72%,HTRA2;FZD5;USP36
prerank,GO_Biological_Process_2021__positive regulation of viral process (GO:0048524),0.30329504746687785,0.7346996889892602,0.9285714285714286,1.0,1.0,14/59,25.46%,RAB7A;KPNA6;PKN2;TYRO3;MDFIC;GTF2F2;TARBP2;RSF1;LARP1;PPIH;ADAR;POLR2F;SRPK2;PABPC1
prerank,GO_Biological_Process_2021__glycerolipid catabolic process (GO:0046503),0.3461175781388712,0.7345395666224497,0.8604651162790697,1.0,1.0,4/17,24.64%,SMPD4;PLA2G4C;ABHD12;PNPLA6
prerank,GO_Biological_Process_2021__glutamate metabolic process (GO:0006536),-0.38937943836660205,-0.7343908613677852,0.875,1.0,1.0,1/17,2.41%,GAD1
prerank,GO_Biological_Process_2021__regulation of actin nucleation (GO:0051125),-0.4305693543148844,-0.7342817123898632,0.8,1.0,1.0,2/11,11.76%,SCIN;VIL1
prerank,GO_Biological_Process_2021__negative regulation of glial cell apoptotic process (GO:0034351),-0.48080555272786807,-0.7342343337250656,0.8301886792452831,1.0,1.0,1/6,12.91%,PRKCH
prerank,GO_Biological_Process_2021__purine ribonucleotide transport (GO:0015868),-0.401808559069992,-0.7340531881176576,0.8421052631578947,1.0,1.0,1/14,2.12%,ABCC6
prerank,GO_Biological_Process_2021__signal peptide processing (GO:0006465),0.42462372129772746,0.7340382262087484,0.8604651162790697,1.0,1.0,5/9,29.73%,FURIN;HM13;PCSK5;SPPL3;SEC11A
prerank,KEGG_2021_Human__NOD-like receptor signaling pathway,0.27523286330368685,0.7339944826758864,1.0,1.0,1.0,24/126,15.70%,ITPR2;BRCC3;BCL2;RIPK2;TRPM2;IFI16;CARD9;PLCB1;MAPK8;ANTXR2;PKN2;MCU;SHARPIN;NAMPT;TICAM1;TANK;FADD;TAB3;GBP4;NFKB1;IRAK4;ANTXR1;GBP2;MAPK12
prerank,Reactome_2022__Mismatch Repair (MMR) Directed By MSH2:MSH3 (MutSbeta) R-HSA-5358606,-0.4008709924486674,-0.7339683686746108,0.8333333333333334,1.0,1.0,1/14,4.30%,RPA3
prerank,GO_Biological_Process_2021__amide transport (GO:0042886),-0.3706457953904791,-0.7339024021144082,0.8378378378378378,1.0,1.0,6/22,15.61%,SLC14A1;ABCG2;UPK3A;SLC14A2;ABCA12;AQP11
prerank,GO_Biological_Process_2021__establishment of Golgi localization (GO:0051683),0.43655841645427634,0.7338007749520292,0.7837837837837838,1.0,1.0,1/7,12.46%,ARHGAP21
prerank,Reactome_2022__M Phase R-HSA-68886,-0.2623337723737247,-0.7337794030741477,1.0,1.0,1.0,38/331,19.80%,NEK2;BUB1;ERCC6L;PSMB9;SPC25;CENPU;ITGB3BP;ZWILCH;H2BC4;NUF2;CENPH;DCTN1;CENPS-CORT;H2AZ1;TUBA4A;CEP72;DYNLL1;RPS27;INCENP;TUBA3D;CC2D1B;NDEL1;TUBB;PSMA3;TUBB6;CEP76;TUBB2A;ARPP19;CDCA8;CENPN;RPS27A;KIF18A;BUB1B;PSMA7;PSMB6;YWHAG;SET;NUP93
prerank,Reactome_2022__FLT3 Signaling R-HSA-9607240,0.29756770456439796,0.7337778637887437,0.9444444444444444,1.0,1.0,17/36,29.85%,CSK;STAT5B;ABL2;AKT2;FLT3;PIK3CA;SLA2;SOS1;PTPRJ;CBL;AKT3;FOXO3;AKT1;FYN;LCK;GAB2;GRAP2
prerank,Reactome_2022__Protein Localization R-HSA-9609507,-0.28874123655291345,-0.7337704221168413,0.9746835443037974,1.0,1.0,18/145,18.81%,AMACR;ACOX2;PIPOX;TOMM20;DAO;ACOT4;CAMLG;CHCHD2;TOMM7;COX17;VDAC1;HAO2;ACOT2;PAM16;TIMM17A;IDH3G;RPS27A;FIS1
prerank,KEGG_2021_Human__Thyroid hormone signaling pathway,0.25759716459484316,0.7337313764165004,1.0,1.0,1.0,19/111,16.67%,FOXO1;HDAC3;MED17;WNT4;PFKP;NCOA3;NCOA2;PLCB1;MYC;SLC16A10;AKT2;TBC1D4;HDAC1;MED16;THRB;PIK3CA;TP53;MED13L;NOTCH1
prerank,GO_Biological_Process_2021__mitochondrial calcium ion homeostasis (GO:0051560),0.355502757109941,0.7336957095849723,0.7878787878787878,1.0,1.0,5/20,13.74%,SLC8A3;MICU1;MCU;PDZD8;RAP1GDS1
prerank,Reactome_2022__Regulation Of Necroptotic Cell Death R-HSA-5675482,0.3298327222019392,0.7336210365095072,0.7741935483870968,1.0,1.0,4/26,13.55%,CFLAR;TANK;FADD;PELI1
prerank,Reactome_2022__Bile Acid And Bile Salt Metabolism R-HSA-194068,-0.3364051241485083,-0.7336143365615783,0.9154929577464789,1.0,1.0,10/39,19.10%,SLC51A;AMACR;ACOX2;HSD3B7;NR1H4;STARD5;SLC10A1;SLCO1A2;ABCB11;SLC27A5
prerank,CellMarker_Augmented_2021__Interneuron:Embryonic Prefrontal Cortex,-0.36349626749525066,-0.7335354520884036,0.9393939393939394,1.0,1.0,2/26,5.77%,GAD1;PPP1R17
prerank,GO_Biological_Process_2021__positive regulation of vasculature development (GO:1904018),-0.3020348699108625,-0.7334503964576996,0.8961038961038961,1.0,1.0,14/83,16.59%,HK2;NODAL;WNT5A;CYP1B1;BRCA1;THBS1;TEK;GATA4;HYAL1;RRAS;EPHA1;GRN;HIPK1;ANGPTL3
prerank,GO_Biological_Process_2021__establishment of protein localization to telomere (GO:0070200),-0.4689312986407871,-0.7334213304552085,0.7692307692307693,1.0,1.0,1/5,10.71%,TERT
prerank,GO_Biological_Process_2021__positive regulation of morphogenesis of an epithelium (GO:1905332),-0.4017909818378195,-0.7333970484290658,0.8591549295774648,1.0,1.0,9/18,31.28%,AGT;ITGAX;SIX4;SOX9;WNT5B;FGF2;PAX2;EGF;PAX8
prerank,GO_Biological_Process_2021__preassembly of GPI anchor in ER membrane (GO:0016254),-0.4049020036651124,-0.733211276584509,0.8701298701298701,1.0,1.0,3/15,14.30%,PIGH;PIGC;PIGL
prerank,GO_Biological_Process_2021__regulation of prostaglandin biosynthetic process (GO:0031392),0.43188846569206363,0.7331882569754249,0.7804878048780488,1.0,1.0,2/5,13.71%,SIRT1;PIBF1
prerank,GO_Biological_Process_2021__dopamine uptake (GO:0090494),0.47132842784899415,0.7328323919112546,0.8205128205128205,1.0,1.0,1/6,5.38%,SNCA
prerank,CellMarker_Augmented_2021__Follicular Helper (Tfh) T cell:Undefined,-0.42484519312881286,-0.7327004199367634,0.8333333333333334,1.0,1.0,6/9,25.47%,IRF4;CXCR5;CD4;MAF;TNFSF4;IL6R
prerank,Reactome_2022__Negative Regulation Of MET Activity R-HSA-6807004,0.3176464135790409,0.7324587047829018,0.8928571428571429,1.0,1.0,6/21,23.99%,SH3KBP1;STAM2;SOS1;SH3GL1;PTPRJ;CBL
prerank,Reactome_2022__Mitochondrial Uncoupling R-HSA-166187,-0.48798673533393633,-0.7324438615038772,0.8412698412698413,1.0,1.0,1/5,11.75%,UCP1
prerank,Reactome_2022__Nuclear Events Mediated By NFE2L2 R-HSA-9759194,-0.31898984622631993,-0.7324351712015551,0.8985507246376812,1.0,1.0,17/68,27.50%,PSMB9;NQO1;RBX1;PSMA3;RPS27A;MAFK;PSMA7;PSMB6;PRDX1;TALDO1;PSMA5;PSMD6;SKP1;PSMC5;PSMB4;PSMB7;PSMD8
prerank,GO_Biological_Process_2021__IRE1-mediated unfolded protein response (GO:0036498),0.27255658955631995,0.7324217760717863,0.9333333333333333,1.0,1.0,11/50,20.34%,EXTL1;PDIA6;CTDSP2;ERN1;PREB;YIF1A;DNAJC3;CXXC1;EDEM1;ADD1;ACADVL
prerank,GO_Biological_Process_2021__protein export from nucleus (GO:0006611),-0.3380895094625901,-0.7322724561741139,0.8703703703703703,1.0,1.0,6/27,18.70%,TGFB1;DUSP16;STRADB;STRADA;EGR2;RANBP3L
prerank,GO_Biological_Process_2021__regulation of macrophage proliferation (GO:0120040),-0.4671344963154713,-0.7322381439734723,0.7884615384615384,1.0,1.0,2/6,30.71%,CSF1R;MAPK3
prerank,Reactome_2022__Sealing Of Nuclear Envelope (NE) By ESCRT-III R-HSA-9668328,-0.3516002145029687,-0.7320891953213687,0.8421052631578947,1.0,1.0,8/25,22.30%,TUBA4A;TUBA3D;CC2D1B;TUBB;TUBB6;TUBB2A;TUBB4A;TUBB4B
prerank,GO_Biological_Process_2021__positive regulation of smooth muscle contraction (GO:0045987),-0.4633088216175503,-0.7319445086878933,0.8135593220338984,1.0,1.0,1/7,5.18%,GPER1
prerank,PanglaoDB_Augmented_2021__Meningeal Cells,-0.2984085967944976,-0.7319069680994642,0.9459459459459459,1.0,1.0,7/103,6.82%,LMOD1;TIMP3;ANGPTL2;TSPAN11;FBXL7;VTN;DCN
prerank,KEGG_2021_Human__Dilated cardiomyopathy,-0.31300799438657356,-0.731853984713139,0.9594594594594594,1.0,1.0,15/81,16.97%,TGFB1;MYH7;ACTC1;MYBPC3;ACTG1;ITGA9;ITGA2B;ITGB6;ITGA5;TTN;TGFB3;ADCY7;AGT;ITGB5;PLN
prerank,GO_Biological_Process_2021__cell chemotaxis (GO:0060326),-0.32486319162196564,-0.7318170807692563,0.9428571428571428,1.0,1.0,8/43,17.24%,XCR1;LPAR1;ACKR4;DEFB109B;CXCR5;LEF1;ACKR2;EGR3
prerank,GO_Biological_Process_2021__ruffle organization (GO:0031529),-0.4101408609332612,-0.7316905927164896,0.8448275862068966,1.0,1.0,3/14,18.74%,RAC1;AIF1L;CSF1R
prerank,GO_Biological_Process_2021__long-chain fatty acid import into cell (GO:0044539),0.38386851415488255,0.7316762601623858,0.8571428571428571,1.0,1.0,3/10,17.52%,SLC27A2;ACSL1;SLC27A4
prerank,GO_Biological_Process_2021__regulation of cysteine-type endopeptidase activity involved in execution phase of apoptosis (GO:2001270),-0.4839844988113453,-0.7316129484482273,0.8392857142857143,1.0,1.0,3/5,26.21%,RFPL1;RPS3;RFFL
prerank,CellMarker_Augmented_2021__Cancer cell:Lung,-0.3070833885939768,-0.7315210635587642,0.9206349206349206,1.0,1.0,13/65,17.22%,MISP;SEMA3F;EPN3;MYO5B;GPR39;LAMC2;SOWAHB;ITGB6;BAIAP2L1;PPIC;TOM1L1;YAP1;SCNN1A
prerank,CellMarker_Augmented_2021__Epithelial cell:Blood,-0.3070833885939768,-0.7315210635587642,0.9206349206349206,1.0,1.0,13/65,17.22%,MISP;SEMA3F;EPN3;MYO5B;GPR39;LAMC2;SOWAHB;ITGB6;BAIAP2L1;PPIC;TOM1L1;YAP1;SCNN1A
prerank,GO_Biological_Process_2021__epithelial cell development (GO:0002064),-0.3796867038427366,-0.731356076472088,0.7931034482758621,1.0,1.0,9/16,28.07%,ROS1;TMEM79;ACTA2;GRHL2;WNT5B;POF1B;EXPH5;LRTOMT;BFSP1
prerank,Reactome_2022__Apoptosis R-HSA-109581,0.26653471899065223,0.7313356694812696,1.0,1.0,1.0,26/156,15.64%,BCL2;CFLAR;DAPK2;PSME4;SEM1;LMNB1;DCC;PPP1R13B;HMGB1;REXO2;PSMA1;MAPK8;CASP3;AKT2;PKN2;PLEC;GAS2;TICAM1;TANK;FNTA;FADD;BID;MAGED1;TP53;CLSPN;ACIN1
prerank,GO_Biological_Process_2021__negative regulation of leukocyte apoptotic process (GO:2000107),0.4515666158722895,0.7313025725280874,0.723404255319149,1.0,1.0,1/6,9.14%,HCLS1
prerank,GO_Biological_Process_2021__cellular response to unfolded protein (GO:0034620),-0.3553599657164074,-0.7312642788768674,0.8783783783783784,1.0,1.0,6/25,24.55%,HSPA1L;HSPA8;HSPA5;OPTN;HSPA2;HSPA13
prerank,GO_Biological_Process_2021__monoacylglycerol catabolic process (GO:0052651),0.4804078657959774,0.7310961339625216,0.8125,1.0,1.0,1/5,21.97%,ABHD12
prerank,GO_Biological_Process_2021__PERK-mediated unfolded protein response (GO:0036499),0.3964460149854962,0.7310255219157291,0.6739130434782609,1.0,1.0,4/8,27.89%,EIF2AK3;QRICH1;NFE2L2;EIF2S1
prerank,"GO_Biological_Process_2021__synaptic transmission, cholinergic (GO:0007271)",0.321992779141572,0.7309691598421627,0.7666666666666667,1.0,1.0,2/16,6.18%,APOE;CHRNA10
prerank,GO_Biological_Process_2021__regulation of lymphocyte migration (GO:2000401),-0.4313729037646261,-0.7308787616299484,0.8103448275862069,1.0,1.0,2/8,17.52%,JAM2;MSN
prerank,CellMarker_Augmented_2021__Neural Crest Stem cell:Hair Follicle,0.27328069168629826,0.7307171756313838,1.0,1.0,1.0,20/91,19.78%,TSHZ3;TBKBP1;P3H3;ITGA4;MMP2;VASH1;BCAT1;TRIB2;COLGALT2;ELOVL4;ZNF569;NCAM1;USP51;CORO2B;MAGEL2;CLIP3;AEBP1;TCF4;ZNF287;PDZD4
prerank,GO_Biological_Process_2021__myelin maintenance (GO:0043217),-0.4314755175666862,-0.7307032897628242,0.8059701492537313,1.0,1.0,3/9,23.25%,CLU;MYRF;PRX
prerank,GO_Biological_Process_2021__regulation of hematopoietic stem cell differentiation (GO:1902036),-0.3052405196318112,-0.7305943027254133,0.9104477611940298,1.0,1.0,1/57,0.62%,PSMB9
prerank,GO_Biological_Process_2021__regulation of cellular response to vascular endothelial growth factor stimulus (GO:1902547),0.4574029419831281,0.73059330149116,0.7428571428571429,1.0,1.0,2/5,13.75%,ADAMTS12;TSPAN12
prerank,GO_Biological_Process_2021__positive regulation of double-strand break repair via homologous recombination (GO:1905168),0.34746285812492145,0.7304910575506335,0.8709677419354839,1.0,1.0,4/14,16.05%,TIMELESS;ARID2;WRAP53;FUS
prerank,Reactome_2022__DAP12 Signaling R-HSA-2424491,0.3179254207351377,0.7302564554638095,0.9,1.0,1.0,1/22,1.42%,KLRD1
prerank,KEGG_2021_Human__Selenocompound metabolism,0.3674806966254609,0.7300483778830195,0.8947368421052632,1.0,1.0,8/15,23.42%,PAPSS2;KYAT1;MTR;PSTK;KYAT3;MARS1;SEPHS1;CTH
prerank,Reactome_2022__Degradation Of GLI1 By Proteasome R-HSA-5610780,-0.31787406476944735,-0.7299100450609307,0.8636363636363636,1.0,1.0,1/51,0.62%,PSMB9
prerank,GO_Biological_Process_2021__B cell proliferation (GO:0042100),-0.42135402689536267,-0.7299010403218894,0.7868852459016393,1.0,1.0,2/9,10.28%,IFNK;PTPRC
prerank,Reactome_2022__Triglyceride Catabolism R-HSA-163560,-0.3544591419539139,-0.7295435507641356,0.7777777777777778,1.0,1.0,1/17,7.72%,PNPLA4
prerank,GO_Biological_Process_2021__DNA conformation change (GO:0071103),-0.3824024124936663,-0.7294667317480817,0.8709677419354839,1.0,1.0,2/14,7.60%,HMGB3;HAT1
prerank,GO_Biological_Process_2021__replication fork protection (GO:0048478),-0.4440272812491474,-0.7288538380957039,0.8,1.0,1.0,1/8,3.82%,DONSON
prerank,GO_Biological_Process_2021__purine ribonucleoside monophosphate metabolic process (GO:0009167),-0.37563977292118356,-0.7288214577442084,0.8571428571428571,1.0,1.0,1/19,1.23%,ADSS1
prerank,GO_Biological_Process_2021__rRNA pseudouridine synthesis (GO:0031118),0.4001755821793962,0.7287582683903904,0.7948717948717948,1.0,1.0,4/10,30.73%,RPUSD1;GAR1;NAF1;RPUSD4
prerank,Reactome_2022__Role Of GTSE1 In G2/M Progression After G2 Checkpoint R-HSA-8852276,-0.32487242708774006,-0.7286837576646734,0.8970588235294118,1.0,1.0,22/53,31.95%,PSMB9;FKBPL;CDKN1A;PSMA3;RPS27A;PSMA7;PSMB6;PSMA5;PSMD6;HSP90AB1;PSMC5;PSMB4;PSMB7;PSMD8;PSMD3;UBB;PSMC1;PSMD7;PSMA8;PSME3;UBC;CCNB1
prerank,Reactome_2022__E2F Mediated Regulation Of DNA Replication R-HSA-113510,0.35294583489348,0.7285331808055265,0.825,1.0,1.0,5/18,28.54%,PPP2R1B;TFDP1;POLA1;RB1;CDK1
prerank,KEGG_2021_Human__GnRH signaling pathway,0.2662655817950296,0.7285085780954864,0.95,1.0,1.0,18/79,21.72%,ITPR2;MMP2;PLCB1;MAPK8;ADCY2;MAP3K1;ADCY3;PLA2G4C;MAPK12;MAP2K7;ADCY6;SOS1;MAP2K6;GNAQ;PLD2;RAF1;GNAS;GNA11
prerank,GO_Biological_Process_2021__hexose metabolic process (GO:0019318),-0.34158476159390294,-0.7283482362291409,0.9152542372881356,1.0,1.0,6/31,16.67%,ALDOB;KCNJ11;OAS1;APOD;GALM;GHRL
prerank,GO_Biological_Process_2021__negative regulation of T cell proliferation (GO:0042130),-0.3712394304167255,-0.7282812817704069,0.8688524590163934,1.0,1.0,5/26,14.67%,PDCD1LG2;SFTPD;VSIG4;HLA-DRB1;CD80
prerank,Reactome_2022__Class I MHC Mediated Antigen Processing And Presentation R-HSA-983169,0.2327333638953465,0.7281927375672987,1.0,1.0,1.0,73/334,21.68%,ASB18;RNF182;KLHL20;UBE2E3;ZNRF1;PSME4;SEM1;KLHL41;TRIM69;SH3RF1;UBE2J1;HMGB1;TRIM71;FBXO15;SEC24C;PSMA1;SEC14L2;RBBP6;CBLB;UBE2O;CTSV;UBE2E1;UBE2D4;ANAPC13;GAN;UBE2E2;FBXL14;UBE3D;RNF217;KLHL3;UBE2A;KLHL42;RNF130;FBXL20;KLHL22;ASB7;FBXO27;SMURF1;TRIM4;CDC26;HERC2;THOP1;KLHL5;SEC22B;UBE2Z;FBXO4;ASB6;NEDD4;UBE2L3;LONRF1;HERC5;LRSAM1;MIB2;ANAPC7;FBXO11;VAMP8;FBXL22;FBXO31;RNF19B;CDC34;UBE2J2;FBXO30;RNF19A;KCTD6;HECTD3;FBXO41;TRIM9;PSMD4;FZR1;SEC61A1;PIK3R4;UBE2D2;CUL1
prerank,GO_Biological_Process_2021__establishment of endothelial barrier (GO:0061028),-0.3582324380666545,-0.7279924354863823,0.8615384615384616,1.0,1.0,4/27,17.52%,MARVELD2;TJP3;F2RL1;MSN
prerank,CellMarker_Augmented_2021__Lymphatic Endothelial cell:Lymph Node,-0.4740156490039222,-0.7277526652462656,0.8135593220338984,1.0,1.0,1/5,7.35%,FLT4
prerank,GO_Biological_Process_2021__nucleotide transport (GO:0006862),0.41805750395025787,0.7277472240889695,0.825,1.0,1.0,1/6,5.65%,SLC25A33
prerank,GO_Biological_Process_2021__regulation of macrophage migration (GO:1905521),-0.4419886950321174,-0.7277430237256168,0.85,1.0,1.0,4/10,22.57%,P2RY12;MTUS1;CD81;MST1
prerank,GO_Biological_Process_2021__negative regulation of growth (GO:0045926),0.27355537218773013,0.7276433486723811,1.0,1.0,1.0,21/100,16.67%,MT1G;BCL6;DCBLD2;SIRT1;DACT3;ST7L;PML;SLIT2;SIPA1;FGFR3;PPP1R9B;SMARCA2;SMARCA4;HSPA1A;PNPT1;ADAM15;CGRRF1;SERTAD2;TP53;MINAR1;NOTCH1
prerank,GO_Biological_Process_2021__peptidyl-serine autophosphorylation (GO:0036289),-0.43655177520474614,-0.7275756504108128,0.7333333333333333,1.0,1.0,1/8,5.61%,PINK1
prerank,GO_Biological_Process_2021__ornithine metabolic process (GO:0006591),-0.4272327390090468,-0.7275151343850264,0.8269230769230769,1.0,1.0,2/8,11.64%,AZIN1;ARG2
prerank,GO_Biological_Process_2021__negative regulation of NF-kappaB transcription factor activity (GO:0032088),-0.3227471083331694,-0.7274558711202416,0.8904109589041096,1.0,1.0,6/63,13.31%,AIM2;NLRP12;CYP1B1;SPI1;NLRC3;NLRP3
prerank,GO_Biological_Process_2021__B cell homeostasis (GO:0001782),-0.4171003705117411,-0.7273901435433933,0.7894736842105263,1.0,1.0,1/8,11.75%,CAMLG
prerank,GO_Biological_Process_2021__positive regulation of defense response (GO:0031349),-0.30589337908516595,-0.7272408487083932,0.9428571428571428,1.0,1.0,10/65,15.82%,WNT5A;NLRP12;IFNK;CYBA;TLR2;SH2D1B;IL18;ZP3;AGT;GRN
prerank,GO_Biological_Process_2021__regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway (GO:2001267),-0.3835197819429917,-0.7271842473674832,0.8103448275862069,1.0,1.0,1/11,2.53%,MMP9
prerank,GO_Biological_Process_2021__regulation of actin filament organization (GO:0110053),-0.4390098813313381,-0.7269680183908339,0.8095238095238095,1.0,1.0,1/7,7.51%,WAS
prerank,Reactome_2022__Synthesis Of Bile Acids And Bile Salts Via 7Alpha-Hydroxycholesterol R-HSA-193368,0.34685864178220344,0.7268754260548687,0.8787878787878788,1.0,1.0,5/22,7.35%,CYP7B1;AKR1C3;NCOA2;AKR1C1;SLC27A2
prerank,GO_Biological_Process_2021__positive regulation of epidermal growth factor receptor signaling pathway (GO:0045742),0.3375747092692106,0.7268568880920064,0.9642857142857143,1.0,1.0,4/27,8.56%,DGKD;HIP1;TGFA;CNOT9
prerank,GO_Biological_Process_2021__cellular response to mechanical stimulus (GO:0071260),0.3105659575357605,0.7268424995431527,0.8857142857142857,1.0,1.0,9/37,15.44%,MAP3K14;TNFSF14;MAPK8;MAP3K1;FADD;CRADD;CASP8AP2;NFKB1;GADD45A
prerank,GO_Biological_Process_2021__cellular nitrogen compound biosynthetic process (GO:0044271),-0.365589601662665,-0.7268285615624681,0.8227848101265823,1.0,1.0,5/26,18.26%,CYP1B1;NQO1;ARG2;NOS2;GCHFR
prerank,GO_Biological_Process_2021__regulation of ryanodine-sensitive calcium-release channel activity (GO:0060314),-0.3881882114777938,-0.726623399849218,0.8461538461538461,1.0,1.0,2/22,6.40%,CASQ2;TRDN
prerank,GO_Biological_Process_2021__lysosome organization (GO:0007040),-0.3526232960588538,-0.7265665746754975,0.8933333333333333,1.0,1.0,10/35,24.32%,ATP10B;ACP3;GRN;HOOK2;SNAPIN;ACP4;TPP1;HPS4;VPS18;ACP2
prerank,GO_Biological_Process_2021__spliceosomal snRNP assembly (GO:0000387),-0.32867913491780804,-0.7265533536446999,0.8636363636363636,1.0,1.0,4/36,15.51%,SNRPD2;DDX20;GEMIN4;STRAP
prerank,GO_Biological_Process_2021__negative regulation of neurotransmitter secretion (GO:0046929),0.4396091123429398,0.7264015884988559,0.7551020408163265,1.0,1.0,3/7,31.80%,RAP1A;FMR1;RAP1B
prerank,GO_Biological_Process_2021__positive regulation of signal transduction by p53 class mediator (GO:1901798),0.3243867199172505,0.726391358852497,0.8484848484848485,1.0,1.0,5/18,18.39%,SPRED3;SPRED2;SPRED1;ATM;ATR
prerank,GO_Biological_Process_2021__positive regulation of vascular associated smooth muscle cell differentiation (GO:1905065),-0.4702120758900317,-0.7263707291916613,0.8245614035087719,1.0,1.0,3/7,11.81%,GPER1;SOD2;ENG
prerank,GO_Biological_Process_2021__regulation of protein catabolic process (GO:0042176),0.27289144117733366,0.7262149859607727,1.0,1.0,1.0,14/88,16.75%,FOXO1;STX5;RAB7A;NKD1;WWP2;FLNA;CHMP6;ODC1;BANP;SMURF1;FURIN;SEC22B;SNF8;NEDD4
prerank,GO_Biological_Process_2021__cellular response to monoamine stimulus (GO:0071868),0.4259555149468494,0.726034825912591,0.782608695652174,1.0,1.0,3/7,18.06%,DRD5;NR4A3;ADCY6
prerank,GO_Biological_Process_2021__regulation of tubulin deacetylation (GO:0090043),0.4385325377448356,0.7260274576511762,0.7916666666666666,1.0,1.0,5/7,29.51%,FNTA;EP300;PRKAA2;TPPP;PRKAA1
prerank,GO_Biological_Process_2021__tetrapyrrole metabolic process (GO:0033013),0.33137414203792237,0.7260232565812194,0.8387096774193549,1.0,1.0,5/17,18.17%,PRSS3;MTR;ABCC1;TCN2;CD320
prerank,GO_Biological_Process_2021__cobalamin metabolic process (GO:0009235),0.33137414203792237,0.7260232565812194,0.8387096774193549,1.0,1.0,5/17,18.17%,PRSS3;MTR;ABCC1;TCN2;CD320
prerank,GO_Biological_Process_2021__production of siRNA involved in RNA interference (GO:0030422),-0.41798213193472733,-0.726010210398128,0.8225806451612904,1.0,1.0,1/9,10.71%,TERT
prerank,GO_Biological_Process_2021__negative regulation of I-kappaB kinase/NF-kappaB signaling (GO:0043124),-0.3504139592161917,-0.7259538358800331,0.8243243243243243,1.0,1.0,8/33,19.41%,NLRP12;ESR1;STAT1;NLRC3;NR1H4;CACTIN;CARD8;CASP8
prerank,GO_Biological_Process_2021__glial cell development (GO:0021782),-0.36768786630095684,-0.7259500431802746,0.8472222222222222,1.0,1.0,4/23,19.63%,SOX10;TLR2;EIF2B2;MYRF
prerank,Reactome_2022__S Phase R-HSA-69242,-0.2820142308265134,-0.7258624242863877,0.9876543209876543,1.0,1.0,17/144,19.11%,PSMB9;CCND1;RPA3;MCM3;CDC25A;CDKN1A;MAX;POLE2;CCNE2;RBX1;CKS1B;PSMA3;POLD4;RPS27A;CDC6;PSMA7;PSMB6
prerank,GO_Biological_Process_2021__cell migration involved in sprouting angiogenesis (GO:0002042),0.3473898995796546,0.7258617925111429,0.7894736842105263,1.0,1.0,5/16,18.53%,GREM1;SLIT2;GPLD1;MIA3;NR4A1
prerank,GO_Biological_Process_2021__negative regulation of glycolytic process (GO:0045820),-0.4390001559378881,-0.7255837092941042,0.8688524590163934,1.0,1.0,1/9,8.67%,ACTN3
prerank,GO_Biological_Process_2021__negative regulation of purine nucleotide metabolic process (GO:1900543),-0.4390001559378881,-0.7255837092941042,0.8688524590163934,1.0,1.0,1/9,8.67%,ACTN3
prerank,Reactome_2022__Peptide Hormone Metabolism R-HSA-2980736,0.3186304505381585,0.7255041328863275,0.8846153846153846,1.0,1.0,3/63,2.33%,BCHE;RAB27A;CRHR2
prerank,GO_Biological_Process_2021__regulation of vesicle-mediated transport (GO:0060627),0.28061758600141545,0.7254559334196482,0.875,1.0,1.0,16/86,17.53%,PACSIN2;HIP1;CDH13;ABL1;RALA;SYT1;ABL2;ZFYVE16;RIMS2;RAB3C;CD22;RAB10;RAB5A;RAB11B;RIT2;RAB3D
prerank,CellMarker_Augmented_2021__Plasma cell:Salivary Gland,-0.2967618624125673,-0.725409335004382,0.9367088607594937,1.0,1.0,11/81,16.08%,SERINC2;CCND1;CLDN1;SEMA3F;SH2D4A;ID1;GPR39;BAIAP2L1;PPIC;TOM1L1;YAP1
prerank,Reactome_2022__Sema4D Induced Cell Migration And Growth-Cone Collapse R-HSA-416572,0.3467595456873147,0.7253559053425287,0.8409090909090909,1.0,1.0,2/20,8.27%,ERBB2;PLXNB1
prerank,GO_Biological_Process_2021__C4-dicarboxylate transport (GO:0015740),-0.40249362318112636,-0.724956130153793,0.8260869565217391,1.0,1.0,3/13,23.32%,SLC25A18;SLC25A22;SLC25A11
prerank,GO_Biological_Process_2021__innate immune response activating cell surface receptor signaling pathway (GO:0002220),-0.29325301724594666,-0.7248451295249411,0.948051948051948,1.0,1.0,5/92,7.28%,PSMB9;CLEC4C;MUCL1;ICAM3;MUC5B
prerank,GO_Biological_Process_2021__stimulatory C-type lectin receptor signaling pathway (GO:0002223),-0.29325301724594666,-0.7248451295249411,0.948051948051948,1.0,1.0,5/92,7.28%,PSMB9;CLEC4C;MUCL1;ICAM3;MUC5B
prerank,GO_Biological_Process_2021__cellular response to lectin (GO:1990858),-0.29325301724594666,-0.7248451295249411,0.948051948051948,1.0,1.0,5/92,7.28%,PSMB9;CLEC4C;MUCL1;ICAM3;MUC5B
prerank,GO_Biological_Process_2021__positive regulation of membrane protein ectodomain proteolysis (GO:0051044),0.37421518648923885,0.7247915792313944,0.8571428571428571,1.0,1.0,6/12,23.34%,APOE;SNX9;FURIN;GPLD1;ADAM8;SH3D19
prerank,GO_Biological_Process_2021__phosphatidic acid metabolic process (GO:0046473),0.31423087223320706,0.7247730795614173,0.8928571428571429,1.0,1.0,12/42,20.45%,DGKD;PLD6;PNPLA3;GPD1;AGPAT5;DGKH;AGPAT2;LCLAT1;ABHD4;PLA2G5;DGKZ;PLD2
prerank,GO_Biological_Process_2021__cellular response to dopamine (GO:1903351),-0.38662475067391633,-0.7247179147427452,0.7407407407407407,1.0,1.0,1/9,8.48%,TGM2
prerank,GO_Biological_Process_2021__response to dopamine (GO:1903350),-0.38662475067391633,-0.7247179147427452,0.7407407407407407,1.0,1.0,1/9,8.48%,TGM2
prerank,GO_Biological_Process_2021__positive regulation of phospholipid biosynthetic process (GO:0071073),-0.44202226567039804,-0.7245573594155189,0.7857142857142857,1.0,1.0,3/7,15.67%,HTR2B;NR1H4;ACSL3
prerank,Reactome_2022__SUMOylation Of Transcription Factors R-HSA-3232118,0.35156407169978204,0.7244274547254059,0.8,1.0,1.0,1/15,2.54%,MITF
prerank,GO_Biological_Process_2021__positive regulation of myeloid leukocyte cytokine production involved in immune response (GO:0061081),0.40363775951802083,0.7244011039105991,0.8604651162790697,1.0,1.0,6/13,20.89%,KIT;SIRT1;TICAM1;NR4A3;LAPTM5;PLCG2
prerank,GO_Biological_Process_2021__negative regulation of actin filament polymerization (GO:0030837),-0.3765400855273967,-0.7243606486986743,0.8260869565217391,1.0,1.0,4/23,14.59%,KANK3;SCIN;VIL1;TMSB10
prerank,GO_Biological_Process_2021__regulation of mononuclear cell migration (GO:0071675),-0.36273925274969326,-0.7240731720341801,0.8448275862068966,1.0,1.0,7/20,30.71%,THBS1;MSN;CSF1R;CXCL17;CCL5;CSF1;MAPK3
prerank,Reactome_2022__COPII-mediated Vesicle Transport R-HSA-204005,-0.30911868754881855,-0.7239447749139136,0.961038961038961,1.0,1.0,1/61,0.35%,F8
prerank,Reactome_2022__Scavenging By Class A Receptors R-HSA-3000480,-0.3654296661674161,-0.7234673751278596,0.8088235294117647,1.0,1.0,4/16,13.95%,COL1A1;MASP1;FTH1;COLEC12
prerank,GO_Biological_Process_2021__positive regulation of cellular component biogenesis (GO:0044089),0.28325987627684346,0.7234523842352976,0.9545454545454546,1.0,1.0,16/74,18.22%,CDH5;SDC4;NRG1;RAB7A;STX18;SMPD3;PIH1D1;GNL3L;SYNPO;BID;SPIDR;SNF8;ICE1;LGALS3;FAF1;LIMK1
prerank,GO_Biological_Process_2021__negative regulation of endothelial cell proliferation (GO:0001937),-0.3551734332137949,-0.723430379130045,0.8382352941176471,1.0,1.0,9/29,16.67%,ALOX5;CNMD;STAT1;COL4A3;THBS1;CAV2;ATP5IF1;IL12A;GHRL
prerank,GO_Biological_Process_2021__nitrogen compound transport (GO:0071705),-0.28270985808322,-0.7233889599483664,0.963855421686747,1.0,1.0,17/119,15.86%,TCN1;SLC7A7;SLC7A3;CHMP3;SLC6A12;SLC3A1;ABCG2;PPT1;SLC18A2;SLC11A1;LRP2;SLC22A3;SLC6A4;SLC22A4;TXNIP;AMN;RHBG
prerank,GO_Biological_Process_2021__positive regulation of angiogenesis (GO:0045766),-0.2961719028582331,-0.7233742329775872,0.925,1.0,1.0,15/95,16.59%,HK2;NODAL;WNT5A;CYP1B1;BRCA1;THBS1;TEK;ITGA5;GATA4;HYAL1;RRAS;EPHA1;GRN;HIPK1;ANGPTL3
prerank,Reactome_2022__SEMA3A-Plexin Repulsion Signaling By Inhibiting Integrin Adhesion R-HSA-399955,-0.40759781807108736,-0.7233063325179281,0.8115942028985508,1.0,1.0,3/14,18.53%,SEMA3A;RRAS;PLXNA3
prerank,GO_Biological_Process_2021__regulation of chromatin silencing (GO:0031935),-0.4185080642169785,-0.723220054818617,0.8088235294117647,1.0,1.0,4/11,24.41%,H1-0;H1-3;HMGA1;H1-2
prerank,GO_Biological_Process_2021__cardiolipin acyl-chain remodeling (GO:0035965),0.4215308984703758,0.7230580781503504,0.8,1.0,1.0,4/7,23.88%,LCLAT1;PLA2G5;HADHB;PLA2G6
prerank,Reactome_2022__Beta Oxidation Of butanoyl-CoA To acetyl-CoA R-HSA-77352,0.4386102051633045,0.7229543464937909,0.7727272727272727,1.0,1.0,2/5,7.98%,ACADS;ECHS1
prerank,Reactome_2022__Lipophagy R-HSA-9613354,-0.4252571404398209,-0.7229359279018288,0.7586206896551724,1.0,1.0,1/7,11.92%,HSPA8
prerank,GO_Biological_Process_2021__response to cytokine (GO:0034097),-0.2892688437519049,-0.7228994015085545,0.958904109589041,1.0,1.0,16/123,14.75%,TIMP3;NLRP12;SP100;MAPKAPK3;CIITA;STAT1;SELP;ANXA1;OSMR;TIMP4;SLC11A1;CXCL16;IL18BP;ITIH4;LEF1;GGT5
prerank,Reactome_2022__NIK To Noncanonical NF-kB Signaling R-HSA-5676590,-0.30108487271717543,-0.7227771340888303,0.9295774647887324,1.0,1.0,2/52,7.07%,PSMB9;NFKB2
prerank,Reactome_2022__Fc Epsilon Receptor (FCERI) Signaling R-HSA-2454202,-0.2899007917085681,-0.7224998487359304,0.9397590361445783,1.0,1.0,4/116,5.08%,PSMB9;RASGRP4;VAV3;TEC
prerank,GO_Biological_Process_2021__gas homeostasis (GO:0033483),-0.4790451220571086,-0.7224093654715935,0.7959183673469388,1.0,1.0,2/5,10.62%,SOD2;ALAS2
prerank,GO_Biological_Process_2021__nuclear membrane organization (GO:0071763),0.3527342500050013,0.7223411579087858,0.9375,1.0,1.0,3/19,9.13%,TOR1B;UBXN2A;SPAST
prerank,GO_Biological_Process_2021__neurotransmitter uptake (GO:0001504),-0.429834668806202,-0.722310386573568,0.8813559322033898,1.0,1.0,1/11,13.81%,SLC22A3
prerank,GO_Biological_Process_2021__triglyceride biosynthetic process (GO:0019432),0.39480876171836615,0.7220627771471555,0.9142857142857143,1.0,1.0,2/16,16.93%,PNPLA3;LPIN2
prerank,GO_Biological_Process_2021__positive regulation of ubiquitin-dependent protein catabolic process (GO:2000060),-0.310500259373447,-0.7219855024179441,0.927536231884058,1.0,1.0,4/72,8.95%,ARIH2;CAV3;DAB2;CLU
prerank,Reactome_2022__Dectin-1 Mediated Noncanonical NF-kB Signaling R-HSA-5607761,-0.2986977562561872,-0.721982108233592,0.9285714285714286,1.0,1.0,2/53,7.07%,PSMB9;NFKB2
prerank,GO_Biological_Process_2021__entry of bacterium into host cell (GO:0035635),0.3832722210074515,0.7218634427112466,0.8461538461538461,1.0,1.0,4/8,44.06%,CBL;MET;GRB2;SRC
prerank,GO_Biological_Process_2021__plasma membrane invagination (GO:0099024),-0.3451231506049421,-0.7216933894687093,0.8484848484848485,1.0,1.0,4/23,15.41%,ITGB2;ARHGAP12;ITGAM;IGLL1
prerank,GO_Biological_Process_2021__dicarboxylic acid transport (GO:0006835),0.31878081709782446,0.7216868896760112,0.90625,1.0,1.0,3/23,11.59%,SLC26A7;SLC19A1;SLC25A12
prerank,GO_Biological_Process_2021__negative regulation of cytokine production involved in inflammatory response (GO:1900016),-0.38344391845717063,-0.7214814720028504,0.7846153846153846,1.0,1.0,3/15,14.93%,APOD;NLRC3;ADCY7
prerank,GO_Biological_Process_2021__positive regulation of cellular protein metabolic process (GO:0032270),0.2599002820060465,0.7213060538830324,0.9090909090909091,1.0,1.0,6/94,6.22%,TBC1D10A;PRR16;PERP;SAMD4A;ERBB2;PCIF1
prerank,Reactome_2022__Defective Pyroptosis R-HSA-9710421,-0.3731479159333661,-0.7211605961774055,0.9090909090909091,1.0,1.0,4/23,14.24%,GSDME;H2BC4;H2AZ1;RBBP7
prerank,GO_Biological_Process_2021__sulfation (GO:0051923),0.3792208889437402,0.7211533712694627,0.8333333333333334,1.0,1.0,3/10,15.36%,HS3ST5;UST;SULT2A1
prerank,Reactome_2022__RAB Geranylgeranylation R-HSA-8873719,-0.31575983205239844,-0.7211202977556997,0.8970588235294118,1.0,1.0,9/55,17.11%,RAB34;RAB44;RAB11A;MPZ;RAB19;RAB6B;RAB8A;RABGGTB;RABGGTA
prerank,GO_Biological_Process_2021__negative regulation of fat cell differentiation (GO:0045599),-0.34351528044366597,-0.7209418901918156,0.9420289855072463,1.0,1.0,4/27,8.28%,TGFB1;WNT5A;GPER1;ZFPM1
prerank,GO_Biological_Process_2021__positive regulation of protein kinase activity (GO:0045860),0.2655799074345471,0.7206590430336368,1.0,1.0,1.0,32/130,21.17%,RASSF2;IRGM;NOX4;CCN1;RALB;SNCA;PAK5;TELO2;CASS4;PIH1D1;TNIK;RAP1A;CCDC88A;SNX9;LRP8;INSR;CLSPN;IL23A;SRCIN1;SYAP1;DUSP19;MMD2;STOX1;GRM5;TAB2;PAK3;PRKAG2;PAK2;MARK2;TRAF6;CACUL1;ACE
prerank,GO_Biological_Process_2021__negative regulation of blood vessel morphogenesis (GO:2000181),-0.32426762171957235,-0.7206445360382049,0.9135802469135802,1.0,1.0,11/58,13.55%,ALOX5;CNMD;STAT1;CD160;DCN;CLDN5;COL4A3;ISM1;THBS1;FOXO4;TEK
prerank,GO_Biological_Process_2021__response to organonitrogen compound (GO:0010243),0.3144741862298611,0.7206242803098211,0.8571428571428571,1.0,1.0,4/37,9.36%,TRPM2;DHFR;DRD4;RHBDD1
prerank,GO_Biological_Process_2021__ceramide metabolic process (GO:0006672),0.27707432251005804,0.7205825330703992,0.9666666666666667,1.0,1.0,12/46,20.35%,ST6GALNAC3;ACER2;SMPD4;NSMAF;PLPP2;ACER3;TLCD3B;PLA2G15;CERS4;SAMD8;FA2H;PLPP3
prerank,GO_Biological_Process_2021__tRNA 5'-end processing (GO:0099116),-0.40561384621447605,-0.7204123793620668,0.8064516129032258,1.0,1.0,1/13,3.12%,RPP38
prerank,GO_Biological_Process_2021__regulation of aldosterone biosynthetic process (GO:0032347),0.4159159115376447,0.7203965239322206,0.8378378378378378,1.0,1.0,1/7,4.40%,WNT4
prerank,GO_Biological_Process_2021__inorganic ion transmembrane transport (GO:0098660),0.3802124330947433,0.7203467132907649,0.8,1.0,1.0,2/9,9.13%,PKD2;ABCC8
prerank,GO_Biological_Process_2021__acyl-CoA metabolic process (GO:0006637),-0.342297325628998,-0.7202462751233896,0.8840579710144928,1.0,1.0,6/33,14.71%,ACSM6;ACOT6;ACOT4;ACSM3;ACOT1;ACOT2
prerank,CellMarker_Augmented_2021__Endothelial cell:Ovary,0.4121070222519844,0.7202226105991028,0.7708333333333334,1.0,1.0,1/7,6.95%,DSP
prerank,GO_Biological_Process_2021__positive regulation of interleukin-10 production (GO:0032733),-0.3703077879107277,-0.720187728687445,0.8870967741935484,1.0,1.0,1/18,2.33%,IRF4
prerank,GO_Biological_Process_2021__negative regulation of macromolecule metabolic process (GO:0010605),-0.28463661098689197,-0.720178147335108,0.961038961038961,1.0,1.0,15/151,14.65%,TGFB1;RIN3;LRPAP1;ESR1;GPER1;PINK1;CLDN5;PTRH2;REST;TERT;SPI1;ENG;HEY2;NOS2;VDR
prerank,GO_Biological_Process_2021__regulation of dendrite morphogenesis (GO:0048814),0.34509816118491293,0.7200245186727321,0.8461538461538461,1.0,1.0,7/31,18.97%,SARM1;RAP2A;TNIK;CUX1;PTPRD;NEDD4;ADGRB3
prerank,GO_Biological_Process_2021__endoplasmic reticulum tubular network organization (GO:0071786),0.359987998518101,0.7200113595280029,0.8064516129032258,1.0,1.0,3/13,32.15%,RAB10;REEP2;REEP1
prerank,Reactome_2022__Integration Of Provirus R-HSA-162592,0.3783831098371496,0.7197879284715198,0.7659574468085106,1.0,1.0,4/10,28.07%,SGIP1;LIG4;BANF1;PPIA
prerank,GO_Biological_Process_2021__mitotic spindle assembly (GO:0090307),-0.3307940997814922,-0.7193654702047976,0.9206349206349206,1.0,1.0,3/40,5.16%,MISP;ABRAXAS1;RAB11A
prerank,GO_Biological_Process_2021__cellular glucan metabolic process (GO:0006073),-0.4085271401372377,-0.7193530524610189,0.7666666666666667,1.0,1.0,1/9,11.23%,PYGL
prerank,GO_Biological_Process_2021__regulation of cellular localization (GO:0060341),0.2826017648066968,0.7192999013336464,0.972972972972973,1.0,1.0,8/45,17.24%,TRIM67;REEP6;FER;EFNA5;CDK16;PARD6B;WWC1;ADGRE2
prerank,CellMarker_Augmented_2021__Hepatocyte:Liver,-0.41921695769051537,-0.7192528213904619,0.7884615384615384,1.0,1.0,5/10,31.64%,CYP3A4;ALB;ABCC2;KRT8;ARG1
prerank,GO_Biological_Process_2021__cellular response to osmotic stress (GO:0071470),0.32416682626268095,0.7192414967492458,0.8648648648648649,1.0,1.0,6/18,27.08%,PKD2;WNK3;SLC4A11;SERPINB6;AQP1;STK39
prerank,Reactome_2022__Regulation Of Gene Expression In Beta Cells R-HSA-210745,0.3376704998793253,0.719235210617585,0.926829268292683,1.0,1.0,6/15,17.45%,FOXO1;AKT2;RFX6;MAP4K2;IAPP;PAX6
prerank,GO_Biological_Process_2021__protein localization to site of double-strand break (GO:1990166),-0.4919371488643006,-0.7192274343607717,0.8181818181818182,1.0,1.0,1/5,23.63%,SLF1
prerank,GO_Biological_Process_2021__nucleosome assembly (GO:0006334),-0.3387663770397509,-0.7189457402687772,0.8571428571428571,1.0,1.0,7/35,21.32%,HAT1;NAP1L2;GRWD1;CHAF1A;SMARCA5;H2BC18;SOX9
prerank,GO_Biological_Process_2021__tetrahydrobiopterin metabolic process (GO:0046146),0.3715037401369896,0.7188493263757438,0.8235294117647058,1.0,1.0,1/10,6.34%,DHFR
prerank,GO_Biological_Process_2021__cellular transition metal ion homeostasis (GO:0046916),0.2749821331201586,0.7188030178379102,0.9583333333333334,1.0,1.0,5/76,5.23%,MT1G;ACO1;SLC30A10;SLC39A8;FLVCR1
prerank,GO_Biological_Process_2021__regulation of chromatin organization (GO:1902275),0.40477909561493874,0.7186568136705455,0.9375,1.0,1.0,6/12,36.38%,MLLT3;METTL4;SSRP1;HNRNPU;SETD5;TLK2
prerank,CellMarker_Augmented_2021__Effector T cell:Undefined,0.4098728185892757,0.7184366419878903,0.8536585365853658,1.0,1.0,5/8,39.07%,IL2RB;BTLA;KLRG1;TNFRSF8;HAVCR2
prerank,GO_Biological_Process_2021__positive regulation of neuroblast proliferation (GO:0002052),0.4136040048051556,0.7184007111057745,0.8717948717948718,1.0,1.0,3/11,8.37%,SMARCD3;CX3CR1;DCT
prerank,GO_Biological_Process_2021__positive regulation of microtubule polymerization (GO:0031116),-0.35009930217130547,-0.7183008095788158,0.859375,1.0,1.0,7/26,22.88%,CAV3;ANKRD53;DCTN1;RAC1;CDK5R1;DRG1;PSRC1
prerank,CellMarker_Augmented_2021__Limbal Mesenchymal cell:Sclerocorneal Tissue,-0.2998689597483315,-0.7182930619997057,0.9315068493150684,1.0,1.0,12/86,14.70%,ANGPTL2;NID1;COL5A1;FBXL7;DAB2;DCN;HEG1;PTX3;ENG;EDNRB;TEK;ACTA2
prerank,GO_Biological_Process_2021__phosphatidylinositol biosynthetic process (GO:0006661),0.24735081899227546,0.7182727299407549,1.0,1.0,1.0,33/115,23.27%,PIGQ;DPM3;PITPNM1;PI4KB;ITPKB;TMEM150A;PIK3C2B;MTMR8;PI4K2B;PIK3CA;PIGA;MTMR3;SMG1;PIP4K2A;RAB5A;TTC7B;IP6K1;PIK3R5;EFR3B;MTMR14;SLA2;MTMR1;MTM1;SOCS7;PIGF;SOCS4;PLCG2;PIK3R4;PTEN;IP6K2;PIGZ;CDS1;VAC14
prerank,GO_Biological_Process_2021__lymphocyte differentiation (GO:0030098),0.28399268997132626,0.7181176062957751,0.9428571428571428,1.0,1.0,17/57,21.76%,KIT;ADGRG3;ITGA4;TOX;LEPR;GPR89A;FLT3;HDAC4;GPR89B;PBX1;IL11;KLF6;HDAC5;PLCG2;ZBTB7A;PTPRJ;JAG2
prerank,GO_Biological_Process_2021__positive regulation of establishment of endothelial barrier (GO:1903142),0.44082719265928516,0.7181071230908179,0.8333333333333334,1.0,1.0,1/5,2.83%,CDH5
prerank,GO_Biological_Process_2021__positive regulation of endothelial cell development (GO:1901552),0.44082719265928516,0.7181071230908179,0.8333333333333334,1.0,1.0,1/5,2.83%,CDH5
prerank,GO_Biological_Process_2021__double-strand break repair (GO:0006302),0.24718833488944023,0.7180544098110595,1.0,1.0,1.0,31/150,18.58%,RFWD3;BRCC3;TENT4A;SEM1;RNF168;HMGB1;SMARCAL1;PPP5C;MAPK8;POLM;SETMAR;KDM2A;REV3L;SMC5;MMS22L;TRIP13;H2AX;PAXX;AP5Z1;SPIDR;HERC2;EYA3;BAZ1B;LIG4;ATM;RAD52;SAMHD1;NSMCE2;FBH1;MDC1;EME2
prerank,Reactome_2022__Acyl Chain Remodelling Of PC R-HSA-1482788,-0.36542383258379013,-0.7179106878873694,0.8571428571428571,1.0,1.0,4/19,20.26%,PLA2G10;PLB1;PLA2G4A;PLA2G4D
prerank,GO_Biological_Process_2021__telomere maintenance via telomere lengthening (GO:0010833),0.3247474950506064,0.7177953224885806,0.8611111111111112,1.0,1.0,6/34,14.52%,ZSCAN4;TELO2;CTC1;TERF1;ACD;WRAP53
prerank,GO_Biological_Process_2021__purine ribonucleotide biosynthetic process (GO:0009152),0.28276483668612656,0.7177564562531434,0.9310344827586207,1.0,1.0,16/42,23.80%,PAPSS2;AMPD1;PANK1;ADCY2;IMPDH1;ADCY3;PPCS;GMPS;SLC25A16;ADCY6;SLC35B2;GUCY1A1;AMPD3;SLC26A2;ACOT7;PANK3
prerank,CellMarker_Augmented_2021__Exhausted CD4+ T cell:Liver,-0.2982155673976127,-0.7177455356174215,0.9210526315789473,1.0,1.0,8/100,8.10%,SIRPG;ARHGAP9;CXCL13;ITM2A;MAPKAPK3;UBE2L6;ETV7;PHEX
prerank,GO_Biological_Process_2021__positive regulation of lipid kinase activity (GO:0090218),-0.35214585392282305,-0.7177179653172505,0.8545454545454545,1.0,1.0,2/24,2.75%,TGFB1;P2RY12
prerank,CellMarker_Augmented_2021__Myeloid cell:Tonsil,-0.43269491904281276,-0.717683096555576,0.803030303030303,1.0,1.0,3/7,19.68%,FCGR3A;ITGAM;ITGAX
prerank,GO_Biological_Process_2021__regulation of pri-miRNA transcription by RNA polymerase II (GO:1902893),-0.34134738446430246,-0.7176194544087487,0.9027777777777778,1.0,1.0,6/35,16.15%,TGFB1;REST;TERT;SPI1;GNL3;SMAD3
prerank,GO_Biological_Process_2021__regulation of receptor internalization (GO:0002090),-0.3380170394908178,-0.7174938891860103,0.9076923076923077,1.0,1.0,5/31,13.58%,RIN3;LRPAP1;SFRP4;CD63;RSPO1
prerank,Reactome_2022__Prostacyclin Signaling Thru Prostacyclin Receptor R-HSA-392851,-0.4086587832149604,-0.7174835802647178,0.8421052631578947,1.0,1.0,5/14,29.93%,GNGT1;GNG13;GNG12;GNG4;GNG3
prerank,GO_Biological_Process_2021__steroid biosynthetic process (GO:0006694),0.29689894421132834,0.7174563145897602,0.9130434782608695,1.0,1.0,6/52,8.63%,CYP7B1;OSBPL3;OSBPL6;AKR1C3;SLC27A2;OSBPL7
prerank,GO_Biological_Process_2021__positive regulation of DNA demethylation (GO:1901537),0.4706538105164624,0.7170185791949891,0.8837209302325582,1.0,1.0,1/5,6.12%,TOX
prerank,GO_Biological_Process_2021__regulation of DNA demethylation (GO:1901535),0.4706538105164624,0.7170185791949891,0.8837209302325582,1.0,1.0,1/5,6.12%,TOX
prerank,GO_Biological_Process_2021__negative regulation of bone remodeling (GO:0046851),0.414476095657333,0.7168546572696473,0.851063829787234,1.0,1.0,2/7,12.54%,GREM1;UBASH3B
prerank,"GO_Biological_Process_2021__base-excision repair, gap-filling (GO:0006287)",-0.3466968783485397,-0.7167784665161288,0.90625,1.0,1.0,6/33,22.81%,RPA3;POLD4;SMUG1;OGG1;RPA2;XRCC1
prerank,KEGG_2021_Human__mTOR signaling pathway,-0.28184871247567567,-0.716591531469334,0.9726027397260274,1.0,1.0,18/138,16.93%,WNT5A;WNT8B;ATP6V1G2;FZD8;ATP6V1C2;ATP6V1D;PIK3R3;DEPDC5;STRADB;WNT8A;WNT6;RRAGA;STRADA;PIK3CB;ATP6V1E1;EIF4E1B;DDIT4;WNT10A
prerank,GO_Biological_Process_2021__positive regulation of secretion by cell (GO:1903532),-0.3048468097611358,-0.7164146251048309,0.9130434782608695,1.0,1.0,6/59,14.43%,TGFB1;GPER1;PLA2G10;ATP6AP1;TTN;TGFB3
prerank,CellMarker_Augmented_2021__Lake Et al.Science.In6:Brain,-0.29699458765279835,-0.7163776029277265,0.9512195121951219,1.0,1.0,7/91,12.76%,EPN1;PINK1;PPP1R1A;CLDN5;CLU;VWF;GPX3
prerank,GO_Biological_Process_2021__autonomic nervous system development (GO:0048483),-0.39464055184462554,-0.7163447780929024,0.819672131147541,1.0,1.0,5/15,19.91%,SOX10;SEMA3A;EDNRB;NTRK1;FN1
prerank,Reactome_2022__Ub-specific Processing Proteases R-HSA-5689880,-0.2805338186656027,-0.7163395985794441,0.9753086419753086,1.0,1.0,20/156,20.52%,PSMB9;MAT2B;CDC25A;TOMM20;H2BC4;PTRH2;USP13;USP17L2;FOXO4;TAF9B;VDAC1;TAF10;SMAD3;PSMA3;RPS27A;PSMA7;PSMB6;SUDS3;H2BC18;OTUB1
prerank,GO_Biological_Process_2021__regulation of T cell differentiation in thymus (GO:0033081),0.3649764087781846,0.716201989675009,0.8095238095238095,1.0,1.0,4/10,25.76%,TOX;BMP4;ADAM8;SHH
prerank,GO_Biological_Process_2021__positive regulation of cell aging (GO:0090343),0.37047678850778964,0.7161699434662383,0.8095238095238095,1.0,1.0,2/10,10.79%,SIRT1;ABI3
prerank,"GO_Biological_Process_2021__positive regulation of CD8-positive, alpha-beta T cell activation (GO:2001187)",0.3997289201134327,0.7161552589152793,0.7678571428571429,1.0,1.0,1/6,3.64%,CBFB
prerank,GO_Biological_Process_2021__melanosome organization (GO:0032438),-0.3648261149424801,-0.7160296391500091,0.8035714285714286,1.0,1.0,4/22,23.62%,ASIP;SNAPIN;BLOC1S2;HPS4
prerank,Reactome_2022__Cellular Response To Hypoxia R-HSA-1234174,0.28341173238482986,0.7159574198634856,1.0,1.0,1.0,5/63,8.65%,EGLN3;PSME4;SEM1;PSMA1;HIF3A
prerank,KEGG_2021_Human__Vitamin digestion and absorption,0.3331640074566937,0.7158740524756407,0.8611111111111112,1.0,1.0,5/21,15.68%,APOB;SLC19A1;AWAT2;ABCC1;TCN2
prerank,GO_Biological_Process_2021__protein modification by small protein conjugation (GO:0032446),0.2438256128695559,0.7157980935487827,1.0,1.0,1.0,61/353,18.43%,RFWD3;RNF182;LZTR1;KLHL20;NUP210;NEUROD2;UBE2E3;NUP42;COMMD1;PEX13;SIRT1;DTX1;KLHL41;RNF168;ARRB2;BCL11A;TRIM69;TRIM35;DCUN1D1;WWP2;HIF3A;RNF152;PDZRN3;UBE2E1;UBE2D4;AAAS;TSPAN17;KLHL18;ANAPC16;MSL2;GAN;TRIM44;RNF38;KLHL24;KLHL3;UBE2A;CCDC22;RNF212;ARRB1;SMURF1;TRIM4;HERC2;SHPRH;CNOT4;BRAP;UBE2Z;MARCHF3;ZNRF3;FBXO4;NEDD4;ARIH1;UBE2L3;NSMCE2;FBH1;HERC5;RNF113A;NFX1;RANBP2;TRIM47;MIB2;ANAPC7
prerank,GO_Biological_Process_2021__response to hydroxyurea (GO:0072710),0.4107756989008643,0.715797429628797,0.7727272727272727,1.0,1.0,2/9,14.75%,TIMELESS;SPIDR
prerank,GO_Biological_Process_2021__gene expression (GO:0010467),0.22645096551779056,0.71576514874159,1.0,1.0,1.0,26/327,11.04%,MLF1;NOX4;CPSF1;NUP210;NOVA1;RPL3L;NXF5;NUP42;ATXN1;DTX1;HNRNPF;BICD1;RBMS1;PPP5C;TAF1B;NXT1;HNRNPH1;NR4A2;NXF1;U2AF1;SRRM1;HNRNPL;AAAS;TSPAN17;ELAVL4;MRPL41
prerank,Reactome_2022__APC/C:Cdc20 Mediated Degradation Of Securin R-HSA-174154,-0.30490564737900455,-0.7153647518278718,0.8933333333333333,1.0,1.0,1/58,0.62%,PSMB9
prerank,GO_Biological_Process_2021__fatty acid elongation (GO:0030497),-0.37546040630787625,-0.7152328207698363,0.7931034482758621,1.0,1.0,1/12,1.18%,ELOVL2
prerank,Reactome_2022__RUNX1 Regulates Transcription Of Genes Involved In Differentiation Of HSCs R-HSA-8939236,-0.29436050313106665,-0.7151121891778175,0.9714285714285714,1.0,1.0,10/69,19.11%,PSMB9;TCF7L1;H2BC4;SPI1;H2AZ1;YAP1;PSMA3;RPS27A;PSMA7;PSMB6
prerank,GO_Biological_Process_2021__regulation of cellular response to heat (GO:1900034),0.26304821103555537,0.7151044855041283,1.0,1.0,1.0,12/76,18.84%,MAPKAPK2;NUP210;NUP42;SIRT1;MLST8;AAAS;HSPA1A;HSF1;ATM;RANBP2;ATR;EP300
prerank,GO_Biological_Process_2021__anterior/posterior pattern specification (GO:0009952),-0.3675327179497375,-0.714885689527764,0.8260869565217391,1.0,1.0,5/26,14.82%,TBX1;WNT8A;ATP6AP2;HEY2;GATA4
prerank,Reactome_2022__Activated NTRK2 Signals Thru FYN R-HSA-9032500,0.43929831000252584,0.7146606279871311,0.8125,1.0,1.0,4/6,31.97%,NTRK2;DOCK3;FYN;GRIN2B
prerank,GO_Biological_Process_2021__beta-catenin destruction complex assembly (GO:1904885),0.4714173818585124,0.714630258182987,0.8918918918918919,1.0,1.0,3/5,37.09%,AXIN1;GSK3B;APC
prerank,GO_Biological_Process_2021__positive regulation of interferon-alpha production (GO:0032727),-0.38229516017636656,-0.714418555010693,0.8507462686567164,1.0,1.0,2/13,14.99%,STAT1;DDX3X
prerank,GO_Biological_Process_2021__cAMP biosynthetic process (GO:0006171),0.3995983115075452,0.7143928550582941,0.8636363636363636,1.0,1.0,3/9,18.06%,ADCY2;ADCY3;ADCY6
prerank,KEGG_2021_Human__Aldosterone synthesis and secretion,0.28191764646841383,0.7143863267412662,0.9523809523809523,1.0,1.0,10/83,11.91%,ITPR2;CREB3L2;CREB3L4;PLCB1;ADCY2;NR4A2;ATF1;LDLR;ADCY3;CAMK1G
prerank,GO_Biological_Process_2021__male gonad development (GO:0008584),0.3041605480892695,0.7142801489671416,0.8918918918918919,1.0,1.0,5/27,9.97%,KIT;WNT4;AKR1C3;KITLG;MAMLD1
prerank,GO_Biological_Process_2021__negative regulation of kinase activity (GO:0033673),0.2821414426615895,0.7141043488041442,0.96,1.0,1.0,17/58,20.34%,HSPB1;CEP85;SNCA;DEPTOR;TRIB2;LRP6;IRS2;SPRED1;UBASH3B;NF1;WWTR1;DUSP19;TAB1;TARBP2;PRKAG2;PAK2;GNAQ
prerank,GO_Biological_Process_2021__regulation of necroptotic process (GO:0060544),0.3420356562851739,0.7138616787189267,0.9,1.0,1.0,1/20,2.32%,CFLAR
prerank,GO_Biological_Process_2021__protein homotetramerization (GO:0051289),0.2917742312741477,0.7137723222048572,0.90625,1.0,1.0,12/45,20.31%,TDO2;TRPM2;PKD2;HCN1;ACACB;ALDH1A2;USP16;HPRT1;SAMHD1;SHMT2;APPL2;CRYZ
prerank,CellMarker_Augmented_2021__Embryonic Stem cell:Tooth,-0.30647040598301345,-0.7136316519227778,0.9305555555555556,1.0,1.0,12/64,13.89%,NODAL;SALL4;SLC7A3;TUNAR;CA14;CLDN6;C1ORF94;FBN3;DRAXIN;CCDC172;ADGRG2;ZBTB8A
prerank,CellMarker_Augmented_2021__Epithelial cell:Thymus,-0.2845761860817745,-0.7136204361711521,0.9868421052631579,1.0,1.0,12/78,17.22%,PKP2;MISP;SEMA3F;EPN3;MYO5B;LAMC2;SOWAHB;BAIAP2L1;PPIC;TOM1L1;YAP1;SCNN1A
prerank,Reactome_2022__mTORC1-mediated Signaling R-HSA-166208,0.33808860776525235,0.7134556659603761,0.8444444444444444,1.0,1.0,7/22,25.85%,MLST8;EEF2K;EIF4EBP1;EIF4E;RRAGD;LAMTOR4;RPS6KB1
prerank,Reactome_2022__Metabolism Of Nitric Oxide: NOS3 Activation And Regulation R-HSA-202131,0.3312645357396006,0.7133172406602298,0.8484848484848485,1.0,1.0,3/15,11.24%,DDAH2;NANOS3;DDAH1
prerank,KEGG_2021_Human__GnRH secretion,0.27141051931326066,0.7131237575165835,1.0,1.0,1.0,10/61,14.95%,ITPR2;ARRB2;HCN1;KCNJ3;KCNJ6;PLCB1;AKT2;ARRB1;HCN3;PIK3CA
prerank,GO_Biological_Process_2021__regulation of actin filament polymerization (GO:0030833),-0.30784694573968474,-0.7130613552421764,0.9240506329113924,1.0,1.0,8/63,12.97%,LMOD1;HCK;C15ORF62;KANK3;ALOX15;VIL1;ARHGAP28;BAIAP2L1
prerank,GO_Biological_Process_2021__myeloid dendritic cell activation (GO:0001773),-0.4331903775519025,-0.7128492273229402,0.8620689655172413,1.0,1.0,1/8,5.45%,DOCK2
prerank,Reactome_2022__Defective CFTR Causes Cystic Fibrosis R-HSA-5678895,-0.3035987474042019,-0.712718848909671,0.9452054794520548,1.0,1.0,1/54,0.62%,PSMB9
prerank,GO_Biological_Process_2021__negative regulation of vascular permeability (GO:0043116),0.3883417904101794,0.7127011773390364,0.8648648648648649,1.0,1.0,3/11,11.24%,ANGPT1;SLIT2;DDAH1
prerank,GO_Biological_Process_2021__positive regulation of histone H3-K27 methylation (GO:0061087),0.4147381489178784,0.712569412940756,0.8478260869565217,1.0,1.0,1/5,21.53%,PHF1
prerank,Reactome_2022__Highly Calcium Permeable Nicotinic Acetylcholine Receptors R-HSA-629597,-0.40281030821367203,-0.7125531723672219,0.796875,1.0,1.0,4/9,27.58%,CHRNA5;CHRNA3;CHRNB2;CHRNA6
prerank,GO_Biological_Process_2021__negative regulation of neurogenesis (GO:0050768),0.3248542980456057,0.7124813787205534,0.8387096774193549,1.0,1.0,7/30,22.04%,PCM1;WNT3A;NF1;NOTCH1;PAX6;APPL2;PTEN
prerank,GO_Biological_Process_2021__response to dsRNA (GO:0043331),-0.4477927681651333,-0.7123757321626099,0.7454545454545455,1.0,1.0,1/7,4.00%,IFNK
prerank,GO_Biological_Process_2021__regulation of cellular response to osmotic stress (GO:0106049),0.4606699799455862,0.7122140047878708,0.8484848484848485,1.0,1.0,2/5,19.44%,MICU1;SLC25A23
prerank,Reactome_2022__Beta-catenin Independent WNT Signaling R-HSA-3858494,-0.29348445624724934,-0.712196722379021,0.975,1.0,1.0,6/127,5.29%,PSMB9;TCF7;WNT5A;PDE6B;FZD8;TCF7L1
prerank,Reactome_2022__Nuclear Events Stimulated By ALK Signaling In Cancer R-HSA-9725371,0.33243060498812893,0.7121879045525977,0.8214285714285714,1.0,1.0,1/18,3.03%,BCL2A1
prerank,Reactome_2022__Metabolism Of Steroids R-HSA-8957322,-0.2837454537589796,-0.7120307333865542,0.9605263157894737,1.0,1.0,23/132,19.47%,SLC51A;AMACR;ACOX2;CYP24A1;PLPP6;HSD3B7;AKR1B15;CYP21A2;LRP2;HSD11B1;NFYB;VDR;NR1H4;STARD5;SLC10A1;SLCO1A2;HSD3B1;ABCB11;LDLRAP1;PKMYT1;SLC27A5;CYP17A1;DAND5
prerank,Reactome_2022__Defective GALNT12 Causes CRCS1 R-HSA-5083636,-0.39612233158649174,-0.711842278266406,0.864406779661017,1.0,1.0,5/13,18.18%,MUCL1;MUC5B;MUC4;MUC17;MUC15
prerank,KEGG_2021_Human__Human papillomavirus infection,-0.2693180840218551,-0.7117919709793593,0.9770114942528736,1.0,1.0,44/281,16.22%,TCF7;WNT5A;WNT8B;ATP6V1G2;CCND1;FZD8;IRF1;COL1A1;TCF7L1;VTN;STAT1;PPP2R3A;HLA-A;ATP6V1C2;ATP6V1D;PIK3R3;ATP6AP1;COL4A4;UBE3A;ITGA9;TNXB;CCND2;COL4A3;THBS1;VWF;TERT;ITGA2B;ATP6V0E2;LAMC2;WNT8A;COL6A6;CDKN1A;ITGB6;WNT6;CHAD;PIK3CB;ITGA5;HEY2;TBPL1;ATP6V1E1;CCNE2;HLA-F;COL4A6;ITGB5
prerank,GO_Biological_Process_2021__response to axon injury (GO:0048678),0.35102277313453917,0.7116653958721814,0.8823529411764706,1.0,1.0,4/15,10.21%,SARM1;DHFR;MORN4;MTR
prerank,Reactome_2022__Defects In Cobalamin (B12) Metabolism R-HSA-3296469,0.34234791983074403,0.7115669351052206,0.8333333333333334,1.0,1.0,4/13,21.21%,MTR;TCN2;CD320;MMAB
prerank,KEGG_2021_Human__Cellular senescence,-0.28718141592323104,-0.7115147863158844,1.0,1.0,1.0,25/139,18.10%,FOXM1;TGFB1;HIPK4;SLC25A31;CCND1;CDC25A;HLA-A;PIK3R3;CCND2;TRAF3IP2;CDKN1A;RAD1;PIK3CB;VDAC1;TGFB3;GATA4;ITPR3;RRAS;CCNE2;HLA-F;HIPK1;SMAD3;ZFP36L1;CALM1;NFATC2
prerank,GO_Biological_Process_2021__protein neddylation (GO:0045116),0.41209700241070535,0.7114599548764262,0.75,1.0,1.0,1/8,7.00%,DCUN1D1
prerank,GO_Biological_Process_2021__glucose transmembrane transport (GO:1904659),-0.3703127274483098,-0.7113562467562237,0.9,1.0,1.0,2/14,10.05%,SLC5A1;HNF1A
prerank,GO_Biological_Process_2021__regulation of adaptive immune response (GO:0002819),-0.38032526343672535,-0.7113370030234576,0.828125,1.0,1.0,3/14,7.49%,AHR;IRF1;ALOX15
prerank,KEGG_2021_Human__Mismatch repair,-0.368395804618184,-0.711312530407069,0.8805970149253731,1.0,1.0,6/22,27.41%,RPA3;POLD4;RPA2;MSH6;MLH1;PCNA
prerank,GO_Biological_Process_2021__reticulophagy (GO:0061709),0.3776995705910975,0.711282568162932,0.8108108108108109,1.0,1.0,4/13,22.73%,ATG2A;ATG2B;RETREG1;STING1
prerank,GO_Biological_Process_2021__transepithelial transport (GO:0070633),-0.36299515546644506,-0.711210300981262,0.8615384615384616,1.0,1.0,5/16,24.67%,ABCG2;ABCB1;RHBG;SLC23A1;ABCC2
prerank,GO_Biological_Process_2021__pyrimidine nucleotide metabolic process (GO:0006220),-0.463703656995038,-0.7110775106721194,0.8367346938775511,1.0,1.0,2/5,22.60%,PRPS1;DCK
prerank,GO_Biological_Process_2021__leucine metabolic process (GO:0006551),0.42462532410228226,0.7110433780136651,0.782608695652174,1.0,1.0,3/7,23.72%,BCAT1;MCCC1;HMGCLL1
prerank,GO_Biological_Process_2021__regulation of protein transport (GO:0051223),0.3144189038020634,0.7109619568853898,0.9090909090909091,1.0,1.0,2/25,7.94%,LLGL1;WWP2
prerank,GO_Biological_Process_2021__protein lipidation (GO:0006497),0.25394208362790294,0.7105491403658182,1.0,1.0,1.0,17/58,23.87%,PIGQ;DPM3;ZDHHC16;ZDHHC18;ZDHHC12;ZDHHC14;PIGA;ZDHHC3;ZDHHC13;GPLD1;ZDHHC9;PIGF;ZDHHC5;ZDHHC23;PIGZ;ATG12;ZDHHC20
prerank,Reactome_2022__RUNX2 Regulates Genes Involved In Cell Migration R-HSA-8941332,0.4070587606064552,0.7104657998549534,0.7954545454545454,1.0,1.0,2/7,9.44%,CBFB;AKT2
prerank,GO_Biological_Process_2021__regulation of cell cycle G2/M phase transition (GO:1902749),-0.300424976809524,-0.7104321394144306,0.95,1.0,1.0,11/79,16.30%,NEK2;KIF14;DCTN1;USP17L2;ATF5;TUBA4A;CEP72;DYNLL1;ATAD5;TUBB;CEP76
prerank,KEGG_2021_Human__Aminoacyl-tRNA biosynthesis,-0.3286180580825945,-0.7103943580374191,0.8382352941176471,1.0,1.0,5/42,16.58%,NARS1;DARS2;WARS1;YARS2;TARS3
prerank,KEGG_2021_Human__Chemokine signaling pathway,-0.27524872797567435,-0.7101963735654155,0.9871794871794872,1.0,1.0,17/132,17.46%,XCR1;HCK;CXCL13;VAV3;GRK7;DOCK2;STAT1;WAS;PIK3R3;GNGT1;CXCL16;CXCR5;PIK3CB;ADCY7;RAC2;RAC1;PIK3CG
prerank,GO_Biological_Process_2021__regulation of gene silencing by miRNA (GO:0060964),0.30141629534987513,0.7099524706910659,0.9259259259259259,1.0,1.0,5/62,10.02%,NUP210;NUP42;PPARG;TRIM71;AAAS
prerank,GO_Biological_Process_2021__cell surface receptor signaling pathway involved in heart development (GO:0061311),-0.4121592217183727,-0.7096859519098454,0.8387096774193549,1.0,1.0,1/15,1.49%,TGFB1
prerank,Reactome_2022__Sialic Acid Metabolism R-HSA-4085001,-0.3442027181892213,-0.7095129907540255,0.9130434782608695,1.0,1.0,3/31,8.60%,ST6GALNAC1;NANS;ST6GALNAC2
prerank,Reactome_2022__RHOBTB2 GTPase Cycle R-HSA-9013418,-0.3524884560131697,-0.7095104539142225,0.9264705882352942,1.0,1.0,8/22,30.35%,ACTG1;CDC37;TMOD3;HSP90AB1;CCT6A;CCT7;CCT2;TXNL1
prerank,"GO_Biological_Process_2021__SRP-dependent cotranslational protein targeting to membrane, translocation (GO:0006616)",0.45312909089979625,0.7093633868908886,0.8148148148148148,1.0,1.0,2/5,27.81%,SEC61A1;SEC61A2
prerank,PanglaoDB_Augmented_2021__Gamma Delta T Cells,-0.34057518423183314,-0.7093176517870615,0.8888888888888888,1.0,1.0,9/31,19.93%,SIRPG;KLRB1;ICAM3;H2AZ1;TUBB;CD8B;ADGRG1;STMN1;SPON2
prerank,GO_Biological_Process_2021__detection of light stimulus involved in sensory perception (GO:0050962),-0.41158401097641956,-0.709308133579375,0.8253968253968254,1.0,1.0,1/10,1.75%,TULP1
prerank,GO_Biological_Process_2021__detection of light stimulus involved in visual perception (GO:0050908),-0.41158401097641956,-0.709308133579375,0.8253968253968254,1.0,1.0,1/10,1.75%,TULP1
prerank,GO_Biological_Process_2021__regulation of centriole replication (GO:0046599),-0.37696534235786927,-0.7090191982576858,0.8571428571428571,1.0,1.0,3/14,17.66%,BRCA1;CEP76;C10ORF90
prerank,Reactome_2022__Cellular Response To Heat Stress R-HSA-3371556,-0.30375690528507204,-0.7090102221545553,0.9615384615384616,1.0,1.0,20/92,25.46%,GML;HSPA1L;RPA3;CRYBA4;HSPA8;COL4A6;DNAJB1;CAMK2A;HSPH1;NUP93;DNAJC2;HSPA4;HSPA5;SEC13;BAG5;HSPA2;HSP90AB1;HSPA13;FKBP4;EEF1A1
prerank,GO_Biological_Process_2021__regulation of receptor binding (GO:1900120),0.40079826655306267,0.7089188709055712,0.7555555555555555,1.0,1.0,1/9,1.25%,GREM2
prerank,GO_Biological_Process_2021__3'-phosphoadenosine 5'-phosphosulfate metabolic process (GO:0050427),0.36476250743309546,0.7089105798495251,0.925,1.0,1.0,1/18,2.21%,PAPSS2
prerank,GO_Biological_Process_2021__regulation of vacuole organization (GO:0044088),-0.35445141430860994,-0.7087858030631168,0.8524590163934426,1.0,1.0,2/21,6.83%,ENO4;ENO2
prerank,GO_Biological_Process_2021__regulation of immunoglobulin mediated immune response (GO:0002889),-0.45603553846549405,-0.7084722336607975,0.82,1.0,1.0,3/5,38.15%,TNFSF4;SUPT6H;CD226
prerank,GO_Biological_Process_2021__regulation of melanin biosynthetic process (GO:0048021),0.3822625147206935,0.7084318290772421,0.8421052631578947,1.0,1.0,3/10,22.58%,ZEB2;OPN3;TYRP1
prerank,GO_Biological_Process_2021__response to misfolded protein (GO:0051788),-0.45859497867981425,-0.7083789172169688,0.864406779661017,1.0,1.0,2/8,18.14%,CLU;STUB1
prerank,GO_Biological_Process_2021__positive regulation of helicase activity (GO:0051096),-0.4359822161897585,-0.7083113982474263,0.8666666666666667,1.0,1.0,1/7,22.25%,MSH6
prerank,GO_Biological_Process_2021__negative regulation of cell migration involved in sprouting angiogenesis (GO:0090051),-0.38957505940210035,-0.7082676545742336,0.873015873015873,1.0,1.0,5/12,31.63%,THBS1;MMRN2;DLL4;TBXA2R;PDCD10
prerank,Reactome_2022__RHO GTPases Activate PKNs R-HSA-5625740,0.28752171984315256,0.70823335551157,0.8461538461538461,1.0,1.0,6/42,13.73%,KLKB1;H2BC21;REXO2;NCOA2;PKN2;H2AX
prerank,GO_Biological_Process_2021__positive regulation of macrophage derived foam cell differentiation (GO:0010744),-0.3865160994952581,-0.708232846637767,0.9193548387096774,1.0,1.0,5/13,16.51%,PLA2G10;PRKCH;IL18;AGT;ALOX15B
prerank,GO_Biological_Process_2021__positive regulation of transferase activity (GO:0051347),-0.2791132599050394,-0.7081621817201513,0.9743589743589743,1.0,1.0,6/133,7.35%,NEK2;TGFB1;ROS1;PLAAT4;PINK1;FLT4
prerank,GO_Biological_Process_2021__negative regulation of ATP metabolic process (GO:1903579),0.33775667298893725,0.7078344780968591,0.8421052631578947,1.0,1.0,3/15,14.76%,PID1;MLXIPL;HDAC4
prerank,GO_Biological_Process_2021__negative regulation of chromatin silencing (GO:0031936),-0.42185415208719335,-0.7078188313002851,0.8676470588235294,1.0,1.0,4/9,24.41%,H1-0;H1-3;HMGA1;H1-2
prerank,GO_Biological_Process_2021__negative regulation of chromatin organization (GO:1905268),-0.42185415208719335,-0.7078188313002851,0.8676470588235294,1.0,1.0,4/9,24.41%,H1-0;H1-3;HMGA1;H1-2
prerank,GO_Biological_Process_2021__negative regulation of gene silencing (GO:0060969),-0.42185415208719335,-0.7078188313002851,0.8676470588235294,1.0,1.0,4/9,24.41%,H1-0;H1-3;HMGA1;H1-2
prerank,GO_Biological_Process_2021__nucleobase biosynthetic process (GO:0046112),0.4201620428516212,0.7077585960132976,0.8181818181818182,1.0,1.0,3/7,18.77%,GMPS;CTPS2;SHMT2
prerank,GO_Biological_Process_2021__regulation of I-kappaB kinase/NF-kappaB signaling (GO:0043122),-0.2700859494946175,-0.7075677139288515,0.9615384615384616,1.0,1.0,15/182,10.21%,TRIM62;S100A13;WNT5A;TERF2IP;NLRP12;LPAR1;ESR1;TRIM5;PINK1;TRIM25;STAT1;HTR2B;EDAR;TRAF3IP2;HLA-DRB1
prerank,GO_Biological_Process_2021__Arp2/3 complex-mediated actin nucleation (GO:0034314),0.39162613105751326,0.7074726292931183,0.8108108108108109,1.0,1.0,4/12,28.72%,ARPC3;MAGEL2;JMY;WHAMM
prerank,Reactome_2022__Attachment Of GPI Anchor To uPAR R-HSA-162791,0.4208952752577698,0.7074351106482577,0.8205128205128205,1.0,1.0,1/6,14.27%,PGAP1
prerank,GO_Biological_Process_2021__negative regulation of cell growth (GO:0030308),0.24786098796871073,0.7073721795733582,1.0,1.0,1.0,20/103,16.51%,BCL6;KIAA0319;DCBLD2;SIRT1;DACT3;DCC;ST7L;PML;SLIT2;SIPA1;PPP1R9B;SMARCA2;SMARCA4;HSPA1A;ADAM15;CGRRF1;SERTAD2;TP53;DIP2B;MINAR1
prerank,GO_Biological_Process_2021__regulation of helicase activity (GO:0051095),0.41137845958496877,0.7073087698972903,0.8529411764705882,1.0,1.0,2/9,15.44%,SIRT1;TP53
prerank,GO_Biological_Process_2021__regulation of bicellular tight junction assembly (GO:2000810),0.34870514711875883,0.7072524830643296,0.926829268292683,1.0,1.0,4/16,15.67%,CBFB;SNAI2;MYO1C;RUNX1
prerank,GO_Biological_Process_2021__camera-type eye development (GO:0043010),0.30951873093480403,0.7072375583224335,0.8888888888888888,1.0,1.0,5/21,13.81%,TSKU;TENM3;CEP290;EFEMP1;NF1
prerank,GO_Biological_Process_2021__endoplasmic reticulum to Golgi vesicle-mediated transport (GO:0006888),0.25288010295840946,0.707003454994958,1.0,1.0,1.0,42/160,24.87%,GOLT1A;SPTBN4;TICAM2;STX5;GBF1;TRAPPC1;SEC24C;F2;TRAPPC12;CNIH3;DYNC1I2;TGFA;SPAST;TMED3;BET1;VTI1A;PREB;COG7;PGAP1;ANK2;YIF1A;SEC22B;CTSC;GOLGB1;MIA3;COG5;COG4;TMEM115;TRIP11;TFG;CAPZA1;TRAPPC11;CD55;COG2;SEC31A;ANK1;COG3;CNIH2;SPTB;ANK3;GAS6;CAPZB
prerank,Reactome_2022__Cellular Responses To Stimuli R-HSA-8953897,0.21750788258308376,0.7067852067786604,1.0,1.0,1.0,72/636,14.81%,ATP6V0D2;EGLN3;MT1G;NOX4;EXTL1;HDAC3;MAPKAPK2;TCIRG1;NUP210;KPTN;RORA;APOB;RPL3L;PHC2;SMARCD3;NUP42;CREB3L2;SIRT1;PSME4;CREB3L4;SEM1;LMNB1;PDIA6;EXOSC1;H2BC21;ATF3;NCOA2;CHAC1;TACO1;CDK6;PSMA1;EIF2AK3;NRIP1;CDK4;MAPK8;MYC;CTDSP2;DYNC1I2;HIF3A;MLST8;KHSRP;MOV10;TNIK;AKT2;ERN1;UBE2E1;AAAS;TERF1;RPS6KA3;SLC7A11;ANAPC16;CSRP1;TNRC6C;SCMH1;MT4;HSPA1A;ABCC1;ACD;COX19;NR3C2;PREB;CHD9;CARM1;H2AX;NFYC;NR3C1;NFKB1;RPS6KA2;GPX1;ETF1;YIF1A;CDC26
prerank,GO_Biological_Process_2021__protein maturation by iron-sulfur cluster transfer (GO:0097428),0.3608911040845068,0.7067154820440366,0.8222222222222222,1.0,1.0,4/13,25.57%,YAE1;ISCA2;CIAO2A;LTO1
prerank,GO_Biological_Process_2021__phosphatidylserine metabolic process (GO:0006658),-0.34891401784760556,-0.7063976049237681,0.8852459016393442,1.0,1.0,5/23,20.26%,PLA2G10;SERINC1;PLA2G4A;MBOAT1;PLA2G4D
prerank,GO_Biological_Process_2021__pattern recognition receptor signaling pathway (GO:0002221),-0.3134010481567723,-0.7062573000155825,0.927536231884058,1.0,1.0,5/43,12.50%,SFTPA1;MAPKAPK3;SFTPD;LACC1;TLR2
prerank,GO_Biological_Process_2021__fatty acid omega-oxidation (GO:0010430),0.45009672713251037,0.7060221887557385,0.8095238095238095,1.0,1.0,1/5,1.24%,CYP4V2
prerank,GO_Biological_Process_2021__positive regulation of chromosome organization (GO:2001252),-0.40167331506738524,-0.7057643448707591,0.921875,1.0,1.0,2/14,13.35%,SHCBP1L;GNL3
prerank,GO_Biological_Process_2021__negative regulation of reactive oxygen species metabolic process (GO:2000378),-0.35645767717517884,-0.7057600542211869,0.8518518518518519,1.0,1.0,3/18,10.60%,PINK1;BRCA1;SLC18A2
prerank,GO_Biological_Process_2021__regulation of rRNA processing (GO:2000232),0.362334599727996,0.705556469250159,0.926829268292683,1.0,1.0,5/16,19.29%,SIRT7;RIOK1;USP36;BUD23;KAT2B
prerank,Reactome_2022__APC Truncation Mutants Have Impaired AXIN Binding R-HSA-5467337,0.3508120874530848,0.7054731888198165,0.8297872340425532,1.0,1.0,7/13,36.83%,PPP2R1B;PPP2R5D;AXIN1;PPP2R5B;PPP2R5E;PPP2R5C;GSK3B
prerank,CellMarker_Augmented_2021__Gastric Stem cell:Gastric Corpus,-0.3021399134513496,-0.7053822333050851,0.9857142857142858,1.0,1.0,11/74,19.27%,PLEKHS1;BPIFB1;MYO5B;LOXL4;NTN1;YAP1;ADH7;SCARA3;CELSR1;SLC44A3;GALNT5
prerank,GO_Biological_Process_2021__midbrain dopaminergic neuron differentiation (GO:1904948),0.40116228086265243,0.7053489670056632,0.813953488372093,1.0,1.0,5/9,14.61%,FZD1;NR4A2;LRP6;WNT3A;RYK
prerank,Reactome_2022__Response Of Mtb To Phagocytosis R-HSA-9637690,-0.3489548710378888,-0.7050173845617415,0.8688524590163934,1.0,1.0,3/19,18.03%,RNF213;DUSP16;RPS27A
prerank,GO_Biological_Process_2021__regulation of acetyl-CoA biosynthetic process from pyruvate (GO:0010510),0.3710365344317709,0.7049818224695225,0.8444444444444444,1.0,1.0,4/8,29.56%,GSTZ1;PDK1;PDP2;PDPR
prerank,GO_Biological_Process_2021__regulation of acyl-CoA biosynthetic process (GO:0050812),0.3710365344317709,0.7049818224695225,0.8444444444444444,1.0,1.0,4/8,29.56%,GSTZ1;PDK1;PDP2;PDPR
prerank,Reactome_2022__PKA-mediated Phosphorylation Of CREB R-HSA-111931,0.32629148151031717,0.7049031309392335,0.8787878787878788,1.0,1.0,8/17,29.07%,ADCY2;PRKAR2A;ADCY6;CREB1;NBEA;PRKACB;ADCY9;ADCY5
prerank,GO_Biological_Process_2021__regulation of tumor necrosis factor production (GO:0032680),-0.2879789435058132,-0.7048673616415227,0.9230769230769231,1.0,1.0,15/81,17.55%,WNT5A;OAS2;CLU;THBS1;CYBA;PTPRC;ARG2;OAS1;TLR2;NLRC3;C1QTNF4;NR1H4;GHRL;VSIR;CACTIN
prerank,Reactome_2022__PD-1 Signaling R-HSA-389948,0.4058636021218045,0.7048491426975717,0.8292682926829268,1.0,1.0,3/12,6.51%,CD247;CSK;HLA-DRA
prerank,GO_Biological_Process_2021__signal transduction in response to DNA damage (GO:0042770),0.3086016239443756,0.7045576170537645,0.9,1.0,1.0,18/47,23.22%,ACER2;ABL1;H2AX;BID;GADD45A;TP53;CLSPN;ATM;RAD17;RAD9A;ATR;SESN2;HINFP;MDM4;CDC5L;ATRIP;BRIP1;BCL3
prerank,GO_Biological_Process_2021__regulation of toll-like receptor 7 signaling pathway (GO:0034155),-0.46305169394674084,-0.7044524077880515,0.8596491228070176,1.0,1.0,1/5,14.99%,DDX3X
prerank,GO_Biological_Process_2021__positive regulation of toll-like receptor 7 signaling pathway (GO:0034157),-0.46305169394674084,-0.7044524077880515,0.8596491228070176,1.0,1.0,1/5,14.99%,DDX3X
prerank,GO_Biological_Process_2021__positive regulation of transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0090100),-0.300385004391364,-0.7042844921059475,0.96,1.0,1.0,8/71,11.95%,TGFB1;NODAL;DAB2;TTK;THBS1;GDF11;ENG;BMP3
prerank,GO_Biological_Process_2021__regulation of biosynthetic process (GO:0009889),-0.4198829109169392,-0.7042520148339971,0.8666666666666667,1.0,1.0,2/10,11.75%,ALOX5;UCP1
prerank,GO_Biological_Process_2021__extracellular matrix assembly (GO:0085029),-0.36245965311035877,-0.7039615189175193,0.8769230769230769,1.0,1.0,3/21,11.05%,TGFB1;TNXB;PXDN
prerank,GO_Biological_Process_2021__protein K48-linked ubiquitination (GO:0070936),0.28285430618881696,0.7038526706648895,0.8333333333333334,1.0,1.0,10/52,13.55%,UBE2E3;ZNRF1;RNF152;UBE2E1;UBE2D4;UBE2E2;KLHL3;UBE2A;RNF146;PELI1
prerank,Reactome_2022__Mismatch Repair R-HSA-5358508,-0.3748240061307393,-0.7037555334642064,0.819672131147541,1.0,1.0,1/15,4.30%,RPA3
prerank,Reactome_2022__Diseases Of DNA Repair R-HSA-9675135,-0.3168000345103439,-0.7036182867288915,0.8888888888888888,1.0,1.0,16/46,29.89%,RPA3;BRCA1;RRAD;OGG1;RMI1;TOPBP1;MSH6;BLM;RAD9B;RMI2;XRCC2;BRCA2;MLH1;KAT5;PMS2;ARTN
prerank,CellMarker_Augmented_2021__Progenitor cell:Skin,0.2661209113324241,0.703510021093024,1.0,1.0,1.0,18/80,16.71%,PLCH1;GOLT1A;FZD5;ERBB2;CKMT1A;ESRP1;FGFR3;WNK2;TSPAN6;CRABP1;MSI1;MAGI1;TMPRSS2;PTPRF;CGN;EFNA2;FRAS1;CKMT1B
prerank,GO_Biological_Process_2021__cell fate commitment involved in formation of primary germ layer (GO:0060795),-0.4560051287506296,-0.7033860694763039,0.8666666666666667,1.0,1.0,2/5,24.17%,RTF1;PAF1
prerank,GO_Biological_Process_2021__sterol import (GO:0035376),0.43545201151911206,0.7032317466483023,0.8695652173913043,1.0,1.0,3/6,22.82%,LDLR;STARD4;SCARB1
prerank,GO_Biological_Process_2021__cholesterol import (GO:0070508),0.43545201151911206,0.7032317466483023,0.8695652173913043,1.0,1.0,3/6,22.82%,LDLR;STARD4;SCARB1
prerank,Reactome_2022__Lysosome Vesicle Biogenesis R-HSA-432720,-0.33478813737591395,-0.7031545470135891,0.84,1.0,1.0,5/31,20.23%,CTSZ;DNASE2;HSPA8;VAMP7;M6PR
prerank,KEGG_2021_Human__Linoleic acid metabolism,-0.370657570318908,-0.703129859505949,0.8939393939393939,1.0,1.0,8/18,20.26%,PLA2G10;ALOX15;CYP2J2;CYP3A4;CYP2E1;PLB1;PLA2G4A;PLA2G4D
prerank,GO_Biological_Process_2021__regulation of gene expression by genetic imprinting (GO:0006349),0.41198613936784073,0.7029624231474607,0.8717948717948718,1.0,1.0,2/8,14.59%,PCGF5;MECP2
prerank,GO_Biological_Process_2021__protein autophosphorylation (GO:0046777),-0.2705113154940969,-0.7029556339772846,0.9875,1.0,1.0,8/149,7.35%,NEK2;HCK;MAK;MAPKAPK3;GRK7;TEC;PINK1;FLT4
prerank,GO_Biological_Process_2021__regulation of protein dephosphorylation (GO:0035304),-0.3210566651275239,-0.702875015884561,0.9180327868852459,1.0,1.0,1/35,1.49%,TGFB1
prerank,GO_Biological_Process_2021__dosage compensation (GO:0007549),-0.43672711333749725,-0.7027301316775594,0.8833333333333333,1.0,1.0,1/10,8.63%,BRCA1
prerank,GO_Biological_Process_2021__regulation of coagulation (GO:0050818),-0.42151233424408624,-0.7025554774368403,0.8727272727272727,1.0,1.0,2/9,6.69%,PROCR;GP1BA
prerank,GO_Biological_Process_2021__regulation of cell adhesion (GO:0030155),0.25329799000600145,0.7025515328321392,1.0,1.0,1.0,27/109,19.69%,ANGPT1;EPHA7;CDH13;SEMA5A;ERBB2;DSCAM;ABL1;PLXNB1;EFNA5;SIPA1;ABL2;TNFRSF18;TFE3;RET;FRMD5;TESC;PKP4;EPHB2;ATM;RSU1;PLXNA4;MIA3;PPP1CB;ADAM10;PDE3B;EPB41L4B;CYTH1
prerank,Reactome_2022__Heme Biosynthesis R-HSA-189451,-0.3781453597765603,-0.7025268169562836,0.8769230769230769,1.0,1.0,3/13,15.97%,ABCG2;ALAS2;UROS
prerank,Reactome_2022__Transport Of Fatty Acids R-HSA-804914,0.4338708517963873,0.7022390385675709,0.8260869565217391,1.0,1.0,1/6,3.36%,LCN12
prerank,Reactome_2022__DNA Methylation R-HSA-5334118,0.33493572611747063,0.7021184323637645,0.9166666666666666,1.0,1.0,3/15,13.73%,DNMT1;H2BC21;H2AX
prerank,GO_Biological_Process_2021__regulation of release of sequestered calcium ion into cytosol (GO:0051279),-0.3406168223099303,-0.7020811763455963,0.9142857142857143,1.0,1.0,3/39,6.40%,CASQ2;GPER1;TRDN
prerank,GO_Biological_Process_2021__regulation of DNA-directed DNA polymerase activity (GO:1900262),0.37776674921765196,0.7020390634208057,0.875,1.0,1.0,1/8,15.95%,DSCC1
prerank,GO_Biological_Process_2021__positive regulation of DNA-directed DNA polymerase activity (GO:1900264),0.37776674921765196,0.7020390634208057,0.875,1.0,1.0,1/8,15.95%,DSCC1
prerank,CellMarker_Augmented_2021__Glial cell:Undefined,-0.39632257065881304,-0.7019460419830124,0.8461538461538461,1.0,1.0,5/13,21.11%,MPZ;PTPRC;ITGAM;MRPS22;NEFL
prerank,CellMarker_Augmented_2021__Type I pneumocyte:Undefined,0.2704738668329684,0.7017946420886104,1.0,1.0,1.0,22/78,19.64%,LAMA3;PERP;ERBB2;DSP;CKMT1A;ESRP1;KIAA1671;FGFR3;VWA2;COBL;TSPAN6;LRIG3;MAGI1;TMPRSS2;BCAM;PTPRF;CGN;WWC1;ARHGEF16;EPB41L4B;TMEM125;PCDH1
prerank,GO_Biological_Process_2021__nucleoside salvage (GO:0043174),0.36904413194939145,0.7014282556030241,0.8108108108108109,1.0,1.0,4/12,18.59%,UPP2;UCK2;HPRT1;PUDP
prerank,Reactome_2022__TP53 Regulates Transcription Of Additional Cell Death Genes With Uncertain Roles In P53-Dependent Apoptosis R-HSA-6803205,0.37001948972374865,0.7013327151609163,0.8780487804878049,1.0,1.0,3/12,6.33%,BCL6;PERP;PPP1R13B
prerank,GO_Biological_Process_2021__regulation of cellular extravasation (GO:0002691),-0.42628673739971207,-0.7012176151146178,0.8484848484848485,1.0,1.0,2/8,21.56%,OLFM4;BST1
prerank,GO_Biological_Process_2021__cellular response to hydroxyurea (GO:0072711),0.4117479486524044,0.7010265829013631,0.7906976744186046,1.0,1.0,2/8,14.75%,TIMELESS;SPIDR
prerank,GO_Biological_Process_2021__drug transport (GO:0015893),0.4558169387461348,0.7010025171957377,0.8536585365853658,1.0,1.0,1/5,6.04%,SLC19A1
prerank,GO_Biological_Process_2021__vascular associated smooth muscle cell differentiation (GO:0035886),-0.4659711550899957,-0.700969371830562,0.7843137254901961,1.0,1.0,3/5,17.81%,ENG;HEY2;MESP1
prerank,GO_Biological_Process_2021__eye morphogenesis (GO:0048592),-0.35883276927697416,-0.7007593724263914,0.8852459016393442,1.0,1.0,5/19,18.49%,COL5A1;FBN2;MFAP5;C12ORF57;ALDH1A3
prerank,GO_Biological_Process_2021__protein K63-linked ubiquitination (GO:0070534),-0.32246273611513926,-0.7007568834104669,0.890625,1.0,1.0,3/39,10.18%,ARIH2;TRIM5;TRAF3IP2
prerank,GO_Biological_Process_2021__regulation of establishment of endothelial barrier (GO:1903140),0.34275794522893616,0.7007103447468368,0.8571428571428571,1.0,1.0,1/14,2.83%,CDH5
prerank,GO_Biological_Process_2021__negative regulation of innate immune response (GO:0045824),-0.32616618059193914,-0.7005630663940698,0.921875,1.0,1.0,8/34,21.63%,VSIG4;OAS1;NLRC3;A2M;GRN;CACTIN;DHX58;ISG15
prerank,GO_Biological_Process_2021__cellular response to reactive oxygen species (GO:0034614),0.2796304995341335,0.7004010747271312,1.0,1.0,1.0,7/56,7.84%,TRPM2;SIRT1;AKR1C3;PKD2;FER;ABL1;MAPK8
prerank,GO_Biological_Process_2021__AMP metabolic process (GO:0046033),-0.40089764680988715,-0.7003822208707434,0.84375,1.0,1.0,1/12,1.23%,ADSS1
prerank,GO_Biological_Process_2021__response to hepatocyte growth factor (GO:0035728),0.43538593000645043,0.7003565302215448,0.9166666666666666,1.0,1.0,3/7,38.13%,APPL2;SIRT2;APPL1
prerank,GO_Biological_Process_2021__cellular response to hepatocyte growth factor stimulus (GO:0035729),0.43538593000645043,0.7003565302215448,0.9166666666666666,1.0,1.0,3/7,38.13%,APPL2;SIRT2;APPL1
prerank,KEGG_2021_Human__Toxoplasmosis,-0.29277626968908155,-0.7003294318795036,0.9473684210526315,1.0,1.0,16/93,14.87%,TGFB1;HSPA1L;ALOX5;HLA-DMA;CIITA;STAT1;HLA-DPB1;HLA-DRB1;LAMC2;HSPA8;TLR2;HLA-DPA1;NOS2;IL12A;TGFB3;IFNGR2
prerank,Reactome_2022__Mismatch Repair (MMR) Directed By MSH2:MSH6 (MutSalpha) R-HSA-5358565,-0.3795696985833672,-0.7002985426786611,0.8225806451612904,1.0,1.0,1/14,4.30%,RPA3
prerank,GO_Biological_Process_2021__regulation of long-term neuronal synaptic plasticity (GO:0048169),0.3513812089142307,0.7002536195943423,0.9210526315789473,1.0,1.0,2/11,17.38%,RAB5A;NETO1
prerank,GO_Biological_Process_2021__regulation of monocyte chemotactic protein-1 production (GO:0071637),-0.42409963002526807,-0.7002157117806396,0.8833333333333333,1.0,1.0,2/7,12.51%,OAS1;APOD
prerank,Reactome_2022__Voltage Gated Potassium Channels R-HSA-1296072,-0.33198871450747597,-0.700197450198952,0.9090909090909091,1.0,1.0,4/39,8.12%,KCNA5;KCNA7;KCNS2;KCNQ1
prerank,GO_Biological_Process_2021__regulation of programmed necrotic cell death (GO:0062098),0.3354244046332286,0.7001962956053525,0.8823529411764706,1.0,1.0,1/19,2.32%,CFLAR
prerank,GO_Biological_Process_2021__eye photoreceptor cell differentiation (GO:0001754),-0.41901398583450095,-0.7000455372317945,0.8461538461538461,1.0,1.0,1/11,1.75%,TULP1
prerank,GO_Biological_Process_2021__positive regulation of interleukin-17 production (GO:0032740),-0.40653626850432606,-0.7000069952751004,0.890625,1.0,1.0,3/12,15.16%,TGFB1;NR1H4;IL18
prerank,Reactome_2022__Arachidonate Production From DAG R-HSA-426048,0.44846253743346554,0.6999107909370739,0.9074074074074074,1.0,1.0,2/5,34.00%,ABHD12;DAGLA
prerank,KEGG_2021_Human__Alzheimer disease,-0.2606015928863247,-0.6998726096391203,1.0,1.0,1.0,69/299,25.41%,COX6A1;WNT5A;SLC25A31;WNT8B;FZD8;BACE2;PIK3R3;ATP5F1E;FRAT1;CASP7;NDUFS2;COX6C;ATP5MC3;WNT8A;WNT6;ATP5PF;TUBA4A;COX7A1;ATG14;PIK3CB;VDAC1;NDUFA2;NOS2;NDUFB4;NDUFC1;TUBA3D;ITPR3;COX7C;NDUFA1;NDUFB9;TUBB;PSMA3;TUBB6;COX7A2;WNT10A;TUBB2A;CDK5R1;CALM1;COX4I1;PSMA7;PSMB6;CASP8;NOX1;NDUFB10;AGER;DKK2;TUBB4A;MAP2K1;NDUFS5;ATP5PB;NDUFB11;PSMA5;TUBB4B;GPR83;ATP5F1A;SDHC;PSMD6;PLCB2;CSNK2A2;PPID;ATP2A2;APH1A;WNT9B;KLC1;NDUFB2;APAF1;WNT5B;KRAS;GRIN2D
prerank,CellMarker_Augmented_2021__Alpha cell:Pancreas,-0.39882030737464547,-0.6998675088456328,0.8870967741935484,1.0,1.0,3/11,13.45%,HMGB3;LOXL4;PTGER3
prerank,GO_Biological_Process_2021__regulation of transmembrane transport (GO:0034762),0.29821831605117816,0.6997892181570317,0.9375,1.0,1.0,5/31,7.94%,BCL2;SNCA;KCNJ3;KCNJ6;WWP2
prerank,GO_Biological_Process_2021__post-translational protein modification (GO:0043687),-0.25758615094178405,-0.6997701087550386,1.0,1.0,1.0,39/299,19.91%,NOTUM;PSMB9;APOL1;DTL;ITIH2;SERPIND1;RAB11A;SDC2;FBXL7;FBXL13;ASB14;PRSS23;GPC3;SERPINA10;CP;COPS5;WFS1;MFGE8;ASB5;F5;RBBP7;FBXO40;CCNF;KLHL2;RAB8A;RBX1;PSMA3;SUMF1;RABGGTB;RABGGTA;COPS4;FBXL18;AMBN;PSMA7;EPAS1;PSMB6;CHGB;FEM1C;FN1
prerank,GO_Biological_Process_2021__negative regulation of lymphocyte migration (GO:2000402),-0.397988750783417,-0.6997632679801927,0.828125,1.0,1.0,1/10,12.51%,APOD
prerank,Reactome_2022__Ion Homeostasis R-HSA-5578775,-0.3407603632428649,-0.6995711210780667,0.9014084507042254,1.0,1.0,9/42,19.15%,TRDN;ATP1A4;KCNJ11;ORAI1;ITPR3;PLN;CALM1;CAMK2A;FXYD6-FXYD2
prerank,KEGG_2021_Human__Hedgehog signaling pathway,0.27443708970435526,0.6994713447283039,0.9629629629629629,1.0,1.0,4/50,5.43%,GPR161;BCL2;SPOPL;ARRB2
prerank,GO_Biological_Process_2021__negative regulation of MAPK cascade (GO:0043409),0.2915570775981743,0.6994137335402616,0.9428571428571428,1.0,1.0,10/80,11.02%,FOXO1;DUSP4;SPRED3;APOE;RGS14;PTPRR;MYC;SPRED2;WNK2;SPRED1
prerank,GO_Biological_Process_2021__cellular protein-containing complex assembly (GO:0034622),-0.27843711547554356,-0.6990140051088328,0.9743589743589743,1.0,1.0,22/143,21.26%,TGFB1;CASQ2;CCDC39;CHMP3;DRC1;HIGD1C;RPL38;CLU;CYBA;TMEM35A;TESPA1;COX7A1;SMAD3;USH1C;COX7A2;NUP93;SRP19;HSPA4;CHCHD4;ANKS4B;NSG1;CHRNA3
prerank,GO_Biological_Process_2021__regulation of T cell cytokine production (GO:0002724),0.3570987478980309,0.6988399627524663,0.9166666666666666,1.0,1.0,2/16,4.56%,CLC;FZD5
prerank,GO_Biological_Process_2021__negative regulation of platelet-derived growth factor receptor signaling pathway (GO:0010642),0.3970854648319439,0.6988036641772186,0.7674418604651163,1.0,1.0,1/8,5.38%,SNCA
prerank,GO_Biological_Process_2021__positive regulation of monooxygenase activity (GO:0032770),0.3215607285389595,0.6987736451064811,0.84375,1.0,1.0,3/21,8.69%,APOE;DHFR;NUS1
prerank,GO_Biological_Process_2021__axonal transport (GO:0098930),0.3102124176999097,0.6987364880715752,0.95,1.0,1.0,6/32,20.51%,MGARP;SPAST;DST;AP3B2;KIF3B;HIF1A
prerank,Reactome_2022__RHO GTPases Activate KTN1 R-HSA-5625970,0.36834979994506306,0.6986621854417655,0.8636363636363636,1.0,1.0,1/10,9.38%,KTN1
prerank,GO_Biological_Process_2021__regulation of intracellular estrogen receptor signaling pathway (GO:0033146),-0.3381184864057205,-0.6984134585547564,0.8545454545454545,1.0,1.0,5/27,16.69%,ESR1;ZNF366;BRCA1;YAP1;WBP2
prerank,Reactome_2022__MAPK1 (ERK2) Activation R-HSA-112411,-0.39353090362063237,-0.6981404588258819,0.8253968253968254,1.0,1.0,2/8,25.47%,PTPN11;IL6R
prerank,Reactome_2022__SARS-CoV-2 Infection R-HSA-9694516,0.2398862956206319,0.6980390651256981,1.0,1.0,1.0,20/246,10.02%,MGAT4C;GPC4;ST6GALNAC3;NUP210;SDC4;VPS16;RIPK2;NUP42;GPC6;PRKCSH;GALNT1;ST3GAL3;REXO2;SEC24C;MAN2A1;SNRPB;CHMP6;GPC5;AKT2;AAAS
prerank,GO_Biological_Process_2021__pulmonary valve development (GO:0003177),0.3740192370764443,0.6979955990546746,0.8285714285714286,1.0,1.0,3/15,7.88%,ROBO2;JAG1;SLIT2
prerank,CellMarker_Augmented_2021__Germ cell:Undefined,0.3404106995889485,0.697980226178041,0.90625,1.0,1.0,5/20,15.72%,KIT;PIWIL1;TESMIN;MSI1;NR6A1
prerank,Reactome_2022__Activated NTRK2 Signals Thru FRS2 And FRS3 R-HSA-9028731,0.37755737229989783,0.6978060726933787,0.8478260869565217,1.0,1.0,3/8,29.48%,SOS1;NTRK2;FRS2
prerank,GO_Biological_Process_2021__G1/S transition of mitotic cell cycle (GO:0000082),-0.29152269411825027,-0.6976352314085801,0.9878048780487805,1.0,1.0,11/79,15.48%,SPDYA;CCND1;CRLF3;CDC25A;LATS2;CDKN2D;CDKN1A;MAX;CDK15;CCNE2;CDKN3
prerank,KEGG_2021_Human__p53 signaling pathway,0.2835556868272795,0.69748125096101,0.967741935483871,1.0,1.0,9/68,7.93%,CCNG1;BCL2;PERP;SERPINE1;TP53AIP1;CDK6;CDK4;CCND3;CASP3
prerank,KEGG_2021_Human__IL-17 signaling pathway,-0.2956468734879541,-0.6974563275095231,0.9393939393939394,1.0,1.0,7/57,20.72%,MMP9;MUC5B;TRAF3IP2;IL5;CASP8;IL17RB;IL17B
prerank,KEGG_2021_Human__Taste transduction,0.3043792686322991,0.6973253510157784,0.9333333333333333,1.0,1.0,6/52,8.76%,GABRA5;HTR1F;TAS2R8;PLCB1;PDE1A;GRM4
prerank,Reactome_2022__Biosynthesis Of DHA-derived SPMs R-HSA-9018677,-0.3959573484104347,-0.6972920829883205,0.8888888888888888,1.0,1.0,4/14,9.84%,ALOX12;ALOX5;ALOX15;CYP3A4
prerank,GO_Biological_Process_2021__potassium ion homeostasis (GO:0055075),0.3398398511850188,0.697223905336216,0.9444444444444444,1.0,1.0,2/20,6.91%,SLC12A1;SLC12A9
prerank,GO_Biological_Process_2021__neural tube development (GO:0021915),-0.3919114631625464,-0.697204146462286,0.8484848484848485,1.0,1.0,1/15,1.49%,TGFB1
prerank,GO_Biological_Process_2021__regulation of endocytic recycling (GO:2001135),0.39385095860430613,0.6967378981629183,0.85,1.0,1.0,5/10,33.10%,RAB11B;ATP9A;EHD1;EIPR1;SORL1
prerank,CellMarker_Augmented_2021__Cancer cell:Undefined,0.4547556220006736,0.6964858235316801,0.825,1.0,1.0,2/7,15.38%,ALDH1A1;NCAM1
prerank,GO_Biological_Process_2021__regulation of interleukin-2 production (GO:0032663),-0.33492849720189555,-0.6962890275257665,0.9242424242424242,1.0,1.0,7/37,10.28%,IRF4;SFTPD;VSIG4;ANXA1;STOML2;GBP1;PTPRC
prerank,GO_Biological_Process_2021__negative regulation of single stranded viral RNA replication via double stranded DNA intermediate (GO:0045869),0.3828393776927149,0.6957820490372523,0.8,1.0,1.0,2/10,16.55%,RESF1;MPHOSPH8
prerank,KEGG_2021_Human__Biosynthesis of unsaturated fatty acids,-0.3283708862612955,-0.6956936213739159,0.859375,1.0,1.0,5/26,14.71%,ELOVL2;ACOT4;ACOT1;ACOT2;HACD4
prerank,Reactome_2022__Dual Incision In GG-NER R-HSA-5696400,-0.31759223864624414,-0.6956782437734639,0.8840579710144928,1.0,1.0,7/38,23.78%,RPA3;POLE2;RBX1;POLD4;RPS27A;POLE3;DDB1
prerank,GO_Biological_Process_2021__neuron projection extension involved in neuron projection guidance (GO:1902284),-0.42557870985031265,-0.6954910639041061,0.8387096774193549,1.0,1.0,2/8,7.50%,SEMA3F;SEMA3A
prerank,GO_Biological_Process_2021__axon extension involved in axon guidance (GO:0048846),-0.42557870985031265,-0.6954910639041061,0.8387096774193549,1.0,1.0,2/8,7.50%,SEMA3F;SEMA3A
prerank,Reactome_2022__Cdc20:Phospho-APC/C Mediated Degradation Of Cyclin A R-HSA-174184,-0.2981193826359233,-0.695463701661518,0.8985507246376812,1.0,1.0,1/63,0.62%,PSMB9
prerank,KEGG_2021_Human__RNA transport,-0.26791744958833674,-0.6954616039943279,0.987012987012987,1.0,1.0,20/154,22.11%,SNORD3A;SMN2;RPP38;NUP210L;EIF1B;RNU5A-1;DDX20;GEMIN4;STRAP;EIF4E1B;EIF2B2;EIF2S3;EIF2S2;EIF4A2;NUP93;EIF1;PHAX;SEC13;TRNT1;SAP18
prerank,Reactome_2022__Thrombin Signaling Thru Proteinase Activated Receptors (PARs) R-HSA-456926,0.31208715181844465,0.69544716307821,0.9090909090909091,1.0,1.0,10/26,27.09%,ARRB2;F2R;ARRB1;GNG7;GNAQ;GNA12;GNA11;GNA13;TTF2;GNA14
prerank,Reactome_2022__Transcription Of E2F Targets Under Negative Control By DREAM Complex R-HSA-1362277,0.3324247654070704,0.6952696391157971,0.8695652173913043,1.0,1.0,8/18,21.88%,TOP2A;RBL1;MYC;LIN52;HDAC1;E2F5;RBBP4;TFDP1
prerank,GO_Biological_Process_2021__regulation of histone H3-K9 acetylation (GO:2000615),0.3540123894082957,0.6950236016824087,0.9148936170212766,1.0,1.0,4/11,20.08%,SMARCB1;PIH1D1;RAPGEF3;HDAC5
prerank,"GO_Biological_Process_2021__maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000463)",-0.3687023260147302,-0.6946164408631252,0.847457627118644,1.0,1.0,3/14,25.29%,WDR12;RPL35;DDX18
prerank,GO_Biological_Process_2021__venous blood vessel morphogenesis (GO:0048845),0.43485232030396676,0.6945854071185543,0.8108108108108109,1.0,1.0,2/5,16.67%,PROX1;NOTCH1
prerank,Reactome_2022__Translesion Synthesis By REV1 R-HSA-110312,-0.36755129699326833,-0.6945438100044464,0.8615384615384616,1.0,1.0,1/16,4.30%,RPA3
prerank,GO_Biological_Process_2021__positive regulation of monocyte chemotactic protein-1 production (GO:0071639),0.47162714125401806,0.6943695184114381,0.8108108108108109,1.0,1.0,2/5,11.29%,TWIST1;LGALS9
prerank,GO_Biological_Process_2021__cellular sodium ion homeostasis (GO:0006883),-0.38956319758214797,-0.6943127352667177,0.8688524590163934,1.0,1.0,3/12,19.66%,ATP1A4;ATP4A;ATP1A1
prerank,GO_Biological_Process_2021__G-quadruplex DNA unwinding (GO:0044806),-0.4383482586195886,-0.69428098017406,0.8813559322033898,1.0,1.0,2/7,22.47%,DDX11;BLM
prerank,GO_Biological_Process_2021__activation of protein kinase A activity (GO:0034199),0.3535978517512214,0.694213402304204,0.8571428571428571,1.0,1.0,4/15,18.06%,ADCY2;PRKAR2A;ADCY3;ADCY6
prerank,GO_Biological_Process_2021__regulation of androgen receptor signaling pathway (GO:0060765),-0.3544972976762757,-0.6940056265250221,0.8414634146341463,1.0,1.0,2/28,6.21%,NODAL;DAB2
prerank,GO_Biological_Process_2021__cellular response to DNA damage stimulus (GO:0006974),-0.2556121429573821,-0.6940024156811859,1.0,1.0,1.0,17/317,8.63%,TICRR;POLQ;DTL;BLK;TRAIP;SPDYA;CIDEB;CCND1;PCLAF;VAV3;BCL2L2;TNFRSF1B;HIC1;FANCF;SUV39H1;UBE2U;BRCA1
prerank,Reactome_2022__Resolution Of D-loop Structures Thru Holliday Junction Intermediates R-HSA-5693568,0.3027599638611825,0.693988368352691,0.9090909090909091,1.0,1.0,9/30,24.57%,SEM1;SPIDR;EXO1;ATM;EME2;RAD51B;DNA2;BRIP1;MUS81
prerank,CellMarker_Augmented_2021__Sertoli cell:Fetal Gonad,0.235222989794045,0.6939666637677753,1.0,1.0,1.0,98/392,21.97%,SMYD2;FRMPD1;MLF1;MYO10;CDH19;LAMA3;ZSWIM5;SDC4;ALDH1A1;SLC3A2;TGIF1;DUSP23;ANKRD18A;PSME4;RAB20;ZBTB20;GLCCI1;CADM1;TOX;DSP;MED25;REEP6;PLOD3;NRIP1;SLC4A7;FSTL3;HACD1;MYO9B;CSDC2;MYOM3;KTN1;ACYP2;CTSV;CORO2A;NTNG2;HID1;CHST3;AMH;OSBPL11;HSPA1A;FNTA;CPT1A;FBXL20;DST;CDH2;LRP8;GSTA4;TECR;PCED1B;INSR;FSCN1;CXXC5;PTPRF;GBP2;FLNB;PPP1R9A;NR6A1;FLYWCH2;SLK;AMIGO2;PTPRE;RELL1;HPRT1;ZNF708;PLEKHG1;KIAA1958;CCNDBP1;GNG7;HERC5;CAMTA1;TRIM47;ASTN2;TTYH1;ARAP2;PNCK;NAV2;ZNF280B;PRPSAP1;KLHL23;BTF3L4;ANKH;PDE4DIP;NMT2;MTM1;VCL;HLTF;BRICD5;KIF21A;JUP;CAMSAP3;SDK2;DMD;TCEA3;CUL1;SAT1;ESYT1;CD55;NCK2
prerank,Reactome_2022__Defective CHST6 Causes MCDC1 R-HSA-3656225,0.40559852707673233,0.6939136628352479,0.7692307692307693,1.0,1.0,2/5,5.24%,CHST6;PRELP
prerank,GO_Biological_Process_2021__metanephric nephron tubule morphogenesis (GO:0072282),-0.4615293698153119,-0.6938629981307695,0.8461538461538461,1.0,1.0,3/5,31.28%,SOX9;PAX2;PAX8
prerank,GO_Biological_Process_2021__negative regulation of locomotion (GO:0040013),-0.40190041713118174,-0.6938409360024976,0.9152542372881356,1.0,1.0,3/11,15.83%,WAS;SPOCK3;ELANE
prerank,CellMarker_Augmented_2021__Endothelial cell:Brain,-0.4532380233211519,-0.693801538501193,0.8787878787878788,1.0,1.0,3/6,13.87%,VWF;APOLD1;A2M
prerank,CellMarker_Augmented_2021__Macrophage:Spleen,-0.47189085574932665,-0.6937347364408067,0.8620689655172413,1.0,1.0,2/5,11.77%,ADGRE1;ITGAM
prerank,GO_Biological_Process_2021__positive regulation of protein dephosphorylation (GO:0035307),-0.33382273889206915,-0.6935916099805864,0.8970588235294118,1.0,1.0,1/28,1.49%,TGFB1
prerank,Reactome_2022__Interaction With Cumulus Cells And Zona Pellucida R-HSA-2534343,-0.445822879841814,-0.6933703243031489,0.8333333333333334,1.0,1.0,2/5,15.80%,ADAM21;ZP3
prerank,GO_Biological_Process_2021__negative regulation of protein tyrosine kinase activity (GO:0061099),0.29158397522656637,0.6931429053558215,0.868421052631579,1.0,1.0,8/22,23.99%,CBLB;CHMP6;GPRC5A;SRCIN1;ZFYVE28;SOCS4;TSG101;CBL
prerank,Reactome_2022__Sensory Perception Of Taste R-HSA-9717189,-0.35755530915123057,-0.6931339751524888,0.8636363636363636,1.0,1.0,8/24,23.88%,GNAT3;ITPR3;SCNN1A;SCNN1G;TAS1R1;GNG13;PLCB2;SCN4B
prerank,GO_Biological_Process_2021__positive regulation of interferon-gamma production (GO:0032729),-0.31217826547869826,-0.6931126954820773,0.9166666666666666,1.0,1.0,11/40,16.13%,HLA-A;ZFPM1;HLA-DPB1;IL27;SLC11A1;TXK;HLA-DPA1;IL12A;IL18;ZP3;F2RL1
prerank,GO_Biological_Process_2021__sensory perception of sour taste (GO:0050915),-0.4528416697786063,-0.6930534551505996,0.796875,1.0,1.0,1/5,20.24%,PKD1L3
prerank,GO_Biological_Process_2021__regulation of monooxygenase activity (GO:0032768),0.3144469344416693,0.6930459168092112,0.972972972972973,1.0,1.0,3/21,11.24%,DDAH2;SNCA;DDAH1
prerank,GO_Biological_Process_2021__regulation of ion transmembrane transporter activity (GO:0032412),0.29169947185433365,0.6930109341555758,0.96,1.0,1.0,6/34,16.75%,UTRN;WWP2;FGF12;ANK2;WNK3;NEDD4
prerank,Reactome_2022__Regulated Necrosis R-HSA-5218859,-0.30784431028801057,-0.6930108863403108,0.9701492537313433,1.0,1.0,11/46,20.89%,IRF1;GSDME;TNFRSF10A;GNL3;IL18;ELANE;CDC37;RPS27A;STUB1;CASP8;MLKL
prerank,Reactome_2022__Resolution Of D-Loop Structures R-HSA-5693537,0.3026287369815802,0.6928579847532422,0.9411764705882353,1.0,1.0,9/31,24.57%,SEM1;SPIDR;EXO1;ATM;EME2;RAD51B;DNA2;BRIP1;MUS81
prerank,GO_Biological_Process_2021__positive regulation of neurotransmitter secretion (GO:0001956),0.4086053841066632,0.6926824789123427,0.8695652173913043,1.0,1.0,1/6,2.68%,NLGN1
prerank,Reactome_2022__Diseases Of Carbohydrate Metabolism R-HSA-5663084,0.3054545327417874,0.6926467914094161,0.9629629629629629,1.0,1.0,5/29,11.28%,SPAM1;G6PC3;ARSB;GYS1;GLB1
prerank,GO_Biological_Process_2021__positive regulation of bone mineralization (GO:0030501),-0.32354537259628413,-0.692605360799755,0.9130434782608695,1.0,1.0,4/30,14.43%,TGFB1;ALOX5;FBN2;TGFB3
prerank,GO_Biological_Process_2021__myeloid cell differentiation (GO:0030099),0.29872773391472,0.6925927402119231,0.9354838709677419,1.0,1.0,11/42,15.67%,KIT;TET2;IFI16;FLVCR1;CASP3;HCLS1;DYRK3;KAT6A;MFHAS1;ACIN1;RUNX1
prerank,GO_Biological_Process_2021__regulation of glucan biosynthetic process (GO:0010962),0.40122730726123285,0.6925555480652366,0.8421052631578947,1.0,1.0,5/9,31.44%,PPP1R3E;PPP1R3D;AKT1;PPP1R3C;PPP1R3G
prerank,GO_Biological_Process_2021__positive regulation of protein import into nucleus (GO:0042307),-0.3235670486453118,-0.6925025761517773,0.921875,1.0,1.0,1/24,1.49%,TGFB1
prerank,GO_Biological_Process_2021__negative regulation of response to wounding (GO:1903035),-0.3659685478446948,-0.6923742003421031,0.8245614035087719,1.0,1.0,1/16,4.10%,ALOX5
prerank,Reactome_2022__Translesion Synthesis By POLI R-HSA-5656121,-0.35791869706890117,-0.6922689725613979,0.8307692307692308,1.0,1.0,1/17,4.30%,RPA3
prerank,GO_Biological_Process_2021__membrane depolarization (GO:0051899),-0.3247603224101961,-0.6922514665666066,0.8787878787878788,1.0,1.0,1/30,1.19%,SCN5A
prerank,GO_Biological_Process_2021__nuclear body organization (GO:0030575),0.37860738934467864,0.6920315718743728,0.8222222222222222,1.0,1.0,3/12,14.52%,PML;DYRK3;WRAP53
prerank,Reactome_2022__NOTCH3 Intracellular Domain Regulates Transcription R-HSA-9013508,0.31647008543342237,0.6916351273817181,0.8235294117647058,1.0,1.0,8/23,19.29%,MAML1;MAMLD1;WWC1;NOTCH1;PBX1;RBPJ;EP300;KAT2B
prerank,Reactome_2022__Chk1/Chk2(Cds1) Mediated Inactivation Of Cyclin B:Cdk1 Complex R-HSA-75035,0.3598048565239531,0.6915165934973732,0.9230769230769231,1.0,1.0,1/12,6.60%,REXO2
prerank,GO_Biological_Process_2021__lymphocyte proliferation (GO:0046651),0.3061702795391148,0.6914436966848949,0.9428571428571428,1.0,1.0,2/18,4.84%,BCL2;TNFSF14
prerank,GO_Biological_Process_2021__protein prenylation (GO:0018342),0.3922222031609183,0.6914253973702583,0.8292682926829268,1.0,1.0,3/9,12.75%,PTAR1;PGGT1B;FNTA
prerank,GO_Biological_Process_2021__ncRNA transcription (GO:0098781),-0.39884841096616513,-0.6914056199752675,0.8548387096774194,1.0,1.0,2/13,10.93%,CAVIN1;POLR1G
prerank,GO_Biological_Process_2021__positive regulation of mononuclear cell migration (GO:0071677),0.350785593475853,0.6913487866092025,0.9565217391304348,1.0,1.0,5/20,18.25%,SERPINE1;HMGB1;LGALS9;LGALS3;MOSPD2
prerank,GO_Biological_Process_2021__modulation by host of symbiont process (GO:0051851),-0.34441399958192676,-0.6911803436796061,0.8709677419354839,1.0,1.0,7/30,18.41%,POU2F3;LRRC19;REST;SAP30;LEF1;NUCKS1;HMGA2
prerank,GO_Biological_Process_2021__metaphase/anaphase transition of cell cycle (GO:0044784),0.42951762952366934,0.6911415173353997,0.8378378378378378,1.0,1.0,1/6,18.43%,ANAPC7
prerank,GO_Biological_Process_2021__metaphase/anaphase transition of mitotic cell cycle (GO:0007091),0.42951762952366934,0.6911415173353997,0.8378378378378378,1.0,1.0,1/6,18.43%,ANAPC7
prerank,GO_Biological_Process_2021__regulation of growth rate (GO:0040009),0.4564349624446852,0.691106976247943,0.9024390243902439,1.0,1.0,2/5,22.25%,NOTCH1;BNIPL
prerank,GO_Biological_Process_2021__positive regulation of epithelial tube formation (GO:1905278),-0.4484467776659062,-0.6908447572297315,0.8225806451612904,1.0,1.0,3/5,30.74%,SIX4;FGF2;EGF
prerank,GO_Biological_Process_2021__skeletal muscle tissue development (GO:0007519),-0.33192667139191656,-0.69082683593026,0.9,1.0,1.0,7/25,18.15%,CSRP3;POPDC2;LMOD3;SVIL;CAV2;MYL6;EGR2
prerank,GO_Biological_Process_2021__dicarboxylic acid biosynthetic process (GO:0043650),0.40692792649777365,0.6904303927393449,0.9428571428571428,1.0,1.0,2/8,13.11%,GLUD1;GLUD2
prerank,GO_Biological_Process_2021__cardiocyte differentiation (GO:0035051),0.38535271093541407,0.690388911920508,0.8,1.0,1.0,1/9,5.50%,NRG1
prerank,GO_Biological_Process_2021__proline metabolic process (GO:0006560),-0.45597865191931786,-0.6903432894494571,0.8979591836734694,1.0,1.0,2/5,17.77%,DAO;PRODH2
prerank,GO_Biological_Process_2021__regulation of Rac protein signal transduction (GO:0035020),0.35453082329511765,0.690325862878421,0.84375,1.0,1.0,1/14,3.86%,AUTS2
prerank,GO_Biological_Process_2021__maintenance of protein localization in endoplasmic reticulum (GO:0035437),-0.41154782052463035,-0.6902399950288541,0.8181818181818182,1.0,1.0,2/11,21.19%,KDELR3;HSPA5
prerank,GO_Biological_Process_2021__embryonic eye morphogenesis (GO:0048048),-0.3975755531586476,-0.6902373225135775,0.8392857142857143,1.0,1.0,3/8,18.49%,FBN2;MFAP5;ALDH1A3
prerank,KEGG_2021_Human__Measles,-0.2795497897161178,-0.6901959586673188,0.9859154929577465,1.0,1.0,12/93,15.42%,HSPA1L;CCND1;STAT1;OAS2;PIK3R3;CCND2;HSPA8;OAS1;TLR2;PIK3CB;IL12A;CCNE2
prerank,GO_Biological_Process_2021__ribosomal large subunit assembly (GO:0000027),-0.3170186025038389,-0.6901779116959389,0.9298245614035088,1.0,1.0,7/22,22.81%,RPL3;BRIX1;NOP53;MRPL20;RPL5;RPL11;RPL24
prerank,GO_Biological_Process_2021__cellular response to gamma radiation (GO:0071480),0.327915584151077,0.6900479629093591,0.8275862068965517,1.0,1.0,4/16,18.39%,HSF1;TP53;ATM;ATR
prerank,GO_Biological_Process_2021__positive regulation of actin nucleation (GO:0051127),0.36599647473841374,0.6899224580933685,0.8918918918918919,1.0,1.0,3/11,15.99%,WASF3;WASF2;FCHSD2
prerank,GO_Biological_Process_2021__amide biosynthetic process (GO:0043604),-0.32221585538177394,-0.6898635478323518,0.9305555555555556,1.0,1.0,6/46,18.74%,DEGS2;ALOX12B;ARG2;SGMS2;CERS3;CLN8
prerank,GO_Biological_Process_2021__positive regulation of collagen biosynthetic process (GO:0032967),-0.36632643162375644,-0.6895153565287284,0.8636363636363636,1.0,1.0,1/15,1.49%,TGFB1
prerank,GO_Biological_Process_2021__artery morphogenesis (GO:0048844),-0.350755164115783,-0.6894938110411774,0.9230769230769231,1.0,1.0,5/22,16.59%,TBX1;LRP2;ENG;HEY2;ANGPTL3
prerank,GO_Biological_Process_2021__positive regulation of potassium ion transmembrane transport (GO:1901381),-0.3144389180384852,-0.6893974323391997,0.927536231884058,1.0,1.0,2/43,8.12%,KCNJ15;KCNQ1
prerank,GO_Biological_Process_2021__oligosaccharide catabolic process (GO:0009313),0.4156305722805846,0.6893829377278928,0.9,1.0,1.0,2/8,15.83%,NEU4;NEU3
prerank,GO_Biological_Process_2021__positive regulation of I-kappaB kinase/NF-kappaB signaling (GO:0043123),0.2695447041241921,0.6893089127665489,1.0,1.0,1.0,44/139,21.34%,CFLAR;MAP3K14;RIPK2;TICAM2;TNFRSF19;TRIM8;LGALS1;TMEM106A;ECM1;PPP5C;CARD9;FLNA;ALPK1;APOL3;SHARPIN;F2R;LGALS9;PPM1A;PIM2;TSPAN6;GPR89A;TICAM1;FADD;CCDC22;TAB3;PELI1;WLS;PELI2;IRAK4;CXXC5;MALT1;ZDHHC13;BRD4;ROR1;S100B;MIB2;EEF1D;TAB2;MID2;TRIM14;TRAF6;SLC35B2;MTDH;TFG
prerank,GO_Biological_Process_2021__nuclear export (GO:0051168),0.2621139184581749,0.6892969935304012,1.0,1.0,1.0,21/74,22.86%,NUP42;RANBP17;ATXN1;NXF1;U2AF1;SRRM1;SRSF4;XPO7;ANKLE1;SMURF1;XPO5;MALT1;NUTF2;EIF4A3;U2AF2;XPO1;EIF4E;NUP214;TPR;NEMF;MAGOHB
prerank,GO_Biological_Process_2021__regulation of cellular respiration (GO:0043457),-0.4027546601331854,-0.6892778413113816,0.9152542372881356,1.0,1.0,4/16,18.44%,ACTN3;NOS2;IL10RB;NOP53
prerank,GO_Biological_Process_2021__mitochondrial translation (GO:0032543),0.25361499379438274,0.6890830230404446,1.0,1.0,1.0,20/94,28.79%,LARS2;MRPL4;MRPL41;NOA1;MRRF;MTRF1;EARS2;DAP3;MRPL2;AURKAIP1;QRSL1;MRPS7;MRPL55;MRPL43;MRPL58;ERAL1;MRPL3;MRPL1;MRPS16;MRPS18A
prerank,GO_Biological_Process_2021__regulation of mitotic cell cycle phase transition (GO:1901990),-0.2641985472268688,-0.6888078831992723,1.0,1.0,1.0,3/170,1.34%,NEK2;PSMB9;KIF14
prerank,Reactome_2022__Nuclear Envelope (NE) Reassembly R-HSA-2995410,0.26463858824122805,0.6887347642826631,0.9310344827586207,1.0,1.0,5/67,9.13%,LMNB1;VRK2;TUBA8;CHMP6;SPAST
prerank,GO_Biological_Process_2021__cellular polysaccharide catabolic process (GO:0044247),-0.3615145573313612,-0.6884578703163694,0.8840579710144928,1.0,1.0,3/14,18.02%,PHKG1;PYGL;CALM1
prerank,GO_Biological_Process_2021__regulation of guanyl-nucleotide exchange factor activity (GO:1905097),0.4324681888481233,0.6882927732072562,0.7894736842105263,1.0,1.0,1/5,11.34%,GPSM1
prerank,Reactome_2022__Global Genome Nucleotide Excision Repair (GG-NER) R-HSA-5696399,-0.29894844735507,-0.6882119282867022,0.9420289855072463,1.0,1.0,14/76,24.92%,RPA3;ACTL6A;TFPT;COPS5;POLE2;RBX1;POLD4;COPS4;RPS27A;POLE3;XRCC1;DDB1;COPS7A;CDK7
prerank,CellMarker_Augmented_2021__Basophil:Peripheral Blood,-0.4482614115620084,-0.6882078606741502,0.82,1.0,1.0,3/5,11.77%,IL3RA;CD63;ITGAM
prerank,Reactome_2022__Transcriptional Regulation By RUNX2 R-HSA-8878166,-0.28397943304451057,-0.6881719365663889,0.9855072463768116,1.0,1.0,18/103,19.11%,PSMB9;CCND1;ESR1;COL1A1;STAT1;ITGBL1;SMAD6;CDKN1A;ITGA5;HEY2;RBX1;GLI3;YAP1;PSMA3;RPS27A;STUB1;PSMA7;PSMB6
prerank,Reactome_2022__PCNA-Dependent Long Patch Base Excision Repair R-HSA-5651801,-0.3574677750114774,-0.688149442607471,0.8852459016393442,1.0,1.0,4/20,21.10%,RPA3;POLE2;POLD4;POLE3
prerank,GO_Biological_Process_2021__regulation of phosphatase activity (GO:0010921),0.32956393944106943,0.687970929918369,0.9166666666666666,1.0,1.0,2/21,3.96%,URI1;PPP1R35
prerank,GO_Biological_Process_2021__regulation of smooth muscle cell differentiation (GO:0051150),0.400389759695151,0.6878780405643642,0.8,1.0,1.0,1/6,6.59%,OLFM2
prerank,GO_Biological_Process_2021__regulation of establishment of planar polarity (GO:0090175),-0.2861584223611149,-0.6876865187657087,0.9868421052631579,1.0,1.0,2/77,2.54%,PSMB9;WNT5A
prerank,GO_Biological_Process_2021__regulation of lipid kinase activity (GO:0043550),0.3836961475730727,0.6876546565073479,0.825,1.0,1.0,2/10,7.77%,F2;RBL1
prerank,GO_Biological_Process_2021__regulation of B cell activation (GO:0050864),-0.356204190017112,-0.6876453556295783,0.847457627118644,1.0,1.0,1/17,1.39%,AHR
prerank,GO_Biological_Process_2021__intrinsic apoptotic signaling pathway in response to DNA damage (GO:0008630),0.30971449933082645,0.6874941232287509,0.9142857142857143,1.0,1.0,7/44,7.57%,BCL2;BCL2A1;HTRA2;SIRT1;IFI16;PML;ABL1
prerank,GO_Biological_Process_2021__positive regulation of cellular protein localization (GO:1903829),0.26529209234101647,0.6873030044156417,0.9428571428571428,1.0,1.0,11/59,14.59%,PYHIN1;BICD1;F2;EIF2AK3;TRAPPC12;CROCC;CEP250;GNL3L;CCDC88A;WWTR1;MARK4
prerank,GO_Biological_Process_2021__regulation of mesenchymal stem cell differentiation (GO:2000739),-0.4202308011815681,-0.6872203975538008,0.9215686274509803,1.0,1.0,2/7,21.32%,REST;SOX9
prerank,Reactome_2022__FCERI Mediated Ca+2 Mobilization R-HSA-2871809,-0.33857221325918235,-0.6870713920293465,0.8888888888888888,1.0,1.0,6/26,18.10%,VAV3;TEC;TXK;ITPR3;CALM1;NFATC2
prerank,GO_Biological_Process_2021__regulation of potassium ion transmembrane transport (GO:1901379),-0.3043242217804055,-0.6868817902175675,0.9264705882352942,1.0,1.0,4/53,10.40%,KCNJ15;CAV3;KCNQ1;CD63
prerank,Reactome_2022__RNA Polymerase I Transcription R-HSA-73864,0.26936390050288683,0.686741573861447,1.0,1.0,1.0,14/59,22.28%,GATAD2A;H2BC21;TAF1B;CCNH;POLR1H;HDAC1;GATAD2B;CHD4;H2AX;ERCC3;KAT2B;H2AJ;RBBP4;POLR2F
prerank,CellMarker_Augmented_2021__Neural Tube cell:Germ,-0.4083869729941428,-0.6867095634945474,0.90625,1.0,1.0,2/9,18.80%,ABCG2;CD81
prerank,GO_Biological_Process_2021__B cell differentiation (GO:0030183),-0.31315248451034705,-0.6864199938168866,0.9310344827586207,1.0,1.0,5/36,12.62%,IFNK;CLCF1;NFAM1;PTPRC;BLNK
prerank,GO_Biological_Process_2021__mast cell mediated immunity (GO:0002448),-0.424257047676395,-0.6861065916584271,0.8695652173913043,1.0,1.0,1/8,1.95%,S100A13
prerank,KEGG_2021_Human__Metabolism of xenobiotics by cytochrome P450,0.31771569219986434,0.686101562118687,0.8611111111111112,1.0,1.0,10/39,13.64%,CYP1A2;UGT2B15;GSTM5;CYP2S1;AKR1C1;GSTO2;GSTM2;ADH4;AKR7L;GSTA4
prerank,Reactome_2022__Protein Ubiquitination R-HSA-8852135,0.27297259894954584,0.685775805047161,0.9523809523809523,1.0,1.0,18/65,26.99%,UBE2E3;PEX13;RNF152;UBE2E1;UBE2A;SHPRH;UBE2Z;UBE2L3;RNF40;CDC34;UBE2J2;HLTF;UBE2D2;PEX14;BCL10;UBE2D3;UBE2G1;LEO1
prerank,Reactome_2022__RHO GTPases Activate WASPs And WAVEs R-HSA-5663213,-0.3209901952603235,-0.6855589810186811,0.9230769230769231,1.0,1.0,3/32,14.11%,ACTG1;WAS;NCKIPSD
prerank,GO_Biological_Process_2021__endosome transport via multivesicular body sorting pathway (GO:0032509),0.30156018132587825,0.6855409962456799,0.9166666666666666,1.0,1.0,3/21,14.10%,MVB12A;CHMP6;VTA1
prerank,CellMarker_Augmented_2021__Lake Et al.Science.In7:Brain,-0.4253791523396508,-0.6853424374334289,0.8666666666666667,1.0,1.0,2/6,14.14%,AOX1;COL24A1
prerank,GO_Biological_Process_2021__negative regulation of DNA-dependent DNA replication (GO:2000104),0.3731238776483412,0.6852276917980455,0.8888888888888888,1.0,1.0,3/13,11.45%,SLFN11;SMARCAL1;TIMELESS
prerank,GO_Biological_Process_2021__positive regulation of podosome assembly (GO:0071803),-0.4438936988331511,-0.6850945026625616,0.8269230769230769,1.0,1.0,2/5,19.23%,LCP1;IL5
prerank,Reactome_2022__Transcriptional Regulation Of Granulopoiesis R-HSA-9616222,0.29677094640354923,0.6849775887091883,0.9615384615384616,1.0,1.0,10/36,19.36%,CBFB;H2BC21;CDK4;PML;MYC;H2AX;RUNX1;EP300;CREB1;H2AJ
prerank,GO_Biological_Process_2021__positive regulation of cell cycle (GO:0045787),-0.30693368355734796,-0.6849168022446431,0.9,1.0,1.0,3/57,8.75%,SPDYA;CCND1;CCND2
prerank,GO_Biological_Process_2021__regulation of fatty acid metabolic process (GO:0019217),0.35170776401060133,0.6848992334904858,0.8181818181818182,1.0,1.0,6/15,22.35%,PPARG;ADIPOR1;ADIPOR2;PRKAA2;PRKAG2;SLC22A13
prerank,GO_Biological_Process_2021__positive regulation of bone resorption (GO:0045780),0.4005904275408807,0.684850699238834,0.8333333333333334,1.0,1.0,2/10,7.32%,DEF8;PLEKHM1
prerank,KEGG_2021_Human__Ferroptosis,-0.3131957153968811,-0.6848506226674452,0.9523809523809523,1.0,1.0,6/35,18.31%,ACSL5;ALOX15;CP;FTH1;ACSL3;MAP1LC3B2
prerank,Reactome_2022__Formation Of Xylulose-5-Phosphate R-HSA-5661270,0.42765252454262737,0.6847763788388643,0.8297872340425532,1.0,1.0,1/5,19.97%,XYLB
prerank,GO_Biological_Process_2021__glucuronate catabolic process to xylulose 5-phosphate (GO:0019640),0.42765252454262737,0.6847763788388643,0.8297872340425532,1.0,1.0,1/5,19.97%,XYLB
prerank,GO_Biological_Process_2021__glucuronate catabolic process (GO:0006064),0.42765252454262737,0.6847763788388643,0.8297872340425532,1.0,1.0,1/5,19.97%,XYLB
prerank,GO_Biological_Process_2021__xylulose 5-phosphate biosynthetic process (GO:1901159),0.42765252454262737,0.6847763788388643,0.8297872340425532,1.0,1.0,1/5,19.97%,XYLB
prerank,Reactome_2022__Regulation Of NF-kappa B Signaling R-HSA-9758274,0.299576404166768,0.6843957861401294,0.9090909090909091,1.0,1.0,5/18,24.24%,N4BP1;TANK;TP53;TRAF6;IKBKB
prerank,GO_Biological_Process_2021__negative regulation of mitotic cell cycle phase transition (GO:1901991),0.24442565727473436,0.6842699092910951,1.0,1.0,1.0,8/79,7.77%,SLFN11;PSME4;PKD2;GFI1B;CDK6;PSMA1;CDK4;RBL1
prerank,GO_Biological_Process_2021__cranial nerve development (GO:0021545),0.42709538194916746,0.6840564861608807,0.875,1.0,1.0,1/7,4.58%,ATOH7
prerank,"GO_Biological_Process_2021__Wnt signaling pathway, calcium modulating pathway (GO:0007223)",-0.3446483675784936,-0.6838273494987337,0.9166666666666666,1.0,1.0,9/33,23.73%,WNT5A;PDE6B;LEF1;PDE6A;CALM1;CAMK2A;PDE6G;GNAT2;PLCB2
prerank,GO_Biological_Process_2021__positive regulation of protein localization to membrane (GO:1905477),0.2529601807827666,0.6833462457680166,1.0,1.0,1.0,20/90,17.94%,BCL2;ERBB2;PPP1R13B;EPHA3;MAPK8;PTPN9;AKT2;ITGA3;DPP10;MIEF2;STAC2;BID;NKD2;MYO1C;TP53;WNK3;EPHB2;CLIP3;LGALS3;ARHGEF16
prerank,GO_Biological_Process_2021__positive regulation of gene expression (GO:0010628),-0.249514274647756,-0.6831314385144357,1.0,1.0,1.0,44/378,16.15%,RHOXF2;C1QTNF1;FGF20;TGFB1;ACTC1;S100A13;WNT5A;GPER1;ALOX12B;EIF6;CLDN5;POLR1C;ACTG1;NFAM1;PIK3R3;BRCA1;HTR2B;CLU;SFRP4;THBS1;SLC11A1;POLR1G;WARS1;RPS4X;VSTM2A;WNT6;TLR2;TXK;PIK3CB;ZNF580;LEF1;HEY2;TTN;EEF2;CTCFL;VDR;ACTA2;FGFR4;DDX3X;METTL14;FGF22;AGT;YAP1;SMAD3
prerank,CellMarker_Augmented_2021__Granulosa cell:Undefined,-0.29326862755534416,-0.6829062455198797,0.9866666666666667,1.0,1.0,7/92,5.75%,LMOD1;TIMP3;ANGPTL2;COL1A1;COL5A1;COL27A1;FBXL7
prerank,GO_Biological_Process_2021__cellular response to ketone (GO:1901655),0.290296619749893,0.6826769651366766,0.9375,1.0,1.0,7/35,14.18%,AKR1C3;DCPS;ADCY2;ADCY3;NDOR1;NR3C1;ADAM15
prerank,Reactome_2022__MAPK3 (ERK1) Activation R-HSA-110056,-0.40450313187169545,-0.6823708962404751,0.8548387096774194,1.0,1.0,4/9,30.71%,MAP2K1;PTPN11;IL6R;MAPK3
prerank,GO_Biological_Process_2021__regulation of myeloid cell differentiation (GO:0045637),0.2827724860958762,0.6822383693746992,0.92,1.0,1.0,16/55,20.28%,MAFB;CBFB;CDK6;MOV10;TNRC6C;DPY30;HDAC1;CNOT4;RUNX1;TNRC6A;NR4A3;AGO3;LGALS3;EP300;KAT2B;KMT2C
prerank,GO_Biological_Process_2021__mast cell activation involved in immune response (GO:0002279),-0.42854053650135093,-0.6820548385161996,0.8478260869565217,1.0,1.0,1/7,1.95%,S100A13
prerank,GO_Biological_Process_2021__mast cell degranulation (GO:0043303),-0.42854053650135093,-0.6820548385161996,0.8478260869565217,1.0,1.0,1/7,1.95%,S100A13
prerank,CellMarker_Augmented_2021__Endothelial cell:Peripheral Blood,0.40586470433110033,0.6820548159896004,0.7878787878787878,1.0,1.0,1/7,2.83%,CDH5
prerank,GO_Biological_Process_2021__response to corticosteroid (GO:0031960),-0.4290984053252245,-0.6820291117499979,0.85,1.0,1.0,1/6,6.43%,SOX30
prerank,GO_Biological_Process_2021__glycogen metabolic process (GO:0005977),0.3280483608713712,0.6819076064013646,0.8888888888888888,1.0,1.0,2/24,8.39%,PER2;GYS1
prerank,GO_Biological_Process_2021__tryptophan catabolic process (GO:0006569),0.3847581163712319,0.6818096190037655,0.925,1.0,1.0,3/11,8.21%,TDO2;KYAT1;AADAT
prerank,GO_Biological_Process_2021__mesenchymal cell differentiation (GO:0048762),-0.30338878717573364,-0.6817239522454864,0.9032258064516129,1.0,1.0,6/44,14.16%,TGFB1;WNT5A;HTR2B;ENG;LEF1;HEY2
prerank,Reactome_2022__Signaling By PDGF R-HSA-186797,-0.3004215468705463,-0.681258000608632,0.925,1.0,1.0,8/51,13.53%,STAT1;COL4A4;COL4A3;PLG;THBS1;COL6A6;PLAT;PIK3CB
prerank,Reactome_2022__Glucose Metabolism R-HSA-70326,-0.28132375840175095,-0.6811324828182186,1.0,1.0,1.0,6/80,8.97%,SLC37A2;ALDOB;TAC4;PKLR;ENO2;GAPDHS
prerank,GO_Biological_Process_2021__amino-acid betaine biosynthetic process (GO:0006578),-0.442263545378216,-0.6809718503330694,0.7843137254901961,1.0,1.0,2/5,20.62%,TMLHE;BBOX1
prerank,GO_Biological_Process_2021__carnitine biosynthetic process (GO:0045329),-0.442263545378216,-0.6809718503330694,0.7843137254901961,1.0,1.0,2/5,20.62%,TMLHE;BBOX1
prerank,GO_Biological_Process_2021__neuron projection organization (GO:0106027),0.327017107620528,0.6809668529953835,0.9512195121951219,1.0,1.0,2/14,14.95%,ABCD2;INSR
prerank,Reactome_2022__RHOBTB1 GTPase Cycle R-HSA-9013422,0.29624636581901076,0.6809330494306729,0.9375,1.0,1.0,4/23,12.78%,RHOBTB1;RBBP6;SRRM1;CPSF7
prerank,KEGG_2021_Human__Melanogenesis,-0.2850091540581237,-0.6808492308336718,0.9743589743589743,1.0,1.0,15/85,18.70%,TCF7;WNT5A;WNT8B;FZD8;TCF7L1;WNT8A;WNT6;EDNRB;LEF1;ASIP;ADCY7;WNT10A;CALM1;CAMK2A;TYR
prerank,GO_Biological_Process_2021__mitochondrial ribosome assembly (GO:0061668),0.41304139008222174,0.6807434739669735,0.9230769230769231,1.0,1.0,1/6,3.07%,MTERF3
prerank,KEGG_2021_Human__VEGF signaling pathway,0.2729927168365156,0.6804752731829564,0.9333333333333333,1.0,1.0,7/49,15.70%,MAPKAPK2;HSPB1;AKT2;PXN;PLA2G4C;PIK3CA;MAPK12
prerank,Reactome_2022__Translesion Synthesis By POLK R-HSA-5655862,-0.35700595522522405,-0.6802892662815211,0.8888888888888888,1.0,1.0,1/17,4.30%,RPA3
prerank,GO_Biological_Process_2021__mitotic nuclear division (GO:0140014),0.2589845786940369,0.6802377161692542,1.0,1.0,1.0,12/67,18.08%,KIFC1;KIFC2;FLNA;SPAST;AAAS;SGO2;EPS8;KLHL22;PIBF1;ESPL1;LSM14A;KIF3B
prerank,Reactome_2022__Transcriptional Regulation Of Pluripotent Stem Cells R-HSA-452723,-0.3590711703691602,-0.6801906657883862,0.8787878787878788,1.0,1.0,3/15,19.03%,SALL4;EPHA1;EPAS1
prerank,GO_Biological_Process_2021__UDP-N-acetylglucosamine metabolic process (GO:0006047),0.31378007371515676,0.6801746588090444,0.875,1.0,1.0,5/12,27.39%,NAGK;UAP1;GNPNAT1;UAP1L1;GFPT2
prerank,Reactome_2022__IRAK2 Mediated Activation Of TAK1 Complex Upon TLR7/8 Or 9 Stimulation R-HSA-975163,0.328067008143577,0.6800778477519562,0.8648648648648649,1.0,1.0,5/14,20.40%,TICAM1;TAB3;TAB1;TAB2;TRAF6
prerank,GO_Biological_Process_2021__regulation of glucagon secretion (GO:0070092),0.4348825591743458,0.6800351412857925,0.8461538461538461,1.0,1.0,2/5,30.89%,SYT7;CRH
prerank,GO_Biological_Process_2021__negative regulation of DNA repair (GO:0045738),0.3686901392005937,0.6799437021980032,0.9285714285714286,1.0,1.0,1/7,9.00%,TWIST1
prerank,GO_Biological_Process_2021__negative regulation of delayed rectifier potassium channel activity (GO:1902260),-0.41830646338680316,-0.6799120480935749,0.9076923076923077,1.0,1.0,4/7,29.76%,KCNE3;KCNE4;KCNAB1;KCNE2
prerank,GO_Biological_Process_2021__negative regulation of cell adhesion mediated by integrin (GO:0033629),0.3998581638528156,0.6796726369357315,0.85,1.0,1.0,4/8,13.98%,SERPINE1;ACER2;SNAI2;NEXMIF
prerank,GO_Biological_Process_2021__positive regulation of mitochondrial fission (GO:0090141),-0.3477810012322948,-0.6796445976231864,0.9365079365079365,1.0,1.0,2/18,6.82%,PINK1;DCN
prerank,GO_Biological_Process_2021__epithelial cell apoptotic process (GO:1904019),0.3798451661824139,0.6796149048565002,0.8064516129032258,1.0,1.0,1/7,3.65%,CAPN10
prerank,Reactome_2022__Signaling By NOTCH4 R-HSA-9013694,-0.28695078106544636,-0.6795616445846907,0.972972972972973,1.0,1.0,10/74,19.11%,PSMB9;FLT4;HEY2;ACTA2;RBX1;SMAD3;PSMA3;RPS27A;PSMA7;PSMB6
prerank,GO_Biological_Process_2021__cAMP metabolic process (GO:0046058),0.3720334034881331,0.679490781872029,0.8780487804878049,1.0,1.0,6/11,29.07%,ADCY2;ADCY3;ADCY6;PDE4D;ADCY9;ADCY5
prerank,GO_Biological_Process_2021__tRNA 5'-leader removal (GO:0001682),-0.40654516146868575,-0.6793242476949752,0.8620689655172413,1.0,1.0,1/11,3.12%,RPP38
prerank,GO_Biological_Process_2021__cell cycle G2/M phase transition (GO:0044839),-0.2709868876483254,-0.6792697494075182,0.9868421052631579,1.0,1.0,15/122,16.36%,NEK2;FOXM1;CDC25A;FBXL7;DCTN1;TPD52L1;CDKN1A;ABCB1;TUBA4A;CEP72;DYNLL1;BORA;TUBB;CEP76;USH1C
prerank,GO_Biological_Process_2021__B cell chemotaxis (GO:0035754),-0.42052836473667776,-0.6790665948980031,0.8627450980392157,1.0,1.0,2/6,8.93%,CXCL13;HSD3B7
prerank,Reactome_2022__APC/C:Cdh1 Mediated Degradation Of Cdc20 And APC/C:Cdh1 Targets In Late Mitosis/Early G1 R-HSA-174178,-0.2894271746949786,-0.679059136313994,0.971830985915493,1.0,1.0,1/63,0.62%,PSMB9
prerank,Reactome_2022__Sodium/Calcium Exchangers R-HSA-425561,0.38368161944699086,0.6789563984057659,0.8780487804878049,1.0,1.0,2/10,5.32%,SLC8A1;SLC8A3
prerank,Reactome_2022__Termination Of O-glycan Biosynthesis R-HSA-977068,-0.3398242766610548,-0.6789539253354195,0.8805970149253731,1.0,1.0,6/20,18.18%,MUCL1;MUC5B;ST6GALNAC2;MUC4;MUC17;MUC15
prerank,GO_Biological_Process_2021__macrophage activation involved in immune response (GO:0002281),0.40080617405205154,0.6788887367070374,0.8529411764705882,1.0,1.0,3/10,20.89%,CX3CR1;LBP;PLCG2
prerank,GO_Biological_Process_2021__negative regulation of axon extension involved in axon guidance (GO:0048843),0.31271028369485426,0.6787847687189655,0.9428571428571428,1.0,1.0,3/19,9.68%,SEMA6C;SEMA5A;SEMA4A
prerank,GO_Biological_Process_2021__regulation of cell growth (GO:0001558),-0.26201258527364435,-0.6785901031760524,0.9883720930232558,1.0,1.0,22/178,16.15%,KIF14;TGFB1;TMC8;TP53TG5;ROS1;CRLF3;TCHP;NUBP1;PAPPA2;CEACAM1;PPT1;CDKN2D;CDKN1A;CXCL16;TAF9B;RBBP7;RERG;HYAL1;DDX3X;AGT;EI24;SMAD3
prerank,GO_Biological_Process_2021__regulation of homophilic cell adhesion (GO:1903385),0.43499979931463834,0.678567349737422,0.7555555555555555,1.0,1.0,3/5,14.40%,PTPRR;TENM3;PTPN23
prerank,Reactome_2022__MyD88 Deficiency (TLR2/4) R-HSA-5602498,-0.3906243636363158,-0.6783780315417278,0.8695652173913043,1.0,1.0,2/9,14.12%,TLR2;NDUFA2
prerank,GO_Biological_Process_2021__positive regulation of integrin-mediated signaling pathway (GO:2001046),0.3808365880903697,0.6782090551479506,0.7857142857142857,1.0,1.0,2/7,11.91%,FLNA;LIMS1
prerank,GO_Biological_Process_2021__COPII-coated vesicle cargo loading (GO:0090110),0.34425205342683995,0.6781135775186143,0.851063829787234,1.0,1.0,5/14,28.22%,SEC24C;MIA3;SEC31A;SEC24B;SAR1A
prerank,GO_Biological_Process_2021__regulation of activation of Janus kinase activity (GO:0010533),-0.4401159351787107,-0.6781047225061143,0.8113207547169812,1.0,1.0,3/5,25.89%,AGT;IL6R;CCL5
prerank,GO_Biological_Process_2021__positive regulation of activation of Janus kinase activity (GO:0010536),-0.4401159351787107,-0.6781047225061143,0.8113207547169812,1.0,1.0,3/5,25.89%,AGT;IL6R;CCL5
prerank,CellMarker_Augmented_2021__Epithelial cell:Ovary,0.4133003908083198,0.677930827558464,0.7843137254901961,0.9999208429480544,1.0,1/6,6.95%,DSP
prerank,GO_Biological_Process_2021__regulation of store-operated calcium entry (GO:2001256),-0.43793986808853985,-0.6778852021238702,0.9615384615384616,1.0,1.0,3/8,25.25%,EFHB;SARAF;CASQ1
prerank,GO_Biological_Process_2021__protein retention in ER lumen (GO:0006621),-0.4540093656866777,-0.677704168374716,0.8813559322033898,1.0,1.0,1/7,18.16%,KDELR3
prerank,KEGG_2021_Human__Proximal tubule bicarbonate reclamation,-0.3488985822261278,-0.6776964607371446,0.9375,1.0,1.0,4/17,20.14%,ATP1A4;CA4;ATP1A1;SLC38A3
prerank,Reactome_2022__Transcriptional Regulation By RUNX1 R-HSA-8878171,-0.2669801016744462,-0.6776112122998459,1.0,1.0,1.0,15/162,10.89%,PSMB9;BLK;CCND1;ESR1;ACTL6A;CBX8;TCF7L1;GP1BA;CLDN5;H2BC4;ZFPM1;CCND2;THBS1;ITGA2B;SPI1
prerank,GO_Biological_Process_2021__positive regulation of histone H3-K9 methylation (GO:0051574),-0.4705827942159384,-0.6774749216384992,0.890625,1.0,1.0,1/6,5.91%,PRDM12
prerank,Reactome_2022__TRAF6 Mediated IRF7 Activation R-HSA-933541,-0.36275842075403764,-0.6774555959494319,0.921875,1.0,1.0,1/13,6.02%,TRIM25
prerank,GO_Biological_Process_2021__regulation of macromolecule metabolic process (GO:0060255),-0.25747484324172193,-0.6772644169688652,1.0,1.0,1.0,15/154,14.49%,EOLA1;AHR;TRIM58;TRIM77;TRIM5;PRDM12;RNF39;IGF2BP2;REST;PTPRC;ALPK2;TXK;RSPO1;RNF187;CGGBP1
prerank,GO_Biological_Process_2021__positive regulation of DNA-binding transcription factor activity (GO:0051091),-0.2594482162348996,-0.6768262270226778,1.0,1.0,1.0,18/198,13.31%,TRIM62;NODAL;AIM2;WNT5A;TERF2IP;BEX1;CARD14;ESR1;TRIM5;TRIM25;NFKB2;NFAM1;CLU;NLRC4;COPS5;TLR2;PRKCH;NLRP3
prerank,GO_Biological_Process_2021__histone H3-K9 methylation (GO:0051567),0.41465787619855526,0.6761726409252014,0.9285714285714286,1.0,1.0,1/6,3.71%,PRDM5
prerank,GO_Biological_Process_2021__eye development (GO:0001654),-0.30933450019606884,-0.6760959459462741,0.9393939393939394,1.0,1.0,7/45,17.48%,MAB21L1;COL5A1;FREM2;FBN2;CRYBA4;HIPK1;SALL2
prerank,GO_Biological_Process_2021__regulation of RNA biosynthetic process (GO:2001141),0.4282053206669874,0.6759316321955984,0.8636363636363636,1.0,1.0,1/6,2.54%,MITF
prerank,Reactome_2022__Generation Of Second Messenger Molecules R-HSA-202433,0.32185728096915195,0.6756498162316998,0.9090909090909091,1.0,1.0,4/23,11.56%,CD247;HLA-DRA;PKN2;EVL
prerank,Reactome_2022__Transcription-Coupled Nucleotide Excision Repair (TC-NER) R-HSA-6781827,-0.28675967484102705,-0.6754974613005192,0.9615384615384616,1.0,1.0,14/75,24.92%,RPA3;UVSSA;COPS5;POLE2;RBX1;POLD4;COPS4;RPS27A;POLE3;XRCC1;POLR2B;DDB1;COPS7A;CDK7
prerank,GO_Biological_Process_2021__T cell mediated cytotoxicity (GO:0001913),-0.41748157793398855,-0.6752885216961277,0.8653846153846154,1.0,1.0,2/6,19.12%,HLA-A;CRTAM
prerank,KEGG_2021_Human__Fatty acid elongation,-0.3251230742081576,-0.6752499709580946,0.9230769230769231,1.0,1.0,7/25,14.71%,ELOVL2;PPT1;ACOT4;ACAA2;ACOT1;ACOT2;HACD4
prerank,GO_Biological_Process_2021__carboxylic acid catabolic process (GO:0046395),-0.3704266422560415,-0.6751972927849206,0.8333333333333334,1.0,1.0,4/12,17.95%,PON3;ACOT4;PON1;RENBP
prerank,GO_Biological_Process_2021__tRNA metabolic process (GO:0006399),-0.3715703302570105,-0.6751884780071928,0.9056603773584906,1.0,1.0,2/15,16.15%,DARS2;YARS2
prerank,GO_Biological_Process_2021__negative regulation of phospholipase activity (GO:0010519),0.38359574198779345,0.6751093732596328,0.8205128205128205,1.0,1.0,2/7,7.57%,BICD1;ABL1
prerank,GO_Biological_Process_2021__anaphase-promoting complex-dependent catabolic process (GO:0031145),-0.28171275375675076,-0.6750529570510732,0.9864864864864865,1.0,1.0,1/73,0.62%,PSMB9
prerank,GO_Biological_Process_2021__amino-acid betaine transport (GO:0015838),0.43597765311216763,0.6750321096046485,0.9333333333333333,1.0,1.0,3/5,10.93%,SLC22A5;SLC6A20;SLC25A29
prerank,Reactome_2022__Myoclonic Epilepsy Of Lafora R-HSA-3785653,0.3754163927709137,0.6749040873290483,0.9302325581395349,1.0,1.0,1/8,8.39%,GYS1
prerank,GO_Biological_Process_2021__positive regulation of leukocyte chemotaxis (GO:0002690),-0.3172102103434384,-0.6746806182863402,0.9076923076923077,1.0,1.0,7/38,19.83%,F7;THBS1;ZNF580;IL12A;F2RL1;CSF1R;CREB3
prerank,GO_Biological_Process_2021__protein deubiquitination (GO:0016579),-0.2545378855476153,-0.6742532148613749,1.0,1.0,1.0,17/229,13.31%,PSMB9;ESR1;ACTL6A;ABRAXAS1;CDC25A;TOMM20;ATXN7L3;BRCA1;USP13;USP50;USP6;TFPT;USP17L2;COPS5;FOXO4;TAF9B;NLRP3
prerank,GO_Biological_Process_2021__ribonucleoprotein complex disassembly (GO:0032988),0.4203601116411448,0.6742035904302736,0.8787878787878788,1.0,1.0,1/7,9.86%,DYRK3
prerank,GO_Biological_Process_2021__positive regulation by symbiont of entry into host (GO:0075294),0.3892639895302722,0.6740435306094905,0.8571428571428571,1.0,1.0,3/9,14.60%,LGALS1;LGALS9;TMPRSS2
prerank,GO_Biological_Process_2021__positive regulation of viral entry into host cell (GO:0046598),0.3892639895302722,0.6740435306094905,0.8571428571428571,1.0,1.0,3/9,14.60%,LGALS1;LGALS9;TMPRSS2
prerank,GO_Biological_Process_2021__maintenance of protein location in nucleus (GO:0051457),-0.3594100829847383,-0.6739168463026255,0.8545454545454545,1.0,1.0,1/18,4.03%,SP100
prerank,GO_Biological_Process_2021__positive regulation of B cell proliferation (GO:0030890),-0.3303858009140277,-0.6739106233836074,0.9402985074626866,1.0,1.0,5/24,10.28%,VAV3;CLCF1;GPR183;IL7;PTPRC
prerank,GO_Biological_Process_2021__epithelial to mesenchymal transition (GO:0001837),-0.29564645349631946,-0.6734700528204433,0.958904109589041,1.0,1.0,5/41,14.16%,TGFB1;WNT5A;ENG;LEF1;HEY2
prerank,GO_Biological_Process_2021__Fc-gamma receptor signaling pathway involved in phagocytosis (GO:0038096),-0.2964692729806054,-0.6734251094645383,0.9705882352941176,1.0,1.0,5/60,7.51%,HCK;VAV3;FCGR3A;ACTG1;WAS
prerank,GO_Biological_Process_2021__Fc-gamma receptor signaling pathway (GO:0038094),-0.2964692729806054,-0.6734251094645383,0.9705882352941176,1.0,1.0,5/60,7.51%,HCK;VAV3;FCGR3A;ACTG1;WAS
prerank,GO_Biological_Process_2021__toll-like receptor 9 signaling pathway (GO:0034162),0.3594775146760008,0.6731104855662938,0.8536585365853658,1.0,1.0,3/10,21.62%,IRAK4;TRAF6;PIK3R4
prerank,Reactome_2022__Signaling By Retinoic Acid R-HSA-5362517,0.27436398453336003,0.6728615442145266,0.967741935483871,1.0,1.0,6/34,12.79%,RARB;ALDH1A1;AKR1C3;ALDH1A2;CRABP1;CPT1A
prerank,Reactome_2022__2-LTR Circle Formation R-HSA-164843,0.387266250326622,0.6727459464590627,0.8636363636363636,1.0,1.0,2/8,16.35%,SGIP1;LIG4
prerank,Reactome_2022__Listeria Monocytogenes Entry Into Host Cells R-HSA-8876384,0.29441945249261464,0.6727342491419455,0.9354838709677419,1.0,1.0,5/19,23.99%,SH3KBP1;STAM2;SH3GL1;FZR1;CBL
prerank,GO_Biological_Process_2021__positive regulation of JUN kinase activity (GO:0043507),0.321154011587216,0.6727317659485126,0.9705882352941176,1.0,1.0,8/17,33.61%,MAP3K10;DUSP19;TRAF6;EDN1;TAOK3;DVL2;MAP3K4;MAP3K7
prerank,GO_Biological_Process_2021__cellular response to glucose stimulus (GO:0071333),0.31365967957067054,0.6726668320915145,0.9411764705882353,1.0,1.0,6/29,19.55%,ZBTB20;ERN1;UNC13B;MLXIPL;RAB11B;PRKAA2
prerank,KEGG_2021_Human__Non-homologous end-joining,0.3327615538687352,0.6724731662741095,0.85,1.0,1.0,2/11,16.35%,POLM;LIG4
prerank,GO_Biological_Process_2021__protein localization to chromatin (GO:0071168),-0.3472891235638515,-0.6723150323766784,0.9180327868852459,1.0,1.0,1/18,4.81%,ESR1
prerank,GO_Biological_Process_2021__tryptophan metabolic process (GO:0006568),0.39376206694933336,0.6722669336539817,0.926829268292683,1.0,1.0,3/10,8.21%,TDO2;KYAT1;AADAT
prerank,GO_Biological_Process_2021__indolalkylamine catabolic process (GO:0046218),0.39376206694933336,0.6722669336539817,0.926829268292683,1.0,1.0,3/10,8.21%,TDO2;KYAT1;AADAT
prerank,GO_Biological_Process_2021__positive regulation of calcium ion-dependent exocytosis (GO:0045956),0.3236809049651418,0.6722073629466064,0.9444444444444444,1.0,1.0,2/12,8.41%,DOC2B;SYT1
prerank,GO_Biological_Process_2021__cardiac conduction system development (GO:0003161),-0.3575302625501159,-0.6721907026020304,0.9166666666666666,1.0,1.0,1/19,1.19%,SCN5A
prerank,GO_Biological_Process_2021__negative regulation of catecholamine secretion (GO:0033604),-0.4275111251324748,-0.6720551304161293,0.85,1.0,1.0,3/6,32.45%,SYT11;SYT4;ADRA2A
prerank,KEGG_2021_Human__Salmonella infection,0.23148489415894907,0.6716552891180549,1.0,1.0,1.0,30/220,15.70%,SNX18;ACTR3C;BCL2;CD14;VPS16;RIPK2;ACBD3;RAB7A;PLEKHM1;PIK3C2B;MAPK8;CASP3;MYC;FLNA;DYNC1I2;RALA;TUBA8;GCC2;AKT2;WASF3;FADD;TAB3;SNX9;ARPC3;EXOC7;NFKB1;PIK3CA;IRAK4;FLNB;MAPK12
prerank,GO_Biological_Process_2021__protein peptidyl-prolyl isomerization (GO:0000413),0.3304002214870881,0.67164914299971,0.8888888888888888,1.0,1.0,8/19,28.83%,PPIB;CWC27;NKTR;PPIH;PPIL2;PPIL6;PPIA;PPIF
prerank,GO_Biological_Process_2021__modification-dependent protein catabolic process (GO:0019941),-0.25745585453176734,-0.6715853243078442,1.0,1.0,1.0,7/182,7.96%,ARIH2;DTL;PINK1;UBE2L6;FBXL7;TRIM25;RNF213
prerank,CellMarker_Augmented_2021__Mast cell:Undefined,-0.37767096156757657,-0.6710819663334843,0.8333333333333334,1.0,1.0,5/12,20.22%,IL3RA;PTPRC;IL5RA;CD24;CSF2RA
prerank,GO_Biological_Process_2021__G2/M transition of mitotic cell cycle (GO:0000086),-0.27296946490412927,-0.6709894368506453,0.9866666666666667,1.0,1.0,15/121,16.36%,NEK2;FOXM1;CDC25A;FBXL7;DCTN1;TPD52L1;CDKN1A;ABCB1;TUBA4A;CEP72;DYNLL1;BORA;TUBB;CEP76;USH1C
prerank,CellMarker_Augmented_2021__Beta cell:Pancreas,-0.36552426207216887,-0.6709436724897454,0.9508196721311475,1.0,1.0,2/13,19.05%,TSPAN7;PFKFB2
prerank,GO_Biological_Process_2021__respiratory electron transport chain (GO:0022904),-0.37487759077819893,-0.6709115491893551,0.8412698412698413,1.0,1.0,3/13,17.64%,SLC25A18;ETFB;SLC25A22
prerank,GO_Biological_Process_2021__organelle fission (GO:0048285),0.30755742198962216,0.670720196534588,0.9393939393939394,1.0,1.0,1/24,4.88%,GDAP1
prerank,GO_Biological_Process_2021__positive regulation of ERBB signaling pathway (GO:1901186),0.3168894267573432,0.6707192753866786,0.9666666666666667,1.0,1.0,2/23,2.90%,DGKD;HIP1
prerank,Reactome_2022__Proton-coupled Monocarboxylate Transport R-HSA-433692,-0.42029637618204496,-0.6706530300155392,0.896551724137931,1.0,1.0,2/6,12.06%,SLC16A8;SLC16A3
prerank,Reactome_2022__RNA Polymerase I Promoter Opening R-HSA-73728,-0.3588634752233948,-0.6706109637850676,0.8450704225352113,1.0,1.0,2/14,12.66%,H2BC4;H2AZ1
prerank,KEGG_2021_Human__Lipid and atherosclerosis,-0.26167631552650666,-0.6705055486962824,1.0,1.0,1.0,29/159,21.19%,HSPA1L;POU2F3;MMP9;VAV3;CYP2A6;PIK3R3;SOD2;SELP;CYP2J2;CASP7;CYBA;HSPA8;TNFRSF10A;TLR2;NLRP3;PIK3CB;RXRG;IL12A;IL18;RAC1;CALM1;NFATC2;CAMK2A;CASP6;CASP8;NOX1;HSPA4;AGER;HSPA5
prerank,GO_Biological_Process_2021__positive regulation of protein glycosylation (GO:0060050),-0.4802119550622962,-0.6701833118493323,0.8888888888888888,1.0,1.0,2/5,26.89%,ALG10B;GOLGA2
prerank,Reactome_2022__RUNX1 Regulates Estrogen Receptor Mediated Transcription R-HSA-8931987,-0.3981810807314287,-0.6701718078999467,0.9183673469387755,1.0,1.0,1/6,4.81%,ESR1
prerank,GO_Biological_Process_2021__plasma membrane organization (GO:0007009),-0.2892923841339854,-0.6699778402455621,0.9736842105263158,1.0,1.0,4/56,11.55%,CAV3;COL5A1;A4GALT;AHNAK2
prerank,Reactome_2022__Resolution Of Abasic Sites (AP Sites) R-HSA-73933,-0.3080004775797823,-0.6696987732850145,0.9402985074626866,1.0,1.0,7/36,22.81%,RPA3;POLE2;POLD4;SMUG1;OGG1;POLE3;XRCC1
prerank,GO_Biological_Process_2021__positive regulation of rRNA processing (GO:2000234),0.3987548709632017,0.6696735216572435,0.9069767441860465,1.0,1.0,2/10,7.20%,SIRT7;RIOK1
prerank,Reactome_2022__Interleukin-1 Signaling R-HSA-9020702,0.22088697255181677,0.6696690917859248,1.0,1.0,1.0,21/98,20.85%,RIPK2;PSME4;SEM1;HMGB1;PSMA1;ALPK1;N4BP1;TANK;NKIRAS2;TAB3;PELI1;NFKB1;PELI2;IRAK4;TP53;S100B;TAB1;TAB2;MAP2K6;TRAF6;PSMD4
prerank,GO_Biological_Process_2021__melanosome assembly (GO:1903232),-0.43369648944426864,-0.6693914414724913,0.8793103448275862,1.0,1.0,1/5,23.62%,HPS4
prerank,Reactome_2022__CaM Pathway R-HSA-111997,0.29733970101700735,0.669364317763855,0.8928571428571429,1.0,1.0,10/31,26.90%,PDE1A;ADCY2;PRKAR2A;ADCY6;CREB1;NBEA;PDE1B;PRKCD;PRKACB;ADCY9
prerank,GO_Biological_Process_2021__replicative senescence (GO:0090399),0.3382976887661883,0.6689312488577009,0.8333333333333334,1.0,1.0,5/11,23.04%,SERPINE1;TP53;ATM;ATR;PLA2R1
prerank,Reactome_2022__RAC2 GTPase Cycle R-HSA-9013404,-0.2910134596907431,-0.6687506651428299,0.9859154929577465,1.0,1.0,7/80,12.97%,VAV3;DOCK2;ARMCX3;PIK3R3;CYBA;DEF6;BAIAP2L1
prerank,CellMarker_Augmented_2021__Neural Stem cell:Undefined,0.28228708017066,0.668713434623123,1.0,1.0,1.0,14/44,18.14%,PAX3;NUMB;CDCP1;SMARCA4;CDH2;ASCL1;MSI1;NCAM1;GABPA;RUNX1;NR6A1;NOTCH1;PAX6;MSI2
prerank,GO_Biological_Process_2021__aortic valve development (GO:0003176),-0.3309743639022025,-0.6686060882704408,0.9375,1.0,1.0,5/30,14.82%,TGFB1;TNFRSF1B;SMAD6;HEY2;GATA4
prerank,GO_Biological_Process_2021__aromatic amino acid family catabolic process (GO:0009074),0.35535490460592845,0.6685129116963379,0.90625,1.0,1.0,3/15,8.21%,TDO2;KYAT1;AADAT
prerank,GO_Biological_Process_2021__enteric nervous system development (GO:0048484),-0.4083142288582462,-0.6684913515792357,0.9137931034482759,1.0,1.0,2/8,13.30%,SOX10;EDNRB
prerank,GO_Biological_Process_2021__transcription initiation from RNA polymerase III promoter (GO:0006384),0.4387283549227991,0.6683105272095919,0.8695652173913043,1.0,1.0,1/5,7.87%,BDP1
prerank,Reactome_2022__MHC Class II Antigen Presentation R-HSA-2132295,0.25708637449991134,0.6681873451703414,0.9130434782608695,1.0,1.0,6/89,9.74%,PRICKLE1;RAB7A;HLA-DRA;SEC24C;DYNC1I2;CTSV
prerank,GO_Biological_Process_2021__nucleobase-containing small molecule interconversion (GO:0015949),-0.3136320028697919,-0.6681619660405784,0.8695652173913043,1.0,1.0,2/25,11.31%,NUDT13;GLRX
prerank,GO_Biological_Process_2021__negative regulation of voltage-gated potassium channel activity (GO:1903817),-0.3980090890797896,-0.6681243801175916,0.8387096774193549,1.0,1.0,5/8,32.97%,KCNE3;KCNE4;KCNAB1;KCNE2;CAV1
prerank,GO_Biological_Process_2021__spliceosomal complex assembly (GO:0000245),0.280209435781909,0.6680094580740193,0.9375,1.0,1.0,7/42,15.37%,PUF60;TXNL4A;CELF5;CELF4;SF3B1;CELF2;LUC7L
prerank,GO_Biological_Process_2021__alanine transport (GO:0032328),0.37682028540539514,0.6678745120579039,0.9090909090909091,1.0,1.0,2/9,16.71%,SLC6A17;SLC36A4
prerank,GO_Biological_Process_2021__regulation of hematopoietic progenitor cell differentiation (GO:1901532),-0.27544654860951695,-0.6678412683164819,0.9705882352941176,1.0,1.0,8/61,20.68%,PSMB9;SPI1;METTL14;YAP1;PSMA3;PSMA7;PSMB6;LMO2
prerank,Reactome_2022__Homologous DNA Pairing And Strand Exchange R-HSA-5693579,-0.31135893015587035,-0.6676403439718045,0.9365079365079365,1.0,1.0,11/40,26.10%,RPA3;BRCA1;RRAD;RMI1;TOPBP1;BLM;RAD9B;CHEK1;RMI2;XRCC2;BRCA2
prerank,Reactome_2022__Glyoxylate Metabolism And Glycine Degradation R-HSA-389661,-0.3330426715582959,-0.6674830431033949,0.9295774647887324,1.0,1.0,5/22,17.77%,DAO;PDHX;GLDC;GNMT;PRODH2
prerank,GO_Biological_Process_2021__response to ionizing radiation (GO:0010212),-0.2856611051777474,-0.667364730776355,0.9833333333333333,1.0,1.0,7/69,13.23%,TICRR;ABRAXAS1;EYA1;BRCA1;ANXA1;CDKN1A;RAD1
prerank,Reactome_2022__Impaired BRCA2 Binding To RAD51 R-HSA-9709570,-0.3126334502386178,-0.6673553271844874,0.9032258064516129,1.0,1.0,9/33,26.10%,RPA3;BRCA1;RRAD;RMI1;TOPBP1;BLM;RAD9B;RMI2;BRCA2
prerank,Reactome_2022__Semaphorin Interactions R-HSA-373755,0.2501650969858455,0.6672955256607975,0.9655172413793104,1.0,1.0,6/61,10.13%,SEMA5A;ERBB2;PLXNB1;FARP2;SEMA4A;PKN2
prerank,GO_Biological_Process_2021__GPI anchor biosynthetic process (GO:0006506),-0.33769130267255265,-0.666484505257155,0.9154929577464789,1.0,1.0,4/28,14.30%,PIGH;MPPE1;PIGC;PIGL
prerank,Reactome_2022__HDR Thru Single Strand Annealing (SSA) R-HSA-5685938,-0.30588905373983905,-0.6664596988633947,0.9076923076923077,1.0,1.0,7/35,23.15%,RPA3;BRCA1;RRAD;RMI1;TOPBP1;BLM;RAD9B
prerank,GO_Biological_Process_2021__intracellular estrogen receptor signaling pathway (GO:0030520),-0.36328827734483243,-0.666250378627995,0.9272727272727272,1.0,1.0,1/14,4.81%,ESR1
prerank,GO_Biological_Process_2021__negative regulation of chemotaxis (GO:0050922),-0.3179222672659061,-0.6661196650573858,0.9538461538461539,1.0,1.0,4/29,9.78%,ANGPT2;SEMA3F;SEMA3A;THBS1
prerank,GO_Biological_Process_2021__determination of left/right asymmetry in lateral mesoderm (GO:0003140),-0.4408792585492763,-0.6657781234855644,0.8709677419354839,1.0,1.0,1/5,19.47%,DAND5
prerank,Reactome_2022__CDK-mediated Phosphorylation And Removal Of Cdc6 R-HSA-69017,-0.2863721163628352,-0.6657764350035754,0.9855072463768116,1.0,1.0,1/63,0.62%,PSMB9
prerank,GO_Biological_Process_2021__interstrand cross-link repair (GO:0036297),-0.2830677236178981,-0.6657220257987609,0.9868421052631579,1.0,1.0,12/50,22.72%,RPA3;FANCF;RAD51AP2;DCLRE1C;NUCKS1;RPS27A;DCLRE1A;FAAP20;RPA2;FANCC;MSH6;FANCI
prerank,GO_Biological_Process_2021__regulation of vascular associated smooth muscle cell proliferation (GO:1904705),-0.31763130802541334,-0.6657181480340657,0.9552238805970149,1.0,1.0,7/34,14.43%,MMP9;GPER1;HTR1B;SOD2;P2RY6;CDKN1A;TGFB3
prerank,Reactome_2022__Regulation Of TLR By Endogenous Ligand R-HSA-5686938,0.3644237785844555,0.6656287099080128,0.8285714285714286,1.0,1.0,2/10,6.42%,APOB;HMGB1
prerank,GO_Biological_Process_2021__regulation of protein-containing complex assembly (GO:0043254),-0.27072796028352436,-0.6655475098001795,0.9873417721518988,1.0,1.0,10/98,11.99%,TGFB1;HCK;TMC8;PINK1;SELP;CLU;BIK;SVIP;HSPA8;WARS1
prerank,Reactome_2022__Lysosphingolipid And LPA Receptors R-HSA-419408,0.3610316097100239,0.6653640675228979,0.9210526315789473,1.0,1.0,6/11,22.73%,PLPPR1;S1PR5;PLPPR3;S1PR1;PLPPR5;PLPPR4
prerank,Reactome_2022__Nucleotide Excision Repair R-HSA-5696398,-0.27318447366995496,-0.6653010562917355,0.9625,1.0,1.0,10/102,18.03%,RPA3;ACTL6A;UVSSA;TFPT;COPS5;POLE2;RBX1;POLD4;COPS4;RPS27A
prerank,CellMarker_Augmented_2021__Mitotic Fetal Germ cell:Fetal Gonad,-0.2399244031294909,-0.6650069869097095,1.0,1.0,1.0,89/579,20.03%,CLIC1;AQP3;ST6GALNAC1;TRIP10;S100A13;DOCK6;NFE2L3;ELK3;SALL4;TEC;SLC7A3;SDC2;ZNF296;EIF6;CLDN6;ENO2;PABIR3;PLAU;POLR1C;PSAP;ENC1;GRWD1;RPL38;SNAP23;EMG1;RPL15;CD63;PXDN;ETV4;RPS4X;TMEM160;RPL3;ARHGAP28;PGAM1;TOMM7;RPL35A;GLDC;GNL3;GABARAPL1;GPX2;EEF2;ABHD14B;GCNT1;LCP1;TMSB10;ORAI1;ANP32E;ETFB;ITM2C;CKS1B;RPL13A;TJP3;TUBB;F2RL1;TUBB6;RPL27A;DDIT4;EIF2S3;RPS16;ZAN;RPL7A;PPP1R3B;SUMF1;LITAF;MYL6;SCPEP1;PAICS;RPL9;CAMKV;RPL13;MYL9;LDLRAP1;CAPN13;RPL34;CD81;MRPL34;PSMB6;RPL4;RPL32;NUDT11;RPL23;RPL41;RPS7;CARHSP1;ZNF428;TMEM123;RPL27;RPL35;LDHB
prerank,GO_Biological_Process_2021__regulation of transcription regulatory region DNA binding (GO:2000677),-0.34195715927242365,-0.6649835636563808,0.8666666666666667,1.0,1.0,2/17,7.35%,TGFB1;H1-0
prerank,GO_Biological_Process_2021__p38MAPK cascade (GO:0038066),0.416171716284075,0.6648481287142536,0.8333333333333334,1.0,1.0,1/5,11.29%,LGALS9
prerank,GO_Biological_Process_2021__positive regulation of ATPase activity (GO:0032781),0.31216648168245986,0.6648479643737922,0.8846153846153846,1.0,1.0,6/36,12.99%,FGF10;RGN;DNAJC24;SETMAR;PLSCR1;MYL3
prerank,Reactome_2022__Presynaptic Phase Of Homologous DNA Pairing And Strand Exchange R-HSA-5693616,-0.3141326896261637,-0.6648473005430307,0.9193548387096774,1.0,1.0,11/37,26.10%,RPA3;BRCA1;RRAD;RMI1;TOPBP1;BLM;RAD9B;CHEK1;RMI2;XRCC2;BRCA2
prerank,GO_Biological_Process_2021__negative regulation of regulated secretory pathway (GO:1903306),-0.38259483030425856,-0.6647567713807978,0.8703703703703703,1.0,1.0,1/8,9.69%,REST
prerank,GO_Biological_Process_2021__positive regulation of ATP biosynthetic process (GO:2001171),-0.4032341512829007,-0.664703545284681,0.8833333333333333,1.0,1.0,1/8,5.61%,PINK1
prerank,GO_Biological_Process_2021__epithelial cell differentiation (GO:0030855),-0.27996817157304904,-0.6643893868924385,0.9620253164556962,1.0,1.0,16/75,20.16%,TBX1;UPK1B;DAB2;UPK1A;UPK3A;ANXA1;VIL1;VDAC1;PTER;DEUP1;MESP1;OVOL3;BASP1;CASP6;ACTL8;MAF
prerank,CellMarker_Augmented_2021__Pluripotent Stem cell:Undefined,-0.38932661881992414,-0.6641104440874661,0.9,1.0,1.0,1/11,8.55%,GPC3
prerank,GO_Biological_Process_2021__negative regulation of interleukin-1 beta production (GO:0032691),0.32217956053136854,0.6640331024296411,0.925,1.0,1.0,2/18,11.44%,CX3CR1;NLRP2B
prerank,GO_Biological_Process_2021__ncRNA 3'-end processing (GO:0043628),-0.36002222368448067,-0.6640073485274164,0.9230769230769231,1.0,1.0,3/14,22.93%,INTS5;TRNT1;PTCD1
prerank,GO_Biological_Process_2021__positive regulation of stress-activated protein kinase signaling cascade (GO:0070304),-0.3487251741129176,-0.6639361209350705,0.9523809523809523,1.0,1.0,1/16,3.74%,SCIMP
prerank,GO_Biological_Process_2021__chemical homeostasis (GO:0048878),0.2448688643371922,0.6637162115696087,1.0,1.0,1.0,13/60,18.13%,PPARG;ZBTB20;PNPLA3;SLC4A7;WNK2;IRS2;TLCD3B;KLHL3;NR1H3;WNK3;TLCD3A;ABHD4;ACOX1
prerank,GO_Biological_Process_2021__phosphatidylcholine acyl-chain remodeling (GO:0036151),-0.3383275525461425,-0.6635020351112049,0.9310344827586207,1.0,1.0,4/22,20.26%,PLA2G10;PLB1;PLA2G4A;PLA2G4D
prerank,CellMarker_Augmented_2021__Activated T cell:Undefined,-0.390640851901508,-0.6634905692753014,0.8181818181818182,1.0,1.0,2/8,15.75%,CD27;CD4
prerank,GO_Biological_Process_2021__piRNA metabolic process (GO:0034587),0.3287503814211374,0.6634601769265474,0.9411764705882353,1.0,1.0,3/19,14.43%,PLD6;PIWIL1;TEX15
prerank,GO_Biological_Process_2021__peptide catabolic process (GO:0043171),0.317461026854476,0.6634545075822437,0.9473684210526315,1.0,1.0,3/23,7.33%,NAALADL1;CHAC1;TRHDE
prerank,GO_Biological_Process_2021__detection of chemical stimulus involved in sensory perception of taste (GO:0050912),-0.3757134776528731,-0.6633501819167651,0.8852459016393442,1.0,1.0,5/12,24.09%,GNAT3;RTP5;PKD1L3;GNAT2;RTP1
prerank,GO_Biological_Process_2021__positive regulation of protein import (GO:1904591),-0.3148506113785722,-0.6632675974886695,0.967741935483871,1.0,1.0,1/25,1.49%,TGFB1
prerank,GO_Biological_Process_2021__positive regulation of sodium ion transmembrane transport (GO:1902307),0.3361095018027646,0.6631980736671421,0.8918918918918919,1.0,1.0,6/11,27.80%,WNK2;WNK3;DMD;WNK1;ANK3;NOS1
prerank,KEGG_2021_Human__Fc gamma R-mediated phagocytosis,-0.27841216294064125,-0.6630318400694066,0.9615384615384616,1.0,1.0,14/82,17.74%,HCK;VAV3;FCGR3A;INPP5D;WAS;PIK3R3;PTPRC;SCIN;CFL1;PIK3CB;RAC2;VASP;RAC1;PLA2G4A
prerank,Reactome_2022__FOXO-mediated Transcription Of Cell Cycle Genes R-HSA-9617828,-0.360693972974932,-0.6628313407171623,0.9482758620689655,1.0,1.0,4/15,16.15%,CCNG2;CDKN1A;FOXO4;SMAD3
prerank,CellMarker_Augmented_2021__Immune cell:Breast,0.40481893786317014,0.6627569037973371,0.8536585365853658,1.0,1.0,1/5,3.69%,CD14
prerank,KEGG_2021_Human__Homologous recombination,-0.3046197384810971,-0.6625643938596315,0.9411764705882353,1.0,1.0,9/37,22.47%,RPA3;ABRAXAS1;BRCA1;SYCP3;POLD4;RAD54L;TOPBP1;RPA2;BLM
prerank,GO_Biological_Process_2021__cellular senescence (GO:0090398),0.2955169565623176,0.6625400485949238,1.0,1.0,1.0,5/23,17.60%,SIRT1;PML;KAT6A;SMC5;NSMCE2
prerank,GO_Biological_Process_2021__negative regulation by symbiont of host programmed cell death (GO:0052041),-0.4124280647662477,-0.6620255618670692,0.8392857142857143,1.0,1.0,1/7,7.96%,RNF213
prerank,Reactome_2022__Defective ST3GAL3 Causes MCT12 And EIEE15 R-HSA-3656243,-0.4551314361845725,-0.6620186095694461,0.9322033898305084,1.0,1.0,2/5,10.43%,OGN;OMD
prerank,GO_Biological_Process_2021__production of small RNA involved in gene silencing by RNA (GO:0070918),0.3391354864287706,0.6618143364736139,0.9,1.0,1.0,7/18,30.61%,TRIM71;AGO3;TARBP2;AGO2;ZC3H7B;DROSHA;PRKRA
prerank,GO_Biological_Process_2021__mitochondrial membrane organization (GO:0007006),-0.3264349729379318,-0.6617185019493504,0.921875,1.0,1.0,1/31,2.67%,SLC25A31
prerank,GO_Biological_Process_2021__negative regulation of adaptive immune response (GO:0002820),-0.4608959522594815,-0.6614325351262382,0.8888888888888888,1.0,1.0,2/5,7.49%,CD160;ALOX15
prerank,Reactome_2022__Regulation Of APC/C Activators Between G1/S And Early Anaphase R-HSA-176408,-0.2793959950427481,-0.6611989016449761,0.9859154929577465,1.0,1.0,1/70,0.62%,PSMB9
prerank,GO_Biological_Process_2021__vesicle organization (GO:0016050),-0.29871161786177536,-0.6611422370634226,0.9552238805970149,1.0,1.0,10/43,28.14%,USP50;CAV2;RNF26;HOOK2;PHETA1;VPS18;ALS2CL;LAMTOR1;LAPTM4B;ANXA8
prerank,GO_Biological_Process_2021__positive regulation of proteasomal protein catabolic process (GO:1901800),-0.27979141394531437,-0.661138977818534,0.9594594594594594,1.0,1.0,4/78,9.25%,ARIH2;DAB2;CLU;USP13
prerank,GO_Biological_Process_2021__regulation of organ growth (GO:0046620),-0.37498264620840893,-0.661114145586036,0.9090909090909091,1.0,1.0,2/10,14.15%,LATS2;SLC6A4
prerank,GO_Biological_Process_2021__interleukin-12-mediated signaling pathway (GO:0035722),-0.30306757596168915,-0.6608133172530702,0.9868421052631579,1.0,1.0,6/37,17.52%,CA1;SOD2;CFL1;IL12A;LCP1;MSN
prerank,GO_Biological_Process_2021__negative regulation of protein dephosphorylation (GO:0035308),-0.33151763907526,-0.6607863368543958,0.8852459016393442,1.0,1.0,4/20,21.14%,PPP1R1B;TIPRL;ARPP19;BOD1
prerank,GO_Biological_Process_2021__snRNA 3'-end processing (GO:0034472),-0.34095186526616694,-0.6607758235031833,0.9,1.0,1.0,3/18,22.14%,INTS5;EXOSC8;EXOSC2
prerank,GO_Biological_Process_2021__ribonucleoprotein complex assembly (GO:0022618),-0.2590999739099752,-0.6607367544879017,1.0,1.0,1.0,32/125,26.27%,EIF6;SNRPD2;RPL38;PWP2;DDX20;RPL3;RPS27;GEMIN4;STRAP;BRIX1;EIF2S3;EIF2S2;SRSF9;SRSF5;NOP53;DDX1;MRPL20;RPL5;RPS14;SRPK3;RPL11;RPS15;SRPK1;DENR;RPL24;CRNKL1;HSP90AB1;RPSA;RPS28;RPS19;ABT1;PRPF19
prerank,GO_Biological_Process_2021__negative regulation of activated T cell proliferation (GO:0046007),-0.3791868561360059,-0.6606466565142608,0.8870967741935484,1.0,1.0,1/10,3.04%,PDCD1LG2
prerank,Reactome_2022__Energy Dependent Regulation Of mTOR By LKB1-AMPK R-HSA-380972,-0.31799234374148433,-0.6605804456352968,0.95,1.0,1.0,3/27,12.82%,STRADB;RRAGA;STRADA
prerank,GO_Biological_Process_2021__electron transport chain (GO:0022900),0.3401431115145929,0.6605299722047467,0.9142857142857143,1.0,1.0,2/13,12.96%,NDOR1;ENOX2
prerank,CellMarker_Augmented_2021__Pluripotent Stem cell:Ovarian Cortex,-0.29986466151612867,-0.6605053244207308,0.9552238805970149,1.0,1.0,8/58,11.06%,SALL4;SLC7A3;TUNAR;CA14;CLDN6;HLA-DPB2;DRAXIN;CCDC172
prerank,GO_Biological_Process_2021__galactosylceramide metabolic process (GO:0006681),0.356070038289434,0.6601149666606643,0.8863636363636364,1.0,1.0,3/8,19.09%,B4GALT3;GAL3ST1;FA2H
prerank,Reactome_2022__AUF1 (hnRNP D0) Binds And Destabilizes mRNA R-HSA-450408,-0.2914729300369999,-0.6600969379381026,0.9565217391304348,1.0,1.0,1/48,0.62%,PSMB9
prerank,Reactome_2022__Formation Of TC-NER Pre-Incision Complex R-HSA-6781823,-0.3007929413823923,-0.659967402582635,0.9342105263157895,1.0,1.0,10/51,26.27%,UVSSA;COPS5;RBX1;COPS4;RPS27A;POLR2B;DDB1;COPS7A;CDK7;PRPF19
prerank,GO_Biological_Process_2021__regulation of actin filament depolymerization (GO:0030834),0.3691050476392577,0.6599299240925578,0.9090909090909091,1.0,1.0,2/10,14.95%,SEMA5A;PIK3CA
prerank,GO_Biological_Process_2021__positive regulation of purine nucleotide biosynthetic process (GO:1900373),-0.3874598470810085,-0.6598820043073589,0.9193548387096774,1.0,1.0,2/10,14.17%,PINK1;NOS2
prerank,GO_Biological_Process_2021__positive regulation of dendritic cell cytokine production (GO:0002732),0.4258832575671681,0.6597500662995285,0.88,1.0,1.0,1/6,1.53%,KIT
prerank,Reactome_2022__p130Cas Linkage To MAPK Signaling For Integrins R-HSA-372708,-0.3805531050631093,-0.6596827345154342,0.8676470588235294,1.0,1.0,3/11,19.91%,VWF;ITGA2B;FN1
prerank,GO_Biological_Process_2021__regulation of neuron migration (GO:2001222),0.2993994635924064,0.6592941569991598,0.9375,1.0,1.0,7/27,19.40%,SRGAP2;PHACTR1;NTNG2;NEXMIF;ZNF609;NIPBL;CTNNA2
prerank,Reactome_2022__RHOBTB GTPase Cycle R-HSA-9706574,-0.2956053682650207,-0.6590349708761161,0.9873417721518988,1.0,1.0,12/34,29.23%,PDE5A;ACTG1;CDC37;RNF20;COPS4;TMOD3;HSP90AB1;CCT6A;CCT7;VIM;RBM15;CCT2
prerank,Reactome_2022__Resolution Of AP Sites Via Multiple-Nucleotide Patch Replacement Pathway R-HSA-110373,-0.33430169475036287,-0.658875484953713,0.9365079365079365,1.0,1.0,4/24,21.10%,RPA3;POLE2;POLD4;POLE3
prerank,GO_Biological_Process_2021__divalent inorganic cation homeostasis (GO:0072507),-0.3236287005234195,-0.6582577511150695,0.8970588235294118,1.0,1.0,2/20,3.64%,TRPV6;TMC8
prerank,Reactome_2022__Lagging Strand Synthesis R-HSA-69186,-0.33282490603339765,-0.658237551795385,0.8852459016393442,1.0,1.0,1/18,4.30%,RPA3
prerank,Reactome_2022__Signaling By NTRK2 (TRKB) R-HSA-9006115,0.3034416232431275,0.6580817417840419,0.9375,1.0,1.0,11/21,35.52%,PIK3CA;SOS1;CDK5;NTRK2;DOCK3;FYN;FRS2;PIGU;GRIN2B;TIAM1;HRAS
prerank,GO_Biological_Process_2021__entry into host (GO:0044409),-0.3670468556181103,-0.6579292841478389,0.9230769230769231,1.0,1.0,1/11,15.75%,CD4
prerank,GO_Biological_Process_2021__regulation of gap junction assembly (GO:1903596),0.4483636529179448,0.6578767285063255,0.9259259259259259,1.0,1.0,1/5,4.67%,CNTNAP2
prerank,"Reactome_2022__Nucleotide-binding Domain, Leucine Rich Repeat Containing NLR Signaling Pathways R-HSA-168643",-0.30646042312099453,-0.6576401911404092,0.9166666666666666,1.0,1.0,6/45,15.44%,AIM2;NFKB2;NLRC4;NLRP3;PSTPIP1;TXNIP
prerank,CellMarker_Augmented_2021__Germinal Stem cell:Ovary,-0.28066082984799395,-0.6575595343331966,0.9866666666666667,1.0,1.0,25/77,26.05%,IFIT3;CLU;GBP1;VWF;FTH1;IFIT1;TEK;C1S;ADGRF5;RRAS;WBP2;ZFP36L1;IFIT2;MYL9;AXL;EPAS1;IFI27;IFI6;IGFBP3;OPTN;IL1R1;MT2A;EHD2;RNASE1;DDX4
prerank,CellMarker_Augmented_2021__Germline Stem cell:Ovarian Cortex,-0.28066082984799395,-0.6575595343331966,0.9866666666666667,1.0,1.0,25/77,26.05%,IFIT3;CLU;GBP1;VWF;FTH1;IFIT1;TEK;C1S;ADGRF5;RRAS;WBP2;ZFP36L1;IFIT2;MYL9;AXL;EPAS1;IFI27;IFI6;IGFBP3;OPTN;IL1R1;MT2A;EHD2;RNASE1;DDX4
prerank,GO_Biological_Process_2021__glutathione catabolic process (GO:0006751),0.43167771950207023,0.6573566728576078,0.8490566037735849,1.0,1.0,1/5,6.86%,CHAC1
prerank,Reactome_2022__BBSome-mediated Cargo-Targeting To Cilium R-HSA-5620922,0.3285833594859269,0.6570850402938758,0.9444444444444444,1.0,1.0,5/21,24.52%,BBS9;BBS12;BBIP1;SSTR3;BBS10
prerank,GO_Biological_Process_2021__positive regulation of protein-containing complex assembly (GO:0031334),-0.2760716613263188,-0.6569880949111345,1.0,1.0,1.0,11/96,15.72%,TGFB1;CXCL13;RPA3;ESR1;CLU;USP50;BIK;WARS1;LCP1;DDX3X;RBX1
prerank,GO_Biological_Process_2021__nucleotide-sugar biosynthetic process (GO:0009226),0.2847551813500735,0.6569781427624827,0.9705882352941176,1.0,1.0,7/19,24.31%,NAGK;UAP1;UGDH;SLC35D1;GNPNAT1;PMM2;UAP1L1
prerank,Reactome_2022__RHOB GTPase Cycle R-HSA-9013026,-0.2843444245137513,-0.6568482667121711,0.9701492537313433,1.0,1.0,9/65,17.95%,ACTC1;CAVIN1;SNAP23;ARHGDIG;PKN3;AKAP13;ECT2;IQGAP3;RTKN
prerank,GO_Biological_Process_2021__negative regulation of cell development (GO:0010721),0.30331497644075656,0.6566001335792221,0.9183673469387755,1.0,1.0,2/20,8.91%,PCM1;WNT3A
prerank,Reactome_2022__TBC/RABGAPs R-HSA-8854214,0.2930991736659302,0.6565253657432437,1.0,1.0,1.0,5/40,10.81%,TBC1D10A;TBC1D16;RAB7A;GGA1;RAB35
prerank,GO_Biological_Process_2021__excitatory chemical synaptic transmission (GO:0098976),-0.4343590491446475,-0.6562255974786853,0.9259259259259259,1.0,1.0,1/7,4.94%,SHISA6
prerank,Reactome_2022__PKA Activation R-HSA-163615,0.31313758983017864,0.6560842174119581,0.9333333333333333,1.0,1.0,7/15,29.07%,ADCY2;PRKAR2A;ADCY6;NBEA;PRKACB;ADCY9;ADCY5
prerank,GO_Biological_Process_2021__positive regulation of myeloid leukocyte differentiation (GO:0002763),0.2855176497032359,0.6557906028826168,0.9722222222222222,1.0,1.0,7/24,15.67%,HCLS1;FADD;TESC;HSF1;IL23A;ACIN1;RUNX1
prerank,GO_Biological_Process_2021__positive regulation of intracellular protein transport (GO:0090316),-0.25117727033102283,-0.6557032091441801,0.9759036144578314,1.0,1.0,18/131,19.58%,ARIH2;TGFB1;HSPA1L;ITGB2;PINK1;PDZK1;ITGAM;TOMM7;OAZ2;SMAD3;RAC2;ECT2;CD81;FIS1;NMT1;YWHAG;CASP8;BBC3
prerank,GO_Biological_Process_2021__alpha-beta T cell differentiation (GO:0046632),0.41513279945758913,0.6555917780642728,0.8125,1.0,1.0,1/5,3.16%,ZBTB7B
prerank,Reactome_2022__RIPK1-mediated Regulated Necrosis R-HSA-5213460,0.28453455286238727,0.6554343752034268,0.967741935483871,1.0,1.0,4/28,13.55%,CFLAR;TANK;FADD;PELI1
prerank,GO_Biological_Process_2021__regulation of mitochondrial fission (GO:0090140),-0.3252076882962193,-0.6554219658043106,0.9682539682539683,1.0,1.0,2/24,6.82%,PINK1;DCN
prerank,GO_Biological_Process_2021__cellular response to interleukin-12 (GO:0071349),-0.30293177184942477,-0.655309374984004,1.0,1.0,1.0,6/39,17.52%,CA1;SOD2;CFL1;IL12A;LCP1;MSN
prerank,Reactome_2022__COPI-independent Golgi-to-ER Retrograde Traffic R-HSA-6811436,0.29298166118323954,0.6551657850029189,0.9629629629629629,1.0,1.0,3/33,8.28%,GALNT1;BICD1;DYNC1I2
prerank,GO_Biological_Process_2021__positive regulation of smooth muscle cell apoptotic process (GO:0034393),-0.4309331590617743,-0.6549404333269235,0.9047619047619048,1.0,1.0,2/7,14.26%,SOD2;IL12A
prerank,GO_Biological_Process_2021__proteasomal protein catabolic process (GO:0010498),0.22077784337441922,0.6548113519479202,1.0,1.0,1.0,36/191,20.85%,KLHL20;ZNRF1;SIRT1;SPOPL;PSME4;ERCC8;ARRB2;TRIM71;UBXN2A;PSMA1;PML;WWP2;MAEA;RHBDD1;SHARPIN;UBE3D;UBE2A;KLHL42;KLHL22;PELI1;ARRB1;SMURF1;NEDD4;SPOP;RNF185;FAF1;UBE4B;FBXL22;RNF122;UBXN2B;CDC34;RNF139;TBL1X;HECTD3;TRIM9;PSMD4
prerank,GO_Biological_Process_2021__proteasome-mediated ubiquitin-dependent protein catabolic process (GO:0043161),0.21943725422440336,0.6545237125893649,1.0,1.0,1.0,85/302,26.63%,AUP1;KLHL20;DERL3;ZNRF1;SIRT1;SPOPL;PSME4;ERCC8;ARRB2;UBE2J1;TRIM71;UBXN2A;PSMA1;PML;WWP2;MAEA;UBE2E1;SHARPIN;ANAPC16;CDC20B;DMAC2;FBXL14;UBE3D;MAN1A1;UBE2A;KLHL42;FBXL20;KLHL22;PELI1;ARRB1;FBXO27;SMURF1;RHBDD2;CDC26;TMUB2;FBXO4;NEDD4;SPOP;RNF185;FAF1;UBE4B;ANAPC7;FBXL6;EDEM1;FBXL22;FBXO31;TMEM67;RNF122;UBXN4;UBXN2B;CDC34;UBE2J2;TBL1X;HECTD3;TRIM9;PSMD4;FZR1;RNF216;CUL1;BAG6;FBXO17;AMN1;NEMF;NFE2L2;USP44;PLK1;TRIM3;APPBP2;AGAP3;UBE4A;FBXL17;FBXL2;PSMB2;ANAPC4;SIAH2;UBE2D3;ANAPC2;RB1;DNAJB14;NHLRC3;UBE2G1;PSMD5;ERLIN1;KCTD5;PSMF1
prerank,GO_Biological_Process_2021__pyrimidine ribonucleotide biosynthetic process (GO:0009220),0.39882620319671913,0.6545220034875027,0.9230769230769231,1.0,1.0,1/7,17.54%,CTPS2
prerank,GO_Biological_Process_2021__negative regulation of fatty acid biosynthetic process (GO:0045717),-0.3778966470908819,-0.6544401008094766,0.9090909090909091,1.0,1.0,2/10,8.63%,CEACAM1;BRCA1
prerank,Reactome_2022__Gap-filling DNA Repair Synthesis And Ligation In GG-NER R-HSA-5696397,-0.3208888693838437,-0.6540632066145633,0.9833333333333333,1.0,1.0,6/25,22.81%,RPA3;POLE2;POLD4;RPS27A;POLE3;XRCC1
prerank,GO_Biological_Process_2021__mitochondrion morphogenesis (GO:0070584),0.32844319749407835,0.6540022913120405,0.9024390243902439,1.0,1.0,3/11,20.11%,PID1;PNPT1;MTM1
prerank,Reactome_2022__G-protein Mediated Events R-HSA-112040,0.26699924548544096,0.6537887126659916,1.0,1.0,1.0,17/50,27.09%,ITPR2;PLCB1;PDE1A;ADCY2;PRKAR2A;ADCY6;CREB1;GNAQ;GNAI2;NBEA;GNA11;PDE1B;PRKCD;PRKACB;PLCB3;ADCY9;GNA14
prerank,Reactome_2022__Interconversion Of Nucleotide Di- And Triphosphates R-HSA-499943,-0.3038587049460083,-0.6537070523278037,0.8985507246376812,1.0,1.0,2/27,11.31%,NUDT13;GLRX
prerank,GO_Biological_Process_2021__cellular copper ion homeostasis (GO:0006878),0.358735513459849,0.6535997530365164,0.8888888888888888,1.0,1.0,2/11,12.94%,COX19;CCDC22
prerank,Reactome_2022__Defective Homologous Recombination Repair (HRR) Due To BRCA2 Loss Of Function R-HSA-9701190,-0.3022308246644709,-0.6533468079395542,0.953125,1.0,1.0,10/38,26.10%,RPA3;BRCA1;RRAD;RMI1;TOPBP1;BLM;RAD9B;RMI2;XRCC2;BRCA2
prerank,GO_Biological_Process_2021__tRNA methylation (GO:0030488),-0.3057094904502976,-0.6532328499751873,0.9577464788732394,1.0,1.0,4/32,11.54%,TRMO;WDR6;TRMT10A;DALRD3
prerank,"GO_Biological_Process_2021__regulation of CD4-positive, alpha-beta T cell proliferation (GO:2000561)",0.3663124530458799,0.6531429830906709,0.8108108108108109,1.0,1.0,2/7,11.29%,TWSG1;LGALS9
prerank,GO_Biological_Process_2021__actin filament bundle assembly (GO:0051017),0.3015380691696173,0.6531177555836051,0.8888888888888888,1.0,1.0,9/30,19.27%,FSCN3;EPS8;FSCN1;ESPN;CALD1;MICAL1;PAWR;CORO1B;ADD1
prerank,GO_Biological_Process_2021__DNA ligation involved in DNA repair (GO:0051103),0.404205552121129,0.6530540920890744,0.8604651162790697,1.0,1.0,3/5,29.63%,LIG4;POLB;LIG3
prerank,CellMarker_Augmented_2021__Secretory Progenitor cell:Large Intestine,-0.33128941998589373,-0.6530106092597099,0.953125,1.0,1.0,4/16,21.06%,NRIP2;ITGAX;MECOM;L3MBTL2
prerank,GO_Biological_Process_2021__positive regulation of posttranscriptional gene silencing (GO:0060148),0.35443683844721285,0.6530101670289258,0.8974358974358975,1.0,1.0,5/10,35.11%,XPO5;STAT3;FMR1;LIMD1;PUM2
prerank,GO_Biological_Process_2021__C-terminal protein amino acid modification (GO:0018410),0.3450962867932109,0.652870963874144,0.9523809523809523,1.0,1.0,4/12,28.09%,AGBL4;GPLD1;ATG12;ATG7
prerank,Reactome_2022__Activation Of Matrix Metalloproteinases R-HSA-1592389,-0.32831075321604003,-0.652778730322437,0.875,1.0,1.0,5/18,15.83%,MMP9;COL18A1;PLG;SPOCK3;ELANE
prerank,GO_Biological_Process_2021__cellular response to hexose stimulus (GO:0071331),0.29589335025874663,0.652637636247723,1.0,1.0,1.0,3/23,11.79%,ZBTB20;ERN1;UNC13B
prerank,GO_Biological_Process_2021__pyrimidine nucleobase biosynthetic process (GO:0019856),0.4279322282903787,0.6523644673669997,0.9069767441860465,1.0,1.0,1/5,17.54%,CTPS2
prerank,GO_Biological_Process_2021__positive regulation of mitotic cell cycle phase transition (GO:1901992),-0.3047687947550807,-0.652145484926362,0.9571428571428572,1.0,1.0,6/55,8.75%,DTL;CCND1;CDC25A;RAB11A;ANXA1;CCND2
prerank,GO_Biological_Process_2021__regulation of transcription from RNA polymerase II promoter in response to stress (GO:0043618),0.24672312163262541,0.6521369368699207,1.0,1.0,1.0,5/74,8.65%,EGLN3;PSME4;ATF3;PSMA1;HIF3A
prerank,KEGG_2021_Human__Platelet activation,-0.26589953010471795,-0.6521239843127297,1.0,1.0,1.0,16/102,17.74%,P2RY12;COL1A1;GP1BA;ACTG1;PIK3R3;SNAP23;VWF;ITGA2B;PIK3CB;ADCY7;ORAI1;ITPR3;VASP;PIK3CG;TBXAS1;PLA2G4A
prerank,KEGG_2021_Human__Prolactin signaling pathway,-0.2857111276454744,-0.6520220613187433,0.9710144927536232,1.0,1.0,7/57,9.58%,CCND1;IRF1;ESR1;STAT1;PIK3R3;CCND2;CGA
prerank,GO_Biological_Process_2021__nodal signaling pathway (GO:0038092),0.4088132453247928,0.651469631255088,0.9459459459459459,1.0,1.0,3/5,24.13%,SMAD2;CFC1;ACVR1B
prerank,GO_Biological_Process_2021__peroxisomal transport (GO:0043574),0.3854584850813308,0.6512154950766216,0.8888888888888888,1.0,1.0,5/8,40.03%,ZFAND6;PEX16;LONP2;PEX12;HACL1
prerank,Reactome_2022__Programmed Cell Death R-HSA-5357801,0.23347859642218638,0.6505026241625044,1.0,1.0,1.0,28/179,15.64%,BCL2;CFLAR;DAPK2;PSME4;SEM1;LMNB1;DCC;PPP1R13B;HMGB1;REXO2;PSMA1;MAPK8;CASP3;CHMP6;AKT2;PKN2;PLEC;GAS2;TICAM1;TANK;FNTA;FADD;PELI1;BID;MAGED1;TP53;CLSPN;ACIN1
prerank,GO_Biological_Process_2021__cellular modified amino acid catabolic process (GO:0042219),0.3595535661499567,0.6502929447369125,0.9130434782608695,1.0,1.0,2/11,9.08%,CHAC1;SARDH
prerank,GO_Biological_Process_2021__negative regulation of inclusion body assembly (GO:0090084),0.36002705455542894,0.6501009018835245,0.8863636363636364,1.0,1.0,2/8,16.02%,HSPA1A;SACS
prerank,GO_Biological_Process_2021__negative regulation of transmembrane transport (GO:0034763),0.3707331319434358,0.6500794484439708,0.8913043478260869,1.0,1.0,2/8,10.67%,AKT2;IRS2
prerank,GO_Biological_Process_2021__positive regulation of collagen metabolic process (GO:0010714),-0.3457237070814906,-0.6500346617363905,0.9375,1.0,1.0,1/16,1.49%,TGFB1
prerank,GO_Biological_Process_2021__cyclic purine nucleotide metabolic process (GO:0052652),-0.3481263062751273,-0.6500273201923588,0.921875,1.0,1.0,5/17,24.71%,GUCY2C;ADCY7;GUCY2F;ADCY1;NPR2
prerank,Reactome_2022__Physiological Factors R-HSA-5578768,-0.38175008573339386,-0.6498665999376063,0.9,1.0,1.0,2/8,16.07%,GATA4;HIPK1
prerank,GO_Biological_Process_2021__vasoconstriction (GO:0042310),-0.3688838728532882,-0.6497744809756023,0.9090909090909091,1.0,1.0,3/9,14.70%,HTR2B;EDNRB;ACTA2
prerank,GO_Biological_Process_2021__positive regulation of cell cycle phase transition (GO:1901989),0.31626667191598723,0.6497437053420028,0.8947368421052632,1.0,1.0,5/14,25.91%,DYRK3;KLHL18;PLCG2;EZH2;ZNF16
prerank,Reactome_2022__TNFR2 Non-Canonical NF-kB Pathway R-HSA-5668541,-0.2686165214955973,-0.6496604948785926,0.972972972972973,1.0,1.0,23/81,27.50%,PSMB9;TNFRSF1B;NFKB2;EDAR;CD27;PSMA3;TNFSF8;TNFRSF11A;RPS27A;PSMA7;PSMB6;TNFSF18;PSMA5;PSMD6;TNFSF4;CD70;SKP1;UBE2M;PSMC5;PSMB4;PSMB7;TNFRSF4;PSMD8
prerank,GO_Biological_Process_2021__regulation of protein localization to chromatin (GO:1905634),-0.3977744333214689,-0.6496229907219432,0.9,1.0,1.0,2/7,23.11%,SPI1;VCPIP1
prerank,Reactome_2022__SARS-CoV Infections R-HSA-9679506,0.21002272234612818,0.6493898194813862,1.0,1.0,1.0,34/319,14.60%,MGAT4C;GPC4;ST6GALNAC3;NUP210;SDC4;VPS16;GATAD2A;RIPK2;NUP42;GPC6;ITGA4;PRKCSH;GALNT1;ST3GAL3;REXO2;SEC24C;MAN2A1;SNRPB;CHMP6;GPC5;AKT2;AAAS;SH3KBP1;SDC3;GEMIN5;FNTA;HDAC1;GATAD2B;TAB3;CHD4;NR3C1;CYSLTR1;TRIM4;TMPRSS2
prerank,GO_Biological_Process_2021__protein modification by small protein removal (GO:0070646),-0.2461071500283719,-0.649315556031402,1.0,1.0,1.0,17/238,13.31%,PSMB9;ESR1;ACTL6A;ABRAXAS1;CDC25A;TOMM20;BRCA1;SENP3;USP13;USP50;USP6;TFPT;USP17L2;COPS5;FOXO4;TAF9B;NLRP3
prerank,GO_Biological_Process_2021__carbohydrate phosphorylation (GO:0046835),0.3529625243468414,0.6491590727219346,1.0,1.0,1.0,3/8,29.68%,ITPK1;IPPK;POMK
prerank,Reactome_2022__Glycolysis R-HSA-70171,-0.2739616721450885,-0.6491185128174557,0.9701492537313433,1.0,1.0,5/63,8.97%,ALDOB;TAC4;PKLR;ENO2;GAPDHS
prerank,GO_Biological_Process_2021__venous blood vessel development (GO:0060841),0.4058014123227841,0.6488839251301124,0.7435897435897436,1.0,1.0,1/5,6.26%,PROX1
prerank,GO_Biological_Process_2021__positive regulation of ERAD pathway (GO:1904294),-0.3646734041081997,-0.6487071264608006,0.9464285714285714,1.0,1.0,2/13,20.12%,USP13;HERPUD1
prerank,GO_Biological_Process_2021__positive regulation of myelination (GO:0031643),-0.3560227292370333,-0.648327928788386,0.8615384615384616,1.0,1.0,5/10,20.21%,TNFRSF1B;EGR2;MYRF;ITGAX;NCMAP
prerank,GO_Biological_Process_2021__transcription by RNA polymerase I (GO:0006360),-0.2878580062687203,-0.6481614994187034,0.9571428571428572,1.0,1.0,3/33,10.93%,CAVIN1;POLR1C;POLR1G
prerank,GO_Biological_Process_2021__histone H3 acetylation (GO:0043966),0.271032501264049,0.6480737585536045,0.9767441860465116,1.0,1.0,8/38,19.37%,JADE3;TAF12;KAT6A;SUPT3H;JADE2;KAT14;KAT2B;KAT6B
prerank,GO_Biological_Process_2021__cellular ion homeostasis (GO:0006873),0.3885827979617683,0.6478673339489576,0.8125,1.0,1.0,2/5,19.85%,RHCG;SLC4A11
prerank,Reactome_2022__ABC-family Proteins Mediated Transport R-HSA-382556,-0.2577457730836784,-0.6474956789844946,1.0,1.0,1.0,13/94,19.11%,PSMB9;ABCC6;KCNJ11;ABCB1;ERLEC1;ABCA12;PSMA3;EIF2S3;ABCF1;EIF2S2;RPS27A;PSMA7;PSMB6
prerank,GO_Biological_Process_2021__B cell activation (GO:0042113),0.2536614691649904,0.6474764290770736,1.0,1.0,1.0,16/57,21.61%,KIT;BCL2;ADGRG3;ITGA4;CD22;FLT3;HDAC4;BANK1;MALT1;EPHB2;IL11;KLF6;HDAC5;PLCG2;ZBTB7A;PTPRJ
prerank,Reactome_2022__CREB1 Phosphorylation Thru Activation Of CaMKII/CaMKK/CaMKIV Cascasde R-HSA-442729,-0.3746213285232059,-0.6473976046962941,0.8939393939393939,1.0,1.0,4/8,31.53%,CALM1;CAMKK2;CAMKK1;KPNA2
prerank,GO_Biological_Process_2021__endoplasmic reticulum calcium ion homeostasis (GO:0032469),0.3221581206264061,0.6473550374288283,0.9393939393939394,1.0,1.0,3/19,13.74%,BCL2;PML;RAP1GDS1
prerank,GO_Biological_Process_2021__negative regulation of cell division (GO:0051782),-0.37586467287339514,-0.6471214933689996,0.8421052631578947,1.0,1.0,4/8,22.47%,TXNIP;RFPL1;ORC6;BLM
prerank,CellMarker_Augmented_2021__Large Granular lymphocyte:Peripheral Blood,0.2658865664290137,0.6470411357263153,1.0,1.0,1.0,15/85,17.08%,PODXL2;SOX12;SYT3;ABL1;NAT14;FGD1;COLGALT2;GPSM1;RIMS4;MMP16;FBLL1;MPP2;PLPPR3;USP51;CLIP3
prerank,Reactome_2022__Antigen Activates B Cell Receptor Leading To Second Messenger Generation R-HSA-983695,-0.3095347860340659,-0.6462552944713736,0.9558823529411765,1.0,1.0,6/27,20.35%,BLK;BLNK;ORAI1;ITPR3;CALM1;PIK3AP1
prerank,GO_Biological_Process_2021__positive regulation of protein catabolic process (GO:0045732),-0.2729651349987242,-0.646122877698808,1.0,1.0,1.0,8/74,14.17%,DTL;WNT5A;TNFRSF1B;GPC3;C4BPA;ASB5;OAZ2;C4BPB
prerank,GO_Biological_Process_2021__granulocyte differentiation (GO:0030851),0.3409758317163284,0.6460273697440874,0.9393939393939394,1.0,1.0,3/15,7.51%,JAGN1;CDK4;PML
prerank,GO_Biological_Process_2021__positive regulation of nervous system process (GO:0031646),0.313918667624967,0.6460155039589487,0.9032258064516129,1.0,1.0,5/17,12.32%,PARD3;RNF10;RIMS2;UNC13B;ATPSCKMT
prerank,Reactome_2022__Defects In Vitamin And Cofactor Metabolism R-HSA-3296482,0.29080170402950883,0.645937823047608,0.9230769230769231,1.0,1.0,7/20,24.93%,MTR;TCN2;PCCA;CD320;MCCC1;MMAB;ACACA
prerank,GO_Biological_Process_2021__regulation of signal transduction by p53 class mediator (GO:1901796),0.24700114805258747,0.6457599491561228,1.0,1.0,1.0,35/142,23.33%,SMYD2;CCNG1;PPP1R13B;SGK1;PML;TAF3;MLST8;TAF12;BANP;KAT6A;HDAC1;CHD4;PLK3;TP53;EXO1;PIP4K2A;ATM;RAD17;TAF4;PRMT5;NOC2L;RAD9A;ATR;EP300;CDK5;PRKAA2;MAP2K6;PRKAG2;DNA2;RBBP4;MDM4;ATRIP;TTC5;BRIP1;JMY
prerank,Reactome_2022__HIV Elongation Arrest And Recovery R-HSA-167287,0.265942258359604,0.6457046143920572,0.9696969696969697,1.0,1.0,6/31,31.71%,ELOA;GTF2F2;POLR2F;SSRP1;CCNT1;POLR2C
prerank,Reactome_2022__Role Of LAT2/NTAL/LAB On Calcium Mobilization R-HSA-2730905,0.3313905990031786,0.6456174134557683,0.9512195121951219,1.0,1.0,3/12,19.27%,SLC7A8;PIK3CA;SOS1
prerank,GO_Biological_Process_2021__positive regulation of release of sequestered calcium ion into cytosol (GO:0051281),-0.3306622637644427,-0.6454133308831191,0.8939393939393939,1.0,1.0,5/24,18.02%,GPER1;TRDN;P2RY6;JPH2;CALM1
prerank,Reactome_2022__Translocation Of SLC2A4 (GLUT4) To Plasma Membrane R-HSA-1445148,0.24630355392822792,0.6453561942562708,1.0,1.0,1.0,14/46,21.50%,REXO2;RALA;AKT2;RALGAPA2;TBC1D4;RAB10;EXOC7;KIF3B;MYO5A;PRKAA2;PRKAG2;EXOC6;MYO1E;EXOC4
prerank,GO_Biological_Process_2021__response to amyloid-beta (GO:1904645),0.2812069657121601,0.6453050875938523,0.95,1.0,1.0,4/32,12.82%,ITGA4;MMP2;GRIN1;ABCC1
prerank,GO_Biological_Process_2021__response to DNA damage checkpoint signaling (GO:0072423),0.42283558180296743,0.6451959544954142,0.8636363636363636,1.0,1.0,2/5,24.57%,FBH1;MUS81
prerank,GO_Biological_Process_2021__response to unfolded protein (GO:0006986),0.2685950352782283,0.6451054415528307,0.9285714285714286,1.0,1.0,6/45,12.47%,HSPB1;TOR1B;DNAJB5;RHBDD1;ERN1;HSPA1A
prerank,Reactome_2022__RNA Pol II CTD Phosphorylation And Interaction With CE R-HSA-77075,0.28194163343054046,0.6448441001584269,0.875,1.0,1.0,4/26,22.28%,CCNH;GTF2F2;ERCC3;POLR2F
prerank,GO_Biological_Process_2021__regulation of proteolysis involved in cellular protein catabolic process (GO:1903050),-0.3252038639815291,-0.6442821670790352,0.9482758620689655,1.0,1.0,4/23,16.35%,PINK1;UBE3A;ATP5IF1;NUDT15
prerank,GO_Biological_Process_2021__negative regulation of response to biotic stimulus (GO:0002832),-0.3225726888920049,-0.6441794403039831,0.921875,1.0,1.0,5/23,20.07%,NLRC3;RNF26;CACTIN;CARD8;DHX58
prerank,CellMarker_Augmented_2021__Spermatogonial Stem cell:Testis,0.38217859064119764,0.644112942559559,0.8571428571428571,1.0,1.0,3/9,15.09%,BCL6;FGFR3;ETV5
prerank,GO_Biological_Process_2021__endoplasmic reticulum membrane organization (GO:0090158),-0.36158038771909884,-0.6440371348271277,0.9538461538461539,1.0,1.0,1/11,6.40%,TRDN
prerank,Reactome_2022__TP53 Regulates Transcription Of Cell Death Genes R-HSA-5633008,0.27222028903522943,0.6439440266984349,0.9642857142857143,1.0,1.0,9/38,16.83%,BCL6;PERP;TP53AIP1;PPP1R13B;CRADD;BID;AIFM2;TP53;ATM
prerank,CellMarker_Augmented_2021__Morula Cell (Blastomere):Embryo,0.22197548279663812,0.6438415081447441,1.0,1.0,1.0,12/88,19.49%,CFLAR;DSP;BCAT1;PSMA1;GLUD1;F2R;TSPAN6;ARPC3;RELL1;FA2H;AKAP12;BTF3L4
prerank,Reactome_2022__C-type Lectin Receptors (CLRs) R-HSA-5621481,-0.2614590477164341,-0.6434167876908213,1.0,1.0,1.0,17/112,19.41%,PSMB9;CLEC4C;MUCL1;ICAM3;NFKB2;MUC5B;MUC4;MUC17;ITPR3;PSMA3;CALM1;RPS27A;NFATC2;MUC15;PSMA7;PSMB6;CASP8
prerank,CellMarker_Augmented_2021__Sertoli cell:Undefined,-0.3889531545942374,-0.6431767904757962,0.896551724137931,1.0,1.0,3/8,14.82%,CLU;CALB2;GATA4
prerank,"GO_Biological_Process_2021__regulation of phagocytosis, engulfment (GO:0060099)",0.3699803424393471,0.6430133253087431,0.9069767441860465,1.0,1.0,1/8,3.06%,RAB31
prerank,GO_Biological_Process_2021__positive regulation of mitochondrial calcium ion concentration (GO:0051561),0.35089091345831636,0.6428261543486934,0.8780487804878049,1.0,1.0,4/8,19.44%,MICU1;MCU;RAP1GDS1;SLC25A23
prerank,Reactome_2022__RET Signaling R-HSA-8853659,-0.30811723486278675,-0.642703277019126,0.9710144927536232,1.0,1.0,3/35,13.53%,GFRA3;PIK3R3;PIK3CB
prerank,GO_Biological_Process_2021__regulation of NIK/NF-kappaB signaling (GO:1901222),-0.280929750721354,-0.6423668742836277,0.96,1.0,1.0,11/60,14.99%,TERF2IP;NLRP12;UACA;LRRC19;SPI1;TLR2;NLRC3;C1QTNF4;NLRP3;CD27;DDX3X
prerank,Reactome_2022__Synthesis Of Wybutosine At G37 Of tRNA(Phe) R-HSA-6782861,-0.41430869688653355,-0.6423498006031704,0.8793103448275862,1.0,1.0,5/5,58.58%,TYW1;TRMT5;TYW3;TYW5;LCMT2
prerank,KEGG_2021_Human__Fanconi anemia pathway,-0.2819060442637321,-0.6423345123596443,0.9705882352941176,1.0,1.0,14/49,27.51%,RPA3;FANCF;BRCA1;CENPS-CORT;RMI1;RPA2;FANCC;BLM;FANCI;RMI2;BRCA2;MLH1;FANCD2;CENPX
prerank,GO_Biological_Process_2021__positive regulation of intrinsic apoptotic signaling pathway (GO:2001244),0.30607155608958,0.642024525315735,1.0,1.0,1.0,6/33,17.62%,BCL2;STYXL1;BID;TP53;NCK1;FBH1
prerank,Reactome_2022__Acyl Chain Remodeling Of CL R-HSA-1482798,0.3808204089356416,0.6418727418666097,0.8823529411764706,1.0,1.0,3/6,23.88%,LCLAT1;HADHB;PLA2G6
prerank,GO_Biological_Process_2021__telomeric D-loop disassembly (GO:0061820),0.3604047190981177,0.6416576634519772,0.8235294117647058,1.0,1.0,1/7,10.31%,TERF1
prerank,GO_Biological_Process_2021__cellular respiration (GO:0045333),0.27321987119737645,0.6411300511505044,1.0,1.0,1.0,4/38,16.04%,SDHAF4;COX10;ME3;NR4A3
prerank,GO_Biological_Process_2021__peroxisome fission (GO:0016559),-0.39109880915040157,-0.6411286692312691,0.9047619047619048,1.0,1.0,1/8,18.81%,FIS1
prerank,KEGG_2021_Human__Serotonergic synapse,-0.2578810787508137,-0.6410669915872736,1.0,1.0,1.0,17/97,18.06%,ALOX12;ALOX5;ALOX12B;ALOX15;HTR1B;HTR2B;CYP2J2;GNGT1;SLC18A2;SLC6A4;HTR3C;ITPR3;ALOX15B;HTR5A;HTR3E;PLA2G4A;HTR3A
prerank,GO_Biological_Process_2021__positive regulation of myeloid cell apoptotic process (GO:0033034),-0.4141306204646176,-0.641055099728603,0.8771929824561403,1.0,1.0,2/6,13.53%,ANXA1;PIK3CB
prerank,Reactome_2022__Late Phase Of HIV Life Cycle R-HSA-162599,0.23348487691800385,0.6404816559338339,1.0,1.0,1.0,24/127,22.33%,NUP210;NUP42;MVB12A;TAF3;CHMP6;TAF12;UBAP1;AAAS;ELOA;CCNH;SGIP1;VTA1;GTF2F2;FURIN;TAF4;ERCC3;RANBP2;NMT2;XPO1;MVB12B;NUP214;POLR2F;TSG101;TPR
prerank,GO_Biological_Process_2021__positive regulation of histone phosphorylation (GO:0033129),0.3829710589387355,0.6404596312112216,0.8888888888888888,1.0,1.0,1/5,13.88%,RPS6KA4
prerank,GO_Biological_Process_2021__protein geranylgeranylation (GO:0018344),0.3896884058714797,0.6403692740089155,0.825,1.0,1.0,2/5,12.75%,PGGT1B;FNTA
prerank,Reactome_2022__DNA Repair R-HSA-73894,-0.2412633981530787,-0.6403567216934415,1.0,1.0,1.0,42/274,23.36%,DTL;TERF2IP;PCLAF;RPA3;ACTL6A;ABRAXAS1;UBE2L6;TRIM25;UVSSA;FANCF;EYA1;H2BC4;BRCA1;TFPT;COPS5;CENPS-CORT;H2AZ1;DCLRE1C;EYA2;POLE2;RBX1;RRAD;POLD4;COPS4;SMUG1;RPS27A;OGG1;DCLRE1A;SMARCA5;FAAP20;RMI1;TOPBP1;POLE3;FANCC;ISG15;MSH6;BLM;UBXN1;FANCI;XRCC1;RAD9B;POLR2B
prerank,GO_Biological_Process_2021__negative regulation of GTPase activity (GO:0034260),0.30826951347025056,0.6402847864566976,1.0,1.0,1.0,2/18,11.34%,RRP1B;GPSM1
prerank,GO_Biological_Process_2021__negative regulation of response to reactive oxygen species (GO:1901032),-0.376452350085894,-0.64002058451478,0.9193548387096774,1.0,1.0,3/8,26.49%,TXN;PARK7;PDE8A
prerank,GO_Biological_Process_2021__defense response to tumor cell (GO:0002357),0.35827712341550166,0.6399656650185703,0.88,1.0,1.0,2/7,11.01%,ABI3;RBMS3
prerank,GO_Biological_Process_2021__positive regulation of immune effector process (GO:0002699),-0.30537115703603646,-0.6396207767229564,0.9857142857142858,1.0,1.0,6/22,20.83%,HLA-DRB1;PTPRC;USP17L2;CD81;DHX58;DDX60
prerank,Reactome_2022__Bicarbonate Transporters R-HSA-425381,0.34752355266710616,0.639396229475906,0.9761904761904762,1.0,1.0,1/9,8.19%,SLC4A7
prerank,Reactome_2022__InlA-mediated Entry Of Listeria Monocytogenes Into Host Cells R-HSA-8876493,-0.3748945897384651,-0.6391893566424448,0.9152542372881356,1.0,1.0,4/8,34.63%,RPS27A;UBB;UBC;CBLL1
prerank,Reactome_2022__Metabolism Of Proteins R-HSA-392499,-0.22521008927329425,-0.6391858744366857,1.0,1.0,1.0,214/1610,20.12%,NOTUM;F8;ARSH;PSMB9;C1QTNF1;ST6GALNAC1;SFTPA1;APOL1;TGFB1;RAB34;F7;RPL37A;MAT2B;DTL;ITIH2;ASGR2;GCNT7;PIGH;B3GNT5;SP100;TGFBI;RAB44;CPM;ESR1;SERPIND1;ACTL6A;ABRAXAS1;CDC25A;RAB11A;HIC1;CBX8;SDC2;UBE2L6;FBXL7;NARS1;MUCL1;AGBL5;SFTPD;TRIM25;NANS;PAPPA2;TOMM20;NFKB2;MUC5B;ARF3;HLA-A;FBXL13;ASB14;H2BC4;PAPPA;DARS2;MPZ;PRSS23;B3GNT9;GPC3;ST6GALNAC2;GNAT3;BRCA1;RPL38;PTRH2;CPB2;GAPDHS;SERPINA10;USP13;RAB19;ART3;FAM110A;PLG;GNGT1;THBS1;RPL15;CP;TFPT;CTSZ;DCTN1;USP17L2;LY6K;GPIHBP1;COPS5;HSPA8;WARS1;RPS4X;RPL3;ETFBKMT;RRAGA;H2AZ1;RPL35A;FOXO4;PIGC;TUBA4A;WFS1;TAF9B;MFGE8;GALNTL5;RAB6B;NLRP3;DYNLL1;CHST4;RPS9;VDAC1;ASB5;FAU;F5;RPS27;ATP6AP2;INCENP;CCT6B;MUC4;RBBP7;PIGL;EEF2;MUC17;GCNT1;RPS21;MCFD2;VDR;NR1H4;FBXO40;GATA4;ADGRF5;TUBA3D;TAF10;PCMT1;CCNF;ETFB;MRPL19;CCNE2;KLHL2;SRP14;RAB8A;TTLL4;EIF2B2;RBX1;SIAH1;PLET1;RPL13A;GALNT6;MRPL40;B4GALNT2;TUBB;SMAD3;YARS2;PSMA3;CHST10;TUBB6;RPL27A;EIF2S3;RPS16;GHRL;RNF20;RPL36;THRA;PDCL;RPS20;RPL7A;SUMF1;RABGGTB;RABGGTA;TUBB2A;RPL9;COPS4;MPDU1;ARSF;ASGR1;CDCA8;EIF2S2;MRPS34;RENBP;RPS8;CALM1;RPS27A;ANPEP;KDELR3;MUC15;RPL21;EIF4A2;FBXL18;RPL34;AMBN;LY6H;EEF1AKMT2;PSMA7;MRPL20;B4GAT1;FAM20A;EEF2KMT;EPAS1;MRPL34;PSMB6;RPL4;RPL32;GALNT5;INHA;CHGB;RPL5;RPL23;ALG10B;RPL41;MOGAT1;RPS7;FEM1C;RPS11;NUP93;GGCX;ACE2;SRP19;SUDS3;FN1;SPON2;RPL27;RPL35;MRPS22;H2BC18;NRN1
prerank,GO_Biological_Process_2021__antigen processing and presentation of peptide antigen via MHC class II (GO:0002495),0.2375014428817434,0.6391480025692483,1.0,1.0,1.0,8/84,12.84%,HLA-DQB1;RAB7A;HLA-DRA;SEC24C;DYNC1I2;CTSV;MARCHF8;KIF4B
prerank,GO_Biological_Process_2021__non-canonical Wnt signaling pathway (GO:0035567),-0.2586449246284988,-0.6390404500415725,1.0,1.0,1.0,4/111,4.31%,PSMB9;WNT5A;PDE6B;FZD8
prerank,GO_Biological_Process_2021__regulation of mRNA stability (GO:0043488),-0.2515071247578674,-0.6389495072894696,1.0,1.0,1.0,2/138,0.62%,TENT5B;PSMB9
prerank,GO_Biological_Process_2021__cytoplasmic sequestering of NF-kappaB (GO:0007253),0.38532587086181214,0.6388989728982342,0.918918918918919,1.0,1.0,2/7,18.00%,CCDC22;FAF1
prerank,Reactome_2022__E2F-enabled Inhibition Of Pre-Replication Complex Formation R-HSA-113507,-0.40676961313527643,-0.638702456343997,0.9649122807017544,1.0,1.0,3/7,34.35%,ORC6;CCNB1;ORC5
prerank,GO_Biological_Process_2021__positive regulation of cholesterol metabolic process (GO:0090205),-0.3831766734712148,-0.6385285245644022,0.9166666666666666,1.0,1.0,1/5,18.30%,LDLRAP1
prerank,GO_Biological_Process_2021__focal adhesion assembly (GO:0048041),-0.3226495728548533,-0.6383810941413417,0.9076923076923077,1.0,1.0,1/20,8.67%,ACTN3
prerank,GO_Biological_Process_2021__regulation of glycogen (starch) synthase activity (GO:2000465),0.38421500899025257,0.6383755023040429,0.847457627118644,1.0,1.0,5/5,61.59%,EPM2AIP1;GSK3B;INPP5K;GSK3A;PPP1R3F
prerank,GO_Biological_Process_2021__dorsal/ventral pattern formation (GO:0009953),-0.34305612276820874,-0.6382104920351069,0.9841269841269841,1.0,1.0,1/14,2.81%,WNT8B
prerank,Reactome_2022__Association Of TriC/CCT With Target Proteins During Biosynthesis R-HSA-390471,0.2783926622712905,0.6380156884432453,0.972972972972973,1.0,1.0,5/37,19.44%,HDAC3;WRAP53;TP53;FBXO4;XRN2
prerank,GO_Biological_Process_2021__negative regulation of JUN kinase activity (GO:0043508),-0.370115546978796,-0.6379721305472109,0.8676470588235294,1.0,1.0,1/11,10.70%,DNAJA1
prerank,GO_Biological_Process_2021__regulation of toll-like receptor 4 signaling pathway (GO:0034143),0.3080409366347992,0.6379066770472925,0.9444444444444444,1.0,1.0,7/17,23.83%,TICAM2;MFHAS1;NR1H3;LBP;APPL2;NINJ1;NR1D1
prerank,GO_Biological_Process_2021__regulation of centrosome cycle (GO:0046605),-0.3206689483674665,-0.6378990080389924,0.9841269841269841,1.0,1.0,2/20,11.55%,CHMP3;ATF5
prerank,Reactome_2022__Mitochondrial Calcium Ion Transport R-HSA-8949215,-0.33365956581238077,-0.6378964818470045,0.9285714285714286,1.0,1.0,3/21,13.77%,MCUB;STOML2;VDAC1
prerank,GO_Biological_Process_2021__negative regulation of skeletal muscle cell differentiation (GO:2001015),-0.4068783003631832,-0.6376700366888849,0.8888888888888888,1.0,1.0,2/5,32.58%,SIX4;EPHB1
prerank,GO_Biological_Process_2021__negative regulation of phosphate metabolic process (GO:0045936),-0.31775904991854786,-0.6373220159819453,0.9117647058823529,1.0,1.0,5/21,22.07%,CDKN2D;CDKN1A;DYNLL1;INHA;CDKN1B
prerank,PanglaoDB_Augmented_2021__Undefined Placental Cells,0.24571196374532261,0.637129108327255,1.0,1.0,1.0,2/84,3.08%,TEAD2;FAM83H
prerank,GO_Biological_Process_2021__protein desumoylation (GO:0016926),-0.3755835918646333,-0.6369980111358574,0.8450704225352113,1.0,1.0,1/7,8.69%,SENP3
prerank,GO_Biological_Process_2021__actin filament bundle organization (GO:0061572),0.2918913861799216,0.6368916383299715,0.8918918918918919,1.0,1.0,9/31,19.27%,FSCN3;EPS8;FSCN1;ESPN;CALD1;MICAL1;PAWR;CORO1B;ADD1
prerank,GO_Biological_Process_2021__regulation of B cell apoptotic process (GO:0002902),-0.38444207275209225,-0.6368131101504327,0.9137931034482759,1.0,1.0,2/8,13.27%,BLK;ORMDL3
prerank,GO_Biological_Process_2021__succinate transmembrane transport (GO:0071422),-0.4235827734952584,-0.6368105662563716,0.8253968253968254,1.0,1.0,1/5,23.32%,SLC25A11
prerank,GO_Biological_Process_2021__L-glutamate transmembrane transport (GO:0015813),-0.36911942379957213,-0.6366259812625681,0.9402985074626866,1.0,1.0,2/10,17.64%,SLC25A18;SLC25A22
prerank,GO_Biological_Process_2021__cardiac muscle cell differentiation (GO:0055007),0.31040369412311103,0.6365877538669577,0.918918918918919,1.0,1.0,2/17,5.50%,SLC8A1;NRG1
prerank,GO_Biological_Process_2021__negative regulation of peptidyl-lysine acetylation (GO:2000757),-0.3859527797192314,-0.6365273488292562,0.9090909090909091,1.0,1.0,2/10,8.63%,TAF7;BRCA1
prerank,GO_Biological_Process_2021__gonad development (GO:0008406),-0.29632496127905433,-0.6364176692775312,0.9696969696969697,1.0,1.0,10/32,21.60%,WNT5A;ADAM21;BIK;LRP2;GATA4;MEA1;BASP1;SIX4;SOX9;AR
prerank,GO_Biological_Process_2021__positive regulation of neuron apoptotic process (GO:0043525),0.3059806402100653,0.6363739285404073,0.9743589743589743,1.0,1.0,1/18,2.88%,EPHA7
prerank,GO_Biological_Process_2021__alpha-amino acid biosynthetic process (GO:1901607),-0.3803610501750711,-0.6362738492948469,0.9245283018867925,1.0,1.0,2/7,14.94%,SDS;SDSL
prerank,Reactome_2022__Pausing And Recovery Of Tat-mediated HIV Elongation R-HSA-167238,0.2697092640901127,0.6362281323632768,1.0,1.0,1.0,6/29,31.71%,ELOA;GTF2F2;POLR2F;SSRP1;CCNT1;POLR2C
prerank,GO_Biological_Process_2021__negative regulation of autophagosome maturation (GO:1901097),0.38973985788011,0.6355181672223656,0.851063829787234,1.0,1.0,4/5,31.37%,CLEC16A;RUBCN;TMEM39A;UBQLN4
prerank,GO_Biological_Process_2021__respiratory system development (GO:0060541),-0.29516909348664067,-0.6349983037912775,1.0,1.0,1.0,1/26,2.89%,CCDC39
prerank,GO_Biological_Process_2021__regulation of proteasomal ubiquitin-dependent protein catabolic process (GO:0032434),0.23719977397391562,0.6349811164834767,1.0,1.0,1.0,13/94,14.39%,FHIT;PRICKLE1;COMMD1;TRIB2;N4BP1;RNF217;EIF3H;HSPA1A;RNF180;RYBP;FOXF2;NKD2;HSPBP1
prerank,GO_Biological_Process_2021__mitochondrion organization (GO:0007005),-0.2473845367675094,-0.6348051995348674,1.0,1.0,1.0,12/162,13.22%,HK2;PINK1;TOMM20;HIGD1C;SLIRP;STOML2;TERT;CAV2;BIK;CHCHD2;TOMM7;COX7A1
prerank,CellMarker_Augmented_2021__Macrophage:Brain,-0.2917477376839032,-0.6346376906613143,0.9538461538461539,1.0,1.0,5/37,13.84%,TGFBI;CIITA;ARG2;FPR3;FOSL2
prerank,GO_Biological_Process_2021__negative regulation of macroautophagy (GO:0016242),0.26744748832090437,0.6344164095371776,1.0,1.0,1.0,8/25,21.39%,USP36;CLEC16A;QSOX1;PIK3CA;SEC22B;SMG1;MTM1;RUBCN
prerank,KEGG_2021_Human__Gap junction,0.23723807238775405,0.6342128402128053,1.0,1.0,1.0,8/82,11.15%,ITPR2;HTR2C;PDGFD;PLCB1;ADCY2;TUBA8;GUCY1A2;ADCY3
prerank,GO_Biological_Process_2021__hyaluronan biosynthetic process (GO:0030213),-0.3949122763677548,-0.6341900499634823,0.8703703703703703,1.0,1.0,1/6,14.93%,HYAL1
prerank,KEGG_2021_Human__Inflammatory mediator regulation of TRP channels,0.247234040632175,0.6341156496823497,1.0,1.0,1.0,19/82,20.89%,NGF;ITPR2;HTR2C;PLCB1;MAPK8;ADCY2;ADCY3;PLA2G4C;HRH1;PIK3CA;MAPK12;ADCY6;PPP1CB;TRPV2;MAP2K6;PRKCE;GNAQ;GNAS;PLCG2
prerank,Reactome_2022__TNFs Bind Their Physiological Receptors R-HSA-5669034,0.283781936482424,0.6340756836477758,1.0,1.0,1.0,4/21,11.68%,EDARADD;TNFSF14;TNFRSF18;TNFSF13B
prerank,KEGG_2021_Human__Nitrogen metabolism,-0.32490806151886426,-0.6335841053692646,0.9473684210526315,1.0,1.0,3/16,15.13%,CA14;CA1;CA4
prerank,"GO_Biological_Process_2021__pentose-phosphate shunt, non-oxidative branch (GO:0009052)",-0.4102462837512733,-0.6334286876842229,0.9354838709677419,1.0,1.0,2/5,21.68%,TALDO1;RPEL1
prerank,GO_Biological_Process_2021__regulation of nervous system development (GO:0051960),-0.3035701394615773,-0.6334272897662762,1.0,1.0,1.0,3/33,7.24%,KIF14;TNFRSF1B;LGI4
prerank,Reactome_2022__Antiviral Mechanism By IFN-stimulated Genes R-HSA-1169410,-0.2645386746199078,-0.6333055015944296,1.0,1.0,1.0,13/76,21.63%,UBE2L6;TRIM25;STAT1;OAS2;IFIT1;OAS1;GNL3;RPS27A;EIF4A2;NUP93;MX1;SEC13;ISG15
prerank,GO_Biological_Process_2021__positive regulation of natural killer cell activation (GO:0032816),-0.33920246875975263,-0.6331623092321734,0.9666666666666667,1.0,1.0,4/12,18.95%,IL12A;IL18;HLA-F;AXL
prerank,GO_Biological_Process_2021__adenylate cyclase-inhibiting serotonin receptor signaling pathway (GO:0007198),0.40814831078813707,0.6330557674320697,0.9090909090909091,1.0,1.0,1/6,2.78%,HTR1F
prerank,GO_Biological_Process_2021__endoplasmic reticulum localization (GO:0051643),-0.38122842339293583,-0.6328379989685277,0.8833333333333333,1.0,1.0,1/6,15.61%,POLR2M
prerank,Reactome_2022__SMAC (DIABLO) Binds To IAPs R-HSA-111463,-0.3915963702643622,-0.6323678667838326,0.8793103448275862,1.0,1.0,1/6,9.49%,CASP7
prerank,Reactome_2022__Activation Of Caspases Thru Apoptosome-Mediated Cleavage R-HSA-111459,-0.3915963702643622,-0.6323678667838326,0.8793103448275862,1.0,1.0,1/6,9.49%,CASP7
prerank,Reactome_2022__Prolactin Receptor Signaling R-HSA-1170546,0.3150484375665642,0.6323216436150908,0.8979591836734694,1.0,1.0,4/10,27.53%,STAT5B;CUL1;PRLR;BTRC
prerank,GO_Biological_Process_2021__regulation of lipid biosynthetic process (GO:0046890),-0.29306062768743696,-0.6323052928338562,0.9523809523809523,1.0,1.0,3/29,7.40%,GPER1;EIF6;CEACAM1
prerank,Reactome_2022__Adenylate Cyclase Inhibitory Pathway R-HSA-170670,-0.34530885447363113,-0.6322531432441587,0.8970588235294118,1.0,1.0,3/12,18.00%,GNAT3;ADCY7;GNAL
prerank,GO_Biological_Process_2021__antigen processing and presentation of exogenous peptide antigen (GO:0002478),-0.25754604487161953,-0.6322093942910091,0.9868421052631579,1.0,1.0,8/86,15.53%,HLA-DMA;HLA-A;HLA-DPB1;HLA-DRB1;DCTN1;HLA-DPA1;DYNLL1;HLA-F
prerank,GO_Biological_Process_2021__regulation of ubiquitin-protein transferase activity (GO:0051438),0.29336623662933137,0.6319944379138378,0.926829268292683,1.0,1.0,7/24,23.71%,DCUN1D1;ABL1;UBE2L3;LIMK1;SMAD7;AXIN1;PLK1
prerank,Reactome_2022__Transcriptional Regulation By E2F6 R-HSA-8953750,0.27796599913613207,0.6318427343053438,1.0,1.0,1.0,9/33,21.88%,E2F6;MGA;RYBP;YAF2;UXT;RNF2;PCGF6;RBBP4;TFDP1
prerank,GO_Biological_Process_2021__regulation of lysosomal protein catabolic process (GO:1905165),-0.38456956077409343,-0.6318108311290128,0.9387755102040817,1.0,1.0,1/6,11.56%,LRP2
prerank,GO_Biological_Process_2021__negative regulation of cellular component organization (GO:0051129),-0.2757895128083626,-0.6312184678867346,0.9875,1.0,1.0,13/68,21.60%,TMC8;CLU;APOM;PON1;SVIP;HSPA8;NR1H4;DDX3X;DNAJB1;NOP53;HSPA5;TFIP11;AR
prerank,GO_Biological_Process_2021__negative regulation of histone modification (GO:0031057),-0.35003670096376327,-0.631180210331372,0.9393939393939394,1.0,1.0,3/16,11.29%,TAF7;BRCA1;USP17L2
prerank,Reactome_2022__Thromboxane Signaling Thru TP Receptor R-HSA-428930,-0.3333801186724888,-0.6310964644812149,0.95,1.0,1.0,7/20,30.19%,GNGT1;GNA15;GNG13;GNG12;GNG4;GNG3;TBXA2R
prerank,GO_Biological_Process_2021__protein K48-linked deubiquitination (GO:0071108),-0.31998065160578787,-0.6308021427942453,0.958904109589041,1.0,1.0,7/23,27.53%,USP50;USP17L2;OTUB1;VCPIP1;OTUD4;YOD1;USP5
prerank,GO_Biological_Process_2021__establishment of protein localization to peroxisome (GO:0072663),0.38558992726791674,0.6307827168021632,0.8918918918918919,1.0,1.0,5/7,40.03%,ZFAND6;PEX16;LONP2;PEX12;HACL1
prerank,GO_Biological_Process_2021__negative regulation of necroptotic process (GO:0060546),0.36742606709330583,0.6306331537128042,0.825,1.0,1.0,1/8,13.55%,PELI1
prerank,GO_Biological_Process_2021__Fc-epsilon receptor signaling pathway (GO:0038095),-0.25339748936994133,-0.6303865137358378,1.0,1.0,1.0,3/98,5.08%,PSMB9;VAV3;TEC
prerank,GO_Biological_Process_2021__positive regulation of fibroblast proliferation (GO:0048146),-0.33842109073763993,-0.6299170012893494,0.9384615384615385,1.0,1.0,4/23,19.91%,WNT5A;CDKN1A;AGT;FN1
prerank,Reactome_2022__Nephrin Family Interactions R-HSA-373753,0.2729677576523205,0.6298345637547256,1.0,1.0,1.0,6/21,21.97%,MAGI2;PIK3CA;NCK1;KIRREL3;CASK;NCK2
prerank,GO_Biological_Process_2021__GPI anchor metabolic process (GO:0006505),-0.32706105011969694,-0.6295758507434855,0.971830985915493,1.0,1.0,4/25,14.30%,PIGH;MPPE1;PIGC;PIGL
prerank,Reactome_2022__Diseases Associated With TLR Signaling Cascade R-HSA-5602358,-0.31503817702526826,-0.629567463759403,0.9384615384615385,1.0,1.0,3/21,14.12%,NFKB2;TLR2;NDUFA2
prerank,KEGG_2021_Human__Tight junction,-0.24279134751366657,-0.629461436643303,1.0,1.0,1.0,22/138,18.23%,MARVELD2;CCND1;CLDN1;CLDN6;CLDN5;ACTG1;CLDN2;WAS;TUBA4A;IGSF5;CLDN18;GATA4;TUBA3D;JAM2;RAB8A;TJP3;CLDN20;VASP;MYL6;RAC1;MSN;MYL9
prerank,GO_Biological_Process_2021__regulation of chromatin assembly or disassembly (GO:0001672),-0.39348118792897424,-0.6293527616247419,0.864406779661017,1.0,1.0,1/6,21.48%,PARP10
prerank,GO_Biological_Process_2021__positive regulation of proteolysis involved in cellular protein catabolic process (GO:1903052),-0.31310878954658466,-0.629186379277882,0.9545454545454546,1.0,1.0,3/27,13.34%,CAV3;CLU;ATP5IF1
prerank,GO_Biological_Process_2021__regulation of cellular response to hypoxia (GO:1900037),-0.4107670281575604,-0.6290976909619703,0.8936170212765957,1.0,1.0,1/5,12.00%,CHCHD2
prerank,CellMarker_Augmented_2021__Megakaryocyte:Fetal Kidney,-0.4200907725147264,-0.6289812551917672,0.896551724137931,1.0,1.0,2/6,22.08%,ITGA2B;FYB1
prerank,Reactome_2022__MTOR Signaling R-HSA-165159,0.26502656167804034,0.6288339496778186,1.0,1.0,1.0,12/37,27.48%,MLST8;AKT2;PPM1A;EEF2K;EIF4EBP1;PRKAA2;PRKAG2;EIF4E;RRAGD;LAMTOR4;RPS6KB1;AKT1
prerank,GO_Biological_Process_2021__DNA repair (GO:0006281),-0.23749199723203893,-0.6288210053908024,1.0,1.0,1.0,41/269,23.15%,TICRR;POLQ;TRAIP;RPA3;ABRAXAS1;FANCF;EYA1;RAD51AP2;TNP1;UBE2U;BRCA1;CDKN2D;REXO4;DCLRE1C;RAD1;POLE2;NUCKS1;PARP4;POLD4;SMUG1;RPS27A;HMGA2;NOP53;RAD54L;DDX1;OGG1;RECQL4;DCLRE1A;SMARCA5;FAAP20;TOPBP1;RPA2;FANCC;APTX;MSH6;BLM;UBXN1;FANCI;XRCC1;VCPIP1;RAD9B
prerank,GO_Biological_Process_2021__regulation of histone H2B ubiquitination (GO:2001166),-0.3881586678159114,-0.6285250576264312,0.9795918367346939,1.0,1.0,2/5,25.58%,RNF20;CDK9
prerank,GO_Biological_Process_2021__phosphatidylinositol-3-phosphate biosynthetic process (GO:0036092),-0.379745356480157,-0.6279593798297223,0.9473684210526315,1.0,1.0,3/8,17.46%,PIK3CB;PIK3C2G;PIK3CG
prerank,GO_Biological_Process_2021__positive regulation of stem cell differentiation (GO:2000738),0.3293795146515861,0.6278185182286105,0.9166666666666666,1.0,1.0,3/11,20.80%,SP7;SOX5;RBM24
prerank,GO_Biological_Process_2021__calcium import into the mitochondrion (GO:0036444),0.35828205386823486,0.6276944116542228,0.9117647058823529,1.0,1.0,3/10,19.44%,MICU1;MCU;SLC25A23
prerank,GO_Biological_Process_2021__positive regulation of insulin secretion involved in cellular response to glucose stimulus (GO:0035774),-0.3267882184342437,-0.6274804451587261,0.9285714285714286,1.0,1.0,2/12,21.05%,HLA-DRB1;BAIAP3
prerank,Reactome_2022__Hedgehog On State R-HSA-5632684,-0.26039718241196,-0.6274076072742154,1.0,1.0,1.0,2/75,2.89%,PSMB9;HHIP
prerank,GO_Biological_Process_2021__regulation of relaxation of cardiac muscle (GO:1901897),0.4035462803235139,0.6272416751743697,0.9090909090909091,1.0,1.0,2/5,21.96%,PDE4B;PDE4D
prerank,GO_Biological_Process_2021__regulation of microtubule polymerization (GO:0031113),0.2586457379655927,0.626839525995187,1.0,1.0,1.0,6/39,10.32%,CDH5;SNCA;ABL1;MAPRE1;NAV3;AKAP9
prerank,Reactome_2022__Purine Salvage R-HSA-74217,0.29522591341796184,0.626768033352773,0.8888888888888888,1.0,1.0,4/11,23.09%,AMPD1;HPRT1;APRT;AMPD3
prerank,GO_Biological_Process_2021__vesicle cytoskeletal trafficking (GO:0099518),-0.28404859297845725,-0.6267248456383614,0.9487179487179487,1.0,1.0,5/36,20.29%,MYO1F;MYO5B;NDEL1;MYO15A;MYO7B
prerank,GO_Biological_Process_2021__negative regulation of NLRP3 inflammasome complex assembly (GO:1900226),-0.4230618995004822,-0.6265084391977795,0.9245283018867925,1.0,1.0,1/5,13.04%,NLRC3
prerank,GO_Biological_Process_2021__telomeric loop disassembly (GO:0090657),0.35884534839745275,0.6265034494123298,0.9090909090909091,1.0,1.0,1/9,10.31%,TERF1
prerank,GO_Biological_Process_2021__release of cytochrome c from mitochondria (GO:0001836),-0.34038258744277894,-0.6263453967591174,0.9607843137254902,1.0,1.0,5/16,21.33%,SOD2;CLU;FIS1;BBC3;IFI6
prerank,GO_Biological_Process_2021__dendritic cell differentiation (GO:0097028),-0.3289524385880662,-0.6262804387504749,0.9464285714285714,1.0,1.0,1/16,2.65%,BLK
prerank,KEGG_2021_Human__Gastric acid secretion,-0.273376840954795,-0.6262577838172256,1.0,1.0,1.0,10/62,19.66%,KCNJ15;ATP1A4;ACTG1;KCNQ1;ADCY7;ITPR3;ATP4A;CALM1;CAMK2A;ATP1A1
prerank,GO_Biological_Process_2021__pyrimidine nucleoside biosynthetic process (GO:0046134),0.3076296526170322,0.6259703263376097,0.9473684210526315,1.0,1.0,4/14,24.51%,UPP2;UCK2;PUDP;CDA
prerank,GO_Biological_Process_2021__positive regulation of myeloid cell differentiation (GO:0045639),-0.29440948031061637,-0.6258773335701758,0.9701492537313433,1.0,1.0,5/32,13.14%,STAT1;FAM210B;SCIN;PITHD1;FAXDC2
prerank,GO_Biological_Process_2021__negative regulation of ATPase activity (GO:0032780),-0.3634584674547485,-0.6258652392909614,0.9333333333333333,1.0,1.0,4/12,16.97%,IFIT1;ATP5IF1;PAM16;PLN
prerank,GO_Biological_Process_2021__calcium-mediated signaling using intracellular calcium source (GO:0035584),-0.3382182207992315,-0.625773668830693,0.896551724137931,1.0,1.0,2/16,10.28%,SELP;PTPRC
prerank,KEGG_2021_Human__Nucleotide excision repair,-0.2889514198634594,-0.6256974858041261,0.9558823529411765,1.0,1.0,8/43,24.92%,RPA3;POLE2;RBX1;POLD4;POLE3;RPA2;DDB1;CDK7
prerank,GO_Biological_Process_2021__regulation of microtubule polymerization or depolymerization (GO:0031110),0.27413631930760624,0.6256152596059553,0.9375,1.0,1.0,13/27,34.77%,ABL1;MAPRE1;SKA1;GBA2;CAMSAP3;MAP2;MAPRE3;CLASP2;SKA3;MAPRE2;GAS2L1;CLASP1;GAS2L2
prerank,GO_Biological_Process_2021__ISG15-protein conjugation (GO:0032020),-0.417435435773016,-0.6252648041521757,0.9310344827586207,1.0,1.0,1/5,5.67%,UBE2L6
prerank,CellMarker_Augmented_2021__Dendritic cell:Liver,-0.40975201201739264,-0.6246956820489165,0.9107142857142857,1.0,1.0,3/5,19.68%,IL3RA;CD80;ITGAX
prerank,KEGG_2021_Human__Glioma,0.2394754944767791,0.6238878692117867,1.0,1.0,1.0,15/68,22.39%,SHC4;CDK6;CDK4;TGFA;AKT2;CAMK1G;PIK3CA;GADD45A;TP53;BRAF;SOS1;RAF1;PLCG2;PTEN;SHC3
prerank,GO_Biological_Process_2021__endodermal cell fate commitment (GO:0001711),-0.39867922382021626,-0.623754029635132,0.8947368421052632,1.0,1.0,2/6,24.17%,RTF1;PAF1
prerank,GO_Biological_Process_2021__glomerulus vasculature development (GO:0072012),-0.3942165056417857,-0.6237091933700323,0.8653846153846154,1.0,1.0,2/6,13.55%,ANGPT2;TEK
prerank,Reactome_2022__RA Biosynthesis Pathway R-HSA-5365859,-0.3478626081782321,-0.6235235991659039,0.9333333333333333,1.0,1.0,2/16,7.55%,CYP26B1;RDH13
prerank,CellMarker_Augmented_2021__Dendritic Cell progenitor:Bone Marrow,0.33018358617933696,0.6235113686259351,0.9111111111111111,1.0,1.0,2/12,4.29%,KIT;CX3CR1
prerank,Reactome_2022__Uptake Of Dietary Cobalamins Into Enterocytes R-HSA-9758881,-0.3946249010600449,-0.6234240071748834,0.9264705882352942,1.0,1.0,1/7,2.37%,TCN1
prerank,GO_Biological_Process_2021__positive regulation of aspartic-type endopeptidase activity involved in amyloid precursor protein catabolic process (GO:1902961),-0.37906095099114523,-0.6233489514941861,0.8478260869565217,1.0,1.0,1/7,20.84%,AGER
prerank,GO_Biological_Process_2021__regulation of vascular associated smooth muscle contraction (GO:0003056),0.39308023439658535,0.623340766914554,0.9285714285714286,1.0,1.0,3/5,31.33%,CHRM3;DOCK4;ZDHHC21
prerank,GO_Biological_Process_2021__response to tumor necrosis factor (GO:0034612),-0.27403569736471267,-0.6231103265285571,1.0,1.0,1.0,11/68,19.41%,GPER1;GSDME;BRCA1;GBP1;CXCL16;GGT5;HYAL1;ZFP36L1;CACTIN;TNFRSF11A;CASP8
prerank,GO_Biological_Process_2021__regulation of plasma membrane bounded cell projection organization (GO:0120035),-0.3038774314664512,-0.6229791177037449,1.0,1.0,1.0,1/25,2.00%,DISC1
prerank,Reactome_2022__Downstream Signaling Events Of B Cell Receptor (BCR) R-HSA-1168372,-0.25601923527279213,-0.622261039347152,0.974025974025974,1.0,1.0,1/71,0.62%,PSMB9
prerank,GO_Biological_Process_2021__lytic vacuole organization (GO:0080171),-0.3085483051439148,-0.6222514026600309,0.9726027397260274,1.0,1.0,9/31,24.32%,ACP3;GRN;HOOK2;SNAPIN;ACP4;TPP1;HPS4;VPS18;ACP2
prerank,Reactome_2022__Diseases Of Programmed Cell Death R-HSA-9645723,0.2629433861052839,0.6217168973342734,1.0,1.0,1.0,9/49,15.44%,LMNB1;DNMT1;CAPN2;H2BC21;ERC2;TANK;FADD;H2AX;TP53
prerank,Reactome_2022__Signaling By WNT In Cancer R-HSA-4791275,0.27516060576294965,0.6215208215767875,1.0,1.0,1.0,4/29,11.36%,LRP6;WNT3A;CTBP2;PPP2R1B
prerank,GO_Biological_Process_2021__carnitine transport (GO:0015879),-0.3951929818279092,-0.6211991363965627,0.9375,1.0,1.0,2/5,14.51%,PDZK1;SLC22A4
prerank,KEGG_2021_Human__One carbon pool by folate,0.3027686479550111,0.6211431759330754,0.9666666666666667,1.0,1.0,4/18,18.77%,DHFR;MTR;MTHFR;SHMT2
prerank,GO_Biological_Process_2021__nephron tubule development (GO:0072080),0.39400591671291507,0.6209120520532952,0.8444444444444444,1.0,1.0,1/5,6.85%,OSR1
prerank,Reactome_2022__RUNX1 Regulates Genes Involved In Megakaryocyte Differentiation And Platelet Function R-HSA-8936459,-0.29346157156776354,-0.6206241210279927,0.9866666666666667,1.0,1.0,6/45,12.66%,GP1BA;H2BC4;ZFPM1;THBS1;ITGA2B;H2AZ1
prerank,GO_Biological_Process_2021__blood vessel diameter maintenance (GO:0097746),-0.2979108463384174,-0.620360012746332,0.9454545454545454,1.0,1.0,7/26,19.87%,GPER1;HTR2B;EDNRB;AGT;F2RL1;SCPEP1;ACE2
prerank,GO_Biological_Process_2021__positive regulation of T cell mediated immunity (GO:0002711),0.2788171965809664,0.6202018527319256,1.0,1.0,1.0,6/26,16.08%,FZD5;HLA-DRA;ZBTB1;FADD;IL23A;MALT1
prerank,GO_Biological_Process_2021__cytoskeleton-dependent cytokinesis (GO:0061640),0.231830304650017,0.6201402825493337,1.0,1.0,1.0,13/67,18.96%,SNX18;SEPTIN10;SPAST;RAB35;KIF4B;SPIRE2;SNX9;SEPTIN9;SEPTIN8;ESPL1;ARL3;BIN3;STAMBP
prerank,Reactome_2022__Apoptosis Induced DNA Fragmentation R-HSA-140342,-0.35059672271229225,-0.6199379787038005,0.9523809523809523,1.0,1.0,2/11,12.80%,H1-0;H1-3
prerank,GO_Biological_Process_2021__retinal cone cell differentiation (GO:0042670),-0.4167420380370501,-0.6196787832254692,0.9047619047619048,1.0,1.0,2/5,16.36%,RP1;USH1C
prerank,GO_Biological_Process_2021__retinal cone cell development (GO:0046549),-0.4167420380370501,-0.6196787832254692,0.9047619047619048,1.0,1.0,2/5,16.36%,RP1;USH1C
prerank,GO_Biological_Process_2021__regulation of bile acid metabolic process (GO:1904251),-0.4017897073090719,-0.619275115091944,0.8870967741935484,1.0,1.0,4/5,21.83%,NR1H4;FGFR4;ABCB11;PANK2
prerank,Reactome_2022__HIV Life Cycle R-HSA-162587,0.21991849975295633,0.6190201482773283,1.0,1.0,1.0,25/137,22.33%,NUP210;NUP42;MVB12A;TAF3;CHMP6;TAF12;UBAP1;AAAS;ELOA;CCNH;SGIP1;VTA1;GTF2F2;FURIN;LIG4;TAF4;ERCC3;RANBP2;NMT2;XPO1;MVB12B;NUP214;POLR2F;TSG101;TPR
prerank,GO_Biological_Process_2021__regulation of protein localization to cell surface (GO:2000008),-0.29914549435035825,-0.6186499576631822,0.9846153846153847,1.0,1.0,1/29,2.76%,CAV3
prerank,GO_Biological_Process_2021__Ras protein signal transduction (GO:0007265),0.2291109055409802,0.6185943167676167,1.0,1.0,1.0,25/130,19.27%,KSR1;CDH13;RALB;DNMT1;RRAS2;RAPGEF1;RALA;RAP2A;MYO9B;FARP2;PHACTR4;EPS8L2;RAP1A;EPS8;NF1;TP53;BRAP;CRKL;RIT2;RAPGEF3;LIMK1;RASSF1;ELMO1;ARHGAP5;SOS1
prerank,GO_Biological_Process_2021__mucosal immune response (GO:0002385),-0.36810567711831405,-0.618437383306499,0.9710144927536232,1.0,1.0,2/8,14.17%,BPIFB1;NOS2
prerank,CellMarker_Augmented_2021__Embryonic Stem cell:Germ,-0.37332330870287617,-0.6183248664069604,0.9655172413793104,1.0,1.0,2/10,17.21%,ABCG2;CD24
prerank,GO_Biological_Process_2021__negative regulation of B cell activation (GO:0050869),-0.33910187531505576,-0.617663277498436,0.9166666666666666,1.0,1.0,1/14,2.65%,BLK
prerank,Reactome_2022__Free Fatty Acids Regulate Insulin Secretion R-HSA-400451,0.30890602235522996,0.6176558589428983,0.9361702127659575,1.0,1.0,6/10,28.50%,PLCB1;GNAQ;GNA11;PLCB3;GNA14;ACSL4
prerank,GO_Biological_Process_2021__ketone body metabolic process (GO:1902224),-0.36577342008832286,-0.6173182293103833,0.8983050847457628,1.0,1.0,2/9,19.10%,ACSS3;SLC27A5
prerank,GO_Biological_Process_2021__regulation of protein sumoylation (GO:0033233),0.3028920143319866,0.6169176684563571,1.0,1.0,1.0,5/14,26.98%,GNL3L;HDAC4;RASD2;EGR1;SAE1
prerank,GO_Biological_Process_2021__regulation of protein processing (GO:0070613),-0.30225492876285426,-0.6165630120682776,0.9605263157894737,1.0,1.0,3/21,11.29%,TNP1;NLRC4;USP17L2
prerank,GO_Biological_Process_2021__mitotic cytokinesis (GO:0000281),0.24932414982737008,0.6163181005981072,0.96875,1.0,1.0,8/45,16.34%,SNX18;CNTROB;SPAST;RAB35;KIF4B;SNX9;ESPL1;ARL3
prerank,Reactome_2022__HIV Infection R-HSA-162906,-0.23009517006212027,-0.6162783156414687,1.0,1.0,1.0,38/210,26.68%,PSMB9;HCK;GTF2E1;TAF7;DOCK2;HLA-A;TAF7L;TAF9B;TAF10;RBX1;CD4;TAF6;PSMA3;CD8B;RPS27A;NMT1;PSMA7;PSMB6;RNMT;HMGA1;NUP93;SEC13;PSMA5;TAF13;TBP;POLR2B;ELOB;TAF5;PSMD6;CDK7;SKP1;CDK9;PSMC5;RNASE1;NDC1;PSMB4;XRCC6;CHMP4B
prerank,GO_Biological_Process_2021__post-transcriptional gene silencing by RNA (GO:0035194),0.2686399350555376,0.6162351017830976,1.0,1.0,1.0,7/19,22.12%,MOV10;TNRC6C;TNRC6A;AGO3;AGO2;CNOT6;NRDE2
prerank,KEGG_2021_Human__Thermogenesis,-0.23362094125120808,-0.6162214071190837,1.0,1.0,1.0,24/183,17.09%,COX6A1;ACSL5;ACTL6A;ACTG1;ATP5F1E;NDUFS2;COX6C;ATP5MC3;UCP1;ATP5PF;COX17;COX7A1;NDUFA2;NDUFB4;NDUFC1;ADCY7;SMARCE1;COX7C;NDUFA1;ACSL3;NDUFB9;ATP5ME;COX7A2;COX20
prerank,GO_Biological_Process_2021__ketone body biosynthetic process (GO:0046951),-0.366280058550021,-0.6158968753927108,0.9166666666666666,1.0,1.0,2/8,19.10%,ACSS3;SLC27A5
prerank,GO_Biological_Process_2021__regulation of histone H4 acetylation (GO:0090239),-0.3847015754965052,-0.6157443313328973,0.9672131147540983,1.0,1.0,2/8,10.89%,TAF7;SPI1
prerank,Reactome_2022__RUNX1 Regulates Transcription Of Genes Involved In BCR Signaling R-HSA-8939245,-0.3819592591408101,-0.6157369139925551,0.9016393442622951,1.0,1.0,1/6,2.65%,BLK
prerank,GO_Biological_Process_2021__death-inducing signaling complex assembly (GO:0071550),0.3700845220900665,0.6154303295554456,0.85,1.0,1.0,1/6,12.94%,FADD
prerank,GO_Biological_Process_2021__protein localization to membrane raft (GO:1903044),-0.39945115971563816,-0.6154036296014738,0.9038461538461539,1.0,1.0,3/5,32.97%,FLOT1;RFTN1;CAV1
prerank,GO_Biological_Process_2021__amyloid fibril formation (GO:1990000),-0.271798704854328,-0.6152418758643226,0.9864864864864865,1.0,1.0,5/43,18.03%,TGFBI;UBE2L6;MFGE8;SIAH1;RPS27A
prerank,Reactome_2022__Selective Autophagy R-HSA-9663891,-0.279282587546683,-0.6150365520873433,0.9848484848484849,1.0,1.0,14/54,25.97%,PINK1;TOMM20;HSPA8;TOMM7;DYNLL1;VDAC1;RPS27A;EPAS1;FUNDC1;DYNLL2;PGAM5;CSNK2A2;PARK7;ULK1
prerank,GO_Biological_Process_2021__regulation of actin cytoskeleton reorganization (GO:2000249),-0.2984190492511881,-0.6148006544067256,0.9523809523809523,1.0,1.0,6/34,18.74%,HCK;BAIAP2L1;TEK;BAIAP2L2;NTRK3;CSF1R
prerank,GO_Biological_Process_2021__positive regulation of protein catabolic process in the vacuole (GO:1904352),0.3850095306549218,0.6143503520669582,0.8888888888888888,1.0,1.0,2/5,10.59%,LDLR;RNF128
prerank,GO_Biological_Process_2021__sensory perception of bitter taste (GO:0050913),-0.3561163195787552,-0.6140938359161313,0.9180327868852459,1.0,1.0,4/11,24.09%,GNAT3;RTP5;GNAT2;RTP1
prerank,"Reactome_2022__Sensory Perception Of Sweet, Bitter, And Umami (Glutamate) Taste R-HSA-9717207",-0.3319506648541308,-0.614037863681488,0.9344262295081968,1.0,1.0,6/19,23.88%,GNAT3;ITPR3;TAS1R1;GNG13;PLCB2;SCN4B
prerank,Reactome_2022__TRAF6 Mediated NF-kB Activation R-HSA-933542,-0.2879409932007456,-0.613715095286378,0.9230769230769231,1.0,1.0,2/22,7.07%,TRIM25;NFKB2
prerank,GO_Biological_Process_2021__negative regulation of cyclin-dependent protein kinase activity (GO:1904030),0.29591052496912457,0.6136802633628479,1.0,1.0,1.0,8/21,24.20%,HEXIM2;LATS1;NR2F2;MEN1;PTEN;TFAP4;PLK1;IPO7
prerank,GO_Biological_Process_2021__positive regulation by host of viral genome replication (GO:0044829),0.3914361879157222,0.613602143658334,0.9142857142857143,1.0,1.0,1/5,10.61%,PPIB
prerank,KEGG_2021_Human__Pancreatic cancer,-0.26331945675046303,-0.6135067050052431,1.0,1.0,1.0,10/74,17.19%,TGFB1;CCND1;STAT1;PIK3R3;CDKN1A;PIK3CB;TGFB3;SMAD3;RAC2;RAC1
prerank,GO_Biological_Process_2021__positive regulation of proteasomal ubiquitin-dependent protein catabolic process (GO:0032436),-0.26567026234674473,-0.6134183695963926,0.9859154929577465,1.0,1.0,9/72,20.12%,ARIH2;DAB2;CLU;RBX1;STUB1;NOP53;RNF144B;RFPL1;HERPUD1
prerank,GO_Biological_Process_2021__regulation of phosphoprotein phosphatase activity (GO:0043666),0.25651461358722466,0.6132837027462756,0.96875,1.0,1.0,4/30,12.99%,MAGI2;BOD1L1;STYXL1;PPP1R15B
prerank,Reactome_2022__Adaptive Immune System R-HSA-1280218,-0.22073026315744146,-0.613180412667602,1.0,1.0,1.0,70/591,19.12%,MICB;PSMB9;ARIH2;ITGB2;BLK;TRAIP;PDCD1LG2;KLRB1;UBE2L6;HLA-DMA;FBXL7;CD160;OSCAR;ICAM3;INPP5D;HLA-A;WAS;FBXL13;ASB14;RNF213;PIK3R3;UBE2U;UBE3A;ERAP2;SNAP23;CYBA;HLA-DRB1;PTPRC;DCTN1;BTN3A3;TLR2;BLNK;HLA-DPA1;DYNLL1;ATG14;CD300LF;PIK3CB;SH2D1B;ASB5;COLEC12;NDUFA2;CD80;FBXO40;ORAI1;ITPR3;CCNF;HLA-F;KLHL2;RBX1;CD4;SIAH1;PSMA3;ITGB5;VASP;BTNL9;LAIR2;CD8B;CALM1;RPS27A;NFATC2;KIF18A;STUB1;FBXL18;ERAP1;CLEC1B;CD81;RNF144B;PSMA7;PSMB6;CRTAM
prerank,GO_Biological_Process_2021__DNA damage checkpoint signaling (GO:0000077),-0.3093370435587618,-0.61302349381115,0.9672131147540983,1.0,1.0,3/29,15.70%,DONSON;RAD1;TIPRL
prerank,GO_Biological_Process_2021__mitochondrial respiratory chain complex assembly (GO:0033108),-0.257930768764677,-0.6126994858996787,0.987012987012987,1.0,1.0,14/76,22.05%,NDUFS2;COX17;TMEM126A;NDUFA2;NDUFB4;NDUFC1;NDUFA1;NDUFB9;COX20;CHCHD4;NDUFB10;NDUFS5;NDUFB11;NDUFAF5
prerank,CellMarker_Augmented_2021__Neuroendocrine cell:Lung,-0.26593676056309695,-0.6126776516196153,0.9864864864864865,1.0,1.0,4/66,8.67%,POU2F3;TOMM20;ADA;ANXA1
prerank,CellMarker_Augmented_2021__Brush Cell (Tuft cell):Lung,-0.26593676056309695,-0.6126776516196153,0.9864864864864865,1.0,1.0,4/66,8.67%,POU2F3;TOMM20;ADA;ANXA1
prerank,GO_Biological_Process_2021__succinate transport (GO:0015744),-0.3999856929352695,-0.6126514165717429,0.8787878787878788,1.0,1.0,1/6,23.32%,SLC25A11
prerank,GO_Biological_Process_2021__regulation of p38MAPK cascade (GO:1900744),0.25573565867013165,0.6124266117054934,0.9696969696969697,1.0,1.0,9/31,26.51%,LGALS9;GDF6;MFHAS1;GADD45A;RELL1;DLG1;BMP2;EMC10;RELL2
prerank,GO_Biological_Process_2021__negative regulation of pathway-restricted SMAD protein phosphorylation (GO:0060394),0.3504784902954549,0.6124003261466754,0.868421052631579,1.0,1.0,5/7,26.53%,GREM1;PMEPA1;EMILIN1;SMAD7;SNX25
prerank,Reactome_2022__Abortive Elongation Of HIV-1 Transcript In Absence Of Tat R-HSA-167242,0.27616831442571244,0.6121725499990209,0.9696969696969697,1.0,1.0,2/22,22.28%,GTF2F2;POLR2F
prerank,GO_Biological_Process_2021__positive regulation of cytokine-mediated signaling pathway (GO:0001961),-0.2925995131025466,-0.6118705534462658,1.0,1.0,1.0,5/28,13.42%,WNT5A;IL7;TXK;C1QTNF4;CD300LF
prerank,GO_Biological_Process_2021__toxin transport (GO:1901998),0.3521911889240574,0.6118688748144616,0.8723404255319149,1.0,1.0,3/9,18.66%,ANTXR2;ANTXR1;ADAM10
prerank,GO_Biological_Process_2021__aortic valve morphogenesis (GO:0003180),0.30582059770099956,0.611698083746024,0.9714285714285714,1.0,1.0,5/26,9.01%,ROBO2;JAG1;SLIT2;TWIST1;SNAI2
prerank,GO_Biological_Process_2021__regulation of cellular protein metabolic process (GO:0032268),-0.2774345916300359,-0.6116780339326836,1.0,1.0,1.0,6/44,16.92%,TGFB1;PLA2G10;RBM4B;EDNRB;AGT;METTL18
prerank,KEGG_2021_Human__Protein export,0.29919443928523015,0.6114731046165903,0.95,1.0,1.0,2/23,6.40%,IMMP2L;IMMP1L
prerank,KEGG_2021_Human__Aldosterone-regulated sodium reabsorption,-0.29230392226332025,-0.6114550149156506,0.9848484848484849,1.0,1.0,7/29,22.45%,ATP1A4;PIK3R3;PIK3CB;SCNN1A;SCNN1G;ATP1A1;HSD11B2
prerank,GO_Biological_Process_2021__anterior/posterior axis specification (GO:0009948),0.32627743579973156,0.6114392906740054,0.9142857142857143,1.0,1.0,3/10,17.21%,FZD5;WLS;SKI
prerank,GO_Biological_Process_2021__calcitonin family receptor signaling pathway (GO:0097646),0.40873049117617044,0.6111159253280724,0.868421052631579,1.0,1.0,2/5,29.59%,IAPP;RAMP1
prerank,GO_Biological_Process_2021__protein trimerization (GO:0070206),0.3298838791695028,0.6108897322826471,0.9285714285714286,1.0,1.0,2/10,14.06%,CLYBL;PNPT1
prerank,GO_Biological_Process_2021__protein homotrimerization (GO:0070207),0.3298838791695028,0.6108897322826471,0.9285714285714286,1.0,1.0,2/10,14.06%,CLYBL;PNPT1
prerank,"GO_Biological_Process_2021__endonucleolytic cleavage of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000479)",0.32650286501555204,0.6108548022830491,0.967741935483871,1.0,1.0,4/13,27.54%,NOP9;NOP14;TBL3;RRS1
prerank,GO_Biological_Process_2021__negative regulation of oligodendrocyte differentiation (GO:0048715),0.367447585137165,0.6107369208962531,0.9545454545454546,1.0,1.0,3/7,16.67%,HES1;NF1;NOTCH1
prerank,GO_Biological_Process_2021__positive regulation of translation (GO:0045727),-0.25666202815810274,-0.6104921355351474,0.9861111111111112,1.0,1.0,12/90,16.56%,BOLL;EIF6;DAZL;MPV17L2;THBS1;RPS4X;RPS9;EEF2;DDX3X;METTL14;RCC1L;EIF2S3
prerank,Reactome_2022__Keratan Sulfate Degradation R-HSA-2022857,-0.37404793103054723,-0.6103880981743196,0.90625,1.0,1.0,2/8,10.43%,OGN;OMD
prerank,GO_Biological_Process_2021__positive regulation of protein localization to plasma membrane (GO:1903078),-0.2766621035886989,-0.6102721790669058,1.0,1.0,1.0,2/48,5.18%,STAC;GPER1
prerank,GO_Biological_Process_2021__regulation of sensory perception of pain (GO:0051930),0.3060381176176438,0.6102677296468974,0.9487179487179487,1.0,1.0,2/11,12.32%,F2R;ATPSCKMT
prerank,GO_Biological_Process_2021__response to laminar fluid shear stress (GO:0034616),0.3432614108940726,0.6096802212093174,0.8918918918918919,1.0,1.0,4/9,22.74%,ABCA1;SREBF2;SMAD7;NFE2L2
prerank,GO_Biological_Process_2021__regulation of cell cycle phase transition (GO:1901987),-0.2558277684174971,-0.6094156591270914,1.0,1.0,1.0,1/84,0.62%,PSMB9
prerank,GO_Biological_Process_2021__G protein-coupled opioid receptor signaling pathway (GO:0038003),0.40599831170913214,0.6093464288029281,0.9111111111111111,1.0,1.0,2/5,18.92%,OPRD1;OPRK1
prerank,GO_Biological_Process_2021__protein polyubiquitination (GO:0000209),-0.22737606939643143,-0.6093037921081915,1.0,1.0,1.0,13/287,8.64%,PSMB9;ARIH2;TRIM62;PRAME;DTL;TRIM5;UBE2L6;FBXL7;FBXL13;RNF213;UBE2U;BRCA1;UBE3A
prerank,Reactome_2022__Pyrimidine Salvage R-HSA-73614,0.3298626364612453,0.6089885040539743,0.8947368421052632,1.0,1.0,4/11,24.51%,UPP2;UCK2;PUDP;CDA
prerank,Reactome_2022__Cyclin D Associated Events In G1 R-HSA-69231,-0.28796759675873057,-0.6088083677823997,0.9848484848484849,1.0,1.0,7/43,18.03%,CCND1;CCND2;CDKN2D;CDKN1A;CCNE2;CKS1B;RPS27A
prerank,GO_Biological_Process_2021__rDNA heterochromatin assembly (GO:0000183),0.3395923264100233,0.6087187365474299,0.9130434782608695,1.0,1.0,1/8,4.59%,SIRT1
prerank,GO_Biological_Process_2021__regulation of cytokine-mediated signaling pathway (GO:0001959),-0.27677864611037073,-0.6087135492683484,1.0,1.0,1.0,11/61,19.41%,STAT1;IL7;PTPRC;PALM3;IFNGR2;HIPK1;CDC37;CD24;SPATA2;AXL;CASP8
prerank,GO_Biological_Process_2021__negative regulation of catabolic process (GO:0009895),-0.2831848843717485,-0.6085578778616773,0.9848484848484849,1.0,1.0,2/36,8.70%,ACTN3;AZIN1
prerank,GO_Biological_Process_2021__negative regulation of voltage-gated calcium channel activity (GO:1901386),0.3382295325757085,0.608270258115633,0.9705882352941176,1.0,1.0,1/9,7.29%,DRD4
prerank,GO_Biological_Process_2021__pyrimidine nucleoside salvage (GO:0043097),0.31590723599764325,0.6078216914388465,0.9210526315789473,1.0,1.0,4/11,24.51%,UPP2;UCK2;PUDP;CDA
prerank,GO_Biological_Process_2021__pyrimidine-containing compound salvage (GO:0008655),0.31590723599764325,0.6078216914388465,0.9210526315789473,1.0,1.0,4/11,24.51%,UPP2;UCK2;PUDP;CDA
prerank,Reactome_2022__Caspase-mediated Cleavage Of Cytoskeletal Proteins R-HSA-264870,0.30402465463294404,0.6076347470247621,0.95,1.0,1.0,3/12,12.36%,CASP3;PLEC;GAS2
prerank,GO_Biological_Process_2021__pexophagy (GO:0000425),0.41181405880205013,0.6076027636231768,0.9333333333333333,1.0,1.0,1/7,16.83%,ATM
prerank,GO_Biological_Process_2021__protein targeting to lysosome (GO:0006622),0.2941353598994708,0.6075402939288048,0.9722222222222222,1.0,1.0,3/20,9.67%,RAB7A;GCC2;ZFYVE16
prerank,Reactome_2022__Cellular Responses To Stress R-HSA-2262752,-0.2187320668272613,-0.6073504677596678,1.0,1.0,1.0,111/627,22.32%,GML;PSMB9;COX6A1;HSPA1L;RPL37A;TERF2IP;ATP6V1G2;RPA3;MAPKAPK3;CBX8;NQO1;H1-0;H2BC4;ATP6V1C2;ATP6V1D;RPL38;DEPDC5;RPL15;COX6C;CYBA;ID1;DNAJA1;ATP6V0E2;DCTN1;ATF5;CRYBA4;CDKN2D;HSPA8;RPS4X;CDKN1A;RPL3;RRAGA;STAP2;H2AZ1;RPL35A;GPX3;H1-3;WFS1;NFYB;NLRP3;DYNLL1;RPS9;FAU;RPS27;GPX2;RBBP7;RPS21;COX7C;ATP6V1E1;CCNE2;TXNIP;RBX1;RPL13A;COL4A6;PSMA3;RPL27A;EIF2S3;ATOX1;RPS16;RPL36;RPS20;RPL7A;COX20;RPL9;EIF2S2;RPS8;RPS27A;KDELR3;RPL21;DNAJB1;CAMK2A;HMGA2;MAFK;EXOSC8;HSPH1;CLEC1B;RPL34;COX4I1;PSMA7;EPAS1;PSMB6;RPL4;RPL32;RPL5;DAND5;RPL23;RPL41;RPS7;HMGA1;RPS11;NUP93;RPL27;RPL35;DNAJC2;HERPUD1;HSPA4;PRDX1;RPS14;RPL11;HSPA5;SEC13;TALDO1;RPS15;ALB;CDKN1B;DDX11;EXOSC2;PSMA5;WTIP;WDR24;RPLP1
prerank,GO_Biological_Process_2021__sarcomere organization (GO:0045214),-0.31464195627728003,-0.607312744228927,0.9545454545454546,1.0,1.0,3/20,14.24%,OBSCN;CSRP3;TTN
prerank,GO_Biological_Process_2021__collagen-activated signaling pathway (GO:0038065),-0.37146558077610775,-0.606988801648502,0.9841269841269841,1.0,1.0,3/9,17.85%,COL1A1;COL4A6;OTOL1
prerank,Reactome_2022__Amyloid Fiber Formation R-HSA-977225,0.25067630994964596,0.6069034115507203,1.0,1.0,1.0,5/47,9.75%,APOE;SNCAIP;SNCA;H2BC21;GGA1
prerank,GO_Biological_Process_2021__positive regulation of transcription initiation from RNA polymerase II promoter (GO:0060261),-0.3143592481502168,-0.6064478723513227,0.9850746268656716,1.0,1.0,2/22,10.05%,ESR1;HNF1A
prerank,GO_Biological_Process_2021__negative regulation of bone resorption (GO:0045779),-0.3954519284096911,-0.6063718531160279,0.9818181818181818,1.0,1.0,1/5,13.18%,CARTPT
prerank,Reactome_2022__mRNA Capping R-HSA-72086,0.2780684193257889,0.6061105220558946,0.9655172413793104,1.0,1.0,4/28,22.28%,CCNH;GTF2F2;ERCC3;POLR2F
prerank,GO_Biological_Process_2021__positive regulation of inflammatory response (GO:0050729),-0.26281293494435537,-0.6060851626989674,0.9859154929577465,1.0,1.0,11/57,20.22%,WNT5A;NLRP12;OSMR;TLR2;IL18;ZP3;AGT;GRN;IFI35;CD81;VAMP7
prerank,Reactome_2022__CD209 (DC-SIGN) Signaling R-HSA-5621575,-0.3250848962491155,-0.6060726323373876,0.9117647058823529,1.0,1.0,1/16,7.01%,ICAM3
prerank,Reactome_2022__G0 And Early G1 R-HSA-1538133,0.2795561665574042,0.6059738897849971,0.9259259259259259,1.0,1.0,5/25,13.17%,TOP2A;RBL1;MYC;LIN52;HDAC1
prerank,GO_Biological_Process_2021__oxaloacetate transport (GO:0015729),-0.40919500519549895,-0.6058761430283914,0.9344262295081968,1.0,1.0,1/5,23.32%,SLC25A11
prerank,GO_Biological_Process_2021__positive regulation of mitochondrial membrane potential (GO:0010918),-0.4039399117853127,-0.6056940320584947,0.9473684210526315,1.0,1.0,1/6,9.90%,STOML2
prerank,Reactome_2022__Cooperation Of PDCL (PhLP1) And TRiC/CCT In G-protein Beta Folding R-HSA-6814122,-0.28602246598113784,-0.6047116102687592,1.0,1.0,1.0,13/31,29.93%,GNGT1;CCT6B;PDCL;GNA15;GNG13;GNG12;CSNK2A2;CCT6A;GNG4;CCT8;CCT7;CCT2;GNG3
prerank,GO_Biological_Process_2021__response to potassium ion (GO:0035864),0.3802169262803124,0.6041251521781862,0.9622641509433962,1.0,1.0,2/6,21.82%,DLG2;CARF
prerank,GO_Biological_Process_2021__cellular response to potassium ion (GO:0035865),0.3802169262803124,0.6041251521781862,0.9622641509433962,1.0,1.0,2/6,21.82%,DLG2;CARF
prerank,GO_Biological_Process_2021__monocarboxylic acid catabolic process (GO:0072329),-0.32031795778897654,-0.6039185199854493,0.9411764705882353,1.0,1.0,3/20,14.39%,CYP26B1;CYP4F12;HAO2
prerank,Reactome_2022__Cellular Response To Chemical Stress R-HSA-9711123,-0.23496696503861472,-0.6034739166244962,1.0,1.0,1.0,20/155,19.11%,PSMB9;COX6A1;NQO1;COX6C;CYBA;STAP2;GPX3;NLRP3;GPX2;COX7C;TXNIP;RBX1;PSMA3;ATOX1;COX20;RPS27A;MAFK;COX4I1;PSMA7;PSMB6
prerank,GO_Biological_Process_2021__Golgi to lysosome transport (GO:0090160),0.32021445871884935,0.6034665703953093,0.972972972972973,1.0,1.0,5/11,35.81%,LAPTM5;EHD3;CCDC91;CLN3;ANKFY1
prerank,Reactome_2022__Signaling By EGFR In Cancer R-HSA-1643713,0.2736898557876575,0.6032660019995412,0.9,1.0,1.0,5/20,26.09%,TGFA;PIK3CA;SOS1;CBL;BTC
prerank,GO_Biological_Process_2021__positive regulation of lyase activity (GO:0051349),0.30992162389447186,0.6029523416917937,0.9743589743589743,1.0,1.0,2/11,13.81%,DRD5;NF1
prerank,GO_Biological_Process_2021__neuron projection maintenance (GO:1990535),0.36677297557886124,0.6029190512333061,0.9210526315789473,1.0,1.0,2/8,14.95%,ABCD2;INSR
prerank,Reactome_2022__Lewis Blood Group Biosynthesis R-HSA-9037629,-0.33300541102054615,-0.6022791629798191,0.9523809523809523,1.0,1.0,2/10,16.01%,FUT2;B4GALNT2
prerank,Reactome_2022__Negative Epigenetic Regulation Of rRNA Expression R-HSA-5250941,0.25100791069972844,0.6017663757818528,1.0,1.0,1.0,9/58,13.73%,SIRT1;DNMT1;H2BC21;TAF1B;CCNH;SAP130;POLR1H;HDAC1;H2AX
prerank,Reactome_2022__trans-Golgi Network Vesicle Budding R-HSA-199992,-0.25896508278043845,-0.6016793675418509,0.9863013698630136,1.0,1.0,6/64,11.92%,SNAP23;CTSZ;FTH1;TPD52L1;DNASE2;HSPA8
prerank,GO_Biological_Process_2021__insulin secretion (GO:0030073),0.305985486810784,0.601418809022924,0.96875,1.0,1.0,3/15,16.83%,CYB5R4;RIMS2;RAB11B
prerank,GO_Biological_Process_2021__protein auto-ADP-ribosylation (GO:0070213),0.3463285145142342,0.6013426404645482,0.9285714285714286,1.0,1.0,6/12,33.42%,PARP11;PARP6;PARP16;TIPARP;TNKS2;TNKS
prerank,GO_Biological_Process_2021__protein insertion into ER membrane by stop-transfer membrane-anchor sequence (GO:0045050),0.2970003138545539,0.6011173260730389,0.9487179487179487,1.0,1.0,4/10,26.02%,EMC2;EMC4;EMC8;EMC10
prerank,GO_Biological_Process_2021__fatty-acyl-CoA metabolic process (GO:0035337),0.29195593320380686,0.6009395723928485,0.975,1.0,1.0,3/19,12.69%,SCD5;SLC25A1;ACSM2A
prerank,GO_Biological_Process_2021__regulation of cell adhesion molecule production (GO:0060353),-0.3721640249182094,-0.600934837952338,0.96,1.0,1.0,4/6,32.99%,COLEC12;FLOT1;CAV1;APOA1
prerank,GO_Biological_Process_2021__regulation of granulocyte differentiation (GO:0030852),-0.3852842512972075,-0.6008127536348095,0.9583333333333334,1.0,1.0,2/7,13.80%,CEACAM1;LEF1
prerank,Reactome_2022__TYSND1 Cleaves Peroxisomal Proteins R-HSA-9033500,0.3525487630017243,0.6005489154706274,0.8974358974358975,1.0,1.0,1/7,18.13%,ACOX1
prerank,Reactome_2022__NOTCH4 Intracellular Domain Regulates Transcription R-HSA-9013695,-0.3063144291616628,-0.6003158927872605,0.9701492537313433,1.0,1.0,4/20,16.15%,FLT4;HEY2;ACTA2;SMAD3
prerank,GO_Biological_Process_2021__negative regulation of protein import (GO:1904590),-0.39238700806567606,-0.6001597485227005,0.9333333333333333,1.0,1.0,1/7,12.51%,APOD
prerank,GO_Biological_Process_2021__negative regulation of protein import into nucleus (GO:0042308),-0.39238700806567606,-0.6001597485227005,0.9333333333333333,1.0,1.0,1/7,12.51%,APOD
prerank,GO_Biological_Process_2021__detection of chemical stimulus involved in sensory perception of bitter taste (GO:0001580),-0.3568877396871498,-0.6000570655262406,0.9193548387096774,1.0,1.0,4/10,24.09%,GNAT3;RTP5;GNAT2;RTP1
prerank,GO_Biological_Process_2021__regulation of epidermis development (GO:0045682),-0.3712373940956276,-0.5996959213768599,0.9454545454545454,1.0,1.0,1/7,13.52%,TMEM79
prerank,GO_Biological_Process_2021__response to exogenous dsRNA (GO:0043330),-0.31036311849470055,-0.5995569552176188,0.9818181818181818,1.0,1.0,3/18,13.95%,IFNK;IFIT1;COLEC12
prerank,GO_Biological_Process_2021__protein K63-linked deubiquitination (GO:0070536),-0.28932068620728446,-0.5994095195550694,0.971830985915493,1.0,1.0,4/30,11.29%,ABRAXAS1;USP13;USP50;USP17L2
prerank,KEGG_2021_Human__RNA polymerase,-0.2839281524228958,-0.5991439299639246,0.9701492537313433,1.0,1.0,4/29,23.36%,POLR1C;POLR3H;POLR1E;POLR2B
prerank,Reactome_2022__Organic Cation Transport R-HSA-549127,0.36924489150628836,0.5987649402155428,0.9142857142857143,1.0,1.0,3/7,15.67%,SLC22A5;SLC22A15;RUNX1
prerank,Reactome_2022__Disinhibition Of SNARE Formation R-HSA-114516,0.377212075328854,0.598700332690474,0.926829268292683,1.0,1.0,5/5,62.29%,STXBP3;PRKCA;STX4;PRKCB;PRKCG
prerank,KEGG_2021_Human__RIG-I-like receptor signaling pathway,0.2286589573989569,0.5983505217166233,1.0,1.0,1.0,14/47,24.41%,TBKBP1;MAPK8;MAP3K1;TANK;FADD;NFKB1;MAPK12;OTUD5;SIKE1;TRAF6;STING1;ATG12;IKBKB;TRAF3
prerank,Reactome_2022__Interleukin-1 Family Signaling R-HSA-446652,0.2041055955362013,0.5983052412369125,1.0,1.0,1.0,19/124,15.44%,RIPK2;PSME4;SEM1;HMGB1;PSMA1;MAPK8;ALPK1;PTPN9;N4BP1;PTPN20;TANK;NKIRAS2;TAB3;PELI1;NFKB1;PTPN23;PELI2;IRAK4;TP53
prerank,GO_Biological_Process_2021__response to acidic pH (GO:0010447),-0.3529350306710448,-0.5980861901186417,0.9696969696969697,1.0,1.0,2/12,20.24%,GPR151;PKD1L3
prerank,GO_Biological_Process_2021__epithelial cell differentiation involved in kidney development (GO:0035850),0.3588958638034178,0.5980205196973107,0.9318181818181818,1.0,1.0,3/6,31.77%,BMP4;MEF2C;SALL1
prerank,GO_Biological_Process_2021__B cell mediated immunity (GO:0019724),0.3515176591841537,0.597680965736035,0.8974358974358975,1.0,1.0,2/6,18.91%,CARD9;SLA2
prerank,"GO_Biological_Process_2021__maturation of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000466)",-0.2868907922928251,-0.5973453454362588,0.9846153846153847,1.0,1.0,5/21,22.14%,RPS21;ERI2;WDR12;EXOSC8;EXOSC2
prerank,Reactome_2022__PTK6 Expression R-HSA-8849473,0.39287008117916344,0.5972372157615263,0.9333333333333333,1.0,1.0,2/5,20.51%,NR3C1;HIF1A
prerank,GO_Biological_Process_2021__store-operated calcium entry (GO:0002115),-0.3852011047580731,-0.5970913279298226,0.9180327868852459,1.0,1.0,2/5,23.82%,ORAI1;CRACR2A
prerank,Reactome_2022__Aberrant Regulation Of Mitotic Cell Cycle Due To RB1 Defects R-HSA-9687139,-0.28668865965793466,-0.5970784936840876,0.9857142857142858,1.0,1.0,4/32,15.42%,CCND1;CCND2;CDKN1A;CCNE2
prerank,GO_Biological_Process_2021__short-chain fatty acid metabolic process (GO:0046459),-0.3615797675538605,-0.5966066977321705,0.9342105263157895,1.0,1.0,1/9,9.32%,ACOT4
prerank,GO_Biological_Process_2021__pyrimidine-containing compound biosynthetic process (GO:0072528),-0.36259536068463244,-0.596588661601963,0.9473684210526315,1.0,1.0,2/7,26.51%,PRPS1;CTPS1
prerank,Reactome_2022__Signaling By FGFR2 IIIa TM R-HSA-8851708,0.2880963353067738,0.5965031273640246,0.967741935483871,1.0,1.0,4/19,31.71%,GTF2F2;POLR2F;FGF13;POLR2C
prerank,Reactome_2022__Impaired BRCA2 Binding To PALB2 R-HSA-9709603,-0.30994830003908386,-0.5964134448814122,0.9322033898305084,1.0,1.0,8/23,29.89%,BRCA1;RMI1;BLM;RMI2;XRCC2;BRCA2;KAT5;ARTN
prerank,GO_Biological_Process_2021__amino acid import across plasma membrane (GO:0089718),0.2871206017582331,0.5962791729052226,1.0,1.0,1.0,5/20,19.41%,SLC3A2;SLC6A20;SLC7A8;SLC16A2;SLC1A3
prerank,GO_Biological_Process_2021__embryonic limb morphogenesis (GO:0030326),-0.30027061827399537,-0.5961966733920895,0.9859154929577465,1.0,1.0,1/28,2.44%,CYP26B1
prerank,Reactome_2022__RNA Polymerase I Transcription Termination R-HSA-73863,-0.2744608537824164,-0.5957530746202719,1.0,1.0,1.0,2/29,10.93%,CAVIN1;POLR1G
prerank,GO_Biological_Process_2021__positive regulation of toll-like receptor signaling pathway (GO:0034123),0.260303436636207,0.5957013307182638,0.972972972972973,1.0,1.0,5/22,15.48%,TICAM2;HMGB1;MFHAS1;NR1H3;LBP
prerank,GO_Biological_Process_2021__establishment of protein localization to endoplasmic reticulum (GO:0072599),0.3208653341285445,0.5953420416275719,0.9523809523809523,1.0,1.0,4/17,21.51%,MAN1A1;RAB10;EDEM1;SEC61A1
prerank,GO_Biological_Process_2021__regulation of histone acetylation (GO:0035065),-0.29305504609006394,-0.595109897722988,1.0,1.0,1.0,3/31,10.89%,TAF7;BRCA1;SPI1
prerank,GO_Biological_Process_2021__T cell receptor signaling pathway (GO:0050852),-0.23719797002654697,-0.5944009813112688,1.0,1.0,1.0,16/134,16.16%,PSMB9;TEC;INPP5D;HLA-A;WAS;HLA-DPB1;STOML2;HLA-DRB1;PTPRC;BTN3A3;TXK;HLA-DPA1;PIK3CB;EIF2B2;CD4;PSMA3
prerank,CellMarker_Augmented_2021__Granulosa cell:Ovarian Follicle,-0.40113159503939333,-0.594185890300143,0.9607843137254902,1.0,1.0,2/5,13.13%,GPX3;GLDC
prerank,GO_Biological_Process_2021__histone arginine methylation (GO:0034969),0.32390275882391484,0.5941516417158182,0.9090909090909091,1.0,1.0,3/9,20.14%,CARM1;PRMT5;PRDM4
prerank,GO_Biological_Process_2021__negative regulation of protein modification process (GO:0031400),-0.25443131130650337,-0.5936841993938407,1.0,1.0,1.0,8/77,18.22%,TGFB1;TERF2IP;WARS1;ATG14;CACTIN;ARPP19;BEX4;NTRK3
prerank,GO_Biological_Process_2021__activation of cysteine-type endopeptidase activity involved in apoptotic process by cytochrome c (GO:0008635),-0.38248594762331983,-0.5936721556992375,0.8333333333333334,1.0,1.0,1/5,25.10%,APAF1
prerank,GO_Biological_Process_2021__establishment of protein localization to vacuole (GO:0072666),0.3530762599454855,0.5933542543894692,0.8421052631578947,1.0,1.0,1/5,16.49%,SNF8
prerank,GO_Biological_Process_2021__protein transport to vacuole involved in ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway (GO:0043328),0.3530762599454855,0.5933542543894692,0.8421052631578947,1.0,1.0,1/5,16.49%,SNF8
prerank,GO_Biological_Process_2021__antigen processing and presentation of exogenous peptide antigen via MHC class II (GO:0019886),0.22302211132067562,0.5927609903175152,1.0,1.0,1.0,6/82,9.74%,HLA-DQB1;RAB7A;HLA-DRA;SEC24C;DYNC1I2;CTSV
prerank,GO_Biological_Process_2021__regulation of myoblast differentiation (GO:0045661),-0.30255750828741806,-0.5927206264162386,0.96875,1.0,1.0,1/28,1.49%,TGFB1
prerank,GO_Biological_Process_2021__membrane biogenesis (GO:0044091),-0.36687602849381407,-0.5926119654574953,0.890625,1.0,1.0,2/7,20.93%,SERINC1;TLCD1
prerank,GO_Biological_Process_2021__protein polyglutamylation (GO:0018095),0.33172387844327655,0.5923144790122464,0.9302325581395349,1.0,1.0,3/11,16.99%,TTLL9;CEP41;TTLL1
prerank,GO_Biological_Process_2021__positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770),-0.3896846799705844,-0.5922454518714426,0.9516129032258065,1.0,1.0,1/5,12.50%,TLR2
prerank,GO_Biological_Process_2021__regulation of NAD(P)H oxidase activity (GO:0033860),0.3807440580202405,0.5920965983292601,0.9433962264150944,1.0,1.0,1/5,4.25%,DRD5
prerank,GO_Biological_Process_2021__regulation of vasculogenesis (GO:2001212),-0.3351608780264701,-0.5917938933136259,0.9666666666666667,1.0,1.0,3/12,15.40%,CEACAM1;HEY2;RRAS
prerank,GO_Biological_Process_2021__acylglycerol biosynthetic process (GO:0046463),-0.30746389543476604,-0.5917547127294109,0.9206349206349206,1.0,1.0,3/21,19.64%,DGAT2L6;PLA2G4A;MOGAT1
prerank,GO_Biological_Process_2021__positive regulation of deoxyribonuclease activity (GO:0032077),-0.3988309436276033,-0.5917096806955405,0.9375,1.0,1.0,3/5,27.41%,DDX11;RPS3;PCNA
prerank,Reactome_2022__Intrinsic Pathway For Apoptosis R-HSA-109606,0.25947258450884925,0.5913536227619461,1.0,1.0,1.0,6/48,9.44%,BCL2;PPP1R13B;REXO2;MAPK8;CASP3;AKT2
prerank,GO_Biological_Process_2021__positive regulation of steroid metabolic process (GO:0045940),0.37266703333185386,0.5911355467656015,0.9318181818181818,1.0,1.0,1/6,2.66%,APOE
prerank,Reactome_2022__TP53 Regulates Transcription Of Death Receptors And Ligands R-HSA-6803211,0.3465374218449947,0.5908156143641857,0.8974358974358975,1.0,1.0,2/9,15.44%,PPP1R13B;TP53
prerank,Reactome_2022__Diseases Of Mitotic Cell Cycle R-HSA-9675126,-0.2793461379987802,-0.5907257428259564,0.971830985915493,1.0,1.0,4/34,15.42%,CCND1;CCND2;CDKN1A;CCNE2
prerank,Reactome_2022__Downstream TCR Signaling R-HSA-202424,-0.23594461900567587,-0.5906405968620597,1.0,1.0,1.0,10/77,19.11%,PSMB9;INPP5D;HLA-DRB1;HLA-DPA1;PIK3CB;CD4;PSMA3;RPS27A;PSMA7;PSMB6
prerank,GO_Biological_Process_2021__regulation of calcium ion transport (GO:0051924),0.25104470553293745,0.5906190977660019,1.0,1.0,1.0,8/43,17.22%,BCL2;IL16;PKD2;EPB41;F2R;ANK2;WNK3;STIM2
prerank,GO_Biological_Process_2021__chromatin assembly (GO:0031497),-0.2716634445208242,-0.5905809422969065,0.9876543209876543,1.0,1.0,10/46,21.32%,H1-0;NAP1L2;GRWD1;H1-3;CHAF1A;HMGA2;SMARCA5;H2BC18;POLE3;SOX9
prerank,GO_Biological_Process_2021__heterochromatin assembly (GO:0031507),0.26971308132610156,0.5901867770832093,0.9722222222222222,1.0,1.0,6/20,22.12%,SIRT1;HDAC1;SMCHD1;BAZ2A;BAHD1;NRDE2
prerank,GO_Biological_Process_2021__regulation of insulin secretion involved in cellular response to glucose stimulus (GO:0061178),-0.276387727235141,-0.5898652051837252,0.9841269841269841,1.0,1.0,3/25,14.91%,HLA-DRB1;NR1H4;ABCA12
prerank,GO_Biological_Process_2021__amyloid-beta formation (GO:0034205),0.33952584821182474,0.5896352052345736,0.975609756097561,1.0,1.0,3/7,32.10%,ABCA7;DYRK1A;NCSTN
prerank,GO_Biological_Process_2021__negative regulation of protein maturation (GO:1903318),-0.32921013844590313,-0.5895298634378929,0.9285714285714286,1.0,1.0,2/10,17.79%,USP17L2;ACP4
prerank,GO_Biological_Process_2021__protein maturation (GO:0051604),-0.24798999526406285,-0.5894614636299756,1.0,1.0,1.0,3/81,8.10%,F7;CPM;PHEX
prerank,GO_Biological_Process_2021__positive regulation of viral life cycle (GO:1903902),0.28684368589702236,0.5891425974890047,0.9722222222222222,1.0,1.0,5/21,14.60%,LGALS1;KPNA6;LGALS9;TYRO3;TMPRSS2
prerank,GO_Biological_Process_2021__regulation of monocyte differentiation (GO:0045655),0.3052115136957189,0.5891018399658376,0.925,1.0,1.0,3/13,15.64%,CDK6;MYC;ACIN1
prerank,GO_Biological_Process_2021__vascular associated smooth muscle cell development (GO:0097084),-0.37257333515314606,-0.5883166006413562,0.921875,1.0,1.0,2/6,14.16%,ENG;HEY2
prerank,GO_Biological_Process_2021__positive regulation of cell cycle process (GO:0090068),-0.24390028260588575,-0.5879709786155786,1.0,1.0,1.0,4/77,12.96%,KIF14;GPSM2;SVIL;CXCR5
prerank,GO_Biological_Process_2021__transcription-dependent tethering of RNA polymerase II gene DNA at nuclear periphery (GO:0000972),-0.3612702595846482,-0.5878347268012352,0.9245283018867925,1.0,1.0,3/6,30.69%,RAE1;NUP133;NUP155
prerank,GO_Biological_Process_2021__regulation of natural killer cell proliferation (GO:0032817),-0.3871669160810143,-0.5877977994255209,0.8909090909090909,1.0,1.0,1/6,15.16%,IL18
prerank,GO_Biological_Process_2021__negative regulation of pinocytosis (GO:0048550),-0.3466427497745036,-0.5876977211276725,0.9183673469387755,1.0,1.0,1/5,15.53%,PROM2
prerank,GO_Biological_Process_2021__regulation of fibroblast proliferation (GO:0048145),-0.28389212777433603,-0.5876130141290775,1.0,1.0,1.0,5/40,15.80%,WNT5A;FTH1;CDKN1A;NLRC3;AGT
prerank,GO_Biological_Process_2021__U4 snRNA 3'-end processing (GO:0034475),-0.3523227701078003,-0.5870863330943603,0.9473684210526315,1.0,1.0,2/7,22.14%,EXOSC8;EXOSC2
prerank,"GO_Biological_Process_2021__nuclear-transcribed mRNA catabolic process, exonucleolytic, 3'-5' (GO:0034427)",-0.3523227701078003,-0.5870863330943603,0.9473684210526315,1.0,1.0,2/7,22.14%,EXOSC8;EXOSC2
prerank,GO_Biological_Process_2021__snRNA modification (GO:0040031),0.3714935575462317,0.5870003407748368,0.9387755102040817,1.0,1.0,2/6,23.39%,METTL16;METTL4
prerank,Reactome_2022__ATF6 (ATF6-alpha) Activates Chaperone Genes R-HSA-381183,-0.35849638958265206,-0.5868461874869786,0.9206349206349206,1.0,1.0,2/9,21.19%,NFYB;HSPA5
prerank,Reactome_2022__SIRT1 Negatively Regulates rRNA Expression R-HSA-427359,-0.30338652620083223,-0.5866365121388906,0.9264705882352942,1.0,1.0,3/19,12.66%,SUV39H1;H2BC4;H2AZ1
prerank,GO_Biological_Process_2021__positive regulation of protein deubiquitination (GO:1903003),0.32622108981364406,0.5863029030679034,0.9459459459459459,1.0,1.0,1/6,12.57%,TANK
prerank,GO_Biological_Process_2021__regulation of potassium ion export across plasma membrane (GO:1903764),-0.3790005228908663,-0.5861744976314767,0.9636363636363636,1.0,1.0,1/6,14.89%,KCNE3
prerank,GO_Biological_Process_2021__nucleosome organization (GO:0034728),-0.2590411481990863,-0.5860786419430661,0.9863013698630136,1.0,1.0,15/64,21.32%,H1-0;NAP1L2;TNP1;GRWD1;H1-3;CHAF1A;SMARCE1;ANP32E;SMARCA5;HMGA1;SET;H2BC18;POLE3;BRDT;SOX9
prerank,Reactome_2022__IRAK4 Deficiency (TLR2/4) R-HSA-5603041,-0.3245106670872706,-0.5860301242759863,0.8904109589041096,1.0,1.0,2/10,14.12%,TLR2;NDUFA2
prerank,GO_Biological_Process_2021__intermembrane lipid transfer (GO:0120009),0.3177028606318808,0.5857549311934717,0.9318181818181818,1.0,1.0,4/6,34.67%,CERT1;PLEKHA8;GLTP;CPTP
prerank,GO_Biological_Process_2021__positive regulation of vasculogenesis (GO:2001214),0.336897310849794,0.5856411373903272,0.8974358974358975,1.0,1.0,2/8,12.41%,RIN2;RAP1A
prerank,"GO_Biological_Process_2021__establishment of mitochondrion localization, microtubule-mediated (GO:0034643)",0.37943653885456274,0.5856058056635142,0.925,1.0,1.0,2/6,27.95%,UXT;LRPPRC
prerank,GO_Biological_Process_2021__spliceosomal tri-snRNP complex assembly (GO:0000244),-0.3115795301516223,-0.5854532183199568,0.9841269841269841,1.0,1.0,1/13,11.94%,DDX20
prerank,GO_Biological_Process_2021__regulation of translational initiation (GO:0006446),0.24143180318722024,0.5854160390512285,1.0,1.0,1.0,16/63,22.33%,HSPB1;ATF3;EIF2AK3;EIF3H;PPP1R15B;EIF3E;YTHDF1;DNAJC3;NCK1;EIF4EBP1;IMPACT;KHDRBS1;AGO2;LARP1;NCK2;TPR
prerank,GO_Biological_Process_2021__Fc receptor signaling pathway (GO:0038093),-0.2337888236115556,-0.5852941531376441,1.0,1.0,1.0,3/98,5.08%,PSMB9;VAV3;TEC
prerank,Reactome_2022__Host Interactions Of HIV Factors R-HSA-162909,-0.23734825772938484,-0.5852566742507903,1.0,1.0,1.0,4/121,7.32%,PSMB9;HCK;DOCK2;HLA-A
prerank,GO_Biological_Process_2021__regulation of memory T cell differentiation (GO:0043380),0.3516282565239141,0.585230865300695,0.9047619047619048,1.0,1.0,2/7,15.56%,HLA-DRA;IL23A
prerank,GO_Biological_Process_2021__positive regulation of memory T cell differentiation (GO:0043382),0.3516282565239141,0.585230865300695,0.9047619047619048,1.0,1.0,2/7,15.56%,HLA-DRA;IL23A
prerank,GO_Biological_Process_2021__phosphatidylinositol metabolic process (GO:0046488),-0.23178839481080937,-0.5852218735887891,1.0,1.0,1.0,14/103,20.45%,PLA2G10;PLEKHA4;INPP5D;ARF3;PIK3R3;PLEKHA2;PIK3CB;PIK3C2G;PIK3CG;BMX;PLA2G4A;CSF1R;PLA2G4D;IMPA1
prerank,GO_Biological_Process_2021__negative regulation of striated muscle cell apoptotic process (GO:0010664),-0.3960653040419657,-0.5847076896781447,0.9636363636363636,1.0,1.0,3/6,30.48%,GATA4;NUPR1;BAG3
prerank,"GO_Biological_Process_2021__maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000462)",-0.29600836698992183,-0.5844274676588169,0.9848484848484849,1.0,1.0,6/30,20.56%,PWP2;TSR2;RPS21;RPS16;RPS8;RPS14
prerank,GO_Biological_Process_2021__regulation of endoplasmic reticulum unfolded protein response (GO:1900101),-0.34854589510448275,-0.5841993544185808,0.927536231884058,1.0,1.0,2/9,21.19%,COPS5;HSPA5
prerank,GO_Biological_Process_2021__ubiquitin-dependent protein catabolic process (GO:0006511),-0.22049285316854772,-0.583983292620357,1.0,1.0,1.0,11/322,8.50%,PSMB9;ARIH2;KIF14;PRAME;DTL;PINK1;UBE2L6;FBXL7;TRIM25;RNF213;UBE2U
prerank,GO_Biological_Process_2021__response to endoplasmic reticulum stress (GO:0034976),-0.23647339719076593,-0.5839484271296348,1.0,1.0,1.0,6/102,13.30%,RASGRF2;ERN2;ALOX15;THBS1;WFS1;ERLEC1
prerank,GO_Biological_Process_2021__purine nucleobase biosynthetic process (GO:0009113),-0.3602653157475341,-0.5833665740869721,0.9230769230769231,1.0,1.0,2/6,18.18%,PAICS;PRPS1
prerank,Reactome_2022__Signaling By B Cell Receptor (BCR) R-HSA-983705,-0.23277602525587443,-0.5833625558890504,1.0,1.0,1.0,2/97,2.65%,PSMB9;BLK
prerank,GO_Biological_Process_2021__muscle tissue development (GO:0060537),-0.33579146326842946,-0.5833550675948974,0.9571428571428572,1.0,1.0,2/12,11.81%,CSRP3;ENG
prerank,GO_Biological_Process_2021__regulation of intracellular signal transduction (GO:1902531),-0.21296778230641983,-0.5832325430693811,1.0,1.0,1.0,46/393,18.75%,TRIP10;RASGRF2;WNT5A;ARHGAP9;TAGAP;NLRP12;TAF7;OBSCN;VAV3;ROS1;RPA3;ARHGAP15;CEACAM1;RHOQ;BRCA1;GBP1;ARHGAP12;ARAP3;VWF;ARHGAP28;ARHGDIG;TAF9B;RAD1;TEK;A2M;ATP6AP2;RBBP7;GATA4;SETD9;TAF10;RRAS;REN;TAF6;HIPK1;AKAP13;F2RL1;DDIT4;RAC2;ECT2;RAC1;CD24;CDK5R1;NTRK3;NOP53;CARD8;ARHGAP31
prerank,Reactome_2022__LTC4-CYSLTR Mediated IL4 Production R-HSA-9664535,-0.38094700993920055,-0.5830854303152259,0.9137931034482759,1.0,1.0,1/5,14.75%,GGT5
prerank,GO_Biological_Process_2021__histone-serine phosphorylation (GO:0035404),-0.37491468977415177,-0.5830664455678702,0.8909090909090909,1.0,1.0,2/5,22.57%,HMGA2;MST1
prerank,"Reactome_2022__SMAC, XIAP-regulated Apoptotic Response R-HSA-111469",-0.35975617797652626,-0.5827969033028446,0.9056603773584906,1.0,1.0,1/7,9.49%,CASP7
prerank,GO_Biological_Process_2021__positive regulation of histone modification (GO:0031058),0.24977194788844043,0.5827400440263901,1.0,1.0,1.0,4/31,17.89%,ZBTB7B;ARRB1;RPS6KA4;NIPBL
prerank,Reactome_2022__NoRC Negatively Regulates rRNA Expression R-HSA-427413,0.24629722527896805,0.5823864123278651,1.0,1.0,1.0,11/55,19.36%,DNMT1;H2BC21;TAF1B;CCNH;SAP130;POLR1H;HDAC1;H2AX;BAZ2A;ERCC3;H2AJ
prerank,GO_Biological_Process_2021__ribose phosphate biosynthetic process (GO:0046390),-0.3587727013381319,-0.582124671941156,0.9583333333333334,1.0,1.0,1/6,18.18%,PRPS1
prerank,Reactome_2022__Regulation Of PTEN Stability And Activity R-HSA-8948751,-0.24454351257631157,-0.5815356134487247,1.0,1.0,1.0,1/60,0.62%,PSMB9
prerank,GO_Biological_Process_2021__regulation of protein import into nucleus (GO:0042306),-0.2751686296033785,-0.5813705562262754,0.9850746268656716,1.0,1.0,4/32,17.06%,TGFB1;APOD;SMAD3;ECT2
prerank,Reactome_2022__Ca-dependent Events R-HSA-111996,0.2591472293868903,0.5813361713670221,1.0,1.0,1.0,10/33,26.90%,PDE1A;ADCY2;PRKAR2A;ADCY6;CREB1;NBEA;PDE1B;PRKCD;PRKACB;ADCY9
prerank,Reactome_2022__Postmitotic Nuclear Pore Complex (NPC) Reformation R-HSA-9615933,-0.27875901806723274,-0.5812900724055653,0.9846153846153847,1.0,1.0,6/26,30.69%,NUP93;SEC13;NDC1;RAN;NUP133;NUP155
prerank,GO_Biological_Process_2021__striated muscle cell differentiation (GO:0051146),-0.3123706231370012,-0.5811956186231011,0.9464285714285714,1.0,1.0,3/15,17.81%,POPDC2;AKAP13;MESP1
prerank,"Reactome_2022__Cobalamin (Cbl, Vitamin B12) Transport And Metabolism R-HSA-196741",-0.32102574801911105,-0.5810534206205982,0.9692307692307692,1.0,1.0,5/18,18.59%,TCN1;LRP2;AMN;LDLRAP1;CBLIF
prerank,GO_Biological_Process_2021__mesoderm morphogenesis (GO:0048332),-0.34451198960796103,-0.5808728245377776,0.9655172413793104,1.0,1.0,2/8,18.40%,MESP1;MESP2
prerank,GO_Biological_Process_2021__regulation of T-helper 2 cell cytokine production (GO:2000551),-0.38695473786863865,-0.5804937185097366,0.88,1.0,1.0,2/6,18.80%,NLRP3;CD81
prerank,GO_Biological_Process_2021__positive regulation of T-helper 2 cell cytokine production (GO:2000553),-0.38695473786863865,-0.5804937185097366,0.88,1.0,1.0,2/6,18.80%,NLRP3;CD81
prerank,Reactome_2022__HATs Acetylate Histones R-HSA-3214847,0.21409020780374696,0.5803152238089195,1.0,1.0,1.0,24/82,27.22%,JADE3;PAX3;H2BC21;NCOA2;TAF12;MSL2;SAP130;KAT6A;SUPT3H;EP300;JADE2;KAT14;KAT2B;KAT6B;ATXN7;ELP3;H2BC26;TAF5L;EP400;DMAP1;TADA2A;ELP5;CREBBP;SUPT7L
prerank,Reactome_2022__Phosphate Bond Hydrolysis By NUDT Proteins R-HSA-2393930,0.3527643731220358,0.5801025338393436,0.9523809523809523,1.0,1.0,3/7,23.57%,NUDT18;NUDT5;ADPRM
prerank,Reactome_2022__Dual Incision In TC-NER R-HSA-6782135,-0.25126434129511077,-0.5798688092027563,1.0,1.0,1.0,10/63,24.92%,RPA3;UVSSA;POLE2;RBX1;POLD4;RPS27A;POLE3;POLR2B;DDB1;CDK7
prerank,GO_Biological_Process_2021__positive regulation of ubiquitin-protein transferase activity (GO:0051443),0.26376502694083437,0.5792191706083791,1.0,1.0,1.0,10/25,27.79%,DCUN1D1;CDC14B;UBE2L3;FZR1;PTEN;AXIN1;PLK1;DCUN1D2;BTRC;GORASP1
prerank,Reactome_2022__Potential Therapeutics For SARS R-HSA-9679191,-0.2471155319656888,-0.578894420764674,1.0,1.0,1.0,21/82,26.11%,ATP1A4;REST;SAP30;BLNK;RBBP7;IFNGR2;SAP30L;RBX1;TUBB;FXYD6-FXYD2;IMPDH2;CHURC1-FNTB;ACE2;SUDS3;SAP18;MTA2;IL1R1;HSP90AB1;FKBP4;IL6R;KDM1A
prerank,Reactome_2022__Glucagon Signaling In Metabolic Regulation R-HSA-163359,0.26763662583777686,0.5786182089418421,1.0,1.0,1.0,8/26,29.07%,ADCY2;PRKAR2A;GNG7;ADCY6;GNAS;PRKACB;ADCY9;ADCY5
prerank,Reactome_2022__Protein Folding R-HSA-391251,-0.24301556249184741,-0.5781745474517026,1.0,1.0,1.0,22/82,26.62%,GAPDHS;GNGT1;TUBA4A;CCT6B;TUBA3D;CCNE2;TUBB;TUBB6;PDCL;TUBB2A;GNA15;TUBB4A;GNG13;TUBB4B;GNG12;PFDN6;CSNK2A2;USP11;TBCC;CCT6A;GNG4;CCT8
prerank,Reactome_2022__KEAP1-NFE2L2 Pathway R-HSA-9755511,-0.23500510545347936,-0.5781623735480801,1.0,1.0,1.0,18/87,27.50%,PSMB9;NQO1;RBX1;PSMA3;RPS27A;MAFK;PSMA7;PSMB6;PRDX1;TALDO1;PSMA5;PSMD6;CSNK2A2;SKP1;PSMC5;PSMB4;PSMB7;PSMD8
prerank,GO_Biological_Process_2021__maintenance of protein location in extracellular region (GO:0071694),-0.37227992665908427,-0.5775004707534914,0.9411764705882353,1.0,1.0,2/5,19.47%,FBN2;DAND5
prerank,CellMarker_Augmented_2021__Paneth cell:Undefined,-0.24368338302187523,-0.5771819424986229,1.0,1.0,1.0,10/85,20.18%,AMACR;PRDX4;PLPP6;STEAP1;PEBP1;MRPL19;MCCC2;B4GAT1;SLC44A3;HSDL2
prerank,GO_Biological_Process_2021__vascular process in circulatory system (GO:0003018),-0.3358432444273307,-0.5770900857685817,0.9824561403508771,1.0,1.0,2/9,19.87%,SCPEP1;ACE2
prerank,GO_Biological_Process_2021__regulation of tube diameter (GO:0035296),-0.3358432444273307,-0.5770900857685817,0.9824561403508771,1.0,1.0,2/9,19.87%,SCPEP1;ACE2
prerank,GO_Biological_Process_2021__negative regulation of protein-containing complex disassembly (GO:0043242),0.32146863718243135,0.5770724472407057,0.9487179487179487,1.0,1.0,4/7,31.37%,CLEC16A;RUBCN;TMEM39A;UBQLN4
prerank,GO_Biological_Process_2021__regulation of entry of bacterium into host cell (GO:2000535),0.3982724426087927,0.5768733185714569,0.9534883720930233,1.0,1.0,3/5,30.84%,EXOC7;EXOC2;ITGAV
prerank,Reactome_2022__Interleukin-20 Family Signaling R-HSA-8854691,-0.3089089292299662,-0.5767630370581196,0.9622641509433962,1.0,1.0,2/16,17.28%,STAT1;IL10RB
prerank,GO_Biological_Process_2021__negative regulation of double-strand break repair via nonhomologous end joining (GO:2001033),-0.36665252142418236,-0.5762567091924667,0.9354838709677419,1.0,1.0,2/7,21.55%,HMGA2;TFIP11
prerank,GO_Biological_Process_2021__mitochondrial proton-transporting ATP synthase complex assembly (GO:0033615),-0.36055644932336517,-0.576174274701418,0.9137931034482759,1.0,1.0,5/5,63.96%,TMEM70;ATP5F1D;ATP23;OXA1L;ATPAF1
prerank,GO_Biological_Process_2021__phosphatidylethanolamine biosynthetic process (GO:0006646),-0.3120945430093158,-0.5760571762276394,0.9,1.0,1.0,1/14,7.49%,ALOX15
prerank,CellMarker_Augmented_2021__8-Cell Stage Cell (Blastomere):Embryo,-0.31662752410692185,-0.5754929020490315,1.0,1.0,1.0,3/15,21.86%,EIF1AD;FAM32A;GTPBP4
prerank,Reactome_2022__Chaperonin-mediated Protein Folding R-HSA-390466,-0.2447318211765464,-0.5753713352136256,1.0,1.0,1.0,21/77,26.62%,GAPDHS;GNGT1;TUBA4A;CCT6B;TUBA3D;CCNE2;TUBB;TUBB6;PDCL;TUBB2A;GNA15;TUBB4A;GNG13;TUBB4B;GNG12;PFDN6;CSNK2A2;USP11;CCT6A;GNG4;CCT8
prerank,GO_Biological_Process_2021__atrioventricular valve development (GO:0003171),-0.3339847975363465,-0.5753573378130533,0.9523809523809523,1.0,1.0,1/10,8.28%,ZFPM1
prerank,GO_Biological_Process_2021__self proteolysis (GO:0097264),0.3366266336904765,0.5752942139453422,0.868421052631579,1.0,1.0,1/6,12.22%,ADGRV1
prerank,GO_Biological_Process_2021__pentose metabolic process (GO:0019321),0.35580188593512846,0.5746180101487166,0.9772727272727273,1.0,1.0,2/7,19.97%,RPIA;XYLB
prerank,GO_Biological_Process_2021__phosphatidylglycerol metabolic process (GO:0046471),-0.29305316785057817,-0.5744319087326056,0.9428571428571428,1.0,1.0,3/17,20.26%,PLA2G10;PLA2G4A;PLA2G4D
prerank,Reactome_2022__RIP-mediated NFkB Activation Via ZBP1 R-HSA-1810476,-0.3283135023353066,-0.5742858639810071,0.9824561403508771,1.0,1.0,1/13,7.07%,NFKB2
prerank,PanglaoDB_Augmented_2021__Reticulocytes,-0.24277085686768352,-0.5742038017093511,1.0,1.0,1.0,6/96,14.09%,MCM2;MCM3;DARS2;DHX38;CHAF1A;INCENP
prerank,GO_Biological_Process_2021__positive regulation of viral genome replication (GO:0045070),0.2506942472424443,0.5737990596016808,1.0,1.0,1.0,10/28,29.03%,TOP2A;PKN2;TARBP2;LARP1;PPIH;ADAR;SRPK2;PABPC1;PPIA;TMEM39A
prerank,GO_Biological_Process_2021__cellular response to light stimulus (GO:0071482),-0.25606944013581634,-0.5737289106348059,0.9855072463768116,1.0,1.0,4/57,9.69%,PDE6B;CDC25A;GPR88;GNGT1
prerank,GO_Biological_Process_2021__regulation of glycogen metabolic process (GO:0070873),0.2903286692706132,0.5735286817322959,0.9487179487179487,1.0,1.0,1/11,6.89%,PPP1R3E
prerank,GO_Biological_Process_2021__mitochondrial RNA processing (GO:0000963),-0.3442044313207928,-0.5734727159785415,0.9491525423728814,1.0,1.0,3/7,26.31%,TRMT10A;SUPV3L1;TRMT10B
prerank,Reactome_2022__Metabolism Of Nucleotides R-HSA-15869,-0.22898599250086082,-0.5731824850767978,1.0,1.0,1.0,8/88,17.40%,ADSS1;NUDT13;ADA;GLRX;TK1;NUDT15;NT5E;PAICS
prerank,GO_Biological_Process_2021__regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway (GO:1903376),0.35859538593707296,0.5723607274976833,0.9024390243902439,1.0,1.0,2/6,27.65%,HIF1A;MCL1
prerank,Reactome_2022__ER To Golgi Anterograde Transport R-HSA-199977,0.21525087957084596,0.5718193013899409,1.0,1.0,1.0,36/122,26.00%,SPTBN4;STX5;TRAPPC1;SEC24C;SEC22A;CNIH3;DYNC1I2;TGFA;TMED3;BET1;PREB;COG7;ANK2;SEC22B;CTSC;GOLGB1;MIA3;COG5;COG4;TMEM115;TFG;CAPZA1;PPP6R3;CD55;COG2;SEC31A;ANK1;COG3;CNIH2;SPTB;ANK3;CAPZB;SEC24B;COPB1;SEC23IP;ANKRD28
prerank,GO_Biological_Process_2021__negative regulation of cell volume (GO:0045794),0.34342765212453863,0.5716132844706895,0.8823529411764706,1.0,1.0,5/5,65.67%,ANO6;CLCN3;KCNMA1;P2RX7;SHANK3
prerank,GO_Biological_Process_2021__regulation of transcription from RNA polymerase II promoter in response to hypoxia (GO:0061418),-0.24559344161586016,-0.5711866170673722,1.0,1.0,1.0,1/64,0.62%,PSMB9
prerank,KEGG_2021_Human__Base excision repair,-0.2685819512916407,-0.5711511387959689,1.0,1.0,1.0,7/30,22.81%,POLE2;PARP4;POLD4;SMUG1;OGG1;POLE3;XRCC1
prerank,Reactome_2022__Gap-filling DNA Repair Synthesis And Ligation In TC-NER R-HSA-6782210,-0.24784784596646692,-0.5707417434016371,1.0,1.0,1.0,11/63,24.92%,RPA3;UVSSA;POLE2;RBX1;POLD4;RPS27A;POLE3;XRCC1;POLR2B;DDB1;CDK7
prerank,GO_Biological_Process_2021__ribonucleoprotein complex biogenesis (GO:0022613),-0.24050728529423027,-0.5700515444244387,1.0,1.0,1.0,18/58,28.18%,RPL38;EMG1;RPL35A;RPS16;WDR12;RPL5;RPS7;RPL11;RPS15;SURF6;EBNA1BP2;RPS28;RPS19;RPS24;RPL26L1;RPS6;DHX37;RBIS
prerank,KEGG_2021_Human__Glutathione metabolism,-0.24709926214331868,-0.5699360070246573,1.0,1.0,1.0,4/43,14.75%,MGST1;GPX3;GPX2;GGT5
prerank,GO_Biological_Process_2021__negative regulation of alpha-beta T cell activation (GO:0046636),0.3388349508274947,0.5699246836025016,0.9069767441860465,1.0,1.0,2/6,22.44%,TWSG1;TNFRSF14
prerank,Reactome_2022__PRC2 Methylates Histones And DNA R-HSA-212300,0.2536586132546801,0.5697826534005446,1.0,1.0,1.0,9/24,26.65%,DNMT1;H2BC21;H2AX;H2AJ;RBBP4;PHF1;H2BC26;EZH2;DNMT3A
prerank,Reactome_2022__Sema4D Mediated Inhibition Of Cell Attachment And Migration R-HSA-416550,0.3494864485272412,0.5693540895275631,0.9411764705882353,1.0,1.0,2/8,13.35%,PLXNB1;ARHGAP35
prerank,GO_Biological_Process_2021__low-density lipoprotein receptor particle metabolic process (GO:0032799),-0.35229531471840986,-0.5688488643275801,0.9365079365079365,1.0,1.0,9/9,64.79%,AP2A2;CLTA;AP2S1;VLDLR;AP2M1;AP2A1;AP2B1;CLTC;MYLIP
prerank,GO_Biological_Process_2021__low-density lipoprotein particle receptor catabolic process (GO:0032802),-0.35229531471840986,-0.5688488643275801,0.9365079365079365,1.0,1.0,9/9,64.79%,AP2A2;CLTA;AP2S1;VLDLR;AP2M1;AP2A1;AP2B1;CLTC;MYLIP
prerank,GO_Biological_Process_2021__positive regulation of transporter activity (GO:0032411),0.3155500967403859,0.5686202028167067,1.0,1.0,1.0,8/11,27.08%,SGK1;SGK2;NR1H3;WNK3;TRPC6;RXRA;KMT2A;STK39
prerank,Reactome_2022__Paracetamol ADME R-HSA-9753281,0.26960355361603944,0.568429722429508,0.9736842105263158,1.0,1.0,3/16,15.36%,UGT2B15;ABCC1;SULT2A1
prerank,GO_Biological_Process_2021__DNA recombination (GO:0006310),-0.2653757408352409,-0.5683186380033889,1.0,1.0,1.0,2/36,9.68%,HMGB3;ENDOG
prerank,GO_Biological_Process_2021__negative regulation of viral-induced cytoplasmic pattern recognition receptor signaling pathway (GO:0039532),0.3211842833588413,0.5681145478027381,0.9545454545454546,1.0,1.0,1/9,11.65%,TSPAN6
prerank,GO_Biological_Process_2021__aerobic respiration (GO:0009060),0.25627812887975177,0.5680019214686053,0.9428571428571428,1.0,1.0,7/20,35.63%,ME3;UQCRC2;UQCRHL;SLC25A14;SDHB;SURF1;MTFR1L
prerank,GO_Biological_Process_2021__ceramide biosynthetic process (GO:0046513),-0.26793879162838924,-0.567966200587339,0.9866666666666667,1.0,1.0,2/38,5.47%,DEGS2;ALOX12B
prerank,GO_Biological_Process_2021__interleukin-1-mediated signaling pathway (GO:0070498),-0.23144309160100032,-0.5676418625889725,1.0,1.0,1.0,1/81,0.62%,PSMB9
prerank,GO_Biological_Process_2021__negative regulation of programmed necrotic cell death (GO:0062099),0.3096024527371027,0.5674622390765134,0.8857142857142857,1.0,1.0,1/9,13.55%,PELI1
prerank,Reactome_2022__Macroautophagy R-HSA-1632852,-0.23336202629927338,-0.567048813126884,1.0,1.0,1.0,12/104,19.03%,PINK1;TOMM20;HSPA8;TOMM7;RRAGA;DYNLL1;ATG14;VDAC1;GABARAPL1;GABARAPL2;RPS27A;EPAS1
prerank,Reactome_2022__Hydrolysis Of LPC R-HSA-1483115,0.3055487700677266,0.566649093095734,0.8260869565217391,1.0,1.0,2/7,15.41%,PLA2G4C;PLA2G15
prerank,GO_Biological_Process_2021__regulation of cation channel activity (GO:2001257),-0.24495527743708456,-0.5666170515760041,1.0,1.0,1.0,4/81,6.54%,STAC;MMP9;SHISA6;KCNS2
prerank,GO_Biological_Process_2021__negative regulation of cellular protein catabolic process (GO:1903363),0.32247474680344934,0.5664407707821167,0.9714285714285714,1.0,1.0,3/9,33.88%,FURIN;EPHA4;NELL1
prerank,GO_Biological_Process_2021__regulation of DNA biosynthetic process (GO:2000278),-0.27076341343478394,-0.5663957345340459,0.9491525423728814,1.0,1.0,4/25,16.80%,CDKN1A;TOM1L1;FGFR4;PARP4
prerank,GO_Biological_Process_2021__negative regulation of protein metabolic process (GO:0051248),-0.2663621115547189,-0.5662647906356548,0.9852941176470589,1.0,1.0,4/40,13.30%,AZIN1;CLU;PTX3;EDNRB
prerank,GO_Biological_Process_2021__dense core granule cytoskeletal transport (GO:0099519),0.34462282682723167,0.5660907794561139,0.9032258064516129,1.0,1.0,1/7,18.10%,PPFIA2
prerank,GO_Biological_Process_2021__regulation of high voltage-gated calcium channel activity (GO:1901841),0.318807922239533,0.5658453566448577,0.9736842105263158,1.0,1.0,1/10,10.30%,PDE4B
prerank,GO_Biological_Process_2021__regulation of ubiquitin protein ligase activity (GO:1904666),-0.28832364434814667,-0.5654790022972913,1.0,1.0,1.0,7/19,27.22%,RPL5;RPL23;RPS7;RPL11;SKP1;GOLGA2;RAB1A
prerank,GO_Biological_Process_2021__regulation of cell division (GO:0051302),0.23139123301844794,0.5651624878906417,1.0,1.0,1.0,18/65,25.76%,SMYD5;NCOA3;MYC;RAB11FIP3;PLK3;MLLT3;CSPP1;SETD2;PIK3R4;GIT1;EFHC1;AURKC;MYO19;PLK1;CDK2AP2;PRDM15;BCL2L1;SHH
prerank,Reactome_2022__Beta-catenin Phosphorylation Cascade R-HSA-196299,-0.30337692474801947,-0.5648538023592632,0.9814814814814815,1.0,1.0,1/16,8.57%,FRAT1
prerank,GO_Biological_Process_2021__snRNA transcription by RNA polymerase II (GO:0042795),0.2163616897581407,0.5645531441106716,1.0,1.0,1.0,11/68,22.28%,INTS11;SP1;INTS14;INTS9;GTF2F2;SNAPC3;ICE1;RPRD2;POU2F1;ICE2;POLR2F
prerank,GO_Biological_Process_2021__regulation of metaphase/anaphase transition of cell cycle (GO:1902099),-0.3492259002851797,-0.5636382125100358,0.9444444444444444,1.0,1.0,1/7,18.65%,CDC6
prerank,Reactome_2022__Resolution Of D-loop Structures Thru Synthesis-Dependent Strand Annealing (SDSA) R-HSA-5693554,0.2492358709849443,0.5636316233175046,1.0,1.0,1.0,6/26,22.84%,SEM1;EXO1;ATM;RAD51B;DNA2;BRIP1
prerank,Reactome_2022__Sema4D In Semaphorin Signaling R-HSA-400685,0.2585197541325826,0.5635430106114059,0.9487179487179487,1.0,1.0,4/24,18.22%,ERBB2;PLXNB1;ARHGAP35;LIMK1
prerank,Reactome_2022__TP53 Regulates Metabolic Genes R-HSA-5628897,-0.24052977193859532,-0.5633320301204537,1.0,1.0,1.0,10/74,20.44%,COX6A1;COX6C;RRAGA;GPX2;COX7C;DDIT4;COX20;COX4I1;YWHAG;PRDX1
prerank,GO_Biological_Process_2021__granulocyte activation (GO:0036230),-0.37528354214996484,-0.5627675606431166,0.98,1.0,1.0,2/6,25.89%,F2RL1;CCL5
prerank,Reactome_2022__Defective HDR Thru Homologous Recombination (HRR) Due To BRCA1 Loss-Of-Function R-HSA-9701192,0.2496504688286629,0.5626997697023176,1.0,1.0,1.0,6/24,22.84%,SEM1;EXO1;ATM;RAD51B;DNA2;BRIP1
prerank,GO_Biological_Process_2021__myelin assembly (GO:0032288),0.30763781427543835,0.5625236946587856,0.9767441860465116,1.0,1.0,3/10,26.07%,TENM4;ABCA2;TPPP
prerank,GO_Biological_Process_2021__membrane raft assembly (GO:0001765),-0.3450815750221329,-0.562463489072621,0.9272727272727272,1.0,1.0,2/6,27.22%,FLOT1;RFTN1
prerank,GO_Biological_Process_2021__oligosaccharide biosynthetic process (GO:0009312),-0.280375479037528,-0.5619012094766351,0.9714285714285714,1.0,1.0,3/17,17.56%,FUT2;B4GALNT2;MPDU1
prerank,Reactome_2022__RUNX1 Regulates Expression Of Components Of Tight Junctions R-HSA-8935964,0.37485191814732893,0.5613936824052382,0.9361702127659575,1.0,1.0,1/5,3.64%,CBFB
prerank,GO_Biological_Process_2021__negative regulation of cell-cell adhesion mediated by cadherin (GO:2000048),-0.3319197051367432,-0.5612559990778939,0.8688524590163934,1.0,1.0,1/10,9.60%,PLG
prerank,GO_Biological_Process_2021__regulation of protein export from nucleus (GO:0046825),-0.2830430685629981,-0.5612286693950364,1.0,1.0,1.0,1/22,4.03%,SP100
prerank,Reactome_2022__APEX1-Independent Resolution Of AP Sites Via Single Nucleotide Replacement Pathway R-HSA-5649702,0.3562325312174744,0.5611029924007338,0.9047619047619048,1.0,1.0,2/7,17.85%,LRIG3;PNKP
prerank,GO_Biological_Process_2021__neutrophil activation (GO:0042119),-0.34348854187209954,-0.561070707558093,0.9642857142857143,1.0,1.0,2/8,25.89%,F2RL1;CCL5
prerank,GO_Biological_Process_2021__dephosphorylation of RNA polymerase II C-terminal domain (GO:0070940),-0.37242046906333287,-0.5604379420803517,0.9818181818181818,1.0,1.0,1/5,20.86%,SSU72
prerank,GO_Biological_Process_2021__regulation of low-density lipoprotein particle clearance (GO:0010988),-0.35971081063370325,-0.5603470200328481,0.96,1.0,1.0,2/5,18.30%,NR1H4;LDLRAP1
prerank,GO_Biological_Process_2021__regulation of extracellular matrix organization (GO:1903053),-0.3003211747871928,-0.5602242559542019,0.9846153846153847,1.0,1.0,3/14,18.66%,FGFR4;AGT;ANGPTL7
prerank,GO_Biological_Process_2021__response to heparin (GO:0071503),-0.36129589217777247,-0.56020393616419,0.8867924528301887,1.0,1.0,3/5,24.21%,GPIHBP1;SOX9;SFRP1
prerank,GO_Biological_Process_2021__nucleoside diphosphate catabolic process (GO:0009134),0.339612259142618,0.560158257844322,0.9574468085106383,1.0,1.0,2/8,19.66%,NUDT5;ENTPD2
prerank,Reactome_2022__RNA Polymerase I Promoter Escape R-HSA-73772,0.23995656998315473,0.5600959266972585,1.0,1.0,1.0,7/40,19.36%,H2BC21;TAF1B;CCNH;POLR1H;H2AX;ERCC3;H2AJ
prerank,Reactome_2022__MET Activates PI3K/AKT Signaling R-HSA-8851907,0.35404095452398887,0.5598295188679555,0.9655172413793104,1.0,1.0,2/6,19.27%,PIK3CA;SOS1
prerank,GO_Biological_Process_2021__regulation of glial cell differentiation (GO:0045685),0.3660780307032242,0.5597810827957275,0.9512195121951219,1.0,1.0,4/6,29.44%,NF1;SLC45A3;CDK1;EPHA4
prerank,Reactome_2022__Uptake And Actions Of Bacterial Toxins R-HSA-5339562,-0.28176838213612854,-0.559604009337184,1.0,1.0,1.0,2/26,6.27%,GUCY2C;SYT2
prerank,GO_Biological_Process_2021__positive regulation of DNA replication (GO:0045740),0.2906203863719108,0.5594111234565677,1.0,1.0,1.0,5/14,29.82%,CTC1;FAF1;DNA2;STN1;BRPF3
prerank,Reactome_2022__RHO GTPases Activate ROCKs R-HSA-5627117,-0.28807016543981334,-0.5589732432266454,0.9836065573770492,1.0,1.0,4/19,24.14%,MYL6;MYL9;MYH11;RHOB
prerank,Reactome_2022__RHO GTPases Activate PAKs R-HSA-5627123,0.2519867873748305,0.5586687654885083,0.96875,1.0,1.0,4/21,18.63%,FLNA;PKN2;LIMK1;PPP1CB
prerank,GO_Biological_Process_2021__malate metabolic process (GO:0006108),0.3393831678608513,0.5584121983280528,0.8918918918918919,1.0,1.0,2/7,28.40%,ME3;ME2
prerank,KEGG_2021_Human__Spliceosome,0.1929468396697154,0.557954826031212,1.0,1.0,1.0,25/122,22.86%,PRPF38B;TRA2A;PUF60;PRPF40B;TXNL4A;SNRPB;U2AF1;LSM2;HSPA1A;SF3B1;SRSF4;ACIN1;FUS;LSM7;EIF4A3;U2AF2;RBM25;SF3B4;LSM6;PPIH;CDC5L;LSM8;DDX46;PRPF18;MAGOHB
prerank,GO_Biological_Process_2021__regulation of neurotransmitter secretion (GO:0046928),-0.266802803931127,-0.5577378513076814,1.0,1.0,1.0,10/31,25.39%,GPER1;SNAPIN;CAMK2A;BAIAP3;CHRNA3;PREPL;VPS18;CPLX2;HCRT;SYT11
prerank,GO_Biological_Process_2021__negative regulation of synaptic transmission (GO:0050805),0.265101964485084,0.5573487153708466,1.0,1.0,1.0,5/22,22.04%,NLGN4X;ACHE;GRIK3;SLC24A2;PTEN
prerank,GO_Biological_Process_2021__regulation of nitric-oxide synthase biosynthetic process (GO:0051769),-0.34191088562370864,-0.5572396772425474,0.9508196721311475,1.0,1.0,1/8,12.50%,TLR2
prerank,KEGG_2021_Human__Porphyrin and chlorophyll metabolism,0.26242710647828194,0.5565114454457326,0.9696969696969697,1.0,1.0,4/23,17.36%,UGT2B15;COX10;EARS2;HMOX2
prerank,GO_Biological_Process_2021__protein insertion into mitochondrial membrane (GO:0051204),0.28376573758885804,0.5562492598754978,0.9705882352941176,1.0,1.0,1/20,5.26%,TIMM29
prerank,GO_Biological_Process_2021__positive regulation of blood pressure (GO:0045777),-0.3261225555843146,-0.5560996806783329,0.9473684210526315,1.0,1.0,1/6,13.18%,CARTPT
prerank,GO_Biological_Process_2021__positive regulation of oxidoreductase activity (GO:0051353),0.3267829091628739,0.5559595943056937,0.972972972972973,1.0,1.0,2/12,8.76%,ABL1;ABL2
prerank,"GO_Biological_Process_2021__endonucleolytic cleavage in ITS1 to separate SSU-rRNA from 5.8S rRNA and LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000447)",0.3403235010210524,0.555478565403577,0.96875,1.0,1.0,2/8,18.57%,NOP9;NOP14
prerank,GO_Biological_Process_2021__histone acetylation (GO:0016573),-0.22906335918437468,-0.5551030383023535,1.0,1.0,1.0,9/67,21.34%,ACTL6A;HAT1;SPI1;LEF1;TAF10;TAF6;TAF6L;POLE3;BRD8
prerank,CellMarker_Augmented_2021__Conventional Dendritic cell:Undefined,-0.34874376624934633,-0.555047396356102,0.9830508474576272,1.0,1.0,2/9,12.50%,PDCD1LG2;TLR2
prerank,Reactome_2022__Processing Of DNA Double-Strand Break Ends R-HSA-5693607,-0.23883811025040375,-0.5546793715541837,1.0,1.0,1.0,4/65,8.63%,RPA3;ABRAXAS1;H2BC4;BRCA1
prerank,Reactome_2022__Cytoprotection By HMOX1 R-HSA-9707564,-0.25539271723556445,-0.554595314728845,1.0,1.0,1.0,9/51,18.81%,COX6A1;COX6C;STAP2;NLRP3;COX7C;TXNIP;COX20;MAFK;COX4I1
prerank,GO_Biological_Process_2021__carbohydrate biosynthetic process (GO:0016051),-0.27640317889949284,-0.5544167012031253,0.9855072463768116,1.0,1.0,3/18,17.56%,FUT2;B4GALNT2;MPDU1
prerank,GO_Biological_Process_2021__regulation of response to stress (GO:0080134),-0.3235948742115067,-0.553695189130744,1.0,1.0,1.0,2/11,13.43%,ABCB1;OPRM1
prerank,GO_Biological_Process_2021__positive regulation of carbohydrate metabolic process (GO:0045913),0.28629645383433977,0.5535930682703967,0.9761904761904762,1.0,1.0,8/22,21.01%,ZBTB20;MLXIPL;NFKB1;INSR;PFKFB4;PRKAA2;HIF1A;PFKFB3
prerank,GO_Biological_Process_2021__cellular response to hydrogen peroxide (GO:0070301),-0.26730185936673256,-0.5535925606186105,0.9855072463768116,1.0,1.0,4/30,17.06%,CYP1B1;ANXA1;ZNF580;ECT2
prerank,Reactome_2022__HDR Thru MMEJ (alt-NHEJ) R-HSA-5685939,0.3099598697960987,0.5533262084860091,1.0,1.0,1.0,2/11,16.90%,LRIG3;RAD52
prerank,GO_Biological_Process_2021__epithelial to mesenchymal transition involved in endocardial cushion formation (GO:0003198),-0.3524468414200497,-0.5532348926969192,0.921875,1.0,1.0,2/7,14.16%,ENG;HEY2
prerank,GO_Biological_Process_2021__negative regulation of MAP kinase activity (GO:0043407),-0.25919230847571645,-0.5530781340196065,1.0,1.0,1.0,4/41,15.80%,CAV3;DNAJA1;PIK3CB;AGT
prerank,GO_Biological_Process_2021__positive regulation of response to endoplasmic reticulum stress (GO:1905898),0.29341405485167427,0.5528283737743968,0.8947368421052632,1.0,1.0,5/15,25.75%,ERN1;NCK1;RNF185;BAG6;TMEM259
prerank,GO_Biological_Process_2021__regulation of plasminogen activation (GO:0010755),-0.31472331698827594,-0.5525187242723991,0.9672131147540983,1.0,1.0,2/11,10.87%,THBS1;CTSZ
prerank,GO_Biological_Process_2021__purine nucleobase metabolic process (GO:0006144),0.33830232707209784,0.5521819658747711,0.95,1.0,1.0,3/8,18.77%,GMPS;HPRT1;SHMT2
prerank,GO_Biological_Process_2021__tail-anchored membrane protein insertion into ER membrane (GO:0071816),-0.282151148238806,-0.5516553125092344,0.9859154929577465,1.0,1.0,2/15,16.60%,CAMLG;EMC1
prerank,Reactome_2022__Activated NTRK3 Signals Thru RAS R-HSA-9034864,-0.36968080671919057,-0.5513072663805297,0.9322033898305084,1.0,1.0,1/6,18.22%,NTRK3
prerank,GO_Biological_Process_2021__mRNA 3'-splice site recognition (GO:0000389),-0.3679264724999415,-0.5511107408373404,0.94,1.0,1.0,2/5,27.74%,SLU7;SF3A1
prerank,GO_Biological_Process_2021__cell-cell junction maintenance (GO:0045217),-0.31713301285320467,-0.5509973857758815,0.9672131147540983,1.0,1.0,3/9,23.48%,F2RL1;CSF1R;PRTN3
prerank,GO_Biological_Process_2021__sensory organ development (GO:0007423),-0.25083957775666993,-0.5506264816627586,0.9857142857142858,1.0,1.0,7/41,21.27%,MAB21L1;FREM2;HIPK1;WNT10A;SALL2;MYO7B;SIX4
prerank,GO_Biological_Process_2021__mitochondrial RNA 3'-end processing (GO:0000965),0.3272022350797014,0.5504822600551553,0.9534883720930233,1.0,1.0,1/5,14.06%,PNPT1
prerank,Reactome_2022__ISG15 Antiviral Mechanism R-HSA-1169408,-0.2331027360052644,-0.549838431861493,1.0,1.0,1.0,16/68,26.12%,UBE2L6;TRIM25;STAT1;IFIT1;GNL3;RPS27A;EIF4A2;NUP93;MX1;SEC13;ISG15;PDZD2;KPNA7;USP18;KPNA5;NDC1
prerank,GO_Biological_Process_2021__C-terminal protein deglutamylation (GO:0035609),0.33983567331812925,0.5494456510937477,0.9148936170212766,1.0,1.0,1/5,11.19%,AGBL4
prerank,Reactome_2022__Blood Group Systems Biosynthesis R-HSA-9033658,-0.2883758272725711,-0.5493997632481664,1.0,1.0,1.0,7/14,30.53%,FUT2;B4GALNT2;FUT1;RHCE;B3GALT2;RHD;B3GALT4
prerank,Reactome_2022__POLB-Dependent Long Patch Base Excision Repair R-HSA-110362,-0.33541548362672724,-0.5491901824912381,0.9682539682539683,1.0,1.0,7/7,66.47%,PARP2;PARG;PARP1;LRIG1;POLG2;APEX1;ADPRS
prerank,Reactome_2022__Estrogen-stimulated Signaling Thru PRKCZ R-HSA-9634635,-0.3552569319579824,-0.5491637387985719,0.9661016949152542,1.0,1.0,5/5,64.49%,PRKCZ;PDPK1;NRAS;MAPK1;HRAS
prerank,Reactome_2022__rRNA Modification In Nucleus And Cytosol R-HSA-6790901,-0.23556237993922566,-0.5490592414112443,1.0,1.0,1.0,4/57,13.72%,DIMT1;PWP2;EMG1;RPS9
prerank,Reactome_2022__Sema3A PAK Dependent Axon Repulsion R-HSA-399954,-0.3009175921779964,-0.548546063716983,0.9710144927536232,1.0,1.0,4/16,26.02%,SEMA3A;PLXNA3;HSP90AB1;RNASE1
prerank,GO_Biological_Process_2021__snRNA transcription (GO:0009301),0.21430066189959326,0.548375665711201,1.0,1.0,1.0,11/69,22.28%,INTS11;SP1;INTS14;INTS9;GTF2F2;SNAPC3;ICE1;RPRD2;POU2F1;ICE2;POLR2F
prerank,Reactome_2022__RHOC GTPase Cycle R-HSA-9013106,-0.23788276428034966,-0.5483565056790772,1.0,1.0,1.0,7/71,17.95%,CCDC187;ARHGEF40;CAVIN1;PKN3;AKAP13;IQGAP3;RTKN
prerank,Reactome_2022__Signal Transduction By L1 R-HSA-445144,-0.29528007184408483,-0.5480289681043323,0.9545454545454546,1.0,1.0,3/18,13.78%,ITGA9;ITGA2B;ITGA5
prerank,GO_Biological_Process_2021__lipid translocation (GO:0034204),-0.2678867471316583,-0.5478317442273788,0.9193548387096774,1.0,1.0,6/23,25.20%,ATP10B;ABCB1;ATP8B3;ATP11C;ABCA4;ATP11A
prerank,GO_Biological_Process_2021__regulation of calcium ion transmembrane transporter activity (GO:1901019),-0.2915309238151166,-0.5477842871179762,0.9523809523809523,1.0,1.0,4/24,18.02%,CAV3;JPH2;PLN;CALM1
prerank,GO_Biological_Process_2021__positive regulation of mitochondrial membrane permeability involved in apoptotic process (GO:1902110),-0.3388932443793643,-0.5472500683272615,0.9642857142857143,1.0,1.0,5/8,37.07%,BLOC1S2;BNIP3;VDAC2;RHOT2;ATF2
prerank,Reactome_2022__Protein Repair R-HSA-5676934,0.34749393980155996,0.546933727742281,0.975,1.0,1.0,2/6,16.61%,MSRB3;MSRB1
prerank,GO_Biological_Process_2021__regulation of transferase activity (GO:0051338),0.2605363734429457,0.54624601394056,1.0,1.0,1.0,8/17,33.32%,ATM;SMG6;LDB2;EMP2;FEM1A;HMBOX1;NLRC5;SPTSSB
prerank,GO_Biological_Process_2021__protein repair (GO:0030091),0.3474060412083276,0.5450434496630878,0.975609756097561,1.0,1.0,2/6,16.61%,MSRB3;MSRB1
prerank,GO_Biological_Process_2021__rRNA base methylation (GO:0070475),0.344328759567602,0.5447589408637465,0.9428571428571428,1.0,1.0,3/6,19.85%,METTL15;BUD23;METTL16
prerank,Reactome_2022__TRIF-mediated Programmed Cell Death R-HSA-2562578,0.31311267183389047,0.5444987687109011,0.95,1.0,1.0,2/7,12.94%,TICAM1;FADD
prerank,GO_Biological_Process_2021__histone H4 acetylation (GO:0043967),-0.24439055484906155,-0.5443498430766011,1.0,1.0,1.0,3/46,13.80%,ACTL6A;HAT1;LEF1
prerank,GO_Biological_Process_2021__acidic amino acid transport (GO:0015800),-0.3091935009364159,-0.5440750674788243,0.9841269841269841,1.0,1.0,2/16,17.64%,SLC25A18;SLC25A22
prerank,GO_Biological_Process_2021__negative regulation of meiotic nuclear division (GO:0045835),-0.35631340796347305,-0.5440744630685173,0.9803921568627451,1.0,1.0,1/6,13.23%,RAD1
prerank,GO_Biological_Process_2021__isocitrate metabolic process (GO:0006102),0.3481634981004412,0.5431030855469845,0.8958333333333334,1.0,1.0,1/5,12.54%,IDH2
prerank,Reactome_2022__TCR Signaling R-HSA-202403,-0.22323580832301482,-0.5420283966769026,1.0,1.0,1.0,13/98,19.11%,PSMB9;INPP5D;WAS;HLA-DRB1;PTPRC;HLA-DPA1;PIK3CB;CD4;PSMA3;VASP;RPS27A;PSMA7;PSMB6
prerank,Reactome_2022__Synthesis Of Pyrophosphates In Cytosol R-HSA-1855167,0.26656604917183946,0.5416016238933669,0.9736842105263158,1.0,1.0,3/10,20.42%,IP6K1;ITPK1;IPPK
prerank,GO_Biological_Process_2021__DNA integrity checkpoint signaling (GO:0031570),0.23610507350176313,0.5412304831947915,0.9761904761904762,1.0,1.0,13/33,22.84%,SETMAR;TIMELESS;H2AX;CLSPN;ATM;RAD17;RAD9A;ATR;DNA2;HINFP;CDC5L;ATRIP;BRIP1
prerank,GO_Biological_Process_2021__DNA catabolic process (GO:0006308),0.28832302615711175,0.5411018087811479,0.975609756097561,1.0,1.0,4/10,24.57%,SETMAR;FBH1;XRN2;MUS81
prerank,GO_Biological_Process_2021__positive regulation of p38MAPK cascade (GO:1900745),0.2515703099454337,0.5407879011826291,1.0,1.0,1.0,7/19,26.51%,GDF6;MFHAS1;GADD45A;RELL1;BMP2;EMC10;RELL2
prerank,Reactome_2022__DARPP-32 Events R-HSA-180024,-0.28851900151583454,-0.5406633551069135,0.96875,1.0,1.0,1/21,3.93%,PPP1R1B
prerank,GO_Biological_Process_2021__regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway (GO:1901028),0.2847536718009137,0.54047815066452,1.0,1.0,1.0,2/14,14.12%,HSPA1A;BID
prerank,GO_Biological_Process_2021__positive regulation of T cell cytokine production (GO:0002726),-0.28993236850941867,-0.5401198331074881,1.0,1.0,1.0,6/18,24.92%,HLA-A;NLRP3;IL18;CD81;IL1R1;TNFSF4
prerank,GO_Biological_Process_2021__regulation of microtubule nucleation (GO:0010968),-0.3033003480632257,-0.5400847116595902,0.9827586206896551,1.0,1.0,1/9,11.15%,DCTN1
prerank,GO_Biological_Process_2021__negative regulation of macrophage migration (GO:1905522),0.32131807491982356,0.5400811555363724,0.94,1.0,1.0,1/6,20.62%,EMILIN1
prerank,GO_Biological_Process_2021__regulation of plasma membrane organization (GO:1903729),0.32696129459638495,0.5391426400293017,0.9555555555555556,1.0,1.0,5/5,67.31%,GSN;MYH9;SYTL4;NOX5;RAB3A
prerank,GO_Biological_Process_2021__regulation of sensory perception (GO:0051931),-0.3047842591443527,-0.5380007554544485,0.9836065573770492,1.0,1.0,1/9,11.90%,ACP3
prerank,GO_Biological_Process_2021__negative regulation of fibroblast growth factor receptor signaling pathway (GO:0040037),-0.30992097335658697,-0.5374477496525017,0.9682539682539683,1.0,1.0,1/11,9.78%,THBS1
prerank,GO_Biological_Process_2021__regulation of fatty acid oxidation (GO:0046320),0.24135757280086426,0.5370692251032855,1.0,1.0,1.0,4/16,20.34%,NR4A3;PRKAG2;APPL2;ACADVL
prerank,GO_Biological_Process_2021__genetic imprinting (GO:0071514),-0.3218720786463602,-0.5368723067027267,1.0,1.0,1.0,1/7,14.63%,CTCFL
prerank,Reactome_2022__Opioid Signaling R-HSA-111885,-0.23373970953253986,-0.5368584083201392,1.0,1.0,1.0,18/79,24.63%,PPP1R1B;PDYN;GNAT3;GNGT1;OPRM1;ADCY7;ITPR3;PLA2G4A;GNAL;CALM1;CAMK2A;PDE4A;GNA15;GNG13;GNG12;PLCB2;ADCY1;CAMKK2
prerank,Reactome_2022__G Beta:Gamma Signaling Thru PLC Beta R-HSA-418217,-0.29317045001217584,-0.5362857359212604,0.9491525423728814,1.0,1.0,5/16,26.22%,GNGT1;GNG13;GNG12;PLCB2;GNG4
prerank,GO_Biological_Process_2021__negative regulation of endoplasmic reticulum unfolded protein response (GO:1900102),-0.27914604402116233,-0.5358052235848406,0.9523809523809523,1.0,1.0,5/13,28.29%,WFS1;HSPA5;UFL1;DDRGK1;RACK1
prerank,GO_Biological_Process_2021__synaptic vesicle transport along microtubule (GO:0099517),-0.3039951309753002,-0.5357173317549052,0.9824561403508771,1.0,1.0,2/11,22.96%,SNAPIN;BLOC1S2
prerank,GO_Biological_Process_2021__anterograde synaptic vesicle transport (GO:0048490),-0.3039951309753002,-0.5357173317549052,0.9824561403508771,1.0,1.0,2/11,22.96%,SNAPIN;BLOC1S2
prerank,GO_Biological_Process_2021__cellular response to platelet-derived growth factor stimulus (GO:0036120),0.3412860001556075,0.5353707794164169,1.0,1.0,1.0,3/7,20.13%,SYAP1;CORO1B;MARS1
prerank,GO_Biological_Process_2021__nucleotide phosphorylation (GO:0046939),0.3006455083795807,0.5351444360396759,1.0,1.0,1.0,1/8,17.85%,PNKP
prerank,"Reactome_2022__Adrenaline,noradrenaline Inhibits Insulin Secretion R-HSA-400042",-0.26225846581225154,-0.535093716510571,1.0,1.0,1.0,4/24,26.22%,GNGT1;GNG13;GNG12;GNG4
prerank,GO_Biological_Process_2021__maturation of SSU-rRNA (GO:0030490),-0.2589636057226351,-0.5346161967950782,1.0,1.0,1.0,6/35,20.56%,PWP2;TSR2;NOB1;RPS16;RPS8;RPS14
prerank,Reactome_2022__Synthesis Of PIPs At Golgi Membrane R-HSA-1660514,-0.28996523301129823,-0.5342135946866015,0.9838709677419355,1.0,1.0,2/16,14.66%,ARF3;PIK3C2G
prerank,Reactome_2022__Constitutive Signaling By EGFRvIII R-HSA-5637810,0.2581471077017047,0.5341516094147488,1.0,1.0,1.0,3/14,23.99%,PIK3CA;SOS1;CBL
prerank,GO_Biological_Process_2021__positive regulation of chromosome segregation (GO:0051984),0.3008754585872235,0.5338346253833538,1.0,1.0,1.0,3/8,28.70%,SMC5;SMC6;NUMA1
prerank,GO_Biological_Process_2021__negative regulation of viral genome replication (GO:0045071),-0.2402666860849965,-0.5333381602443841,1.0,1.0,1.0,8/38,21.85%,OAS2;IFIT1;OAS1;HMGA2;MX1;PARP10;ISG15;SRPK1
prerank,GO_Biological_Process_2021__cellular response to nitrogen compound (GO:1901699),0.2695369134340832,0.5330715221205297,0.975609756097561,1.0,1.0,3/17,15.27%,TIMELESS;SPIDR;HSF1
prerank,Reactome_2022__Ovarian Tumor Domain Proteases R-HSA-5689896,-0.2525596624097123,-0.5323567914533903,1.0,1.0,1.0,2/36,6.02%,ESR1;TRIM25
prerank,Reactome_2022__RNA Polymerase II Transcribes snRNA Genes R-HSA-6807505,0.2118399019036195,0.5320585950910244,1.0,1.0,1.0,11/71,22.28%,INTS11;PCF11;INTS14;INTS9;GTF2F2;SNAPC3;ICE1;RPRD2;POU2F1;ICE2;POLR2F
prerank,GO_Biological_Process_2021__response to thyroid hormone (GO:0097066),-0.30337356876313465,-0.5308798143656578,0.9850746268656716,1.0,1.0,4/12,31.29%,LMO2;BRD8;KLF9;CTSS
prerank,GO_Biological_Process_2021__ether lipid metabolic process (GO:0046485),0.2693363627757265,0.530866649110102,0.9722222222222222,1.0,1.0,13/13,73.08%,DHRS7B;PLA2G6;NCEH1;TMEM86B;PEX7;AGPS;FAR1;GNPAT;PAFAH1B1;AGMO;PLAAT3;LIPE;PLA2G7
prerank,GO_Biological_Process_2021__cellular response to thyroid hormone stimulus (GO:0097067),-0.30362030873958545,-0.5300244067869236,0.9850746268656716,1.0,1.0,4/11,31.29%,LMO2;BRD8;KLF9;CTSS
prerank,GO_Biological_Process_2021__regulation of calcineurin-NFAT signaling cascade (GO:0070884),-0.27465320596118403,-0.5297079307093727,1.0,1.0,1.0,2/19,14.41%,ACTN3;EFHB
prerank,GO_Biological_Process_2021__positive regulation of microtubule nucleation (GO:0090063),0.32519497806647846,0.5296043562331053,0.9512195121951219,1.0,1.0,3/6,21.79%,HSPA1A;MECP2;GIT1
prerank,GO_Biological_Process_2021__positive regulation of transcription by RNA polymerase III (GO:0045945),0.2745540717735326,0.5293883478535815,1.0,1.0,1.0,5/10,36.49%,ICE1;ICE2;CEBPA;CHD8;ZC3H8
prerank,Reactome_2022__DDX58/IFIH1-mediated Induction Of Interferon-Alpha/Beta R-HSA-168928,-0.2226649004920906,-0.5284393291522388,1.0,1.0,1.0,3/60,7.07%,UBE2L6;TRIM25;NFKB2
prerank,GO_Biological_Process_2021__regulation of phosphate metabolic process (GO:0019220),-0.26733710765851115,-0.5280890924354664,1.0,1.0,1.0,2/14,17.21%,PGAM1;CD24
prerank,GO_Biological_Process_2021__regulation of delayed rectifier potassium channel activity (GO:1902259),-0.29583642638047525,-0.5278842842191646,0.9818181818181818,1.0,1.0,4/14,23.50%,KCNS2;KCNE3;KCNE4;KCNS1
prerank,Reactome_2022__ATF6 (ATF6-alpha) Activates Chaperones R-HSA-381033,-0.31736805269511226,-0.5274768149714489,0.9682539682539683,1.0,1.0,2/11,21.19%,NFYB;HSPA5
prerank,Reactome_2022__G2/M DNA Damage Checkpoint R-HSA-69473,-0.23420301832677687,-0.5272630595682244,1.0,1.0,1.0,4/62,8.63%,RPA3;ABRAXAS1;H2BC4;BRCA1
prerank,GO_Biological_Process_2021__mesenchyme morphogenesis (GO:0072132),0.27790454731127,0.5268883006725208,1.0,1.0,1.0,6/10,25.69%,SMAD2;NOTCH1;ACVR1;MDM4;BMPR1A;BMP2
prerank,GO_Biological_Process_2021__RNA secondary structure unwinding (GO:0010501),-0.32469812624876593,-0.5266464747837265,0.9649122807017544,1.0,1.0,1/7,14.99%,DDX3X
prerank,GO_Biological_Process_2021__platelet activating factor metabolic process (GO:0046469),-0.3189206828764345,-0.5264956649634397,0.9642857142857143,1.0,1.0,2/8,17.74%,PLA2G10;PLA2G4A
prerank,GO_Biological_Process_2021__7-methylguanosine mRNA capping (GO:0006370),0.22811594649642697,0.526058362852452,1.0,1.0,1.0,4/30,22.28%,CCNH;GTF2F2;ERCC3;POLR2F
prerank,GO_Biological_Process_2021__7-methylguanosine RNA capping (GO:0009452),0.22811594649642697,0.526058362852452,1.0,1.0,1.0,4/30,22.28%,CCNH;GTF2F2;ERCC3;POLR2F
prerank,GO_Biological_Process_2021__positive regulation of nuclear cell cycle DNA replication (GO:0010571),-0.3350210571144655,-0.5260335262587574,0.9791666666666666,1.0,1.0,6/6,66.51%,CDC7;DBF4;DBF4B;ATRX;WIZ;INO80
prerank,GO_Biological_Process_2021__cellular response to prostaglandin E stimulus (GO:0071380),-0.3066968868360452,-0.5259579062173955,0.9827586206896551,1.0,1.0,2/6,24.92%,SFRP1;TNFSF4
prerank,GO_Biological_Process_2021__choline transport (GO:0015871),0.3315770160416364,0.5257158413397176,0.9423076923076923,1.0,1.0,2/5,33.49%,SLC44A2;SLC44A4
prerank,GO_Biological_Process_2021__regulation of meiotic nuclear division (GO:0040020),0.30636002271436696,0.5256239111111688,0.9375,1.0,1.0,7/7,69.37%,DMRT1;SIRT2;NPM2;FBXO5;OOEP;WEE2;FBXO43
prerank,Reactome_2022__Autophagy R-HSA-9612973,-0.2071989298394266,-0.5253492956986782,1.0,1.0,1.0,24/118,26.70%,PINK1;TOMM20;HSPA8;TOMM7;RRAGA;DYNLL1;ATG14;VDAC1;GABARAPL1;GABARAPL2;RPS27A;EPAS1;FUNDC1;LAMP2;DYNLL2;PGAM5;CSNK2A2;HSP90AB1;EEF1A1;PARK7;ULK1;RNASE1;CHMP4B;LAMTOR1
prerank,GO_Biological_Process_2021__nucleobase-containing small molecule catabolic process (GO:0034656),0.28051488561573756,0.5250359442197112,0.9761904761904762,1.0,1.0,4/14,23.57%,NUDT18;NUDT5;ENTPD2;ADPRM
prerank,Reactome_2022__InlB-mediated Entry Of Listeria Monocytogenes Into Host Cell R-HSA-8875360,0.2659142996426773,0.5248608682268461,1.0,1.0,1.0,4/15,23.99%,SH3KBP1;STAM2;SH3GL1;CBL
prerank,Reactome_2022__CHL1 Interactions R-HSA-447041,-0.2997598243804642,-0.5245201552202514,0.9558823529411765,1.0,1.0,1/9,11.92%,HSPA8
prerank,GO_Biological_Process_2021__regulation of lymphocyte differentiation (GO:0045619),-0.2745734915164233,-0.5242268375731528,1.0,1.0,1.0,5/14,26.40%,ZFP36L1;CRTAM;PRDM1;SPINK5;XRCC6
prerank,Reactome_2022__HDR Thru Homologous Recombination (HRR) R-HSA-5685942,-0.22928538597224396,-0.5238086820156939,1.0,1.0,1.0,15/62,26.10%,RPA3;BRCA1;POLE2;RRAD;POLD4;RPS27A;RMI1;TOPBP1;POLE3;BLM;RAD9B;CHEK1;RMI2;XRCC2;BRCA2
prerank,GO_Biological_Process_2021__regulation of G0 to G1 transition (GO:0070316),-0.24218581957990173,-0.5237437582753238,1.0,1.0,1.0,9/38,25.10%,BRCA1;MAX;FOXO4;RBBP7;L3MBTL2;DUX4;CDC7;CHEK1;APAF1
prerank,GO_Biological_Process_2021__vitamin K metabolic process (GO:0042373),-0.3424982699790615,-0.5237126650772304,0.9827586206896551,1.0,1.0,1/6,13.26%,CYP4F12
prerank,GO_Biological_Process_2021__regulation of histone H3-K27 methylation (GO:0061085),0.3017555481947665,0.5235637186099902,0.9772727272727273,1.0,1.0,6/6,69.83%,PHF1;OGT;MACROH2A1;PHF19;SUPT6H;MTF2
prerank,Reactome_2022__Downregulation Of ERBB4 Signaling R-HSA-1253288,-0.30450935476489016,-0.5233910873342624,0.9629629629629629,1.0,1.0,3/9,31.83%,RPS27A;UBB;UBC
prerank,Reactome_2022__Condensation Of Prophase Chromosomes R-HSA-2299718,-0.2567767299021093,-0.5233626041795396,1.0,1.0,1.0,2/24,12.66%,H2BC4;H2AZ1
prerank,GO_Biological_Process_2021__regulation of protein exit from endoplasmic reticulum (GO:0070861),0.30191396213531047,0.5233272539408128,0.95,1.0,1.0,1/11,9.27%,GCC2
prerank,GO_Biological_Process_2021__polyamine biosynthetic process (GO:0006596),0.2960818617948945,0.522886890121819,0.9615384615384616,1.0,1.0,3/6,24.22%,SAT1;SMS;SRM
prerank,GO_Biological_Process_2021__dynamin family protein polymerization involved in mitochondrial fission (GO:0003374),0.302958436618369,0.5226242933376554,0.9545454545454546,1.0,1.0,3/8,30.95%,MIEF2;DNM2;DNM3
prerank,GO_Biological_Process_2021__dynamin family protein polymerization involved in membrane fission (GO:0003373),0.302958436618369,0.5226242933376554,0.9545454545454546,1.0,1.0,3/8,30.95%,MIEF2;DNM2;DNM3
prerank,Reactome_2022__G Beta:Gamma Signaling Thru PI3Kgamma R-HSA-392451,-0.2707388982193181,-0.5225968320217017,1.0,1.0,1.0,5/21,26.22%,GNGT1;PIK3CG;GNG13;GNG12;GNG4
prerank,GO_Biological_Process_2021__nuclear membrane reassembly (GO:0031468),0.21976778523701182,0.522563716177744,1.0,1.0,1.0,3/51,9.13%,UBXN2A;CHMP6;SPAST
prerank,GO_Biological_Process_2021__RNA interference (GO:0016246),-0.2590759626187249,-0.5223480200410926,0.9857142857142858,1.0,1.0,1/16,10.71%,TERT
prerank,Reactome_2022__Glycogen Synthesis R-HSA-3322077,0.24738128026713102,0.5221972643420069,0.975,1.0,1.0,2/12,19.80%,GYS1;PGM1
prerank,GO_Biological_Process_2021__mitochondrial cytochrome c oxidase assembly (GO:0033617),-0.28726282590357954,-0.522013803074653,1.0,1.0,1.0,2/16,17.09%,COX17;COX20
prerank,GO_Biological_Process_2021__regulation of hydrogen peroxide-induced cell death (GO:1903205),-0.30392152288479773,-0.5220121959396177,1.0,1.0,1.0,3/10,26.49%,TXN;PARK7;PDE8A
prerank,GO_Biological_Process_2021__histone phosphorylation (GO:0016572),0.2966419636124653,0.5217003431721452,0.9512195121951219,1.0,1.0,3/8,24.44%,RPS6KA4;BAZ1B;PRKCD
prerank,GO_Biological_Process_2021__phospholipid homeostasis (GO:0055091),-0.2970502489372039,-0.521241123688066,1.0,1.0,1.0,3/11,20.93%,ANGPTL3;ABCB11;TLCD1
prerank,GO_Biological_Process_2021__regulation of tumor necrosis factor-mediated signaling pathway (GO:0010803),0.23057356508569943,0.5206996579606172,1.0,1.0,1.0,13/47,24.85%,CFLAR;SHARPIN;NLRP2B;HSPA1A;FADD;CLIP3;ZNF675;CPNE1;LAPTM5;CCDC3;IKBKB;TRAF1;GAS6
prerank,GO_Biological_Process_2021__lymphoid progenitor cell differentiation (GO:0002320),-0.3340694669946097,-0.5205424079040338,0.9838709677419355,1.0,1.0,1/6,10.89%,SPI1
prerank,GO_Biological_Process_2021__cellular response to interleukin-1 (GO:0071347),0.18322289236788028,0.5203753227157495,1.0,1.0,1.0,20/111,20.85%,RIPK2;ADAMTS12;PSME4;PSMA1;PLCB1;TANK;TAB3;PELI1;RPS6KA4;NFKB1;PELI2;IRAK4;GBP2;PTGIS;RC3H1;TAB1;TAB2;TRAF6;HIF1A;PSMD4
prerank,GO_Biological_Process_2021__dosage compensation by inactivation of X chromosome (GO:0009048),-0.2962972003953403,-0.5203601561973518,0.9523809523809523,1.0,1.0,1/12,8.63%,BRCA1
prerank,GO_Biological_Process_2021__negative regulation of ubiquitin-protein transferase activity (GO:0051444),-0.2855731626324491,-0.52017802596389,0.984375,1.0,1.0,6/14,25.54%,RPL5;RPL23;RPS7;RPL11;BAG5;PARK7
prerank,GO_Biological_Process_2021__positive regulation of ER-associated ubiquitin-dependent protein catabolic process (GO:1903071),-0.3252400709773498,-0.518853995336094,0.9622641509433962,1.0,1.0,4/7,37.54%,HERPUD1;CAV1;UBQLN2;BCAP31
prerank,GO_Biological_Process_2021__translational termination (GO:0006415),0.18998656065853722,0.5181334828458074,1.0,1.0,1.0,17/85,28.79%,MRPL4;MRPL41;MRRF;MTRF1;ETF1;DAP3;MRPL2;AURKAIP1;MRPS7;MRPL55;MRPL43;MRPL58;ERAL1;MRPL3;MRPL1;MRPS16;MRPS18A
prerank,GO_Biological_Process_2021__negative regulation of nuclear division (GO:0051784),0.2908795580195376,0.517606547410867,1.0,1.0,1.0,4/10,23.62%,TOM1L2;AURKAIP1;BMP4;DMRT1
prerank,GO_Biological_Process_2021__bone marrow development (GO:0048539),-0.3397433187581422,-0.5173318584902588,0.9615384615384616,1.0,1.0,1/5,10.28%,PTPRC
prerank,GO_Biological_Process_2021__phosphorylation of RNA polymerase II C-terminal domain (GO:0070816),0.31152627037175734,0.5173245061656078,0.9791666666666666,1.0,1.0,2/8,24.91%,CCNH;CDK13
prerank,GO_Biological_Process_2021__regulation of histone deacetylase activity (GO:1901725),-0.3243422297936778,-0.5168541102906768,0.9655172413793104,1.0,1.0,7/7,67.58%,PRKD2;SPHK2;CAMK2D;VEGFA;PRKD1;C6ORF89;KDM5A
prerank,GO_Biological_Process_2021__establishment of endothelial intestinal barrier (GO:0090557),-0.28985155335030344,-0.5166739634253423,0.9649122807017544,1.0,1.0,4/11,31.34%,TJP3;RAB1A;RAP2C;RAPGEF6
prerank,Reactome_2022__Zinc Efflux And Compartmentalization By SLC30 Family R-HSA-435368,0.3141357874677019,0.5166397873204642,1.0,1.0,1.0,3/7,36.17%,SLC30A5;SLC30A8;SLC30A3
prerank,GO_Biological_Process_2021__negative regulation of G0 to G1 transition (GO:0070317),-0.2424889026581118,-0.51638791525139,1.0,1.0,1.0,9/37,25.10%,BRCA1;MAX;FOXO4;RBBP7;L3MBTL2;DUX4;CDC7;CHEK1;APAF1
prerank,GO_Biological_Process_2021__regulation of transforming growth factor beta2 production (GO:0032909),-0.3115409540127889,-0.5162197463055753,0.9473684210526315,1.0,1.0,1/6,16.15%,SMAD3
prerank,GO_Biological_Process_2021__acute-phase response (GO:0006953),0.303633457267282,0.5161313386489351,0.9512195121951219,1.0,1.0,2/8,15.48%,PLSCR1;LBP
prerank,GO_Biological_Process_2021__maintenance of synapse structure (GO:0099558),0.31956228789747787,0.5153729911054898,0.9459459459459459,1.0,1.0,2/7,18.70%,ERC2;ERC1
prerank,GO_Biological_Process_2021__negative regulation of phosphatidylinositol 3-kinase signaling (GO:0014067),-0.3151934213094688,-0.5153318387995205,0.96875,1.0,1.0,3/8,22.70%,NLRC3;NOP53;PIK3IP1
prerank,GO_Biological_Process_2021__internal peptidyl-lysine acetylation (GO:0018393),0.2430360276133387,0.5152350979181296,1.0,1.0,1.0,8/25,28.03%,KAT6A;EP300;KAT2B;KAT6B;BAG6;PHF20L1;CREBBP;CPA4
prerank,GO_Biological_Process_2021__regulation of macrophage differentiation (GO:0045649),0.2838246487523324,0.5144205604607278,0.967741935483871,1.0,1.0,2/11,15.27%,FADD;HSF1
prerank,GO_Biological_Process_2021__cellular response to dsRNA (GO:0071359),-0.2629459586772755,-0.5142579565465611,0.9833333333333333,1.0,1.0,2/16,13.95%,IFIT1;COLEC12
prerank,GO_Biological_Process_2021__endothelial tube morphogenesis (GO:0061154),0.3130439672273846,0.5129132770116874,0.9473684210526315,1.0,1.0,2/8,21.65%,RBPJ;BMP4
prerank,GO_Biological_Process_2021__neutral lipid catabolic process (GO:0046461),0.30341079721804687,0.5128029209823581,0.9464285714285714,1.0,1.0,1/5,21.97%,ABHD12
prerank,GO_Biological_Process_2021__neuroblast proliferation (GO:0007405),0.32435467103222343,0.5127408325378642,0.9772727272727273,1.0,1.0,4/6,40.42%,SHH;EML1;PLXNB2;RACGAP1
prerank,GO_Biological_Process_2021__postsynaptic endocytosis (GO:0140239),-0.33068663398925957,-0.5127018833333101,0.9454545454545454,1.0,1.0,1/5,21.14%,MX1
prerank,GO_Biological_Process_2021__postsynaptic neurotransmitter receptor internalization (GO:0098884),-0.33068663398925957,-0.5127018833333101,0.9454545454545454,1.0,1.0,1/5,21.14%,MX1
prerank,Reactome_2022__AKT Phosphorylates Targets In Cytosol R-HSA-198323,-0.27290912101901715,-0.5126127981366381,0.9852941176470589,1.0,1.0,2/13,22.07%,CDKN1A;CDKN1B
prerank,GO_Biological_Process_2021__proton-transporting ATP synthase complex assembly (GO:0043461),0.31571475890786915,0.5124703931571568,0.9555555555555556,1.0,1.0,6/6,68.44%,ATPAF2;ATPAF1;OXA1L;ATP23;ATP5F1D;TMEM70
prerank,GO_Biological_Process_2021__regulation of non-membrane spanning protein tyrosine kinase activity (GO:1903995),-0.33048477472878696,-0.5113205560249382,0.9833333333333333,1.0,1.0,1/7,16.19%,DUSP22
prerank,GO_Biological_Process_2021__synaptic vesicle budding from presynaptic endocytic zone membrane (GO:0016185),0.29607555120401846,0.5111201274317032,0.9795918367346939,1.0,1.0,3/7,30.95%,SNAP91;DNM2;DNM3
prerank,Reactome_2022__MET Activates PTPN11 R-HSA-8865999,-0.3412708844867991,-0.5100342375391946,0.9516129032258065,1.0,1.0,2/5,25.22%,RNMT;PTPN11
prerank,Reactome_2022__Assembly Of ORC Complex At Origin Of Replication R-HSA-68616,-0.26947503893684177,-0.5098398625870072,1.0,1.0,1.0,2/19,12.66%,H2BC4;H2AZ1
prerank,GO_Biological_Process_2021__regulation of multicellular organismal development (GO:2000026),0.24882460242527293,0.5096636524180567,1.0,1.0,1.0,6/24,21.95%,GFI1B;HPSE;INSR;NIPBL;DUSP6;BAG6
prerank,Reactome_2022__Interleukin-37 Signaling R-HSA-9008059,0.27892353752692006,0.509541344892943,0.9705882352941176,1.0,1.0,5/19,24.19%,PTPN9;PTPN20;PTPN23;PTPN14;PTPN12
prerank,GO_Biological_Process_2021__endocardial cushion development (GO:0003197),-0.28708587532028784,-0.509130341452242,1.0,1.0,1.0,4/12,25.02%,ENG;GATA4;SOX9;HEY1
prerank,Reactome_2022__E3 Ubiquitin Ligases Ubiquitinate Target Proteins R-HSA-8866654,0.20491224295163588,0.5089355315470518,1.0,1.0,1.0,13/48,25.41%,PEX13;RNF152;UBE2E1;UBE2A;SHPRH;UBE2L3;RNF40;UBE2J2;HLTF;UBE2D2;PEX14;BCL10;UBE2D3
prerank,GO_Biological_Process_2021__negative regulation of phagocytosis (GO:0050765),-0.26620339600371146,-0.508778724401591,1.0,1.0,1.0,5/14,28.29%,TLR2;CD300LF;PRTN3;SYT11;RACK1
prerank,GO_Biological_Process_2021__mitotic nuclear membrane organization (GO:0101024),-0.22930815372298813,-0.5085138263290128,1.0,1.0,1.0,11/48,31.95%,CHMP3;CC2D1B;NUP93;SEC13;NDC1;CHMP4B;RAN;VPS4A;NUP133;NUP155;CCNB1
prerank,GO_Biological_Process_2021__mitotic nuclear membrane reassembly (GO:0007084),-0.22930815372298813,-0.5085138263290128,1.0,1.0,1.0,11/48,31.95%,CHMP3;CC2D1B;NUP93;SEC13;NDC1;CHMP4B;RAN;VPS4A;NUP133;NUP155;CCNB1
prerank,GO_Biological_Process_2021__cardiac right ventricle morphogenesis (GO:0003215),0.31056508419798656,0.5077761860506236,0.9761904761904762,1.0,1.0,1/8,5.28%,JAG1
prerank,Reactome_2022__CREB1 Phosphorylation Thru Activation Of Adenylate Cyclase R-HSA-442720,0.2599492520369123,0.5073415141189833,0.95,1.0,1.0,3/11,25.03%,PRKAR2A;CREB1;PRKACB
prerank,GO_Biological_Process_2021__positive regulation of sprouting angiogenesis (GO:1903672),-0.27367891435243064,-0.5072050728845888,1.0,1.0,1.0,3/14,28.14%,ITGA5;FUT1;FGF2
prerank,Reactome_2022__Mitochondrial tRNA Aminoacylation R-HSA-379726,-0.2631674992540972,-0.507126491694139,0.9852941176470589,1.0,1.0,2/19,16.15%,DARS2;YARS2
prerank,GO_Biological_Process_2021__positive regulation of long-term synaptic potentiation (GO:1900273),0.24159803086244414,0.5071197380490707,0.972972972972973,1.0,1.0,13/13,75.86%,EPHB2;EIF2AK4;SHISA7;ZDHHC2;ADCY8;SQSTM1;APP;CHRNA7;LGMN;RELN;AKAP5;SHANK3;ADCY1
prerank,GO_Biological_Process_2021__positive regulation of tissue remodeling (GO:0034105),-0.3151391833608766,-0.5068178603243565,0.9642857142857143,1.0,1.0,2/6,25.80%,IL18;TMBIM1
prerank,GO_Biological_Process_2021__negative regulation of interleukin-8 production (GO:0032717),0.26661181603046785,0.5066194570269661,1.0,1.0,1.0,3/12,14.61%,SSC5D;ARRB1;OTUD7B
prerank,GO_Biological_Process_2021__cellular response to heat (GO:0034605),-0.25170023523781304,-0.5062910773680518,1.0,1.0,1.0,6/31,21.01%,THBS1;RBBP7;IER5;STUB1;SLU7;HSBP1L1
prerank,Reactome_2022__FBXW7 Mutants And NOTCH1 In Cancer R-HSA-2644605,-0.3226777481984102,-0.5062003639143487,0.9672131147540983,1.0,1.0,2/5,25.24%,RBX1;SKP1
prerank,Reactome_2022__Calcitonin-like Ligand Receptors R-HSA-419812,0.31273497132646666,0.5054669186713477,0.926829268292683,1.0,1.0,2/6,29.59%,IAPP;RAMP1
prerank,GO_Biological_Process_2021__positive regulation of necrotic cell death (GO:0010940),-0.3287593451310684,-0.5053207046066152,0.9848484848484849,1.0,1.0,5/5,67.14%,SLC6A6;MT3;RIPK1;SLC6A13;HEBP2
prerank,GO_Biological_Process_2021__histone H3-K4 demethylation (GO:0034720),0.26113293265817983,0.5052975181941222,0.9795918367346939,1.0,1.0,8/8,73.90%,KDM5B;KDM5D;KDM5A;RIOX2;KDM1B;KDM5C;RIOX1;KDM1A
prerank,GO_Biological_Process_2021__peptidyl-glutamic acid modification (GO:0018200),-0.2798140842435767,-0.5052281743003978,1.0,1.0,1.0,4/20,23.60%,AGBL5;TTLL4;GGCX;TPGS1
prerank,GO_Biological_Process_2021__regulation of lymphocyte activation (GO:0051249),-0.2965165335444803,-0.5047368433364097,0.9836065573770492,1.0,1.0,3/10,25.89%,CD4;CRTAM;CCL5
prerank,GO_Biological_Process_2021__cellular response to X-ray (GO:0071481),0.3003095000108534,0.5046981310792105,0.9607843137254902,1.0,1.0,2/5,17.89%,ATM;NIPBL
prerank,"Reactome_2022__Synthesis Of IP2, IP, And Ins In Cytosol R-HSA-1855183",0.25794524916612244,0.504499155970646,0.9777777777777777,1.0,1.0,7/13,33.99%,INPP1;MTMR9;INPP4B;ISYNA1;INPP4A;OCRL;INPP5J
prerank,GO_Biological_Process_2021__positive regulation of glycolytic process (GO:0045821),0.2599551876882124,0.5043287648122475,1.0,1.0,1.0,7/19,21.01%,ZBTB20;MLXIPL;INSR;PFKFB4;PRKAA2;HIF1A;PFKFB3
prerank,GO_Biological_Process_2021__positive regulation of purine nucleotide metabolic process (GO:1900544),0.2599551876882124,0.5043287648122475,1.0,1.0,1.0,7/19,21.01%,ZBTB20;MLXIPL;INSR;PFKFB4;PRKAA2;HIF1A;PFKFB3
prerank,GO_Biological_Process_2021__negative regulation of mitotic nuclear division (GO:0045839),0.2917599982805032,0.5041435191464132,1.0,1.0,1.0,3/8,21.65%,TOM1L2;AURKAIP1;BMP4
prerank,GO_Biological_Process_2021__positive regulation of RNA binding (GO:1905216),0.344010595982495,0.5037373573637192,0.9791666666666666,1.0,1.0,1/5,13.40%,EIF3E
prerank,GO_Biological_Process_2021__positive regulation of attachment of spindle microtubules to kinetochore (GO:0051987),0.3194378726223149,0.5035121475685359,1.0,1.0,1.0,5/5,68.06%,HNRNPU;SIRT2;RCC2;BECN1;CCNB1
prerank,GO_Biological_Process_2021__medium-chain fatty acid biosynthetic process (GO:0051792),0.31544335796801143,0.5033271687719809,0.9487179487179487,1.0,1.0,2/6,15.24%,ABHD3;OXSM
prerank,GO_Biological_Process_2021__positive regulation of homotypic cell-cell adhesion (GO:0034112),-0.319528463500902,-0.5033195513497447,0.9444444444444444,1.0,1.0,2/7,25.89%,PLAUR;CCL5
prerank,GO_Biological_Process_2021__inositol metabolic process (GO:0006020),-0.297937428938038,-0.5032973523910805,0.9655172413793104,1.0,1.0,2/7,20.45%,IMPA2;IMPA1
prerank,GO_Biological_Process_2021__cellular response to exogenous dsRNA (GO:0071360),-0.2673594394430133,-0.5032948047733161,0.9649122807017544,1.0,1.0,2/13,13.95%,IFIT1;COLEC12
prerank,GO_Biological_Process_2021__cardiac atrium development (GO:0003230),-0.3350339331492894,-0.5032364383016843,0.9852941176470589,1.0,1.0,2/6,19.47%,ENG;DAND5
prerank,GO_Biological_Process_2021__positive regulation of endocytic recycling (GO:2001137),-0.3175429463820927,-0.5014954583488634,0.9830508474576272,1.0,1.0,8/8,68.26%,EHD2;AKAP5;PLA2G4E;ACTN2;ZDHHC2;SORL1;EIPR1;EHD1
prerank,GO_Biological_Process_2021__regulation of muscle system process (GO:0090257),-0.3015194837240601,-0.5011171358171486,1.0,1.0,1.0,1/9,18.23%,MYL9
prerank,GO_Biological_Process_2021__neuromuscular process (GO:0050905),-0.29147856249980236,-0.5005371597482322,0.984375,1.0,1.0,1/11,11.15%,DCTN1
prerank,GO_Biological_Process_2021__pentose catabolic process (GO:0019323),-0.3310298996759721,-0.500068349216272,0.9803921568627451,1.0,1.0,2/5,21.68%,DHDH;RPEL1
prerank,GO_Biological_Process_2021__regulation of neurotrophin TRK receptor signaling pathway (GO:0051386),-0.33783270123652526,-0.49840084206876206,0.9464285714285714,1.0,1.0,2/5,18.22%,AGT;NTRK3
prerank,GO_Biological_Process_2021__positive regulation of ligase activity (GO:0051351),0.2851925173145895,0.49836776709673325,0.9761904761904762,1.0,1.0,1/9,12.32%,ATPSCKMT
prerank,GO_Biological_Process_2021__regulation of histamine secretion by mast cell (GO:1903593),-0.30924517131677187,-0.49763145604813913,0.9473684210526315,1.0,1.0,1/5,20.22%,VAMP7
prerank,GO_Biological_Process_2021__positive regulation of calcium ion import (GO:0090280),-0.2929359710251812,-0.4972861982395037,0.967741935483871,1.0,1.0,2/8,27.86%,GRM6;RAMP3
prerank,GO_Biological_Process_2021__response to hydroperoxide (GO:0033194),0.27841811136255334,0.49708083767108935,1.0,1.0,1.0,1/7,7.74%,SP1
prerank,GO_Biological_Process_2021__positive regulation of dendritic cell chemotaxis (GO:2000510),-0.3322315748091288,-0.4961997558472737,0.9583333333333334,1.0,1.0,1/5,14.26%,IL12A
prerank,GO_Biological_Process_2021__Notch receptor processing (GO:0007220),0.2971420829696726,0.4954936308341785,1.0,1.0,1.0,3/7,32.10%,ADAM10;GALNT11;NCSTN
prerank,GO_Biological_Process_2021__regulation of sequestering of zinc ion (GO:0061088),-0.3253051954197028,-0.49454316025288675,0.9807692307692307,1.0,1.0,5/5,67.48%,SLC30A2;SLC30A4;AP3D1;SLC30A3;SLC30A8
prerank,Reactome_2022__APOBEC3G Mediated Resistance To HIV-1 R-HSA-180689,0.3179753056221521,0.49444115727382876,1.0,1.0,1.0,3/6,28.07%,SGIP1;BANF1;PPIA
prerank,GO_Biological_Process_2021__smoothened signaling pathway (GO:0007224),-0.23574968709402058,-0.4943407913650093,1.0,1.0,1.0,4/30,16.07%,TMEM17;IFT27;GLI3;HIPK1
prerank,GO_Biological_Process_2021__rescue of stalled ribosome (GO:0072344),0.30666469074753727,0.493904901689706,0.9607843137254902,1.0,1.0,1/5,22.51%,NEMF
prerank,GO_Biological_Process_2021__regulation of transmission of nerve impulse (GO:0051969),-0.2964284639970377,-0.4938839917123413,0.9583333333333334,1.0,1.0,1/6,13.18%,CARTPT
prerank,Reactome_2022__Triglyceride Metabolism R-HSA-8979227,-0.22362656739794975,-0.4938683090062032,1.0,1.0,1.0,1/29,7.72%,PNPLA4
prerank,Reactome_2022__TP53 Regulates Transcription Of DNA Repair Genes R-HSA-6796648,0.19904850439221636,0.4936988040606834,1.0,1.0,1.0,11/57,26.13%,ELOA;CCNH;GTF2F2;TP53;ATM;ERCC3;MDC1;FOS;POLR2F;CDK13;SSRP1
prerank,GO_Biological_Process_2021__cardiac left ventricle morphogenesis (GO:0003214),-0.28700186217109636,-0.493249481259793,0.9833333333333333,1.0,1.0,1/10,14.16%,HEY2
prerank,Reactome_2022__CTLA4 Inhibitory Signaling R-HSA-389513,0.23530242673929647,0.4928933501135492,1.0,1.0,1.0,9/19,32.89%,AKT2;PPP2R1B;PPP2R5D;AKT3;AKT1;FYN;LCK;PPP2R5B;PPP2R5E
prerank,GO_Biological_Process_2021__positive regulation of granulocyte macrophage colony-stimulating factor production (GO:0032725),-0.30671646694518395,-0.4926002666111222,1.0,1.0,1.0,2/7,15.16%,CD80;IL18
prerank,GO_Biological_Process_2021__regulation of granulocyte macrophage colony-stimulating factor production (GO:0032645),-0.30671646694518395,-0.4926002666111222,1.0,1.0,1.0,2/7,15.16%,CD80;IL18
prerank,GO_Biological_Process_2021__DNA deamination (GO:0045006),0.2956593118435564,0.4923579622642403,0.9487179487179487,1.0,1.0,2/7,28.20%,EXOSC5;CDADC1
prerank,GO_Biological_Process_2021__regulation of cartilage development (GO:0061035),-0.24961116663545896,-0.4921919655983925,1.0,1.0,1.0,4/17,28.20%,SCIN;SOX9;BMP1;PTHLH
prerank,GO_Biological_Process_2021__microtubule nucleation (GO:0007020),0.23258924823059307,0.4921846052358338,1.0,1.0,1.0,5/19,29.79%,AKAP9;TPPP;CCDC57;NDE1;CLASP2
prerank,GO_Biological_Process_2021__regulation of protein neddylation (GO:2000434),-0.285034414048914,-0.4918337857786907,1.0,1.0,1.0,4/9,22.87%,EPAS1;RPL5;RPL11;COPS9
prerank,CellMarker_Augmented_2021__Epidermal Stem cell:Skin,-0.2755405915751495,-0.4902339603120582,0.9824561403508771,1.0,1.0,2/10,24.66%,YAP1;NES
prerank,GO_Biological_Process_2021__protein catabolic process (GO:0030163),-0.2197422369138149,-0.48989268267885827,1.0,1.0,1.0,13/53,26.27%,CEACAM1;PPT1;HSPA8;SIAH1;ELANE;CLN8;LAMP2;TPP1;DDB1;FBXO2;DENND3;CELA2A;PRPF19
prerank,GO_Biological_Process_2021__regulation of mast cell activation (GO:0033003),-0.2853795339681515,-0.48880432035756866,1.0,1.0,1.0,1/8,13.42%,CD300LF
prerank,GO_Biological_Process_2021__positive regulation of cellular extravasation (GO:0002693),-0.2784967245097217,-0.4883885649919731,0.984375,1.0,1.0,1/10,20.84%,AGER
prerank,GO_Biological_Process_2021__negative regulation of heterotypic cell-cell adhesion (GO:0034115),0.2969289736431173,0.48808514859626084,0.9787234042553191,1.0,1.0,6/6,70.32%,WNK1;MAPK7;MBP;MAP2K5;APOA1;MYADM
prerank,GO_Biological_Process_2021__regulation of cell-cell adhesion involved in gastrulation (GO:0070587),0.2969289736431173,0.48808514859626084,0.9787234042553191,1.0,1.0,6/6,70.32%,WNK1;MAPK7;MBP;MAP2K5;APOA1;MYADM
prerank,GO_Biological_Process_2021__regulation of dendritic cell chemotaxis (GO:2000508),-0.3224166720915891,-0.48796162467161924,0.9791666666666666,1.0,1.0,1/6,14.26%,IL12A
prerank,Reactome_2022__Sensing Of DNA Double Strand Breaks R-HSA-5693548,0.2862786472650334,0.487556736717981,0.9428571428571428,1.0,1.0,1/6,16.83%,ATM
prerank,GO_Biological_Process_2021__regulation of transforming growth factor beta activation (GO:1901388),0.30666282445854176,0.48750885973679026,0.9574468085106383,1.0,1.0,1/5,7.55%,LTBP1
prerank,GO_Biological_Process_2021__positive regulation of protein sumoylation (GO:0033235),-0.2898232657114672,-0.4868365845476066,0.9833333333333333,1.0,1.0,1/9,13.35%,GNL3
prerank,GO_Biological_Process_2021__forebrain neuron differentiation (GO:0021879),-0.29751088396744274,-0.48615326599910047,1.0,1.0,1.0,7/7,70.26%,INHBA;SHANK3;LHX6;ERBB4;RAPGEF2;SALL1;ZSWIM6
prerank,GO_Biological_Process_2021__regulation of peptidyl-cysteine S-nitrosylation (GO:2000169),0.30559353033915343,0.48600645039966334,0.9777777777777777,1.0,1.0,2/6,21.57%,ACE;DMD
prerank,GO_Biological_Process_2021__peptide hormone secretion (GO:0030072),0.22567344949835494,0.4851389633210451,1.0,1.0,1.0,3/18,15.09%,CYB5R4;RIMS2;CDK16
prerank,GO_Biological_Process_2021__urogenital system development (GO:0001655),0.2539409613894283,0.48508332290062806,0.95,1.0,1.0,3/10,16.57%,OSR1;AMH;EPHB2
prerank,GO_Biological_Process_2021__synaptic vesicle budding (GO:0070142),0.29604247541926537,0.4846780194924865,1.0,1.0,1.0,3/8,30.95%,SNAP91;DNM2;DNM3
prerank,CellMarker_Augmented_2021__Induced Pluripotent Stem cell:Undefined,-0.24390093144511138,-0.48356744165244714,1.0,1.0,1.0,8/22,28.61%,ABCG2;SMAD3;VSIR;MAF;TPBG;THAP11;L1TD1;KLF5
prerank,KEGG_2021_Human__Arginine biosynthesis,-0.24701551637213937,-0.48355289302201243,1.0,1.0,1.0,3/16,21.18%,ARG2;NOS2;ABHD14A-ACY1
prerank,GO_Biological_Process_2021__regulation of transcription elongation from RNA polymerase II promoter (GO:0034243),0.2399802570482055,0.48269455689720947,1.0,1.0,1.0,9/26,31.96%,RNF168;ZMYND11;BRD4;TCERG1;CDK13;LEO1;CDC73;HNRNPU;EAPP
prerank,GO_Biological_Process_2021__regulation of cell-cell adhesion mediated by cadherin (GO:2000047),-0.24391245902026729,-0.482377486380142,1.0,1.0,1.0,1/17,9.60%,PLG
prerank,GO_Biological_Process_2021__nucleotide-excision repair (GO:0006289),-0.20454294909700835,-0.4820623227355597,1.0,1.0,1.0,17/98,26.27%,RPA3;UVSSA;COPS5;RBX1;POLD4;COPS4;RPS27A;OGG1;RPA2;FANCC;XRCC1;POLR2B;DDB1;COPS7A;CDK7;BRCA2;PRPF19
prerank,Reactome_2022__VxPx Cargo-Targeting To Cilium R-HSA-5620916,-0.24268141240953262,-0.48022466044136636,1.0,1.0,1.0,1/19,5.16%,RAB11A
prerank,GO_Biological_Process_2021__ammonium transmembrane transport (GO:0072488),-0.2905962044583615,-0.48020703263899633,0.9830508474576272,1.0,1.0,4/7,30.17%,RHBG;SLC12A7;RHCE;RHD
prerank,"GO_Biological_Process_2021__positive regulation of protein localization to chromosome, telomeric region (GO:1904816)",-0.27798158414643487,-0.47982190345440456,1.0,1.0,1.0,5/12,29.23%,GNL3;CCT6A;CCT8;CCT7;CCT2
prerank,GO_Biological_Process_2021__positive regulation of establishment of protein localization to telomere (GO:1904851),-0.2834319359792229,-0.47941612292042907,1.0,1.0,1.0,4/10,29.23%,CCT6A;CCT8;CCT7;CCT2
prerank,GO_Biological_Process_2021__response to hydrogen peroxide (GO:0042542),-0.226037406531026,-0.47792368648871125,1.0,1.0,1.0,4/40,17.06%,CYP1B1;ANXA1;ZNF580;ECT2
prerank,GO_Biological_Process_2021__ventricular cardiac muscle cell membrane repolarization (GO:0099625),-0.2879242956958175,-0.47680412345160256,0.9791666666666666,1.0,1.0,1/8,8.12%,KCNQ1
prerank,GO_Biological_Process_2021__positive regulation of translation in response to stress (GO:0032056),-0.296223378906444,-0.47508126966039943,0.9375,1.0,1.0,1/5,14.99%,DDX3X
prerank,Reactome_2022__Negative Feedback Regulation Of MAPK Pathway R-HSA-5674499,0.270199222641184,0.47465100257027515,1.0,1.0,1.0,1/5,17.32%,BRAF
prerank,Reactome_2022__Signaling By FGFR4 In Disease R-HSA-5655291,0.23326975637507436,0.4732078215096035,1.0,1.0,1.0,4/10,30.11%,PIK3CA;SOS1;FRS2;PIGU
prerank,GO_Biological_Process_2021__regulation of protein ADP-ribosylation (GO:0010835),-0.28904451749291715,-0.4711228786949213,0.9791666666666666,1.0,1.0,2/7,22.81%,WARS1;XRCC1
prerank,GO_Biological_Process_2021__membrane fusion (GO:0061025),-0.2334894693052912,-0.4710366330268434,1.0,1.0,1.0,1/32,9.16%,SNAP23
prerank,GO_Biological_Process_2021__regulation of interleukin-5 production (GO:0032674),-0.26662282399332826,-0.47049618382194625,0.9833333333333333,1.0,1.0,1/7,13.80%,LEF1
prerank,GO_Biological_Process_2021__mitochondrial translational termination (GO:0070126),0.17442326643317402,0.4704466658117762,1.0,1.0,1.0,16/79,28.79%,MRPL4;MRPL41;MRRF;MTRF1;DAP3;MRPL2;AURKAIP1;MRPS7;MRPL55;MRPL43;MRPL58;ERAL1;MRPL3;MRPL1;MRPS16;MRPS18A
prerank,GO_Biological_Process_2021__positive regulation of protein exit from endoplasmic reticulum (GO:0070863),-0.2685648960454491,-0.47024825721301544,1.0,1.0,1.0,3/11,29.10%,CD81;TMEM30A;SEC16A
prerank,GO_Biological_Process_2021__negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway (GO:1902236),0.22515555018358002,0.4699749991083873,1.0,1.0,1.0,4/14,27.28%,HSPA1A;CREB3L1;BCL2L1;TXNDC12
prerank,GO_Biological_Process_2021__nucleoside diphosphate metabolic process (GO:0009132),0.23649704142011851,0.4695340923249949,1.0,1.0,1.0,14/14,76.37%,ENTPD2;ENTPD7;AK4;ENTPD6;ENTPD4;CMPK1;AK1;AK7;AK5;ENTPD3;AK8;ENTPD1;CMPK2;ENTPD5
prerank,GO_Biological_Process_2021__mesenchymal to epithelial transition involved in metanephros morphogenesis (GO:0003337),0.29748272925144315,0.4689787086917475,1.0,1.0,1.0,5/5,70.26%,BMP4;SALL1;SMO;PAX8;PAX2
prerank,GO_Biological_Process_2021__chaperone-mediated protein complex assembly (GO:0051131),-0.2466594580906749,-0.4684402111227516,1.0,1.0,1.0,6/19,26.14%,CLU;TMEM35A;HSPA4;PFDN6;HSP90AB1;PSMG1
prerank,GO_Biological_Process_2021__negative regulation of p38MAPK cascade (GO:1903753),0.27497279136894887,0.46798457652750214,0.9574468085106383,1.0,1.0,6/6,72.51%,DLG1;PTPN22;DUSP1;EZR;DUSP10;CYLD
prerank,GO_Biological_Process_2021__negative regulation of organ growth (GO:0046621),-0.30905636236471323,-0.46703593163971135,0.9811320754716981,1.0,1.0,1/5,14.15%,SLC6A4
prerank,GO_Biological_Process_2021__regulation of viral genome replication (GO:0045069),-0.20008990736996934,-0.46538094237338967,1.0,1.0,1.0,13/52,27.72%,OAS2;IFIT1;OAS1;DDX3X;MX1;PARP10;ISG15;SRPK1;DDB1;PPID;CCL5;ISG20;APOBEC3G
prerank,GO_Biological_Process_2021__regulation of histone modification (GO:0031056),0.24971601666035614,0.4652295019666236,1.0,1.0,1.0,11/11,75.04%,MTHFR;MYOCD;SETD5;UBE2N;NNMT;AKAP8L;HPF1;PARG;CDK9;PARK7;AKAP8
prerank,GO_Biological_Process_2021__modulation by host of viral genome replication (GO:0044827),-0.2479438461062743,-0.46307191039401396,0.9841269841269841,1.0,1.0,2/11,20.19%,NUCKS1;IFI27
prerank,"GO_Biological_Process_2021__retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum (GO:0006890)",0.17240262192533176,0.46289358480455695,1.0,1.0,1.0,17/80,25.95%,GBF1;STX18;TMED3;KIF4B;COG7;SEC22B;SCYL1;KIF3B;COG4;TMEM115;PLPP3;COG3;BNIP1;TAPBP;PITPNB;DNAJC28;COPB1
prerank,GO_Biological_Process_2021__oligodendrocyte differentiation (GO:0048709),-0.2608685396476808,-0.46167606200492967,1.0,1.0,1.0,5/20,24.47%,SOX10;EIF2B2;MYRF;SOX9;ZNF488
prerank,GO_Biological_Process_2021__response to hexose (GO:0009746),-0.23232762847474941,-0.4614064523176787,1.0,1.0,1.0,2/19,15.69%,THBS1;EIF2B2
prerank,GO_Biological_Process_2021__regulation of cellular protein catabolic process (GO:1903362),-0.24708835509111088,-0.4610541713633223,1.0,1.0,1.0,5/17,35.87%,MSN;ATRAID;VPS35;AMER1;EZR
prerank,GO_Biological_Process_2021__oxidative DNA demethylation (GO:0035511),0.2946437020914166,0.4609203031475449,1.0,1.0,1.0,5/5,70.54%,ALKBH3;FTO;ALKBH2;ALKBH1;TDG
prerank,GO_Biological_Process_2021__contact inhibition (GO:0060242),-0.27856171808762736,-0.4607396632424289,1.0,1.0,1.0,1/6,16.08%,YAP1
prerank,Reactome_2022__WNT Mediated Activation Of DVL R-HSA-201688,-0.291000283902716,-0.46073286873812025,0.9636363636363636,1.0,1.0,5/5,70.91%,CSNK2A2;DVL3;PIP5K1B;CSNK1E;DVL2
prerank,KEGG_2021_Human__Phenylalanine metabolism,0.22975222241345988,0.4601643632728824,0.9487179487179487,1.0,1.0,3/11,25.08%,IL4I1;AOC3;PAH
prerank,Reactome_2022__CD28 Dependent Vav1 Pathway R-HSA-389359,-0.2633058474284514,-0.45841867372538625,0.9841269841269841,1.0,1.0,5/11,32.43%,CD80;CD86;RNASE1;VAV1;ARHGEF7
prerank,GO_Biological_Process_2021__ammonium transport (GO:0015696),0.2825356149515518,0.4582470451267185,1.0,1.0,1.0,1/6,10.28%,RHCG
prerank,GO_Biological_Process_2021__positive regulation of syncytium formation by plasma membrane fusion (GO:0060143),0.2464145406352063,0.4564041289214268,1.0,1.0,1.0,12/12,75.37%,RAPGEF3;EHD1;MAPK14;ADGRB1;IL4;CAMK1;RIPOR2;CD53;ADAM9;DCSTAMP;EHD2;FLOT1
prerank,GO_Biological_Process_2021__somatic recombination of immunoglobulin gene segments (GO:0016447),0.2667121444319652,0.4561756341539296,0.9782608695652174,1.0,1.0,1/7,16.35%,LIG4
prerank,GO_Biological_Process_2021__aldehyde biosynthetic process (GO:0046184),0.2718127508973971,0.45561018786266005,1.0,1.0,1.0,1/5,22.46%,PNPO
prerank,GO_Biological_Process_2021__positive regulation of peptidyl-lysine acetylation (GO:2000758),-0.23483708421855848,-0.45529553385714094,1.0,1.0,1.0,1/19,8.63%,BRCA1
prerank,Reactome_2022__Triglyceride Biosynthesis R-HSA-75109,-0.25916571799956306,-0.45522347660171264,1.0,1.0,1.0,2/12,22.71%,MOGAT1;GK3
prerank,CellMarker_Augmented_2021__Lung Epithelial cell:Lung,0.2853830502058391,0.4549540919828654,1.0,1.0,1.0,6/6,71.47%,ABCA3;LPCAT1;NAPSA;SFTPC;SLC34A2;SFTPB
prerank,GO_Biological_Process_2021__natural killer cell differentiation (GO:0001779),-0.264053973114005,-0.4549142129509796,0.9807692307692307,1.0,1.0,2/8,18.95%,PTPRC;AXL
prerank,GO_Biological_Process_2021__cellular hyperosmotic response (GO:0071474),0.29147345509605377,0.4541780177941546,1.0,1.0,1.0,5/5,70.86%,AQP1;YBX3;ARHGEF2;AKR1B1;RCSD1
prerank,Reactome_2022__TP53 Regulates Transcription Of Caspase Activators And Caspases R-HSA-6803207,-0.25115727815185007,-0.4540414649166202,0.9827586206896551,1.0,1.0,3/10,25.10%,NLRC4;CASP6;APAF1
prerank,GO_Biological_Process_2021__mitochondrial protein catabolic process (GO:0035694),-0.2965989250212912,-0.4540142595911821,0.9833333333333333,1.0,1.0,2/6,23.60%,SPATA18;BNIP3
prerank,GO_Biological_Process_2021__regulation of fibroblast growth factor receptor signaling pathway (GO:0040036),-0.24137793706818778,-0.4528758093799091,0.984375,1.0,1.0,2/16,19.71%,THBS1;LRIT3
prerank,GO_Biological_Process_2021__negative regulation of keratinocyte proliferation (GO:0010839),0.2813806492968593,0.4525757924693239,0.9795918367346939,1.0,1.0,2/7,21.25%,SNAI2;CASK
prerank,Reactome_2022__MASTL Facilitates Mitotic Progression R-HSA-2465910,0.2563906387015193,0.45149215076649185,0.9782608695652174,1.0,1.0,1/9,11.36%,PPP2R1B
prerank,Reactome_2022__PTK6 Regulates RTKs And Their Effectors AKT1 And DOK1 R-HSA-8849469,-0.26514137887592687,-0.45052122805299566,1.0,1.0,1.0,3/8,31.83%,RPS27A;UBB;UBC
prerank,GO_Biological_Process_2021__negative regulation of lipid kinase activity (GO:0090219),0.2721709042550493,0.44934155839031753,0.9772727272727273,1.0,1.0,2/8,21.39%,PIP4K2A;RUBCN
prerank,GO_Biological_Process_2021__cardiac muscle cell membrane repolarization (GO:0099622),-0.2537529875094921,-0.44829678087687486,1.0,1.0,1.0,1/11,8.12%,KCNQ1
prerank,GO_Biological_Process_2021__regulation of JUN kinase activity (GO:0043506),0.18884760084962476,0.44822186266196706,1.0,1.0,1.0,8/28,29.10%,MAP3K10;ZNF675;DUSP19;TRAF6;AIDA;EDN1;TAOK3;DVL2
prerank,GO_Biological_Process_2021__glycerol metabolic process (GO:0006071),-0.26671284056660477,-0.44746650662716475,1.0,1.0,1.0,3/9,27.00%,ANGPTL3;TKFC;TPI1
prerank,GO_Biological_Process_2021__positive regulation of peroxisome proliferator activated receptor signaling pathway (GO:0035360),-0.30265094763999656,-0.4465132306036453,1.0,1.0,1.0,1/5,18.76%,GPS2
prerank,Reactome_2022__Constitutive Signaling By Ligand-Responsive EGFR Cancer Variants R-HSA-1236382,-0.22806830810743906,-0.4458125645483705,0.9846153846153847,1.0,1.0,2/18,18.03%,CDC37;RPS27A
prerank,GO_Biological_Process_2021__endoplasmic reticulum mannose trimming (GO:1904380),-0.23323172933942105,-0.4453712547750159,1.0,1.0,1.0,6/18,34.61%,RPS27A;MAN1B1;UBB;UBC;SEL1L;TRIM13
prerank,GO_Biological_Process_2021__inositol phosphate dephosphorylation (GO:0046855),0.24176802768799727,0.44191058032753794,0.9811320754716981,1.0,1.0,3/11,26.78%,INPP1;PTEN;SYNJ2
prerank,GO_Biological_Process_2021__phosphorylated carbohydrate dephosphorylation (GO:0046838),0.24176802768799727,0.44191058032753794,0.9811320754716981,1.0,1.0,3/11,26.78%,INPP1;PTEN;SYNJ2
prerank,GO_Biological_Process_2021__endocardial cushion morphogenesis (GO:0003203),0.23343299886466817,0.4414201312539154,0.9705882352941176,1.0,1.0,6/11,25.69%,NOTCH1;ACVR1;MDM4;BMP4;BMPR1A;BMP2
prerank,GO_Biological_Process_2021__positive regulation of mast cell degranulation (GO:0043306),-0.2605881934489433,-0.44140287869476275,0.9538461538461539,1.0,1.0,1/7,20.22%,VAMP7
prerank,GO_Biological_Process_2021__regulation of transforming growth factor beta production (GO:0071634),-0.2313083727532318,-0.44106320777762575,1.0,1.0,1.0,3/15,19.91%,ITGB6;SMAD3;FN1
prerank,GO_Biological_Process_2021__angiotensin-activated signaling pathway (GO:0038166),-0.27821746217876575,-0.4404566848563741,1.0,1.0,1.0,1/6,18.38%,CAMK2A
prerank,GO_Biological_Process_2021__protein mono-ADP-ribosylation (GO:0140289),-0.25214296012159104,-0.43936152114972443,1.0,1.0,1.0,5/12,29.37%,PARP4;PARP10;PARP15;PARP14;PARP9
prerank,GO_Biological_Process_2021__negative regulation of mRNA polyadenylation (GO:1900364),0.23605468258632226,0.439124409289656,1.0,1.0,1.0,2/8,19.39%,ZC3H14;RNF40
prerank,Reactome_2022__Defective HLCS Causes Multiple Carboxylase Deficiency R-HSA-3371599,0.26328759225389814,0.4391078080653927,1.0,1.0,1.0,3/7,24.93%,PCCA;MCCC1;ACACA
prerank,Reactome_2022__Defects In Biotin (Btn) Metabolism R-HSA-3323169,0.26328759225389814,0.4391078080653927,1.0,1.0,1.0,3/7,24.93%,PCCA;MCCC1;ACACA
prerank,GO_Biological_Process_2021__regulation of urine volume (GO:0035809),-0.2643676333867855,-0.4386651105870438,1.0,1.0,1.0,2/6,30.72%,NPR3;TRPV5
prerank,Reactome_2022__Presynaptic Function Of Kainate Receptors R-HSA-500657,-0.24624917285617753,-0.4380197618658865,1.0,1.0,1.0,5/17,26.22%,GNGT1;GNG13;GNG12;PLCB2;GNG4
prerank,GO_Biological_Process_2021__glyoxylate metabolic process (GO:0046487),0.2834295602075349,0.437925272237741,1.0,1.0,1.0,2/6,22.00%,AGXT2;ALDH4A1
prerank,GO_Biological_Process_2021__glycerol ether metabolic process (GO:0006662),-0.2894861360840352,-0.4368466192187337,1.0,1.0,1.0,5/5,71.06%,LIPE;PLAAT3;AGMO;TMEM86B;NCEH1
prerank,GO_Biological_Process_2021__regulation of T cell apoptotic process (GO:0070232),0.27199669461255244,0.43629550750412044,0.9444444444444444,1.0,1.0,1/7,17.42%,LGALS3
prerank,CellMarker_Augmented_2021__Primordial Germ cell:Undefined,0.2200236686390532,0.4349002025119791,1.0,1.0,1.0,14/14,78.01%,POU2F1;SMAD5;SMAD4;ITGA6;PUM2;SMAD1;PRDM14;CCNA2;IFITM3;SLC2A3;POU5F1;DDX4;EPCAM;PRDM1
prerank,Reactome_2022__G-protein Beta:Gamma Signaling R-HSA-397795,0.19157011082618094,0.4344380875034071,1.0,1.0,1.0,4/28,18.04%,PLCB1;AKT2;GNG7;PIK3R5
prerank,GO_Biological_Process_2021__histone H2B ubiquitination (GO:0033523),0.23655317815987661,0.4328817286062548,1.0,1.0,1.0,2/9,19.39%,UBE2E1;RNF40
prerank,Reactome_2022__Spry Regulation Of FGF Signaling R-HSA-1295596,-0.23632590053720046,-0.42856868519912167,1.0,1.0,1.0,5/15,31.83%,RPS27A;PTPN11;UBB;MAPK3;UBC
prerank,Reactome_2022__Trafficking Of GluR2-containing AMPA Receptors R-HSA-416993,-0.22151727238335933,-0.4268560293583612,1.0,1.0,1.0,1/16,15.22%,TSPAN7
prerank,GO_Biological_Process_2021__positive regulation of cell-cell adhesion mediated by cadherin (GO:2000049),-0.26140450501608936,-0.42672152722308176,1.0,1.0,1.0,7/7,73.87%,FLOT1;ADAM19;PTPRU;SERPINF2;TJP1;DENND6A;AFDN
prerank,Reactome_2022__Mitochondrial Translation Elongation R-HSA-5389840,-0.18344935826932876,-0.42670580262091046,1.0,1.0,1.0,12/73,28.47%,MRPL19;MRPL40;MRPS34;MRPL20;MRPL34;MRPS22;MRPS25;MRPS26;MRPS2;GADD45GIP1;MRPL50;MRPL21
prerank,Reactome_2022__MAP3K8 (TPL2)-dependent MAPK1/3 Activation R-HSA-5684264,-0.2221252935751949,-0.4264411257792206,1.0,1.0,1.0,6/16,31.83%,RPS27A;MAP2K1;SKP1;TNIP2;UBB;UBC
prerank,GO_Biological_Process_2021__vacuole organization (GO:0007033),-0.2727487815265225,-0.4260526638161871,0.9661016949152542,1.0,1.0,6/6,72.74%,VPS18;VPS4A;NDP;VPS11;ATP13A2;ULK3
prerank,GO_Biological_Process_2021__response to prostaglandin E (GO:0034695),0.2420499716070414,0.4240873534446644,1.0,1.0,1.0,7/7,75.80%,ADCY6;TGFBR3;GNG2;GNB1;PTGER2;TNFSF4;SFRP1
prerank,GO_Biological_Process_2021__diacylglycerol biosynthetic process (GO:0006651),0.24547359324294543,0.42396291260097774,0.9787234042553191,1.0,1.0,1/7,15.41%,PLA2G15
prerank,GO_Biological_Process_2021__cytidine to uridine editing (GO:0016554),0.2771968012113757,0.42372246838954714,1.0,1.0,1.0,6/6,72.29%,APOBEC1;APOBEC3A;APOBEC2;APOBEC3H;A1CF;APOBEC3G
prerank,Reactome_2022__Mitochondrial Translation Initiation R-HSA-5368286,-0.18214229026950127,-0.42334010761553104,1.0,1.0,1.0,12/73,28.47%,MRPL19;MRPL40;MRPS34;MRPL20;MRPL34;MRPS22;MRPS25;MRPS26;MRPS2;GADD45GIP1;MRPL50;MRPL21
prerank,GO_Biological_Process_2021__regulation of mRNA 3'-end processing (GO:0031440),-0.2401232260533387,-0.42296299814455135,1.0,1.0,1.0,2/11,24.17%,ZFP36L1;PAF1
prerank,Reactome_2022__FLT3 Signaling By CBL Mutants R-HSA-9706377,0.2452844493213373,0.42034575834633964,1.0,1.0,1.0,2/6,23.99%,FLT3;CBL
prerank,GO_Biological_Process_2021__negative regulation of tubulin deacetylation (GO:1904428),-0.2839615776939226,-0.42021797016770496,1.0,1.0,1.0,1/5,17.78%,BEX4
prerank,GO_Biological_Process_2021__negative regulation of membrane potential (GO:0045837),0.2360039752023092,0.4156930660146071,1.0,1.0,1.0,8/8,76.41%,RNF122;HEBP2;MAPT;PIP5KL1;BAX;PRELID1;ARL6IP5;BNIP3
prerank,GO_Biological_Process_2021__nuclear pore organization (GO:0006999),-0.22342137650288743,-0.415126964183209,1.0,1.0,1.0,13/13,77.68%,NUP93;NDC1;NUP133;RTN4;NUP35;NUP107;AHCTF1;NUP205;NUP54;NUP98;NUP153;SEH1L;TPR
prerank,"GO_Biological_Process_2021__regulation of DNA-templated transcription, elongation (GO:0032784)",0.19478521062758444,0.41418946259006884,1.0,1.0,1.0,7/24,34.38%,ZMYND11;THOC1;HMGN1;SCAF8;CCNT1;ALYREF;SETD5
prerank,GO_Biological_Process_2021__regulation of glomerular mesangial cell proliferation (GO:0072124),0.2546607362543768,0.41359901735400073,1.0,1.0,1.0,5/5,74.54%,BMP4;PDGFB;BMP7;PDGFA;IL6R
prerank,"GO_Biological_Process_2021__Notch receptor processing, ligand-dependent (GO:0035333)",0.2567078342757301,0.41321945371505275,0.975609756097561,1.0,1.0,1/5,18.66%,ADAM10
prerank,GO_Biological_Process_2021__mesenchymal to epithelial transition (GO:0060231),-0.2552424643330187,-0.41177834383682554,1.0,1.0,1.0,3/6,31.28%,BASP1;PAX2;PAX8
prerank,GO_Biological_Process_2021__negative regulation of mRNA 3'-end processing (GO:0031441),0.21962463190517195,0.41045310031903937,1.0,1.0,1.0,2/9,19.39%,ZC3H14;RNF40
prerank,Reactome_2022__Activated NTRK2 Signals Thru CDK5 R-HSA-9032845,-0.26839606412045025,-0.40942522273450205,1.0,1.0,1.0,2/5,26.02%,CDK5R1;RNASE1
prerank,GO_Biological_Process_2021__negative regulation of hydrogen peroxide-induced cell death (GO:1903206),-0.2314311972266659,-0.4087829946280228,1.0,1.0,1.0,4/12,28.29%,TXN;PARK7;PDE8A;RACK1
prerank,GO_Biological_Process_2021__tRNA threonylcarbamoyladenosine metabolic process (GO:0070525),0.27145831361786676,0.40855266063873347,0.9795918367346939,1.0,1.0,5/5,72.86%,TPRKB;TRIT1;TP53RK;OSGEP;LAGE3
prerank,Reactome_2022__Adenylate Cyclase Activating Pathway R-HSA-170660,-0.24510341493671364,-0.407639878137423,1.0,1.0,1.0,3/8,24.15%,ADCY7;GNAL;ADCY1
prerank,GO_Biological_Process_2021__mitotic chromosome condensation (GO:0007076),0.2125281696953309,0.40654208357095345,1.0,1.0,1.0,1/24,4.60%,TENT4A
prerank,Reactome_2022__Activation Of AMPK Downstream Of NMDARs R-HSA-9619483,-0.24481235456313397,-0.40645904617471573,1.0,1.0,1.0,2/8,24.63%,CALM1;CAMKK2
prerank,GO_Biological_Process_2021__negative regulation of protein polyubiquitination (GO:1902915),-0.2721916175250665,-0.40316606192954396,0.9803921568627451,1.0,1.0,2/5,21.48%,GPS2;PARP10
prerank,GO_Biological_Process_2021__ATF6-mediated unfolded protein response (GO:0036500),-0.2347765244844468,-0.40103275153992224,0.9848484848484849,1.0,1.0,4/9,36.97%,HSPA5;MBTPS2;MBTPS1;HSP90B1
prerank,GO_Biological_Process_2021__regulation of systemic arterial blood pressure by hormone (GO:0001990),0.23195919974899867,0.3999378247575904,1.0,1.0,1.0,3/8,30.60%,ACE;EDN1;EDN3
prerank,GO_Biological_Process_2021__respiratory chain complex IV assembly (GO:0008535),-0.20292880783534006,-0.3950433739204972,1.0,1.0,1.0,2/18,17.09%,COX17;COX20
prerank,Reactome_2022__ER Quality Control Compartment (ERQC) R-HSA-901032,0.1855753366339663,0.3948488411696662,1.0,1.0,1.0,3/20,20.56%,RNF185;EDEM1;RNF139
prerank,GO_Biological_Process_2021__cellular response to acidic pH (GO:0071468),-0.24410720848454742,-0.39453894574974335,1.0,1.0,1.0,2/9,20.24%,NOX1;PKD1L3
prerank,GO_Biological_Process_2021__positive regulation of mRNA binding (GO:1902416),0.25588977797192847,0.393767052786384,1.0,1.0,1.0,1/6,13.40%,EIF3E
prerank,Reactome_2022__VLDLR Internalisation And Degradation R-HSA-8866427,-0.22318864216203518,-0.3919895254273011,1.0,1.0,1.0,7/15,37.12%,RPS27A;UBB;UBC;AP2A2;CLTA;AP2S1;VLDLR
prerank,GO_Biological_Process_2021__leucine catabolic process (GO:0006552),-0.25769813428938704,-0.3909578845808496,0.9821428571428571,1.0,1.0,1/5,17.91%,MCCC2
prerank,GO_Biological_Process_2021__DNA double-strand break processing (GO:0000729),-0.21828370562095878,-0.39077314242966354,1.0,1.0,1.0,1/18,8.63%,BRCA1
prerank,GO_Biological_Process_2021__nuclear pore complex assembly (GO:0051292),-0.22928232066812612,-0.3892436014967883,1.0,1.0,1.0,3/9,30.60%,NUP93;NDC1;RTN4
prerank,GO_Biological_Process_2021__mitochondrion-endoplasmic reticulum membrane tethering (GO:1990456),0.24771773680383946,0.38785597046544246,1.0,1.0,1.0,3/6,29.41%,PDZD8;VMP1;PACS2
prerank,Reactome_2022__Early Phase Of HIV Life Cycle R-HSA-162594,-0.21768390978677382,-0.385915044233356,1.0,1.0,1.0,3/12,26.40%,CD4;HMGA1;XRCC6
prerank,GO_Biological_Process_2021__translational elongation (GO:0006414),0.14713353636295134,0.38575593895964894,1.0,1.0,1.0,18/93,28.79%,MRPL4;EEFSEC;MRPL41;EEF2K;DAP3;MRPL2;AURKAIP1;EEF1D;MRPS7;NEMF;MRPL55;MRPL43;MRPL58;ERAL1;MRPL3;MRPL1;MRPS16;MRPS18A
prerank,GO_Biological_Process_2021__alditol metabolic process (GO:0019400),-0.2620294032691535,-0.3846032341003362,1.0,1.0,1.0,1/5,16.59%,ANGPTL3
prerank,Reactome_2022__Phosphate Bond Hydrolysis By NTPDase Proteins R-HSA-8850843,0.23641870149536262,0.3833597987522225,1.0,1.0,1.0,7/7,76.37%,ENTPD2;ENTPD7;ENTPD6;ENTPD4;ENTPD3;ENTPD1;ENTPD5
prerank,Reactome_2022__Mitochondrial Translation Termination R-HSA-5419276,-0.16506208890780866,-0.38238063391026694,1.0,1.0,1.0,13/73,28.69%,MRPL19;MRPL40;MRPS34;MRPL20;MRPL34;MRPS22;MRPS25;MRPS26;MRPS2;GADD45GIP1;MRPL50;MRPL21;GFM2
prerank,Reactome_2022__Noncanonical Activation Of NOTCH3 R-HSA-9017802,-0.2483793119765296,-0.37993269070811014,1.0,1.0,1.0,6/6,75.17%,APH1A;APH1B;PSEN1;NOTCH3;NCSTN;YBX1
prerank,GO_Biological_Process_2021__inositol phosphate catabolic process (GO:0071545),0.2062160712518659,0.3769029797500996,1.0,1.0,1.0,1/12,9.52%,INPP1
prerank,GO_Biological_Process_2021__polyadenylation-dependent snoRNA 3'-end processing (GO:0071051),0.22135995835896471,0.37216732663865787,1.0,0.9999761468306154,1.0,6/6,77.87%,EXOSC5;EXOSC10;PARN;EXOSC4;EXOSC6;EXOSC2
prerank,GO_Biological_Process_2021__replication-born double-strand break repair via sister chromatid exchange (GO:1990414),0.22807930724459372,0.3708302609798176,1.0,0.99982038920174,1.0,6/6,77.20%,NIPBL;RAD21L1;REC8;RAD21;FANCB;XRCC1
prerank,Reactome_2022__Mitochondrial Translation R-HSA-5368287,-0.15536737134268938,-0.36862843614551133,1.0,1.0,1.0,13/79,28.69%,MRPL19;MRPL40;MRPS34;MRPL20;MRPL34;MRPS22;MRPS25;MRPS26;MRPS2;GADD45GIP1;MRPL50;MRPL21;GFM2
prerank,GO_Biological_Process_2021__mitochondrial translational elongation (GO:0070125),-0.15397660154847986,-0.36735301265891407,1.0,1.0,1.0,13/79,28.69%,MRPL19;MRPL40;MRPS34;MRPL20;MRPL34;MRPS22;MRPS25;MRPS26;MRPS2;GADD45GIP1;MRPL50;MRPL21;GFM2
prerank,GO_Biological_Process_2021__positive regulation of voltage-gated potassium channel activity (GO:1903818),-0.21965866475086995,-0.366667489698208,0.9818181818181818,1.0,1.0,2/8,22.92%,ALG10B;LRRC38
prerank,GO_Biological_Process_2021__nucleoside phosphate catabolic process (GO:1901292),-0.19662974533749883,-0.36415797053803084,1.0,0.9999378797702357,1.0,13/13,80.35%,NUDT15;ENTPD5;ENTPD1;ENTPD3;ENPP3;ENTPD4;ENTPD6;DCTPP1;ENTPD7;ITPA;ENPP1;SMPDL3A;ENTPD2
prerank,GO_Biological_Process_2021__regulation of mitotic sister chromatid separation (GO:0010965),0.18650887573964503,0.36231264202377017,1.0,0.9997656150813674,1.0,14/14,81.36%,ANAPC7;TPR;PLK1;HECW2;CDC16;CENPE;RIOK2;CDC23;CDC27;NEK6;ANAPC1;TACC3;PTTG1;CDC6
prerank,Reactome_2022__MET Activates RAS Signaling R-HSA-8851805,-0.22158364019160826,-0.3615856716891821,1.0,0.9997279695043215,1.0,1/9,19.55%,RNMT
